tag_chrom,trait_reported,count
X,"""Type 2 diabetes, definitions combined""",1476
X,Mean corpuscular hemoglobin,9335
X,"""Sleep apnoea, including avohilmo""",2785
X,malignant neoplasm of male genital organs,656
X,LDL cholesterol,61
X,Temporomandibular joint disorder [Hispanic],10
X,Serum total protein level,75
X,Hypertensive diseases,28
X,Delayed reward discounting,124
X,Tuberculosis (SNP x SNP interaction),64
X,Male-pattern baldness,3808
X,Malignant neoplasm of prostate,640
X,Hypertensive diseases (excluding secondary),367
X,Gonarthrosis,44
X,Leiomyoma of uterus (controls excluding all cancers),155
X,Other follicular disorders,10
X,Other and unspecified immunodeficiencies with predominantly antibody defects,2
X,Parkinson's disease (more control exclusions),7
X,Parkinson's disease,7
X,"""Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified""",38
X,Other enthesopathies,10
X,"""Viral haemorrhagic fevers, not elsewhere classified/unspecified""",13
X,Antihypertensive medication - note that there are other indications,621
X,"Red blood cell traits [Hgb, AA]",2353
X,"""Endocrine, nutritional and metabolic diseases""",78
X,Ischemic heart diseases,270
X,Calcium levels,12
X,"Red blood cell traits [MCV, AA]",2353
X,Serum uric acid levels,22
X,Uterine fibroids,229
X,"""Type 2 diabetes, strict (exclude DM1)""",1477
X,Benign neoplasm: Adrenal gland (controls excluding all cancers),1106
X,Soft tissue disorders,136
X,Chronic pancreatitis,59
X,Body mass index,11
X,Alcohol-induced chronic pancreatitis,59
X,"""Mental and behavioural disorders due to alcohol, excluding acute intoxication""",52
X,Statin medication,1922
X,Systemic atrophies primarly affecting the central nervous system,421
X,Hemoglobin,3231
X,Other Chron's disease,131
X,3-hydroxy-1-methylpropylmercapturic acid levels in smokers [AA],165
X,Triglycerides [EA],11
X,Complications of labour and delivery,1
X,"""Diabetes, varying definitions""",825
X,Type 2 diabetes,1600
X,"""Hypothyroidism, strict autoimmune""",42
X,Rheumatoid arthritis,696
X,Chron's disease NAS,10
X,Other  prurigo,5
X,Benign neoplasm: Adrenal gland,1077
X,"""Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)""",44
X,Sleep apnoea,2877
X,Serum albumin levels,2442
X,Pure hypercholesterolaemia,1643
X,Vitiligo,9
X,Serum creatinine levels,2
X,"""Malignant neoplasm of kidney, except renal pelvis (controls excluding all cancers)""",99
X,Leiomyoma of uterus,284
X,Entropion and trichiasis of eyelid,33
X,Graves' disease,108
X,"""Parkinson's disease, strict definition""",7
X,Immune reponse to smallpox (secreted IFN-alpha) [AA],4
X,Red cell distribution width,12300
X,Renal failure,744
X,Rheumatoid arthritis [East Asian],332
X,"""Parkinson's disease, including avohilmo""",7
X,Inguinal hernia,69
X,Systolic blood pressure,40
X,Total cholesterol levels [EA],11
X,Serum alkaline phosphatase levels,739
X,Myopia (age of diagnosis),8
X,Serum levels of protein MNX1,7
X,Type 2 diabetes without complications,150
X,Coronary atherosclerosis,270
X,Disorders of lipoprotein metabolism and other lipidaemias,1619
X,Diabetes mellitus,818
X,3-hydroxy-1-methylpropylmercapturic acid levels in smokers [Native Hawaiian],35
X,malignant neoplasm of male genital organs (controls excluding all cancers),911
X,"""Gonarthrosis,primary""",67
X,Symptoms and signs involving the digestive system and abdomen,15
X,"""Artrosis, including avohilmo""",69
X,"""Diabetes, insuline treatment (Kela reimbursement)""",948
X,Birth weight,186
X,Total cholesterol levels,418
X,"""Ischaemic heart disease, wide definition""",270
X,Gonarthrosis [arthrosis of knee](FG),44
X,Red blood cell count,6888
X,Arthrosis,83
X,Hernia,22
X,Finngen Rheumatological endpoints,69
X,"""Other diabetes, wide definition""",854
X,Diseases of liver,69
X,Adolescent idiopathic scoliosis,696
X,"Red blood cell traits [Ht, AA]",2353
X,Certain disorders involving the immune mechanism,1
X,Hemoglobin A1c levels,41
X,Low density lipoprotein cholesterol levels,11
X,Prostate cancer,837
X,Height,579
X,"""Type 2 diabetes, definitions combined, including avohilmo""",1620
X,Other infiltrative disorders of skin and subcutaneous tissue,91
X,Fibromyalgia,27
X,"""Organic, including symptomatic, mental disorders""",13
X,"""Type 2 diabetes, wide definition""",114
X,Mitochondrial DNA copy number,87
X,Varicose veins,576
X,"""Diabetes, insuline treatment (Kela reimbursement) (more control exclusions)""",828
X,"""Hypertension, essential""",2
X,Other osteochondropathies,67
X,Other and unspecified spinal muscular atrophies,506
X,Acohol-induced acute pancreatitis,59
X,Abnormal findings in secretions and smears from cervix uteri vagina vulva,305
X,Type 2 diabetes with other specified/multiple/unspecified complications,1697
X,"""Gonarthrosis, primary, with knee surgery""",55
X,Weight,3
X,Diarrhoea in darapladib-treated cardiovascular disease (time to event),2368
X,"""Malignant neoplasm of kidney, except renal pelvis""",112
X,Glycated hemoglobin levels,6993
X,Low density lipoprotein cholesterol levels [EA],11
X,"""Thrombocytopenia, unspecified""",66
X,Mean corpuscular volume [AA],2971
X,Triglycerides,11
X,"Hematology traits [AA, RBC]",2971
X,Hyperplasia of prostate,1619
X,Hematocrit,3231
X,Malignant neoplasm of prostate (controls excluding all cancers),665
X,"""Primary gonarthrosis, bilateral""",58
X,Mean corpuscular volume,6395
X,Hypertension,28
X,Glaucoma,71
X,Abdominal and pelvic pain,323
X,Acute pancreatitis,127
1,Plays computer games,9048
1,Dysmenorrheic pain severity,181
1,Electrocardiogram morphology (amplitude at temporal datapoints) [76 ms],1560
1,Asthma onset (childhood vs adult),363
1,Serum C-reactive protein concentration in obesity,114
1,Myocardial fractal dimension (slice 7),49
1,Protein quantitative trait loci (liver) [C4B],30
1,"None of the above | medication for cholesterol, blood pressure or diabetes",31661
1,Serum levels of protein CLGN,815
1,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test) [African],1183
1,"""Other diabetes, wide definition""",3644
1,LDL cholesterol levels [BMI unadjusted],1786
1,3-methoxytyramine sulfate levels,1953
1,CD3 on HLA DR+ T cell,1537
1,Parkinson's disease or first degree relation to individual with Parkinson's disease,23293
1,Serum metabolite levels (CMS) [M_HDL_P],23256
1,Disorders of the thyroid gland,5042
1,Hair shape,2733
1,Optic disc parameters,200
1,Number of older siblings,16
1,Triglyceride levels [BMI unadjusted],23950
1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],70737
1,Verbal-numerical reasoning,19173
1,Neurological blood protein biomarker levels [CTSS],95641
1,Yes | hearing difficulty/problems,66632
1,"Blood protein levels [PRDX6, 5018_68_1]",18994
1,Electrocardiogram morphology (amplitude at temporal datapoints) [38 ms],2793
1,Protein quantitative trait loci [CNTN2],3375
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-476 ms],423
1,"Blood protein levels [EA, Cathepsin S]",85893
1,Electrocardiogram morphology (amplitude at temporal datapoints) [354 ms],3694
1,"""Excessive, freguent and irrelgular menstruation""",111
1,Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS)),5039
1,Protein quantitative trait loci (liver) [CNN2],62
1,Pulse pressure x alcohol consumption interaction (2df test) [EA],2475
1,Bone mineral density (total hip),117
1,Hyperinsulinemia in obesity,361
1,Serum levels of protein C17orf78,203
1,Other embolism and thrombosis,77
1,Electrocardiographic conduction measures [QRS duration - CHARGE],102
1,Malignant neoplasm of pancreas (controls excluding all cancers),15
1,Age at first sexual intercourse,98286
1,Urinary metabolite levels in chronic kidney disease [4-guanidinobutanoate],22430
1,Electrocardiogram morphology (amplitude at temporal datapoints) [154 ms],6158
1,Coronary heart disease,6113
1,Narcolepsy,545
1,Type 1 diabetes and autoimmune thyroid diseases,1146
1,LDL cholesterol levels in current drinkers [AA],2027
1,Ulcerative rectosigmoiditis,1269
1,Phlebitis and thrombophlebitis (not including DVT),22
1,Hemoglobin A1c levels,389471
1,Migraine and/or diastolic blood pressure,13710
1,"Blood protein levels [B3GALT6, 7981_230_3]",33901
1,Lymphocyte count,15830
1,Fibrinogen,2721
1,ADHD vs autism spectrum disorder (ordinary least squares (OLS)),13706
1,Frequency of tiredness / lethargy in last 2 weeks,2779
1,Facial morphology (columella inclination),145
1,Serum levels of protein MINPP1,1191
1,Enterococcus abundance in stool,237
1,6mm asymmetry angle (left),42
1,Microalbuminuria,360
1,Myeloid white cell count,120296
1,Inflammatory skin disease [Opposed],28016
1,Serum creatinine levels,165607
1,Fish oil (including cod liver oil) | mineral and other dietary supplements,2318
1,"Intra-ocular pressure, goldmann-correlated (right)",11638
1,Extremely high intelligence,5976
1,G_Alistipes abundance,2555
1,IgD- CD38+ B cell %B cell,287
1,Anorexia nervosa,66
1,Protein quantitative trait loci (liver) [IGKC],2
1,"Blood protein levels [EA, Catalase]",2027
1,Plasma factor V levels in venous thrombosis,2594
1,Plasmacytoid Dendritic Cell %Dendritic Cell,9156
1,Glaucoma (primary angle closure),500
1,Usual walking pace,2628
1,Mortality after unrelated donor allogeneic hematopoietic cell transplantation (donor-recipient mismatch),79
1,Interleukin-6 levels in HIV infection [AA],64
1,CCR2 on monocyte,1072
1,Breast size,3085
1,Pediatric asthma,749
1,Sortilin levels (ELISA),2027
1,Autism spectrum disorder or schizophrenia,12105
1,Electrocardiogram morphology (amplitude at temporal datapoints) [70 ms],1560
1,Macular thickness,7990
1,Plasma proprotein convertase subtilisin/kexin type 9 levels in stable coronary artery disease [statin-free],176
1,Serum levels of protein PLA2G12B,1923
1,Left parahippocampal gyrus cortical thickness [EA],110
1,Serum levels of protein CXCL6,113
1,Time spent doing light physical activity,63
1,Morbidity-free survival,258
1,Megasphaera elsdenii abundance in stool,152
1,Femur bone mineral density x serum urate levels interaction,10783
1,Folate pathway vitamin levels [Plasma homocysteine],10768
1,Waist circumference [EA],5388
1,N-terminal pro B-type natriuretic peptide levels [Conditional],2876
1,CD62L on monocyte,11373
1,"Blood protein levels [PPT1, 9244_27_3]",5968
1,Electrocardiogram morphology (amplitude at temporal datapoints) [266 ms],758
1,Fasting plasma glucose,767
1,Protein quantitative trait loci (liver) [ATOX1],617
1,Protein quantitative trait loci (liver) [LAMP2],430
1,Folding of antihelix,26
1,Adolescent idiopathic scoliosis,62981
1,Cancer,7885
1,Serum levels of protein SULT1B1,4060
1,"Blood protein levels [CFHR5, 3666_17_4]",15567
1,Electrocardiogram morphology (amplitude at temporal datapoints) [30 ms],29621
1,PDL-1 on CD14- CD16+ monocyte,8728
1,Serum levels of protein S100A4,7430
1,Glycated haemoglobin HbA1c levels adjusted for BMI,2714
1,Lumbar spine bone mineral density (trabecular),1822
1,Bone mineral density (hip),2602
1,Facial morphology (segment 13),396
1,"Blood protein levels [NEGR1, 7050_5_3]",1108
1,Circulatory disease nec,68
1,Serum levels of protein AMY2B,398
1,Body mass index (joint analysis main effects and smoking interaction) [men],602
1,Fatty acid(16:1)_[M-H]1- levels,1
1,Temperament (bipolar disorder) [Irritable],8104
1,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 measurement",17550
1,"Body mass index [EA, women]",5513
1,Complement C3 and C4 levels [Serum level of C3],2115
1,Chymotrypsin C levels,161
1,"Pneumothorax | non-cancer illness code, self-reported",2406
1,Headache [allelic],415
1,Biomedical quantitative traits [pulse rate],6129
1,IgE levels,3318
1,Serum metabolite ratios in chronic kidney disease [Decanoylcarnitine/Tetradecenoylcarnitine],52432
1,"Blood protein levels [PPIE, 5238_26_3]",8433
1,"Hypothyroidism/myxoedema | non-cancer illness code, self-reported",56263
1,Isobutyrylcarnitine (c4) levels,3726
1,Electrocardiogram morphology (amplitude at temporal datapoints) [170 ms],15390
1,Leukocyte telomere length,3224
1,Anxiety,1598
1,Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis),6941
1,Leiomyoma of uterus,1345
1,"Large bowel cancer/colorectal cancer | cancer code, self-reported",359
1,Processed meat consumption,32
1,Schizophrenia or schizoaffective disorder,4
1,Colon polyp,5484
1,6mm weak meridian (right),38045
1,Malignant neoplasm of skin,17898
1,C4b binding protein levels [%a7b0],1468
1,Electrocardiogram morphology (amplitude at temporal datapoints) [84 ms],7916
1,"""Coxarthrosis, primary, with hip surgery""",2015
1,"Blood protein levels [EA, Chitotriosidase-1]",1000
1,Seronegative rheumatoid arthritis,178
1,Unspecified urinary incontinence,206
1,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant III (Mandible), Segment 6]",287
1,"""Type 1 diabetes, strict (exclude DM2)""",178
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-62 ms],86
1,"Blood protein levels [NTNG1, 5637_81_3]",154
1,Carotid Intima-media thickness (mean of the maximum cIMT),31
1,Precentral gyrus volume,2
1,Breast cancer (estrogen-receptor negative),19911
1,Acylcarnitine levels [Decenoylcarnitine],52776
1,Blood glucose levels,32075
1,Serum metabolite levels [decanoylcarnitine],157506
1,Word interpolation | fi3 ,14427
1,Serum metabolite levels (CMS) [L_LDL_C],1923
1,Electrocardiogram morphology (amplitude at temporal datapoints) [342 ms],4890
1,Serum levels of protein ST6GALNAC2,6106
1,Addison's disease,178
1,"Sphingomyelin (d18:2/16:0, d18:1/16:1) levels",911
1,Gluten-free | type of special diet followed,231
1,Dessert consumers,25
1,Disorders of lipoid metabolism,25649
1,Lymphocyte counts,1475977
1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),23270
1,"Blood protein levels [CFHR4, 6471_53_3]",20498
1,Whole body fat-free mass,245437
1,Cataracts [female],5542
1,"Blood protein levels [EFCAB14, 9514_46_3]",14018
1,Urinary metabolite levels in chronic kidney disease [glucuronide of C10H18O2 (12],6741
1,Current | smoking status,4531
1,Ascending aorta maximum area,2874
1,Urinary metabolite levels in chronic kidney disease [phosphoethanolamine],38
1,"""Chronic myeloid leukaemia [CML], BCR/ABL-positive""",35
1,Feeling worry,10697
1,Serum levels of protein INPP5B,7321
1,Body mass index [EA],8450
1,Complement component C8 gamma chain measurement,6937
1,Acne,236
1,Serum levels of protein CXCL5,113
1,Brain region volumes [left inferior parietal],28
1,Venous thromboembolism,12591
1,"Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",20043
1,Serum levels of protein ZAP70,12212
1,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction),7926
1,Palmar fascial fibromatosis [Dupuytren],3281
1,Serum levels of protein IL34,6106
1,Serum amyloid A-2 protein measurement,1355
1,Serum metabolite levels (CMS) [TG_PG],1221
1,Wholemeal or wholegrain | bread type,32
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-38 ms],27
1,Subcortical volume (MOSTest),118343
1,Citramalate levels,2064
1,Serum metabolite levels [indoleacetylglutamine],43794
1,Diastolic blood pressure x smoking status (ever vs never) interaction (2df test) [EA],23164
1,HLA DR on Dendritic Cell,8685
1,Protein quantitative trait loci (liver) [USP14],47
1,"Disorders of muscle, ligament, and fascia",4934
1,Interleukin-6 gene expression levels in non-alcoholic fatty liver disease x mastiha supplementation interaction,723
1,Osteoarthritis (hospital diagnosed),950
1,Serum C-reactive protein concentration,2509
1,Protein quantitative trait loci (liver) [EIF2B1],445
1,Protein quantitative trait loci (liver) [SLC25A13],118
1,Chronic parodontitis,70
1,"Systolic blood pressure x alcohol consumption interaction (2df test) [AA, EA]",389
1,Cheft hard palate NOS,39
1,"""Seropositive rheumatoid arthritis, wide""",178
1,Chin morphology,3018
1,Current tobacco smoking,4531
1,Serum levels of protein CSMD2,2391
1,Feeling guilty,902
1,Amyotrophic lateral sclerosis,2490
1,Other arrhytmias,489
1,BAFF-R on IgD- CD27- B cell,1072
1,Body fat distribution (trunk fat ratio),26503
1,Serum levels of protein TNFRSF13B,24914
1,Serum levels of protein C3orf18,6106
1,Arrhythmia,7620
1,Ratio of apolipoprotein A1 to apolipoprotein B,1923
1,"Thyroid problem (not cancer) | non-cancer illness code, self-reported",1664
1,Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular) [additive model],178
1,Ever suffered mental distress preventing usual activities,117
1,1-linoleoyl-gpc (18:2) levels,20
1,Leg | fractured bone site(s),140
1,Blood protein levels in cardiovascular risk,35836
1,Total cholesterol levels [Trans-ethnic initial],88934
1,Blood metabolite levels [decanoylcarnitine],52776
1,Diprobase cream | treatment/medication code,5694
1,CD62L on CD62L+ Dendritic Cell,3837
1,Ever used hormone-replacement therapy (hrt),1570
1,Migraine - clinic-based,301
1,Congenital anomalies of great vessels,142
1,Depressive symptom (fatigue) (ordinal trait),1438
1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Asian],23178
1,ADHD vs anorexia nervosa (ordinary least squares (OLS)),562
1,Protein quantitative trait loci (liver) [COL18A1],12073
1,Coffee consumption (cups per day),782
1,Protein quantitative trait loci (liver) [ATIC],57
1,"Monocyte differentiation antigen CD14, soluble measurement",1200
1,Choline phosphate levels,2147
1,CD33 on CD33dim HLA DR+ CD11b-,1072
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-456 ms],423
1,Protein quantitative trait loci (liver) [LDHB],647
1,Growth-regulated protein alpha levels,2283
1,Blood protein levels [GMP140],128
1,Acute pancreatitis,54
1,Betnovate cream | treatment/medication code,45
1,LDL cholesterol levels in current drinkers,70701
1,Orofacial clefts,8734
1,Blood protein levels [Calcium/calmodulin-dependent protein kinase type 1],3417
1,TB-LM or TBLH-BMD (pleiotropy),1111
1,Serum levels of protein PPT1,11017
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-122 ms],315
1,"Waist circumference [EA, women]",2202
1,Chronic obstructive pulmonary disease in non-current smokers,554
1,Normal facial asymmetry (angle of surface orientation score) [≥14 yr],227
1,Inflammatory biomarkers in Kawasaki disease [C-reactive protein],1021
1,Human milk oligosaccharide concentration (3'-fucosyllactose) in secretors,39
1,Waist-to-hip ratio adjusted for body mass index [women],12387
1,"Blood protein levels [ANGPTL1, 11142_11_3]",1748
1,BAFF-R on IgD+ CD38dim B cell,1072
1,CX3CR1 on CD14- CD16+ monocyte,1072
1,Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis),5265
1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Asian],2027
1,CD3 on CD4+ T cell,917
1,"Blood protein levels [LEPR, 5400_52_3]",2178
1,Urinary calculus,464
1,Sphingomyelin_42:3_[M+OAc]1- levels,18
1,Ventral thalamic nuclei volume,12439
1,Mean corpuscular haemoglobin,218497
1,Age started hormone-replacement therapy (hrt),1412
1,Corneal hysteresis (right),3135
1,Carotid artery stenosis,1470
1,Pancreas fat,2148
1,Brain region volumes [cerebellar vermal lobules VI VII],1107
1,Post bronchodilator FEV1/FVC ratio,97
1,Facial morphology (segment 14),14424
1,Serum levels of protein BAG5,203
1,Serum levels of protein WFDC1,23145
1,Multivitamins +/- minerals | vitamin and mineral supplements,13913
1,QRS duration [EA],5243
1,Oily fish intake,2798
1,Vitamin C levels,1238
1,Percentage of invited food questionnaires completed,8867
1,Protein quantitative trait loci (liver) [SPTAN1],88
1,Tobacco use disorder,1994
1,Serum metabolite levels [S_LDL_FC],1923
1,"Blood protein levels [C4BPA, 9449_150_3]",608
1,Protein levels in obesity [NPS-PLA2],284
1,Lipoma of skin and subcutaneous tissue,85
1,Pulmonary embolism,138
1,Bone mineral density (Ward's triangle area),38
1,Hepatitis,243
1,Osteoarthritis,47995
1,Serum levels of protein SYNCRIP,6106
1,"Blood protein levels [ANAPC7, 11690_47_3]",29372
1,Hip bone size,12394
1,Diabetes mellitus,4188
1,"""Coxarthrosis,""",990
1,FSC-A on Natural Killer,686
1,Colon cancer,522
1,Diffusing capacity of carbon monoxide [EA],211
1,Immune response to measles vaccine (measles-specific neutralising antibody titre) [EA],9202
1,Urinary metabolite levels in chronic kidney disease [hexanoylglycine],52413
1,Epilepsy,2502
1,Blood protein levels [SORT1],1923
1,Blood protein levels [Dynein light chain roadblock-type 1],243
1,Hemoglobin concentration,729310
1,Lung function (FVC) [adults],91659
1,Cortical surface area,375544
1,6mm strong meridian (left),34956
1,CX3CR1 on CD14+ CD16+ monocyte,1072
1,"Inguinal hernia | non-cancer illness code, self-reported",3686
1,Protein quantitative trait loci (liver) [S100A9],1414
1,High myopia,1587
1,Electrocardiogram morphology (amplitude at temporal datapoints) [14 ms],709
1,Dickkopf-related protein 1 levels,225
1,Response to statins (LDL cholesterol change),2027
1,Amyotrophic lateral sclerosis [survival],3740
1,CAG-245 sp000435175 abundance in stool,2355
1,Hyperthyroidism or thyrotoxicosis,10437
1,Serum metabolite levels [S_LDL_CE],1923
1,Platelet count [conditional on round 2],1120
1,Electrocardiogram morphology (amplitude at temporal datapoints) [128 ms],7867
1,Electrocardiogram morphology (amplitude at temporal datapoints) [366 ms],3694
1,Serum levels of protein TST,2299
1,Serum levels of protein EPHA2,5884
1,Degeneration of macula and posterior pole,6106
1,Serum levels of protein DPT,1132
1,Prostate cancer [EA],1959
1,Blood protein levels [Kunitz-type protease inhibitor 1],2765
1,Lipoprotein-associated phospholipase A2 activity and mass [Activity concentrations],1923
1,Electrocardiogram morphology (amplitude at temporal datapoints) [272 ms],758
1,Protein quantitative trait loci (liver) [WARS],156
1,Brain region volumes [right parahippocampal],34
1,Age at voice drop,4212
1,Digit length ratio (right hand),26477
1,Low density lipoprotein cholesterol levels,662634
1,Age-related macular degeneration [EA],6035
1,Hippurate levels,6012
1,"Blood protein levels [TIE1, 2844_53_2]",10846
1,Insomnia symptoms (never/rarely vs. sometimes/usually),2853
1,Serum levels of protein NCF2,6106
1,Eye morphology [Intercanthal width],1328
1,Brain region volumes [right cerebellum white matter],1825
1,Acute tubulo-interstitial nephritis,652
1,Thyroid hormone levels [TSH],2284
1,Electrocardiogram morphology (amplitude at temporal datapoints) [106 ms],1407
1,Electrocardiogram morphology (amplitude at temporal datapoints) [260 ms],758
1,Dermatitis and eczema,854
1,Carpal tunnel syndrome,729
1,Protein quantitative trait loci (liver) [MTHFS],62
1,Type 2 diabetes [EA],19
1,Vitamin B levels in ischemic stroke [Vitamin B6],1026
1,Serum levels of protein DSG1,6106
1,Electrocardiogram morphology (amplitude at temporal datapoints) [12 ms],47268
1,Plasma thyroid-stimulating hormone levels,3777
1,Ambidextrousness,1161
1,Amino acid levels [Serine],560
1,Sodium levels,119298
1,Serum levels of protein MYNN,6106
1,Birth weight (MTAG),3739
1,Goiter,7696
1,Serum levels of protein APCS,2759
1,Exudative age-related macular degeneration,8325
1,Parkinson's disease (more control exclusions),1169
1,Serum metabolite levels (CMS) [LDL_C],1923
1,Non-rheumatic valve diseases,156
1,"Pernicious anaemia | non-cancer illness code, self-reported",178
1,Urate levels in overweight individuals,343
1,Serum metabolite levels (CMS) [L_VLDL_FC],592
1,Other/unspecified rheumatoid arthritis,178
1,"Hip circumference adjusted for BMI [EA, women]",9527
1,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 measurement",6106
1,Serum levels of protein CA4,6106
1,Serum levels of protein MMP1,5848
1,Noninfective enteritis and colitis,6624
1,Serum metabolite levels [IDL_FC],1923
1,Serum 25-Hydroxyvitamin D level variance,1238
1,"Yes, now a lot of the time | tinnitus",142
1,Diabetic ketoacidosis,178
1,Protein quantitative trait loci (liver) [AP1G2],44
1,QT dynamics during exercise [female],6215
1,Total cerebellar volume (excluding Crus I vermis),4727
1,Adult onset asthma and/or BMI,2718
1,CD40 on CD14+ CD16+ monocyte,1072
1,Second line medication for Crohns disease,384
1,Diabetic neuropathy,178
1,Optic disc area [Asian],467
1,Sphingomyelin_42:2_[M+OAc]1- levels,18
1,Metabolic syndrome,64686
1,White matter microstructure (mode of anisotropy) [Anterior limb of internal capsule],12928
1,Gout,33345
1,Serum metabolite levels (CMS) [S_VLDL_TG],23848
1,Serum levels of protein SFRP2,6106
1,CD62L- plasmacytoid Dendritic Cell %Dendritic Cell,8769
1,"Red blood cell traits [EA, MCHC]",2805
1,Serum total protein level [conditional on round 5],1114
1,Amias 2mg tablet | treatment/medication code,1746
1,Betamethasone | treatment/medication code,1367
1,Glycemic traits (pleiotropy),74
1,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [methylsuccinoylcarnitine,  X-24468,  X-24469,  X-24971]",346
1,Local histogram emphysema pattern [normal],105
1,"Blood protein levels [EA, Calcium/calmodulin-dependent protein kinase type 1]",53
1,Protein quantitative trait loci (liver) [CROT],1
1,Medication use (diuretics),61956
1,Time spend outdoors in summer,48106
1,Total testosterone levels,296827
1,Metabolic syndrome [HDL],599
1,Fasting glucose,8194
1,Affective disorder and suicide attempts,717
1,"Blood protein levels [PIGR, 3216_2_2]",4526
1,Dokdonella abundance in stool,62
1,Progranulin levels,3950
1,High light scatter reticulocyte count,477440
1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],23178
1,Plaquenil 200mg tablet | treatment/medication code,2342
1,Soluble E-selectin levels (adjusted for ABO rs2519093 genotypes),3177
1,Vascular endothelial growth factor levels,658
1,Acute anterior uveitis (with or without ankylosing spondylitis),532
1,Nonalcoholic fatty liver disease,92
1,Protein quantitative trait loci (liver) [PKM],156
1,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),7621
1,Mean reticulocyte volume,518902
1,"Blood pressure medication | medication for cholesterol, blood pressure or diabetes",25480
1,Electrocardiogram morphology (amplitude at temporal datapoints) [352 ms],3694
1,Ischemic heart diseases,10920
1,Serum levels of protein FRZB,6106
1,Serum levels of protein S100A6,7430
1,Diabetic retinopathy (more control exclusions),6284
1,C-reactive protein levels [women],5516
1,Serum levels of protein S100A5,1088
1,Fusobacteriaceae abundance in stool,2669
1,Sex ratio,5170
1,Public transport | types of transport used (excluding work),245
1,Facial morphology traits (63 three-dimensional facial segments) [facial module 41],413
1,Interleukin-6 levels,14723
1,Serum levels of protein CRYZ,9931
1,"Blood protein levels [ANGPTL3, 10391_1_3]",23256
1,Other diabetic retinopathy,178
1,Metabolite levels [NG monomethyl arginine],7392
1,Paroxetine | treatment/medication code,26
1,Protein quantitative trait loci (liver) [HIST1H1C],22
1,Azathioprine | treatment/medication code,113
1,ADHD vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),4
1,"Blood protein levels [NDUFS4, 10584_7_3]",32309
1,Leisure sedentary behaviour (television watching),45823
1,Pre-treatment viral load in HIV-1 infection,3580
1,Adult onset Still's disease,428
1,Protein quantitative trait loci (liver) [NAGA],197
1,"Blood protein levels [EPHB2, 8348_4_3]",335
1,C-reactive protein levels or LDL-cholesterol levels (pleiotropy),2503
1,Glaucoma (multi-trait analysis),23713
1,Left ventricular end-systolic volume,9676
1,Calcium levels,285338
1,Hypothyroidism or myxedema,56731
1,Blood metabolite ratios [acetylcarnitine/hexanoylcarnitine],52789
1,"""Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)""",8320
1,CD3 on Terminally Differentiated CD4+ T cell,890
1,Chronic lymphocytic leukemia,2221
1,Cylindrical power (left),522
1,Lung function (FEV1) and waist circumference adjusted for BMI [East Asian],439
1,DNER levels,131
1,Calculus of ureter,337
1,Triglycerides x physical activity interaction (2df test),23256
1,"Diastolic blood pressure x alcohol consumption interaction (2df test) [AA, EA, Hispanic]",17360
1,Protein quantitative trait loci (liver) [RTN4],1163
1,Serum levels of protein GPD1L,6106
1,Electrocardiogram morphology (amplitude at temporal datapoints) [300 ms],5057
1,BAFF-R on IgD- CD24- B cell,1072
1,BMI in non-smokers [EA],766
1,Hematocrit [Hispanic/Latino],92
1,Serum levels of protein TPMT,106
1,Other adrenocortical overactivity,88
1,Particulate matter air pollution (pm10); 2007,1
1,Febrile seizures [MMR-related vs MMR-unrelated],9836
1,Urinary metabolite levels in chronic kidney disease [heptanoylglutamine],52432
1,Hydrocortisone | treatment/medication code,861
1,Bendroflumethiazide | treatment/medication code,434
1,"Hayfever/allergic rhinitis | non-cancer illness code, self-reported",916
1,Serum levels of protein HFE2,2027
1,Aortic valve stenosis,142
1,Urinary albumin-to-creatinine ratio in diabetes,383
1,Type 1 diabetes with neurological complications,178
1,Lobe attachment (rater-scored or self-reported),5425
1,Male-pattern baldness,122353
1,"Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA, men]",3754
1,Total cholesterol levels [EA],79822
1,CD62L- CD86+ myeloid Dendritic Cell %Dendritic Cell,9072
1,DNA methylation-estimated granulocyte proportions,18448
1,SLAM family member 7 levels,466
1,Serum levels of protein SVEP1,4169
1,Urinary metabolite levels in chronic kidney disease [X - 10457],2684
1,Threonate levels,941
1,Neuroblastoma (pediatric),230
1,Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction),119
1,"Cholelithiasis/gall stones | non-cancer illness code, self-reported",174
1,Fruit consumption,18370
1,Serum metabolite levels (CMS) [PC],23256
1,Electrocardiogram morphology (amplitude at temporal datapoints) [156 ms],21337
1,Sleep (1/2-day periodicity),559
1,Hair curvature (quantitative),722
1,Brain region volumes [cerebellar vermal lobules VIII X],2997
1,Beef intake,1065
1,CD3 on activated & secreting CD4 regulatory T cell,1208
1,Hypothyroidism nos,11073
1,Orofacial clefts [Asian],3894
1,"Paracetamol | medication for pain relief, constipation, heartburn",25376
1,Metabolite levels (lipid measures) [serum total triglycerides],22685
1,"""Parkinson's disease, strict definition""",1297
1,Lentiform nucleus volume,1051
1,6mm cylindrical power (right),88
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-170 ms],86
1,"Blood protein levels [EA, Complement factor H-related protein 5]",7453
1,Non-Richardson's syndrome vs Richardson's syndrome in progressive supranuclear palsy,2736
1,Electrocardiogram morphology (amplitude at temporal datapoints) [282 ms],3694
1,Serum levels of protein RNPEP,3564
1,Erythritol levels,1825
1,Protein quantitative trait loci (liver) [VDAC2],118
1,Circulating myeloperoxidase levels (serum),3928
1,Ankylosing spondylitis,12829
1,Age when periods started (menarche),23363
1,"Electron transfer flavoprotein subunit alpha, mitochondrial measurement",6106
1,Serum metabolite levels [tetradecanedioate],4625
1,Coronary artery disease or large artery stroke,2163
1,Electrocardiogram morphology (amplitude at temporal datapoints) [216 ms],8838
1,Electrocardiogram morphology (amplitude at temporal datapoints) [320 ms],6253
1,Motion sickness,520
1,Hernia abdominopelvic cavity,331
1,Obesity [Obesity class I],2999
1,Serum metabolite levels (CMS) [EstC],2068
1,Hallux valgus,35
1,Waist-to-hip ratio adjusted for body mass index [men],1679
1,"Cholesterol lowering medication | medication for cholesterol, blood pressure or diabetes",25861
1,Electrocardiogram morphology (amplitude at temporal datapoints) [26 ms],29621
1,Myopia (pathological),3666
1,Serum levels of protein C2orf40,6106
1,Metabolite levels (lipoprotein measures) [Phospholipids in very large HDL],1242
1,Sphingomyelin_34:1_[M+OAc]1- levels,18
1,Psoriasis,65478
1,Blood protein levels [GRN],1923
1,"Lipid metabolism phenotypes [VLDL.small, whole]",23256
1,Adult diffuse glioma (IDH mutation),4108
1,Urate levels [East Asian],8974
1,Distance between home and job workplace,472
1,Femoral hernia,331
1,Dementia with Lewy bodies,623
1,Noninflammatory disorders of female genital tract,97
1,Glomerular filtration rate in non diabetics (creatinine),11561
1,Matrix metalloproteinase-8 levels,4400
1,Urinary metabolite ratios in chronic kidney disease [Decadienoylcarnitine/Glutarylcarnitine],23668
1,Chlamydia trachomatis momp D antibody levels,4415
1,Serum metabolite levels [caprylate (8:0],17218
1,"None of the above | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",77530
1,Trunk fat-free mass,280517
1,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),6749
1,Cholesterol levels,2745
1,IgA nephropathy,3170
1,Coronary angiopasty,2294
1,"Pulse pressure [EA, initial]",3708
1,"Blood protein levels [EA, Carbonic anhydrase 6]",395
1,Homocysteine levels [WGHS],142
1,Hallucinations in long-term cannabis use [EA],21
1,Protein quantitative trait loci (liver) [C9],2
1,Total cholesterol levels,601560
1,SSC-A on HLA DR+ Natural Killer,9072
1,Serum levels of protein SEL1L2,6106
1,Standing height,527004
1,Hip circumference [EA],7819
1,CD3 on HLA DR+ CD4+ T cell,890
1,Serum CC16 levels,4155
1,Serum metabolite levels [M_LDL_FC],1923
1,Beclometasone dipropionate+salbutamol | treatment/medication code,137
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-60 ms],86
1,Electrocardiogram morphology (amplitude at temporal datapoints) [86 ms],2068
1,Diverticular disease of intestine,679
1,Anaemias,178
1,Serum metabolite levels [2-hydroxy-3-methylvalerate],319
1,Sedentary behaviour duration,35
1,CD24+ CD27+ B cell %B cell,27
1,Peak expiratory flow,170246
1,"Number of decayed, missing and filled tooth surfaces or use of dentures",4938
1,Serum levels of protein CCL1,6106
1,Serum metabolite levels [S_LDL_C],1923
1,"Select biomarker traits [CRP average 2,6,7]",648
1,"Disc problem | non-cancer illness code, self-reported",91
1,Fasting plasma glucose [Non diabetics],7
1,Serum levels of protein MAN1B1,6106
1,Serum levels of protein NADK,21510
1,Blood protein levels [Fc receptor-like protein 3],1585
1,Electrocardiogram morphology (amplitude at temporal datapoints) [224 ms],3781
1,Blood protein levels [Neurexophilin-1],584
1,Fat-free mass [male],27957
1,"Light brown | hair colour (natural, before greying)",3478
1,"""Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium""",18393
1,CD86+ myeloid Dendritic Cell %Dendritic Cell,8728
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-150 ms],4748
1,Rheumatoid arthritis [EA],17505
1,CD11c on monocyte,1072
1,Optic cup area [EA],3232
1,Serum levels of protein CRP,648
1,Protein quantitative trait loci (liver) [HSPA6],264
1,Lipid traits [triglycerides],115
1,Alcohol consumption x experiences in childhood (felt loved by family member) interaction,332
1,Membrane-bound aminopeptidase P levels,9142
1,Serum levels of protein AMY1A,156
1,Age-related macular degeneration (geographic atrophy),6106
1,Febrile seizures (MMR vaccine-related),5826
1,Birth weight of first child,18435
1,"""Type 1 diabetes, wide definition""",178
1,Other heart diseases,1358
1,Electrocardiogram morphology (amplitude at temporal datapoints) [306 ms],6253
1,Hippocampal atrophy [Hippocampal volume],3301
1,Ischemic stroke (large artery atherosclerosis),118
1,Help-seeking from a GP,157
1,Degeneration of macula and posterior pole of retina,6106
1,Acylcarnitine levels [Octanoylcarnitine],52776
1,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [men],2210
1,interferon-related traits [IFNGR1_of_monocytes],1072
1,Serum metabolite levels (CMS) [ApoB],907
1,Long QT syndrome,669
1,Corneal astigmatism,1184
1,Accommodative esotropia,59
1,Geographic atrophy lesion growth rate in age-related macular degeneration,121
1,C-reactive protein levels [AA],242
1,Systolic blood pressure,1226310
1,Depression,38501
1,Mitochondrial DNA copy number,7383
1,Electrocardiogram morphology (amplitude at temporal datapoints) [132 ms],6770
1,Leisure sedentary behaviour (computer use),20316
1,Pork consumption,2349
1,Lipid metabolism phenotypes [L-LDL-FC],75
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-32 ms],27
1,Life satisfaction,50281
1,Platelet distribution width,816042
1,Other non-epithelial cancer of skin,14151
1,High density lipoprotein cholesterol levels [EA],43770
1,Serum metabolite levels [M_HDL_TG],23256
1,Red blood cell (erythrocyte) distribution width,225071
1,Sub-foveal choroidal thickness,3631
1,Abdominal aortic aneurysm,4540
1,Other diseases of oesophagus,66
1,Electrocardiogram morphology (amplitude at temporal datapoints) [100 ms],1560
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-78 ms],86
1,Age-related macular degeneration,61645
1,Meat-related diet,10252
1,Bipolar disorder (MTAG),112563
1,Serum alkaline phosphatase levels,296201
1,"Blood protein levels [ECM1, 3366_51_2]",25064
1,"Forced expiratory volume in 1-second (fev1), predicted percentage",54679
1,QT dynamics during exercise [male],6215
1,Major depressive disorder or stress-related disorder,643
1,"Gout | non-cancer illness code, self-reported",2763
1,Malaria [dominant],4007
1,"Bone mineral density (paediatric, upper limb)",1250
1,Brain region volumes [X4th ventricle],34
1,Metabolic traits [serine],560
1,Crohn's disease,208752
1,Intelligence (MTAG),38880
1,Brain region volumes [right caudate],536
1,CX3CR1 on monocyte,1072
1,Platelet aggregation [ADP high 2],225
1,Smoking initiation (ever regular vs never regular) [Conditioned on chr1:50603995],130
1,Home location - east co-ordinate (rounded),21
1,Urinary metabolite levels in chronic kidney disease [X - 24403],6
1,Cognitive ability,62899
1,FSC-A on HLA DR+ Natural Killer,10242
1,Serum levels of protein ICAM4,17964
1,Serum levels of protein EPHB2,670
1,Automobile speeding propensity,6438
1,Electrocardiogram morphology (amplitude at temporal datapoints) [340 ms],6253
1,"""Disorders of plasma-protein metabolism, not elsewhere classified""",23
1,Coronary artery disease,220232
1,Cholesterol [total cholesterol],1786
1,"Blood protein levels [EA, L-Selectin]",857
1,Faecalicatena sp000364245 abundance in stool,101
1,Depressed affect,13008
1,Non-obstructive azoospermia,1541
1,N-acetylleucine levels,1523
1,"Blood protein levels [CNTN2, 3296_92_2]",3225
1,Electrocardiogram morphology (amplitude at temporal datapoints) [46 ms],2849
1,Invasive breast cancer [mixed effect],509
1,Serum levels of protein MMP7,527
1,Serum metabolite levels (CMS) [S_LDL_PL],1923
1,Low high density lipoprotein cholesterol levels,283
1,Age at first live birth,106
1,Memory decline,61
1,Social science traits (pleiotropy) (HIPO component 1),25393
1,LDL cholesterol levels in current drinkers [EA],70701
1,Thumb osteoarthritis,3449
1,Blood metabolite levels [erythritol],52603
1,"Fracture fibula | non-cancer illness code, self-reported",1171
1,Dendritic Cell Absolute Count,8685
1,IgG glycosylation patterns [IgG2_G1Fn],74
1,Obese vs. thin,150
1,Lysophosphatidylcholine_15:0_[M+H]1+/Lysophosphatidylethanolamine_18:0_[M+H]1+ levels,4818
1,Radiation-related disorders of the skin and subcutaneous tissue,5806
1,Cardiac problem,4804
1,"Heart/cardiac problem | non-cancer illness code, self-reported",970
1,Thyroid volume [thyroid volume],7670
1,Obesity (extreme),143
1,"Blood protein levels [EA, Hemopexin]",819
1,Body fat percentage [male],162
1,Cortical surface area [Lateral Orbitofrontal],15
1,"Insulin | medication for cholesterol, blood pressure or diabetes",178
1,Mental health study participation (completed survey),25238
1,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],19905
1,Serum levels of protein AGT,494
1,"Lipid metabolism phenotypes [VLDL.small, fasting]",23211
1,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)",9614
1,"Blood protein levels [NADK, 13624_17_3]",20321
1,Lercanidipine | treatment/medication code,7092
1,Acne (severe),5582
1,CD64 on monocyte,15861
1,Lung function (FVC) [EA],619
1,Thyroid hormone levels [TSH - Females],2145
1,Cardiac dysrhythmias,2593
1,Kineothrix abundance in stool,21
1,Serum linoleic acid concentration in metabolic syndrome,134
1,Musculoskeletal symptoms referable to limbs,112
1,Triglycerides,470368
1,Age-related macular degeneration (extreme sampling),7175
1,Celiac disease,39949
1,Acylcarnitine levels [Decanoylcarnitine],52776
1,Serum levels of protein DCUN1D5,6106
1,"Heart attack/myocardial infarction | non-cancer illness code, self-reported",4908
1,Electrocardiogram morphology (amplitude at temporal datapoints) [120 ms],7916
1,"Icd10: c43.9 malignant melanoma of skin, unspecified | underlying (primary) cause of death",118
1,Feeling fed-up,699
1,Heart rate increase in response to exercise,35
1,"Waist circumference adjusted for body mass index [EA, women]",3700
1,Height [AA],3025
1,Serum levels of protein RBM24,6106
1,"Blood protein levels [S100A5, 14222_68_3]",6765
1,Ischemic stroke (large artery atherosclerosis) [CCSp],82
1,Lung function (FEV1) [African],56
1,Morning person,302206
1,Blood metabolite levels [octanoylcarnitine],52776
1,Sitting height,392824
1,Protein quantitative trait loci (liver) [NCL],364
1,Cardiovascular disease risk factors [LDL],2027
1,Serum metabolite levels [1-stearoyl-2-arachidonoyl-GPI (18:0/20:4],47196
1,Biological sex,38927
1,Protein levels in obesity [ECM1],25064
1,Natriuretic peptide levels,12757
1,Electrocardiogram morphology (amplitude at temporal datapoints) [68 ms],1560
1,Mean corpuscular volume [Asian],132
1,Fitting and adjustment of other devices,124
1,Ganglion cell inner plexiform layer (GCIPL) thickness,21
1,"Blood protein levels [EA, Peptidyl-prolyl cis-trans isomerase E]",8546
1,N-acetylhistidine levels,6576
1,Serum levels of protein NOG,5848
1,Brain region volumes [right precuneus],301
1,IgG glycosylation patterns [IgG2_G0FNn],74
1,malignant neoplasm of male genital organs,26077
1,HLA DR on myeloid Dendritic Cell,8685
1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Hispanic],2027
1,Hydrogenophaga abundance in stool,127
1,6-oxopiperidine-2-carboxylate levels,58
1,Cooked vegetable consumption,21396
1,Use of sun/uv protection,43524
1,"Systolic blood pressure [EA, initial]",23022
1,Childhood maltreatment,432
1,Electrocardiogram morphology (amplitude at temporal datapoints) [82 ms],1560
1,Strep throat,1388
1,Skin fluorescence in type 1 diabetes,473
1,BMI at adiposity peak,431
1,Stool frequency,188
1,Nasopharyngeal carcinoma (SNP x SNP interaction),200
1,Protein quantitative trait loci (liver) [CLU],21
1,Diastolic blood pressure (cigarette smoking interaction),34883
1,Obesity (extreme) (SNP x SNP interaction),157664
1,Serum metabolite levels [L_LDL_FC],1923
1,Serum metabolite levels [N-oleoyltaurine],12467
1,CCR2 on myeloid Dendritic Cell,10561
1,Serum amyloid A-1 protein measurement,4265
1,Serum metabolite levels (CMS) [S_LDL_C],1923
1,Facial morphology (segment 11),1164
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-176 ms],86
1,"Response to radiotherapy in cancer (late toxicity) [Prostate cancer, rectal incontinence, univariable analysis]",172
1,Hemoglobin levels,487413
1,Waist-hip ratio [EA],3932
1,"Lipid metabolism phenotypes [TG.by.NMR, fasting]",23256
1,Benign neoplasm of other parts of digestive system,11885
1,Ebbinghaus illusion (overestimation),1809
1,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant II (Nose), Segment 41]",1278
1,"Blood protein levels [AGT, 3484_60_2]",431
1,Type 1 diabetes with other specified/multiple/unspecified complications,178
1,Serum metabolite concentrations in chronic kidney disease [alpha-hydroxyisovalerate],25
1,Local histogram emphysema pattern [Moderate Centrilobular],105
1,Testicular germ cell tumor,59696
1,Glaucoma,19911
1,Phosphatidylinositol_38:4_[M+H]1+ levels,23256
1,Total body bone mineral density [European],1822
1,Serum metabolite levels (CMS) [S_LDL_CE],1923
1,Protein quantitative trait loci (liver) [COQ9],79
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-96 ms],86
1,Number of children ever born,23643
1,Body size at age 10,67304
1,"Waist-to-hip ratio adjusted for body mass index [EA, men]",3889
1,Eye color [EA],19982
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-152 ms],4834
1,Mucosal proctocolitis,3779
1,"Blood protein levels [CGREF1, 6257_56_3]",452
1,Eosinophil percentage of white cells,357518
1,Pulse pressure [EA],1932
1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Hispanic],23178
1,Body fat distribution (leg fat ratio),13535
1,Facial morphology (lower lip protrusion),3124
1,Serum levels of protein B4GALT2,4695
1,Spherical power (right),15917
1,Neovascular age-related macular degeneration,3631
1,Blood protein levels [Low affinity immunoglobulin gamma Fc region receptor III-B],786
1,Asymmetrical dimethylarginine levels,3673
1,White matter microstructure (mean diusivities) [Superior fronto-occipital fasciculus],1109
1,Interstitial lung disease endpoints,1231
1,Electrocardiogram morphology (amplitude at temporal datapoints) [158 ms],1370
1,Phospholipase D3 measurement,26
1,Serum metabolite levels (CMS) [MUFA],23256
1,Serum metabolite levels [4-guanidinobutanoate],21736
1,"Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)",11799
1,High altitude adaptation,2250
1,"1,5-anhydroglucitol levels [EA]",977
1,"Blood protein levels [MFAP2, 9294_45_3]",2582
1,Electrocardiogram morphology (amplitude at temporal datapoints) [364 ms],3694
1,Lumigan 0.3mg/ml eye drops | treatment/medication code,2001
1,Abdominal aortic calcification levels [EA],153
1,Protein quantitative trait loci (liver) [SUCLA2],1
1,Heel bone mineral density,688921
1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),45464
1,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [women],4804
1,Serum levels of protein F13B,1969
1,Electrocardiogram morphology (amplitude at temporal datapoints) [348 ms],3694
1,"Blood protein levels [BAG5, 12743_18_3]",978
1,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) [Modelling analysis]",1187
1,Sleep duration (long sleep),247
1,Triglyceride levels in small HDL,67
1,Frequency of friend/family visits,250
1,Senile cataract,32
1,Eosinophil counts,1203549
1,Diseases of the musculoskeletal system and connective tissue,18750
1,Methotrexate | treatment/medication code,178
1,Serum metabolite levels (CMS) [L_LDL_L],1923
1,"Blood protein levels [EA, Interleukin-23 receptor]",520
1,"""Other (seronegative) rheumatoid arthritis, wide""",178
1,Protein quantitative trait loci (liver) [CES1],229
1,Serum levels of protein UFM1,160
1,Intertrochanteric region size,239
1,Serum levels of protein CXCL8,113
1,Cardiac Troponin-T levels [Dichotomous variable],84
1,Bronchitis,7
1,Lifetime smoking index,18849
1,Body fat distribution (trunk fat ratio) [females],25197
1,"Blood protein levels [CHI3L2, 9383_24_3]",1401
1,Fresh fruit intake,14441
1,Urinary metabolite levels in chronic kidney disease [cysteinylglycine],1993
1,Change in neurofilament light levels,1870
1,Protein quantitative trait loci (liver) [TKT],471
1,Lipoma,68
1,Natural Killer %lymphocyte,12
1,Plasma pyridoxal phosphate to pyridoxal ratio,4995
1,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),23235
1,Autoimmune thyroid disease,23784
1,Systolic blood pressure x smoking status (ever vs never) interaction (2df test) [EA],12533
1,Serum metabolite levels [3-hydroxybutyrylcarnitine (2],48669
1,White | bread type,41579
1,Tea intake,119091
1,"""Abnormal findings on diagnostic imaging and in function studies, without diagnosis""",208
1,Cigarettes smoked per day in Schizophrenia,50
1,Meat-related diet [female],9556
1,Basophill count,22911
1,Chronic obstructive pulmonary disease or resting heart rate (pleiotropy),4345
1,Attention deficit hyperactivity disorder or cannabis use,4710
1,White matter microstructure (axial diusivities) [Cingulate gyrus],640
1,Metabolic traits [CRP],648
1,Cardiovascular diseases,923
1,Medication use (immunosuppressants),318
1,"""Atopic dermatitis, strict definition with reimbursement""",49
1,Atrial fibrillation,50707
1,Impedance of leg (left),300651
1,"Osteoporosis-related phenotypes [NW, men & women]",5541
1,"Blood protein levels [PTGFRN, 12727_7_3]",75
1,"Lipid metabolism phenotypes [LDL.total, whole]",1923
1,Cytokine network levels (multivariate analysis),4060
1,Waist circumference adjusted for BMI in non-smokers,7386
1,Triglyceride levels x long total sleep time interaction (1df test),70
1,Basophil percentage of granulocytes,44698
1,Refractive error,122212
1,Serum levels of protein CLEC12B,6106
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-16 ms],9112
1,"Intra-ocular pressure, corneal-compensated (left)",11408
1,CD14+ CD16+ monocyte %monocyte,8728
1,Processed meat intake,622
1,Electrocardiogram morphology (amplitude at temporal datapoints) [114 ms],1560
1,Serum metabolite levels (CMS) [IDL_PL],1923
1,Serum polyunsaturated fatty acid concentration x sex interaction in metabolic syndrome [total PUFA],4926
1,Completion of the aide-memoire,34
1,Health precaution | reason former drinker stopped drinking alcohol,8
1,Protein quantitative trait loci (liver) [IGHG1],2
1,Neutrophil percentage of granulocytes,49029
1,Dried fruit intake,14956
1,"Seen a psychiatrist for nerves, anxiety, tension or depression",6155
1,Impedance of leg (right),282188
1,Myopia (age of diagnosis),914
1,"Diastolic blood pressure x alcohol consumption interaction (2df test) [AA, Asian, EA, Hispanic]",15951
1,Brain region volumes [left parahippocampal],568
1,"Blood pressure measurement (low sodium intervention) [DBP, during intervention]",11
1,Excessive hairiness,3932
1,Urinary albumin excretion,33153
1,Smoking status (ever vs never smokers),45044
1,Educational attainment (years of education) [conditional-joint],141077
1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Asian],24933
1,Serum levels of protein PMVK,6106
1,Cortical thickness,340755
1,Pattern 1 | hair/balding pattern,104461
1,Skin changes due to chronic exposure to nonionizing radiation,5806
1,Serum levels of protein PSG2,6106
1,CD3 on naive CD8+ T cell,1785
1,Urinary metabolite levels in chronic kidney disease [X - 21827],6321
1,"Blood protein levels [EPHA2, 4834_61_2]",4207
1,"Blood protein levels [MLL2, 13623_4_3]",6470
1,Blood protein levels [Interleukin-6R (IL-6R],2290
1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,1984
1,Diabetic hypoglycemia,178
1,Serum levels of protein M6PR,6106
1,Serum metabolite levels (CMS) [LA],23256
1,Electrocardiogram morphology (amplitude at temporal datapoints) [248 ms],3568
1,Duration to first press of snap-button in each round,18236
1,Electrocardiogram morphology (amplitude at temporal datapoints) [96 ms],8494
1,Heart failure and coronary heart disease,211
1,Common traits (Other) [hair curl],8360
1,"Migraine | non-cancer illness code, self-reported",7563
1,"Blood protein levels [ROR1, 8474_6_3]",828
1,Polymyositis,178
1,Type 2 diabetes with ophthalmic complications,178
1,Protein quantitative trait loci (liver) [CP],2
1,Body mass index,1583838
1,Mean corpuscular volume,1650389
1,Type 2 diabetes,655144
1,HDL cholesterol levels in current drinkers,45327
1,Glucuronate levels,37895
1,Serum levels of protein MPZL2,6106
1,Place of birth in uk - east co-ordinate,53651
1,High-sensitivity cardiac troponin T levels,508
1,Aspirin | treatment/medication code,1923
1,Serum metabolite levels [L_LDL_CE],1923
1,Endometrial cancer,308
1,"Post-traumatic stress disorder [EA, male]",134
1,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction),4799
1,Comparative body size at age 10,61241
1,Optic disc area [EA],4203
1,Schizophrenia vs bipolar disorder (ordinary least squares (OLS)),32483
1,"Diastolic blood pressure, automated reading",54615
1,Thyroid hormone levels [FT4-Females],2158
1,"""Systemic lupus erythematosus, unspecified""",131
1,Protein quantitative trait loci (liver) [EPHA6],40
1,Serum levels of protein CTXN3,6106
1,"Blonde | hair colour (natural, before greying)",84717
1,Impedance of whole body,305380
1,Thyroxine product | treatment/medication code,4137
1,Blood protein levels [MPO],10320
1,Serum metabolite levels (CMS) [VLDL_TG],589
1,Cerebrospinal fluid t-tau:AB1-42 ratio,3973
1,Serum metabolite levels [L_LDL_PL],1923
1,Colonic or urogenital fistula,218
1,Lung cancer in ever smokers,178
1,"Blood protein levels [FCGR2A, 3309_2_2]",1397
1,Inactive tyrosine-protein kinase transmembrane receptor ROR1 levels,190
1,BMI in smokers [women],148
1,Reaction time,10386
1,Schizophrenia (MTAG),153216
1,Serum metabolite levels [FAw6],23256
1,Feeling nervous,1025
1,Serum levels of protein C3,3914
1,Electrocardiogram morphology (amplitude at temporal datapoints) [210 ms],9277
1,Low density lipoprotein cholesterol levels (on statin treatment),2027
1,"Fracture metatarsal | non-cancer illness code, self-reported",540
1,Other disorders of Eustachian tube,53
1,Alcohol intake frequency.,19868
1,"Mean arterial pressure x alcohol consumption interaction (2df test) [AA, EA, Hispanic]",17261
1,dCTP pyrophosphatase 1 measurement,7676
1,"""Diabetes, insuline treatment (Kela reimbursement)""",3284
1,Benign neoplasm: Adrenal gland,5161
1,Electrocardiogram morphology (amplitude at temporal datapoints) [48 ms],2849
1,Gut bacterial pathway abundance (HISTSYN.PWY..L.histidine.biosynthesis),725
1,Gut microbiota (bacterial taxa) [k__Bacteria|p__Proteobacteria|c__Betaproteobacteria|o__Burkholderiales|f__Sutterellaceae],337
1,Multiple sclerosis and type 2 diabetes (pleiotropy),616
1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),70737
1,Amino-terminal enhancer of split measurement,6106
1,N-acyl ethanolamine levels [LEA],2461
1,"Parental longevity (combined parental attained age, Martingale residuals)",2027
1,Cerebrospinal fluid biomarker levels [Chitotriosidase-1],1420
1,Benign neoplasm of ovary,1455
1,Follicular cysts of skin and subcutaneous tissue,155
1,Bipolar ii disorder | bipolar and major depression status,700
1,General factor of neuroticism,204
1,Pulmonary congestion and hypostasis,8304
1,Medication use (calcium channel blockers),123501
1,Cataracts (operation),32458
1,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA],4894
1,Complement factor H-related protein 1 levels,38927
1,Leukocyte telomere length [East Asian],1538
1,Electrocardiogram morphology (amplitude at temporal datapoints) [226 ms],3626
1,Neuranatomic and neurocognitive phenotypes,4283
1,Depressive symptoms (sum-score),1438
1,White matter microstructure (fractional anisotropy) [Superior longitudinal fasciculus],739
1,L-selectin levels [HIS],407
1,Gut microbiota (bacterial taxa) [Unclassified Enterobacteriaceae],1406
1,Cancer of bladder,190
1,Neutrophil percentage of white cells,459345
1,Direct low density lipoprotein cholesterol levels,137031
1,Serum levels of protein TNFRSF18,6106
1,"Blood protein levels [ERO1LB, 7994_41_3]",6809
1,Forced vital capacity (fvc),99845
1,Lipid metabolism phenotypes [XL-HDL-CE],7924
1,Electrocardiogram morphology (amplitude at temporal datapoints) [162 ms],5256
1,Self-reported risk-taking behaviour,10644
1,"""Parkinson's disease, including avohilmo""",1169
1,Serum metabolite levels [S-allylcysteine],1895
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-480 ms],423
1,3-month functional outcome in ischaemic stroke (modified Rankin score),67
1,Red blood cell folate levels,18798
1,C-reactive protein levels [men],5516
1,"Blood protein levels [EA, Alcohol dehydrogenase [NADP(+)]]",34748
1,"Blood protein levels [CFHR5, 7885_17_3]",20498
1,Brain region volumes [right accumbens area],341
1,Childhood sunburn occasions,434
1,Chitotriosidase-1 levels,1063
1,Myocardial fractal dimension (slice 8),34
1,Tartronate (hydroxymalonate) levels,42
1,D-dimer levels in HIV infection,216
1,HDL cholesterol levels x smoking (current vs non smokers) interaction (2df test) [African],6
1,Bilirubin levels,184789
1,Serum levels of protein TPM2,6106
1,Serum levels of protein IL6R,17566
1,Immature reticulocyte fraction,114760
1,Other malignant neoplasms of skin (=non-melanoma skin cancer) (controls excluding all cancers),14287
1,Serum levels of protein IGFL3,6106
1,Electrocardiogram morphology (amplitude at temporal datapoints) [62 ms],1560
1,Serum levels of protein IGHG1;IGHG2;IGHG3;IGHG4;IGL;IGK,7121
1,Medication use (antiglaucoma preparations and miotics),4052
1,Facial morphology (segment 51),976
1,Neuropsychiatric disorders,1225
1,"Blood protein levels [ROR1, 2590_69_4]",833
1,"""Dislocation, sprain and strain of joints and ligaments at ankle and foot level""",26
1,HDL cholesterol levels x long total sleep time interaction (2df test),10333
1,Overall health rating,11597
1,"Blood protein levels [FCRL1, 5728_60_3]",8235
1,Hard cardiovascular diseases,2027
1,Bone mineral density [spine],1257
1,"Bone mineral density (paediatric, skull) [EA]",456
1,Complement C3 levels,1475
1,Other serious medical condition/disability diagnosed by doctor,178
1,LDL cholesterol levels [AA],2027
1,"Blood protein levels [EPHB2, 8225_86_3]",335
1,Allergic asthma (mode),49
1,Schizophrenia or bipolar disorder [SCZ or BP vs. controls],322
1,Antithrombin-III measurement,15
1,Adult body size,108624
1,Heel bone mineral density x serum urate levels interaction [female],3505
1,Serum levels of protein CEACAM7,3947
1,"Blood protein levels [S100A12, 5852_6_3]",472
1,Regular attendance at a pub or social club,221
1,"""Pain (limb, back, neck, head abdominally)""",9
1,High light scatter reticulocyte percentage of red cells,224239
1,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],70567
1,Primary open angle glaucoma,2001
1,Electrocardiogram morphology (amplitude at temporal datapoints) [252 ms],3568
1,Electrocardiogram morphology (amplitude at temporal datapoints) [350 ms],3694
1,Complement factor H measurement,5074
1,Rosuvastatin | treatment/medication code,1717
1,P wave terminal force,293
1,Rough skin frequency,212
1,Body mass index [AA and Sub-Saharan],83
1,Cheese intake,17
1,Protein quantitative trait loci (liver) [PSMD14],62
1,Rheumatoid arthritis,117970
1,Positive affect,34813
1,"Pulmonary function (smoking interaction) [FEV1/FVC, Pack-years]",8471
1,Paracetamol of NSAID medication,14094
1,Total body bone mineral density (MTAG),9237
1,Diverticulosis,24176
1,Male puberty timing (age at voice breaking MTAG),8924
1,Total protein levels x insomnia interaction,1669
1,Chronic kidney disease,8345
1,HDL cholesterol x physical activity interaction (2df test) [EA],592
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-466 ms],423
1,Benign neoplasm of colon,32530
1,Complement factor H-related protein 4 levels,14148
1,Other metabolic disorders,1070
1,Ras-related protein Rab-1A measurement,9738
1,Electrocardiogram morphology (amplitude at temporal datapoints) [172 ms],9368
1,Electrocardiogram morphology (amplitude at temporal datapoints) [302 ms],5057
1,"Blood protein levels [FCN3, 14077_6_3]",8376
1,Gastric polyp,5153
1,Lipoprotein-associated phospholipase A2 activity and mass [activity],3846
1,"Bone mineral density (paediatric, skull)",456
1,"Hereditary/genetic haematological disorder | non-cancer illness code, self-reported",134
1,Diabetic background retinopathy,178
1,Body mass index [men],1416
1,Metabolite levels [C16],217
1,Hydroxyasparagine levels,64
1,Platelet count,2823992
1,Offspring birth weight,33033
1,Midregional pro atrial natriuretic peptide levels [Conditional],8489
1,Diastolic blood pressure [East Asian],10646
1,N-acyl ethanolamine levels [PEA],2461
1,Serum levels of protein LRRC19,1568
1,Serum metabolite levels [M_LDL_PL],1923
1,Bilateral oophorectomy (both ovaries removed),1250
1,Serum metabolite levels (CMS) [S_VLDL_PL],592
1,Triglyceride levels [Trans-ethnic initial],46343
1,Urinary metabolite levels in chronic kidney disease [N-octanoylglutamine],52413
1,Urinary metabolite levels in chronic kidney disease [imidazole lactate],22134
1,Protein quantitative trait loci (liver) [PSMB4],24224
1,Mean time to correctly identify matches,23035
1,Serum metabolite levels (CMS) [XL_VLDL_TG],589
1,Total amyloid (SNP x SNP interaction),5
1,Cognitive performance,88636
1,Serum metabolite ratios in chronic kidney disease [Decanoylcarnitine/Dodecanoylcarnitine],52471
1,"Blood protein levels [CHIT1, 3600_2_3]",1000
1,P wave duration,2337
1,Insomnia [Female],928
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-446 ms],423
1,Carotenoid levels (alpha-carotene),4096
1,C-reactive protein measurement,5380
1,Facial morphology (segment 30),1430
1,Monocyte differentiation antigen CD14 measurement,7306
1,Global electrical heterogeneity phenotypes [SAI QRST],1101
1,CD3 on Terminally Differentiated CD8+ T cell,985
1,Insulin-like growth factor 1 levels,544477
1,Spleen volume,5055
1,Atrial fibrillation [EA],16750
1,LDL cholesterol x physical activity interaction (2df test),2457
1,Age completed full time education,12648
1,Serum folate levels,11071
1,C-reactive protein levels [HIS],1582
1,Number of self-reported cancers,2469
1,Group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP,512
1,Low density lipoprotein cholesterol levels [AA],2040
1,Serpin A12 levels,263
1,Serum levels of protein AGER,35
1,Mammographic density (non-dense area),2929
1,Protein quantitative trait loci [GRN],1923
1,Neuroticism score,30339
1,Bicuspid aortic valve,142
1,L-selectin levels [EA],407
1,Urolithiasis,1507
1,Fervidobacteriaceae abundance in stool,66
1,"""Appendicitis, broad definition""",55
1,Morning vs. evening chronotype,31417
1,Penicillin | treatment/medication code,7229
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-90 ms],86
1,Other and unspecified urticaria,72
1,Type 1 diabetes with renal complications,178
1,Left atrial maximum volume,145
1,Triiodothyronine levels,42
1,Phosphorus levels,7089
1,Urinary metabolite levels in chronic kidney disease [Decadienoylcarnitine],22069
1,Serum metabolite levels [octanoylcarnitine],157506
1,Serum metabolite levels [PC],23256
1,Problematic opioid prescription use,13706
1,Butter/spreadable butter | spread type,626
1,Magnetospirillum A abundance in stool,63
1,Monocyte count,1619389
1,Triglyceride levels in current drinkers [Hispanic],23211
1,Glucose levels,32049
1,Serum metabolite levels [3-hydroxylaurate],24546
1,Thyroid volume [goiter],8893
1,Nonsyndromic cleft lip,4977
1,Eye morphology,4060
1,Levothyroxine sodium | treatment/medication code,34297
1,Serum metabolite levels [N-oleoylserine],6582
1,Inflammatory biomarkers [hsCRP],2025
1,"Blood protein levels [INPP5B, 12641_3_3]",7321
1,Thumb osteoarthritis severity (hand Klsum),3468
1,Vigorous physical activity,1718
1,Protein quantitative trait loci [sLeptin R],2247
1,Protein quantitative trait loci [Hemopexin],3220
1,BMI in smokers,602
1,"""Benign neoplasm: Connective and other soft tissue of head, face and neck""",102
1,Serum metabolite concentrations in chronic kidney disease [2-hydroxy-3-methylvalerate],25
1,Glomerular filtration rate (creatinine),47507
1,Experiencing mood swings,17083
1,Medication use (drugs used in diabetes),28588
1,Cutaneous malignant melanoma,101858
1,Macular degeneration | eye problems/disorders,6129
1,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA],6561
1,Uterine prolapse,771
1,Uterine fibroids,10730
1,Serum levels of protein F5,4166
1,Waist circumference adjusted for BMI in active individuals [EA],6059
1,Electrocardiogram morphology (amplitude at temporal datapoints) [370 ms],3694
1,Electrocardiogram morphology (amplitude at temporal datapoints) [18 ms],2047
1,High density lipoprotein cholesterol levels,209927
1,Gamma glutamyl transpeptidase,155314
1,Serum levels of protein PLA2G2A,1373
1,Serum levels of protein GSK3A;GSK3B,6106
1,"Blood protein levels [CHIT1, 10460_1_3]",1719
1,Serum metabolite levels [ADpSGEGDFXAEGGGVR*],2449
1,Platelet aggregation [ADP low 2],225
1,"Blood protein levels [IL6R, 4139_71_2]",2290
1,Number of self-reported non-cancer illnesses,1081
1,Ascending aorta minimum area,567
1,CD3 on CD28+ CD4+ T cell,917
1,Brain region volumes [left lingual],34
1,Adizem-60 m/r tablet | treatment/medication code,292
1,Serum levels of protein PRDX3,177
1,Other retinal disorders,12390
1,Brain region volumes [left cerebellum exterior],4456
1,Epithelial ovarian cancer,12561
1,Electrocardiogram morphology (amplitude at temporal datapoints) [110 ms],2068
1,Progressive supranuclear palsy,3339
1,Total cholesterol levels [AA],7900
1,Mental and behavioural disorders due to psychoctive substance use,223
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-174 ms],86
1,Valvular heart disease including rheumatic fever,786
1,Hypertensive heart and/or renal disease,465
1,Triglyceride levels x loop diuretics use interaction [EA],59
1,Physical activity (walking duration),22753
1,Electrocardiogram morphology (amplitude at temporal datapoints) [118 ms],32195
1,Electrocardiogram morphology (amplitude at temporal datapoints) [336 ms],6253
1,Smokes on most or all days | tobacco smoking,2529
1,Waist circumference adjusted for BMI in inactive individuals [EA],975
1,Serum levels of protein PRG2,1072
1,White matter microstructure (axial diusivities) [Superior longitudinal fasciculus],695
1,Systemic lupus erythematosus [Hispanic],131
1,Antineutrophil cytoplasmic antibody-associated vasculitis,178
1,Bipolar disorder vs ADHD (ordinary least squares (OLS)),268
1,Cleft lip and cleft palate,59
1,Participation in an health questionnaire (not invited vs invited),25178
1,"Forced vital capacity (fvc), best measure",148571
1,Antihypertensive medication - note that there are other indications,20071
1,Serum levels of protein RGS8,6106
1,Pure hypercholesterolaemia,1941
1,Composite immunoglobulin trait (IgA x IgG/IgM),753
1,Malignant neoplasm of breast (controls excluding all cancers),89
1,Serum levels of protein FCN3,25697
1,Instant coffee | coffee type,1799
1,"Systolic blood pressure, manual reading",18556
1,Nasal polyp,90186
1,Blood metabolite levels [tetradecanedioate],6518
1,Waist-to-hip ratio adjusted for BMI (additive genetic model),6000
1,Electrocardiogram morphology (amplitude at temporal datapoints) [310 ms],6253
1,Estimated glomerular filtration rate in non-diabetics,35341
1,Electrocardiogram morphology (amplitude at temporal datapoints) [146 ms],15834
1,Heel broadband ultrasound attenuation (left),3437
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-462 ms],423
1,Congenital heart malformation,196
1,Educational attainment (years of education),356808
1,Dilated cardiomyopathy,13465
1,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) [women],5971
1,TPE interval (resting) [women],10600
1,Serum levels of protein SURF1,5978
1,"""Hypothyroidism, strict autoimmune, 3 medication purchases required""",13272
1,Serum levels of protein PA2G4,8334
1,Electrocardiogram morphology (amplitude at temporal datapoints) [228 ms],3781
1,Serum levels of protein TRIL,6106
1,Electrocardiogram morphology (amplitude at temporal datapoints) [134 ms],2154
1,Glucosamine product | treatment/medication code,244
1,HDL cholesterol levels x smoking (current vs non smokers) interaction (1df test) [African],6
1,Number of sexual partners,17413
1,Serum levels of protein FMR1,6106
1,Serum metabolite levels (CMS) [XXL_VLDL_CE],23552
1,Electrocardiogram morphology (amplitude at temporal datapoints) [150 ms],2154
1,"Blood protein levels [NEGR1, 13109_82_3]",1108
1,Electrocardiogram morphology (amplitude at temporal datapoints) [104 ms],364
1,Inflammatory biomarkers [MCP-1],689
1,Autoimmune thyroiditis,178
1,Daytime nap,102693
1,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [AA],23143
1,Serum levels of protein FCRL4,2986
1,Diabetic maculopathy,356
1,Facial morphology (lip protrusion),3124
1,Platelet aggregation [epinephrine],225
1,Facial ageing,1235
1,Diastolic blood pressure,741066
1,Blood protein levels [Contactin-2],6470
1,Serum metabolite levels (CMS) [IDL_P],1923
1,"Blood protein levels [CTSS, 3181_50_2]",9525
1,Serum metabolite levels (CMS) [Serum_TG],23256
1,Regional enteritis,1118
1,Type 2 diabetes (adjusted for BMI),31034
1,"Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA, women]",4638
1,Heart rate response to recovery post exercise (10 sec),374
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-450 ms],423
1,Corneal resistance factor (left),599
1,Body mass index in physically active individuals [men],599
1,Sleep duration (short sleep),3246
1,Nonatopic asthma or type 2 diabetes,13416
1,Metabolic traits [SM-14 + 6 other traits],4995
1,Lymphocyte-to-monocyte ratio,55022
1,Rheumatoid arthritis [East Asian],1738
1,Chronic periodontitis (mean interproximal clinical attachment level) [Hispanics],2041
1,Wet age-related macular degeneration,6106
1,Urinary albumin excretion (no hypertensive medication),184
1,Electrocardiogram morphology (amplitude at temporal datapoints) [102 ms],364
1,"Blood protein levels [CREG1, 9357_4_3]",209
1,All pneumoniae,155
1,CD62L- monocyte Absolute Count,17189
1,Hypertensive diseases (excluding secondary),7404
1,DNA methylation variation (age effect),9729
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-488 ms],423
1,"""Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8""",404
1,Chronic diseases of tonsils and adenoids,1323
1,Serum metabolite concentrations in chronic kidney disease [10-undecenoate (11:1n1],78
1,Systemic juvenile idiopathic arthritis [Additive],132
1,Apolipoprotein A1 levels,490497
1,CD62L- CD86+ myeloid Dendritic Cell Absolute Count,8728
1,"Blood protein levels [FN1, 3434_34_1]",25064
1,Dry age-related macular degeneration (includes geographic atrophy),6106
1,BMI in non-smokers,3898
1,Certain disorders involving the immune mechanism,939
1,Cleft lip with or without cleft palate [EA],172
1,Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified),155
1,"LDL cholesterol levels [Asian initial, BMI unadjusted]",2464
1,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],19905
1,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test) [EA],27016
1,Brain region volumes [cerebellar vermal lobules I V],5559
1,Serum levels of protein ST6GALNAC1,6106
1,"""Primary open-angle glaucoma, strict""",2576
1,"Hyperthyroidism/thyrotoxicosis | non-cancer illness code, self-reported",178
1,Systemic lupus erythematosus or rheumatoid arthritis [same effect],178
1,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),43076
1,"Blood protein levels [TST, 12663_1_3]",32309
1,Impedance of arm (left),165865
1,Mood instability,175
1,CD14- CD16- Absolute Count,7160
1,Electrocardiogram morphology (amplitude at temporal datapoints) [202 ms],6782
1,Risk taking,8504
1,Systemic lupus erythematosus and Systemic sclerosis [lcSSc],4932
1,Spherical equivalent [EA],11076
1,Xalatan 0.005% eye drops | treatment/medication code,2001
1,Birth length,1863
1,Serum levels of protein YWHAE,3749
1,Sarcoidosis,2805
1,Hypothyroidism,63811
1,Tonsillectomy,11180
1,Neurofibrillary tangles (SNP x SNP interaction),57881
1,"Blood protein levels [PRLR, 9224_20_3]",11811
1,Myocardial infarction (early onset),4990
1,Cleft lip with or without cleft palate,5563
1,Serum levels of protein SOCS3,1320
1,Serum levels of protein IGFBP1,2027
1,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction) [women],344
1,Adult-onset Still disease,178
1,Electrocardiogram morphology (amplitude at temporal datapoints) [292 ms],3694
1,"Bone mineral density (paediatric, total body less head) [EA]",1257
1,Frequency of tenseness / restlessness in last 2 weeks,458
1,Hereditary deficiency of other clotting factors,94
1,Metabolite levels (lipoprotein measures) [Free cholesterol in medium HDL],641
1,Malignant neoplasm of bladder,190
1,Triglyceride levels in very small VLDL,23529
1,Congenital deficiency of other clotting factors (including factor vii),103655
1,Macular degeneration (senile) of retina nos,6106
1,Non-lobar intracerebral hemorrhage (MTAG),18318
1,Alpha-galactosidase A measurement,6106
1,Immune reponse to smallpox (secreted IL-2) [AA],1521
1,Serum levels of protein BCAN,15312
1,X-11787 levels,8763
1,Worry too long after an embarrassing experience,2874
1,CD3 on CD45RA+ CD4+ T cell,1785
1,Serum levels of protein LRIT3,4060
1,Serum alkaline phosphatase levels [conditional on round 5],431
1,Protein quantitative trait loci (liver) [CTSS],175
1,Pulmonary heart disease,228
1,Secondary parkinsonism,114
1,Facial morphology [right endocanthion-subnasale distance],583
1,CD33 on CD33dim HLA DR-,72
1,UBA1777 sp900319835 abundance in stool,4
1,Disease progression in age-related macular degeneration,7175
1,Central corneal thickness,7639
1,"Lipid metabolism phenotypes [VLDL.total, fasting]",23256
1,Hot drink temperature,1616
1,"Seen doctor (gp) for nerves, anxiety, tension or depression",7968
1,CD3 on CD8+ T cell,1785
1,Electrocardiogram morphology (amplitude at temporal datapoints) [196 ms],8769
1,"Blood protein levels [RNPEP, 12386_11_3]",2117
1,Manufactured cigarettes | type of tobacco previously smoked,456
1,"For short-sightedness, i.e. only or mainly for distance viewing such as driving, cinema etc (called 'myopia') | reason for glasses/contact lenses",131
1,Osteoarthritis; localized,953
1,Becloforte 250micrograms inhaler | treatment/medication code,1314
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-454 ms],423
1,Menorrhagia,94
1,Neurociticism,25184
1,"Asthma | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",15465
1,Electrocardiogram morphology (amplitude at temporal datapoints) [0 ms],22511
1,Serum levels of protein BACH1,6106
1,Statin medication,27934
1,"""Atopic  dermatitis, strict definition""",3469
1,Lumbar spine bone mineral density,1366
1,Mood swings,921
1,Corneal structure,1631
1,"Oesophagitis/barretts oesophagus | non-cancer illness code, self-reported",171
1,"Rheumatoid arthritis | non-cancer illness code, self-reported",178
1,Serum metabolite levels (CMS) [XL_VLDL_P],23845
1,Electrocardiogram morphology (amplitude at temporal datapoints) [332 ms],6253
1,"None of the above | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",3251
1,Albumin-globulin ratio,4828
1,Serum levels of protein DLL3,6106
1,Cholesterol [LDL],1786
1,"Hip circumference [EA,women]",2666
1,Electrocardiogram morphology (amplitude at temporal datapoints) [98 ms],1560
1,Anxiety and stress-related disorders (psychiatric co-morbidity weighting design),643
1,Serum metabolite concentrations in chronic kidney disease [N-palmitoylglycine],977
1,Protein quantitative trait loci (liver) [AKR1A1],1341
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-82 ms],86
1,Basal cell carcinoma,41628
1,AP-2 complex subunit alpha-2 measurement,6287
1,Atorvastatin | treatment/medication code,1941
1,Coronary heart disease x type 2 diabetes interaction,2027
1,Palmitic acid (16:0) levels,2032
1,Pre-treatment pain in head and neck squamous cell carcinoma,1471
1,Protein quantitative trait loci (liver) [ARSA],197
1,Urinary creatinine levels,6982
1,Fish- and plant-related diet [female],1802
1,One or more previous psychiatric episodes with this health care provider | history of psychiatric care on admission,750
1,Medication use (opioids),1769
1,"Blood protein levels [IL6R, 8092_29_3]",2290
1,Spine bone size,173
1,Home location - north co-ordinate (rounded),1054
1,Hay fever and/or eczema,15162
1,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [men],5187
1,Colorectal cancer [EA],4578
1,"Blood protein levels [EA, T-lymphocyte surface antigen Ly-9]",947
1,Heart rate [Conditonal on rs11118555],1924
1,QT interval (tricyclic/tetracyclic antidepressant use interaction) [Hispanic or Latino],125
1,Cocaine dependence (time to event),97
1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],45464
1,"Heel bone mineral density (bmd) t-score, automated (right)",24752
1,Cognitive traits (MTAG),3763
1,Warfarin | treatment/medication code,247
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-74 ms],86
1,BMI in non-smokers [women],148
1,Severe diabetic background retinopathy,272
1,"Blood protein levels [EA, P-Selectin]",128
1,Myocardial fractal dimension (slice 4),78
1,Manganese levels,3483
1,Gamma glutamyl transferase levels,359731
1,Left-handedness,39993
1,Serum levels of protein C8G,4719
1,Age first had sexual intercourse,12757
1,Contracture of palmar fascia [dupuytren's disease],5534
1,Eye color (saturation),8927
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-484 ms],423
1,Sum eosinophil basophil counts,56060
1,Diastolic blood pressure x smoking status (ever vs never) interaction (2df test),23164
1,IgA nephropathy [East Asian],4498
1,Serum levels of protein PPP2R3A,6106
1,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [hexanoylglycine,  isocaproylglycine,  X-16567,  X-24402]",52413
1,Vegetable consumption,26529
1,Other disorders of veins,1506
1,Serum metabolite levels [uracil],352
1,Mammographic density (dense area),1448
1,Inflammatory skin disease [Atopic dermatitis],11968
1,Ankylosing spondylitis [EA],7513
1,Red blood cell (erythrocyte) count,303750
1,Autoimmune diseases,14446
1,Eczema or dermatitis,2818
1,BMI at 1.5 years old,1057
1,Pyridoxal 5'-phosphate levels,38
1,1-stearoyl-2-linoleoyl-gpc (18:0/18:2) levels,30
1,Malignant neoplasm,89
1,Protein quantitative trait loci (liver) [KRT18],22
1,Maternal smoking around birth,13742
1,Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL) [AA],20275
1,CD64 on CD14+ CD16+ monocyte,15861
1,Trunk predicted mass,276554
1,Creatinine (enzymatic) in urine,2427
1,Body mass index (joint analysis main effects and smoking interaction) [EA],766
1,Acute ischemic stroke x type 2 diabetes interaction,1065
1,Type 1 diabetes without complications,178
1,"""Postprocedural endocrine and metabolic disorders, not elsewhere classified""",382
1,Metabolite levels,23211
1,Medication use (anilides),19701
1,Medication use (salicylic acid and derivatives),6225
1,Brain region volumes [left amygdala],6173
1,Neutrophill count,174607
1,Subcortical volume (min-P),11044
1,Brain region volumes [white matter],29774
1,Electrocardiogram morphology (amplitude at temporal datapoints) [164 ms],8640
1,Facial morphology (segment 41),235
1,Serum levels of protein GSKIP,6106
1,Electrocardiogram morphology (amplitude at temporal datapoints) [190 ms],6073
1,Body mass index (adult),148
1,Proprotein convertase subtilisin/kexin type 9 levels,5228
1,Nervous feelings,670
1,Levodopa wearing off effect (time symptoms uncontrolled) in Parkinson's disease (response to zonisamide),1083
1,Candidiasis,117
1,Matrix metalloproteinase-7 levels,511
1,Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy,34
1,Alcoholic chronic pancreatitis,161
1,Protein quantitative trait loci (liver) [GPX4],9
1,Advanced age-related macular degeneration [EA],6529
1,Platelet-to-lymphocyte ratio,47831
1,"Blood protein levels [NPPB, 7655_11_3]",9237
1,Psoriasis or type 2 diabetes (trans-disease meta-analysis),8159
1,Electrocardiogram morphology (amplitude at temporal datapoints) [264 ms],758
1,"""Other or unspecified ileus, impaction or obstruction""",5323
1,CD33 on CD33dim HLA DR+ CD11b+,1072
1,Neurological blood protein biomarker levels [FcRL2],2376
1,Waist circumference adjusted for BMI (adjusted for smoking behaviour) [men],4239
1,Cerebrospinal fluid biomarker levels [Hemopexin],1189
1,Anxiety/tension (special factor of neuroticism),545
1,Protein quantitative trait loci (liver) [SDHB],118
1,"Blood protein levels [Phospholipase A2, membrane associated]",74
1,"Blood pressure measurement (low sodium intervention) [MAP, during intervention]",11
1,Triacylglycerol_53:4_[M+NH4]1+ levels,26
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-148 ms],4748
1,Serum metabolite levels [oleoyl ethanolamide],6582
1,"Mean arterial pressure x alcohol consumption interaction (2df test) [AA, Asian, EA, Hispanic]",15951
1,Asthma [conditional],427
1,Calculus of kidney and ureter,405
1,Spinal stenosis,246
1,Social disorders starting during childhood or adolecense (more control exclusions),8
1,Feeling miserable,9864
1,Congenital coagulation defects,68414
1,Body mass index (bmi),304010
1,Leg predicted mass (right),220635
1,Sunburns,4397
1,BAFF-R on switched memory B cell,1072
1,Platelet aggregation [ADP],225
1,Serum levels of protein FCRL1,4501
1,COVID-19 (hospitalized vs population) RELEASE 5,755
1,Salt added to food,1870
1,"Blood protein levels [IFNLR1, 7192_37_3]",80
1,Gut microbiota (bacterial taxa) [Unclassified Acidaminococcaceae],60
1,Beef consumption,32
1,Digit length ratio (left hand),26477
1,Core binding factor acute myeloid leukemia,44925
1,High blood pressure | illnesses of siblings,18435
1,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [4-hydroxyglutamate,  5-hydroxylysine,  X-24462]",2176
1,Hypertension [East Asian],340
1,Doctor diagnosed asthma,449
1,Risedronate sodium | treatment/medication code,159
1,Body fat percentage [female],150
1,Age-related hearing impairment (MTAG),103
1,Caffeine consumption from coffee or tea,3962
1,Lysophosphatidylcholine_16:0_[M+H]1+/Lysophosphatidylethanolamine_19:0_[M+H]1+ levels,4818
1,C-reactive protein [AA Women],933
1,Serum metabolite levels [L_LDL_L],1923
1,Protein quantitative trait loci (liver) [AGXT],139
1,Mean platelet volume,1035561
1,Chronotype,358052
1,Serum levels of protein CNDP2,6106
1,acne vulgaris,15471
1,Stable angina pectoris,12138
1,Other erythrocyte phenotypes [MCHC],1861
1,Diabetes | illnesses of adopted siblings,2868
1,Soluble E-selectin levels,3177
1,Anthropometric traits [height],246
1,Spontaneous coronary artery dissection,5731
1,Arthritis (juvenile idiopathic),1715
1,Protein quantitative trait loci (liver) [DDB1],24
1,"Aspirin | medication for pain relief, constipation, heartburn",1923
1,Serum levels of protein KERA,161
1,Brain morphology (MOSTest),244439
1,Dilated cardiomyopathy (MTAG),13465
1,Serum levels of protein PIGR,4592
1,Glutamine levels,154
1,Disorders of choroid and retina,6284
1,Sleeplessness / insomnia,2188
1,LDL cholesterol levels in current drinkers [Hispanic],2027
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-94 ms],86
1,Cortical thickness [Superior parietal],89
1,HVEM on CD45RA- CD4+ T cell,6812
1,PDL-1 on monocyte,8769
1,Serum levels of protein DEFB132,6106
1,Serum levels of protein CAT,1923
1,Ever smoked,15297
1,Electrocardiogram morphology (amplitude at temporal datapoints) [142 ms],6180
1,Serum metabolite levels (CMS) [L_VLDL_P],589
1,Substance abuse (more control exclusions),251
1,Lung adenocarcinoma,178
1,Hypertensive Heart Disease,503
1,Pediatric autoimmune diseases,866
1,Depressive symptom (low self-esteem) (ordinal trait),1644
1,Male puberty timing (early vs. average onset facial hair),6273
1,Chronic obstructive pulmonary disease x current smoker interaction (main effect),554
1,Serum levels of protein SELPLG,779
1,Blood pressure [Mean Arterial Pressure],18393
1,Tumor necrosis factor beta levels,493
1,Fasting blood insulin (BMI interaction),545
1,Leiomyoma of uterus (controls excluding all cancers),1269
1,Alzheimer's disease (onset between ages 58 and 79),1148
1,Body fat distribution (trunk fat ratio) [males],246
1,Ever sought or received professional help for mental distress,117
1,Triglyceride levels x long total sleep time interaction (2df test),23411
1,Waist circumference adjusted for BMI in non-smokers [men],3565
1,Brain region volumes [right pallidum],12306
1,Arm fat percentage (right),89992
1,Electrocardiogram morphology (amplitude at temporal datapoints) [108 ms],2603
1,Electrocardiogram morphology (amplitude at temporal datapoints) [240 ms],3695
1,Serum C-reactive protein concentration in high fat diet,652
1,Problematic alcohol use,651
1,Systemic connective tissue disorders,1047
1,"Other abdominal problem | non-cancer illness code, self-reported",2136
1,Serum metabolite levels (CMS) [M_LDL_FC],1923
1,Rate of cognitive decline in mild cognitive impairment (time interaction),851
1,Serum levels of protein CDSN,113
1,1-arachidonoyl-gpc (20:4n6) levels,582
1,Protein quantitative trait loci (liver) [PCCB],16
1,Eosinophil percentage of granulocytes,56276
1,Job involves heavy manual or physical work,24142
1,Serum levels of protein EFCAB14,6106
1,Electrocardiogram morphology (amplitude at temporal datapoints) [368 ms],3694
1,Serum levels of protein LAMC2,2956
1,Gut bacterial pathway abundance (HISDEG.PWY..L.histidine.degradation.I),929
1,Phlebitis and thrombophlebitis,3817
1,Neurological blood protein biomarker levels [DRAXIN],439
1,"""Type 2 diabetes, definitions combined, including avohilmo""",1756
1,"Blood protein levels [IL23R, 5088_175_3]",542
1,Other and unspecified coagulation defects,450
1,CD33 on basophil,72
1,Optic disc size,60848
1,White matter microstructure (mode of anisotropy) [Superior corona radiata],53762
1,Pattern 4 | hair/balding pattern,24490
1,Self-rated health,3432
1,Cardiac arrhytmias,3862
1,Seropositive rheumatoid arthritis,178
1,Pernicious anemia,287
1,Heart rate response to recovery post exercise,146
1,Neutrophil count,1136286
1,Diffuse large B-cell lymphoma or multiple sclerosis,2013
1,Medication use (glucocorticoids),2167
1,T wave morphology restitution during exercise (MTAG),4080
1,Systemic sclerosis,12752
1,Nonsyndromic cleft lip with cleft palate,4049
1,Total cholesterol levels [BMI unadjusted],1786
1,Akkermansia muciniphila B abundance in stool,4001
1,Interleukin-1 receptor type 1 measurement,6106
1,Cerebrovascular diseases (FINNGEN),255
1,Diabetic nephropathy,178
1,Bipolar disorder,909
1,Neuroticism,99720
1,Total cholesterol levels [Hispanic],25251
1,Electrocardiogram morphology (amplitude at temporal datapoints) [138 ms],6662
1,O levels/gcses or equivalent | qualifications,5303
1,"Skin cancer | cancer code, self-reported",878
1,Stress-related disorders,643
1,"""Ulcerative colitis (strict definition, require KELA)""",2367
1,Gut bacterial pathway abundance (PWY_REDCITCYC..TCA.cycle.VIII..helicobacter.),61
1,Sum neutrophil eosinophil counts,106908
1,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],23143
1,N-terminal prohormone brain natriuretic peptide levels,18252
1,Electrocardiogram morphology (amplitude at temporal datapoints) [322 ms],6253
1,Female genital prolapse,1269
1,Age-related macular degeneration (MTAG),12147
1,Urinary electrolytes (magnesium/calcium ratio),301
1,Cortical surface area [Inferior Parietal],251
1,Trazodone | treatment/medication code,730
1,Other coagulation defects,22
1,HDL cholesterol levels,464614
1,Miserableness,13014
1,Platelet aggregation [ephinephrine low 2],225
1,"Blood protein levels [SLAMF7, 5487_7_3]",1717
1,"Blood protein levels [EA, SLAM family member 7]",262
1,Femoral neck bone mineral density and trunk fat mass adjusted by trunk lean mass,1
1,Granulocyte percentage of myeloid white cells,98273
1,CD62L- myeloid Dendritic Cell Absolute Count,16861
1,Malaria,3803
1,Serum levels of protein CFHR4,3413
1,"Blood protein levels [GSTM3, 9748_31_3]",3295
1,"""Tooth agenesis EXCLUDE clefts and syndromes , including avohilmo""",1769
1,Electrocardiogram morphology (amplitude at temporal datapoints) [236 ms],3695
1,Frequency of needing morning drink of alcohol after heavy drinking session in last year,23
1,Protein quantitative trait loci (liver) [HSD17B4],80
1,Electrocardiogram morphology (amplitude at temporal datapoints) [308 ms],6253
1,C-reactive protein levels or triglyceride levels (pleiotropy),17693
1,Serum levels of protein ANGPTL1,7077
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-158 ms],4834
1,BMI at 6 months old,1057
1,Moyamoya disease,4370
1,Autoimmune hyperthyroidism,178
1,Serum levels of protein CHIT1,346
1,"Pulse pressure x alcohol consumption interaction (2df test) [Asian, EA]",19186
1,Electrocardiogram morphology (amplitude at temporal datapoints) [324 ms],6253
1,Serum levels of protein NRP1,592
1,LDL cholesterol [Hispanic],2156
1,CD3 on CD45RA- CD4+ T cell,890
1,Irritable mood,1869
1,Depressive symptoms,51713
1,Liver enzyme levels (alanine transaminase),148112
1,Serum levels of protein ANGPTL3,46837
1,Serum metabolite levels [LA],23256
1,Leg predicted mass (left),209910
1,Subjective well-being,329
1,Free thyroxine concentration,2158
1,Sensitivity / hurt feelings,7927
1,Myo-inositol levels,1277
1,Skimmed | milk type used,1288
1,CD3 on Effector Memory CD4+ T cell,890
1,Number of fluid intelligence questions attempted within time limit,1455
1,Anthropometric traits (multi-trait analysis),246
1,Glycine levels,160171
1,IgG levels,8795
1,Interleukin-7 receptor subunit alpha measurement,6106
1,Serum levels of protein SYT11,5311
1,Electrocardiogram morphology (amplitude at temporal datapoints) [22 ms],27398
1,Brain region volumes [right cerebellum exterior],4720
1,Electrocardiogram morphology (amplitude at temporal datapoints) [330 ms],6253
1,"Duodenal ulcer | non-cancer illness code, self-reported",134
1,Number of treatments/medications taken,3790
1,Vitamin B12 deficiency anaemia,178
1,Childhood body fatness,930
1,Platelet aggregation [ephinephrine high 2],225
1,Swelling of limb,112
1,Triglyceride levels in current drinkers,23211
1,Diabetes,23241
1,IgM levels,7471
1,Body mass index in physically active individuals [women],2861
1,Chitinase-3-like protein 1 levels,5365
1,Blood protein levels [SLAM family member 7],3362
1,Microvirga abundance in stool,15
1,Serum levels of protein PON1,6106
1,Breast cancer [East Asian],1815
1,Parental lifespan,1047
1,Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event) [EA],992
1,Glioblastoma,502
1,Fasting insulin adjusted for BMI,190
1,LDL cholesterol levels x short total sleep time interaction (2df test),25143
1,Waist-hip index,56235
1,Lipid traits [TC],23950
1,Complement factor H-related protein 5 levels,1392
1,Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis),6898
1,"Heel bone mineral density (bmd) t-score, automated (left)",18803
1,WU polyomavirus VP1 antibody levels,14195
1,Asthma (childhood onset),18962
1,"Blood protein levels [B4GALT2, 9595_11_3]",4695
1,Electrocardiogram morphology (amplitude at temporal datapoints) [318 ms],6253
1,Electrocardiogram morphology (amplitude at temporal datapoints) [64 ms],1245
1,Cardiac congenital anomalies,142
1,Peptic ulcer,9
1,Depression (broad),9574
1,Adventurousness,140280
1,Cortical surface area (MOSTest),33983
1,CCR2 on CD62L+ myeloid Dendritic Cell,7121
1,"Medication use (adrenergics, inhalants)",17038
1,Age at menopause (last menstrual period),68259
1,Serum levels of protein CD55,6157
1,Pyruvate levels,1521
1,Electrocardiogram morphology (amplitude at temporal datapoints) [42 ms],1653
1,Rheumatoid arthritis and other inflammatory polyarthropathies,178
1,Pelvic organ prolapse,1269
1,Brain region volumes [right lingual],34
1,Eotaxin levels,113
1,Protein quantitative trait loci (liver) [TNC],34
1,Serum levels of protein HDGF,4920
1,"Heel broadband ultrasound attenuation, direct entry",88502
1,Cerebrospinal fluid biomarker levels [Leptin receptor],2206
1,Takayasu arteritis,4039
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-472 ms],423
1,Cortical surface area [Superior Frontal],931
1,Serum metabolite levels (CMS) [L_LDL_FC],1923
1,"Blood clot in the leg (dvt) | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",68
1,IDL particle concentration,45
1,Worry too long after embarrassment,5993
1,Varicose veins,24702
1,"Bone mineral density (paediatric, total body less head)",2530
1,"Systolic blood pressure x alcohol consumption interaction (2df test) [EA, Hispanic]",3450
1,Cortical surface area [Posterior Cingulate],277
1,"Blood protein levels [H6PD, 7161_25_3]",1750
1,"Fracture jaw | non-cancer illness code, self-reported",1591
1,Idiopathic central precocious puberty,402
1,Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease,1810
1,Urinary metabolite levels in chronic kidney disease [kynurenate],37
1,Congenital iodine-deficiency syndrome/hypothyroidism,178
1,Morningness,154162
1,Testosterone levels,54532
1,Average total household income before tax,13127
1,Serum levels of protein POLR1C,6106
1,Haemoglobin concentration,221394
1,"Waist circumference adjusted for BMI in active individuals [EA, men]",3989
1,"Multiple sclerosis | non-cancer illness code, self-reported",474
1,Waist-hip ratio,174234
1,C-reactive protein levels,360249
1,Eye color [discovery],1036
1,"""Parkinson's disease, strict definition (more control exclusions)""",1169
1,Serum levels of protein BAMBI,6106
1,Keloid,382
1,COPD/asthma/ILD related pneumonia or pneumonia derived septichaemia,155
1,Serum levels of protein PTGFRN,362
1,Protein quantitative trait loci (liver) [SLC25A3],118
1,Smoking initiation (ever regular vs never regular) [Conditioned on chr1:236872829],26
1,Immune response to measles vaccine (measles-specific neutralising antibody titre),9187
1,Triglyceride levels,633509
1,Serum metabolite levels [palmitoyl ethanolamide],11830
1,Skin removed from poultry,11618
1,Serum total cholesterol levels,1923
1,Serum metabolite levels (CMS) [L_VLDL_PL],592
1,Urticaria,216
1,Recent worrying too much about different things,46
1,Facial morphology (segment 2),167
1,Arm predicted mass (right),248422
1,Actinic keratosis,5806
1,Urinary metabolite levels in chronic kidney disease [X - 24518],3709
1,CD3 on Central Memory CD8+ T cell,890
1,Gut microbiota (bacterial taxa) [OTU13305 FecalibacteriumSpecies-level OTU],508
1,"Blood protein levels [AMY2B, 10439_57_3]",180
1,Lymphocyte percentage of white cells,427453
1,Serum metabolite levels (CMS) [HDL_TG],23211
1,Electrocardiogram morphology (amplitude at temporal datapoints) [254 ms],1073
1,"Blood protein levels [EA, Leptin receptor]",666
1,Body fat distribution (arm fat ratio) [males],150
1,Hallucinations in long-term cannabis use,21
1,Age-related hearing impairment [recessive],6
1,Hypertension,269381
1,Corneal curvature,69935
1,Educational attainment (MTAG) [MTAG],318790
1,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [women],5612
1,Smoking status (current vs never) [EA],27349
1,Sex hormone-binding globulin levels adjusted for BMI,713609
1,Serum metabolite levels [L_LDL_P],1923
1,"Blood protein levels [HDGF, 8953_47_3]",4920
1,Asthma (adult onset),2939
1,"Schizophrenia, schizoaffective disorder or bipolar disorder",288
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-500 ms],423
1,Smoking status,38140
1,Waist circumference adjusted for body mass index [EA],12530
1,Body fat distribution (arm fat ratio) [females],12242
1,Weight,561875
1,Serum levels of protein IL36A,6106
1,"Blood protein levels [CEACAM7, 7184_13_3]",17561
1,Metabolic disorders,1941
1,Sleep duration,8649
1,Butyrate (4:0) levels,1153
1,Electrocardiogram morphology (amplitude at temporal datapoints) [378 ms],3694
1,Wheeze or whistling in the chest in last year,3640
1,Electrocardiogram morphology (amplitude at temporal datapoints) [176 ms],6427
1,Length of mobile phone use,2486
1,Electrocardiogram morphology (amplitude at temporal datapoints) [280 ms],3694
1,"Blood protein levels [PTPRU, 8337_65_3]",166
1,Reticulocyte count,614640
1,Body fat percentage or coronary artery disease (MTAG),7004
1,Serum metabolite levels (CMS) [TotFA],23256
1,Nontoxic multinodular goitre,8106
1,Fish- and plant-related diet,18607
1,1-stearoyl-2-arachidonoyl-gpc (18:0/20:4) levels,3532
1,"Blood protein levels [BCAN, 3461_58_1]",10534
1,"Lipid metabolism phenotypes [LDL.total, fasting]",1923
1,Serum metabolite levels [M_LDL_CE],1923
1,Serum levels of protein C8A;C8B;C8G,102
1,Triacylglycerol_53:5_[M+NH4]1+ levels,26
1,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [X-11852,  X-21803,  X-24403]",6
1,Coagulation defects,41451
1,QRS complex (12-leadsum) [EA],44873
1,Insomnia symptoms (never/rarely vs. usually),27883
1,B-type natriuretic peptide levels,9698
1,Obesity [Obesity class II],2076
1,Gut microbiota (bacterial taxa) [Prevotella_oulorum],4517
1,Cerebrospinal fluid biomarker levels [Interleukin-6 receptor subunit alpha],4597
1,COPD/asthma/ILD related infections,1277
1,Taking other prescription medications,858
1,Vogt-Koyanagi-Harada syndrome,920
1,"Blood protein levels [EA, Phospholipase A2, membrane associated]",284
1,Disorders of lens,101
1,Diverticulosis and diverticulitis,24176
1,Blood metabolite ratios [ADSGEGDFXAEGGGVR/ADpSGEGDFXAEGGGVR],1341
1,Age-related hearing impairment (high frequency) [EA],66195
1,Protein FAM162A measurement,23068
1,Keratoconus,6583
1,Primary biliary cirrhosis,3300
1,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],2027
1,Tooth agenesis,1489
1,Waist-to-hip ratio adjusted for BMI x sex interaction,516
1,CD3 on CD28- CD8+ T cell,921
1,Calculus of kidney,78
1,Rheumatoid arthritis (ACPA-positive),27169
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-8 ms],21397
1,Cereal intake,12804
1,Pediatric bone mineral content (hip) [Males],5919
1,Electrocardiogram morphology (amplitude at temporal datapoints) [194 ms],6073
1,GDP-fucose protein O-fucosyltransferase 1 measurement,6106
1,Fusobacterium A abundance in stool,2633
1,Serum levels of protein TMCC3,6106
1,Type 1 diabetes with ophthalmic complications,178
1,Celiac disease or Rheumatoid arthritis,297
1,"Sciatica | non-cancer illness code, self-reported",153
1,"Allergic disease (asthma, hay fever and/or eczema) (age of onset)",29100
1,"Blood protein levels [CFP, 2960_66_2]",30760
1,Electrocardiogram morphology (amplitude at temporal datapoints) [56 ms],1511
1,Serum levels of protein NPTX2,3749
1,Blood protein levels [Coagulation Factor V],2371
1,Multiple sclerosis [Cluxel size],36
1,Longest period of depression,3
1,Intraocular pressure,150202
1,Estimated glomerular filtration rate,570791
1,Tense / 'highly strung',23306
1,Serum uric acid levels [Japanese],25061
1,Systemic lupus erythematosus [conditional],4048
1,Serum levels of protein PIK3CG,6106
1,Gut microbiota presence (genus Turicibacter id.2162),61
1,Ribulonate/xylulonate levels,1748
1,Gut microbiota (functional units) [POLYAMINSYN3-PWY_superpathway_of_polyamine_biosynthesis_II],9773
1,Recent feelings of tiredness or low energy,1644
1,Endometriosis or depression (pleiotropy),1858
1,Serum levels of protein EHBP1,3855
1,Thyroxine sodium | treatment/medication code,178
1,Diastolic blood pressure [Japanese],164
1,Hashimoto thyroiditis versus Graves' disease,3878
1,HDL cholesterol x physical activity interaction (2df test),62158
1,"Forced expiratory volume in 1-second (fev1), predicted",145185
1,Serum levels of protein RBP7,6106
1,Glaucoma (low intraocular pressure),1976
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-104 ms],1163
1,Hypertension risk in short sleep duration [SNP+sleep],874
1,Type 1 diabetes with coma,178
1,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event) [Cox proportional hazards regression model],61
1,White matter microstructure (radial diusivities) [Retrolenticular part of internal capsule],20
1,Cataracts [male],5344
1,Calcichew 1.25g chewable tablet | treatment/medication code,87
1,Thyroid hormone levels [TSH - Males],2145
1,C-reactive protein [AA women],1618
1,Smoking initiation (ever regular vs never regular) [Conditioned on chr1:73824909],680
1,"Fracture tibia | non-cancer illness code, self-reported",690
1,Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis),178
1,Eczema,33562
1,Urinary metabolite levels in chronic kidney disease [glucuronide of C10H18O2 (11],4635
1,CD86+ myeloid Dendritic Cell Absolute Count,8728
1,Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis),8037
1,Serum metabolite levels [IDL_P],1923
1,Endoplasmic reticulum lectin 1 measurement,6106
1,Paralytic ileus and intestinal obstruction,5323
1,"Blood protein levels [EA, Coagulation Factor V]",93
1,Blood metabolite levels [glutaroyl carnitine],346
1,White matter hyperintensity volume (adjusted for hypertension),21259
1,Lifetime number of sexual partners,7182
1,HLA DR+ Natural Killer  %CD3- lymphocyte,8728
1,Serum metabolite levels [imidazole lactate],32045
1,None of the above | vascular/heart problems diagnosed by doctor,113078
1,Fluid intelligence score,42624
1,Urinary albumin-to-creatinine ratio [EA],26496
1,Electrocardiogram morphology (amplitude at temporal datapoints) [116 ms],21881
1,Electrocardiogram morphology (amplitude at temporal datapoints) [270 ms],758
1,"Aging traits (healthspan, parental lifespan or longevity) (multivariate analysis)",2970
1,Coronary artery disease or ischemic stroke,2163
1,Cerebrospinal fluid biomarker levels [Low affinity immunoglobulin gamma Fc region receptor II-a/b],1943
1,Hematological and biochemical traits [ALP],239
1,Diabetic nephropathy (more control exclusions),178
1,Antitragus size,26
1,Creatinine levels,456821
1,"Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",20093
1,"Systolic blood pressure x alcohol consumption interaction (2df test) [Asian, EA]",18634
1,A levels/as levels or equivalent | qualifications,24115
1,Mean platelet (thrombocyte) volume,328837
1,"Basal cell carcinoma | cancer code, self-reported",3309
1,Ventral hernia,1066
1,LDL cholesterol levels in current drinkers [Asian],2027
1,Smoking initiation (ever regular vs never regular) [Conditioned on chr1:154206358],530
1,Electrocardiogram morphology (amplitude at temporal datapoints) [376 ms],3694
1,"""Coagulation defects, purpura and other haemorrhagic conditions""",22
1,Cortical thickness (min-P),133
1,Early-onset Parkinson's disease,17
1,Gastroesophageal reflux disease,27674
1,Liver enzyme levels [ALP],2895
1,Ceramide levels [N24S19 ratio],8583
1,CD16-CD56 on HLA DR+ Natural Killer,8728
1,Interleukin-2 receptor subunit beta measurement,6106
1,Oxalate (ethanedioate) levels,8787
1,Serum metabolite levels [2'-O-methylcytidine],3351
1,Cosopt 2%/0.5% eye drops | treatment/medication code,2001
1,CD16-CD56 on Natural Killer,686
1,"Blood protein levels [EA, Extracellular matrix protein 1]",8817
1,Body mass index (age <50),1397
1,Serum metabolite levels (CMS) [XL_HDL_FC],296
1,BMI (adjusted for smoking behaviour) [EA],766
1,Brain region volumes [left cerebellum white matter],49
1,IgD+ CD24- B cell %B cell,27
1,DVT of lower extremities and pulmonary embolism,22
1,Erythrocyte sedimentation rate,96464
1,Educational attainment,5200
1,Comparative height size at age 10,281714
1,Simvastatin | treatment/medication code,25859
1,Electrocardiogram morphology (amplitude at temporal datapoints) [32 ms],28853
1,"""Ulcerative colitis (strict definition, require KELA, min 2 HDR)""",2836
1,"Blood protein levels [IL10RA, 10344_334_3]",6470
1,Serum levels of protein TFPI,106
1,Ear morphology,26
1,Basophil percentage of white cells,183835
1,Alcohol consumption (drinks per week),17330
1,Total triglycerides levels,24006
1,HDL cholesterol levels [Trans-ethnic initial],51554
1,Waist-to-hip ratio adjusted for BMI in active individuals [EA],5094
1,"Diastolic blood pressure [EA, initial]",35543
1,Externalizing behaviour (multivariate analysis),96315
1,Lumbar spine bone mineral density (integral),1769
1,Protein quantitative trait loci (liver) [SLC25A5],3391
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-10 ms],1338
1,Serum levels of protein KLK6,6106
1,Serum metabolite levels (CMS) [S_LDL_P],1923
1,LDL cholesterol levels x long total sleep time interaction (2df test),71116
1,Ease of skin tanning,107505
1,Serum levels of protein MATN3,6106
1,Serum levels of protein ERO1B,6809
1,"Dark brown | hair colour (natural, before greying)",62746
1,CD86+ plasmacytoid Dendritic Cell %Dendritic Cell,8769
1,Serum metabolite levels [10undecenoate111n1],11128
1,None of the above | qualifications,44245
1,Monobrow,4128
1,Serum levels of protein AKR7A2,2529
1,Phlebitis and thrombophlebitis of lower extremities,3817
1,D-dimer levels,1021
1,Hyperinsulinemia in less-fat diet,5
1,Tuberculosis,9513
1,Midregional pro atrial natriuretic peptide levels,18393
1,Serum levels of protein AHSA1,6106
1,Serum levels of protein STIP1,6106
1,"""Diabetes, insuline treatment (Kela reimbursement) (more control exclusions)""",3279
1,Inflammatory biomarkers (multivariate analysis),4139
1,End-stage coagulation [FXIIIB],1952
1,Serum levels of protein KMT2D,6106
1,"""Hyperlipidaemia, other/unspecified""",2045
1,CD14+ CD16+ monocyte Absolute Count,8728
1,1-stearoyl-2-oleoyl-gpc (18:0/18:1) levels,216
1,Never/rarely use spread | spread type,32
1,Serum total protein level,494694
1,Hyperlipidemia,25451
1,Serum levels of protein HNRNPAB,6106
1,Atrial fibrillation and flutter,10040
1,Arthropathies,5593
1,Daytime dozing / sleeping (narcolepsy),11356
1,Frusemide | treatment/medication code,549
1,Prochlorperazine | treatment/medication code,2243
1,Body mass index variance,671
1,Food supplement/plant/herbal extract | treatment/medication code,2176
1,Incident atrial fibrillation,771
1,Average weekly beer plus cider intake,146
1,"Allergic disease (asthma, hay fever or eczema)",32071
1,Medication use (beta blocking agents),53741
1,Heel bone mineral density (MTAG),16717
1,CD62L- myeloid Dendritic Cell %Dendritic Cell,14697
1,CD62L on CD62L+ plasmacytoid Dendritic Cell,6900
1,Cystatin C levels,342636
1,Electrocardiogram morphology (amplitude at temporal datapoints) [316 ms],6253
1,Serum levels of protein UTS2,6106
1,"Blood protein levels [EA, Properdin]",4821
1,Serum metabolite levels [10-undecenoate (11:1n1],4625
1,Blood protein levels [IL6R],2434
1,Femoral neck bone mineral density,3377
1,Serum metabolite levels [S-methylcysteine],1702
1,"""Endomtriosis ASRM stages 1,2""",1129
1,Waist circumference adjusted for BMI (adjusted for smoking behaviour),7621
1,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)",60895
1,"Intra-ocular pressure, corneal-compensated (right)",2027
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-4 ms],22511
1,Pattern 3 | hair/balding pattern,5811
1,"""Disorders of gallbladder, biliary tract and pancreas""",2693
1,"Blood protein levels [AKR1A1, 4192_10_2]",1380
1,Acute graft versus host disease in bone marrow transplantation (recipient effect),745
1,White blood cell count [African],278
1,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),70567
1,Low density lipoprotein cholesterol levels [EA],79822
1,Vertex-wise sulcal depth,515225
1,Immunoglobulin G measurement,8050
1,Protein levels in obesity [Factor H],3811
1,Periodontal disease-related phenotype (Socransky),6044
1,Bipolar disorder or body mass index,1511
1,Waist circumference variance,135
1,1-palmitoyl-2-arachidonoyl-gpc (16:0/20:4n6) levels,74
1,Hyperparathyroidism,82
1,Osteoporosis,33619
1,Serum levels of protein TIMP3,46987
1,Electrocardiogram morphology (amplitude at temporal datapoints) [276 ms],4452
1,6mm strong meridian (right),67585
1,Obesity,780
1,Select biomarker traits [MCP1],2392
1,"Blood protein levels [FAM151A, 7856_51_3]",2569
1,Sleep end time,182
1,Mean corpuscular hemoglobin,1393618
1,Serum levels of protein CFHR5,16478
1,Alcohol consumption,5475
1,"Body mass index in physically active individuals [EA,women]",2670
1,Gamma-glutamyl-alpha-lysine levels,1490
1,Serum levels of protein GP6,674
1,Electrocardiogram morphology (amplitude at temporal datapoints) [126 ms],872
1,BAFF-R on IgD+ CD24- B cell,1072
1,Serum levels of protein PTPRU,167
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-92 ms],86
1,Multiple sclerosis,132385
1,"None of the above | medication for pain relief, constipation, heartburn",41925
1,Serum levels of protein GALK1,5851
1,Serum levels of protein OSM,6106
1,Migraine without aura and/or diastolic blood pressure,5848
1,Low density lipoprotein cholesterol levels [Indian],2027
1,Lactate dehydrogenase levels,3908
1,Electrocardiogram morphology (amplitude at temporal datapoints) [242 ms],3568
1,"Lipid metabolism phenotypes [APOB.assay, fasting]",1923
1,"Age hay fever, rhinitis or eczema diagnosed",408
1,Waist-to-hip ratio adjusted for BMI (age >50) [women],516
1,Granulocyte count,114344
1,Triglyceride levels in current drinkers [AA],23211
1,CD62L- Dendritic Cell Absolute Count,8728
1,Protein quantitative trait loci [ECM1],25064
1,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),4997
1,Psoriasis [EA],4478
1,Serum levels of protein MRPL58,580
1,Past tobacco smoking,17626
1,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) [men],4089
1,Medication use (antithrombotic agents),3950
1,Neutrophil-to-lymphocyte ratio,107203
1,Heel bone mineral density (bmd) (right),35955
1,Monocyte percentage,197935
1,Inflammatory skin disease [Psoriasis],5043
1,White blood cell count [AA],2048
1,Body mass index in physically active individuals [EA],6250
1,Electrocardiogram morphology (amplitude at temporal datapoints) [290 ms],3694
1,White matter microstructure (mode of anisotropy) [Superior longitudinal fasciculus],753
1,Pain medicine use during menstruation,181
1,Background diabetic retinopathy,178
1,Serum levels of protein CD3G,14
1,Prostate-specific antigen levels,20115
1,Very small VLDL particle concentration,46467
1,Colorectal cancer or advanced adenoma,35667
1,Endometriosis [EA],1250
1,"Body mass index (joint analysis main effects and physical activity interaction) [EA, women]",4663
1,Physical activity (Total log acceleration 6pm-8pm),5969
1,Brain region volumes [right amygdala],2498
1,Eye or eyelid problem,2001
1,Calcific aortic valve stenosis,663
1,Gut microbiota (functional units) [UBISYN-PWY_superpathway_of_ubiquinol-8_biosynthesis_(prokaryotic],620
1,Neutrophil level response to clozapine in treatment-resistant schizophrenia,255
1,Serum levels of protein TNFRSF11B,6106
1,"""Hypothyroidism,  other/unspecified""",17857
1,Complement C3 levels [EA],1475
1,Protein S100-A12 levels,9948
1,Benign neoplasms,7095
1,Non-melanoma skin cancer,4281
1,Blood metabolite levels [alpha-hydroxyisovalerate],1085
1,Myasthenia gravis,356
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-470 ms],423
1,"Long-standing illness, disability or infirmity",925
1,"Blood protein levels [S100A7, 7916_10_3]",326
1,Chronic obstructive pulmonary disease,17365
1,Serum metabolite concentrations in chronic kidney disease [Nonanoylcarnitine],26600
1,CAG-245 abundance in stool,2355
1,Endometriosis of pelvic peritoneum,1129
1,Serum metabolite levels [TG_PG],1221
1,Coagulation Factor VIII measurement,4006
1,"Anorexia/bulimia/other eating disorder | non-cancer illness code, self-reported",205
1,"Neurological, eye or psychiatric disease",5501
1,Lymphocyte percentage,275806
1,Coronary atherosclerosis,16116
1,Electrocardiogram morphology (amplitude at temporal datapoints) [208 ms],6274
1,Benign neoplasm: Adrenal gland (controls excluding all cancers),5161
1,Thyroid hormone levels [FT4-Males],2158
1,Coffee intake,327
1,Electrocardiogram morphology (amplitude at temporal datapoints) [78 ms],1560
1,Large artery stroke (CCSp classification)j,82
1,CD45 on granulocyte,1052
1,Heel bone mineral density (bmd),103219
1,Electrocardiogram morphology (amplitude at temporal datapoints) [204 ms],6782
1,Serum levels of protein IL12RB2,2337
1,Leprosy,2776
1,Autoimmune traits,22225
1,Digit length ratio (left hand) [EA],26477
1,Cognitive aspects of educational attainment,98057
1,Serum levels of protein MYOM3,6106
1,Forns index in high alcohol intake,1982
1,Triglyceride levels [African American],510
1,Serum levels of protein CD48,1491
1,"Blood protein levels [LY9, 3324_51_1]",1638
1,Hypertrophic scar,1120
1,Cholesterol ester levels in medium HDL,592
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-486 ms],423
1,Monocyte chemoattractant protein-4 levels,113
1,Meniere disease,11
1,"Blood protein levels [PLA2G2A, 2692_74_2]",483
1,Protein quantitative trait loci (liver) [F2],23
1,Diisocyanate-induced asthma,17
1,HDL cholesterol,274356
1,Balding type 1,109204
1,Diabetes diagnosed by doctor,19545
1,"Diastolic blood pressure x alcohol consumption interaction (2df test) [AA, EA]",17276
1,Serum levels of protein SPINT1,3043
1,Cystic fibrosis-related diabetes,1328
1,Wrist | fractured bone site(s),3607
1,CD3 on resting CD4 regulatory T cell,1143
1,Serum levels of protein SUMF1,713
1,An181 abundance in stool,154
1,Dysmenorrheic pain,181
1,Sex hormone-binding globulin levels [Men + Women],3218
1,6mm strong meridian angle (left),3358
1,"Diabetes | non-cancer illness code, self-reported",8061
1,Serum metabolite levels [dodecanedioate],4625
1,Glaucoma suspect,2788
1,CD3 on CD28+ CD45RA+ CD8+ T cell,1785
1,Serum levels of protein CHGA,106
1,White matter microstructure (global fractional anisotropy),73
1,Other arthropathies,49
1,Salamol 100micrograms inhaler | treatment/medication code,8
1,Alcohol dependence,13710
1,Crohn's disease [EA],36223
1,LDL cholesterol levels,270064
1,Electrocardiogram morphology (amplitude at temporal datapoints) [60 ms],1733
1,Waist circumference adjusted for BMI in active individuals [men],5376
1,Longest period of unenthusiasm / disinterest,1296
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-100 ms],1163
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-76 ms],86
1,Glyceryl trinitrate | treatment/medication code,901
1,Mouth ulcers,22273
1,Injury or trauma resulting in loss of vision | eye problems/disorders,1529
1,Scalp hair shape,351
1,Unstable angina pectoris,2316
1,"""Ulcerative colitis (strict definition, all Crohn cases excluded)""",4651
1,Serum levels of protein SLAMF7,1456
1,Finger osteoarthritis,1920
1,Interleukin-6 (red blood cell fatty acid level interaction) [ALA],224
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-6 ms],21397
1,Hypertensive diseases,5613
1,Cortical surface area [Pericalcarine],10116
1,Blood metabolite levels [Stearoylcarnitine],177
1,White matter microstructure (fractional anisotropy) [Superior corona radiata],93
1,Heel bone mineral density variance,53
1,Autoimmune traits (pleiotropy),20903
1,Brain region volumes [left hippocampus],1714
1,"""Hypothyroidism, strict autoimmune""",7700
1,Total body bone mineral density,5730
1,Cleft lip with or without cleft palate or cleft palate (pleiotropy),2272
1,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant II (Nose), Segment 47]",413
1,"Blood protein levels [EA, C-C motif chemokine 1]",584
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-160 ms],86
1,C-X-C motif chemokine 6 levels,113
1,Metabolite levels [C12/C10],52589
1,Red cell distribution width,2138262
1,Subjective well-being (MTAG),9883
1,C-reactive protein levels [BMI-adjusted],17958
1,Myeloid Dendritic Cell Absolute Count,9414
1,1-carboxyethylvaline levels,3088
1,Serum levels of protein MFAP2,3888
1,"Hayfever, allergic rhinitis or eczema | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",18988
1,Parental longevity (father's attained age),1923
1,Protein quantitative trait loci (liver) [FKBP1A],156
1,Heart failure,2121
1,Protein quantitative trait loci (liver) [ACSM2A],128
1,Protein quantitative trait loci (liver) [S100A4],159
1,Anxiety [EA],18
1,Potassium levels,148
1,Age-related macular degeneration (choroidal neovascularisation),6106
1,Electrocardiogram morphology (amplitude at temporal datapoints) [4 ms],20059
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-154 ms],6048
1,Fat removed from meat,1713
1,Vitamin b12  | vitamin and/or mineral supplement use,1238
1,T cell lymphocyte profile difference,1007
1,Levocetirizine | treatment/medication code,370
1,Severe bacterial meningitis,168
1,Medication use (HMG CoA reductase inhibitors),69264
1,Trunk fat percentage,99406
1,Vertical cup-disc ratio (adjusted for vertical disc diameter),6320
1,CD62L on CD62L+ myeloid Dendritic Cell,6114
1,Waist circumference adjusted for BMI in non-smokers [women],1547
1,Electrocardiogram morphology (amplitude at temporal datapoints) [218 ms],8838
1,Nontoxic diffuse goitre,2145
1,Serum metabolite levels [serine],1580
1,Monocyte chemoattractant protein-1 levels,1375
1,Electrocardiogram morphology (amplitude at temporal datapoints) [296 ms],5057
1,CD33dim HLA DR+ CD11b- %CD33dim HLA DR+,1072
1,Insomnia [Male],727
1,Serum levels of protein CGREF1,421
1,"Blood protein levels [MAN1C1, 13427_66_3]",222
1,Parkinson's disease [Sporadic],186
1,Serum levels of protein PDGFRA,18
1,Fibrinogen levels,12199
1,Urea levels,37210
1,Serum levels of protein WIF1,6106
1,Serum metabolite levels [hexanoylcarnitine (C6],50050
1,Arm fat mass (left),88691
1,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),6452
1,Serum metabolite levels (CMS) [S_HDL_PL],592
1,Serum metabolite levels (CMS) [M_LDL_P],1923
1,Myopia,808
1,Nevus count,591
1,Percent liver fat,115
1,Ulcerative colitis,106917
1,Cortical surface area [Lingual],18495
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-20 ms],9112
1,Stem cell growth factor beta levels,4119
1,Alzheimer's disease (late onset),4646
1,Electrocardiogram morphology (amplitude at temporal datapoints) [192 ms],6073
1,Urate levels [Urate],343
1,Protein quantitative trait loci (liver) [RNPEP],1743
1,Colorectal polyp and colorectal cancer (MTAG) [Colorectal polyp],96
1,Cerebrospinal fluid immune biomarker levels [YKL-40],36
1,Serum metabolite levels (CMS) [M_VLDL_L],23848
1,Electrocardiogram morphology (amplitude at temporal datapoints) [6 ms],20059
1,Lectin-like oxidized LDL receptor 1 levels,6852
1,Bipolar disorder or major depressive disorder,3989
1,Electrocardiogram morphology (amplitude at temporal datapoints) [274 ms],758
1,Chronic obstructive pulmonary disease (severe),155
1,Benign neoplasm of ovary (controls excluding all cancers),1110
1,Serum metabolite levels (CMS) [M_VLDL_TG],592
1,COPD/asthma related pneumonia or pneumonia derived septichaemia,155
1,XCL1 levels,576
1,Protein quantitative trait loci (liver) [GSTK1],105
1,"Sulfasalazine-induced agranulocytosis [conditioned on rs9266634, rs111876221 and rs113887891]",3
1,Spherical equivalent (joint analysis main effects and education interaction),11175
1,Hematocrit,1350252
1,Butyrylcholinesterase levels,3247
1,Serum levels of protein IL10RA,6106
1,Electrocardiogram morphology (amplitude at temporal datapoints) [92 ms],3111
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-498 ms],423
1,Blood protein levels [Dermatopontin],314
1,Protein quantitative trait loci (liver) [HBD],389
1,Serum levels of protein DPYSL2,102
1,Insulinoma-associated antigen 2 autoantibody levels in type 1 diabetes,7986
1,Serum levels of protein CFH,1549
1,Pancreas volume,3617
1,"Bone mineral density (paediatric, lower limb)",1257
1,Alzheimer disease and age of onset [between families],70
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-182 ms],86
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-34 ms],27
1,Body fat mass,105
1,Ease of getting up in the morning,94369
1,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction) [men],4046
1,Serum metabolite concentrations in chronic kidney disease [Decanoylcarnitine],52432
1,P wave duration [EA],2211
1,Number of days/week of vigorous physical activity 10+ minutes,848
1,Peripheral vascular disease,110
1,Serum levels of protein CXCL2;CXCL3,113
1,Haemorrhoidal disease,8163
1,Body fat percentage,159479
1,Serum levels of protein GBP6,6106
1,Major coronary heart disease event,15145
1,Kawasaki disease,1249
1,Parental longevity (father's age at death or father's attained age),1923
1,Creatine kinase levels,340
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-84 ms],86
1,Protein quantitative trait loci (liver) [HPX],2
1,"Eye color (brightness) [conditional on rs16891982, rs12203592, rs10809826, rs1800404, rs12913832 and rs1426654]",8927
1,Sex hormone-binding globulin levels,953717
1,Blood protein levels [Extracellular matrix protein 1],25034
1,White blood cell (leukocyte) count,118571
1,None of the above (group 1) | illnesses of siblings,2843
1,Ewing sarcoma,1876
1,Serum levels of protein KIAA2013,7722
1,Angina | vascular/heart problems diagnosed by doctor,3933
1,Drug-induced liver injury in interferon-beta-treated multiple sclerosis,1013
1,Anxiety and stress-related disorders (excluding adjustment disorder),643
1,Serum levels of protein GSTM3,2072
1,LDL cholesterol levels [Hispanic],2027
1,Cortical surface area [Precuneus],167
1,Started insulin within one year diagnosis of diabetes,178
1,Anxiety and stress-related disorders (psychiatric co-morbidity covariate model),643
1,Serum 25-Hydroxyvitamin D levels,1495268
1,"Mean arterial pressure x alcohol consumption interaction (2df test) [Asian, EA]",19186
1,Type 2 diabetes [conditional],29697
1,Serum levels of protein NFASC,6286
1,Electrocardiogram morphology (amplitude at temporal datapoints) [312 ms],6253
1,Arm fat mass (right),77930
1,"Allergy, hypersensitivity or anaphylaxis",1942
1,Serum levels of protein NID1,452
1,Serum levels of protein CDH7,7256
1,C-reactive protein [HA women],2510
1,Myocardial fractal dimension (slice 6),101
1,Electrocardiogram morphology (amplitude at temporal datapoints) [74 ms],1560
1,Nutritional anaemias,178
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-184 ms],86
1,QRS complex (Cornell) [EA],72
1,Lung function (FEV1) [adults],94294
1,LDL cholesterol levels [EA],26202
1,Facial morphology (segment 53),3222
1,Serum levels of protein ISG15,24903
1,Heel broadband ultrasound attenuation (right),26658
1,6mm weak meridian (left),36245
1,Chin dimples,6151
1,Relative age of first facial hair,10875
1,"""Disorders of thyroid, IBD co-morbidities""",466
1,Red blood cell fatty acid levels [OA],177
1,BMI at 8 months old,1057
1,Appendicular lean mass,1252173
1,"Lipid metabolism phenotypes [VLDL.medium, fasting]",23256
1,Serum metabolite levels [N-acetylneuraminate],1257
1,Urinary metabolite levels in chronic kidney disease [X - 21842],1993
1,Age asthma diagnosed by doctor,784
1,Total cholesterol levels in LDL,1923
1,Pancreatic cancer [EA],225
1,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant I (Philtrum), Segment 4]",287
1,Breast cancer,248540
1,"Systolic blood pressure x alcohol consumption interaction (2df test) [AA, EA, Hispanic]",15619
1,Serum levels of protein PRDX6,18756
1,Electrocardiogram morphology (amplitude at temporal datapoints) [148 ms],15620
1,Serum levels of protein NOTCH2,5727
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-478 ms],423
1,Cirrhosis (multi-trait analysis),92
1,Protein quantitative trait loci (liver) [LRRC59],95
1,Ischemic heart disease,5062
1,Waist-to-hip ratio adjusted for BMI in active individuals,5012
1,Vitamin b12,3806
1,Optic cup area,7634
1,Total cholesterol levels [Indian],2027
1,Electrocardiogram morphology (amplitude at temporal datapoints) [136 ms],2154
1,Metabolite levels [LDL],1786
1,Cardiorespiratory fitness (vo2 max),518
1,Blood protein levels [Chitotriosidase-1],1649
1,"Yes, because of illness | major dietary changes in the last 5 years",226
1,Fournierella massiliensis abundance in stool,55
1,Post bronchodilator FEV1,16
1,Idiopathic dilated cardiomyopathy,13465
1,Non-albumin protein levels,13002
1,Chronic obstructive pulmonary disease or high blood pressure (pleiotropy),48416
1,Methylmalonate (mma) levels,27449
1,Serum levels of protein SELP,3996
1,"Other chronic ischemic heart disease, unspecified",4790
1,Myeloid Dendritic Cell %Dendritic Cell,9072
1,Blood protein levels [CHI3L1],1442
1,Multisite chronic pain,131317
1,"Waist-to-hip ratio adjusted for body mass index [EA, women]",12482
1,Blood protein levels [Low affinity immunoglobulin gamma Fc region receptor II-a/b],1971
1,Electrocardiogram morphology (amplitude at temporal datapoints) [182 ms],13871
1,Complement factor H-related protein 2 levels,20995
1,"Headaches (not migraine) | non-cancer illness code, self-reported",2452
1,Height [EA],1338
1,Hypertrophy of breast,789
1,Endometrial cancer (endometrioid histology),252
1,Marginal zone lymphoma or multiple sclerosis,2013
1,Hip index,35878
1,"""Ischaemic heart disease, wide definition""",20470
1,Adiposity [WHR in women],669
1,LDL levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder,53
1,Intracranial aneurysm,67
1,Protein quantitative trait loci (liver) [EHHADH],40
1,Generalized epilepsy [JME],37
1,Blood urea nitrogen levels,277108
1,Morning/evening person (chronotype),100497
1,Intrinsic epigenetic age acceleration,36609
1,"Lipid metabolism phenotypes [VLDL.total, whole]",23256
1,6mm asymmetry index (right),22963
1,Leg fat-free mass (left),208462
1,Age asthma diagnosed,496
1,Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI,106
1,"Blood protein levels [QSOX1, 6217_23_3]",978
1,Major depressive disorder vs anorexia nervosa (ordinary least squares (OLS)),97
1,"""Pulmonary heart disease, diseases of pulmonary circulation""",138
1,Serum levels of protein MAN1C1,222
1,Protein quantitative trait loci (liver) [FERMT2],119
1,Cortical surface area (min-P),28944
1,Time spent using computer,41331
1,Acceptance of an invitation to participate in a mental health questionnaire,30815
1,Diacylglycerol_38:4_[M+H-H2O]1+ levels,23256
1,Serum levels of protein GRN,2027
1,Electrocardiogram morphology (amplitude at temporal datapoints) [198 ms],6782
1,Electrocardiogram morphology (amplitude at temporal datapoints) [346 ms],3694
1,COPD/asthma related infections,1277
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-18 ms],10244
1,Electrocardiogram morphology (amplitude at temporal datapoints) [304 ms],6253
1,Crohn's disease vs ulcerative colitis (ordinary least squares (OLS)),2856
1,Testosterone levels x fluid intelligence interaction,497
1,Rapid response to perioperative phenylephrine (change in systolic blood pressure) [Hispanic],5
1,Complement factor B measurement,8995
1,Serum levels of protein PCDHB4,6106
1,"Lipid metabolism phenotypes [TG.by.NMR, whole]",23256
1,Hypothyroidism and >3 levothyroxin purchases,4137
1,Serum levels of protein TBCE,6515
1,Body mass index and type 2 diabetes (pairwise),14816
1,Electrocardiogram morphology (amplitude at temporal datapoints) [238 ms],3695
1,CD27 on Plasma Blast-Plasma Cell,1072
1,Idiopathic polyneuropathy,387
1,General cognitive ability,93279
1,Left ventricular global circumferential strain,9676
1,Epithelial ovarian cancer [Serous],5705
1,Dyslipidemia,2027
1,Urinary metabolite levels in chronic kidney disease [X - 16567],52413
1,Waist circumference adjusted for BMI in smokers,2773
1,Raw vegetable consumption,21396
1,P-selectin glycoprotein ligand 1 levels,11394
1,Vitamin b6 preparation | treatment/medication code,1170
1,Brain region volumes [right pericalcarine],9400
1,Liver volume,278
1,Large artery stroke (CCS and TOAST classification),82
1,White matter microstructure (mode of anisotropy) [Corticospinal tract ],25
1,Plasma homocysteine levels,16712
1,Serum levels of protein PFKFB3,6106
1,Lamb/mutton intake,1140
1,Behcet's disease,1785
1,Serum metabolite levels [EstC],1923
1,Protein quantitative trait loci (liver) [PSMA1],1338
1,Blood protein levels [C-reactive protein],1511
1,CD27 on switched memory B cell,1072
1,T wave morphology restitution during exercise,386
1,Serum levels of protein TOR1AIP1,106
1,HDL cholesterol levels in current drinkers [EA],45327
1,Hair morphology,1385
1,Kidney stones,928
1,Osteoarthritis (with total hip replacement),747
1,Metabolite levels [C6],71
1,Non-cardia gastric cancer,96025
1,Youthful appearance (self-reported),3744
1,"Blood protein levels [TNFRSF18, 5526_53_3]",6470
1,"Blood protein levels [CREB3L4, 11308_8_3]",18665
1,Electrocardiogram morphology (amplitude at temporal datapoints) [130 ms],2627
1,Facial morphology (segment 48),13
1,Pulse rate,5614
1,Mean diameter of LDL particles [conditioned on 885 SNPs],626
1,Electrocardiogram morphology (amplitude at temporal datapoints) [268 ms],758
1,Proximal colorectal cancer,336
1,"""Coxarthrosis, primary""",1552
1,Cluster headache,177
1,Regular attendance at a gym or sports club,152
1,Protein quantitative trait loci (liver) [CPT2],277
1,"Blood protein levels [EA, Dermatopontin]",147
1,Cortical thickness (MOSTest),40651
1,"Waist circumference adjusted for BMI in active individuals [EA,women]",2658
1,Place of birth in uk - north co-ordinate,1857
1,Chronic obstructive pulmonary disease x ever smoker interaction (2df),554
1,"""Endomtriosis ASRM stages 3,4""",1312
1,"Urinary frequency / incontinence | non-cancer illness code, self-reported",2628
1,Hernia,890
1,Hematological disease,121
1,"""Type1 diabetes, definitions combined""",178
1,Phosphatidylcholine_33:3_[M+H]1+/Phosphatidylethanolamine_36:3_[M+H]1+/Phosphatidate_38:4_[M+NH4]1+ levels,7
1,Schizophrenia,341622
1,Glomerular filtration rate,101588
1,Nonatopic asthma,5969
1,Serum levels of protein LAYN,6106
1,Waist circumference,140018
1,"Blood protein levels [ISG15, 14151_4_3]",11382
1,"Blood protein levels [SERPINF2, 3024_18_2]",25064
1,Serum levels of protein AZGP1,6106
1,Waist-to-hip ratio adjusted for BMI in non-smokers,3514
1,Serum levels of protein PDGFA,177
1,Blood metabolite ratios [DSGEGDFXAEGGGVR/ADpSGEGDFXAEGGGVR],1341
1,Body fat percentage and type 2 diabetes (pairwise),338
1,Protein quantitative trait loci (liver) [SFPQ],412
1,"Eye color [EA, discovery]",579
1,"Deep venous thrombosis (dvt) | non-cancer illness code, self-reported",68
1,Cardiac and circulatory congenital anomalies,142
1,Neurological disease,238
1,Hematuria,158
1,Other disorders of circulatory system,68
1,Self-reported math ability,247025
1,Serum levels of protein C4orf32,6106
1,PDL-1 on CD14+ CD16+ monocyte,1072
1,CD3 on Effector Memory CD8+ T cell,1742
1,Varicose veins of lower extremity,358
1,"Blood protein levels [APCS, 2474_54_5]",1253
1,Other diseases of the teeth and supporting structures,288
1,Other/unspecified seropositiverheumatoid arthritis,178
1,Memory B cell %B cell,27
1,Neuroblastoma or malignant cutaneous melanoma,52906
1,Alcohol-related hepatocellular carcinoma,16234
1,Serum levels of protein PAK3,6106
1,Electrocardiogram morphology (amplitude at temporal datapoints) [166 ms],8622
1,Serum metabolite levels (CMS) [M_LDL_CE],1923
1,Body fat distribution (leg fat ratio) [males],246
1,Cortical volume [Fusiform],34
1,Streptococcus sanguinis abundance in stool,16
1,Cognitive performance (MTAG) [MTAG],152133
1,Eosinophill count,146821
1,High blood pressure | vascular/heart problems diagnosed by doctor,133327
1,Type 2 diabetes with other specified/multiple/unspecified complications,40514
1,Electrocardiogram morphology (amplitude at temporal datapoints) [160 ms],5396
1,Protein levels in obesity [HAI-1],3043
1,Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in non-secretors,457
1,Osteoprotegerin levels,221
1,"Neck problem/injury | non-cancer illness code, self-reported",507
1,Heart failure and antihypertensive medication,378
1,Serum levels of protein NTNG1,154
1,JT interval (sulfonylurea treatment interaction) [EA],218
1,Hypertrophic cardiomyopathy (MTAG),9290
1,Atrial fibrillation and flutter with reimbursement,2713
1,Serum levels of protein CA10,2027
1,Use of antiglaucoma preparations and miotics,77
1,Mean corpuscular hemoglobin concentration,989271
1,Spherical equivalent or myopia (age of diagnosis),16801
1,Age of smoking initiation (MTAG),23777
1,Open-angle glaucoma,2001
1,TPE interval (resting) [men],11882
1,T-cell surface glycoprotein CD1c levels,6122
1,Acisoga levels,6687
1,Serum levels of protein C1S,7579
1,Total body bone mineral density (age 30-45),983
1,Gastrointestinal or abdominal disease,312
1,Serum metabolite levels (CMS) [M_VLDL_PL],589
1,Protein quantitative trait loci (liver) [CLIC4],62
1,Major depressive disorder vs ADHD (ordinary least squares (OLS)),13639
1,"Light diy (eg: pruning, watering the lawn) | types of physical activity in last 4 weeks",5942
1,"Blood protein levels [FN1, 3435_53_2]",25064
1,Electrocardiogram morphology (amplitude at temporal datapoints) [174 ms],10599
1,"Tinnitus / tiniitis | non-cancer illness code, self-reported",160
1,Optic disc area,33853
1,Hashimoto thyroiditis,4222
1,Allergic rhinitis,5977
1,Serum levels of protein FOLH1,6208
1,Neuroticism (MTAG),4813
1,Home location at assessment - north co-ordinate (rounded),1026
1,Other sexually transmitted chlamydial diseases,4661
1,Insulin-related traits (multivariate analysis),4308
1,"Blood protein levels [PEAR1, 8275_31_3]",1595
1,Brain region volumes [right lateral ventricle],343
1,Thrombomodulin levels,131
1,Intracerebral hemorrhage [nonlobar],18124
1,Mean arterial pressure,169767
1,Urinary sodium excretion [EA],4899
1,Serum levels of protein NDUFB4,6106
1,"Heel bone mineral density (bmd) t-score, automated",91639
1,Thyrotoxicosis,1947
1,HLA DR on HLA DR+ Natural Killer,8812
1,Electrocardiogram morphology (amplitude at temporal datapoints) [326 ms],6253
1,Iron status biomarkers (ferritin levels),271
1,High-sensitivity C-reactive protein levels in HIV infection,4136
1,Pattern 2 | hair/balding pattern,2741
1,Anxiety and stress-related disorders (excluding co-morbid schizophrenia),643
1,Zomig 2.5mg tablet | treatment/medication code,442
1,"Pulmonary embolism +/- dvt | non-cancer illness code, self-reported",90
1,LDL cholesterol,397374
1,Protein quantitative trait loci [Complement factor H-related protein 2 (FHR-2],3947
1,Aspartate aminotransferase levels,512709
1,Electrocardiogram morphology (amplitude at temporal datapoints) [144 ms],5746
1,FSC-A on myeloid Dendritic Cell,8685
1,"Blood protein levels [CA6, 3352_80_3]",237
1,Electrocardiogram morphology (amplitude at temporal datapoints) [90 ms],1560
1,Serum levels of protein S100A12,472
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-460 ms],423
1,Serum levels of protein COCH,24
1,Red blood cell count,2135742
1,Depressive symptoms (MTAG),14811
1,Age-related macular degeneration (whether dry or wet),6106
1,CD3 on Central Memory CD4+ T cell,1355
1,Serum levels of protein CA6,791
1,Immunological or systemic disorder,890
1,"""Diabetes, several complications""",178
1,Neuronal pentraxin-1 measurement,1072
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-98 ms],86
1,Smoking cessation (MTAG),21190
1,Serum levels of protein STIM1,1622
1,Electrocardiogram morphology (amplitude at temporal datapoints) [88 ms],2068
1,Facial morphology (segment 10),13457
1,Protein quantitative trait loci [NPS-PLA2],938
1,Left ventricular global radial strain,600
1,Serum metabolite levels (CMS) [L_VLDL_TG],589
1,Serum metabolite levels [kynurenate],71
1,Allergic sensitization,229
1,Gingivitis and periodontal diseases,70
1,Asthma,218357
1,Interleukin-1 receptor antagonist protein measurement,6106
1,CD3 on CD4 regulatory T cell,976
1,CD40 on monocytes,1072
1,Manevac granules | treatment/medication code,3283
1,Fasting plasma glucose (childhood),1209
1,Diabetic maculopathy (more control exclusions),178
1,Townsend deprivation index at recruitment,172
1,Gillisia abundance in stool,145
1,Nevus count or cutaneous melanoma,164682
1,Bioavailable testosterone levels,72015
1,Hypertrophic cardiomyopathy (sarcomere negative),8116
1,Blood protein levels [Complement factor H],977
1,Doublebase gel | treatment/medication code,4603
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-162 ms],86
1,Uterine fibroids (MTAG),1139
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-114 ms],86
1,Urinary albumin-to-creatinine ratio,43656
1,Type 1 diabetes,70770
1,IBD patients in KELA-register,5921
1,Major coronary heart disease event excluding revascularizations,1941
1,Protein quantitative trait loci [C1s],1379
1,Osteoarthritis (hip) [additive],870
1,Systolic blood pressure x alcohol consumption interaction (2df test) [EA],18810
1,Peptidyl-prolyl cis-trans isomerase FKBP7 measurement,6331
1,Whole body fat mass,121183
1,Basal metabolic rate,271092
1,"Body mass index [EA, men]",747
1,Insulin product | treatment/medication code,178
1,"Blood protein levels [MAN1A2, 9077_10_3]",98
1,Protein quantitative trait loci (liver) [HBG1],18
1,Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test),7022
1,Worry,5321
1,Length of menstrual cycle,417
1,Body mass index [women],5841
1,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],43076
1,Serum levels of protein ZNF276,6106
1,"Blood protein levels [EA, Complement C1s subcomponent]",4841
1,"Heel quantitative ultrasound index (qui), direct entry (left)",10100
1,Malignant neoplasm of skin (controls excluding all cancers),14287
1,"Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)",29100
1,CD64 on CD14- CD16-,14789
1,DNA methylation Hannum age acceleration,11078
1,Problematic alcohol use (MTAG),11582
1,Serum levels of protein SMR3A,1622
1,Blood protein levels [Interleukin-6 receptor subunit alpha],2290
1,Resistant hypertension,431
1,Cerebrospinal fluid sTREM-2 levels,34
1,Cardiometabolic and hematological traits [PLT],36
1,Serum levels of protein LRP8,6155
1,Use both right and left hands equally | handedness (chirality/laterality),23056
1,Serum metabolite levels [N-palmitoylglycine],6582
1,Arm fat-free mass (left),240129
1,"""Hypertension, essential""",2704
1,Papulosquamous disorders,1003
1,Serum metabolite levels [Serum_C],1923
1,Global electrical heterogeneity phenotypes [SVG azimuth],83
1,"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment",787
1,CD33dim HLA DR+ CD11b+ %CD33dim HLA DR+,1072
1,Serum levels of protein UBC,6106
1,Serum metabolite levels [octanoylcarnitine (C8],50050
1,"Blood protein levels [PPP2R3A, 13665_35_3]",19110
1,Glaucoma | eye problems/disorders,2001
1,Electrocardiogram morphology (amplitude at temporal datapoints) [374 ms],3694
1,Facial morphology (chin protrusion 1),3124
1,Visceral adipose tissue/subcutaneous adipose tissue ratio [overall],710
1,C-X-C motif chemokine 1 levels,113
1,Hair shape [EA],430
1,Basophill percentage,48022
1,Electrocardiogram morphology (amplitude at temporal datapoints) [20 ms],27398
1,Intralaminar thalamic nuclei volume,2683
1,Facial morphology (segment 61),1387
1,Paget's disease,847
1,Crohn's disease or systemic sclerosis,420
1,Plateletcrit,610115
1,N-acyl ethanolamine levels [VEA],2461
1,Serum levels of protein TNFSF11,6106
1,Serum levels of protein ERO1A,6106
1,Serum levels of protein ENTPD1,6106
1,CD11b on Monocytic Myeloid-Derived Suppressor Cells,1072
1,Obesity-related traits [MCP1 ],113
1,"Sphingomyelin (d18:1/20:0, d16:1/22:0) levels",4174
1,Serum total protein level [conditional on round 4],1466
1,Serum levels of protein C1QTNF1,2027
1,Gynecologic disease (multivariate analysis) [uterine fibroid],1139
1,"Tennis elbow / lateral epicondylitis | non-cancer illness code, self-reported",2443
1,Serum metabolite levels (CMS) [VLDL_D],592
1,Hepatocellular carcinoma,16597
1,Blood metabolite levels [X-13431--nonanoylcarnitine],26705
1,Ankle spacing width,134190
1,"""Hypertension complicating pregnancy, childbirth, and the puerperium""",18393
1,Cerebrospinal fluid levels of Alzheimer's disease-related proteins [Interleukin-6 receptor],2290
1,Dorzolamide | treatment/medication code,2096
1,KELA_REIMBURSEMENT_202,178
1,Nonsuppurative otitis media,76
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-86 ms],86
1,Reticulocyte fraction of red cells,276487
1,Never | smoking status,29486
1,Malignant neoplasm of prostate (controls excluding all cancers),25863
1,Protein quantitative trait loci [sIL-6R],2290
1,Serum levels of protein POMC,522
1,"Blood protein levels [EPHB2, 5077_28_3]",335
1,Symbicort 100/6 turbohaler | treatment/medication code,25
1,Idiopathic inflammatory myopathy,178
1,Systolic blood pressure x smoking status (current vs non-current) interaction (1df test) [African],22
1,Protein quantitative trait loci (liver) [IGKV4-1],2
1,Delta-5 desaturase activity response to n3-polyunsaturated fat supplement,8
1,Electrocardiogram morphology (amplitude at temporal datapoints) [338 ms],6253
1,Bone mineral density (hip) and hip bone size,11376
1,Myocardial fractal dimension (slice 5),870
1,Serum levels of protein IL22RA1,805
1,Renin levels,677
1,Other intervertebral disc disorders,30
1,Household income (MTAG),45060
1,HVEM on Central Memory CD8+ T cell,6812
1,Serum levels of protein ECM1,25064
1,malignant neoplasm of male genital organs (controls excluding all cancers),26077
1,Protein quantitative trait loci (liver) [DDAH1],3588
1,"Mean arterial pressure x alcohol consumption interaction (2df test) [EA, Hispanic]",3313
1,Serum levels of protein CHI3L2,1401
1,Propranolol | treatment/medication code,1439
1,Facial morphology (segment 1),457
1,Mental health study participation (provided email address),185
1,Brain region volumes [grey matter],490
1,Protein quantitative trait loci (liver) [NUCB1],35
1,Pulmonary fibrosis,19
1,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],23143
1,HVEM on T cell,6812
1,Urinary metabolite levels in chronic kidney disease [beta-guanidinopropanoate],22576
1,Cleft lip,4953
1,E-selectin levels,7927
1,Atrial fibrillation/atrial flutter,8357
1,"""Diabetes, varying definitions""",4107
1,Electrocardiogram morphology (amplitude at temporal datapoints) [262 ms],758
1,Arterial stiffness index,531
1,Colorectal cancer [East Asian],160
1,Pulse pressure [East Asian],284
1,Neutrophil count in HIV-infection,67
1,"""Myocardial infarction, strict""",18
1,Spherical equivalent,29134
1,Diastolic blood pressure x alcohol consumption interaction (2df test) [EA],30515
1,SSC-A on myeloid Dendritic Cell,8348
1,Resistin levels,20057
1,Time to complete round,17832
1,QT dynamics during exercise,6215
1,Smoking initiation (ever regular vs never regular) [Conditioned on chr1:8484823],188
1,"Blood protein levels [FMOD, 6367_66_3]",434
1,White matter hyperintensity burden,18124
1,Osteoarthritis (hip),31049
1,Major depressive disorder (MTAG),9060
1,Aortic aneurysm,1486
1,"Blood protein levels [GSKIP, 12849_25_3]",14018
1,Other malignant neoplasms of skin (=non-melanoma skin cancer),17396
1,C-reactive protein levels or total cholesterol levels (pleiotropy),3290
1,Serum levels of protein KLRG2,608
1,Serum metabolite levels (CMS) [L_VLDL_C],592
1,"Other (e.g. cornflakes, frosties) | cereal type",176
1,Docusate sodium | treatment/medication code,13
1,Protein quantitative trait loci (liver) [GNMT],43
1,Natural Killer %CD3- lymphocyte,12
1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)",70234
1,Acylcarnitine levels [Nonaylcarnitine],26705
1,Heel bone mineral density T score,306952
1,Urinary metabolite levels in chronic kidney disease [X - 12636],52413
1,Protein quantitative trait loci (liver) [CRYZ],2868
1,"Heel quantitative ultrasound index (qui), direct entry",91639
1,Heel bone mineral density (bmd) (left),18119
1,Dentures,4554
1,Electrocardiogram morphology (amplitude at temporal datapoints) [230 ms],3781
1,Body mass index (joint analysis main effects and smoking interaction),4678
1,Gut microbiota relative abundance (bacterial taxa) [Paenibacillus],107
1,Serum metabolite levels (CMS) [L_VLDL_CE],592
1,Protein quantitative trait loci (liver) [HK1],10
1,Metabolic biomarkers (multivariate analysis),56822
1,3mm strong meridian (left),60403
1,Serum metabolite levels (CMS) [S_VLDL_L],589
1,Cerebrospinal fluid biomarker levels [Contactin-2],10846
1,Electrocardiogram morphology (amplitude at temporal datapoints) [384 ms],3694
1,Vitamin D insufficiency,3312
1,CD27 on IgD- CD38- B cell,1072
1,Peripheral arterial disease (traffic-related air pollution interaction) [AA],833
1,Serum levels of protein FCGR2B,214
1,Triiodothyronine levels and thyroxine levels,42
1,Body fat distribution (arm fat ratio),16462
1,Household income,12632
1,Attention deficit hyperactivity disorder (MTAG),46888
1,Interleukin-6 receptor subunit alpha levels,60027
1,Electrocardiogram morphology (amplitude at temporal datapoints) [152 ms],6592
1,Alzheimer's disease or family history of Alzheimer's disease,13131
1,Neuroticism conditioned on self-rated math ability (multi-trait conditioning and joint analysis),6941
1,Serum levels of protein LY9,1638
1,"""Thyrotoxicosis, other and/or unspecified""",1783
1,General anaesthetic | anaesthetics administered post delivery,2066
1,"N,n,n-trimethyl-alanylproline betaine (tmap) levels",1727
1,Serum metabolite levels (CMS) [VLDL_C],592
1,Protein quantitative trait loci (liver) [EPHX1],1747
1,Protein quantitative trait loci (liver) [TXNL1],412
1,Electrocardiogram morphology (amplitude at temporal datapoints) [16 ms],2047
1,Disorder of skin and subcutaneous tissue nos,15
1,Other cns infection and poliomyelitis,8
1,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [heptanoylglutamine,  hexanoylglutamine,  isocaproylglutamine,  N-octanoylglutamine,  X-12636,  X-12839,  X-24347,  X-24350]",52413
1,QRS duration,15216
1,Granulins levels,1923
1,Electrocardiogram morphology (amplitude at temporal datapoints) [244 ms],3568
1,Serum metabolite levels (CMS) [IDL_L],1923
1,Lung function (FEV1/FVC) [conditioned on rs12140637],393
1,"""Seropositive rheumatoid arthritis, strict definition""",178
1,"""Migraine, single triptan purchase ok & required. ICD-code if available is included""",230
1,Global electrical heterogeneity phenotypes [QRS-T angle],83
1,Physical activity,197
1,Total cholesterol levels in medium HDL,580
1,Asthma and major depressive disorder,6834
1,Fat body mass [Adjusted by Lean body mass],84556
1,Fc receptor-like protein 1 levels,4607
1,Serum levels of protein TNFRSF8,6106
1,Serum levels of protein IFNAR1,6106
1,Electrocardiogram morphology (amplitude at temporal datapoints) [184 ms],13449
1,Worrier / anxious feelings,1547
1,BMI (adjusted for smoking behaviour),4737
1,Smoking x traumatic event in childhood (sexually molested) interaction,427
1,Blood protein levels [Carbonic anhydrase 6],217
1,Heart rate,415
1,Ever believed in an un-real conspiracy against self,535
1,Serum immune biomarker levels [YKL-40],72
1,Superior frontal gyrus grey matter volume [Right superior frontal gyrus],15642
1,Body fat distribution (leg fat ratio) [females],22596
1,Blood protein levels [Leptin receptor],4245
1,Valvular operations,786
1,"Clotting disorder/excessive bleeding | non-cancer illness code, self-reported",118
1,Gut bacterial pathway abundance (PWY.6151..S.adenosyl.L.methionine.cycle.I),7
1,Caffeine consumption from tea,102514
1,Forced expiratory volume in 1-second (fev1),128604
1,Leg fat mass (left),129837
1,Electrocardiogram morphology (amplitude at temporal datapoints) [286 ms],3694
1,Pilonidal cyst,641
1,Gait rhythm [Single support time],61
1,"""Hernia of abodminal wall, postoperative""",533
1,"""SLE, strict definition""",131
1,Fibulin-5 measurement,6106
1,Serum metabolite levels (CMS) [L_LDL_PL],1923
1,Electrocardiogram morphology (amplitude at temporal datapoints) [24 ms],28538
1,Serum metabolite levels [decanoylcarnitine (C10],50050
1,Leg fat mass (right),115378
1,BAFF-R on naive-mature B cell,1072
1,"""Hypothyroidism, levothyroxin purchases""",4137
1,Serum levels of protein SEPT10,783
1,Protein quantitative trait loci (liver) [UGT2B15],118
1,Immune reponse to smallpox (secreted IFN-alpha) [AA],437
1,Tea consumption,11863
1,Serum metabolite levels [PUFA],23529
1,White matter microstructure (axial diusivities) [Posterior limb of internal capsule],15370
1,Ankle spacing width (left),37662
1,"Blood protein levels [SCGB1A1, 10569_28_3]",2582
1,HDL cholesterol levels [EA],2468
1,COVID-19 (RELEASE 5),693
1,Electrocardiogram morphology (amplitude at temporal datapoints) [52 ms],1511
1,"""Artrosis, including avohilmo""",33
1,FEV1,200623
1,Serum levels of protein TMOD3,6106
1,Protein quantitative trait loci (liver) [NIPSNAP1],688
1,"""Endocrine, nutritional and metabolic diseases""",4137
1,Thyroid function,1940
1,Mid-point of the five least active hours of the day,366
1,Gut microbiota (functional units) [GO:0045944|BP|08|positive regulation of transcription from RNA polymerase II promoter],47
1,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial measurement",73268
1,Serum metabolite levels (CMS) [M_VLDL_FC],23848
1,Electrocardiogram morphology (amplitude at temporal datapoints) [94 ms],2603
1,None of the above | mouth/teeth dental problems,27669
1,Reticulocyte percentage,29732
1,Type 1 diabetes with ketoacidosis,8063
1,Exposure to tobacco smoke outside home,2071
1,Electrocardiogram morphology (amplitude at temporal datapoints) [44 ms],1653
1,Strenuous sports or other exercises,9344
1,Loperamide | treatment/medication code,285
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-474 ms],423
1,HDL cholesterol levels x smoking (current vs non smokers) interaction (2df test),2310
1,Urinary metabolite levels in chronic kidney disease [N-acetylmethionine sulfoxide],1822
1,Electrocardiographic traits [QT],695
1,Electrocardiogram morphology (amplitude at temporal datapoints) [186 ms],1016
1,Femur bone mineral density x serum urate levels interaction [female],1495
1,"""Benign neoplasm: Connective and other soft tissue of head, face and neck (controls excluding all cancers)""",146
1,Hereditary retinal dystrophy,13
1,Protein quantitative trait loci (liver) [NUCB2],9
1,"Hip circumference adjusted for BMI [EA,men]",16223
1,Nonalcoholic fatty liver disease (imputed),26013
1,Opioid dependence,763
1,White matter microstructure (fractional anisotropy) [Corticospinal tract ],713
1,Protein quantitative trait loci (liver) [SEPT11],1065
1,Serum levels of protein CCL17,113
1,Driving (hours per day),1866
1,Serum metabolite levels (CMS) [FreeC],1923
1,"Local histogram emphysema pattern [normal, EA]",105
1,"Blood protein levels [EA, Ephrin type-B receptor 2]",277
1,Immature fraction of reticulocytes,555577
1,Waist-to-hip ratio adjusted for body mass index [EA],15096
1,"2,3-dihydroxy-2-methylbutyrate levels",4671
1,Mouth ulcers | mouth/teeth dental problems,25185
1,Benign neoplasms (controls excluding all cancers),5915
1,Malignant neoplasm of prostate,26294
1,Alcohol consumption (transferrin glycosylation) [CDT percent],806
1,Macular telangiectasia type 2,1680
1,Broad depression or major depressive disorder (self-reported),187
1,Serum levels of protein CXCL1,113
1,Protein quantitative trait loci (liver) [APRT],18
1,Protein quantitative trait loci (liver) [TOMM70],5
1,Left–right brain asymmetry,34
1,Cataracts,47528
1,Osteoarthritis of the hip or knee (with total joint replacement),2461
1,Serum metabolite levels [adipoylcarnitine (C6-DC],4742
1,QT dynamics during recovery from exercise,1433
1,Protein quantitative trait loci (liver) [CYP2D6],1845
1,Metabolite levels [C5-DC],197
1,"""Bacterial infection, other or unspecified""",193
1,"""Articial joint operation, menisceal resection""",184
1,Waist circumference adjusted for body mass index [men],5503
1,LDL cholesterol x physical activity interaction (2df test) [EA],45102
1,Triglyceride levels in current drinkers [Asian],23211
1,Serum levels of protein NPPB,8408
1,Family history of Alzheimer's disease,4700
1,Electrocardiographic traits [QT interval],6573
1,Inflammatory bowel disease and other gastroenteritis and colitis,4599
1,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),1192
1,Protein quantitative trait loci (liver) [FDX1],246
1,Logical memory (delayed recall) in normal cognition,151
1,Serum levels of protein VTN,102
1,Serum metabolite levels [3-hydroxydecanoate],34977
1,Smoking initiation (ever regular vs never regular),130252
1,Asthma or allergic disease (pleiotropy),19560
1,Alcohol usually taken with meals,44905
1,"Systolic blood pressure, automated reading",182235
1,Cataract,7118
1,Serum magnesium levels,27963
1,No | major dietary changes in the last 5 years,12462
1,CD3 on HLA DR+ CD8+ T cell,929
1,Serum levels of protein MASP1,8449
1,Urinary metabolite levels in chronic kidney disease [cytidine],1169
1,YKL-40 levels,1442
1,CD3 on activated CD4 regulatory T cell,1089
1,"Blood protein levels [EA, MAP kinase-activated protein kinase 2]",794
1,Unspecified diabetes,178
1,Respiratory diseases,11294
1,Alcohol consumption (drinks per week) (MTAG),83290
1,Serum levels of protein PRLR,6200
1,HVEM on Central Memory CD4+ T cell,6812
1,Electrocardiogram morphology (amplitude at temporal datapoints) [214 ms],8838
1,Brain region volumes [CSF],34
1,CD27 on IgD- CD38dim B cell,1072
1,Serum levels of protein FCGR3B,520
1,IgA levels,545
1,Facial morphology traits (63 three-dimensional facial segments) [facial module 7],14424
1,"Blood protein levels [LRRC19, 7014_27_3]",25839
1,TPE interval (resting),11976
1,Hair curvature (observational),1656
1,Protein quantitative trait loci (liver) [VDAC1],134
1,Waist-to-hip ratio adjusted for BMI,207317
1,Serum levels of protein SCGB1A1,3120
1,Serum metabolite levels [TotFA],23256
1,"""Type 2 diabetes, strict (exclude DM1)""",1827
1,T wave morphology restitution during recovery from exercise (MTAG),6189
1,CD3 on Naive CD4+ T cell,1143
1,Renal tubulo-intestitial diseases,781
1,Secondary parkinsonism+Parkinsonism in other disease,137
1,Nonatopic asthma and/or BMI,8068
1,Aspartate aminotransferase to alanine aminotransferase ratio,35270
1,Blood metabolite levels [hexanoylcarnitine],52683
1,"Blood protein levels [C1S, 3590_8_3]",32309
1,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test) [EA],15095
1,Femur bone mineral density x serum urate levels interaction [male],4261
1,CD3 on CD39+ secreting CD4 regulatory T cell,1344
1,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [AA],2027
1,Cleft lip with or without cleft palate [Asian],883
1,Protein quantitative trait loci (liver) [SH3BGRL3],12
1,Allergy,3398
1,Finngen Rheumatological endpoints,178
1,Fall on same level,16
1,CD25 on CD39+ resting CD4 regulatory T cell,35
1,Osteoarthrosis,26037
1,Urate levels,691212
1,Serum levels of protein DTX1,5463
1,Urinary metabolite levels in chronic kidney disease [hexanoylglutamine],52432
1,Urate levels [women],3181
1,Systolic blood pressure [East Asian],6929
1,Electrocardiogram morphology (amplitude at temporal datapoints) [200 ms],6782
1,Male puberty timing (late vs. average onset facial hair),1796
1,Protein quantitative trait loci (liver) [MGMT],407
1,"Blood protein levels [KLRG2, 10762_2_3]",608
1,Cardiovascular diseases (excluding rheumatic etc),928
1,Psychotic experience (distressing),281
1,Total body bone mineral density (age 0-15),1255
1,Influenza and pneumonia,155
1,Something else not mentioned | behavioural and miscellaneous addictions,113
1,None of the above | transport type for commuting to job workplace,24
1,Atopic march,885
1,Acute appendicitis,55
1,Protein quantitative trait loci (liver) [RAD23B],47
1,Heart rate response to recovery post exercise (30 sec),35
1,CD45 on CD33+ HLA DR+ CD14-,16
1,White blood cell count (basophil),50358
1,Feeling hurt,6940
1,Bitter non-alcoholic beverage consumption,91334
1,Alcohol use disorder,654
1,"Diastolic blood pressure x alcohol consumption interaction (2df test) [Asian, EA]",19186
1,Serum levels of protein PCDHB14,6106
1,Serum metabolite levels [ribitol],956
1,Mean sphered cell volume,204974
1,Fasciitis,4887
1,Chronic central serous retinopathy,3811
1,HLA DR+ Natural Killer %Natural Killer,9414
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-452 ms],423
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-178 ms],86
1,"Mean arterial pressure x alcohol consumption interaction (2df test) [AA, EA]",176
1,Parkinson's disease,35656
1,von Willebrand factor A domain-containing protein 1 measurement,6813
1,Electrocardiogram morphology (amplitude at temporal datapoints) [258 ms],3253
1,Electrocardiogram morphology (amplitude at temporal datapoints) [36 ms],2793
1,"Red blood cell traits [EA, RBCC]",201
1,Facial morphology [pronasale-left alare distance],988
1,Systolic blood pressure (long-term average),120
1,Cancer of urinary organs (incl. kidney and bladder),117
1,Phosphatidylinositol(36:2)_[M-H]1- levels,23130
1,"Blood pressure medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",75821
1,"""Inflammatory bowel disease, strict (require KELA)""",6144
1,Electrocardiogram morphology (amplitude at temporal datapoints) [356 ms],3694
1,Early-onset schizophrenia,161
1,Unilateral cleft lip,2788
1,Facial morphology (nose roundness 1),556
1,General risk tolerance (MTAG),86530
1,Urinary metabolite levels in chronic kidney disease [isocaproylglycine],52413
1,Serum metabolite levels [pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC],4625
1,Interleukin-6 receptor subunit alpha measurement,16179
1,Serum metabolite levels [S_LDL_L],1923
1,Serum levels of protein SELL,6900
1,Cleft lip or cleft lip with cleft palate (pleiotropy),1069
1,Biological medication for rheuma,178
1,White blood cell count,1564316
1,Blood protein levels [Complement decay-accelerating factor],6247
1,Electrocardiogram morphology (amplitude at temporal datapoints) [294 ms],5057
1,Non-glioblastoma glioma,3678
1,B6 vitamer levels (multivariate analysis),4995
1,Blood metabolite levels [X-10395],1093
1,Neuritic plaques (SNP x SNP interaction),133
1,Activated partial thromboplastin time,7617
1,Well-being spectrum (multivariate analysis),40803
1,Lipid metabolism phenotypes [MobCH],23211
1,Moderate to vigorous physical activity levels,6868
1,"Blood protein levels [EA, Complement factor H]",4062
1,3mm cylindrical power (right),592
1,Crohn's disease of large intestine,55
1,Atopic dermatitis (moderate to severe) [general],40
1,Open-angle glaucoma and optic cup area [EA],249
1,Arthropathy nos,47
1,Blond vs. brown/black hair color,100496
1,Vertical cup-disc ratio (multi-trait analysis),34316
1,Coagulation factor XIII B chain measurement,14064
1,Anxiety and stress-related disorders,1535
1,Dermatologic disease,3913
1,BMI (adjusted for smoking behaviour) [women],1890
1,Birth length (MTAG),6191
1,CD27 on CD24+ CD27+ B cell,1072
1,"Light smokers, at least 100 smokes in lifetime",300
1,Serum levels of protein PCSK9,592
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-166 ms],86
1,Retinal nerve fibre layer thickness or ganglion cell inner plexiform layer thickness (MTAG),21
1,Serum levels of protein RAB5C,6106
1,Corneal hysteresis (left),6511
1,Electrocardiographic traits [QTc interval],8200
1,Electrocardiogram morphology (amplitude at temporal datapoints) [222 ms],3781
1,Serum metabolite levels [S_LDL_P],1923
1,Electrocardiogram morphology (amplitude at temporal datapoints) [72 ms],1560
1,Sleep (1/3-day periodicity),279
1,Facial wrinkles (principal components analysis),389
1,Number of days/week walked 10+ minutes,39333
1,Mean arterial pressure [East Asian],13984
1,"Blood protein levels [MAN1B1, 7071_23_4]",29372
1,Arm predicted mass (left),263414
1,Cortical surface area (visual PC2) [EA],9910
1,CD27 on unswitched memory B cell,1072
1,"Fracture wrist / colles fracture | non-cancer illness code, self-reported",841
1,Serum levels of protein C1QL1,480
1,Electrocardiogram morphology (amplitude at temporal datapoints) [40 ms],1653
1,"Insulin | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",178
1,Colorectal cancer,44439
1,Birth weight,43912
1,"Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA, men]",5166
1,Triglyceride levels [EA],23499
1,Serum metabolite levels [HDL_TG],23211
1,"Intra-ocular pressure, goldmann-correlated (left)",27069
1,Atrial fibrillation [Japanese],538
1,"Subdural haemorrhage/haematoma | non-cancer illness code, self-reported",47
1,Renal function-related traits (BUN),86579
1,QT interval,88798
1,Nap during day,102702
1,Pulmonary function [FEV1/FVC],8788
1,CD64 on CD14- CD16+ monocyte,14789
1,Complement factor H-related protein 3 levels,35791
1,Cholelithiasis,3362
1,Serum levels of protein RAB17,6106
1,Serum metabolite levels [LDL_C],1923
1,Bipolar I disorder,4017
1,Thyroid stimulating hormone levels,2145
1,"Kidney stone, ureter stone or bladder stone",254
1,"Black | hair colour (natural, before greying)",63
1,Cognitive ability (MTAG),68660
1,Risk-taking tendency (4-domain principal component model),5370
1,CD62L- monocyte %monocyte,11383
1,P-selectin levels,7564
1,No | hearing difficulty/problems,66632
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-106 ms],1163
1,Serum levels of protein RAD51,6106
1,Fat-free mass [female],5478
1,Protein quantitative trait loci (liver) [GSTM3],3169
1,Coxarthrosis [arthrosis of hip](FG),1556
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-448 ms],423
1,Ezetimibe | treatment/medication code,1923
1,Electrocardiogram morphology (amplitude at temporal datapoints) [256 ms],758
1,Frailty index,506
1,C-reactive protein levels [Asian],235
1,Benign neoplasm: Short bones of upper limb (controls excluding all cancers),58
1,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) [subset analysis]",102947
1,Triglycerides [EA],25305
1,Direct bilirubin levels,56869
1,High cholesterol,29495
1,Lipoprotein (a) levels,4390
1,LDL cholesterol [AA],1066
1,Psoriatic arthritis,1382
1,Ischemic stroke,20139
1,Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis),6516
1,Serum metabolite levels [L_LDL_C],1923
1,Matrix metalloproteinase-1 levels,3274
1,Body mass index x sex x age interaction (4df test),1397
1,RR interval (heart rate),597
1,Autism spectrum disorder (MTAG),1209
1,Body mass index in physically inactive individuals [EA],146
1,Arthropathy associated with neurological disorders,63
1,Parental longevity (combined parental age at death),11
1,Biological sex (age adjusted),4
1,Soluble leptin receptor levels [Nurses Health Study],4742
1,Intelligence,86725
1,Early age-related macular degeneration,20376
1,Whole body water mass,268682
1,Serum levels of protein IL23R,1332
1,Serum metabolite levels (CMS) [ApoB_ApoA1],1923
1,Allopurinol | treatment/medication code,4402
1,Mean arterial pressure [Japanese],164
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-468 ms],423
1,C-reactive protein levels or HDL-cholesterol levels (pleiotropy),36766
1,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test),15095
1,Cutaneous squamous cell carcinoma,96030
1,College or university degree | qualifications,120181
1,Electrocardiogram morphology (amplitude at temporal datapoints) [8 ms],20059
1,Endometriosis,7546
1,Body mass index in physically active individuals,5483
1,Lung cancer,674
1,A behaviour | behavioural and miscellaneous addictions,944
1,Nontoxic multinodular goiter,2365
1,Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis,329
1,Circulating fibroblast growth factor 23 levels,16
1,Longevity,50501
1,Type 2 diabetes or prostate cancer (pleiotropy),5787
1,Serum levels of protein PTPN1,6106
1,Hand grip strength (left),39424
1,Heart attack | vascular/heart problems diagnosed by doctor,4908
1,"Blood protein levels [CRYZ, 13983_27_3]",4061
1,Alzheimer's disease/dementia | illnesses of mother,3450
1,Electrocardiogram morphology (amplitude at temporal datapoints) [58 ms],1511
1,Serum C-reactive protein concentration in inactive individuals,648
1,Serum metabolite levels [M_HDL_PL],592
1,P wave terminal force [EA],308
1,Spinal anaesthetic | anaesthetics administered during delivery,201
1,Rheumatoid arthritis [ACPA-positive RA vs controls],178
1,Skin cancer,28047
1,Permanent tooth development,1638
1,Medication use (thyroid preparations),72288
1,Hypertrophic cardiomyopathy,17957
1,Essential hypertension,54378
1,Thyroid problem (not cancer),60508
1,Serum levels of protein LRP1B,6106
1,Serum levels of protein AKT3,6106
1,Serum metabolite levels [hexanoylglutamine],50050
1,Macrovascular complications in type 2 diabetes,3749
1,Vegetarian | type of special diet followed,749
1,Fuchs's corneal dystrophy,17657
1,CD3 on CD39+ activated CD4 regulatory T cell,1089
1,Asthma (age of onset),545
1,Dupuytren's disease,2460
1,Prevotella sp002933775 abundance in stool,84
1,"Visceral fat, circulating phospholipid PC(16:0/2:0) and white matter microstructure (shared variance)",4625
1,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),8082
1,Lung function (FEV1),3052
1,Serum metabolite levels (CMS) [FAw6],23256
1,Myeloperoxidase levels,10329
1,Migraine,32257
1,T wave morphology restitution during recovery from exercise,6189
1,Panic disorder,564
1,Chronic obstructive pulmonary disease x current smoker interaction (2df),554
1,"""Type 1 diabetes, strict definition""",178
1,Triglyceride levels in current drinkers [EA],23211
1,Blood protein levels [IL6RA],34431
1,Electrocardiogram morphology (amplitude at temporal datapoints) [34 ms],28853
1,Plantar warts,8317
1,Diastolic blood pressure [EA],10420
1,Blood metabolite levels [10-undecenoate (11:1n1],6614
1,N-acetylglucosamine/n-acetylgalactosamine levels,835
1,HDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test),2310
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-70 ms],86
1,Early cardiac repolarization,333
1,N-acyl ethanolamine levels [DHEA],2461
1,Serum levels of protein CFP,3729
1,Electrocardiogram morphology (amplitude at temporal datapoints) [380 ms],3694
1,3mm cylindrical power angle (right),2509
1,"Macular degeneration | non-cancer illness code, self-reported",805
1,CD3 on CD28+ CD45RA- CD8+ T cell,1785
1,Free cholesterol levels in large LDL,268
1,Mometasone | treatment/medication code,27
1,Composite immunoglobulin trait (IgA/IgM),22718
1,Breastfed as a baby,27003
1,Serum levels of protein CDK5;CDK5R1,6106
1,Serum metabolite levels (CMS) [M_VLDL_C],23848
1,Brain region volumes [left pallidum],11237
1,"Blood protein levels [LRP8, 3323_37_1]",757
1,"Angina | non-cancer illness code, self-reported",1923
1,"Blood protein levels [EA, Low affinity immunoglobulin gamma Fc region receptor II-a/b]",2668
1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [AA],2027
1,Height [Conditioned on rs17346452],132
1,"Varicose veins | non-cancer illness code, self-reported",358
1,Melanoma,117344
1,"Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",20043
1,Psoriasis vulgaris,8130
1,Identify largest number | fi2 ,1992
1,"Blood protein levels [LAMC2, 9580_5_3]",2058
1,QRS duration [European],4760
1,"Ankylosing spondylitis [conditioned on rs11209026, EA]",321
1,Smoking status (heavy vs never),373
1,Disorders of parathyroid gland,95
1,"Osteoporosis | non-cancer illness code, self-reported",394
1,Gemmatimonadaceae abundance in stool,13
1,Facial morphology (segment 9),243
1,Bone mineral density [Trabecular vBMD],53
1,Graves' disease,19693
1,"Atopic dermatitis [EA, fixed effects]",37727
1,Protein quantitative trait loci [Complement factor H-related protein 1 (FHR-1],11242
1,Left ventricular ejection fraction,13230
1,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Hispanic],23143
1,Alzheimer's disease or waist-hip ratio (pleiotropy),3450
1,Educational attainment (college completion),2028
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-464 ms],423
1,Serum metabolite levels (CMS) [M_VLDL_CE],592
1,"Body mass index (adult) [AA, Women]",148
1,Migraine without aura,96
1,Gliclazide | treatment/medication code,7
1,Mean spheric corpuscular volume,413270
1,Serum levels of protein DDX46,6106
1,"Blood protein levels [FCN3, 5462_62_3]",8376
1,Macrophage colony-stimulating factor 1 levels,820
1,Obstructive sleep apnea trait (average oxyhemoglobin saturation across sleep episode),437
1,Telomere length x n-3 polyunsaturated fatty acid level interaction,274
1,"Waist circumference [EA, men]",135
1,Brain region volumes [right inferior parietal],234
1,Urate levels [AA],17143
1,Cancer (pleiotropy),89171
1,Kidney injury molecule 1 levels,2133
1,Severe influenza A (H1N1) infection,3195
1,Pain in joint,1043
1,CD3 on CD39+ resting CD4 regulatory T cell,890
1,Anxiety and stress-related disorders (including obsessive-compulsive disorder),643
1,Facial morphology [right exocanthion-right cheilion distance],782
1,Systolic blood pressure (cigarette smoking interaction),29101
1,BMI at 3 months old,1057
1,Glaucoma (high intraocular pressure),4052
1,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],24619
1,Basophil count,354416
1,COVID-19 or psoriasis (trans-disease meta-analysis),11461
1,Angina,2226
1,"Bone disorder | non-cancer illness code, self-reported",1499
1,Left atrial active emptying fraction,1062
1,Brain region volumes [left caudate],365
1,Body mass index (joint analysis main effects and smoking interaction) [women],148
1,Vitiligo,13148
1,Serum levels of protein DES,6106
1,Serum metabolite levels (CMS) [S_VLDL_P],23845
1,Age started wearing glasses or contact lenses,13036
1,Complement factor H-related protein 4A levels,4008
1,Electrocardiogram morphology (amplitude at temporal datapoints) [298 ms],5057
1,Hematological or dermatological disease,2760
1,Transient global amnesia,891
1,Serum levels of protein ACP7,106
1,C-reactive protein,64184
1,Liver enzyme levels (gamma-glutamyl transferase),133587
1,Myocardial infarction,47758
1,Water intake,7805
1,Nonsyndromic cleft lip with or without cleft palate,5251
1,Had menopause,4559
1,Serum metabolite levels [IDL_L],1923
1,Bipolar disorder vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),1957
1,Blood protein levels [Granulins],2027
1,Interleukin-6 levels in HIV infection,2254
1,Gestational age at birth (maternal effect),1264
1,Naive-mature B cell %B cell,27
1,Protein quantitative trait loci (liver) [ALDOA],156
1,Alanine aminotransferase levels,433897
1,X-23739 levels,1585
1,Leg fat-free mass (right),219886
1,3-indoxyl sulfate levels,3900
1,Resistance to antihypertensive treatment in hypertension,239
1,"Blood protein levels [CD5L, 3293_2_4]",3591
1,Serum levels of protein CD5L,2721
1,Abdominal hernia,709
1,Waist-to-hip ratio adjusted for BMI in non-smokers [women],326
1,CD40 on CD14+ CD16- monocyte,1072
1,Vitamin K-dependent protein C measurement,1574
1,Cerebrospinal fluid biomarker levels [Angiotensinogen],792
1,Coagulation factor XIII measurement,1838
1,C-reactive protein levels in ischemic stroke,652
1,CD11c on CD62L+ myeloid Dendritic Cell,269
1,IgG glycosylation patterns [IgG2_G1F],74
1,Fed-up feelings,3905
1,Electrocardiogram morphology (amplitude at temporal datapoints) [140 ms],6662
1,Schizophrenia [EA],11255
1,Electrocardiogram morphology (amplitude at temporal datapoints) [278 ms],3694
1,Medication use (vasodilators used in cardiac diseases),2735
1,Facial morphology traits (63 three-dimensional facial segments) [facial module 13],3329
1,Bone disorder,1563
1,Electrocardiogram morphology (amplitude at temporal datapoints) [372 ms],3694
1,Protein quantitative trait loci (liver) [ALDH5A1],4
1,von Willebrand factor A domain-containing protein 2 measurement,6106
1,Brain region volumes [left inferior lateral ventricle],39557
1,Electrocardiogram morphology (amplitude at temporal datapoints) [2 ms],22511
1,Thyroid cancer,146
1,Childhood obesity [EA],455
1,"Diastolic blood pressure x alcohol consumption interaction (2df test) [EA, Hispanic]",4299
1,Endometriosis of ovary,1467
1,"Pulse pressure x alcohol consumption interaction (2df test) [EA, Hispanic]",1956
1,Diabetic retinopathy,6462
1,Chronic bronchitis/emphysema | illnesses of mother,261
1,Protein quantitative trait loci (liver) [FDXR],158
1,Protein quantitative trait loci (liver) [ACSM2B],67
1,Highest math class taken,107350
1,Fish- and plant-related diet [male],17579
1,Electrocardiogram morphology (amplitude at temporal datapoints) [288 ms],3694
1,Depressive symptoms (binary sum-score),1438
1,17-hydroxyprogesterone (17-OHP) levels,296
1,Electrocardiogram morphology (amplitude at temporal datapoints) [360 ms],3694
1,CD45 on CD33- HLA DR-,686
1,Kawasaki disease [EA],1189
1,Serum C-reactive protein concentration in visceral obesity (waist circumference),156
1,Other disorders of soft tissues,61
1,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction) [women],4513
1,"Ground coffee (include espresso, filter etc) | coffee type",3420
1,Impedance of arm (right),156295
1,Fasting insulin,1744
1,Systemic lupus erythematosus [EA],1552
1,Body fat percentage variance,594
1,Urinary metabolite levels in chronic kidney disease [mannose],910
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-36 ms],27
1,Alanine transaminase levels in high alcohol intake,92
1,Impacted teeth,9
1,Blood trace element (Cu levels),9868
1,Age at first birth,143529
1,Serum levels of protein FCER1A,6106
1,Blood metabolite levels [cis-4-decenoyl carnitine],52683
1,Electrocardiogram morphology (amplitude at temporal datapoints) [28 ms],29621
1,Trunk fat mass,111670
1,Pancreatic cancer,10294
1,Low density lipoprotein cholesterol levels [Hispanic],2027
1,Serum levels of protein NEGR1,1475
1,Left atrial total emptying fraction,1256
1,Fasting blood glucose (BMI interaction),74
1,Protein quantitative trait loci (liver) [HNRNPH3],137
1,Nonalcoholic steatohepatitis,377
1,"""Postprocedural musculoskeletal disorders, not elsewhere classified""",51
1,Serum levels of protein FN1,50885
1,Serum levels of protein GAL3ST1,6106
1,Icd10: c90.0 multiple myeloma | underlying (primary) cause of death,3024
1,Serum levels of protein CLK2,6106
1,"Blood protein levels [NFASC, 7179_69_3]",592
1,Treponema D abundance in stool,1655
1,Free cholesterol levels in IDL,2009
1,3mm strong meridian angle (left),63
1,Phospholipid levels in medium LDL,1
1,Glaucoma (primary open-angle),22583
1,HDL cholesterol levels [Asian],24619
1,Cortical volume [Pericalcarine],6630
1,"Glaucoma | non-cancer illness code, self-reported",2001
1,Relative age voice broke,4000
1,Protein quantitative trait loci (liver) [CTSB],480
1,6mm cylindrical power (left),522
1,NT-proBNP levels in acute coronary syndrome,9126
1,Photic sneeze reflex,368
1,Self-reported math ability (MTAG) [MTAG],302484
1,Alcohol intake versus 10 years previously,18894
1,Body mass index [Japanese],71385
1,"Blood protein levels [CFB, 4129_72_1]",11091
1,"Forced expiratory volume in 1-second (fev1), best measure",110443
1,"Cerebrospinal fluid biomarker levels [6-phosphogluconate dehydrogenase, decarboxylating]",2637
1,Bone mineral density [FNK],1098
1,"Blood protein levels [EA, Dynein light chain roadblock-type 1]",4057
1,Phosphatidylcholine-O_18:0_[M+H]1+/Lysophosphatidylethanolamine_21:0_[M+H]1+ levels,5241
1,IgG glycosylation patterns [IgG2_G0FN],74
1,"Triglyceride levels [Asian initial, BMI unadjusted]",23211
1,Serum metabolite levels (CMS) [TotPG],23256
1,Electrocardiogram morphology (amplitude at temporal datapoints) [314 ms],6253
1,"Psoriasis | non-cancer illness code, self-reported",4256
1,"Eczema/dermatitis | non-cancer illness code, self-reported",3527
1,Serum metabolite levels [IDL_PL],1923
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-120 ms],315
1,Allergic asthma (mode) (more control exclusions),49
1,Malignant neoplasm of urinary organs,39
1,Serum levels of protein LGMN,30
1,Smoking behaviour (cigarette pack-years),911
1,Alanine aminotransferase level after methotrexate initiation in rheumatoid arthritis,719
1,Heart rate response to exercise [males],146
1,"Blood protein levels [CHI3L1, 11104_13_3]",1719
1,Obsessive compulsive disorder (ocd) | mental health problems ever diagnosed by a professional,48
1,Protein quantitative trait loci [IL-6 sRa],2290
1,Blood metabolite levels [X-11786--methylcysteine],4782
1,CX3CR1 on CD14+ CD16- monocyte,1072
1,Anorexia nervosa | mental health problems ever diagnosed by a professional,229
1,Benign neoplasm: Short bones of upper limb,58
1,First line medication for Crohns disease,178
1,Gastric cancer,379456
1,Age at menopause,219817
1,Age-related disease endophenotypes,1923
1,Heart rate response to recovery post exercise (20 sec),975
1,Autism and major depressive disorder (MTAG),52
1,Obesity [Overweight],1946
1,Hip circumference,114336
1,Inguinal hernia,3184
1,Respiratory or ear-nose-throat disease,7895
1,Tumor necrosis factor receptor 2 levels,1903
1,Coronary revascularization (ANGIO or CABG),10716
1,Glaucoma (primary angle closure) [Asian],261
1,Platelet aggregation [ephinephrine low 1],225
1,Serum metabolite levels [alpha-hydroxyisovalerate],319
1,Polyarthropathies,178
1,X-24295 levels,163
1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [AA],23178
1,Serum levels of protein TIE1,10825
1,Serum levels of protein PPIE,8433
1,Vertex-wise cortical surface area,293140
1,Electrocardiogram morphology (amplitude at temporal datapoints) [358 ms],3694
1,Protein quantitative trait loci (liver) [CALR],3382
1,Endometriosis diagnosis and infertility diagnosis occurring together,1316
1,Frozen shoulder,1178
1,"Trapped nerve/compressed nerve | non-cancer illness code, self-reported",749
1,Juvenile Open Angle Glaucoma,2039
1,Asthma (moderate or severe),921
1,"Local histogram emphysema pattern [Moderate Centrilobular, EA]",105
1,Diabethic neuropathy,178
1,Serum levels of protein FMOD,434
1,Protein quantitative trait loci [SLAF7],79
1,"""Type 2 diabetes, wide definition""",201
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-112 ms],86
1,Serum levels of protein ADGRE5,6106
1,Leg fat percentage (right),205987
1,Electrocardiographic traits (multivariate),6228
1,Waist-to-hip ratio adjusted for BMI in active individuals [women],5017
1,Electrocardiogram morphology (amplitude at temporal datapoints) [50 ms],1511
1,Serum levels of protein CREG1,209
1,Protein quantitative trait loci (liver) [PLPBP],47
1,Smoking initiation (ever regular vs never regular) (MTAG),146626
1,Drive faster than motorway speed limit,5153
1,"Waist circumference adjusted for body mass index [EA, men]",9600
1,Cortical surface area [Rostral Middle Frontal],3120
1,Serum metabolite levels [caproate (6:0],100320
1,"Blood protein levels [GALK1, 11448_34_3]",11811
1,Electrocardiogram morphology (amplitude at temporal datapoints) [168 ms],9508
1,Blood metabolite levels [carnitine],2041
1,Electrocardiogram morphology (amplitude at temporal datapoints) [328 ms],6253
1,Protein quantitative trait loci [FCRL3],7986
1,Electrocardiogram morphology (amplitude at temporal datapoints) [178 ms],6427
1,"Other professional qualifications eg: nursing, teaching | qualifications",1188
1,Systolic blood pressure x educational attainment (some college) interaction (2df) [African],189
1,BAFF-R on IgD+ CD38+ B cell,1072
1,Infant length,439
1,Ras-related protein Rab-2A measurement,225
1,1-methyl-5-imidazoleacetate levels,67
1,Midgestational total 25-hydroxyvitamin D levels (antenatal blood),61
1,"Blood protein levels [EA, Angiotensinogen]",48
1,Serum levels of protein CFB,3928
1,None of the above | pain type(s) experienced in last month,13453
1,LDL cholesterol levels [Asian],2027
1,Sleep traits (multi-trait analysis),519
1,"Blood protein levels [AKR7A2, 4188_1_2]",2176
1,Latent autoimmune diabetes vs. type 2 diabetes,178
1,Ischemic stroke (cardioembolic),1437
1,BAFF-R on B cell,1072
1,Serum metabolite levels (CMS) [L_VLDL_L],1255
1,Respiratory failure,112
1,Snoring,25163
1,ERO1-like protein beta measurement,14594
1,"Blood protein levels [HPX, 2768_56_2]",20498
1,Serum metabolite levels [linoleoyl ethanolamide],6582
1,"Blood protein levels [EA, Interleukin-6 receptor subunit alpha]",2948
1,"Blood protein levels [KIAA2013, 6538_90_3]",7722
1,Serum metabolite levels [erythritol],1276
1,Electrocardiogram morphology (amplitude at temporal datapoints) [66 ms],1245
1,For 'astigmatism' | reason for glasses/contact lenses,1035
1,"Blood protein levels [DPT, 4979_34_2]",1132
1,Body mass index (joint analysis main effects and physical activity interaction) [men],747
1,Gut microbiota (beta diversity),92
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-110 ms],86
1,"Blood protein levels [F13B, 5658_64_3]",24290
1,Serum metabolite levels [cis-4-decenoylcarnitine (C10:1],50050
1,Electrocardiogram morphology (amplitude at temporal datapoints) [80 ms],1560
1,"Blood protein levels [CA6, 13747_9_3]",237
1,"Respiratory failure, insufficiency, arrest",106
1,Serum levels of protein CXCL11,113
1,Activated CD4 regulatory T cell %CD4 regulatory T cell,2
1,Eye movement in schizophrenia (horizontal position gain),5773
1,Primary sclerosing cholangitis,20062
1,Skin colour,62205
1,Hearing difficulty/problems with background noise,9323
1,"Blood metabolite ratios [linoleate (18:2n6)/X-12442--5,8-tetradecadienoate]",26600
1,Serum metabolite levels (CMS) [M_HDL_PL],23848
1,Hand grip strength (right),40309
1,Electrocardiogram morphology (amplitude at temporal datapoints) [124 ms],4849
1,Obesity (early onset extreme),2054
1,Body mass index (joint analysis main effects and physical activity interaction) [women],4854
1,Accelerometer-based physical activity measurement (average acceleration),481
1,Gynecologic disease,2278
1,Brain region volumes [right hippocampus],1714
1,Uric acid levels,368
1,"""Rheumatoid arthritis , including avohilmo""",178
1,Serum levels of protein YWHAQ;SFN;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ,6106
1,Serum levels of protein NRXN3,6106
1,"Blood protein levels [FCRL4, 8973_23_3]",3729
1,Resting heart rate,8351
1,HDL cholesterol levels x short total sleep time interaction (2df test),2050
1,Electrocardiogram morphology (amplitude at temporal datapoints) [188 ms],6782
1,End-stage coagulation [FXIIIA],10130
1,"Blood protein levels [PDGFRA, 10366_11_3]",3543
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-172 ms],86
1,"Blood clot in the lung | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",90
1,Protein quantitative trait loci (liver) [MYO1B],671
1,Sum basophil neutrophil counts,135132
1,Schizophrenia vs ADHD (ordinary least squares (OLS)),22690
1,Leg fat percentage (left),196389
1,Amlodipine | treatment/medication code,14030
1,Nonsyndromic cleft palate,7759
1,Hypothyroidism (congenital or acquired),4137
1,Serum metabolite levels (CMS) [S_LDL_L],1923
1,Waist-to-hip ratio adjusted for BMI (age <50) [women],516
1,Granulocyte Absolute Count,344
1,Serum levels of protein CCL2,113
1,Digit length ratio,26477
1,Waist circumference adjusted for BMI (adjusted for smoking behaviour) [women],4513
1,Phosphatidylinositol_36:2_[M+NH4]1+ levels,23211
1,Serum metabolite levels (CMS) [PUFA],23529
1,Stem cell factor levels,4525
1,Doctor diagnosed hayfever or allergic rhinitis,953
1,Autism spectrum disorders (social interaction),362
1,Hippocampal tail volume (corrected for total hippocampal volume),2123
1,Hallux valgus (acquired),104
1,Adiponectin levels,1052
1,"Blood protein levels [EA, Neurexophilin-1]",118
1,Intracerebral hemorrhage,2
1,Hypercholesterolemia,34258
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-2 ms],22511
1,Arm fat percentage (left),90164
1,Blood metabolite ratios [10-undecenoate (11:1n1)/X-11438],6518
1,Serum levels of protein C1QC,3425
1,White blood cell count (monocyte),11343
1,Serum levels of protein FAM151A,2819
1,Erythropoietin levels,1511
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-458 ms],423
1,Brain morphology (min-P),39847
1,Vertex-wise cortical thickness,344717
1,Coronary artery bypass grafting,5319
1,White blood cell types [basophil count],9092
1,"Crohns disease | non-cancer illness code, self-reported",1270
1,Educational attainment [College],1629
1,Obstructive sleep apnea trait (percentage sleep with oxyhemoglobin saturation less than 90%),437
1,Body mass index (change over time) [females],219
1,"Heavy diy (eg: weeding, lawn mowing, carpentry, digging) | types of physical activity in last 4 weeks",116
1,Serum levels of protein CCL11,113
1,Diseases of appendix,55
1,Waist-to-hip ratio adjusted for body mass index,12972
1,Spherical equivalent (joint analysis main effects and education interaction) [European ancestry],11175
1,Waist circumference adjusted for BMI in active individuals [women],5812
1,Metabolic traits [SM-5 + 17 other traits],52589
1,Hip pain | pain type(s) experienced in last month,50907
1,Electrocardiogram morphology (amplitude at temporal datapoints) [382 ms],3694
1,Major depressive disorder (unexposed to adversity),4419
1,Protein quantitative trait loci (liver) [FNTA],4620
1,Urate levels [men],3181
1,Protein quantitative trait loci (liver) [PGM1],1299
1,Serum metabolite levels (CMS) [L_LDL_CE],1923
1,Cognitive impairment,560
1,Pallidum volume,407
1,Serum metabolite levels (CMS) [M_LDL_PL],1923
1,"Blood protein levels [EA, Contactin-2]",63
1,Body mass index (adult) [AA],148
1,Cleft palate,59
1,Response to antiepileptic mood-stabilizing treatment in bipolar disorder,9
1,BMI at 1 year old,1057
1,Lysophosphatidylethanolamine_16:0_[M-H]1- levels,4818
1,Cerebrospinal fluid biomarker levels [Extracellular matrix protein 1],50454
1,"Blood protein levels [ANGPTL3, 10382_1_3]",23211
1,N-acyl ethanolamine levels [sumEA],2461
1,Disease progression to choroidal neovascularization form in age-related macular degeneration,433
1,Systolic blood pressure [EA],1932
1,Serum levels of protein MAN1A2,2076
1,CD11b on CD33+ HLA DR+ CD14dim,1072
1,Gastric adenocarcinoma (histologically verified),10703
1,Ulcerative colitis [EA],33862
1,"Prostate cancer [EA, early-onset]",2830
1,Serum urea levels,89669
1,Serum levels of protein CTSS,9651
1,X-21286 levels,1350
1,Serum metabolite levels [M_LDL_L],1923
1,3mm weak meridian angle (right),2509
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-168 ms],86
1,Plasma proprotein convertase subtilisin/kexin type 9 levels in stable coronary artery disease,208
1,Alzheimer's disease or fasting insulin levels (pleiotropy),1148
1,Serum metabolite levels (CMS) [IDL_FC],1923
1,Umbilical hernia,1030
1,"HDL cholesterol levels [Asian initial, BMI adjusted]",583
1,Blood cell traits (multivariate analysis),149
1,Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes [AA],30
1,Serum uric acid levels,308027
1,Attention deficit hyperactivity disorder,19290
1,Insomnia,16166
1,Waist circumference adjusted for body mass index [women],5187
1,Vitamin D levels,172776
1,Serum levels of protein ECE1,6106
1,Serum metabolite levels (CMS) [M_HDL_TG],23256
1,Peak expiratory flow (pef),82014
1,Neutrophill percentage,176061
1,Serum metabolite levels (CMS) [S_LDL_FC],1923
1,Itch intensity from mosquito bite,4650
1,Immunoglobulin measurement (zinc sulfate turbidity test),1894
1,Invasive cervical cancer,16
1,Meconium ileus in cystic fibrosis,1091
1,Predicted visceral adipose tissue,44458
1,"Waist circumference adjusted for body mass index [EA,women]",4659
1,Serum levels of protein CNTN2,3868
1,"Pulse rate, automated reading",91068
1,BAFF-R on IgD+ B cell,1072
1,Electrocardiogram morphology (amplitude at temporal datapoints) [362 ms],3694
1,"Total cholesterol levels [Asian initial, BMI unadjusted]",2464
1,Serum levels of protein JAM3,177
1,Contrast sensitivity,44
1,Serum levels of protein LILRB5,203
1,Protein quantitative trait loci (liver) [DPP7],7
1,Polyomavirus 2  JC VP1 antibody levels,13
1,Protein quantitative trait loci (liver) [PLD3],4
1,Broad depression or schizophrenia,36614
1,Serum uric acid levels [EA],16665
1,Serum metabolite levels [MUFA],23256
1,Symmetrical dimethylarginine levels,3709
1,Blood protein levels [Hemopexin],1473
1,CD3 on secreting CD4 regulatory T cell,1301
1,"Response to tocilizumab in rheumatoid arthritis [CSJC , EA, RF-]",108
1,Complement factor H levels,1535
1,Thyrotoxicosis with toxic multinodular goitre,1723
1,Pulse wave arterial stiffness index,444
1,3mm cylindrical power (left),522
1,Medication use (antihypertensives),415
1,"Blood protein levels [SELP, 4154_57_2]",128
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-28 ms],425
1,Magnesium levels,46560
1,Hair color,107515
1,Coffee consumption,64414
1,Walking pace,20164
1,Phosphatidylcholine-O_18:1_[M+H]1+/Phosphatidylcholine-P_18:0_[M+H]1+ levels,4818
1,Estimated glomerular filtration rate [EA],8707
1,Serum metabolite levels [dimethylarginine (SDMA + ADMA],4349
1,Electrocardiogram morphology (amplitude at temporal datapoints) [220 ms],3849
1,Prothrombin time,6675
1,Serum metabolite levels (CMS) [Serum_C],1923
1,Early onset atrial fibrillation,1932
1,X-23308 levels,225
1,Severe non-proliferative background diabetic retinopathy,178
1,Peptic ulcer disease,134
1,Menarche (age at onset),72799
1,Lung function (FEV1/FVC),588665
1,Total PHF-tau (SNP x SNP interaction),88692
1,"Asthma | non-cancer illness code, self-reported",18373
1,Electrocardiogram morphology (amplitude at temporal datapoints) [206 ms],6782
1,Other and/or unspecified nontoxic goitre,2145
1,Crohn disease,575
1,Budesonide+formoterol | treatment/medication code,118
1,Urticaria and erythema,72
1,"Smoking initiation (ever regular vs never regular) [Conditioned on chr1:72752073, chr1:73824909]",183
1,"Blood protein levels [CRP, 4337_49_2]",648
1,Pulse wave reflection index,27
1,Loneliness,6165
1,Eosinophill percentage,132642
1,CD16 on CD14+ CD16+ monocyte,8728
1,Serum metabolite levels (CMS) [S_VLDL_C],23256
1,Cardiovascular heart disease in diabetics,827
1,Heart disease | illnesses of father,4119
1,Low white blood cell count,255
1,Unspecified diabetic retinopathy,178
1,Autism,228
1,Pulse pressure,720255
1,Axial length,3852
1,"Blood protein levels [THSD7A, 11174_8_3]",608
1,Prevalent atrial fibrillation,2492
1,X-23644 levels,1475
1,Heart rate response to recovery post exercise (40 sec),35
1,Oligomenorrhoea,63
1,Body mass index (joint analysis main effects and physical activity interaction),73379
1,"Blood metabolite levels [X12442--5,8-tetradecadienoate]",24402
1,Urinary metabolite levels in chronic kidney disease [methylsuccinoylcarnitine],5035
1,Iron status biomarkers (iron levels),3504
1,Serum C3d:C3 ratio (systemic complement activation),1549
1,Systemic lupus erythematosus [Chinese],1359
1,"""Hypodontia, including avohilmo""",1677
1,Systolic blood pressure [Japanese],164
1,Natural Killer Absolute Count,12
1,"Blood protein levels [FCRL3, 4440_15_2]",10984
1,Haematocrit percentage,247055
1,"""UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)""",5330
1,Metabolic traits [SM-9 + 17 other traits],6614
1,Serum levels of protein SPACA7,5978
1,Electrocardiogram morphology (amplitude at temporal datapoints) [112 ms],2068
1,Tinnitus,98
1,Hypertension [Japanese],164
1,I was more confident than usual | manifestations of mania or irritability,9
1,Keratinocyte cancer (MTAG),17050
1,Cutaneous melanoma or hair colour,7762
1,Total bilirubin levels,65501
1,Serum levels of protein SERPINF2,25064
1,Electrocardiogram morphology (amplitude at temporal datapoints) [54 ms],1511
1,Nephropathy,2492
1,Nose size,1345
1,CD33dim HLA DR+ CD11b+ Absolute Count,1072
1,Smoking status (current vs never) [African American],733
1,Prednisolone | treatment/medication code,128
1,Other mental disorder,566
1,Victim of sexual assault,119
1,Late-onset Alzheimer's disease,1148
1,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],20043
1,Serum levels of protein ENTPD3,6106
1,Serum metabolite levels [hexanoylcarnitine],157506
1,Oily fish consumption,2349
1,Medication use (antimigraine preparations),12311
1,Body mass index (joint analysis main effects and physical activity interaction) [EA],8991
1,Serum levels of protein THSD7A,608
1,Protein quantitative trait loci (liver) [HSPH1],122
1,Trunk fat mass adjusted for trunk lean mass,2
1,Inflammatory bowel disease,249794
1,Monocyte percentage of white cells,495628
1,Smoking initiation,47788
1,CD11c+ CD62L- monocyte Absolute Count,8685
1,Schizophrenia vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),2243
1,Complement component C8 measurement,6208
1,"Cholesterol lowering medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",25673
1,Electrocardiogram morphology (amplitude at temporal datapoints) [334 ms],6253
1,Electrocardiogram morphology (amplitude at temporal datapoints) [232 ms],3781
1,Serum metabolite levels [M_LDL_P],1923
1,Protein quantitative trait loci (liver) [CAPN2],53
1,Total body bone mineral density (age 45-60),1778
1,"Blood protein levels [C1QC, 14100_63_3]",240
1,Malignant neoplasm of pancreas,15
1,"Cholesterol, total",387674
1,PR interval,137634
1,Diabetes or endocrine disease,10316
1,Serum levels of protein LTA;LTB,6106
1,Blood metabolite levels [serine],1416
1,Platelet crit,383756
1,HVEM on Effector Memory CD8+ T cell,6812
1,Atopic asthma,2693
1,Neutralising antibody response to interferon beta therapy in multiple sclerosis (antibody titre; IFNβ-1a intramuscular),1641
1,Alzheimer's disease in APOE e4+ carriers,1148
1,White matter microstructure (mode of anisotropy) [Cingulate gyrus],1252
1,Protein quantitative trait loci (liver) [CPQ],35
1,Bread intake,10
1,"Blood protein levels [EA, Complement component C8]",11
1,Lung function (FVC),404061
1,Cerebrospinal fluid pyridoxal phosphate to pyridoxal ratio,1622
1,Coagulation Factor V measurement,15660
1,"Cys-gly, oxidized levels",3056
1,CX3CR1 on CD14- CD16-,4594
1,Serum levels of protein ROR1,2332
1,IgA nephropathy [EA],2515
1,Body fat percentage and LDL-C (pairwise),8585
1,Disorders of lipoprotein metabolism and other lipidaemias,3619
1,Osteoarthritis of the hip or knee (hospital diagnosed),950
1,White matter microstructure (fractional anisotropy) [Cingulate gyrus],739
1,Hematology traits [WBC],221
1,Aspartate aminotransferase platelet ratio index in high alcohol intake,72
1,Inflammatory bowel disease [EA],39262
1,Feeling tense,24206
1,hemolysis of donated blood (osmotic),4953
1,Electrocardiogram morphology (amplitude at temporal datapoints) [344 ms],4890
1,Mean corpuscular haemoglobin concentration,57049
1,N6-succinyladenosine levels,453
1,HVEM on CD8+ T cell,7640
1,"Waist-hip ratio [EA, women]",2965
1,Other bacterial diseases,155
1,Acne (severe) [fixed effect model],104
1,"""Burn and corrosion of hip and lower limb, except ankle and foot""",267
1,Type 2 diabetes [Japanese],604
1,Facial morphology (nose size),167
1,Arthrosis,42
1,Childhood body mass index,6922
1,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test),27016
1,Medication use (agents acting on the renin-angiotensin system),158375
1,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),7387
1,Serum metabolite levels [3-hydroxyoctanoate],24546
1,"Hypertension | non-cancer illness code, self-reported",91195
1,Metabolite levels [serine],1120
1,"Waist-to-hip ratio adjusted for BMI in active individuals [EA, women]",4485
1,Total cholesterol levels in small LDL,404
1,"Dental caries [DMFS5max, DMFS5]",4
1,Apolipoprotein B levels,272216
1,Noncognitive aspects of educational attainment,16225
1,Ascorbate (vitamin c) levels,1710
1,Serum levels of protein CTSC,6106
1,"Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA, women]",3380
1,Thyroid hormone levels [FT4],2158
1,DNA methylation-estimated plasminogen activator inhibitor-1 levels,1866
1,"Blood protein levels [NID1, 3213_65_2]",452
1,"Hematology traits [AA, WBC]",226
1,X-13728 levels,242
1,Systemic lupus erythematosus,99351
1,Serum cancer antigen 15.3 levels,12233
1,Ankle spacing width (right),108983
1,"Blood protein levels [CFH, 4159_130_1]",13360
1,Chronic kidney disease [eGFRcrea],2220
1,"Blood protein levels [EA, Polymeric immunoglobulin receptor]",3428
1,Sodium in urine,1643
1,Vertigo,1
1,Smoking behaviour (cigarettes smoked per day),5813
1,"High cholesterol | non-cancer illness code, self-reported",56794
1,"Pulse pressure x alcohol consumption interaction (2df test) [AA, Asian, EA]",1917
1,Urinary metabolite levels in chronic kidney disease [X - 24462],2176
1,Serum metabolite levels (CMS) [L_LDL_P],1923
1,Electrocardiogram morphology (amplitude at temporal datapoints) [284 ms],3694
1,Primary open-angle glaucoma,2237
1,"Blood protein levels [EA, Serum amyloid P-component]",1297
1,Airomir 100micrograms cfc-free inhaler | treatment/medication code,614
1,Vesicoureteral reflux [dominant],87
1,"""Type 1 diabetes, strict definition, subgroup 1""",178
1,Disorders of other endocrine glands,158
1,Change in glucose in response to thiazide diuretic treatment in hypertension [AA],462
1,Rubneribacter sp002159915 abundance in stool,69
1,6mm regularity index (right),18
1,Homocysteine levels,42463
1,HLA DR+ Natural Killer Absolute Count,8728
1,Serum levels of protein CREB3L4,17516
1,Asthma/COPD (KELA code 203),35843
1,Serum levels of protein KLK12,6106
1,Serum levels of protein C4BPA,608
1,Inflammatory biomarkers [ESR],3019
1,Posterior thalamic nuclei volume,2204
1,"Atrial fibrillation | non-cancer illness code, self-reported",1985
1,CD38 on transitional B cell,189
1,Pericardial adipose tissue adjusted for height and weight,8194
1,Lipoprotein phospholipase A2 activity in cardiovascular disease,1810
1,Cigarettes smoked per day (MTAG),23869
1,Urinary metabolite levels in chronic kidney disease [X - 12097],3709
1,Serum levels of protein C11orf87,7523
1,Serum levels of protein SEMG1,842
1,Clopidogrel | treatment/medication code,1979
1,Serum levels of protein ANAPC7,6106
1,Fissure and fistula of anal and rectal regions,218
1,"5,6-dihydrothymine levels",496
1,Fibrinogen [EA],4608
1,Depressive symptom (anhedonia) (ordinal trait),90
1,Protein quantitative trait loci (liver) [MCCC2],13
1,Diaphragmatic hernia,5
1,Premature separation of placenta [abruptio placentae],11
1,Prostate cancer,259665
1,Mosaic loss of chromosome Y (Y chromosome dosage),50920
1,CD11b on CD14+ monocyte,1072
1,Common traits (Other) [asparagus anosmia],19714
1,"Blood protein levels [IL12RB2, 3815_14_1]",2337
1,CD80 on myeloid Dendritic Cell,8728
1,1-(1-enyl-palmitoyl)-2-arachidonoyl-gpc (p-16:0/20:4) levels,3829
1,Serum metabolite levels [spermidine],615
1,Fasting blood insulin,255
1,Presence of other devices,124
1,CAG-274 sp000432155 abundance in stool,9
1,Microalbumin in urine,5
1,Complement factor H binding to malondialdehyde,12212
1,Angina pectoris,15857
1,Serum levels of protein RPS10,6106
1,Electrocardiogram morphology (amplitude at temporal datapoints) [212 ms],8769
1,"""Ulcerative colitis, NAS""",1764
1,CD40 on CD14- CD16+ monocyte,1072
1,Heart rate response to recovery post exercise (50 sec),2344
1,CD11c on granulocyte,1723
1,Glucosamine/chondroitin  | vitamin and/or mineral supplement use,1
1,Waist circumference adjusted for BMI in active individuals,7639
1,Getting up in morning,85417
1,Spherical power (left),17795
1,Major depressive disorder,22283
1,Regular attendance at a religious group,1223
1,BAFF-R on IgD- CD38dim B cell,1072
1,Other and unspecified types of non-Hodgkin lymphoma,44
1,Bipolar disorder vs obsessive compulsive disorder (ordinary least squares (OLS)),441
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-88 ms],86
1,Glioma,502
1,Highest math class taken (MTAG) [MTAG],246217
1,HVEM on CD4+ T cell,6812
1,CD64 on CD14+ CD16- monocyte,15861
1,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [H],2027
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-482 ms],423
1,Snoring [adjusted for BMI],1314
1,White matter microstructure (fractional anisotropy) [External capsule ],739
1,Serum metabolite levels [glutarylcarnitine (C5-DC],498
1,Spinal canal stenosis,383
1,Type 1 diabetes with low genetic risk score,815
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-80 ms],86
1,Platelet aggregation [ADP low 1],225
1,Caffeine consumption from coffee,1
1,Diverticular disease,24367
1,Hip circumference adjusted for BMI,75585
1,Triglyceride levels x short total sleep time interaction (2df test),23273
1,Low affinity immunoglobulin gamma Fc region receptor II-b levels,20315
1,Urinary metabolite levels in chronic kidney disease [isocaproylglutamine],52413
1,Dentures | mouth/teeth dental problems,28063
1,Symptoms involving skin and other integumentary tissue,1067
1,Serum levels of protein AURKB,6106
1,Eye movement (horizontal position gain),5773
1,"Orofacial clefts [Meta-All, NSCL/P]",1729
1,"""Type 2 diabetes, definitions combined""",1827
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-180 ms],86
1,Vertical cup-disc ratio,16219
1,TNF-related apoptosis-inducing ligand levels,3525
1,CD3 on CD39+ CD8+ T cell,890
1,Caudate nucleus volume,365
1,Serum metabolite levels (CMS) [S_VLDL_FC],589
1,Diffuse large B-cell lymphoma or rheumatoid arthritis,9950
1,Hip circumference adjusted for BMI [EA],25639
1,Triglyceride levels [Asian],23499
1,Serum metabolite levels [S_LDL_PL],1923
1,Serum levels of protein BCL2L1,6106
1,Aortic root size,306
1,Renal cell carcinoma,2749
1,Pain in limb,184
1,Ventolin 100micrograms inhaler | treatment/medication code,208
1,Serum levels of protein KIAA0040,106
1,Serum levels of protein SUN5,6106
1,Bone mineral density (spine),3989
1,Guilty feelings,606
1,Length of time at current address,1041
1,Sarcoidosis [EA],939
1,Hemostatic factors and hematological phenotypes [ACVn ratio],765
1,"Blood protein levels [FCGR2B, 3310_62_1]",2827
1,Migraine and/or pulse pressure,1438
1,A body shape index,43331
1,Electrocardiogram morphology (amplitude at temporal datapoints) [122 ms],4898
1,Pace-maker,305
1,End-stage coagulation [D-dimer],236
1,"""Type 1 diabetes, wide definition, subgroup 1""",178
1,Gut microbiota relative abundance (bacterial taxa) [Paenibacillaceae_1],107
1,Malignant neoplasm of urinary organs (controls excluding all cancers),39
1,Serum albumin levels,270268
1,Stroke,9293
1,Systolic blood pressure x smoking status (ever vs never) interaction (2df test),12533
1,Electrocardiogram morphology (amplitude at temporal datapoints) [250 ms],3568
1,"Blood protein levels [SYT11, 7089_42_3]",5127
1,Serum metabolite levels (CMS) [M_VLDL_P],592
1,Serum levels of protein QSOX1,1174
1,Low tan response,234
1,Previous | smoking status,442
1,"Response to tocilizumab in rheumatoid arthritis [CHAQ, EA, RF-]",61
1,Peripheral arterial disease (traffic-related air pollution interaction) [EA],12659
1,White blood cell count (neutrophil),58331
1,Serum metabolite levels (CMS) [TotCho],23256
1,3mm strong meridian (right),49940
1,Corneal resistance factor (right),32250
1,Arm fat-free mass (right),239287
1,Serum levels of protein H6PD,3330
1,Electrocardiogram morphology (amplitude at temporal datapoints) [234 ms],3781
1,Social anxiety or social phobia | mental health problems ever diagnosed by a professional,560
1,Alzheimer's disease,2296
1,Migraine and/or systolic blood pressure,5848
1,Other systemic involvement of connective tissue (FG),178
1,"""Acute appendicitis, no complications""",55
1,Fibrosis-4 index in high alcohol intake,373
1,Serum levels of protein TMEM230,106
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-108 ms],86
1,Receptor for advanced glycosylation end products levels,56
1,Protein quantitative trait loci (liver) [ALDH16A1],83
1,Red blood cell traits [MCH],6316
1,Serum phosphate levels,62576
1,Rheumatoid arthritis [conditional on rs2301888],14298
1,Blood metabolite levels [hexadecanedioate],6518
1,Folate pathway vitamin levels [Plasma PLP],5075
1,Palmitoyl-protein thioesterase 1 measurement,11017
1,Alzheimer's disease [AA],2296
1,CD14 on CD33dim HLA DR+ CD11b+,1072
1,Heart rate response to exercise,146
1,Visceral adipose tissue/subcutaneous adipose tissue ratio,106
1,Alcohol-related disorders,32
1,"Blood protein levels [CD55, 5069_9_3]",6157
1,Diabetes | illnesses of adopted father,332
1,Body mass index in physically inactive individuals,146
1,"Ulcerative colitis | non-cancer illness code, self-reported",4524
1,"Age-related diseases, mortality and associated endophenotypes",1923
1,White blood cell count (eosinophil),47
1,Menstruation quality of life impact (dysmenorrhea),181
1,SLE (Finngen),131
1,Waist circumference adjusted for body mass index,233334
1,LDL cholesterol levels [Trans-ethnic initial],94137
1,CD3 on CD39+ CD4+ T cell,976
1,Cortical surface area [Pars Orbitalis],14424
1,Paracetamol | treatment/medication code,8542
1,Scavenger receptor class A member 5 measurement,6106
1,Hernia of abodminal wall,533
1,Diffuse plaques (SNP x SNP interaction),2428
1,Diabetes | illnesses of adopted mother,762
1,"Vasculitis | non-cancer illness code, self-reported",286
1,Protein levels in obesity [Carbonic anhydrase 6],198
1,Restless legs syndrome,232
1,Serum levels of protein TP53I13,24
1,Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis,12327
1,Medication use (drugs affecting bone structure and mineralization),24064
1,Serum levels of protein B3GALT6,33901
1,Serum metabolite levels [X-11421],157506
1,Protein quantitative trait loci (liver) [DDAH2],10080
1,3mm weak meridian (right),41981
1,Pregnancy hypertension,18393
1,Tissue factor levels,9755
1,"Blood protein levels [SELL, 4831_4_2]",4031
1,Serum levels of protein CCL14,113
1,Electrocardiogram morphology (amplitude at temporal datapoints) [246 ms],3568
1,Pregnancy with abortive outcome,35
1,"Fracture vertebra / crush fracture / vertebral collapse | non-cancer illness code, self-reported",11
1,Fat-free mass,54672
1,Triglyceride levels [Hispanic],23499
1,Smoking status (current vs never),425
1,"Lipid metabolism phenotypes [APOB.assay, whole]",1923
1,Hip circumference variance,1723
1,CD11c on myeloid Dendritic Cell,269
1,Folic acid product | treatment/medication code,178
1,Body mass index (SNP x SNP interaction),73
1,Rate of cognitive decline in Alzheimer's disease [GEE model],154
1,Trochanter size,239
1,"Non-infective hepatitis | non-cancer illness code, self-reported",7
1,Glycated hemoglobin levels,253901
1,Lysophosphatidic acid phosphatase type 6 levels,60106
1,"Blood protein levels [CFHR1, 5982_50_3]",30921
1,Serum levels of protein MOCS3,6106
1,"Blood protein levels [FCGR3B, 3311_27_1]",520
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-156 ms],5119
1,Soluble levels of adhesion molecules [P-Selectin],1317
1,"Blood protein levels [EA, Repulsive guidance molecule A]",2027
1,Care cetirizine hayfever relief 10mg tablet | treatment/medication code,795
1,Chronic Coagulation defects,144
1,Protein quantitative trait loci (liver) [AARS],47
1,Mitochondrial DNA levels,4511
1,Low myopia vs hyperopia,12250
1,Sortilin levels (OLINK),24504
1,Blood pressure [Diastolic],9256
1,"Blood protein levels [DLL3, 9974_8_3]",6470
1,BMI in non-smokers [men],602
1,Total body bone mineral density (age over 60),1054
1,Serum levels of protein GUCA1A,106
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-164 ms],86
1,Cardiovascular disease,198586
1,Primary biliary cholangitis,50391
1,Serum levels of protein C10orf105,6106
1,Serum metabolite levels [3-hydroxysebacate],30920
1,Serum metabolite levels [TotPG],23256
1,Electrocardiogram morphology (amplitude at temporal datapoints) [10 ms],47268
1,High light scatter reticulocyte percentage,42106
1,Serum levels of protein FJX1,2027
1,Thyroid peroxidase antibody levels,1047
1,Serum levels of protein LILRA5,1379
1,Hypertrophic disorders of skin,230
1,IgD+ CD24+ B cell %B cell,27
1,"Orofacial clefts [Meta-All, NSCLP]",36
1,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),5211
1,Menopause (age at onset),73671
1,Headache,23299
1,Blood metabolite levels [X-03094],22552
1,"Blood protein levels [TBCE, 11211_7_3]",6047
1,3mm weak meridian (left),40653
1,Phospholipid levels (plasma) [proportions],3441
1,Knee pain | pain type(s) experienced in last month,1056
1,Cognitive function,162
1,Sensitivity to environmental stress and adversity,188
1,Time spent watching television (tv),38762
1,Hemoglobin,678224
1,"Heel quantitative ultrasound index (qui), direct entry (right)",24752
1,Prozac 20mg capsule | treatment/medication code,15958
1,"""Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified""",12279
1,Serum levels of protein PLXDC2,3689
1,Hyperinsulinemia x BMI interaction,270
1,Any other phobia (eg disabling fear of heights or spiders) | mental health problems ever diagnosed by a professional,614
1,CD14 on CD14+ CD16+ monocyte,1189
1,1-palmitoyl-2-linoleoyl-gpc (16:0/18:2) levels,72
1,Proliferative diabetic retinopathy,356
1,"Cholesterol, total [Hispanic]",1689
1,Phyllocontin continus 225mg m/r tablet | treatment/medication code,1324
1,Age-related hearing impairment [additive],64364
1,Folate pathway vitamin levels [vitamin B6],4995
1,Liver enzyme levels (alkaline phosphatase),68948
1,Headache | pain type(s) experienced in last month,17094
1,Electrocardiogram morphology (amplitude at temporal datapoints) [180 ms],14794
1,"""Pneumonia, organism unsepcified""",155
1,Atopic/contact dermatitis due to other or unspecified,253
1,Survival in sporadic amyotrophic lateral sclerosis,521
1,Atopic dermatitis,60019
1,Stearic acid (18:0) levels,16399
1,Lipitor 10mg tablet | treatment/medication code,1609
1,Serum levels of protein MAP2K4,1838
1,"Cerebral palsy | non-cancer illness code, self-reported",3269
1,Serum metabolite levels (CMS) [M_LDL_L],1923
1,BMI (adjusted for smoking behaviour) [men],602
1,Electrocardiogram morphology (amplitude at temporal datapoints) [-26 ms],425
1,Autism spectrum disorder vs obsessive compulsive disorder (ordinary least squares (OLS)),2
1,Migraine without aura and/or systolic blood pressure,5848
1,Creutzfeldt-Jakob disease (sporadic),1581
1,Osteoarthritis of the hip or knee,712
1,Hyperthyroidism,140
1,Thyrotoxicosis with diffuse goitre,178
1,Malignant lymphoma,346
1,Height,2245620
1,Celiac disease and Rheumatoid arthritis,10457
1,CD62L- Dendritic Cell %Dendritic Cell,15098
1,DNA methylation PhenoAge acceleration,9946
1,Hand grip strength,9968
1,Peripheral artery disease,3745
1,"Sexual dimorphism in anthropometric traits [WHRadjBMI, women]",516
1,"""Hypothyroidism, drug reimbursement""",4137
1,Facial morphology [left endocanthion-subnasale distance],583
2,"Total bilirubin levels in HIV-1 infection [rs4148324, rs3771341]",1071
2,Sjögren's syndrome,860
2,Urate levels [South Asian],383
2,CAG-452 abundance in stool,128
2,Fasting blood glucose (BMI interaction),23945
2,Hypothyroidism nos,2205
2,Cholelithiasis or gall stones,1105
2,Automobile speeding propensity,128
2,Body mass index (joint analysis main effects and physical activity interaction) [women],12545
2,Waist-to-hip ratio adjusted for body mass index [women],9113
2,Electrocardiogram morphology (amplitude at temporal datapoints) [8 ms],6476
2,"""Hypothyroidism,  other/unspecified""",2180
2,Electrocardiogram morphology (amplitude at temporal datapoints) [124 ms],1570
2,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,297
2,"Blood protein levels [FN1, 3435_53_2]",299
2,Coronary atherosclerosis,88306
2,Liver enzyme levels (alkaline phosphatase),76931
2,Urinary metabolite levels in chronic kidney disease [N2-acetyllysine],23640
2,CD45RA+ CD8+ T cell Absolute Count,320
2,Serum levels of protein GPR101,40
2,Glucuronate levels,18532
2,Serum levels of protein REG3G,1590
2,Blood metabolite levels [glycine],10
2,FEV1,68862
2,General risk tolerance (MTAG),36743
2,Endometriosis [EA],2409
2,Phosphatidylcholine-O_34:2_[M+H]1+/Phosphatidylcholine-P_34:1_[M+H]1+/Phosphatidylethanolamine-O_37:2_[M+H]1+ levels,2043
2,Migraine - clinic-based,674
2,Ulcerative colitis [EA],16540
2,Serum bilirubin levels in metabolic syndrome,21391
2,Whole body fat-free mass,190853
2,Serum levels of protein CCL28,9268
2,Iron status biomarkers (transferrin levels),162
2,Serum metabolite levels [3b-hydroxy-5-cholenoic acid],240
2,"Blood protein levels [EA, Fibronectin Fragment 3]",533
2,CD4+ CD8dim T cell %lymphocyte,2454
2,Anxiety disorder (factor score),25675
2,Left–right brain asymmetry,28740
2,Proline levels,8993
2,Serum metabolite concentrations in chronic kidney disease [N-acetylkynurenine],5784
2,Cholelithiasis with acute cholecystitis,842
2,N-glycan levels [TA],386
2,Dentures,7785
2,CD8 on Effector Memory CD8+ T cell,4149
2,Coagulation factor IXab measurement,2171
2,Cerebrospinal fluid biomarker levels [Low molecular weight phosphotyrosine protein phosphatase],18700
2,Red blood cell (erythrocyte) distribution width,77181
2,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [AA],2171
2,White matter microstructure (mode of anisotropy) [Anterior limb of internal capsule],345
2,Ismn - isosorbide mononitrate | treatment/medication code,73
2,Protein quantitative trait loci (liver) [CYB5R3],91
2,All-cause Heart Failure,31
2,Protein quantitative trait loci (liver) [TOMM70],146
2,Breast cancer,113288
2,Estimated glomerular filtration rate [discovery],11226
2,Macrophage receptor MARCO levels,7239
2,Ankle spacing width (right),31464
2,Anterior thalamic nuclei volume,4059
2,Iris characteristics [Furrows],4091
2,Effector Memory CD4-CD8- T cell %T cell,2189
2,Optic cup area [EA],281
2,Non-glioblastoma glioma,729
2,Upper eyelid morphology [Tangent line angle of er3],274
2,Relapse in multiple sclerosis,146
2,Erosive tooth wear (severe vs non-severe),56
2,Metabolic syndrome,15163
2,Metabolic syndrome [SBP],6913
2,Rose wine intake,23
2,Stenosis and insufficiency of lacrimal passages,1
2,"Heel quantitative ultrasound index (qui), direct entry (left)",15870
2,Arm fat percentage (left),149053
2,Sudden cardiac arrest in coronary artery disease,1730
2,Coxarthrosis [arthrosis of hip](FG),727
2,"Gynecologic disease (multivariate analysis) [uterine fibroid,endometriosis]",340
2,Metabolite levels (small molecules and protein measures) [Valine],60
2,Sperm motility,18
2,Neurofibrillary tangles (SNP x SNP interaction),51315
2,Biological sex,31164
2,Leg fat percentage (left),114340
2,Electrocardiogram morphology (amplitude at temporal datapoints) [236 ms],1295
2,CD45RA on naive CD8+ T cell,357
2,Lipoprotein (a) levels,1607
2,Diabetes | illnesses of adopted siblings,806
2,Medication use (antithrombotic agents),311
2,Oral cavity cancer,14089
2,Leg fat mass (left),63799
2,Peptidyl-prolyl cis-trans isomerase FKBP7 measurement,3602
2,Lactate dehydrogenase levels,2043
2,CD8 on HLA DR+ CD8+ T cell,4149
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-6 ms],257
2,Electrocardiogram morphology (amplitude at temporal datapoints) [328 ms],358
2,Major depressive disorder (probable),426
2,Protein quantitative trait loci (liver) [SAA1],35
2,Serum 25-Hydroxyvitamin D levels,115497
2,Hypercholesterolemia,6254
2,malignant neoplasm of male genital organs,1218
2,"Body mass index in physically inactive individuals [EA, men]",2604
2,Facial morphology (segment 1),833
2,Conditional arithmetic | fi6 ,113
2,Rheumatoid arthritis [ACPA+ cases vs. all controls],502
2,HDL cholesterol levels x long total sleep time interaction (2df test),406
2,Complication of internal orthopedic device,14
2,Electrocardiogram morphology (amplitude at temporal datapoints) [2 ms],257
2,Electrocardiogram morphology (amplitude at temporal datapoints) [170 ms],5345
2,Sleep duration (long sleep),790
2,Male puberty timing (age at voice breaking MTAG),7131
2,"Black | hair colour (natural, before greying)",425
2,LDL cholesterol levels x short total sleep time interaction (2df test),14182
2,Blood metabolite levels [Arginine / Glycine],25025
2,Serum metabolite levels [M_VLDL_P],2043
2,Telfast 30 tablet | treatment/medication code,1967
2,Psoriatic arthritis,1941
2,Calculus of kidney and ureter,1213
2,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [3-hydroxy-3-methylglutarate, 3-methylglutaconate, 3-methylglutarate, 2-methylglutarate, 3-methylglutarylcarnitine]",10
2,Body fat percentage or coronary artery disease (MTAG),25380
2,Protein quantitative trait loci [PPAC],11445
2,Blood metabolite levels [pantothenate],24060
2,CD25++ CD8+ T cell Absolute Count,1456
2,Electrocardiogram morphology (amplitude at temporal datapoints) [188 ms],5345
2,Type 1 diabetes with other specified/multiple/unspecified complications,2214
2,Crohn's disease and celiac disease [combined],2818
2,Cooked vegetable consumption,676
2,"Blood protein levels [IL1RL2, 2994_71_2]",523
2,Body mass index and type 2 diabetes (pairwise),861
2,"Blood protein levels [LRP1B, 7640_29_3]",113
2,"""UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)""",169
2,Alistipes shahii abundance in stool,38
2,Waist-to-hip ratio adjusted for BMI,258455
2,Sphingomyelin(37:1)_[M+H]1+ levels,1904
2,"""Coxarthrosis, primary, with hip surgery""",727
2,Electrocardiogram morphology (amplitude at temporal datapoints) [122 ms],275
2,C-C motif chemokine 20 levels,809
2,Electrocardiogram morphology (amplitude at temporal datapoints) [342 ms],358
2,Urinary metabolite ratios in chronic kidney disease [Acetylornithine/Propionylcarnitine],24553
2,White matter hyperintensity volume (adjusted for hypertension),27792
2,Sitting height,345649
2,Certain disorders involving the immune mechanism,1659
2,Alcohol consumption (drinks per week) [Conditioned on chr2:27730940],13960
2,Electrocardiogram morphology (amplitude at temporal datapoints) [102 ms],275
2,Lysophosphatidylethanolamine_18:0_[M-H]1- levels,2043
2,Mood swings,256
2,Sclerosing cholangitis and ulcerative colitis (combined) [PSC],90
2,Type 2 diabetes,359627
2,Coronary artery disease or ischemic stroke,23140
2,"Body mass index [EA, women]",12446
2,Urinary metabolite levels in chronic kidney disease [X - 13698],24553
2,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Hispanic],2171
2,Heel broadband ultrasound attenuation (left),14873
2,Bilirubin levels [Indirect bilirubin],2549
2,Terminally Differentiated CD4+ T cell %T cell,1284
2,"Blood protein levels [SET, 5364_7_3]",299
2,Beclometasone dipropionate+salbutamol | treatment/medication code,553
2,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test),234
2,"""Diabetes, varying definitions""",6882
2,Serum levels of protein UGT1A6,5780
2,Diverticulosis and diverticulitis,1007
2,Blood metabolite levels [total homocysteine],690
2,Night sleep phenotypes [sleep offset],478
2,Gestational [pregnancy-induced] hypertension,32
2,Other special examinations and investigations of persons without complaint or reported diagnosis,34
2,CD28 on CD28+ CD45RA- CD8+ T cell,2593
2,Facial morphology (segment 21),19159
2,Serum metabolite levels [N-acetylhistidine],32570
2,LDL cholesterol levels in current drinkers,4378
2,"Liver/biliary/pancreas problem | non-cancer illness code, self-reported",5553
2,Eosinophil cationic protein levels,1013
2,Electrocardiogram morphology (amplitude at temporal datapoints) [156 ms],5345
2,Hedonic well-being,382
2,Serum levels of protein FRZB,2715
2,3-methylglutarylcarnitine (2) levels,1104
2,Atorvastatin | treatment/medication code,3051
2,Inflammatory biomarkers (multivariate analysis),968
2,White matter microstructure (mode of anisotropy) [Uncinate fasciculus],239
2,Serum metabolite levels [homoarginine],240
2,"Gastritis/gastric erosions | non-cancer illness code, self-reported",15
2,Urate levels,415524
2,Hip index,11518
2,Chronic obstructive pulmonary disease [conditional on rs62191105],3571
2,Diastolic blood pressure x alcohol consumption interaction (2df test) [EA],2489
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-158 ms],118
2,Interleukin-2 receptor subunit beta measurement,349
2,Iron+folic acid | treatment/medication code,133
2,"Eyebrow thickness [East Asian, Hispanic and Other admixed]",212
2,Other hereditary haemolytic anaemias,21
2,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),62428
2,Motion sickness,4501
2,Fasting triglyceride levels,2043
2,"Forced expiratory volume in 1-second (fev1), predicted percentage",855
2,Frequency of needing morning drink of alcohol after heavy drinking session in last year,62
2,Waist-to-hip ratio adjusted for BMI in active individuals,3520
2,Obesity (extreme),11236
2,Gilbert syndrome,5509
2,Interleukin-10 levels,1200
2,Hypothyroidism (congenital or acquired),2535
2,White matter microstructure (mean diusivities) [Average across all tracts],5151
2,Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid),2043
2,Meat-related diet,60
2,"Hirschsprung disease [East Asian, recessive]",517
2,Risky sexual behaviors in alcohol dependence [AA],152
2,Drive faster than motorway speed limit,13
2,Suicide attempts in bipolar disorder,2365
2,Type 2 diabetes (adjusted for BMI),10862
2,White blood cell types [monocyte count],547
2,Tissue factor pathway inhibitor levels,8644
2,Electrocardiogram morphology (amplitude at temporal datapoints) [322 ms],275
2,Cardiovascular diseases,1573
2,Triglyceride levels [EA],2166
2,Risedronate sodium | treatment/medication code,142
2,Lateral ventricle temporal horn volume,14
2,Facial morphology (brow ridge protrusion 1),25
2,G_Prevotella prevalence,23
2,Tumor necrosis factor receptor 1 levels,13860
2,"Paracetamol | medication for pain relief, constipation, heartburn",32432
2,Depressive symptoms (MTAG),2810
2,BMI (adjusted for smoking behaviour) [women],12446
2,Phosphatidylcholine_32:2_[M+OAc]1-/Phosphatidylserine_36:1_[M-H]1- levels,2043
2,6mm weak meridian (right),15273
2,Diabetes | illnesses of father,7200
2,Protein quantitative trait loci (liver) [CLTC],147
2,Serum metabolite levels (CMS) [L_VLDL_FC],2043
2,Urinary metabolite levels in chronic kidney disease [N-acetylglutamine],23191
2,Lacri-lube eye ointment | treatment/medication code,7701
2,Serum metabolite levels (CMS) [M_VLDL_PL],2497
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-4 ms],257
2,None of the above (group 1) | illnesses of mother,743
2,"Blood protein levels [VIT, 6234_74_3]",403
2,C-reactive protein and white blood cell count [CRP],277
2,Blood pressure [Systolic],130
2,Gout [EA],2043
2,"Blood protein levels [F3, 4931_59_1]",5509
2,Arm fat-free mass (left),146288
2,"Medication use (adrenergics, inhalants)",11893
2,Diacylglycerol_34:3_[M+H-H2O]1+ levels,2043
2,Waist circumference adjusted for BMI in non-smokers [women],598
2,Serum metabolite levels (CMS) [S_LDL_P],976
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-96 ms],118
2,Serum metabolite levels [N-acetylphenylalanine],17945
2,Home location - north co-ordinate (rounded),7787
2,Alzheimer's disease or HDL levels (pleiotropy),628
2,Oily fish intake,306
2,"""Type 1 diabetes, strict definition""",1157
2,Childhood dental caries in primary teeth [EA],270
2,Protein quantitative trait loci (liver) [ALDOA],28
2,Average weekly red wine intake,4876
2,Activated & secreting CD4 regulatory T cell %CD4+ T cell,1462
2,Impedance of arm (right),85329
2,Doxazosin | treatment/medication code,672
2,Ascorbate (vitamin c) levels,110
2,Free cholesterol levels,147
2,Male puberty timing (late vs. average onset voice breaking),14
2,Hip circumference,95659
2,"Blood protein levels [EA, Low molecular weight phosphotyrosine protein phosphatase]",13173
2,"Blood protein levels [EA, Interleukin-1 beta]",438
2,Electrocardiogram morphology (amplitude at temporal datapoints) [108 ms],1295
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-26 ms],2461
2,"Light brown | hair colour (natural, before greying)",1929
2,"Blood protein levels [ALPPL2, 6715_63_3]",666
2,Metabolite levels [Glycine],510
2,Cortical surface area [Pericalcarine],360
2,Facial morphology [right endocanthion-right alare distance],140
2,High altitude adaptation,145
2,Chronic obstructive pulmonary disease in non-current smokers,2022
2,Serum metabolite levels [L_VLDL_P],2043
2,Common traits (Other) [hair curl],2261
2,CD39+ resting CD4 regulatory T cell %CD4 regulatory T cell,1462
2,Hypertension (SNP x SNP interaction),440
2,Total mean fractional anisotropy measurement in first episode schizophrenia,24
2,Forced expiratory volume in 1-second (fev1),143670
2,3mm weak meridian angle (left),2615
2,Rate of cognitive decline in Alzheimer's disease [LME model],1072
2,Corneal endothelial cell shape (percentage of hexagonally shaped cells),1176
2,Mesial temporal lobe epilepsy with hippocampal sclerosis [MTLEHS vs. Controls],501
2,Any gastric operation,266
2,Facial morphology (segment 22),287
2,Cognitive decline rate in late mild cognitive impairment,173
2,Bilateral oophorectomy (both ovaries removed),415
2,Hand grip strength,132516
2,Electrocardiogram morphology (amplitude at temporal datapoints) [186 ms],5345
2,Immature reticulocyte fraction,208729
2,Total protein levels x insomnia interaction,2558
2,Brain functional connectivity measurement (global efficiency),756
2,"Diverticular disease/diverticulitis | non-cancer illness code, self-reported",196
2,Cortical volume [Parahippocampal],3
2,Subcortical volume (MOSTest),58681
2,Diabetes or endocrine disease,26058
2,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [N2, N6-diacetyllysine, N-acetylasparagine, N-acetylglutamine, N-acetylhistidine, N-acetylleucine]",23191
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-120 ms],618
2,Electrocardiogram morphology (amplitude at temporal datapoints) [234 ms],1295
2,Serum metabolite levels (CMS) [Ala],2043
2,Eukaryotic translation initiation factor 4E type 2 measurement,1487
2,Leukocyte telomere length,847
2,Sulfhydryl oxidase 2 measurement,285
2,Physical activity (Relative amplitude),28
2,Protein quantitative trait loci (liver) [HSD17B11],16
2,Protein quantitative trait loci (liver) [LDHA],1
2,Cortical surface area (min-P),5940
2,Retinal nerve fibre layer (RNFL) thickness,28657
2,Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI),264
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-24 ms],2461
2,"""Alcohol use disorder, ICD-based""",1516
2,Renal cell carcinoma,1150
2,Angitil sr 90 m/r capsule | treatment/medication code,154
2,"Cholesterol, total",72599
2,Serum metabolite levels [pyrraline],42354
2,FSC-A on myeloid Dendritic Cell,4071
2,5-hydroxyindoleacetate levels,477
2,Severe skin toxicity response to cetuximab in stage 3 colon cancer,115
2,Nonsyndromic cleft lip with or without cleft palate [EA],52
2,"Refractive astigmatism [EA, 25 years or older]",1
2,Resting heart rate,8370
2,Driving (hours per day),8391
2,Electrocardiogram morphology (amplitude at temporal datapoints) [16 ms],33246
2,Body fat distribution (trunk fat ratio),811
2,Resting CD4 regulatory T cell Absolute Count,1753
2,Glucosamine/chondroitin  | vitamin and/or mineral supplement use,572
2,Male puberty timing (late vs. average onset facial hair),2057
2,Leg fat-free mass (left),106465
2,Cognitive ability,6398
2,Schizophrenia or schizoaffective disorder [Latino],851
2,Leg fat mass and leg lean mass (pleiotropy),264
2,Cereal intake,205
2,Lipitor 10mg tablet | treatment/medication code,215
2,Asthma (childhood onset),45899
2,Maternal history of Alzheimer's disease,174
2,Childhood body fatness,12496
2,Diacylglycerol_34:2_[M+H-H2O]1+ levels,2043
2,"Blood protein levels [PXDN, 13463_1_3]",303
2,Spondylosis,50
2,Brain region volumes [cerebellar vermal lobules I V],513
2,Protein quantitative trait loci (liver) [IGHG2],160
2,Not performed - other reason | oct measured (right),49
2,Diacylglycerol_34:2_[M+NH4]1+ levels,2171
2,Hyperglycemia,1092
2,Interleukin-1 receptor-like 2 levels,987
2,Gut microbiota relative abundance (bacterial taxa) [Klebsiella],88
2,Sodium in urine,47103
2,"Hayfever/allergic rhinitis | non-cancer illness code, self-reported",27107
2,Serum metabolite concentrations in chronic kidney disease [Nonanoylcarnitine],1292
2,Diverticulosis,1007
2,Triglyceride levels in current drinkers [Hispanic],2171
2,Electrocardiogram morphology (amplitude at temporal datapoints) [126 ms],1570
2,"Formally detained under part ii, mental health act 1983 | detention categories",26
2,Isosorbide mononitrate | treatment/medication code,9
2,Sunburns,6366
2,Bone mineral density,26901
2,Cholecystitis,1926
2,Body mass index and HDL-C (pairwise),862
2,Sex hormone-binding globulin levels [Women],2043
2,Dyslipidemia,3174
2,Serum metabolite levels (CMS) [XL_VLDL_CE],2043
2,Schizophrenia [Chinese],1361
2,Serum metabolite levels [isovalerylglycine],420
2,Aneurinibacillaceae abundance in stool,75
2,Gut microbiota (bacterial taxa) [Lactobacillales order],259
2,Gut microbiota (bacterial taxa) [k__Bacteria|p__Firmicutes|c__Negativicutes|o__Selenomonadales|f__Veillonellaceae|g__Dialister|s__Dialister_invisus],137
2,Plateletcrit,452339
2,Neutrophil percentage of white cells,246060
2,Smoking status,20394
2,Autoimmune traits (pleiotropy),10082
2,Weight change compared with 1 year ago,8451
2,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test) [EA],2505
2,Electrocardiogram morphology (amplitude at temporal datapoints) [158 ms],5345
2,"Blood protein levels [SLC5A8, 13691_10_3]",113
2,Serum levels of protein WFDC1,40
2,Arthrosis,871
2,Serum levels of protein B3GNT2,421
2,X-23308 levels,158
2,LDL cholesterol [LDL],271
2,Calculus of bile duct,421
2,1-palmitoyl-2-arachidonoyl-gpc (16:0/20:4n6) levels,668
2,Gondoic acid (20:1n-9) levels,1776
2,"Serum metabolite concentrations in chronic kidney disease [bilirubin (E,E]",620
2,Something else not mentioned | behavioural and miscellaneous addictions,283
2,Bone ultrasound measurement (velocity of sound),464
2,Adult onset asthma and/or waist-to-hip ratio adjusted for BMI,219
2,Cognitive function,30
2,Breast milk fatty acid composition (maternal genotype effect) [lauric acid],21
2,Gallstone disease,55786
2,Childhood body mass index,25180
2,Doctor diagnosed hayfever or allergic rhinitis,18205
2,Nifedipine | treatment/medication code,4993
2,Low density lipoprotein cholesterol levels [Hispanic],1456
2,Antisaccade tracking error rate,2820
2,Smoking initiation (ever regular vs never regular) [Conditioned on chr2:60024857],217
2,Thyroxine product | treatment/medication code,1574
2,Gonarthrosis,867
2,Dentures | mouth/teeth dental problems,384
2,HDL cholesterol levels x short total sleep time interaction (2df test),808
2,Protein quantitative trait loci (liver) [IARS2],201
2,Protein quantitative trait loci (liver) [KRT2],40
2,Soya with calcium | type milk consumed,913
2,Blood metabolite levels [X-13431--nonanoylcarnitine],1408
2,Mitochondrial DNA copy number,212
2,Gut microbiota (functional units) [PWY-4722_creatinine_degradation_II],15
2,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [N-acetylalanine, N-acetylmethionine, N-acetylmethionine sulfoxide, sarcosine, X-12199]",23191
2,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],3218
2,Serum levels of protein FN1,897
2,Diacylglycerol_32:1_[M+NH4]1+ levels,535
2,Gout,11349
2,"Skin cancer | cancer code, self-reported",743
2,"Smoking initiation (ever regular vs never regular) [Conditioned on chr2:59819545, chr2:60477052, chr2:60024857]",47
2,Barrett's esophagus  or Esophageal adenocarcinoma,1052
2,Breast cancer | illnesses of mother,46
2,QRS duration [EA],1128
2,Hernia abdominopelvic cavity,756
2,Fractures,459
2,Immunoglobulin A,89
2,Serum metabolite concentrations in chronic kidney disease [cysteinylglycine],13
2,Colorectal cancer or advanced adenoma,36897
2,Type 2 diabetes [conditional],38383
2,Low myopia vs hyperopia,5951
2,Phosphatidylcholine-O_31:2_[M+H]1+/Phosphatidylcholine-P_31:1_[M+H]1+/Phosphatidylethanolamine-O_34:2_[M+H]1+ levels,2043
2,Gout (combined type),2043
2,Activated & resting CD4 regulatory T cell Absolute Count,1462
2,Osteoarthrosis,2076
2,Serum levels of protein PROC,13080
2,Serum levels of protein NAGK,8992
2,acne vulgaris,7640
2,C-reactive protein levels [BMI-adjusted],6380
2,Brain region volumes [cerebellar vermal lobules VI VII],1175
2,Ear morphology,2046
2,Serum levels of protein OLA1,1713
2,malignant neoplasm of male genital organs (controls excluding all cancers),1193
2,Viral infection,285
2,"""Hyperlipidaemia, other/unspecified""",985
2,Other and unspecified intracranial injuries,70
2,Protein quantitative trait loci (liver) [DPP7],29
2,Estimated glomerular filtration rate in non-diabetics,18543
2,Triglyceride levels in current drinkers [AA],2171
2,Blood protein levels [Interleukin-1 receptor-like 1],10661
2,Thyrotoxicosis,1640
2,Asthma (time to onset),3881
2,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),1376
2,Metabolite levels [TAG 50:4],2043
2,"""Type 1 diabetes, wide definition, subgroup 1""",1759
2,Iron status biomarkers (transferrin saturation),707
2,Pulmonary arterial hypertension,504
2,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Hispanic],1352
2,Vitamin b compound tablet | treatment/medication code,1068
2,Body mass index [age 1-17],9892
2,Creatinine levels,336552
2,Citramalate levels,4641
2,Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis),5704
2,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction),3127
2,Serum metabolite levels [X-13431],10218
2,Rhodanobacter abundance in stool,5
2,Psoriasis vulgaris,5021
2,Cortical volume [Transverse temporal],360
2,Mean arterial pressure x alcohol consumption interaction (2df test) [EA],672
2,Metabolite levels [quinolinic acid],342
2,Alloimmunization response to pregnancy (HLA class I),223
2,Gut microbiota (functional units) [PWY-6731_starch_degradation_III],81
2,Electrocardiogram morphology (amplitude at temporal datapoints) [304 ms],275
2,Serum levels of protein KCNMB3,113
2,Estimated glomerular filtration rate in diabetes,26951
2,Protein C levels [EA],16415
2,3-hydroxypropylmercapturic acid levels in smokers [Japanese],384
2,Sphingomyelin_33:1_[M+H]1+ levels,2043
2,Factor VII activity,1994
2,Serum metabolite levels (CMS) [L_VLDL_C],2043
2,Hippocampal tail volume,510
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-92 ms],118
2,Body fat percentage [men],231
2,LDL levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder,65
2,Systemic lupus erythematosus,58293
2,Worrier / anxious feelings,2209
2,Limited cutaneous systemic scleroderma,564
2,Knee osteoarthritis,2450
2,Proctosedyl ointment | treatment/medication code,300
2,Benign prostatic hyperplasia and lower urinary tract symptoms,49
2,Triglycerides [EA],8805
2,Fat-free mass [male],11389
2,"Stomach disorder | non-cancer illness code, self-reported",312
2,6mm strong meridian angle (left),717
2,Plasma free amino acid levels (adjusted for one other PFAA) [Asn (adjusted for Gly],261
2,Plasma free amino acid levels (adjusted for one other PFAA) [Ser (adjusted for Asn],261
2,Peripheral arterial disease (traffic-related air pollution interaction) [AA],497
2,Protein quantitative trait loci (liver) [PGM2],196
2,White matter microstructure (fractional anisotropy) [Average across all tracts],28291
2,Serum levels of protein NFKB1,14100
2,Urinary metabolite levels in chronic kidney disease [X - 11357],21059
2,Urate levels in obese individuals,2043
2,"Liver, biliary or pancreas problem",6614
2,Protein quantitative trait loci (liver) [GSTT2B],617
2,Protein quantitative trait loci (liver) [ECI2],17
2,Glycated hemoglobin levels,215430
2,Hydrocele,6209
2,Type 1 diabetes without complications,2911
2,Total body bone mineral density (age 45-60),1966
2,Electrocardiogram morphology (amplitude at temporal datapoints) [216 ms],5345
2,Serum metabolite levels [S_VLDL_TG],2497
2,Left eye | which eye(s) affected by myopia (short sight),1381
2,Serum levels of protein PDGFA,40
2,Broad depression or schizophrenia,2
2,Eosinophil counts,1006696
2,Predicted visceral adipose tissue,32286
2,Serum phosphate levels,118150
2,Serum metabolite concentrations in chronic kidney disease [N-acetylleucine],5784
2,Diacylglycerol_44:7_[M+H-H2O]1+ levels,2043
2,Triglyceride levels in medium VLDL,13400
2,Serum metabolite levels [M_VLDL_L],2043
2,TestASV_30 (Paraprevotella) prevalence,40
2,Fish- and plant-related diet [female],140
2,Pulmonary function (FVC) x omega-3 PUFA (docosahexaenoic acid) interaction (2df),50
2,Optic disc area,53
2,Skeletal muscle index,4825
2,"Light smokers, at least 100 smokes in lifetime",27628
2,Alzheimer's disease or family history of Alzheimer's disease,4518
2,Serum metabolite levels [bilirubinEE],5509
2,CD28- CD4-CD8- T cell Absolute Count,2189
2,Cigarettes smoked per day (MTAG),3802
2,"Metabolite levels (lipoprotein measures) [Free cholesterol in large LDL, conditioned]",1435
2,Waist circumference adjusted for body mass index [men],2158
2,Hypertension [Japanese],733
2,"Lipid metabolism phenotypes [LDL.total, whole]",1476
2,Other/unspecified seropositiverheumatoid arthritis,1167
2,Waist circumference adjusted for body mass index [non-East Asian],756
2,Sjögren's syndrome [EA],237
2,"Diastolic blood pressure x alcohol consumption interaction (2df test) [AA, EA, Hispanic]",704
2,Urinary potassium excretion [EA],4294
2,Pattern 1 | hair/balding pattern,18990
2,Tonsillectomy,948
2,Systemic lupus erythematosus [Hispanic],264
2,17-hydroxyprogesterone (17-OHP) levels,819
2,"Sphingomyelin (d18:1/20:0, d16:1/22:0) levels",247
2,"Blood protein levels [DNER, 9769_48_3]",18
2,Serum metabolite levels [cinnamoylglycine],240
2,LDL cholesterol x physical activity interaction (2df test),5099
2,Salt added to food,39229
2,Serum levels of protein CAPG,6539
2,Multiple myeloma,1843
2,Serum metabolite levels (CMS) [S_VLDL_PL],2043
2,Gut microbiota abundance (family Bifidobacteriaceae id.433),1027
2,"""Type1 diabetes, definitions combined""",1157
2,"Seen doctor (gp) for nerves, anxiety, tension or depression",385
2,Smoking behaviour (cigarette pack-years),606
2,Longest period of unenthusiasm / disinterest,65
2,Lung function (FVC) [EA],15479
2,"Malabsorption/coeliac disease | non-cancer illness code, self-reported",10552
2,Mammographic density (dense area),1335
2,Medication use (beta blocking agents),2822
2,"Blood metabolite levels [1,5-anhydroglucitol (1,5-AG]",1414
2,Alzheimer's disease in APOE e4+ carriers,174
2,Triacylglyceride levels [TAG(50:1;0],352
2,Rate of cognitive decline in Alzheimer's disease [GEE model],64
2,Psoriasis,21189
2,Sensitivity to environmental stress and adversity,6345
2,Non-hodgkins lymphoma,1845
2,circulating leptin levels adjusted for BMI,16576
2,Waist circumference [EA],2776
2,Coagulation factor IX measurement,2043
2,"Body mass index [Japanese, Male]",3147
2,"Waist circumference adjusted for BMI in active individuals [EA,women]",598
2,Other osteochondrodysplasias,26
2,White matter microstructure (mean diusivities) [External capsule ],23070
2,"Serum metabolite levels [N2,N5-diacetylornithine]",17900
2,Waist-to-hip ratio adjusted for BMI in active individuals [women],598
2,Late-onset myasthenia gravis,570
2,"Sexual dimorphism in anthropometric traits [WHRadjBMI, women]",598
2,Protein quantitative trait loci (liver) [CYP2D6],856
2,Amino acid levels [Serine],10
2,Basal cell carcinoma,62163
2,Sarcoidosis [EA],3926
2,Cognitive performance,33221
2,Medication use (thyroid preparations),102161
2,Asthma and attention deficit hyperactivity disorder,29656
2,Relative age of first facial hair,11270
2,Had menopause,19592
2,QT dynamics during exercise,1295
2,Acute anterior uveitis (with or without ankylosing spondylitis),486
2,"Lipid metabolism phenotypes [LDL-C.assay, fasting]",1131
2,HLA DR++ monocyte %monocyte,220
2,Systolic blood pressure (cigarette smoking interaction),792
2,Nasal or sinus disorder,5
2,Urinary metabolite levels in chronic kidney disease [X - 16567],10
2,Hip circumference [EA],22679
2,Serum metabolite levels [N-delta-acetylornithine],47648
2,Insomnia [Male],2254
2,Sick sinus syndrome,447
2,Intrahepatic Cholestasis of Pregnancy (ICP)  (more control exclusions),4300
2,Electrocardiogram morphology (amplitude at temporal datapoints) [340 ms],358
2,Mometasone | treatment/medication code,258
2,"Mean arterial pressure x alcohol consumption interaction (2df test) [Asian, EA]",165
2,Coronary heart disease,23643
2,Hypertension,70629
2,Heel bone mineral density (bmd),60879
2,Asthma-related pneumonia or sepsis,7832
2,Disorders of bilirubin excretion,11948
2,"Blood protein levels [ADAM23, 7049_2_3]",474
2,Eye or eyelid problem,443
2,Hydroxyasparagine levels,446
2,Lysophosphatidylcholine_20:3_[M+OAc]1- levels,9
2,White matter microstructure (radial diusivities) [External capsule ],23140
2,Participation in an health questionnaire (not invited vs invited),40252
2,Liver iron content,25853
2,"Blood protein levels [ACP1, 3858_5_1]",11445
2,"Age-related diseases, mortality and associated endophenotypes",14591
2,circulating leptin levels,6231
2,Interleukin-6 levels,2849
2,Mouth ulcers,1407
2,Other than those specified above | delivery methods,738
2,Neurological disease,663
2,Blood metabolite levels [X-13477],24393
2,Heart rate,8410
2,Gastrointestinal diseases,551
2,Composite immunoglobulin trait (IgA x IgG/IgM),12
2,Metabolite levels (lipoprotein measures) [Free cholesterol in IDL],130
2,Morning/evening person (chronotype),43800
2,Vertex-wise cortical thickness,225787
2,Electrocardiogram morphology (amplitude at temporal datapoints) [232 ms],1295
2,Plasma free amino acid levels [Ser],261
2,"Bran cereal (e.g. all bran, branflakes) | cereal type",12283
2,Monocyte count [EA],509
2,Diastolic blood pressure x smoking status (ever vs never) interaction (2df test) [EA],1811
2,Use of sun/uv protection,62
2,Lumbar spine bone mineral density,5152
2,Vertigo,9025
2,Asthma (only as main-diagnosis) (more control exclusions),5444
2,Feeling nervous,6901
2,G_Alphaproteobacteria abundance,1465
2,Blood metabolite levels [X-11441],5509
2,Snoring,1271
2,Electrocardiogram morphology (amplitude at temporal datapoints) [212 ms],1570
2,Triacylglycerol_52:0_[M+NH4]1+ levels,2043
2,Systolic blood pressure x alcohol consumption interaction (2df test) [EA],856
2,Alzheimer's disease,6317
2,Brain functional connectivity measurement (strength salience),712
2,1-methyl-5-imidazoleacetate levels,350
2,Effector Memory CD4-CD8- T cell Absolute Count,2189
2,Blood metabolite levels [N-acetylglycine],10
2,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction),3642
2,"Lipid metabolism phenotypes [VLDL.large, whole]",2043
2,"Serum metabolite levels [bilirubin (E,E)*]",2441
2,Serum metabolite levels (CMS) [VLDL_TG],2043
2,Prevotellamassilia abundance in stool,462
2,Resistant hypertension,32
2,Protein quantitative trait loci (liver) [CTSD],4
2,Atrial fibrillation and flutter with reimbursement,10075
2,High myopia,5153
2,Chronic obstructive pulmonary disease x current smoker interaction (2df),2022
2,Electrocardiogram morphology (amplitude at temporal datapoints) [164 ms],1570
2,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)",136
2,C-X-C motif chemokine 16 levels,298
2,Dermatitis herpetiformis,38
2,Alcohol consumption (heavy vs. light/non-drinkers),2043
2,Diacylglycerol_34:0_[M+H-H2O]1+ levels,2211
2,Digit length ratio,2107
2,Left ventricular end-diastolic volume,845
2,Stomach disorder,40
2,Neuroblastoma,9219
2,Regular attendance at a religious group,4077
2,Immune reponse to smallpox (secreted IFN-alpha) [AA],1562
2,Metabolite levels [PC 34:3],2043
2,Electrocardiogram morphology (amplitude at temporal datapoints) [162 ms],1570
2,"For short-sightedness, i.e. only or mainly for distance viewing such as driving, cinema etc (called 'myopia') | reason for glasses/contact lenses",1687
2,Serum metabolite levels (CMS) [S_VLDL_P],2497
2,Creutzfeldt-Jakob disease (variant),439
2,Anxiety disorders (more control exclusions),937
2,Cardiovascular diseases (excluding rheumatic etc),576
2,Senile cataract,610
2,Protein quantitative trait loci (liver) [GSTP1],128
2,Maltreatment syndromes,100
2,Reticulocyte fraction of red cells,513207
2,Fat-free mass,22526
2,IgG levels,2271
2,Electrocardiogram morphology (amplitude at temporal datapoints) [184 ms],5345
2,Sarcoidosis,4049
2,Electrocardiogram morphology (amplitude at temporal datapoints) [260 ms],3775
2,Cortical surface area [Caudal Anterior Cingulate],510
2,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA],3409
2,N-acetylhistidine levels,1326
2,"Body mass index in physically inactive individuals [EA, women]",2604
2,Able to confide,612
2,Serum metabolite levels (CMS) [TotFA],2497
2,Serum levels of protein BIN1,174
2,Protein quantitative trait loci (liver) [SDS],254
2,"""Malignant neoplasm of breast, HER2-negative (controls excluding all cancers)""",46
2,Esophageal squamous cell carcinoma,16598
2,"Serum metabolite levels [1,5-anhydroglucitol (1,5-AG]",1448
2,3mm cylindrical power (left),4838
2,Triglyceride levels x loop diuretics use interaction [EA],189
2,Ascending aorta minimum area,239
2,Sum neutrophil eosinophil counts,133434
2,Body mass index in physically active individuals [women],12446
2,Serum levels of protein PAXIP1,5509
2,CD4-CD8- T cell Absolute Count,2189
2,Facial pigmentation measurement (polar light),1178
2,Free cholesterol levels in large LDL,944
2,Large LDL particle concentration,207
2,"""Coxarthrosis, primary""",727
2,Malignant neoplasm of endocrine gland,132
2,Prevotella sp000434975 abundance in stool,24
2,Worry too long after embarrassment,141
2,Urinary sodium excretion [EA],43954
2,Serum metabolite levels [N-acetyltyrosine],18063
2,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],2171
2,X-11612 levels,1092
2,Eisenbergiella sp900066775 abundance in stool,3495
2,Length of mobile phone use,1356
2,Blood protein levels [Secreted frizzled-related protein 3],42
2,Feeling guilty,31702
2,Urinary albumin-to-creatinine ratio,86497
2,Protein quantitative trait loci (liver) [DBI],642
2,Total body bone mineral density [European],3639
2,"""Hypertension, essential""",1169
2,"Osteoarthritis | non-cancer illness code, self-reported",903
2,Mesial temporal lobe epilepsy with hippocampal sclerosis [MTLEHS+FS vs. Controls],501
2,Gut microbiota presence (genus Ruminiclostridium6 id.11356),527
2,Type 2 diabetes without complications,264
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-170 ms],118
2,Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy) [Hispanic],53
2,Brain region volumes [left medial orbitofrontal],3
2,Cardiac problem,16
2,Worry,15413
2,Mouth ulcers | mouth/teeth dental problems,1437
2,Facial morphology (segment 24),802
2,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test) [African],58
2,3-aminoisobutyrate levels,23819
2,Metabolite levels [TAG 48:2],2043
2,Serum levels of protein PA2G4,3551
2,Serum metabolite levels [L_VLDL_C],2043
2,Fasting plasma glucose [Non diabetics],3412
2,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],839
2,Butyrate (4:0) levels,108
2,Protein quantitative trait loci (liver) [PSMD1],19
2,Gut microbiota (beta diversity),21
2,Brown vs. black hair color,30
2,Cognitive ability (MTAG),3178
2,Lung cancer (SNP x SNP interaction),49725
2,Serum levels of protein IL18R1,27013
2,A levels/as levels or equivalent | qualifications,18362
2,Household income (MTAG),8467
2,Prothrombin time,2043
2,Body mass index and fasting insulin (pairwise),862
2,HDL cholesterol levels in current drinkers [EA],829
2,"LDL cholesterol levels [Asian initial, BMI unadjusted]",177
2,"Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [Asian, EA]",241
2,Chloride levels,2210
2,Glycine levels,994
2,Serum metabolite levels (CMS) [L_VLDL_L],2043
2,Ratio of apolipoprotein A1 to apolipoprotein B,454
2,BMI at 1.5 years old,12035
2,Mammographic density (non-dense area),12242
2,Chronic obstructive pulmonary disease x current smoker interaction (main effect),2022
2,Major coronary heart disease event excluding revascularizations,46817
2,Total bilirubin levels in HIV-1 infection,9874
2,Cancer diagnosed by doctor,5477
2,Eosinophil counts [EA],7501
2,"""Type 1 diabetes, strict definition, subgroup 1""",1157
2,Protein quantitative trait loci (liver) [ADHFE1],279
2,Diisocyanate-induced asthma,129
2,Serum levels of protein ADAM23,670
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-38 ms],32217
2,CD45 on Natural Killer,2992
2,Dehydroepiandrosterone sulphate levels,1864
2,Inflammatory skin disease [Psoriasis],1600
2,Disorders of refraction and accommodation,25
2,Ischemic stroke,672
2,Body fat percentage and HDL-C (pairwise),862
2,Blood protein levels [Collectin-11],438
2,Heart failure and bmi 25plus,31
2,Photic sneeze reflex,389
2,Plasma free amino acid levels [Met],92
2,Obstructive sleep apnea trait (minimum oxyhemoglobin saturation across sleep episode),152
2,Serum levels of protein PPBP,120
2,Beta thalassemia/hemoglobin E disease,27
2,Autoimmune traits,67633
2,Cancer,17395
2,Protein quantitative trait loci (liver) [SCLY],22307
2,"""Atopic  dermatitis, strict definition""",11864
2,Weekly usage of mobile phone in last 3 months,11774
2,Schizophrenia [East Asian],1533
2,Electrocardiogram morphology (amplitude at temporal datapoints) [208 ms],5345
2,Musculoskeletal disorder or trauma,1161
2,"Lipid metabolism phenotypes [TG.assay, whole]",2497
2,Blood protein levels [Fibronectin Fragment 3],288
2,"""Type 2 diabetes, wide definition""",264
2,Diabetic peripheral neuropathy in type 2 diabetes [EA],728
2,Itch intensity from mosquito bite,287
2,Number of treatments/medications taken,261
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-154 ms],118
2,Urinary potassium to creatinine ratio,10
2,Serum protein levels (sST2),13093
2,Neuroticism score,10074
2,Diabetes mellitus in pregnancy,3055
2,Cholesteryl ester levels [CE(20:2;0],266
2,"Diastolic blood pressure x alcohol consumption interaction (2df test) [EA, Hispanic]",144
2,Height,1626151
2,Height adjusted BMI,9892
2,Age completed full time education,27969
2,Blood metabolite levels [N-acetylornithine],24393
2,"Forced expiratory volume in 1-second (fev1), best measure",146581
2,"""Myocardial infarction, strict""",23593
2,Febrile seizures (MMR vaccine-unrelated),2374
2,Electrocardiogram morphology (amplitude at temporal datapoints) [138 ms],5345
2,High-grade serous ovarian cancer,1748
2,First line medication for Crohns disease,425
2,Serum levels of protein SFTPB,788
2,"Smoking initiation (ever regular vs never regular) [Conditioned on chr2:162101261, chr2:162802993]",1412
2,Smoking initiation (ever regular vs never regular) [Conditioned on chr2:624205],60
2,Serum levels of protein APOB,113
2,Lamb/mutton intake,842
2,Tooth agenesis EXCLUDE clefts and syndromes,155
2,Number of self-reported cancers,5477
2,Primary biliary cholangitis,13181
2,Brain region volumes [cerebellar vermal lobules VIII X],1486
2,Protein quantitative trait loci (liver) [VDAC1],87
2,Neuroticism (MTAG),2150
2,BMI in non-smokers [men],2604
2,"Blood protein levels [FAM171B, 8851_42_3]",924
2,"Blood protein levels [HS6ST1, 5465_32_3]",723
2,Tea consumed,87
2,Serum levels of protein NOG,90
2,Frequency of stair climbing in last 4 weeks,10
2,Urinary metabolite levels in chronic kidney disease [tigloylglycine],10
2,Glomerular filtration rate (creatinine),58589
2,Schizophrenia (MTAG),235937
2,"""Asthma, hospital admissions , main diagnosis only""",10284
2,Malignant neoplasm,11077
2,Systolic blood pressure [EA],701
2,Biological sex (age adjusted),80
2,Halomonadaceae abundance in stool,12
2,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [1-methylhistidine, homocitrulline, X-23587]",22932
2,"""Rheumatoid arthritis , including avohilmo""",1490
2,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [men],2390
2,Domperidone | treatment/medication code,358
2,Difference in mobile phone use compared to two years previously,398
2,Non-lobar intracerebral hemorrhage (MTAG),22870
2,Basal metabolic rate,104192
2,Follistatin levels,2043
2,"Age hay fever, rhinitis or eczema diagnosed",7879
2,"Lipid metabolism phenotypes [VLDL.total, whole]",454
2,Ipratropium | treatment/medication code,26
2,Protein quantitative trait loci (liver) [CYP3A5],34
2,Protein quantitative trait loci (liver) [SULT2A1],3
2,ST2 protein levels,64902
2,Serum alkaline phosphatase levels,464008
2,kallikrein-11 levels,1103
2,Vitamin K-dependent protein C measurement,6540
2,White blood cell (leukocyte) count,110841
2,Obesity [Obesity class II],2604
2,CD45RA on Terminally Differentiated CD8+ T cell,269
2,RR interval (tricyclic/tetracyclic antidepressant use interaction) [EA],187
2,Protein quantitative trait loci (liver) [ME1],53
2,Protein quantitative trait loci (liver) [ACTN4],51
2,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) [subset analysis]",81535
2,Serous invasive ovarian cancer,1748
2,Gastroesophageal reflux disease,3416
2,Childhood asthma with severe exacerbations,4631
2,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],1493
2,Eosinophilic esophagitis,523
2,Phytosterol levels [campesterol],421
2,Phospholipid levels (plasma) [levels],6800
2,Glycemic traits (pleiotropy),2416
2,Blood metabolite levels [X-11530],5509
2,Alzheimer disease and age of onset [between families],1161
2,Serum levels of protein GIP,122
2,Post-term birth,3292
2,Major depressive disorder vs anorexia nervosa (ordinary least squares (OLS)),1620
2,Metabolic traits [GLU],1369
2,Electrocardiogram morphology (amplitude at temporal datapoints) [370 ms],28
2,Time spent using computer,267
2,Age at first live birth,467
2,Smoking initiation (ever regular vs never regular) [Conditioned on chr2:51341259],70
2,Age cataract diagnosed,183
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-112 ms],2912
2,Diacylglycerol_44:6_[M+H-H2O]1+ levels,2043
2,Arm fat percentage (right),158718
2,Alzheimer disease and age of onset [within families],1080
2,"Intra-ocular pressure, corneal-compensated (right)",1923
2,Sphingomyelin_43_2_[M+OAc]1- levels,5490
2,Previous | smoking status,1904
2,Ceramide_42:2_[M-H]1- levels,426
2,Electrocardiogram morphology (amplitude at temporal datapoints) [112 ms],275
2,"Loneliness, isolation",122
2,Nonsyndromic cleft lip with or without cleft palate [All],52
2,Protein quantitative trait loci (liver) [ACSS3],8
2,Depressed affect,34118
2,Nonatopic asthma,7379
2,Fed-up feelings,27192
2,Neutrophil-to-lymphocyte ratio,50992
2,Body mass index and LDL-C (pairwise),2641
2,Electrocardiogram morphology (amplitude at temporal datapoints) [130 ms],5345
2,C_Alphaproteobacteria abundance,1465
2,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Hispanic],2171
2,Protein quantitative trait loci (liver) [MT1H],69
2,Age of smoking initiation (MTAG),35029
2,Triglyceride levels [BMI unadjusted],3653
2,Gut microbiota abundance (phylum Actinobacteria id.400),22856
2,Asthma onset (childhood vs adult),7393
2,Strenuous sports or other exercises,1306
2,Otitis media (chronic/recurrent),320
2,Thyroid hormone levels [TSH],125
2,Ultradistal forearm bone mineral density,18
2,"Other professional qualifications eg: nursing, teaching | qualifications",53
2,3mm asymmetry index (right),1
2,Rheumatoid arthritis,61166
2,Colorectal cancer,90017
2,Urinary metabolites [2.031 ppm],24553
2,Waist-to-hip ratio adjusted for BMI in active individuals [EA],3565
2,Adult diffuse glioma (IDH mutation),6250
2,Pattern 2 | hair/balding pattern,3083
2,Gestational age at birth (child effect),3292
2,"Blood protein levels [GNLY, 14102_6_3]",2454
2,Serum metabolite levels (CMS) [L_VLDL_P],2043
2,Worry/vulnerability (special factor of neuroticism),34
2,Pancreas volume,34
2,Feeling fed-up,28818
2,Alcohol consumption (drinks per week) (MTAG),51370
2,Haemoglobin concentration,211930
2,DNA methylation variation (age effect),3888
2,Serum metabolite concentrations in chronic kidney disease [N-acetylglutamine],5784
2,"Hip circumference adjusted for BMI [EA, women]",5058
2,Creatine kinase M-type:Creatine kinase B-type heterodimer measurement,278
2,Time spend outdoors in summer,612
2,Pravastatin | treatment/medication code,46
2,Serum levels of protein IGFBP5,10
2,Bone mineral density [femoral neck],2027
2,Atrial fibrillation,197318
2,Forced vital capacity (fvc),122129
2,Conjunctivitis,5583
2,Spherical equivalent (joint analysis main effects and education interaction) [European ancestry],11546
2,Serum metabolite levels [X-11442],5509
2,Gut microbiota abundance (order Bifidobacteriales id.432),1027
2,Serum levels of protein IL19,438
2,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [AA],1352
2,Turicibacteraceae abundance in stool,1414
2,Sleep traits (multi-trait analysis),818
2,Protein quantitative trait loci (liver) [CIITA],772
2,"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment",381
2,Protein quantitative trait loci (liver) [CRK],43
2,Android total mass,25
2,Total PHF-tau (SNP x SNP interaction),59536
2,Migraine and/or diastolic blood pressure,25124
2,Fasting plasma glucose,8717
2,Composite immunoglobulin trait (IgA/IgM),3917
2,Gulonate levels,2020
2,Serum metabolite concentrations in chronic kidney disease [biliverdin],620
2,Electrocardiogram morphology (amplitude at temporal datapoints) [160 ms],1570
2,Malignant neoplasm of prostate,1218
2,Gut microbiota relative abundance (bacterial taxa) [Klebsiella_variicola],88
2,Nonatopic asthma or type 2 diabetes,45
2,1-stearoyl-gpc (18:0) levels,782
2,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [N-acetylkynurenine,  N-acetylphenylalanine,  N-acetyltryptophan,  N-acetyltyrosine]",24659
2,"Heel bone mineral density (bmd) t-score, automated",57400
2,Asthma (more control exclusions),10284
2,Metabolite levels [SM],822
2,Follicle stimulating hormone levels in polycystic ovary syndrome,337
2,"Systolic blood pressure x alcohol consumption interaction (2df test) [Asian, EA]",176
2,Smoking initiation (ever regular vs never regular) [Conditioned on chr2:226332033],1188
2,Serum metabolite levels [propionylglycine],240
2,Electrocardiogram morphology (amplitude at temporal datapoints) [96 ms],275
2,Alcohol consumption,16338
2,Electrocardiogram morphology (amplitude at temporal datapoints) [62 ms],225
2,Bone ultrasound measurement (broadband ultrasound attenuation),464
2,Gut microbiota (bacterial taxa) [Bacilli class],259
2,Dementia due to Parkinsons disease,13
2,Other acquired musculoskeletal deformity,15748
2,Liver disease biomarker [Bilirubin],5509
2,Metabolic syndrome [GLU],1369
2,Protein quantitative trait loci (liver) [CALR],1165
2,Endometriosis of rectovaginal septum and vagina,575
2,White matter microstructure (axial diusivities) [Average across all tracts],232
2,Priadel 200mg m/r tablet | treatment/medication code,132
2,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [H],155
2,Tiotropium | treatment/medication code,129
2,Type 2 diabetes [Japanese],1
2,"Mumps / epidemic parotitis | non-cancer illness code, self-reported",1462
2,Renal underexcretion gout,2043
2,Protein quantitative trait loci (liver) [MTHFS],513
2,Laterality in neovascular age-related macular degeneration,393
2,Alcohol consumption (drinks per week) [Conditioned on chr2:45155276],156
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-126 ms],244
2,"Hip circumference adjusted for BMI [EA,men]",756
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-166 ms],118
2,3-hydroxypropylmercapturic acid levels in smokers [Latino],1
2,Coronary artery disease,366298
2,Daytime nap,19712
2,Urinary metabolite levels in chronic kidney disease [X - 23590],21059
2,"Psoriasis | non-cancer illness code, self-reported",1503
2,Triacylglycerol_48:2_[M+NH4]1+ levels,2171
2,Brain region volumes [left parahippocampal],4500
2,Serum metabolite levels [3-methylglutaconate],240
2,Bipolar disorder or body mass index,760
2,"""Coxarthrosis,""",727
2,Non-albumin protein levels,20595
2,Lung function (FVC),257667
2,Serum metabolite levels [gamma-glutamylthreonine],24493
2,Urinary metabolite levels in chronic kidney disease [X - 13431],1357
2,Place of birth in uk - north co-ordinate,8834
2,Osteoarthritis (hip),1964
2,Serum metabolite levels (CMS) [XL_VLDL_TG],2043
2,Heart rate response to recovery post exercise (10 sec),381
2,Branched-chain amino acid levels (Isoleucine),2043
2,Serum levels of protein NDUFS4,299
2,Hip pain | pain type(s) experienced in last month,19
2,Allergy,17597
2,Birth weight of first child,17467
2,"Smoking initiation (ever regular vs never regular) [Conditioned on chr2:417167, chr2:624205]",11035
2,Serum levels of protein PRG3,40029
2,Ex-smoker | tobacco smoking,3128
2,1-stearoyl-2-linoleoyl-gpc (18:0/18:2) levels,331
2,Facial skin colour (CIELAB index b* value),753
2,"""Gonarthrosis,primary""",867
2,Esophageal adenocarcinoma,514
2,Gut microbiota (bacterial taxa) [Clostridium_purinilyticum],1026
2,Central Memory CD4+ T cell %CD4+ T cell,191
2,White matter microstructure (fractional anisotropy) [Posterior limb of internal capsule],245
2,Balsalazide disodium | treatment/medication code,6
2,Headache,663
2,Total body bone mineral density (age 0-15),1986
2,"Arthritis (nos) | non-cancer illness code, self-reported",1765
2,"Serum metabolite levels [Bilirubin (E,E]",620
2,CD8 on Natural Killer T,2189
2,Disorders of vitreous body,2401
2,Differentiated thyroid cancer,172
2,Heart rate response to recovery post exercise (20 sec),219
2,Any mental disorder,12
2,Bipolar disorder vs ADHD (ordinary least squares (OLS)),27
2,Terminally Differentiated CD8+ T cell %T cell,269
2,Serum metabolite levels [Gp],2043
2,"""Disorders of thyroid, IBD co-morbidities""",1474
2,Thyrotoxicosis with diffuse goitre,1157
2,White matter microstructure (mode of anisotropy) [Posterior limb of internal capsule],1182
2,Serum levels of protein MLN,363
2,Electrocardiogram morphology (amplitude at temporal datapoints) [318 ms],275
2,Schizophrenia vs ADHD (ordinary least squares (OLS)),21125
2,Serum levels of protein KYNU,1257
2,Serum levels of protein CMPK1,5077
2,Glycemic traits (pregnancy) [FCP],1660
2,Vitamin D insufficiency,2564
2,"Blood protein levels [EA, Interleukin-1 receptor-like 2]",779
2,Other biliary tract disease,266
2,2-o-methylascorbic acid levels,183
2,Protein quantitative trait loci (liver) [AHNAK],29
2,Facial morphology [n-men 3D dist],63
2,Serum levels of protein PLA2R1,16295
2,"Blood protein levels [EA, Granulysin]",3172
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-114 ms],2912
2,"""Seropositive rheumatoid arthritis, wide""",1223
2,Terminally Differentiated CD4-CD8- T cell %CD4-CD8- T cell,269
2,Alcohol dependence or heroin dependence or methamphetamine dependence,4
2,Birth weight,217745
2,Time spent watching television (tv),17350
2,Cortical surface area,255165
2,"Blood protein levels [HIBCH, 12396_19_3]",18853
2,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),13615
2,Phosphatidylcholine-O_34:3_[M+H]1+/Phosphatidylcholine-P_34:2_[M+H]1+/Phosphatidylethanolamine-P_37:2_[M+H]1+ levels,2043
2,"Pulmonary function (smoking interaction) [FEV1, Ever-smoking]",622
2,Body fat percentage [European men],231
2,Electrocardiogram morphology (amplitude at temporal datapoints) [324 ms],275
2,Naive CD8+ T cell %T cell,218
2,Atopic dermatitis (moderate to severe) [additive],619
2,Palmitoyl dihydrosphingomyelin (d18:0/16:0) levels,254
2,Fetal hemoglobin levels [African],57
2,Self-reported math ability,80936
2,Serum uric acid levels [EA],18316
2,Urokinase plasminogen activator surface receptor levels,10772
2,Serum metabolite levels [N-acetylkynurenine (2],18423
2,"Blood protein levels [CKAP4, 7221_56_3]",5509
2,N-acetylglucosamine/n-acetylgalactosamine levels,1915
2,Tuberculosis (SNP x SNP interaction),694
2,Metabolite levels [TAG 48:3],2043
2,"Long-standing illness, disability or infirmity",654
2,Metabolic biomarkers (multivariate analysis),68427
2,Urinary metabolite levels in chronic kidney disease [N-delta-acetylornithine],23640
2,"Asthma | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",23139
2,Sphingomyelin(33:1)_[M-CH3]1- levels,1904
2,Migraine without aura,1337
2,Allopurinol | treatment/medication code,2043
2,Chitinase-3-like protein 1 levels,2062
2,"Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA, men]",2409
2,Osteoporosis,2518
2,Severe influenza A (H1N1) infection,930
2,Number of self-reported non-cancer illnesses,5682
2,Nontyphoidal Salmonella bacteraemia [recessive model],116
2,Intra-individual response time variability (selective attention) [intra-individual coefficient of variation],57
2,Serum metabolite levels [gamma-glutamyl-2-aminobutyrate],60
2,BMI (adjusted for smoking behaviour),12503
2,Serum metabolite levels [N-acetylarginine],84228
2,"Waist-to-hip ratio adjusted for body mass index [EA, women]",9080
2,Leflunomide | treatment/medication code,199
2,Hyperglycemia in more-fat diet,1092
2,Two-hour glucose,2043
2,Co-proxamol | treatment/medication code,446
2,Plasma free amino acid levels (adjusted for one other PFAA) [Arg (adjusted for Gly],261
2,Maximum workload during fitness test,265
2,Waist circumference adjusted for BMI (adjusted for smoking behaviour),10601
2,Rheumatoid arthritis (ACPA-positive),15055
2,Urinary metabolite levels in chronic kidney disease [N-acetyl-3-methylhistidine],24553
2,Cervical cancer,5231
2,Plasma norclozapine levels in treatment-resistant schizophrenia,2564
2,"Blood pressure measurement (high sodium and potassium intervention) [DBP, during intervention]",135
2,Left ventricular end-systolic volume,2084
2,"Lipid metabolism phenotypes [APOB.assay, whole]",1476
2,Craniofacial microsomia,339
2,Triglyceride levels in IDL,236
2,"Blood protein levels [IL1R2, 14133_93_3]",1343
2,Intracranial aneurysm,19821
2,Lung function (FEV1),26029
2,Serum metabolite levels [alliin],18423
2,Hyperlipidemia,10858
2,1-stearoyl-2-arachidonoyl-gpc (18:0/20:4) levels,634
2,Low tan response,584
2,Serum metabolite levels [L_VLDL_L],2043
2,Serum cancer antigen 125 levels,6400
2,Glomerular filtration rate [3-measure model],24393
2,Arm fat-free mass (right),157122
2,"Waist circumference adjusted for body mass index [EA, women]",598
2,Serum levels of protein F3,5509
2,Cardiovascular disease risk factors [TRIG],2043
2,Chronic sinusitis,4756
2,Triglyceride levels x long total sleep time interaction (2df test),2518
2,Left ventricular ejection fraction,845
2,1-(1-enyl-palmitoyl)-2-oleoyl-gpc (p-16:0/18:1) levels,658
2,Serum metabolite levels [Creatine],10
2,Atrial fibrillation [EA],72632
2,"Blood pressure medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",15441
2,Protein quantitative trait loci (liver) [FDXR],55
2,Kandleria vitulina abundance in stool,215
2,Immune reponse to smallpox (secreted IFN-alpha) [EA],72
2,Aging,86
2,DNA methylation-estimated plasminogen activator inhibitor-1 levels,30
2,Age at first sexual intercourse,121501
2,Febrile seizures [Overall],2630
2,CD45 on CD33- HLA DR-,3177
2,Acceptance of an invitation to participate in a mental health questionnaire,584
2,"Red blood cell traits [EA, MCV]",387
2,Serum metabolite levels [N-acetyltryptophan],50265
2,Electrocardiogram morphology (amplitude at temporal datapoints) [14 ms],33246
2,Ventolin 100micrograms inhaler | treatment/medication code,7811
2,"""Disorders of gallbladder, biliary tract and pancreas""",56515
2,Diseases of pancreas,266
2,Gout vs asymptomatic hyperuricemia,2043
2,Malate levels,372
2,Facial morphology (segment 27),449
2,Protein quantitative trait loci (liver) [UGT2B4],9
2,"Blood protein levels [ACYP2, 12812_25_3]",27394
2,"Blood protein levels [PAXIP1, 12894_3_3]",5509
2,CD28 on CD39+ CD8+ T cell,2265
2,"B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)",249
2,Breakfast skipping,111
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-164 ms],118
2,Serum levels of protein TFF1,205
2,Current tobacco smoking,32
2,Body mass index (age>50),13044
2,Waist-hip ratio,220933
2,C-reactive protein levels,200580
2,Urinary metabolite ratios in chronic kidney disease [Tryptophan/Acetylornithine],24553
2,Serum metabolite levels [X-12093],57844
2,Word interpolation | fi3 ,166
2,Nonsyndromic cleft lip with or without cleft palate,663
2,Brain morphology (min-P),25510
2,Blood protein levels [IL18],28053
2,Mitochondrial DNA levels,5532
2,Waist-to-hip ratio adjusted for BMI (age <50) [women],598
2,Spherical equivalent [EA],638
2,Postmenopausal atrophic vaginitsi,835
2,LDL cholesterol levels [BMI unadjusted],906
2,Myocardial infarction (early onset),23140
2,Glycine levels [conditional],11117
2,Diacylglycerol_32:2_[M+H-H2O]1+ levels,2043
2,Age at menopause (last menstrual period),52446
2,Tense / 'highly strung',548
2,AV-block,2186
2,Anxiety,1862
2,Protein quantitative trait loci [Granulysin],2454
2,Stopping prescribed medication | methods of self-harm used,153
2,Ovarian dysfunction,26
2,Cytomegalovirus reactivation after ﻿allogeneic hematopoietic cell transplantation (﻿recipients),131
2,Delayed reward discounting,5
2,"Blood protein levels [IAPP, 5647_51_3]",76
2,Infant head circumference (MTAG),35
2,Deviated nasal septum,33
2,PR interval [AA],240
2,Serum metabolite levels [XXL_VLDL_TG],2043
2,Pulse wave arterial stiffness index,455
2,Proteinuria,292
2,Serum levels of protein TNS2,40
2,Hip circumference variance,14699
2,Urolithiasis,16128
2,Endometriosis,3880
2,Facial morphology (nasion depth 1),25
2,Diverticular disease of intestine,430
2,Ventral hernia,879
2,Pericardial adipose tissue adjusted for height and weight,1079
2,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Asian],2171
2,CD45RA+ CD8+ T cell %T cell,269
2,Electrocardiogram morphology (amplitude at temporal datapoints) [306 ms],275
2,Serum metabolite levels [N-palmitoylglycine],240
2,Papillary thyroid cancer,41
2,"""Carcinoma in situ of breast, lobular (controls excluding all cancers)""",4
2,Birth weight (MTAG),31601
2,"Body mass index in physically active individuals [EA, men]",2604
2,White | bread type,13957
2,Electrocardiogram morphology (amplitude at temporal datapoints) [142 ms],5345
2,Monocyte percentage,148445
2,"Cholelithiasis/gall stones | non-cancer illness code, self-reported",1622
2,Total amyloid (SNP x SNP interaction),7724
2,Methylsuccinoylcarnitine levels,4083
2,Frequency of drinking alcohol,2417
2,"Lipid metabolism phenotypes [LDL.total, fasting]",1476
2,Serum metabolite levels (CMS) [S_VLDL_TG],2497
2,Serum levels of protein C1QL2,438
2,Protein quantitative trait loci (liver) [GLDC],243
2,Iron status biomarkers (ferritin levels),8587
2,Serum metabolite levels [pantothenate],59622
2,Allergic conjunctivitis,5728
2,"""Congenital malformations of ovaries, fallopian tubes and broad ligaments""",5188
2,Interleukin-27 levels,71
2,Phospholipid levels (plasma) [proportions],146
2,Matrix metalloproteinase-1 levels,34
2,Educational attainment (years of education) [conditional-joint],20192
2,Corneal structure,1821
2,Protein quantitative trait loci (liver) [HAAO],12054
2,Coffee consumption (cups per day),2043
2,Ankylosing spondylitis,3311
2,"Blood protein levels [ALPPL2, 6706_18_3]",484
2,Body mass index in physically inactive individuals [EA],2604
2,5-acetylamino-6-amino-3-methyluracil levels,374
2,Hypertensive Heart Disease,672
2,Eye movement (horizontal position gain),6
2,Bipolar I disorder,6282
2,"""Atopic dermatitis, strict definition with reimbursement""",11864
2,Never/rarely have milk | milk type used,5197
2,Phosphatidylcholine_34:3_[M+OAc]1-/Phosphatidylserine_38:2_[M-H]1- levels,2043
2,Townsend deprivation index at recruitment,688
2,Facial morphology (segment 15),244
2,Melanoma,22777
2,Serum uric acid levels [Japanese],44587
2,LDL cholesterol levels in current drinkers [Hispanic],1557
2,"Blood protein levels [QPCT, 7849_3_3]",14690
2,Haematocrit percentage,215812
2,"Ground coffee (include espresso, filter etc) | coffee type",16612
2,Systemic sclerosis,4193
2,"Gout | non-cancer illness code, self-reported",2043
2,"Blood protein levels [IL19, 3035_80_2]",438
2,Job involves heavy manual or physical work,3300
2,Ceramide_40:1_[M-H]1- levels,426
2,Marginal zone lymphoma or systemic lupus erythematosus,1130
2,Serum metabolite levels [succinimide],2441
2,Diabetic ketoacidosis,89
2,Serum levels of protein CD163,18
2,Monocyte count,925187
2,Respiratory diseases,30602
2,Neurociticism,13547
2,Diacylglycerol_34:1_[M+H-H2O]1+ levels,2043
2,Nervous feelings,333
2,Urinary albumin-to-creatinine ratio in diabetes,1693
2,Bacillus U abundance in stool,771
2,Triglyceride levels x short total sleep time interaction (2df test),2988
2,Body mass index (adult),2604
2,Experiencing mood swings,1604
2,Sleep (1/2-day periodicity),974
2,Triglyceride levels in current drinkers [EA],2985
2,Serum levels of protein NPNT,299
2,Corneal endothelial cell density,2504
2,Gut microbiota relative abundance (bacterial taxa) [Bacteroides_nordii],1751
2,"N-glycan levels [TA, women]",386
2,TB-LM or TBLH-BMD (pleiotropy),2027
2,Keratinocyte cancer (MTAG),17616
2,"Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA, women]",6461
2,Spinal canal stenosis,16414
2,White matter microstructure (mode of anisotropy) [Superior longitudinal fasciculus],6208
2,LDL cholesterol levels x long total sleep time interaction (2df test),1517
2,Oramorph 10mg/5ml oral solution | treatment/medication code,70
2,Burn and corrosion confined to eye and adnexa,135
2,LDL cholesterol [AA],90
2,"None of the above | illness, injury, bereavement, stress in last 2 years",98
2,Help-seeking from a GP,79
2,Body mass index (age <50),12391
2,BMI at 8 months old,12035
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-22 ms],4341
2,Straight vs curly hair [East Asian],3549
2,Dizziness and giddiness,25
2,Physical activity,20
2,Myeloid white cell count,95397
2,Insulin-like growth factor 1 levels,525010
2,Metabolically unhealthy in normal weight,4803
2,"Urinary metabolites (H-NMR features) [0.8475, Unknown]",6933
2,Serous borderline ovarian cancer,874
2,Maleate levels,964
2,Number of days/week of moderate physical activity 10+ minutes,5349
2,Triacylglycerol_50:5_[M+NH4]1+ levels,2043
2,Protein quantitative trait loci (liver) [DDB1],792
2,Medication use (immunosuppressants),255
2,Smoking initiation (ever regular vs never regular) [Conditioned on chr2:80999398],380
2,Protein quantitative trait loci (liver) [GAMT],86
2,"Atrial fibrillation | non-cancer illness code, self-reported",78
2,Serum uric acid levels,111893
2,Getting up in morning,12374
2,Alcohol use disorder (consumption score) [EA],3138
2,Serum levels of protein CHMP3,9042
2,Arm fat mass (right),59444
2,"Diabetes | non-cancer illness code, self-reported",6721
2,"Blood protein levels [PKDCC, 8664_36_3]",3538
2,Bendroflumethiazide | treatment/medication code,672
2,Blood metabolite levels [creatine],10
2,"Blood protein levels [IL18R1, 14079_14_3]",11864
2,Serum levels of protein TMEM52B,5077
2,BRCA2 mutation in breast cancer,2147
2,Electrocardiogram morphology (amplitude at temporal datapoints) [114 ms],275
2,Myocardial fractal dimension (slice 3),1981
2,Walk | types of transport used (excluding work),2101
2,Blood pressure [Mean Arterial Pressure],148
2,Fetal hemoglobin levels,42
2,Smoking initiation (ever regular vs never regular),74585
2,Inflammatory skin disease [Shared],3959
2,Red vs. brown/black hair color,2109
2,Brain connectivity [Strength - L-inferior parietal],68
2,Facial morphology traits (63 three-dimensional facial segments) [facial module 26],17
2,Alpha electroencephalogram frequency O1O2,4
2,Pain medicine use during menstruation,3243
2,Body fat percentage,239876
2,White matter microstructure (mode of anisotropy) [Anterior corona radiata],23194
2,Body fat percentage [male],10156
2,Serum albumin levels,99292
2,Lobe attachment,2046
2,Average weekly champagne plus white wine intake,354
2,Educational attainment (college completion),2738
2,Diastolic blood pressure [Pomak],574
2,Milk intake,19
2,Abscess of anal and rectal regions,8
2,Mean arterial pressure,65215
2,Circulating leptin levels or HOMA-IR,1660
2,White matter microstructure (mean diusivities) [Cingulate gyrus],6559
2,Feeling hurt,4452
2,High density lipoprotein cholesterol levels [EA],4116
2,Salmeterol+fluticasone propionate | treatment/medication code,740
2,"Lipid metabolism phenotypes [TG.by.NMR, fasting]",2043
2,Hemoglobin A1c levels [Hispanic/Latino],348
2,Effector Memory CD8+ T cell %T cell,162
2,Intelligence (MTAG),37362
2,Metabolite levels [FPG],2871
2,Hemoglobin,503523
2,"Blood protein levels [KYNU, 4559_64_2]",1257
2,Serum levels of protein PCYOX1,19810
2,Palmitoleic acid (16:1n-7) levels,4137
2,Nap during day,5395
2,Bone mineral density (hip),740
2,"Hepatitis C induced liver fibrosis [Duration F0-1/F3-4, transfused]",8813
2,Protein quantitative trait loci [KYNU],1257
2,Electrocardiogram morphology (amplitude at temporal datapoints) [222 ms],5345
2,Total cholesterol levels in LDL,944
2,Severe depression | illnesses of adopted mother,67
2,Adcal 600mg chewable tablet | treatment/medication code,220
2,Protein quantitative trait loci (liver) [RAC2],128
2,Age of smoking initiation,18202
2,Schizophrenia [EA],42089
2,Blood metabolite levels [alanine],2043
2,Intrahepatic Cholestasis of Pregnancy (ICP),4323
2,N-acetylvaline levels,36
2,Average log acceleration during the five least active hours of the day,28
2,Impedance of arm (left),116064
2,Triacylglycerol_50:3_[M+NH4]1+ levels,2043
2,LDL (oxidized),454
2,Waist circumference adjusted for body mass index [East Asian men],756
2,"Mean arterial pressure x alcohol consumption interaction (2df test) [AA, EA, Hispanic]",704
2,Ganglion cell inner plexiform layer (GCIPL) thickness,647
2,Metabolic traits [glycine + 17 other traits],267
2,"Allergic disease (asthma, hay fever and/or eczema) (age of onset)",14685
2,Waist circumference and related phenotypes [triglycerides],2171
2,"""Hypothyroidism, strict autoimmune""",2419
2,Alcohol intake frequency.,15797
2,Electrocardiogram morphology (amplitude at temporal datapoints) [316 ms],275
2,Ebbinghaus illusion (overestimation),144
2,Mycoplasmoidaceae abundance in stool,20
2,Protein quantitative trait loci (liver) [LTF],15
2,Refractive error,41508
2,Cholesterol [total cholesterol],10285
2,Urinary metabolite levels in chronic kidney disease [X - 12093],24285
2,None of the above | qualifications,14270
2,High blood pressure | illnesses of siblings,672
2,Thyroid peroxidase antibody positivity,816
2,Body mass index (joint analysis main effects and smoking interaction) [men],2604
2,"Metabolite levels [Ala, Gln]",2043
2,Chronic lymphocytic leukemia or systemic lupus erythematosus,1130
2,Chronic obstructive pulmonary disease in ever smokers,24
2,Mild influenza (H1N1) infection,1950
2,CD28- CD4-CD8- T cell %T cell,2189
2,Mosquito bite size,3874
2,Serum metabolite levels (CMS) [M_VLDL_FC],2043
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-128 ms],244
2,Doctor's advice | reason for reducing amount of alcohol drunk,72
2,White matter microstructure (mean diusivities) [Anterior limb of internal capsule],23070
2,Electrocardiogram morphology (amplitude at temporal datapoints) [224 ms],5345
2,Smoking behaviour (cigarettes smoked per day),555
2,Kidney disease (end stage renal disease or albuminuria) in type 1 diabetes,279
2,Hair/balding pattern: Pattern 1 (UKB data field 2395_1),200
2,Electrocardiographic traits [PR],406
2,Rheumatoid arthritis [EA],20219
2,"Urinary metabolites (H-NMR features) [2.7875, N-Acetylated compunds]",24606
2,Urinary metabolite levels in chronic kidney disease [N-acetylkynurenine (2],24659
2,Whole body water mass,194492
2,Medication use (anilides),2312
2,Unspecified diffuse connective tissue disease,52
2,"Blood protein levels [NPNT, 6342_10_3]",299
2,Protein quantitative trait loci (liver) [WARS],687
2,Chronic diseases of tonsils and adenoids,124
2,Heart disease | illnesses of adopted father,63
2,Straight vs curly hair,392
2,Protein quantitative trait loci (liver) [HSD17B4],14
2,Chronotype,238459
2,White matter microstructure (fractional anisotropy) [Genu of corpus callosum],23211
2,Urinary metabolite levels in chronic kidney disease [N-acetylarginine],21059
2,"Nasal polyps | non-cancer illness code, self-reported",6862
2,B cell lymphocyte profile difference (7 days post influenza vaccination),200
2,Facial morphology [right exocanthion-nasion distance],101
2,Diseases of sebaceous glands,155
2,middle facial morphology traits (quantitative measurement) [Nasion position],66
2,Phenyllactate (pla) levels,186
2,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),7904
2,"Blood protein levels [IL18R1, 3446_7_2]",11864
2,Resistin levels,2084
2,Lung adenocarcinoma,729
2,O_Burkholderiales abundance,346
2,Serum levels of protein IL1R2,1343
2,Burns and corrosions confined to eye and internal organs,135
2,"Ibuprofen (e.g. nurofen) | medication for pain relief, constipation, heartburn",73
2,Facial morphology traits (63 three-dimensional facial segments) [facial module 10],101
2,Cytokine network levels (multivariate analysis) [conditioned on rs6722871],11
2,Obesity,16952
2,Orofacial clefts,1467
2,Basophil count,351230
2,Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in secretors,8102
2,BMI (adjusted for smoking behaviour) [men],12446
2,3mm weak meridian (right),15191
2,Deoxycarnitine levels,2146
2,Fibrosis-4 index in high alcohol intake,420
2,Serum levels of protein GCA,34
2,(N(1) + N(8))-acetylspermidine levels,816
2,Facial morphology [right endocanthion-nasion distance],101
2,Plasma free amino acid levels [Thr],92
2,Vertical cup-disc ratio (multi-trait analysis),5590
2,Total bilirubin levels,14104
2,Cerebrospinal fluid biomarker levels [Interleukin-1 receptor-like 1],22544
2,Electrocardiogram morphology (amplitude at temporal datapoints) [110 ms],275
2,Asthma (adult onset),42698
2,Serum levels of protein PKDCC,3233
2,Electrocardiogram morphology (amplitude at temporal datapoints) [152 ms],1570
2,Sphingomyelin_34:1_[M+H]1+ levels,2043
2,"Cholecystitis | non-cancer illness code, self-reported",266
2,Gut microbiota (bacterial taxa) [Gammaproteobacteria class],240
2,Blood metabolite levels [mannose],2043
2,Alopecia areata,2258
2,Osteoarthritis,17992
2,Body fat percentage and fasting insulin (pairwise),861
2,Protein quantitative trait loci (liver) [HNRNPH3],66
2,Phosphatidylcholine-O_34:1_[M+OAc]1-/Phosphatidylcholine-P_34:0_[M+OAc]1-/Phosphatidylserine-O_38:0_[M-H]1- levels,2043
2,Bilirubin levels [Direct bilirubin],4469
2,Diffuse diseases of connective tissue,52
2,Electrocardiogram morphology (amplitude at temporal datapoints) [118 ms],275
2,Urinary metabolite levels in chronic kidney disease [isovalerylglycine],10
2,Mean spheric corpuscular volume,260342
2,College or university degree | qualifications,41306
2,Urate levels [men],3620
2,CD45RA on naive CD4+ T cell,1806
2,"""SLE, strict definition""",218
2,Electrocardiogram morphology (amplitude at temporal datapoints) [372 ms],28
2,"""Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified""",4
2,Type 1 diabetes,93901
2,Body mass index in physically active individuals,12446
2,Blood urea nitrogen levels,304947
2,"Hayfever, allergic rhinitis or eczema | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",47169
2,"Heel quantitative ultrasound index (qui), direct entry",57400
2,Electrocardiogram morphology (amplitude at temporal datapoints) [150 ms],5345
2,"Blood protein levels [EA, Interleukin-18 receptor accessory protein]",2725
2,Chlocystitis,4134
2,Phosphatidylethanolamine_34:1_[M-H]1- levels,2043
2,Serum metabolite levels (CMS) [M_VLDL_C],2043
2,Syncope and collapse,240
2,CD28+ CD45RA+ CD8+ T cell Absolute Count,320
2,Protein quantitative trait loci (liver) [ALDH5A1],106
2,Plasma free amino acid levels (adjusted for one other PFAA) [Gly (adjusted for Ser],261
2,Protein quantitative trait loci (liver) [GYG2],58
2,Urinary metabolite levels in chronic kidney disease [isocaproylglycine],10
2,Hypertriglyceridemia,28451
2,Urinary metabolite levels in chronic kidney disease [N-acetylphenylalanine],23318
2,Electrocardiogram morphology (amplitude at temporal datapoints) [76 ms],6425
2,Loneliness,9733
2,Triacylglycerol_50:4_[M+NH4]1+ levels,2043
2,Brain region volumes [right transverse temporal],1487
2,Plasma free amino acid levels (adjusted for twenty other PFAAs) [Gly],844
2,"Macular degeneration | non-cancer illness code, self-reported",239
2,White blood cell count,1469824
2,Plays computer games,5902
2,Lymphocyte count,73540
2,Seborrhoeic keratosis,1821
2,Childhood acute lymphoblastic leukemia (TCF3-PBX1 fusion) [EA],55
2,Other heart diseases,12
2,Dried fruit intake,10070
2,Generalized epilepsy,3528
2,Anorexia nervosa,1620
2,Serum metabolite levels (CMS) [XL_VLDL_P],2043
2,Human milk oligosaccharide concentration (lacto-N-fucopentaose III),163
2,Fresh fruit intake,3579
2,Hippurate levels,797
2,Protein quantitative trait loci (liver) [CORO1A],128
2,Waist circumference adjusted for BMI in non-smokers,10187
2,High light scatter reticulocyte percentage of red cells,609757
2,Hip circumference adjusted for BMI,224099
2,"Hip circumference [EA,women]",12496
2,Leg fat percentage (right),110424
2,Two-hour glucose in pregnancy (gestational week 30-32),285
2,QRS duration,4459
2,Metabolic traits [glucose/mannose + 54 other traits],2043
2,Nonsyndromic cleft lip,1053
2,Monobrow thickness,60
2,"""Malignant neoplasm of breast, HER2-negative""",46
2,Sum eosinophil basophil counts,93391
2,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)",81294
2,Kidney stones,4146
2,Epithelial ovarian cancer,2778
2,Height [AA],9979
2,Serum metabolite levels [MUFA],2043
2,Esophageal or stomach cancer,925
2,Gonarthrosis [arthrosis of knee](FG),867
2,Hippocampal tail volume (corrected for total hippocampal volume),510
2,Peak expiratory flow (pef),21275
2,Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis),39534
2,Problematic alcohol use,4515
2,Metabolic syndrome (multivariate analysis),2043
2,Cataracts [female],115
2,Femoral hernia,64
2,Gut microbiota relative abundance (bacterial taxa) [Erysipelothrix],4
2,Allergic sensitization,8987
2,Electrocardiogram morphology (amplitude at temporal datapoints) [330 ms],2342
2,Caffeine consumption from coffee,4647
2,Muesli | cereal type,3362
2,"Hyperthyroidism/thyrotoxicosis | non-cancer illness code, self-reported",1143
2,Oxalate (ethanedioate) levels,2880
2,"""Lactose intolerance, other/unspecified""",295
2,Clostridia abundance in stool,2930
2,Osteosarcoma,32
2,Inflammatory bowel disease,143455
2,Protein C levels [AA],11732
2,Medication use (vasodilators used in cardiac diseases),25971
2,Plasma free amino acid levels (adjusted for one other PFAA) [Ser (adjusted for Gln],261
2,Protein quantitative trait loci (liver) [SCP2],49
2,Adolescent idiopathic scoliosis,53088
2,Cognitive aspects of educational attainment,55079
2,Serum levels of protein CD8A,4762
2,Never | smoking status,27614
2,Serum metabolite levels (CMS) [VLDL_D],2043
2,Vasomotor and allergic rhinitis,5095
2,QT interval,9602
2,White matter microstructure (radial diusivities) [Superior fronto-occipital fasciculus],419
2,Triglyceride levels in very small VLDL,454
2,Naive CD4+ T cell %CD4+ T cell,1462
2,Serum metabolite levels [Pyruvate],86
2,Serum levels of protein VIT,1618
2,Nucleated red blood cell percentage,13586
2,Serum metabolite levels [X-11787],112797
2,Urinary metabolite levels in chronic kidney disease [X - 12125],24553
2,Duration to first press of snap-button in each round,6445
2,6mm weak meridian (left),14029
2,Interleukin-1 receptor type 2 levels,1343
2,Systolic blood pressure [East Asian],3004
2,Other and unspecified corneal deformities and disorders,635
2,Abdominal and pelvic pain,326
2,CD4+ CD8dim T cell %leukocyte,2189
2,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction) [women],598
2,Cipralex 5mg tablet | treatment/medication code,45
2,Hair color,80751
2,Secreting CD4 regulatory T cell %CD4+ T cell,1462
2,Body fat distribution (arm fat ratio),12983
2,Serum metabolite levels [XL_VLDL_TG],2043
2,Gout and other crystal arthropathies,2171
2,Electrocardiogram morphology (amplitude at temporal datapoints) [230 ms],1295
2,Diverticulitis,196
2,Full cream | milk type used,49
2,Facial morphology (segment 36),64
2,UBA2821 abundance in stool,183
2,Planum temporale asymmetry index,499
2,"Blood protein levels [PCYOX1, 6431_68_3]",76
2,Addiction [Opiates - African ancestry men - allelic test],37
2,Ever had hysterectomy (womb removed),8
2,Depressive symptoms,32511
2,Angina,23214
2,Serum levels of protein TNFAIP6,24057
2,"Cholesterol lowering medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",4860
2,St john's wort/hypericum [ctsu] | treatment/medication code,3253
2,HDL cholesterol x physical activity interaction (2df test) [EA],924
2,Urinary metabolite levels in chronic kidney disease [methylmalonate (MMA],7833
2,Mastocytosis (KIT D816V positive),66
2,Insomnia symptoms (never/rarely vs. sometimes/usually),7115
2,Total body bone mineral density,7425
2,Triglyceride levels in current drinkers [Asian],2171
2,Spherical power (left),9798
2,"Cancer of other lymphoid, histiocytic tissue",1845
2,Progression free survival in metastatic colorectal cancer (chemotherapy interaction),172
2,Inverse distance to the nearest major road,41
2,"Blood protein levels [REG1A, 13095_51_3]",12
2,Blood metabolite levels [X-08988],10
2,Thick vs thin eyebrows,32045
2,Apolipoprotein B levels,141722
2,CD4-CD8- Natural Killer T Absolute Count,2189
2,Impedance of leg (right),191338
2,High light scatter reticulocyte percentage,18918
2,Triglycerides [East Asian],2043
2,Other diseases of upper respiratory tract,5203
2,Ever tried to stop smoking,1289
2,Serum levels of protein NRP1,2171
2,"Pulmonary function (smoking interaction) [FEV1/FVC, Pack-years]",317
2,Protein quantitative trait loci (liver) [TNC],21
2,Medication use (HMG CoA reductase inhibitors),27127
2,BMI at 2 years old,12035
2,"Urinary metabolites (H-NMR features) [1.6975, N-Acetylated compunds]",24963
2,Brain region volumes [right precentral],16249
2,Low density lipoprotein cholesterol levels [EA],6528
2,CD4-CD8- T cell %leukocyte,2263
2,Metabolic disorders,1360
2,"""Acute appendicitis, no complications""",776
2,"Pleurisy | non-cancer illness code, self-reported",391
2,Serum metabolite levels (CMS) [Gly],261
2,IgA levels,2
2,Prostate cancer,341266
2,Morning vs. evening chronotype,48260
2,Creatine kinase levels,7656
2,White matter microstructure (radial diusivities) [Anterior corona radiata],28291
2,Urinary metabolite levels in chronic kidney disease [homocitrulline],24393
2,Fructosamine levels,3415
2,Lipid traits (pleiotropy) (HIPO component 1),8392
2,Lung function (FEV1) and body mass index [East Asian],1450
2,Electrocardiogram morphology (amplitude at temporal datapoints) [0 ms],257
2,Metabolite levels [glycine],420
2,Relative age voice broke,14
2,Blood metabolite levels [2-aminobutyrate],60
2,Hereditary retinal dystrophy,11
2,Disability living allowance | attendance/disability/mobility allowance,3
2,Highest math class taken,91074
2,Metabolite levels [N-ACu],25457
2,Gestational diabetes (for exclusion),4001
2,Average total household income before tax,3673
2,Phosphatidylcholine-O_40:5_[M+H]1+/Phosphatidylcholine-P_40:4_[M+H]1+ levels,2043
2,Smoking initiation,11819
2,Electrocardiogram morphology (amplitude at temporal datapoints) [146 ms],5345
2,Electrocardiogram morphology (amplitude at temporal datapoints) [202 ms],5345
2,Disorders of lipoprotein metabolism and other lipidaemias,1242
2,Alcohol consumption [women],2043
2,Addison's disease,1408
2,Activated & resting CD4 regulatory T cell %CD4 regulatory T cell,1640
2,Total hippocampal volume,510
2,Meat-related diet [female],60
2,Polycystic ovarian syndrome,24
2,White matter microstructure (mode of anisotropy) [Average across all tracts],23751
2,Electrocardiogram morphology (amplitude at temporal datapoints) [134 ms],5345
2,Walking pace,19771
2,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [N2,  N6-diacetyllysine,  N-acetylasparagine,  N-acetylglutamine,  N-acetylhistidine,  N-acetylleucine]",6062
2,Pollinosis,1187
2,Ovarian cancer [All invasive],874
2,Serum metabolite levels [3-methylglutarylcarnitine (2],240
2,"""Additional codes for the location of defect, injury or illness""",33
2,Hemoglobin A2 levels in sickle cell anemia,57
2,Sociability score,5985
2,Vegetable consumption,336
2,"""Cholelithiasis, broad definition with cholecystitis""",58514
2,Serum metabolite levels [alanine],22322
2,Total cholesterol levels [BMI unadjusted],4518
2,Electrocardiogram morphology (amplitude at temporal datapoints) [178 ms],5345
2,CD4-CD8- Natural Killer T %T cell,2263
2,Irritable mood,4012
2,Body fat percentage [female],60
2,Serum metabolite levels (CMS) [TG_PG],2043
2,Serum metabolite levels (CMS) [M_VLDL_TG],2043
2,Serum levels of protein SHMT2,10
2,"Blood protein levels [EA, Interleukin-18 receptor 1]",4639
2,Cognitive function (generalized correlation coefficient),399
2,Protein quantitative trait loci (liver) [STAT1],17
2,Migraine and/or pulse pressure,23185
2,Hemoglobin A1c levels,317685
2,Triacylglycerol_48:1_[M+NH4]1+ levels,2171
2,Body fat percentage [European],908
2,Metabolite levels,3926
2,Protein quantitative trait loci (liver) [SEPT11],306
2,Gut bacterial pathway abundance (PWY.6708..ubiquinol.8.biosynthesis..prokaryotic.),82
2,Endometriosis of ovary,599
2,Corneal ulcer,244
2,HDL cholesterol,61040
2,Cortical thickness (min-P),17168
2,Fibrinogen [EA],5007
2,Hand grip strength (left),57184
2,Serum metabolite levels [N-acetylalliin],17896
2,Renal overload gout,2043
2,TPE interval (resting) [women],3723
2,Alcohol consumption in current drinkers,2043
2,Non-oily fish consumption,2043
2,Granulocyte count,116214
2,Type 2 diabetes or prostate cancer (pleiotropy),18916
2,hemolysis of donated blood (osmotic),62995
2,Renin levels,23442
2,"Forced vital capacity (fvc), best measure",161661
2,Female genital prolapse,514
2,Hematological and biochemical traits [ALB],2043
2,Phosphatidylcholine-O_36:3_[M+H]1+/Phosphatidylcholine-P_36:2_[M+H]1+ levels,2043
2,Rheumatoid arthritis [ACPA-positive RA vs ACPA-negative RA],593
2,Fybogel orange s/f granules | treatment/medication code,235
2,CD14+ CD16- monocyte Absolute Count,548
2,Interstitial lung disease endpoints,90
2,Facial morphology (brow ridge protrusion 3),37
2,Relative amplitude of rest-activity cycles,28
2,CD28 on CD4 regulatory T cell,3157
2,Urinary metabolite levels in chronic kidney disease [X - 12124],22932
2,None of the above | vascular/heart problems diagnosed by doctor,51709
2,Prevalent atrial fibrillation,12634
2,Triglycerides x physical activity interaction (2df test),2043
2,"Bilirubin (z,z) levels",4716
2,Body mass index [women],12545
2,Electrocardiogram morphology (amplitude at temporal datapoints) [132 ms],1570
2,Waist-to-hip ratio adjusted for body mass index [EA],9848
2,CD8 on Central Memory CD8+ T cell,4815
2,Serum levels of protein GNLY,11267
2,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test) [EA],234
2,"Blood protein levels [LMAN2L, 8013_9_3]",3102
2,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),3021
2,CD25++ CD45RA+ CD4 not regulatory T cell Absolute Count,1462
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-118 ms],2822
2,4-chlorobenzoic acid levels,743
2,Serum levels of protein EDAR,211
2,Body fat percentage and coronary artery disease (pairwise),231
2,Osteoarthritis of the hip or knee,6081
2,"Heel bone mineral density (bmd) t-score, automated (right)",17821
2,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),839
2,Serum metabolite levels [M_VLDL_FC],2043
2,Distance between home and job workplace,109
2,Obesity and other hyperalimentation,2643
2,Cortical surface area [Superior temporal],1504
2,Protein quantitative trait loci (liver) [EPHX1],72
2,Lung function (FEV1/FVC) [adults],96
2,Urinary metabolite levels in chronic kidney disease [3-methylglutarylcarnitine (2],10
2,Age at menopause,91453
2,Smoking cessation (MTAG),96362
2,"Urinary metabolites (H-NMR features) [2.0375, N-Acetylated compunds]",24606
2,Leiomyoma of uterus,474
2,Protein quantitative trait loci (liver) [HNRNPD],308
2,Pleasant difference startle modulation,7
2,Ulcer of esophagus,135
2,Protein quantitative trait loci (liver) [CTH],35
2,Coronary angiopasty,23224
2,Rosuvastatin | treatment/medication code,944
2,Parabacteroides abundance in stool,275
2,Schizophrenia vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),4911
2,"Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) [Asian, EA]",241
2,Systolic blood pressure x smoking status (ever vs never) interaction (2df test) [EA],170
2,Malignant neoplasm of thyroid gland,43
2,Attention deficit hyperactivity disorder or putamen volume (pleiotropy),1
2,Mean platelet volume,834387
2,Educational attainment (MTAG) [MTAG],220330
2,Macular thickness,11278
2,Waist circumference adjusted for body mass index [EA],11831
2,Energy expenditure [Lean],1380
2,"Blood protein levels [IL1RL1, 4234_8_2]",6297
2,Protein quantitative trait loci (liver) [GALM],2804
2,Arm fat mass (left),40715
2,Mean corpuscular haemoglobin,143986
2,Mean platelet (thrombocyte) volume,196223
2,Prostate cancer | illnesses of siblings,5140
2,CD28 on activated & secreting CD4 regulatory T cell,2491
2,"Blood protein levels [SFTPB, 10672_75_3]",2496
2,Metabolite levels [alpha hydroxybutyric acid],2043
2,Hernia of abodminal wall,1334
2,Corneal hysteresis (left),1373
2,Protein C levels [Conditioned on rs7580658 and rs1799808],228
2,Urinary metabolite levels in chronic kidney disease [Glutamine],456
2,Smoking status (current vs never),92
2,Medication use (glucocorticoids),19628
2,White matter hyperintensities,93266
2,Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis),40844
2,Electrocardiogram morphology (amplitude at temporal datapoints) [196 ms],5345
2,Obesity [Overweight],12506
2,Sodium levels,4236
2,Protein quantitative trait loci (liver) [ACSL4],2054
2,Other disorders of biliary tract,266
2,Follicle stimulating hormone levels,337
2,Pyridoxal levels,224
2,Vitamin C levels,9715
2,Serum metabolite levels [S_VLDL_PL],2043
2,Gut microbiota (bacterial taxa) [Unclassified Acidaminococcaceae],436
2,Breast cancer (estrogen-receptor positive),104
2,Serum levels of protein AQP4,40
2,QRS interval (sulfonylurea treatment interaction) [EA],844
2,Serum total protein level,231614
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-116 ms],2822
2,Subiculum volume,510
2,Deep endometriosis,603
2,"Hemoglobin levels [HbF, Sardinian]",27
2,Facial morphology (columella size),77
2,Eczema,71326
2,Peak expiratory flow,34975
2,Leisure sedentary behaviour (television watching),46705
2,"Sitting height ratio [EA, men]",8816
2,CD45RA- CD4+ T cell %T cell,1462
2,Respiratory or ear-nose-throat disease,20548
2,"Light diy (eg: pruning, watering the lawn) | types of physical activity in last 4 weeks",33053
2,Adverse response to chemotherapy in breast cancer (alopecia) [Recessive],2439
2,Celiac disease or Rheumatoid arthritis,1505
2,Cortical surface area [Isthmus Cingulate],3356
2,Recombination measurement [African-enrichment],892
2,Plasma free amino acid levels (adjusted for one other PFAA) [Gly (adjusted for Gln],261
2,Serum metabolite levels [Glycine],15
2,Trunk total mass,25
2,Waist Circumference - Triglycerides (WC-TG),17551
2,Birth length (MTAG),31601
2,Uterine fibroids,75995
2,Pattern 4 | hair/balding pattern,37066
2,Fasting blood glucose adjusted for BMI,3412
2,Pulse pressure [EA],391
2,Hernia,878
2,Protein quantitative trait loci (liver) [COX6B1],239
2,Serum metabolite concentrations in chronic kidney disease [Glycine],10
2,Intraocular pressure,88626
2,Urinary metabolite ratios in chronic kidney disease [Tyrosine/Acetylornithine],24553
2,Electrocardiogram morphology (amplitude at temporal datapoints) [206 ms],5345
2,Sleep duration (short sleep),995
2,Bone mineral density (hip) and hip bone size,215
2,Serum levels of protein NXPH1,40
2,Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in non-secretors,69
2,Response to antipsychotic treatment in schizophrenia,81
2,Butyrylcholinesterase levels,8300
2,Fasting glucose adjusted for BMI,28789
2,Phosphatidylcholine_40:5_[M+H]1+ levels,2626
2,Blood metabolite ratios [glucose/mannose],2043
2,Asthma or allergic disease (pleiotropy),7356
2,Leiomyoma of uterus (controls excluding all cancers),2240
2,Serum metabolite levels (CMS) [MUFA],2043
2,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant II (Nose), Segment 46]",227
2,"Blood protein levels [REG3G, 9352_86_3]",1047
2,"Blood protein levels [TFF1, 9185_15_3]",205
2,Oropharynx cancer,403
2,Kidney volume,204
2,Paroxetine | treatment/medication code,70
2,Metabolite levels (small molecules and protein measures) [Glycine],10
2,Non-small cell lung cancer,16568
2,Urinary metabolite levels in chronic kidney disease [N-acetylhistidine],23318
2,Cortical surface area [Posterior Cingulate],3626
2,Cortical surface area [Superior Temporal],3747
2,Calcium levels,230915
2,Waist-to-hip ratio adjusted for body mass index,9605
2,Ras-related protein Rab-1A measurement,6817
2,Corneal hysteresis (right),3815
2,"""Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8""",3972
2,CD28+ CD45RA+ CD8dim T cell %CD8dim T cell,781
2,LDL cholesterol levels [EA],4129
2,"""Other diabetes, wide definition""",3130
2,Ovarian cancer [Serious invasive],874
2,Insomnia,45355
2,Spherical power (right),9638
2,Wholemeal or wholegrain | bread type,4562
2,CD28+ CD45RA+ CD8dim T cell Absolute Count,1452
2,N-glycan levels [DG11],386
2,Gallbladder polyp,266
2,Cooked vegetable intake,262
2,Atopic dermatitis,151065
2,Bipolar disorder,14928
2,Mean corpuscular volume,1003755
2,Ovarian cancer-related tumor marker CA 125 levels,9749
2,Medication use (diuretics),6761
2,Serum metabolite levels [isobutyrylglycine],420
2,Body fat percentage and triglycerides (pairwise),862
2,Myopia (severe),36
2,Coronary artery disease or large artery stroke,23140
2,Lymphocyte percentage of white cells,301425
2,Stress urinary incontinence [adjusted for known risk factors],35842
2,Phosphatidylcholine-O_36:4_[M+H]1+/Phosphatidylcholine-P_36:3_[M+H]1+ levels,2043
2,Serum metabolite levels (CMS) [XL_VLDL_FC],2043
2,Serum metabolite levels (CMS) [Serum_TG],2043
2,Interleukin-1 receptor antagonist protein measurement,9903
2,"None of the above | medication for pain relief, constipation, heartburn",881
2,CD4+ CD8dim T cell Absolute Count,2189
2,Serum metabolite levels [TG_PG],2043
2,Age-related diseases and mortality,8
2,Hypodontia,310
2,Gastric polyp,117
2,Mucosal proctocolitis,90
2,Protein quantitative trait loci (liver) [AKR1B10],6
2,Protein quantitative trait loci (liver) [USP5],22
2,Ulcerative colitis,66908
2,Urinary albumin excretion,52779
2,Serum metabolite concentrations in chronic kidney disease [N-acetyl-3-methylhistidine],5784
2,Electrocardiogram morphology (amplitude at temporal datapoints) [72 ms],608
2,"""Endocrine, nutritional and metabolic diseases""",1683
2,Cancer (pleiotropy)(bidirectional),2327
2,Tooth agenesis,443
2,Brain region volumes [left hippocampus],503
2,"""Malignant neoplasm of breast, HER-positive""",46
2,"Measles / morbillivirus | non-cancer illness code, self-reported",280
2,Cortical thickness [average],39598
2,Ischemic heart diseases,45941
2,"""Hypodontia, including avohilmo""",155
2,Epilepsy [All epilepsy],938
2,Waist circumference adjusted for BMI (adjusted for smoking behaviour) [men],1170
2,Interleukin-6 (red blood cell fatty acid level interaction) [DHA],86
2,Had other major operations,266
2,Varicose veins of lower extremity,8029
2,Cortical surface area [Precuneus],3509
2,Asthma (age of onset),10637
2,Psoriasis or type 2 diabetes (trans-disease meta-analysis),1936
2,Terminally Differentiated CD8+ T cell Absolute Count,269
2,Bone mineral accretion in asthma (oral corticosteroid dose interaction),16
2,Urinary metabolite levels in chronic kidney disease [isobutyrylglycine],10
2,Phospholipid levels in chylomicrons and largest VLDL,15012
2,Self-reported risk-taking behaviour,39852
2,Daytime dozing / sleeping (narcolepsy),13381
2,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),23418
2,"""Hypothyroidism, strict autoimmune, 3 medication purchases required""",2438
2,Diverticular disease,1844
2,Cortical surface area [Transverse temporal],500
2,Serum metabolite levels (CMS) [XL_VLDL_L],2043
2,Serum levels of protein P4HB,299
2,Serum metabolite levels [glycine],507
2,Protein quantitative trait loci (liver) [MYO1B],150
2,Thermococci abundance in stool,7
2,Eosinophil percentage of granulocytes,50499
2,Femoral neck bone mineral density,12086
2,Cortical thickness (MOSTest),29683
2,Fat-free mass [female],4845
2,Leg fat mass (right),58719
2,Nonsyndromic cleft lip with cleft palate,5734
2,Fasting insulin adjusted for BMI,2528
2,Electrocardiogram morphology (amplitude at temporal datapoints) [88 ms],5817
2,LDL cholesterol levels,51693
2,Bitter alcoholic beverage consumption,3640
2,N-acetyl neuraminic acid levels,23819
2,Lymphocyte-to-monocyte ratio,115448
2,Phosphatidylcholine-2O_32:0_[M+H]1+ levels,2043
2,White matter microstructure (radial diusivities) [Superior corona radiata],23140
2,Age started wearing glasses or contact lenses,13448
2,Diacylglycerol_30:0_[M+H-H2O]1+ levels,2171
2,Low hand grip strength (60 years and older) (EWGSOP),1022
2,Electrocardiogram morphology (amplitude at temporal datapoints) [228 ms],1295
2,Protein quantitative trait loci (liver) [LUM],1
2,C-reactive protein,26696
2,Serum metabolite levels [threonine],24493
2,Serum metabolite levels [VLDL_TG],2043
2,Airway wall thickness [FEV1/FVC < 80%],271
2,Blood metabolite levels [X-12556],3669
2,Serum levels of protein PXDN,303
2,Aneurinibacillales abundance in stool,75
2,Thyroiditis,9
2,Urinary metabolites [3.555 ppm/2.547 ppm],10
2,Urinary albumin-to-creatinine ratio [EA],36961
2,Fasting blood glucose,16051
2,Age-related disease endophenotypes,3503
2,Glycated hemoglobin levels [conditional],838
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-104 ms],2668
2,Pediatric areal bone mineral density (spine vs radius & hip discordant skeletal phenotype) [female],2111
2,Chronic lymphocytic leukemia or rheumatoid arthritis,1141
2,Protein quantitative trait loci (liver) [UGT1A1],1122
2,"Bone mineral density (paediatric, total body less head)",4054
2,"Hypothyroidism/myxoedema | non-cancer illness code, self-reported",22620
2,BMI in smokers,2604
2,Myopia,7050
2,Bilirubin levels [Conditional on rs11891311],629
2,Systemic sclerosis (anti-centromere-positive) [EA],183
2,Snoring [adjusted for BMI],72
2,Heel bone mineral density x serum urate levels interaction [male],14
2,Leprosy,23891
2,Caffeine consumption from coffee or tea,2043
2,"Body mass index in physically active individuals [EA,women]",12446
2,Cystatin C levels,365107
2,Fluid intelligence score,5784
2,Impedance of leg (left),178364
2,3-hydroxyisobutyrate levels,276
2,"""Asthma, unspecified (mode)""",9137
2,Obesity (early onset extreme),2604
2,Circulating leptin levels or fasting insulin levels,1660
2,"Diastolic blood pressure x alcohol consumption interaction (2df test) [Asian, EA]",1806
2,Lung function (FVC) and body mass index [East Asian],22350
2,"Blood protein levels [EA, [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial]",603
2,Pulse pressure [Japanese],776
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-94 ms],118
2,Hyperplasia of prostate,173
2,Kidney disease (reduced eGFR and albuminuria or end stage renal disease) in type 1 diabetes,279
2,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant I (Philtrum), Segment 34]",64
2,"Pericardial problem | non-cancer illness code, self-reported",35
2,Plasma homocysteine levels (post-methionine load test),10
2,Circulating leptin levels or HOMA-B,45
2,"Number of decayed, missing and filled tooth surfaces or use of dentures",18133
2,Hypothyroidism and >3 levothyroxin purchases,2535
2,"Blood protein levels [FRZB, 13740_51_3]",603
2,Brain region volumes [right hippocampus],503
2,"""Type 1 diabetes, strict (exclude DM2)""",1157
2,Thyroid cancer,485
2,Nonspecific chest pain,1562
2,Protein quantitative trait loci (liver) [ACSM2B],179
2,Vitamin b6  | vitamin and/or mineral supplement use,162
2,Lean body mass,228
2,Heart rate response to recovery post exercise [females],2
2,Appendicular lean mass,865456
2,Body mass index and triglycerides (pairwise),109181
2,Diastolic blood pressure [East Asian],6836
2,Fasting insulin,10544
2,Pattern 3 | hair/balding pattern,8231
2,Microalbuminuria,1556
2,Facial morphology [right exocanthion-right cheilion distance],789
2,"None of the above | medication for cholesterol, blood pressure or diabetes",1104
2,Mitral valve prolapse,240
2,Heel broadband ultrasound attenuation (right),15951
2,Straight vs curly hair [Uyghur ancestry],3549
2,Blood metabolite levels [X-11442],5509
2,Body mass index in physically inactive individuals [women],2604
2,Beclometasone | treatment/medication code,7432
2,Waist circumference adjusted for BMI in active individuals [men],2390
2,CD25++ CD45RA+ CD4 not regulatory T cell %T cell,1759
2,Effector Memory CD4-CD8- T cell %CD4-CD8- T cell,183
2,Instant coffee | coffee type,12
2,Fibrinogen,10
2,Total cholesterol levels,277365
2,Pulse pressure,317166
2,Periventricular white matter hyperintensities,23766
2,Childhood obesity [EA],11421
2,"Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)",9737
2,Verbal-numerical reasoning,10225
2,Serum levels of protein IL1RL2,1216
2,Regular attendance at a pub or social club,567
2,Urinary metabolite levels in chronic kidney disease [glycine conjugate of C9H16O2],1357
2,High density lipoprotein cholesterol levels [Hispanic],454
2,Mean corpuscular hemoglobin,1215749
2,Gallstone disease [EA],421
2,Opioid overdose severity score [AA],154
2,Protein quantitative trait loci (liver) [LGALS4],3
2,Mental health study participation (provided email address),3
2,Body mass index x sex x age interaction (4df test),12391
2,Allergic asthma (mode) (more control exclusions),3002
2,Serum metabolite levels (CMS) [L_HDL_PL],2043
2,Alcohol dependence,2734
2,Sebaceous cyst,155
2,Feeling lonely,40
2,Generalized epilepsy [All GGE],14
2,Total bone mineral density x gut microbiota (﻿genus Dialister) interaction,3764
2,"""Ischaemic heart disease, wide definition""",45922
2,Serum metabolite levels [M_VLDL_PL],2043
2,Protein quantitative trait loci (liver) [ARHGDIB],128
2,Lung volume,467
2,Balding type 1,61553
2,Metabolic traits [SM-4 + 74 other traits],5509
2,"Lipid metabolism phenotypes [APOB.assay, fasting]",1476
2,Upper eyelid morphology [Tangent line angle of el3],274
2,Facial morphology (segment 18),875
2,Renal cell carcinoma [Western European],405
2,Protein quantitative trait loci (liver) [TTC38],12
2,Educational attainment [College],1459
2,Low hand grip strength (60 years and older) (FNIH),3103
2,Usual walking pace,4691
2,Use a helpline / voluntary organization | actions taken following self-harm,795
2,Bone mineral density (spine),464
2,Number of days/week of vigorous physical activity 10+ minutes,150
2,Pulmonary function [FEV1/FVC],75
2,Serum levels of protein SYT11,40
2,Glomerular filtration rate,29933
2,Cluster headache,8952
2,"Waist circumference [EA, women]",2776
2,Interleukin-1 receptor type 2 measurement,2506
2,Methylmalonate (mma) levels,783
2,"Smoking initiation (ever regular vs never regular) [Conditioned on chr2:146283610, chr2:146140132]",396
2,"Blood protein levels [MDH1, 3853_56_1]",1398
2,Biliary atresia,235
2,Cerebrospinal fluid immune biomarker levels [IL-8],29
2,Visceral adipose tissue mass,25
2,Skin cancer,23998
2,White matter microstructure (fractional anisotropy) [Anterior corona radiata],5570
2,1-linoleoyl-gpc (18:2) levels,2487
2,Serum metabolite levels [XL_VLDL_PL],2043
2,Body mass index in physically inactive individuals,2604
2,"Lipid metabolism phenotypes [TG.by.NMR, whole]",2043
2,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),860
2,"Waist circumference adjusted for BMI in active individuals [EA, men]",747
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-122 ms],362
2,Signal-to-noise-ratio (snr) of triplet (left),37
2,N1-methyl-2-pyridone-5-carboxamide levels,7183
2,Serum metabolite levels (CMS) [XXL_VLDL_TG],2043
2,Immature Myeloid-Derived Suppressor Cells %CD33dim HLA DR- CD66b-,221
2,Homeostasis model assessment of beta-cell function,1369
2,"Triglyceride levels [Asian initial, BMI unadjusted]",1776
2,Electrocardiogram morphology (amplitude at temporal datapoints) [104 ms],275
2,Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis),39325
2,Age first had sexual intercourse,19374
2,"Diastolic blood pressure, automated reading",88343
2,"""Type 2 diabetes, strict (exclude DM1)""",10131
2,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),3000
2,Serum levels of protein HS6ST1,723
2,Serum metabolite levels (CMS) [M_VLDL_L],2043
2,Macroalbuminuria in type 1 diabetes,279
2,Electrocardiogram morphology (amplitude at temporal datapoints) [94 ms],275
2,X-24686 levels,269
2,LDL cholesterol [Hispanic],130
2,Serum levels of protein IAPP,2931
2,Height [Conditioned on rs3791675],789
2,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [N-acetylarginine, N-acetylcitrulline, X-13698]",24553
2,"Lipid metabolism phenotypes [TG.assay, fasting]",2497
2,Hypertensive diseases (excluding secondary),4130
2,Facial morphology [Right facial angle of en-ex-go],705
2,Urinary metabolite levels in chronic kidney disease [hexanoylglycine],10
2,Chronic obstructive pulmonary disease or resting heart rate (pleiotropy),885
2,Corneal endothelial cell size variation coefficient,1176
2,Vesicoureteral reflux [recessive],3227
2,Cognitive traits (MTAG),5894
2,Other intervertebral disc disorders,2997
2,Percent glycated albumin [EA],1994
2,Hepcidin levels [Subset],64
2,Body mass index and systole blood pressure (pairwise),264
2,Sleep duration,23295
2,Extranodal natural killer T-cell lymphoma (nasal type),22544
2,Total testosterone levels,130528
2,Stable angina pectoris,22439
2,Lamb consumption,564
2,Alanine transaminase levels in high alcohol intake,739
2,Aliivibrio abundance in stool,3
2,Ferritin levels,27945
2,Red cell distribution width,1102058
2,Panic attacks | mental health problems ever diagnosed by a professional,3131
2,"""Asthma, unspecified (mode) (more control exclusions)""",9137
2,Serum metabolite levels [L_VLDL_TG],2043
2,Serum metabolite levels [M_VLDL_TG],2043
2,Serum metabolite levels [L_VLDL_PL],2043
2,Telomere length,847
2,Ceramide_42:1_[M-H]1- levels,426
2,Schizophrenia,335249
2,Glomerular filtration rate [Single-measure model],24393
2,CD28 on CD4+ T cell,3999
2,Serum metabolite levels (CMS) [M_VLDL_P],2497
2,Electrocardiogram morphology (amplitude at temporal datapoints) [174 ms],5345
2,3mm cylindrical power angle (left),2615
2,Serum metabolite levels [XL_VLDL_L],2043
2,Number of attempts,877
2,Dysmenorrheic pain severity,5369
2,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)",58203
2,White matter microstructure (axial diusivities) [Fornix (cres) / Stria terminalis],3379
2,Urinary metabolite levels in chronic kidney disease [N-acetyl-1-methylhistidine],21059
2,Body mass index and coronary artery disease (pairwise),258
2,"Waist-hip ratio [EA, men]",232
2,Phosphatidylcholine-O_34:1_[M+H]1+/Phosphatidylcholine-P_34:0_[M+H]1+/Phosphatidylethanolamine-O_37:1_[M+H]1+ levels,2043
2,SLE (Finngen),218
2,Systolic blood pressure [Japanese],95
2,Serum levels of protein CXCL16,156
2,Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event) [EA],276
2,Smoking initiation (ever regular vs never regular) (MTAG),169358
2,Frailty index,9237
2,BMI at 6 months old,12035
2,Serum metabolite levels [L_VLDL_FC],2043
2,Serum metabolite levels (CMS) [XXL_VLDL_PL],2043
2,Handedness (Left-handed vs. non-left-handed),868
2,Waist-to-hip ratio adjusted for BMI x sex interaction,598
2,Visceral fat [women],1096
2,Blood metabolite levels [pyroglutamine],10
2,Anxiety x maternal smoking during pregnancy interaction [Additive model],266
2,Visceral adipose tissue volume,25
2,Hearing aid user,4036
2,Glomerular filtration rate [6-measure model],24393
2,Platelet count,1701340
2,Protein quantitative trait loci (liver) [IGHM],199
2,Other peripheral nerve disorders,2153
2,Response to radiotherapy in prostate cancer (toxicity) [late toxicity],491
2,Bilirubin levels [Total bilirubin],2549
2,Number of live births,328
2,Permanent tooth development,322
2,Selective IgA deficiency,89
2,Protein quantitative trait loci (liver) [CBR3],390
2,Guilty feelings,31793
2,Protein C levels,16352
2,Triglycerides [AA],1121
2,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),7123
2,Suffer from 'nerves',704
2,P wave duration [EA],239
2,Serum levels of protein LRP1B,113
2,Facial morphology [subnasale-right alare distance],227
2,Facial morphology (jaw slope 2),3
2,Basophil percentage of granulocytes,13268
2,Vertex-wise sulcal depth,248652
2,Electrocardiogram morphology (amplitude at temporal datapoints) [86 ms],5817
2,Childhood absence epilepsy,1126
2,Diaphragmatic hernia,624
2,"Sarcoma/fibrosarcoma | cancer code, self-reported",1602
2,Adhesion G protein-coupled receptor E2 levels,114
2,"""Ulcerative colitis (strict definition, require KELA, min 2 HDR)""",144
2,Systolic blood pressure,550386
2,Serum metabolite levels [N-acetylcitrulline],38843
2,Ankle spacing width (left),9827
2,Chronic obstructive pulmonary disease,14888
2,Glycemic traits (pregnancy) [FPG],2325
2,Serum levels of protein EFEMP1,976
2,Activated & secreting CD4 regulatory T cell %CD4 regulatory T cell,1753
2,Mid-point of the five least active hours of the day,28
2,Neutrophil count,1053951
2,Serum metabolite levels [biliverdin],7950
2,"Heel bone mineral density (bmd) t-score, automated (left)",17260
2,Serum metabolite levels (CMS) [L_VLDL_PL],2043
2,Electrocardiogram morphology (amplitude at temporal datapoints) [100 ms],275
2,Metabolite levels [Cer d18:2/26:0],18
2,LDL cholesterol,104288
2,High IL-1beta levels in gingival crevicular fluid,3114
2,Spermatocele,7953
2,Body mass index [men],2604
2,Serum metabolite levels (CMS) [L_VLDL_TG],2043
2,CD45RA on resting CD4 regulatory T cell,2331
2,Phosphatidylcholine-O_44:5_[M+OAc]1-/Phosphatidylcholine-P_44:4_[M+OAc]1- levels,2043
2,Abscess of Bartholin gland,21
2,White matter hyperintensity burden [EA],23495
2,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [N-acetyl-1-methylhistidine,  N-delta-acetylornithine,  X-11357,  X-23590]",21059
2,Other disorders of ear,7426
2,Pericarditis,3591
2,3mm strong meridian angle (right),2690
2,Plasma free amino acid levels (adjusted for one other PFAA) [Gly (adjusted for Pro],261
2,Sensitive skin,456
2,Protein quantitative trait loci (liver) [GSN],57
2,Protein quantitative trait loci (liver) [LRRK2],8
2,Cardiovascular disease,109127
2,Blood metabolite levels [Arginine],24155
2,Thyroid problem (not cancer),91019
2,Asthma (mode),10124
2,Waist circumference adjusted for BMI in active individuals [women],2158
2,Feeling worry,1176
2,Language functional connectivity,2997
2,Hallux valgus (acquired),4468
2,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Hispanic],1563
2,Electrocardiogram morphology (amplitude at temporal datapoints) [116 ms],275
2,Pulse wave peak to peak time,65
2,Other/unspecified rheumatoid arthritis,46
2,Body mass index (joint analysis main effects and physical activity interaction) [EA],12545
2,White matter microstructure (fractional anisotropy) [Anterior limb of internal capsule],23194
2,Electrocardiogram morphology (amplitude at temporal datapoints) [18 ms],33167
2,Coronary revascularization (ANGIO or CABG),45992
2,Serum metabolite levels [Serum_TG],2043
2,Emotionally unstable personality disorder,717
2,Serum metabolite levels [cholesterol],955
2,Diabetes in response to antihypertensive drug treatment (treatment strategy interaction),1151
2,Caspase 8 levels,1305
2,Iron status biomarkers (iron levels),707
2,Brain morphology (MOSTest),131110
2,Hot drink temperature,15160
2,Taking other prescription medications,8393
2,Serum urea levels,245982
2,Serum levels of protein QPCT,4739
2,"Hip circumference [EA, men]",2604
2,Facial morphology (segment 25),3640
2,CD25++ CD8+ T cell %CD8+ T cell,1456
2,Blood protein levels [Interleukin-19],438
2,Kynurenate levels,472
2,Rheumatoid arthritis [all cases vs. all controls],502
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-124 ms],362
2,Male-pattern baldness,78970
2,Diffuse plaques (SNP x SNP interaction),31418
2,Interleukin-1-receptor antagonist levels,15452
2,Blood protein levels [Low molecular weight phosphotyrosine protein phosphatase],12375
2,"Cholesterol lowering medication | medication for cholesterol, blood pressure or diabetes",4842
2,Electrocardiogram morphology (amplitude at temporal datapoints) [172 ms],5345
2,Sphingomyelin_35:1_[M+H]1+ levels,2043
2,Ovarian cancer,874
2,Protein quantitative trait loci (liver) [PCBD1],14
2,Fibrinogen levels,21757
2,Eosinophil percentage of white cells,149899
2,Triglyceride levels in current drinkers,3000
2,Plasma lactate levels,1994
2,Blood sugar levels,5347
2,CD25++ CD8+ T cell %T cell,1456
2,Plasma free amino acid levels (adjusted for one other PFAA) [Gly (adjusted for Phe],261
2,Cutaneous squamous cell carcinoma,8031
2,Unstable angina pectoris,21669
2,Phosphatidylcholine_32:1_[M+H]1+/Phosphatidylethanolamine_35:1_[M+H]1+/Phosphatidate_37:2_[M+NH4]1+ levels,2171
2,"Yes, during the last year | ever been injured or injured someone else through drinking alcohol",3541
2,"Intra-ocular pressure, goldmann-correlated (right)",8705
2,Metformin | treatment/medication code,10250
2,Prostate cancer [EA],8649
2,Haloplasmatales abundance in stool,1414
2,Serum albumin levels [EA],1776
2,Electrocardiogram morphology (amplitude at temporal datapoints) [54 ms],608
2,Smoking x traumatic event in childhood (sexually molested) interaction,494
2,"Fibromyalgia | non-cancer illness code, self-reported",41
2,Fasting blood insulin (BMI interaction),2468
2,Hypospadias,23308
2,Smoking cessation,31388
2,Waist-to-hip ratio adjusted for BMI (additive genetic model),23608
2,Serum metabolite levels [VLDL_D],2043
2,Cardiac arrhytmias,10678
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-106 ms],2912
2,Nitrolingual 400micrograms spray | treatment/medication code,594
2,"""Delirium, not induced by alcohol and other psychoactive substances""",530
2,Heart rate response to exercise,198
2,Facial morphology (segment 49),230
2,Angina pectoris,87628
2,N-delta-acetylornithine levels,24553
2,Blood protein levels [ST2],11557
2,Contracture of palmar fascia [dupuytren's disease],8405
2,Electrocardiogram morphology (amplitude at temporal datapoints) [128 ms],5345
2,Joint disorder,867
2,Posterior cortical atrophy and Alzheimer's disease,285
2,Hip bone mineral density and total body fat mass (bivariate analysis),734
2,"Polio / poliomyelitis | non-cancer illness code, self-reported",15
2,Triglyceride levels in small VLDL,19270
2,Alcohol consumption (drinks per week),25851
2,Hypothyroidism or myxedema,103429
2,"Forced expiratory volume in 1-second (fev1), predicted",175718
2,Asthma (only as main-diagnosis),5726
2,Serum metabolite concentrations in chronic kidney disease [N2-acetyllysine],5449
2,Serum levels of protein LMAN2L,3102
2,Hematuria,286
2,Carpal tunnel syndrome,5151
2,Plasma lactate levels [EA],1994
2,Heel bone mineral density T score,255540
2,Firmicutes A abundance in stool,2930
2,FSC-A on HLA DR+ Natural Killer,209
2,Serum metabolite levels (CMS) [Gp],2043
2,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [N-acetylarginine,  N-acetylcitrulline,  X-13698]",175
2,Diffuse large B cell lymphoma,1036
2,Gut microbiota relative abundance (bacterial taxa) [Clostridium_xylanovorans],83
2,Gut microbiota (functional units) [GO:0048598|BP|03|embryonic morphogenesis],25
2,Polycystic ovary syndrome,13233
2,Phosphatidylcholine_34:4_[M+H]1+/Phosphatidylethanolamine_37:4_[M+H]1+/Phosphatidate_39:5_[M+NH4]1+ levels,2171
2,QRS complex (12-leadsum) [EA],1350
2,"Adenosine 3',5'-cyclic monophosphate (camp) levels",1019
2,Protein quantitative trait loci (liver) [SDHB],106
2,Pelvic organ prolapse,1270
2,"Red blood cell traits [EA, PCV]",208
2,White matter microstructure (radial diusivities) [Fornix (column and body],40
2,"Energy expenditure [Men, Overweight/Obese]",39
2,Sleep activity levels,28
2,Reticulocyte count,862767
2,Fasting glucose,60695
2,Mean time to correctly identify matches,14600
2,"Serum metabolite levels [bilirubin (E,Z or Z,E)*]",2441
2,Breast size,2931
2,Facial morphology [nasion-left endocanthion distance],101
2,Femur bone mineral density x serum urate levels interaction,1546
2,Anti-chlamydia trachomatis IgG seropositivity,11
2,Other and unspecified psoriasis,1
2,Factor VII activity or levels,2043
2,Pubertal anthropometrics [Pubertal growth],8151
2,Response to dolutegravir (body weight gain),5
2,Body mass index (adult) [AA],2604
2,Metabolite levels [ALB],3612
2,Direct bilirubin levels x insomnia interaction,5509
2,Brain functional connectivity measurement (strength limbic),756
2,Body fat percentage and type 2 diabetes (pairwise),861
2,Effector Memory CD8+ T cell %CD8+ T cell,320
2,"Sarcoidosis | non-cancer illness code, self-reported",503
2,UBA9475 sp002161675 abundance in stool,48
2,Urinary metabolite levels in chronic kidney disease [N-acetyltyrosine],23640
2,Electrocardiogram morphology (amplitude at temporal datapoints) [168 ms],5345
2,3mm strong meridian (left),14562
2,Childhood sunburn occasions,9033
2,6mm strong meridian (left),15815
2,"Body mass index [EA, men]",2604
2,"Blood protein levels [NDUFS4, 10584_7_3]",299
2,Protein quantitative trait loci (liver) [GPX4],2
2,Carbamazepine-induced serious cutaneous adverse reaction,317
2,N-acetylphenylalanine levels,19007
2,Corneal resistance factor (right),13594
2,Multisite chronic pain,507
2,CD45RA- CD4+ T cell %CD4+ T cell,1462
2,Medication use (antimigraine preparations),2511
2,Electrocardiogram morphology (amplitude at temporal datapoints) [220 ms],5345
2,Leuconostoc mesenteroides abundance in stool,1414
2,Arthritis (juvenile idiopathic),3253
2,Diabetic nephropathy in type 1 diabetes,279
2,Amino acid levels [Glycine],267
2,Pork consumption,424
2,"Blood protein levels [EA, Mannan-binding lectin serine protease 1]",314
2,Crohn's disease [EA],90739
2,Myocardial infarction,288552
2,Trunk predicted mass,182409
2,Simvastatin | treatment/medication code,5549
2,"Blood protein levels [GNLY, 3195_50_2]",2454
2,Gallbladder disease,1105
2,Low high density lipoprotein cholesterol levels,12542
2,Serum metabolite concentrations in chronic kidney disease [N-delta-acetylornithine],5600
2,Alzheimer's disease (onset between ages 58 and 79),858
2,High cholesterol,13804
2,Serum metabolite levels (CMS) [XL_VLDL_PL],2043
2,"Overweight, obesity and other hyperalimentation",1821
2,Myocardial fractal dimension (slice 4),2123
2,"Lipid metabolism phenotypes [LDL-C.assay, whole]",976
2,"Cys-gly, oxidized levels",504
2,Electrocardiogram morphology (amplitude at temporal datapoints) [374 ms],28
2,"Raynaud's phenomenon/disease | non-cancer illness code, self-reported",75
2,"Blood protein levels [APOB, 2797_56_2]",113
2,Gut microbiota presence (family Peptococcaceae id.2024),35
2,"""Other and unspecified nerve root and plexus disorders, also in other diseases""",8
2,Glomerular filtration rate in non diabetics (creatinine),42537
2,Diastolic blood pressure,627902
2,"""Hypothyroidism, drug reimbursement""",1794
2,Vertical cup-disc ratio (adjusted for vertical disc diameter),2215
2,Serum metabolite levels [Gly],261
2,Metabolite levels (lipoprotein measures) [Total cholesterol in LDL],266
2,Inflammatory bowel disease and other gastroenteritis and colitis,2409
2,Stachydrine levels,149
2,Noninfective enteritis and colitis,90
2,Fish oil (including cod liver oil) | mineral and other dietary supplements,12
2,White blood cell count (basophil),13940
2,Risk-taking tendency (4-domain principal component model),19801
2,Adventurousness,17602
2,Glomerular filtration rate [EA],13887
2,Mean reticulocyte volume,491979
2,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],6216
2,Hashimoto thyroiditis,1008
2,Serum metabolite levels (CMS) [XS_VLDL_TG],2497
2,Serum metabolite levels [serine],240
2,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction) [women],598
2,Mosaic loss of chromosome Y (Y chromosome dosage),99
2,Percentage of invited food questionnaires completed,160
2,Optic disc size,11419
2,Blood protein levels in cardiovascular risk,24429
2,Other malignant neoplasms of skin (=non-melanoma skin cancer),11935
2,BMI in non-smokers [women],12446
2,Crohn's disease vs ulcerative colitis (ordinary least squares (OLS)),9564
2,Eosinophill count,157641
2,C-reactive protein levels or triglyceride levels (pleiotropy),4892
2,"High cholesterol | non-cancer illness code, self-reported",11169
2,Nasopharyngeal carcinoma (SNP x SNP interaction),1377
2,Cataracts,6164
2,Blood protein levels [Kynureninase],695
2,N1-methyladenosine levels,221
2,Menopause (age at onset) [Japanese],39
2,Inflammatory bowel disease [EA],88505
2,Alcohol usually taken with meals,12616
2,Comparative body size at age 10,52402
2,Serum levels of protein MDH1,29863
2,"Blonde | hair colour (natural, before greying)",67169
2,"""Type 2 diabetes, definitions combined""",10141
2,Helix rolling [FDR adjusted],2821
2,Lung function (FEV1) [adults],96
2,Protein quantitative trait loci (liver) [UGT2B15],1122
2,Heel bone mineral density,603376
2,Inflammatory biomarkers [IL18],14055
2,Malignant neoplasm of skin (controls excluding all cancers),11330
2,Essential hypertension,15473
2,"Blood protein levels [IL1R1, 2991_9_2]",2040
2,Progressive supranuclear palsy,1709
2,Breast cancer (estrogen-receptor negative),6417
2,"Red | hair colour (natural, before greying)",2272
2,Total cholesterol levels [East Asian],2043
2,LDL cholesterol levels [Hispanic],1507
2,Triglyceride levels [Hispanic],1788
2,High blood pressure | illnesses of father,704
2,Electrocardiogram morphology (amplitude at temporal datapoints) [120 ms],275
2,Current | smoking status,66
2,Direct low density lipoprotein cholesterol levels,56585
2,Menstruation quality of life impact (dysmenorrhea),5369
2,Serum levels of protein FKBP7,3628
2,"Blood protein levels [EA, Apolipoprotein B]",53
2,Lifetime number of sexual partners,14165
2,Cytokine levels [PDGF-BB],1574
2,Methionine sulfone levels,26167
2,Serum levels of protein HIBCH,19440
2,Scavenger receptor class A member 5 measurement,2171
2,Parkinson disease and lewy body pathology,4
2,"Body mass index (joint analysis main effects and physical activity interaction) [EA, women]",12446
2,"Heel broadband ultrasound attenuation, direct entry",56235
2,Overall health rating,15278
2,Diastolic blood pressure (cigarette smoking interaction),792
2,Selenium ace tablet | treatment/medication code,1178
2,White blood cell count [Monocytes],565
2,Maximum heart rate during fitness test,392
2,High blood pressure | illnesses of mother,672
2,Facial pigmentation measurement (UV light),1178
2,Schizophrenia or schizoaffective disorder,274
2,Platelet-derived growth factor subunit B levels,40
2,Protein quantitative trait loci (liver) [RAB14],133
2,Protein quantitative trait loci (liver) [EIF2B1],5
2,Migraine,28605
2,Body mass index (bmi),218235
2,Coagulation Factor X measurement,3240
2,Hippocampal volume,510
2,"Blood protein levels [UXS1, 8258_22_3]",1218
2,N-acetyl-3-methylhistidine levels,2345
2,"Waist-to-hip ratio adjusted for BMI in active individuals [EA, women]",598
2,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test),2505
2,Electrocardiogram morphology (amplitude at temporal datapoints) [56 ms],608
2,Serum levels of protein INHBB,42
2,Leisure sedentary behaviour (computer use),237
2,White matter microstructure (mode of anisotropy) [Sagittal stratum],43
2,"Bronchiectasis | non-cancer illness code, self-reported",70
2,Esophageal cancer,16492
2,Gamma glutamyl transpeptidase,61045
2,Cholelithiasis with other cholecystitis,1105
2,Age asthma diagnosed,10810
2,Trunk fat-free mass,186243
2,Disorders of porphyrin and bilirubin metabolism,5509
2,Psychological wellbeing index 1 (lack of subjective wellbeing and health),804
2,Electrocardiogram morphology (amplitude at temporal datapoints) [166 ms],5345
2,Bilirubin levels in tenofovir-treated HIV infection,968
2,CD25++ CD45RA+ CD4 not regulatory T cell %CD4+ T cell,1759
2,Smoking initiation (ever regular vs never regular) [Conditioned on chr2:113240183],4159
2,Cortical surface area [Transverse Temporal],851
2,Response to statins (LDL cholesterol change),252
2,Epilepsy [GGE],621
2,Diastolic blood pressure [Japanese],112
2,Brain region volumes [total brain volume],33
2,Cortical surface area [Inferior Temporal],228
2,Objective response to lithium treatment,36
2,Sodium thyroxine | treatment/medication code,1
2,Risk taking,26307
2,Serum metabolite levels [Nacetylornithine],86199
2,Electrocardiogram morphology (amplitude at temporal datapoints) [190 ms],5345
2,Facial morphology (segment 32),6313
2,Electrocardiogram morphology (amplitude at temporal datapoints) [80 ms],883
2,FSC-A on monocyte,4178
2,Facial morphology (segment 11),2227
2,CD28 on activated CD4 regulatory T cell,2491
2,Testicular germ cell tumor,1974
2,Brain functional connectivity measurement (characteristic path length),756
2,"Ecg, heart rate",590
2,"Sphingomyelin (d18:2/16:0, d18:1/16:1) levels",135
2,IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis),1376
2,"Orofacial clefts [Meta-All, NSCL/P]",1790
2,Paternal history of Alzheimer's disease,174
2,Gut microbiota presence (genus Odoribacter id.952),155
2,Electrocardiogram morphology (amplitude at temporal datapoints) [368 ms],28
2,Educational attainment,2990
2,N-acetylarginine levels,24759
2,"Urinary metabolite levels in chronic kidney disease [N2,N6-diacetyllysine]",23819
2,"Dark brown | hair colour (natural, before greying)",24397
2,Pelvic organ prolapse [conditioned on rs3791675],924
2,Serum levels of protein DNAJC10,2622
2,Systemic lupus erythematosus [EA],1138
2,Lysophosphatidylethanolamine_16:0_[M-H]1- levels,2043
2,Heart failure and antihypertensive medication,764
2,"Mean arterial pressure x alcohol consumption interaction (2df test) [EA, Hispanic]",144
2,Symptoms and signs involving the digestive system and abdomen,266
2,White matter hyperintensity volume x hypertension interaction (2df),32240
2,Circulating leptin levels or type 2 diabetes,2568
2,Electrocardiogram morphology (amplitude at temporal datapoints) [180 ms],5345
2,Waist circumference adjusted for BMI (adjusted for smoking behaviour) [women],598
2,Serum metabolite levels [creatine],240
2,Addiction [codependence - African ancestry men - adjusted analysis],37
2,Blond vs. brown/black hair color,11201
2,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Asian],1408
2,Alcohol use disorder [EA],2126
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-156 ms],118
2,Lung function (FEV1) and waist circumference adjusted for BMI [East Asian],1450
2,Forns index in high alcohol intake,1327
2,Sphingomyelin_34:0_[M+H]1+ levels,2043
2,CD28 on CD45RA+ CD4+ T cell,2491
2,Facial morphology (segment 30),382
2,Brain region volumes [left inferior temporal],106
2,Keratitis,410
2,Childhood and early adolescence aggressive behavior,35
2,"Urinary tract infection/kidney infection | non-cancer illness code, self-reported",107
2,Idiopathic membranous nephropathy,5752
2,Total cholesterol levels [Hispanic],3501
2,C-reactive protein levels [women],2043
2,White matter microstructure (mean diusivities) [Superior fronto-occipital fasciculus],23115
2,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],1352
2,Diastolic blood pressure [EA],1349
2,Diastolic blood pressure [Hispanic],135
2,Leg fat mass (lean adjusted),264
2,Plasma free amino acid levels (adjusted for one other PFAA) [Gln (adjusted for Gly],261
2,Hereditary monor and sensory neuropathy,22
2,Cortical surface area [Superior Parietal],9
2,Medication use (drugs used in diabetes),27480
2,Parkinson's disease or first degree relation to individual with Parkinson's disease,14007
2,Diabetes,10240
2,"Allergy, hypersensitivity or anaphylaxis",6367
2,Phosphatidylcholine_32:0_[M+H]1+/Phosphatidylethanolamine_35:0_[M+H]1+/Phosphatidate_37:1_[M+NH4]1+ levels,2043
2,interleukin-18 receptor 1 levels,11864
2,"""Type 2 diabetes, definitions combined, including avohilmo""",10141
2,Smoking initiation (ever regular vs never regular) [Conditioned on chr2:45159091],5348
2,Oxidized LDL cholesterol levels,454
2,Lobe size,2046
2,"Blood protein levels [CD8A, 5992_50_3]",4149
2,6mm regularity index (right),118
2,Urinary metabolite levels in chronic kidney disease [2-methylbutyrylglycine],10
2,Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia,37
2,Triglycerides,221614
2,Urea levels,94863
2,Retinal vascular fractal density,11445
2,Bone ultrasound measurement (broadband ultrasound attenuation) [female],464
2,Femur bone mineral density x serum urate levels interaction [male],6163
2,Obstructive sleep apnea trait (average oxyhemoglobin desaturation per event),4078
2,Creatinine (enzymatic) in urine,1736
2,Optic cup area,744
2,Cerebral glucose metabolic decline (left angular gyrus),79
2,Aprovel 75mg tablet | treatment/medication code,69
2,Allergic march (atopic dermatitis to asthma),22
2,Alzheimer's disease (cognitive decline),15
2,Betaine levels in individuals undergoing cardiac evaluation,10
2,"Total cholesterol levels [Asian initial, BMI unadjusted]",789
2,Total cholesterol levels [Trans-ethnic initial],7978
2,Urinary metabolite levels in chronic kidney disease [N-acetylpyrraline],23819
2,Circulating cell-free DNA,5509
2,Dilated cardiomyopathy (MTAG),1914
2,Electrocardiogram morphology (amplitude at temporal datapoints) [214 ms],1570
2,CD28- CD8dim T cell %T cell,84
2,Urinary creatinine levels,267
2,Autoimmune thyroiditis,8
2,Arterial stiffness,65
2,Terminally Differentiated CD4+ T cell Absolute Count,1462
2,Mean sphered cell volume,369450
2,Diabetes diagnosed by doctor,5038
2,Diacylglycerol_32:0_[M+H-H2O]1+ levels,2043
2,Strontium product | treatment/medication code,95
2,Bilirubin levels [random effects model],938
2,Medication use (antihistamines for systemic use),4700
2,Mucinous ovarian carcinoma,4832
2,Electrocardiogram morphology (amplitude at temporal datapoints) [144 ms],5345
2,Peripheral vascular disease,127
2,Depressive symptom (sleep problems) (binary trait),756
2,Variation in diet,307
2,"Number of operations, self-reported",266
2,"Gut microbiota (bacterial taxa, hurdle binary method) [G_Lactococcus_HB]",7
2,Menopause (age at onset),99745
2,Estimated glomerular filtration rate [EA],18498
2,White matter microstructure (radial diusivities) [Anterior limb of internal capsule],23194
2,Serum metabolite concentrations in chronic kidney disease [N-acetyl-1-methylhistidine],1663
2,"Heel quantitative ultrasound index (qui), direct entry (right)",17821
2,"Adult diffuse glioma (IDH mutation, 1p/19q non-codeleted)",1557
2,"Blood protein levels [PROC, 3758_63_3]",6540
2,Metabolite levels  (X-11787),11510
2,3mm strong meridian (right),13598
2,Electrocardiogram morphology (amplitude at temporal datapoints) [140 ms],5345
2,Serum levels of protein TYK2,5077
2,Serum metabolite levels [S_VLDL_P],2497
2,Left-handed | handedness (chirality/laterality),875
2,Hypertension [East Asian],1416
2,Diabetes | illnesses of mother,273
2,Brain region volumes [left rostral anterior cingulate],53
2,Polycystic ovary syndrome (adjusted for age),24
2,Spherical equivalent,18433
2,"Waist circumference [EA, men]",2867
2,Nasal polyp,7890
2,X-12101 levels,929
2,"Metabolite levels [2,6 dimethylheptanoyl carnitine]",1292
2,Cortical surface area [Lingual],369
2,Serum levels of protein IL1RL1,6297
2,No | hearing difficulty/problems,3392
2,Gut microbiota abundance (genus Bifidobacterium id.436),1027
2,"Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA, women]",598
2,3mm weak meridian (left),15421
2,Diabetes mellitus,11909
2,Electrocardiogram morphology (amplitude at temporal datapoints) [332 ms],2342
2,Lung function (forced vital capacity) [EA],181
2,CD28 on CD45RA- CD4 not regulatory T cell,3105
2,Free cholesterol levels in IDL,1483
2,Arrhythmia,1772
2,C-reactive protein levels or LDL-cholesterol levels (pleiotropy),2817
2,Serum metabolite levels [N-acetylglycine],240
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-162 ms],118
2,Central corneal thickness,11221
2,White matter microstructure (fractional anisotropy) [External capsule ],23140
2,Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis),39041
2,Platelet crit,190261
2,Statin medication,5873
2,Urate levels [women],8389
2,Free thyroxine concentration,4522
2,O levels/gcses or equivalent | qualifications,3476
2,Metabolite levels [C9/C10:2],1357
2,Spherical equivalent or myopia (age of diagnosis),19179
2,Body fat distribution (leg fat ratio),774
2,Multiple sclerosis,22415
2,Serum metabolite levels [N-acetylleucine],42079
2,Systemic lupus erythematosus [anti-dsDNA +],324
2,"Blood pressure measurement (cold pressor test) [SBP, Time 0]",397
2,Serum levels of protein MCTS1,5077
2,Electrocardiogram morphology (amplitude at temporal datapoints) [210 ms],1570
2,Protein quantitative trait loci (liver) [COL14A1],9
2,Ischemic heart disease,41305
2,"Atopic dermatitis [EA, fixed effects]",26608
2,Hypothyroidism,90417
2,Comparative height size at age 10,296387
2,Body mass index [age 8],9892
2,Body fat percentage [women],2604
2,Asthma-related pneumonia,7832
2,Acute upper respiratory infections,5199
2,"Other renal/kidney problem | non-cancer illness code, self-reported",314
2,Allergic asthma (mode),3002
2,P-cresol sulfate levels,1693
2,Electrocardiogram morphology (amplitude at temporal datapoints) [308 ms],275
2,"Helicobacter pylori | non-cancer illness code, self-reported",98
2,T cell lymphocyte profile difference,29
2,Type 1 diabetes nephropathy [ESRD vs. non-ESRD],859
2,Cancer (pleiotropy),34799
2,"Systolic blood pressure, automated reading",78177
2,Bitter beverage consumption,2043
2,Progressive supranuclear palsy [controlling for rs7571971],703
2,"Body mass index (joint analysis main effects and physical activity interaction) [EA, men]",2604
2,Body fat distribution (leg fat ratio) [females],816
2,Lung function (FEV1/FVC),592919
2,"Blood protein levels [EA, Interleukin-1 receptor-like 1]",9093
2,Sudden cardiac arrest,1780
2,"Blood protein levels [COLEC11, 4430_44_3]",438
2,Cholesterol [TG],2043
2,Cholecystitis without cholelithiasis,421
2,"""Inflammatory bowel disease, strict (require KELA)""",90
2,Congenital left-sided heart lesions,495
2,"Unclassifiable | cancer code, self-reported",118
2,Medication use (antiglaucoma preparations and miotics),2197
2,Prostate-specific antigen levels,98
2,Facial morphology [nasion-left exocanthion distance],101
2,Number of incorrect matches in round,76
2,Protein quantitative trait loci (liver) [C9orf64],8
2,Psoriasis [conditional on rs1990760],14
2,Serum metabolite levels [N-acetylasparagine],53437
2,Urinary albumin excretion (no hypertensive medication),3405
2,"Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",733
2,Helix rolling,1839
2,Fasting blood insulin adjusted for BMI,2307
2,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant I (Philtrum), Segment 33]",197
2,Insomnia complaints (dichotomous),28
2,Right eye only | ever had cataract surgery,23
2,Male puberty timing (early vs. average onset facial hair),14
2,Mean corpuscular hemoglobin concentration,623168
2,Interleukin-1 receptor-like 1 measurement,20801
2,Total cholesterol levels [EA],12613
2,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [N2-acetyllysine,  N-alpha-acetylornithine,  X-12124,  X-12125,  X-15666]",6062
2,Serum metabolite levels (CMS) [Remnant_C],2043
2,CD4RA on Terminally Differentiated CD4+ T cell,136
2,Lachnospirales abundance in stool,2930
2,Frontal fibrosing alopecia,11
2,Protein quantitative trait loci (liver) [TXNL1],4
2,Cortical surface area [Frontal Pole],5699
2,Direct bilirubin levels,147795
2,Lachnospiraceae abundance in stool,2930
2,Metabolite levels [lactate],2043
2,Diabetic nephropathy,261
2,Gallstone disease [Chilean Latinos],266
2,"""Ulcerative colitis (strict definition, all Crohn cases excluded)""",261
2,Hyperthyroidism or thyrotoxicosis,1279
2,Advanced age-related macular degeneration [EA],258
2,Blood pressure (anthropometric measures interaction) [SBP],12
2,Crohn's disease,165746
2,Glycemic traits (multi-trait analysis),5494
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-100 ms],708
2,Myocardial fractal dimension (slice 6),955
2,Hyperopia,502
2,"Blood protein levels [EA, Tumor necrosis factor receptor superfamily member EDAR]",578
2,Venous thromboembolism,1853
2,Insulin-related traits (multivariate analysis),3424
2,High blood pressure | vascular/heart problems diagnosed by doctor,53102
2,Metabolite levels (small molecules and protein measures) [Alanine],2043
2,Triacylglycerol_50:2_[M+NH4]1+ levels,2043
2,Protein quantitative trait loci (liver) [PON1],1151
2,"Blood pressure medication | medication for cholesterol, blood pressure or diabetes",938
2,Gut microbiota abundance (class Actinobacteria id.419),1155
2,Lactose intolerance,295
2,DNA methylation Hannum age acceleration,1447
2,Rheumatoid arthritis [conditional on rs3087243],1105
2,PR segment duration,245
2,Terminally Differentiated CD4-CD8- T cell Absolute Count,183
2,Number of days/week walked 10+ minutes,185
2,Protein quantitative trait loci (liver) [AMBP],3
2,Chronic lymphocytic leukemia,42791
2,Asthma (moderate or severe),15326
2,Apolipoprotein A1 levels,164632
2,Ease of skin tanning,6222
2,Chronic kidney disease [eGFRcrea],25872
2,Serum metabolite levels [XXL_VLDL_P],2043
2,Antihypertensive medication - note that there are other indications,4153
2,Heart valve problem or heart murmur,1040
2,Abdominal aortic aneurysm,514
2,Adiponectin levels,491
2,Parental lifespan,709
2,Blood protein levels [Fibronectin],288
2,Macrovascular complications in type 2 diabetes,34176
2,Body mass index (joint analysis main effects and smoking interaction) [women],12446
2,Heel bone mineral density x serum urate levels interaction [female],1371
2,Past tobacco smoking,2982
2,Phosphatidylcholine-O_30:1_[M+H]1+/Phosphatidylcholine-P_30:0_[M+H]1+/Phosphatidylethanolamine-O_33:1_[M+H]1+ levels,2043
2,Year ended full time education,422
2,Waist circumference adjusted for body mass index [women],2158
2,CD28+ CD45RA+ CD8dim T cell %T cell,1411
2,Paenibacillus J abundance in stool,215
2,Platelet-derived growth factor BB levels,1276
2,Insomnia complaints (continuous),28
2,Urinary metabolites [1.067 ppm/1.049 ppm],6993
2,Type 2 diabetes [EA],8222
2,Electrocardiogram morphology (amplitude at temporal datapoints) [198 ms],18875
2,"Blood protein levels [FAM171B, 8786_6_3]",1330
2,Electrocardiographic traits (multivariate),1474
2,Lobe attachment (rater-scored or self-reported) [EA],228
2,C_Betaproteobacteria abundance,346
2,Blood metabolite levels [glutaroyl carnitine],10
2,Excessive hairiness,30494
2,Sex hormone-binding globulin levels,691472
2,Place of birth in uk - east co-ordinate,13600
2,Cheese intake,10941
2,Systemic lupus erythematosus [Chinese],3194
2,Electrocardiogram morphology (amplitude at temporal datapoints) [204 ms],5345
2,Focal epilepsy,274
2,Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals,11
2,Triglyceride levels,538469
2,Insomnia [Female],22348
2,"Blood protein levels [NAGK, 3894_15_2]",2612
2,Serum levels of protein ALPPL2,5531
2,Facial morphology [left alare-subnasale distance],984
2,Acylcarnitine levels [Nonaylcarnitine],1357
2,X-24452 levels,67
2,Urinary metabolite levels in chronic kidney disease [3-methylglutarate/2-methylglutarate],10
2,Serum metabolite levels [N-acetylornithine],5726
2,Serum metabolite levels [2-hydroxyoctanoate],41255
2,Trunk fat percentage,118680
2,Dysplasia of cervi uteri,6132
2,Alcohol use disorder,4057
2,White blood cell count (monocyte),1641
2,Plasma free amino acid levels (adjusted for one other PFAA) [Orn (adjusted for Gly],261
2,"Blood protein levels [EFEMP1, 8480_29_3]",1068
2,Metoprolol | treatment/medication code,352
2,Ovarian cyst,340
2,Facial ageing,10000
2,Body mass index in physically active individuals [EA],12446
2,Electrocardiogram morphology (amplitude at temporal datapoints) [154 ms],15100
2,Blood metabolite ratios [X-11444/X-12844],565
2,Current | alcohol drinker status,110
2,Homocysteine levels,20
2,Homeostasis model assessment of insulin resistance in more-fat diet,5
2,Vitiligo,7703
2,Estimated glomerular filtration rate,458201
2,Hemoglobin levels,491589
2,Urinary metabolite levels in chronic kidney disease [X - 12379],23819
2,Serum levels of protein FAP,3573
2,"""Type 1 diabetes, wide definition""",2418
2,Protein quantitative trait loci (liver) [GALE],59
2,Scavenger receptor cysteine-rich type 1 protein M130 levels,28
2,Atrial fibrillation/atrial flutter,24242
2,Phosphatidylcholine-O_31:0_[M+H]1+/Phosphatidylethanolamine-O_34:0_[M+H]1+ levels,2043
2,Time to complete round,8149
2,Leg predicted mass (right),112658
2,"Asthma | non-cancer illness code, self-reported",20562
2,Glucose levels,12307
2,Subjective well-being (MTAG),2146
2,"Serum metabolite levels [Bilirubin (Z,Z]",620
2,White matter microstructure (fractional anisotropy) [Corticospinal tract ],53
2,UBA9475 sp002161235 abundance in stool,50
2,Allergic rhinitis,67836
2,Physical violence by partner or ex-partner as an adult,1314
2,"Blood protein levels [TNFAIP6, 5036_50_1]",23323
2,"Intra-ocular pressure, goldmann-correlated (left)",12374
2,CD8 on CD28+ CD45RA+ CD8+ T cell,4383
2,Triglycerides-Blood Pressure (TG-BP),2043
2,Bipolar disorder vs major depressive disorder (ordinary least squares (OLS)),3037
2,Electrocardiogram morphology (amplitude at temporal datapoints) [238 ms],1295
2,Plasma free amino acid levels (adjusted for one other PFAA) [Arg (adjusted for Ser],261
2,Terminally Differentiated CD8+ T cell %CD8+ T cell,1600
2,"Blood protein levels [FN1, 4131_72_2]",299
2,Cardiorespiratory fitness (vo2 max),590
2,Serum metabolite levels [indolepropionate],1908
2,Ascending aorta maximum area,263
2,"Body composition traits [M, Waist-to-hip ratio]",27
2,"Lipid metabolism phenotypes [VLDL.small, fasting]",454
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-18 ms],57
2,3-hydroxy-1-methylpropylmercapturic acid levels in smokers [AA],3
2,Renal function-related traits (BUN),8663
2,Serum metabolite levels [mannose],24656
2,Mean arterial pressure [Japanese],5905
2,Hearing difficulty/problems with background noise,1175
2,"Lymphoedema | non-cancer illness code, self-reported",319
2,Brain region volumes [right lateral ventricle],40
2,Lymphocytic leukemia,458
2,Facial morphology (segment 14),314
2,Reaction time,90257
2,Problematic alcohol use (MTAG),5333
2,Gestational insulin sensitivity,1660
2,Extremely high intelligence,8001
2,Late-onset Alzheimer's disease,3653
2,Phosphatidylcholine-O_36:2_[M+H]1+/Phosphatidylcholine-P_36:1_[M+H]1+/Phosphatidylethanolamine-P_39:1_[M+H]1+ levels,2043
2,Blood metabolite levels [X-11444],565
2,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA],3631
2,Mental health study participation (completed survey),446
2,Yes | hearing difficulty/problems,3459
2,Amlodipine | treatment/medication code,672
2,Sex hormone-binding globulin levels adjusted for BMI,660519
2,Blood metabolite levels [X-12510--2-aminooctanoic acid],23819
2,Psoriasis [EA],717
2,Serum metabolite levels [thyroxine],1005
2,Metabolite levels [TAG 50:3],2043
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-172 ms],118
2,"Waist circumference adjusted for body mass index [EA,women]",598
2,Inflammatory biomarkers [IL-1ra],4952
2,Age-related hearing impairment (MTAG),3899
2,"Fracture clavicle / collar bone | non-cancer illness code, self-reported",1155
2,Urinary metabolites [glycine/threonine],10
2,"Blood protein levels [SERPINE2, 3217_74_2]",40
2,Bilirubin levels,190733
2,"Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)",13785
2,Body fat distribution (trunk fat ratio) [females],8474
2,Lobe attachment (rater-scored or self-reported),1650
2,Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded),49
2,Family history of Alzheimer's disease,522
2,Feeling miserable,38300
2,Life satisfaction,19813
2,Heme oxygenase 1 measurement,12608
2,Asthma/COPD (KELA code 203),12005
2,Other abnormal uterine and caginal bleeding,361
2,Serum metabolite levels [X-11793],5509
2,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction) [men],1170
2,Gut microbiota (functional units) [PWY-5862_superpathway_of_demethylmenaquinol-9_biosynthesis],14
2,C-reactive protein and white blood cell count [WBC],12
2,Asthma x Hispanic interaction (2df),4
2,Bipolar disorder (MTAG),146715
2,Blood metabolite levels [X-11787],24393
2,Serum total cholesterol levels,944
2,Raw vegetable consumption,4648
2,Brain region volumes [right cerebellum exterior],21
2,Benign neoplasm of other parts of digestive system,166
2,Digit length ratio (left hand) [EA],1368
2,Interleukin-1 receptor-like 2 measurement,1285
2,Blood metabolite levels [serine],10
2,"Blood pressure measurement (low sodium intervention) [MAP, during intervention]",15
2,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),10601
2,Blood glucose levels,26067
2,"Blood protein levels [UGT1A6, 7891_45_3]",5509
2,Metabolite levels [alanine],2043
2,Waist circumference adjusted for body mass index [East Asian],756
2,Sulfasalazine | treatment/medication code,126
2,Serum metabolite concentrations in chronic kidney disease [N-acetylphenylalanine],1663
2,Chylomicron and largest VLDL particle concentration,6894
2,Chronic lower respiratory diseases,11286
2,Body fat percentage variance,598
2,Facial morphology (segment 29),1343
2,Postprandial triglyceride levels,2043
2,Frequency of tiredness / lethargy in last 2 weeks,160
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-168 ms],118
2,Alzheimer's disease/dementia | illnesses of adopted mother,58
2,Blood protein levels [Ep-CAM],8
2,Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test),6285
2,BMI at 1 year old,12035
2,Atrial fibrillation and flutter,23372
2,Inguinal hernia,22804
2,Left-handedness,8495
2,Cholelithiasis,115883
2,Blood metabolite levels [X-11793--oxidized bilirubin],5509
2,"None of the above | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",672
2,Sex hormone-binding globulin levels [Men + Women],2043
2,Serum levels of protein COLEC11,1337
2,"Lipid metabolism phenotypes [VLDL.large, fasting]",2043
2,Electrocardiogram morphology (amplitude at temporal datapoints) [240 ms],3775
2,Nonalcoholic fatty liver disease (imputed),204
2,"""Ulcerative colitis, NAS""",90
2,Matrix metalloproteinase-7 levels,38
2,Self-reported math ability (MTAG) [MTAG],208057
2,General factor of neuroticism,36776
2,Sensorineural hearing loss,7426
2,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],7904
2,Waist circumference variance,2664
2,Electrocardiogram morphology (amplitude at temporal datapoints) [226 ms],5345
2,LDL cholesterol [total cholesterol],271
2,Waist-to-hip ratio adjusted for BMI in non-smokers [women],598
2,Lobe attachment (rater scored) [Chinese],88
2,"Blood protein levels [GKN2, 6416_8_3]",205
2,Sweets intake,11
2,Fasciitis,8434
2,Hip circumference adjusted for BMI [EA],7284
2,Glycated haemoglobin HbA1c levels adjusted for BMI,6763
2,"Blood metabolite levels [bilirubin (E,Z or Z,E]",5509
2,"2,3-dihydroxy-2-methylbutyrate levels",1675
2,White matter microstructure (mean diusivities) [Genu of corpus callosum],5151
2,Homeostasis model assessment of beta-cell function (dietary factor interaction) [n-6 PUFA],213
2,Fasting blood insulin,6422
2,Adult body size,130594
2,Liver enzyme levels (gamma-glutamyl transferase),91660
2,"Blood metabolite levels [bilirubin (Z,Z]",5509
2,Joint mobility (Beighton score),3299
2,Serum metabolite levels [Biliverdin],620
2,CD28 on CD28+ CD4-CD8- T cell,2529
2,Alzheimer's disease/dementia | illnesses of mother,174
2,Body fat percentage and systolic blood pressure (pairwise),264
2,DNA methylation (parent-of-origin) [KvDMR 21],260
2,Feeling tense,2341
2,Serum levels of protein DNER,3095
2,"Pulse pressure x alcohol consumption interaction (2df test) [AA, EA]",672
2,Body fat percentage and LDL-C (pairwise),869
2,Heart disease | illnesses of father,971
2,Plasma free amino acid levels (adjusted for one other PFAA) [Ser (adjusted for Phe],261
2,Episodic memory (pairs-matching),105
2,ADHD vs anorexia nervosa (ordinary least squares (OLS)),157
2,"Neck problem/injury | non-cancer illness code, self-reported",366
2,Adverse response to chemotherapy (amenorrhea) in breast cancer,172
2,Blood protein levels [Granulysin],2454
2,Relative protein intake,2043
2,Adult onset asthma and/or BMI,219
2,Thermococcaceae abundance in stool,7
2,"Bone mineral density (paediatric, upper limb)",2027
2,Lymphocyte counts,984199
2,Cognitive performance (MTAG) [MTAG],164030
2,Electrocardiogram morphology (amplitude at temporal datapoints) [90 ms],1570
2,"""Hypothyroidism, levothyroxin purchases""",2535
2,LDL cholesterol levels in current drinkers [Asian],1402
2,Naive CD8+ T cell %CD8+ T cell,74
2,White matter microstructure (fractional anisotropy) [Fornix (column and body],40
2,Generalized epilepsy [GAE],129
2,Persons encountering health services for specific procedures and health care,2
2,Trunk fat mass,112926
2,High density lipoprotein cholesterol levels,43041
2,Lachnospira rogosae abundance in stool,15679
2,Mixed hyperlipidaemia,4178
2,"Serum metabolite levels [bilirubin (Z,Z]",2441
2,Primary biliary cirrhosis,2067
2,Number of pregnancies,328
2,Right-handed | handedness (chirality/laterality),875
2,Brain region volumes [right thalamus proper],321
2,Anorexia,279
2,Heel bone mineral density x serum urate levels interaction,26
2,Urinary metabolite levels in chronic kidney disease [X - 24402],10
2,"""Malignant neoplasm of breast, HER-positive (controls excluding all cancers)""",46
2,Intelligence,73806
2,Offspring birth weight,18032
2,Weight,327278
2,TPE interval (resting),4069
2,Moderate to vigorous physical activity levels,4795
2,HDL cholesterol levels in current drinkers,839
2,Muscular dystrophy,94
2,Thyroid stimulating hormone levels,125
2,Android fat mass,25
2,Physical activity (Total log acceleration 12am-2am),28
2,Digit length ratio (right hand),2107
2,Major depressive disorder,25993
2,Non-melanoma skin cancer,20994
2,Serum metabolite levels [N-acetyl-1-methylhistidine*],47911
2,Aspartate aminotransferase to alanine aminotransferase ratio,5125
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-98 ms],452
2,Close to major road,17
2,Mitochondrial heteroplasmy measurement,3330
2,Terrisporobacter othiniensis abundance in stool,14589
2,Serum metabolite concentrations in chronic kidney disease [N-acetylasparagine],5784
2,Heel bone mineral density (bmd) (right),17411
2,Homeostasis model assessment of insulin resistance,2048
2,Brain region volumes [right caudate],1308
2,Basophill percentage,1957
2,"Svt / supraventricular tachycardia | non-cancer illness code, self-reported",1100
2,Age at last live birth,688
2,Acetylcarnitine (c2) levels,268
2,interferon-related traits [IFNalpha_ABC_of_CD8p_T],54
2,Low density lipoprotein cholesterol levels,309662
2,Body size at age 10,131128
2,Blood metabolite levels [Arginine / Citrulline],24155
2,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event) [Cox proportional hazards regression model],1173
2,Blood metabolite levels [X-11470],565
2,Invasive epithelial ovarian cancer,1748
2,Serum levels of protein OLFM3,1575
2,JT interval (sulfonylurea treatment interaction) [AA],262
2,Protein quantitative trait loci (liver) [GCKR],358
2,Acisoga levels,76
2,Facial morphology (nasion depth 2),62
2,Pediatric asthma,6805
2,Serum metabolite levels [X-12510],86753
2,Neuroblastoma (pediatric),1225
2,Ever smoked,1065
2,Malignant neoplasm of breast,46
2,Waist-to-hip ratio adjusted for BMI (age >50) [women],598
2,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [hexanoylglycine, isocaproylglycine, X-16567, X-24402]",10
2,"Basal cell carcinoma | cancer code, self-reported",5477
2,Asthma-related acute respiratory infections,8473
2,Childhood asthma (age<16) (more control exclusions),5040
2,Beef intake,792
2,Scalp hair shape,1839
2,Dentate gyrus molecular layer volume,510
2,CAG-822 abundance in stool,240
2,Idiopathic dilated cardiomyopathy,294
2,"Blood pressure (smoking interaction) [SBP,Pack-years]",144
2,Alzheimer's disease (late onset),3947
2,Serum levels of protein ACYP2,27394
2,Urinary metabolite levels in chronic kidney disease [N-acetylcitrulline],21059
2,"Blood protein levels [PROC, 2961_1_2]",6845
2,Sensitivity / hurt feelings,6319
2,Brain region volumes [X3rd ventricle],3716
2,"Pediatric areal bone mineral density (spine vs radius & hip discordant skeletal phenotype) [EA, female]",2111
2,Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event),73
2,Smoking initiation (ever regular vs never regular) [Conditioned on chr2:104126983],15
2,Asthma,243751
2,Urinary metabolite levels in chronic kidney disease [Acetylornithine],24553
2,Wheeze or whistling in the chest in last year,19541
2,Blood protein levels [Tumor necrosis factor-inducible gene 6 protein],5510
2,Red blood cell (erythrocyte) count,228524
2,Bone properties (heel) [BUA],464
2,Metabolic syndrome [TG],2469
2,"Intra-ocular pressure, corneal-compensated (left)",2061
2,Umbilical hernia,335
2,Liver enzyme levels (alanine transaminase),26292
2,Curly vs straight hair,32045
2,Serum metabolite levels [2-hydroxyglutarate],615
2,Oily fish consumption,424
2,Metabolite levels (small molecules and protein measures) [Glucose],1369
2,Electrocardiogram morphology (amplitude at temporal datapoints) [92 ms],275
2,"""Migraine, single triptan purchase ok & required. ICD-code if available is included""",663
2,"Migraine | non-cancer illness code, self-reported",663
2,White matter microstructure (radial diusivities) [Average across all tracts],28291
2,Malignant neoplasm of skin,11935
2,"""Acquired absence of organs, not elsewhere classified""",942
2,Acute graft versus host disease in bone marrow transplantation (recipient effect),1188
2,Left atrial passive emptying fraction,1652
2,"Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",733
2,Serum metabolite levels (CMS) [XXL_VLDL_P],2043
2,Acute insulin response [EA],51
2,"Retinal artery/vein occlusion | non-cancer illness code, self-reported",90
2,Hodgkin's lymphoma,912
2,Basophill count,56
2,"Gut microbiota (bacterial taxa, hurdle binary method) [G_unclassified_F_Erysipelotrichaceae_HB]",100
2,Arterial stiffness index,65
2,Pollen allergy,2
2,Corneal resistance factor,2352
2,Aspartate aminotransferase levels,211490
2,Mean corpuscular haemoglobin concentration,67776
2,Febrile seizures (MMR vaccine-related),1391
2,Phosphatidylcholine-O_32:1_[M+H]1+/Phosphatidylcholine-P_32:0_[M+H]1+/Phosphatidylethanolamine-O_35:1_[M+H]1+ levels,2043
2,"Blood protein levels [P4HB, 11450_110_3]",299
2,Plasma free amino acid levels (adjusted for one other PFAA) [Ser (adjusted for Pro],261
2,Protein quantitative trait loci (liver) [MCCC2],105
2,Sum basophil neutrophil counts,130511
2,Basophil percentage of white cells,70065
2,Blood metabolite levels [X-12093],19882
2,Spondylopathies,14588
2,Myasthenia gravis,1543
2,Diabetic nephropathy (more control exclusions),261
2,Urinary sodium to potassium ratio,2171
2,Polycystic ovary syndrome (reproductive subtype),1761
2,lower facial morphology traits (quantitative measurement) [chin protrusion],1839
2,Phosphatidylcholine-O_38:4_[M+H]1+/Phosphatidylcholine-P_38:3_[M+H]1+ levels,2043
2,Zomig 2.5mg tablet | treatment/medication code,543
2,Systemic lupus erythematosus and Systemic sclerosis,75
2,Episodic memory,6493
2,Neutrophil percentage of granulocytes,54289
2,Lipid traits [TG],3612
2,Electrocardiogram morphology (amplitude at temporal datapoints) [20 ms],33167
2,Home location at assessment - north co-ordinate (rounded),20545
2,Electrocardiogram morphology (amplitude at temporal datapoints) [200 ms],18875
2,"Blood protein levels [EA, N-acetyl-D-glucosamine kinase]",2171
2,Cleft lip with or without cleft palate,640
2,Blood pressure [Pulse Pressure],101
2,Cortical volume [Postcentral],336
2,Electrocardiogram morphology (amplitude at temporal datapoints) [314 ms],275
2,Varicose veins,43223
2,Electrocardiogram morphology (amplitude at temporal datapoints) [182 ms],18875
2,Sphingomyelin_34:2_[M+H]1+ levels,2043
2,PR interval [Hispanic],265
2,Parkinson's disease,10174
2,Asthma-related infections,10763
2,"""Asthma, including avohilmo""",10284
2,Femur bone mineral density x serum urate levels interaction [female],2678
2,Malignant neoplasm of endocrine gland (controls excluding all cancers),132
2,Cholesteryl ester_18:2_[M+NH4]1+ levels,2043
2,CD28- CD8dim T cell Absolute Count,84
2,TCF3-PBX1 fusion in childhood acute lymphoblastic leukemia [EA],62
2,Blood metabolite levels [betaine],10
2,Wilms tumor,1720
2,Household income,2677
2,Waist-hip index,45246
2,Obesity [Obesity class I],12496
2,Urinary metabolite levels in chronic kidney disease [X - 23423],24393
2,Autoimmune diseases,2457
2,Body mass index (joint analysis main effects and physical activity interaction) [men],2604
2,Adrenomedullin levels,3663
2,Facial morphology (segment 2),1297
2,Smoking initiation (ever regular vs never regular) [Conditioned on chr2:162802993],166
2,"Diastolic blood pressure [EA, initial]",820
2,"Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",733
2,Serum levels of protein SLC5A8,454
2,Fasting glucose [conditional],479
2,Acute pancreatitis,798
2,Celiac disease,72894
2,Body mass index in physically inactive individuals [men],2604
2,Body fat distribution (arm fat ratio) [females],13606
2,Protein quantitative trait loci [IL-1 R4],7387
2,Serum metabolite levels [XL_VLDL_P],2043
2,Neutrophill percentage,156976
2,Skin colour,13748
2,Serum metabolite levels [bilirubinZZ],5509
2,"""Obesity, other/unspecified""",2622
2,Factor VII activity [EA],1994
2,QRS duration [European],1119
2,Gram negative septicemia,931
2,"Icd10: c71.9 brain, unspecified | underlying (primary) cause of death",15
2,Aortic vascular smooth muscle cell calcification in response to osteogenic stimuli,10
2,Heart disease | illnesses of mother,13
2,Bread intake,23785
2,Neutrophill count,137619
2,Type 2 diabetes with other specified/multiple/unspecified complications,3371
2,Secreting CD4 regulatory T cell %CD4 regulatory T cell,1640
2,N-desmethylclozapine concentration in schizophrenia,2564
2,Thyroid hormone levels [TSH - Males],125
2,Facial morphology (segment 61),69
2,Pneumocystosis,1
2,Prostate cancer (advanced),10
2,Autoimmune thyroid disease,24116
2,Liver volume,2043
2,"Ecg, load",299
2,Disorders of conjunctiva,5634
2,Total bilirubin levels x insomnia interaction,5509
2,B cell lymphocyte profile difference (90 days post influenza vaccination),757
2,Chin dimples,1752
2,Asphyxia and hypoxemia,134
2,Polycystic ovary syndrome (metabolic subtype),95
2,Plasma free amino acid levels (adjusted for one other PFAA) [Gly (adjusted for Asn],261
2,Proteinuria (mild),292
2,Attention deficit hyperactivity disorder (MTAG),106
2,KELA_REIMBURSEMENT_202,268
2,Serum levels of protein CXADR,40
2,"Pulse pressure [EA, initial]",102
2,Graves' disease,6363
2,High light scatter reticulocyte count,1256312
2,Subcortical volume (min-P),7803
2,Retinal nerve fibre layer thickness or ganglion cell inner plexiform layer thickness (MTAG),29285
2,Serum albumin levels [Japanese],1776
2,Heel bone mineral density (bmd) (left),17537
2,Resting CD4 regulatory T cell %CD4 regulatory T cell,1753
2,Urinary sodium excretion,38616
2,White matter microstructure (radial diusivities) [Hippocampus ],8819
2,No | major dietary changes in the last 5 years,14336
2,Major depressive disorder (MTAG),1779
2,Phospholipid levels in medium VLDL,6894
2,Hyperthyroidism,365
2,"""Artrosis, including avohilmo""",983
2,Serum levels of protein SSR1,299
2,Educational attainment (years of education),277892
2,Erythritol levels,8513
2,White matter microstructure (axial diusivities) [Body of corpus callosum],3330
2,CD45RA+ CD8+ T cell %CD8+ T cell,511
2,Lipid or lipoprotein levels [Oxidized LDL],454
2,Type 2 diabetes and end-stage kidney disease,11
2,Body mass index variance,14834
2,White matter integrity (fractional anisotropy),28142
2,Bipolar disorder or major depressive disorder,14834
2,"Chronic lymphocytic | cancer code, self-reported",1854
2,Fetal hemoglobin levels in sickle cell anemia,61
2,Cardiac dysrhythmias,14105
2,Pediatric autoimmune diseases,9564
2,Lifetime smoking index,21863
2,SSC-A on myeloid Dendritic Cell,4071
2,Glaucoma,6561
2,Serum metabolite levels [N2-acetyllysine],101851
2,Nucleated red blood cell count,8493
2,Pulse rate,6798
2,Length of menstrual cycle,6941
2,Digit length ratio (left hand),1368
2,Body mass index in physically active individuals [men],2604
2,Acne (severe),1023
2,"5,6-dihydrouridine levels",270
2,Serum levels of protein CCL13,40
2,Intra-individual response time variability (selective attention) [standard deviation],57
2,None of the above | pain type(s) experienced in last month,3
2,Sun-seeking behavior,3
2,PR interval,47253
2,Depression,19747
2,"Blood protein levels [PLA2R1, 10916_44_3]",6495
2,Electrocardiogram morphology (amplitude at temporal datapoints) [136 ms],5345
2,Serum metabolite levels [XXL_VLDL_PL],2043
2,Serum metabolite levels (CMS) [Leu],2043
2,CD8 on naive CD8+ T cell,2189
2,Attention deficit hyperactivity disorder,850
2,Plasma free amino acid levels (adjusted for one other PFAA) [Thr (adjusted for Gly],261
2,Protein quantitative trait loci (liver) [DIABLO],6
2,Disorders of lipoid metabolism,7246
2,Red blood cell count,1709569
2,Neuroticism,127685
2,Electrocardiogram morphology (amplitude at temporal datapoints) [6 ms],6102
2,Urinary sodium to creatinine ratio,2053
2,White matter microstructure (mode of anisotropy) [Inferior fronto-occipital fasciculus],1271
2,Self-rated health,1227
2,Neuritic plaques (SNP x SNP interaction),2866
2,Hepatocellular carcinoma in hepatitis B infection,339
2,Mean arterial pressure [East Asian],2967
2,Cataracts [male],1288
2,Body mass index (joint analysis main effects and smoking interaction),12503
2,Cervical intraepithelial neoplasia grade 3 and invasive cervical cancer,5231
2,Hand grip strength (right),75051
2,Reticulocyte percentage,23700
2,C-reactive protein levels or total cholesterol levels (pleiotropy),6182
2,CD28+ CD45RA+ CD8+ T cell %T cell,269
2,"""Endomtriosis ASRM stages 3,4""",603
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-2 ms],257
2,Electrocardiogram morphology (amplitude at temporal datapoints) [84 ms],275
2,"""Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified""",7153
2,Positive affect,20326
2,Blood metabolite levels [biliverdin],5509
2,Protein quantitative trait loci (liver) [ACAT2],150
2,Immunological or systemic disorder,6287
2,Serum metabolite levels (CMS) [VLDL_C],2043
2,Hair shape,3152
2,Electrocardiogram morphology (amplitude at temporal datapoints) [218 ms],5345
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-110 ms],2668
2,Sudden cardiac arrest [Recessive],3454
2,Bone disorder,361
2,Regular attendance at a gym or sports club,1393
2,Protein quantitative trait loci (liver) [SPTAN1],200
2,Keloid,81
2,Malignant neoplasm of breast (controls excluding all cancers),46
2,Electrocardiogram morphology (amplitude at temporal datapoints) [192 ms],5345
2,Body fat mass,14261
2,Other disorders of metabolism,5509
2,"Lipid metabolism phenotypes [VLDL.total, fasting]",454
2,Alzheimer's disease in APOE e4- carriers,174
2,"Blood protein levels [KCNMB3, 8905_20_3]",113
2,Menarche (age at onset) [Japanese],39
2,Serum metabolite levels [2-aminobutyrate],60
2,Cutaneous malignant melanoma,12538
2,CD28 on CD39+ activated CD4 regulatory T cell,4582
2,Cerebrospinal fluid biomarker levels [Interleukin-18 receptor 1],22544
2,Urinary metabolite levels in chronic kidney disease [N-acetylmethionine sulfoxide],23191
2,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),6216
2,Vitamin D levels,23797
2,Urate levels [Urate],2043
2,Childhood ear infection,1000
2,Hip bone size,165
2,Neuroblastoma (high-risk),5083
2,Metabolite levels [creatine],280
2,Age at menarche,422
2,Pulmonary function [FEV1],622
2,Urinary metabolites [1.086 ppm],3669
2,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [N2-acetyllysine, N-alpha-acetylornithine, X-12124, X-12125, X-15666]",23819
2,Conductive and sensorineural hearing loss,7426
2,Electrocardiogram morphology (amplitude at temporal datapoints) [176 ms],5345
2,Terminally Differentiated CD4-CD8- T cell %T cell,2372
2,Albumin-globulin ratio,5748
2,Buprenorphine | treatment/medication code,492
2,Coagulation factor Xa measurement,2743
2,Impedance of whole body,213773
2,CD4-CD8- T cell %T cell,2263
2,Coffee consumption,6750
2,Gout [Japanese],1660
2,"Blood protein levels [SSR1, 8106_15_3]",299
2,Gut microbiota (bacterial taxa) [Clostridium_XII],1026
2,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [glycine conjugate of C9H16O2, X-12459, X-13431]",1357
2,Hippocampal atrophy [Hippocampal volume],126
2,Blood metabolite levels [Arginine / Ornithine],25025
2,CD28 on CD28+ CD4+ T cell,2438
2,Public transport | transport type for commuting to job workplace,7715
2,Pancreas fat,8285
2,1-methylnicotinamide levels,1252
2,Corneal curvature,581
2,Chronic obstructive pulmonary disease x ever smoker interaction (2df),1955
2,"""Diseases of arteries, arterioles and capillaries (FINNGEN)""",265
2,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant II (Nose), Segment 43]",81
2,X-24813 levels,240
2,CAG-452 sp000434035 abundance in stool,128
2,Bitter taste perception [PROP paper],52
2,Polycystic ovary syndrome (adjusted for age and BMI),24
2,LDL cholesterol levels [Trans-ethnic initial],3207
2,Body mass index [Japanese],21763
2,Serum metabolite levels [N-acetylglutamine],17848
2,Liver fat content (MRI proton density fat fraction measure),2043
2,Body mass index [EA],12545
2,Neuroticism conditioned on self-rated math ability (multi-trait conditioning and joint analysis),7735
2,LDL cholesterol levels [Asian],1352
2,Esophageal cancer  (alcohol interaction),122
2,Home location - east co-ordinate (rounded),10
2,Carotenoid levels (alpha-carotene),9
2,Major coronary heart disease event,45992
2,Cholelithiasis and cholecystitis,6633
2,Triglyceride levels [Trans-ethnic initial],2007
2,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) [women],2473
2,Terminally Differentiated CD4+ T cell %CD4+ T cell,1284
2,Serum levels of protein FABP1,401
2,"Blood pressure measurement (high sodium and potassium intervention) [MAP, during intervention]",15
2,Cognitive decline rate in late mild cognitive impairment [EA],180
2,Cortical volume [Caudal middle frontal],114
2,Iron status biomarkers (total iron binding capacity),250
2,Response to paclitaxel,11
2,"Malignant neoplasm of rectum, rectosigmoid junction, and anus",553
2,Fish- and plant-related diet,2114
2,"""Thyrotoxicosis, other and/or unspecified""",1215
2,Brain functional connectivity measurement (strength somatomotor),712
2,Electrocardiogram morphology (amplitude at temporal datapoints) [106 ms],275
2,Sleeplessness / insomnia,11296
2,Waist circumference,70643
2,Dermatitis and eczema,11864
2,Nevus count or cutaneous melanoma,11306
2,Lung function (low FEV1 vs high FEV1),8767
2,Lung function (FVC) and waist circumference adjusted for BMI [East Asian],1450
2,Malignant neoplasm of prostate (controls excluding all cancers),1210
2,Diastolic blood pressure response to thiazide and thiazide-like diuretics in hypertension [AA],975
2,Senna | treatment/medication code,1092
2,Endometrial cancer,190
2,"Blood protein levels [EA, Tumor necrosis factor-inducible gene 6 protein]",692
2,Chronic venous disease,140
2,Gamma-glutamyl hydrolase measurement,2043
2,CD4-CD8- Natural Killer T %lymphocyte,2263
2,Accelerometer-based physical activity measurement (fraction of time with accelerations >425 milli-gravities) [model 2],577
2,Diastolic blood pressure x smoking status (ever vs never) interaction (2df test),1811
2,"Disorders of muscle, ligament, and fascia",53
2,Facial morphology (segment 58),53
2,Galanin peptide levels,216
2,Body mass index [AA and Sub-Saharan],8067
2,"None of the above | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",41030
2,Diseases of the respiratory system,4754
2,Gut microbiota (bacterial taxa) [Blautia genus],2126
2,Pallidum volume,2479
2,"Pulmonary function (smoking interaction) [FEV1/FVC, Ever-smoking]",341
2,6mm strong meridian (right),18146
2,Turicibacter abundance in stool,1414
2,Ear protrusion,1839
2,Waist circumference adjusted for BMI in active individuals [EA],1150
2,Fracture of femur,193
2,Serum levels of protein GKN2,205
2,Platelet distribution width,363899
2,Waist circumference adjusted for body mass index,352694
2,Lobe attachment (rater scored) [Hispanic],246
2,Levothyroxine sodium | treatment/medication code,20523
2,Erectile dysfunction and prostate cancer treatment,102
2,Disorders of lens,610
2,Ezetimibe | treatment/medication code,995
2,Facial attractiveness (male raters),106
2,Breast milk fatty acid composition (maternal genotype effect) [eicosenoic acid],13
2,Hemoglobin concentration,666531
2,Waist-hip ratio [EA],5121
2,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [women],6461
2,"Waist-hip ratio [EA, women]",598
2,Metabolite levels [PC 32:2],2043
2,Thrombin measurement,2171
2,Disorders of the thyroid gland,2261
2,CD8 on CD8+ T cell,4815
2,LDL cholesterol x physical activity interaction (2df test) [EA],1785
2,White matter hyperintensity burden,114
2,"Metabolite levels [Ala, Val]",60
2,Triglycerides [Hispanic],34413
2,Chronic kidney disease,1985
2,Membranous nephropathy,29165
2,"""Diabetes, insuline treatment (Kela reimbursement) (more control exclusions)""",3082
2,Glaucoma (primary open-angle),7767
2,Celiac disease and Rheumatoid arthritis,6310
2,Serum levels of protein FAM171B,1839
2,C-reactive protein levels [men],2043
2,Alzheimer's disease or body fat percentage (pleiotropy),4522
2,Phosphatidylcholine-O_32:0_[M+H]1+/Phosphatidylethanolamine-O_35:0_[M+H]1+ levels,2043
2,Non-albumin protein levels [ALB],2043
2,Body fat percentage [European women],2604
2,Handedness (left-handed vs. right-handed),868
2,"Red blood cell traits [Ht, AA]",176
2,Age at voice drop,14
2,"Adverse response to drug [ACE inhibitors, plain [C09AA]]",26
2,Granulocyte percentage of myeloid white cells,50812
2,General cognitive ability,19926
2,Well-being spectrum (multivariate analysis),31826
2,Total triglycerides levels,16356
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-108 ms],2912
2,Lacunar stroke,44559
2,"Hypertension | non-cancer illness code, self-reported",37504
2,Serum levels of protein CKAP4,5509
2,Serum levels of protein REG1A,118
2,"Chronic bronchitis and chronic obstructive pulmonary disease [EA, COPDGene + GenKOLS]",50
2,Acute and subacute iridocyclitis,73
2,"""Tooth agenesis EXCLUDE clefts and syndromes , including avohilmo""",235
2,CAG-145 sp002320005 abundance in stool,68
2,Serum creatinine levels,169517
2,Other malignant neoplasms of skin (=non-melanoma skin cancer) (controls excluding all cancers),11330
2,"Blood protein levels [OLA1, 12659_13_3]",1713
2,Electrocardiogram morphology (amplitude at temporal datapoints) [78 ms],6425
2,LDL cholesterol levels in current drinkers [EA],2688
2,"Blood protein levels [ALPP, 7813_6_3]",666
2,White matter microstructure (mode of anisotropy) [Cingulate gyrus],94
2,Estradiol levels,3217
2,Leg fat-free mass (right),113440
2,"Blood protein levels [VIT, 9627_15_3]",406
2,Uric acid levels,2043
2,Lobe attachment (rater scored),438
2,Bone mineral density (Ward's triangle area),29915
2,Neurological blood protein biomarker levels [KYNU],1292
2,Serum levels of protein MUSK,438
2,Electrocardiogram morphology (amplitude at temporal datapoints) [74 ms],608
2,"Blood protein levels [FN1, 3434_34_1]",299
2,IBD patients in KELA-register,90
2,Frequency of solarium/sunlamp use,54
2,Vertex-wise cortical surface area,241896
2,Total cerebellar volume (excluding Crus I vermis),2239
2,Uterine prolapse,1396
2,3mm regularity index (right),435
2,Diacylglycerol_34:3_[M+NH4]1+ levels,2043
2,Age-related nuclear cataracts,239
2,Malignant neoplasm of thyroid gland (controls excluding all cancers),43
2,Behcet's disease,1681
2,Interleukin-18 levels,65855
2,"Allergic disease (asthma, hay fever or eczema)",49481
2,Urinary metabolite levels in chronic kidney disease [X - 15666],23819
2,Protein quantitative trait loci (liver) [HIBCH],220010
2,Arm predicted mass (left),148888
2,Restless legs syndrome,14895
2,Fractures (vertebral),471
2,CD39+ resting CD4 regulatory T cell Absolute Count,1462
2,Cardiovascular disease risk factors [LDL],207
2,General episode | hospital episode type,285
2,Aerodigestive squamous cell cancer (pleiotropy),72
2,Cortical volume [Precuneus],77
2,Bipolar disorder lithium response (continuous) or schizophrenia,25545
2,"Aging traits (healthspan, parental lifespan or longevity) (multivariate analysis)",11786
2,Testosterone levels,18120
2,Urinary metabolite levels in chronic kidney disease [N6-carboxyethyllysine],24375
2,Rheumatoid arthritis [East Asian],1911
2,Coffee intake,4660
2,IgD- CD38dim B cell %lymphocyte,1027
2,Fibroblast growth factor 23 levels,979
2,TNF-alpha gene expression levels in non-alcoholic fatty liver disease x mastiha supplementation interaction,85
2,Serum levels of protein GALNT10,124
2,Facial morphology (segment 44),123
2,Miserableness,35598
2,"Blood protein levels [FKBP7, 9288_7_3]",3602
2,Electrocardiogram morphology (amplitude at temporal datapoints) [10 ms],6102
2,Abdominal hernia,805
2,"Inflammatory bowel disease | non-cancer illness code, self-reported",427
2,Protein quantitative trait loci (liver) [FTH1],230
2,Systolic blood pressure x smoking status (ever vs never) interaction (2df test),170
2,Urinary metabolite levels in chronic kidney disease [3-methylcrotonylglycine],10
2,Neuroblastoma (MYCN amplification),5014
2,Myopia (age of diagnosis),17492
2,Noncognitive aspects of educational attainment,16874
2,Blood metabolite levels [X-12095--N1-methyl-3-pyridone-4-carboxamide],4497
2,Low testosterone levels,2043
2,Nonalcoholic fatty liver disease,6129
2,Adiposity,263
2,Hay fever and/or eczema,44228
2,Gamma glutamyl transferase levels,219903
2,Hypertensive diseases,4460
2,Other arthropathies,1185
2,Pure hypercholesterolaemia,1242
2,Plasma free amino acid levels [Gly],479
2,Systolic blood pressure [East Asians],94
2,Body fat distribution (arm fat ratio) [males],12270
2,Doctor diagnosed asthma,20078
2,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [homocitrate, X-24519]",22213
2,Pancreatic cancer,6546
2,Atopic asthma,27097
2,Triacylglycerol_49:3_[M+NH4]1+ levels,2171
2,Medication use (antihypertensives),1405
2,Serum metabolite levels [Ala],2043
2,Resting CD4 regulatory T cell %CD4+ T cell,1753
2,"Ranitidine (e.g. zantac) | medication for pain relief, constipation, heartburn",224
2,"Pulse pressure x alcohol consumption interaction (2df test) [Asian, EA]",175
2,Other and unspecified tonssillitis,873
2,Brain region volumes [left cerebellum exterior],21
2,Heart rate [Heart rate],380
2,White blood cell count (eosinophil),88
2,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [2-methylbutyrylglycine, 3-methylcrotonylglycine, indoleacetylglutamine, indoleacetylglycine, isobutyrylglycine, isovalerylglutamine, isovalerylglycine, tigloylglycine, X-17688]",10
2,Brain region volumes [left lingual],1487
2,Blood protein levels [Interleukin-18 receptor 1],10576
2,Ankle spacing width,45187
2,Endoplasmic reticulum lectin 1 measurement,7350
2,Other non-epithelial cancer of skin,12766
2,Metabolic traits [TG],2497
2,Serum levels of protein IL1R1,2531
2,Stroke (ischemic) [SVD],230
2,Metabolic syndrome [HDL],454
2,Neuropsychiatric disorders,851
2,"Psoriasis [EA, conditional on rs1990760]",14
2,Nasal polyps,47070
2,HDL cholesterol levels,164568
2,CD28 on resting CD4 regulatory T cell,2868
2,Cholelithiasis-related traits in sickle cell anemia,620
2,Urate levels [East Asian],1843
2,Phosphatidylcholine_32:2_[M+H]1+/Phosphatidylethanolamine_35:2_[M+H]1+/Phosphatidate_37:3_[M+NH4]1+ levels,2171
2,Cholesterolosis of gallbladder,266
2,F-cell distribution,27
2,Blood pressure [SBP],12
2,Asthma and hay fever,4948
2,"Other exercises (eg: swimming, cycling, keep fit, bowling) | types of physical activity in last 4 weeks",3017
2,Urinary metabolite levels in chronic kidney disease [X - 24809],24285
2,End-stage renal disease in Type 1 diabetics [Women],23
2,Hip minimal joint space width,867
2,Pulse pressure [East Asian],866
2,Cathepsin D levels,2043
2,"Lipid metabolism phenotypes [VLDL.small, whole]",454
2,Hematocrit [Hispanic/Latino],205
2,BMI in non-smokers,12503
2,Medication use (calcium channel blockers),41281
2,Age when periods started (menarche),32539
2,Corneal resistance factor (left),7917
2,Whole body fat mass,86452
2,Protein quantitative trait loci (liver) [GK2],1267
2,Cytokine network levels (multivariate analysis),1574
2,Waist circumference adjusted for BMI in active individuals,2559
2,Triglyceride levels [Asian],1788
2,Cough in response to angiotensin-converting enzyme inhibitor drugs,173
2,Mood instability,92
2,Total body bone mineral density (age over 60),6
2,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),4579
2,"""Diabetes, insuline treatment (Kela reimbursement)""",2995
2,"Systolic blood pressure [EA, initial]",1598
2,Leuconostoc abundance in stool,3741
2,Vitamin b6,327
2,None of the above | mouth/teeth dental problems,320
2,Brain region volumes [Brain stem],226
2,"Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [Asian, EA]",241
2,Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL) [AA],10
2,Urinary metabolite levels in chronic kidney disease [3-methylglutaconate],10
2,Pain in thoracic spine,3
2,White matter hyperintensity volume,59916
2,Eczema or dermatitis,11864
2,Pre-treatment viral load in HIV-1 infection,2715
2,Barrett's esophagus,1553
2,Obsessive compulsive disorder (ocd) | mental health problems ever diagnosed by a professional,132
2,Thyroid peroxidase antibody levels,509
2,"Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)",42197
2,Urinary metabolite levels in chronic kidney disease [N-acetylasparagine],23191
2,Serum metabolite levels [X-11441],5509
2,Gastrointestinal or abdominal disease,464
2,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [AA],1408
2,"Muscle or soft tissue injuries | non-cancer illness code, self-reported",242
2,Blood protein levels [Fibronectin Fragment 4],288
2,"""Ulcerative colitis (strict definition, require KELA)""",219
2,Activated & resting CD4 regulatory T cell %CD4+ T cell,191
2,HDL cholesterol x physical activity interaction (1df test),13710
2,Irritability,4303
2,Alanine aminotransferase levels,161588
2,Childhood asthma (age<16),5040
2,Serum metabolite levels [X-11530],5509
2,Papulosquamous disorders,4225
2,Anxiety/tension (special factor of neuroticism),730
2,Metabolite levels [Glc],1369
2,Serum metabolite levels (CMS) [S_VLDL_L],2497
2,DNA methylation PhenoAge acceleration,892
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-160 ms],118
2,Persistent mood disorders,84
2,Systolic blood pressure x educational attainment (some college) interaction (2df) [African],4
2,Cortical surface area [Inferior Parietal],9
2,Monocyte percentage of white cells,299507
2,Loneliness (MTAG),9700
2,Serum metabolite levels [XS_VLDL_TG],2497
2,Corneal hysteresis,2352
2,Seropositive rheumatoid arthritis,1249
2,"""Disorders of sclera, cornea, iris and ciliary body""",542
2,"Polycythaemia vera | non-cancer illness code, self-reported",1210
2,Morningness,91420
2,Lymphocyte percentage,213443
2,Smoking status (ever vs never smokers),25427
2,Paracetamol | treatment/medication code,3419
2,Alcohol intake versus 10 years previously,2379
2,LDL cholesterol to HDL cholesterol ratio,124
2,"Blood protein levels [FABP1, 11516_7_3]",401
2,Vitamin B12 deficiency anaemia,89
2,Deep ovarian and/or rectovaginal disease with dense adhesions,299
2,Monocyte-lymphocyte ratio,493
2,Primary tooth development (number of teeth),318
2,Cortical surface area [Pars Orbitalis],53
2,Facial morphology (segment 7),145
2,Body mass index,1720817
2,Hematocrit,1151906
2,Plasmacytoid Dendritic Cell Absolute Count,15613
2,Protein levels in obesity [TSG-6],5880
2,Arm predicted mass (right),158601
2,Youthful appearance (self-reported),9885
2,Blood metabolite levels [Mannose levels],2043
2,Type 1 diabetes with ophthalmic complications,1188
2,Alcohol use disorder (total score),2109
2,Pericardial fat,711
2,Serum alpha1-antitrypsin levels,2043
2,"""Heart failure, not strict""",31
2,"N-glycan levels [DG11, women]",386
2,Plasma free amino acid levels (adjusted for one other PFAA) [Thr (adjusted for Ser],261
2,Cortical thickness,182515
2,Blood metabolite ratios [N-acetylornithine/myo-inositol],23819
2,"Waist circumference adjusted for body mass index [EA, men]",5371
2,Hematological and biochemical traits [Hemoglobin],325
2,Added milk to standard tea,87
2,Serum levels of protein HSPA1L,40
2,Externalizing behaviour (multivariate analysis),108844
2,Urinary metabolite levels in chronic kidney disease [N-acetylleucine],23191
2,Urinary metabolite levels in chronic kidney disease [N-alpha-acetylornithine],24553
2,Electrocardiogram morphology (amplitude at temporal datapoints) [194 ms],1570
2,Effector Memory CD4+ T cell Absolute Count,1645
2,Serum metabolite concentrations in chronic kidney disease [N-acetylarginine],5663
2,Waist circumference adjusted for BMI in non-smokers [men],756
2,Triacylglycerol_52:6_[M+NH4]1+ levels,2043
2,Eosinophilic granulomatosis with polyangiitis,219
2,Carotid intima media thickness x smoking interaction,66
2,Autism spectrum disorder or schizophrenia,36167
2,Percent mammographic density,9974
2,Metabolite levels [Bilirubin],5509
2,Self-reported allergy,15678
2,Systemic sclerosis [EA],544
2,Epilepsy,1818
2,Electrocardiogram morphology (amplitude at temporal datapoints) [98 ms],275
2,Asthma [conditional],13093
2,Urinary metabolite levels in chronic kidney disease [X - 24519],22213
2,Headache | pain type(s) experienced in last month,1750
2,LDL cholesterol levels in current drinkers [AA],1402
2,Serum levels of protein UXS1,1366
2,White matter microstructure (axial diusivities) [Retrolenticular part of internal capsule],2494
2,Naive CD8+ T cell Absolute Count,472
2,Morning person,84318
2,Ease of getting up in the morning,27376
2,Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis),39738
2,Platelet-to-lymphocyte ratio,171394
2,Eosinophill percentage,68255
2,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [women],2158
2,Cutaneous melanoma or hair colour,3521
2,Alcohol consumption (drinkers vs non-drinkers),2043
2,Tegretol 100mg tablet | treatment/medication code,1320
2,Serum metabolite levels [betaine],240
2,Insomnia complaints,56
2,Serum metabolite concentrations in chronic kidney disease [N-acetylcitrulline],5784
2,Brain region volumes [right fusiform],343
2,HDL cholesterol levels [EA],378
2,Cortical thickness [Lingual],272
2,Influenza A (H1N1) infection,45
2,Neuritic plaques or neurofibrillary tangles (pleiotropy),19
2,Excessive sweating,4579
2,Highest math class taken (MTAG) [MTAG],227662
2,Obese vs. thin,12353
2,Cortical surface area (MOSTest),52959
2,Standing height,487445
2,Potassium levels,3236
2,Fruit consumption,4888
2,Beard thickness,1352
2,Macular telangiectasia type 2,150
2,Phosphatidylcholine-O_44:5_[M+H]1+/Phosphatidylcholine-P_44:4_[M+H]1+ levels,2043
2,Dementia with Lewy bodies,174
2,Ankylosing spondylitis [EA],353
2,Odorant perception (isobutyraldehyde),4654
2,Glaucoma (multi-trait analysis),11675
2,Spleen volume,8324
2,Neurological blood protein biomarker levels [sFRP-3],866
2,Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis),1143
2,Seretide 50 evohaler | treatment/medication code,5166
2,Serum levels of protein CFD,1027
2,P wave duration,239
2,Male sexual orientation,253
2,Asthma with severe exacerbations,326
2,Physical activity (Total log acceleration 2am-4am),28
2,"""Carcinoma in situ of breast, lobular""",4
2,Immune response to smallpox vaccine (IL-6) [AA],17
2,Number of sexual partners,30131
2,Age at first birth,25605
2,Intrinsic epigenetic age acceleration,2399
2,Adverse response to drug [Propionic acid derivatives [M01AE]],2786
2,Breakfast cereal skipping frequency,111
2,High fetal hemoglobin in sickle cell disease,61
2,Body mass index (joint analysis main effects and physical activity interaction),12545
2,Interleukin-1 receptor type 1 measurement,6980
2,Metabolic traits [SM-2 + 2 other traits],23672
2,Alcohol use disorder (consumption score),15427
2,Age-related hearing impairment [additive],1045
2,CD8 on CD39+ CD8+ T cell,1142
2,Agouti-related protein levels,2638
2,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],3216
2,Percent liver fat,4206
2,Phosphatidylcholine_34:4_[M+OAc]1-/Phosphatidylserine_38:3_[M-H]1- levels,2043
2,Monobrow,1999
2,Serum levels of protein SERPINE2,1549
2,Electrocardiogram morphology (amplitude at temporal datapoints) [148 ms],1570
2,CAG-822 sp000432855 abundance in stool,240
2,HDL cholesterol levels [Trans-ethnic initial],231
2,"Blood protein levels [MUSK, 11547_84_3]",299
2,Other disorders of gallbladder,266
2,A body shape index,28693
2,Protein quantitative trait loci [IL-18 Ra],11864
2,Serum metabolite levels [2-aminooctanoate],17848
2,Leg predicted mass (left),105961
2,Menarche (age at onset),43639
2,Serum metabolite levels [xanthurenate],2441
2,"""Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)""",7153
2,Osteoarthritis (with total hip replacement),727
2,CD28 on secreting CD4 regulatory T cell,2491
2,Neurological blood protein biomarker levels [MATN3],3912
2,Brainstem volume,1677
2,Movelat gel | treatment/medication code,78
2,Hemiplegia,45
2,Spherical equivalent (joint analysis main effects and education interaction),11546
2,Immature fraction of reticulocytes,613005
2,"Pulse rate, automated reading",60129
2,Metabolite levels [xanthurenate],5509
2,Bilirubin levels in extreme obesity,5509
2,Other headache syndromes,153
2,Neurological blood protein biomarker levels [ADAM 23],689
2,Sleep start time,28
2,White matter microstructure (mean diusivities) [Fornix (column and body],40
2,Bioavailable testosterone levels,42622
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-20 ms],1880
2,"Blood metabolite levels [bilirubin (E,E]",5509
2,Congenital anomalies of face and neck,661
2,Blepharochalasis,197
2,"Smoking initiation (ever regular vs never regular) [Conditioned on chr2:60477052, chr2:60024857]",2
2,Phocea massiliensis abundance in stool,1414
2,Primary sclerosing cholangitis,5246
2,Insomnia symptoms (never/rarely vs. usually),6638
2,Hard cardiovascular diseases,1421
2,Electrocardiogram morphology (amplitude at temporal datapoints) [-386 ms],171
2,Serum metabolite levels [gamma-glutamylglycine],240
2,Aspartate aminotransferase platelet ratio index in high alcohol intake,465
2,Serum levels of protein QSOX2,285
2,Medication use (agents acting on the renin-angiotensin system),23845
2,C-reactive protein [AA women],1631
2,CD8 on CD28+ CD45RA- CD8+ T cell,2858
2,Haemorrhoidal disease,24597
2,Coronary artery bypass grafting,45992
2,Alanine transaminase levels,4812
2,Time spent outdoors in winter,79
2,Alpha-hydroxyisovalerate levels,603
2,Duration screen displayed,94
2,Allergic rhinitis [Latino],39
2,Symptoms and signs involving the urinary system,9
3,Plateletcrit,283892
3,Job involves heavy manual or physical work,120621
3,"Blood protein levels [PRDM1, 14197_2_3]",33846
3,Impedance of leg (left),289112
3,Ascending aorta maximum area,4112
3,IgG fucosylation phenotypes (multivariate analysis),839
3,Malignant neoplasm of skin (controls excluding all cancers),875
3,Inflammatory skin disease [Opposed],244
3,Body fat distribution (trunk fat ratio),109419
3,Body fat percentage variance,1025
3,Serum levels of protein CD27,305
3,Cardiovascular disease risk factors [BCHE],248
3,Electrocardiogram morphology (amplitude at temporal datapoints) [8 ms],99
3,Chronic lymphocytic leukemia or systemic lupus erythematosus,5140
3,Waist-to-hip ratio adjusted for body mass index [women],286555
3,Blood protein levels [Teratocarcinoma-derived growth factor 1],1858
3,Serum metabolite levels [1-methylhistamine],741
3,CAG-1000 abundance in stool,999
3,White | bread type,105537
3,Bacillus velezensis abundance in stool,209
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-118 ms],1144
3,Plasma renin activity levels,457
3,Asthma onset (childhood vs adult),417
3,"Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [Asian, EA]",311
3,Diseases of the myoneural junction and muscle,51
3,Losartan | treatment/medication code,38
3,Gut microbiota (bacterial taxa) [Unclassified Marinilabiliaceae],103
3,Breast cancer,104773
3,Diseases of hair and hair follicles,5386
3,Body mass index [EA],5356
3,Cortical surface area [Supramarginal],525
3,Gliclazide | treatment/medication code,886
3,Electrocardiogram morphology (amplitude at temporal datapoints) [190 ms],174
3,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,226
3,Cerebrospinal fluid levels of Alzheimer's disease-related proteins [Monocyte chemotactic protein 1],66
3,Hemoglobin concentration,682153
3,Brain morphology (min-P),5175
3,"Systolic blood pressure x alcohol consumption interaction (2df test) [AA, Asian, EA]",3804
3,Cognitive function (generalized correlation coefficient),2925
3,"Chronic obstructive airways disease/copd | non-cancer illness code, self-reported",1468
3,Hashimoto thyroiditis,341
3,"Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)",417
3,B cell lymphocyte profile difference (7 days post influenza vaccination),227
3,Waist-to-hip ratio adjusted for BMI (age <50) [women],148
3,Height,1819118
3,Cerebrospinal fluid biomarker levels [Teratocarcinoma-derived growth factor 1],2587
3,Impedance of leg (right),297162
3,Blood protein levels [Alpha-2-HS-glycoprotein],307
3,Number of days/week of moderate physical activity 10+ minutes,1048
3,3-hydroxy-1-methylpropylmercapturic acid levels in smokers [EA],54
3,Not performed - equipment failure | oct measured (left),10
3,Calcific tendinitis,6
3,"Blood protein levels [EA, C-C motif chemokine 21]",6567
3,3mm weak meridian (left),57003
3,Axial length,6399
3,Cutaneous squamous cell carcinoma,775
3,"2,3-dihydroxy-2-methylbutyrate levels",243
3,Serum levels of protein XXYLT1,1957
3,Protein quantitative trait loci [Cripto],1945
3,Diseases of the skin and subcutaneous tissue,308
3,Bipolar disorder vs ADHD (ordinary least squares (OLS)),1190
3,Response to serotonin-norepinephrine reuptake inhibitors (responders vs non-responders),217
3,Colorectal cancer,18601
3,Time spent watching television (tv),101985
3,Sex hormone-binding globulin levels adjusted for BMI,463927
3,"Blood protein levels [HAAO, 5861_78_3]",1487
3,"Osteoporosis | non-cancer illness code, self-reported",341
3,Low-density lipoprotein receptor levels,57
3,Fibrinogen levels,22442
3,"Diastolic blood pressure [EA, initial]",136311
3,Age-related hearing impairment (high frequency) [EA],21548
3,"Diastolic blood pressure, automated reading",274313
3,Ankle spacing width (right),37335
3,Chest pain or discomfort when walking uphill or hurrying,1103
3,Hypertrophic cardiomyopathy (MTAG),99
3,Phosphatidylinositol levels [PI(18:0;0-18:1;0],602
3,Alcohol dependence (age at onset),151
3,Clinical laboratory measurements [calcium levels],3403
3,Corneal resistance factor (left),8259
3,BMI in non-smokers,3536
3,Intertrochanteric region size,1440
3,Infant head circumference (MTAG),3040
3,T wave morphology restitution during recovery from exercise,710
3,Hypertension [East Asian],524
3,"Blood protein levels [RAB6B, 14271_23_3]",699
3,COVID-19 (hospitalized vs population) RELEASE 5,1718
3,Right | usual side of head for mobile phone use,1826
3,Potassium levels,2516
3,Number of unsuccessful stop-smoking attempts,1366
3,Retinal nerve fibre layer (RNFL) thickness,1503
3,Serum levels of protein MAPK9,872
3,Lipid traits (pleiotropy) (HIPO component 1),839
3,Sum neutrophil eosinophil counts,65198
3,Number of treatments/medications taken,72276
3,Body mass index [women],1484
3,Diverticulosis and diverticulitis,2735
3,"Blood protein levels [IL5RA, 13686_2_3]",175
3,Malaria [additive],193
3,"Blood protein levels [APOC3, 6461_54_3]",248
3,Extraversion,1289
3,Weekly usage of mobile phone in last 3 months,109
3,Other cataract,28
3,Heel bone mineral density (bmd) (left),46552
3,Metabolic syndrome,6823
3,"BMI (adjusted for smoking behaviour) [EA, women]",229
3,vascular endothelial growth factor D levels,710
3,Bacillales A abundance in stool,1135
3,Body mass index (joint analysis main effects and physical activity interaction) [men],646
3,Oxytetracycline | treatment/medication code,484
3,"Paracetamol | medication for pain relief, constipation, heartburn",61
3,Smoking status (ever vs never smokers),25462
3,Conditional arithmetic | fi6 ,51051
3,"Blood protein levels [NMES1, 6406_3_3]",286288
3,"""Malignant neoplasm of breast, HER2-negative (controls excluding all cancers)""",5179
3,Serum levels of protein ACE,910
3,First degree av block,2210
3,Body fat percentage and fasting glucose (pairwise),271
3,Serum levels of protein LRPPRC,536
3,Lymphocyte percentage,31442
3,Height [AA],32360
3,Angina pectoris,2061
3,"""Disorders of gallbladder, biliary tract and pancreas""",773
3,"Blood protein levels [HNRNPH1, 14309_8_3]",1241
3,"A sedative, benzodiazepine or sleeping tablet | substance of prescription or over-the-counter medication addiction",283
3,"Waist-to-hip ratio adjusted for body mass index [AA, Women]",130
3,Autism spectrum disorder or schizophrenia,148893
3,Hypothyroidism and >3 levothyroxin purchases,417
3,Mean corpuscular hemoglobin concentration,443424
3,Gamma glutamyl transferase levels,444343
3,Vertex-wise sulcal depth,425859
3,"""Malignant neoplasm of breast, HER2-negative""",5179
3,acne vulgaris,9560
3,"Blood protein levels [IL17RD, 3376_49_2]",880
3,Lipoprotein lipase levels,439
3,Regular attendance at a gym or sports club,71474
3,Diastolic blood pressure [EA],244075
3,Age at first birth [females],8749
3,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],53676
3,"Bronchiectasis | non-cancer illness code, self-reported",12
3,Smoking initiation (ever regular vs never regular) [Conditioned on chr3:52886605],261
3,Neutrophil percentage of granulocytes,56811
3,Cutaneous malignant melanoma,5140
3,Keratinocyte cancer (MTAG),2385
3,"Blood protein levels [DEPP, 7178_59_3]",1933
3,Smoking initiation (ever regular vs never regular) [Conditioned on chr3:71064431],45
3,Meniscus derangement,2
3,Bitter alcoholic beverage consumption,3737
3,Time spend outdoors in summer,104111
3,Yes | hearing difficulty/problems,18652
3,Gut microbiota abundance (order Gastranaerophilales id.1591),989
3,Corneal hysteresis (left),6059
3,Optic cup area [EA],773
3,Lipid traits (pleiotropy) (HIPO component 2),871
3,Serum levels of protein PMEPA1,343
3,Serum levels of protein BCL2L2,131
3,Electrocardiogram morphology (amplitude at temporal datapoints) [130 ms],6807
3,Change in serum metabolite levels (CMS) [LA_FA],292
3,IgG glycosylation patterns [IgG2 FGS1/(F+FG+FGS1],839
3,"Blood protein levels [PLXNA1, 9005_16_3]",2749
3,PR interval [Hispanic/Latino],705
3,"Gut microbiota (functional units) [GO:0016706|MF|04|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors]",7
3,Protein quantitative trait loci (liver) [LAMP1],6
3,Non-small cell lung cancer,11135
3,Vigorous physical activity,526
3,6mm weak meridian (right),10617
3,Platelet crit,111623
3,COVID-19 (very severe respiratory confirmed vs population) RELEASE 5,1718
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-498 ms],406
3,5-oxoproline levels,166
3,Disc degeneration (lumbar),11
3,Mean corpuscular hemoglobin,1374926
3,Osteoarthritis; localized,127137
3,Serum levels of protein PRDM1,33846
3,Cortical surface area [Pericalcarine],2640
3,Ischemic heart diseases,2061
3,Glomerular filtration rate in non diabetics (creatinine),4028
3,Calcium levels [conditional on round 3],4761
3,Activated partial thromboplastin time,3394
3,Body fat percentage [female],851
3,Electrocardiogram morphology (amplitude at temporal datapoints) [38 ms],525
3,Crohn's disease-related phenotypes [CDC stricturing],439
3,Cooked vegetable intake,38
3,Heart rate response to recovery post exercise,1777
3,Staphylococcus aureus nasal carriage (intermittent),586
3,Waist circumference adjusted for BMI (adjusted for smoking behaviour) [women],1215
3,P-cresol sulfate levels,1504
3,Serum levels of protein BMP7,158
3,"Blood protein levels [PFKFB3, 12456_5_3]",1040
3,Cortical volume [Inferior parietal],175
3,Blood metabolite levels [X-11315],494
3,Endometriosis or endometrial cancer (pleiotropy),79
3,Electrocardiogram morphology (amplitude at temporal datapoints) [264 ms],291
3,Late-onset Alzheimer’s disease in APOEe4 non-carriers,14
3,Inflammatory bowel disease,145428
3,Neuroticism,491499
3,Neuropsychiatric disorders,121275
3,Uterine fibroids,25976
3,Serum total protein level,249384
3,White matter microstructure (axial diusivities) [Posterior limb of internal capsule],23507
3,Protein quantitative trait loci (liver) [EIF2B1],636
3,Pulmonary function [FEV1/FVC],85
3,Arm fat mass (left),210366
3,Cortical surface area [Lateral Occipital],3007
3,Eotaxin levels,3718
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-40 ms],125
3,Eudaimonic well-being,173
3,Educational attainment (years of education),618051
3,Male puberty timing (age at voice breaking MTAG),14292
3,Noninflammatory disorders of female genital tract,15416
3,Cortical surface area [Pars triangularis],275
3,Vitamin c product | treatment/medication code,448
3,Diabetic retinopathy in type 2 diabetes,79
3,Brain region volumes [left lingual],1432
3,Vitiligo,13612
3,White matter microstructure (axial diusivities) [Genu of corpus callosum],579
3,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),4954
3,Unstable angina pectoris,153
3,"Blood metabolite levels [bradykinin, des-arg(9]",457
3,IgG glycosylation patterns [IgG4 FGS1/(FG+FGS1],839
3,Schizophrenia or bipolar disorder [SCZ or BP vs. controls],1190
3,Protein quantitative trait loci (liver) [NPC2],27
3,Monoclonal gammopathy of undetermined significance,29
3,Anemia,10
3,High light scatter reticulocyte percentage of red cells,182178
3,"Blood protein levels [ZNF334, 12763_69_3]",112165
3,Hypospadias,5696
3,Erythritol levels,1284
3,Electrocardiogram morphology (amplitude at temporal datapoints) [448 ms],1430
3,"Blood protein levels [XG, 10492_51_3]",923
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-70 ms],650
3,UBA7177 abundance in stool,52
3,Mean corpuscular haemoglobin,187071
3,Serum levels of protein APOE,248
3,Other malignant neoplasms of skin (=non-melanoma skin cancer),923
3,"Fracture clavicle / collar bone | non-cancer illness code, self-reported",1734
3,Other special examinations and investigations of persons without complaint or reported diagnosis,606
3,Chin dimples,958
3,"Blood protein levels [EA, Inosine-5'-monophosphate dehydrogenase 1]",15
3,Otitis externa,7
3,Electrocardiogram morphology (amplitude at temporal datapoints) [16 ms],3631
3,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [women],1987
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-156 ms],682
3,Waist-hip index,389360
3,Noninfective enteritis and colitis,40015
3,Brain region volumes [right inferior temporal],1151
3,Medication use (antihypertensives),5744
3,IgG glycosylation [IGP28],1560
3,Hearing difficulty/problems with background noise,330
3,Expressive vocabulary in infants [15-18 months],2
3,Serum levels of protein PLA2G7,248
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-208 ms],525
3,Phosphatidylinositol_36:2_[M+H]1+ levels,368
3,Zoton 15mg capsule | treatment/medication code,24
3,Blood metabolite levels [X-09789],125
3,Ruminococcus E sp900100595 abundance in stool,27
3,Predicted visceral adipose tissue,113032
3,Obesity [Obesity class I],1348
3,GDP-fucose protein O-fucosyltransferase 1 measurement,158
3,Eukaryotic translation initiation factor 4E type 2 measurement,158
3,Cortical surface area [Inferior Parietal],229
3,Neonatal cytokine/chemokine levels (fetal genetic effect) [IL-10],196
3,Immune reponse to smallpox (secreted IFN-alpha) [AA],7
3,Smoking cessation,219675
3,Lung function (FEV1) [adults],15818
3,Biological sex,34643
3,Mitochondrial DNA copy number,62873
3,Atrial fibrillation and flutter with reimbursement,2838
3,1-palmitoyl-2-arachidonoyl-gpc (16:0/20:4n6) levels,642
3,Age-related nuclear cataracts,41
3,Protein quantitative trait loci (liver) [RAN],15
3,Serum levels of protein PFKFB3,925
3,Brain region volumes [left superior parietal],688
3,Serum levels of protein ITIH1,119777
3,Amyotrophic lateral sclerosis,1050
3,Serum levels of protein PDGFRL,4858
3,"Blood protein levels [CLK2, 11327_56_3]",248
3,Idiopathic dilated cardiomyopathy,47
3,Job involves mainly walking or standing,36138
3,Serum levels of protein C15orf48,112165
3,Prostate-specific antigen levels (conditioned on lead SNPs) [conditional on Round 1 SNPs],1905
3,Protein levels in obesity [PUR8],2899
3,Mitochondrial heteroplasmy measurement,1146
3,Serum levels of protein BTD,157
3,Systolic blood pressure [EA],3208
3,Ebbinghaus illusion (overestimation),91
3,Protein quantitative trait loci (liver) [CYP27A1],10
3,Hypertension,208448
3,Electrocardiogram morphology (amplitude at temporal datapoints) [6 ms],2538
3,Body mass index in physically active individuals,3462
3,"Blood protein levels [CDCP1, 6565_68_3]",2220
3,Glaucoma (low intraocular pressure),376
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-124 ms],125
3,Myocardial infarction,35908
3,Mental health study participation (completed survey),8787
3,"Blood protein levels [TF, 4162_54_2]",3334
3,"""Cholangitis (primary sclerosing, PSC), with reimbursement 202""",36
3,LDL cholesterol,45417
3,3mm strong meridian (left),58245
3,Brain region volumes [right accumbens area],1310
3,Interleukin-1 Receptor accessory protein measurement,2135
3,"Hypertension | non-cancer illness code, self-reported",135707
3,IgG glycosylation patterns [IgG4_G1FS1],804
3,Estradiol levels,145
3,Systemic lupus erythematosus and Systemic sclerosis [ACA],13362
3,Medication use (drugs used in diabetes),17288
3,Neutrophill count,165563
3,"""Inflammatory bowel disease, strict (require KELA)""",34280
3,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 measurement",8382
3,Serum levels of protein CPN2,1665
3,RR interval (tricyclic/tetracyclic antidepressant use interaction) [EA],626
3,Serum levels of protein IL17RD,1629
3,Calsyntenin-2 levels,523
3,Coeliac disease,417
3,Blood protein levels [Interleukin-17 receptor D],718
3,Total cholesterol levels,156000
3,"Hip circumference adjusted for BMI [EA,men]",20899
3,CR(E)ST syndrome,985
3,Diseases of the ear and mastoid process,5
3,Protein quantitative trait loci (liver) [HBG1],2
3,Primary sclerosing cholangitis,102146
3,Cigarettes smoked per day (MTAG),131297
3,"Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA, women]",73167
3,Vitamin D levels,181502
3,Heel bone mineral density (bmd) (right),60505
3,Melanoma,2299
3,Serum levels of protein CCL17,1314
3,"Superoxide dismutase [Mn],mitochondrial levels",699
3,Electrocardiogram morphology (amplitude at temporal datapoints) [34 ms],525
3,Cataract,25
3,"Heel quantitative ultrasound index (qui), direct entry (right)",60555
3,Electrocardiogram morphology (amplitude at temporal datapoints) [176 ms],174
3,Feeling worry,76382
3,Insomnia symptoms (never/rarely vs. usually),82245
3,Impedance of arm (left),286926
3,Trunk predicted mass,160949
3,Migraine and/or systolic blood pressure,848
3,Protein quantitative trait loci (liver) [ACADVL],1
3,Waist circumference adjusted for BMI in active individuals,194649
3,Whole body water mass,160414
3,"Waist circumference adjusted for BMI in active individuals [EA, men]",2296
3,"Other professional qualifications eg: nursing, teaching | qualifications",286
3,Metabolite levels (small molecules and protein measures) [Glycine],497
3,"Sphingomyelin (d18:1/14:0, d16:1/16:0) levels",92
3,Protein quantitative trait loci (liver) [ABAT],1
3,Serum levels of protein SUN3,113338
3,IgG glycosylation patterns [IgG1 FGS1/(F+FG+FGS1],839
3,Coronary revascularization (ANGIO or CABG),1937
3,Total body bone mineral density,1519
3,Hyperlipidemia,5551
3,MAP/microtubule affinity-regulating kinase 3 measurement,158
3,Skin changes due to chronic exposure to nonionizing radiation,933
3,IgG glycosylation patterns [IgG1_G1FS1/IgG1_G1F],804
3,Serum levels of protein SYT11,284
3,"Blood protein levels [CHL1, 3601_54_3]",99
3,Illicit drug use,177
3,"Icd10: c25.9 pancreas, unspecified | underlying (primary) cause of death",34
3,COVID-19 (covid respiratory support vs population),17518
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-24 ms],16430
3,Electrocardiogram morphology (amplitude at temporal datapoints) [218 ms],19823
3,Pulse pressure [Japanese],201
3,Serum levels of protein ICAM2,1147
3,Strenuous sports or other exercises,65278
3,Multisite chronic pain,68775
3,Chronic obstructive pulmonary disease x current smoker interaction (2df),12324
3,Serum levels of protein LHCGR,37306
3,Offspring birth weight,25788
3,Birth weight (MTAG),1296
3,Cortical volume [Supramarginal],463
3,Two-hour glucose,1150
3,Neutrophil percentage of white cells,69279
3,Serum levels of protein CREBBP,248
3,O levels/gcses or equivalent | qualifications,264
3,Nasopharyngeal carcinoma (SNP x SNP interaction),308
3,"Diastolic blood pressure x alcohol consumption interaction (2df test) [Asian, EA]",368
3,"Blood protein levels [IL5RA, 4491_4_2]",175
3,LDL cholesterol levels x long total sleep time interaction (2df test),11
3,Parkinson's disease or first degree relation to individual with Parkinson's disease,116383
3,Caffeine consumption from coffee,61241
3,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],59847
3,Type 2 diabetes with other specified/multiple/unspecified complications,2441
3,Body mass index (joint analysis main effects and physical activity interaction) [women],1484
3,IgG glycosylation [IGP31],839
3,Sociability score,1318
3,Serum levels of protein LANCL1,372
3,Serum levels of protein SLC35G2,305
3,Active to sedentary transition probability,1262
3,TestASV_15 (Bacteroides) prevalence,56
3,Multiple myeloma (hyperdiploidy) [HD vs. controls],242766
3,Parkinson's disease,105785
3,Electrocardiogram morphology (amplitude at temporal datapoints) [164 ms],6807
3,Serum levels of protein AHSG,823
3,Protein quantitative trait loci (liver) [USP5],60
3,Headache,83
3,Retention of urine,59
3,Lipid traits [HDL],16
3,Alcohol consumption (drinks per week),47599
3,"""Malignant neoplasm of breast, HER-positive (controls excluding all cancers)""",5078
3,Serum levels of protein HNRNPH1,982
3,COVID-19 (critical illness vs population),2577
3,"Blood protein levels [ARHGAP30, 12807_89_3]",248
3,Electrocardiogram morphology (amplitude at temporal datapoints) [136 ms],174
3,Serum levels of protein A4GNT,518
3,Electrocardiogram morphology (amplitude at temporal datapoints) [166 ms],174
3,Neutrophil count,569241
3,Idiopathic pulmonary fibrosis,6047
3,Bone mineral density (hip) and hip bone size,2562
3,Aspartate aminotransferase platelet ratio index in high alcohol intake,195
3,Fasting blood insulin,827
3,Adult body size,228898
3,Feeling hurt,1355
3,TNF-related apoptosis-inducing ligand levels,869
3,Kynurenine levels,1412
3,Sick sinus syndrome,525
3,Difficulty stopping worrying during worst period of anxiety,120
3,Pattern 2 | hair/balding pattern,772
3,"Blood protein levels [HSPA1L, 12041_33_3]",248
3,Protein quantitative trait loci (liver) [APOC1],1
3,"Forced expiratory volume in 1-second (fev1), predicted percentage",2833
3,Circulating leptin levels or type 2 diabetes,2081
3,Other diseases of lip and oral mucosa,154
3,Bronchitis,14
3,"Overweight, obesity and other hyperalimentation",16440
3,Eosinophil percentage of granulocytes,48702
3,Irritable mood,131124
3,Aspartate aminotransferase to alanine aminotransferase ratio,65061
3,Serum levels of protein TXNDC12,36449
3,Pulse pressure x alcohol consumption interaction (2df test) [EA],195232
3,"Black | hair colour (natural, before greying)",7677
3,Pro-interleukin-16 levels,197
3,Relative protein intake,18
3,Lung function (FVC),684467
3,Poultry intake,38106
3,Liver enzyme levels (alanine transaminase),106046
3,"Blood protein levels [PMEPA1, 6936_7_3]",248
3,Blood protein levels [IL17RB],874
3,Cortical surface area [Pars Orbitalis],42
3,Serum metabolite levels [N-acetylcarnosine],423
3,Restless legs syndrome,1806
3,Serum levels of protein SAT2,372
3,Pulse wave reflection index,16
3,Iron status biomarkers (total iron binding capacity),10780
3,Lung function (low FEV1 vs high FEV1),3179
3,Leiomyoma of uterus,5329
3,Serum levels of protein SIGIRR,4927
3,Lumbar spine bone mineral density,3440
3,Serum levels of protein SLITRK3,257
3,Longest period of unenthusiasm / disinterest,804
3,Monobrow,17
3,Direct bilirubin levels,38809
3,1-stearoyl-2-linoleoyl-gpc (18:0/18:2) levels,870
3,Serum levels of protein PCOLCE2,1048
3,Psychogenic and somatoform disorders,61
3,GCA-900066755 sp900066755 abundance in stool,15
3,Intraocular pressure,31450
3,General risk tolerance (MTAG),37401
3,Cycle | types of transport used (excluding work),16270
3,Beclazone 50 inhaler | treatment/medication code,1719
3,Problematic alcohol use (MTAG),7022
3,Gut microbiota (beta diversity),950
3,Fish- and plant-related diet,6125
3,Nexium 20mg tablet | treatment/medication code,247
3,Clopidogrel active metabolite levels,79
3,Blood protein levels in cardiovascular risk,37
3,Serum levels of protein NXT1,952
3,Autoimmune traits (pleiotropy),1216
3,prednisolone sensitivity in B-cell precursor acute lymphoblastic leukaemia,445
3,Anadin tablet | treatment/medication code,75
3,Nodular sclerosis Hodgkin lymphoma,34
3,Protein quantitative trait loci (liver) [HP],7
3,Protein quantitative trait loci (liver) [CYP4A11],5
3,Benign neoplasm of other parts of digestive system,5814
3,Electrocardiogram morphology (amplitude at temporal datapoints) [160 ms],6807
3,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction) [men],2296
3,Thyroxine product | treatment/medication code,417
3,Serum metabolite levels [pyroglutamine*],267
3,Diaphragmatic hernia,3
3,Anorexia nervosa vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),12
3,"Body mass index in physically active individuals [EA,women]",1753
3,"Blood protein levels [BTD, 9269_7_3]",144
3,Human milk oligosaccharide concentration (lacto-N-fucopentaose III),153
3,White blood cell count (basophil),17476
3,Oily fish consumption,6067
3,Low hand grip strength (60 years and older) (EWGSOP),2045
3,Time to complete round,9422
3,None of the above | types of physical activity in last 4 weeks,1248
3,"Smoking initiation (ever regular vs never regular) [Conditioned on chr3:159048333, chr3:158284861]",143
3,Brain region volumes [right cuneus],208
3,UNC496MF abundance in stool,44
3,Response to aripiprazole in schizophrenia,6
3,Urate levels,641859
3,Smoking behaviour (cigarettes smoked per day),132360
3,Urinary albumin-to-creatinine ratio,89683
3,Thyrotropin subunit beta levels,10473
3,Neonatal cytokine/chemokine levels (fetal genetic effect) [CXCL9],669
3,Blood protein levels [Dual specificity mitogen-activated protein kinase kinase 4],423
3,Severe influenza A (H1N1) infection,129
3,Obesity [Obesity class II],1767
3,Myopia (pathological),272
3,Keratoconus,225
3,"""Disorders of sclera, cornea, iris and ciliary body""",9
3,Body mass index (joint analysis main effects and physical activity interaction),5249
3,"Allergic disease (asthma, hay fever and/or eczema) (age of onset)",417
3,Serum levels of protein CFD,271
3,Sodium in urine,172
3,Gut microbiota abundance (genus Peptococcus id.2037),32
3,Fibrinogen [EA],4972
3,IgG monogalactosylation phenotypes (multivariate analysis),839
3,Serum levels of protein POMGNT2,1641
3,Leukocyte telomere length [East Asian],4363
3,Acetobacteraceae abundance in stool,35
3,5-hydroxyindoleacetate levels,20
3,"Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)",17773
3,Cortical surface area [Postcentral],525
3,Myopia (age of diagnosis),2260
3,Medication use (antihistamines for systemic use),81
3,HDL cholesterol,254942
3,Diastolic blood pressure x smoking status (ever vs never) interaction (2df test) [EA],6971
3,Procollagen galactosyltransferase 1 measurement,5622
3,Butter/spreadable butter | spread type,298
3,Fat-free mass [female],2266
3,Waist circumference [East Asian],814
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-476 ms],163
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-112 ms],1230
3,Self-reported risk-taking behaviour,5053
3,DVT of lower extremities,2722
3,Malaria [dominant],193
3,Post bronchodilator FEV1/FVC ratio [AA],11
3,Protein quantitative trait loci (liver) [PYCARD],33
3,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),46012
3,Asthma (only as main-diagnosis) (more control exclusions),6587
3,Total hippocampal volume,2235
3,Vitamin d  | vitamin and/or mineral supplement use,213
3,Hypertension [Japanese],393
3,Ulcerative colitis [EA],40470
3,Serum levels of protein CCL21,7367
3,Alcohol use disorder (total score),5659
3,Electrocardiogram morphology (amplitude at temporal datapoints) [32 ms],650
3,"""Haemangioma, any site (controls excluding all cancers)""",125
3,Early-onset Parkinson's disease,110
3,Acute lymphoblastic leukemia (childhood) [ETV6-RUNX1 positive],52
3,Allergic rhinitis,3063
3,Low density lipoprotein cholesterol levels,402436
3,Epstein-Barr virus EBNA-1 antibody levels,3824
3,Serum levels of protein CTAG1A,8218
3,Serum levels of protein MYCT1,1299
3,Blood protein levels [Interleukin-1 Receptor accessory protein],453
3,"Blood protein levels [LRPPRC, 9046_46_3]",923
3,Depressive symptom (depressed mood) (binary trait),1209
3,Dimethylglycine levels,249
3,CAG-465 sp000433135 abundance in stool,121
3,Chronic venous disease,6
3,"Blood protein levels [ST3GAL6, 6947_4_3]",3024
3,Body mass index (bmi),762702
3,KDEL motif-containing protein 2 measurement,458
3,Serum levels of protein KLKB1,439
3,Electrocardiogram morphology (amplitude at temporal datapoints) [184 ms],174
3,White matter microstructure (radial diusivities) [Corticospinal tract ],143
3,Serum levels of protein KNG1,4241
3,Muesli | cereal type,55116
3,malignant neoplasm of male genital organs,5481
3,"Other (e.g. cornflakes, frosties) | cereal type",708
3,Smoking behaviour (age at first cigarette),314
3,Electrocardiogram morphology (amplitude at temporal datapoints) [204 ms],174
3,White matter microstructure (mean diusivities) [Average across all tracts],945
3,Electrocardiogram morphology (amplitude at temporal datapoints) [208 ms],174
3,"Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) [AA,women]",112
3,Inter-alpha-trypsin inhibitor heavy chain H3 measurement,287978
3,Leprosy,1233
3,Serum levels of protein CDCP1,2283
3,"N,n,n-trimethyl-alanylproline betaine (tmap) levels",2726
3,Blood protein levels [Histidine-rich glycoprotein],145
3,Persons encountering health services for examination and investigation,235
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-68 ms],650
3,Protein quantitative trait loci (liver) [PEA15],29
3,"Sphingomyelin (d18:1/22:1, d18:2/22:0, d16:1/24:1) levels",12816
3,"Blood protein levels [DCBLD2, 9338_2_3]",3024
3,Serum levels of protein LST1,1146
3,Bipolar disorder or body mass index,1767
3,Psoriasis [EA],295
3,Prostaglandin E synthase 2 measurement,407
3,Smoking initiation (ever regular vs never regular) [Conditioned on chr3:117822149],43
3,Intestinal malabsorption (non-celiac),26265
3,Liver enzyme levels (gamma-glutamyl transferase),251978
3,Lung adenocarcinoma [East Asian],4123
3,Moderate to vigorous physical activity levels,3887
3,Serum levels of protein VSNL1,1215
3,"GrpE protein homolog 1, mitochondrial measurement",158
3,White matter microstructure (mode of anisotropy) [Posterior limb of internal capsule],1310
3,Goiter,90
3,Protein quantitative trait loci (liver) [SERPINF1],24
3,Extremely high intelligence,34897
3,Current tobacco smoking,1727
3,"Hip circumference [EA,women]",2043
3,Blood protein levels [LTF],27614
3,Corneal structure,794
3,"Blood protein levels [AHSG, 3581_53_3]",1744
3,Bimatoprost | treatment/medication code,567
3,White blood cell count [Basophils],720
3,Squamous cell lung carcinoma [East Asian],6
3,Protein quantitative trait loci (liver) [HBD],2
3,Sum eosinophil basophil counts,147339
3,Mean corpuscular haemoglobin concentration,14681
3,Low myopia vs hyperopia,2057
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-174 ms],157
3,"Blood protein levels [PLA2G7, 5015_15_1]",248
3,TNF-related activation-induced cytokine levels,197
3,"Number of operations, self-reported",26434
3,Electrocardiogram morphology (amplitude at temporal datapoints) [122 ms],174
3,TRAIL levels,570
3,Age asthma diagnosed,417
3,Protein quantitative trait loci (liver) [COL14A1],2
3,Protein FAM162A measurement,12244
3,Hepatitis C induced liver fibrosis [QTF],923
3,CX3CR1 on CD14+ CD16- monocyte,474
3,"Nervous breakdown | non-cancer illness code, self-reported",1105
3,Respiratory or ear-nose-throat disease,1022
3,Protein quantitative trait loci (liver) [ANP32A],24
3,General factor of neuroticism,16140
3,SSC-A on granulocyte,1243
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-74 ms],852
3,Frequency of drinking alcohol,633
3,Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis),417
3,Lobe attachment (rater scored),112
3,Papulosquamous disorders,9
3,Crohn's disease,196141
3,Pediatric autoimmune diseases,34930
3,Blood pressure [Mean Arterial Pressure],85525
3,Total cholesterol levels [EA],13084
3,Eyebrow thickness,5722
3,Sleep duration (short sleep),1336
3,Diabetes | illnesses of siblings,891
3,Interleukin-6 receptor subunit beta measurement,948
3,Cerebrospinal P-tau181p levels,1310
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-492 ms],406
3,Ease of skin tanning,6327
3,White matter hyperintensity volume x hypertension interaction (2df),21958
3,Mammographic density (dense area),894
3,Total body bone mineral density (MTAG),670
3,Protein quantitative trait loci (liver) [HIBCH],202
3,Serum levels of protein PROK2,68
3,Protein quantitative trait loci (liver) [FGG],5
3,"""Hypothyroidism, strict autoimmune""",6113
3,Spherical equivalent or myopia (age of diagnosis),6247
3,Fasting glucose adjusted for BMI,1162
3,"Blood protein levels [DCUN1D5, 8760_10_3]",248
3,Type 2 diabetes [South Asians],872
3,"Eyebrow thickness [East Asian, Hispanic and Other admixed]",626
3,Water intake,204
3,Coronary artery disease,344917
3,"Blood protein levels [TDGF1, 5810_25_3]",3379
3,Arm fat-free mass (right),145421
3,Serum levels of protein RAB6B,699
3,Heel broadband ultrasound attenuation (right),8250
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-184 ms],4696
3,Male puberty timing (late vs. average onset facial hair),48
3,"Blood protein levels [PROK2, 10754_113_3]",1173
3,Blood metabolite levels [carnitine],213
3,Protein quantitative trait loci (liver) [VDAC1],48
3,Protein quantitative trait loci (liver) [FERMT2],6
3,Inter-alpha-trypsin inhibitor heavy chain H4 measurement,17745
3,3-hydroxy-2-ethylpropionate levels,1137
3,Serum levels of protein SIRT2,5475
3,X-23308 levels,971
3,Coronary heart disease,4382
3,Diseases of the respiratory system,843
3,Place of birth in uk - east co-ordinate,1074
3,Sedentary behaviour duration,147
3,Serum phosphate levels,46488
3,Serum levels of protein ZNF334,116001
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-140 ms],2538
3,White matter microstructure (mode of anisotropy) [Anterior limb of internal capsule],139
3,Amino-terminal enhancer of split measurement,158
3,"Blood protein levels [EA, Semaphorin-3A]",145
3,Protein quantitative trait loci (liver) [EIF4A1],15
3,Platelet distribution width,561618
3,Worry too long after embarrassment,12203
3,Cancer (pleiotropy) [subset analysis],4085
3,Serum levels of protein ETHE1,53075
3,Vertex-wise cortical thickness,403851
3,Pattern 4 | hair/balding pattern,16188
3,circulating leptin levels adjusted for BMI,3018
3,IgG glycosylation patterns [IgG2_G1FS1],804
3,White matter microstructure (mean diusivities) [Fornix (column and body],1310
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-222 ms],525
3,Relative age voice broke,10
3,Self-harmed in past year,325
3,Urinary sodium excretion,35
3,Waist-to-hip ratio adjusted for body mass index [AA],130
3,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)",154844
3,Complement component C8 measurement,248
3,"Blood protein levels [LRRC15, 6557_50_3]",1487
3,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant I (Philtrum), Segment 33]",254
3,Bone mineral density (hip) [trochanter],13
3,Electrocardiogram morphology (amplitude at temporal datapoints) [142 ms],174
3,Protein quantitative trait loci (liver) [MAP4],6
3,Nevus count or cutaneous melanoma,9905
3,"""Ulcerative colitis (strict definition, require KELA)""",34280
3,"Blood protein levels [C2orf40, 6362_6_3]",248
3,Waist circumference adjusted for body mass index [men],1987
3,Serum levels of protein PDCD1LG2,902
3,Bone mineral density,307
3,Walking pace,185774
3,Average total household income before tax,41597
3,Lung cancer [Adenocarcinoma],266
3,"Blood protein levels [FASLG, 3052_8_2]",33846
3,Urinary metabolites [2.916 ppm],835
3,Facial morphology (nose roundness 1),2637
3,Chronic kidney disease [eGFRcrea],2269
3,Serum metabolite levels [andro steroid monosulfate C19H28O6S (1)*],212
3,"Blood protein levels [RAB17, 11118_107_3]",248
3,Lobe attachment (rater scored) [Chinese],112
3,Total cholesterol levels [Trans-ethnic initial],957
3,"Blood protein levels [EA, Thioredoxin domain-containing protein 12]",54571
3,Heel broadband ultrasound attenuation (left),2380
3,Serum levels of protein RPLP2,4831
3,Iron status biomarkers [Total iron-binding capacity],3334
3,Corneal resistance factor,1530
3,"Blood protein levels [BCHE, 8239_223_3]",248
3,Nervous feelings,145722
3,Serum alkaline phosphatase levels,484330
3,"Blood protein levels [SYT11, 7089_42_3]",284
3,CCR2 on CD14- CD16-,5397
3,"""Diabetes, insuline treatment (Kela reimbursement)""",4340
3,Serum levels of protein CCL4L1,5272
3,Diabetes | illnesses of father,1157
3,Facial morphology (segment 30),745
3,Protein quantitative trait loci (liver) [GARS],189
3,"Urinary tract infection/kidney infection | non-cancer illness code, self-reported",95
3,"Blood protein levels [ITIH3, 7145_1_3]",286288
3,Body mass index and HDL-C (pairwise),1753
3,Lipoprotein (a) levels,9287
3,Amlodipine | treatment/medication code,9325
3,Protein levels in obesity [Carbonic anhydrase I],2899
3,Electrocardiogram morphology (amplitude at temporal datapoints) [148 ms],174
3,Psychoticism,65
3,Depressive symptoms (binary sum-score),61321
3,Mouth ulcers | mouth/teeth dental problems,17558
3,Asthma or allergic disease (pleiotropy),1181
3,"Blood protein levels [TMEM87B, 13485_20_3]",792
3,IgG glycosylation patterns [IgG1 FG2S1/(FG2+FG2S1],804
3,IgG disialylation phenotypes (multivariate analysis),839
3,Urinary metabolite levels in chronic kidney disease [succinylcarnitine (C4-DC],202
3,Gut microbiota (functional units) [GO:0009229|BP|05|thiamine diphosphate biosynthetic process],160
3,Esomeprazole | treatment/medication code,110
3,Senile cataract,25
3,UCG-010 sp003150215 abundance in stool,12
3,HDL cholesterol levels,328655
3,Frequency of stair climbing in last 4 weeks,7023
3,Cerebrospinal fluid biomarker levels [Lactotransferrin],2334
3,Serum levels of protein H2AFZ,1146
3,Serum levels of protein HIST2H2BE,1146
3,Headache | pain type(s) experienced in last month,83
3,Car/motor vehicle | types of transport used (excluding work),136
3,Alanine transaminase levels,12669
3,"Waist-to-hip ratio adjusted for body mass index [EA, women]",392986
3,Thyroid problem (not cancer),11445
3,Serum levels of protein RBL2,119891
3,"Heel bone mineral density (bmd) t-score, automated (right)",60555
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-32 ms],2674
3,Electrocardiogram morphology (amplitude at temporal datapoints) [238 ms],174
3,Alcohol consumption,2800
3,Myocardial fractal dimension (slice 8),164
3,Medication use (drugs affecting bone structure and mineralization),652
3,Juvenile Open Angle Glaucoma,53
3,Lung function (FVC) [adults],15818
3,"Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [Asian, EA]",3894
3,IgG glycosylation [IGP26],839
3,"Blood protein levels [AHSG, 10966_1_3]",2340
3,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial measurement",354
3,Lobe attachment (rater-scored or self-reported),23462
3,Major coronary heart disease event,2123
3,Lateral thalamic nuclei volume,9652
3,Gestational age at birth (maternal effect),6156
3,"HDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test) [EA, trans-ethnic]",1255
3,Serum levels of protein SULF2,372
3,Attention deficit hyperactivity disorder or amygdala volume (pleiotropy),25
3,Disorders of skin appendages,26
3,Lymphocyte counts,446505
3,Blood urea nitrogen levels,102721
3,Malignant neoplasm of prostate (controls excluding all cancers),5481
3,QRS duration [African American],27
3,von Willebrand factor A domain-containing protein 1 measurement,1897
3,Loneliness,2641
3,Electrocardiogram morphology (amplitude at temporal datapoints) [196 ms],358
3,Endoplasmic reticulum lectin 1 measurement,158
3,Takayasu arteritis,7
3,Systolic blood pressure,1615551
3,Age completed full time education,91429
3,Gut microbiota (bacterial taxa) [OTU10032 unclassified Enterobacteriaceae Species-level OTU],1306
3,"Blood protein levels [TXNDC12, 4815_25_3]",346038
3,Immature reticulocyte fraction,114909
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-18 ms],1137
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-30 ms],5055
3,"Waist-to-hip ratio adjusted for body mass index [EA, men]",1025
3,Serum levels of protein HSPA1L,248
3,Neuritic plaques (SNP x SNP interaction),203
3,Serum levels of protein PSD2,248
3,Gut microbiota (bacterial taxa) [Marinilabiliaceae family],103
3,"Pulse pressure x alcohol consumption interaction (2df test) [AA, EA]",195034
3,Maxalt 5mg tablet | treatment/medication code,4927
3,Gallbladder disease,2903
3,Serum levels of protein CD200,3124
3,Waist-to-hip ratio adjusted for BMI in non-smokers [women],127
3,Diverticulosis,2672
3,Phosphatidylinositol_34:1_[M-H]1- levels,410
3,Intrinsic epigenetic age acceleration,56161
3,Blood protein levels [CCL4],13919
3,T wave morphology restitution during exercise,525
3,Bread intake,1721
3,Tea consumption,1005
3,Serum levels of protein CPB1,127
3,Nystagmus and other irregular eye movements,71
3,Salt added to food,59154
3,Serum CC16 levels,68
3,Non-allergic asthma (mode),167
3,A levels/as levels or equivalent | qualifications,75586
3,"Blood protein levels [ICT1, 6380_23_3]",165076
3,"Waist circumference adjusted for body mass index [EA, men]",7413
3,Ascorbate (vitamin c) levels,998
3,Metformin | treatment/medication code,2000
3,CD11c+ HLA DR++ monocyte %monocyte,417
3,IgG glycosylation patterns [IgG1 G2S1/(G2+G2S1],993
3,Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in secretors,51
3,Smoking cessation (MTAG),100042
3,HDL cholesterol levels in current drinkers [EA],4972
3,Mean platelet (thrombocyte) volume,183732
3,"Blood protein levels [CCDC126, 6388_21_3]",248
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-162 ms],682
3,IgG sialylation phenotypes (multivariate analysis),839
3,Protein quantitative trait loci (liver) [PON1],215
3,"""Congenital malformations of ovaries, fallopian tubes and broad ligaments""",7
3,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test) [EA],7147
3,Behcet's disease,3101
3,IgG glycosylation patterns [IgG2 Sialylation],839
3,Sleep (1/2-day periodicity),1236
3,Gut microbiota (bacterial taxa) [Lactobacillales order],89
3,Change in serum metabolite levels [LA_FA],292
3,Neonatal cytokine/chemokine levels (fetal genetic effect) [CX3CL1],196
3,"Blood protein levels [XXYLT1, 6375_75_3]",44
3,Cerebrospinal fluid biomarker levels [Interleukin-17 receptor D],2142
3,Cortical thickness (min-P),1310
3,Serum levels of protein UMOD,902
3,IgG glycosylation patterns [IgG1_G2S1/IgG1_G2],993
3,Cortical volume [Superior temporal],336
3,Keloid,2281
3,"Blood protein levels [PPT1, 9244_27_3]",248
3,Electrocardiographic traits (multivariate),454
3,Ras-related protein Rab-1A measurement,158
3,Early response to risperidone in schizophrenia,109
3,Stroke | illnesses of siblings,189
3,Body fat distribution (trunk fat ratio) [females],106456
3,IgG glycosylation [IGP24],1560
3,Age at first live birth,94600
3,Type 2 diabetes [DGI+FUSION+WTCCC],1758
3,Brain region volumes [left postcentral],611
3,Bone mineral density (hip),345
3,Monocyte count [EA],63
3,"Body mass index (joint analysis main effects and physical activity interaction) [EA, men]",22
3,Hodgkin's lymphoma,1201
3,Myopia,1503
3,Fasting plasma glucose [Non diabetics],939
3,Waist circumference adjusted for BMI in non-smokers [women],1215
3,"Skin, hair and eye pigmentation (multivariate analysis)",203
3,Renal cell carcinoma,39548
3,Colorectal cancer [EA],1956
3,Benign neoplasms (controls excluding all cancers),5140
3,Anxiety disorder,1116
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-194 ms],650
3,Other and unspecified primary disorders of muscles,347
3,Serum levels of protein PPT1,248
3,Electrocardiographic traits [QRS complex],492
3,"Blood protein levels [APOE, 2418_55_9]",248
3,Normal-pressure hydrocephalus,34
3,White matter microstructure (fractional anisotropy) [Sagittal stratum],76
3,Reticulocyte count,643189
3,Age of smoking initiation,313
3,High light scatter reticulocyte percentage,151419
3,Essential hypertension (time to event),6310
3,Bipolar disorder [Latent Class 2],42
3,Adolescent idiopathic scoliosis,34666
3,Average weekly spirits intake,65620
3,None of the above | qualifications,108467
3,Blood metabolite ratios [X-11315/pyroglutamine],835
3,"Blood protein levels [CD200R1, 5103_30_3]",2583
3,Electrocardiogram morphology (amplitude at temporal datapoints) [18 ms],3637
3,Electrocardiographic traits [PR interval],1029
3,Neonatal cytokine/chemokine levels (fetal genetic effect) [CXCL13],196
3,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event) [Cox proportional hazards regression model],165
3,Serum levels of protein FSTL1,16
3,Risk-taking tendency (4-domain principal component model),121495
3,Bipolar disorder or major depressive disorder,21274
3,Hereditary hemochromatosis-related traits (HFE mutation homozygotes) [Serum Iron levels],3334
3,Osteoporosis nos,42174
3,Malignant neoplasm of breast (controls excluding all cancers),4779
3,Glioma (high-grade),3929
3,Vertical cup-disc ratio (adjusted for vertical disc diameter),3049
3,Serum levels of protein CAMP,248
3,Paroxetine | treatment/medication code,115
3,Cortical surface area [Lingual],753
3,Low high density lipoprotein cholesterol levels,277
3,Multiple myeloma,379569
3,Educational attainment,73369
3,Lacunar stroke,63478
3,White blood cell (leukocyte) count,155779
3,Red blood cell (erythrocyte) count,302875
3,Serum levels of protein F9,872
3,Serum metabolite levels [erythronate*],820
3,Clostridium saudiense abundance in stool,874
3,Malaria [heterogeneous],193
3,Serum levels of protein DEFB1,178
3,Dietary macronutrient intake [Carbohydrate],38
3,Serum levels of protein HAAO,48
3,Protein quantitative trait loci (liver) [ACSS3],41
3,Both eyes | ever had cataract surgery,1011
3,Spherical equivalent,8021
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-500 ms],406
3,Fish- and plant-related diet [male],30
3,"Blood protein levels [EA, Endothelin-converting enzyme 1]",416
3,"Type 2 diabetes [South Asian, East Asian, Europeans]",872
3,Mental and behavioural disorders due to alcohol,1313
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-90 ms],1301
3,Nontoxic multinodular goitre,90
3,Urolithiasis,4583
3,Malignant neoplasm,231
3,White blood cell types [basophil count],413
3,CD3 on CD45RA+ CD4+ T cell,765
3,T wave morphology restitution during exercise (MTAG),525
3,Diffuse large B-cell lymphoma or systemic lupus erythematosus,102
3,"Blood protein levels [NCK1, 5014_49_1]",131
3,Mean sphered cell volume,512323
3,White matter microstructure (fractional anisotropy) [Fornix (column and body],1310
3,Reaction time,1104
3,Brain region volumes [left cuneus],416
3,"Blood protein levels [IL1RAP, 14048_7_3]",644
3,Electrocardiogram morphology (amplitude at temporal datapoints) [140 ms],174
3,Electrocardiogram morphology (amplitude at temporal datapoints) [110 ms],174
3,Acute lymphoblastic leukemia (childhood),52
3,Bipolar disorder (MTAG),385350
3,Transferrin receptor protein 1 levels,3922
3,Electrocardiogram morphology (amplitude at temporal datapoints) [128 ms],6807
3,Glucose levels,10055
3,Major depressive disorder [50% oldest-onset cases],355
3,No | surgery/amputation of toe or leg,135
3,Myocardial fractal dimension (slice 6),440
3,"""Ulcerative colitis (strict definition, all Crohn cases excluded)""",34280
3,Total protein levels x insomnia interaction,3080
3,Serum levels of protein LRRC15,1487
3,Phosphatidylinositol_36:4_[M-H]1- levels,871
3,Serum levels of protein ADM,379
3,Serum levels of protein LTF,1523
3,Cortical surface area [Precuneus],2314
3,Age-related nuclear cataracts [Random effect],90
3,Depressive symptoms (MTAG),121823
3,Doctor diagnosed hayfever or allergic rhinitis,365
3,Bacillus C abundance in stool,478
3,Invasive epithelial ovarian cancer,4715
3,Gallstone disease,1629
3,Mood swings,3520
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-186 ms],4696
3,Diabetes related eye disease | eye problems/disorders,879
3,"Aging traits (healthspan, parental lifespan or longevity) (multivariate analysis)",239
3,Platelet count [AA],15
3,Depressed affect,42537
3,Gastric cancer,207
3,Processed meat consumption,1373
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-138 ms],2538
3,Electrocardiogram morphology (amplitude at temporal datapoints) [138 ms],174
3,"Hiv/aids | non-cancer illness code, self-reported",141
3,Arm total mass,7
3,BAFF-R on CD20- B cell,3
3,Resting heart rate,51151
3,Glomerular filtration rate,30717
3,Leg pain on walking,99420
3,Antihypertensive medication - note that there are other indications,3600
3,Heart rate response to recovery post exercise (20 sec),1235
3,Electrocardiogram morphology (amplitude at temporal datapoints) [192 ms],174
3,Triglyceride levels [Trans-ethnic initial],4750
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-34 ms],101
3,Serum levels of protein IL10RA,248
3,Systemic lupus erythematosus [EA],61
3,"Trouble falling or staying asleep, or sleeping too much",307
3,"Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA, men]",1987
3,Gut bacterial pathway abundance (PWY.841..superpathway.of.purine.nucleotides.de.novo.biosynthesis.I),1043
3,Protein quantitative trait loci [TXD12],2905
3,"Ankylosing spondylitis | non-cancer illness code, self-reported",434
3,Phenylacetylglutamine levels,39
3,Inflammatory bowel disease [EA],41929
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-66 ms],650
3,Photic sneeze reflex,376
3,"Orofacial clefts [Meta-All, NSCL/P]",1125
3,Betaine levels,835
3,"""Disorder of thyroid, unspecified""",107
3,Waist circumference adjusted for BMI (adjusted for smoking behaviour) [men],96798
3,Diabetes or endocrine disease,32271
3,Electrocardiogram morphology (amplitude at temporal datapoints) [24 ms],2244
3,Low testosterone levels,5633
3,Cholelithiasis or gall stones,3239
3,Often | worked with materials containing asbestos,247
3,Atenolol | treatment/medication code,763
3,Age at first birth,528404
3,Immature fraction of reticulocytes,245692
3,Average weekly beer plus cider intake,79288
3,"Blood protein levels [MANF, 9223_11_3]",48024
3,Brain region volumes [left accumbens area],1310
3,Type 2 diabetes [Japanese],879
3,Cardiorespiratory fitness (vo2 max),1049
3,Electrocardiogram morphology (amplitude at temporal datapoints) [158 ms],174
3,Testosterone levels,25386
3,Mean arterial pressure,36527
3,Birth length (MTAG),3311
3,Type 2 diabetes and end-stage kidney disease,186
3,Sebaceous cyst,4460
3,Serum levels of protein SEMA3G,12227
3,None of the above | vascular/heart problems diagnosed by doctor,134225
3,IgG glycosylation patterns [IgG4 FG2S1/(FG2+FG2S1],839
3,N-acetylglucosamine/n-acetylgalactosamine levels,3254
3,"Blood protein levels [FAM3D, 13102_1_3]",865
3,IgG N-glycosylation phenotypes (multivariate analysis),1826
3,Daytime dozing / sleeping (narcolepsy),1721
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-110 ms],1144
3,"Sphingomyelin (d18:1/20:0, d16:1/22:0) levels",221
3,Excessive hairiness,9
3,"Blood protein levels [EA, Vascular endothelial growth factor receptor 3]",101
3,Low urine pH,190
3,Protein quantitative trait loci (liver) [ARHGDIA],33
3,Smoking initiation (ever regular vs never regular),144686
3,Ascending aorta minimum area,113981
3,"Heel broadband ultrasound attenuation, direct entry",112823
3,IgG glycosylation [IGP29],1560
3,"Blood protein levels [EA, Methionine aminopeptidase 2]",15
3,Waist-to-hip ratio adjusted for BMI x sex interaction,5444
3,Non-small cell lung cancer [East Asian],4334
3,Diastolic blood pressure (cigarette smoking interaction),7641
3,Caffeine consumption from coffee or tea,4922
3,"Blood pressure medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",13859
3,Essential (haemorrhagic) thrombocythaemia,90
3,Bipolar disorder vs major depressive disorder (ordinary least squares (OLS)),1190
3,Butyrate (4:0) levels,73
3,GCA-900066755 abundance in stool,15
3,"""Primary open-angle glaucoma, strict""",53
3,Serum albumin levels,63164
3,"Asthma | non-cancer illness code, self-reported",17767
3,Waist-to-hip ratio adjusted for body mass index [men],1025
3,Vitamin K-dependent protein C measurement,263
3,Relative sugar intake,38
3,Protein quantitative trait loci (liver) [AGXT],7
3,Protein quantitative trait loci (liver) [PCCB],5
3,Waist circumference adjusted for BMI in active individuals [EA],194968
3,Risky sexual behaviors (alcohol dependence interaction) [men],4978
3,Obesity [Overweight],1593
3,Migraine without aura and/or pulse pressure,881
3,Albumin-globulin ratio,578
3,Cannabis dependence symptom count [AA],30
3,Sleep apnoea,42
3,Facial morphology (segment 15),22
3,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) [subset analysis]",36564
3,"Blood protein levels [LHCGR, 14634_13_3]",267223
3,Brugada syndrome,1826
3,Bacillaceae A abundance in stool,1135
3,Rabeprazole sodium | treatment/medication code,2
3,Number of sexual partners,17358
3,Macular thickness,8830
3,Oily fish intake,3710
3,"Blood protein levels [ADM, 14115_34_3]",379
3,Gut microbiota (bacterial taxa) [Bacilli class],208
3,Other arthropathies,940
3,Brain region volumes [Brain stem],529
3,Ever sought or received professional help for mental distress,81
3,Medication use (HMG CoA reductase inhibitors),12784
3,HDL cholesterol levels x long total sleep time interaction (2df test),5389
3,IgG glycosylation [IGP17],839
3,QRS complex (12-leadsum) [EA],692
3,Bone mineral density or trunk lean mass (pleiotropy),307
3,Metabolite levels [indoxyl sulfate],64
3,Protein quantitative trait loci (liver) [GNMT],14
3,Diastolic blood pressure,2420903
3,Serum uric acid levels [EA],5728
3,Cortical thickness [average],4508
3,Alcohol consumption (transferrin glycosylation) [Total transferrin],3334
3,Protein quantitative trait loci [HRG],1282
3,Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI,278
3,Brain region volumes [left hippocampus],321
3,Serum levels of protein ARHGAP30,248
3,"Systolic blood pressure x alcohol consumption interaction (2df test) [Asian, EA]",48
3,Lung volume,15
3,Protein quantitative trait loci (liver) [PREP],2
3,Waist circumference adjusted for BMI (adjusted for smoking behaviour),176089
3,Pulse pressure [EA],240971
3,"Blood protein levels [MST1, 4407_10_1]",210932
3,"Blood protein levels [MYCT1, 13541_1_3]",1523
3,X-11612 levels,2874
3,LDL cholesterol levels [Trans-ethnic initial],19005
3,Bipolar disorder vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),2507
3,Idiopathic central precocious puberty,14899
3,Serum levels of protein MRPL58,52911
3,Electrocardiogram morphology (amplitude at temporal datapoints) [46 ms],525
3,Limited cutaneous systemic scleroderma,1146
3,Clostridium M sp001304855 abundance in stool,267
3,TNF-related apoptosis-inducing ligand receptor 2 levels,39
3,Femur total bone mineral density x gut microbiota (﻿genus Lactococcus) interaction,44
3,Other disorders of white blood cells,1
3,Highest math class taken (MTAG) [MTAG],368207
3,Dentures,97216
3,Cortical thickness (MOSTest),7655
3,Monocyte chemoattractant protein-1 levels,12938
3,College or university degree | qualifications,120183
3,Previous | smoking status,6072
3,IgG glycosylation patterns [IgG1_G2FS1/IgG1_G2F],804
3,Lawsonibacter sp002161175 abundance in stool,769
3,Basophil percentage of granulocytes,7548
3,Nonpyogenic thrombosis of intracranial venous system,66
3,Developmental stuttering,73
3,Maternal care related to the fetus and amniotic cavity and possible delivery problems,6
3,Leg total mass,7
3,Waist circumference adjusted for body mass index [EA],289420
3,Total cerebellar volume (excluding Crus I vermis),95547
3,Hypothyroidism nos,1361
3,Skin cancer,4228
3,Bipolar disorder vs autism spectrum disorder (ordinary least squares (OLS)),1190
3,X-18887 levels,819
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-154 ms],682
3,"""Artrosis, including avohilmo""",39
3,"Other renal/kidney problem | non-cancer illness code, self-reported",361
3,White matter microstructure (mode of anisotropy) [Superior longitudinal fasciculus],209
3,Automobile speeding propensity,129376
3,Medication use (beta blocking agents),216243
3,Osteoarthritis (hip) [additive],112165
3,Electrocardiogram morphology (amplitude at temporal datapoints) [220 ms],19823
3,Number of fluid intelligence questions attempted within time limit,2601
3,CD62L- monocyte %monocyte,332
3,CAG-448 abundance in stool,5
3,CAG-977 abundance in stool,16
3,Multiple sclerosis,77009
3,Diastolic blood pressure x smoking status (ever vs never) interaction (2df test),16958
3,1-palmitoyl-2-linoleoyl-gpc (16:0/18:2) levels,917
3,Brainstem volume,529
3,Tonsillectomy,194
3,Protein quantitative trait loci (liver) [AKR1D1],47
3,Protein quantitative trait loci (liver) [CPQ],3
3,Serum levels of protein IL22,372
3,"Blood protein levels [EA, Fetuin-B]",81
3,Electrocardiogram morphology (amplitude at temporal datapoints) [182 ms],174
3,Urinary albumin excretion,1062
3,Executive function (trail making test B),111779
3,Year ended full time education,33837
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-158 ms],3220
3,"""Diabetes, insuline treatment (Kela reimbursement) (more control exclusions)""",4340
3,Serum levels of protein CACNA2D3,417
3,Age at menopause,77527
3,"Waist circumference adjusted for body mass index [EA, women]",73167
3,"""Disorders of eyelid, lacrimal system and orbit""",1925
3,Cortical volume [Postcentral],463
3,Heart rate variability traits (pvRSA/HF),320
3,"Blood protein levels [Alkaline phosphatase, tissue-nonspecific isozyme]",989
3,Anorexia nervosa,38527
3,Suffer from 'nerves',3915
3,Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],69166
3,Cognitive aspects of educational attainment,626524
3,Diverticular disease,2542
3,IgG glycosylation patterns [IgG1 SA per Gal],804
3,QRS duration [European],2713
3,PR interval [AA],624
3,Gut microbiota (functional units) [ARO-PWY_chorismate_biosynthesis_I],209
3,Electrocardiogram morphology (amplitude at temporal datapoints) [260 ms],291
3,Chronic iridocyclitis,6
3,High density lipoprotein cholesterol levels,205494
3,Schizophrenia [East Asian],2107
3,Barrett's esophagus  or Esophageal adenocarcinoma,46
3,Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis),2245
3,COVID-19 (hospitalized vs not hospitalized) RELEASE 5,8472
3,Levothyroxine sodium | treatment/medication code,5493
3,interleukin 17 receptor B levels,874
3,Mitochondrial DNA levels,13072
3,4-chlorobenzoic acid levels,371
3,Blautia A sp900066355 abundance in stool,1681
3,Primary biliary cirrhosis,5532
3,Obesity-related traits [MCP1 ],2241
3,Magnesium citrate | treatment/medication code,176
3,Thymus and reactivation regulated chemokine levels,278
3,Electrocardiogram morphology (amplitude at temporal datapoints) [170 ms],174
3,Femur bone mineral density x serum urate levels interaction,764
3,Open-angle glaucoma and vertical cup-disc ratio [EA],582
3,Attention deficit hyperactivity disorder or cannabis use,25
3,Betamethasone | treatment/medication code,36
3,Leg fat mass (right),226357
3,Flax oil tablet | treatment/medication code,1719
3,Composite immunoglobulin trait (IgA x IgG/IgM),11586
3,"Blood protein levels [CD200, 5112_73_3]",2534
3,Hepcidin levels [Tf],3334
3,Mental health study participation (provided email address),1148
3,Supervision of normal pregnancy,276
3,Protein quantitative trait loci (liver) [AK1],6
3,Autism spectrum disorder (MTAG),127781
3,"""UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)""",34280
3,Moxonidine | treatment/medication code,144
3,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),127
3,Inverse distance to the nearest major road,25
3,Electrocardiogram morphology (amplitude at temporal datapoints) [20 ms],6
3,High-grade serous ovarian cancer,4715
3,Loneliness (MTAG),1318
3,PR interval [Hispanic],440
3,Fractures,343
3,Neonatal cytokine/chemokine levels (fetal genetic effect) [CCL7],196
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-128 ms],125
3,IgG glycosylation [IGP15],1560
3,Thrombin measurement,439
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-202 ms],525
3,C-reactive protein levels or HDL-cholesterol levels (pleiotropy),5828
3,Electrocardiogram morphology (amplitude at temporal datapoints) [118 ms],6807
3,6mm weak meridian (left),58082
3,Sporadic neuroblastoma,11629
3,Lung adenocarcinoma,8730
3,Asthma and anxiety disorder,1116
3,Language functional connectivity,4286
3,Facial morphology (segment 3),260
3,Retinal vascular fractal density,1829
3,Serum levels of protein CNTN4,113
3,Calcium | mineral and other dietary supplements,67
3,"Allergy or anaphylactic reaction to food | non-cancer illness code, self-reported",52
3,Neurofibrillary tangles (SNP x SNP interaction),19874
3,Sensitivity / hurt feelings,1310
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-494 ms],406
3,Coronary angiopasty,2065
3,Metabolite levels [quinolinic acid],298
3,Protein quantitative trait loci (liver) [IGKV4-1],4
3,Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined),7
3,Mean platelet volume,939726
3,"Blood protein levels [EA, Teratocarcinoma-derived growth factor 1]",924
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-190 ms],125
3,Gut microbiota presence (family Peptococcaceae id.2024),17
3,Anterior chamber depth,7498
3,Gut microbiota abundance (unknown family id.1000001214),989
3,Ever smoked,5000
3,COVID-19 (RELEASE 5),14350
3,Serum levels of protein IL12B,357
3,Brain region volumes [right postcentral],592
3,"Blood protein levels [KNG1, 4495_33_2]",1141
3,Acceptance of an invitation to wear a physical activity monitor,145
3,Serum levels of protein TIE1,902
3,Intelligence,209941
3,Overall health rating,40556
3,"""Type 2 diabetes, strict (exclude DM1)""",4498
3,Electrocardiogram morphology (amplitude at temporal datapoints) [228 ms],174
3,"Red blood cell traits [EA, MCH]",1705
3,Protein quantitative trait loci (liver) [HIST1H1C],7
3,Sleep duration,29171
3,Hip circumference adjusted for BMI,288246
3,Electrocardiogram morphology (amplitude at temporal datapoints) [224 ms],19639
3,Glucuronate levels,2284
3,"Seen doctor (gp) for nerves, anxiety, tension or depression",308
3,Serum levels of protein CRTAC1,536
3,Serum levels of protein BGN,343
3,Serum levels of protein FLT4,902
3,EGFR mutation-positive lung adenocarcinoma,185
3,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)",109905
3,No | hearing difficulty/problems,18653
3,Haemoglobin concentration,345289
3,Magnesium levels,397
3,DNA methylation GrimAge acceleration,6053
3,"Body mass index (joint analysis main effects and physical activity interaction) [EA, women]",1732
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-84 ms],525
3,Irritable bowel syndrome,185
3,Interleukin-27 levels,178
3,Osteoarthritis of the hip or knee,113664
3,Frailty index,99214
3,"Heel quantitative ultrasound index (qui), direct entry (left)",45227
3,Gut microbiota (bacterial taxa) [EscherichiaShigella],1424
3,Migraine and/or pulse pressure,848
3,Serum metabolite levels (CMS) [Gly],513
3,"Sphingomyelin (d18:1/20:1, d18:2/20:0) levels",654
3,"Blood protein levels [FSTL1, 13112_179_3]",16
3,Brugada syndrome [conditioned on rs10428132],34
3,Myeloproliferative diseases (CML excluded),17
3,Presence of other functional implants,28
3,Epithelial ovarian cancer,9430
3,Anxiety,49313
3,Serum levels of protein TMPRSS11D,33846
3,"Systolic blood pressure, automated reading",125480
3,Serum levels of protein ST3GAL6,5240
3,von Willebrand factor A domain-containing protein 2 measurement,2324
3,Serum levels of protein B4GAT1,768
3,Mometasone | treatment/medication code,1105
3,Heart rate response to exercise,509
3,"Blood protein levels [NXPH2, 9511_61_3]",248
3,"Blood protein levels [GAL3ST1, 8696_15_3]",248
3,Serum metabolite levels [androsterone sulfate],212
3,Barrett's esophagus,2
3,Injury of muscle and tendon at forearm level,5
3,Respiratory diseases,12575
3,Age at first sexual intercourse,158995
3,Household income (MTAG),175107
3,Usual walking pace,101419
3,Frequency of unenthusiasm / disinterest in last 2 weeks,14805
3,C-X-C motif chemokine 16 levels,12000
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-28 ms],2416
3,"Blood protein levels [DNAJB11, 7110_2_3]",1070
3,Alcohol consumption (transferrin glycosylation) [CDT percent],267
3,Depressive symptom measurement or major depressive disorder,288
3,Serum amyloid A-1 protein measurement,347
3,Diabetes | illnesses of adopted siblings,57
3,Protein quantitative trait loci (liver) [AMBP],17
3,Urinary metabolite levels in chronic kidney disease [Decanoylcarnitine],22
3,Smoking status,144266
3,Total PHF-tau (SNP x SNP interaction),32699
3,Age-related macular degeneration,2438
3,Psychiatric diseases (pleiotropy) (HIPO component 1),249
3,Protein quantitative trait loci (liver) [CTSS],427
3,Ebbinghaus illusion (underestimation),26
3,Insomnia [Female],132191
3,"""Thyrotoxicosis, other and/or unspecified""",417
3,Fibrinogen,5686
3,Serum levels of protein MAPK3,372
3,"Blood protein levels [PCOLCE2, 6081_52_3]",695
3,"Blood protein levels [CYP3A4, 2943_5_2]",248
3,Hypothyroidism (congenital or acquired),417
3,Blood protein levels [Vascular endothelial growth factor receptor 3],266
3,Protein quantitative trait loci (liver) [SERPINA1],40
3,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),100573
3,Depression,273455
3,None of the above | mouth/teeth dental problems,3773
3,Protein quantitative trait loci (liver) [ATOX1],293
3,Protein quantitative trait loci (liver) [LAMP2],6
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-48 ms],8
3,Ovarian cancer [All invasive],4715
3,Lung function (FEV1/FVC),443961
3,Sex hormone-binding globulin levels,802063
3,Liver enzyme levels (alkaline phosphatase),224623
3,Electrocardiogram morphology (amplitude at temporal datapoints) [222 ms],19639
3,Serum metabolite levels [orotate],9696
3,Interleukin-17 levels,284
3,Intracranial volume,619
3,Diverticular disease of intestine,3065
3,COVID-19 (severe respiratory symptoms vs population),2138
3,CAG-302 abundance in stool,821
3,"Blood protein levels [SEC13, 14689_3_3]",248
3,Qrs duration,141
3,Adiponectin levels,177016
3,"Medication use (adrenergics, inhalants)",129079
3,Subcortical volume (min-P),6889
3,Mean time to correctly identify matches,41802
3,Dorsopathies,1579
3,Response to antipsychotic treatment in schizophrenia,87
3,Alcohol consumption in current drinkers,116
3,Protein quantitative trait loci (liver) [ORM2],56
3,Phospholipase D3 measurement,158
3,Diseases of the eye and adnexa,27
3,Unspecified monoarthritis,21
3,Medication use (opioids),129787
3,CCL4 levels,6841
3,Public transport | transport type for commuting to job workplace,4308
3,Serum levels of protein ASGR1,1523
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-490 ms],406
3,Aspirin hydrolysis (plasma),249
3,Frequency of needing morning drink of alcohol after heavy drinking session in last year,4
3,Total bilirubin levels,86127
3,Ankle spacing width,136340
3,Electrocardiogram morphology (amplitude at temporal datapoints) [4 ms],2538
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-216 ms],525
3,Colon polyp,185
3,Electrocardiogram morphology (amplitude at temporal datapoints) [206 ms],174
3,Bladder cancer,5710
3,Fasting blood glucose,3789
3,Femur bone mineral density x serum urate levels interaction [male],921
3,"Age-related diseases, mortality and associated endophenotypes",787
3,Non-glioblastoma glioma,707
3,Choline phosphate levels,1649
3,Alzheimer disease and age of onset [between families],108
3,Serum levels of protein PSG6,40
3,Chronotype,66810
3,Fresh fruit intake,3981
3,Flavonifractor sp002159265 abundance in stool,769
3,1-stearoyl-2-arachidonoyl-gpc (18:0/20:4) levels,662
3,Cataracts [male],24
3,Serum urea levels,79747
3,White matter microstructure (radial diusivities) [Hippocampus ],5790
3,Serum levels of protein CPT1B,248
3,"Blood protein levels [EA, CD27 antigen]",423
3,"""Hypertension complicating pregnancy, childbirth, and the puerperium""",420
3,Forced vital capacity (fvc),129633
3,Varicose veins,7722
3,Electrocardiogram morphology (amplitude at temporal datapoints) [198 ms],358
3,Plasma homocysteine levels (post-methionine load test),457
3,Cortical surface area [Pars Triangularis],602
3,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),282
3,Serum levels of protein ARL11,343
3,Velopharyngeal dysfunction,55
3,General cognitive ability,224158
3,Salad / raw vegetable intake,6161
3,"Mean arterial pressure x alcohol consumption interaction (2df test) [Asian, EA, Hispanic]",2034
3,Externalizing behaviour (multivariate analysis),127789
3,Hand grip strength (left),50403
3,Ventral thalamic nuclei volume,4039
3,Monocyte chemoattractant protein-1 (red blood cell fatty acid level interaction) [OA],224
3,IgG glycosylation patterns [IgG2 FG1S1/(FG1+FG1S1],839
3,Serum metabolite levels [epiandrosterone sulfate],212
3,Facial morphology (segment 11),374
3,Something else not mentioned | behavioural and miscellaneous addictions,17
3,Insulin-like growth factor 1 levels,528199
3,Gout [EA],9789
3,"Waist circumference adjusted for body mass index [EA,women]",18796
3,Psoriasis vulgaris,883
3,Cortical surface area [Rostral Middle Frontal],642
3,Dried fruit intake,1102
3,IgG glycosylation [IGP32],1560
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-72 ms],807
3,Dilated cardiomyopathy,573
3,"Anthropometric traits in newborns [Birthweight, Model 2]",965
3,Protein quantitative trait loci (liver) [PRDX5],36
3,Relative carbohydrate intake,37
3,Protein quantitative trait loci (liver) [DCN],7
3,Coronary atherosclerosis,18230
3,"Blood protein levels [TMPRSS11D, 6547_83_3]",33846
3,Myocardial fractal dimension (slice 3),387
3,Allergy,417
3,Carpal tunnel syndrome,364
3,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),18533
3,"Blood protein levels [PDIA5, 5593_11_3]",284
3,Other osteochondrodysplasias,10
3,Longitudinal change in brain amyloid plaque burden,41
3,Receive help from friends / family / neighbours | actions taken following self-harm,13
3,Morning/evening person (chronotype),32015
3,Arm fat-free mass (left),199136
3,Interstitial lung disease,4692
3,Lobe size,182
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-160 ms],682
3,Autism and educational attainment (MTAG),53
3,QRS duration [Hispanic/Latino],27
3,circulating leptin levels,1993
3,Mammographic density (non-dense area),1084
3,"Blood protein levels [ITIH1, 7955_195_3]",286288
3,"None of the above | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",6133
3,Serum levels of protein MAP2K4,1550
3,Paracetamol | treatment/medication code,81
3,Left ventricular ejection fraction,352
3,Neonatal cytokine/chemokine levels (fetal genetic effect) [CCL17],669
3,Help-seeking from a GP,308
3,Small (125ml) | size of rose wine glass drunk,194
3,CAG-884 sp000433875 abundance in stool,47
3,Glycine levels,5348
3,Other endocrine disorders,19
3,Cheese intake,72407
3,Frequency of tenseness / restlessness in last 2 weeks,11168
3,"Blood protein levels [CPN2, 6415_90_3]",1487
3,Marginal zone lymphoma or systemic lupus erythematosus,102
3,White blood cell count [Monocytes],516
3,Eye morphology,1522
3,Longevity (100 years and older) [EA],48
3,Adizem-60 m/r tablet | treatment/medication code,170
3,"""Atherosclerosis, excluding cerebral, coronary and PAD""",20
3,Electrocardiogram morphology (amplitude at temporal datapoints) [174 ms],174
3,Venous thromboembolism,34
3,Atrial fibrillation,30157
3,Arm fat percentage (left),218146
3,White blood cell count (monocyte),184
3,IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis),839
3,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),176089
3,Mean reticulocyte volume,401305
3,Serum levels of protein TIMP4,7255
3,Mucosal proctocolitis,34280
3,Serum levels of protein ITIH2,7042
3,Ischemic stroke (large artery atherosclerosis),310
3,"Acute lymphoblastic leukemia (childhood) [ETV6-RUNX1 positive, Northern European]",52
3,Serum levels of protein FAM3D,865
3,Bipolar disorder (early vs late onset),488
3,Schizophrenia,831958
3,Cortical surface area,332296
3,Lateral ventricular volume in normal aging,1082
3,Neonatal cytokine/chemokine levels (fetal genetic effect) [CCL19],669
3,"""Type 2 diabetes, definitions combined""",4414
3,Facial morphology (segment 5),624
3,Myocardial fractal dimension (slice 2),387
3,Mental composite score,42
3,Estimated glomerular filtration rate,616694
3,Glaucoma | eye problems/disorders,134
3,"Retinal detachment | non-cancer illness code, self-reported",474
3,Left–right brain asymmetry,250
3,Protein quantitative trait loci (liver) [ALDH5A1],3
3,Prostate cancer,182334
3,Folic acid  | vitamin and/or mineral supplement use,1167
3,Cortical surface area (min-P),1831
3,"Septicaemia / sepsis | non-cancer illness code, self-reported",1517
3,Smoking initiation (ever regular vs never regular) [Conditioned on chr3:173353739],59
3,Acute graft versus host disease in bone marrow transplantation (recipient effect),83
3,Uterine prolapse,4963
3,Pattern 1 | hair/balding pattern,16183
3,Chronic obstructive pulmonary disease x current smoker interaction (main effect),12324
3,Serum levels of protein CCL11,2861
3,Smoking initiation (ever regular vs never regular) [Conditioned on chr3:147106319],18
3,Signal-to-noise-ratio (snr) of triplet (right),10
3,Accelerometer-based physical activity measurement (average acceleration),860
3,Total body bone mineral density (age 30-45),341
3,Brain region volumes [white matter],823
3,Electrocardiogram morphology (amplitude at temporal datapoints) [188 ms],174
3,IgG glycosylation [IGP38],1560
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-94 ms],525
3,N-glycan levels [plasma glycan peak 41],943
3,Mean corpuscular volume,1637825
3,Triglycerides,132677
3,Mumps,1325
3,Electrocardiographic conduction measures [QRS duration - CHARGE],984
3,Electrocardiogram morphology (amplitude at temporal datapoints) [40 ms],525
3,Hematological and biochemical traits [BUN],647
3,Factor XI,439
3,Educational attainment (college completion),101061
3,Insomnia symptoms (never/rarely vs. sometimes/usually),85707
3,Facial morphology traits (63 three-dimensional facial segments) [facial module 16],3562
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-92 ms],1301
3,Leisure/social activities: Sports club or gym,4214
3,Calculus of kidney and ureter,2563
3,Lansoprazole | treatment/medication code,4443
3,Total body bone mineral density (age 45-60),335
3,Brain region volumes [left inferior lateral ventricle],1929
3,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],253
3,Age first had sexual intercourse,28617
3,Alcohol intake frequency.,3587
3,"""Asthma, including avohilmo""",5696
3,Subjective well-being,781
3,Bone disorder,344
3,Proliferative diabetic retinopathy (vs NPDR and no DR) [AA],225
3,Interleukin-1 receptor type 1 levels,902
3,PR interval [Conditional],384
3,Granulocyte count,65121
3,Sensitivity to environmental stress and adversity,14533
3,"Blood protein levels [ETHE1, 3847_56_2]",52911
3,Arm fat mass (right),271520
3,BMI in smokers,2400
3,Phosphatidate(44:6)_[M+OAc]1-/Phosphatidylglycerol(43:6)_[M-H]1- levels,369
3,General symptoms and signs,1
3,"Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",68812
3,Eczema,51398
3,Household income,35001
3,Type 2 diabetes or prostate cancer (pleiotropy),13921
3,Impedance of whole body,415163
3,Pre-treatment viral load in HIV-1 infection,2421
3,"Aspirin | medication for pain relief, constipation, heartburn",864
3,Waist-hip ratio [EA],1215
3,"Seen a psychiatrist for nerves, anxiety, tension or depression",18
3,Gut microbiota relative abundance (bacterial taxa) [Blautia_glucerasea],9
3,Red cell distribution width,1265869
3,Worry,80056
3,Mosaic loss of chromosome Y (Y chromosome dosage),25935
3,Brain region volumes [cerebellar vermal lobules VIII X],1765
3,Other non-epithelial cancer of skin,1098
3,Waist circumference variance,851
3,Participation in an health questionnaire (not invited vs invited),51450
3,Neutrophil-to-lymphocyte ratio,14184
3,Electrocardiogram morphology (amplitude at temporal datapoints) [12 ms],3631
3,Cerebrospinal T-tau levels,1310
3,Waist-to-hip ratio adjusted for BMI in non-smokers,127
3,CAG-822 abundance in stool,47
3,Processed meat intake,1514
3,Cardiac arrhytmias,3069
3,Serum metabolite levels [1-stearoyl-2-oleoyl-GPI (18:0/18:1)*],553
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-204 ms],525
3,"Hodgkins lymphoma / hodgkins disease | cancer code, self-reported",189
3,Serum levels of protein CCDC126,343
3,Serum levels of protein LSAMP,53
3,Serum levels of protein HS3ST1,48
3,FEV1,222585
3,Body mass index [recessive model],63935
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-168 ms],2695
3,"Blood protein levels [FETUB, 3367_8_3]",792
3,Cardiac dysrhythmias,2538
3,Protein quantitative trait loci (liver) [ME1],301
3,Renal function-related traits (BUN),933
3,"Urinary metabolites [Alanine/N,N-dimethylglycine ratio]",835
3,Colorectal cancer [East Asian],270
3,Response to metformin in type 2 diabetes (HbA1c reduction) [EA],911
3,White matter hyperintensity volume,43596
3,Cataracts,117388
3,Lifetime number of sexual partners,4424
3,Noncognitive aspects of educational attainment,210313
3,"Blood protein levels [JAKMIP3, 9068_17_3]",286288
3,Body fat percentage and type 2 diabetes (pairwise),1122
3,Cortical surface area [total],2244
3,"Blood protein levels [TP53I11, 13022_20_3]",248
3,Facial morphology (segment 23),44
3,Amyotrophic lateral sclerosis (sporadic),3692
3,Blood glucose levels,24470
3,"1,5-anhydroglucitol (1,5-ag) levels",9968
3,"""Type 2 diabetes, definitions combined, including avohilmo""",3300
3,Other malignant neoplasms of skin (=non-melanoma skin cancer) (controls excluding all cancers),869
3,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction) [women],127
3,Dentate gyrus volume x schizophrenia interaction,22594
3,Diastolic blood pressure x alcohol consumption interaction (2df test) [EA],120627
3,Electrocardiogram morphology (amplitude at temporal datapoints) [210 ms],19823
3,Meat-related diet,3042
3,Smoking initiation (ever regular vs never regular) [Conditioned on chr3:50192760],1470
3,Electrocardiogram morphology (amplitude at temporal datapoints) [126 ms],174
3,Electrocardiogram morphology (amplitude at temporal datapoints) [168 ms],174
3,Electrocardiogram morphology (amplitude at temporal datapoints) [212 ms],358
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-182 ms],157
3,"Blood protein levels [SEMA3G, 5628_21_3]",176772
3,Basal metabolic rate,186137
3,Facial morphology (segment 18),3562
3,Glycated haemoglobin HbA1c levels adjusted for BMI,620
3,Serum levels of protein FETUB,714
3,Distance between home and job workplace,157
3,CAG-448 sp003150135 abundance in stool,25
3,Birth weight,78565
3,Subjective well-being (MTAG),93079
3,General happiness with own health,16497
3,IgG glycosylation patterns [IgG2_G1FS1/IgG2_G1F],839
3,Asthma (age of onset),417
3,Serum lipopolysaccharide activity,439
3,Personality traits in bipolar disorder [TCI-C3],533
3,Proheparin-binding EGF-like growth factor levels,158
3,Electrocardiogram morphology (amplitude at temporal datapoints) [112 ms],174
3,High myopia,285
3,Other disorders of thyroid,107
3,"Blood protein levels [EA, Hepatocyte growth factor-like protein]",31351
3,Impedance of arm (right),251426
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-100 ms],611
3,Serum levels of protein NAALAD2,3601
3,"Intra-ocular pressure, goldmann-correlated (left)",1639
3,A disintegrin and metalloproteinase with thrombospondin motifs 13 levels,305
3,UBA3792 abundance in stool,29
3,Brain-derived neurotrophic factor levels,13285
3,White matter microstructure (axial diusivities) [Anterior limb of internal capsule],3644
3,Muscular dystrophy,486
3,Fasting blood insulin (BMI interaction),122
3,Protein quantitative trait loci (liver) [B2M],198
3,"Blood pressure medication | medication for cholesterol, blood pressure or diabetes",100282
3,Leg predicted mass (left),122126
3,BMI (adjusted for smoking behaviour) [men],650
3,Adventurousness,10543
3,Alcohol consumption (drinks per week) (MTAG),63728
3,Gout,30416
3,IBD patients in KELA-register,34280
3,Cetirizine | treatment/medication code,198
3,"Blood protein levels [GRAMD1C, 8842_16_3]",364
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-496 ms],406
3,"Long-standing illness, disability or infirmity",48
3,"Daytime sleep phenotypes [daytime napping duration, weekdays]",23
3,Melanomas of skin,11
3,Blond vs. brown/black hair color,21280
3,A body shape index,403213
3,HDL cholesterol levels [Trans-ethnic initial],46105
3,Pappalysin-1 levels,6569
3,Chronic obstructive pulmonary disease x ever smoker interaction (2df),12324
3,Schizophrenia vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),2265
3,Multiple sclerosis and triglyceride levels (pleiotropy),1203
3,Number of self-reported non-cancer illnesses,1237
3,"""Cholelithiasis, broad definition with cholecystitis""",773
3,"Cholelithiasis/gall stones | non-cancer illness code, self-reported",1629
3,General examination and investigation of persons without complaint and reported diagnosis,508
3,DNA methylation variation (age effect),2610
3,HDL cholesterol x physical activity interaction (2df test),45492
3,Age stroke diagnosed,1323
3,Brain region volumes [left inferior temporal],960
3,Nap during day,2856
3,Weight,541605
3,Cystatin C levels,378694
3,Vitamin K-dependent protein S measurement,1949
3,Serum levels of protein MAN1B1,439
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-488 ms],406
3,Early-onset schizophrenia,262
3,Psoriasis,14268
3,Eosinophil counts,1449004
3,Cognitive performance (MTAG) [MTAG],266329
3,Refractive error,160068
3,Blood protein levels [Thioredoxin domain-containing protein 12],99079
3,Waist-hip ratio and type 2 diabetes (pairwise),851
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-98 ms],525
3,"Blood protein levels [HMGN1, 9187_2_3]",923
3,White matter microstructure (mode of anisotropy) [Posterior corona radiata ],212
3,Anti-human herpes virus 6 IE1A IgG seropositivity,863
3,Cerebrospinal fluid t-tau:AB1-42 ratio,237
3,Lercanidipine | treatment/medication code,175
3,Heart rate,511
3,Hair color,52582
3,QRS duration,15762
3,Motion sickness,3722
3,Pork consumption,6067
3,Non-allergic asthma (mode) (more control exclusions),167
3,Lung function (FEV1/FVC) [EA],50
3,Myeloproliferative diseases,17
3,Fibrosis and chirrhosis of liver,2
3,Apolipoprotein B levels,190603
3,Snoring,77553
3,Response to opioid analgesics in cancer (pain decrease),127
3,N-formylanthranilic acid levels,132
3,"Blood protein levels [ACE, 10714_7_3]",792
3,Lateral ventricle temporal horn volume,142
3,Rest days during mixed shift periods,9
3,Other and unspecified coagulation defects,3
3,Hemoglobin levels,687541
3,Systolic blood pressure x smoking status (ever vs never) interaction (2df test) [EA],16958
3,BMI (adjusted for smoking behaviour) [women],1753
3,Longevity,2997
3,Upper cheek morphology,1522
3,Hypercholesterolemia,5496
3,Serum levels of protein KDR,902
3,Protein quantitative trait loci (liver) [AKR1B10],85
3,Ethylmalonate levels,382
3,"Anthropometric traits in newborns [Fat Mass, Model 2]",965
3,Cutaneous melanoma or hair colour,60
3,"Blood protein levels [LSAMP, 2999_6_2]",53
3,White matter hyperintensities,21713
3,Risk taking,6763
3,Lung cancer,604
3,"Blood protein levels [EA, Alpha-2-HS-glycoprotein]",948
3,"Varicose veins | non-cancer illness code, self-reported",569
3,Protein quantitative trait loci (liver) [BPNT1],82
3,Red blood cell fatty acid levels [AA],273
3,Protein quantitative trait loci (liver) [COL18A1],7
3,Body mass index in physically active individuals [EA],2400
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-146 ms],3063
3,Eosinophil counts [EA],1215
3,Gonarthrosis [arthrosis of knee](FG),371
3,Rarely/never | workplace very noisy,35
3,Diverticulitis,18
3,Cognitive ability (MTAG),79817
3,High density lipoprotein cholesterol levels [EA],23469
3,Pentraxin-related protein PTX3 levels,124411
3,Gallbladder polyp,354
3,Urate levels [East Asian],3299
3,Serum levels of protein LEAP2,872
3,"Body mass index [EA, men]",646
3,N-glycan levels [Tetrasialylated],161
3,Electrocardiogram morphology (amplitude at temporal datapoints) [230 ms],174
3,Medication use (calcium channel blockers),65275
3,Statin medication,14574
3,Systolic blood pressure [East Asian],3709
3,"Blood protein levels [EA, interleukin-17 receptor B]",616
3,Obesity-related traits [BMI],618
3,"Electron transfer flavoprotein subunit alpha, mitochondrial measurement",453
3,Facial morphology (segment 21),17
3,Platelet count,1315304
3,Chronic obstructive pulmonary disease or resting heart rate (pleiotropy),11694
3,Cortical surface area (MOSTest),108961
3,"Light smokers, at least 100 smokes in lifetime",4224
3,Programmed cell death 1 ligand 2 levels,902
3,Metabolite levels [orotic acid],29694
3,CD80 on monocyte,21943
3,Alzheimer’s disease (Late onset) (more control exclusions),2248
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-80 ms],1099
3,Serum levels of protein NXPH2,249
3,Major mood disorders,117779
3,Serum uric acid levels [Japanese],15330
3,Hypothyroidism or myxedema,54159
3,Monocyte percentage,56212
3,Autoimmune diseases,16337
3,Type 2 diabetes [EA],2207
3,Serum levels of protein TMEM87B,677
3,Fasting insulin adjusted for BMI,899
3,Mytonic disorders,154
3,"""Hypertension, Pulmonary Arterial""",126
3,Toxoplasma gondii sag1 antibody levels,24
3,Major depressive disorder vs anorexia nervosa (ordinary least squares (OLS)),37725
3,Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis),10775
3,Proximal colorectal cancer,429
3,T cell lymphocyte profile difference,391
3,Optic nerve head parameters (multi-trait analysis) [EA],12
3,Moyamoya disease,2074
3,Mouth ulcers,2538
3,Serum levels of protein CXCL16,12871
3,Electrocardiogram morphology (amplitude at temporal datapoints) [42 ms],525
3,Body mass index and fasting insulin (pairwise),851
3,Fruit consumption,1265
3,Metabolite levels [kynurenine],298
3,COVID-19 (covid pneumonia vs population),2138
3,Serum levels of protein DEFB113,872
3,Protein quantitative trait loci (liver) [XYLB],162
3,Cognitive empathy [female],627
3,Serum levels of protein AAGAB,48
3,Infection of intervertebral disc (pyogenic),27
3,Protein quantitative trait loci (liver) [DPP7],7
3,Mean spheric corpuscular volume,307476
3,C-C motif chemokine 4 levels,19914
3,3mm strong meridian (right),54694
3,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),1922
3,Serum levels of protein PLXNA1,2248
3,Breast cancer (estrogen-receptor negative),37
3,Ferrous salt product | treatment/medication code,53
3,Self-reported math ability (MTAG) [MTAG],202640
3,Aging (facial),6025
3,Aspartate transaminase levels in high alcohol intake,11586
3,Disorders of lipoid metabolism,5551
3,Migraine,900
3,Mastocytosis,1421
3,IgG glycosylation patterns [IgG2 FG2S1/(FG2+FG2S1],804
3,Diabetes diagnosed by doctor,2540
3,"""Asthma, hospital admissions , main diagnosis only""",5696
3,Brain connectivity [Clustering coefficient - R-insula],574
3,Femur bone mineral density x serum urate levels interaction [female],737
3,Serum levels of protein DNAJB11,1070
3,Intelligence (MTAG),185621
3,C-reactive protein levels,636637
3,Hip circumference adjusted for BMI [EA],39796
3,Ribulonate/xylulonate levels,1691
3,Hand grip strength (right),65040
3,Electrocardiogram morphology (amplitude at temporal datapoints) [152 ms],6807
3,Protein quantitative trait loci [IL-1 R AcP],644
3,Serum levels of protein MST1,12920
3,Nasal polyps,1960
3,"HDL cholesterol levels x smoking (current vs non smokers) interaction (2df test) [EA, trans-ethnic]",1255
3,Diastolic blood pressure [East Asian],1151
3,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),253
3,Systemising,53
3,Protein quantitative trait loci (liver) [HACL1],77
3,Nasopharyngeal carcinoma,230
3,Body fat percentage [male],851
3,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],334
3,Glycine levels [conditional],662
3,Gut microbiota abundance (unknown genus id.1000001215),989
3,Severe COVID-19 infection with respiratory failure (analysis II),890
3,Serum levels of protein TF,3334
3,Intercellular adhesion molecule 2 levels,1258
3,Interstitial lung abnormalities,2
3,Protein quantitative trait loci (liver) [FXN],7
3,Depressive symptoms,247420
3,Obesity,15227
3,6mm strong meridian (left),54802
3,"Blonde | hair colour (natural, before greying)",16167
3,"Red blood cell traits [EA, MCV]",3787
3,"""Hypothyroidism, levothyroxin purchases""",417
3,Back pain,173
3,"Cerebrospinal fluid biomarker levels [Alkaline phosphatase, tissue-nonspecific isozyme]",2334
3,Other and unspecified disorders of white blood cells,1
3,LDL cholesterol levels,40735
3,Hip circumference,166715
3,Setpoint viral load in HIV-1 infection,1605
3,BMI in non-smokers [women],2880
3,Severe COVID-19 infection with respiratory failure (analysis I),890
3,UBA6382 abundance in stool,138
3,White matter microstructure (axial diusivities) [Body of corpus callosum],87
3,Protein quantitative trait loci (liver) [GSTT2B],63
3,Body mass index variance,1188
3,Number of children fathered,3903
3,Intestinimonas massiliensis abundance in stool,149
3,CX3CR1 on monocyte,474
3,Diltiazem | treatment/medication code,165
3,Neurociticism,12819
3,Smoking initiation (ever regular vs never regular) (MTAG),172944
3,Angiopoietin-1 receptor levels,902
3,Leg fat percentage (left),229431
3,Nucleus accumbens volume,619
3,Nicotine dependence [AA],145
3,Electrocardiogram morphology (amplitude at temporal datapoints) [194 ms],358
3,Protein quantitative trait loci (liver) [SDHA],84
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-122 ms],125
3,Osteoarthritis,117201
3,Major depressive disorder (MTAG),140557
3,Childhood maltreatment,234
3,Educational attainment (years of education) [conditional-joint],199453
3,C-reactive protein levels [BMI-adjusted],104198
3,Fasting glucose,11657
3,Cortical volume [Precuneus],933
3,"Blood protein levels [NAALAD2, 7986_98_3]",3334
3,Medication use (antiglaucoma preparations and miotics),2676
3,Serum levels of protein STX7,588
3,Hernia,232
3,Protein quantitative trait loci (liver) [SDHB],13
3,Protein quantitative trait loci (liver) [HSPB1],18
3,Schizophrenia vs ADHD (ordinary least squares (OLS)),37147
3,"Hayfever, allergic rhinitis or eczema | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",41340
3,Shingles,297
3,Mean arterial pressure [Japanese],510
3,IgG digalactosylation phenotypes (multivariate analysis),839
3,"""Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)""",1025
3,Electrocardiogram morphology (amplitude at temporal datapoints) [232 ms],174
3,Schizophrenia [Chinese],2181
3,Recent feelings of tiredness or low energy,59984
3,"Blood protein levels [CRELD1, 7628_40_3]",90144
3,"Blood protein levels [CREBBP, 13614_6_3]",248
3,Other specified and unspecified personality disorders,149
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-120 ms],170
3,Cataracts (operation),25
3,White matter hyperintensity volume (adjusted for hypertension),15728
3,Hot drink temperature,38396
3,Osteoporosis,70877
3,Never | smoking status,7550
3,Blood protein levels [Kininogen-1],696
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-88 ms],525
3,Blood metabolite levels [succinylcarnitine],296
3,Spirillospora abundance in stool,231
3,Heart rate response to recovery post exercise (30 sec),217
3,Lymphocyte percentage of white cells,108984
3,Serum metabolite levels [16a-hydroxy DHEA 3-sulfate],212
3,"Asthma | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",16153
3,Spleen volume,2706
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-76 ms],852
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-150 ms],157
3,Electrocardiogram morphology (amplitude at temporal datapoints) [214 ms],358
3,Disorders of lens,25
3,Neonatal cytokine/chemokine levels (fetal genetic effect) [IL-2],196
3,Lung function [FVC],26
3,IgD on transitional B cell,12
3,Cisplatin drug response (IC50),8
3,Neonatal cytokine/chemokine levels (fetal genetic effect) [CCL21],6096
3,Feeling tense,9084
3,Bipolar disorder or type 2 diabetes,11840
3,"Pubertal anthropometrics [Pubertal growth, females]",1640
3,IgG glycosylation [IGP37],1560
3,Hip circumference [EA],8359
3,Serum amyloid A-2 protein measurement,345
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-2 ms],2538
3,Serum levels of protein IL12B;IL23A,357
3,Mean arterial pressure x alcohol consumption interaction (2df test) [EA],356
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-178 ms],682
3,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],311
3,Electrocardiogram morphology (amplitude at temporal datapoints) [234 ms],174
3,Body mass index,2500565
3,Body fat distribution (leg fat ratio),106456
3,Eosinophill count,225649
3,Lung function (FEV1),12899
3,"Blood protein levels [POMGNT2, 6359_50_3]",1641
3,Waist circumference adjusted for BMI in non-smokers [men],1987
3,Urinary sodium excretion [EA],151
3,Protein quantitative trait loci (liver) [SERPING1],11
3,Alcohol consumption (drinks per week) [Conditioned on chr3:85457240],3695
3,Mortality after unrelated donor allogeneic hematopoietic cell transplantation (recipient effect),1694
3,Gelsolin measurement,145
3,CX3CR1 on CD14- CD16-,474
3,Focal epilepsy (with hippocampal sclerosis),415
3,Major depressive disorder,109594
3,B cell lymphocyte profile difference (90 days post influenza vaccination),209
3,Coronary atherosclerosis (time to event),418
3,Etoricoxib | treatment/medication code,261
3,"Blood protein levels [KNG1, 4918_21_1]",131
3,Electrocardiogram morphology (amplitude at temporal datapoints) [150 ms],174
3,Bone mineral density (hip) [intertrochanter],13
3,Cataracts [female],24
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-22 ms],16955
3,Leg fat mass (left),254858
3,Chronic lymphocytic leukemia or multiple sclerosis,4692
3,Leiomyoma of uterus (controls excluding all cancers),5177
3,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant II (Nose), Segment 23]",44
3,"N-glycan levels [Tetrasialylated, men]",183
3,Glycemic traits (pleiotropy),271
3,"Systolic blood pressure x alcohol consumption interaction (2df test) [AA, EA]",83
3,Schizophrenia [EA],127920
3,"Pulse rate, automated reading",181530
3,Hip bone size,4002
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-38 ms],509
3,CCR2 on CD14+ CD16- monocyte,1117
3,Electrocardiogram morphology (amplitude at temporal datapoints) [156 ms],174
3,Brain region volumes [total brain volume],38
3,PR interval [conditioned on rs3922844 and rs6801957],211
3,Plasma free amino acid levels [Leu],49
3,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test),17171
3,Progressive supranuclear palsy,4689
3,Broad depression or schizophrenia,110548
3,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),4972
3,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA],214960
3,Low density lipoprotein cholesterol levels [EA],13084
3,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),549
3,"Meningitis | non-cancer illness code, self-reported",3429
3,CX3CL1 levels,855
3,Haemolytic anaemias,12
3,Educational attainment (MTAG) [MTAG],359794
3,Comparative height size at age 10,348619
3,Diabetes,3524
3,Serum levels of protein CD5,902
3,Electrocardiogram morphology (amplitude at temporal datapoints) [180 ms],358
3,"Liver, biliary or pancreas problem",2998
3,Mastocytosis (KIT D816V positive),1298
3,Planococcaceae abundance in stool,1135
3,Age-related hearing impairment (SNP x SNP interaction),694
3,Thyroid cancer,4692
3,"Blood protein levels [MAP2K4, 5242_37_3]",923
3,C-reactive protein,8157
3,COVID-19 (hospitalized covid vs population),18377
3,"""Gout, FINNGEN""",9952
3,"Diabetes | non-cancer illness code, self-reported",40101
3,"High cholesterol | non-cancer illness code, self-reported",6752
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-126 ms],125
3,"Hip circumference adjusted for BMI [EA, women]",7758
3,Atopic asthma,24292
3,Serum levels of protein RPN1,5385
3,Basophill count,2207
3,"Blood protein levels [EA, C-C motif chemokine 4-like]",4097
3,Serotransferrin measurement,3334
3,QRS duration [EA],3982
3,Protein quantitative trait loci [VEGF sR3],902
3,"Blood protein levels [CAMP, 9384_17_3]",248
3,Poultry consumption,217
3,Liver fibrosis severity in HIV/hepatitis C co-infection,55
3,Placebo response in major depressive disorder (% change in symptom score),190
3,Preeclampsia (maternal genotype effect),123
3,Electrocardiogram morphology (amplitude at temporal datapoints) [308 ms],184
3,"Intra-ocular pressure, corneal-compensated (left)",134
3,Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test),246791
3,Peak expiratory flow,89681
3,Basophil percentage of white cells,27093
3,"Type 1 diabetes | non-cancer illness code, self-reported",2333
3,Diseases of sebaceous glands,4460
3,Blood protein levels [MCP-1],979
3,Serum levels of protein RNF13,409
3,Protein quantitative trait loci (liver) [CTH],53
3,Microalbumin in urine,41
3,"Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",68963
3,"Heel bone mineral density (bmd) t-score, automated",23275
3,None of the above | pain type(s) experienced in last month,120713
3,Atrial fibrillation and flutter,11315
3,Abnormal serum enzyme levels,5007
3,"Blood protein levels [EA, C-C motif chemokine 17]",1076
3,"Blood protein levels [STX7, 8274_64_3]",449
3,Lactadherin measurement,248
3,Neuropathic pain in head and neck cancer,72
3,Keratitis,6
3,Cardiovascular disease,260884
3,"Blood protein levels [NPPB, 10387_1_3]",112165
3,Atrial fibrillation [EA],13739
3,"Blood protein levels [CPB1, 6356_3_3]",127
3,Facial morphology traits (63 three-dimensional facial segments) [facial module 20],624
3,Colon cancer,21943
3,Relative age of first facial hair,52376
3,Trunk fat mass,280484
3,Serum levels of protein IL1RAP,2540
3,"Blood protein levels [BGN, 13690_26_3]",248
3,Total body bone mineral density [European],1056
3,Inflammatory skin disease [Psoriasis],400
3,vWF levels,23047
3,Birth weight of first child,8369
3,Eosinophill percentage,279461
3,Cognitive ability,1235
3,Brain region volumes [X3rd ventricle],1310
3,Arterial stiffness (carotid-femoral pulse wave velocity),1396
3,Protein quantitative trait loci (liver) [AP1B1],73
3,Fed-up feelings,46571
3,Systemic sclerosis [ACA positive],10448
3,Whole body fat-free mass,165142
3,Colpermin 0.2ml m/r gel e/c capsule | treatment/medication code,43133
3,Waist circumference adjusted for BMI in active individuals [women],2296
3,Glaucoma (multi-trait analysis),8298
3,Urea levels,2065
3,Breast cancer (early onset),4113
3,Protein levels in obesity [Cripto],1945
3,Body fat percentage and fasting insulin (pairwise),851
3,Facial morphology (segment 2),254
3,Serum levels of protein NCK1,98
3,Mean corpuscular volume [Asian],73
3,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA],170043
3,Medial thalamic nuclei volume,1310
3,"Fatty acid-binding protein, adipocyte levels",851
3,Chronic lymphocytic leukemia,7797
3,Blood protein levels [Macrophage inflammatory protein-1b],5272
3,IgM levels,1598
3,Hypertrophic cardiomyopathy (sarcomere negative),610
3,IgG glycosylation patterns [IgG1 FGS1/(FG+FGS1],839
3,"""Hypertension, essential""",187
3,Pulse wave peak to peak time,403
3,Protein quantitative trait loci (liver) [AGT],6
3,Migraine without aura and/or diastolic blood pressure,848
3,Salivary metabolite levels [creatinine],600
3,Heel bone mineral density (MTAG),670
3,Age at last live birth,94555
3,Rheumatoid arthritis [EA],3240
3,"Blood protein levels [CPT1B, 11709_29_3]",248
3,Electrocardiogram morphology (amplitude at temporal datapoints) [114 ms],174
3,Adipose morphology,54
3,Total bone mineral density x gut microbiota (﻿genus Dialister) interaction,16
3,Protein quantitative trait loci (liver) [ABHD10],7
3,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) [women],5595
3,"Dark brown | hair colour (natural, before greying)",14727
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-106 ms],705
3,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant III (Mandible), Segment 24]",893
3,Protein quantitative trait loci (liver) [WARS],21
3,Monocyte count,596922
3,Serum levels of protein ADIPOQ,578
3,Serum levels of protein TFPI2,7042
3,Blood metabolite levels [pyroglutamine],835
3,"Blood protein levels [EA, Persulfide dioxygenase ETHE1, mitochondrial]",81
3,Cannabis use,5304
3,Attention deficit hyperactivity disorder (MTAG),64
3,Forns index in high alcohol intake,195
3,Myeloperoxidase levels,5564
3,"Trapped nerve/compressed nerve | non-cancer illness code, self-reported",1143
3,Serum levels of protein KIAA1324L,372
3,Response to cosmetics (uncomfortable frequency),88
3,Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis),415
3,"Blood protein levels [PCDH10, 8780_2_3]",318
3,ERO1-like protein beta measurement,158
3,Protein levels in obesity [IL-1 R AcP],644
3,Optic disc area,1547
3,"Other exercises (eg: swimming, cycling, keep fit, bowling) | types of physical activity in last 4 weeks",70848
3,Resistin levels,1654
3,Protein quantitative trait loci (liver) [LIPA],427
3,Butyrylcholinesterase levels,248
3,Particulate matter air pollution (pm10); 2007,1884
3,White matter microstructure (radial diusivities) [Fornix (column and body],1310
3,Serum levels of protein RNF146,7042
3,"Basal cell carcinoma | cancer code, self-reported",687
3,IgG glycosylation patterns [IgG1_G1FS1],804
3,Acute graft versus host disease in bone marrow transplantation (donor effect),114
3,Cognitive decline rate in late mild cognitive impairment [EA],357
3,Cerebrospinal AB1-42 levels in Alzheimer's disease dementia,44
3,"Smoking initiation (ever regular vs never regular) [Conditioned on chr3:85475292, chr3:85460131]",139
3,Waist-hip ratio,694617
3,Chronic obstructive pulmonary disease or high blood pressure (pleiotropy),16193
3,Smoking initiation (ever regular vs never regular) [Conditioned on chr3:85460131],3695
3,"Blood protein levels [RPN1, 10490_3_3]",5717
3,Brain region volumes [left lateral occipital],384
3,"Systolic blood pressure [EA, initial]",397
3,X-11261 levels,273
3,Glycated hemoglobin levels,351305
3,Lifetime smoking index,102097
3,Diastolic blood pressure (long-term average),137086
3,Cortical thickness,382545
3,Hypertensive diseases,1660
3,Problematic alcohol use,3821
3,Serum levels of protein NME1,1523
3,Cardiometabolic and hematological traits [PLT],48
3,Chronic diseases of tonsils and adenoids,117
3,"""Haemangioma, any site""",125
3,Intracranial aneurysm [French Canadians],6
3,Male-pattern baldness,28353
3,Morningness,159495
3,Bipolar I disorder,174853
3,Leisure sedentary behaviour (television watching),107442
3,"Pulse pressure [EA, initial]",121089
3,Lifetime anxiety disorder [EA],294
3,"Blood protein levels [KNG1, 7784_1_3]",449
3,Pediatric asthma,664
3,Fibrosis-4 index in high alcohol intake,195
3,Alzheimer's disease biomarkers [tau],1300
3,Gut microbiota relative abundance (bacterial taxa) [Anaerofilum],111
3,Menarche (age at onset),521528
3,Waist circumference adjusted for BMI in non-smokers,175671
3,"Heel bone mineral density (bmd) t-score, automated (left)",46400
3,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [women],5250
3,Fenofibrate | treatment/medication code,1106
3,Diabetes | illnesses of mother,1150
3,Human milk oligosaccharide concentration (fucosyllacto-N-hexaose),30
3,Platelet count [EA],15
3,"Ground coffee (include espresso, filter etc) | coffee type",60469
3,Leg fat-free mass (left),122164
3,C-reactive protein levels or triglyceride levels (pleiotropy),5229
3,Body mass index (joint analysis main effects and smoking interaction) [women],2403
3,Electrocardiogram morphology (amplitude at temporal datapoints) [36 ms],525
3,Snoring [adjusted for BMI],691
3,Midgestational cytokine/chemokine levels (maternal genetic effect) [CCL11],94
3,Protein quantitative trait loci (liver) [CFL1],29
3,Bipolar disorder,493527
3,Serum uric acid levels,111414
3,Intraocular pressure and central corneal thickness (multi-trait analysis) [EA],38
3,Follicular lymphoma,110
3,Diffuse plaques (SNP x SNP interaction),1823
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-104 ms],1144
3,Anxiety [EA],679
3,Multiple sclerosis and C-reactive protein levels (pleiotropy),458
3,Mitral valve prolapse,245
3,"Blood protein levels [RNF13, 8087_250_3]",396
3,Heel bone mineral density,420339
3,"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment",38356
3,Miserableness,98040
3,Leg predicted mass (right),134660
3,"Blood protein levels [ADIPOQ, 3554_24_1]",578
3,Valsartan | treatment/medication code,139
3,Serum levels of protein FAIM,18
3,Protein quantitative trait loci (liver) [PCCA],5
3,Immune reponse to smallpox (secreted IL-2) [AA],15109
3,Psychological or psychiatric problem,55378
3,"Heart attack/myocardial infarction | non-cancer illness code, self-reported",6293
3,Protein quantitative trait loci (liver) [EIF4G1],1990
3,Simvastatin | treatment/medication code,4276
3,Congenital iodine-deficiency syndrome/hypothyroidism,210
3,Cardiorespiratory fitness (800m run time),123
3,Joint mobility (Beighton score),229
3,Age of smoking initiation (MTAG),117812
3,Serum levels of protein JAKMIP3,116001
3,Corneal resistance factor (right),2975
3,Neuroticism score,20930
3,Serum levels of protein CRELD1,1123
3,Early progression to active pulmonary tuberculosis in Mycobacterium tuberculosis-infected individuals,150
3,Subjective wellbeing conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis),44
3,Leptospirales abundance in stool,4
3,Body mass index and systole blood pressure (pairwise),83521
3,Iron status biomarkers (transferrin saturation),14128
3,Body fat distribution (arm fat ratio) [females],3473
3,Non-albumin protein levels,131125
3,6mm strong meridian (right),68780
3,Experiencing mood swings,4355
3,Gut microbiota (functional units) [PWY-7282_4-amino-2-methyl-5-phosphomethylpyrimidine_biosynthesis_(yeast],197
3,Ischemic stroke in dyslipidemia,39
3,Metalloproteinase inhibitor 4 levels,256
3,Anti-herpes simplex virus 2 IgG seropositivity,74
3,Ulcerative colitis,252887
3,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)",323249
3,Waist-to-hip ratio adjusted for body mass index [EA],497072
3,Serum levels of protein FAM163B,581
3,Myocardial fractal dimension (slice 7),440
3,Electrocardiogram morphology (amplitude at temporal datapoints) [172 ms],174
3,Flavobacteriales abundance in stool,8
3,Youthful appearance (self-reported),97974
3,Body mass index (joint analysis main effects and smoking interaction) [men],650
3,Malignant neoplasm of skin,881
3,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction) [women],1215
3,High cholesterol,7704
3,Serum levels of protein KDELC2,4519
3,Waist circumference adjusted for body mass index [women],1987
3,"Hip circumference [EA, men]",2043
3,"Blood protein levels [MAPK14, 5007_1_1]",792
3,Electrocardiogram morphology (amplitude at temporal datapoints) [44 ms],525
3,Protein quantitative trait loci (liver) [ARHGDIB],31
3,Periodontal disease-related phenotype (Socransky),45
3,Neutrophill percentage,29822
3,Electrocardiogram morphology (amplitude at temporal datapoints) [10 ms],874
3,Estimated glomerular filtration rate in non-diabetics,1821
3,1-stearoyl-2-oleoyl-gpc (18:0/18:1) levels,1324
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-130 ms],125
3,Serum levels of protein XG,1072
3,MS-disease / Multiple Sclerosis,3
3,Serum levels of protein RARRES1,10592
3,Blood metabolite levels [erythronate],3327
3,Chronic obstructive pulmonary disease in non-current smokers,12324
3,"Blood protein levels [EA, Estrogen receptor]",278
3,Facial morphology (segment 4),652
3,Trigger finger,16
3,Body fat percentage,408258
3,Blood pressure [DBP],120564
3,Trunk fat percentage,199096
3,Triglyceride levels x long total sleep time interaction (2df test),5207
3,Cutaneous mastocytosis,363
3,Waist circumference adjusted for body mass index,1547245
3,Urinary potassium to creatinine ratio,2278
3,Apolipoprotein A1 levels,241063
3,Retinal nerve fibre layer thickness or ganglion cell inner plexiform layer thickness (MTAG),1584
3,Physical activity (overall physical activity time),860
3,COVID-19 (RELEASE 4),880
3,Serum levels of protein IRF6,343
3,Serum levels of protein MPZ,372
3,"Allergic disease (asthma, hay fever or eczema)",36246
3,Age when periods started (menarche),219273
3,"Heel quantitative ultrasound index (qui), direct entry",23275
3,3mm weak meridian (right),53374
3,Electrocardiogram morphology (amplitude at temporal datapoints) [200 ms],358
3,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction),5250
3,"""Ulcerative colitis (strict definition, require KELA, min 2 HDR)""",34280
3,Iron status biomarkers (iron levels),8085
3,IgG glycosylation patterns [IgG4 SA per Gal],839
3,Protein quantitative trait loci (liver) [ACLY],87
3,Creatinine levels,427242
3,Thyroglobulin plasma levels,666
3,HDL cholesterol levels x long total sleep time interaction (2df test) [EA],304
3,Multiple sclerosis and HDL levels (pleiotropy),18422
3,Alcohol intake versus 10 years previously,105083
3,CCR2 on plasmacytoid Dendritic Cell,6466
3,Serum levels of protein BOC,3882
3,Electrocardiogram morphology (amplitude at temporal datapoints) [30 ms],2769
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-36 ms],2538
3,Infantile hypertrophic pyloric stenosis [EA],1157
3,Parietal lobe volume,244
3,Visceral adipose tissue/subcutaneous adipose tissue ratio,278
3,Acceptance of an invitation to participate in a mental health questionnaire,4023
3,"Smoking initiation (ever regular vs never regular) [Conditioned on chr3:48731487, chr3:50192760]",74043
3,"Information processing speed [LDST/DSST- age, sex, and education adjusted]",3914
3,Phenyllactate (pla) levels,2366
3,Serum levels of protein MANF,48024
3,Apolipoprotein A1 levels [conditioned on 885 SNPs],347
3,Brain region volumes [right superior parietal],628
3,Ginseng product | treatment/medication code,315
3,Other disorders of Eustachian tube,248
3,White matter microstructure (axial diusivities) [Fornix (column and body],1310
3,Serum levels of protein MINPP1,371
3,Parental longevity (mother's age at death or mother's attained age),71167
3,Bioavailable testosterone levels,206378
3,Bilirubin levels,147414
3,Arm predicted mass (left),201718
3,Ras-related protein Rab-2A measurement,158
3,Serum levels of protein TGFB3,372
3,"Diabetic eye disease | non-cancer illness code, self-reported",277
3,Brain region volumes [left amygdala],6
3,Blood sugar levels,2947
3,Standing height,458507
3,Pattern 3 | hair/balding pattern,1653
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-142 ms],2538
3,Free thyroxine concentration,27
3,T wave morphology restitution during recovery from exercise (MTAG),710
3,Protein quantitative trait loci (liver) [AKR1B1],49
3,Protein quantitative trait loci [MSP],76939
3,Serum creatinine levels,96900
3,Blood protein levels [Hepatocyte growth factor-like protein],40098
3,Trandolapril | treatment/medication code,177
3,Protein quantitative trait loci (liver) [AOC3],37
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-172 ms],157
3,QT interval,40494
3,Multiple myeloma and monoclonal gammopathy,120794
3,Cereal intake,2473
3,Fasting insulin,64116
3,Duration to first press of snap-button in each round,32829
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-196 ms],650
3,Neurological blood protein biomarker levels [LXN],702
3,PR segment duration,525
3,Co-amilozide | treatment/medication code,223
3,Ear morphology,182
3,Daytime nap,24607
3,Frequency of tiredness / lethargy in last 2 weeks,74728
3,CD80 on CD62L+ myeloid Dendritic Cell,21943
3,Age-related hearing impairment (MTAG),18465
3,Hip index,138779
3,"Neurological, eye or psychiatric disease",117289
3,Menopause (age at onset),20547
3,Spherical power (left),2904
3,"Blood protein levels [EA, Kininogen-1]",1129
3,"Pulse pressure x alcohol consumption interaction (2df test) [Asian, EA, Hispanic]",2034
3,Chlamydia trachomatis momp D antibody levels,1923
3,Neonatal cytokine/chemokine levels (fetal genetic effect) [IL-6],196
3,Cleft lip with or without cleft palate,6622
3,Fasting plasma glucose,1058
3,Hay fever and/or eczema,30511
3,"""Diabetes, varying definitions""",4361
3,Raw vegetable consumption,200
3,Belief that own life is meaningful,173
3,"Blood protein levels [SLITRK3, 10565_19_3]",257
3,Protein quantitative trait loci (liver) [HNRNPH3],24
3,Serum levels of protein KRT23,7042
3,Urate levels [men],4945
3,Thyroid stimulating hormone levels,7591
3,Dermatitis and eczema,343
3,Calcium levels,290124
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-166 ms],3220
3,Protein quantitative trait loci (liver) [AZGP1],727
3,Comparative body size at age 10,126596
3,Skin colour,14544
3,Waist-to-hip ratio adjusted for BMI (age >50) [women],5444
3,Response to tofacitinib treatment (herpes zoster)(time to event),484
3,Asthma (mode),891
3,Total body bone mineral density (age over 60),220
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-180 ms],157
3,Chronic obstructive pulmonary disease in ever smokers,75
3,Gamma glutamyl transpeptidase,85426
3,Heel bone mineral density (bmd),25759
3,IgG glycosylation patterns [IgG2_G2FS1/IgG2_G2F],804
3,Nose size,976
3,Alcohol consumption [women],138
3,Myeloproliferative neoplasms,278
3,AP-2 complex subunit alpha-2 measurement,158
3,Facial morphology (segment 52),98
3,Serum metabolite levels (CMS) [Serum_C],57
3,"Schizophrenia, schizoaffective disorder or bipolar disorder",8582
3,Neurological blood protein biomarker levels [CD200R1],4575
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-108 ms],1230
3,CAG-884 abundance in stool,47
3,Blood protein levels [Coagulation Factor XI],457
3,Protein quantitative trait loci [MP2K4],372
3,Poisoning by medicine,41
3,Femoral neck bone mineral density,7672
3,Cancer (pleiotropy),19108
3,Duration of walks,2958
3,Protein quantitative trait loci (liver) [PSMD14],1067
3,Eosinophil percentage of white cells,307969
3,PR interval,232749
3,IgG galactosylation phenotypes (multivariate analysis),839
3,Corneal curvature,2004
3,Allergic sensitization,728
3,Clonidine | treatment/medication code,215
3,Friendships satisfaction,53
3,White blood cell count (neutrophil),111
3,Urate levels [women],2330
3,"Forced vital capacity (fvc), best measure",142661
3,Electrocardiogram morphology (amplitude at temporal datapoints) [154 ms],6807
3,Electrocardiogram morphology (amplitude at temporal datapoints) [28 ms],525
3,BMI x  environmental factors (excluding physical activity) interaction,92
3,"""Endocrine, nutritional and metabolic diseases""",410
3,"Blood protein levels [PSD2, 9118_7_3]",248
3,Childhood onset type 2 diabetes,712
3,Chronic obstructive pulmonary disease,23197
3,Body mass index [men],1143
3,Length of mobile phone use,1152
3,COVID-19,859
3,"Tense, sore, or aching muscles during worst period of anxiety",399
3,Schizophrenia (MTAG),564091
3,Hereditary hemochromatosis-related traits (HFE mutation homozygotes) [Trasferrin],3334
3,Macular telangiectasia type 2,4101
3,"""Other diabetes, wide definition""",4328
3,"Light brown | hair colour (natural, before greying)",7376
3,Electrocardiogram morphology (amplitude at temporal datapoints) [146 ms],201
3,Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis),415
3,Cystitis,241
3,Serum levels of protein BCHE,344
3,Ropinirole | treatment/medication code,166
3,Internar derangement of knee,14
3,Morning person,111095
3,Essential hypertension,41204
3,Verbal-numerical reasoning,180450
3,Serum levels of protein IL1R1,902
3,Serum levels of protein FASLG,33846
3,Caffeine consumption from tea,11659
3,Serum levels of protein GCSH,677
3,Not performed - equipment failure | oct measured (right),10
3,Protein quantitative trait loci (liver) [DUSP3],10
3,Protein quantitative trait loci (liver) [LTF],24
3,Crohn's disease [EA],66861
3,Time spent using computer,40039
3,Body fat distribution (leg fat ratio) [females],106456
3,CCL11 levels,745
3,Aversive difference startle modulation,1179
3,Eumovate cream | treatment/medication code,468
3,"Urinary metabolites [N,N-dimethylglycine/alanine]",835
3,Knee pain | pain type(s) experienced in last month,80
3,Iron status biomarkers (transferrin levels),5589
3,Macrophage inflammatory protein 1b levels,24928
3,High light scatter reticulocyte count,882906
3,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),3575
3,Serum levels of protein ITIH3,121212
3,Pulse rate,104072
3,Body mass index (joint analysis main effects and physical activity interaction) [EA],5356
3,"Blood protein levels [IL10RA, 10344_334_3]",248
3,Serum levels of protein C2orf40,248
3,Ocular sarcoidosis,46
3,Malignant neoplasm of breast,4779
3,Potassium in urine,3072
3,Type 1 diabetes,5282
3,Phospholipid levels (plasma) [proportions],621
3,Waist-to-hip ratio adjusted for BMI in active individuals [women],5250
3,Cerebrospinal fluid levels of Alzheimer's disease-related proteins [Macrophage Inflammatory protein-1 beta],5116
3,Thyrotoxicosis with diffuse goitre,417
3,Drive faster than motorway speed limit,4423
3,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],4954
3,Serous invasive ovarian cancer,4715
3,"Hypothyroidism/myxoedema | non-cancer illness code, self-reported",6492
3,"Blood protein levels [CACNA2D3, 8885_6_3]",387
3,Isosorbide mononitrate | treatment/medication code,90
3,Protein quantitative trait loci (liver) [DDB1],3
3,Monocyte percentage of white cells,230518
3,P wave duration,3177
3,Ever highly irritable/argumentative for 2 days,65794
3,Menopause (age at onset) [japanese],15721
3,Systolic blood pressure x alcohol consumption interaction (2df test) [EA],2393
3,Blood protein levels [Leucine carboxyl methyltransferase 1],696
3,Urticaria,768
3,Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder,281
3,Cholelithiasis and cholecystitis,2077
3,Threonate levels,656
3,HLA DR on CD14- CD16+ monocyte,417
3,Regular attendance at a religious group,6386
3,"Pulse pressure x alcohol consumption interaction (2df test) [Asian, EA]",3804
3,"Blood protein levels [LTF, 2780_35_2]",1523
3,Nonsyndromic cleft palate,735
3,"Blood protein levels [PDGFRL, 9713_67_3]",3379
3,Heel bone mineral density x serum urate levels interaction [female],186
3,Smoking initiation (ever regular vs never regular) [Conditioned on chr3:158284861],244
3,Benign neoplasm of colon,351
3,Smoking initiation,199002
3,"Waist-hip ratio [EA, women]",5658
3,Infantile hypertrophic pyloric stenosis,6616
3,"Blood protein levels [EA, Histidine-rich glycoprotein]",918
3,Esophageal disorder,38
3,Protein quantitative trait loci (liver) [GATM],14
3,Granulocyte percentage of myeloid white cells,33913
3,Autoimmune traits,27881
3,Sunburns,93038
3,Waist-to-hip ratio adjusted for BMI in active individuals [EA],108679
3,Vertex-wise cortical surface area,305406
3,Asthma (only as main-diagnosis),6587
3,Height [Conditioned on rs572169],303
3,Beef consumption,83
3,Protein quantitative trait loci (liver) [LGMN],180
3,Protein quantitative trait loci (liver) [AADAC],5
3,Childhood ear infection,49848
3,Taking other prescription medications,57543
3,Left-handedness,20443
3,Hemoglobin A1c levels,297556
3,IgG glycosylation [IGP35],1560
3,Galanin peptide levels,5613
3,Birth weight variance,1025
3,Peptidyl-prolyl cis-trans isomerase FKBP7 measurement,158
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-78 ms],650
3,Anaeromassilibacillus sp001305115 abundance in stool,9
3,Protein quantitative trait loci (liver) [HAO1],17
3,Well-being spectrum (multivariate analysis),196175
3,Waist-to-hip ratio adjusted for BMI (additive genetic model),235517
3,Leukocyte telomere length,17337
3,Heart attack | vascular/heart problems diagnosed by doctor,6293
3,Electrocardiogram morphology (amplitude at temporal datapoints) [216 ms],19639
3,"""Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified""",1046
3,Bilateral cleft lip,150
3,Physical activity (Relative amplitude),28338
3,Major depressive disorder [males],1515
3,Fat-free mass [male],2341
3,"Anthropometric traits in newborns [Sum of Skinfolds, Model 2]",965
3,"Blood protein levels [POGLUT1, 6467_65_3]",5019
3,Serum levels of protein PAPPA,735
3,Human herpes virus 6 IE1A antibody levels,863
3,Age cataract diagnosed,1636
3,Protein quantitative trait loci (liver) [BDH1],10
3,Osteoarthrosis,53042
3,Insomnia,156165
3,DNA methylation PhenoAge acceleration,3666
3,High blood pressure | vascular/heart problems diagnosed by doctor,147446
3,"Cholesterol lowering medication | medication for cholesterol, blood pressure or diabetes",2071
3,"""Type 2 diabetes, wide definition""",4059
3,Drug-induced liver injury (flucloxacillin) [B*5701 positive],1211
3,Addison's disease,417
3,"Blood protein levels [AZGP1, 9312_8_3]",248
3,Tooth agenesis (maxillary lateral incisors),165
3,Nonatopic asthma,14026
3,Serum levels of protein NPPB,119777
3,Pulse wave arterial stiffness index,1192
3,Colorectal cancer or advanced adenoma,2445
3,Adult onset asthma and/or BMI,1315
3,3-hydroxypropylmercapturic acid levels in smokers [Japanese],488
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-114 ms],1144
3,Diastolic blood pressure [Japanese],414
3,Physical activity (Total log acceleration 2am-4am),479
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-152 ms],157
3,Heart rate response to recovery post exercise (50 sec),20
3,"Melanomas of skin, dx or hx",11
3,Protein quantitative trait loci [a2-HS-Glycoprotein],1875
3,Percent mammographic density,859
3,Brain region volumes [right pars triangularis],1096
3,Dilated cardiomyopathy (MTAG),506
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-188 ms],282
3,Interleukin-1 receptor type 1 measurement,902
3,Major coronary event in placebo-treated cardiovascular disease (time to event),32
3,"""Hypothyroidism, drug reimbursement""",417
3,Corneal hysteresis (right),5187
3,White blood cell count (eosinophil),2283
3,Electrocardiogram morphology (amplitude at temporal datapoints) [124 ms],174
3,Follicular cysts of skin and subcutaneous tissue,26
3,Body fat distribution (arm fat ratio),1430
3,"Intra-ocular pressure, corneal-compensated (right)",28589
3,Male puberty timing (early vs. average onset facial hair),48
3,Migraine and/or diastolic blood pressure,848
3,Hemiplegia,130
3,6mm asymmetry index (right),6
3,Asthma (childhood onset),34622
3,Basal cell carcinoma,5244
3,Palmitoyl-protein thioesterase 1 measurement,406
3,Inguinal hernia,807
3,Lectin-like oxidized LDL receptor 1 levels,2043
3,Depressive symptom (depressed mood) (ordinal trait),1209
3,Protein quantitative trait loci (liver) [SLC25A13],48
3,Blautia sp001304935 abundance in stool,166
3,Social communication problems [Age 17],704
3,DNA methylation Hannum age acceleration,6180
3,Basophill percentage,3671
3,Serum levels of protein TNFAIP6,5360
3,Proline levels,701
3,Electrocardiogram morphology (amplitude at temporal datapoints) [186 ms],174
3,Electrocardiogram morphology (amplitude at temporal datapoints) [236 ms],174
3,Protein quantitative trait loci (liver) [ASAH1],59
3,Waist-to-hip ratio adjusted for body mass index,287492
3,Endometriosis or depression (pleiotropy),140751
3,Childhood sunburn occasions,33916
3,Neonatal cytokine/chemokine levels (fetal genetic effect) [IFN-gamma],196
3,Electrocardiogram morphology (amplitude at temporal datapoints) [26 ms],2769
3,Urinary albumin-to-creatinine ratio [EA],1062
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-192 ms],125
3,Myalgia,8
3,Red blood cell count,2286217
3,Feeling fed-up,36349
3,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),53676
3,Frequency of solarium/sunlamp use,3953
3,Oxalate (ethanedioate) levels,7592
3,Serum parathyroid hormone levels,3509
3,Urinary potassium excretion [EA],2261
3,Type 2 diabetes [South Asian],879
3,Serum levels of protein DEFA5,118
3,Brain region volumes [left lateral ventricle],1310
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-224 ms],525
3,"Blood protein levels [KLKB1, 4152_58_2]",449
3,Asthma [conditional],278
3,"Blood protein levels [A1CF, 12423_38_3]",131
3,Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in non-secretors,23
3,Instant coffee | coffee type,76
3,Candesartan cilexetil | treatment/medication code,5
3,Body size at age 10,127940
3,CCR2 on monocyte,2202
3,Trunk fat-free mass,162203
3,Psoriasis or type 2 diabetes (trans-disease meta-analysis),2801
3,IgG glycosylation patterns [IgG4 FG1S1/(FG1+FG1S1],804
3,Fasting blood glucose (BMI interaction),1982
3,Pregnancy hypertension,420
3,Pizotifen | treatment/medication code,244
3,"1,5-anhydroglucitol levels [EA]",408
3,Gut microbiota (functional units) [GO:0015238|MF|03|drug transmembrane transporter activity],25
3,Hematocrit,1357198
3,Gastroesophageal reflux disease,192788
3,Hemoglobin,627140
3,Reticulocyte percentage,69265
3,"Blood protein levels [RARRES1, 8398_277_3]",19395
3,Anti-adalimumab antibody production in response to treatment in Crohn's disease,1750
3,Serum levels of protein CCL2,979
3,Clostridium difficile infection in multiple myeloma,94
3,Blood metabolite levels [X-12244--N-acetylcarnosine],469
3,Depressive symptom (fatigue) (ordinal trait),59984
3,Age at menopause (last menstrual period),12585
3,"""Gout, strict definition""",9896
3,Vertical cup-disc ratio (multi-trait analysis),3701
3,Ganglion cell inner plexiform layer (GCIPL) thickness,921
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-96 ms],525
3,"B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)",128747
3,Varicose veins of lower extremity,579
3,Mean corpuscular hemoglobin [Asian],73
3,Celiac disease and Rheumatoid arthritis,15301
3,Neonatal cytokine/chemokine levels (fetal genetic effect) [IL-1beta],196
3,Leucine-rich repeats and immunoglobulin-like domains protein 1 levels,1872
3,E-selectin levels,902
3,Pancreatic cancer,136
3,Electrocardiogram morphology (amplitude at temporal datapoints) [144 ms],174
3,Positive affect,194518
3,Asthma,107510
3,Mean arterial pressure [East Asian],4814
3,Serum levels of protein CAPN1;CAPNS1,707
3,IgG glycosylation patterns [IgG2 SA per Gal],804
3,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [men],1987
3,N-acetyl-3-methylhistidine levels,217
3,Papillary thyroid cancer,24
3,Triglyceride levels,514333
3,Facial ageing,75628
3,Arm predicted mass (right),229611
3,Lymphocyte count,4563
3,Ever unenthusiastic/disinterested for a whole week,5437
3,Catechol O-methyltransferase measurement,249
3,Complement component C8 gamma chain measurement,413
3,KELA_REIMBURSEMENT_202,135
3,Doctor's advice | why stopped smoking,12
3,Hand grip strength,52662
3,Irritability,35283
3,Dyslipidemia,4687
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-164 ms],682
3,Neurological blood protein biomarker levels [Siglec-9],902
3,Urine pH measurement,1525
3,IgG glycosylation patterns [IgG4_G2FS1/IgG4_G2F],839
3,Other diseases of upper respiratory tract,97
3,Protein quantitative trait loci (liver) [PRDX3],68
3,Subcortical volume (MOSTest),143664
3,"Blood protein levels [NME1, 5909_51_3]",1523
3,Red blood cell (erythrocyte) distribution width,131356
3,Serum levels of protein CD200R1,1707
3,"Blood protein levels [FHIT, 9826_135_3]",586
3,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant I (Philtrum), Segment 8]",254
3,LDL cholesterol levels in current drinkers,267
3,Reticulocyte fraction of red cells,161883
3,Worry too long after an embarrassing experience,11627
3,Fat-free mass,117256
3,Osteoarthritis (with total hip replacement),113433
3,Serum levels of protein CHL1,27405
3,"Blood protein levels [SIGIRR, 8326_63_3]",286288
3,Forced expiratory volume in 1-second (fev1),119210
3,Securon 40mg tablet | treatment/medication code,501
3,Iron status biomarkers (ferritin levels),3920
3,Atopic dermatitis (moderate to severe) [additive],201
3,COVID-19 (hospitalized vs population),859
3,Hepatocyte growth factor levels,18
3,Myocardial fractal dimension (slice 9),123
3,Kidney stones,4240
3,Systemic sclerosis,18646
3,Appendicular lean mass,804687
3,"Blood protein levels [GCSH, 10956_82_3]",923
3,Systemic lupus erythematosus,29262
3,Body mass index (joint analysis main effects and smoking interaction),3931
3,"Blood protein levels [BOC, 4328_2_2]",3698
3,Electrocardiographic traits [QRS duration],525
3,Nonatopic asthma and/or waist-to-hip ratio adjusted for BMI,168
3,Body mass index and fasting glucose (pairwise),271
3,Type 2 diabetes [Obese],879
3,Diabetes mellitus,34258
3,Systolic blood pressure x smoking status (ever vs never) interaction (2df test),16958
3,Alcohol usually taken with meals,986
3,Vertical cup-disc ratio,2642
3,Allergic rhinitis [Latino],39
3,Getting up in morning,8987
3,"""Ischaemic heart disease, wide definition""",2061
3,Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event),2674
3,"Blood protein levels [CLEC3B, 5701_81_3]",1074
3,Disorders of the thyroid gland,1808
3,CAG-1000 sp000434555 abundance in stool,999
3,Insomnia [Male],392
3,Electrocardiogram morphology (amplitude at temporal datapoints) [262 ms],291
3,Age-related hearing impairment [additive],106
3,Self-rated health,71976
3,Medication use (thyroid preparations),72538
3,Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis,902
3,Body mass index (change over time) in chronic obstructive pulmonary disease,131
3,Lung function [FEV1],26
3,Other specified and unspecified  disorders of eyelid,71
3,Brain region volumes [left pars triangularis],250
3,Cortisol levels (plasma),782
3,Serum levels of protein IL5RA,530
3,"Fracture hand | non-cancer illness code, self-reported",48
3,Protein quantitative trait loci (liver) [S100A4],31
3,Arm fat percentage (right),230803
3,Average weekly red wine intake,935
3,Systolic blood pressure [Japanese],581
3,Benign neoplasm: Vagina (controls excluding all cancers),122
3,Cortical volume [Pars triangularis],463
3,"""Acute otitis externa, noninfective""",38
3,Beconase 50micrograms nasal spray | treatment/medication code,4669
3,Polyp of the female genital tract,3681
3,IgG glycosylation [IGP23],839
3,UBA7177 sp002491225 abundance in stool,52
3,Variation in diet,44725
3,Electrocardiogram morphology (amplitude at temporal datapoints) [120 ms],6807
3,"Waist-to-hip ratio adjusted for BMI in active individuals [EA, women]",5384
3,Ovarian cancer [Serious invasive],4715
3,White blood cell count,806060
3,Osteoarthritis (hip),233304
3,Sleeplessness / insomnia,30191
3,vWF levels [EA],23047
3,Ever taken cannabis,3690
3,Protein quantitative trait loci (liver) [SLC25A5],84
3,"Blood protein levels [VSNL1, 13522_20_3]",1110
3,Leptospirae abundance in stool,4
3,Protein quantitative trait loci (liver) [MCCC2],78
3,Serum levels of protein LRP1,372
3,Depressive symptom (appetite changes) (binary trait),59984
3,"Sphingomyelin (d18:2/16:0, d18:1/16:1) levels",3207
3,"Diastolic blood pressure x alcohol consumption interaction (2df test) [AA, Asian, EA]",2034
3,Neck circumference (BMI adjusted),568
3,Iron,22
3,Anaemias,8
3,Feeling miserable,133171
3,Rhinocort 50micrograms nasal spray | treatment/medication code,313
3,Serum levels of protein GRAMD1C,1563
3,High-sensitivity cardiac troponin I concentration,2538
3,Selenium ace tablet | treatment/medication code,2400
3,Asthma (adult onset),1315
3,"Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) [Asian, EA]",311
3,Often | workplace had a lot of diesel exhaust,64
3,Waist circumference [EA],5279
3,Testicular germ cell tumor,14982
3,"Body mass index [EA, women]",1753
3,Protein quantitative trait loci (liver) [LAP3],179
3,Cortical surface area [Superior Parietal],304
3,"Blood protein levels [F11, 2190_55_1]",449
3,Heel bone mineral density T score,105180
3,Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis),8832
3,Serum levels of protein DCBLD2,1512
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-20 ms],16955
3,Past tobacco smoking,7297
3,Facial morphology (segment 6),312
3,Myeloid white cell count,71151
3,"Systolic blood pressure x alcohol consumption interaction (2df test) [Asian, EA, Hispanic]",2034
3,Type 2 diabetes [conditional],11552
3,1-stearoyl-2-docosahexaenoyl-gpc (18:0/22:6) levels,4286
3,"Type 2 diabetes [South Asians, East Asians]",872
3,Gut microbiota abundance (family Oxalobacteraceae id.2966),724
3,"Helicobacter pylori | non-cancer illness code, self-reported",85
3,COVID-19 (covid vs negative),28
3,Brain morphology (MOSTest),211537
3,Optic cup area,1517
3,3-methyl-2-oxobutyrate levels,247
3,Coagulation Factor XI measurement,777
3,Rice/oat/vegetable milk | type milk consumed,23
3,Serum levels of protein RIPK2,42
3,Serum 25-Hydroxyvitamin D levels,1053280
3,Serum levels of protein CDHR3,112165
3,Ankle spacing width (left),12040
3,"Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA, women]",5384
3,Phosphorus levels,4801
3,Plays computer games,1010
3,Microalbuminuria,87
3,B cell non-Hodgkin lymphoma,741
3,Coagulation Factor X measurement,291
3,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test),17171
3,Attention deficit hyperactivity disorder,10927
3,Facial morphology [right endocanthion-right cheilion distance],105
3,Brain connectivity [Clustering coefficient - L-isthmus of the cingulate],70
3,Spherical power (right),2564
3,"Blood protein levels [CNTN4, 3298_52_2]",37
3,Other erythematous conditions,132
3,Protein quantitative trait loci (liver) [LRG1],7
3,Body mass index and type 2 diabetes (pairwise),2128
3,Glaucoma,6476
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-16 ms],612
3,Cerebrospinal fluid biomarker levels [Histidine-rich glycoprotein],125
3,"Pulmonary function (smoking interaction) [FEV1/FVC, Pack-years]",85
3,Posterior thalamic nuclei volume,7
3,Fluid intelligence score,54082
3,"""Malignant neoplasm of breast, HER-positive""",5258
3,Serum levels of protein TMCC3,349
3,Platelet-to-lymphocyte ratio,22857
3,Estimated glomerular filtration rate [EA],23731
3,SAPHO syndrome,769
3,Electrocardiogram morphology (amplitude at temporal datapoints) [202 ms],174
3,Malignant neoplasm of prostate,11379
3,Cortical surface area [Cuneus],286
3,Cholecystitis,335
3,Brain region volumes [right vessel],1629
3,Gut microbiome composition (summer and winter) [genus_Anaerostipes],44
3,Primary biliary cholangitis,20669
3,Sitting height,339386
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-206 ms],525
3,Blood metabolite ratios [phosphate/erythronate],3327
3,IgG glycosylation patterns [IgG2 FGS1/(FG+FGS1],839
3,Strenuous sports | types of physical activity in last 4 weeks,3965
3,Electrocardiogram morphology (amplitude at temporal datapoints) [132 ms],174
3,Gut microbiota (functional units) [PWY-6215_4-chlorobenzoate_degradation],87
3,"""Hypothyroidism,  other/unspecified""",15416
3,"Blood protein levels [IL1RAP, 2630_12_2]",644
3,Glomerular filtration rate (creatinine),5870
3,Electrocardiogram morphology (amplitude at temporal datapoints) [226 ms],174
3,Squamous cell carcinoma,1192
3,Place of birth in uk - north co-ordinate,621
3,Family history of malignant neoplasm,163
3,CCR2 on CD62L+ plasmacytoid Dendritic Cell,6466
3,Itch intensity from mosquito bite,758
3,Systemic mastocytosis,363
3,Self-reported allergy,417
3,X-25109 levels,92
3,Serum levels of protein PDILT,7
3,Autoimmune thyroid disease,13329
3,IgG glycosylation patterns [IgG1 FG1S1/(FG1+FG1S1],804
3,Phosphatidylcholine_36:6_[M+OAc]1-/Phosphatidylserine_40:5_[M-H]1- levels,388
3,Electrocardiogram morphology (amplitude at temporal datapoints) [14 ms],3631
3,BMI in non-smokers [men],639
3,Serum levels of protein EHMT2,343
3,Blood protein levels [Interleukin-5 receptor subunit alpha],127
3,Electrocardiogram morphology (amplitude at temporal datapoints) [134 ms],174
3,Central corneal thickness,66569
3,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test) [EA],10024
3,Ever had period of mania / excitability,60151
3,"Blood protein levels [RBL2, 13565_2_3]",286288
3,BMI (adjusted for smoking behaviour),3927
3,"Malabsorption/coeliac disease | non-cancer illness code, self-reported",18419
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-170 ms],3220
3,Serum levels of protein A1CF,131
3,"None of the above | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",44516
3,malignant neoplasm of male genital organs (controls excluding all cancers),5481
3,Systolic blood pressure (cigarette smoking interaction),7641
3,Medication use (agents acting on the renin-angiotensin system),256272
3,Rap1 GTPase-GDP dissociation stimulator 1 measurement,158
3,Synonym | fi7 ,857
3,"Blood protein levels [APOE, 2937_10_2]",248
3,Recurring oral aphthae,63
3,White matter microstructure (axial diusivities) [Average across all tracts],141
3,Osteoprotegerin levels,19
3,Highest math class taken,156149
3,Direct low density lipoprotein cholesterol levels,70940
3,Serum levels of protein AXL,5272
3,Rheumatoid arthritis (ACPA-positive),1872
3,Serum levels of protein F11,537
3,Schizophrenia vs bipolar disorder (ordinary least squares (OLS)),7314
3,Medication use (glucocorticoids),380
3,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],282
3,Creatine kinase levels,1042
3,Fish- and plant-related diet [female],4026
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-148 ms],157
3,"PR interval [conditioned on rs3922844,  rs6801957 and rs7374004]",137
3,Esophageal adenocarcinoma,1837
3,Diastolic blood pressure (baseline),133862
3,Adiponectin levels (BMI-adjusted),104681
3,Aspartate aminotransferase levels,150475
3,1-carboxyethylphenylalanine levels,3730
3,"Forced expiratory volume in 1-second (fev1), best measure",119980
3,Age-related diseases and mortality,787
3,Serum levels of protein CDSN,2861
3,Colon adenocarcinoma (controls excluding all cancers),68
3,Cooked vegetable consumption,12
3,Serum levels of protein SPP1,5475
3,Age started wearing glasses or contact lenses,25787
3,Cholelithiasis,4961
3,Haemorrhoidal disease,19432
3,Bendroflumethiazide | treatment/medication code,2706
3,Type 2 diabetes without complications,1036
3,Esophageal cancer (squamous cell),1032
3,"Mean arterial pressure x alcohol consumption interaction (2df test) [Asian, EA]",368
3,Electrocardiogram morphology (amplitude at temporal datapoints) [268 ms],291
3,Primary open-angle glaucoma,135
3,Neonatal cytokine/chemokine levels (fetal genetic effect) [CXCL12],40
3,"None of the above | medication for cholesterol, blood pressure or diabetes",37858
3,Myo-inositol levels,2265
3,Electrocardiogram morphology (amplitude at temporal datapoints) [162 ms],6807
3,Low-grade serous and serous borderline ovarian cancer,837
3,Frequency of friend/family visits,1389
3,IgG glycosylation patterns [IgG4_G1FS1/IgG4_G1F],804
3,Interleukin-1 receptor antagonist protein measurement,181
3,Serum levels of protein APOC3,249
3,Hippurate levels,299
3,Sum basophil neutrophil counts,58497
3,Iron status biomarkers [transferrin],3334
3,N-acetylhistidine levels,1787
3,"Blood protein levels [EA, Interleukin-1 Receptor accessory protein]",547
3,Cutaneous mastocytosis (childhood),462
3,Benign neoplasm of skin,4708
3,Suffering from nerves,1281
3,Iron status biomarkers [TIBC],1514
3,"""Coxarthrosis, primary""",639
3,Advanced age-related macular degeneration [EA],754
3,Blood metabolite levels [hydroxyisovaleroyl carnitine],1941
3,1-methylnicotinamide levels,1188
3,Serum metabolite concentrations in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:0],237
3,Serum levels of protein TMEM52B,115
3,Drug abuse [AA],284
3,Acetobacterales abundance in stool,35
3,Number of days/week walked 10+ minutes,420
3,Protein quantitative trait loci (liver) [MYL6],142
3,"""Injuries to the abdomen, lower back, lumbar spine and pelvis""",18
3,Neuroticism conditioned on self-rated math ability (multi-trait conditioning and joint analysis),9652
3,Metabolic biomarkers (multivariate analysis),141380
3,Dentures | mouth/teeth dental problems,90490
3,"Forced expiratory volume in 1-second (fev1), predicted",181411
3,Polychlorinated biphenyl levels [PCB74],23
3,C-C motif chemokine 17 levels,340
3,"Blood protein levels [CHL1, 8958_51_3]",99
3,Mosquito bite size,357
3,T cell lymphocyte profile difference (90 days post influenza vaccination),130
3,"Blood protein levels [EA, Dynein light chain roadblock-type 1]",15
3,Polycythaemia vera,17
3,Chronic obstructive pulmonary disease in current smokers,75
3,Cognitive traits (MTAG),115954
3,Total testosterone levels,151886
3,"Blood protein levels [TIMP4, 6462_12_3]",7176
3,Whole body fat mass,194831
3,Hyperthyroidism or thyrotoxicosis,401
3,Cognitive performance,193082
3,Type 2 diabetes (adjusted for BMI),45394
3,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],4972
3,Arthritis (juvenile idiopathic),5357
3,Drug-induced hypoglycaemia without coma,139
3,Celiac disease,68538
3,Age-related hearing impairment [recessive],18422
3,"Blood protein levels [APOL1, 9506_10_3]",1487
3,CD80 on myeloid Dendritic Cell,21943
3,P wave duration [EA],572
3,"Smoking initiation (ever regular vs never regular) [Conditioned on chr3:70890288, chr3:71064431]",678
3,Waist circumference adjusted for BMI in active individuals [men],2296
3,Plakophilin-2 measurement,158
3,Body mass index in physically active individuals [women],1753
3,Serum metabolite levels [Gly],513
3,Phospholipid levels (plasma) [levels],44
3,Body mass index [Male],149
3,"Small intestine/small bowel cancer | cancer code, self-reported",39
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-144 ms],3063
3,Serum ceruloplasmin levels,437
3,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction),278998
3,Life satisfaction,175614
3,Pulse pressure [East Asian],70077
3,HDL cholesterol levels in current drinkers,45772
3,Depressive symptoms (sum-score),59984
3,Benign neoplasms,5140
3,Mood instability,3667
3,"Blood protein levels [ASGR1, 5452_71_3]",1523
3,Protein quantitative trait loci (liver) [ACSM2B],3
3,1-(1-enyl-palmitoyl)-2-arachidonoyl-gpc (p-16:0/20:4) levels,351
3,Protein quantitative trait loci (liver) [HEXA],427
3,Serum levels of protein COPS7B,249
3,Liver volume,8
3,Hip bone mineral density and total body fat mass (bivariate analysis),2803
3,Pulmonary function [FEV1],1143
3,HLA DR on CD33dim HLA DR+ CD11b+,402
3,Migraine - clinic-based,391
3,Pulse pressure,1128978
3,Body mass index [Japanese],107791
3,Ischemic heart disease,3663
3,Metabolite levels [BUN],561
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-116 ms],1144
3,Serum levels of protein HMGN1,305
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-82 ms],650
3,Worrier / anxious feelings,76568
3,Nonalcoholic fatty liver disease (imputed),48837
3,Rheumatoid arthritis,9737
3,Cortical surface area (global PC1) [EA],1968
3,Current | smoking status,1727
3,HDL cholesterol levels x short total sleep time interaction (2df test),906
3,Right eye only | ever had refractive laser eye surgery,845
3,Alcohol consumption (transferrin glycosylation) [CDT concentration],832
3,Feeling nervous,122347
3,Broad depression or bipolar disorder,109905
3,"Diastolic blood pressure x alcohol consumption interaction (2df test) [AA, EA]",110738
3,Neurological blood protein biomarker levels [NEP],52911
3,Leg fat-free mass (right),147560
3,Blood protein levels [Plasma kallikrein],457
3,Protein quantitative trait loci (liver) [GYG2],36
3,Lymphocyte-to-monocyte ratio,46058
3,Non-melanoma skin cancer,3418
3,Brain region volumes [right lateral ventricle],1310
3,Urinary metabolites [glycolate],251
3,Protein quantitative trait loci (liver) [IGHG2],14
3,Demyelenating diseases of the central nervous system,3
3,Waist-to-hip ratio adjusted for BMI,1807408
3,Waist circumference,191357
3,Balding type 1,13049
3,Tense / 'highly strung',8995
3,"Blood protein levels [AAGAB, 11926_23_3]",1487
3,Alcohol consumption (drinks per week) [Conditioned on chr3:141267295],1933
3,Protein quantitative trait loci (liver) [ACAA1],7
3,Medication use (diuretics),228523
3,Glaucoma (primary open-angle),3476
3,Peak expiratory flow (pef),4628
3,Type 2 diabetes [additive model],879
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-176 ms],157
3,Beef intake,83
3,Leisure sedentary behaviour (computer use),34982
3,Serum levels of protein BNIP3,42
3,"""Hypothyroidism, strict autoimmune, 3 medication purchases required""",15399
3,Interleukin-18 levels,2299
3,Serum levels of protein SEC13,248
3,Anorexia nervosa | mental health problems ever diagnosed by a professional,37
3,Quetiapine | treatment/medication code,144
3,Telomere length,27851
3,"Number of decayed, missing and filled tooth surfaces or use of dentures",101004
3,SARS-CoV-2 infection,13386
3,Atrial fibrillation/atrial flutter,9715
3,Graves' disease,756
3,IgA nephropathy,695
3,Peritonsillar abscess,1178
3,Hypertrophic cardiomyopathy,99
3,Protein quantitative trait loci (liver) [EPHX1],12
3,"Waist circumference adjusted for BMI in active individuals [EA,women]",99971
3,Serum levels of protein ATP13A1,52911
3,Leg fat percentage (right),227652
3,Haematocrit percentage,295407
3,Atopic dermatitis,20544
3,"Intra-ocular pressure, goldmann-correlated (right)",2965
3,COVID-19 (hospitalized vs population) RELEASE 4,21
3,Sjögren's syndrome,194
3,Electrocardiogram morphology (amplitude at temporal datapoints) [258 ms],291
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-86 ms],1099
3,Iron status biomarkers [serum transferrin],6523
3,Gastric polyp,4871
3,"Blood protein levels [HRG, 4996_66_1]",1615
3,Serum levels of protein VWA2,178
3,Interstitial lung abnormalities [EA],2
3,"Cholesterol, total",18393
3,Self-reported math ability,158661
3,Optic disc size,12178
3,Alanine aminotransferase levels,369489
3,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],46012
3,CX3CR1 on CD14+ CD16+ monocyte,474
3,Serum levels of protein POGLUT1,7139
3,"Gout | non-cancer illness code, self-reported",9932
3,Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid),2743
3,Facial morphology (segment 1),10439
3,IgG monosialylation phenotypes (multivariate analysis),839
3,Cystatin D levels,99
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-198 ms],157
3,Citramalate levels,133
3,Wears glasses or contact lenses,25
3,P wave duration [AA],27
3,Hypothyroidism,68758
3,Wheeze or whistling in the chest in last year,89967
3,Smoking initiation (ever regular vs never regular) [Conditioned on chr3:60459291],166
3,Serum levels of protein MAPK14,305
3,Electrocardiogram morphology (amplitude at temporal datapoints) [-210 ms],525
3,Cortical surface area (visual PC2) [EA],171
3,Alcohol consumption x experiences in childhood (felt loved by family member) interaction,11
3,Blood pressure traits (multi-trait analysis) [Het],121320
3,Type 2 diabetes,437480
3,Anxiety/tension (special factor of neuroticism),130425
3,Basophil count,81889
3,Serum levels of protein CLEC3B,1074
3,White blood cell types [eosinophil count],413
3,Phosphatidylcholine_38:9_[M+OAc]1-/Phosphatidylserine_42:8_[M-H]1- levels,871
3,Electrocardiogram morphology (amplitude at temporal datapoints) [178 ms],358
4,Trunk fat-free mass,142588
4,"Blood protein levels [EA, Hepatocyte growth factor activator]",2376
4,Electrocardiogram morphology (amplitude at temporal datapoints) [84 ms],1045
4,Serum levels of protein BTC,1057
4,Serum uric acid levels in response to allopurinol in gout [EA],844
4,Conduct disorder (symptom count),705
4,Retinal nerve fibre layer thickness or ganglion cell inner plexiform layer thickness (MTAG),33
4,Low back pain,11
4,Serum levels of protein MCL1,135
4,Urinary sodium excretion [EA],24
4,Bladder cancer,34731
4,Colchicine | treatment/medication code,2524
4,High blood pressure | illnesses of father,262
4,Hard cardiovascular diseases,488
4,"Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels) [S-DCT/S-CT ratio, adjusted for CYP2C19]",6
4,High density lipoprotein cholesterol levels,18338
4,HDL cholesterol levels,168922
4,Blood protein levels [ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2],11652
4,Opioid use disorder vs exposed controls,8418
4,Thyroid hormone levels [TSH - Females],259
4,Autoimmune traits (pleiotropy),275
4,vWF levels,46
4,Alcohol consumption (heavy vs. light/non-drinkers),1359
4,Cancer (pleiotropy),5148
4,Blood protein levels [Afamin],2921
4,Metabolite levels (small molecules and protein measures) [Valine],1032
4,Polyneuropathies and other disorders of the peripheral nervous system,408
4,Bipolar disorder vs ADHD (ordinary least squares (OLS)),1265
4,Autism spectrum disorder or schizophrenia,3570
4,Itch intensity from mosquito bite adjusted by bite size,1012
4,Dihydropteridine reductase levels,2627
4,Gut microbiota (bacterial taxa) [Unclassified Marinilabiliaceae],520
4,"Blood protein levels [PCDH15, 14228_1_3]",552
4,Midgestational total 25-hydroxyvitamin D levels (antenatal blood),77
4,Body mass index in physically active individuals,80
4,Protein quantitative trait loci (liver) [AGXT2],5
4,Activated partial thromboplastin time,4519
4,"Blood protein levels [KLKB1, 4152_58_2]",3128
4,Electrocardiogram morphology (amplitude at temporal datapoints) [160 ms],225
4,"Blood protein levels [SPON2, 8099_42_3]",3724
4,Serum levels of protein MAN2B2,723
4,Alzheimer's disease or family history of Alzheimer's disease,396
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-16 ms],651
4,Vitamin D levels [Age 6],84
4,None of the above | pain type(s) experienced in last month,272
4,Hot drink temperature,2291
4,Protein quantitative trait loci (liver) [FASN],494
4,Vitamin D insufficiency,6711
4,Serum levels of protein PPID,2731
4,"""Diabetes, varying definitions""",8518
4,Serum levels of protein DNAJC11,1553
4,Brain region volumes [right ventral DC],821
4,"Blood protein levels [PSG5, 9314_9_3]",552
4,Endometriosis of fallopian tube,956
4,Local histogram emphysema pattern [normal],195
4,"Fracture jaw | non-cancer illness code, self-reported",164
4,Vitamin D levels (dietary vitamin D intake interaction),55
4,Gilbert syndrome,7
4,Recombination rate (males),15012
4,Tyrosine-protein kinase Mer levels,1899
4,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],1290
4,Triglyceride levels [Trans-ethnic initial],3622
4,Serum levels of protein HGFAC,358
4,BMI at 1 year old,1951
4,"""Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium""",120
4,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA],1513
4,Serum levels of protein NDUFAF8,2580
4,Eosinophil percentage of granulocytes,6978
4,Neurological blood protein biomarker levels [CD38],2422
4,Bipolar disorder vs major depressive disorder (ordinary least squares (OLS)),10
4,Kawasaki disease,24631
4,Intelligence,58744
4,Urate levels [East Asian],7050
4,Opioid use disorder,8418
4,Strenuous sports | types of physical activity in last 4 weeks,990
4,Chronic bronchitis and chronic obstructive pulmonary disease [EA],495
4,Coronary artery disease or large artery stroke,214
4,"Blood protein levels [EMC1, 11989_35_3]",11045
4,"Heel quantitative ultrasound index (qui), direct entry (right)",22112
4,"None of the above | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",39054
4,Quinine | treatment/medication code,340
4,Leisure sedentary behaviour (computer use),12010
4,White blood cell (leukocyte) count,33548
4,Asthma [conditional],3285
4,"Blood protein levels [CFI, 2567_5_6]",966
4,Cerebrospinal fluid immune biomarker levels [IL-8],61
4,6mm asymmetry index (left),36
4,Arrhythmia [conditional],145
4,White matter microstructure (axial diusivities) [Inferior fronto-occipital fasciculus],1
4,Age at first birth,9211
4,Growth-regulated protein alpha levels [Conditioned on rs508977],2883
4,Adrenomedullin levels,1899
4,Persantin 25mg tablet | treatment/medication code,1705
4,"""Excessive, freguent and irrelgular menstruation""",707
4,Cerebrospinal fluid biomarker levels [ADP-ribosyl cyclase 2],951
4,Medication use (antithrombotic agents),1804
4,Mean arterial pressure x alcohol consumption interaction (2df test) [EA],147
4,Mean corpuscular hemoglobin concentration,190411
4,"Age hay fever, rhinitis or eczema diagnosed",14715
4,Medication use (thyroid preparations),9037
4,Serum levels of protein HIF1A,2580
4,Body mass index variance,362
4,"Yes, because of illness | major dietary changes in the last 5 years",272
4,Serum uric acid levels,67892
4,Estimated glomerular filtration rate in non-diabetics,23024
4,Neutrophill count,33577
4,Serum levels of protein BMP4,2580
4,Acceptance of an invitation to participate in a mental health questionnaire,10506
4,Childhood sunburn occasions,3772
4,"None of the above | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",1389
4,Doctor diagnosed bronchiectasis,362
4,Blood metabolite levels [2-aminobutyrate],104
4,Schizophrenia,221248
4,Serum levels of protein ITIH4,2028
4,Job-related exhaustion in shift workers,254
4,Warfarin | treatment/medication code,3410
4,Number of incorrect matches in round,122
4,"Blood protein levels [UNC5C, 5139_32_3]",196
4,Serum levels of protein PSMD9,552
4,Essential tremor,152
4,Urinary metabolite levels in chronic kidney disease [N-acetylglucosamine/N-acetylgalactosamine],3106
4,Urate levels [Urate],1554
4,Bone mineral density [spine],466
4,"Emphysema imaging phenotypes [Perc15, All]",205
4,Alcohol consumption x experiences in childhood (felt loved by family member) interaction,17
4,Protein quantitative trait loci (liver) [UGT1A9],18
4,Fluid intelligence score,17456
4,"""Primary gonarthrosis, bilateral""",2191
4,Number of sexual partners,3092
4,Insulin product | treatment/medication code,2895
4,Thrombin measurement,3101
4,Congenital heart malformation,288
4,HDL cholesterol levels x short total sleep time interaction (2df test) [EA],37
4,Plasminogen measurement,61
4,"Blood protein levels [NAAA, 3173_49_2]",4187
4,"Blood protein levels [PSMD9, 13931_22_3]",552
4,Blood pressure [Diastolic],500
4,Endometriosis of ovary,638
4,Fractional exhaled nitric oxide (childhood) [EA],143
4,Medication use (antiglaucoma preparations and miotics),3870
4,Mean corpuscular haemoglobin,47142
4,Venlafaxine | treatment/medication code,367
4,JT interval (sulfonylurea treatment interaction) [AA],37
4,Neuroblastoma (1p deletion),75
4,Facial morphology (segment 53),433
4,TestASV_27 (Ruminococcaceae) abundance,82
4,Serum metabolite levels [X-11799],106
4,Chronic diseases of tonsils and adenoids,3215
4,"""Endomtriosis ASRM stages 1,2""",638
4,Medication use (salicylic acid and derivatives),960
4,Protein quantitative trait loci (liver) [PIPOX],12
4,"Blood protein levels [FGFR3, 3809_1_2]",552
4,Other nutritional deficiencies,36
4,Serum levels of protein SETD2,2580
4,Bendroflumethiazide | treatment/medication code,115
4,Cardiomyopathy,357
4,Sodium cromoglicate | treatment/medication code,17
4,Mosaic loss of chromosome Y (Y chromosome dosage),16012
4,Salivary metabolite levels [urate],1235
4,Ascending aorta minimum area,345
4,Gut microbiota (functional units) [PWY-6948_sitosterol_degradation_to_androstenedione],77
4,Serum uric acid levels [Conditioned on rs7678287],1904
4,Pre-treatment viral load in HIV-1 infection,5912
4,Corneal hysteresis (right),5507
4,Other arthropathies,116
4,Current tobacco smoking,30
4,"Heel quantitative ultrasound index (qui), direct entry",37094
4,"Diabetes | non-cancer illness code, self-reported",5416
4,Height [EA],839
4,Neurociticism,13034
4,"Alcohol consumption (drinks per week) [Conditioned on chr4:100254520, chr4:100443853,chr4:100286085 ,chr4:100260679, chr4:100444363, chr4:100239319]",1404
4,Protein quantitative trait loci (liver) [CYP2A6],858
4,"Blood protein levels [PLXDC1, 9235_3_3]",2984
4,Serum levels of protein HPGDS,5246
4,P-cresol sulfate levels,456
4,"None of the above | illness, injury, bereavement, stress in last 2 years",144
4,Serum vitamin D-binding protein levels in type 2 diabetes [conditional on [rs7041]],20
4,Obesity and other hyperalimentation,36
4,Bipolar disorder or major depressive disorder,6383
4,Sitting height,129853
4,Fibrinogen measurement,1698
4,Longest period of unenthusiasm / disinterest,62
4,Brain region volumes [right inferior parietal],2
4,"Diastolic blood pressure, automated reading",80321
4,Estimated glomerular filtration rate [discovery],3821
4,Vitamin D levels [Age 14],58
4,Relative age voice broke,1
4,Serum levels of protein SNCA,3238
4,Blood protein levels [Plasma kallikrein],2152
4,Regular attendance at a religious group,11768
4,Atopic dermatitis (moderate to severe) [additive],917
4,Spherical equivalent (joint analysis main effects and education interaction) [Asian ancestry],1458
4,Brain region volumes [left accumbens area],264
4,Leg predicted mass (right),161984
4,Triglyceride levels x short total sleep time interaction (2df test),2007
4,Variation in diet,5838
4,Attention deficit hyperactivity disorder (MTAG),474
4,Blood protein levels [Coagulation Factor XI],144
4,Amlodipine | treatment/medication code,120
4,Protein quantitative trait loci (liver) [CNN2],40
4,Cognitive ability,4549
4,Subcortical volume (min-P),805
4,CD3 on Terminally Differentiated CD8+ T cell,104
4,Gut microbiota abundance (genus Enterorhabdus id.820),9
4,Impedance of leg (left),60198
4,Serum levels of protein CD4,2558
4,"""Gonarthrosis,primary""",2191
4,Heart rate response to beta blockers (atenolol add-on therapy) [EA],449
4,Chronic obstructive pulmonary disease x current smoker interaction (main effect),3800
4,Osteoarthritis of the hip or knee (with total joint replacement),11577
4,Blood metabolite levels [octanoylcarnitine],2731
4,Urate levels in lean individuals [Men],2000
4,Self-reported allergy,14792
4,Smoking intensity (cotinine levels/cigarettes per day),3149
4,Age cataract diagnosed,58
4,6mm asymmetry angle (right),171
4,Metabolic syndrome,4413
4,Youthful appearance (self-reported),18918
4,Angiopoietin-1 levels,24762
4,Schizophrenia (MTAG),1246
4,Serum immune biomarker levels [YKL-40],82
4,Serum vitamin D-binding protein levels,55
4,Pulmonary function [FEV1],29732
4,Body mass index (bmi),15674
4,Eosinophil counts,185025
4,Cortical surface area [Supramarginal],907
4,Triglyceride levels in very large HDL,305
4,"""Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified""",916
4,Serum levels of protein SCGB2A1,552
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-54 ms],304
4,Calcium levels,66448
4,Alcohol use disorder (consumption score) [EA],6945
4,None of the above | qualifications,25997
4,Serum levels of protein EGF,3143
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-206 ms],1000
4,Post-traumatic stress disorder symptoms in trauma-exposed soldiers,13
4,Risky sexual behaviors in alcohol dependence [AA],2
4,Phlebitis and thrombophlebitis,626
4,"""Other diabetes, wide definition""",96497
4,Speech perception in dyslexia [MMNb],233
4,Osteoarthritis (with total hip replacement),64
4,Waist-to-hip ratio adjusted for body mass index [EA],4912
4,LDL cholesterol levels [Trans-ethnic initial],44
4,Alcohol use disorder (dependence and problematic use scores),1547
4,Number of attempts,332
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-14 ms],651
4,Age-related disease endophenotypes,538
4,Total body bone mineral density,6850
4,Serum levels of protein SGK3,2558
4,Problematic alcohol use (MTAG),9798
4,Interstitial lung disease,1292
4,Serum levels of protein CTSO,1961
4,Arthrotec tablet | treatment/medication code,1162
4,Hypertensive heart and/or renal disease,161
4,Testicular germ cell tumor,116988
4,Glaucoma (primary open-angle),25310
4,Cognitive performance,55865
4,Blood pressure [Mean Arterial Pressure],240
4,Pulmonary function,364
4,Osteoarthrosis nos,67
4,Lateral thalamic nuclei volume,116
4,5-methylthioadenosine (mta) levels,134
4,Facial morphology (nose roundness 3),61
4,Blood protein levels [CXCL10],93
4,Blood protein levels [Beta globulins (%],2
4,Glomerular filtration rate in non diabetics (creatinine),22373
4,Blood metabolite levels [3-methyl-2-oxovalerate],351
4,Branched-chain amino acid levels (Valine),351
4,Serum levels of protein COL20A1,2580
4,Fracture of forearm,3721
4,Liver fibrosis and steatohepatitis severity (MRI cT1 measure),116
4,"""Other and unspecified polyneuropathies, also in other diseases""",453
4,Senna | treatment/medication code,3
4,"Cholesterol lowering medication | medication for cholesterol, blood pressure or diabetes",4332
4,"Intra-ocular pressure, corneal-compensated (right)",3238
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-92 ms],1000
4,Urinary sodium excretion,24
4,Place of birth in uk - east co-ordinate,5
4,Allergic sensitization,40670
4,Facial morphology (segment 5),3607
4,Electrocardiogram morphology (amplitude at temporal datapoints) [386 ms],1045
4,Urolithiasis,4083
4,Chloroflexales abundance in stool,205
4,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],1290
4,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,12
4,Pulse pressure,161868
4,Monocyte percentage,40649
4,Body mass index (joint analysis main effects and physical activity interaction) [EA],74
4,"Alcohol consumption (drinks per week) [Conditioned on chr4:100286085, chr4:100260679,chr4:100444363 ,chr4:100239319]",1276
4,N-acetylglucosamine/n-acetylgalactosamine levels,1361
4,Itch intensity from mosquito bite adjusted by bite size [men],506
4,Hypothyroidism (congenital or acquired),263
4,Amount of alcohol drunk on a typical drinking day,1359
4,Alcohol dependence [EA],48
4,Small vessel stroke (CCS and TOAST classification),122
4,HDL cholesterol,71490
4,Heel bone mineral density (bmd) (right),18363
4,"Systolic blood pressure x alcohol consumption interaction (2df test) [AA, EA]",498
4,"Medication use (anti-inflammatory and antirheumatic products, non-steroids)",2250
4,Serum levels of protein PGK1,552
4,Serum levels of protein EIF4EBP2,1016
4,Cardioembolic stroke (CCSc classification),198
4,Asthma (age of onset),13101
4,Worrier / anxious feelings,3305
4,Lung function (FEV1/FVC) variance,364
4,PR interval [Hispanic/Latino],725
4,Cortical surface area [Lingual],610
4,Ever believed in un-real communications or signs,99
4,Waist circumference adjusted for BMI in active individuals [EA],66
4,Rate of cognitive decline in Alzheimer's disease [GEE model],13
4,Serum levels of protein DBNL,2028
4,Cortical surface area [Superior Parietal],8411
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-106 ms],1000
4,Serum metabolite levels [Leucylphenylalanine],1016
4,None of the above | mineral and other dietary supplements,2417
4,Flecainide | treatment/medication code,363
4,Vitiligo,2966
4,Hip index,22118
4,Brain region volumes [grey matter],2440
4,Blood metabolite levels [decanoylcarnitine],2731
4,Dihydrocodeine | treatment/medication code,1721
4,Musculoskeletal disorder or trauma,1995
4,Atrial fibrillation and flutter with reimbursement,456
4,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [AA],29
4,Protein quantitative trait loci (liver) [AK1],4
4,Household income,23486
4,Cortical surface area [Superior temporal],2991
4,HDL cholesterol x physical activity interaction (2df test),268
4,Body mass index (adult),35
4,"Allergic disease (asthma, hay fever or eczema)",103662
4,Cognitive ability (MTAG),15416
4,"Aging traits (healthspan, parental lifespan or longevity) (multivariate analysis)",6551
4,Body fat percentage,45820
4,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],3306
4,Stable angina pectoris,2289
4,Serum metabolite levels (CMS) [Leu],1407
4,Blood metabolite levels [Urate levels],1244
4,Icd10: c56 malignant neoplasm of ovary | underlying (primary) cause of death,645
4,Mesalazine | treatment/medication code,92
4,Facial morphology [right endocanthion-right alare distance],34
4,Leg predicted mass (left),111133
4,Cotinine glucuronidation,2017
4,Lichen simplex chronicus and prurigo,189
4,Serum levels of protein ID2,552
4,Photic sneeze reflex,1031
4,Urinary microalbumin levels,9
4,Never | alcohol drinker status,24
4,Smoking initiation (ever regular vs never regular),11433
4,3mm strong meridian (right),81989
4,Serum levels of protein C19orf18,2558
4,Serum levels of protein CD5,2558
4,Serum levels of protein PF4V1,464
4,Maximum digits remembered correctly,1
4,Verbal-numerical reasoning,49203
4,High blood pressure | vascular/heart problems diagnosed by doctor,114040
4,Telomere length,69
4,"Pulse pressure x alcohol consumption interaction (2df test) [AA, Asian, EA]",492
4,"Serum metabolite levels [glycosyl ceramide (d18:1/20:0, d16:1/22:0)*]",92
4,Crisp intake,28
4,Electrocardiogram morphology (amplitude at temporal datapoints) [354 ms],13
4,Testosterone levels,43320
4,Protein quantitative trait loci (liver) [S100A11],5359
4,Embolic stroke with flimmer,313
4,Type 2 diabetes,691941
4,Coronary artery disease,70300
4,Immunological or systemic disorder,19952
4,Body fat distribution (leg fat ratio),1612
4,Oily fish intake,2618
4,Roseibacillus abundance in stool,51
4,Prospective memory result,332
4,Current | alcohol drinker status,24
4,Height,822806
4,LDL cholesterol,2252
4,Ear morphology,773
4,High-sensitivity cardiac troponin I concentration,2028
4,4-chlorobenzoic acid levels,488
4,Thimet oligopeptidase levels,121
4,"Waist circumference [EA, men]",22
4,Protein quantitative trait loci [ASAHL],12758
4,"Blood protein levels [IDUA, 3169_70_2]",9526
4,Diltiazem | treatment/medication code,401
4,Relative protein intake,1219
4,Electrocardiographic traits (multivariate),1443
4,"""Benign neoplasm: Middle ear, nasal cavity and accessory sinuses""",7
4,Male puberty timing (age at voice breaking MTAG),19735
4,Arm fat percentage (right),31345
4,Oral cavity and pharyngeal cancer,23114
4,Protein quantitative trait loci [Prekallikrein],3101
4,Sleep duration,5072
4,Kidney volume,279
4,Betnovate cream | treatment/medication code,222
4,Acute laryngitis and tracheitis,21
4,Uric acid levels,29219
4,Serum levels of protein FAM174B,2580
4,White blood cell count (basophil),14899
4,Water intake,1024
4,Endometriosis,1276
4,Protein quantitative trait loci (liver) [FLNA],40
4,Non-albumin protein levels [NAP],31
4,Fractured/broken bones in last 5 years,3769
4,Total testosterone levels,139603
4,Serum levels of protein POMC,2580
4,"""Alcohol related diseases and deaths, all endoints""",2336
4,"Gut microbiota (bacterial taxa, rank normal transformation method) [O_Rhodospirillales_RNT]",2437
4,Protein quantitative trait loci (liver) [MYO1B],843
4,Dermatologic disease,1171
4,Maximum habitual alcohol consumption [EA],24
4,Protein quantitative trait loci (liver) [S100A6],24
4,Smoking status (current vs never) [EA],6006
4,"Mean arterial pressure x alcohol consumption interaction (2df test) [Asian, EA]",107
4,Autoimmune thyroid disease,1262
4,Serum levels of protein PPARA,2580
4,Coronary angiopasty,203
4,Alcohol use disorder (consumption score) [Latino],24
4,Time spent doing moderate physical activity,7
4,Pulse wave reflection index,5
4,Fibrinogen,6927
4,Serum levels of protein PTK6,2580
4,Cisplatin-induced ototoxicity,2509
4,"Blood pressure [EA, SBP, Age 50-59]",119
4,Prostate cancer | illnesses of adopted father,9
4,"""Asthma, including avohilmo""",13620
4,Atopic dermatitis,8749
4,Serum lycopene concentrations,290
4,"Blood protein levels [NLGN4X, 5357_60_3]",552
4,Opticrom allergy eye drops | treatment/medication code,165
4,Lung function (FEV1) [adults],127
4,Graves' disease,856
4,Response to bupropion in depression,160
4,Serous borderline ovarian cancer,41
4,Facial morphology [left endocanthion-left alare distance],34
4,Total body bone mineral density (age 0-15),4748
4,Brain morphology (MOSTest),61028
4,"Osteoporosis | non-cancer illness code, self-reported",3240
4,Cirrhosis (alcohol related),3870
4,Protein levels in obesity [Factor I],4433
4,Protein quantitative trait loci (liver) [AKR1B10],12
4,"Heel bone mineral density (bmd) t-score, automated (left)",14781
4,Idiopathic gout,1469
4,Diastolic blood pressure x sodium interaction (2df test),3188
4,Blood pressure [Pulse Pressure],236
4,Blood protein levels [CXCL6],3742
4,Peptac liquid | treatment/medication code,2361
4,Protein quantitative trait loci (liver) [FERMT2],1261
4,"Blood protein levels [DBNL, 4978_54_2]",2984
4,Central corneal thickness,2629
4,Low hand grip strength (60 years and older) (FNIH),17
4,Hip circumference [EA],929
4,Number of days/week walked 10+ minutes,120
4,Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy,21
4,Osteoarthritis,12972
4,Percent liver fat,6463
4,Serum metabolite levels (CMS) [Val],1014
4,Thyrotoxic hypokalemic periodic paralysis and Graves disease,403
4,!Aliquae complicationes praecoces traumatis,35
4,Serum levels of protein FAM210A,20
4,Cognitive aspects of educational attainment,72587
4,Age-related macular degeneration (whether dry or wet),4006
4,Serum metabolite levels [urate],11113
4,Blood metabolite levels [cis-4-decenoyl carnitine],2731
4,Levothyroxine sodium | treatment/medication code,468
4,Cardiac pacemaker in situ,304
4,Urea levels,40
4,Viral hepatitis,37
4,Neonatal cytokine/chemokine levels (fetal genetic effect) [CXCL11],67446
4,Gout and other crystal arthropathies,2800
4,QT interval,2729
4,HDL cholesterol levels [Trans-ethnic initial],1248
4,Drive faster than motorway speed limit,267
4,"Hip circumference [EA,women]",35
4,"Blood protein levels [KDR, 3651_50_5]",10
4,DVT of lower extremities,441
4,Congenital heart disease [ASD],897
4,"Peripheral nerve injury | non-cancer illness code, self-reported",133
4,Serum levels of protein PROC,2580
4,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),2355
4,Alcohol usually taken with meals,3306
4,Serum levels of protein HSP90AA1;HSP90AB1,2580
4,Well-being spectrum (multivariate analysis),952
4,Serum levels of protein NPNT,85
4,Lean body mass [EA],16
4,Alzheimer's disease/dementia | illnesses of siblings,11
4,Body fat distribution (arm fat ratio) [females],10204
4,Leiomyoma of uterus (controls excluding all cancers),1718
4,"Blood protein levels [SPARCL1, 13707_27_3]",2489
4,"Blood protein levels [DNAJC11, 9783_75_3]",552
4,Cough,420
4,Chronic obstructive pulmonary disease in never smokers,1868
4,Primary biliary cirrhosis,17345
4,High density lipoprotein cholesterol levels [EA],3254
4,Total amyloid (SNP x SNP interaction),779
4,Muesli | cereal type,116
4,Obese vs. thin,308
4,Mild influenza (H1N1) infection,9
4,KLE1615 sp900066985 abundance in stool,1
4,Low density lipoprotein cholesterol levels,45787
4,Direct bilirubin levels,34514
4,Aspartate aminotransferase platelet ratio index in high alcohol intake,3672
4,"""Gout, strict definition""",1854
4,Hip shape (DXA scan) [hip shape mode 2],367
4,"Hormone replacement therapy | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",126
4,Aspartate aminotransferase to alanine aminotransferase ratio,3794
4,Medication use (beta blocking agents),3244
4,Leiomyoma of uterus,1722
4,Atrial fibrillation [AA],207
4,"Esophagitis, gerd and related diseases",434
4,Congenital malformations of the urinary system,747
4,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Asian],1557
4,Schizophrenia [EA],513
4,Depressive symptom (sleep problems) (binary trait),119
4,Simvastatin | treatment/medication code,120
4,Response to antipsychotic treatment [ziprasidone-hip circumference],62
4,Sporadic neuroblastoma [non-African],31
4,Protein quantitative trait loci (liver) [HSD17B4],18
4,Inverse distance to the nearest major road,4
4,Facial morphology (segment 31),52467
4,Hydroxyasparagine levels,9519
4,Diabetes,12704
4,C-X-C motif chemokine 1 levels,8368
4,Blood protein levels [GC],1959
4,Mosquito bite size,1543
4,Renal function and chronic kidney disease [eGFRcrea],2779
4,Lifetime number of sexual partners,10458
4,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),25
4,Corneal structure,195
4,Prolargin levels,1899
4,Place of birth in uk - north co-ordinate,26080
4,High light scatter reticulocyte percentage,65169
4,Type 2 diabetes (adjusted for BMI),8031
4,Moderate to vigorous physical activity levels,5349
4,Fat-free mass [female],10301
4,Facial morphology (nostril size),61
4,Atopic dermatitis (moderate to severe) [general],303
4,Midgestational cytokine/chemokine levels (maternal genetic effect) [IL1-alpha],191
4,Waist circumference adjusted for BMI in active individuals [women],66
4,"Body mass index [EA, men]",74
4,Hemoglobin levels,42750
4,Pollen allergy,13421
4,Diabetes diagnosed by doctor,6286
4,Adult onset asthma and/or BMI,872
4,CD38 on IgD+ CD38+ B cell,100
4,3mm cylindrical power (left),1585
4,Epithelial ovarian cancer [Serous],478
4,Electrocardiogram morphology (amplitude at temporal datapoints) [64 ms],13
4,Granulocyte count,66217
4,Mean corpuscular hemoglobin,524261
4,Apolipoprotein A1 levels,166616
4,Platelet-to-lymphocyte ratio,38472
4,Cortical surface area [Pericalcarine],7643
4,Arm fat-free mass (right),100363
4,"Hip circumference adjusted for BMI [EA, women]",1029
4,Migraine,916
4,Wheeze or whistling in the chest in last year,664
4,Obesity,36
4,Neurofibrillary tangles (SNP x SNP interaction),28321
4,Occipital lobe volume,3526
4,D-dimer measurement,1686
4,Femoral neck bone mineral density,1093
4,Parkinson's disease [Sporadic],1350
4,"Bronchitis | non-cancer illness code, self-reported",925
4,Glucuronate levels,690
4,Electrocardiogram morphology (amplitude at temporal datapoints) [172 ms],225
4,Hypertensive Heart Disease,161
4,Response to antipsychotic treatment in schizophrenia,18
4,Serum levels of protein VPS29,552
4,Age at first live birth,986
4,Eczema,31038
4,Non-albumin protein levels,27092
4,Essential hypertension,10651
4,Attention deficit hyperactivity disorder (inattention symptoms),254
4,Neoclarityn 5mg tablet | treatment/medication code,208
4,"Heart arrhythmia | non-cancer illness code, self-reported",289
4,Renal overload gout,11877
4,Fat-free mass,19892
4,Urinary metabolite levels in chronic kidney disease [2'-deoxyguanosine],8202
4,"Intra-ocular pressure, goldmann-correlated (left)",4478
4,Serum levels of protein CD70,2558
4,Urate levels in obese individuals [women],1235
4,"Blood protein levels [PGK1, 5020_50_1]",552
4,Thyroxine product | treatment/medication code,259
4,"Blood protein levels [FGFR3, 13669_6_3]",7105
4,Inflammatory bowel disease,8891
4,Glaucoma (multi-trait analysis),6620
4,Serum metabolite levels [N-acetylglucosamine/N-acetylgalactosamine],12774
4,"""Mental and behavioural disorders due to alcohol, excluding acute intoxication""",24
4,Protein quantitative trait loci (liver) [HINT2],2
4,Adolescent idiopathic scoliosis,96844
4,Electrocardiogram morphology (amplitude at temporal datapoints) [182 ms],225
4,Home location - east co-ordinate (rounded),12
4,Problematic alcohol use,31232
4,Fracture of radius and ulna,3721
4,Serum levels of protein SERPINA5,3101
4,"Blood protein levels [ETNK1, 8328_9_3]",4340
4,Haematocrit percentage,7572
4,Aspirin | treatment/medication code,16361
4,Extremely high intelligence,4321
4,Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis),2027
4,"Blood protein levels [AFM, 4763_31_3]",1410
4,Heart failure,309
4,Serum 25-Hydroxyvitamin D levels [AA + Hispanic],40
4,Plasma clozapine-norclozapine ratio in treatment-resistant schizophrenia,8557
4,Thyroid problem (not cancer),6735
4,Osteoporosis,5979
4,Gut microbiota (beta diversity),580
4,Duration screen displayed,108
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-50 ms],304
4,None of the above | vitamin and mineral supplements,1618
4,Sphingolipid levels [levels],138
4,Total protein levels x insomnia interaction,957
4,Blood metabolite levels [tryptophan],118
4,Gout,54008
4,"Alcohol consumption (drinks per week) [Conditioned on chr4:100443853, chr4:100286085,chr4:100260679 ,chr4:100444363, chr4:100239319]",2292
4,"Blood metabolite levels [bradykinin, des-arg(9]",1899
4,"Subarachnoid haemorrhage | non-cancer illness code, self-reported",300
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-114 ms],289
4,Serum levels of protein LAIR2,2580
4,Bone mineral density (hip) and hip bone size,342
4,"Pulmonary embolism +/- dvt | non-cancer illness code, self-reported",794
4,Atrial fibrillation/atrial flutter,977
4,Chronic heart failure,247
4,Protein quantitative trait loci (liver) [ORM1],11
4,Serum 25-Hydroxyvitamin D levels,171885
4,Systolic blood pressure x alcohol consumption interaction (2df test) [EA],1216
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-34 ms],978
4,Brain imaging measurements [Imaging-derived phenotype IDP_T1_FAST_ROIs_R_ventral_striatum],116
4,Factor VII activity or levels,26229
4,Glucose levels,9964
4,3mm weak meridian (left),81469
4,Beard thickness,604
4,Serum levels of protein IDUA,10619
4,Cheese intake,5767
4,Chronic obstructive pulmonary disease [conditional on rs34712979],7021
4,Serum levels of protein CEP57,2580
4,Body fat percentage or heart failure (MTAG),36
4,Smoking initiation (ever regular vs never regular) [Conditioned on chr4:35501032],6
4,Membranous nephropathy,37203
4,Metabolite levels (small molecules and protein measures) [Creatinine],2042
4,Serum levels of protein ETHE1,1899
4,"Pulse rate, automated reading",56288
4,Allergic conjunctivitis,13341
4,"""Alcohol related diseases, tilastokeskus definition""",2336
4,"""Type 2 diabetes, strict (exclude DM1)""",8909
4,Pre bronchodilator FEV1/FVC ratio,372
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-204 ms],1000
4,Serum levels of protein DKK2,136
4,Hand grip strength (right),21650
4,Triglyceride levels [Asian],1686
4,Thyroid stimulating hormone levels,259
4,Age at menopause (last menstrual period),53006
4,Life satisfaction,510
4,Pediatric asthma,2246
4,Serum levels of protein CETN2,2580
4,Uric acid levels [women],1557
4,Positive affect,775
4,Total body bone mineral density (age 45-60),9284
4,Body fat percentage and HDL-C (pairwise),1309
4,Serum levels of protein RAP1GDS1,1553
4,vascular endothelial growth factor D levels,1899
4,Serum levels of protein CXADR,2580
4,Protein quantitative trait loci (liver) [CSTA],660
4,"Blood protein levels [MAN2B2, 9251_28_3]",723
4,Sick sinus syndrome,304
4,Parkinson's disease [EA],7171
4,Pediatric bone mineral content (hip) [Females],1101
4,Protein levels in obesity [IDS],29
4,"""Alcohol use disorder, Swedish definition""",2336
4,Diastolic blood pressure [East Asian],456
4,Serum levels of protein F11,1700
4,"Blood protein levels [STX1B, 6966_144_3]",552
4,Myocardial infarction,17519
4,Urinary metabolite levels in chronic kidney disease [3-methylcytidine],8249
4,Fasting insulin,3038
4,Epithelial ovarian cancer,478
4,Cognitive function (generalized correlation coefficient),707
4,Psoriasis,1102
4,"Alcohol consumption (drinks per week) [Conditioned on chr4:100444363, chr4:100239319]",262
4,BMI in non-smokers [men],22
4,Obesity due to excess calories,36
4,Systemic lupus erythematosus [conditional],8
4,Self-reported math ability (MTAG) [MTAG],53771
4,Waist-to-hip ratio adjusted for BMI (additive genetic model),51102
4,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) [subset analysis]",16618
4,"Blood protein levels [NUDT9, 9482_110_3]",2186
4,DNA methylation (variation) [KvDMR],78
4,Electrocardiogram morphology (amplitude at temporal datapoints) [122 ms],13
4,Age when periods started (menarche),3895
4,Arm fat-free mass (left),88542
4,Diabetic maculopathy,140
4,Blood metabolite levels [X-11799],106
4,Parkinson's disease in GBA mutation carriers,1350
4,CD62L- plasmacytoid Dendritic Cell %Dendritic Cell,5038
4,Vertex-wise sulcal depth,108759
4,Metabolite levels (small molecules and protein measures) [Histidine],1899
4,Autoimmune traits,1943
4,CXCL5 levels,7576
4,Serum levels of protein PLXDC1,1899
4,"Diastolic blood pressure [EA, initial]",240
4,6mm regularity index (right),19
4,Chitinase-3-like protein 1 levels,3
4,Mean arterial pressure,14321
4,Diabetes mellitus,15096
4,Blood metabolite ratios [urate/histidine],1836
4,Chronic obstructive pulmonary disease in non-current smokers,3800
4,Parental lifespan,5681
4,Age at first sexual intercourse,3800
4,Birth length (MTAG),2942
4,"""Hypertension, essential""",731
4,Nose morphology,61
4,Hypospadias,20
4,Icd10: c20 malignant neoplasm of rectum | underlying (primary) cause of death,23
4,Total cholesterol levels in small VLDL,2580
4,Medication use (agents acting on the renin-angiotensin system),113028
4,Gamma glutamyl transferase levels,52286
4,Immune reponse to smallpox (secreted IL-12p40) [EA],73
4,Serum levels of protein LRIT2,51
4,Gamma glutamyl transpeptidase,29973
4,Rap1 GTPase-GDP dissociation stimulator 1 measurement,6550
4,Serum metabolite levels [N-acetylglucosaminylasparagine],1415
4,Serum levels of protein LRRC4B,2558
4,Protein quantitative trait loci (liver) [EPHX1],3782
4,Essential hypertension (time to event),19
4,Ventolin 100micrograms inhaler | treatment/medication code,17039
4,"""Benign neoplasm: Middle ear, nasal cavity and accessory sinuses (controls excluding all cancers)""",7
4,Invasive breast cancer [mixed effect],67
4,Body fat distribution (trunk fat ratio),12202
4,HDL cholesterol levels in current drinkers,1701
4,CD123 on plasmacytoid Dendritic Cell,4670
4,"""Endocrine, nutritional and metabolic diseases""",180
4,Serum levels of protein SPOCK3,1058
4,Statin medication,110
4,Waist circumference variance,36
4,Protein quantitative trait loci (liver) [TSN],40
4,Intralaminar thalamic nuclei volume,11085
4,Serum levels of protein CYTL1,1213
4,Serum metabolite levels [octanoylcarnitine (C8],2541
4,"Fracture radius | non-cancer illness code, self-reported",2730
4,"""Alcohol use disorder, ICD-based""",24
4,Parkinson's disease (age of onset),3018
4,Serum levels of protein QDPR,2357
4,Disorders of lipoid metabolism,162
4,Infection,75
4,Mild age-related type 2 diabetes,40
4,Age of smoking initiation,26515
4,Subjective well-being (MTAG),2253
4,Serum levels of protein SPINK2,4731
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-90 ms],1000
4,Enthesopathy,272
4,Cardiac pacemaker/device in situ,304
4,Time spent doing light physical activity,28
4,Spherical equivalent,28008
4,Alcohol consumption [men],1219
4,Mean sphered cell volume,184599
4,Haemorrhoidal disease,11354
4,"""Atopic dermatitis, strict definition with reimbursement""",3837
4,Atrial fibrillation and flutter,1574
4,Growth-regulated protein alpha levels,2071
4,3mm cylindrical power (right),1585
4,Glomerular filtration rate (cystatin C),2527
4,Vertigo,3444
4,Preeclampsia (maternal genotype effect),124
4,Major coronary heart disease event excluding revascularizations,203
4,Protein quantitative trait loci (liver) [SERPINA1],11
4,Post-traumatic stress disorder [Whole cohort; EA],25
4,Oil of peppermint | treatment/medication code,3
4,Urinary albumin excretion,32204
4,Bitter alcoholic beverage consumption,6522
4,"""Heart failure, not strict""",342
4,N-acetylhistidine levels,46
4,Diabetes or endocrine disease,7910
4,Body size at age 10,2574
4,Glomerular filtration rate [EA],1294
4,Height [AA],2500
4,"Blood protein levels [EGF, 5509_7_3]",3172
4,Thymidine phosphorylase levels,1899
4,"Blood protein levels [HPSE, 5604_30_3]",2055
4,Total cholesterol levels in small LDL,583
4,Femur bone mineral density x serum urate levels interaction,534
4,Peak expiratory flow x sex interaction,350
4,Valvular operations,304
4,Serum levels of protein JAG1,55
4,Diverticulosis,826
4,Forced vital capacity (fvc),63476
4,Impedance of whole body,142743
4,"Waist-to-hip ratio adjusted for body mass index [EA, women]",3804
4,Gallstone disease,2262
4,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],1002
4,Serum levels of protein NCR2,2558
4,Budesonide | treatment/medication code,10
4,"Blood pressure medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",3649
4,Educational attainment (college completion),79
4,Neonatal total 25-hydroxyvitamin D levels (cord blood),130
4,Alcohol dependence symptom count,24
4,"Blood protein levels [SOD3, 8463_2_3]",9
4,Urate levels,233841
4,Average total household income before tax,25366
4,"Pulmonary function (smoking interaction) [FEV1, Ever-smoking]",14791
4,"Blood protein levels [EA, Coagulation Factor XI]",2229
4,D-dimer levels,650
4,Body fat percentage and triglycerides (pairwise),1309
4,Protein quantitative trait loci [HGFA],854
4,Ever addicted to alcohol,288
4,Protein quantitative trait loci (liver) [TTN],342
4,Facial morphology traits (63 three-dimensional facial segments) [facial module 45],34
4,Angina pectoris,3692
4,FEV1/FVC ratio x sex interaction,364
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-88 ms],1000
4,Seropositive rheumatoid arthritis,275
4,Serum levels of protein KDR,154
4,Cortical surface area [Temporal Pole],48
4,Glomerular filtration rate,5492
4,Serum levels of protein POMGNT2,60731
4,Ischemic stroke,3101
4,"Blood protein levels [EA, Peptidyl-prolyl cis-trans isomerase D]",2556
4,Cardiovascular diseases (excluding rheumatic etc),675
4,Major coronary heart disease event,203
4,"""Sleep apnoea, including avohilmo""",711
4,Cardiovascular disease risk factors [UA],4723
4,Multisite chronic pain,2828
4,Body fat distribution (trunk fat ratio) [females],12202
4,"Forced expiratory volume in 1-second (fev1), predicted",37060
4,Metformin | treatment/medication code,5834
4,Triglyceride levels in current drinkers,1557
4,"Fatty acid-binding protein,intestinal levels",1923
4,Serum levels of protein GSTT2,552
4,Atazanavir levels,176
4,Valsartan | treatment/medication code,68
4,Insulin-like growth factor 1 levels,178659
4,Cirrhosis (multi-trait analysis),3656
4,Chronic obstructive pulmonary disease in current smokers,918
4,Thyroid hormone levels [FT4],6158
4,Dementia with Lewy bodies,6602
4,"Pulse pressure [EA, initial]",361
4,Mood swings,38
4,"Blood protein levels [CDH15, 11215_6_3]",2984
4,Lymphocyte percentage,206102
4,Intestinal malabsorption (non-celiac),1219
4,Brainstem volume,218
4,Body mass index (joint analysis main effects and smoking interaction) [men],80
4,Body mass index in physically active individuals [EA],80
4,General factor of neuroticism,72
4,Asthma and hay fever,13459
4,Hip circumference adjusted for BMI,115904
4,Liver enzyme levels (alanine transaminase),112151
4,Cholelithiasis with other cholecystitis,2262
4,Gout [Japanese],1707
4,Serum levels of protein HNF1A,2580
4,Diastolic blood pressure (cigarette smoking interaction),1237
4,Fasciitis,75
4,Metabolite levels [HexCer d18:1/18:0],315
4,Waist circumference adjusted for body mass index [women],66
4,Polycystic ovary syndrome (reproductive subtype),18
4,Age at menopause,83368
4,Ever smoked,6843
4,Urate levels in overweight individuals,2282
4,Serum levels of protein LGALS7,1123
4,Lipid traits (pleiotropy) (HIPO component 1),1097
4,Waist-to-hip ratio adjusted for body mass index [women],1309
4,Serum levels of protein GCNT2,2558
4,Periodontal disease related phenotype (PCT3),290
4,Triglyceride levels x smoking (current vs non smokers) interaction (2df test) [EA],706
4,Red blood cell count [Asian],98
4,Alcohol consumption (drinks per week),25963
4,Total body bone mineral density (age 15-30),6338
4,Platelet distribution width,54700
4,Serum levels of protein STX7,144
4,Aerodigestive squamous cell cancer (pleiotropy),24
4,Electrocardiogram morphology (amplitude at temporal datapoints) [104 ms],13
4,Cortical surface area (MOSTest),14660
4,Cardioembolic stroke (CCSp classification),168
4,Urate levels [South Asian],797
4,Potassium in urine,42
4,Been in serious accident believed to be life-threatening,332
4,Voxel-wise structural brain imaging measurements [right putamen peak voxel],116
4,Potassium levels,102
4,Lesion of radial nerve,8
4,Electrocardiogram morphology (amplitude at temporal datapoints) [192 ms],225
4,Cholelithiasis or gall stones,2271
4,Basophill count,3754
4,Subjective well-being,572
4,Highest math class taken,11118
4,Serum levels of protein ANXA6,2558
4,Pregabalin | treatment/medication code,1156
4,Total cholesterol levels [EA],245
4,Urinary metabolite levels in chronic kidney disease [X - 23311],106
4,Cholesteryl ester_18:3_[M+NH4]1+ levels,24
4,Serum levels of protein FGFR3,7277
4,"""Cholelithiasis, broad definition with cholecystitis""",2271
4,Itch intensity from mosquito bite,4503
4,Sleeplessness / insomnia,144
4,Disorders of the thyroid gland,534
4,"Blood protein levels [IGFBP7, 3320_49_2]",525
4,Coronary revascularization (ANGIO or CABG),219
4,Erythema nodosum in inflammatory bowel disease,12
4,Monocyte count,490140
4,"Blood protein levels [DKK2, 6546_41_3]",136
4,1-carboxyethylvaline levels,197
4,Serum levels of protein HAT1,2558
4,Gout vs. Hyperuricemia,4872
4,Serum levels of protein CLEC7A,2558
4,Xanthine levels,92
4,"Cholesterol, total",276
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-124 ms],289
4,Pre bronchodilator FEV1/FVC ratio in never-smokers,400
4,College or university degree | qualifications,40531
4,Basophil percentage of granulocytes,11613
4,Systolic blood pressure x sodium interaction (2df test),3188
4,Serum uric acid levels [Japanese],2642
4,Urinary metabolite levels in chronic kidney disease [X - 23299],106
4,Diastolic blood pressure x smoking status (current vs non-current) interaction (1df test) [African],35
4,Body mass index and systole blood pressure (pairwise),89
4,"Insomnia | non-cancer illness code, self-reported",137
4,Rosuvastatin | treatment/medication code,80
4,High altitude adaptation,1174
4,Type 2 diabetes without complications,6089
4,Smoking behaviour (cigarettes smoked per day) [Conditioned on chr4:67086288],90
4,Serum levels of protein IFNLR1,552
4,Hypothyroidism and >3 levothyroxin purchases,260
4,BMI (adjusted for smoking behaviour),80
4,Leg fat-free mass (left),111144
4,5-year breast cancer-specific survival (ER negative treated with chemotherapy),17
4,High light scatter reticulocyte count,529994
4,Respiratory or ear-nose-throat disease,18095
4,Protein quantitative trait loci (liver) [CYP2E1],873
4,Chronic lower respiratory diseases,15055
4,"""Atopic  dermatitis, strict definition""",3837
4,Gut microbiota relative abundance (bacterial taxa) [Clostridium_xylanovorans],2028
4,Self-reported risk-taking behaviour,345
4,Tuberculosis,95
4,Serum levels of protein EMC1,464
4,Delta-5 desaturase activity response to n3-polyunsaturated fat supplement,36
4,"Blood protein levels [KITLG, 9377_25_3]",7999
4,Myopia (pathological),2620
4,Thrombopoietin levels,1899
4,Hypertensive diseases (excluding secondary),1476
4,Diastolic blood pressure [East Asians],102
4,Triacylglyceride levels [TAG(50:1;0],161
4,Heel bone mineral density,169420
4,Predicted visceral adipose tissue,5297
4,Lymphocyte-to-monocyte ratio,33097
4,Serum levels of protein NAAA,143893
4,Serum levels of protein LEAP2,1899
4,"Blood protein levels [GPLD1, 11939_11_3]",2984
4,Age hayfever or allergic rhinitis diagnosed by doctor,14773
4,Serum levels of protein ADH7,498
4,Protein quantitative trait loci (liver) [PARVA],40
4,Phenylalanine levels,8
4,"""Schizophrenia, schizotypal and delusional disorders""",5
4,Metabolite levels [C10],2567
4,"""Myocardial infarction, strict""",203
4,Deep venous thrombosis,508
4,Electrocardiogram morphology (amplitude at temporal datapoints) [82 ms],13
4,Serum levels of protein TMEM87B,1899
4,"Heel bone mineral density (bmd) t-score, automated",37094
4,Corneal curvature,19161
4,Plasma norclozapine levels in treatment-resistant schizophrenia,3136
4,Serum metabolite levels [Alb],2558
4,Brain region volumes [cerebellar vermal lobules VI VII],249
4,Metabolic traits [SM-12 + 1 other trait],667
4,Serum 25-Hydroxyvitamin D levels [Hispanic],509
4,Diastolic blood pressure [Japanese],102
4,"Long-standing illness, disability or infirmity",272
4,Cytokine-stimulated IL-6 production,355
4,"Appendicitis | non-cancer illness code, self-reported",415
4,High light scatter reticulocyte percentage of red cells,225630
4,Cortical surface area,82303
4,"Hypertension | non-cancer illness code, self-reported",112934
4,Length of mobile phone use,415
4,Brain region volumes [white matter],116
4,"""Melanocytic naevi of eyelid, including canthus (controls excluding all cancers)""",8
4,Alcohol consumption (drinkers vs non-drinkers) [EA],24
4,Serum levels of protein PLBD1,11
4,"""Disorders of gallbladder, biliary tract and pancreas""",2271
4,Body mass index (joint analysis main effects and physical activity interaction) [men],74
4,Bacteroides eggerthii abundance in stool,27
4,"Blood protein levels [ART3, 7970_315_3]",345
4,Cotinine levels in current smokers,3149
4,Pulse pressure x alcohol consumption interaction (2df test) [AA],458
4,"Diastolic blood pressure x alcohol consumption interaction (2df test) [AA, EA]",40
4,Allergy,15450
4,Automobile speeding propensity,2775
4,Creatinine levels,153632
4,Haemoglobin concentration,10747
4,"Blood protein levels [QDPR, 11257_1_3]",2357
4,"Yes, during the last year | ever had known person concerned about, or recommend reduction of, alcohol consumption",272
4,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),1248
4,"Blood protein levels [HERC1, 12705_9_3]",552
4,Cardioembolic stroke (TOAST classification),186
4,"Body mass index (joint analysis main effects and physical activity interaction) [EA, men]",52
4,"Blood protein levels [PF4V1, 5663_18_3]",11045
4,Mammographic density (dense area),1455
4,Chronic obstructive pulmonary disease (moderate to severe),680
4,Stroke (ischemic) [CS],208
4,Chronic obstructive pulmonary disease x ever smoker interaction (2df),3774
4,Intracranial aneurysm,1360
4,Microalbuminuria,3547
4,Fasting glucose [Hispanic/Latino],89
4,"Non-melanoma skin cancer | cancer code, self-reported",157
4,"""Acute appendicitis, no complications""",45
4,Varicose veins of lower extremity,18
4,Candida albicans stimulated MCP-2 levels,40
4,Insomnia symptoms (never/rarely vs. sometimes/usually),144
4,Protein quantitative trait loci (liver) [EHHADH],18
4,Myeloproliferative diseases,29
4,Body mass index,199807
4,"Dark brown | hair colour (natural, before greying)",4668
4,Balding type 1,5237
4,"Gut microbiota (bacterial taxa, hurdle binary method) [G_unclassified_O_Bacteroidales_HB]",2
4,Urinary metabolite levels in chronic kidney disease [X - 19434 ],6468
4,Serum metabolite levels (CMS) [XS_VLDL_CE],652
4,"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment",2217
4,"Blood protein levels [VPS29, 14318_1_3]",552
4,CD28+ CD45RA- CD8+ T cell %CD8+ T cell,1182
4,Electrocardiogram morphology (amplitude at temporal datapoints) [112 ms],1058
4,Bioavailable testosterone levels,36036
4,Vertex-wise cortical surface area,106215
4,Heel bone mineral density (bmd) (left),22993
4,Serum levels of protein CRIM1,2558
4,Neuritic plaques (SNP x SNP interaction),2253
4,"Blood protein levels [SULT1E1, 9878_3_3]",552
4,Psychosis in Alzheimer's disease,211
4,Monokine induced by gamma interferon levels,16261
4,Gout (combined type),4512
4,Morning/evening person (chronotype),2489
4,"Diastolic blood pressure x alcohol consumption interaction (2df test) [AA, Asian, EA, Hispanic]",1109
4,Otosclerosis,694
4,Lung function (low FEV1 vs high FEV1),374
4,Triglyceride levels,153080
4,Serum levels of protein KLKB1,3101
4,"""Type 2 diabetes, wide definition""",4989
4,"Waist circumference adjusted for body mass index [EA, men]",885
4,PR segment duration,1000
4,General cognitive ability,32616
4,Liver enzyme levels (alkaline phosphatase),128024
4,"Blood protein levels [ITIH4, 4811_33_3]",2984
4,"Blonde | hair colour (natural, before greying)",5245
4,"Blood protein levels [CREBBP, 13614_6_3]",4340
4,Pappalysin-1 levels,82
4,Gastroesophageal reflux disease,21874
4,Serum levels of protein FAM209B,1553
4,Urinary metabolite levels in chronic kidney disease [glucuronide of C12H22O4 (2],6601
4,Electrocardiogram morphology (amplitude at temporal datapoints) [158 ms],225
4,Plasma parathyroid hormone levels,21
4,Injuries to the head,6
4,Sum basophil neutrophil counts,65846
4,Sotalol | treatment/medication code,304
4,Other arrhytmias,304
4,Cortical surface area [total],116
4,Birth weight (MTAG),2708
4,Phosphatidylcholine-O_44:5_[M+H]1+/Phosphatidylcholine-P_44:4_[M+H]1+ levels,521
4,Serum levels of protein RMDN3,2558
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-56 ms],304
4,Diabetes | illnesses of adopted mother,201
4,Protein quantitative trait loci (liver) [ANP32A],114
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-52 ms],304
4,Other disorders of urethra and urinary tract,21
4,"Blood protein levels [SOD3, 5660_51_3]",9
4,Appendicular lean mass,448897
4,Hypertension,173479
4,Eosinophill percentage,17184
4,Corneal astigmatism,3933
4,O-phosphoseryl-tRNA(Sec) selenium transferase measurement,2272
4,"Blood protein levels [F11, 2190_55_1]",3128
4,Coronary artery bypass grafting,219
4,Protein quantitative trait loci (liver) [NDRG2],38
4,Sodium in urine,24
4,Crohn's disease [EA],19158
4,Serum levels of protein NAB2,2558
4,Smoking initiation,2882
4,Hypertrophy of breast,442
4,Brain region volumes [left cerebellum exterior],311
4,Benign neoplasms (controls excluding all cancers),32
4,Family history of certain disabilities and chronic diseases leading to disablement,7
4,Schizophrenia or delusion,5
4,Triglyceride levels in current drinkers [EA],3508
4,Chronic obstructive pulmonary disease x current smoker interaction (2df),4718
4,Cataracts,356
4,Chronic obstructive pulmonary disease or high blood pressure (pleiotropy),1152
4,Vitamin c product | treatment/medication code,296
4,Waist circumference [EA],22
4,Serum levels of protein MANBA,68977
4,Lung function in never smokers (low FEV1 vs high FEV1),16715
4,Emphysema distribution in smoking [diff950],129
4,Resistin levels,2
4,Asthma (childhood onset),29946
4,"Osteopenia | non-cancer illness code, self-reported",1286
4,Insomnia,3100
4,"Blood protein levels [AXIN2, 12925_105_3]",552
4,Nonsyndromic cleft lip with cleft palate,178
4,Fibrinogen [EA],72
4,Bipolar disorder vs autism spectrum disorder (ordinary least squares (OLS)),10
4,C-reactive protein levels,64790
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-104 ms],1000
4,"""Cardiomyopathies, Primary/intrinsic""",357
4,Serum levels of protein IGSF9B,1553
4,Brain region volumes [left ventral DC],1317
4,"None of the above | medication for pain relief, constipation, heartburn",10
4,Chronic obstructive pulmonary disease in ever smokers,1370
4,Protein quantitative trait loci [IDUA],4337
4,"Blood protein levels [EA, Complement factor I]",1141
4,Job involves mainly walking or standing,4368
4,Serum levels of protein KLHL12,2580
4,Circulating vasoactive peptide levels [ET],2028
4,"Fibromyalgia | non-cancer illness code, self-reported",205
4,Congestive heart failure,247
4,Other disorders of veins,18
4,Body mass index in physically active individuals [men],22
4,Vertex-wise cortical thickness,66708
4,Serum levels of protein WNT7A,2580
4,Cardioembolic stroke (CCS and TOAST classification),200
4,Total PHF-tau (SNP x SNP interaction),27832
4,"Heel bone mineral density (bmd) t-score, automated (right)",22112
4,CD80 on CD62L+ plasmacytoid Dendritic Cell,4670
4,Female genital prolapse,369
4,Ultradistal forearm bone mineral density,1059
4,Measles,784
4,Alcohol use disorder (consumption score) [AA],99
4,Worry too long after embarrassment,1930
4,Branched-chain amino acid levels (Leucine),351
4,Obesity (extreme),2
4,Osteoarthritis of the hip or knee,11880
4,Cervical cancer [Matched],1752
4,Brain imaging measurements [Imaging-derived phenotype IDP_T1_FAST_ROIs_R_putamen],116
4,Serum metabolite levels [phenylalanylglycine],1768
4,Arthropathy nos,116
4,Serum levels of protein SPARCL1,10128
4,N-acetylglutamine levels,1310
4,Glutamate levels,3349
4,Spherical power (left),2159
4,Serum metabolite levels [Val],1014
4,Neuroticism conditioned on self-rated math ability (multi-trait conditioning and joint analysis),2171
4,"""Endomtriosis ASRM stages 3,4""",638
4,Serum metabolite levels [HXGXA],1016
4,Pace-maker,100
4,Glycated hemoglobin levels,187051
4,Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis),2076
4,Arm fat mass (right),5617
4,Unstable angina pectoris,835
4,Smoking initiation (ever regular vs never regular) [Conditioned on chr4:147797913],61
4,Protein quantitative trait loci (liver) [PHYH],18
4,Number of treatments/medications taken,83681
4,Serum levels of protein ADAMDEC1,2558
4,Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis),2124
4,Cereal intake,1249
4,Serum levels of protein TMCC3,552
4,Other/unspecified seropositiverheumatoid arthritis,275
4,Nucleus accumbens volume,116
4,Lecithin product | treatment/medication code,199
4,Yes | hearing difficulty/problems,114
4,Relative fat intake,24
4,Longitudinal brain connectivity change (characteristic path length),6
4,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),2626
4,Sex hormone-binding globulin levels adjusted for BMI,389013
4,Serum total protein level,101805
4,"Blood protein levels [GCH1, 11185_145_3]",2055
4,Age-related hearing impairment (MTAG),114
4,Left-handedness,116
4,BMI (adjusted for smoking behaviour) [women],22
4,Blood protein levels [CXCL5],3788
4,Feeling nervous,4715
4,FSC-A on myeloid Dendritic Cell,177
4,Liver enzyme levels (gamma-glutamyl transferase),16334
4,Lung volume,1937
4,Gallbladder disease,2271
4,Mental and behavioural disorders due to psychoctive substance use,2336
4,Serum levels of protein MYC,2580
4,middle facial morphology traits (quantitative measurement) [Nose tip angle],267
4,Mitochondrial DNA copy number,311
4,Early complications of trauma,35
4,Hip bone mineral density and total body fat mass (bivariate analysis),212
4,Alcohol dependence,11755
4,"Atrial fibrillation | non-cancer illness code, self-reported",594
4,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],25
4,Coronary heart disease,922
4,Cholecystitis,1373
4,Serum levels of protein SCG2,1553
4,"Blood protein levels [NPPA, 5443_62_2]",552
4,Metabolite levels [HexCer d18:1/16:0],315
4,Decaffeinated coffee (any type) | coffee type,116
4,Mean arterial pressure [East Asians],84
4,Factor XI,144
4,"Mean arterial pressure x alcohol consumption interaction (2df test) [AA, EA]",40
4,Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer,24
4,Protein quantitative trait loci (liver) [SERPINA3],8
4,Wholemeal or wholegrain | bread type,21456
4,Serum levels of protein BMP10,2558
4,"Blood protein levels [IFNLR1, 7192_37_3]",552
4,Urinary bladder cancer,11577
4,Triglycerides,80934
4,Time spent watching television (tv),37228
4,Triglyceride levels in current drinkers [Asian],1557
4,Lipoprotein lipase levels,1899
4,"Blood protein levels [TMCC3, 8922_4_3]",552
4,Protein quantitative trait loci (liver) [AGRN],513
4,ST2 protein levels,268
4,Heart disease | illnesses of father,224
4,"No | ever had known person concerned about, or recommend reduction of, alcohol consumption",24
4,Any mental disorder,5
4,Serum metabolite levels (CMS) [Alb],24650
4,Total body bone mineral density [European],6850
4,Bitter beverage consumption,976
4,"""Soft tissue disorders related to use, overuse and pressure""",2
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-76 ms],1000
4,"""Gonarthrosis, primary, with knee surgery""",2191
4,Pulmonary function [FEV1/FVC],714
4,Triglyceride levels [BMI adjusted],3331
4,Estimated glomerular filtration rate in diabetes,1294
4,Benign neoplasms,82
4,"Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA, men]",66
4,Self-reported math ability,53170
4,Neutrophil-to-lymphocyte ratio,69308
4,Spherical equivalent or myopia (age of diagnosis),4467
4,Daytime nap,5795
4,Metabolic traits [decanoylcarnitine + 25 other traits],2731
4,"Blood protein levels [TNFAIP8, 12563_2_3]",11045
4,Serum immune biomarker levels [TIMP-2],35
4,Facial morphology (segment 27),21
4,"Blood protein levels [SERPINA5, 3389_7_2]",2984
4,"Systolic blood pressure, automated reading",35486
4,Serum levels of protein DEFB119,2580
4,Hippocampal tail volume,286
4,Serum vitamin D-binding protein levels in type 2 diabetes,30
4,Colon adenocarcinoma,20
4,Colonoscopy-negative controls vs population controls,1
4,Glaucoma,49079
4,Metabolic biomarkers (multivariate analysis),6287
4,Heel broadband ultrasound attenuation (right),19783
4,Juvenile Open Angle Glaucoma,6540
4,Alcohol use disorder [EA],5438
4,Serum levels of protein INPP5E,2558
4,Fed-up feelings,140
4,Voxel-wise structural brain imaging measurements [left putamen peak voxel],116
4,Advanced age-related macular degeneration [EA],56
4,Substance abuse (more control exclusions),24
4,Whole body water mass,118780
4,Peripheral artery disease,1881
4,Brain region volumes [Brain stem],1177
4,Urate levels [women],3133
4,Serum levels of protein PSME3,2558
4,Age asthma diagnosed,1429
4,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [men],66
4,CX3CL1 levels,2028
4,Systolic blood pressure [Japanese],102
4,Dried fruit intake,24644
4,Menopause (age at onset) [japanese],37094
4,Methylmalonate (mma) levels,21122
4,Hand grip strength (left),11294
4,Mental and behavioural disorders due to alcohol,2336
4,Unspecified abortion,77
4,Colorectal cancer,673
4,Forced expiratory volume in 1 second x sex interaction,350
4,Heart disease | illnesses of adopted mother,271
4,Serum levels of protein VCAN,2580
4,Salt added to food,1524
4,Electrocardiogram morphology (amplitude at temporal datapoints) [176 ms],225
4,Age-related hearing impairment [additive],114
4,"Blood protein levels [NPNT, 6342_10_3]",46
4,"""Diseases of arteries, arterioles and capillaries (FINNGEN)""",85
4,Serum levels of protein HHIP,54
4,Creatine kinase levels,31
4,Daytime sleepiness,4
4,Macular thickness,6655
4,Prostate cancer,44455
4,Ankle spacing width,45931
4,Heel broadband ultrasound attenuation (left),10733
4,Whole body fat mass,18490
4,Peripheral arterial disease (traffic-related air pollution interaction) [AA],433
4,Diabetic maculopathy (more control exclusions),70
4,Electrocardiogram morphology (amplitude at temporal datapoints) [178 ms],225
4,Longest period of depression,5
4,Atrial fibrillation,161312
4,Multiple sclerosis,93999
4,Serum levels of protein DEFB129,2558
4,"Blood protein levels [CXCL5, 2979_8_2]",4340
4,Circulating chromogranin peptide levels [CHGA361–372],1980
4,Obesity [Obesity class II],36
4,Peripheral enthesopathies and allied syndromes,116
4,Heart failure and coronary heart disease,215
4,Frequency of memory loss due to drinking alcohol in last year,24
4,Distance between home and job workplace,76
4,Alcohol consumption,10656
4,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)",18025
4,Waist circumference adjusted for body mass index,86912
4,Serum metabolite levels [bradykinindesarg9],1899
4,Glomerular filtration rate [6-measure Model],2527
4,"Systolic blood pressure x alcohol consumption interaction (2df test) [Asian, EA, Hispanic]",1109
4,Spherical power (right),3460
4,Other disorders of circulatory system,481
4,Urinary potassium excretion [EA],42
4,Serum metabolite concentrations in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C38:0],37
4,Alcohol dependence [AA],5781
4,Electrocardiogram morphology (amplitude at temporal datapoints) [376 ms],1045
4,Chronic lymphocytic leukemia,5300
4,White blood cell count,678540
4,HDL cholesterol levels x smoking (current vs non smokers) interaction (2df test),2214
4,"""Diabetes, insuline treatment (Kela reimbursement) (more control exclusions)""",5981
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-126 ms],48
4,Acylcarnitine levels [Decanoylcarnitine],2731
4,A levels/as levels or equivalent | qualifications,12372
4,Calculus of kidney and ureter,933
4,Mean arterial pressure [Japanese],102
4,Alcohol use disorder (consumption score),4255
4,Urate levels in lean individuals [Women],1554
4,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],2355
4,Ischemic heart disease,1613
4,LDL cholesterol levels x long total sleep time interaction (2df test),237
4,Body fat percentage or coronary artery disease (MTAG),22
4,Time spend outdoors in summer,6961
4,Educational attainment,10672
4,Serum levels of protein GABBR1,2558
4,Chronic kidney disease [eGFRcrea],2779
4,Serum VEGFR2 concentration,272
4,Electrocardiographic traits [PR interval],999
4,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test) [African],35
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-118 ms],289
4,Ulcerative colitis,16250
4,Serum levels of protein PSMD7,2580
4,"Blood protein levels [SPINK2, 13405_61_3]",2102
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-208 ms],1000
4,Microalbumin in urine,10
4,Atopic asthma,1230
4,Educational attainment (years of education) [conditional-joint],28748
4,Glycine levels [conditional],2028
4,"Blood protein levels [HGFAC, 3617_80_4]",135
4,Caffeine consumption from coffee or tea,4640
4,Selenium ace tablet | treatment/medication code,71
4,Maximum habitual alcohol consumption [AA],20
4,Protein quantitative trait loci (liver) [APRT],10
4,Faecalibacterium sp002160895 abundance in stool,3728
4,Response to allopurinol in gout (change in serum uric acid levels),319
4,Flixotide 25micrograms inhaler | treatment/medication code,455
4,"""Artrosis, including avohilmo""",2197
4,Protein quantitative trait loci (liver) [ACSM2B],515
4,"Pulse pressure x alcohol consumption interaction (2df test) [Asian, EA]",85
4,Protein quantitative trait loci (liver) [BPNT1],4
4,Cognitive performance (MTAG) [MTAG],78901
4,Basophil count,101664
4,Aspartate transaminase levels in high alcohol intake,3398
4,"Blood pressure medication | medication for cholesterol, blood pressure or diabetes",86191
4,"Blood protein levels [MANBA, 6382_17_3]",88177
4,6mm weak meridian (left),81960
4,Serum levels of protein ART3,3260
4,Ischemic stroke (cardioembolic),1124
4,Chronic obstructive pulmonary disease [conditional on rs13140176],68
4,Oropharynx cancer,24
4,Ulcerative colitis [EA],10895
4,PR interval,23559
4,Usual walking pace,12526
4,Serum levels of protein CXCL11,11124
4,Heel bone mineral density (bmd),37365
4,Esophageal cancer,1653
4,Average weekly red wine intake,134
4,"""Hypertension complicating pregnancy, childbirth, and the puerperium""",82
4,Body fat percentage [male],152
4,Protein quantitative trait loci [SPARCL1],4263
4,Nicotine glucouronidation,895
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-202 ms],1000
4,Serum levels of protein EFNB2,2558
4,Serum levels of protein TXNDC11,552
4,"Hip circumference [EA, men]",929
4,Serum metabolite concentrations in chronic kidney disease [histidylalanine],514
4,Dermovate cream | treatment/medication code,711
4,"Inflammatory bowel disease | non-cancer illness code, self-reported",380
4,Hip shape (DXA scan) [hip shape mode 1],717
4,Protein quantitative trait loci (liver) [HP],30
4,"Blood protein levels [SCG2, 8377_87_4]",552
4,Gut microbiota relative abundance (bacterial taxa) [Gordonibacter_pamelaeae],67
4,Insulin-related traits [IR],3616
4,Serum lipopolysaccharide activity,2271
4,Social science traits (pleiotropy) (HIPO component 1),698
4,"Blood protein levels [EA, C-X-C motif chemokine 5]",1424
4,Chronic airway obstruction,367
4,Forns index in high alcohol intake,388
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-82 ms],1000
4,Pediatric autoimmune diseases,37
4,Obesity [Overweight],36
4,Myeloproliferative diseases (CML excluded),29
4,Waist-to-hip ratio adjusted for BMI,210550
4,Mean spheric corpuscular volume,237483
4,"N,n,n-trimethyl-alanylproline betaine (tmap) levels",840
4,Late-onset Alzheimer's disease,140
4,Insulin-related traits (multivariate analysis),46
4,Cardiac troponin-I levels,2028
4,Testicular cancer,20873
4,Lymphocyte count,22848
4,Morning person,4595
4,N-desmethylclozapine concentration in schizophrenia,3126
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-108 ms],1000
4,Diverticular disease,813
4,Type 1 diabetes with low genetic risk score,84
4,Cellulitis of external ear,32
4,Pulmonary embolism,441
4,Chronic bronchitis,246
4,Biochemical measures [uric acid],1235
4,Hemoglobin A1c levels,309295
4,Arm fat percentage (left),21110
4,Gonarthrosis,2463
4,Feeling worry,2632
4,Thrombosis,441
4,"Blood protein levels [HGFAC, 8385_248_3]",135
4,Body mass index in physically active individuals [women],22
4,Type 2 diabetes with other specified/multiple/unspecified complications,8546
4,Cardiovascular diseases,712
4,Matrix extracellular phosphoglycoprotein levels,1899
4,"Glaucoma | non-cancer illness code, self-reported",1776
4,Current | smoking status,34
4,Immune reponse to smallpox (secreted IFN-alpha) [AA],46
4,Body mass index (adult) [AA],35
4,"Crohns disease | non-cancer illness code, self-reported",15
4,Electrocardiogram morphology (amplitude at temporal datapoints) [114 ms],13
4,Myeloid white cell count,68963
4,Depressive symptoms (MTAG),9923
4,"Allergy, hypersensitivity or anaphylaxis",19825
4,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),74
4,Cortical surface area (min-P),915
4,Phenytoin | treatment/medication code,245
4,Alcohol consumption (drinkers vs non-drinkers),543
4,Protein quantitative trait loci (liver) [PON1],1796
4,Contracture of palmar fascia [dupuytren's disease],718
4,Asthma onset (childhood vs adult),14485
4,Vertical cup-disc ratio (multi-trait analysis),2818
4,"Blood protein levels [ADH7, 11377_19_3]",498
4,Post bronchodilator FEV1,330
4,Prostate-specific antigen levels,1470
4,Medication use (diuretics),25623
4,"Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)",29368
4,Eosinophil percentage of white cells,46852
4,"""Type 2 diabetes, definitions combined, including avohilmo""",8742
4,Neuritic plaque [Case/control],106
4,Offspring birth weight,7655
4,Serum levels of protein DNAJC15,2558
4,Diverticulosis and diverticulitis,823
4,Spinal stenosis,58
4,Chronic obstructive pulmonary disease or resting heart rate (pleiotropy),367
4,Lung function (FEV1/FVC) [EA],263
4,Hereditary ataxia,33
4,Hay fever and/or eczema,33534
4,Fat-free mass [male],14767
4,Whole body fat-free mass,119229
4,Celiac disease,13008
4,Conduction disorders,414
4,"""Ischaemic heart disease, wide definition""",108
4,Factor VII activity [EA],26229
4,Cholelithiasis,11838
4,"Blood protein levels [AFP, 5792_8_2]",1090
4,Bipolar disorder vs anorexia nervosa (ordinary least squares (OLS)),823
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-120 ms],289
4,Serum levels of protein ARL1,552
4,"Serum metabolite levels [glycosyl ceramide (d18:2/24:1, d18:1/24:2)*]",92
4,"Blood protein levels [ART3, 10970_3_3]",345
4,Basal metabolic rate,109875
4,LDL cholesterol levels x short total sleep time interaction (2df test),1120
4,Chin dimples,1883
4,Endometriosis of pelvic peritoneum,638
4,Electrocardiogram morphology (amplitude at temporal datapoints) [62 ms],13
4,Protein quantitative trait loci (liver) [UGT1A4],9
4,Red blood cell (erythrocyte) distribution width,74049
4,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)",610
4,Co-amilofruse | treatment/medication code,229
4,"Hip circumference adjusted for BMI [EA,men]",66
4,Rotator cuff syndrome,6
4,Systemic sclerosis,25620
4,Other diseases of upper respiratory tract,11453
4,Diffuse plaques (SNP x SNP interaction),1775
4,"Metabolic traits [bradykinin, des-arg(9]",1899
4,Alzheimer's disease (late onset),893
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-58 ms],304
4,Colorectal polyp and colorectal cancer (MTAG) [Colorectal polyp],814
4,"Femoral hernia | non-cancer illness code, self-reported",118
4,Alcohol dependence (tolerance),24
4,Allergic march (atopic dermatitis to allergic rhinitis),12
4,Epidermal growth factor levels,2995
4,Time to complete round,15542
4,"Blood protein levels [SLC3A2, 7056_16_3]",11045
4,"""Acute appendicitis, with complications""",29
4,Protein quantitative trait loci (liver) [PRELP],40
4,Serum levels of protein PSAPL1,340
4,Home location - north co-ordinate (rounded),10
4,Medication use (calcium channel blockers),27037
4,Platelet crit,81945
4,Frailty index,6504
4,Height [Conditioned on rs7689420],642
4,"Systolic blood pressure x alcohol consumption interaction (2df test) [Asian, EA]",1208
4,Bisoprolol fumarate+hydrochlorothiazide 10mg/6.25mg tablet | treatment/medication code,90
4,Protein quantitative trait loci (liver) [NARS],13
4,"Waist circumference adjusted for BMI in active individuals [EA, men]",66
4,Alanine transaminase levels in high alcohol intake,3398
4,Sex hormone-binding globulin levels,431565
4,Crohn's disease,6032
4,Gastric cancer,282
4,Chronic bronchitis and chronic obstructive pulmonary disease,510
4,BMI in non-smokers,22
4,Recombination rate (females),14671
4,Breast cancer,50798
4,Birth weight,17094
4,Facial morphology (segment 25),5375
4,Serum levels of protein RRBP1,2580
4,Duration to first press of snap-button in each round,1632
4,Relative brain age,541
4,Body mass index [EA],74
4,Worry/vulnerability (special factor of neuroticism),267
4,Frequency of inability to cease drinking in last year,24
4,Parkinson's disease,62503
4,Coiled-coil domain-containing protein 80 levels,1899
4,Serum levels of protein DDR1,1553
4,Lipoprotein (a) levels,5090
4,Frequency of drinking alcohol,1243
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-130 ms],48
4,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],44
4,Coronary heart disease (SNP X SNP interaction),1684
4,Thyrotoxic periodic paralysis,120
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-18 ms],651
4,"Blood protein levels [SPARCL1, 4467_49_2]",4263
4,CXCL6 levels,3654
4,Childhood maltreatment,603
4,"Blood protein levels [RAP1GDS1, 14106_46_3]",552
4,Ischemic stroke (cardioembolic) [CCSp],305
4,Prevotella sp900318625 abundance in stool,130
4,Serum levels of protein GALNT3,2558
4,Serum metabolite levels [Hexadecanedioate],1611
4,"""Hypothyroidism, strict autoimmune, 3 medication purchases required""",627
4,"Mania, hypomania, bipolar or manic-depression | mental health problems ever diagnosed by a professional",45
4,Brain volume in infants (grey matter),9
4,Immature reticulocyte fraction,83757
4,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant I (Philtrum), Segment 39]",114
4,Facial morphology (segment 24),3
4,"Blood protein levels [CXCL10, 4141_79_1]",69304
4,Blood glucose levels,12059
4,Serum 25-Hydroxyvitamin D level variance,6772
4,Plasma thyroid-stimulating hormone levels,259
4,Creatinine (enzymatic) in urine,352
4,Age started wearing glasses or contact lenses,219
4,Red cell distribution width,733362
4,Urinary metabolite levels in chronic kidney disease [11-ketoetiocholanolone sulfate],6527
4,Hypothyroidism or myxedema,8584
4,Alopecia areata,3336
4,"""Pulmonary heart disease, diseases of pulmonary circulation""",441
4,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],84
4,"Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",102
4,Sum neutrophil eosinophil counts,16294
4,"Aspirin | medication for pain relief, constipation, heartburn",14832
4,Serum levels of protein TMEM57,2558
4,UBA8621 abundance in stool,689
4,L-arginine levels [random effects model],1394
4,Weight [East Asian],229
4,Manganese levels,116
4,Reaction time,851
4,Acylcarnitine levels [Octanoylcarnitine],2731
4,Facial morphology (segment 2),565
4,"Cholelithiasis/gall stones | non-cancer illness code, self-reported",2271
4,"Liver, biliary or pancreas problem",2271
4,Post bronchodilator FEV1/FVC ratio,700
4,Ebbinghaus illusion (overestimation),558
4,"Emphysema imaging phenotypes [%LAA-950, All]",205
4,Hyperlipidemia,162
4,Iron status biomarkers (total iron binding capacity),22
4,Pulse pressure [East Asian],643
4,Smoking behaviour (cigarettes smoked per day),74247
4,Protein quantitative trait loci (liver) [SERPINC1],5359
4,Other intervertebral disc disorders,552
4,Serum levels of protein KITLG,1016
4,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),272
4,Psychological resilience (self-assessed),43
4,Urinary creatinine levels,77
4,Average weekly beer plus cider intake,24
4,Tonsillectomy,33604
4,Male-pattern baldness,61285
4,Corneal resistance factor (right),5700
4,"Blood protein levels [CXCL11, 3038_9_2]",10847
4,"Metabolic traits [urate, histidine]",2758
4,Citramalate levels,479
4,Frequency of needing morning drink of alcohol after heavy drinking session in last year,4
4,Serum uric acid levels [EA],1420
4,Extrinsic epigenetic age acceleration,1627
4,Cardioembolic stroke (CCS or TOAST classification),139
4,"Waist circumference [EA, women]",22
4,Large proline-rich protein BAG6 levels,35
4,Educational attainment (MTAG) [MTAG],120452
4,Urinary albumin-to-creatinine ratio [EA],33922
4,Leg fat percentage (right),57559
4,Osteopontin levels,4535
4,Chained arithmetic | fi8 ,4645
4,Systolic blood pressure [East Asian],1039
4,Urinary metabolite levels in chronic kidney disease [X - 13688],188
4,Endometriosis [EA],638
4,Mature T/NK-cell lymphomas,62
4,Gut microbiota relative abundance (bacterial taxa) [Clostridium_propionicum],25
4,Hematocrit,188755
4,DNA methylation Hannum age acceleration,18548
4,Protein quantitative trait loci (liver) [LBP],1026
4,Facial morphology (segment 34),70
4,All anxiety disorders,29
4,Highest math class taken (MTAG) [MTAG],80843
4,Free thyroxine concentration,5851
4,Basophill percentage,19331
4,Serum levels of protein HMP19,2600
4,Serum levels of protein SERPINA1,2558
4,Percent mammographic density,45
4,Maximum habitual alcohol consumption,24
4,Reticulocyte percentage,61412
4,Serum metabolite levels [decanoylcarnitine (C10],2541
4,Gut microbiota (bacterial taxa) [Unclassified Porphyromonadaceae],2316
4,Triacylglyceride levels [TAG(50:2;0],161
4,Duration of light diy,108
4,Facial morphology [pronasale-left alare distance],1
4,Reticulocyte count,441906
4,Chronotype,52798
4,Bone mineral density (hip),7214
4,Heart failure and antihypertensive medication,494
4,TPE interval (resting),1045
4,Pulse rate,550
4,Glaucoma | eye problems/disorders,2012
4,Monobrow,3521
4,Receptor for advanced glycosylation end products levels,1196
4,"Blood protein levels [CPZ, 6493_9_3]",6599
4,P wave duration [EA],727
4,Other heart diseases,861
4,Urate levels [EA],1186
4,Intelligence (MTAG),57733
4,Doctor diagnosed hayfever or allergic rhinitis,16820
4,Leg fat-free mass (right),162130
4,Guilty feelings,2148
4,Serum levels of protein NFU1,2580
4,"""Hypothyroidism, strict autoimmune""",1999
4,Household income (MTAG),18513
4,Carpal tunnel syndrome,1965
4,Serum levels of protein ALDH1A3,1653
4,Transplant-related mortality after unrelated donor allogeneic hematopoietic cell transplantation (donor-recipient mismatch),1441
4,Heme oxygenase 1 levels,1899
4,Myeloproliferative neoplasms,29
4,Dimethylarginine (sdma + adma) levels,3
4,Asthma,142454
4,"Hayfever, allergic rhinitis or eczema | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",28220
4,Total cholesterol levels [Trans-ethnic initial],44
4,Serum metabolite levels [octanoylcarnitine],2731
4,Triglyceride levels x long total sleep time interaction (2df test),3149
4,Prothrombin time,570
4,Systolic blood pressure,305412
4,Physiological aging rate,4434
4,Diabetes | illnesses of mother,5372
4,Smoking status (ever vs never smokers),10712
4,"""Cardiomyopathy, other and unspecified""",313
4,Serum levels of protein ELF5,2558
4,Protein quantitative trait loci (liver) [SEPT7],40
4,TPE interval (recovery after exercise),5
4,Sarcoidosis [EA],75384
4,Pattern 2 | hair/balding pattern,1133
4,Helix rolling,773
4,Diastolic blood pressure (long-term average),53
4,Diastolic blood pressure [EA],288
4,Myopia,960
4,Left–right brain asymmetry,3082
4,Cognitive traits (MTAG),272
4,Cortical thickness (min-P),272
4,Body mass index (joint analysis main effects and smoking interaction) [women],22
4,Protein quantitative trait loci (liver) [SEPT11],4
4,Gut microbiota (bacterial taxa) [Butyricicoccus_pullicaecorum],13
4,Menarche (age at onset),9612
4,Lifetime smoking index,26806
4,Type 2 diabetes [EA],23899
4,Externalizing behaviour (multivariate analysis),56184
4,3mm strong meridian (left),80150
4,Neutrophil percentage of granulocytes,7724
4,Serum levels of protein CA2,2558
4,Alcohol consumption (drinks per week) [Conditioned on chr4:39414993],1219
4,D-dimer levels in HIV infection,1619
4,Theta electroencephalogram power,144
4,Resting heart rate,196
4,Protein quantitative trait loci (liver) [GNMT],2
4,Brain morphology (min-P),1376
4,Serum levels of protein CPQ,2580
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-20 ms],651
4,"Cataract | non-cancer illness code, self-reported",24
4,Pulmonary embolism with or without deep venous thrombosis,1666
4,Electrocardiogram morphology (amplitude at temporal datapoints) [12 ms],5835
4,Lung function in never smokers (low FEV1 vs average FEV1),85
4,Autoimmune diseases,428
4,Protein quantitative trait loci (liver) [SNRPD3],7
4,Total bilirubin levels,49396
4,Serum levels of protein GCH1,2007
4,Hypothyroidism nos,1004
4,Serum levels of protein FMR1,2558
4,Optic disc area,981
4,Alcohol consumption [women],1219
4,Sleep disorders (combined),78
4,"""Hypothyroidism, levothyroxin purchases""",260
4,Major depressive disorder vs ADHD (ordinary least squares (OLS)),7855
4,"""Type 2 diabetes, definitions combined""",8909
4,Refractive error,9394
4,High blood pressure | illnesses of siblings,115
4,Serum levels of protein WFDC13,1553
4,Serum levels of protein EDDM3B,2558
4,Response to tofacitinib treatment in psoriasis (herpes zoster)(time to event) [EA],52
4,Gut microbiota (bacterial taxa) [Butyricicoccus],13
4,Renal underexcretion gout,17432
4,Peak expiratory flow (pef),18544
4,Blood metabolite levels [valine],351
4,Hirsutism,55
4,Pure hypercholesterolaemia,43
4,Overall health rating,38793
4,Early onset atrial fibrillation,458
4,HDL cholesterol levels x long total sleep time interaction (2df test),1457
4,Idiopathic pulmonary fibrosis,744
4,Protein quantitative trait loci (liver) [CAND1],13
4,"Blood protein levels [BST1, 4535_50_2]",8061
4,Protein quantitative trait loci (liver) [VCL],26106
4,Brimonidine tartrate | treatment/medication code,3996
4,Electrocardiogram morphology (amplitude at temporal datapoints) [152 ms],1045
4,Brain imaging measurements [Imaging-derived phenotype IDP_T1_FAST_ROIs_L_ventral_striatum],116
4,Calcium carbonate+colecalciferol 1.25g/5micrograms tablet | treatment/medication code,13
4,Serum creatinine levels,80489
4,Electrocardiogram morphology (amplitude at temporal datapoints) [384 ms],1045
4,"Pulmonary function (smoking interaction) [FEV1/FVC, Ever-smoking]",1149
4,Mean corpuscular haemoglobin concentration,3190
4,Brain imaging measurements [Imaging-derived phenotype IDP_T1_FAST_ROIs_L_putamen],116
4,Leukocyte telomere length [East Asian],325
4,Peripheral artery disease in diabetes,3
4,Total cholesterol levels,47836
4,Cardiovascular disease,235722
4,Anxiety,5662
4,Cotinine and 3'-hydroxycotinine levels in current smokers,3139
4,Inflammatory bowel disease [EA],3426
4,"Blood protein levels [SCGB2A1, 5001_6_2]",552
4,Urate levels in overweight individuals [women],1554
4,Protein quantitative trait loci (liver) [FTH1],1516
4,Electrocardiogram morphology (amplitude at temporal datapoints) [120 ms],13
4,Intrinsic epigenetic age acceleration,29
4,"""Appendicitis, broad definition""",45
4,Body fat percentage [female],36
4,Protein quantitative trait loci (liver) [LDHB],40
4,Protein quantitative trait loci (liver) [PREP],3
4,Fibrinogen levels,8883
4,Rheumatoid arthritis,3688
4,Parkinson's disease | illnesses of mother,2036
4,Depressive symptoms,1040
4,Lung function (FEV1/FVC) [conditioned on rs2045517],918
4,Electrocardiogram morphology (amplitude at temporal datapoints) [156 ms],283
4,Brain region volumes [left thalamus proper],25
4,Headache,38
4,Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in non-secretors,62
4,Protein quantitative trait loci (liver) [TGM2],37
4,Nonsyndromic cleft lip,13
4,Programmed cell death 1 ligand 2 levels,1899
4,C-C motif chemokine 4 levels,13433
4,"Blood protein levels [ID2, 9426_73_3]",11045
4,Serum levels of protein ZNRF4,2580
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-78 ms],1000
4,Protein quantitative trait loci (liver) [CKB],40
4,"Body mass index in physically active individuals [EA,women]",22
4,Lung function (FVC),220648
4,Alcohol use disorder,35855
4,Serum levels of protein ADH4,26184
4,"Blood protein levels [RELB, 11464_9_3]",552
4,Cardiac dysrhythmias,560
4,High blood pressure | illnesses of mother,120
4,Frequency of feeling guilt or remorse after drinking alcohol in last year,24
4,Body mass index in physically inactive individuals,22
4,Serum levels of protein GPLD1,1899
4,Ramipril | treatment/medication code,38950
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-84 ms],1000
4,Serum metabolite levels [tiglylcarnitine (C5:1-DC],658
4,Uric acid levels [men],1557
4,Circulating vasoactive peptide levels [ADM],2028
4,"Other professional qualifications eg: nursing, teaching | qualifications",297
4,"Blood protein levels [EA, Insulin-like growth factor-binding protein 7]",296
4,Gut microbiota relative abundance (bacterial taxa) [Gordonibacter],67
4,Protein quantitative trait loci (liver) [DCN],40
4,Optic cup area,17
4,"Number of operations, self-reported",6024
4,Regular attendance at a pub or social club,1089
4,OTU97_11 (Parabacteroides) prevalence,7
4,Mood instability,563
4,Serum levels of protein STAT3,2558
4,Blond vs. brown/black hair color,2802
4,"Cys-gly, oxidized levels",1108
4,Urate levels [AA],1626
4,Hepatocyte growth factor levels,549
4,QRS duration [EA],319
4,Worry too long after an embarrassing experience,458
4,Vertigo of central origin,87
4,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),83091
4,Vitamin D levels,29338
4,Leg fat mass (left),9426
4,"""Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)""",501
4,Bioavailable vitamin D levels in type 2 diabetes,26
4,Comparative height size at age 10,106381
4,"""Articial joint operation, menisceal resection""",2191
4,Hypothyroidism,8240
4,Direct low density lipoprotein cholesterol levels,1443
4,"Intra-ocular pressure, corneal-compensated (left)",1065
4,Rheumatoid arthritis (ACPA-positive),488
4,Pulmonary emphysema [Chinese],305
4,Gut microbiota relative abundance (bacterial taxa) [Coprococcus_comes],60
4,Cortical thickness,48953
4,Serum levels of protein RSRP1,2580
4,PR interval [Hispanic],725
4,Low hand grip strength (60 years and older) (EWGSOP),384
4,Heart failure and bmi 25plus,342
4,Body mass index (joint analysis main effects and smoking interaction),80
4,Protein quantitative trait loci (liver) [CORO1A],24
4,DNA methylation (parent-of-origin) [NESPAS CpG02],104
4,Insomnia complaints,29
4,6mm strong meridian (right),82214
4,Protein quantitative trait loci (liver) [MGMT],144
4,Endovascular or surgical operations to intracerebral aneurysms,11
4,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),1954
4,Impedance of arm (left),175378
4,Asthma (adult onset),4938
4,Triglycerides [EA],2843
4,Fibrinogen gamma chain measurement,1686
4,Paracetamol of NSAID medication,48
4,Alcohol,24
4,Acute appendicitis,90
4,Waist-to-hip ratio adjusted for body mass index,1309
4,Branched-chain amino acid levels (Isoleucine),831
4,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant III (Mandible), Segment 53]",698
4,Bisoprolol | treatment/medication code,307
4,Drug-induced neutropenia,113
4,Composite immunoglobulin trait (IgG/IgM),13101
4,Substance abuse,2336
4,Shoulder impingement or rotator cuff tear,116
4,Mean arterial pressure [East Asian],1239
4,"Yes, but not in the last year | ever been injured or injured someone else through drinking alcohol",24
4,Alcohol consumed,24
4,Cardiac problem,889
4,"Alcohol consumption (drinks per week) [Conditioned on chr4:99713350, chr4:101243023,chr4:100000136 ,chr4:100254520, chr4:100443853, chr4:100286085, chr4:100260679, chr4:100444363, chr4:100239319]",35
4,"Airway imaging phenotypes [WAP, All]",3
4,Lung function (FEV1/FVC),161838
4,Plateletcrit,325469
4,Systemic lupus erythematosus,46524
4,Albumin-globulin ratio,12634
4,Breast size,946
4,C-reactive protein,3502
4,Body fat distribution (leg fat ratio) [females],1612
4,Serum levels of protein WISP3,552
4,Attention deficit hyperactivity disorder,193
4,Circulatory disease nec,496
4,Familial squamous cell lung carcinoma,19885
4,Serum levels of protein CSF2RB,2558
4,Serum levels of protein NLGN4X,552
4,Lesion of sciatic nerve,404
4,Stroke (ischemic),330
4,"Myositis/myopathy | non-cancer illness code, self-reported",177
4,Electrocardiogram morphology (amplitude at temporal datapoints) [194 ms],225
4,Xalacom 0.005%/0.5% eye drops | treatment/medication code,57
4,"Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",526
4,Serum levels of protein VNN2,11
4,Protein quantitative trait loci (liver) [SBDS],6
4,Total body bone mineral density (age 30-45),3488
4,Rheumatoid arthritis [EA],446
4,Serum levels of protein CREBBP,552
4,Femur bone mineral density x serum urate levels interaction [female],46
4,Serum metabolite levels [DSGEGDFXAEGGGVR*],48
4,"Allergic disease (asthma, hay fever and/or eczema) (age of onset)",29368
4,Serum levels of protein COLQ,2558
4,Spherical equivalent [EA],818
4,Nonsyndromic cleft palate,2565
4,"""Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523""",4062
4,"Mean arterial pressure x alcohol consumption interaction (2df test) [Asian, EA, Hispanic]",1109
4,Lisinopril | treatment/medication code,154
4,Glomerular filtration rate (creatinine),16740
4,Waist circumference adjusted for BMI (adjusted for smoking behaviour),11459
4,"Blood protein levels [SEC11C, 10658_28_3]",2984
4,Metabolite levels,5600
4,Serum levels of protein TRAT1,2580
4,XCL1 levels,1899
4,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),11459
4,Waist-hip index,38471
4,Leg fat mass (right),12499
4,Electrocardiogram morphology (amplitude at temporal datapoints) [110 ms],1058
4,Oxalate (ethanedioate) levels,1057
4,Protein quantitative trait loci (liver) [EMILIN2],30
4,Menopause (age at onset),62906
4,"Sphingomyelin (d18:1/22:1, d18:2/22:0, d16:1/24:1) levels",3071
4,Apolipoprotein B levels,6524
4,CD80 on plasmacytoid Dendritic Cell,4670
4,Cancer (pleiotropy)(bidirectional),1035
4,A disintegrin and metalloproteinase with thrombospondin motifs 13 levels,1899
4,Serum levels of protein ADH5,41766
4,Serum levels of protein SCARF2,2580
4,Blood protein levels [Growth-regulated alpha protein],4234
4,Feeling fed-up,438
4,"Systolic blood pressure [EA, initial]",406
4,Poisoning by antibiotics,440
4,Renal function-related traits (sCR),1725
4,No | hearing difficulty/problems,114
4,Sweet biscuits intake,96
4,Leg fat percentage (left),53252
4,Spleen volume,3162
4,Appendiceal conditions,45
4,Serum levels of protein UNC5C,567
4,Neonatal cytokine/chemokine levels (fetal genetic effect) [CXCL6],1151
4,Varicose veins,99
4,Venous thromboembolism,11811
4,Congestive heart failure; nonhypertensive,304
4,"Blood protein levels [EA, ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2]",673
4,Nevus count or cutaneous melanoma,293
4,"Local histogram emphysema pattern [normal, EA]",195
4,Serum levels of protein RAB39B,552
4,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [X-13847, X-23299, X-23314, X-23502]",106
4,Generalized epilepsy,251
4,Cardiomyopathy (excluding other),357
4,Serum levels of protein HPSE,2055
4,"Blood protein levels [ADH4, 8325_37_3]",30010
4,"Blood protein levels [RIC3, 11228_37_3]",552
4,Biological sex,24422
4,"Gout | non-cancer illness code, self-reported",2951
4,Theta EEG coherence [centro-parietal low theta coherence at C4-P4-C3-P3],472
4,Home location at assessment - north co-ordinate (rounded),1047
4,Gut microbiota relative abundance (bacterial taxa) [Butyricimonas_paravirosa],12
4,Ankle spacing width (left),15497
4,Serum levels of protein NUDT9,2166
4,Serum levels of protein MBD4,2558
4,Hyperuricemia,1620
4,Mean platelet volume,363723
4,Forced expiratory volume in 1-second (fev1),81208
4,"Intra-ocular pressure, goldmann-correlated (right)",6292
4,Metabolite levels [C14:1-OH/C10],2731
4,Height [Conditioned on rs6449353],1917
4,Systolic blood pressure [South Asians],102
4,Glycine levels,1899
4,Frequency of difficulty controlling worry during worst period of anxiety,188
4,Serum levels of protein MYZAP,2580
4,Antihypertensive medication - note that there are other indications,11359
4,"Blood protein levels [EIF4EBP2, 4184_43_3]",7999
4,"Medication use (adrenergics, inhalants)",6466
4,Blood protein levels in cardiovascular risk,6542
4,Carotid plaque,210
4,Facial morphology [left alare-labiale superius distance],89
4,Sunburns,4624
4,Medication use (drugs used in diabetes),46996
4,Bilirubin levels,98984
4,Mouth ulcers,11790
4,Walking pace,2888
4,Hip circumference adjusted for BMI [EA],4184
4,Blood protein levels [SPARC-like protein 1],2661
4,"Light brown | hair colour (natural, before greying)",4412
4,"Whooping cough / pertussis | non-cancer illness code, self-reported",204
4,"""Pre-existing hypertension complicating pregnancy, childbirth and the puerperium""",120
4,Lung function in heavy smokers (low FEV1 vs high FEV1),85
4,Other reason | reason for reducing amount of alcohol drunk,24
4,Mean reticulocyte volume,598911
4,"2,3-dihydroxy-2-methylbutyrate levels",6386
4,CD123 on CD62L+ plasmacytoid Dendritic Cell,4670
4,Obesity [Obesity class I],36
4,Systolic blood pressure (cigarette smoking interaction),1449
4,Blood metabolite levels [X-11792],1899
4,Alanine transaminase levels,7413
4,High cholesterol,1310
4,Disorders of breast,982
4,Blood protein levels [N-acylethanolamine-hydrolyzing acid amidase],14496
4,Childhood body mass index,460
4,Serum levels of protein HIKESHI,464
4,Diisocyanate-induced asthma,89
4,Urinary metabolite levels in chronic kidney disease [X - 23314],106
4,Food allergy (maternal genetic effects),42
4,Sepsis (28-day mortality),5
4,"Yes, but not in the last year | ever had known person concerned about, or recommend reduction of, alcohol consumption",24
4,Granulocyte percentage of myeloid white cells,19361
4,Pattern 1 | hair/balding pattern,5190
4,"Blood protein levels [KPNA4, 12698_72_3]",552
4,Childhood body fatness,36
4,"Asthma | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",18056
4,None of the above | vascular/heart problems diagnosed by doctor,126591
4,"Blood protein levels [RAB39B, 12403_30_3]",11045
4,Pattern 4 | hair/balding pattern,7152
4,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],1273
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-200 ms],1000
4,Occlusion of cerebral arteries,304
4,Ever stopped smoking for 6+ months,28
4,Atrial fibrillation [EA],74567
4,1-methylnicotinamide levels,255
4,Metabolite levels [HexCer d18:2/24:0],340
4,"""Gout, unspecified""",1554
4,Thyroid hormone levels [TSH],259
4,Protein quantitative trait loci (liver) [ISOC2],1
4,Coagulation Factor XI measurement,4630
4,Heel bone mineral density T score,59110
4,Mean platelet (thrombocyte) volume,86137
4,"None of the above | medication for cholesterol, blood pressure or diabetes",2238
4,"Malabsorption/coeliac disease | non-cancer illness code, self-reported",1150
4,Ganglion cell inner plexiform layer (GCIPL) thickness,33
4,Low myopia vs hyperopia,26
4,BMI (adjusted for smoking behaviour) [men],80
4,Alanine aminotransferase levels,217983
4,"Blood protein levels [ETHE1, 3847_56_2]",2984
4,Mean arterial pressure x sodium interaction (2df test),3188
4,"""Obesity, other/unspecified""",36
4,Urate levels in overweight individuals [men],482
4,Prevotella sp900317685 abundance in stool,130
4,Neck or shoulder pain | pain type(s) experienced in last month,272
4,Interferon gamma-induced protein 10 levels,56
4,Age first had sexual intercourse,1896
4,Tea intake,338
4,HDL cholesterol levels [BMI adjusted],3331
4,Electrocardiogram morphology (amplitude at temporal datapoints) [174 ms],225
4,Length of longest manic/irritable episode,215
4,Serum levels of protein STX1B,552
4,Alcohol use disorder [AA],86
4,Multivitamins capsule | treatment/medication code,162
4,"Red blood cell traits [EA, RBCC]",143
4,Peripheral atherosclerosis,127
4,Metabolic disorders,87
4,Oral cavity cancer,24
4,Aspartate aminotransferase levels,123031
4,Gonarthrosis [arthrosis of knee](FG),2463
4,Metabolite levels [Fischer's ratio],351
4,Serum levels of protein IL7,2580
4,Serum levels of protein CDK2AP1,2558
4,Sphingolipid levels [GluCer],138
4,Disorders of lipoprotein metabolism and other lipidaemias,29
4,Facial morphology (segment 20),131
4,"Other exercises (eg: swimming, cycling, keep fit, bowling) | types of physical activity in last 4 weeks",129
4,Age of smoking initiation (MTAG),28199
4,Diastolic blood pressure,261349
4,Age-related macular degeneration,9015
4,Alcohol-associated liver disease in non drinkers,357
4,"""Primary open-angle glaucoma, strict""",6540
4,"Fracture ulna | non-cancer illness code, self-reported",125
4,Red blood cell (erythrocyte) count,35603
4,Serum levels of protein CDH15,2028
4,Risk taking,376
4,Hyperthyroidism or thyrotoxicosis,278
4,Appendicitis,74
4,Factor VII activity,26229
4,Pantothenate levels,250
4,Serum urate levels,3367
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-74 ms],1000
4,Waist circumference adjusted for body mass index [EA],12399
4,Interleukin-8 levels,4372
4,Mental health study participation (completed survey),4321
4,Polyarthropathies,1880
4,"""Hypothyroidism,  other/unspecified""",627
4,Serum metabolite levels [hypotaurine],389
4,Glucagon levels in response to oral glucose tolerance test (decremental area under the curve for 0-30 minutes),21
4,Waist circumference adjusted for BMI in active individuals [men],66
4,Allergic rhinitis,71988
4,Serum levels of protein DHFR,1553
4,Ankle spacing width (right),24408
4,Serum levels of protein KPNA4,552
4,Gut microbiota (functional units) [PWY-6518_glycocholate_metabolism_(bacteria],137
4,Waist circumference adjusted for BMI in non-smokers,1471
4,Smoking initiation (ever regular vs never regular) [Conditioned on chr4:94052854],74
4,"Diastolic blood pressure x alcohol consumption interaction (2df test) [Asian, EA]",107
4,Priadel 200mg m/r tablet | treatment/medication code,16
4,Total antioxidant status in non-alcoholic fatty liver disease x mastiha supplementation interaction,7
4,Tumor biomarkers [AFP],3671
4,Monocyte percentage of white cells,90583
4,BMI at 1.5 years old,1951
4,"Alcohol dependency | non-cancer illness code, self-reported",728
4,Electrocardiogram morphology (amplitude at temporal datapoints) [150 ms],225
4,Alcohol use disorder [Latino],24
4,Chronic kidney disease,2679
4,"Blood protein levels [ICT1, 6380_23_3]",2984
4,Bone disorder,3240
4,Blood metabolite levels [leucine],351
4,Atrial fibrillation [Japanese],488
4,Protein quantitative trait loci (liver) [UGT2B15],18
4,Cystatin-B levels,2
4,Neutrophil count,439441
4,FEV1,73944
4,Snoring,3684
4,Bipolar disorder,1398
4,Electrocardiogram morphology (amplitude at temporal datapoints) [196 ms],225
4,Thalamus volume,577
4,Other insterstitial pulmonary diseases,5
4,Platelet count,1184442
4,Hemoglobin,101309
4,Adventurousness,13502
4,Neuroticism score,614
4,Hernia,2441
4,DVT of lower extremities and pulmonary embolism,441
4,Colon adenocarcinoma (controls excluding all cancers),20
4,Type 2 diabetes [conditional],92806
4,Sodium warfarin | treatment/medication code,309
4,Kidney stones,338
4,Immune reponse to smallpox (secreted IL-1beta) [EA],2242
4,"Other joint disorder | non-cancer illness code, self-reported",146
4,Protein quantitative trait loci (liver) [HIST1H1C],4
4,Alcohol use disorder (total score),1957
4,Health precaution | reason for reducing amount of alcohol drunk,1243
4,Bipolar I disorder,1388
4,Serum levels of protein SEC11C,1899
4,Serum levels of protein PSG5,552
4,Heel bone mineral density x serum urate levels interaction,13
4,Cerebrospinal fluid biomarker levels [N-acylethanolamine-hydrolyzing acid amidase],1823
4,Trunk fat mass,37678
4,Hair shape,906
4,CD62L- plasmacytoid Dendritic Cell Absolute Count,4670
4,Bone morphogenetic protein 6 levels,1899
4,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event) [Cox proportional hazards regression model],526
4,"Fracture wrist / colles fracture | non-cancer illness code, self-reported",231
4,"Disorders of muscle, ligament, and fascia",75
4,KLE1615 abundance in stool,1
4,Asthma or allergic disease (pleiotropy),14744
4,Serum levels of protein ARSA,2580
4,Serum levels of protein ZBTB33,2558
4,Cytokine and corticosteroid-stimulated IL-6 production,355
4,Hypercholesterolemia,149
4,Alcohol consumption x traumatic event in childhood (felt hated by family member) interaction,52
4,Intraocular pressure,40193
4,Glaucoma (high intraocular pressure),836
4,Cerebrovascular diseases (FINNGEN),340
4,BMI at adiposity rebound,36
4,"Metabolite levels [His, Val]",1899
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-100 ms],1000
4,Peptidyl-prolyl cis-trans isomerase FKBP4 levels,139
4,Urinary albumin excretion (no hypertensive medication),57
4,"""Aneurysms, operations, SAH""",11
4,Brain region volumes [right accumbens area],116
4,Modified Stumvoll Insulin Sensitivity Index (BMI interaction),4
4,Peak expiratory flow,24659
4,"""Heart failure,strict""",335
4,Hip bone size,940
4,Electrocardiogram morphology (amplitude at temporal datapoints) [118 ms],13
4,Adiponectin levels,1248
4,Facial morphology (segment 15),176
4,Miserableness,170
4,Primary biliary cholangitis,126685
4,Participation in an health questionnaire (not invited vs invited),20259
4,Cystatin C levels,136995
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-98 ms],1000
4,Ovarian cancer in BRCA1 mutation carriers,1780
4,Longest period spent worried or anxious,28
4,Type 2 diabetes with ketoacidosis,2
4,Osteoarthritis (hip),12100
4,Urinary albumin-to-creatinine ratio,39083
4,Nicotine metabolite ratio in current smokers,6527
4,Daunorubicin drug response (IC50),33
4,Dronedarone medication,265
4,Cough in response to angiotensin-converting enzyme inhibitor drugs,17
4,Epilepsy [All epilepsy],42
4,Optic disc size,2157
4,Serum levels of protein CLEC2L,2580
4,Serum levels of protein DEFB118,2558
4,Tense / 'highly strung',221
4,"Age-related diseases, mortality and associated endophenotypes",524
4,Myo-inositol levels,275
4,"Urinary frequency / incontinence | non-cancer illness code, self-reported",79
4,Diabetic neuropathy in type 2 diabetes,84
4,Neonatal total 25-hydroxyvitamin D levels (fetal genetic effect),58
4,Lung function (FEV1),17410
4,DNA methylation-estimated granulocyte proportions,3101
4,Plasma renin activity levels,48
4,Worry,7880
4,"Body mass index [EA, women]",22
4,Electrocardiogram morphology (amplitude at temporal datapoints) [180 ms],225
4,Urinary metabolite levels in chronic kidney disease [X - 19141],6527
4,Serum metabolite levels [allantoin],1679
4,Stroke,663
4,Cardiac arrhytmias,522
4,Ascorbic acid 3-sulfate levels,308
4,Chronic obstructive pulmonary disease,48484
4,Fasting glucose,84375
4,Insomnia [Female],6494
4,3mm weak meridian (right),82660
4,C-C motif chemokine 3 levels,13613
4,Smoking status,5430
4,Hearing difficulty/problems with background noise,292
4,Pulse pressure x alcohol consumption interaction (2df test) [EA],492
4,Alcohol-associated liver disease in light drinkers,357
4,Nurofen 200mg tablet | treatment/medication code,110
4,Body mass index [Japanese],17
4,Serum levels of protein VAPB,2558
4,Thrombomodulin sensitivity ratio (normalized endogenous thrombin potential to thrombomodulin),1899
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-110 ms],1241
4,Blood protein levels [Fibroblast growth factor 2],618
4,Thyroid function,259
4,Caffeine consumption from tea,338
4,Perceived unattractiveness to mosquitoes,506
4,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],89
4,Lung function (FEV1/FVC) [adults],127
4,Ischemic heart diseases,103
4,Had menopause,41499
4,"Blood protein levels [PSAPL1, 8814_33_3]",74
4,Serum metabolite levels [glycosyl-N-palmitoyl-sphingosine (d18:1/16:0],92
4,Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test),29850
4,Relative age of first facial hair,21025
4,Impedance of arm (right),183818
4,Arm predicted mass (right),111657
4,Chronic obstructive pulmonary disease x ever smoker interaction (main effect),1868
4,Urinary metabolite levels in chronic kidney disease [X - 13847],106
4,Current eye infection,753
4,Ascorbate (vitamin c) levels,856
4,Systolic blood pressure [EA],169
4,Sum eosinophil basophil counts,5959
4,Job involves heavy manual or physical work,11760
4,Chordin-like protein 2 levels,1899
4,Waist circumference,13144
4,"Hypothyroidism/myxoedema | non-cancer illness code, self-reported",4121
4,Adult body size,11881
4,Acne (severe),2525
4,1-palmitoyl-2-linoleoyl-gpc (16:0/18:2) levels,677
4,Alcohol-related disorders,24
4,Hypertension [East Asian],914
4,Serum metabolite levels [glycosyl-N-stearoyl-sphingosine (d18:1/18:0],206
4,Respiratory mometasone | treatment/medication code,296
4,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)",6932
4,Atenolol | treatment/medication code,120
4,Type 1 diabetes and autoimmune thyroid diseases,235
4,Acute renal failure,23
4,Alcohol consumption in current drinkers,6578
4,Schizophrenia vs ADHD (ordinary least squares (OLS)),83273
4,Medication use (drugs affecting bone structure and mineralization),5128
4,Urate levels in obese individuals,1963
4,Serum uric acid levels [conditional on round 2],849
4,Body mass index (joint analysis main effects and physical activity interaction),74
4,Other disorders of arteries and arterioles,166
4,Pregnancy hypertension,82
4,Human milk oligosaccharide concentration (lacto-N-fucopentaose III),137
4,"Blood protein levels [SNCA, 8458_111_3]",1664
4,Renal function-related traits (eGRFcrea),1725
4,Abdominal aortic aneurysm,3137
4,Serum levels of protein HERC1,1553
4,Gout [EA],280
4,"Bronchiectasis | non-cancer illness code, self-reported",2
4,Lumbar spine bone mineral density,9457
4,Renal function-related traits (urea),5420
4,Neutrophil percentage of white cells,153914
4,Low testosterone levels,3686
4,"Alcohol consumption (drinks per week) [Conditioned on chr4:100260679, chr4:100444363,chr4:100239319]",2291
4,Frequency of consuming six or more units of alcohol,1359
4,"Parkinsons disease | non-cancer illness code, self-reported",89
4,Zolpidem | treatment/medication code,43
4,3-hydroxy-1-methylpropylmercapturic acid levels in smokers [Latino],12
4,6mm strong meridian (left),83515
4,Headache | pain type(s) experienced in last month,6587
4,B-type natriuretic peptide levels,1016
4,Anterior thalamic nuclei volume,116
4,middle facial morphology traits (quantitative measurement) [Columella Inclination],267
4,Reticulocyte fraction of red cells,198891
4,Alzheimer's disease progression score [corrected for APOE4 status and baseline cortical amyloid],10287
4,Eosinophill count,30372
4,"Blood protein levels [EVA1B, 8062_15_3]",7999
4,Serum levels of protein CFI,966
4,Chondromalacia,132
4,White matter microstructure (fractional anisotropy) [Inferior fronto-occipital fasciculus],7
4,Never | smoking status,5614
4,Insulin-related traits [FI],3616
4,NT-proBNP levels in acute coronary syndrome,89
4,"Osteoarthritis | non-cancer illness code, self-reported",116
4,Serum metabolite levels [methyl glucopyranoside (alpha + beta],40
4,"Mouth morphology (principal component model) [Uyghur, male]",2
4,Alcohol consumption (drinks per week) (MTAG),21823
4,Alcohol intake frequency.,12282
4,Alzheimer's disease,2035
4,Diastolic blood pressure x alcohol consumption interaction (2df test) [EA],1141
4,Protein quantitative trait loci [BST1],7590
4,Total cerebellar volume (excluding Crus I vermis),1799
4,Urate levels [men],1331
4,Body mass index [men],74
4,Asthma and attention deficit hyperactivity disorder,11254
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-190 ms],1000
4,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),9320
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-122 ms],289
4,Drug-induced hepatocellular liver injury,5167
4,Hemoglobin concentration,118676
4,Educational attainment (years of education),95935
4,Serum metabolite levels [glycosyl-N-(2-hydroxynervonoyl)-sphingosine (d18:1/24:1(2OH))*],4165
4,Meat-related diet,3903
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-80 ms],1000
4,Depressed affect,448
4,Tooth agenesis (mandibular second premolars),535
4,Abandon | final attempt correct,10
4,Triglyceride levels [EA],44
4,Chlamydia trachomatis momp D antibody levels,103
4,Lymphocyte percentage of white cells,248581
4,Gout vs asymptomatic hyperuricemia,2024
4,Autism and major depressive disorder (MTAG),1089
4,Gtn 400micrograms spray | treatment/medication code,941
4,Cancer (pleiotropy) [subset analysis],1035
4,Protein quantitative trait loci (liver) [POLR2H],63
4,Facial morphology [left exocanthion-left alare distance],34
4,No | ever been injured or injured someone else through drinking alcohol,24
4,3mm regularity index (right),6
4,Serum levels of protein LRFN1,11
4,Metabolite levels [asparagine],1783
4,Impedance of leg (right),75828
4,Basophil percentage of white cells,30542
4,Serum levels of protein DNAJB2,3291
4,Bone mineral density [FNK],3607
4,Blood metabolite ratios [octanoylcarnitine/X-13435],2686
4,Hematological or dermatological disease,821
4,Celiac disease and Rheumatoid arthritis,3285
4,Alcohol consumption (drinks per week) [Conditioned on chr4:100239319],855
4,Serum levels of protein EVA1B,552
4,None of the above | transport type for commuting to job workplace,660
4,Alcohol consumption (drinks per week) [EA],24
4,Lymphocyte counts,530063
4,"Asthma | non-cancer illness code, self-reported",18056
4,Primary open-angle glaucoma,6540
4,Hip circumference,25641
4,Erythritol levels,673
4,Systolic blood pressure [Hispanic],70
4,Lymecycline | treatment/medication code,97
4,DNA methylation variation (age effect),16643
4,Infant length,10227
4,Cerebral aneurysm,1523
4,6-oxopiperidine-2-carboxylate levels,1151
4,Serum levels of protein MRPL58,2028
4,Hypertrichosis,55
4,CD3 on CD28- CD8+ T cell,104
4,BMI in non-smokers [women],22
4,Serum albumin levels,56387
4,Triglycerides x physical activity interaction (2df test),1575
4,Vertical cup-disc ratio (adjusted for vertical disc diameter),943
4,Arthrosis,2191
4,AV-block,99
4,Estimated glomerular filtration rate,222540
4,Urokinase plasminogen activator surface receptor levels,3927
4,Serum levels of protein NPPA,1553
4,C-reactive protein and white blood cell count [CRP],853
4,Glomerular filtration rate [3-measure model],2503
4,Waist circumference adjusted for body mass index [men],66
4,Family history of Alzheimer's disease,190
4,DNA methylation-estimated plasminogen activator inhibitor-1 levels,1088
4,"Blood protein levels [CXCL6, 3495_15_2]",4211
4,Serum metabolite levels [decanoylcarnitine],2731
4,Blood metabolite levels [urate],1681
4,Ingesting alcohol or a recreational or illicit drug | methods of self-harm used,130
4,Type 1 diabetes,10973
4,Serum levels of protein DRAXIN,2558
4,Brain region volumes [cerebellar vermal lobules VIII X],5078
4,Serum levels of protein CASP2,2558
4,Coronary atherosclerosis,415
4,Arrhythmia,1286
4,Body mass index [women],22
4,"Blood protein levels [ADH5, 11369_23_3]",27320
4,Risk-taking tendency (4-domain principal component model),23226
4,middle facial morphology traits (quantitative measurement) [Nose protrusion],267
4,Adopted father still alive,53
4,Protein quantitative trait loci (liver) [CA1],101
4,Chronic obstructive pulmonary disease (severe),680
4,"Hayfever/allergic rhinitis | non-cancer illness code, self-reported",14975
4,Major depressive disorder,3585
4,Apolipoprotein A-IV levels,1899
4,ADHD vs obsessive compulsive disorder (ordinary least squares (OLS)),7855
4,Digoxin | treatment/medication code,304
4,Serum levels of protein TNFAIP8,1016
4,Red blood cell count,511350
4,Caffeine consumption from coffee,4321
4,Taking other prescription medications,288
4,Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis),2212
4,Protein quantitative trait loci (liver) [ALDH5A1],74
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-86 ms],1000
4,Lipoprotein-associated phospholipase A2 activity change in response to statin therapy [percent change],319
4,"Body mass index (joint analysis main effects and physical activity interaction) [EA, women]",22
4,Protein quantitative trait loci (liver) [RPS23],3
4,C-X-C motif chemokine 6 levels,12709
4,"Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)",1695
4,Serum urate levels in chronic kidney disease,3005
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-94 ms],1000
4,Cerebrovascular disease,342
4,Response to statins (LDL cholesterol change) [fractional LDL-C reduction],338
4,"Blood protein levels [WFDC13, 9345_436_3]",552
4,Gout in chronic kidney disease,280
4,"Abdominal hernia | non-cancer illness code, self-reported",140
4,Mean corpuscular volume,1075438
4,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) [women],1248
4,Serum levels of protein SLC3A2,464
4,White matter microstructure (radial diusivities) [Splenium of corpus callosum],400
4,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [women],66
4,Protein quantitative trait loci (liver) [LUM],40
4,Leisure sedentary behaviour (television watching),44049
4,Childhood steroid-sensitive nephrotic syndrome,601
4,Ventricular arrhythmia,494
4,Ever used hormone-replacement therapy (hrt),134
4,Serum levels of protein ETNK1,552
4,Cervical artery dissection,212
4,Hair color,7808
4,"Black | hair colour (natural, before greying)",1646
4,Thrombomodulin sensitivity ratio (normalized peak thrombin generation to thrombomodulin),1899
4,Immune reponse to smallpox (secreted IL-10) [AA],45
4,Time spent using computer,29750
4,Hallux valgus (bunion),125
4,Diseases of appendix,45
4,Fractures,10979
4,Blood metabolite levels [histidine],1967
4,Estimated glomerular filtration rate [EA],1397
4,Number of days/week of vigorous physical activity 10+ minutes,2737
4,"Blood protein levels [SNCA, 8458_16_3]",1636
4,Body mass index [AA and Sub-Saharan],17
4,Diseases of liver,4676
4,Birth weight of first child,4209
4,Cystic kidney disease,714
4,Serum levels of protein C6orf25,3130
4,Aortic vascular smooth muscle cell calcification in response to osteogenic stimuli [calcification (osteogenic media],93
4,"Blood protein levels [PPID, 5202_4_3]",2731
4,Phlebitis and thrombophlebitis of lower extremities,441
4,Emphysema distribution in smoking [ratio950],155
4,Facial morphology (nose roundness 1),61
4,Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis),4157
4,Severity of nausea and vomiting of pregnancy,10601
4,Endometriosis or depression (pleiotropy),1841
4,Coffee consumption,1228
4,Lysophosphatidylcholine-2O_16:0_[M+H]1+ levels,73
4,Hypertensive diseases,1954
4,"Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",1211
4,Past tobacco smoking,7632
4,Feeling miserable,149
4,Serum levels of protein MAPKAPK5,2580
4,"Blood protein levels [NCF4, 14060_67_3]",2984
4,"Blood clot in the leg (dvt) | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",508
4,"Deep venous thrombosis (dvt) | non-cancer illness code, self-reported",508
4,Diastolic blood pressure [South Asians],102
4,Estradiol levels,12965
4,Cortical thickness (MOSTest),416
4,Age-related macular degeneration (choroidal neovascularisation),966
4,Pattern 3 | hair/balding pattern,326
4,Allergy/adverse effect of penicillin,561
4,Neuroticism,19418
4,Smoking cessation (MTAG),1585
4,Serum metabolite levels [4-hydroxychlorothalonil],1207
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-116 ms],289
4,Serum levels of protein IGFBP7,525
4,Urate levels in obese individuals [men],163
4,Protein quantitative trait loci (liver) [FKBP1A],40
4,Mitochondrial DNA levels,4356
4,"Blood protein levels [EA, N-acylethanolamine-hydrolyzing acid amidase]",3468
4,"High cholesterol | non-cancer illness code, self-reported",1153
4,Interleukin-16 levels,839
4,Serum levels of protein SULT1E1,552
4,Age high blood pressure diagnosed,152
4,Ease of getting up in the morning,6934
4,Noncognitive aspects of educational attainment,9779
4,6mm weak meridian (right),94146
4,Comparative body size at age 10,3610
4,Serum levels of protein GRP,2558
4,Serum levels of protein AFM,1126
4,Facial morphology (segment 9),114
4,Parkinson's disease or first degree relation to individual with Parkinson's disease,31981
4,"Forced expiratory volume in 1-second (fev1), predicted percentage",16491
4,Depression,13259
4,Arm fat mass (left),7278
4,"Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",1211
4,Myopia (age of diagnosis),3520
4,Serum levels of protein COL26A1,2580
4,Insomnia symptoms (never/rarely vs. usually),757
4,Uric acid levels [Non-obese],2080
4,Non-rheumatic valve diseases,260
4,Prevotella sp002437285 abundance in stool,130
4,Phosphatidylglycerol(32:1)_[M+OAc]1- levels,1135
4,Femur bone mineral density x serum urate levels interaction [male],340
4,"Alcohol consumption (drinks per week) [Conditioned on chr4:100000136, chr4:100254520,chr4:100443853 ,chr4:100286085, chr4:100260679, chr4:100444363, chr4:100239319]",720
4,"Blood protein levels [ZPBP, 8635_283_3]",552
4,Allopurinol | treatment/medication code,3280
4,"Blood protein levels [TMEM87B, 13485_20_3]",2984
4,"Herpes simplex | non-cancer illness code, self-reported",6
4,Gut microbiota presence (genus Enterorhabdus id.820),83
4,Facial morphology [pronasale-right alare distance],1
4,Respiratory diseases,14570
4,Leukocyte telomere length,27550
4,Weight,166168
4,Serum levels of protein CXCL5,3788
4,Butyrate (4:0) levels,2577
4,"Blood protein levels [ARMC5, 8785_1_3]",552
4,All-cause Heart Failure,342
4,3mm asymmetry angle (right),170
4,Lateral ventricle temporal horn volume,371
4,Tacrolimus | treatment/medication code,13
4,"""Diabetes, insuline treatment (Kela reimbursement)""",5979
4,"Heel quantitative ultrasound index (qui), direct entry (left)",9589
4,Bipolar disorder (MTAG),544
4,Serum levels of protein TRDMT1,1553
4,Serum levels of protein SYT17,2558
4,Mature T/NK-cell lymphomas (controls excluding all cancers),62
4,Smoking initiation (ever regular vs never regular) (MTAG),47769
4,Morningness,7642
4,Brain region volumes [right cerebellum exterior],2097
4,acne vulgaris,2827
4,Primary sclerosing cholangitis,2508
4,Gabapentin | treatment/medication code,41
4,"Alcohol consumption (drinks per week) [Conditioned on chr4:100273594, chr4:99713350,chr4:101243023 ,chr4:100000136, chr4:100254520, chr4:100443853, chr4:100286085, chr4:100260679, chr4:100444363, chr4:100239319]",56
4,Symptoms and signs involving the digestive system and abdomen,6
4,"""Gout, FINNGEN""",1854
4,Neutrophill percentage,85994
4,Serum levels of protein CRAT,2580
4,"Bladder cancer | cancer code, self-reported",11513
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-96 ms],1000
4,Subcortical volume (MOSTest),8759
4,Gut microbiota (bacterial taxa) [Marinilabiliaceae family],520
4,Ascending aorta maximum area,345
4,Torticollis,3
4,Prostate cancer [EA],6
4,Serum levels of protein ARMC5,552
4,Blood protein levels [C-X-C motif chemokine 6],2713
4,Incident atrial fibrillation,260
4,Serum levels of protein AXIN2,552
4,Amantadine | treatment/medication code,18
4,Former alcohol drinker,24
4,Hypertension [Japanese],102
4,Protein quantitative trait loci (liver) [HSD17B13],7139
4,Waist circumference adjusted for BMI (adjusted for smoking behaviour) [men],10054
4,Smoking x experiences in childhood (felt loved by family member) interaction,408
4,Insulin-like growth factors [IGFBP-3],402
4,Serum phosphate levels,16933
4,"Blood protein levels [LEAP2, 5708_1_3]",2984
4,Severe influenza A (H1N1) infection,78
4,Brain region volumes [right pallidum],653
4,Serum levels of protein RELB,552
4,Magnesium levels,2527
4,"Blood protein levels [ARL1, 12392_30_3]",552
4,Serum urea levels,85156
4,Serum levels of protein COLEC12,2558
4,Arm predicted mass (left),84106
4,Fasting blood insulin (BMI interaction),1087
4,Lipid traits (pleiotropy) (HIPO component 2),695
4,Number of self-reported non-cancer illnesses,83732
4,2'-deoxyuridine levels,2214
4,Pulmonary heart disease,970
4,Urate levels [Gout],1554
4,Prevalent atrial fibrillation,330
4,Electroencephalogram traits [alphaCz],1548
4,General risk tolerance (MTAG),16837
4,Serum levels of protein SMDT1,2558
4,A body shape index,39209
4,"Blood protein levels [EA, Calcineurin]",725
4,Joint disorder,1654
4,Pulse pressure [EA],761
4,HDL cholesterol levels in current drinkers [EA],89
4,Alcohol withdrawal symptoms,88
4,Immature fraction of reticulocytes,290984
4,Cigarettes smoked per day (MTAG),24522
4,Nonalcoholic fatty liver disease (imputed),4191
4,Hand grip strength,5016
4,Facial ageing,435
4,Serum metabolite levels [aspartate],445
4,"Blood protein levels [WISP3, 5927_4_3]",552
4,"Blood protein levels [TRIL, 14104_1_3]",552
4,Serum 25-Hydroxyvitamin D levels [AA],44
4,Nap during day,4475
4,Cardiometabolic and hematological traits [PCV],2438
4,Pulse pressure [Japanese],650
4,"""Seropositive rheumatoid arthritis, wide""",275
4,Ease of skin tanning,161
4,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction),683
4,Influenza A (H1N1) infection,9
4,Interleukin-27 levels,14605
4,"Blood protein levels [EA, Caspase-3]",30928
4,Ischemic stroke (large artery atherosclerosis),204
4,Uterine fibroids,9640
4,Alcohol intake versus 10 years previously,1243
4,Cholelithiasis and cholecystitis,2262
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-128 ms],48
4,Blood urea nitrogen levels,33646
4,"Blood protein levels [CYTL1, 8402_22_3]",1194
4,Cotinine levels in smokers with chronic obstructive pulmonary disease,3126
4,"GrpE protein homolog 1, mitochondrial measurement",1120
4,Parkinson's disease [Asian],121
4,Waist-hip ratio,155659
4,Parkinson's disease [conditioned on rs356182],5691
4,"Heel broadband ultrasound attenuation, direct entry",18474
4,Clozapine-to-N-desmethylclozapine metabolic ratio in schizophrenia,3126
4,Neurological blood protein biomarker levels [NAAA],16896
4,Phlebitis and thrombophlebitis (not including DVT),475
4,"Blood protein levels [STX7, 8274_64_3]",144
4,Femoral neck size,598
4,Metabolite levels [HexCer d18:1/22:0],340
4,Glutamine levels,6
4,"Blood protein levels [EA, cGMP-specific 3',5'-cyclic phosphodiesterase]",2273
4,Medication use (vasodilators used in cardiac diseases),1260
4,Other embolism and thrombosis,441
4,Albuminuria,9
4,SSC-A on plasmacytoid Dendritic Cell,5069
4,Type 2 diabetes [Japanese],1897
4,Urate levels in lean individuals,2282
4,Protein quantitative trait loci (liver) [RAB7A],7
4,Lobe attachment (rater-scored or self-reported),9325
4,"Forced vital capacity (fvc), best measure",54005
4,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),3306
4,"Blood clot in the lung | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",794
4,Serum metabolite levels [vanillylmandelate (VMA],732
4,Triglycerides x physical activity interaction (2df test) [EA],44
4,Cardiometabolic and hematological traits [Uric acid],26
4,Maternal smoking around birth,2250
4,Cardiac valvular disease,287
4,"""Melanocytic naevi of eyelid, including canthus""",8
4,Alcohol dependence (desire to cut drinking),24
4,Coffee consumption (cups per day),24982
4,Frequency of tiredness / lethargy in last 2 weeks,5741
4,"Forced expiratory volume in 1-second (fev1), best measure",58203
4,Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis),13341
4,Pulse wave arterial stiffness index,235
4,LDL cholesterol levels,1274
4,"Blood protein levels [GSTT2B, 11273_176_3]",552
4,Polycythaemia vera,29
4,Body mass index (joint analysis main effects and physical activity interaction) [women],22
4,"Problematic alcohol use in trauma-exposed individuals [AA, initial]",173
4,Bone mineral density (spine),3341
4,TB-LM or TBLH-BMD (pleiotropy),1514
4,Trunk predicted mass,143610
4,Gout (normal type),909
4,Electrocardiogram morphology (amplitude at temporal datapoints) [-112 ms],1241
4,Sex hormone-binding globulin levels [Men],695
4,Fybogel orange s/f granules | treatment/medication code,88
4,Asthma/COPD (KELA code 203),85
4,Trunk fat percentage,49813
4,Colorectal cancer or advanced adenoma,2267
4,"Metabolite levels (small molecules and protein measures) [Valine, conditioned]",1299
4,Serum levels of protein BACH2,1899
4,Fibroblast growth factor 5 levels,152
4,Protein quantitative trait loci (liver) [CAPN2],40
4,Helicobacter pylori serologic status,13488
4,Serum alkaline phosphatase levels,303774
4,Male puberty timing (late vs. average onset facial hair),16510
4,Standing height,197224
4,Coronary artery disease [additive model],3378
4,Serum levels of protein CXCL1,3046
4,"Risky sexual behaviors (alcohol dependence interaction) [EA, men]",441
4,Inguinal hernia,320
4,None of the above (group 1) | illnesses of siblings,153
4,Medication use (HMG CoA reductase inhibitors),22030
4,"Blood protein levels [EA, C-X-C motif chemokine 11]",66012
4,Serum levels of protein NLGN3,2559
4,"Localized superficial swelling, mass, or lump",995
4,Valvular heart disease including rheumatic fever,304
4,Sleep duration (short sleep),888
4,"Blood protein levels [DDR1, 14704_10_3]",552
4,Serum levels of protein RIC3,552
4,Verbal declarative memory [CERAD-dr],19
5,"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment",13499
5,Yes | breathing problems responsible for leaving job,48798
5,Lumbar spine bone mineral density (trabecular),269
5,interferon-related traits [IFNgamma_CXCL9_of_Monocytes],319
5,Blood protein levels [SPINK1],440
5,Urinary metabolite levels in chronic kidney disease [3-aminoisobutyrate],118
5,Major depressive disorder [% improvement - 12 weeks],52
5,Serum levels of protein RAD51,15
5,"""Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)""",77300
5,Worry too long after an embarrassing experience,11562
5,OTU97_101 (Sutterella) prevalence,3149
5,Restless legs syndrome,7560
5,Ganglion cell inner plexiform layer (GCIPL) thickness,473
5,White matter microstructure (radial diusivities) [Hippocampus ],133
5,Alcohol use disorder (consumption score) [EA],173
5,Glioma [males],124
5,Current | smoking status,129
5,"Diastolic blood pressure x alcohol consumption interaction (2df test) [AA, EA]",29
5,Ebbinghaus illusion (overestimation),25
5,Lymphocyte percentage of white cells,136357
5,"""Malignant neoplasm of breast, HER-negative""",11087
5,Cutaneous malignant melanoma,4898
5,Serum levels of protein NRXN3,15
5,Protein quantitative trait loci (liver) [HEXB],2
5,Proteinase-activated receptor 1 levels,9618
5,Clostridium difficile infection in multiple myeloma,140
5,Serum levels of protein RAB5C,15
5,"Red | hair colour (natural, before greying)",70
5,Granulocyte count,115280
5,Asthma (adult onset),47462
5,Alanine aminotransferase levels,26877
5,Predicted visceral adipose tissue,22390
5,"Serum metabolite levels [5alpha-pregnan-3beta,20beta-diol monosulfate (1]",254
5,Bipolar disorder lithium response (continuous) or schizophrenia,155
5,"Blood protein levels [FRZB, 2841_13_2]",15
5,Global electrical heterogeneity phenotypes [QRS-T angle],99
5,Sleep duration (short sleep),76285
5,Other malignant neoplasms of skin (=non-melanoma skin cancer),859
5,Hematological or dermatological disease,44
5,Hemoglobin concentration,123925
5,3mm strong meridian (right),27135
5,Attention deficit hyperactivity disorder or cannabis use,3645
5,1-stearoyl-2-linoleoyl-gpc (18:0/18:2) levels,3545
5,Dentures | mouth/teeth dental problems,369
5,"""Type 2 diabetes, definitions combined""",120
5,Electrocardiogram morphology (amplitude at temporal datapoints) [192 ms],86
5,Protein quantitative trait loci (liver) [GK2],221
5,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],17
5,Metabolic disorders,2907
5,Benign neoplasm of colon,619
5,Other diseases of upper respiratory tract,714
5,White matter microstructure (mean diusivities) [Superior corona radiata],133
5,Facial morphology (segment 9),1651
5,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,36
5,Used an inhaler for chest within last hour,45
5,Early-onset Parkinson's disease,65
5,Depression,92436
5,Serum uric acid levels,96850
5,"""Ischaemic heart disease, wide definition""",513
5,CDH6 protein levels in plasma,245
5,Serum levels of protein FCER1A,15
5,Mood disorders (more control exclusions),21
5,Serum metabolite levels [3dehydrocarnitine],32601
5,Spherical equivalent,12140
5,Birth weight of first child,2968
5,Bone mineral density,452
5,Thyroid stimulating hormone levels,1122
5,Modified Stumvoll Insulin Sensitivity Index (BMI interaction),8
5,Protein quantitative trait loci (liver) [CIITA],26
5,Disorders of lipoid metabolism,4121
5,Intralaminar thalamic nuclei volume,67475
5,"Pneumothorax | non-cancer illness code, self-reported",2010
5,Electrocardiogram morphology (amplitude at temporal datapoints) [208 ms],1592
5,Rosacea symptom severity,387
5,White matter microstructure (fractional anisotropy) [Posterior thalamic radiation],133
5,Neurological blood protein biomarker levels [IL12],147
5,Immunoglobulin measurement (zinc sulfate turbidity test),7978
5,Leg predicted mass (right),94459
5,IgG glycosylation [IGP43],107
5,Medication use (vasodilators used in cardiac diseases),353
5,"Blood protein levels [EA, Superoxide dismutase [Mn], mitochondrial]",994
5,None of the above | mouth/teeth dental problems,253
5,Low density lipoprotein cholesterol levels [East Asian],12466
5,Mean corpuscular hemoglobin concentration [Asian],1037
5,Nevus count,319
5,Finngen Rheumatological endpoints,92
5,High cholesterol,3225
5,Age hayfever or allergic rhinitis diagnosed by doctor,2297
5,White matter microstructure (radial diusivities) [Sagittal stratum],133
5,Left ventricular global radial strain,1428
5,Never/rarely have milk | milk type used,829
5,White matter microstructure (radial diusivities) [Superior corona radiata],133
5,Oxytetracycline | treatment/medication code,41155
5,Total cholesterol levels [Trans-ethnic initial],5334
5,Protein quantitative trait loci (liver) [GGH],896
5,Place of birth in uk - north co-ordinate,2059
5,"""Hypothyroidism,  other/unspecified""",1150
5,Oxalate (ethanedioate) levels,2200
5,Strenuous sports or other exercises,7708
5,Fluid intelligence score,693
5,QRS complex (Cornell) [EA],223
5,Phospholipase D3 measurement,630
5,Skin reflectance (Melanin index),85
5,Problematic alcohol use (MTAG),14725
5,Serum levels of protein IL6ST,2535
5,HDL cholesterol levels x long total sleep time interaction (2df test),3390
5,Glaucoma | eye problems/disorders,753
5,Nephrolithiasis,4397
5,"Age-related diseases, mortality and associated endophenotypes",8589
5,Alcohol dependence symptom count [additive],71
5,Sudden cardiac arrest [Recessive],434
5,Metabolite levels (small molecules and protein measures) [Phenylalanine],994
5,Body fat percentage and fasting insulin (pairwise),248
5,Gut microbiota (bacterial taxa) [Unclassified Porphyromonadaceae],66
5,Cognitive performance (MTAG) [MTAG],129162
5,Acylcarnitine levels [Acetylcarnitine],30652
5,Blond vs. brown/black hair color,8742
5,Offspring birth weight,4631
5,Electrocardiogram morphology (amplitude at temporal datapoints) [20 ms],491
5,Facial morphology (segment 43),363
5,Metformin | treatment/medication code,960
5,Protein quantitative trait loci (liver) [MARC2],21
5,Bilirubin levels,53273
5,Blood metabolite levels [carnitine],30652
5,"""Hypothyroidism, drug reimbursement""",694
5,Feeling lonely,734
5,Hemoglobin,79429
5,Medication use (glucocorticoids),7498
5,Waist-to-hip ratio adjusted for body mass index [EA],5433
5,First line medication for Crohns disease,1335
5,Childhood gender nonconformity,528
5,White matter microstructure (mean diusivities) [Hippocampus ],133
5,Skin pigmentation traits [Skin color phototype score],185
5,Blood pressure [Systolic],254
5,Protein quantitative trait loci (liver) [VDAC2],64
5,Serum total protein level,158711
5,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [men],1273
5,Type 2 diabetes with other specified/multiple/unspecified complications,687
5,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),7325
5,Inflammatory biomarkers (multivariate analysis),508
5,CD28- CD8+ T cell %CD8+ T cell,699
5,Bone morphogenetic protein 6 levels,994
5,Airflow obstruction [Smoker],890
5,Gamma glutamyl transpeptidase,31237
5,High blood pressure | illnesses of father,2739
5,Arm fat mass (left),53179
5,Lung cancer in ever smokers,2583
5,Serum levels of protein DCK,994
5,Time to complete round,268
5,TPE interval (resting),441
5,Electrocardiogram morphology (amplitude at temporal datapoints) [120 ms],359
5,Pizotifen | treatment/medication code,268
5,Vegetable consumption,75
5,Immature reticulocyte fraction,37941
5,Smoking initiation (ever regular vs never regular) [Conditioned on chr5:80263865],2386
5,Lamb consumption,2255
5,Left-handedness,1949
5,Colorectal cancer (controls excluding all cancers),153
5,Acute pancreatitis,333
5,"""Hypertension complicating pregnancy, childbirth, and the puerperium""",137
5,Malignant neoplasm of prostate,113
5,Fibrinogen,7912
5,Rheumatoid arthritis,32926
5,Kidney injury molecule 1 levels,7667
5,Serum levels of protein LGALS7,994
5,Metabolite levels (Pyroglutamine),1114
5,Basophill count,911
5,Protein quantitative trait loci (liver) [SEPT11],260
5,High blood pressure | illnesses of mother,216
5,White matter microstructure (mean diusivities) [Posterior limb of internal capsule],14619
5,5-hydroxyindoleacetate levels,345
5,Electrocardiogram morphology (amplitude at temporal datapoints) [198 ms],86
5,Optic disc size,15827
5,Estimated glomerular filtration rate in non-diabetics,4092
5,Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count) [Adalimumab],149
5,Gut microbiota abundance (k_Bacteria.p_Bacteroidetes.c_Bacteroidia.o_Bacteroidales.f_Rikenellaceae),206
5,Forced expiratory volume in 1 second (occupational environmental exposures interaction) [Gases and fumes],208
5,High light scatter reticulocyte percentage of red cells,127114
5,Male-pattern baldness,22275
5,Serum metabolite levels [phenylalanylglycine],1396
5,Serum metabolite levels [pregnen-diol disulfate C21H34O8S2*],254
5,Seborrhoeic keratosis,153
5,Protein quantitative trait loci (liver) [PARVA],16
5,End-stage coagulation [vWF],12
5,Plateletcrit,169235
5,Electrocardiogram morphology (amplitude at temporal datapoints) [-4 ms],3219
5,Indoleacetate levels,1953
5,Electrocardiogram morphology (amplitude at temporal datapoints) [194 ms],86
5,White matter microstructure (mean diusivities) [Cingulate gyrus],133
5,Crohn's disease [EA],124939
5,Leg fat mass (left),39722
5,Serum levels of protein LEAP2,15719
5,Physical activity,172
5,Sarcoidosis [EA],315
5,Type 2 diabetes [Japanese],192
5,"Waist-to-hip ratio adjusted for BMI in non-smokers [EA, men]",254
5,Interstitial lung abnormalities,9
5,Monocyte count,527480
5,Sleep duration,206319
5,Fat-free mass [male],43687
5,Inflammatory skin disease [Opposed],4269
5,Fibrinogen [EA],4780
5,Contracture of palmar fascia [dupuytren's disease],5042
5,"Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction) [Dilation, amyloid positive]",3
5,Retinal vascular fractal dimension,641
5,Erosive tooth wear (severe vs non-severe) [male],730
5,Ease of skin tanning,5277
5,Electrocardiogram morphology (amplitude at temporal datapoints) [10 ms],1930
5,"Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",335
5,White matter microstructure (axial diusivities) [Inferior fronto-occipital fasciculus],133
5,Hyperthyroidism,496
5,Vesicular integral-membrane protein VIP36 measurement,21069
5,Electrocardiogram morphology (amplitude at temporal datapoints) [8 ms],2091
5,Cognitive decline rate in late mild cognitive impairment [EA],29
5,Atrial fibrillation and flutter,11466
5,Monocyte differentiation antigen CD14 measurement,24449
5,"Blood protein levels [ERAP2, 8960_3_3]",72170
5,Diabetes mellitus,931
5,Protein quantitative trait loci (liver) [EIF3K],705
5,Blautia hansenii abundance in stool,54
5,Femur bone mineral density x serum urate levels interaction [male],206
5,Gestational [pregnancy-induced] hypertension,137
5,"Forced vital capacity (fvc), best measure",111472
5,LDL cholesterol levels [BMI unadjusted],3315
5,Bilateral oophorectomy (both ovaries removed),159
5,Asparaginase hypersensitivity in acute lymphoblastic leukemia,293
5,Recombination measurement (males) [Fraction of recombinations in hotspots],88
5,"Urinary metabolites (H-NMR features) [3.0275, Aminoisobutyrate]",110
5,Skin pigmentation traits [Skin sensitivity to sun],185
5,Nucleus accumbens volume,12
5,Protein quantitative trait loci (liver) [TAGLN],16
5,Systolic blood pressure,556801
5,White matter integrity (mean diffusivity) [Conditioned on rs13164785],193
5,Retinal arteriolar caliber,458
5,Interleukin-6 receptor subunit beta measurement,5057
5,TPE interval (resting) [men],503
5,Diabetes or endocrine disease,2239
5,Diastolic blood pressure x alcohol consumption interaction (2df test) [EA],29
5,Protein quantitative trait loci (liver) [CCDC58],668
5,Automobile speeding propensity,197
5,Opioid dependence x sex interaction,3295
5,Alcohol intake frequency.,523
5,Serum thyroid-stimulating hormone levels [EA],456
5,Subcortical volume (MOSTest),15924
5,Psoriasis [fixed],33179
5,Waist-hip ratio and triglycerides (pairwise),254
5,"""Rheumatoid arthritis , including avohilmo""",92
5,"""Occlusion and stenosis of arteries, not leading to stroke""",37
5,Waist-hip ratio and type 2 diabetes (pairwise),248
5,Carotid intima media thickness (mean),6
5,CD14 on CD14+ CD16- monocyte,23010
5,Bipolar disorder,6589
5,Plays computer games,2409
5,"High cholesterol | non-cancer illness code, self-reported",2571
5,Waist circumference [East Asian],1642
5,Distance between home and job workplace,265
5,IgG glycosylation [IGP55],107
5,"Blood protein levels [LRRC74A, 8389_8_3]",15
5,Malignant neoplasm of bladder (controls excluding all cancers),139
5,Disorders of vitreous body,208
5,Electrocardiogram morphology (amplitude at temporal datapoints) [188 ms],86
5,Electrocardiogram morphology (amplitude at temporal datapoints) [-28 ms],200
5,None of the above | qualifications,19915
5,Insomnia [Male],5680
5,"Diabetic eye disease | non-cancer illness code, self-reported",1202
5,Electrocardiogram morphology (amplitude at temporal datapoints) [334 ms],776
5,Protein quantitative trait loci (liver) [EPHX1],69
5,Respiratory diseases,26520
5,Medication use (calcium channel blockers),20469
5,Participation in an health questionnaire (not invited vs invited),13474
5,Urinary albumin excretion,1109
5,Protein quantitative trait loci (liver) [LAP3],110
5,Home location - north co-ordinate (rounded),451
5,Gut microbiota relative abundance (bacterial taxa) [Ruminococcus_flavefaciens],332
5,Recombination measurement [Hotspot usage],34
5,Jiangellaceae abundance in stool,4
5,Salivary metabolite levels [dimethylglycine],1269
5,Protein quantitative trait loci (liver) [ERAP1],18153
5,"Insulin | medication for cholesterol, blood pressure or diabetes",670
5,Gut microbiota abundance (k_Bacteria.p_Bacteroidetes.c_Bacteroidia.o_Bacteroidales.f_Rikenellaceae.g_Alistipes),206
5,Heart failure,2539
5,Ischemic stroke,184
5,Hypospadias,10220
5,Medication use (thyroid preparations),30569
5,Asthma (only as main-diagnosis),18140
5,Serum levels of protein HAVCR2,5659
5,Breast cancer (estrogen-receptor negative),650
5,"Diastolic blood pressure x alcohol consumption interaction (2df test) [Asian, EA, Hispanic]",129
5,Postoperative survival time in hepatocellular carcinoma,44
5,Serum levels of protein TNFRSF8,15
5,Pediatric asthma,1080
5,Uterine fibroids,18162
5,Diabetes,2190
5,Never | smoking status,8092
5,Serum levels of protein SEMA5A,336
5,Electrocardiogram morphology (amplitude at temporal datapoints) [44 ms],332
5,"Blood protein levels [EA, Arylsulfatase B]",82
5,Protein quantitative trait loci [PDGF Rb],508
5,Low density lipoprotein cholesterol levels,159480
5,Cortical surface area [Pericalcarine],20138
5,Whole body fat-free mass,144331
5,Psoriasis or type 2 diabetes (trans-disease meta-analysis),7930
5,Total cholesterol levels [BMI unadjusted],3315
5,vWF levels [EA],4277
5,Pancreatic cancer [EA],2669
5,Chin dimples,883
5,Glioblastoma (age-stratified) [Below median age-at-diagnosis],124
5,Other respiratory diseases principally affecting the interstitium,56
5,Urinary metabolites [3-aminoisobutyrate],118
5,6mm index of best keratometry results (right),6
5,Sum neutrophil eosinophil counts,115280
5,Asthma (childhood onset),57019
5,Language functional connectivity,5307
5,Serum levels of protein THBS4,398
5,Myeloproliferative neoplasms,247
5,Ketonuria (moderate to severe),6046
5,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),28916
5,"Heel quantitative ultrasound index (qui), direct entry (left)",1228
5,Electrocardiogram morphology (amplitude at temporal datapoints) [-26 ms],200
5,Response to paliperidone in schizophrenia (positive Marder score) [MLM],46
5,Serum levels of protein RAB17,15
5,Diabetes diagnosed by doctor,1327
5,Alfacalcidol | treatment/medication code,5805
5,Total hippocampal volume,339
5,Other renal tubulo-interstitial diseases,140
5,Protein quantitative trait loci (liver) [FKBP1A],16
5,"Other therapeutic activities such as mindfulness, yoga or art classes | activities undertaken to treat depression",7
5,Phosphorus levels,4556
5,White matter microstructure (radial diusivities) [Superior longitudinal fasciculus],13810
5,Serum levels of protein CCL1,15
5,Protein quantitative trait loci (liver) [RPL17-C18orf32],35
5,"Blood protein levels [BAMBI, 6935_123_3]",15
5,White matter integrity (mean diffusivity),13943
5,Ankylosing spondylitis [EA],13613
5,Electrocardiogram morphology (amplitude at temporal datapoints) [-8 ms],1428
5,Atopic march,6728
5,Glucose levels,1533
5,Chronic pancreatitis,306
5,Circulating chromogranin peptide levels [CHGA361–372],519
5,Coronary revascularization (ANGIO or CABG),403
5,"""Carcinoma in situ of breast, lobular""",12
5,Chronic kidney disease,19720
5,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),13329
5,"Blood protein levels [HAVCR2, 5134_52_2]",5659
5,Obesity (extreme),1642
5,Electrocardiogram morphology (amplitude at temporal datapoints) [202 ms],1592
5,Colorectal cancer or advanced adenoma,1521
5,Protein quantitative trait loci (liver) [SLC25A5],64
5,Asthma and hay fever,2864
5,Alcohol-induced chronic pancreatitis,345
5,Electrocardiogram morphology (amplitude at temporal datapoints) [182 ms],86
5,Serum levels of protein PCDHB4,15
5,Interstitial lung disease endpoints,1500
5,Squamous cell carcinoma,575
5,None of the above (group 1) | illnesses of siblings,23
5,"Psoriatic arthropathy | non-cancer illness code, self-reported",5
5,Brain region volumes [left pericalcarine],11940
5,Lymphocyte percentage,183323
5,Stem cell growth factor beta levels,1077
5,Glioblastoma,243
5,Arm predicted mass (left),99997
5,Peak expiratory flow (pef),4980
5,Retinal vascular fractal density,486
5,"Waist-to-hip ratio adjusted for BMI in non-smokers [AA, men]",248
5,Protein quantitative trait loci (liver) [AGXT2],128
5,Polyarthropathies,92
5,Serum levels of protein BCL2L10,15
5,Hair morphology traits [Hair color (light],185
5,Non-melanoma skin cancer,5336
5,"Systolic blood pressure [EA, initial]",130
5,Neurofibrillary tangles (SNP x SNP interaction),15280
5,Gluten-free | type of special diet followed,97
5,Glucosamine | mineral and other dietary supplements,861
5,"Psoriasis [conditional on rs7709212, rs4921493]",718
5,"""Oedema, not elsewhere classified""",1009
5,"Systolic blood pressure x alcohol consumption interaction (2df test) [AA, EA, Hispanic]",29
5,Cortical thickness (MOSTest),20258
5,Fasting glucose,3036
5,Body fat distribution (arm fat ratio),6433
5,Chronic obstructive pulmonary disease [conditional on rs10866659],3131
5,Brain region volumes [cerebellar vermal lobules VIII X],3015
5,Thyroid hormone levels [TSH],496
5,Reflux esophagitis,11900
5,Cancer within the respiratory system,2053
5,Relative age of first facial hair,2265
5,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),223
5,Vertical cup-disc ratio (multi-trait analysis),5889
5,"Disorders of muscle, ligament, and fascia",3113
5,Heart rate response to recovery post exercise (50 sec),194
5,"Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA, men]",39
5,White matter microstructure (radial diusivities) [Genu of corpus callosum],12746
5,Epilim 100mg crushable tablet | treatment/medication code,872
5,Antihypertensive medication - note that there are other indications,168
5,Mean corpuscular hemoglobin,255945
5,Cortical thickness,129958
5,COPD/asthma related infections,1671
5,"Myasthenia gravis | non-cancer illness code, self-reported",955
5,White blood cell count (neutrophil),89
5,"""Type 2 diabetes, wide definition""",2
5,Recent trouble relaxing,2
5,Blood metabolite levels [betaine],843
5,Chronic obstructive pulmonary disease x ever smoker interaction (2df),4751
5,Serum alkaline phosphatase levels,40003
5,Electrocardiogram morphology (amplitude at temporal datapoints) [228 ms],1506
5,Protein quantitative trait loci (liver) [CTSB],221
5,Facial wrinkles (principal components analysis),319
5,Pericardial fat,5
5,Frequency of stair climbing in last 4 weeks,6760
5,Waist circumference adjusted for body mass index [women],1273
5,Blood trace element (Se levels),1424
5,Response to paliperidone in schizophrenia (Multivariate) [MLM],46
5,"Blood protein levels [NRXN3, 9799_3_3]",15
5,Chronic obstructive pulmonary disease [Hispanic],13
5,"Blood protein levels [C1QTNF3, 7251_64_3]",3180
5,LDL cholesterol x physical activity interaction (2df test),2840
5,Alzheimer disease and age of onset [between families],2396
5,Electrocardiogram morphology (amplitude at temporal datapoints) [220 ms],1506
5,Length of mobile phone use,2218
5,Atopic dermatitis [conditional on rs6419573],2672
5,3mm strong meridian angle (left),1358
5,Skin pigmentation traits [Freckling (categorical],356
5,Facial pigmentation measurement (UV light),738
5,Body fat percentage and type 2 diabetes (pairwise),234
5,LDL cholesterol,51894
5,Fat-free mass,68077
5,None of the above (group 2) | illnesses of father,539
5,"Intra-ocular pressure, corneal-compensated (right)",808
5,Obstructive sleep apnea trait (apnea hypopnea index),23
5,Piroxicam | treatment/medication code,194
5,Serum levels of protein MOCS3,15
5,Self-reported allergy,3680
5,3mm asymmetry angle (left),4804
5,Serum levels of protein PDGFB,508
5,Vertex-wise cortical thickness,127093
5,Age first had sexual intercourse,20058
5,C-reactive protein,13499
5,Life satisfaction,2466
5,Pattern 1 | hair/balding pattern,4141
5,Cervical intraepithelial neoplasia grade 3 and invasive cervical cancer,2554
5,Alloimmunization response to red blood cell transfusion in sickle cell anemia,165
5,Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer,100
5,Cigars or pipes | type of tobacco previously smoked,113
5,Crohn's disease or systemic sclerosis,5960
5,Time spend outdoors in summer,1860
5,Serum levels of protein KLKB1,994
5,"Waist-hip ratio [EA, women]",2195
5,Acisoga levels,753
5,Waist circumference,95791
5,3mm strong meridian (left),11351
5,Worry too long after embarrassment,13578
5,Height [AA],1841
5,"Blood protein levels [BTNL8, 9026_40_3]",3470
5,Psoriasis and related disorders,31
5,Serum levels of protein CCL5,102
5,Smoking status (current vs mixed) [EA],91
5,Hair morphology traits [Hair color (black],185
5,joint destruction in rheumatoid arthritis (rapid vs slow),97
5,White matter microstructure (axial diusivities) [Cingulate gyrus],137
5,Left–right brain asymmetry,788
5,"Blood protein levels [IL34, 4556_10_2]",15
5,Protein quantitative trait loci (liver) [APOC1],6
5,White matter microstructure (axial diusivities) [Posterior limb of internal capsule],16
5,Perceived unattractiveness to mosquitoes,61112
5,Daytime nap,76694
5,1-palmitoyl-2-linoleoyl-gpc (16:0/18:2) levels,7209
5,Electrocardiogram morphology (amplitude at temporal datapoints) [0 ms],1428
5,Tea intake,2770
5,Blood urea nitrogen levels,96197
5,Sedentary behaviour duration,2315
5,Mental health study participation (provided email address),850
5,Retinal vascular caliber [Retinal venular caliber],460
5,Urinary metabolites [1.171 ppm/1.973 ppm],118
5,"""Alcohol related diseases and deaths, all endoints""",34
5,Serum levels of protein APOM,15
5,Body mass index [Japanese],5496
5,Asthma-related acute respiratory infections,4853
5,Brain region volumes [white matter],838
5,Adiponectin levels,1157
5,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction),1428
5,Black vs. blond hair color,371
5,Number of children ever born,89
5,Heart rate,151
5,Protein quantitative trait loci (liver) [AGT],1
5,High light scatter reticulocyte count,254622
5,Respiratory or ear-nose-throat disease,26492
5,Mean platelet (thrombocyte) volume,210171
5,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA],1622
5,Phosphatidylethanolamine-O_38:3_[M-H]1-/Phosphatidylethanolamine-P_38:2_[M-H]1- levels,6865
5,Mood disorders,34
5,Detrusitol 1mg tablet | treatment/medication code,637
5,Electrocardiogram morphology (amplitude at temporal datapoints) [26 ms],273
5,"Blood protein levels [GCNT4, 10854_15_3]",15
5,Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome,60
5,Atopic dermatitis (moderate to severe) [additive],309
5,Protein quantitative trait loci (liver) [GSN],15
5,Lung function in heavy smokers (low FEV1 vs high FEV1),923
5,Behcet's disease [Turkish cases with Uveitis - Recessive Model],7790
5,Interleukin-6 levels in non-alcoholic fatty liver disease x mastiha supplementation interaction,1235
5,Intracranial aneurysm,55397
5,Galectin-3-binding protein measurement,3593
5,Inguinal hernia,8557
5,Hyperthyroidism or thyrotoxicosis,2927
5,Serum levels of protein HBEGF,994
5,Fresh fruit intake,925
5,"Waist-to-hip ratio adjusted for body mass index [EA, men]",293
5,Mosquito bite size,43068
5,Barrett's esophagus or esophageal adenocarcinoma x sex interaction (2df test),14291
5,College or university degree | qualifications,16731
5,Cellulitis and abscess of arm/hand,1009
5,Full cream | milk type used,448
5,Educational attainment (MTAG) [MTAG],206859
5,C-reactive protein levels or LDL-cholesterol levels (pleiotropy),346
5,"""Other diabetes, wide definition""",120
5,"Waist circumference adjusted for BMI in active individuals [EA,women]",379
5,Subjective well-being,81
5,Granulocyte percentage of myeloid white cells,96140
5,Schizophrenia vs ADHD (ordinary least squares (OLS)),4196
5,Melanomas of skin,2884
5,Testicular cancer,1320
5,Cholelithiasis,14346
5,White matter microstructure (mean diusivities) [Superior longitudinal fasciculus],13810
5,White matter hyperintensity volume (adjusted for hypertension),427
5,Serum levels of protein DEFB113,994
5,Eye color [eye color],185
5,ER4 sp002437735 abundance in stool,652
5,Intrinsic epigenetic age acceleration,185
5,Serum levels of protein DSG1,15
5,White matter integrity (fractional anisotropy),13943
5,Testosterone levels,12574
5,White matter microstructure (radial diusivities) [Average across all tracts],13810
5,Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis),1820
5,Able to confide,528
5,Fasciitis,5386
5,Electrocardiogram morphology (amplitude at temporal datapoints) [296 ms],776
5,Ectonucleoside triphosphate diphosphohydrolase 5 levels,12
5,Often | workplace had a lot of diesel exhaust,1
5,Number of sexual partners,3425
5,"Systolic blood pressure, automated reading",29713
5,IgG glycosylation [IGP53],107
5,Cortical surface area [Caudal Middle Frontal],632
5,Recombination measurement [African-enrichment],34
5,White matter microstructure (mean diusivities) [Inferior fronto-occipital fasciculus],133
5,Breast cancer,328473
5,Nasopharyngeal carcinoma,3395
5,"Waist circumference adjusted for body mass index [EA, men]",1740
5,Diabetic retinopathy,3401
5,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) [subset analysis]",56563
5,Atrial fibrillation,29919
5,"Blood protein levels [ERAP1, 4964_67_1]",7713
5,Total bilirubin levels,835
5,Spasmonal 60mg capsule | treatment/medication code,191
5,Conductive and sensorineural hearing loss,3130
5,Electrocardiogram morphology (amplitude at temporal datapoints) [-2 ms],1428
5,"Waist circumference adjusted for BMI in active individuals [EA, men]",145
5,Brain region volumes [right isthmus cingulate],128
5,"Blood protein levels [STX6, 10945_11_3]",15
5,Neutrophil percentage of white cells,328374
5,Pollen allergy,3077
5,Response to antipsychotic treatment [olanzapine-hemoglobin A1c],182
5,Electrocardiogram morphology (amplitude at temporal datapoints) [6 ms],2091
5,"Sphingomyelin (d18:1/22:1, d18:2/22:0, d16:1/24:1) levels",1551
5,Lifetime smoking index,17413
5,"Urinary metabolites (H-NMR features) [3.1075, Aminoisobutyrate]",118
5,Calcichew 1.25g chewable tablet | treatment/medication code,280
5,Protein quantitative trait loci (liver) [CYP2C8],5
5,Myo-inositol levels,270
5,Serum levels of protein LRRC74A,15
5,Cardiovascular disease,66752
5,Colorectal polyp and colorectal cancer (MTAG) [Colorectal polyp],552
5,"Cellulitis and abscess of leg, except foot",1009
5,Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals [corrected for genomic control],67
5,"Blood protein levels [IL12B, 13733_5_3]",147
5,Protein quantitative trait loci (liver) [CNN3],16
5,Coronary artery disease in type 1 diabetes [EA],10
5,Testicular germ cell tumor,6598
5,BMI (adjusted for smoking behaviour) [women],8752
5,Fasting blood glucose adjusted for BMI,718
5,"""Diabetes, varying definitions""",120
5,Itch intensity from mosquito bite adjusted by bite size [women],31628
5,Electrocardiogram morphology (amplitude at temporal datapoints) [316 ms],776
5,Soluble CD14 levels [conditioned],20152
5,Number of self-reported non-cancer illnesses,4115
5,Serum levels of protein ADM,994
5,Urinary metabolite levels in chronic kidney disease [X - 12097],118
5,Diastolic blood pressure (cigarette smoking interaction),124
5,Electrocardiogram morphology (amplitude at temporal datapoints) [16 ms],159
5,A behaviour | behavioural and miscellaneous addictions,285
5,"Blood protein levels [RAD51, 2871_73_2]",15
5,Duration to first press of snap-button in each round,15050
5,Body mass index (adult) [AA],1511
5,Serum CC16 levels,2077
5,Protein quantitative trait loci (liver) [ACLY],65
5,Ovarian cyst,172
5,Prostate cancer aggressiveness,371
5,Allergic rhinitis,15794
5,Arm fat percentage (right),35633
5,Medication use (HMG CoA reductase inhibitors),8647
5,"Blood protein levels [SPINK6, 5731_1_3]",2445
5,Major coronary heart disease event,490
5,HOMA-B (corrected for HOMA-IR),186
5,"2,3-dihydroxy-2-methylbutyrate levels",100
5,Fish- and plant-related diet,3690
5,Apolipoprotein A1 levels,126923
5,Blood metabolite levels [propionylcarnitine],28334
5,Ankle spacing width (right),38080
5,Platelet crit,55094
5,General cognitive ability,14468
5,Average total household income before tax,2669
5,"Rheumatoid arthritis | non-cancer illness code, self-reported",136
5,Suggestive for eosinophilic asthma,16365
5,Statin medication,2994
5,Fasting blood glucose (BMI interaction),669
5,Blood pressure [Pulse Pressure],130
5,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],341
5,HDL cholesterol,45560
5,Insomnia symptoms (never/rarely vs. usually),73773
5,Hernia,2705
5,Hip shape (DXA scan) [hip shape mode 2],1125
5,Leiomyoma of uterus (controls excluding all cancers),151
5,Merkel cell polyomavirus VP1 antibody levels,9464
5,Cerebrospinal fluid biomarker levels [Endoplasmic reticulum aminopeptidase 1],35754
5,Blood metabolite levels [oleoylcarnitine],32601
5,Anisometropia and aniseikonia,52482
5,Bread intake,1492
5,"Inguinal hernia | non-cancer illness code, self-reported",632
5,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],223
5,White matter hyperintensity volume x hypertension interaction (2df),381
5,Medication use (beta blocking agents),4549
5,Vertical cup-disc ratio (adjusted for vertical disc diameter),3285
5,Glioblastoma [males],124
5,Eye color [EA],11
5,Protein quantitative trait loci (liver) [LTF],3
5,Electrocardiogram morphology (amplitude at temporal datapoints) [-16 ms],12532
5,Body mass index (joint analysis main effects and physical activity interaction) [EA],4471
5,Nasopharyngeal carcinoma (SNP x SNP interaction),670
5,Physiological dysregulation (Mahalanobis distance),1019
5,Attention deficit hyperactivity disorder,136
5,Type 2 diabetes without complications,1014
5,Neuroticism (MTAG),1045
5,Blood protein levels [Endoplasmic reticulum aminopeptidase 1],27550
5,Dovonex 50micrograms/g cream | treatment/medication code,819
5,Protein quantitative trait loci (liver) [PTGR1],7
5,Sphingolipid levels [levels],15
5,Alopecia areata,202
5,Mitochondrial DNA levels,3729
5,Electrocardiogram morphology (amplitude at temporal datapoints) [314 ms],776
5,"Blood protein levels [THBS4, 3340_53_1]",398
5,Serum levels of protein CTSA,51
5,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),248
5,Protein quantitative trait loci (liver) [CKB],16
5,Year ended full time education,7298
5,Type 2 diabetes (adjusted for BMI),1522
5,OTU99_116 (Sutterella) prevalence,3149
5,Age-related hearing impairment (MTAG),2995
5,Disorders of porphyrin and bilirubin metabolism,599
5,Serum levels of protein AHSA1,15
5,Mean diameter of LDL particles,16
5,Blood metabolite levels [acetylcarnitine],30652
5,Asthma (moderate or severe),9995
5,Asthma onset (childhood vs adult),3836
5,vascular endothelial growth factor D levels,994
5,Lung function (FVC) and body mass index [East Asian],71122
5,Chlorphenamine | treatment/medication code,4333
5,Lung function (FEV1) [EA],2762
5,Protein quantitative trait loci (liver) [GLUL],13
5,Pulse pressure,187036
5,Amyotrophic lateral sclerosis (sporadic),548
5,"Blood protein levels [LEAP2, 5708_1_3]",14725
5,Neurociticism,4475
5,Electrocardiogram morphology (amplitude at temporal datapoints) [214 ms],1592
5,Atrial fibrillation and flutter with reimbursement,5067
5,Immune reponse to smallpox (secreted IFN-alpha) [EA],1876
5,White matter microstructure (fractional anisotropy) [Hippocampus ],133
5,Polycystic ovary syndrome (adjusted for age),18
5,"""Delivery, wide proxy""",11
5,malignant neoplasm of male genital organs,113
5,Serum levels of protein CAPN1;CAPNS1,6884
5,Breast cancer (early onset),2167
5,I needed less sleep than usual | manifestations of mania or irritability,1314
5,Electrocardiogram morphology (amplitude at temporal datapoints) [38 ms],332
5,Non-small cell lung cancer,257
5,Myeloproliferative diseases (CML excluded),149
5,Lactulose product | treatment/medication code,273
5,Hair color,29969
5,Peak expiratory flow,31932
5,Standing height,303580
5,Total body bone mineral density (MTAG),4143
5,Polycystic ovary syndrome (reproductive subtype),16
5,Waist circumference adjusted for BMI in active individuals,1446
5,Malignant neoplasm of digestive organs,153
5,Birth weight (MTAG),413
5,"""Type 2 diabetes, strict (exclude DM1)""",264
5,Endothelial cell-specific molecule 1 levels,2003
5,Basophill percentage,4002
5,Budesonide+formoterol | treatment/medication code,255
5,Coronary artery disease,31499
5,Lung function (FVC),277790
5,Well-being spectrum (multivariate analysis),17100
5,Myasthenia gravis,978
5,Salt added to food,1266
5,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],238
5,Complement C1r subcomponent measurement,415
5,Carpal tunnel syndrome,596
5,Jaundice (not of newborn),352
5,Pericardial adipose tissue adjusted for height and weight,17
5,Cholesterol [total cholesterol],10232
5,Arm fat percentage (left),32827
5,Aspartate aminotransferase to alanine aminotransferase ratio,12476
5,Urine 6-bromotryptophan levels in chronic kidney disease,292
5,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) [men],248
5,Serum levels of protein CTRL,15
5,Total body bone mineral density,15733
5,6mm weak meridian (right),11225
5,Macular thickness,6473
5,Serum levels of protein DCN,1667
5,Autoimmune diseases,2144
5,Lymphocyte count,1133
5,Protein levels in obesity [C7],1322
5,Electrocardiogram morphology (amplitude at temporal datapoints) [12 ms],159
5,Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis),201
5,Waist-hip ratio variance,254
5,Protein quantitative trait loci (liver) [ACTN4],8
5,Non-albumin protein levels,16728
5,Menopause (age at onset) [japanese],9340
5,"Hip circumference [EA,women]",10412
5,Skin colour,7098
5,"Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA, men]",1273
5,General factor of neuroticism,1541
5,Brain region volumes [left vessel],313
5,Serum levels of protein POLR1C,15
5,N-acetylphenylalanine levels,45
5,"Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) [EA, men]",254
5,"""Asthma, unspecified (mode) (more control exclusions)""",16365
5,Body mass index (adult),1511
5,Repeated disturbing thoughts of stressful experience in past month,206
5,Irritable mood,2253
5,IgD+ B cell %B cell,10
5,"Nasal/sinus disorder | non-cancer illness code, self-reported",86
5,Mean spheric corpuscular volume,46020
5,Distal/Left-sided colorectal cancer,827
5,Serum levels of protein ATP13A1,994
5,Lung function (FEV1/FVC) variance,923
5,Skin pigmentation traits [Fitzpatrick phototype score],185
5,Electrocardiogram morphology (amplitude at temporal datapoints) [166 ms],86
5,"Ureteric obstruction/hydronephrosis | non-cancer illness code, self-reported",21
5,Ventolin 100micrograms inhaler | treatment/medication code,3126
5,Serum levels of protein CST4,253
5,Pulmonary fibrosis,56
5,Hip minimal joint space width,78
5,White matter microstructure (fractional anisotropy) [Posterior corona radiata ],66
5,Superficial cellulitis and abscess,1035
5,Blood metabolite levels [isovalerylcarnitine],37735
5,Papulosquamous disorders,4651
5,Systolic blood pressure [East Asian],2566
5,"""Pain (limb, back, neck, head abdominally)""",62
5,Serum levels of protein C8A;C8B;C8G,15
5,Hip index,28113
5,White matter microstructure (mean diusivities) [Fornix (cres) / Stria terminalis],1208
5,Metabolite levels [LDL],2671
5,Circulating leptin levels x sex interaction in high cardiovascular risk,265
5,Obstructive sleep apnea trait (average oxyhemoglobin saturation across sleep episode),371
5,Polymyalgia rheumatica,92
5,Polycystic ovary syndrome,11318
5,Corneal resistance factor (right),3354
5,IBD patients in KELA-register,6223
5,Convulsions,1308
5,Disorders of the thyroid gland,1150
5,Serum levels of protein TMEM87B,994
5,Response to paliperidone in schizophrenia (PANSS score) [MLM],46
5,Vasomotor and allergic rhinitis,2854
5,Urinary sodium excretion [EA],2116
5,White matter microstructure (mean diusivities) [Posterior corona radiata ],133
5,Brainstem volume,9050
5,Insulin-like growth factor 1 levels,93020
5,Time spent using computer,29370
5,Serum levels of protein ADAM19,2114
5,Haematocrit percentage,29953
5,Serum levels of protein IFNAR1,15
5,Electrocardiographic traits (multivariate),21971
5,Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis),1826
5,"""Malignant neoplasm of breast, HER2-negative (controls excluding all cancers)""",14023
5,Brown vs. black hair color,1800
5,Electrocardiogram morphology (amplitude at temporal datapoints) [40 ms],332
5,Protein quantitative trait loci (liver) [STAT1],28
5,Protein quantitative trait loci (liver) [PRDX5],35
5,Gut microbiota relative abundance (bacterial taxa) [Actinobacteria],17
5,"Medication use (adrenergics, inhalants)",35377
5,Estimated glomerular filtration rate [EA],4832
5,Serum levels of protein KNG1,994
5,Age at first birth,13438
5,Cholesterol [LDL],2671
5,Cancer of bronchus; lung,2053
5,Other and unspecified disorders of vitreous body,208
5,Other chronic nonalcoholic liver disease,36
5,Atopic asthma,8301
5,Serum levels of protein ETHE1,994
5,Metabolite levels [Phe],994
5,White matter microstructure (axial diusivities) [Body of corpus callosum],559
5,Major depressive disorder vs autism spectrum disorder (ordinary least squares (OLS)),130
5,Gordonibacter abundance in stool,81
5,Serum levels of protein TMOD3,15
5,BMI in non-smokers [men],8576
5,White matter microstructure (mean diusivities) [Average across all tracts],13810
5,White matter microstructure (fractional anisotropy) [Superior longitudinal fasciculus],13810
5,Cerebrospinal fluid biomarker levels [Complement component C7],1254
5,Corneal hysteresis (right),840
5,Serum levels of protein SPINK1,440
5,"""Hypothyroidism, strict autoimmune, 3 medication purchases required""",1150
5,Childhood sunburn occasions,1039
5,Protein quantitative trait loci (liver) [ETFDH],64
5,Essential hypertension (time to event),527
5,Electrocardiogram morphology (amplitude at temporal datapoints) [-6 ms],3219
5,Interleukin-12 subunit B levels,147
5,Plasminogen activator inhibitor 1 measurement,51
5,Electrocardiogram morphology (amplitude at temporal datapoints) [18 ms],491
5,Lung function (FEV1/FVC),321865
5,Brain morphology (MOSTest),91397
5,Hyperlipidemia,5928
5,Serum metabolite levels [homostachydrine*],138
5,Serum levels of protein PTHLH,994
5,Cortical surface area [total],240
5,Urinary metabolite levels in chronic kidney disease [X - 24387],118
5,Smoking initiation (ever regular vs never regular),23509
5,White matter microstructure (fractional anisotropy) [Average across all tracts],13810
5,Hand grip strength (right),42945
5,Mean corpuscular haemoglobin concentration,3923
5,Luteine | treatment/medication code,419
5,Electrocardiogram morphology (amplitude at temporal datapoints) [112 ms],359
5,Protein quantitative trait loci (liver) [HEXA],221
5,Dried fruit intake,106
5,Protein quantitative trait loci (liver) [SERPINA3],20
5,Systemic lupus erythematosus [AA],17
5,Waist-hip index,155630
5,Arthrosis,12215
5,Vitamin D levels,2256
5,Low-grade serous and serous borderline ovarian cancer,262
5,Place of birth in uk - east co-ordinate,244
5,Electrocardiogram morphology (amplitude at temporal datapoints) [162 ms],86
5,"Blood protein levels [C1QTNF9, 6019_12_3]",15
5,Diverticulosis,12876
5,Serum levels of protein CD14,23010
5,Serum levels of protein IL7R,2295
5,Other and unspecified aplastic anaemias,12
5,Lung cancer,13900
5,Cancer of brain,244
5,"Mean arterial pressure x alcohol consumption interaction (2df test) [Asian, EA, Hispanic]",129
5,Blood protein levels [IL-12],147
5,Intelligence,27804
5,Electrocardiogram morphology (amplitude at temporal datapoints) [-14 ms],12532
5,Chromatiales abundance in stool,316
5,"Blood protein levels [C8A C8B C8G, 2429_27_4]",15
5,Vertex-wise cortical surface area,101712
5,Serum levels of protein CFC1,994
5,Fibrinogen levels,12782
5,Waist circumference adjusted for body mass index [EA],36771
5,Anti-Merkel cell polyomavirus IgG seropositivity,9464
5,Bipolar disorder lithium response (categorical) or schizophrenia,49
5,Subcortical volume (min-P),12250
5,Serum levels of protein IL9,17062
5,"Psoriasis | non-cancer illness code, self-reported",2333
5,High density lipoprotein cholesterol levels [EA],445
5,Electrocardiogram morphology (amplitude at temporal datapoints) [212 ms],1592
5,Carbimazole | treatment/medication code,459
5,Urinary metabolites [3-Aminoisobutyrate concentration],118
5,Body mass index in physically active individuals,3531
5,Femur bone mineral density x serum urate levels interaction [female],567
5,In situ neoplasms,59
5,Serum metabolite levels (CMS) [M_HDL_L],24
5,Chronic obstructive pulmonary disease x current smoker interaction (main effect),4751
5,acne vulgaris,44446
5,Blood metabolite levels [citrate],869
5,Electrocardiogram morphology (amplitude at temporal datapoints) [312 ms],776
5,P wave duration [EA],754
5,Hypertension [East Asian],223
5,IgG digalactosylation phenotypes (multivariate analysis),3102
5,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)",106078
5,3mm asymmetry angle (right),5225
5,Left atrial passive emptying fraction,1414
5,Gut microbiota relative abundance (bacterial taxa) [Clostridium_IV],735
5,Gut microbiota (bacterial taxa) [Bifidobacteriaceae],144
5,Electrocardiogram morphology (amplitude at temporal datapoints) [76 ms],553
5,Hodgkin's lymphoma [EBV-negative cHL],202
5,"Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA, women]",245
5,Educational attainment,3119
5,Vitamin B12 levels,1735
5,"Waist circumference [EA, women]",10190
5,Serum levels of protein LGMN,994
5,Obsessive compulsive disorder (ocd) | mental health problems ever diagnosed by a professional,621
5,IgD+ CD38+ B cell Absolute Count,500
5,Sero-negative rheumatoid arthritis,163
5,Cortical surface area [Caudal Anterior Cingulate],73
5,Atrial fibrillation [EA],4721
5,White matter microstructure (fractional anisotropy) [Splenium of corpus callosum],14646
5,Isovalerate (i5:0) levels,17170
5,Coffee intake,1086
5,"Gout | non-cancer illness code, self-reported",4694
5,Chronic obstructive pulmonary disease or resting heart rate (pleiotropy),424
5,Protein quantitative trait loci (liver) [CTSA],221
5,Electrocardiogram morphology (amplitude at temporal datapoints) [-98 ms],611
5,Systolic blood pressure (cigarette smoking interaction),124
5,Platelet count,688469
5,Basophil percentage of white cells,21966
5,Youthful appearance (self-reported),41466
5,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],3556
5,Gestational diabetes only,941
5,Hodgkin's lymphoma,442
5,Alcohol consumption x experiences in childhood (felt loved by family member) interaction,45
5,Red cell distribution width,635630
5,Asthma (more control exclusions),18423
5,Ascending aorta minimum area,6282
5,Urinary electrolytes (magnesium/calcium ratio),2410
5,Other disorders of bladder,2618
5,"Psoriasis [Chinese, conditional on rs1990760]",223
5,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [men],39
5,Nasobec aqueous 50micrograms nasal spray | treatment/medication code,108
5,Ulcerative colitis,76615
5,3mm weak meridian (left),12864
5,Serum levels of protein PRSS8,5318
5,Had menopause,9282
5,Serum metabolite levels [ergothioneine],45160
5,Hashimoto thyroiditis,506
5,Serum levels of protein SERPINA5,994
5,Primary biliary cholangitis,18876
5,Age started wearing glasses or contact lenses,34659
5,LDL cholesterol levels,18663
5,Diseases of hair and hair follicles,2588
5,IgG glycosylation [IGP3],107
5,Suicide attempts [model 1],1138
5,Leprosy,429
5,Alzheimer's disease,11717
5,Neutrophil percentage of granulocytes,73618
5,Sex hormone-binding globulin levels adjusted for BMI,106976
5,"Diastolic blood pressure, automated reading",87923
5,Body fat percentage [male],1001
5,"Nasal polyps | non-cancer illness code, self-reported",38
5,"Blood protein levels [IL6ST, 2620_4_2]",2535
5,Malignant neoplasm of bladder,2618
5,Corneal resistance factor (left),5461
5,Circulating fibroblast growth factor 23 levels [EA],4957
5,White matter microstructure (radial diusivities) [Superior fronto-occipital fasciculus],133
5,Body mass index in childhood asthma [recessive model],56
5,Multiple sclerosis,50701
5,Non-small cell lung cancer [East Asian],2741
5,Sociability score,715
5,Tuberculosis susceptibility in HIV infection,193
5,"None of the above | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",33083
5,Waist circumference [East Asian women],1642
5,Valvular operations,5
5,Age at menopause (last menstrual period),16467
5,Leg fat mass (right),36860
5,Smoking initiation,1277
5,Physical activity (Total log acceleration 6pm-8pm),374
5,Electrocardiogram morphology (amplitude at temporal datapoints) [222 ms],1506
5,Carotid intima media thickness (mean) [women],132
5,"Cervical spondylosis | non-cancer illness code, self-reported",114
5,Waist circumference adjusted for BMI (adjusted for smoking behaviour),27897
5,Osteoarthritis of the hand,959
5,Waist circumference [EA],10190
5,Electrocardiogram morphology (amplitude at temporal datapoints) [-106 ms],611
5,Thyroid cancer,2502
5,Massiliomicrobiota sp002160815 abundance in stool,171
5,L-arginine levels [random effects model],994
5,Glioma (high-grade),168
5,"Heel bone mineral density (bmd) t-score, automated (right)",8065
5,Metabolite levels [Cer d16:1/24:0],1290
5,Use of sun/uv protection,482
5,FEV1,95758
5,Blood metabolite levels [homostachydrine],37735
5,Cigarettes smoked per day (MTAG),2797
5,Cancer of bladder,2568
5,BMI (adjusted for smoking behaviour),8752
5,"Eye color [EA, discovery]",4683
5,Body mass index (bmi),94943
5,Multiple myeloma and monoclonal gammopathy,3169
5,Uterine prolapse,246
5,Cerebrospinal fluid biomarker levels [Platelet-derived growth factor receptor beta],694
5,Superficial frostbite,105
5,Interleukin-8 levels,9
5,Other benign neoplasms of uterus,19
5,"Smoking initiation (ever regular vs never regular) [Conditioned on chr5:166778503, chr5:165096435, chr5:167614971, chr5:166989513]",15
5,Inverse distance to the nearest major road,4
5,Neutrophil-to-lymphocyte ratio,21799
5,Serum levels of protein BTNL8,13690
5,Diabetes mellitus in pregnancy,778
5,Waist-hip ratio and HDL-C (pairwise),272
5,Takayasu arteritis,480
5,"Blood metabolite levels [X-11445--5-alpha-pregnan-3beta,20alpha-disulfate]",511
5,Response to antipsychotic treatment in schizophrenia,924
5,Cortical surface area [Posterior Cingulate],289
5,Global electrical heterogeneity phenotypes [SVG azimuth],99
5,Protein quantitative trait loci (liver) [VARS],221
5,Psoriatic arthritis,1963
5,Electrocardiogram morphology (amplitude at temporal datapoints) [32 ms],332
5,Arthropathic psoriasis,805
5,Liver enzyme levels (alanine transaminase),22901
5,Asthma (mode),3339
5,hemolysis of donated blood (oxidative),1538
5,Hearing aid user,989
5,Electrocardiogram morphology (amplitude at temporal datapoints) [226 ms],1506
5,Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive),83
5,Urinary sodium excretion,510
5,Classic bladder exstrophy,287
5,Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event),176
5,Serum levels of protein STX6,15
5,Bipolar disorder (MTAG),12344
5,Nap during day,63594
5,"""Ankylosing spondylitis, strict definition""",9373
5,Gut bacterial pathway abundance (PWY.7209..superpathway.of.pyrimidine.ribonucleosides.degradation),10478
5,White matter integrity (fractional anisotropy) [Conditioned on rs67827860],193
5,White matter microstructure (mode of anisotropy) [Cingulate gyrus],289
5,Hypothyroidism (congenital or acquired),1150
5,Breast cancer [East Asian],389
5,Anxiety,252
5,Protein quantitative trait loci (liver) [TKFC],5
5,Highest math class taken (MTAG) [MTAG],211716
5,Neutrophill count,182340
5,Triglyceride levels [Trans-ethnic initial],902
5,Oral cavity cancer,200
5,"Pulse pressure x alcohol consumption interaction (2df test) [Asian, EA]",13
5,"Blood protein levels [POLR1C, 12939_1_3]",15
5,Vitamin C levels,6234
5,Albumin-globulin ratio,11703
5,Lateral thalamic nuclei volume,135
5,Hypertension,119501
5,Itch intensity from mosquito bite adjusted by bite size [men],108154
5,"Atopic dermatitis [EA, fixed effects]",9827
5,Serum levels of protein TGFBI,1748
5,Serum levels of protein ITIH4,994
5,Serous borderline ovarian cancer,262
5,Electrocardiogram morphology (amplitude at temporal datapoints) [176 ms],86
5,Other insterstitial pulmonary diseases,56
5,"Blood protein levels [FCER1A, 9254_18_3]",15
5,Body fat percentage,83177
5,White matter microstructure (mode of anisotropy) [Posterior limb of internal capsule],17296
5,Psoriatic arthropathies,232
5,Malignant neoplasm of pancreas,2572
5,"Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction) [Baseline, amyloid positive]",345
5,Pollinosis,1098
5,"""Atopic  dermatitis, strict definition""",294
5,Past tobacco smoking,228
5,Height [Conditioned on rs1173727],161
5,Protein quantitative trait loci (liver) [SDHA],64
5,Adopted as a child,57
5,Connective tissue disorder,6
5,Estimated glomerular filtration rate,164538
5,CD62L- monocyte Absolute Count,9647
5,Liver enzyme levels (gamma-glutamyl transferase),9246
5,Cystatin C levels,192426
5,White matter microstructure (radial diusivities) [Splenium of corpus callosum],14606
5,Keratinocyte cancer (MTAG),3888
5,T-Cell Immunoglobulin and Mucin domain 1 levels,4574
5,Fracture of forearm or wrist,10334
5,Electrocardiogram morphology (amplitude at temporal datapoints) [-10 ms],1949
5,White matter hyperintensity volume,647
5,Body fat distribution (arm fat ratio) [females],4677
5,Skin pigmentation traits [Skin color],185
5,Parapsoriasis,11
5,Longest period of depression,7
5,Giant cell arteritis,6171
5,Mean time to correctly identify matches,11125
5,Ascending aorta maximum area,2568
5,3-hydroxy-1-methylpropylmercapturic acid levels in smokers [Latino],89
5,Protein quantitative trait loci (liver) [HBD],504
5,Urinary metabolite levels in chronic kidney disease [X - 12096],118
5,Electrocardiogram morphology (amplitude at temporal datapoints) [190 ms],86
5,Electrocardiogram morphology (amplitude at temporal datapoints) [-22 ms],360
5,DNA methylation Hannum age acceleration,220
5,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],7340
5,Follistatin levels,531
5,Serum levels of protein HTN3,994
5,Cerebrospinal fluid biomarker levels [Arylsulfatase B],929
5,Savoury snack consumers,242
5,Coronary arterial lesions in patients with Kawasaki disease,50
5,Retinal nerve fibre layer (RNFL) thickness,8
5,Glycated hemoglobin levels,29629
5,"Heel broadband ultrasound attenuation, direct entry",19389
5,"""Malignant neoplasm of breast, HER-positive (controls excluding all cancers)""",14066
5,Smoking cessation,1636
5,White matter microstructure (mean diusivities) [Body of corpus callosum],133
5,Lung function (FEV1) [African],27
5,Rhodococcus abundance in stool,2
5,Daytime dozing / sleeping (narcolepsy),4894
5,"Blood protein levels [CRHBP, 6039_24_3]",3147
5,3mm weak meridian (right),13010
5,Meat-related diet,3902
5,Hypercholesterolemia,3879
5,Cardiometabolic and hematological traits [PLT],1984
5,Serum levels of protein FZD10,1077
5,Cardia gastric cancer,1286
5,Losartan potassium+hydrochlorothiazide 50mg/12.5mg tablet | treatment/medication code,59
5,Lung cancer in never smokers,2583
5,Invasive breast cancer [mixed effect],161
5,Dorsopathies,16
5,HDL cholesterol levels [Trans-ethnic initial],1448
5,Eosinophilic esophagitis (pediatric),3660
5,White | bread type,506
5,Carotid intima media thickness,1315
5,Total body bone mineral density (age 45-60),232
5,Protein quantitative trait loci (liver) [HSPA8],221
5,Glioblastoma (age-stratified) [Median age-at-diagnosis],124
5,Urinary calculus,4646
5,Hand grip strength,15523
5,White matter microstructure (fractional anisotropy) [Retrolenticular part of internal capsule],14251
5,Serum levels of protein CD63,994
5,Lifetime number of sexual partners,393
5,Protein quantitative trait loci (liver) [RSU1],16
5,Menopause (age at onset),24782
5,Positive affect,12840
5,Waist circumference adjusted for body mass index,181321
5,Comparative body size at age 10,13792
5,Fasting blood glucose,1415
5,"Ground coffee (include espresso, filter etc) | coffee type",13715
5,Protein quantitative trait loci (liver) [TTN],723
5,Electrocardiogram morphology (amplitude at temporal datapoints) [324 ms],776
5,Rheumatoid arthritis [EA],16214
5,Arm predicted mass (right),135118
5,Obesity [Overweight],10412
5,C-reactive protein levels or total cholesterol levels (pleiotropy),346
5,Electrocardiogram morphology (amplitude at temporal datapoints) [180 ms],86
5,Kidney stones,17621
5,Heel bone mineral density T score,136662
5,White matter microstructure (mean diusivities) [Splenium of corpus callosum],13893
5,Experiencing mood swings,2302
5,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction) [men],119
5,Red blood cell count,314605
5,Prostate cancer,25144
5,Blood glucose levels,1944
5,Mood swings,905
5,Body mass index and fasting glucose (pairwise),718
5,Hallux valgus (acquired),202
5,Electrocardiogram morphology (amplitude at temporal datapoints) [34 ms],1919
5,Percent mammographic density,494
5,Heel bone mineral density x serum urate levels interaction [female],164
5,Sensitivity to environmental stress and adversity,176
5,"Blood protein levels [ZAP70, 4476_22_2]",15
5,Facial morphology (segment 6),430
5,Total body bone mineral density [European],3136
5,White matter microstructure (fractional anisotropy) [Posterior limb of internal capsule],13677
5,High-grade serous ovarian cancer,262
5,Fibrinogen measurement,4366
5,Serum 25-Hydroxyvitamin D levels [AA],538
5,Brain region volumes [cerebellar vermal lobules VI VII],39
5,Hematocrit,168479
5,Cardiac arrhytmias,5794
5,"Waist circumference adjusted for body mass index [EA,women]",4634
5,Psoriasis [conditional on rs7709212],353
5,Osteoarthritis (with total hip replacement),57
5,Waist circumference adjusted for BMI in active individuals [women],145
5,Recombination measurement (females) [Fraction of recombinations in hotspots],88
5,Blood metabolite levels [tryptophan betaine ],2246
5,Carotid plaque maximum area [men],1305
5,Cutaneous psoriasis,1567
5,Serum levels of protein OSM,15
5,Biological sex,45873
5,Blood metabolite levels [hexanoylcarnitine],30652
5,Lung adenocarcinoma,3878
5,Body fat distribution (trunk fat ratio) [females],2920
5,Alcohol use disorder (consumption score),78
5,Electrocardiogram morphology (amplitude at temporal datapoints) [322 ms],776
5,Ergothioneine levels,106
5,Ankylosing spondylitis,59665
5,"Heel quantitative ultrasound index (qui), direct entry (right)",8065
5,Lung adenocarcinoma [East Asian],2741
5,Caffeine consumption from coffee,1086
5,Hippocampal tail volume,545
5,Protein quantitative trait loci (liver) [S100A6],16
5,Mean corpuscular volume,316788
5,Mean sphered cell volume,51839
5,N-acetylleucine levels,2221
5,Asthma (only as main-diagnosis) (more control exclusions),18189
5,Ease of getting up in the morning,5727
5,Serum 25-Hydroxyvitamin D levels,15637
5,Sensitivity / hurt feelings,2948
5,"Urinary metabolites [N,N-dimethylglycine/betaine]",1256
5,Pancreatic cancer,7774
5,Height [Conditioned on rs12153391],460
5,Cytokine network levels (multivariate analysis),508
5,Light-intensity physical activity duration,52
5,Serum levels of protein LRRC25,15
5,"Allergy, hypersensitivity or anaphylaxis",6053
5,Arm fat mass (right),53108
5,Height [EA],2760
5,Proinsulin levels,726
5,"Seen a psychiatrist for nerves, anxiety, tension or depression",2735
5,Adult-onset Still disease,92
5,Worry,38813
5,Pulmonary function [FEV1/FVC],3698
5,Fat-free mass [female],32982
5,Cortical surface area [Transverse Temporal],22488
5,Lung cancer | illnesses of adopted father,665
5,Mean arterial pressure [Japanese],254
5,Disorders of vitreous body and globe,208
5,Corneal hysteresis,2865
5,White matter microstructure (fractional anisotropy) [Uncinate fasciculus],199
5,White matter microstructure (radial diusivities) [Anterior corona radiata],14005
5,Blood protein levels [Complement component C7],1292
5,Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia,1086
5,Protein quantitative trait loci (liver) [BPNT1],12
5,Social science traits (pleiotropy) (HIPO component 1),14
5,Atopic dermatitis,19802
5,Ankle spacing width,70761
5,"Intra-ocular pressure, goldmann-correlated (right)",8819
5,Facial morphology (segment 5),2888
5,CD127 on CD4+ T cell,1151
5,Autoimmune traits,23829
5,C-reactive protein levels,151511
5,Serum levels of protein PDLIM4,10437
5,Testicular germ cell cancer,1498
5,Facial pigmentation measurement (polar light),738
5,Skin pigmentation,779
5,Radiation-related disorders of the skin and subcutaneous tissue,1888
5,Protein quantitative trait loci (liver) [PSME1],11
5,Protein quantitative trait loci (liver) [A2M],14
5,Blood metabolite levels [3-dehydrocarnitine],32601
5,Eosinophill percentage,80628
5,"None of the above | medication for cholesterol, blood pressure or diabetes",3653
5,Hair morphology traits [Hair color phototype score],185
5,Triglycerides [EA],844
5,Acohol-induced acute pancreatitis,358
5,Anorexia nervosa,74
5,Intelligence (MTAG),41058
5,Blood protein levels [Interleukin-7 receptor subunit alpha],881
5,Pregnancy hypertension,137
5,"Blood protein levels [C5 C6, 4482_66_2]",15
5,Trunk fat percentage,75672
5,Protein quantitative trait loci (liver) [DIABLO],47
5,Electrocardiogram morphology (amplitude at temporal datapoints) [-108 ms],611
5,Multisite chronic pain,1498
5,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],3235
5,Electrocardiogram morphology (amplitude at temporal datapoints) [52 ms],553
5,Low tan response,863
5,Attention deficit hyperactivity disorder [males],192
5,Prozac 20mg capsule | treatment/medication code,342
5,Protein quantitative trait loci (liver) [HIST1H1C],98
5,"Hypothyroidism/myxoedema | non-cancer illness code, self-reported",13500
5,Protein quantitative trait loci (liver) [VDAC1],2151
5,Loneliness,1577
5,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) [women],2159
5,Metabolite levels (lipoprotein measures) [Total cholesterol in small LDL],2278
5,Electrocardiogram morphology (amplitude at temporal datapoints) [310 ms],776
5,Idiopathic pulmonary fibrosis,895
5,White matter microstructure (fractional anisotropy) [Sagittal stratum],930
5,Serum metabolite levels [homoarginine],152
5,Serum dimethylarginine levels (asymmetric/symetric ratio),118
5,Sitting height,277342
5,Extremely high intelligence,7298
5,"Melanomas of skin, dx or hx",2884
5,Serum levels of protein DPEP2,994
5,"Blood pressure medication | medication for cholesterol, blood pressure or diabetes",3648
5,Risk-taking tendency (4-domain principal component model),1226
5,Bipolar disorder vs ADHD (ordinary least squares (OLS)),693
5,Male puberty timing (late vs. average onset facial hair),12
5,Protein quantitative trait loci (liver) [TXNL1],2
5,Household income,19304
5,Protein quantitative trait loci (liver) [CNN2],1694
5,Waist circumference adjusted for body mass index [men],1482
5,Manlignant and unknown neoplasms of brain and nervous system,268
5,Circulating leptin levels or type 2 diabetes,1673
5,Myocardial fractal dimension (slice 7),332
5,"Hayfever/allergic rhinitis | non-cancer illness code, self-reported",6253
5,Urinary metabolite levels in chronic kidney disease [X - 24348],452
5,Yes | breathing problems improved/stopped away from workplace or on holiday,245
5,Response to antipsychotic treatment [Effect of Quetiapine on PGI],131
5,Facial morphology (segment 2),278
5,Attention deficit hyperactivity disorder (MTAG),137
5,Basal cell carcinoma,17382
5,Chronic obstructive pulmonary disease in non-current smokers,4751
5,Serum metabolite concentrations in chronic kidney disease [3-aminoisobutyrate],505
5,Itch intensity from mosquito bite adjusted by bite size,64810
5,Malignant neoplasm of ovary,2
5,Cutaneous squamous cell carcinoma,780
5,Cholesterol levels,1168
5,Psoriatic arthropathy,788
5,Colon polyp,259
5,Neurological blood protein biomarker levels [CDH6],32
5,Iritis,11187
5,Serum phosphate levels,65081
5,Job involves heavy manual or physical work,2227
5,Nervous feelings,2146
5,White matter microstructure (mean diusivities) [Uncinate fasciculus],133
5,Ascending aorta distensibility,90
5,"""Other (seronegative) rheumatoid arthritis, wide""",92
5,Eosinophil percentage of granulocytes,60872
5,Cutaneous melanoma or hair colour,4186
5,Brain region volumes [left precentral],45
5,"Blood protein levels [SKIL, 14670_1_3]",15
5,Serum levels of protein KLK12,15
5,Neutrophil count,1097923
5,Refractive error,77647
5,Bipolar I disorder,24613
5,Serum levels of protein LECT2,1989
5,Firmicutes E abundance in stool,285
5,Heart rate increase in response to exercise,98
5,Acne (severe),5225
5,Cortical surface area [Middle Temporal],3827
5,High light scatter reticulocyte percentage,8699
5,Hypothyroidism and >3 levothyroxin purchases,1150
5,Hippocampal tail volume (corrected for total hippocampal volume),1091
5,Diastolic blood pressure [EA],2621
5,Freckles,929
5,Gut microbiota (functional units) [GO:0003697|MF|06|single-stranded DNA binding],443
5,Facial morphology (segment 28),568
5,Ascorbate (vitamin c) levels,639
5,Adventurousness,31738
5,Salicylate levels,1974
5,Serum metabolite levels [2-methylbutyrylcarnitine (C5],39327
5,Neuroticism score,1953
5,Electrocardiogram morphology (amplitude at temporal datapoints) [22 ms],491
5,Eosinophilic esophagitis,15422
5,Serum metabolite levels (CMS) [HDL2_C],7660
5,Type 2 diabetes [conditional],3770
5,Electrocardiogram morphology (amplitude at temporal datapoints) [28 ms],605
5,Versican core protein levels,342
5,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [3-aminoisobutyrate, 5-aminovalerate, X-12096, X-12097, X-12117, X-24518]",118
5,Protein quantitative trait loci (liver) [MYO1B],41
5,Serum levels of protein CA4,15
5,Cortical thickness [Lateral occipital],3473
5,White matter microstructure (axial diusivities) [Posterior thalamic radiation],15039
5,Chronic obstructive pulmonary disease or high blood pressure (pleiotropy),890
5,Systolic blood pressure change trajectory [Trajectory class 2],66
5,White matter microstructure (fractional anisotropy) [Body of corpus callosum],53274
5,Dermatitis and eczema,4718
5,HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes [AA],4182
5,Ever thought that life not worth living,284
5,Narrowest width of the femoral neck,284
5,6mm regularity index (left),4
5,Photic sneeze reflex,295
5,Sex hormone-binding globulin levels,180777
5,Urea levels,31630
5,Osteoarthritis of the hip or knee,547
5,Age asthma diagnosed,7063
5,Aortic root size,240
5,Crohn's disease,311406
5,Electrocardiogram morphology (amplitude at temporal datapoints) [-100 ms],611
5,Calculus of kidney and ureter,4646
5,White matter microstructure (axial diusivities) [Retrolenticular part of internal capsule],498
5,Uterine fibroids and heavy menstrual bleeding,119
5,Protein quantitative trait loci [BGH3],2184
5,Crohn's disease vs ulcerative colitis (ordinary least squares (OLS)),3296
5,Serum levels of protein SIRT5,994
5,Varicose veins of lower extremity,1411
5,Mycoses,21
5,Back pain,2
5,Reticulocyte count,167205
5,Impedance of whole body,152251
5,Primary biliary cirrhosis,1777
5,Psoriasis [EA],666
5,Pulse pressure [East Asian],554
5,Protein quantitative trait loci (liver) [AGXT],60
5,Platelet distribution width,127756
5,Asthma [conditional],7311
5,Serum creatinine levels,19063
5,Protein quantitative trait loci (liver) [HSPA9],221
5,vWF levels,4320
5,"Blood pressure medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",37267
5,Ankle spacing width (left),49816
5,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [women],1273
5,Insomnia [females],1705
5,Soluble CD14 levels,692
5,Factor VIII levels [EA],4158
5,Arm fat-free mass (left),105189
5,"Allergic disease (asthma, hay fever and/or eczema) (age of onset)",9061
5,Benign prostatic hyperplasia and lower urinary tract symptoms,3578
5,"Number of decayed, missing and filled tooth surfaces or use of dentures",463
5,Protein quantitative trait loci (liver) [MPO],26
5,Myocardial fractal dimension (slice 4),448
5,Serum metabolite levels [isovalerylcarnitine],30652
5,Adult body size,34399
5,Osteoporosis,2682
5,"""Hypothyroidism, levothyroxin purchases""",1150
5,Thyroid hormone levels [TSH - Females],496
5,Tanning,383
5,Corneal hysteresis (left),835
5,Never smoked | tobacco smoking,158
5,Red blood cell (erythrocyte) count,42474
5,Lung function (FEV1/FVC) [conditioned on rs1990950],3245
5,Serum levels of protein CCK,1009
5,Subclinical trait of interstitial lung disease (basilar peel-core ratio of high attentuation areas on CT scan) [EA],342
5,KELA_REIMBURSEMENT_202,92
5,Serum albumin levels,70822
5,White matter microstructure (mean diusivities) [Anterior corona radiata],14005
5,"""Hypothyroidism, strict autoimmune""",1150
5,Pure hypercholesterolaemia,2398
5,Coffee consumption,1086
5,Metabolite levels [SM 24:1],871
5,Diabetes | illnesses of adopted mother,118
5,Comparative height size at age 10,154335
5,Leg fat-free mass (left),91778
5,Body mass index in physically active individuals [EA],9105
5,"Diabetes | non-cancer illness code, self-reported",1275
5,Hair morphology traits [Hair color],185
5,Protein quantitative trait loci (liver) [UGT2B15],98
5,Gut microbiota (bacterial taxa) [Bifidobacterium],144
5,Fasting insulin adjusted for BMI,1323
5,Thyroid hormone levels [TSH - Males],496
5,High-sensitivity cardiac troponin I concentration,994
5,Myopia (pathological),2477
5,"Urinary metabolites (H-NMR features) [3.0925, Aminoisobutyrate]",136
5,Urinary metabolite levels in chronic kidney disease [5-aminovalerate],118
5,Metabolite levels [indoxyl sulfate],30
5,Serum levels of protein FOLH1,15
5,Gamma glutamyl transferase levels,104359
5,Hypertensive diseases,25307
5,Total protein levels x insomnia interaction,1233
5,Electrocardiogram morphology (amplitude at temporal datapoints) [-24 ms],360
5,O levels/gcses or equivalent | qualifications,2172
5,Wholemeal or wholegrain | bread type,177
5,Bone mineral density (total hip),231
5,Hydroxychloroquine | treatment/medication code,532
5,Serum levels of protein GCNT4,15
5,Red vs. brown/black hair color,70
5,Skin pigmentation traits [Skin sensitivity to sun (high-medium to low-medium],185
5,Alcohol dependence (age at onset),12
5,Gastric cancer,9002
5,HDL cholesterol levels,118743
5,Colorectal cancer [EA],610
5,Systemic lupus erythematosus [Hispanic],289
5,Heart rate response to exercise [females],610
5,"Number of decayed, missing and filled tooth surfaces",170
5,Non-glioblastoma glioma,124
5,Protein quantitative trait loci (liver) [TPM4],394
5,"Blood protein levels [RAB17, 11118_107_3]",15
5,Diffuse plaques (SNP x SNP interaction),26612
5,Chronic obstructive pulmonary disease x ever smoker interaction (main effect),3019
5,Electrocardiogram morphology (amplitude at temporal datapoints) [178 ms],86
5,Diastolic blood pressure [East Asian],1280
5,Friendships satisfaction,92
5,Alzheimer's disease (SNP x SNP interaction) [men],40
5,Walk | transport type for commuting to job workplace,241
5,Spondylopathies,1
5,Age at first sexual intercourse,23552
5,"Ankylosing spondylitis [conditioned on rs30187 & rs2910686, EA]",3974
5,Blood trace element (Se levels) [Conditioned on rs921943],513
5,Body mass index (physical activity interaction) [EA],169
5,"Blood protein levels [CDK5 CDK5R1, 3358_51_2]",15
5,Prostate-specific antigen levels,2970
5,CD127 on CD45RA- CD4 not regulatory T cell,1151
5,Serum metabolite levels [tryptophan betaine],2630
5,Autoimmune traits (pleiotropy),318
5,Protein quantitative trait loci (liver) [COL18A1],19
5,Diverticulosis and diverticulitis,12808
5,Educational attainment (years of education) [conditional-joint],31633
5,Systolic blood pressure x educational attainment (some college) interaction (2df) [EA],345
5,Multiple myeloma,12182
5,IgE levels,4230
5,"Light brown | hair colour (natural, before greying)",1107
5,Methylmalonate (mma) levels,1580
5,Serum levels of protein ANP32B,994
5,Serum levels of protein CDH15,994
5,White matter microstructure (radial diusivities) [Posterior corona radiata ],133
5,Glaucoma (primary open-angle),6364
5,Worrier / anxious feelings,69417
5,Serum levels of protein CRHBP,3221
5,Electrocardiogram morphology (amplitude at temporal datapoints) [136 ms],86
5,Hypertrophic cardiomyopathy,10971
5,Electrocardiogram morphology (amplitude at temporal datapoints) [-20 ms],11802
5,Serum uric acid levels [EA],574
5,Atopic dermatitis [random effects],1387
5,Chronic lymphocytic leukemia or systemic lupus erythematosus,124
5,"LDL cholesterol levels [Asian initial, BMI unadjusted]",1840
5,"Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA, women]",234
5,Clarityn 10mg tablet | treatment/medication code,65
5,Cortical volume [Caudal anterior cingulate],90
5,"Blood protein levels [SPINK5, 8028_22_3]",7276
5,Breast cancer | illnesses of mother,550
5,"Blood protein levels [IL7R, 5089_11_3]",2295
5,Chronic lower respiratory diseases,1692
5,Hair morphology traits [Hair color (brown],185
5,Electrocardiogram morphology (amplitude at temporal datapoints) [186 ms],86
5,Serum levels of protein FRZB,15
5,Seropositive rheumatoid arthritis,92
5,"Cholesterol, total",18447
5,Electrocardiogram morphology (amplitude at temporal datapoints) [2 ms],1428
5,6mm strong meridian (left),11732
5,Immunological or systemic disorder,6111
5,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),3235
5,Leg fat-free mass (right),97798
5,Protein quantitative trait loci [ARTS1],7713
5,Allergic sensitization,1456
5,Bendroflumethiazide | treatment/medication code,1422
5,Electrocardiogram morphology (amplitude at temporal datapoints) [298 ms],776
5,Alcohol consumption,288
5,"Blood protein levels [TNFRSF8, 2605_49_2]",15
5,Hip circumference adjusted for BMI [EA],731
5,White matter microstructure (axial diusivities) [Superior corona radiata],216
5,QRS duration [European],99
5,Haemorrhoidal disease,18813
5,Subjective well-being (MTAG),1109
5,Sleep (1/3-day periodicity),601
5,"""Cluster headache, wide""",56
5,Ankle-brachial index [Puerto Rican],14265
5,Body size at age 10,19413
5,Nasal polyp,26273
5,3-hydroxy-1-methylpropylmercapturic acid levels in smokers [AA],32
5,Brain region volumes [right inferior temporal],13
5,Mental health study participation (completed survey),2460
5,Hands-free device/speakerphone use with mobile phone in last 3 month,102
5,Depressed affect,1493
5,"Pulse pressure x alcohol consumption interaction (2df test) [AA, EA]",254
5,Blood protein levels [Platelet-derived growth factor receptor beta],607
5,Protein quantitative trait loci (liver) [CTSC],221
5,Nose length [Uyghur],32
5,malignant neoplasm of male genital organs (controls excluding all cancers),237
5,Benign neoplasms,137
5,Plasma factor VII activating protease levels,184
5,White blood cell count,1442889
5,Serum levels of protein F9,1988
5,Systemic lupus erythematosus [EA],4573
5,Protein quantitative trait loci (liver) [ECI2],504
5,White matter microstructure (radial diusivities) [External capsule ],133
5,Serum levels of protein C1QTNF9,15
5,Leg predicted mass (left),136153
5,Interleukin-18 levels,2454
5,Morningness,12249
5,Glomerular filtration rate [Japanese],3744
5,LDL cholesterol levels x long total sleep time interaction (2df test),2701
5,Glycated haemoglobin HbA1c levels adjusted for BMI,254
5,Current tobacco smoking,110
5,"""Ulcer of lower limb, not elsewhere classified""",161
5,Glycemic traits (pregnancy) [FPG],718
5,Glioblastoma [females],124
5,Resting heart rate,22677
5,"Other professional qualifications eg: nursing, teaching | qualifications",4140
5,Acceptance of an invitation to participate in a mental health questionnaire,3639
5,Nonatopic asthma,6816
5,Mortality in heart failure,1187
5,IgA levels,3288
5,Fed-up feelings,1844
5,"Blood protein levels [C9, 3060_43_2]",398
5,Urate levels,338222
5,Hemoglobin A1c levels,80975
5,Lipid traits [TC],2374
5,Hepatitis,159
5,"Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)",9061
5,"Blood protein levels [CD14, 8969_49_3]",23109
5,Hay fever and/or eczema,24623
5,Serum metabolite levels [dimethylglycine],2786
5,Blood and toenail selenium levels,1424
5,Electrocardiogram morphology (amplitude at temporal datapoints) [48 ms],332
5,White matter microstructure (radial diusivities) [Uncinate fasciculus],133
5,Bendrofluazide | treatment/medication code,190
5,Paroxysmal tachycardia,363
5,Bisphosphonate-associated atypical femoral fracture,2
5,"Blood protein levels [EA, Endoplasmic reticulum aminopeptidase 1]",21569
5,"Urinary metabolites (H-NMR features) [3.0975, Aminoisobutyrate]",118
5,Electrocardiogram morphology (amplitude at temporal datapoints) [200 ms],1592
5,Lung disease severity in cystic fibrosis,13171
5,Kidney Injury Molecule levels,1398
5,Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in secretors,38
5,Fasting insulin,958
5,Fasting insulin (dietary factor interaction) [Carbohydrate],604
5,"Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) [AA, men]",248
5,Stroke,184
5,Electrocardiogram morphology (amplitude at temporal datapoints) [172 ms],86
5,Ketonuria,6046
5,Forns index in high alcohol intake,2751
5,Medication use (agents acting on the renin-angiotensin system),40411
5,Nonsyndromic cleft lip with cleft palate,339
5,"None of the above | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",279
5,White matter microstructure (axial diusivities) [Genu of corpus callosum],133
5,Blood protein levels [Transforming growth factor-beta-induced protein ig-h3],536
5,"Smoking initiation (ever regular vs never regular) [Conditioned on chr5:106455988, chr5:106825618]",573
5,Gestational diabetes (for exclusion),726
5,Brain region volumes [left rostral anterior cingulate],885
5,Eye color traits [Eye color phototype score],185
5,White matter microstructure (mean diusivities) [Anterior limb of internal capsule],129
5,Serum levels of protein FLT4,111
5,White matter microstructure (fractional anisotropy) [Anterior corona radiata],133
5,Spondylosis,15
5,6mm weak meridian (left),11529
5,Pattern 2 | hair/balding pattern,667
5,Electrocardiogram morphology (amplitude at temporal datapoints) [290 ms],776
5,Electrocardiogram morphology (amplitude at temporal datapoints) [196 ms],86
5,Serum levels of protein PAM,57991
5,Electrocardiogram morphology (amplitude at temporal datapoints) [206 ms],1592
5,Hot drink temperature,910
5,Otomize ear spray | treatment/medication code,88
5,Age-related disease endophenotypes,2805
5,Huntington's disease progression,41197
5,Chronotype,17677
5,Waist-to-hip ratio adjusted for body mass index,5565
5,Heart rate response to exercise [males],610
5,Mitochondrial heteroplasmy measurement,1526
5,Iron deficiency anemia,85
5,Neuritic plaques (SNP x SNP interaction),360
5,Gut microbiota presence (genus Coprococcus1 id.11301),123
5,IgG glycosylation [IGP13],107
5,Cognitive aspects of educational attainment,111415
5,Urinary metabolite levels in chronic kidney disease [X - 24796],136
5,Chronic lymphocytic leukemia,138
5,Protein quantitative trait loci (liver) [SEPT7],16
5,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),7340
5,Irritability,2296
5,Gout,10060
5,Triglyceride levels in current drinkers,7340
5,Central corneal thickness [conditional],1399
5,Allergic asthma (mode),2426
5,1-stearoyl-2-arachidonoyl-gpc (18:0/20:4) levels,2610
5,Alzheimer's disease (cognitive decline),2212
5,Psoriasis [Chinese],223
5,Immune response to smallpox vaccine (IL-6) [AA],90
5,Feeling tense,75829
5,Waist-to-hip ratio adjusted for BMI,472578
5,Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded),3469
5,Threonate levels,1868
5,Feeling miserable,1065
5,Electrocardiogram morphology (amplitude at temporal datapoints) [46 ms],332
5,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 measurement",51
5,Basophil percentage of granulocytes,4236
5,"Light diy (eg: pruning, watering the lawn) | types of physical activity in last 4 weeks",27
5,Facial morphology (segment 62),97
5,Body mass index,549822
5,Simvastatin | treatment/medication code,2337
5,Electrocardiogram morphology (amplitude at temporal datapoints) [288 ms],776
5,Estradiol levels,857
5,Hair morphology traits [Hair color (blond],371
5,BMI in non-smokers,8576
5,Autoimmune thyroid disease,8728
5,Neuroticism,13459
5,Femoral neck bone mineral density,366
5,Serum levels of protein PIK3CG,15
5,Protein quantitative trait loci (liver) [FLNA],16
5,Pilonidal cyst,13184
5,Waist circumference adjusted for BMI in active individuals [EA],1404
5,Leisure/social activities: Sports club or gym,1391
5,Serum levels of protein ALDH1A3,994
5,"Poisoning by analgesics, antipyretics, and antirheumatics",108
5,Other than those specified above | delivery methods,1
5,Adcal-d3 1.5g/10micrograms chewable tablet | treatment/medication code,7
5,Acylcarnitine levels [Carnitine],2246
5,Heel bone mineral density (bmd) (right),8286
5,Rheumatoid factor seropositivity in rheumatoid arthritis,306
5,Atopy,989
5,Diabetes | illnesses of adopted siblings,984
5,"Systolic blood pressure, manual reading",260
5,Vascular endothelial growth factor levels,51
5,Sum basophil neutrophil counts,116776
5,Heel bone mineral density (bmd),27124
5,Age when periods started (menarche),14833
5,Electrocardiogram morphology (amplitude at temporal datapoints) [164 ms],86
5,Diisocyanate-induced asthma,231
5,Non-cardia gastric cancer,2572
5,"""Asthma, including avohilmo""",1601
5,Serum levels of protein ERAP1,1843
5,Hair color [hair color],185
5,Electrocardiogram morphology (amplitude at temporal datapoints) [302 ms],776
5,Allergic asthma (mode) (more control exclusions),2426
5,Brain region volumes [right hippocampus],352
5,Chronic obstructive pulmonary disease in ever smokers,905
5,Colorectal cancer or advanced adenoma [conditioned on lead SNPs in LD],290
5,Bone mineral density [femoral neck],231
5,Hemoglobin levels,90870
5,Educational attainment (college completion),10671
5,Overall health rating,902
5,Chronic kidney disease [eGFRcrea],2410
5,Direct bilirubin levels,504
5,Alanine transaminase levels,1341
5,"Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event) [Dominant, Mixture cure model]",358
5,Diastolic blood pressure,482633
5,Migraine and/or diastolic blood pressure,10412
5,Number of incorrect matches in round,1905
5,Salmeterol | treatment/medication code,117
5,EGFR mutation-positive lung adenocarcinoma,274
5,"Blonde | hair colour (natural, before greying)",3949
5,Brain region volumes [right putamen],1976
5,Integrin beta-2 levels,341
5,Fibrosis-4 index in high alcohol intake,179
5,"Sphingomyelin (d18:1/20:0, d16:1/22:0) levels",204
5,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant IV (Upper face), Segment 60]",3
5,Blood protein levels [Hepatitis A virus cellular receptor 2],6858
5,Age cataract diagnosed,1335
5,"Polycythaemia vera | non-cancer illness code, self-reported",256
5,Spherical power (left),2753
5,"Medication use (anti-inflammatory and antirheumatic products, non-steroids)",1710
5,Mathematical ability,210
5,Neuronal pentraxin receptor levels,308
5,Attention deficit hyperactivity disorder or caudate nucleus volume (pleiotropy),15
5,None of the above | vascular/heart problems diagnosed by doctor,31649
5,Glycine levels,5494
5,Electrocardiogram morphology (amplitude at temporal datapoints) [36 ms],1760
5,Protein quantitative trait loci (liver) [SLC25A13],64
5,Protein quantitative trait loci (liver) [AKR1D1],71
5,Serum metabolite concentrations in chronic kidney disease [Serine],4
5,Sum eosinophil basophil counts,58005
5,3-hydroxybutyrate + 3-aminoisobutyrate levels,2533
5,LDL cholesterol levels x short total sleep time interaction (2df test),4219
5,Methotrexate | treatment/medication code,269
5,White matter microstructure (axial diusivities) [Posterior corona radiata ],133
5,Toxoplasma gondii sag1 antibody levels,10
5,Depressive symptoms (MTAG),152550
5,Urinary metabolite levels in chronic kidney disease [X - 12117],118
5,Malignant neoplasm of digestive organs (controls excluding all cancers),153
5,Gut microbiota (bacterial taxa) [Actinobacteridae],144
5,PDL-1 on CD14+ CD16- monocyte,19468
5,"Disc degeneration | non-cancer illness code, self-reported",1327
5,Adult diffuse glioma (IDH wildtype),168
5,Brain region volumes [right cerebellum white matter],45
5,"Atrial fibrillation | non-cancer illness code, self-reported",5966
5,Hypothyroidism,29406
5,Imdur 60mg durule | treatment/medication code,1500
5,Frequency of tiredness / lethargy in last 2 weeks,1325
5,Dentures,343
5,Warfarin | treatment/medication code,703
5,Total testosterone levels,36712
5,Serous invasive ovarian cancer,262
5,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],335
5,Skin changes due to chronic exposure to nonionizing radiation,1888
5,"Blood protein levels [C7, 2888_49_2]",15
5,Serum metabolite levels [valylleucine],1396
5,Serum levels of protein SPINK6,14094
5,Other psoriatic arthropathies,219
5,Skin pigmentation traits [Phototype score],185
5,"Urinary metabolites (H-NMR features) [2.6125, Aminoisobutyrate]",118
5,"Asthma | non-cancer illness code, self-reported",24236
5,Body mass index and HDL-C (pairwise),1183
5,Transitional B cell Absolute Count,500
5,Serum levels of protein ARL1,994
5,Waist circumference adjusted for BMI (adjusted for smoking behaviour) [men],119
5,Elusimicrobiaceae abundance in stool,9
5,Hypertrophic cardiomyopathy (MTAG),10971
5,Essential hypertension,18002
5,Thyroid function,496
5,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction) [men],248
5,"Waist circumference adjusted for body mass index [EA, women]",245
5,Corneal structure,1348
5,Lifetime anxiety disorder [EA],52
5,Leukocyte telomere length,481
5,White matter microstructure (axial diusivities) [External capsule ],133
5,Dorsalgia,26
5,Serum levels of protein MCEMP1,15
5,Yes | breathing problems during period of job,10
5,Age of smoking initiation (MTAG),12340
5,"""Inflammatory bowel disease, strict (require KELA)""",7533
5,Lung function (FVC) [EA],4193
5,"Psoriasis [EA, conditional on rs7709212]",353
5,Degraded stimulus continuous performance test score,131
5,Serum levels of protein PLXDC1,994
5,Smoking behaviour (cigarette pack-years),14
5,COPD/asthma/ILD related infections,1671
5,Mean area of carotid plaque [men],1305
5,Sjögren's syndrome,807
5,Electrocardiogram morphology (amplitude at temporal datapoints) [-96 ms],611
5,Dyslipidemia,2947
5,"Kidney stone/ureter stone/bladder stone | non-cancer illness code, self-reported",4646
5,Electrocardiogram morphology (amplitude at temporal datapoints) [-18 ms],12323
5,Cardiorespiratory fitness slope,1246
5,Abdominal hernia,204
5,Home location at assessment - north co-ordinate (rounded),406
5,Fibroblast growth factor 23 levels,8156
5,Serum metabolite levels [leucylglycine],1396
5,Calcipotriol | treatment/medication code,1039
5,Protein quantitative trait loci (liver) [POLR2H],21
5,G_Barnesiella prevalence,159
5,Psoriatic and enteropathic arthropathies,202
5,Electrocardiogram morphology (amplitude at temporal datapoints) [216 ms],86
5,Feeling hurt,2972
5,"Cholesterol lowering medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",2337
5,Impedance of arm (left),61354
5,Uveal melanoma,5136
5,Cognitive ability (MTAG),2749
5,Spleen volume,234
5,Metabolite levels [Cer d18:1/16:0],62
5,Inflammatory bowel disease [EA],118385
5,Lymphocyte counts,544035
5,Serum immune biomarker levels [sCD14],86791
5,Metabolite levels [beta aminoisobutyric acid],1950
5,Psoriasis vulgaris,2532
5,"Intra-ocular pressure, goldmann-correlated (left)",3460
5,Electrocardiogram morphology (amplitude at temporal datapoints) [230 ms],1506
5,Major depressive disorder [% improvement - SSRI treated - 2 weeks],126
5,Serum levels of protein TMCC3,15
5,Urinary metabolite levels in chronic kidney disease [tryptophan],292
5,Serum levels of protein CREBBP,58
5,Serum levels of protein CDK5;CDK5R1,15
5,Self-reported math ability (MTAG) [MTAG],168803
5,Menarche (age at onset),45578
5,Mouth ulcers,2344
5,Eosinophil counts [EA],864
5,Paediatric migraine [AA],9796
5,Serum levels of protein PDCL2,994
5,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,327
5,Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis),156
5,Eosinophill count,72072
5,Smoking cessation (MTAG),3036
5,Heavy menstrual bleeding,119
5,Insulin-related traits (multivariate analysis),718
5,High blood pressure | vascular/heart problems diagnosed by doctor,30456
5,Gastroesophageal reflux disease,2223
5,Mouth ulcers | mouth/teeth dental problems,432
5,Colorectal cancer x fine particulate matter exposure levels interaction,370
5,Broad depression or major depressive disorder (self-reported),23
5,Protein quantitative trait loci (liver) [AP1B1],8
5,Cognitive performance,31965
5,Diseases of the respiratory system,3764
5,Fruit consumption,102
5,"Fracture tibia | non-cancer illness code, self-reported",266
5,Executive function (trail making test B) x time interaction,42
5,Lipitor 10mg tablet | treatment/medication code,63
5,Asthma-related infections,3277
5,Cereal intake,88
5,Cortical surface area [Inferior Parietal],885
5,Blood pressure [Mean Arterial Pressure],164
5,Gut microbiota (functional units) [PWY-6948_sitosterol_degradation_to_androstenedione],10
5,Educational attainment (years of education),98523
5,Red blood cell (erythrocyte) distribution width,46674
5,Malignant neoplasm of skin,859
5,Cervical cancer,884
5,Sleep (1/2-day periodicity),871
5,Adolescent idiopathic scoliosis,43094
5,Urinary potassium excretion [EA],14006
5,Potassium in urine,14040
5,Waist-to-hip ratio adjusted for BMI (additive genetic model),3566
5,Cortical surface area [Superior Parietal],3105
5,"Blood protein levels [FLT4, 2358_19_2]",1070
5,Allergy,3056
5,Urinary metabolite levels in chronic kidney disease [N-acetylglucosamine conjugate of C24H40O4 bile acid],511
5,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event) [Cox proportional hazards regression model],32
5,"Number of operations, self-reported",17
5,Herpes simplex virus 2 mgG-1 antibody levels,1
5,Central corneal thickness,22570
5,Leg fat percentage (right),67998
5,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),3556
5,Chronic sinusitis,1529
5,Eosinophilic granulomatosis with polyangiitis,10
5,Hip circumference adjusted for BMI,61606
5,White matter microstructure (radial diusivities) [Posterior thalamic radiation],13810
5,"Blood protein levels [EA, Platelet-derived growth factor receptor beta]",1083
5,Benzoate levels,110
5,Atorvastatin | treatment/medication code,2546
5,Urinary magnesium-to-creatinine ratio,661
5,Serum levels of protein SNX7,15
5,White blood cell count (basophil),41909
5,Sodium in urine,2179
5,Urinary metabolite levels in chronic kidney disease [tyrosine],292
5,Urinary metabolite levels in chronic kidney disease [3-hydroxykynurenine],292
5,"""Other dorsopathies, not elsewhere classified""",1
5,Lung function (FEV1) and body mass index [East Asian],71122
5,"Heel bone mineral density (bmd) t-score, automated",27780
5,Serum levels of protein COL4A3BP,3215
5,Alcohol consumption (drinks per week),469
5,Gut microbiota relative abundance (bacterial taxa) [Eubacterium_ruminantium],3052
5,Calculus of kidney,4646
5,Protein quantitative trait loci (liver) [PCK1],89
5,Serum levels of protein SERPINE1,51
5,Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event),33
5,Systemic lupus erythematosus,51227
5,White matter microstructure (radial diusivities) [Retrolenticular part of internal capsule],13810
5,Stool frequency,11439
5,"Response to radiotherapy in prostate cancer (toxicity, urinary frequency)",274
5,Glycemic traits (pleiotropy),2
5,Insomnia,28361
5,Lung function (low FEV1 vs high FEV1),890
5,White matter hyperintensities,184
5,Blood protein levels [Interleukin-6 receptor subunit beta],2070
5,Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder,500
5,Putamen volume,510
5,Gouty arthropathy,200
5,Serum metabolite levels [pregn steroid monosulfate C21H34O5S*],254
5,Verbal memory,2
5,"Blood protein levels [TXNDC15, 6366_38_3]",13351
5,Metabolic syndrome,10456
5,Heel broadband ultrasound attenuation (left),1212
5,Femur bone mineral density x serum urate levels interaction,296
5,Serum levels of protein RAET1L,994
5,Nicorandil | treatment/medication code,694
5,Delivery,11
5,Meningococcal infection,7
5,Asthma,226347
5,Menarche (age at onset) [japanese],9340
5,Protein quantitative trait loci (liver) [AKR7A3],34
5,Cancer of brain and nervous system,202
5,Electrocardiogram morphology (amplitude at temporal datapoints) [174 ms],86
5,Facial morphology (segment 56),93
5,DNA methylation variation (age effect),12113
5,"Hayfever, allergic rhinitis or eczema | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",37532
5,Impedance of leg (right),122948
5,Eosinophil counts,562410
5,Triglyceride levels,136327
5,Type 1 diabetes,23777
5,Physical activity (overall physical activity time),2318
5,Keratoconus,652
5,HDL cholesterol levels in current drinkers,221
5,Protein quantitative trait loci (liver) [CTSZ],10
5,Thyroid problem (not cancer),13162
5,Hip circumference,100365
5,Other and unspecified dermatitis,54228
5,Malignant neoplasm of skin (controls excluding all cancers),849
5,Triglyceride levels x short total sleep time interaction (2df test),1136
5,Myeloid clonal hematopoiesis,168
5,Urolithiasis,22282
5,Birth weight,9995
5,Eczema or dermatitis,1829
5,Other disorders of veins,1836
5,Cardiac dysrhythmias,3161
5,Total cholesterol levels [EA],6415
5,Job involves mainly walking or standing,1354
5,Bitter alcoholic beverage consumption,510
5,Serum levels of protein IL12B,89
5,Ischemic stroke (cardioembolic),645
5,Bioavailable testosterone levels,19846
5,Wheeze or whistling in the chest in last year,3357
5,Skin colour saturation,356
5,Depressive symptoms,93304
5,Barrett's esophagus,2289
5,Regular attendance at a religious group,1202
5,"Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",341
5,Neuroticism conditioned on self-rated math ability (multi-trait conditioning and joint analysis),158
5,Type 2 diabetes [EA],258
5,Protein quantitative trait loci (liver) [TGFBI],16
5,Injury of cranial nerves,16
5,Bone mineral density (hip),231
5,6mm regularity index (right),46
5,Melanoma,9322
5,Electrocardiogram morphology (amplitude at temporal datapoints) [210 ms],1592
5,"Urinary metabolites (H-NMR features) [1.2025, Aminoisobutyrate]",908
5,Caffeine consumption from tea,2433
5,Brain region volumes [left accumbens area],1534
5,Gut microbiota (bacterial taxa) [OTU10032 unclassified Enterobacteriaceae],132
5,Frequency of friend/family visits,42
5,Schizophrenia,324832
5,Type 2 diabetes,265834
5,Smoking initiation (ever regular vs never regular) (MTAG),39073
5,Interleukin-16 levels,994
5,Coronary atherosclerosis,1006
5,Iron status biomarkers (transferrin saturation),23
5,Snoring,46812
5,Noncognitive aspects of educational attainment,42645
5,Total cerebellar volume (excluding Crus I vermis),14487
5,Major depressive disorder,97304
5,Serum metabolite levels [hexanoylcarnitine (C6],21716
5,Forced expiratory volume in 1-second (fev1),131759
5,Waist-to-hip ratio adjusted for body mass index [men],293
5,Total amyloid (SNP x SNP interaction),716
5,Homeostasis model assessment of insulin resistance (dietary factor interaction) [Carbohydrate],604
5,Valvular heart disease including rheumatic fever,6
5,Ulcerative colitis [EA],31403
5,Leisure sedentary behaviour (television watching),18942
5,Fatty acid(22:5)_[M-H]1- levels,37314
5,Sensorineural hearing loss,2106
5,Morning/evening person (chronotype),1690
5,White matter microstructure (radial diusivities) [Fornix (cres) / Stria terminalis],80
5,Capecitabine sensitivity [EA],7
5,Externalizing behaviour (multivariate analysis),104700
5,White matter microstructure (mean diusivities) [Genu of corpus callosum],14111
5,Getting up in morning,2735
5,Skin and soft tissue infections,1009
5,UBA7703 abundance in stool,61
5,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),318
5,Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis),156
5,Skin pigmentation traits [Skin sensitivity to sun (high to low],185
5,"Urinary metabolites (H-NMR features) [2.6275, Aminoisobutyrate]",118
5,Monocyte percentage of white cells,185892
5,Knee osteoarthritis,609
5,Leisure sedentary behaviour (computer use),10440
5,Acylcarnitine levels [Octadecenoylcarnitine],27764
5,Cortical surface area,100653
5,Body mass index [additive model],2609
5,Neurological blood protein biomarker levels [GDNF],589
5,Tryptophan betaine levels,2589
5,Serum levels of protein LAMTOR3,994
5,"Blood protein levels [AHSA1, 11633_89_3]",15
5,Rheumatoid arthritis (ACPA-positive),7644
5,"Waist-to-hip ratio adjusted for body mass index [EA, women]",8156
5,Glomerular filtration rate,10748
5,Protein quantitative trait loci (liver) [SDHB],2151
5,Serum levels of protein HAVCR1,3355
5,"Blood protein levels [PCSK1, 13388_57_3]",718
5,Angina pectoris,111
5,"Forced expiratory volume in 1-second (fev1), predicted percentage",7374
5,Total PHF-tau (SNP x SNP interaction),22978
5,"Blood protein levels [ADAM19, 8948_13_3]",2114
5,"Blood protein levels [MGAT4B, 7141_21_3]",364
5,"Self-injury such as self-cutting, scratching or hitting, etc. | methods of self-harm used",48
5,Serum levels of protein NOG,102
5,White matter microstructure (mean diusivities) [Posterior thalamic radiation],13810
5,Whole body water mass,139880
5,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),1001
5,Serum levels of protein TPMT,994
5,White matter microstructure (mean diusivities) [Sagittal stratum],133
5,General risk tolerance (MTAG),65430
5,PR interval,33702
5,Reaction time,24770
5,Vertex-wise sulcal depth,189905
5,Mood [affective] disorders,34
5,"""Malignant neoplasm of breast, HER-positive""",14099
5,Body fat distribution (arm fat ratio) [males],5686
5,Staphylococcus aureus abundance in stool,236
5,Visceral adipose tissue adjusted for BMI,903
5,Corneal curvature,12164
5,Interstitial lung disease,650
5,Activated partial thromboplastin time,4430
5,Heel bone mineral density (MTAG),8967
5,Serum levels of protein C7,2998
5,Lamb/mutton intake,2213
5,Male puberty timing (age at voice breaking MTAG),10437
5,Glaucoma (high intraocular pressure),776
5,"Smoking initiation (ever regular vs never regular) [Conditioned on chr5:165096435, chr5:167614971, chr5:166989513]",106
5,Common neurobiological substrate measurement (PC1),620
5,Pulse wave arterial stiffness index,214
5,Joint mobility (Beighton score),52
5,Fasting blood insulin,222
5,Metabolic traits [isovalerylcarnitine + 7 other traits],30652
5,Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in non-secretors,44
5,Cortical surface area (MOSTest),24473
5,Direct low density lipoprotein cholesterol levels,15442
5,Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test),9244
5,Colorectal cancer [East Asian],3659
5,Circulating vasoactive peptide levels [ET],994
5,Other cardiomyopathy,74
5,Protein quantitative trait loci (liver) [UCHL3],7
5,Morning person,12085
5,Tense / 'highly strung',72295
5,"Monocyte differentiation antigen CD14, soluble measurement",24519
5,Nonalcoholic fatty liver disease (imputed),571
5,White matter microstructure (mean diusivities) [Retrolenticular part of internal capsule],133
5,Childhood asthma (age<16),10
5,Inflammatory bowel disease,306482
5,White matter microstructure (fractional anisotropy) [Genu of corpus callosum],12746
5,"Kidney stone, ureter stone or bladder stone",4646
5,Feeling fed-up,1055
5,Body mass index and type 2 diabetes (pairwise),1236
5,Bipolar II disorder,442
5,Heart rate response to exercise,305
5,Factor VIII levels,4158
5,Heel broadband ultrasound attenuation (right),7628
5,Bladder cancer,5728
5,IgG glycosylation [IGP57],107
5,Waist-hip ratio [EA],248
5,Malignant neoplasm of prostate (controls excluding all cancers),113
5,Myeloproliferative diseases,264
5,Urinary metabolite levels in chronic kidney disease [X - 24518],118
5,Cognitive function (generalized correlation coefficient),109
5,G_Paraprevotella abundance,15
5,Protein quantitative trait loci (liver) [PON1],28
5,"Chronic obstructive airways disease/copd | non-cancer illness code, self-reported",26
5,Serum levels of protein ENTPD1,15
5,Psoriasis,49411
5,Cortical surface area [Parahippocampal],21176
5,Creatine kinase levels,2974
5,Cortical volume [Pericalcarine],6072
5,LDL cholesterol levels [Trans-ethnic initial],5334
5,P wave duration,754
5,Seborrheic keratosis,166
5,Alzheimer's disease (late onset) [adjusted for APOE],78
5,Electrocardiogram morphology (amplitude at temporal datapoints) [204 ms],86
5,Cortical thickness (min-P),82
5,Age at menopause,27567
5,White matter microstructure (fractional anisotropy) [Cingulate gyrus],14188
5,Methionine sulfone levels,2671
5,Urinary metabolite levels in chronic kidney disease [kynurenine],292
5,1-arachidonoyl-gpc (20:4n6) levels,1170
5,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),238
5,"""Endocrine, nutritional and metabolic diseases""",192
5,Seborrheic dermatitis,49
5,Serum levels of protein C5;C6,15
5,Multivitamins capsule | treatment/medication code,16
5,Eczema,46851
5,"""Asthma, hospital admissions , main diagnosis only""",17901
5,Age spots,929
5,Electrocardiogram morphology (amplitude at temporal datapoints) [-12 ms],2158
5,White matter microstructure (axial diusivities) [Sagittal stratum],1566
5,Heart rate response to recovery post exercise,305
5,Serum levels of protein GHR,74
5,Sleeplessness / insomnia,21049
5,Obesity [Obesity class II],10412
5,Colpermin 0.2ml m/r gel e/c capsule | treatment/medication code,474
5,"""Psoriatic arthropathies, ICD10""",219
5,Birdshot chorioretinopathy,72437
5,Glioma,1301
5,"Helicobacter pylori | non-cancer illness code, self-reported",1313
5,No | hearing difficulty/problems,2891
5,Electrocardiogram morphology (amplitude at temporal datapoints) [42 ms],332
5,Milk chocolate intake,41
5,Hip circumference [EA],10412
5,Medication use (drugs used in diabetes),47991
5,Acute anterior uveitis (with or without ankylosing spondylitis),9900
5,Autism spectrum disorder (MTAG),2021
5,Body fat distribution (trunk fat ratio),2920
5,Average weekly red wine intake,174
5,Bipolar disorder vs major depressive disorder (ordinary least squares (OLS)),195
5,Visceral adipose tissue volume,254
5,Malignant neoplasm of ovary (controls excluding all cancers),2
5,White matter microstructure (radial diusivities) [Body of corpus callosum],35212
5,Glomerular filtration rate in non diabetics (creatinine),4997
5,Serum levels of protein APLP2,994
5,Benign neoplasms (controls excluding all cancers),138
5,"Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1) [BDRBASE, AA]",36
5,Insomnia [Female],30845
5,Coronary angiopasty,403
5,Cancer (pleiotropy)(bidirectional),1339
5,Moderate to vigorous physical activity levels,226
5,Forced vital capacity (fvc),45461
5,Metabolite levels (small molecules and protein measures) [Citrate],869
5,Systemic sclerosis,1814
5,Hearing difficulty/problems with background noise,945
5,Chronic obstructive pulmonary disease,22461
5,Chronic obstructive pulmonary disease x current smoker interaction (2df),15392
5,White blood cell (leukocyte) count,127093
5,"Crohns disease | non-cancer illness code, self-reported",5418
5,Age-related hearing impairment (SNP x SNP interaction),12425
5,Female genital prolapse,4837
5,Intestinal adhesions without obstruction,63
5,Triglycerides,46362
5,Verbal-numerical reasoning,20398
5,Amyotrophic lateral sclerosis,3595
5,"Body mass index (adult) [AA,Women]",1511
5,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),2283
5,Serum metabolite levels [dimethylarginine (SDMA + ADMA],152
5,"Spine arthritis/spondylitis | non-cancer illness code, self-reported",392
5,Voltarol emulgel | treatment/medication code,1414
5,interleukin 12 receptor subunit beta-1 levels,147
5,Heart rate response to recovery post exercise (40 sec),72
5,Blood protein levels in cardiovascular risk,655
5,Uveitis,11012
5,Calcium levels,122040
5,Time spent watching television (tv),34160
5,Budesonide | treatment/medication code,864
5,Thrombin measurement,994
5,Mean arterial pressure [East Asian],2396
5,Pulmonary function [FEV1],890
5,Serum levels of protein MRPL58,994
5,White matter microstructure (mean diusivities) [Superior fronto-occipital fasciculus],133
5,Longest period of unenthusiasm / disinterest,16
5,White matter microstructure (radial diusivities) [Anterior limb of internal capsule],133
5,"Blood protein levels [C7, 13731_14_3]",15
5,"Blood protein levels [PDGFRB, 3459_49_2]",532
5,Systolic blood pressure (dietary potassium intake interaction),508
5,Serum levels of protein THPO,138
5,Hypertension (SNP x SNP interaction),565
5,Eosinophil percentage of white cells,212238
5,Serum levels of protein C1QTNF5,36615
5,Autism spectrum disorder or schizophrenia,5488
5,Body fat distribution (leg fat ratio) [males],1009
5,Major depressive disorder [partial response - 2 weeks],158
5,Cancer (pleiotropy) [subset analysis],11384
5,Electrocardiogram morphology (amplitude at temporal datapoints) [304 ms],776
5,"Blood protein levels [LECT2, 5970_61_3]",1989
5,"Blood protein levels [FOLH1, 3218_8_2]",15
5,Cortical volume [Superior parietal],44
5,Femoral neck length,18
5,Distal bite,14
5,Intraocular pressure,29310
5,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),5669
5,Varicose veins,20492
5,Perceived skin darkness,383
5,Venous thromboembolism (SNP x SNP interaction),1984
5,White matter microstructure (axial diusivities) [Hippocampus ],230
5,Bone mineral density [FNK],120
5,Pulse pressure x alcohol consumption interaction (2df test) [EA],129
5,Protein quantitative trait loci (liver) [CAPN2],16
5,Bipolar disorder or major depressive disorder,5147
5,Frequency of needing morning drink of alcohol after heavy drinking session in last year,131
5,Electrocardiogram morphology (amplitude at temporal datapoints) [156 ms],86
5,Acute cholecystitis,31
5,Citramalate levels,746
5,Electrocardiogram morphology (amplitude at temporal datapoints) [4 ms],1428
5,Spherical equivalent or myopia (age of diagnosis),950
5,Electrocardiogram morphology (amplitude at temporal datapoints) [224 ms],1506
5,"Blood protein levels [TGFBI, 3283_21_1]",1748
5,Serum levels of protein SOD2,994
5,Rheumatoid arthritis and other inflammatory polyarthropathies,119
5,Sitting height ratio,410
5,White matter microstructure (axial diusivities) [Superior longitudinal fasciculus],133
5,Protein quantitative trait loci (liver) [CLIC4],16
5,Delirium due to conditions classified elsewhere,16
5,"""Carcinoma in situ of breast, lobular (controls excluding all cancers)""",17
5,Trunk fat mass,99445
5,Pulse rate,3252
5,"Black | hair colour (natural, before greying)",2986
5,Coversyl 2mg tablet | treatment/medication code,432
5,C-reactive protein levels [BMI-adjusted],1497
5,Serum levels of protein IL34,15
5,Diastolic blood pressure x educational attainment (graduated college) interaction (2df),23
5,White matter microstructure (axial diusivities) [Anterior corona radiata],13810
5,Epithelial ovarian cancer,124
5,Low density lipoprotein cholesterol levels [EA],6415
5,QRS duration [EA],124
5,Morbidity-free survival,36
5,"Sphingomyelin (d18:2/16:0, d18:1/16:1) levels",28
5,Doctor diagnosed hayfever or allergic rhinitis,7032
5,Chalazion,36792
5,Acute and subacute iridocyclitis,11936
5,Diverticular disease,1938
5,Esophageal cancer,1273
5,"Long-standing illness, disability or infirmity",199
5,Self-reported math ability,99053
5,Waist circumference adjusted for BMI in non-smokers,119
5,Alcoholic chronic pancreatitis,64
5,OTU97_51 (Barnesiella) prevalence,159
5,Leiomyoma of uterus,124
5,Serum levels of protein ZNF276,15
5,IgE grass sensitization,1258
5,Loneliness (MTAG),1883
5,Myocardial infarction,7049
5,Snoring [adjusted for BMI],9679
5,Zapain caplet | treatment/medication code,2372
5,Other non-epithelial cancer of skin,2828
5,"Psoriasis [EA, conditional on rs7709212, rs4921493]",718
5,Waist-hip ratio and fasting glucose (pairwise),254
5,Monocyte count [Japanese],819
5,"Systolic blood pressure x alcohol consumption interaction (2df test) [AA, Asian, EA, Hispanic]",13
5,Asthma or allergic disease (pleiotropy),13619
5,"Ankylosing spondylitis [conditioned on rs30187, EA]",71731
5,Weight,337565
5,Protein quantitative trait loci (liver) [CA1],504
5,Frequency of unusual or psychotic experiences in past year,2113
5,Brain region volumes [CSF],175
5,Serum levels of protein ADGRE5,15
5,Glomerular filtration rate (creatinine),11499
5,Doctor diagnosed asthma,11101
5,Hyperplasia of prostate,2509
5,Atrial fibrillation/atrial flutter,2323
5,Monobrow,1138
5,Allergic conjunctivitis,218
5,"Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [Asian, EA]",135
5,Protein quantitative trait loci (liver) [FDXR],16
5,Serum levels of protein C9,174
5,Highest math class taken,55052
5,Reticulocyte percentage,6944
5,Urinary metabolite levels in chronic kidney disease [phenylalanine],292
5,Adult diffuse glioma (TERT mutation only),172
5,Balding type 1,16305
5,Metabolic biomarkers (multivariate analysis),33217
5,Serum levels of protein OXT,994
5,Systolic blood pressure x alcohol consumption interaction (2df test) [EA],277
5,Witnessed sudden violent death,481
5,Lymphocyte-to-monocyte ratio,7096
5,Mosaic loss of chromosome Y (Y chromosome dosage),556
5,Adenocarcinoma in never smokers,2583
5,Glioblastoma (age-stratified) [Above median age-at-diagnosis],124
5,"N,n,n-trimethyl-alanylproline betaine (tmap) levels",1771
5,Schizophrenia [EA],4499
5,"Blood protein levels [SPINK1, 8243_55_3]",595
5,Serum levels of protein DBNL,994
5,Triglycerides x physical activity interaction (2df test),244
5,Human milk oligosaccharide concentration (lacto-N-fucopentaose III),38
5,Protein quantitative trait loci (liver) [CLIC1],16
5,High density lipoprotein cholesterol levels,55407
5,"Heel bone mineral density (bmd) t-score, automated (left)",2447
5,Accelerometer-based physical activity measurement (average acceleration),3291
5,"Blood protein levels [GHR, 2948_58_2]",127
5,Polycythaemia vera,115
5,Caffeine consumption from coffee or tea,63
5,Otherand unspecified haemorrhagic conditions,7
5,"Urinary metabolites (H-NMR features) [1.1975, Aminoisobutyrate]",118
5,Blood protein levels [TIM],636
5,Electrocardiogram morphology (amplitude at temporal datapoints) [152 ms],86
5,Cheese consumers,29
5,CD127 on CD28+ CD45RA- CD8+ T cell,1
5,Creatinine levels,145923
5,Arm fat-free mass (right),134104
5,Hip circumference (psychosocial stress interaction) [EA],500
5,White matter microstructure (axial diusivities) [Uncinate fasciculus],349
5,Second line medication for Crohns disease,97
5,Aortic aneurysm,9
5,Basal metabolic rate,176222
5,Myopia (age of diagnosis),8156
5,Blood protein levels [IL12B],147
5,Cortical surface area [Postcentral],102
5,Body fat percentage and HDL-C (pairwise),500
5,Cancer,294
5,Generalized epilepsy,1221
5,"Pulmonary function (smoking interaction) [FEV1/FVC, Ever-smoking]",3019
5,High blood pressure | illnesses of siblings,254
5,"Mean arterial pressure x alcohol consumption interaction (2df test) [AA, EA, Hispanic]",13
5,Waist-to-hip ratio adjusted for body mass index [women],7922
5,"Tinnitus / tiniitis | non-cancer illness code, self-reported",4765
5,"""Other complications of labour and delivery, not elsewhere classified""",1302
5,Skin cancer,1273
5,Urate levels [men],341
5,Cholesteatoma of external ear,88
5,Esophageal squamous cell carcinoma,4260
5,Heel bone mineral density,287526
5,Medication use (diuretics),7860
5,Body fat percentage and triglycerides (pairwise),488
5,Disease-related mortality after unrelated donor allogeneic hematopoietic cell transplantation (donor effect),496
5,Electrocardiogram morphology (amplitude at temporal datapoints) [154 ms],86
5,Contusion,3
5,Inflammatory bowel disease and other gastroenteritis and colitis,32378
5,Serum parathyroid hormone levels,7085
5,Itch intensity from mosquito bite,32839
5,Asthma (age of onset),4727
5,Reticulocyte fraction of red cells,70054
5,Anthropometric traits (multi-trait analysis),2094
5,Electrocardiogram morphology (amplitude at temporal datapoints) [300 ms],776
5,Electrocardiogram morphology (amplitude at temporal datapoints) [14 ms],159
5,Rest days during mixed shift periods,71
5,Venous thromboembolism,72
5,Diaphragmatic hernia,10
5,Basophil count,175634
5,"Cellulitis and abscess of foot, toe",1009
5,Thyrotoxicosis,363
5,Pre-treatment viral load in HIV-1 infection,531
5,Recent inability to stop or control worrying,3
5,"""Asthma, unspecified (mode)""",16365
5,QT interval,8196
5,Urinary albumin-to-creatinine ratio [EA],4677
5,Percentage of invited food questionnaires completed,110
5,Major depressive disorder vs ADHD (ordinary least squares (OLS)),143
5,Protein quantitative trait loci (liver) [EMILIN2],84
5,Aspartate aminotransferase levels,256105
5,Late-onset Alzheimer's disease,4589
5,"Sphingomyelin (d18:1/20:1, d18:2/20:0) levels",2467
5,Resistant hypertension,90
5,Gordonibacter pamelaeae abundance in stool,81
5,Protein quantitative trait loci (liver) [CAPNS1],16
5,White matter microstructure (radial diusivities) [Cingulate gyrus],13810
5,Chronic obstructive pulmonary disease in never smokers,3019
5,Nevus count or cutaneous melanoma,7889
5,Waist-hip ratio and fasting insulin (pairwise),254
5,"""Dislocation, sprain and strain of joints and ligaments of knee""",148
5,Toenail selenium levels,5130
5,Levothyroxine sodium | treatment/medication code,10267
5,"Blood protein levels [PDLIM4, 12387_7_3]",10468
5,Serum metabolite levels [betaine],1696
5,Mammographic density (dense area),259
5,Mean reticulocyte volume,91178
5,"Pulse rate, automated reading",32997
5,"Heel quantitative ultrasound index (qui), direct entry",27780
5,"Forced expiratory volume in 1-second (fev1), best measure",125812
5,Leg fat percentage (left),38381
5,Symmetrical dimethylarginine levels,254
5,Coagulation factor XIII measurement,1630
5,Monocyte percentage,27031
5,Azopt 10mg/ml eye drops | treatment/medication code,2599
5,Degenerative skin conditions and other dermatoses,214
5,Retinal nerve fibre layer thickness or ganglion cell inner plexiform layer thickness (MTAG),467
5,Protein quantitative trait loci (liver) [USP5],99
5,N-acetylglucosamine/n-acetylgalactosamine levels,1350
5,Electrocardiogram morphology (amplitude at temporal datapoints) [320 ms],776
5,Nasal polyps,73465
5,Worry/vulnerability (special factor of neuroticism),28366
5,Serum levels of protein IGF1,15
5,Brinzolamide | treatment/medication code,53
5,Trauma exposure,514
5,"Eyebrow thickness [East Asian, Hispanic and Other admixed]",623
5,Cortical surface area (min-P),16147
5,Brain region volumes [left ventral DC],11140
5,Impedance of arm (right),60255
5,Malignant neoplasm of pancreas (controls excluding all cancers),2572
5,Oxybutynin | treatment/medication code,49
5,Betaine levels in individuals undergoing cardiac evaluation,11903
5,Mean corpuscular hemoglobin concentration,133145
5,Facial ageing,39987
5,Major depressive disorder (MTAG),898
5,Serum levels of protein MGAT4B,364
5,Glioma [females],124
5,Calcium carbonate+cholecalciferol 1.25g/5micrograms tablet | treatment/medication code,377
5,Iridocyclitis,11198
5,"Basal cell carcinoma | cancer code, self-reported",2588
5,Serum prostate-specific antigen levels,2583
5,Interleukin-7 receptor subunit alpha measurement,2295
5,Invasive epithelial ovarian cancer,262
5,Ever had prostate specific antigen (psa) test,2568
5,Cortical surface area [Posterior cingulate],270
5,Breast Cancer in BRCA1 mutation carriers,124
5,Poseidoniaceae abundance in stool,17
5,Household income (MTAG),8085
5,Blood metabolite ratios [valine/isovalerylcarnitine],30652
5,Whole body fat mass,101710
5,Glucuronate levels,2014
5,Processed meat consumption,1086
5,Serum levels of protein THBS1,994
5,White matter microstructure (axial diusivities) [Average across all tracts],133
5,Carotid intima media thickness [Multiple-adjusted],159
5,High altitude adaptation,292
5,Vitamin b12  | vitamin and/or mineral supplement use,16
5,Appendicular lean mass,464368
5,Haemoglobin concentration,33791
5,Waist-to-hip ratio adjusted for BMI in non-smokers [men],248
5,Protein quantitative trait loci (liver) [HADHB],64
5,Arthritis (juvenile idiopathic),75366
5,Platelet-to-lymphocyte ratio,15335
5,Serum levels of protein TXNDC15,13108
5,Trunk fat-free mass,134392
5,"""Malignant neoplasm of breast, HER-negative (controls excluding all cancers)""",11087
5,Serum metabolite levels [3-aminoisobutyrate],1914
5,Obesity due to excess calories,37
5,Eye color traits [Eye color],185
5,Frequency of walking for pleasure in last 4 weeks,127
5,Protein quantitative trait loci (liver) [RBP1],16
5,Lipid traits (pleiotropy) (HIPO component 1),4448
5,Feeling worry,60139
5,Urinary albumin-to-creatinine ratio,48095
5,Body mass index [EA],4974
5,Vertical cup-disc ratio,3403
5,Philtrum width,5956
5,Neuroblastoma (pediatric),8268
5,Hypothyroidism nos,7050
5,Systemic lupus erythematosus and Systemic sclerosis,457
5,"""Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)""",4495
5,Lamotrigine | treatment/medication code,970
5,Brain region volumes [left putamen],146
5,Electrocardiogram morphology (amplitude at temporal datapoints) [184 ms],86
5,N-acetylhistidine levels,9
5,Pediatric autoimmune diseases,17578
5,Estimated glomerular filtration rate in diabetes,3127
5,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)",9600
5,Hand grip strength (left),35894
5,Asthma/COPD (KELA code 203),22949
5,Relative age voice broke,2914
5,"Blood metabolite ratios [X-12038/bradykinin, des-arg(9]",994
5,Skin aging (microtopography measurement),371
5,Sunburns,1103
5,Glaucoma (multi-trait analysis),2875
5,"Pulse pressure [EA, initial]",500
5,Type of accident,191
5,"Blood protein levels [SEMA5A, 13132_14_3]",70
5,Protein quantitative trait loci (liver) [MT1H],76
5,"Blood protein levels [RAB5C, 14287_6_3]",15
5,Smoking status (ever vs never smokers),15947
5,Brain morphology (min-P),28397
5,6mm strong meridian (right),16563
5,Squamous cell lung carcinoma,5108
5,QRS complex (Sokolow-Lyon) [EA],1458
5,Myeloproliferative disease,138
5,"Hypertension | non-cancer illness code, self-reported",44352
5,"""Malignant neoplasm of breast, HER2-negative""",14023
5,Lung function (FEV1),5004
5,Body mass index (joint analysis main effects and smoking interaction),8752
5,Zinc product | treatment/medication code,349
5,Smoking initiation (ever regular vs never regular) [Conditioned on chr5:106825618],663
5,Nicotine product | treatment/medication code,302
5,Electrocardiogram morphology (amplitude at temporal datapoints) [74 ms],553
5,Protein quantitative trait loci (liver) [GARS],221
5,Serum metabolite levels [X-11445],452
5,Urinary metabolites [histidine/τ-methylhistidine],292
5,Rarely/never | workplace very hot,34
5,Protein quantitative trait loci (liver) [SHMT1],3
5,Coprobacter secundus abundance in stool,1
5,Pattern 4 | hair/balding pattern,7674
5,Waist-hip ratio and systolic blood pressure (pairwise),4435
5,Electrocardiogram morphology (amplitude at temporal datapoints) [30 ms],491
5,Mood instability,1019
5,Schizophrenia (MTAG),35647
5,Mean arterial pressure,17759
5,QRS duration,2926
5,Dermatologic disease,658
5,Childhood asthma with severe exacerbations,1864
5,"Urinary metabolites (H-NMR features) [2.6075, Aminoisobutyrate]",118
5,Serum uric acid levels [Japanese],20279
5,"Total cholesterol levels [Asian initial, BMI unadjusted]",1840
5,Protein quantitative trait loci (liver) [FERMT2],557
5,Protein quantitative trait loci (liver) [RNASE2],97
5,"Blood protein levels [C9, 2292_17_4]",398
5,"Blood protein levels [C9, 13722_105_3]",441
5,Benign neoplasm of breast,8
5,Apolipoprotein B levels,44938
5,Skin pigmentation traits [Skin sensitivity to sun phototype score],185
5,Circulating vasoactive peptide levels [ADM],994
5,Rate of cognitive decline in Alzheimer's disease [GEE model],756
5,"Icd10: c18.9 colon, unspecified | underlying (primary) cause of death",43
5,Hydroxyasparagine levels,7394
5,White matter microstructure (mean diusivities) [External capsule ],133
5,Macular telangiectasia type 2,1376
5,Hypothyroidism or myxedema,14601
5,"""Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified""",21848
5,Anthropometric traits [height],1918
5,Yes | hearing difficulty/problems,3165
5,Body fat distribution (leg fat ratio),3929
5,"Blood protein levels [EA, Complement component C7]",1743
5,Cardioembolic stroke (CCSc classification),1348
5,"Loneliness, isolation",856
5,Diseases of sebaceous glands,2509
5,Mean platelet volume,692689
5,Parkinson's disease,5888
5,Impedance of leg (left),120039
5,CD127 on CD28+ CD45RA+ CD8+ T cell,1207
5,Liver enzyme levels (alkaline phosphatase),9371
5,Lung cancer | illnesses of father,2357
5,Hyperinsulinemia in lower physical activity,276
5,Body fat distribution (leg fat ratio) [females],2920
5,"Skin, hair and eye pigmentation (multivariate analysis)",319
5,Sebaceous cyst,2568
5,Electrocardiogram morphology (amplitude at temporal datapoints) [24 ms],491
5,Myocardial fractal dimension (slice 3),360
5,Symptoms in COVID-19 outpatients at risk of severe disease (time to remission),177
5,Drive faster than motorway speed limit,276
5,Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab),55
5,Serum levels of protein CLEC12B,15
5,Bacteroides stercoris abundance in stool,9
5,Obesity [Obesity class I],10190
5,Disorders of lipoprotein metabolism and other lipidaemias,2398
5,A levels/as levels or equivalent | qualifications,7817
5,"Age hay fever, rhinitis or eczema diagnosed",3070
5,Cerebrospinal fluid biomarker levels [Hyaluronan and proteoglycan link protein 1],384
5,Parkinson's disease or first degree relation to individual with Parkinson's disease,74236
5,White matter microstructure (radial diusivities) [Posterior limb of internal capsule],14128
5,Weight gain in amisulpride-treated first-episode psychosis,3979
5,Palmar fascial fibromatosis [Dupuytren],5926
5,4-chlorobenzoic acid levels,401
5,Icd10: c56 malignant neoplasm of ovary | underlying (primary) cause of death,246
5,Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis),156
5,Serum levels of protein ZAP70,15
5,"Blood protein levels [ENTPD1, 3182_38_2]",15
5,Body mass index (joint analysis main effects and physical activity interaction),3418
5,CD14 on CD14+ CD16+ monocyte,18185
5,A body shape index,37197
5,X-23308 levels,427
5,Hypertensive diseases (excluding secondary),2430
5,Infantile hypertrophic pyloric stenosis [EA],641
5,Actinic keratosis,1896
5,Leukocyte telomere length [East Asian],234
5,Rheumatoid arthritis (ACPA-negative),163
5,Human milk oligosaccharide concentration (difucosyllacto-N-hexaose) in non-secretors,44
5,Essential (haemorrhagic) thrombocythaemia,170
5,Neutrophill percentage,174023
5,Age-related hearing impairment [additive],5749
5,"Dark brown | hair colour (natural, before greying)",6241
5,Diabetes | illnesses of father,366
5,"Blood protein levels [HAVCR1, 9021_1_3]",655
5,Endometriosis,1566
5,"Asthma | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",25073
5,Thyrotoxicosis with toxic multinodular goitre,437
5,Urate levels [women],341
5,Serum levels of protein GPNMB,994
5,Metabolite levels [betaine],843
5,Serum levels of protein AZGP1,15
5,IgG sialylation phenotypes (multivariate analysis),3102
5,Menarche and menopause (age at onset) [age at natural menopause],8585
5,Trunk predicted mass,126118
5,Tumor necrosis factor receptor 2 levels,8838
5,Cancer of urinary organs (incl. kidney and bladder),2603
5,CD127 on CD45RA+ CD4+ T cell,1216
5,Pattern 3 | hair/balding pattern,648
5,Electrocardiogram morphology (amplitude at temporal datapoints) [292 ms],776
5,Dimensional psychopathology (Social),31
5,Longevity (90 years and older),34
5,"Forced expiratory volume in 1-second (fev1), predicted",72504
5,Protein quantitative trait loci (liver) [BHMT],1953
5,Urinary albumin excretion (no hypertensive medication),785
5,Cancer (pleiotropy),792
5,Type 2 diabetes or prostate cancer (pleiotropy),2216
5,Serum levels of protein GZMK,200
5,Diseases of the musculoskeletal system and connective tissue,36
5,Malignant neoplasm,22
5,Cortical volume [Pars opercularis],5
5,Soft tissue disorders,1
5,Immature fraction of reticulocytes,184489
5,Smoking status,17644
5,Metabolite levels [dimethylglycine],1269
5,Lyrica 25mg capsule | treatment/medication code,17973
5,Processed meat intake,1042
5,Cortical surface area [Insula],73
5,Microalbumin in urine,58
5,"""Cluster headache, wide,, including avohilmo""",56
5,Serum levels of protein SKIL,15
5,Opiates and related narcotics causing adverse effects in therapeutic use,11
5,3mm asymmetry index (left),9
5,Malignant neoplasm of breast (controls excluding all cancers),14084
5,Protein quantitative trait loci (liver) [HBG1],504
5,Ever smoked,108
5,Protein quantitative trait loci (liver) [TTC36],22
5,Childhood asthma (age<16) (more control exclusions),10
5,Episodal and paroxysmal disorders,20
5,Alcohol consumption (drinks per week) (MTAG),24241
5,Serum urea levels,25389
5,"Cholesterol lowering medication | medication for cholesterol, blood pressure or diabetes",2623
5,Mean corpuscular haemoglobin,16885
5,Glaucoma,4362
5,Serum metabolite levels [Dimethyl-glycine],1269
5,Fibroblastic disorders,10
5,Kela-code for behavioural disturbances in mental retardation,4
5,Total cholesterol levels,107310
5,Malignant neoplasm of breast,14020
5,Infantile hypertrophic pyloric stenosis,10707
5,Insulinogenic index,1154
5,Cardiorespiratory fitness (vo2 max),1521
5,Number of days/week walked 10+ minutes,115
5,Tea consumption,2886
5,Nonsyndromic cleft lip,25042
5,Inflammatory skin disease [Psoriasis],10421
5,Systolic blood pressure [Japanese],241
5,Colorectal cancer,11613
5,Heel bone mineral density (bmd) (left),2407
5,"Eczema/dermatitis | non-cancer illness code, self-reported",2291
5,Other malignant neoplasms of skin (=non-melanoma skin cancer) (controls excluding all cancers),849
5,Metabolite levels,994
5,Serum lipopolysaccharide activity,994
5,Smoking initiation (ever regular vs never regular) [Conditioned on chr5:166989513],105
5,"Blood protein levels [MCEMP1, 6283_60_3]",15
5,Myeloid white cell count,116287
5,"Allergic disease (asthma, hay fever or eczema)",37556
5,Fasting blood proinsulin levels,718
5,"Systolic blood pressure x alcohol consumption interaction (2df test) [EA, Hispanic]",129
5,Aortic vascular smooth muscle cell proliferation in response to IL-1 beta,17
5,Height,731898
5,Brain region volumes [grey matter],661
5,Serum levels of protein NPW,994
5,Aerodigestive squamous cell cancer (pleiotropy),2568
5,Pork intake,418
5,Sleep-related phenotypes [Sleepiness],221
5,"Hair colour (natural, before greying): Black (UKB data field 1747_5)",10
5,Angiotensin-converting enzyme inhibitor intolerance,9
5,Waist-hip ratio,224659
5,"""Hypertension, essential""",2487
5,Behcet's disease [All Turkish cases - Recessive Model],7790
5,Medication use (antihistamines for systemic use),4310
5,Lipid traits [LDL],2374
5,Optic cup area,1448
5,Self-harm ideation,40
5,"""Type 2 diabetes, definitions combined, including avohilmo""",129
5,White matter microstructure (radial diusivities) [Inferior fronto-occipital fasciculus],417
5,Mitochondrial DNA copy number,184
5,Black vs. red hair color,371
5,"""Atopic dermatitis, strict definition with reimbursement""",294
5,"Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) [Asian, EA]",135
6,HTLV-1 associated myelopathy,153186
6,"Blood protein levels [PIK3CG, 3391_10_2]",11021
6,Brain region volumes [right cerebellum white matter],1283
6,"Metabolite levels [Ala, Tyr]",3065
6,Anxious temperament,117
6,Visceral adipose tissue/subcutaneous adipose tissue ratio,250
6,Cholelithiasis,214
6,Home location - north co-ordinate (rounded),474
6,Electrocardiogram morphology (amplitude at temporal datapoints) [286 ms],3633
6,White matter microstructure (radial diusivities) [Anterior corona radiata],5049
6,OTU97_23 (Faecalibacterium) prevalence,151
6,Endometriosis of uterus,407
6,Gut microbiota (functional units) [PWY-5345_superpathway_of_L-methionine_biosynthesis_(by_sulfhydrylation],98
6,Tumor necrosis factor receptor 1 levels,72
6,Peak expiratory flow,335661
6,Serum levels of protein IL34,14017
6,"None of the above | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",32093
6,"Blonde | hair colour (natural, before greying)",8610
6,"Blood protein levels [IL15, 10795_32_3]",10591
6,Myeloproliferative neoplasms,2166
6,Brain region volumes [left pallidum],11585
6,Facial morphology [right endocanthion-nasion distance],376
6,Electrocardiogram morphology (amplitude at temporal datapoints) [72 ms],3280
6,Serum metabolite levels [tyrosine],632
6,Protein quantitative trait loci (liver) [HBD],391
6,Skin pigmentation traits [Skin color phototype score],44
6,Ceramide_42:1_[M+H-H2O]1+ levels,80
6,Breast cancer in BRCA2 mutation carriers,226
6,Sum neutrophil eosinophil counts,261773
6,Body fat distribution (leg fat ratio),36163
6,Dried fruit intake,21515
6,"Blood protein levels [CDK8 CCNC, 3359_11_2]",11021
6,Sitting height,229329
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-10 ms],4375
6,Contraceptive management,311
6,"""Valgus deformity, not elsewhere classified""",80
6,Facial morphology (segment 53),1318
6,Hair morphology traits [Hair color (brown],44
6,Gut microbiota (bacterial taxa) [k__Archaea|p__Euryarchaeota|c__Methanobacteria|o__Methanobacteriales|f__Methanobacteriaceae],1
6,Erythrocyte thioguanine concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia,3061
6,Beef consumption,10518
6,Complement C4 levels,101435
6,Gamma glutamyl transpeptidase,46141
6,"Blood protein levels [RAB17, 11118_107_3]",11021
6,CD20 on IgD+ CD38- B cell,245
6,Hip circumference adjusted for BMI [men],95
6,Small cell lung carcinoma,91114
6,Major depressive episode treated with electroconvulsive therapy,19571
6,Liver enzyme levels (alanine transaminase),64948
6,"Blood protein levels [CCL1, 2770_51_2]",11021
6,HDL cholesterol levels x short total sleep time interaction (2df test),9328
6,Hypospadias,236
6,Protein quantitative trait loci (liver) [ARSA],763
6,Protein quantitative trait loci (liver) [EPHX1],3
6,Homocysteine levels,38604
6,Sarcoidosis (Lofgren's syndrome),79914
6,Major depressive disorder (lifetime),17690
6,CD4 on CD39+ secreting CD4 regulatory T cell,70650
6,Gluten-free | type of special diet followed,52913
6,Electrocardiogram morphology (amplitude at temporal datapoints) [356 ms],3280
6,Dentures,16077
6,IgD on unswitched memory B cell,6285
6,"Blood protein levels [MANEA, 8014_359_3]",2909
6,Skin pigmentation traits [Skin sensitivity to sun (high-medium to low-medium],44
6,Delirium dementia and amnestic and other cognitive disorders,13
6,Diseases of esophagus,104072
6,Asthma (childhood onset),342655
6,Parkinson's disease or first degree relation to individual with Parkinson's disease,167136
6,Serum levels of protein KLK6,16139
6,Serum levels of protein CFB,62055
6,Eosinophill count,322503
6,Celiac disease (PheCode 557.1),3031
6,Monocyte count [Japanese],2477
6,Breast cancer,136380
6,"Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)",87105
6,Serum levels of protein LDLRAD4,9219
6,"Blood protein levels [C2, 3186_2_2]",34752
6,"""Artrosis, including avohilmo""",8
6,White blood cell count (basophil),57289
6,Mixed cellularity Hodgkin lymphoma,33458
6,Pemphigus foliaceus,102053
6,Irritable bowel syndrome,60985
6,Serum levels of protein ENTPD3,16139
6,"Blood protein levels [MST1R, 2640_3_2]",11021
6,Atrial fibrillation [EA],7045
6,Waist-to-hip ratio adjusted for BMI in non-smokers [women],1630
6,Pattern 2 | hair/balding pattern,5071
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-486 ms],353
6,"Heart rate [Conditional on rs1015451, rs11154027]",269
6,Endometriosis [EA],265
6,Kawasaki disease,219085
6,Vogt-Koyanagi-Harada syndrome,236846
6,Medication use (thyroid preparations),185510
6,Medication use (salicylic acid and derivatives),26985
6,Electrocardiogram morphology (amplitude at temporal datapoints) [178 ms],10824
6,"Blood protein levels [ZNF276, 14692_3_3]",11021
6,Lobe attachment (rater scored),944
6,Femoral neck bone mineral density,978
6,Brain region volumes [left ventral DC],1292
6,Adult body size,186473
6,"Medication use (anti-inflammatory and antirheumatic products, non-steroids)",31225
6,HDL cholesterol levels [EA],352
6,"Waist circumference adjusted for body mass index [EA, women]",1431
6,Autism spe,256
6,Parental longevity (both parents in top 10%),80
6,Coronary heart disease,42995
6,Epstein Barr virus nuclear antigen 1 IgG levels,72873
6,EGFR mutation-positive lung adenocarcinoma,19623
6,HLA DR on CD14- CD16+ monocyte,45953
6,Bilirubin levels,55323
6,Smoking initiation (ever regular vs never regular) [Conditioned on chr6:101329173],551
6,Glaucoma (multi-trait analysis),19173
6,Serum urea levels,50375
6,Thalamus volume,848
6,"B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)",985
6,Protein quantitative trait loci (liver) [TAGLN],76
6,Lung cancer in ever smokers,541936
6,Lymphoma [NHL],273204
6,HLA DR on CD33+ HLA DR+ CD14-,23598
6,Iron status biomarkers [Unsaturated iron-binding capacity],1063
6,Metabolite levels (small molecules and protein measures) [Tyrosine],1324
6,Systemic connective tissue disorders,125
6,Spondyloarthritis,176
6,Polyarthropathies,68
6,Serum alkaline phosphatase levels [conditional on round 6],18
6,Eye color traits [Eye color phototype score],44
6,Klebsiella pneumoniae abundance in stool,4
6,"Cholesterol, total",59195
6,Sum basophil neutrophil counts,210782
6,Diaphragmatic hernia,60183
6,Neuroticism score,51232
6,Metabolite levels (lipoprotein measures) [VLDL diameter],80
6,"""Seropositive rheumatoid arthritis, strict definition""",1928
6,Aprovel 75mg tablet | treatment/medication code,459
6,"Blood protein levels [EA, CD109 antigen]",2709
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-116 ms],635
6,Serum metabolite levels [N-acetylglucosaminylasparagine],320
6,"Blood protein levels [UST, 8364_74_3]",44
6,Electrocardiogram morphology (amplitude at temporal datapoints) [304 ms],3633
6,Ceramide levels [N26S19],332
6,Blond vs non-blond hair color,44
6,Waist circumference adjusted for body mass index [women],2223
6,Electrocardiogram morphology (amplitude at temporal datapoints) [324 ms],3633
6,"Blood protein levels [POLR1C, 12939_1_3]",11021
6,Other malignant neoplasms of skin (=non-melanoma skin cancer) (controls excluding all cancers),159
6,Cognitive decline rate in late mild cognitive impairment [EA],6
6,Migraine without aura and/or pulse pressure,7600
6,"Forced vital capacity (fvc), best measure",248108
6,Other and unspecified psoriasis,6950
6,CD20 on memory B cell,2382
6,4-chlorobenzoic acid levels,1054
6,Lp (a) levels,2573
6,Medication use (antiglaucoma preparations and miotics),1565
6,"""Cholelithiasis, broad definition with cholecystitis""",220
6,"Vesicoureteral reflux [additive, female]",58
6,Thionamide-induced agranulocytosis in Graves' disease [trend],69983
6,facial morphology traits (multivariate analysis),3610
6,Total bilirubin levels,44362
6,Protein quantitative trait loci (liver) [SBDS],28109
6,"Blood protein levels [EA, Thrombospondin-2]",104
6,Sodium in urine,2881
6,Heart disease | illnesses of mother,512
6,Medication use (vasodilators used in cardiac diseases),2040
6,P wave terminal force,382
6,Faecalicatena glycyrrhizinilyticum abundance in stool,82
6,Fasting glucose [African American],56
6,Serum levels of protein BCL2L1,16139
6,Whole body fat-free mass,268330
6,Serum levels of protein CDH7,12356
6,Electrocardiogram morphology (amplitude at temporal datapoints) [272 ms],3280
6,Cerebrospinal fluid biomarker levels [Acid sphingomyelinase-like phosphodiesterase 3a],322
6,Cutaneous malignant melanoma,14437
6,Galanin peptide levels,171
6,Electrocardiogram morphology (amplitude at temporal datapoints) [34 ms],727
6,Obesity [Obesity class II],162
6,Coronary artery calcification,56
6,Serum levels of protein GNLY,115932
6,Early diabetic kidney disease in type 2 diabetes [EA],1082
6,Serum levels of protein AGER,4642
6,BRCA1/2-negative high-risk breast cancer,1280
6,Heart rate response to exercise,1414
6,Townsend deprivation index at recruitment,188
6,Blood metabolite levels [X-12244--N-acetylcarnosine],165
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-106 ms],635
6,Iron status biomarkers (transferrin saturation),8015
6,Intelligence (MTAG),219126
6,Serum metabolite levels [N-acetylglucosamine/N-acetylgalactosamine],131
6,Basophil percentage of white cells,24642
6,Total PHF-tau (SNP x SNP interaction),41407
6,Hand grip strength (left),14230
6,Trunk fat-free mass,282819
6,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant II (Nose), Segment 44]",538
6,Glomerular filtration rate (creatinine),5517
6,Plantar warts,1187
6,CD34 on Hematopoietic Stem Cell,6274
6,"Blood protein levels [NDUFB4, 10677_9_3]",11021
6,Generalized epilepsy,494
6,Electrocardiogram morphology (amplitude at temporal datapoints) [316 ms],5075
6,Glycated haemoglobin HbA1c levels adjusted for BMI,4147
6,Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease,13
6,Daytime dozing / sleeping (narcolepsy),1664
6,Furosemide | treatment/medication code,25
6,Subclinical trait of interstitial lung disease (basilar percentage of high attenuation areas on CT scan) [AA],317
6,Spontaneous coronary artery dissection,51
6,Chickenpox,112642
6,Response to hepatitis B vaccine,352214
6,Fat-free mass,44648
6,Non-chemotherapy drug induced agranulocytosis [adjusted for rs114291795],10981
6,Serum levels of protein FTMT,239591
6,Ganglion cell inner plexiform layer (GCIPL) thickness,2613
6,Ascorbate (vitamin c) levels,3893
6,Motion sickness,3044
6,Esomeprazole | treatment/medication code,221
6,Glycine levels,4852
6,Immunological or systemic disorder,6564
6,Endometrial cancer (endometrioid histology),2969
6,CD8 on CD8+ T cell,1274
6,Diabetic nephropathy (more control exclusions),1455
6,LDL cholesterol x physical activity interaction (2df test),1028
6,Barrett's esophagus  or Esophageal adenocarcinoma,30566
6,Sero-negative rheumatoid arthritis,30961
6,"Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)",324131
6,Male puberty timing (age at voice breaking MTAG),10643
6,Liver volume,13671
6,Ankle spacing width (right),25922
6,Hypertensive diseases,25757
6,CD8 on CD28- CD8+ T cell,41161
6,Kidney volume,2839
6,Urinary metabolite levels in chronic kidney disease [indolelactate],5100
6,Hematuria,132364
6,Endometriosis,10614
6,Chronotype,80786
6,Posterior thalamic nuclei volume,22271
6,Birth length (MTAG),3043
6,Podoconiosis,4765
6,Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid),7254
6,Self-reported allergy,18200
6,Type 1 diabetes and autoimmune thyroid diseases,374667
6,Albumin-globulin ratio,205588
6,Migraine and/or systolic blood pressure,7762
6,Neutralising antibody response to interferon beta therapy in multiple sclerosis (antibody titre; IFNβ-1a subcutaneous and intramuscular),121839
6,Brain region volumes [left lateral orbitofrontal],5032
6,Other systemic involvement of connective tissue (FG),44176
6,Diastolic blood pressure [Japanese],1307
6,"Blood protein levels [CLPS, 5749_53_3]",1841
6,Protein quantitative trait loci (liver) [SHMT2],129
6,Neutralising antibody response to interferon beta therapy in multiple sclerosis (antibody titre; IFNβ-1a subcutaneous),107333
6,"Blood protein levels [GLO1, 9883_29_3]",1092
6,KELA_REIMBURSEMENT_202,46509
6,"""Sacroiliitis, not elsewhere classified""",290
6,Cylindrical power (right),160
6,Acylcarnitine levels [Octadecadienylcarnitine],126
6,"Blood pressure measurement (high sodium intervention) [SBP, during intervention]",34
6,IgG levels,45744
6,Ebbinghaus illusion (overestimation),202358
6,Ankylosing spondylitis [less than],26904
6,Terminally Differentiated CD4+ T cell %T cell,109284
6,Electrocardiogram morphology (amplitude at temporal datapoints) [134 ms],6637
6,Serum levels of protein PSMD11,6979
6,Chronic kidney disease [eGFRcrea],2521
6,"Infant, child and juvenile death (proportion of children died <15 years)",212
6,Metformin | treatment/medication code,612
6,Valvular heart disease including rheumatic fever,80
6,Eye color (brightness),35
6,Skin pigmentation traits [Skin sensitivity to sun phototype score],44
6,Secondary polycythaemia,13
6,Thyrotoxicosis,43631
6,Fractures,4011
6,Bipolar disorder lithium response (continuous) or schizophrenia,28185
6,Balding type 1,17073
6,6mm weak meridian (right),132224
6,Subpleural-predominant interstitial lung abnormalities,793
6,Blood metabolite levels [Palmitoylcarnitine],126
6,Tanning,55
6,"Blood protein levels [TNXB, 5698_60_3]",24337
6,Arthritis (juvenile idiopathic),15278
6,Blood metabolite levels [inosine],6025
6,Coronary artery disease [conditional],506
6,RR interval (heart rate),1173
6,Home location at assessment - north co-ordinate (rounded),11
6,Decaffeinated coffee (any type) | coffee type,71
6,Protein quantitative trait loci (liver) [RAB14],22
6,Childhood ear infection,726320
6,Body fat percentage,249614
6,"Blood protein levels [AZGP1, 9312_8_3]",11021
6,Hepcidin/ferritin ratio,3467
6,Serum levels of protein ALB,4989
6,Lipid traits (pleiotropy) (HIPO component 2),1888
6,Naive CD4-CD8- T cell %T cell,2924
6,High blood pressure | illnesses of siblings,526
6,Dermatologic disease,1008
6,"Other exercises (eg: swimming, cycling, keep fit, bowling) | types of physical activity in last 4 weeks",277
6,Insomnia complaints,59
6,Incident myocardial infarction [EA],20
6,Type 2 diabetes,885937
6,Urinary metabolite levels in chronic kidney disease [X - 21829],5298
6,"""Diabetes, insuline treatment (Kela reimbursement)""",6008
6,Change in intraocular pressure in response to steroid treatment (triamcinolone acetonide),8206
6,"Blood protein levels [EA, Alpha-2-macroglobulin receptor-associated protein]",15355
6,Protein quantitative trait loci (liver) [CKB],12768
6,Other medical care,80
6,Fat-free mass [female],34593
6,acne vulgaris,16443
6,Arm fat mass (right),83929
6,Autoimmune traits (pleiotropy),1542
6,Digit length ratio,59
6,Hepatic cancer,1807
6,Serum levels of protein TRIL,14017
6,Urinary metabolite levels in chronic kidney disease [X - 15497 ],6218
6,Haemoglobin concentration,291552
6,Electrocardiogram morphology (amplitude at temporal datapoints) [312 ms],5191
6,Diabetic ketoacidosis,536
6,Primary open-angle glaucoma,127
6,Aortic-valve calcification [EA],70
6,Methylmalonate (mma) levels,109
6,Asthma (adult onset),198319
6,Leukocyte telomere length,39143
6,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) [Modelling analysis]",8177
6,Serum levels of protein TPM2,16139
6,Vitamin C levels,10865
6,Electrocardiogram morphology (amplitude at temporal datapoints) [68 ms],3280
6,Asthma (only as main-diagnosis) (more control exclusions),1273
6,Serum levels of protein LPO,342
6,Retinal nerve fibre layer (RNFL) thickness,966
6,Cortical surface area (min-P),839
6,Bone properties (heel) [BUA],2334
6,Autism spectrum disorder (MTAG),40376
6,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [3-hydroxysebacate, X-13874, X-18888, X-18938, X-21827]",4724
6,Serum levels of protein RACGAP1,34994
6,Corneal curvature,1436
6,Morning person,3411
6,White wine liking,4378
6,Atenolol | treatment/medication code,1312
6,Blood metabolite levels [X-12798],797
6,Electrocardiogram morphology (amplitude at temporal datapoints) [94 ms],128
6,Electrocardiogram morphology (amplitude at temporal datapoints) [230 ms],123
6,White matter microstructure (mode of anisotropy) [Retrolenticular part of internal capsule],753
6,Testicular germ cell tumor,123465
6,Respiratory diseases,18674
6,Acute anterior uveitis (with or without ankylosing spondylitis),26904
6,Basophil count,499257
6,"Blood protein levels [CLK2, 11327_56_3]",11021
6,"Total cholesterol levels [Asian initial, BMI unadjusted]",242
6,"Yes, because of other reasons | major dietary changes in the last 5 years",1187
6,Left atrial active emptying fraction,33
6,"Sexual dimorphism in anthropometric traits [WHRadjBMI, women]",150
6,Total amyloid (SNP x SNP interaction),349
6,Narcolepsy (age of onset),24089
6,"Sarcoidosis | non-cancer illness code, self-reported",159336
6,Interleukin-7 levels,1214
6,Postydysenteric arthropathy,961
6,Lobe attachment (rater-scored or self-reported) [EA],834
6,Iron status biomarkers [Total iron-binding capacity],1063
6,Corneal astigmatism,86
6,Non-chemotherapy drug induced agranulocytosis,26904
6,"Blood protein levels [FCER1A, 9254_18_3]",11021
6,"Urinary metabolite levels in chronic kidney disease [adenosine 3',5'-cyclic monophosphate (cAMP]",5100
6,Bread intake,56149
6,Leg fat-free mass (left),262447
6,Arm fat percentage (left),150854
6,"""Delivery, wide proxy""",3291
6,Heat shock 27 kDa protein levels,5677
6,Alzheimer's disease (cognitive decline),380
6,CD24 on unswitched memory B cell,475
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-120 ms],635
6,Metabolite levels [DAG 36:1],100
6,Urate levels [AA],51
6,"""Sleep disorders, other/unspeficied""",44
6,General cognitive ability,219448
6,Primary sclerosing cholangitis,180802
6,Pulse pressure,282388
6,Daytime nap,40112
6,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],31298
6,"Gynecologic disease (multivariate analysis) [uterine fibroid, uterine cervical cancer]",13369
6,Heart disease | illnesses of adopted siblings,1940
6,Blood protein levels [VEGFA],1052
6,Baclofen | treatment/medication code,1913
6,Gliclazide | treatment/medication code,1112
6,Dysphagia,50
6,Bone ultrasound measurement (broadband ultrasound attenuation) [male],343
6,Freckles,93
6,Type 1 diabetes with renal complications,78
6,Axial length,20
6,Serum albumin levels,76896
6,HLA DR on CD33- HLA DR+,34869
6,Mean spheric corpuscular volume,319598
6,"""Type 2 diabetes, definitions combined, including avohilmo""",4351
6,Sudden cardiac arrest [Recessive],134
6,C-reactive protein levels or triglyceride levels (pleiotropy),28852
6,Age started wearing glasses or contact lenses,35861
6,Language functional connectivity,5141
6,DNA methylation GrimAge acceleration,12566
6,Strenuous sports | types of physical activity in last 4 weeks,16143
6,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [X-13529, X-15497, X-18889, X-19561, X-22102]",6218
6,Serum metabolite levels [N-acetylcarnosine],1608
6,Qrs duration,905
6,"Urinary metabolite levels in chronic kidney disease [Butyrylcarnitine, Isobutyrylcarnitine]",93
6,Glaucoma (low intraocular pressure),160
6,Basal metabolic rate,304540
6,"Takayasu arteritis [conditional on rs2844678, rs9262437, rs61444472 and rs17193507]",269255
6,Hemoglobin A1c levels,292866
6,Pemphigus,7759
6,Electrocardiogram morphology (amplitude at temporal datapoints) [116 ms],6372
6,Optic disc size,7306
6,Spinal canal stenosis,3199
6,Coronary atherosclerosis,3678
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-118 ms],635
6,Bone mineral density (hip),970
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-104 ms],635
6,Carotid Intima-media thickness (mean of the maximum cIMT),214
6,C-C motif chemokine 20 levels,296
6,Facial morphology (segment 23),989
6,Fasting plasma glucose,18652
6,Hepatocellular carcinoma in hepatitis B infection [Japanese],141870
6,"Blood protein levels [AHSA1, 11633_89_3]",11021
6,Diastolic blood pressure x smoking status (ever vs never) interaction (2df test),28355
6,Colonoscopy-negative controls vs population controls,14244
6,Foot ulcer in diabetes and neuropathy,5740
6,Occipital lobe volume,187
6,White matter hyperintensity volume,637
6,Facial pigmentation,44
6,Klebsiella abundance in stool,7
6,LDL cholesterol,454457
6,Neutrophil percentage of granulocytes,123057
6,Educational attainment (years of education) [conditional-joint],81861
6,Serum metabolite levels (CMS) [XL_HDL_L],395
6,Type 1 diabetes with ketoacidosis,1248
6,Body mass index and systole blood pressure (pairwise),4843
6,Coffee intake,1467
6,Interstitial lung abnormalities [EA],604
6,Diastolic blood pressure x sodium interaction (1df test),36
6,Chronic obstructive pulmonary disease [conditional on rs9399401],153
6,High myopia,458
6,CD28 on CD45RA+ CD4+ T cell,58
6,Hepatitis B vaccine response,105710
6,Serotransferrin measurement,42166
6,Aspirin | treatment/medication code,518
6,Primary biliary cholangitis,139860
6,Heart rate response to beta blockers [AA],2335
6,Body fat percentage variance,48324
6,"Body mass index (joint analysis main effects and physical activity interaction) [EA, women]",28277
6,Serum creatinine levels,46454
6,Serum levels of protein C6orf25,43423
6,"Blood protein levels [RACGAP1, 13587_10_3]",30710
6,Effector Memory CD8+ T cell Absolute Count,3073
6,Biological medication for rheuma,176
6,Major coronary heart disease event excluding revascularizations,108
6,F-cell distribution,1632
6,Polymyositis,174079
6,Adventurousness,23012
6,Triglyceride levels [EA],23876
6,Direct low density lipoprotein cholesterol levels,69462
6,Neutralising antibody response to interferon beta therapy in multiple sclerosis (antibody titre; IFNβ-1b subcutaneous),179366
6,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C38:5/Phosphatidylcholine with diacyl residue sum C42:5],1519
6,Electrocardiogram morphology (amplitude at temporal datapoints) [280 ms],3633
6,Renal function-related traits (sCR),4466
6,Serum levels of protein PREP,975
6,"Waist circumference adjusted for BMI in active individuals [EA,women]",631
6,Body mass index in physically active individuals [women],160
6,Spondylopathies,529
6,Prostate cancer [conditioned on rs9364554],13
6,Retinal breaks without detachment,1
6,Protein quantitative trait loci (liver) [MARC2],2
6,White matter microstructure (mean diusivities) [Anterior corona radiata],9349
6,Cutaneous mastocytosis,64020
6,Diastolic blood pressure x smoking status (ever vs never) interaction (2df test) [EA],37198
6,Estimated glomerular filtration rate [EA],105079
6,Tumor necrosis factor beta levels,3253
6,Interstitial lung disease endpoints,511
6,Neuroticism,402702
6,"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment",63270
6,Fasting insulin,11681
6,Electrocardiogram morphology (amplitude at temporal datapoints) [150 ms],7085
6,Electrocardiogram morphology (amplitude at temporal datapoints) [302 ms],5075
6,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction),10504
6,Alcohol intake frequency.,9729
6,Atrial fibrillation [Japanese],731
6,Electrocardiogram morphology (amplitude at temporal datapoints) [288 ms],3633
6,Cataracts,1969
6,"Blood clot in the lung | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",137
6,Ulcerative colitis [Analysis III],2207
6,malignant neoplasm of male genital organs,13
6,Smoking initiation (ever regular vs never regular) (MTAG),130555
6,Adult onset asthma or type 2 diabetes,67326
6,Left-handedness,62609
6,Benign prostatic hyperplasia and lower urinary tract symptoms,16382
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-122 ms],635
6,Body mass index (adult) [AA],827
6,Dyslipidemia,432
6,Western dietary pattern,66
6,Schizophrenia [EA],182792
6,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test),28580
6,Bipolar I disorder,68641
6,Impedance of arm (left),71220
6,QRS complex (12-leadsum) [EA],415
6,Lung function (forced vital capacity) [EA],467
6,"Systolic blood pressure x alcohol consumption interaction (2df test) [AA, Asian, EA]",426
6,Visceral fat [adjusted for total body fat],31
6,Lipoprotein-associated phospholipase A2 activity and mass [Activity concentrations],810
6,Celiac disease,474934
6,CD8 on Effector Memory CD8+ T cell,76409
6,Bone properties (heel) [VOS],2523
6,Puberty onset,874
6,Plasma thyroid-stimulating hormone levels,1626
6,"""Type 1 diabetes, strict definition""",1275
6,Pulse wave reflection index,5
6,Hearing difficulty/problems with background noise,54515
6,Hyperthyroidism or thyrotoxicosis,210124
6,"Heel bone mineral density (bmd) t-score, automated",143411
6,"Blood pressure medication | medication for cholesterol, blood pressure or diabetes",7534
6,Cathepsin L1 levels,1808
6,Protein quantitative trait loci (liver) [COL18A1],42
6,Body fat percentage [male],12589
6,Chronic sinusitis,185069
6,Drive faster than motorway speed limit,6751
6,Hammer toe (acquired),447
6,Peripheral vascular disease,80
6,Creatine kinase M-type:Creatine kinase B-type heterodimer measurement,12
6,"Blood protein levels [IGF2R, 3676_15_3]",118
6,Brain region volumes [cerebellar vermal lobules VI VII],3
6,Gut microbiota (bacterial taxa) [k__Archaea|p__Euryarchaeota|c__Methanobacteria],1
6,Serum metabolite levels [VLDL_TG],63634
6,"Blood protein levels [MOCS3, 14229_5_3]",11021
6,Serum levels of protein APOM,18863
6,Cardiac dysrhythmias,796
6,"Blood protein levels [VEGFA, 4867_15_2]",227
6,"Blood protein levels [TREML2, 5736_1_3]",444
6,Unstable angina (intermediate coronary syndrome),665
6,Electrocardiogram morphology (amplitude at temporal datapoints) [250 ms],717
6,Participation in an health questionnaire (not invited vs invited),350
6,Scarlet fever,38430
6,Non-small cell lung cancer,83488
6,Body fat distribution (leg fat ratio) [females],38250
6,Hyperthyroidism,70099
6,Serum levels of protein ANXA10,16139
6,Serum levels of protein RAD51,16139
6,Electrocardiogram morphology (amplitude at temporal datapoints) [292 ms],3633
6,Nevus count or cutaneous melanoma,878
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-8 ms],387
6,Body mass index (SNP x SNP interaction),707
6,Psoriatic arthritis,257843
6,Highest math class taken,111667
6,"Blood protein levels [COL11A2, 11278_4_3]",5380
6,Electrocardiogram morphology (amplitude at temporal datapoints) [98 ms],3220
6,Pubertal anthropometrics [Late pubertal growth],831
6,Iron status biomarkers [sTfR],1117
6,Total body bone mineral density,14233
6,Waist-hip ratio,514251
6,"Ground coffee (include espresso, filter etc) | coffee type",18225
6,Serum levels of protein VEGFA,2156
6,Other disorders of arteries and arterioles,1199
6,Bipolar disorder or attention deficit hyperactivity disorder,3391
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-96 ms],635
6,Vitiligo (late onset),183276
6,Carbamazepine-induced serious cutaneous adverse reaction,12147
6,Serum metabolite levels (CMS) [VLDL_TG],63634
6,Impedance of leg (left),146217
6,Waist circumference adjusted for BMI in non-smokers,9762
6,Childhood maltreatment,4695
6,Serum levels of protein RSPO3,3006
6,Gaviscon liquid | treatment/medication code,252
6,Brain region volumes [CSF],331
6,Protein quantitative trait loci [MICB],154361
6,Thyroid hormone levels [TSH - Females],1472
6,"Blood protein levels [KLK12, 3199_54_2]",11021
6,Low vWF levels,939
6,Childhood dental caries in permanent teeth,55
6,Carcinoma in situ of skin (controls excluding all cancers),44
6,Phospholipid levels (plasma) [proportions],10776
6,Wheat-dependent exercise-induced anaphylaxis,29130
6,Height [Conditioned on rs2780226],22452
6,"Blood protein levels [EA, Complement factor B]",8923
6,Tumor necrosis factor receptor 2 levels,110
6,Cataract (time to event),10095
6,"Malabsorption/coeliac disease | non-cancer illness code, self-reported",211743
6,"Waist-to-hip ratio adjusted for BMI in active individuals [EA, women]",1691
6,Waist-to-hip ratio adjusted for BMI (age <50) [women],150
6,Urate levels [women],15757
6,Body mass index and triglycerides (pairwise),4993
6,Disorders of lipoid metabolism,871
6,Age-related hearing impairment [additive],6799
6,Cortical surface area [Precuneus],1462
6,Skin removed from poultry,133
6,"Mean arterial pressure x alcohol consumption interaction (2df test) [AA, Asian, EA]",426
6,Lung function (FVC),437432
6,Receptor for advanced glycosylation end products levels,62236
6,Serum levels of protein ZNF276,16139
6,Cerebrospinal fluid biomarker levels [Complement factor B],7945
6,HDL cholesterol levels [Trans-ethnic initial],2841
6,Carpal tunnel syndrome,9709
6,Ear morphology,802
6,Protein quantitative trait loci (liver) [FUCA1],50
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-488 ms],353
6,Arterial embolism and thrombosis of lower extremity artery,155
6,Cerebral blood flow [right carotid flow velocity],8355
6,Hodgkin's lymphoma [Total cHL],259555
6,IgD on IgD+ CD38+ B cell,16382
6,HLA DR on plasmacytoid Dendritic Cell,14066
6,Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis),11328
6,3mm weak meridian (right),117852
6,Lymphocyte count,213670
6,Brain region volumes [Brain stem],1993
6,Serum levels of protein CLPS,2005
6,Electrocardiogram morphology (amplitude at temporal datapoints) [328 ms],3633
6,Plasminogen measurement,1074
6,Ezetimibe | treatment/medication code,512
6,Response to statins (LDL cholesterol percent change),80
6,Nodular sclerosis Hodgkin lymphoma,62086
6,FEV1,125453
6,Coffee consumption (cups per day),72212
6,CD4+/CD8+ T cell,7522
6,"Blood protein levels [RSPO3, 13094_75_3]",1503
6,Reiter disease,1194
6,Benign neoplasms,303
6,Fetal hemoglobin levels in sickle cell anemia,226
6,Anaeromassilibacillus sp001305115 abundance in stool,5
6,Nephrotic syndrome,4857
6,Serum levels of protein PRTN3,243349
6,Serum levels of protein UXS1,6911
6,CD4+ CD8dim T cell %leukocyte,8023
6,Electrocardiogram morphology (amplitude at temporal datapoints) [96 ms],3220
6,Waist circumference adjusted for BMI (adjusted for smoking behaviour) [women],2439
6,"""Atopic  dermatitis, strict definition""",422
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-98 ms],635
6,Bipolar disorder and schizophrenia,344
6,"Lymphoid leukemia, chronic",123
6,LDL cholesterol x physical activity interaction (2df test) [EA],114
6,Body mass index in physically active individuals,160
6,Gastroesophageal reflux disease,190754
6,Bipolar disorder or major depressive disorder,57776
6,Serum levels of protein IGF2R,125089
6,Serum metabolite levels [S-adenosylhomocysteine (SAH],194479
6,"Sjogren's syndrome/sicca syndrome | non-cancer illness code, self-reported",54097
6,Noninflammatory disorders of female genital tract,447
6,Advanced glycation end-product levels [Blacks],1737
6,Dermatomyositis,1588
6,Health precaution | reason former drinker stopped drinking alcohol,3184
6,Crohn's disease and celiac disease [combined],583
6,6mm asymmetry index (left),34
6,Nasopharyngeal carcinoma (SNP x SNP interaction),23566
6,Body fat percentage and type 2 diabetes (pairwise),4901
6,"Diastolic blood pressure x alcohol consumption interaction (2df test) [AA, Asian, EA, Hispanic]",1287
6,"Red blood cell traits [MCH, AA]",1548
6,"Mean arterial pressure x alcohol consumption interaction (2df test) [AA, Asian, EA, Hispanic]",1287
6,Firmicutes E abundance in stool,258
6,Granulocyte count,212291
6,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)",27547
6,Serum levels of protein PDIA5,173397
6,"Blood protein levels [EA, MHC class I polypeptide-related sequence B]",75808
6,"Heel bone mineral density (bmd) t-score, automated (left)",19326
6,"Gout | non-cancer illness code, self-reported",37358
6,Resistin levels,3024
6,Spells in hospital,1174
6,Epithelial ovarian cancer [Serous],1358
6,Glaucoma (primary open-angle),39541
6,Hepatitis C (spontaneous viral clearance) [female],43807
6,Chronic glomerulonephritis,18211
6,Electrocardiogram morphology (amplitude at temporal datapoints) [114 ms],6377
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-30 ms],372
6,Myocardial fractal dimension (slice 8),2787
6,Immunoglobulin A vasculitis,128526
6,Nonalcoholic fatty liver disease (imputed),82950
6,Yes | hearing difficulty/problems,7650
6,Diabetes diagnosed by doctor,982
6,Urate levels in overweight individuals,5298
6,Chlamydia trachomatis momp D antibody levels,531
6,Adiposity [WC],171
6,"Parental longevity (combined parental attained age, Martingale residuals)",107
6,Sarcoidosis [Chronic],25099
6,Asthma and hay fever,246022
6,Cardiovascular disease,142857
6,Sunburns,6434
6,Serum metabolite levels [Tyr],6760
6,Gastric polyp,26
6,Mean corpuscular volume [Asian],154
6,Alcohol consumption (drinks per week),56
6,Serum levels of protein IFNAR1,10350
6,White matter microstructure (radial diusivities) [Superior corona radiata],9332
6,"Hereditary/genetic haematological disorder | non-cancer illness code, self-reported",7017
6,Place of birth in uk - north co-ordinate,13021
6,Brown vs. black hair color,2679
6,Metabolic traits [isoleucine/tyrosine + 10 other traits],3563
6,Insomnia [males],59
6,Cortical surface area (global PC1) [EA],20
6,Age of smoking initiation (MTAG),26978
6,Waist circumference adjusted for BMI in active individuals [EA],9534
6,Serum levels of protein PCDHB4,16139
6,Serum levels of protein CA4,16139
6,"Blood protein levels [IL34, 4556_10_2]",11021
6,Fasciitis,4335
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-34 ms],372
6,Nap during day,3626
6,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [women],2223
6,Osteoarthritis of the hip or knee (with total joint replacement),2705
6,Type 2 diabetes without complications,467
6,Atopic asthma,89172
6,Lipoprotein-associated phospholipase A2 activity and mass [Mass concentrations],5316
6,Brain region volumes [left putamen],6105
6,Cholesteryl ester_22:6_[M+NH4]1+ levels,1519
6,Heart attack | vascular/heart problems diagnosed by doctor,170
6,Worrier / anxious feelings,323
6,Hair morphology traits [Hair color (black],44
6,Asthma [EA],254
6,Malignant neoplasm of prostate (controls excluding all cancers),13
6,Electrocardiogram morphology (amplitude at temporal datapoints) [132 ms],7379
6,Smoking behaviour (cigarettes smoked per day),9410
6,Type 1 diabetes with other specified/multiple/unspecified complications,5604
6,Insomnia [Female],8563
6,Cardiac structure and function [LV internal diastolic dimensions],1110
6,Anthropometric traits (multi-trait analysis),1496
6,Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder,113
6,Monobrow,1408
6,Hepatitis C (spontaneous viral clearance),205492
6,Handedness (non-right-handed vs right-handed),6573
6,Waist circumference,119541
6,White blood cell types [monocyte count],25454
6,Cirrhosis of liver without mention of alcohol,3092
6,Systemic sclerosis [ACA positive],32517
6,Selective IgA deficiency,10370
6,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),58512
6,Epstein Barr virus nuclear antigen 1 IgG levels [non-Mexican American parents],186421
6,Doctor diagnosed sarcoidosis,143726
6,"Serum metabolite levels [androstenediol (3beta,17beta) disulfate (2]",8483
6,"Heel quantitative ultrasound index (qui), direct entry (left)",12152
6,Paracetamol | treatment/medication code,125697
6,Sleep duration [EA],9027
6,CD20 on CD24+ CD27+ B cell,2330
6,Lipoprotein-associated phospholipase A2 activity and mass [activity],810
6,Alzheimer's disease biomarkers [ptau],434
6,Blood metabolite levels [Acetylcarnitine],126
6,"Other professional qualifications eg: nursing, teaching | qualifications",22
6,Depressive symptoms (MTAG),326469
6,Anxiety,164879
6,Neutrophill count,312065
6,"Blood protein levels [EA, Neutrophil collagenase]",17129
6,Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in non-secretors,1507
6,Hyperparathyroidism,3261
6,Retinal vascular caliber [Retinal venular caliber],535
6,Other and unspecified intracranial injuries,44
6,Uveal melanoma,44
6,Coffee consumption,38404
6,Electrocardiogram morphology (amplitude at temporal datapoints) [172 ms],10654
6,Lichen planus,251072
6,Electrocardiographic traits (multivariate),1718
6,"Blood protein levels [TREM1, 9266_1_3]",879
6,Pantoprazole | treatment/medication code,197
6,Body mass index (joint analysis main effects and smoking interaction),74412
6,Heel bone mineral density,400025
6,White matter microstructure (fractional anisotropy) [Anterior corona radiata],5049
6,"Hip circumference adjusted for BMI [EA,men]",79212
6,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],25905
6,"Blood protein levels [LDLRAD4, 9004_24_3]",11021
6,"Hypertension | non-cancer illness code, self-reported",41582
6,Corrected insulin response,289
6,Pain in limb,163
6,Laryngeal squamous cell carcinoma,11442
6,Colorectal cancer,138687
6,Mitochondrial heteroplasmy measurement,145839
6,Hip circumference adjusted for BMI [EA],84025
6,Hematological and biochemical traits [HbA1c],744
6,Heel bone mineral density T score,98533
6,Microalbuminuria in type 1 diabetes,4521
6,Benign neoplasm of unspecified sites,291
6,Calcific tendinitis of shoulder,624
6,Hernia of abodminal wall,313
6,Ibandronic acid | treatment/medication code,1346
6,Waist circumference adjusted for BMI in active individuals [women],818
6,Protein quantitative trait loci (liver) [SERPINF1],31
6,Asthma (time to event),48494
6,Left ventricular global circumferential strain,2434
6,Total body bone mineral density [European],13021
6,Blood protein levels [TIE2],164817
6,Number of incorrect matches in round,21295
6,Lymphocyte percentage,193023
6,Headaches for 3+ months,5626
6,Scoliosis,1134
6,Electrocardiogram morphology (amplitude at temporal datapoints) [300 ms],3633
6,Electrocardiogram morphology (amplitude at temporal datapoints) [348 ms],3280
6,Electrocardiogram morphology (amplitude at temporal datapoints) [210 ms],241
6,Esophageal cancer,664
6,Bipolar disorder or body mass index,22454
6,Systolic blood pressure x alcohol consumption interaction (2df test) [EA],4968
6,Leg fat-free mass (right),248633
6,Type 2 diabetes [Japanese],608
6,Serum levels of protein GPC3,1854
6,(N(1) + N(8))-acetylspermidine levels,1696
6,Electrocardiogram morphology (amplitude at temporal datapoints) [174 ms],7424
6,Blood pressure [DBP],1686
6,"Multiple sclerosis | non-cancer illness code, self-reported",2253
6,Blood protein levels [Cation-independent mannose-6-phosphate receptor],757
6,Bipolar disorder [Latent Class 1],31
6,Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid),2370
6,Urinary albumin-to-creatinine ratio,75843
6,Anti-JC polyomavirus IgG seropositivity,159672
6,CD8 on CD39+ CD8+ T cell,13126
6,Serum levels of protein LILRB1,1764
6,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],4147
6,Sulfasalazine-induced agranulocytosis,1009
6,Waist circumference adjusted for BMI in non-smokers [men],818
6,Metabolic traits [SM-16 + 7 other traits],1519
6,Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome),575235
6,Atrial fibrillation,111266
6,Heel bone mineral density (MTAG),15318
6,Hip circumference [EA],37309
6,Chronic obstructive pulmonary disease x current smoker interaction (2df),316474
6,Mean arterial pressure [East Asian],6677
6,Blood metabolite levels [hypoxanthine],863
6,Waist circumference adjusted for BMI in non-smokers [women],2430
6,Hypothyroidism and >3 levothyroxin purchases,1928
6,"Fatty acid-binding protein, adipocyte levels",235
6,Serum alkaline phosphatase levels,261030
6,Sensitivity to environmental stress and adversity,39068
6,Cortical surface area (global PC1),5032
6,Medication use (calcium channel blockers),62438
6,Glycerophospholipid levels [Phosphatidylcholine diacyl C42:6],2441
6,Spherical equivalent (joint analysis main effects and education interaction) [Asian ancestry],538
6,"Red blood cell traits [EA, MCV]",6151
6,Ventolin 2mg tablet | treatment/medication code,7079
6,Phosphatidylinositol_36:0_[M-H]1- levels,1561
6,Liver transplant-free survival in primary sclerosing cholangitis (time to event),22
6,Essential hypertension,106874
6,Glaucoma,20812
6,White matter microstructure (radial diusivities) [Posterior corona radiata ],9349
6,Haematocrit percentage,293890
6,Mean time to correctly identify matches,8779
6,Urate levels [South Asian],4389
6,Blood metabolite levels [X-11469],6599
6,Asthma/COPD (KELA code 203),1282
6,Carcinoma in situ of skin,44
6,Parkinson's disease (age of onset),240
6,"Night sleep phenotypes [sleep efficiency, weekdays]",36
6,Inflammatory bowel disease,79528
6,HDL cholesterol,299220
6,Headache,55797
6,Serum levels of protein RPL30,74540
6,Eosinophill percentage,132640
6,Creatinine (enzymatic) in urine,7288
6,Fasting insulin adjusted for BMI,795
6,"For long-sightedness, i.e. for distance and near, but particularly for near tasks like reading (called 'hypermetropia') | reason for glasses/contact lenses",25
6,Spontaneous preterm birth (preterm birth),89
6,Hair morphology traits [Hair color],44
6,Menopause (age at onset),73786
6,Hip minimal joint space width,5449
6,Phosphorus levels,9022
6,Total cholesterol levels,775361
6,White matter microstructure (mean diusivities) [Corticospinal tract ],47882
6,"Hayfever, allergic rhinitis or eczema | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",28669
6,Urate levels [East Asian],37343
6,Lamb consumption,641
6,"Pulse pressure x alcohol consumption interaction (2df test) [Asian, EA]",4968
6,Brain region volumes [white matter],1067
6,Heel bone mineral density x serum urate levels interaction [female],104
6,Breast cancer (estrogen-receptor negative),6339
6,Appendicular lean mass,881839
6,Age-related hearing impairment (MTAG),7587
6,Suicide attempt,28733
6,Smoking initiation (ever regular vs never regular) [Conditioned on chr6:26171250],55765
6,Migraine with aura and/or systolic blood pressure,6738
6,Electrocardiogram morphology (amplitude at temporal datapoints) [140 ms],6500
6,CD2-associated protein levels,2228
6,Prostate cancer (early onset),626
6,Blood metabolite levels [isobutyrylcarnitine],111
6,Iron status biomarkers [serum transferrin],1063
6,Protein quantitative trait loci (liver) [AOC3],89
6,Apolipoprotein A1 levels,815856
6,IgA nephropathy [EA],243522
6,CD20 on IgD- CD24- B cell,133303
6,"For short-sightedness, i.e. only or mainly for distance viewing such as driving, cinema etc (called 'myopia') | reason for glasses/contact lenses",10571
6,"Blood protein levels [CFP, 2960_66_2]",11021
6,Early age-related macular degeneration,457
6,"Blood protein levels [GFRAL, 6920_1_3]",185
6,Electrocardiogram morphology (amplitude at temporal datapoints) [36 ms],329
6,"Peripheral vascular disease, unspecified",80
6,"Waist circumference [EA, men]",162
6,CD4 on naive CD4+ T cell,51
6,Age-related macular degeneration,137855
6,Body mass index,1634485
6,Triglyceride levels in very small VLDL,59605
6,Systemic sclerosis [ATA positive],191117
6,Mean corpuscular hemoglobin [conditional on round 2],11450
6,Serum levels of protein SYNCRIP,16139
6,Ease of getting up in the morning,20077
6,QRS duration [Hispanic/Latino],6259
6,C-reactive protein measurement,5146
6,interferon-related traits [IFNgamma_STAT1_of_CD4p_T],133
6,Mean corpuscular volume,1933249
6,Prostate cancer,392157
6,Dilzem sr 60mg long acting m/r capsule | treatment/medication code,1592
6,"Hip circumference adjusted for BMI [EA, women]",10150
6,Age at menopause (last menstrual period),1930
6,Breast cancer [conditional],674
6,Urinary metabolite levels in chronic kidney disease [pterin],1919
6,Wrist | fractured bone site(s),1503
6,Macrovascular complications in type 2 diabetes,20
6,Acute and subacute iridocyclitis,235
6,Hemoglobin,428937
6,Body fat percentage [female],7908
6,Trunk lean mass,154
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-450 ms],57
6,Thyroid peroxidase antibody positivity,58
6,Light vs. dark hair color,44
6,Waist-to-hip ratio adjusted for body mass index [EA],47236
6,Trunk fat percentage,79726
6,Bone mineral density (spine),2505
6,None of the above (group 1) | illnesses of siblings,664
6,Serum metabolite levels (CMS) [Tyr],6760
6,Malignant neoplasm,104
6,Heart failure and coronary heart disease,108
6,Alcohol dependence symptom count [additive],311
6,malignant neoplasm of male genital organs (controls excluding all cancers),13
6,Parental longevity (mother's age at death),54
6,High density lipoprotein cholesterol levels [EA],32156
6,Skin pigmentation traits [Freckling (binary - has freckles],44
6,"""Type 2 diabetes, strict (exclude DM1)""",4432
6,Dermatitis herpetiformis,43166
6,Acute insulin response,409
6,Facial morphology (segment 62),10895
6,Stable angina pectoris,9929
6,Serum levels of protein GNMT,21690
6,Blood protein levels [SFTPD],14588
6,Electrocardiogram morphology (amplitude at temporal datapoints) [128 ms],6548
6,Serum levels of protein AHSA1,16139
6,Glomerular filtration rate (cystatin C),1287
6,L-arginine levels,1742
6,Iron status biomarkers (iron levels),30592
6,Electrocardiogram morphology (amplitude at temporal datapoints) [282 ms],3633
6,Ankylosing spondylitis [Iranian],24055
6,LDL cholesterol levels [EA],65
6,Non-small cell lung cancer [East Asian],650
6,Renal cell carcinoma,305
6,Lymphotoxin-beta receptor levels,173
6,Depressive symptoms x herpes simplex 1 infection interaction [additive],14
6,Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN),105975
6,Osteoarthritis of the hip or knee,98829
6,"Aging traits (healthspan, parental lifespan or longevity) (multivariate analysis)",24630
6,Type 2 diabetes [EA],34099
6,"Blood protein levels [NMS, 9503_1_3]",11021
6,Severe coronary stenosis,1264
6,Electrocardiogram morphology (amplitude at temporal datapoints) [130 ms],6671
6,Reticulocyte percentage,25993
6,Lipoprotein (a) levels in response to niacin in statin-treated individuals,1571
6,Serum metabolite levels [21-hydroxypregnenolone disulfate],8420
6,Basophil percentage of granulocytes,2440
6,Peak expiratory flow x sex interaction,502
6,Macular thickness,135444
6,Peak expiratory flow (pef),208215
6,Heel bone mineral density (bmd),140570
6,Endometriosis of rectovaginal septum and vagina,1381
6,Systemic lupus erythematosus or rheumatoid arthritis [same effect],379
6,"Cholesterol lowering medication | medication for cholesterol, blood pressure or diabetes",623
6,Visceral fat [adjusted for subcutaneous fat],31
6,Pre-treatment viral load in HIV-1 infection,27527
6,Risk taking,26779
6,Menarche (age at onset) [japanese],19048
6,Whole body water mass,266165
6,"""Hypertension, essential""",25592
6,Electrocardiogram morphology (amplitude at temporal datapoints) [160 ms],7654
6,Protein quantitative trait loci (liver) [TPMT],3067
6,Lamotrigine | treatment/medication code,1317
6,Background diabetic retinopathy,262
6,"Blood protein levels [MAPK13, 5006_71_1]",1100
6,CD24 on memory B cell,497
6,Atopic dermatitis,334963
6,Frequency of tiredness / lethargy in last 2 weeks,3702
6,Chronic obstructive pulmonary disease-related biomarkers [SP-D],63634
6,Chronic obstructive pulmonary disease x current smoker interaction (main effect),316474
6,Serum phosphate levels,69262
6,Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis),9557
6,Electrocardiogram morphology (amplitude at temporal datapoints) [180 ms],11085
6,"Blood protein levels [SYNCRIP, 4224_7_2]",11021
6,Citramalate levels,4341
6,Idiopathic pulmonary fibrosis,302
6,Hemoglobin levels in non-alcoholic fatty liver disease x mastiha supplementation interaction,296
6,Plaquenil 200mg tablet | treatment/medication code,1198
6,Protein quantitative trait loci (liver) [TTN],391
6,Response to statins (LDL cholesterol change) [fractional LDL-C reduction],80
6,Trem-like transcript 2 protein levels,77
6,Sleep duration,134437
6,Hyperlipidemia (time to event),140711
6,White matter microstructure (mean diusivities) [Average across all tracts],7584
6,Cardiovascular diseases,18720
6,Leiomyoma of uterus,7348
6,Smoking status,9893
6,Electrocardiogram morphology (amplitude at temporal datapoints) [322 ms],3633
6,"Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)",731
6,Neuroblastoma (MYCN amplification),136
6,Post-traumatic stress disorder [EA],195
6,FEV1/FVC ratio x sex interaction,57
6,Endometrial cancer,9039
6,Eosinophilic esophagitis,158650
6,LDL cholesterol levels x loop diuretics use interaction [African],731
6,White matter microstructure (axial diusivities) [Corticospinal tract ],15519
6,Psychological or psychiatric problem,52986
6,Serum levels of protein MICB,426286
6,High blood pressure | vascular/heart problems diagnosed by doctor,43878
6,"Blood protein levels [PCDHGA11, 6563_78_3]",16851
6,"Blood protein levels [TPM2, 4472_5_2]",11021
6,Retinal nerve fibre layer thickness or ganglion cell inner plexiform layer thickness (MTAG),2616
6,Had menopause,1799
6,Osteoarthritis (hip),35362
6,LDL cholesterol levels in current drinkers,25606
6,Body mass index (joint analysis main effects and smoking interaction) [women],6240
6,"Mean arterial pressure x alcohol consumption interaction (2df test) [EA, Hispanic]",1287
6,QT dynamics during exercise [male],1066
6,Epithelial ovarian cancer [HGSOC],94
6,Serum levels of protein GRAMD1C,12
6,Tonsillectomy,146931
6,Handedness (Right-handed vs. non-right-handed),26117
6,"""Type 1 diabetes, strict (exclude DM2)""",11694
6,vWF levels [EA],6805
6,Asthma (more control exclusions),1687
6,Number of treatments/medications taken,378
6,"LDL cholesterol levels [Asian initial, BMI unadjusted]",1632
6,Chemerin levels,284
6,Anxiety [EA],157
6,Osteoarthritis,75124
6,Keratinocyte cancer (MTAG),152616
6,Waist circumference adjusted for BMI (adjusted for smoking behaviour),16504
6,"Blood protein levels [NRXN3, 9799_3_3]",11021
6,Tartrate-resistant acid phosphatase type 5 levels,168
6,"Blood protein levels [NQO2, 9754_33_3]",3294
6,Oropharynx cancer,11814
6,Electrocardiogram morphology (amplitude at temporal datapoints) [236 ms],205
6,Metabolic traits [isobutyrylcarnitine + 3 other traits],111
6,"Schizophrenia, bipolar disorder or recurrent major depressive disorder x sex interaction (3df)",42
6,"Blood protein levels [FLT1, 8231_122_3]",227
6,Low tan response,44
6,HLA DR on Hematopoietic Stem Cell,71532
6,Serum levels of protein AKT3,16139
6,Coeliac disease,50767
6,Electrocardiogram morphology (amplitude at temporal datapoints) [344 ms],3280
6,Urate levels [men],9139
6,CD24 on IgD- CD38- B cell,475
6,Type 2 diabetes [Lean],448
6,"""Other noninflammatory disorders of uterus, except cervix""",321
6,Weight,554907
6,Multiple myeloma,154705
6,Myositis,1470515
6,Waist circumference adjusted for body mass index,549733
6,Hand grip strength,369615
6,Cognitive performance (MTAG) [MTAG],216802
6,Glomerular filtration rate in non diabetics (creatinine),3361
6,Malignant neoplasm of prostate,3463
6,Ceramide_42:1_[M+H]1+ levels,80
6,Serum levels of protein PSMB1,26893
6,Certain disorders involving the immune mechanism,74540
6,Electrocardiogram morphology (amplitude at temporal datapoints) [10 ms],3710
6,Phospholipid levels in very small VLDL,2637
6,Urgency urinary incontinence,2
6,Diastolic blood pressure (cigarette smoking interaction),15148
6,Serum uric acid levels [EA],5315
6,Average total household income before tax,6173
6,Tumor necrosis factor levels,8284
6,Migraine with aura and/or diastolic blood pressure,6836
6,"""Hypothyroidism, strict autoimmune""",3951
6,"Bone mineral density (paediatric, upper limb)",154
6,Protein quantitative trait loci (liver) [TNC],84
6,Childhood obesity [EA],167
6,Behauvioural and emotional disorders with onset usually occuring in childhood and adolescence,135
6,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),189770
6,White matter microstructure (fractional anisotropy) [Average across all tracts],5049
6,Type 2 diabetes [conditional],20499
6,"Blood protein levels [C4A C4B, 4481_34_2]",81202
6,CD20 on unswitched memory B cell,2678
6,Heel broadband ultrasound attenuation (left),6121
6,Serum levels of protein TEK,3180
6,Coronary artery bypass grafting,479
6,Stomatitis and related lesions,48
6,Wholemeal or wholegrain | bread type,1
6,High light scatter reticulocyte count,571508
6,Itch intensity from mosquito bite adjusted by bite size,129034
6,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)",46278
6,White matter microstructure (radial diusivities) [Splenium of corpus callosum],71566
6,Electrocardiogram morphology (amplitude at temporal datapoints) [70 ms],3280
6,Vascular endothelial growth factor levels in major depressive disorder,1214
6,Protein quantitative trait loci (liver) [IGHA2],31
6,HDL cholesterol levels in current drinkers,333
6,Mean corpuscular volume [EA],236
6,Alcohol usually taken with meals,1
6,Bipolar disorder lithium response (categorical) or schizophrenia,55007
6,Mean corpuscular hemoglobin concentration [Asian],1514
6,Cerebrospinal fluid t-tau:AB1-42 ratio,1795
6,Pancreatic beta-cell glucose sensitivity,289
6,Vitiligo,576054
6,6mm strong meridian (left),123144
6,Immune reponse to smallpox (secreted IFN-alpha) [AA],910
6,"Bone mineral density (paediatric, upper limb) [EA]",154
6,Electrocardiogram morphology (amplitude at temporal datapoints) [352 ms],3280
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-452 ms],57
6,"Blood protein levels [PLG, 3710_49_2]",114
6,White blood cell count,1726333
6,Interleukin-12p70 levels,5342
6,"Number of decayed, missing and filled tooth surfaces or use of dentures",13629
6,CD8 on CD28+ CD45RA+ CD8+ T cell,60798
6,Achromobacter abundance in stool,390
6,Urinary metabolite levels in chronic kidney disease [X - 12839],6599
6,Mixed cellularity Hodgkin lymphoma [conditioned on rs1633096],5304
6,CD20 on IgD+ CD24- B cell,1347
6,Diabetes,1527
6,Phosphatidylinositol_40:6_[M-H]1- levels,2427
6,Red blood cell count [Asian],3876
6,"Fracture wrist / colles fracture | non-cancer illness code, self-reported",25
6,Other disorders of urethra and urinary system,108
6,Digit length ratio (right hand),59
6,Blood metabolite levels [Carnitine free],126
6,"Forced expiratory volume in 1-second (fev1), best measure",206541
6,Phosphatidylcholine_40:5_[M+H]1+ levels,2441
6,Urinary metabolite levels in chronic kidney disease [X - 24350],6599
6,Disorders of parathyroid gland,520
6,"Hemoglobin levels [HbF, Sardinian]",1632
6,Metabolic disorders,1160
6,Spondylopathies (FG),119
6,"Blood protein levels [ENPP5, 6556_5_3]",499
6,"Blood protein levels [CRISP2, 9282_12_3]",346
6,Depression,246304
6,Body mass index variance,43627
6,Serum levels of protein C2,88672
6,Serum levels of protein ENPP5,6925
6,6mm weak meridian (left),122200
6,Metabolite levels [BUN],1847
6,Serum levels of protein PPIL1,125
6,Electrocardiogram morphology (amplitude at temporal datapoints) [4 ms],790
6,Serum metabolite levels [isobutyrylcarnitine (C4],93
6,Cortical surface area [Cuneus],25
6,Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy) [EA],45
6,QRS complex (Cornell) [EA],36614
6,Self-reported risk-taking behaviour,10944
6,Parental longevity (father's age at death or father's attained age),4474
6,Serum levels of protein IL15,10591
6,"""Rheumatoid arthritis , including avohilmo""",20162
6,Protein levels in obesity [Factor B],16139
6,"Sleep apnoea | non-cancer illness code, self-reported",451
6,Ventral hernia,14
6,Platelet count,1106586
6,Waist-to-hip ratio adjusted for BMI in non-smokers,161548
6,Childhood asthma with severe exacerbations,246022
6,Neurological blood protein biomarker levels [Alpha-2-MRAP],10766
6,Mean reticulocyte volume,802610
6,Heel bone mineral density (bmd) (left),10140
6,"""Atopic dermatitis, strict definition with reimbursement""",11111
6,Electrocardiogram morphology (amplitude at temporal datapoints) [124 ms],6495
6,Spherical equivalent [EA],304
6,Place of birth in uk - east co-ordinate,708
6,Venous thromboembolism adjusted for sickle cell variant rs77121243-T,17
6,Urolithiasis,11110
6,Autoimmune hyperthyroidism,43631
6,Migraine and/or diastolic blood pressure,7978
6,Sepsis (90-day mortality),13383
6,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),908
6,Adiponectin levels,150
6,Protein quantitative trait loci (liver) [ACADS],446
6,Subiculum volume (corrected for total hippocampal volume),48
6,Other anemias,42006
6,CD4:CD8 lymphocyte ratio,114343
6,Eosinophil counts,1852250
6,"Forced expiratory volume in 1-second (fev1), predicted",157531
6,Papulosquamous disorders,28395
6,Menstruation quality of life impact (fever),433
6,Chronic obstructive pulmonary disease or high blood pressure (pleiotropy),1474
6,Injuries to the shoulder and upper arm,2386
6,Response to gemcitabine in pancreatic cancer,103
6,TPE interval (resting),529
6,"""Fracture of lower leg, including ankle""",1424
6,Brain region volumes [right cerebellum exterior],1361
6,Brain region volumes [left vessel],319
6,"Lipoprotein (a) levels [EA, South Asian, Afro-Caribbean]",80
6,Schizophrenia (MTAG),579220
6,Serum levels of protein NPTX1,100857
6,Cardiovascular disease risk factors [UA],6599
6,Dentures | mouth/teeth dental problems,93862
6,Forced expiratory volume in 1-second (fev1),297772
6,Morning/evening person (chronotype),10981
6,Pulse wave arterial stiffness index,1651
6,"Type 1 diabetes | non-cancer illness code, self-reported",1625
6,Medication use (antimigraine preparations),9136
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-2 ms],790
6,Autism,256
6,Nocturnal enuresis,23230
6,Myositis [Conditioning on HLA-DRB1*03:01],123070
6,"""Obesity, other/unspecified""",170
6,Clozapine-induced cytotoxicity [30x],117
6,"Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [Asian, EA]",410
6,Systemic sclerosis,140935
6,C-reactive protein levels [BMI-adjusted],11522
6,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],27473
6,Cylindrical power (left),169
6,Chronic iridocyclitis,235
6,Pulmonary embolism with or without deep venous thrombosis,137
6,2-hydroxyadipate levels,104
6,"Fracture fibula | non-cancer illness code, self-reported",38
6,Educational attainment (MTAG) [MTAG],261551
6,"Takayasu arteritis [conditional on rs2844678, rs9262437 and rs61444472]",13311
6,Serum levels of protein B2M,78990
6,Leiomyoma of uterus (controls excluding all cancers),7381
6,Spherical equivalent (joint analysis main effects and education interaction),266
6,Chronic lymphocytic leukemia (time to first treatment),49
6,Serum uric acid levels,68082
6,"Red blood cell traits [EA, MCH]",8230
6,SSC-A on CD4+ T cell,109284
6,Late-onset Alzheimer's disease,21081
6,Trunk predicted mass,281177
6,Height [AA],3550
6,Iron status biomarkers [serum iron],1063
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-500 ms],353
6,Cortical volume [Lingual],168
6,IgG glycosylation [IGP7],40
6,Systemic lupus erythematosus [anti-dsDNA +],76700
6,Help-seeking from a GP,436464
6,"Allergic disease (asthma, hay fever and/or eczema) (age of onset)",131396
6,Interleukin-10 levels,1256
6,"Eye color [EA, discovery]",3388
6,Entorhinal cortical volume (Alzheimer's disease interaction),363
6,"2,3-dihydroxy-2-methylbutyrate levels",802
6,Electrocardiogram morphology (amplitude at temporal datapoints) [222 ms],123
6,Protein quantitative trait loci (liver) [GPX4],12
6,Barrett's esophagus,101450
6,Lupus (localized and systemic),105915
6,Blood glucose levels,28114
6,"Blood protein levels [CA4, 3177_49_2]",11021
6,Ultradistal forearm bone mineral density,2899
6,CD20 on IgD+ CD38dim B cell,1347
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-498 ms],353
6,Eye color traits [Eye color],44
6,Black vs. blond hair color,44
6,Periventricular white matter hyperintensities,88
6,Eye color,35
6,Alzheimer's disease (APOE e4 interaction),1
6,Response to inhaled glucocorticoid treatment in asthma (change in FEV1),1
6,Creatinine levels,134502
6,Cigarettes smoked per day (MTAG),9410
6,Pulmonary function [FEV1],34397
6,Takayasu arteritis [conditional on rs2844678 and rs9262437],2039
6,Malignant lymphoma,32198
6,Adult asthma,452328
6,Ankylosing spondylitis,43824
6,Electrocardiogram morphology (amplitude at temporal datapoints) [112 ms],6377
6,Magnesium carbonate | treatment/medication code,415
6,Urinary metabolite levels in chronic kidney disease [N-acetylglucosaminylasparagine],264
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-108 ms],635
6,Type 1 diabetes with neurological complications,113
6,Complement C4 levels [EA],101435
6,"Blood metabolite ratios [DHEA-S/4-androsten-3beta,17beta-diol disulfate 2]",5298
6,Maximum heart rate during fitness test,353
6,Blood metabolite levels [tryptophan],715
6,Serum levels of protein GLO1,1092
6,Longevity (100 years and older) [EA],203
6,Digit length ratio (left hand),59
6,Immune reponse to smallpox (secreted IL-12p40) [EA],3
6,Fasting blood insulin (BMI interaction),28928
6,IgM levels,74728
6,Help-seeking from a psychiatrist,270729
6,"Blood protein levels [ATF6B, 11387_3_3]",9274
6,Body mass index (age>50),4831
6,Ease of skin tanning,6130
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-4 ms],790
6,Focal epilepsy (with hippocampal sclerosis),276
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-100 ms],635
6,Protein quantitative trait loci (liver) [ORM2],1
6,CD20 on IgD+ CD24+ B cell,2730
6,Priapism in sickle cell disease,142
6,Variation in diet,294
6,Inflammatory skin disease [Opposed],27
6,Educational attainment,14060
6,Gynecologic disease,46580
6,Total cholesterol levels [Trans-ethnic initial],135571
6,None of the above | vascular/heart problems diagnosed by doctor,30254
6,Migraine without aura and/or systolic blood pressure,7600
6,Electrocardiogram morphology (amplitude at temporal datapoints) [86 ms],3280
6,Cortical surface area [total],1114
6,Infant length,7589
6,Body mass index (joint analysis main effects and physical activity interaction) [EA],6231
6,HDL cholesterol levels in current drinkers [EA],664
6,Protein quantitative trait loci (liver) [MYL6],72
6,"Fracture foot | non-cancer illness code, self-reported",142
6,Chloride levels,46197
6,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),64581
6,Apolipoprotein B levels,557222
6,Youthful appearance (self-reported),50383
6,"Pulse rate, automated reading",76950
6,Time to complete round,137967
6,Facial morphology (forehead protrusion 1),10535
6,"Systolic blood pressure x alcohol consumption interaction (2df test) [EA, Hispanic]",1291
6,Platelet count [conditional on round 3],3070
6,CD127- CD8+ T cell Absolute Count,3073
6,Serum levels of protein TXNDC15,9687
6,Mood swings,1695
6,"Waist-hip ratio [EA, men]",1562
6,Hypoglycemia,510
6,Protein quantitative trait loci (liver) [GSTA2],16949
6,Arm fat-free mass (left),295359
6,Blood pressure [SBP],1686
6,High cholesterol,3015
6,Electrocardiogram morphology (amplitude at temporal datapoints) [330 ms],3633
6,Blood metabolite levels [X-12627],2427
6,Benign neoplasms (controls excluding all cancers),303
6,Serum levels of protein SERPINF2,84
6,Medication use (diuretics),23100
6,"Hyperthyroidism/thyrotoxicosis | non-cancer illness code, self-reported",169881
6,"Blood protein levels [DEFB119, 13455_10_3]",10591
6,"""Primary coxarthrosis, bilateral""",5260
6,"Fracture clavicle / collar bone | non-cancer illness code, self-reported",99
6,CD20 on B cell,236
6,"""Complications of the puerperium, not elsewhere classified""",8
6,Feeling guilty,133060
6,Waist-to-hip ratio adjusted for BMI in active individuals [EA],89898
6,Smoking status (current vs never) [EA],3378
6,Strenuous sports or other exercises,27733
6,Urinary metabolite levels in chronic kidney disease [isoxanthopterin],1919
6,Bipolar disorder [addtive],10118
6,Electrocardiogram morphology (amplitude at temporal datapoints) [0 ms],790
6,Mammographic density (dense area),384
6,Leisure sedentary behaviour (computer use),28
6,"Systolic blood pressure x alcohol consumption interaction (2df test) [Asian, EA, Hispanic]",1287
6,Eczema or dermatitis,864
6,Venous thromboembolism (SNP x SNP interaction),372
6,Interleukin-10 levels [AA],52
6,Mosquito bite size,100592
6,Automobile speeding propensity,29548
6,DNA methylation PhenoAge acceleration,5120
6,Asthma (only as main-diagnosis),1273
6,Coronary artery disease or large artery stroke,1213
6,Electrocardiogram morphology (amplitude at temporal datapoints) [238 ms],205
6,Prospective memory result,132
6,Body fat distribution (trunk fat ratio) [males],831
6,Smoking x traumatic event in childhood (felt hated by family member) interaction,37
6,UBA1448 abundance in stool,4642
6,Electrocardiogram morphology (amplitude at temporal datapoints) [126 ms],6500
6,Serum levels of protein DEFB119,8398
6,Behcet's disease [Greater Middle Eastern],17574
6,Urinary metabolite levels in chronic kidney disease [X - 18938],5298
6,Heel bone mineral density variance,951
6,White blood cell count [EA],892
6,Coronary angiopasty,108
6,Electrocardiogram morphology (amplitude at temporal datapoints) [192 ms],123
6,Serum metabolite levels [isobutyrylcarnitine],111
6,Diverticular disease of intestine,20
6,Antineutrophil cytoplasmic antibody-associated vasculitis,274517
6,Mean corpuscular hemoglobin,1170618
6,Itch intensity from mosquito bite,96067
6,Total cholesterol levels [EA],256060
6,Blood urea nitrogen levels,21968
6,Complement factor B measurement,4164
6,Dermol 500 lotion | treatment/medication code,1836
6,Bronchiectasis,1573
6,X-23308 levels,701
6,Other disorders of central nervous system,200
6,Tuberculosis,379501
6,Stroke,5862
6,Other juvenile arthritis,111
6,"Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA, women]",1947
6,Body mass index (joint analysis main effects and smoking interaction) [men],162
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-494 ms],353
6,Asthma (moderate or severe),72491
6,Offspring birth weight,75301
6,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test) [African],7774
6,Latent autoimmune diabetes vs. type 2 diabetes,3101
6,White matter hyperintensity volume x hypertension interaction (2df),422
6,"Gut microbiota (bacterial taxa, rank normal transformation method) [G_Parabacteroides_RNT]",73
6,Waist-to-hip ratio adjusted for BMI,1181901
6,Electrocardiogram morphology (amplitude at temporal datapoints) [102 ms],3408
6,Hypertrophic cardiomyopathy,2207
6,Serum levels of protein LIPA,15396
6,None of the above | vitamin and mineral supplements,5662
6,"""Other diabetes, wide definition""",734
6,Protein quantitative trait loci [IGF-II receptor],316
6,Butter/spreadable butter | spread type,80
6,Other and unspecified iridocyclitis,126
6,"Atopic dermatitis [EA, fixed effects]",12561
6,Complement C2 measurement,114441
6,Other type of bread | bread type,51878
6,"Blood protein levels [C4A C4B, 2182_54_1]",40868
6,White matter microstructure (radial diusivities) [Retrolenticular part of internal capsule],5049
6,Blood metabolite levels [X-13435],4743
6,Statin medication,2922
6,"Bone mineral density (paediatric, skull)",366
6,Electrocardiogram morphology (amplitude at temporal datapoints) [354 ms],3280
6,Human papilloma virus 16 positive oropharyngeal cancer,1607
6,Longest period spent worried or anxious,7
6,Neuromyelitis optica (AQP4-IgG-positive),160441
6,HLA DR on myeloid Dendritic Cell,7553
6,"""Seropositive rheumatoid arthritis, wide""",19818
6,Serum levels of protein LRPAP1,33581
6,Sitting height ratio [EA],1817
6,Urinary metabolite levels in chronic kidney disease [X - 24339],5298
6,Skin colour,3477
6,Protein quantitative trait loci (liver) [FGA],72
6,Protein quantitative trait loci (liver) [CALD1],73
6,Protein quantitative trait loci (liver) [PRDX2],105
6,Plasma plasminogen levels [Conditioned on rs4252129 and rs1084651],8
6,Protein quantitative trait loci (liver) [ACSL4],1
6,Immunoglobulin G index levels in multiple sclerosis,64788
6,Plasma homocysteine levels,2278
6,Childhood steroid-sensitive nephrotic syndrome,216203
6,Corneal resistance factor (left),1884
6,Electrocardiogram morphology (amplitude at temporal datapoints) [318 ms],5075
6,Red vs. brown/black hair color,543
6,Mood instability,199
6,Waist-hip ratio [BMI_pooled],165
6,Protein quantitative trait loci (liver) [HIBCH],5
6,IgE grass sensitization,25406
6,Parental lifespan,23258
6,Help-seeking from a GP (without major depressive disorder symptoms),116620
6,Electrocardiogram morphology (amplitude at temporal datapoints) [16 ms],3280
6,"""Diseases of arteries, arterioles and capillaries (FINNGEN)""",432
6,"Hemoglobin levels [HbA2, Sardinian]",1632
6,Urate levels in lean individuals,5298
6,Serum metabolite concentrations in chronic kidney disease [Octadecadienoylcarnitine],126
6,Obesity,164
6,Lung adenocarcinoma [East Asian],650
6,Electrocardiogram morphology (amplitude at temporal datapoints) [260 ms],82
6,Sleep traits (multi-trait analysis),196
6,Protein quantitative trait loci (liver) [SEPT11],6
6,BMI in non-smokers,74405
6,IgA levels,279909
6,Venous thromboembolism,162452
6,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) [EA],31788
6,Acute anterior uveitis (with or without ankylosing spondylitis) [conditioned on rs116488202],26904
6,Mononucleosis,1817
6,Serum levels of protein SMPDL3A,446
6,CD24 on IgD+ CD24+ B cell,475
6,Ascending aorta maximum area,1532
6,Intestinal malabsorbtion,43931
6,"Blood protein levels [CD97, 2822_56_2]",11021
6,"Blood protein levels [RSPO3, 8427_118_3]",1503
6,CD80 on myeloid Dendritic Cell,1460
6,Urinary metabolite levels in chronic kidney disease [N-octanoylglutamine],6599
6,Chronic lymphocytic leukemia or multiple sclerosis,908
6,Electrocardiogram morphology (amplitude at temporal datapoints) [220 ms],123
6,Intracranial aneurysm,5012
6,Takayasu arteritis [Turkish],52059
6,Systemic lupus erythematosus [conditional],55412
6,Low-density lipoprotein receptor-related protein 11 levels,113747
6,Thyroid problem (not cancer),159161
6,Other erythrocyte phenotypes [RBC],1822
6,Hyperopia,229
6,Lipoprotein-associated phospholipase A2 activity change in response to statin therapy [percent change],80
6,Total testosterone levels,172758
6,Serum levels of protein BGLAP,189323
6,HDL cholesterol levels x long total sleep time interaction (2df test),1089
6,Other specified/unspecified inflammatory spondylopathies,151
6,"Body mass index [EA, men]",162
6,Diabetic kidney disease [additive ],84
6,Pneumonia,326651
6,Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease),197149
6,Insulin-like growth factor 1 levels,427593
6,Body mass index [women],28277
6,Age first had sexual intercourse,48208
6,Cortical surface area [Lateral Orbitofrontal],5891
6,Coronary heart disease [CAD],28
6,Diastolic blood pressure x sodium interaction (2df test),36
6,Menarche and menopause (age at onset) [age at menarche],59
6,Systolic blood pressure [East Asian],8767
6,Lipid metabolism phenotypes [XXL-VLDL-P],40908
6,Red blood cell (erythrocyte) count,228870
6,Chronic heart failure,780
6,Time spent outdoors in winter,1445
6,Crohn's disease,506046
6,Stroke (ischemic) [LAA],423
6,Bevacizumab-induced composite toxicity (either hypertension or proteinuria),51
6,Protein quantitative trait loci (liver) [DPP7],7
6,Autoimmune traits,34752
6,Testosterone levels,84357
6,T cell Absolute Count,111335
6,CD28+ CD45RA+ CD8+ T cell %T cell,5288
6,Serum levels of protein CDK5;CDK5R1,16139
6,Anti-varicella zoster virus IgG seropositivity,2414
6,Takayasu arteritis [conditional on rs2844678 and rs12524487],4130
6,Photic sneeze reflex,455
6,Cortical thickness (min-P),1067
6,Smoking status (heavy vs never),322
6,Insulin-related traits (multivariate analysis),191
6,Major coronary heart disease event,231
6,Coronary artery disease in diabetes,80
6,"""Ischaemic heart disease, wide definition""",141
6,Protein quantitative trait loci (liver) [ACO2],16
6,"Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma) [NCGC]",1314
6,Mean sphered cell volume,562325
6,"Invitation to complete online 24-hour recall dietary questionnaire, acceptance",114
6,End-stage coagulation [FXIIIA],730
6,Red blood cell traits [RBC count],1151
6,Hypercholesterolemia,654
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-20 ms],410
6,Narcolepsy,20688
6,Allergic sensitization,86265
6,HIV-1 control [setpoint],51728
6,Non-Hodgkin's lymphoma,103372
6,"Blood protein levels [RAB5C, 14287_6_3]",11021
6,Ankle spacing width,183297
6,Blood protein levels [CD109 antigen],2946
6,"Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma) [All Cancers]",1314
6,P wave terminal force [EA],382
6,HIV-1 control [progression],122009
6,Takayasu arteritis [EA],18517
6,Phosphatidylcholine(40:6)_[M+H]1+/Phosphatidylethanolamine(43:6)_[M+H]1+ levels,1159
6,White matter microstructure (mean diusivities) [Posterior thalamic radiation],49381
6,Standing height,305622
6,Arm fat-free mass (right),284562
6,Serum metabolite levels [X-12798],797
6,Attention deficit hyperactivity disorder (MTAG),235
6,Irritability,921
6,Cortical surface area [Parahippocampal],22
6,Atopic march,2070
6,vWF levels,23909
6,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [women],1947
6,Hand grip strength (right),55847
6,"Medication use (adrenergics, inhalants)",14220
6,Alzheimer disease and age of onset [between families],87
6,Primary central nervous system lymphoma,27
6,Persons encountering health services for examination and investigation,44
6,Corneal resistance factor,9
6,Age-related macular degeneration (choroidal neovascularisation),24865
6,White matter microstructure (mean diusivities) [Superior longitudinal fasciculus],74157
6,Subacute thyroiditis,876
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-236 ms],353
6,Feeling worry,323
6,Clostridium tertium abundance in stool,286
6,Nevus count [Han & Eskin random effects],44
6,Morningness,56934
6,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test) [EA],39691
6,Schizophrenia vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),5944
6,Serum levels of protein PCDHB14,16139
6,Electrocardiogram morphology (amplitude at temporal datapoints) [314 ms],5075
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-32 ms],372
6,Fresh fruit intake,397
6,CD20 on IgD- CD27- B cell,245
6,Combined immunodeficiencies,36
6,Schizophrenia or bipolar disorder [SCZ vs. controls],40376
6,Triglycerides x physical activity interaction (2df test) [EA],22169
6,Urinary metabolite levels in chronic kidney disease [X - 13866],4832
6,Waist circumference adjusted for BMI in active individuals,8508
6,Electrocardiogram morphology (amplitude at temporal datapoints) [18 ms],3280
6,HLA DR on CD33+ HLA DR+ CD14dim,901
6,Lymphocyte percentage of white cells,278079
6,High altitude adaptation,36740
6,Serum levels of protein KLRC3,16139
6,White matter microstructure (fractional anisotropy) [Splenium of corpus callosum],68172
6,Electrocardiogram morphology (amplitude at temporal datapoints) [276 ms],3280
6,Iron status biomarkers (ferritin levels),5571
6,Urinary metabolite levels in chronic kidney disease [X - 12822],5298
6,Rheumatoid arthritis [EA],356350
6,Asthma [conditional],32742
6,Lipoprotein (a) levels,38803
6,Inflammatory bowel disease [Children],5996
6,"Adenosine 3',5'-cyclic monophosphate (camp) levels",2653
6,Cortical surface area [Lingual],187
6,Neutrophil count,1723410
6,Autism spectrum disorder or schizophrenia,578585
6,Cortical thickness (MOSTest),67574
6,Essential hypertension (time to event),211453
6,Type 1 diabetes (age at diagnosis),203383
6,Brain region volumes [X4th ventricle],4749
6,"Dark brown | hair colour (natural, before greying)",12372
6,Whole body fat mass,69634
6,Matrix metalloproteinase-9 levels,3010
6,Subjective well-being,824
6,Facial morphology (segment 7),323
6,Age at adiposity rebound,21
6,Type 2 diabetes (adjusted for BMI),26394
6,"Blood protein levels [RAD51, 2871_73_2]",11021
6,Serum levels of protein THBS2,240
6,Waist circumference [East Asian],3309
6,Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis),10530
6,Vertex-wise cortical thickness,133878
6,"Blood protein levels [PCDHB4, 10522_167_3]",11021
6,Gynecologic disease (multivariate analysis) [uterine cervical cancer],4336
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-110 ms],635
6,Electrocardiographic traits [QRS duration],763
6,Skin colour saturation,44
6,HDL cholesterol levels [BMI adjusted],90
6,Cutaneous lupus erythematosus,538487
6,Neuromyelitis optica,160441
6,PR interval,14822
6,Subcortical volume (min-P),115105
6,Major depressive disorder (MTAG),150288
6,White matter microstructure (mean diusivities) [Cingulate gyrus],9349
6,Electrocardiogram morphology (amplitude at temporal datapoints) [152 ms],11101
6,"Blood protein levels [LRP11, 8330_1_3]",111613
6,Impedance of whole body,219938
6,Migraine without aura and/or diastolic blood pressure,6995
6,Antihypertensive medication - note that there are other indications,6551
6,Psoriatic and enteropathic arthropathies,184
6,Rosacea symptom severity,145109
6,Oily fish intake,137100
6,Non-melanoma skin cancer,304418
6,Electrocardiogram morphology (amplitude at temporal datapoints) [118 ms],6372
6,Waist circumference adjusted for BMI (adjusted for smoking behaviour) [men],9141
6,DHEAS levels,3699
6,Facial ageing,1166
6,UBA8517 abundance in stool,148
6,CD28 on CD4+ T cell,58
6,Childhood sunburn occasions,109625
6,Serum levels of protein FCER1A,16139
6,Diabetes | illnesses of mother,452
6,Cervical artery dissection,28
6,Invasive breast cancer [mixed effect],48
6,Nontoxic multinodular goitre,266
6,ADAMTS13 activity,70
6,Allergic rhinitis,146154
6,Aerodigestive squamous cell cancer (pleiotropy),765972
6,"Hematology traits [EA, WBC]",54421
6,Fat-free mass [male],40752
6,Gastric cancer,29667
6,Serum levels of protein CFTR,190744
6,Serum levels of protein TREM1,12403
6,Immature reticulocyte fraction,75529
6,Serum levels of protein CMPK1,5643
6,Psoriasis [EA],6354
6,"Intra-ocular pressure, goldmann-correlated (left)",1953
6,Doctor diagnosed emphysema,2985
6,Facial morphology (segment 22),3179
6,Neuronal pentraxin-1 measurement,163
6,"Pulmonary function (smoking interaction) [FEV1/FVC, Ever-smoking]",766
6,Lobe size,802
6,Negativibacillus massiliensis abundance in stool,7
6,UBA6398 sp002451695 abundance in stool,1
6,Idiopathic inflammatory myopathy,104315
6,Well-being spectrum (multivariate analysis),617688
6,Serum metabolite levels [N-acetyltryptophan],8420
6,Naive CD8+ T cell %T cell,5288
6,Severity of nausea and vomiting of pregnancy,228
6,C-reactive protein levels or total cholesterol levels (pleiotropy),143419
6,Anti-rubella virus IgG levels,91473
6,Gout,49493
6,Started insulin within one year diagnosis of diabetes,17804
6,Asthma (age of onset),7189
6,Facial morphology (segment 21),960
6,Electrocardiogram morphology (amplitude at temporal datapoints) [144 ms],3998
6,Heart failure,1311
6,Frequency of other exercises in last 4 weeks,101
6,Hepcidin levels [Tf Sat],1063
6,White matter microstructure (mean diusivities) [Uncinate fasciculus],172
6,Folic acid product | treatment/medication code,85
6,Gut microbiota (bacterial taxa) [k__Archaea|p__Euryarchaeota],1
6,Major depressive disorder or stress-related disorder,102497
6,"Blood protein levels [CLEC12B, 10837_131_3]",11021
6,Electrocardiogram morphology (amplitude at temporal datapoints) [342 ms],3633
6,Electrocardiogram morphology (amplitude at temporal datapoints) [26 ms],368
6,Gout and other crystal arthropathies,5298
6,Coronary artery disease or ischemic stroke,1261
6,Insulin levels adjusted for BMI,315
6,Type 2 diabetes [additive model],452
6,Hypertrophy of breast,360
6,Gut microbiota presence (family Pseudomonadaceae id.3718),36
6,Skin cancer,27011
6,Total body bone mineral density (age over 60),10090
6,Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies),239327
6,Total body bone mineral density (MTAG),7757
6,Serum levels of protein ATF6B,12048
6,Serum levels of protein ATF6,12048
6,Male puberty timing (early vs. average onset voice breaking),1105
6,Response to antidepressants [nortriptyline],621
6,Phosphatidylcholine_38:6_[M+H]1+/Phosphatidylethanolamine_41:6_[M+H]1+ levels,1519
6,Cancer,88
6,Thiopurine S-methyltransferase activity,3137
6,Coronary artery disease,157219
6,Hip shape (DXA scan) [hip shape mode 1],1067
6,Oral cavity cancer,42307
6,Estimated glomerular filtration rate [discovery],6046
6,Epstein-Barr virus VCA p18 antibody levels,8906
6,Urinary metabolite levels in chronic kidney disease [X - 24347],6599
6,Electrocardiogram morphology (amplitude at temporal datapoints) [76 ms],3285
6,Blood metabolite levels [tyrosine],2669
6,"""Hyperlipidaemia, other/unspecified""",602
6,White blood cell count [Lymphocytes],2544
6,Coronary revascularization (ANGIO or CABG),141
6,Subcutaneous adipose tissue attenuation (Hounsfield unit scale),152
6,Epidural or caudal anaesthetic | anaesthetics administered during delivery,41257
6,CD8+ T cell %T cell,7522
6,Beclazone 50 inhaler | treatment/medication code,225
6,Malignant neoplasm of breast (controls excluding all cancers),412
6,Subpleural-predominant interstitial lung abnormalities [EA],827
6,Corneal structure,79
6,Lifetime smoking index,14387
6,Interleukin-6 levels,45302
6,Complement C3 and C4 levels [Serum level of C4],154353
6,Serum levels of protein CLEC12B,16139
6,Electrocardiogram morphology (amplitude at temporal datapoints) [106 ms],6500
6,Dimethyl sulfone levels,3193
6,CD28- CD8+ T cell Absolute Count,3073
6,Fruit consumption,531
6,Warfarin-associated bleeding,130
6,Electrocardiogram morphology (amplitude at temporal datapoints) [190 ms],123
6,Hypertension,285622
6,Nose size,20053
6,Hip circumference,169254
6,Age at first sexual intercourse,143486
6,"Blood protein levels [EA, Mediator of RNA polymerase II transcription subunit 1]",10340
6,"Waist circumference adjusted for BMI in active individuals [EA, men]",5412
6,Factor VIII levels [EA],886
6,Black vs. red hair color,44
6,Generalized anxiety disorder,114
6,Body mass index in physically active individuals [EA],160
6,Myopia,56157
6,Serum levels of protein GZMA,13275
6,"Heel broadband ultrasound attenuation, direct entry",87498
6,Unspecified diabetic retinopathy,30430
6,Electrocardiogram morphology (amplitude at temporal datapoints) [170 ms],14177
6,No | hearing difficulty/problems,7650
6,"""Type 2 diabetes, wide definition""",788
6,"Heel bone mineral density (bmd) t-score, automated (right)",48888
6,Spherical power (right),71004
6,Medication use (beta blocking agents),30710
6,DNA-incorporated thioguanine levels in 6-mercaptopurine-treated acute lymphoblastic leukaemia,3061
6,Feeling tense,330
6,"Diastolic blood pressure x alcohol consumption interaction (2df test) [AA, Asian, EA]",426
6,Visceral adipose tissue adjusted for BMI [EA],311
6,Cortical surface area [Middle temporal],22
6,Hydroxyasparagine levels,28
6,Myopia (age of diagnosis),163687
6,"Blood protein levels [KLRC3, 7795_14_3]",11021
6,"Cellulitis | non-cancer illness code, self-reported",2824
6,"Waist-hip ratio [EA, women]",2092
6,Prostate cancer | illnesses of father,219
6,Juvenile arthritis (FINNGEN),111
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-444 ms],57
6,Urate levels [Urate],5964
6,Deep endometriosis,1186
6,Urinary potassium excretion [EA],1048
6,Serum uric acid levels [Japanese],13715
6,Medication use (glucocorticoids),14442
6,Serum levels of protein BAGE3,15380
6,Advanced age-related macular degeneration [EA],8970
6,Glomerular filtration rate,22639
6,Moderate to vigorous physical activity levels,54592
6,Response to hepatitis B vaccine [Adults],87859
6,IgA nephropathy [East Asian],419125
6,"Psoriasis | non-cancer illness code, self-reported",23205
6,Diabetes | illnesses of father,478
6,Stool frequency,4540
6,Central corneal thickness,1679
6,Theobromine levels,489
6,Naramig 2.5mg tablet | treatment/medication code,725
6,Percent mammographic density,24
6,Protein quantitative trait loci (liver) [TOMM70],32
6,HIV-1 control [EA],22446
6,White blood cell count [WBC],85873
6,White matter microstructure (radial diusivities) [Average across all tracts],5049
6,Frequency of needing morning drink of alcohol after heavy drinking session in last year,86
6,Intracranial volume,1311
6,Scoliosis [East Asian],1134
6,Getting up in morning,527
6,Hematological and biochemical traits [fasting blood glucose],744
6,Educational attainment (college completion),187
6,Neutrophil percentage of white cells,326290
6,Number of fluid intelligence questions attempted within time limit,150786
6,Serum metabolite levels (CMS) [S_VLDL_TG],63634
6,Hypertension [East Asian],1307
6,"""Asthma, including avohilmo""",2032
6,Oily fish consumption,162683
6,Cortical surface area (MOSTest),5783
6,Serum levels of protein CPXM1,95364
6,"Blood protein levels [EA, MHC class I polypeptide-related sequence A]",180722
6,"Blood protein levels [CTGF, 2975_19_2]",769
6,Serum levels of protein GZMB,12971
6,Serum levels of protein NCR3,4891
6,Lung function (FEV1/FVC) [adults],57
6,Galectin-9 levels,34
6,"Facial morphology (factor 9, facial height related to vertical position of nasion)",63
6,Hard cardiovascular diseases,108
6,Antinuclear antibody levels,233729
6,Loneliness,5933
6,interferon-related traits [IFNAR2_of_CD20p],103120
6,Waist circumference adjusted for body mass index [EA],79591
6,CD20 on IgD+ CD38+ B cell,28389
6,Electrocardiogram morphology (amplitude at temporal datapoints) [82 ms],6372
6,Blood protein levels [Neutrophil collagenase],2642
6,"Blood protein levels [LAYN, 2635_61_2]",11021
6,"""Coxarthrosis, primary""",5120
6,"Anti-thyroid drug induced agranulocytosis [adjusted for rs652888, rs199564443]",135
6,Lung cancer,1532187
6,Drug-induced liver injury (flucloxacillin),90460
6,Thyrotoxic hypokalemic periodic paralysis and Graves disease,55771
6,"Allergic disease (asthma, hay fever or eczema)",43133
6,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction) [women],1639
6,Meat-related diet [male],5355
6,6mm strong meridian (right),134504
6,Takayasu arteritis [conditional on rs12110437 and rs1264697],15275
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-16 ms],3628
6,Celiac disease and Rheumatoid arthritis,1196
6,Response to statin therapy,80
6,Primary tooth development (time to first tooth eruption),197
6,Marginal zone lymphoma,180141
6,Cheese intake,4039
6,Type 2 diabetes [Indian],9227
6,Arm fat mass (left),85487
6,Arm predicted mass (left),281965
6,Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection,9528
6,"Intra-ocular pressure, corneal-compensated (left)",1198
6,Heart rate,3797
6,Anger [Temperament],1213
6,"1,5-anhydroglucitol (1,5-ag) levels",797
6,Mild influenza (H1N1) infection,59936
6,Neuroticism (MTAG),98548
6,Mental health study participation (completed survey),17379
6,Vertex-wise cortical surface area,21399
6,TPE interval (resting) [women],529
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-434 ms],410
6,Spondylosis,628
6,Electrocardiogram morphology (amplitude at temporal datapoints) [40 ms],329
6,Scavenger receptor class A member 5 measurement,3
6,Schizophrenia,1121676
6,Alcohol consumption (drinks per week) (MTAG),63401
6,"Blood protein levels [RPS10, 13011_20_3]",11021
6,Thyroid hormone levels [TSH],1738
6,Phosphatidylcholine_38:5_[M+H]1+/Phosphatidylethanolamine_41:5_[M+H]1+/Phosphatidate_43:6_[M+NH4]1+ levels,2370
6,"""Endocrine, nutritional and metabolic diseases""",823
6,Electrocardiogram morphology (amplitude at temporal datapoints) [162 ms],6808
6,Metabolite levels [xanthosine],863
6,Breast Cancer in BRCA1 mutation carriers,772
6,Mean corpuscular hemoglobin concentration,841253
6,Mosaic loss of chromosome Y (Y chromosome dosage),143805
6,Resting heart rate,5193
6,"Ibuprofen (e.g. nurofen) | medication for pain relief, constipation, heartburn",159
6,Nephropathy,122845
6,Multiple myeloma and monoclonal gammopathy,86255
6,Intrinsic epigenetic age acceleration,31612
6,"Takayasu arteritis [conditional on rs2844678, rs12524487, rs17193507 and rs12526858]",33868
6,Arm predicted mass (right),286769
6,Electrocardiogram morphology (amplitude at temporal datapoints) [84 ms],6377
6,Protein quantitative trait loci (liver) [HAO1],471
6,Colorectal cancer [distal colon cancer],557
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-114 ms],635
6,Serum levels of protein VEGFB,1256
6,Thyroid hormone levels [TSH - Males],114
6,"Other chronic ischemic heart disease, unspecified",1030
6,"Blood protein levels [VEGFA, 14032_2_3]",227
6,"Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA, men]",64794
6,Electrocardiogram morphology (amplitude at temporal datapoints) [196 ms],7667
6,Hematological parameters [PLT],937
6,Age at first live birth,556
6,Protein quantitative trait loci (liver) [MGMT],412
6,Insomnia,154420
6,Head and neck squamous cell carcinoma,74018
6,BMI (adjusted for smoking behaviour) [women],6240
6,"Acute anterior uveitis (with or without ankylosing spondylitis) [conditioned on rs116488202, rs114102658]",3703
6,Medication use (agents acting on the renin-angiotensin system),40251
6,"Heel quantitative ultrasound index (qui), direct entry (right)",48888
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-6 ms],790
6,Epstein-Barr virus EA-D antibody levels,115
6,Blood metabolite levels [X-11261],111
6,Ebbinghaus illusion (underestimation),71926
6,Parental lifespan [EA],23464
6,Unspecified/other endometriosis,307
6,Tea intake,317
6,Obesity due to excess calories,164
6,Vitiligo (early onset),183276
6,Autoimmune hepatitis,15540
6,Serum levels of protein DCUN1D5,16139
6,Leg predicted mass (left),261912
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-484 ms],353
6,Diprosalic ointment | treatment/medication code,1054
6,"Blood protein levels [TDO2, 9880_33_3]",114
6,Smoking x experiences in childhood (felt loved by family member) interaction,46
6,Time spent doing light physical activity,46
6,Status post-ami,80
6,Osteoarthritis (with total hip replacement),10847
6,Urinary metabolite levels in chronic kidney disease [gamma-CEHC sulfate],4832
6,Electrocardiogram morphology (amplitude at temporal datapoints) [290 ms],3633
6,Beef intake,7908
6,Body fat percentage and LDL-C (pairwise),4843
6,Lipoprotein (a) - cholesterol levels,2297
6,Serum levels of protein HNF4A,5056
6,Phosphatidylcholine_38:6_[M+OAc]1-/Phosphatidylserine_42:5_[M-H]1- levels,1540
6,CD24 on switched memory B cell,497
6,Type 2 diabetes [DGI+FUSION+WTCCC],478
6,"""Myocardial infarction, strict""",379
6,Thyrotoxicosis with or without goiter,123364
6,Mean corpuscular haemoglobin,152265
6,Electrocardiogram morphology (amplitude at temporal datapoints) [164 ms],6803
6,Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; all treatment preparations),1059
6,Blood metabolite ratios [docosapentaenoate (n3 DPA; 22:5n3)/X-12627],1519
6,Rheumatoid arthritis [ACPA- cases vs. all controls],7264
6,Cytokine levels [VEGF-A],1214
6,"Blood protein levels [VEGFA, 2597_8_3]",227
6,Restless legs syndrome,2337
6,Doctor diagnosed asthma,127
6,Type 1 diabetes with peripheral circulatory complications,78
6,Dermatomyositis or juvenile dermatomyositis,104315
6,Past tobacco smoking,21826
6,Systolic blood pressure [Japanese],5131
6,White matter microstructure (radial diusivities) [Cingulate gyrus],9349
6,"Blood protein levels [IL36A, 14150_7_3]",48445
6,Leg fat percentage (left),173162
6,Ischemic heart disease,3652
6,Hair color,25292
6,Effector Memory CD4+ T cell %CD4+ T cell,10223
6,Electrocardiogram morphology (amplitude at temporal datapoints) [296 ms],3633
6,Osteosarcoma,301
6,Eosinophil percentage of white cells,413464
6,Cervical cancer (MTAG),19104
6,Neuroticism conditioned on self-rated math ability (multi-trait conditioning and joint analysis),11328
6,Serum levels of protein EEF2K,29430
6,Monocyte percentage,77811
6,Pancreas volume,1887
6,Urinary metabolite levels in chronic kidney disease [X - 18888],4832
6,Septic shock,149
6,Colon polyp,129
6,"Diabetic kidney disease [American Indian, dominant ]",888
6,Hair greying,35
6,Heart rate response to recovery post exercise (20 sec),103
6,Age when periods started (menarche),61974
6,Serum levels of protein GCNT4,14017
6,Takayasu arteritis [conditional on rs12524487],43814
6,Thiopurine-induced myelosuppression in inflammatory bowel disease,1412
6,"Blood protein levels [SMPDL3A, 14086_11_3]",169
6,White matter integrity (fractional anisotropy),25985
6,Vertex-wise sulcal depth,163464
6,"Icd10: i64 stroke, not specified as haemorrhage or infarction | underlying (primary) cause of death",7517
6,Sensorineural hearing loss,12992
6,Adult onset asthma and/or BMI,322
6,Cardiac problem,1067
6,Rheumatoid arthritis [conditional on rs7749323 and rs17264332],97
6,Guilty feelings,107593
6,"Hip circumference [EA, men]",9990
6,Diacylglycerol_38:5_[M+H-H2O]1+ levels,1519
6,Electrocardiogram morphology (amplitude at temporal datapoints) [12 ms],3362
6,Electrocardiogram morphology (amplitude at temporal datapoints) [146 ms],4287
6,"""Diabetes, insuline treatment (Kela reimbursement) (more control exclusions)""",1274
6,Snoring,3207
6,Urokinase plasminogen activator surface receptor levels,1003
6,Urinary metabolite levels in chronic kidney disease [hexanoylglutamine],5298
6,Epaderm ointment | treatment/medication code,718
6,Blood sugar levels,886
6,Total protein levels x insomnia interaction,45
6,Radiation-related disorders of the skin and subcutaneous tissue,44
6,Red cell distribution width,1408837
6,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test),28580
6,CD8-positive T-lymphocyte count,114343
6,HLA DR on CD33dim HLA DR+ CD11b+,45953
6,Electrocardiogram morphology (amplitude at temporal datapoints) [142 ms],6500
6,Electrocardiogram morphology (amplitude at temporal datapoints) [104 ms],3403
6,Distance between home and job workplace,858
6,Body fat percentage or heart failure (MTAG),80
6,Biscuit cereal (e.g. weetabix) | cereal type,11
6,Lymphoma [FL],568856
6,"Blood protein levels [PCDHB14, 10715_5_3]",11021
6,Serum levels of protein PRSS8,15380
6,CD24 on IgD+ CD38+ B cell,486
6,Simvastatin | treatment/medication code,518
6,LDL cholesterol levels x short total sleep time interaction (2df test),291
6,Protein quantitative trait loci (liver) [YARS],1500
6,Skin pigmentation traits [Skin color],44
6,Interleukin-10 levels in non-alcoholic fatty liver disease x mastiha supplementation interaction,277
6,Other/unspecified rheumatoid arthritis,43
6,Protein quantitative trait loci (liver) [EIF3E],78
6,Gut microbiota (bacterial taxa) [k__Archaea|p__Euryarchaeota|c__Methanobacteria|o__Methanobacteriales],1
6,Depressive and manic episodes in bipolar disorder,2025
6,Medication use (antihistamines for systemic use),38142
6,Waist circumference variance,119507
6,Number of days/week of moderate physical activity 10+ minutes,55690
6,"Blood protein levels [WIF1, 2848_2_2]",11021
6,"None of the above | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",7997
6,X-24686 levels,154
6,Blood metabolite levels [X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide],111
6,"Trapped nerve/compressed nerve | non-cancer illness code, self-reported",274
6,IgD+ CD38- B cell %B cell,3
6,Cluster headache,5537
6,Serum levels of protein IL18RAP,30427
6,Squamous cell carcinoma,524
6,"Aspirin | medication for pain relief, constipation, heartburn",95
6,Disorders of choroid and retina,71
6,Protein quantitative trait loci (liver) [MT1H],9
6,Diabetes or endocrine disease,107971
6,Serum levels of protein TREML1,4670
6,"""Coxarthrosis, primary, with hip surgery""",5120
6,Electrocardiogram morphology (amplitude at temporal datapoints) [184 ms],3999
6,Survival in pancreatic cancer,103
6,C-reactive protein levels or LDL-cholesterol levels (pleiotropy),68772
6,Severe autoimmune type 2 diabetes,3101
6,Serum levels of protein ISG15,114330
6,Serum metabolite levels [hexanoylglutamine],4405
6,Pulse pressure x alcohol consumption interaction (2df test) [EA],4968
6,Number of days/week of vigorous physical activity 10+ minutes,1092
6,Body mass index (joint analysis main effects and physical activity interaction) [men],162
6,Diabetic background retinopathy,262
6,Symptoms and signs involving the digestive system and abdomen,153
6,Cutaneous psoriasis,77976
6,Liver enzyme levels (alkaline phosphatase),43865
6,Vitamin D levels,3569
6,Blood metabolite ratios [X-12798/phenylalanine],797
6,Electrocardiogram morphology (amplitude at temporal datapoints) [156 ms],9900
6,White blood cell (leukocyte) count,246690
6,"Oesophagitis/barretts oesophagus | non-cancer illness code, self-reported",1433
6,Blood protein levels [AGER],5414
6,17-hydroxyprogesterone (17-OHP) levels,35430
6,Nvq or hnd or hnc or equivalent | qualifications,5
6,C-reactive protein and white blood cell count [CRP],2
6,Triglyceride levels in current drinkers,32062
6,Serum levels of protein PIK3CG,16139
6,Uterine fibroids,9370
6,Blood metabolite levels [Acylcarnitine total],126
6,Electrocardiogram morphology (amplitude at temporal datapoints) [120 ms],6372
6,Brain region volumes [total brain volume],1267
6,Phosphatidylethanolamine-P_40:7_[M-H]1- levels,1519
6,Schizophrenia [East Asian],1035
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-474 ms],353
6,Hay fever and/or eczema,741644
6,Smoking initiation,15613
6,Osteoporosis,20159
6,"Blood protein levels [IL10RA, 10344_334_3]",11021
6,Electrocardiogram morphology (amplitude at temporal datapoints) [110 ms],6377
6,Diabetes (gestational),744
6,Protein quantitative trait loci (liver) [C9orf64],12
6,Protein quantitative trait loci (liver) [ACLY],1
6,BMI (adjusted for smoking behaviour),74412
6,Liver iron content,53787
6,Serum levels of protein CRABP1,16139
6,Serum levels of protein C2orf40,16139
6,"Blood protein levels [NCR3, 3003_29_2]",2725
6,Serum levels of protein SPAG11B,22775
6,Ferritin levels,3725
6,Metabolite levels,1519
6,Diffuse plaques (SNP x SNP interaction),3629
6,Clopidogrel | treatment/medication code,221
6,Serum levels of protein F13B,183
6,AIDS progression,45230
6,Takayasu arteritis,228171
6,Holdemania sp900120005 abundance in stool,30780
6,Lymphocyte-to-monocyte ratio,91584
6,Externalizing behaviour (multivariate analysis),117622
6,Early-onset myasthenia gravis,175075
6,Electrocardiogram morphology (amplitude at temporal datapoints) [166 ms],10018
6,Aspartate aminotransferase platelet ratio index in high alcohol intake,1632
6,Other disorders of pancreatic internal secretion,510
6,Hepatitis,86
6,Idiopathic membranous nephropathy,311536
6,Prostate cancer [EA],52660
6,Noncognitive aspects of educational attainment,371962
6,"Blood protein levels [CDK5 CDK5R1, 3358_51_2]",11021
6,Parental longevity (father's attained age),531
6,Eye color traits [Eye color (dark],44
6,Retinal haemorrhage,3
6,Red blood cell count [conditional on round 2],10474
6,Serum levels of protein IL21,159077
6,Blood protein levels [MIC-A],41793
6,"Asthma | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",62138
6,Red blood cell (erythrocyte) distribution width,235653
6,Facial morphology (lip protrusion),199
6,Smoking cessation,2467
6,"Blood protein levels [ULBP3, 2747_3_2]",374
6,No | major dietary changes in the last 5 years,949
6,Triglyceride levels,667496
6,Migraine with aura and/or pulse pressure,6738
6,Waist-to-hip ratio adjusted for BMI in non-smokers [EA],31844
6,Cortical thickness,144305
6,Particulate matter air pollution (pm10); 2007,9907
6,Insomnia [Male],6634
6,Type 2 diabetes with other specified/multiple/unspecified complications,1604
6,Erosive tooth wear (severe vs non-severe) [female],777
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-492 ms],353
6,None of the above (group 1) | illnesses of father,80
6,Peanut allergy [EA],111740
6,Hemoglobin concentration,610862
6,Platelet-to-lymphocyte ratio,264409
6,Cortical surface area,28085
6,Serum levels of protein PLG,2840
6,Optic cup area,1358
6,QRS duration [European],2060
6,"Non-melanoma skin cancer | cancer code, self-reported",2635
6,Ossification of the posterior longitudinal ligament of the spine,533
6,"Blood protein levels [EA, Acid sphingomyelinase-like phosphodiesterase 3a]",169
6,Serum metabolite levels [arginine],680
6,Serum levels of protein UST,44
6,Endometrial endometrioid carcinoma,3009
6,Subcortical volume (MOSTest),187067
6,Takayasu arteritis [conditional on rs2844678],44540
6,Platelet distribution width,193850
6,Serum levels of protein DES,11021
6,Ever smoked,59230
6,White matter microstructure (axial diusivities) [Superior longitudinal fasciculus],66025
6,Second line medication for Crohns disease,16532
6,Anti-sp100 seropositivity in primary biliary cholangitis,18579
6,Angina | vascular/heart problems diagnosed by doctor,888
6,Electrocardiogram morphology (amplitude at temporal datapoints) [310 ms],3749
6,Cortical surface area [Global],664
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-478 ms],353
6,Household income,89
6,Lung adenocarcinoma,218368
6,Brainstem volume,113275
6,Vertical cup-disc ratio (multi-trait analysis),19368
6,Rheumatoid arthritis [all cases vs. all controls],8456
6,Other bullous disorders,43544
6,Electrocardiogram morphology (amplitude at temporal datapoints) [14 ms],3280
6,Serum levels of protein MLN,3962
6,Prostate-specific antigen levels,969
6,Osteoarthrosis,411
6,Juvenile Open Angle Glaucoma,97
6,Blood metabolite levels [Isovalerylcarnitine / Leucine|Isoleucine],126
6,Sporadic neuroblastoma [European American],61
6,Nasal polyps,193217
6,HLA DR on Dendritic Cell,137770
6,"Blood protein levels [GNMT, 14006_36_3]",20781
6,High light scatter reticulocyte percentage,61334
6,Electrocardiogram morphology (amplitude at temporal datapoints) [122 ms],6372
6,Initial pursuit acceleration [African],89
6,Senile cataract,325
6,Age at voice drop,831
6,Iron status biomarkers [iron],5123
6,Systemic lupus erythematosus [anti-dsDNA -],38280
6,"Insulin | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",25420
6,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction) [women],2439
6,"Waist circumference adjusted for BMI in inactive individuals [EA, women]",117
6,"Schizophrenia, bipolar disorder or major depressive disorder x sex interaction (3df)",42
6,Waldenström macroglobulinemia / lymphoplasmacytic lymphoma,27
6,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),190933
6,Fulminant type 1 diabetes,233668
6,Ankylosing spondylitis [Turkish],25705
6,HLA DR++ monocyte Absolute Count,65767
6,Serum levels of protein IL18R1,16139
6,Nevirapine-induced rash,13800
6,Epstein-Barr virus immune response (EBNA-1) [Conditional on rs477515 - Quantitative],10260
6,Electrocardiogram morphology (amplitude at temporal datapoints) [370 ms],3280
6,"Blood protein levels [MICA, 2730_58_2]",28470
6,N-acetylglucosamine/n-acetylgalactosamine levels,9992
6,Lactate dehydrogenase levels,899
6,Interleukin-5 levels,1214
6,Electrocardiogram morphology (amplitude at temporal datapoints) [28 ms],368
6,Sepsis (hospital admission),14829
6,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) [5 degree of freedom test]",114201
6,Systemic lupus erythematosus [EA],73638
6,Coagulation Factor X measurement,7932
6,White matter microstructure (mean diusivities) [Posterior corona radiata ],74157
6,White matter microstructure (radial diusivities) [Superior longitudinal fasciculus],9332
6,Melanoma,466
6,Response to ketogenic dietary therapies in epilepsy,68
6,Peripheral atherosclerosis,945
6,Protein quantitative trait loci (liver) [EMILIN2],73
6,Low density lipoprotein cholesterol levels (on statin treatment),80
6,Skin pigmentation traits [Freckling phototype score],44
6,Serum 25-Hydroxyvitamin D levels,28526
6,Folate pathway vitamin levels [Plasma Vitamin B12],23354
6,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],58512
6,HLA DR+ T cell%T cell,26159
6,Mitochondrial DNA copy number,22504
6,Muesli | cereal type,39506
6,Health precaution | why stopped smoking,39487
6,Serum levels of protein CD109,6736
6,Eye morphology [Right eye tail length],18202
6,Serum levels of protein SEMA6C,16851
6,Psoriasis and related disorders,12308
6,Serum metabolite levels [adenosine],5960
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-18 ms],3690
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-26 ms],1304
6,"Blood protein levels [THBS2, 3339_33_1]",240
6,Pork consumption,162683
6,Serum levels of protein POLR1C,16139
6,"""Hypothyroidism, drug reimbursement""",92433
6,Waist circumference adjusted for body mass index [men],6817
6,Visceral adipose tissue adjusted for BMI,311
6,Parental longevity (mother's attained age),95
6,Viscotears liquid eye gel | treatment/medication code,335
6,HIV-1 control [AA],10611
6,Autoimmune hepatitis in primary sclerosing cholangitis,10924
6,Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded),16382
6,Interleukin-1-beta levels,81816
6,"""Primary open-angle glaucoma, strict""",97
6,Arrhythmia,1403
6,Protein quantitative trait loci (liver) [C4B],24
6,Benign neoplasm of colon,138
6,X-12007 levels,11
6,Feeling nervous,5075
6,Composite immunoglobulin trait (IgA/IgG),5102
6,middle facial morphology traits (quantitative measurement) [Nose bridge breadth],3610
6,Osteoarthritis (hip) [additive],10893
6,Serum levels of protein RAB17,16139
6,White matter microstructure (mean diusivities) [Genu of corpus callosum],19521
6,Diabetic maculopathy (more control exclusions),30430
6,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) [subset analysis]",1720
6,Physical activity (Total log acceleration 2am-4am),596
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-432 ms],57
6,Benign neoplasm of skin,44
6,Retinal vascular fractal density,44
6,Triglycerides,302048
6,Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis),8493
6,White matter microstructure (mean diusivities) [Superior corona radiata],72602
6,"Systolic blood pressure x alcohol consumption interaction (2df test) [Asian, EA]",4968
6,Systemic lupus erythematosus and Systemic sclerosis,379
6,Hair color [hair color],44
6,Protein quantitative trait loci (liver) [LGMN],29
6,Multiple sclerosis,1154399
6,Granulocyte percentage of myeloid white cells,142829
6,Takayasu arteritis [conditional on rs12110437],69069
6,Serum levels of protein PCDHGA11,16851
6,Year ended full time education,15421
6,Renal function-related traits (eGRFcrea),4466
6,Ramipril | treatment/medication code,80
6,Brugada syndrome,10010
6,Number of cigarettes previously smoked daily,16210
6,Shingles [EA],10621
6,"Blood protein levels [EA, Complement C4]",52355
6,Dovonex 50micrograms/g cream | treatment/medication code,9058
6,Serum levels of protein CFP,11021
6,Acute-on-chronic liver failure in hepatitis B,22992
6,Reticulocyte count,708921
6,Vigorous physical activity,51273
6,Nonatopic asthma and/or BMI,60269
6,Cancer (pleiotropy),65839
6,Angina pectoris,50822
6,"Blood protein levels [BCL2L1, 4423_77_2]",11021
6,Pulmonary arterial hypertension,1392
6,Neurological disease,4478
6,"""Type 1 diabetes, wide definition""",771
6,Crohn's disease or systemic sclerosis,1140
6,2-hydroxyglutarate levels,532
6,Congenital anomalies of great vessels,80
6,Erectile dysfunction,49
6,Lung function in never smokers (low FEV1 vs high FEV1),38586
6,"Blood protein levels [PILRA, 8683_119_3]",21436
6,Height [Conditiond on rs2780226],20387
6,Mitochondrial DNA levels,7908
6,QRS duration [EA],4192
6,Menopause (age at onset) [japanese],11516
6,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant I (Philtrum), Segment 37]",780
6,"""Disorders of sclera, cornea, iris and ciliary body""",235
6,Rheumatoid arthritis,994839
6,Number of sexual partners,59872
6,"Systolic blood pressure [EA, initial]",11244
6,Potassium in urine,44843
6,Type 1 diabetes with coma,10532
6,Electrocardiogram morphology (amplitude at temporal datapoints) [74 ms],3285
6,Chronic obstructive pulmonary disease in ever smokers,1461
6,Actonel 5mg tablet | treatment/medication code,630
6,Electrocardiogram morphology (amplitude at temporal datapoints) [244 ms],123
6,Waist-to-hip ratio adjusted for BMI x sex interaction,150
6,CAG-349 abundance in stool,34
6,Serum metabolite levels [linoleoylcarnitine (C18:2)*],99
6,Heart rate reached safety level | completion status of test,69
6,Degenerative skin conditions and other dermatoses,44
6,Self-reported math ability,142012
6,Systemic lupus erythematosus [Chinese],18503
6,Diabetes mellitus,2712
6,Exudative age-related macular degeneration,3312
6,Serum levels of protein TAPBP,8278
6,Unstable angina pectoris,2012
6,Hair morphology traits [Hair color phototype score],44
6,Protein quantitative trait loci (liver) [PCK1],74
6,Hematocrit,829457
6,Shingles,157632
6,Red blood cell traits [MCV],2731
6,Body mass index [Japanese],195243
6,Pattern 4 | hair/balding pattern,17283
6,Serum levels of protein TMEM52B,5643
6,Urinary metabolite levels in chronic kidney disease [X - 23196],6599
6,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test) [EA],28580
6,Spherical power (left),3927
6,Serum metabolite levels [serotonin],166
6,Calcium levels,97607
6,Triglyceride levels in current drinkers [EA],22964
6,Aspartate aminotransferase to alanine aminotransferase ratio,22375
6,Electrocardiogram morphology (amplitude at temporal datapoints) [194 ms],4144
6,Electrocardiogram morphology (amplitude at temporal datapoints) [306 ms],3633
6,"Intra-ocular pressure, corneal-compensated (right)",857
6,Iron status biomarkers [ferritin],2172
6,Heart disease | illnesses of father,540
6,Injuries to the elbow and forearm,1484
6,Gastrointestinal event in colchicine-treated recent myocardial infarction (time to event),11
6,Follicular lymphoma [FL],275814
6,Rheumatoid arthritis [ACPA-positive RA vs ACPA-negative RA],46593
6,Effector Memory CD4+ T cell %T cell,109284
6,"Pulmonary function (smoking interaction) [FEV1/FVC, Pack-years]",6927
6,Brain region volumes [left cerebellum white matter],1283
6,"Hayfever/allergic rhinitis | non-cancer illness code, self-reported",11117
6,Ascending aorta minimum area,1041
6,Red blood cell fatty acid levels [DPA-n3],2441
6,Hematological or dermatological disease,62
6,Corneal hysteresis (right),33
6,Other non-epithelial cancer of skin,102
6,CD20 on transitional B cell,226
6,Angiotensin-converting enzyme inhibitor intolerance,138
6,For just reading/near work as you are getting older (called 'presbyopia') | reason for glasses/contact lenses,2
6,Multiple sclerosis (OCB status),124748
6,Alzheimer's disease or family history of Alzheimer's disease,350518
6,Esophageal disorder,15543
6,Broad depression or major depressive disorder (self-reported),6356
6,Femur total bone mineral density x gut microbiota (﻿genus Lactococcus) interaction,420
6,Serum levels of protein DLK2,1693
6,QT dynamics during exercise,1829
6,Serum levels of protein GFRAL,877
6,Myo-inositol levels,1806
6,Father's age at death,438
6,Anthropometric traits [height],748
6,Body fat percentage and HDL-C (pairwise),150
6,Hodgkin's lymphoma,196623
6,BMI in non-smokers [women],6233
6,Ankylosing spondylitis [EA],37601
6,Cognitive traits (MTAG),57810
6,Insomnia symptoms (never/rarely vs. usually),10125
6,Insulin levels,315
6,Number of attempts,132
6,Cortical volume [Pericalcarine],160
6,Finger osteoarthritis,143
6,Protein quantitative trait loci (liver) [TGM2],26
6,Sun-seeking behavior,1
6,Hip index,107231
6,Serum levels of protein RBM19,8694
6,Serum levels of protein USP25,40769
6,Leg fat mass (left),94950
6,Electrocardiogram morphology (amplitude at temporal datapoints) [154 ms],7208
6,Body fat distribution (leg fat ratio) [males],831
6,Opioid use disorder,174
6,Endometriosis of ovary,325
6,Adopted as a child,64
6,Graft survival time in renal transplantation (donor effect) x APOL1 genotype interaction,119
6,Narcolepsy (onset before 2009 H1N1 influenza pandemic),208287
6,Waist-hip ratio and HDL-C (pairwise),185807
6,Urea levels,11483
6,Brain region volumes [left hippocampus],111866
6,Blood protein levels [MHC class I polypeptide-related sequence A],61525
6,Narcolepsy with cataplexy,1890
6,Hypothyroidism (congenital or acquired),2293
6,Digit length ratio (left hand) [EA],59
6,Diabetic hypoglycemia,103
6,Eosinophil percentage of granulocytes,140294
6,Serum total protein level [EA],14774
6,Anti-human herpes virus 6 IE1A IgG seropositivity,9842
6,"Blood protein levels [PCDHGB4, 10721_76_3]",11021
6,Serum metabolite levels [guanosine],5166
6,Bone properties (heel) [BMD-DXA],1503
6,Private healthcare,6169
6,Knee pain | pain type(s) experienced in last month,1230
6,Kidney stones,1186
6,Phosphatidylcholine_40:6_[M+H]1+/Phosphatidylethanolamine_43:6_[M+H]1+ levels,1519
6,Obesity [Overweight],171
6,Primary vesicoureteric reflux,173
6,Walking pace,92008
6,"Diastolic blood pressure [EA, initial]",25573
6,Medication use (immunosuppressants),84009
6,Serum levels of protein MST1R,16139
6,Electrocardiogram morphology (amplitude at temporal datapoints) [176 ms],7716
6,Parkinson's disease [Sporadic],959
6,Serum levels of protein DDR1,17892
6,Cardiac arrhytmias,1376
6,Time spend outdoors in summer,10062
6,Systemic mastocytosis,20833
6,Blood metabolite levels [Propionylcarnitine],126
6,Phosphatidylcholine-ether levels [PCO(16:1;0-16:0;0],29
6,"""Complications of genitourinary prosthetic devices, implants and grafts""",31
6,Nicorandil | treatment/medication code,111
6,Brain region volumes [right lateral occipital],44
6,Platelet count [AA],1009
6,Sex hormone-binding globulin levels adjusted for BMI,332515
6,Serum levels of protein RNF43,16139
6,"Light brown | hair colour (natural, before greying)",4577
6,"Serum metabolite concentrations in chronic kidney disease [Butyrylcarnitine, Isobutyrylcarnitine]",132
6,Osteoarthritis (hip) [recessive],1063
6,Glomerular disorders in diseases classified elsewhere,1812
6,Refractive astigmatism,265
6,Gut microbiota (bacterial taxa) [k__Archaea],1
6,Alopecia areata,125013
6,Chronic hepatitis B infection,1421484
6,Giant cell arteritis,299604
6,Electrocardiogram morphology (amplitude at temporal datapoints) [372 ms],3280
6,Alcohol use disorder,17379
6,Glycerophospholipid levels [Phosphatidylcholine diacyl C42:5],2441
6,Bone disorder,2108
6,Interferon gamma-induced protein 10 levels,3909
6,Protein quantitative trait loci (liver) [CS],444
6,Protein quantitative trait loci (liver) [MPO],2
6,Random C-peptide levels in type I diabetes,68613
6,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [men],64794
6,Blood protein levels [MICA],57857
6,Trunk fat mass,75034
6,"Systemic lupus erythematosis/sle | non-cancer illness code, self-reported",45451
6,Hepcidin/ferritin ratio [Subset],3315
6,Composite immunoglobulin trait (IgA/IgM),4729
6,Keratoconus,178
6,Rheumatoid arthritis and other inflammatory polyarthropathies,85
6,Electrocardiogram morphology (amplitude at temporal datapoints) [228 ms],123
6,Protein quantitative trait loci (liver) [MCCC2],10
6,Metabolic syndrome,74324
6,A body shape index,550085
6,Serum metabolite levels [butyrylcarnitine (C4],274
6,Electrocardiogram morphology (amplitude at temporal datapoints) [248 ms],635
6,Trichloroethylene-induced hypersensitivity syndrome,51918
6,Psoriasis vulgaris,100704
6,Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFNβ-1b subcutaneous),179366
6,"Blood protein levels [MICB, 5102_55_3]",58860
6,Electrocardiogram morphology (amplitude at temporal datapoints) [158 ms],6758
6,Schizophrenia [Chinese],6052
6,Stromal cell-derived factor 2 measurement,10796
6,Mean arterial pressure [Japanese],7635
6,"Osteoarthritis | non-cancer illness code, self-reported",254
6,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),564
6,Urate levels,893491
6,Mastocytosis,67614
6,Glucose levels,38330
6,Serum levels of protein MICA,15988
6,Other erythrocyte phenotypes [MCHC],1664
6,Facial morphology (segment 11),889
6,Total body bone mineral density (age 45-60),1871
6,Brain region volumes [right lateral orbitofrontal],333
6,Response to statins (LDL cholesterol change),160
6,"""Articial joint operation, menisceal resection""",55
6,Rosuvastatin | treatment/medication code,80
6,Obstructive sleep apnea trait (average respiratory event duration) [Hispanic],204
6,COVID-19 (critical illness vs population),73321
6,Left ventricular global longitudinal strain,3107
6,Total cerebellar volume (excluding Crus I vermis),26520
6,College or university degree | qualifications,32418
6,"Hypothyroidism/myxoedema | non-cancer illness code, self-reported",94488
6,Ulcerative colitis [EA],3903
6,Beard thickness,343
6,Resting heart rate [Random effects analysis],454
6,Male puberty timing (late vs. average onset voice breaking),1177
6,Irritable mood,325
6,Morning vs. evening chronotype,304
6,Malignant neoplasm of skin (controls excluding all cancers),159
6,Lipoprotein phospholipase A2 activity in cardiovascular disease,83
6,Rheumatoid arthritis [ACPA+ cases vs. all controls],8456
6,Schizophrenia [male],151020
6,Seropositive rheumatoid arthritis,19757
6,Other diabetic retinopathy,10074
6,"Blood protein levels [OSM, 2693_20_3]",11021
6,Electrocardiogram morphology (amplitude at temporal datapoints) [298 ms],3633
6,Disc degeneration (lumbar),3716
6,Waist circumference adjusted for BMI in active individuals [men],818
6,Metabolically unhealthy in normal weight,707
6,Multiple sclerosis and systolic blood pressure (pleiotropy),6546
6,Immature fraction of reticulocytes,216251
6,Pollinosis,19564
6,"Other (e.g. cornflakes, frosties) | cereal type",49403
6,Electrocardiogram morphology (amplitude at temporal datapoints) [168 ms],6931
6,Blood protein levels [Complement C4],17506
6,Cholesteryl ester_20:5_[M+NH4]1+ levels,2427
6,Electrocardiogram morphology (amplitude at temporal datapoints) [308 ms],3633
6,Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals,552
6,Lactoylglutathione lyase levels,266
6,Brain region volumes [right lingual],44
6,Response to thiopurine immunosuppressants in inflammatory bowel disease (pancreatitis) (azathioprine and mercaptopurine),61793
6,Chronic obstructive pulmonary disease x ever smoker interaction (main effect),246508
6,Serum levels of protein WIF1,16139
6,"Blood protein levels [EA, gp41 C34 peptide, HIV]",35793
6,Never | smoking status,47982
6,Blood pressure [Mean Arterial Pressure],5150
6,Phosphatidylcholine(38:6)_[M+H]1+/Phosphatidylethanolamine(41:6)_[M+H]1+ levels,1143
6,HbA2 levels,1632
6,Urinary metabolite levels in chronic kidney disease [ferulic acid 4-sulfate],5298
6,Disorders of breast,788
6,Lymphoid leukemia,158
6,"Mean arterial pressure x alcohol consumption interaction (2df test) [AA, EA, Hispanic]",1291
6,Cervical cancer [Matched],134
6,Coronary heart disease [LAD],28
6,Rheumatoid arthritis (ACPA-negative),226619
6,Menarche (age at onset),259556
6,Estimated glomerular filtration rate in diabetes,593210
6,Anti-anoctamin 2 antibody levels,131133
6,Type 2 diabetes or prostate cancer (pleiotropy),9527
6,CD28- CD8+ T cell %CD8+ T cell,11221
6,Serum levels of protein PRSS57,12396
6,Survival in colorectal cancer (distant metastatic) [Overall Survival],2413
6,Serum levels of protein IL36A,9094
6,Glyceryl trinitrate | treatment/medication code,778
6,Skin pigmentation traits [Freckling (categorical],44
6,Serum levels of protein PTN,598
6,Pneumococcal meningitis x streptococcus pneumoniae antigen allele interaction [pspC-8],34
6,Mean platelet volume,627403
6,Non-albumin protein levels,119738
6,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA],90077
6,"Blood protein levels [DNAJB9, 11214_40_3]",11021
6,Leisure/social activities: Sports club or gym,18946
6,Tetanus toxoid IgG concentrations post childhood immunization,5068
6,"Meningitis | non-cancer illness code, self-reported",376
6,Endometriosis or depression (pleiotropy),918
6,Neurological blood protein biomarker levels [N2DL2],1595
6,Bone mineral density [femoral neck],130
6,Osteoarthritis; localized,14112
6,Systolic blood pressure x smoking status (ever vs never) interaction (2df test) [EA],28355
6,"Blood protein levels [ISG15, 14148_2_3]",45773
6,Urinary metabolite levels in chronic kidney disease [heptanoylglutamine],5298
6,Urinary metabolite levels in chronic kidney disease [isocaproylglutamine],6599
6,Electrocardiogram morphology (amplitude at temporal datapoints) [336 ms],3633
6,Fear of minor pain,62
6,Blood metabolite levels [Leucine|Isoleucine / Propionylcarnitine],126
6,Electrocardiogram morphology (amplitude at temporal datapoints) [208 ms],123
6,Erythematous conditions,43931
6,Educational attainment (years of education),232488
6,Cystatin C levels,141198
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-430 ms],57
6,Enteric fever,6803
6,Myocardial infarction,45673
6,Bioavailable testosterone levels,110312
6,Serum levels of protein RPS10,16139
6,Fracture of forearm,2206
6,Type 2 diabetes [Obese],448
6,Duration of walks,2
6,Neurofibrillary tangles (SNP x SNP interaction),554158
6,LDL cholesterol levels [Trans-ethnic initial],133860
6,White matter microstructure (radial diusivities) [Corticospinal tract ],2533
6,Chronic lower respiratory diseases,1618
6,Diabetic retinopathy,33801
6,Renal function-related traits (BUN),1842
6,Menarche and menopause (age at onset) [age at natural menopause],270
6,Abdominal and pelvic pain,152
6,Protein quantitative trait loci (liver) [SDHA],159
6,Obese vs. thin,13540
6,Salad / raw vegetable intake,32470
6,CD25 on CD28+ CD4+ T cell,38531
6,Migraine and/or pulse pressure,7606
6,Glycosuria in pregnancy (offspring genotype effect),6174
6,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) [women],1933
6,Alcohol consumption (transferrin glycosylation) [Total transferrin],1063
6,Electrocardiogram morphology (amplitude at temporal datapoints) [38 ms],329
6,Ewing sarcoma,63
6,Longest period of unenthusiasm / disinterest,9
6,Primary dental caries (decayed and filled teeth),4
6,Chronic lymphocytic leukemia,392070
6,IgA nephropathy,788216
6,C-reactive protein levels,365402
6,Urinary sodium excretion [EA],1558
6,Takayasu arteritis [conditional on rs12524487and rs62392216],43619
6,"""Migraine, single triptan purchase ok & required. ICD-code if available is included""",4478
6,Cerebrospinal fluid biomarker levels [Platelet-activating factor acetylhydrolase],2339
6,Advanced glycation end-product levels [EA],1449
6,Cytokine network levels (multivariate analysis) [conditioned on rs7767396],1003
6,"Heart attack/myocardial infarction | non-cancer illness code, self-reported",546
6,Addison's disease,1266
6,Hypertrophic cardiomyopathy (sarcomere negative),631
6,Presence of other devices,445
6,"Blood protein levels [EA, Angiostatin]",15
6,Follicular lymphoma,205095
6,Direct bilirubin levels,27213
6,Worry too long after an embarrassing experience,14127
6,Hematological parameters [MCV],4284
6,Breast cancer (male),1136
6,"Emphysema imaging phenotypes [%LAA-950, All]",2804
6,Iron status biomarkers (transferrin levels),1063
6,Facial morphology traits (63 three-dimensional facial segments) [facial module 30],254
6,Hot drink temperature,84287
6,Comparative body size at age 10,165902
6,Lifetime number of sexual partners,48468
6,Ischemic stroke,9417
6,"""Excessive, freguent and irrelgular menstruation""",13130
6,Systemic juvenile idiopathic arthritis [Additive],3423
6,Relative age of first facial hair,10434
6,Immune reponse to smallpox (secreted IL-2) [EA],224
6,Electrocardiogram morphology (amplitude at temporal datapoints) [206 ms],241
6,Brown vs. non-brown hair color,44
6,Systolic blood pressure x alcohol consumption interaction (2df test) [AA],24
6,Smoking status (current vs never) [Hispanic],15
6,O levels/gcses or equivalent | qualifications,1
6,Perceived unattractiveness to mosquitoes,177422
6,Neurociticism,65791
6,Household income (MTAG),16763
6,CD8+ Natural Killer T Absolute Count,28893
6,High blood pressure | illnesses of mother,1323
6,Gut microbiota (functional units) [PWY-6728_methylaspartate_cycle],223
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-436 ms],353
6,Percentage gas trapping [All],2711
6,"Ganglion and cyst of synovium, tendon, and bursa",161
6,"""Diabetes, several complications""",1080
6,Cutaneous squamous cell carcinoma,228
6,Physically abused by family as a child,4
6,Serum levels of protein RGS8,16139
6,Inflammatory bowel disease [Adult],5996
6,CD28- CD8+ T cell %T cell,3973
6,Musculoskeletal disorder or trauma,223
6,Serum levels of protein CTGF,859
6,Hepatocellular carcinoma,183502
6,Blond vs. brown/black hair color,26991
6,Factor VIII levels,179503
6,"Diastolic blood pressure x alcohol consumption interaction (2df test) [EA, Hispanic]",13766
6,Epstein-Barr virus ZEBRA antibody levels,32271
6,Cinnarizine | treatment/medication code,846
6,Iron status biomarkers [transferrin saturation],1527
6,Electrocardiogram morphology (amplitude at temporal datapoints) [258 ms],82
6,"Bone mineral density (paediatric, skull) [EA]",366
6,Iron status biomarkers [MCV],1063
6,Voltarol emulgel | treatment/medication code,202
6,Psoriasis,822120
6,Relative brain age,1067
6,"Seen a psychiatrist for nerves, anxiety, tension or depression",113639
6,Wheeze or whistling in the chest in last year,9679
6,Metabolic syndrome [HDL],155464
6,"Blood pressure medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",54458
6,Tenofovir clearance in HIV infection,9551
6,"""Type1 diabetes, definitions combined""",1275
6,OTU97_27 (Bacteroides) prevalence,28
6,ACPA-positive rheumatoid arthritis (smoking interaction) [adjusted for HLA shared epitope],253213
6,Predicted visceral adipose tissue,102338
6,Serum levels of protein DNAJC10,92955
6,Forced vital capacity (fvc),236139
6,Sleep start time,232
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-12 ms],3585
6,Gut bacterial pathway abundance (GLYCOCAT.PWY..glycogen.degradation.I..bacterial.),659
6,"""Heart failure,strict""",1044
6,JT interval,699
6,Bone mineral density [spine],146
6,Facial morphology (segment 1),29
6,Cardiac and circulatory congenital anomalies,80
6,Peripheral artery disease,479394
6,Sex hormone-binding globulin levels,430780
6,Mean platelet (thrombocyte) volume,114128
6,Infant head circumference (MTAG),452
6,Ischemic heart diseases,108
6,Femur bone mineral density x serum urate levels interaction [male],66829
6,Serum levels of protein CCL19,47989
6,QRS complex (Sokolow-Lyon) [EA],3069
6,Relative age voice broke,986
6,Autism spe (more control exclusions),300
6,Body mass index (adult),827
6,Goiter,266
6,Body fat distribution (arm fat ratio) [males],21
6,Waist-hip ratio and systolic blood pressure (pairwise),409
6,Protein quantitative trait loci (liver) [APOD],29
6,Myasthenia gravis,247276
6,Hemoglobin levels,581383
6,CD8 on CD28+ CD45RA- CD8+ T cell,41161
6,Electrocardiogram morphology (amplitude at temporal datapoints) [66 ms],3280
6,"Sporadic neuroblastoma [European American, conditioned on rs72990858]",157
6,Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes [AA],195
6,Butyrate (4:0) levels,78
6,HPV seropositivity,82096
6,Cervical cancer,266010
6,Basal cell carcinoma,323281
6,Estimated glomerular filtration rate,347949
6,Disorders of iron metabolism,259192
6,Haemorrhoidal disease,7024
6,Vitamin B12 deficiency anaemia,10437
6,CD4+ CD8dim T cell Absolute Count,8023
6,None of the above | pain type(s) experienced in last month,8440
6,Breast cancer | illnesses of mother,366
6,Epithelial ovarian cancer [serous],94
6,"Sphingomyelin (d18:1/20:0, d16:1/22:0) levels",716
6,Cardiac congenital anomalies,80
6,Strep throat,43393
6,Serum levels of protein IL10RA,16139
6,Serum levels of protein KLK12,16139
6,Serum metabolite levels [inosine],12164
6,Serum levels of protein CD8A,39524
6,Current tobacco smoking,8737
6,Unspecified diabetes,1229
6,3mm cylindrical power (right),160
6,Obesity and other hyperalimentation,164
6,Hepatitis B,944875
6,Poor prognosis in Crohn's disease,202907
6,Neuropsychiatric disorders,39726
6,Ever depressed for a whole week,53899
6,Blood metabolite ratios [X-11444/X-11470],8302
6,Headache | pain type(s) experienced in last month,140029
6,None of the above | qualifications,40691
6,Femur bone mineral density x serum urate levels interaction,39985
6,Bowel problem,12819
6,Heart rate variability traits (RMSSD),1085
6,Blood protein levels in cardiovascular risk,14089
6,HLA DR on HLA DR+ Natural Killer,471
6,Low myopia vs hyperopia,404
6,"Waist circumference [EA, women]",162
6,White | bread type,1
6,Electrocardiogram morphology (amplitude at temporal datapoints) [326 ms],3633
6,"Blood metabolite levels [4-androsten-3beta,17beta-diol disulfate 2]",5298
6,"Blood protein levels [EA, Cation-independent mannose-6-phosphate receptor]",312
6,BMI in smokers,162
6,CD40 on CD14- CD16+ monocyte,6
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-24 ms],6825
6,"Blood protein levels [EA, Granzyme A]",208773
6,Age diabetes diagnosed,10999
6,CD8+ T cell %leukocyte,3073
6,Hypertension (SNP x SNP interaction),972
6,Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis),11432
6,Protein quantitative trait loci [Factor B],14274
6,Lumbar spine bone mineral density,1726
6,Serum levels of protein NAALAD2,1032
6,Fasting blood insulin,95
6,1-linoleoyl-gpc (18:2) levels,696
6,3mm asymmetry angle (left),288
6,Electrocardiogram morphology (amplitude at temporal datapoints) [6 ms],790
6,Menarche (age at onset) [Japanese],920
6,Electrocardiogram morphology (amplitude at temporal datapoints) [214 ms],123
6,Other type of spread/margarine | spread type,80
6,"Blood protein levels [PLG, 4151_6_2]",114
6,Response to anti-TNF therapy in rheumatoid arthritis [response at 6 months],78
6,"Seen doctor (gp) for nerves, anxiety, tension or depression",104215
6,Use of sun/uv protection,33637
6,Body mass index (joint analysis main effects and physical activity interaction) [women],28277
6,Serum levels of protein CCL1,16139
6,Bumetanide | treatment/medication code,1931
6,1-stearoyl-2-arachidonoyl-gpc (18:0/20:4) levels,140
6,Triglyceride levels x long total sleep time interaction (2df test),125
6,Crohn's disease [EA],31629
6,Varicose veins of lower extremity,9833
6,COVID-19 (hospitalized vs population),383
6,Asthma and attention deficit hyperactivity disorder,7266
6,HLA DR on CD33dim HLA DR+ CD11b-,110975
6,Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications,93719
6,Electrocardiogram morphology (amplitude at temporal datapoints) [108 ms],6377
6,Esophageal adenocarcinoma,458
6,"Pulmonary embolism +/- dvt | non-cancer illness code, self-reported",137
6,Severe influenza A (H1N1) infection,787
6,6mm cylindrical power (left),86
6,Cerebrospinal fluid immune biomarker levels [YKL-40],11
6,Cortical volume [Caudal middle frontal],22
6,Wegener's granulomatosis,99841
6,CD8 on Central Memory CD8+ T cell,34988
6,White matter microstructure (radial diusivities) [Posterior thalamic radiation],51231
6,Electrocardiogram morphology (amplitude at temporal datapoints) [138 ms],9446
6,Diabetic maculopathy,57834
6,Electrocardiogram morphology (amplitude at temporal datapoints) [2 ms],790
6,"""Endomtriosis ASRM stages 1,2""",1430
6,Severe coronary stenosis (family history of CAD interaction),1264
6,Myeloproliferative disease,1032
6,Other disorders of veins,288
6,White matter integrity (mean diffusivity),35174
6,Serum levels of protein PCSK7,69435
6,Heel broadband ultrasound attenuation (right),19423
6,Other/unspecified seropositiverheumatoid arthritis,18561
6,"Blood protein levels [UBC, 6172_7_4]",11021
6,Urinary albumin-to-creatinine ratio [EA],1850
6,Angiostatin measurement,4018
6,Schizophrenia or bipolar disorder [SCZ or BP vs. controls],40376
6,"Waist circumference adjusted for body mass index [EA, men]",14518
6,Neutrophil-to-lymphocyte ratio,419199
6,Low density lipoprotein cholesterol levels [EA],15924
6,Salt added to food,5202
6,Survival in colorectal cancer (distant metastatic) [Disease-Specific Survival],2413
6,Hydroxocobalamin | treatment/medication code,479
6,Triglyceride levels [Trans-ethnic initial],1092
6,Serum metabolite levels [oleoylcarnitine (C18:1],99
6,Urinary metabolite levels in chronic kidney disease [nicotinamide riboside],93
6,Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations),59337
6,Body size at age 10,514047
6,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],55532
6,CD8+ T cell Absolute Count,3073
6,Pediatric asthma,969
6,SARS-CoV-2 infection,383
6,T cell lymphocyte profile difference,153
6,Broad depression or schizophrenia,26409
6,Multiple sclerosis (OCB status) [OCB positive vs. controls],270329
6,Protein quantitative trait loci [LPA],593
6,Diffuse large B cell lymphoma,167956
6,Comparative height size at age 10,225531
6,Epstein Barr virus nuclear antigen 1 IgG levels [non-Mexican American parents and children],186421
6,Age at first birth,7278
6,Electrocardiogram morphology (amplitude at temporal datapoints) [294 ms],3633
6,Otosclerosis,16332
6,Basophill percentage,2818
6,"Blood protein levels [MLN, 5631_83_3]",3657
6,"Psoriatic arthropathy | non-cancer illness code, self-reported",1873
6,White blood cell count [Japanese],1595
6,"""Hypothyroidism, levothyroxin purchases""",1928
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-480 ms],353
6,Myocardial infarction (early onset),862
6,Thiopurine methyltransferase activity in acute lymphoblastic leukemia patients treated with mercaptopurines,3679
6,Cold sores,9612
6,Intelligence,94505
6,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),32543
6,Diastolic blood pressure [East Asian],6382
6,Sialomucin core protein 24 levels,71753
6,"Blood protein levels [TMCC3, 11294_7_3]",11021
6,Age-related macular degeneration (geographic atrophy),14274
6,Serum levels of protein BMP7,1626
6,Time spent using computer,3046
6,Neuroblastoma,3779
6,Medication use (antihypertensives),1307
6,Home location at assessment - east co-ordinate (rounded),285
6,Pipecolate levels,881
6,Refractive error,92105
6,HLA DR on CD14+ CD16+ monocyte,45953
6,"Diastolic blood pressure, automated reading",107383
6,Anti-thyroid drug induced agranulocytosis,964
6,Coxarthrosis [arthrosis of hip](FG),5120
6,Hernia,750
6,Waist-to-hip ratio adjusted for BMI in active individuals,29619
6,Reticulocyte fraction of red cells,330718
6,Smoking status (ever vs never smokers),93818
6,Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies; IFNβ-1b subcutaneous),186893
6,"Blood protein levels [EA, Complement C4b]",8631
6,Electrocardiogram morphology (amplitude at temporal datapoints) [278 ms],3633
6,Electrocardiogram morphology (amplitude at temporal datapoints) [358 ms],3280
6,"Parathyroid gland problem (not cancer) | non-cancer illness code, self-reported",5809
6,Alanine transaminase levels,469
6,Facial wrinkles (frown lines) [men],1949
6,Brain morphology (min-P),117709
6,CD45RA+ CD8+ T cell %T cell,6029
6,"Blood protein levels [TMEM38B, 9509_4_3]",29884
6,"Forced expiratory volume in 1-second (fev1), predicted percentage",61480
6,Pemphigus vulgaris,9522
6,"Cholesterol lowering medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",2969
6,"""Type 1 diabetes, wide definition, subgroup 1""",1190
6,Longest period of depression,132
6,Brain region volumes [left pericalcarine],16
6,Fybogel mebeverine sachet | treatment/medication code,2568
6,Plays computer games,301
6,Alcohol consumption x traumatic event in childhood (felt hated by family member) interaction,160
6,Nortriptyline | treatment/medication code,119
6,Hypothyroidism,563562
6,Behcet's disease,54488
6,QRS duration,43563
6,General risk tolerance (MTAG),115355
6,Cervical cancer [Stringently Matched],32285
6,"Blood protein levels [PDIA5, 5593_11_3]",21436
6,Amlodipine | treatment/medication code,1348
6,Serum levels of protein ADGRF5,1744
6,Serum levels of protein TF,1032
6,Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; all treatment preparations) [conditional on rs9272071 + rs28746882],2199
6,Phosphatidylethanolamine_38:5_[M-H]1- levels,1519
6,Urinary metabolite levels in chronic kidney disease [N-acetylglucosamine/N-acetylgalactosamine],264
6,Diffusing capacity of the lung for carbon monoxide traits [DLCO per alveolar volume],57
6,Malignant neoplasm of skin,86
6,Cervical intraepithelial neoplasia grade 3 and invasive cervical cancer,38764
6,Serum levels of protein MAPK13,731
6,Idiopathic achalasia,12112
6,"Blood protein levels [CD109, 3290_50_2]",5434
6,BMI (adjusted for smoking behaviour) [men],162
6,Obesity (extreme),162
6,Gut microbiota relative abundance (bacterial taxa) [Deltaproteobacteria],334
6,Zoster [herpes zoster],54
6,"Sensory disturbances after bilateral sagittal split ramus osteotomy [Hypoesthesia, Recessive]",12
6,Leprosy,121999
6,Depressive symptoms,549174
6,Systolic blood pressure (cigarette smoking interaction),15148
6,Serum levels of protein DSG1,16139
6,Serum levels of protein SURF1,10735
6,Serum levels of protein LRP11,111613
6,Basophill count,1831
6,"Blood protein levels [IGFL3, 6961_14_3]",11021
6,Microscopic colitis,1558
6,Experiencing mood swings,1613
6,Alzheimer's disease,6744
6,CD28+ CD45RA+ CD8dim T cell %T cell,675
6,Disorders of plasma protein metabolism,73
6,Protein quantitative trait loci (liver) [ACAD11],2
6,Brain morphology (MOSTest),189046
6,"Blood protein levels [IL36A, 10928_7_3]",11021
6,Other systemic involvement of connective tissue,43848
6,Serum levels of protein AZGP1,16139
6,Hemoglobin levels [Hispanic/Latino],3620
6,Disorders of lipoprotein metabolism and other lipidaemias,441
6,Serum levels of protein GBP6,16139
6,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction),1982
6,DHEAS levels [men],3699
6,Acquired toe deformities,594
6,Water intake,147
6,Nerve plexus lesions,138
6,Lipid or lipoprotein levels [Lipoprotein A],80
6,Nasopharyngeal carcinoma,192197
6,Lung function (FEV1/FVC),299592
6,"Hip circumference [EA,women]",22442
6,Cortical surface area [Lateral Occipital],187
6,Facial morphology (brow ridge protrusion 2),713
6,Skin pigmentation traits [Skin sensitivity to sun],44
6,Nexium 20mg tablet | treatment/medication code,492
6,Atherosclerosis,80
6,"Waist-to-hip ratio adjusted for body mass index [EA, men]",223656
6,Waist-to-hip ratio adjusted for body mass index [men],66591
6,CD8+ and CD8dim T cell %leukocyte,7522
6,Cycle | transport type for commuting to job workplace,18119
6,"Blood protein levels [EA, Trefoil factor 3]",28465
6,Electrocardiogram morphology (amplitude at temporal datapoints) [8 ms],3710
6,Depression | mental health problems ever diagnosed by a professional,51066
6,Uric acid levels,10940
6,Myocardial fractal dimension (slice 6),4208
6,Paraglaciecola abundance in stool,2159
6,"Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) level)",89
6,Risk-taking tendency (4-domain principal component model),45680
6,Vertical cup-disc ratio (adjusted for vertical disc diameter),17858
6,Serum levels of protein COL11A2,10871
6,Uveitis,26216
6,Electrocardiogram morphology (amplitude at temporal datapoints) [368 ms],3280
6,Alzheimer's disease (late onset),6913
6,Abdominal aortic aneurysm,864
6,"Schizophrenia, schizoaffective disorder or bipolar disorder",2118
6,Parental longevity (combined parental age at death),684
6,1-palmitoyl-2-arachidonoyl-gpc (16:0/20:4n6) levels,69
6,"Low forceps, not breech | delivery methods",280
6,"Blood protein levels [HSPA1A, 4124_24_2]",16851
6,Ventolin 100micrograms inhaler | treatment/medication code,1426
6,Regular attendance at a gym or sports club,78
6,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],150
6,"""Type 1 diabetes, strict definition, subgroup 1""",865
6,Hepcidin levels [Tf],1063
6,Metabolite levels [tyrosine],553
6,Low density lipoprotein cholesterol levels,436238
6,Lung function (low FEV1 vs high FEV1),41998
6,Caffeine consumption from coffee or tea,4713
6,Lipoprotein-associated phospholipase A2 activity and mass [mass],5316
6,UBA1448 sp002329405 abundance in stool,4642
6,None of the above | attendance/disability/mobility allowance,69445
6,Hereditary retinal dystrophy,1161
6,Gut microbiota (bacterial taxa) [Ruminococcus_gnavus],399
6,Diastolic blood pressure x smoking status (current vs non-current) interaction (1df test) [African],1
6,Estimated glomerular filtration rate in non-diabetics,23476
6,Waist-to-hip ratio adjusted for body mass index [women],47236
6,"Paracetamol | medication for pain relief, constipation, heartburn",133093
6,Levothyroxine sodium | treatment/medication code,147294
6,Atrial fibrillation and flutter,3276
6,Drug-induced liver injury,10244
6,Facial morphology (segment 59),839
6,CD24 on IgD- CD38dim B cell,497
6,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),78407
6,Serum levels of protein TFF3,79478
6,"Blood protein levels [MICB, 9328_55_3]",58860
6,Male puberty timing (early vs. average onset facial hair),1221
6,CD24 on IgD+ CD38- B cell,475
6,Acute graft versus host disease in bone marrow transplantation (recipient effect),103571
6,Depressed affect,11043
6,Composite immunoglobulin trait (IgA x IgG x IgM),60075
6,Type 1 diabetes without complications,1522
6,Myopia (pathological),319
6,Daytime sleep phenotypes [daytime resting],126
6,Freckling,44
6,CD24 on CD24+ CD27+ B cell,639
6,Thyrotoxicosis with diffuse goitre,81891
6,Brain region volumes [right ventral DC],2356
6,Breast size,1955
6,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],4147
6,Percent liver fat,355
6,Genitourinary diseases,2625
6,Adverse response to inhaled corticosteroid treatment x age interaction in asthma,394
6,Peripheral artery disease in ever smokers,80
6,Ulcerative colitis,1147187
6,Plateletcrit,328832
6,"Allergy, hypersensitivity or anaphylaxis",6634
6,Brain region volumes [right pallidum],967
6,Inflammatory skin disease [Psoriasis],764
6,Electrocardiogram morphology (amplitude at temporal datapoints) [216 ms],123
6,Body mass index (joint analysis main effects and physical activity interaction),6233
6,Thyrotoxic periodic paralysis,9690
6,Impedance of leg (right),123142
6,Diabetic retinopathy (more control exclusions),2342
6,Triglycerides x physical activity interaction (2df test),1689
6,Polycythemia vera,1063
6,Phosphatidylcholine_36:5_[M+OAc]1-/Phosphatidylserine_40:4_[M-H]1- levels,1570
6,"""Endomtriosis ASRM stages 3,4""",413
6,Calcific aortic valve stenosis,80
6,Monocyte percentage of white cells,256035
6,IgG galactosylation phenotypes (multivariate analysis),163411
6,Rheumatoid arthritis (ACPA-positive),78525
6,CD4 on CD28+ CD4+ T cell,26490
6,Bell's palsy,448
6,QT interval,32828
6,Sjögren's syndrome,449498
6,Red blood cell count,1270713
6,Cirrhosis,12976
6,"Blood protein levels [FTMT, 8048_9_3]",43048
6,Arm fat percentage (right),149083
6,Beta thalassemia/hemoglobin E disease,1616
6,Neurological blood protein biomarker levels [MDGA1],1794
6,Serum levels of protein PILRA,1179
6,Childhood body mass index,341
6,Diastolic blood pressure,598315
6,Extranodal natural killer T-cell lymphoma (nasal type),222710
6,Bipolar disorder (MTAG),327330
6,Bipolar disorder,72646
6,Mean corpuscular volume [conditional on round 2],10474
6,Metabolite levels [S1P d16:1],118745
6,Ankle spacing width (left),16870
6,Metabolic traits [inosine + 1 other trait],6025
6,Bone mineral density [Cortical vBMD],1286
6,Serum levels of protein METTL24,228
6,CD28 on CD28+ CD4+ T cell,58
6,Aortic valve stenosis,80
6,Hypothyroidism nos,108656
6,Sjögren's syndrome [EA],5022
6,Bullous disorders,72659
6,Age-related hearing impairment [recessive],3804
6,Fracture of radius and ulna,1503
6,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Asian],150
6,White matter microstructure (axial diusivities) [Uncinate fasciculus],207
6,Protein quantitative trait loci (liver) [HSPA6],42
6,Hepatocellular carcinoma in hepatitis B infection,207645
6,Recurrence of Clostridium difficile infection x bezlotuxumab treatment interaction (2df test),20944
6,Blood metabolite levels [X-11470],2781
6,Spine bone size,5210
6,Inflammatory bowel disease [EA],28340
6,"""Type 2 diabetes, definitions combined""",4893
6,"Blood protein levels [ATF6, 11277_23_3]",9274
6,Serum metabolite levels [S_VLDL_TG],63634
6,"Ankylosing spondylitis | non-cancer illness code, self-reported",46921
6,Electrocardiogram morphology (amplitude at temporal datapoints) [340 ms],3280
6,Electrocardiogram morphology (amplitude at temporal datapoints) [274 ms],3280
6,Smoking initiation (ever regular vs never regular) [Conditioned on chr6:98636905],2583
6,DNA methylation-estimated plasminogen activator inhibitor-1 levels,189
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-496 ms],353
6,Electrocardiogram morphology (amplitude at temporal datapoints) [242 ms],205
6,"Skin, hair and eye pigmentation (multivariate analysis)",35
6,Total cholesterol levels in HDL,94353
6,Mean corpuscular hemoglobin concentration [conditional on round 2],26556
6,Heme oxygenase 1 measurement,3798
6,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [3-(4-hydroxyphenyl)lactate, 4-hydroxyphenylpyruvate, indolelactate, phenyllactate(PLA), X-16071]",6218
6,Phosphatidylcholine_40:6_[M+OAc]1-/Phosphatidylserine_44:5_[M-H]1- levels,1519
6,Protein quantitative trait loci (liver) [HINT1],391
6,Other diseases of spinal cord,8
6,Asthma or allergic disease (pleiotropy),246022
6,Epstein Barr virus nuclear antigen 1 IgG levels [non-Mexican American sero-positive children],186421
6,3mm weak meridian (left),176827
6,Electrocardiogram morphology (amplitude at temporal datapoints) [186 ms],7064
6,First line medication for Crohns disease,514
6,Electrocardiogram morphology (amplitude at temporal datapoints) [252 ms],82
6,Carbimazole | treatment/medication code,20
6,Acute anterior uveitis in ankylosing spondylitis,19820
6,Amino acid levels [Tyrosine],2669
6,Waist circumference [EA],29971
6,"Blood protein levels [TGM3, 4471_50_2]",22620
6,Serum levels of protein PCDHGB4,11021
6,Serum metabolite levels [acisoga],1578
6,Loneliness (MTAG),2956
6,Urinary metabolite levels in chronic kidney disease [X - 23518],5298
6,Urinary metabolite levels in chronic kidney disease [pyridoxal],5298
6,Subjective well-being (MTAG),75875
6,Verbal-numerical reasoning,42526
6,Joint disorder,4724
6,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [adenosine 3, 5-cyclic monophosphate, biopterin]",4212
6,"Angina | non-cancer illness code, self-reported",881
6,Cereal intake,516
6,"Diastolic blood pressure x alcohol consumption interaction (2df test) [AA, EA, Hispanic]",1291
6,Juvenile rheumatoid arthritis,197
6,"Nervous breakdown | non-cancer illness code, self-reported",629
6,Graves' disease,639402
6,Joint mobility (Beighton score),15131
6,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction) [men],9141
6,Gastroesophageal reflux disease or gastric reflux,20538
6,Serum levels of protein FAS,9355
6,Red blood cell traits [MCH],3300
6,Electrocardiogram morphology (amplitude at temporal datapoints) [136 ms],6637
6,"""Pain (limb, back, neck, head abdominally)""",163
6,Liver enzyme levels [ALP],2467
6,Fludrocortisone | treatment/medication code,1834
6,Serum levels of protein TYK2,6942
6,Terminally Differentiated CD4+ T cell Absolute Count,5243
6,Use a helpline / voluntary organization | actions taken following self-harm,767
6,White matter hyperintensities,147
6,Mammographic density (non-dense area),418
6,Biomedical quantitative traits [pulse rate],478
6,Basal metabolic rate variance,34022
6,Miserableness,19414
6,Hepatitis B (viral clearance) [Protective effects against CHB],180631
6,Serum levels of protein ZAP70,32278
6,Blood protein levels [MHC class I polypeptide-related sequence B],64354
6,Urinary metabolite levels in chronic kidney disease [X - 24515],18805
6,"Blood protein levels [CFB, 4129_72_1]",21612
6,"Waist-to-hip ratio adjusted for body mass index [EA, women]",5100
6,"""Malignant neoplasm of breast, HER2-negative""",397
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-28 ms],372
6,Facial morphology (segment 28),212
6,Electrocardiogram morphology (amplitude at temporal datapoints) [226 ms],123
6,Valsartan | treatment/medication code,2
6,Severe aplastic anemia,197659
6,Nonatopic asthma,165916
6,Leg predicted mass (right),248850
6,Mean corpuscular haemoglobin concentration,97541
6,Iritis,13889
6,"Blood protein levels [RGS8, 11666_72_3]",11021
6,Weight [male],5104
6,Intestinal malabsorption (non-celiac),245189
6,Non-cardia gastric cancer,4600
6,Lymphocyte counts,1594948
6,CD45 on CD4+ T cell,209005
6,Serum levels of protein LAYN,14017
6,Hip pain | pain type(s) experienced in last month,113320
6,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [men],6817
6,Electrocardiogram morphology (amplitude at temporal datapoints) [364 ms],3280
6,Taking other prescription medications,247
6,Response to Pazopanib in cancer (hepatotoxicity) [Time to ALT>3 x upper limit of normal event],3834
6,Hematological and biochemical traits [ALP],2824
6,Inflammatory biomarkers (multivariate analysis),2259
6,Progressive supranuclear palsy,1225
6,"""Diabetes, varying definitions""",2035
6,Electrocardiogram morphology (amplitude at temporal datapoints) [224 ms],123
6,Malignant neoplasm of breast,412
6,Mean corpuscular hemoglobin [EA],236
6,Type 1 diabetes,1170104
6,CCL19 levels,25406
6,MHC class I polypeptide-related sequence A levels,77557
6,Itch intensity from mosquito bite adjusted by bite size [women],69851
6,CD28+ CD45RA- CD8+ T cell %CD8+ T cell,3189
6,Serum levels of protein H6PD,194084
6,"Blood protein levels [MPZL2, 9372_157_3]",11021
6,"Asthma | non-cancer illness code, self-reported",54788
6,Body fat percentage and triglycerides (pairwise),4993
6,"Blood protein levels [CREB3L4, 11308_8_3]",21436
6,Cytokine network levels (multivariate analysis),1214
6,Physical activity (Total log acceleration 12am-2am),596
6,3mm cylindrical power (left),86
6,Obesity [Obesity class I],171
6,Actinic keratosis,88
6,Lymphocytic leukemia,99
6,Coronary artery calcification [females],28
6,Usual walking pace,86279
6,"Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA, women]",1431
6,Reaction time,2818
6,White blood cell count (lymphocyte),6525
6,Protein quantitative trait loci (liver) [APRT],437
6,Facial morphology (segment 19),197
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-112 ms],635
6,Skin pigmentation,35
6,Cognitive performance,85494
6,Social science traits (pleiotropy) (HIPO component 1),1298
6,Glycated hemoglobin levels,123280
6,Nose morphology,61042
6,Connective tissue disorder,117769
6,Chronic kidney disease,1107
6,Disorders of mineral metabolism,157033
6,Fish- and plant-related diet,188812
6,Eosinophil counts [conditional on round 3],15596
6,Naive CD4+ T cell %CD4+ T cell,109284
6,"Blood protein levels [USP25, 9215_117_3]",20573
6,Leg fat percentage (right),151298
6,Hashimoto thyroiditis,11052
6,Urinary metabolite levels in chronic kidney disease [X - 19561 ],6218
6,Flecainide | treatment/medication code,4230
6,Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid),2427
6,"Red | hair colour (natural, before greying)",1193
6,Cystitis,30
6,Serum levels of protein PCDHA4,27
6,Electrocardiogram morphology (amplitude at temporal datapoints) [256 ms],82
6,Serum levels of protein FRS2,103
6,White blood cell types [eosinophil count],28140
6,IgD on IgD+ CD24+ B cell,43720
6,Serum levels of protein TAPBPL,104236
6,Serum levels of protein SULT4A1,8694
6,Pattern 3 | hair/balding pattern,5791
6,Atrial fibrillation and flutter with reimbursement,1242
6,Neuropathic bladder,1377
6,Setpoint viral load in HIV-1 infection,44729
6,Hyperlipidemia,871
6,CD20 on IgD+ B cell,1338
6,Cerebrospinal fluid biomarker levels [MHC class I polypeptide-related sequence A],109234
6,"None of the above | medication for pain relief, constipation, heartburn",74253
6,Tissue factor levels,184
6,"""Reactive arthropathies, FINNGEN""",656
6,Ceramide_42:1_[M-H]1- levels,80
6,Systolic blood pressure x smoking status (ever vs never) interaction (2df test) [African],3
6,Fracture of upper limb,1513
6,Drug-induced liver injury (amoxicillin-clavulanate),106230
6,Fibrinogen levels,204677
6,Squamous cell lung carcinoma,972551
6,Age at menopause,141576
6,Serum levels of protein TGM3,42307
6,Contracture of palmar fascia [dupuytren's disease],5015
6,Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia,3486
6,Myocardial fractal dimension (slice 5),14821
6,Iridocyclitis,178
6,Cerebrospinal fluid AB1-42 levels,1670
6,Hip bone mineral density and total body fat mass (bivariate analysis),558
6,Body mass index [men],162
6,Serum levels of protein PTPN1,16139
6,Benign neoplasm of parathyroid gland,469
6,Electrocardiogram morphology (amplitude at temporal datapoints) [200 ms],123
6,Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN),89701
6,Waist-to-hip ratio adjusted for body mass index,94522
6,Late-onset myasthenia gravis,11973
6,Spherical equivalent or myopia (age of diagnosis),94771
6,Smoking initiation (ever regular vs never regular),312017
6,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),39299
6,Alcohol use disorder [Latino],25091
6,Mouth ulcers | mouth/teeth dental problems,72093
6,Smoking cessation (MTAG),14301
6,Serum levels of protein MOCS3,16139
6,Serum metabolite levels (CMS) [XS_VLDL_TG],1656
6,Electrocardiogram morphology (amplitude at temporal datapoints) [362 ms],3280
6,Glucuronate levels,832
6,Serum metabolite levels [ornithine],351
6,Body fat distribution (arm fat ratio) [females],21
6,IgG glycosylation [IGP23],391
6,Worry,59829
6,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [3-(4-hydroxyphenyl)lactate, 4-hydroxyphenylpyruvate, indolelactate, phenyllactate (PLA), X-16071]",68255
6,"Takayasu arteritis [conditional on rs2844678, rs12524487 and rs17193507]",17132
6,"Blood protein levels [DSG1, 2976_58_2]",11021
6,Blood protein levels [LPA],4046
6,Blood metabolite levels [propionylcarnitine],111
6,Methadone dose in opioid dependence [AA],67
6,Other diseases caused by chlamydiae,24
6,Pork intake,12594
6,HVEM on naive CD8+ T cell,157818
6,Pulse pressure [East Asian],7751
6,Electrocardiogram morphology (amplitude at temporal datapoints) [198 ms],3764
6,Body mass index and HDL-C (pairwise),150
6,CD24 on transitional B cell,486
6,White matter hyperintensity volume (adjusted for hypertension),103
6,Electrocardiogram morphology (amplitude at temporal datapoints) [234 ms],123
6,"Blood pressure measurement (high sodium and potassium intervention) [SBP, during intervention]",34
6,Systolic blood pressure x smoking status (ever vs never) interaction (2df test),28358
6,Waist-hip index,829286
6,Forns index in high alcohol intake,10436
6,"Rheumatoid arthritis | non-cancer illness code, self-reported",1944
6,Bronchitis,80
6,Nonspecific chest pain,58368
6,Hydrolysed wheat protein allergy,134745
6,Aspartate aminotransferase levels,452340
6,Liver enzyme levels (gamma-glutamyl transferase),28743
6,Migraine,24447
6,Migraine without aura,12429
6,Mumps,7894
6,Myocardial fractal dimension (slice 7),4208
6,"Diabetes | non-cancer illness code, self-reported",1050
6,"""Coxarthrosis,""",5287
6,Bone mineral density (hip) and hip bone size,92
6,"Ecg, heart rate",1454
6,Spherical equivalent (joint analysis main effects and education interaction) [European ancestry],266
6,Reactive arthropathies,258
6,Serum metabolite levels [suberoylcarnitine (C8-DC],274
6,Methotrexate | treatment/medication code,85
6,Abdominal hernia,43431
6,Diffuse diseases of connective tissue,117128
6,Disease progression in age-related macular degeneration,5852
6,Intraocular pressure,379085
6,Cardiometabolic and hematological traits [WBC],277096
6,Lung volume,1471
6,"Blood protein levels [DES, 12030_82_3]",11021
6,"""Hypothyroidism, strict autoimmune, 3 medication purchases required""",13254
6,Acute myeloid leukemia (normal cytogenetics),29972
6,Proliferative diabetic retinopathy,5178
6,Cortical surface area [Pericalcarine],409
6,Interstitial lung disease,302
6,Dengue shock syndrome,29089
6,Body fat distribution (trunk fat ratio),36163
6,"Waist circumference adjusted for body mass index [EA,women]",2439
6,Atrial fibrillation/atrial flutter,10322
6,White matter microstructure (mean diusivities) [Retrolenticular part of internal capsule],9332
6,Left–right brain asymmetry,6281
6,Sociability score,4377
6,Lipoprotein (a) levels in coronary artery disease (percutaneous coronary intervention),1066
6,"""Atherosclerosis, excluding cerebral, coronary and PAD""",441
6,Alcohol use disorder [EA],118
6,Skin changes due to chronic exposure to nonionizing radiation,44
6,Rheumatoid arthritis [ACPA-positive RA vs controls],190709
6,HLA DR++ monocyte %monocyte,68828
6,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [heptanoylglutamine, hexanoylglutamine, isocaproylglutamine, N-octanoylglutamine, X-12636, X-12839, X-24347, X-24350]",6599
6,"Blood protein levels [LRP11, 6713_4_3]",111078
6,17-hydroxyprogesterone (17-OHP) levels [women],3474
6,Hypertrophic cardiomyopathy (MTAG),1392
6,Serum levels of protein ERP29,5643
6,Interleukin-13 levels,1214
6,C-reactive protein levels or HDL-cholesterol levels (pleiotropy),481
6,Erythrocyte methylated 6-mercaptopurine metabolite concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia,3061
6,Latent autoimmune diabetes vs. type 1 diabetes,3101
6,Urate levels in lean individuals [Women],5298
6,Esophageal varix,3656
6,"Blood protein levels [SPAG11B, 5762_35_3]",9274
6,Fracture of lower limb,1503
6,X-21733 levels,2039
6,Chlamydia trachomatis PorB antibody levels,280
6,Thyroid stimulating hormone levels,11935
6,Cancer (pleiotropy)(bidirectional),61690
6,Major depressive disorder,647178
6,Serum levels of protein ADGRE5,16139
6,White matter microstructure (axial diusivities) [Posterior corona radiata ],74157
6,Anxiety/tension (special factor of neuroticism),1261
6,GIP levels in response to oral glucose tolerance test (120 minutes),165
6,"Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) [Asian, EA]",410
6,Alverine | treatment/medication code,2328
6,Executive function in ADHD,148
6,Caffeine consumption from tea,95
6,Eye color [eye color],44
6,Adolescent idiopathic scoliosis,23020
6,CD28+ CD45RA+ CD8+ T cell Absolute Count,6029
6,Spleen volume,9077
6,"""Ankylosing spondylitis, strict definition""",235
6,T wave morphology restitution during exercise (MTAG),635
6,3-indoxyl sulfate levels,1761
6,"Blood protein levels [PREP, 14273_19_3]",194
6,CD28- CD25++ CD8+ T cell Absolute Count,28893
6,Fluid intelligence score,28285
6,Bone ultrasound measurement (velocity of sound),2225
6,Peak insulin response,412
6,Body fat distribution (arm fat ratio),21
6,Chronic hepatitis C infection,145354
6,Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test),51000
6,Hepatocellular carcinoma in hepatitis C infection,81570
6,LDL cholesterol levels in current drinkers [EA],23519
6,Gamma glutamyl transferase levels,157447
6,X-24295 levels,3872
6,Free thyroxine concentration,12228
6,TPE interval (resting) [men],4550
6,Disorders of lens,325
6,Protein quantitative trait loci (liver) [IGKC],31
6,Chin dimples,6529
6,Frontal fibrosing alopecia,249692
6,Cortical volume [Global],640
6,Serum levels of protein UTS2,16139
6,Neutrophill percentage,131187
6,Other retinal disorders,22588
6,Type 1 diabetes with ophthalmic complications,152
6,Cognitive ability,2172
6,Gastric intrinsic factor levels,533
6,Urinary metabolite levels in chronic kidney disease [isobutyrylcarnitine (C4],111
6,Sum eosinophil basophil counts,133826
6,Hip circumference variance,93599
6,Cognitive aspects of educational attainment,905886
6,Serum levels of protein NRXN3,16139
6,"""Disorders of thyroid, IBD co-morbidities""",43631
6,Protein quantitative trait loci (liver) [TPT1],1600
6,Age-related hearing impairment (SNP x SNP interaction),1325
6,Serum levels of protein FN1,267
6,Atopic dermatitis (moderate to severe) [additive],188
6,Serum levels of protein SYT11,267
6,Breastfed as a baby,189
6,Bacillus AY abundance in stool,12
6,Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in secretors,10
6,Frontotemporal dementia [All Frontotemporal dementia],44616
6,Highest math class taken (MTAG) [MTAG],191478
6,Frequency of stair climbing in last 4 weeks,62065
6,Body fat distribution (trunk fat ratio) [females],38250
6,CD20 on naive-mature B cell,1338
6,Sarcoidosis,117637
6,Electrocardiogram morphology (amplitude at temporal datapoints) [182 ms],476
6,Atorvastatin | treatment/medication code,666
6,Other contact dermatitis,17
6,HIV-1 susceptibility,9050
6,Serum metabolite levels [N-acetylkynurenine (2],8420
6,Impedance of arm (right),67462
6,Sicca syndrome [Sjögren],82249
6,"Blood protein levels [ECE1, 8767_44_3]",11021
6,Hepcidin levels [Iron],1063
6,Electrocardiogram morphology (amplitude at temporal datapoints) [218 ms],123
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-490 ms],353
6,Glaucoma suspect,127
6,Corneal resistance factor (right),33
6,Dopamine 3-o-sulfate levels,63102
6,Serum levels of protein RAB5C,16139
6,Medication use (drugs used in diabetes),22257
6,"Blood protein levels [G6B, 7065_1_4]",33641
6,Vascular endothelial growth factor levels,16130
6,Number of days/week walked 10+ minutes,338
6,Protein quantitative trait loci (liver) [BPHL],1998
6,6mm asymmetry index (right),154
6,Pure hypercholesterolaemia,80
6,Protein quantitative trait loci (liver) [MAT2A],23
6,UBA1066 sp900317515 abundance in stool,24
6,Self-reported math ability (MTAG) [MTAG],227913
6,Life satisfaction,275796
6,Body mass index [EA],10262
6,Arthropathic psoriasis,13597
6,Waist-hip ratio [EA],2092
6,Disorders of protein plasma/amino-acid transport and metabolism,82
6,Geobacteraceae abundance in stool,55
6,Hepatitis C induced liver cirrhosis,114049
6,Plasma homocysteine levels (post-methionine load test),20781
6,Eczema,227376
6,HDL cholesterol levels,1036399
6,Psoriasis or type 2 diabetes (trans-disease meta-analysis),78832
6,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],32543
6,Metabolic biomarkers (multivariate analysis),108479
6,"Heel quantitative ultrasound index (qui), direct entry",143411
6,3mm strong meridian (left),130799
6,Pulmonary function [FEV1/FVC],14742
6,Electrocardiogram morphology (amplitude at temporal datapoints) [284 ms],3633
6,Cognitive ability (MTAG),1553
6,Glycemic traits [1-hPG],732
6,IgG N-glycosylation phenotypes (multivariate analysis),97
6,Oligoclonal band status in multiple sclerosis,110360
6,CD4+ CD8dim T cell %lymphocyte,8023
6,Glaucoma (high intraocular pressure),856
6,Serum levels of protein HSPA1A,16851
6,Bendroflumethiazide | treatment/medication code,1978
6,Extremely high intelligence,1092
6,"Blood protein levels [ADGRF5, 6409_57_3]",923
6,QT dynamics during exercise [female],1106
6,Vertical cup-disc ratio,1876
6,Oxalate (ethanedioate) levels,3422
6,Serum levels of protein NDUFB4,16139
6,Blood protein levels [Complement factor B],10482
6,"High cholesterol | non-cancer illness code, self-reported",2581
6,"Blood protein levels [gp41 C34 peptide, HIV]",11908
6,"Migraine | non-cancer illness code, self-reported",5744
6,CD8 on naive CD8+ T cell,1826
6,Male puberty timing (late vs. average onset facial hair),1221
6,Neuritic plaques (SNP x SNP interaction),1335
6,Blood metabolite levels [multi-metabolite PC1],85
6,"Diastolic blood pressure x alcohol consumption interaction (2df test) [AA, EA]",254
6,C-reactive protein [AA women],65
6,Hepatitis B (viral clearance) [Clearance of HBV],180631
6,"Blood protein levels [IFNAR1, 6055_53_3]",21612
6,Respiratory or ear-nose-throat disease,7097
6,Dupuytren's disease,2665
6,Waist-to-hip ratio adjusted for BMI in active individuals [women],1691
6,Waist-to-hip ratio adjusted for BMI (age >50) [women],776
6,Endometriosis diagnosis and infertility diagnosis occurring together,439
6,Skin aging (microtopography measurement),44
6,Dermatophytosis,42
6,Systemic lupus erythematosus,2526853
6,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),16654
6,Amyotrophic lateral sclerosis,57919
6,Serum levels of protein TMCC3,16139
6,Serum levels of protein IGFL3,16139
6,Serum levels of protein SIGLEC8,11021
6,A levels/as levels or equivalent | qualifications,15432
6,"Orofacial clefts (maternal alcohol consumption interaction) [Maternal alcohol consumption, 1df]",211
6,"Vesicoureteral reflux [recessive, male]",42
6,Other malignant neoplasms of skin (=non-melanoma skin cancer),86
6,Pulmonary collapse; interstitial and compensatory emphysema,18
6,Myeloid white cell count,229512
6,Epstein Barr virus nuclear antigen 1 IgG levels [Mexican American],72873
6,Mean arterial pressure,61930
6,Serum levels of protein BCL2L10,16139
6,Blood protein levels [Complement C4b],9107
6,Body mass index (bmi),435546
6,Electrocardiogram morphology (amplitude at temporal datapoints) [360 ms],3280
6,Cadmium levels,944
6,End-stage coagulation [FXIII activity],163
6,IgE levels,370822
6,Asthma and major depressive disorder,192977
6,Body mass index and coronary artery disease (pairwise),4978
6,Hip circumference adjusted for BMI,678924
6,Overall health rating,23255
6,Inguinal hernia,148853
6,"""Hypothyroidism,  other/unspecified""",13380
6,Leisure sedentary behaviour (television watching),22332
6,Number of self-reported non-cancer illnesses,5321
6,Heart disease | illnesses of siblings,512
6,Tea consumption,91
6,Acute myeloid leukemia or myelodysplastic syndrome (pleiotropy),44
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-270 ms],353
6,Ever highly irritable/argumentative for 2 days,60
6,"Malignant neoplasm of kidney, except pelvis",44
6,Primary biliary cirrhosis,70285
6,Age completed full time education,6600
6,Fish- and plant-related diet [female],30380
6,"Insulin | medication for cholesterol, blood pressure or diabetes",27611
6,Sleep duration (short sleep),4373
6,Carotid intima media thickness,793
6,1-carboxyethylvaline levels,688
6,Vascular endothelial growth factor A levels,194
6,Creatine kinase levels,1841
6,Ever unenthusiastic/disinterested for a whole week,224
6,Lung function (FEV1/FVC) [EA],46
6,Neonatal lupus,155464
6,Chronic obstructive pulmonary disease x ever smoker interaction (2df),390438
6,Medication use (anilides),43276
6,Serum levels of protein OSM,11021
6,Brain region volumes [right putamen],6105
6,"Systolic blood pressure, automated reading",54343
6,Phosphatidylinositol(40:6)_[M-H]1- levels,2056
6,Parental longevity (father's age at death),2231
6,Manic episode,120
6,Hydroxycholesterol_[M+H-2H2O]1+ levels,441
6,Lumiracoxib-related liver injury,91556
6,Chronic obstructive pulmonary disease,329896
6,Triglycerides [EA],126234
6,Terminally Differentiated CD4+ T cell %CD4+ T cell,109284
6,Protein quantitative trait loci (liver) [NQO2],8854
6,Other diseases of the digestive system,83996
6,Electrocardiogram morphology (amplitude at temporal datapoints) [148 ms],7208
6,CD28 on CD28+ CD45RA+ CD8+ T cell,425
6,Number of vehicles in household,14
6,Mouth ulcers,183377
6,"Blood protein levels [IL21, 7124_18_3]",27872
6,"Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [Asian, EA]",410
6,Electrocardiogram morphology (amplitude at temporal datapoints) [366 ms],3280
6,Duration to first press of snap-button in each round,518
6,Salazopyrin 500mg tablet | treatment/medication code,8622
6,Protein quantitative trait loci (liver) [HBG1],391
6,Electrocardiogram morphology (amplitude at temporal datapoints) [240 ms],123
6,Cleft palate,57
6,LDL levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder,176
6,"Long-standing illness, disability or infirmity",61
6,Electrocardiogram morphology (amplitude at temporal datapoints) [92 ms],5
6,High density lipoprotein cholesterol levels,589181
6,Gout [Japanese],40037
6,Chronic obstructive pulmonary disease in never smokers,246508
6,Heart rate variability traits (pvRSA/HF),1497
6,Cutaneous melanoma or hair colour,841
6,Low testosterone levels,1105
6,High-sensitivity cardiac troponin I concentration,188
6,Posterior cortical atrophy and Alzheimer's disease,51
6,Nervous feelings,70740
6,"Body mass index [EA, women]",28277
6,Chronic obstructive pulmonary disease in non-current smokers,316474
6,Hypertensive diseases (excluding secondary),20719
6,Cardiovascular disease risk factors [FERR],1063
6,Regular attendance at a religious group,231
6,Protein quantitative trait loci (liver) [CTSD],325
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-22 ms],410
6,Mean corpuscular hemoglobin [Asian],158
6,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant II (Nose), Segment 45]",4
6,Leg fat mass (right),96143
6,Time spent watching television (tv),5038
6,Doctor diagnosed hayfever or allergic rhinitis,16835
6,Cholesteryl ester_22:5_[M+NH4]1+ levels,1519
6,Glaucoma (primary open-angle) [European],138
6,Age at menarche,566
6,Other nutritional deficiencies,164
6,Maternal smoking around birth,10801
6,Merkel cell polyomavirus VP1 antibody levels,13901
6,Electrocardiogram morphology (amplitude at temporal datapoints) [350 ms],3280
6,Pulse rate,4528
6,Presence of cardiac and vascular implants and grafts,80
6,Low myopia,25
6,Serum total protein level,122134
6,Monocyte count,1304691
6,Birth weight,80832
6,Diastolic blood pressure x alcohol consumption interaction (2df test) [EA],5438
6,Protein quantitative trait loci (liver) [AFMID],6440
6,Optic nerve head parameters (multi-trait analysis) [EA],13
6,Beta-2 microglubulin plasma levels,277897
6,LDL cholesterol levels,312777
6,Body mass index and LDL-C (pairwise),4843
6,Lymphocyte Absolute Count,110360
6,White matter microstructure (fractional anisotropy) [Posterior thalamic radiation],9349
6,"Blood protein levels [TREML1, 9329_28_3]",4670
6,Vesicare 5mg tablet | treatment/medication code,4119
6,Blood protein levels [Natural cytotoxicity triggering receptor 3],6182
6,Fasting blood glucose adjusted for BMI,2085
6,Magnesium  | vitamin and/or mineral supplement use,440
6,Total cholesterol levels [BMI unadjusted],545
6,Circulating myeloperoxidase levels (serum),105
6,Cardiorespiratory fitness (vo2 max),353
6,Electrocardiogram morphology (amplitude at temporal datapoints) [204 ms],241
6,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [X-12822, X-17682, X-19913, X-24339, X-24588]",6488
6,Pattern 1 | hair/balding pattern,13194
6,Knee osteoarthritis,10644
6,Red blood cell traits (multivariate analysis),16466
6,"Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA, men]",6817
6,Electrocardiogram morphology (amplitude at temporal datapoints) [188 ms],3403
6,Femur bone mineral density x serum urate levels interaction [female],470
6,Urinary metabolite levels in chronic kidney disease [X - 17323],111
6,Protein quantitative trait loci (liver) [HMGCS1],41
6,Serum levels of protein CREB3L4,35590
6,Chronic obstructive pulmonary disease [conditional on rs2284174],59627
6,Endometriosis of pelvic peritoneum,1430
6,Plasma plasminogen activator levels,907
6,"Intra-ocular pressure, goldmann-correlated (right)",3544
6,"Heart rate [Conditional on rs1015451, rs17083533]",94
6,Non-oily fish intake,54
6,Triglyceride levels in IDL,443426
6,C-reactive protein,75911
6,Fasting glucose,9734
6,CD28 on resting CD4 regulatory T cell,425
6,Colorectal cancer [East Asian],297
6,Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms,579
6,Icd10: c80 malignant neoplasm without specification of site | underlying (primary) cause of death,333
6,"Cytokine levels [VEGF-A, conditioned on rs7767396]",1003
6,"Food addiction [mYscore, continuous]",12
6,Lung function (FEV1),40772
6,Multisite chronic pain,20452
6,Serum levels of protein UBC,14017
6,Heel bone mineral density (bmd) (right),48610
6,Medication use (HMG CoA reductase inhibitors),41422
6,PR interval in Tripanosoma cruzi seropositivity,11650
6,Cortical surface area [Caudal Middle Frontal],5032
6,"None of the above | medication for cholesterol, blood pressure or diabetes",10319
6,CD80 on CD62L+ myeloid Dendritic Cell,1460
6,Mean arterial pressure x alcohol consumption interaction (2df test) [EA],4911
6,Electrocardiogram morphology (amplitude at temporal datapoints) [90 ms],3097
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-482 ms],353
6,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event) [Cox proportional hazards regression model],421
6,"""Malignant neoplasm of breast, HER2-negative (controls excluding all cancers)""",397
6,Retinal vascular fractal dimension,111
6,Iron status biomarkers (total iron binding capacity),3803
6,CD4 on HLA DR+ CD4+ T cell,55003
6,FSC-A on CD4+ T cell,110360
6,"Blood protein levels [PSMB1, 12612_37_3]",25264
6,3mm strong meridian (right),153625
6,Fibrosis-4 index in high alcohol intake,5825
6,"""Disorders of gallbladder, biliary tract and pancreas""",670
6,Serum levels of protein NQO2,2610
6,Adenocarcinoma,672
6,Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI,250
6,LDL cholesterol levels x long total sleep time interaction (2df test),146
6,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),30699
6,Frequency of tenseness / restlessness in last 2 weeks,2688
6,Medication use (drugs affecting bone structure and mineralization),8044
6,Hypothyroidism or myxedema,132100
6,Serum levels of protein MRPL55,85741
6,Electrocardiogram morphology (amplitude at temporal datapoints) [88 ms],3280
6,Diabetic nephropathy,29972
6,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),40630
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-124 ms],635
6,Height [EA],43
6,Often | worked with materials containing asbestos,209
6,Height,2148550
6,CAG-81 sp000435795 abundance in stool,112886
6,Autoimmune diseases,20855
6,Insulin product | treatment/medication code,32330
6,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA],14575
6,Electrocardiographic conduction measures [QRS duration - CHARGE],3864
6,Electrocardiogram morphology (amplitude at temporal datapoints) [346 ms],3280
6,"Blood protein levels [EA, Plasminogen]",862
6,Circulating vasoactive peptide levels [ET],190
6,Systolic blood pressure,439373
6,Waist-to-hip ratio adjusted for BMI (additive genetic model),30495
6,Sleeplessness / insomnia,1105
6,Serum levels of protein KCNE2,43609
6,Bone ultrasound measurement (broadband ultrasound attenuation),2225
6,Platelet-derived growth factor BB levels,3843
6,CD20 on IgD- CD38dim B cell,10194
6,Angina,867
6,Cozaar 25mg tablet | treatment/medication code,31
6,Autoimmune thyroid disease,31516
6,Serum levels of protein FRZB,16139
6,Electrocardiogram morphology (amplitude at temporal datapoints) [338 ms],3633
6,Electrocardiogram morphology (amplitude at temporal datapoints) [-14 ms],3280
6,SSC-A on myeloid Dendritic Cell,8441
6,Coagulation Factor VIII measurement,902
6,Fatty acid(22:5)_[M-H]1- levels,933
6,Protein quantitative trait loci (liver) [AMBP],508
6,Cortical surface area (visual PC2) [EA],187
6,Parkinson's disease,270877
6,Positive affect,319400
6,Gout [EA],5073
6,IgD on transitional B cell,16382
6,Birth weight of first child,4703
6,"Black | hair colour (natural, before greying)",4026
6,Varicella zoster virus glycoproteins E and I antibody levels,133850
6,Platelet crit,170163
6,Meat-related diet,7860
6,N-acetylhistidine levels,2527
6,Previous | smoking status,3376
6,Electrocardiogram morphology (amplitude at temporal datapoints) [332 ms],3633
6,Serum levels of protein CRISP2,3820
6,Opioid dependence,276
6,Valvular operations,80
6,DNA methylation variation (age effect),30111
6,Medication use (antithrombotic agents),34801
6,Serum levels of protein KIR2DS2,68107
6,Serum levels of protein DNAJB11,21675
6,"Blood protein levels [MMP8, 2954_56_2]",29884
6,Biological sex,19024
6,"Blood protein levels [KLK6, 3450_4_2]",11021
6,Chronic or degenerative neurological problem,2613
6,CD20 on switched memory B cell,750
6,Treatment or medication use - levothyroxine sodium (UKB data field 20003_1141191044),2630
6,Asthma,634499
6,Colorectal cancer or advanced adenoma,125134
6,Urate levels in overweight individuals [men],5298
6,Electrocardiogram morphology (amplitude at temporal datapoints) [334 ms],3633
6,"Body composition traits [M, Waist-to-hip ratio]",1790
6,Serum levels of protein EPO,1632
6,Electrocardiogram morphology (amplitude at temporal datapoints) [100 ms],3408
6,Asthma (mode),1467
6,Electrocardiogram morphology (amplitude at temporal datapoints) [212 ms],241
6,Caffeine consumption from coffee,109
6,Varicose veins,136555
6,Blood cell traits (multivariate analysis),9567
6,Persistent hepatitis B virus infection,180631
6,"Blood protein levels [UTS2, 6020_52_3]",11021
6,Chronic obstructive pulmonary disease or resting heart rate (pleiotropy),5103
6,Fast beta electroencephalogram,5994
6,Fractured/broken bones in last 5 years,1503
6,Electrocardiogram morphology (amplitude at temporal datapoints) [320 ms],3749
6,Umbilical hernia,318
6,Electrocardiogram morphology (amplitude at temporal datapoints) [254 ms],82
6,Depression (broad),50164
6,Spherical equivalent,80260
6,Serum levels of protein C4A;C4B,109483
6,Protein quantitative trait loci (liver) [GNMT],49634
6,Disorders of the thyroid gland,14992
6,"""Thyrotoxicosis, other and/or unspecified""",43544
6,Electrocardiogram morphology (amplitude at temporal datapoints) [202 ms],4144
6,Pulse pressure [EA],718
6,Non-oily fish consumption,55
6,Body fat percentage or coronary artery disease (MTAG),70
6,Membranous nephropathy,329382
6,High light scatter reticulocyte percentage of red cells,262669
6,Smoking initiation (ever regular vs never regular) [Conditioned on chr6:28129789],53790
6,"Blood protein levels [ZAP70, 4476_22_2]",11021
6,Conductive and sensorineural hearing loss,12992
6,Urate levels [EA],4177
6,Vegetarian | type of special diet followed,5406
6,Total body bone mineral density (age 30-45),1062
6,Heart rate variability traits (SDNN),1492
6,Menopause (age at onset) [Japanese],920
6,Polycystic ovary syndrome,98
6,Family history of Alzheimer's disease,35
6,Male-pattern baldness,65785
6,Allergy,37096
6,Lobe attachment (rater-scored or self-reported),66754
6,Rheumatoid arthritis [East Asian],354000
6,Alanine aminotransferase levels,273538
6,Cerebrospinal fluid biomarker levels [MHC class I polypeptide-related sequence B],29800
6,Birth weight (MTAG),3122
6,Allopurinol | treatment/medication code,5298
6,Phosphatidylethanolamine_40:6_[M-H]1- levels,2427
6,"Body mass index in physically active individuals [EA,women]",160
6,Electrocardiogram morphology (amplitude at temporal datapoints) [232 ms],123
6,Dilated cardiomyopathy (MTAG),876
6,Serum levels of protein MANEA,518
6,Lamb/mutton intake,196
7,Parkinson's disease,166924
7,Hemoglobin A1c levels,283312
7,Dermatitis and eczema,243
7,Protein quantitative trait loci (liver) [MAP4],24
7,Daytime nap,36584
7,Free cholesterol levels in medium VLDL,16711
7,Plateletcrit,371867
7,Childhood sunburn occasions,7333
7,"Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, Asian, EA]",824
7,"Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [Asian, EA]",890
7,1-palmitoyl-2-linoleoyl-gpc (16:0/18:2) levels,1888
7,Facial ageing,9607
7,Tense / 'highly strung',1590
7,"Blood protein levels [PIP, 6060_2_3]",442
7,Glioma [females],148
7,Ulcerative enterocolitis,22
7,Often | worked with pesticides,213
7,Gastroesophageal reflux disease,14366
7,Nonalcoholic fatty liver disease (imputed),3071
7,"Blood protein levels [TMEM106B, 8687_26_3]",4489
7,Bone mineral density [hip],1486
7,6mm weak meridian (right),3630
7,Paraoxonase activity [Serum Paraoxonases activity],198
7,Predicted visceral adipose tissue,22132
7,Parental longevity (father's age at death),36268
7,Standing height,138243
7,Infant head circumference (MTAG),2413
7,Femoral neck bone mineral density,2073
7,Protein quantitative trait loci (liver) [CES2],17
7,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),45350
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-472 ms],3668
7,Household income,9745
7,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [women],1702
7,Type 1 diabetes,84689
7,Diabetes,16391
7,Calceos chewable tablet | treatment/medication code,2702
7,Frequency of friend/family visits,3521
7,Paraoxonase activity,5691
7,Previous | smoking status,3893
7,Brugada syndrome,721
7,Mean arterial pressure x alcohol consumption interaction (2df test) [AA],640
7,Cardiovascular diseases,46
7,Triglycerides,228893
7,Cotinine glucuronidation,21350
7,IgD on IgD+ CD24- B cell,4469
7,Red blood cell (erythrocyte) distribution width,14793
7,Ascending aorta minimum area,3698
7,Heart rate response to recovery post exercise (40 sec),3330
7,"Sphingomyelin (d18:1/14:0, d16:1/16:0) levels",1786
7,Current tobacco smoking,658
7,Sleeplessness / insomnia,28407
7,Cataracts,30697
7,Ulna and radius bone mineral density,2311
7,Electrocardiogram morphology (amplitude at temporal datapoints) [162 ms],1043
7,Facial morphology traits (63 three-dimensional facial segments) [facial module 55],206
7,Acute pancreatitis,85
7,Brain region volumes [X4th ventricle],10734
7,"Heel bone mineral density (bmd) t-score, automated (right)",14584
7,Leg fat-free mass (right),60013
7,LDL cholesterol levels,34296
7,"Intra-ocular pressure, corneal-compensated (right)",8306
7,Femur bone mineral density x serum urate levels interaction [female],3537
7,Insulin-like growth factors [IGFBP-3],278
7,Brevibacillus B abundance in stool,39
7,LDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test) [African],22
7,"Mean arterial pressure x alcohol consumption interaction (2df test) [AA, Asian, EA]",425
7,LDL levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder,43
7,Nap during day,30449
7,Leg predicted mass (left),56721
7,KELA_REIMBURSEMENT_202,4984
7,Electrocardiogram morphology (amplitude at temporal datapoints) [332 ms],1547
7,Serum levels of protein VWC2,214
7,Gut microbiota relative abundance (bacterial taxa) [Ruminococcus_gnavus],68
7,Autism spectrum disorder,60
7,Spondyloarthritis,22
7,Macrovascular complications in type 2 diabetes,1698
7,Schizophrenia vs ADHD (ordinary least squares (OLS)),19728
7,Plasma free amino acid levels [Trp],22
7,"Cholesterol, total",40768
7,Bitter alcoholic beverage consumption,2155
7,Motion sickness,3555
7,Cholecystitis,2822
7,Eye color [EA],996
7,Glioblastoma,476
7,Basophil count,81604
7,Deep ovarian and/or rectovaginal disease with dense adhesions,1551
7,Electrocardiogram morphology (amplitude at temporal datapoints) [170 ms],1043
7,Mitochondrial heteroplasmy measurement,27
7,Waist circumference adjusted for body mass index [men],9346
7,"Blood protein levels [RARRES2, 3079_62_2]",43044
7,Systemic lupus erythematosus [anti-dsDNA +],2130
7,Thyroid problem (not cancer),13317
7,Bendroflumethiazide | treatment/medication code,2078
7,Average 24-hour sound level of noise pollution,76
7,Medication use (thyroid preparations),13199
7,Sphingomyelin_34:1_[M+H]1+ levels,11613
7,Vertical cup-disc ratio (multi-trait analysis),5677
7,Multisite chronic pain,11203
7,Carotid intima media thickness [Plaque],100
7,Major depression and alcohol dependence [AA],32
7,Fracture of hand or wrist,1164
7,Calcific aortic valve stenosis,1300
7,Nasopharyngeal carcinoma (SNP x SNP interaction),257
7,Nonsyndromic cleft palate,4145
7,Neurological diseases,93
7,Brain region volumes [white matter],734
7,Depression (broad),4783
7,Hip circumference [EA],12417
7,Electrocardiogram morphology (amplitude at temporal datapoints) [338 ms],1547
7,"""Type 2 diabetes, wide definition""",9253
7,Myopia (age of diagnosis),1359
7,Brain region volumes [left caudal anterior cingulate],54
7,Cortical surface area [Lateral Orbitofrontal],1472
7,Impedance of leg (right),83568
7,Response to serotonin reuptake inhibitors in non-psychotic unipolar depression,207
7,Protein quantitative trait loci (liver) [EMILIN2],2007
7,Barrett's esophagus  or Esophageal adenocarcinoma,664
7,Survival in colon cancer,178
7,"Forced expiratory volume in 1-second (fev1), predicted",29864
7,Neutrophill count,121665
7,"""Type 2 diabetes, definitions combined, including avohilmo""",9028
7,circulating leptin levels adjusted for BMI,17114
7,Electrocardiogram morphology (amplitude at temporal datapoints) [310 ms],1547
7,Glioma,296
7,Participation in an health questionnaire (not invited vs invited),2053
7,Problematic alcohol use,108
7,Glaucoma (primary angle closure) [Asian],93
7,White matter microstructure (radial diusivities) [Splenium of corpus callosum],96
7,Protein quantitative trait loci (liver) [ANP32A],22
7,Bipolar disorder lithium response (continuous) or schizophrenia,32
7,Mitochondrial DNA copy number,7750
7,Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in non-secretors,532
7,Pelvic organ prolapse,107
7,Protein quantitative trait loci (liver) [HINT1],9
7,Protein levels in obesity [TIG2],43044
7,Arm predicted mass (right),68875
7,Pre-treatment viral load in HIV-1 infection,697
7,LDL cholesterol levels in current drinkers [EA],6603
7,Smoking initiation (ever regular vs never regular) [Conditioned on chr7:3503207],1038
7,Autism spectrum disorders (social interaction),516
7,"Serum metabolite levels [5alpha-androstan-3beta,17beta-diol monosulfate (2]",588
7,Insulin-like growth factors [IGF-I],5
7,Cortical surface area (MOSTest),8637
7,Reticulocyte count,365548
7,Heel broadband ultrasound attenuation (left),9586
7,Triglycerides [EA],10416
7,Electrocardiogram morphology (amplitude at temporal datapoints) [112 ms],1043
7,"""Obesity, other/unspecified""",2132
7,Regular attendance at a religious group,240
7,Major coronary heart disease event,94
7,Facial morphology (segment 5),68
7,Help-seeking from a GP,4531
7,Regional enteritis,647
7,"Osteopenia | non-cancer illness code, self-reported",210
7,Insomnia symptoms (never/rarely vs. usually),8808
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-28 ms],3178
7,Mean corpuscular haemoglobin,24631
7,Serum metabolite levels [Glc],1386
7,Lactose-free | type of special diet followed,293
7,Facial morphology (segment 3),634
7,Protein quantitative trait loci (liver) [CSTA],475
7,Age high blood pressure diagnosed,112
7,"""Inguinal hernia, unilateralk""",96
7,Offspring birth weight,19561
7,Sphingomyelin_32:1_[M+H]1+ levels,11543
7,"Heel quantitative ultrasound index (qui), direct entry (right)",14584
7,Home location at assessment - north co-ordinate (rounded),6744
7,Impedance of leg (left),124377
7,"Caffeine metabolism (plasma 1,3,7-trimethylxanthine (caffeine) level)",226
7,6mm cylindrical power (left),94
7,Highest math class taken,32489
7,Menarche (age at onset),45847
7,Serum metabolite levels [S_VLDL_TG],8648
7,Age first had sexual intercourse,31288
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-38 ms],1792
7,Brain region volumes [left isthmus cingulate],792
7,Electrocardiogram morphology (amplitude at temporal datapoints) [188 ms],1043
7,Protein quantitative trait loci (liver) [PPA1],55
7,Sum basophil neutrophil counts,44901
7,Serum levels of protein TPST1,39067
7,Tea intake,36835
7,Other non-epithelial cancer of skin,1350
7,Oily fish intake,840
7,Iron+folic acid | treatment/medication code,42
7,Alcohol consumption (drinks per week) (MTAG),49120
7,"Blood protein levels [GPNMB, 5080_131_3]",42437
7,"""Hypothyroidism, strict autoimmune, 3 medication purchases required""",204
7,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA],2399
7,Medial thalamic nuclei volume,10393
7,Body mass index [EA],2018
7,Serum levels of protein C6orf58,3182
7,Multiple myeloma and monoclonal gammopathy,313
7,Protein quantitative trait loci (liver) [RAB14],278
7,hemolysis of donated blood (osmotic),1716
7,Serum metabolite levels [dehydroisoandrosterone sulfate (DHEA-S],588
7,Neuroticism,52414
7,Refractive error,72726
7,Telomere length,8254
7,"Disorders of muscle, ligament, and fascia",3282
7,Longevity (age >99th survival percentile),161
7,Other diseases of intestines,1686
7,Longest period of unenthusiasm / disinterest,233
7,Beard thickness,35
7,Rheumatoid arthritis [EA],3726
7,Blood protein levels [CCL24],31595
7,Serum metabolite levels [serine],5863
7,Polyarthropathies,1087
7,Alzheimer's disease (late onset),6422
7,Enterobacteriaceae abundance in stool,274
7,Microalbuminuria,89
7,middle facial morphology traits (quantitative measurement) [Nose wing breadth],144
7,Lymphocyte-to-monocyte ratio,14744
7,Metabolite levels [gamma aminoisobutyric acid],2193
7,Opioid use disorder,1126
7,Metabolite levels [indole-3-propionate],239
7,Chin dimples,214
7,Height,687724
7,Triglyceride levels [Asian],11049
7,Glutamine levels,5485
7,Insomnia [Male],551
7,Cortical surface area [Pars triangularis],476
7,"Allergic disease (asthma, hay fever and/or eczema) (age of onset)",280
7,"Overweight, obesity and other hyperalimentation",17
7,FEV1,38029
7,"Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) [Asian, EA]",890
7,IgG glycosylation [IGP2],2289
7,"None of the above | medication for cholesterol, blood pressure or diabetes",1262
7,Metabolic syndrome [GLU],527
7,Red cell distribution width,356160
7,"Talking therapies, such as psychotherapy, counselling, group therapy or cbt | activities undertaken to treat anxiety",4531
7,T wave morphology restitution during exercise,713
7,Protein quantitative trait loci (liver) [HP],36
7,Protein quantitative trait loci (liver) [S100A6],3
7,Migraine,1084
7,P wave duration [EA],2736
7,Protein quantitative trait loci (liver) [RAC2],2477
7,Trauma exposure,553
7,Periodontal disease related phenotype (PCT4),105
7,Unknown and unspecified causes of morbidity,27
7,Blood protein levels in cardiovascular risk,1050
7,Obesity and other hyperalimentation,2069
7,"Adult diffuse triple positive glioma (IDH and TERT mutations, 1p19q codeletion)",356
7,Facial morphology (ear size),127
7,Type 1 diabetes without complications,97
7,High blood pressure | illnesses of siblings,46
7,Knee osteoarthritis,12
7,Cholelithiasis and cholecystitis,15580
7,Coronary heart disease,16944
7,Urinary metabolite levels in chronic kidney disease [tauro-beta-muricholate],693
7,"Colon cancer/sigmoid cancer | cancer code, self-reported",1147
7,Perforation of tympanic membrane,581
7,CD39 on granulocyte,13
7,Medication use (beta blocking agents),41290
7,"Forced vital capacity (fvc), best measure",48200
7,Major depressive disorder (probable),4489
7,Solpadol caplet | treatment/medication code,617
7,Duration to first press of snap-button in each round,1
7,Body fat distribution (trunk fat ratio),13613
7,"Hip circumference adjusted for BMI [EA,men]",12552
7,Phosphatidylcholine-O_32:1_[M+H]1+/Phosphatidylcholine-P_32:0_[M+H]1+/Phosphatidylethanolamine-O_35:1_[M+H]1+ levels,11613
7,Depressive symptom (fatigue) (ordinal trait),656
7,Brain region volumes [X3rd ventricle],9180
7,"Blood protein levels [PTN, 3045_72_2]",437
7,Primary biliary cholangitis,7797
7,Number in household,69
7,"Blood protein levels [EA, Ephrin type-A receptor 1]",1034
7,Vertical cup-disc ratio,40
7,Educational attainment (MTAG) [MTAG],248513
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-118 ms],1073
7,Heat shock 27 kDa protein levels,3429
7,Other ulcerative colitis,22
7,"""Torsion of ovary, ovarian pedicle and fallobian tube""",72
7,Hip pain | pain type(s) experienced in last month,278
7,Galectin-3 levels,23018
7,"Fracture hand | non-cancer illness code, self-reported",9682
7,Triglyceride levels in current drinkers,10123
7,Dilated cardiomyopathy,862
7,Cereal intake,3761
7,Hot drink temperature,19967
7,Number of treatments/medications taken,5288
7,Peripheral artery disease,227
7,White matter microstructure (axial diusivities) [Genu of corpus callosum],185
7,"Blood protein levels [EA, Transmembrane glycoprotein NMB]",17195
7,Sodium in urine,9255
7,Fasting glucose adjusted for BMI,4357
7,Osteoclast-associated immunoglobulin-like receptor levels,2490
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-94 ms],1073
7,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [AA],92
7,3mm weak meridian angle (right),277
7,Interstitial lung disease,9723
7,C-reactive protein levels or total cholesterol levels (pleiotropy),27030
7,Electrocardiogram morphology (amplitude at temporal datapoints) [402 ms],1832
7,"Intra-ocular pressure, goldmann-correlated (right)",8379
7,IgG glycosylation [IGP72],789
7,Renal function-related traits (sCR),441
7,Average night-time sound level of noise pollution,76
7,Lung function (FVC),91899
7,Brain morphology (min-P),16219
7,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction),2501
7,Blood pressure [SBP],640
7,Hematocrit [Asian],4570
7,Hippurate levels,672
7,Indometacin | treatment/medication code,593
7,Diastolic blood pressure x alcohol consumption interaction (2df test) [EA],686
7,Puerperal sepsis,27
7,Lean body mass,8
7,Benign neoplasm of colon,1
7,Hemoglobin concentration,121925
7,Lipoprotein (a) levels,8173
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-116 ms],1073
7,Serum levels of protein GPNMB,126127
7,Triglyceride levels in current drinkers [Hispanic],8553
7,Other nutritional deficiencies,2052
7,Systemic sclerosis (anti-topoisomerase-positive) [EA],1761
7,Walking pace,2553
7,Corneal curvature,876
7,Red blood cell traits [MCH],2065
7,Disorders of lens,242
7,Develomental delays and disorders,102
7,"Seen doctor (gp) for nerves, anxiety, tension or depression",4542
7,Sitting height,132167
7,Low density lipoprotein cholesterol levels [EA],730
7,Social science traits (pleiotropy) (HIPO component 1),678
7,Resistin levels,13
7,C-reactive protein levels,221821
7,General factor of neuroticism,10706
7,Hirschsprung disease,349
7,Yes | hearing difficulty/problems,4437
7,Glaucoma (primary angle closure),93
7,Facial morphology (eye position 1),10
7,"Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)",138
7,Co-tenidone | treatment/medication code,262
7,HDL cholesterol,148721
7,Diastolic blood pressure,314638
7,"""Other diabetes, wide definition""",8822
7,Sensitivity to environmental stress and adversity,2088
7,"Blood protein levels [IGFALS, 6605_17_3]",447
7,Bone disorder,1721
7,Total body bone mineral density (MTAG),111
7,Cytomegalovirus pp28 antibody levels,16
7,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)",31463
7,Major depressive disorder,12691
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-36 ms],1792
7,Electrocardiogram morphology (amplitude at temporal datapoints) [148 ms],1043
7,"Bone mineral density (paediatric, upper limb)",8658
7,IgG glycosylation [IGP42],2289
7,Electrocardiogram morphology (amplitude at temporal datapoints) [136 ms],1043
7,LDL cholesterol,106073
7,Total cholesterol levels,154496
7,Problematic alcohol use (MTAG),24893
7,Caffeine consumption from coffee,44221
7,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction) [women],1702
7,4-chlorobenzoic acid levels,4738
7,Pattern 3 | hair/balding pattern,2211
7,Urinary metabolite levels in chronic kidney disease [1-methylhistamine],2193
7,Headache | pain type(s) experienced in last month,438
7,"Glaucoma | non-cancer illness code, self-reported",1135
7,Total amyloid (SNP x SNP interaction),176
7,Other malignant neoplasms of skin (=non-melanoma skin cancer) (controls excluding all cancers),356
7,Protein quantitative trait loci (liver) [CTSB],52
7,Attention deficit hyperactivity disorder or cannabis use,551
7,Electrocardiographic traits [PR interval],806
7,Codeine | treatment/medication code,360
7,Protein quantitative trait loci (liver) [TXNL1],25
7,Number of fluid intelligence questions attempted within time limit,6208
7,Arm fat percentage (left),31920
7,Body mass index [Japanese],370
7,"Age-related diseases, mortality and associated endophenotypes",14240
7,Blond vs. brown/black hair color,3460
7,LDL cholesterol levels x short total sleep time interaction (2df test),9227
7,Water intake,13248
7,Serum metabolite levels [X-12063],88203
7,Electrocardiogram morphology (amplitude at temporal datapoints) [340 ms],1547
7,CD20 on naive-mature B cell,1331
7,Serum levels of protein IGFALS,280
7,Protein quantitative trait loci (liver) [PFKL],18
7,Varicose veins,16579
7,Basophil percentage of granulocytes,3144
7,Electrocardiogram morphology (amplitude at temporal datapoints) [180 ms],1043
7,Something not listed | methods of self-harm used,66
7,Alanine transaminase levels,19628
7,Glaucoma,10888
7,Diverticulosis,9779
7,White blood cell types [neutrophil count],630
7,Schizophrenia vs bipolar disorder (ordinary least squares (OLS)),162
7,same-sex sexual behaviour,73
7,Weight,178028
7,Direct low density lipoprotein cholesterol levels,84132
7,"""Diabetes, insuline treatment (Kela reimbursement) (more control exclusions)""",6626
7,Anxiety [EA],1838
7,Interstitial lung diseases in rheumatoid arthritis,2613
7,Breast milk fatty acid composition (maternal genotype effect) [oleic acid],57
7,"""Crohn disease (strict definition, require KELA)""",22
7,Plasma proprotein convertase subtilisin/kexin type 9 levels in stable coronary artery disease,17
7,White blood cell count (neutrophil),10
7,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),6516
7,Use of sun/uv protection,11617
7,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],8071
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-458 ms],3668
7,Finngen Rheumatological endpoints,2869
7,Severe influenza A (H1N1) infection,1514
7,Electrocardiogram morphology (amplitude at temporal datapoints) [198 ms],1043
7,Metoprolol | treatment/medication code,336
7,Protein quantitative trait loci (liver) [COL18A1],12
7,Protein quantitative trait loci (liver) [FAHD1],8
7,Hemoglobin levels,77343
7,Rheumatoid arthritis,14052
7,Other and unspcified rosacea,44
7,Protein quantitative trait loci (liver) [CLTCL1],52
7,Appendicular lean mass,360311
7,"""SLE, strict definition""",3486
7,Plays computer games,1179
7,"Blood protein levels [EPHB6, 5078_82_3]",618
7,Rhinophyma,130
7,Smoking initiation (ever regular vs never regular) [Conditioned on chr7:77771983],70
7,Red blood cell count,481330
7,Electrocardiogram morphology (amplitude at temporal datapoints) [172 ms],1043
7,Serum levels of protein CCDC126,3391
7,"Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA, men]",217
7,Dilated cardiomyopathy (MTAG),862
7,IgG glycosylation [IGP45],1462
7,Serum metabolite levels [androsteronesulfate],23076
7,Trunk predicted mass,91114
7,Otosclerosis,704
7,Ebbinghaus illusion (overestimation),604
7,Other Chron's disease,22
7,Conductive and sensorineural hearing loss,2
7,Reticulocyte percentage,14740
7,Feeling hurt,2106
7,Non-melanoma skin cancer,735
7,Blood protein levels [Semaphorin-3E],863
7,"""Myocardial infarction, strict""",46
7,Mitochondrial DNA levels,18262
7,Sex hormone levels [Progesterone],1674
7,Systolic blood pressure x alcohol consumption interaction (2df test) [EA],185
7,Interleukin-10 levels,478
7,Lung function (FEV1/FVC),197465
7,General risk tolerance (MTAG),26117
7,Male-pattern baldness,15408
7,Atrial fibrillation [Japanese],3070
7,Huntington's disease (age at onset) [Hispanic],764
7,Plasma free amino acid levels (adjusted for one other PFAA) [Ser (adjusted for Pro],13191
7,Allopurinol | treatment/medication code,9858
7,Serum 25-Hydroxyvitamin D levels x season interaction,36907
7,PR interval [Hispanic],345
7,Cerebral amyloid angiopathy in APOEe4 non-carrier Alzheimer’s disease,89
7,Snoring,5897
7,Tonsillectomy,30256
7,Electrocardiogram morphology (amplitude at temporal datapoints) [322 ms],1547
7,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) [women],3370
7,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test) [EA],1161
7,3mm cylindrical power angle (right),266
7,Crohn's disease,25756
7,Platelet distribution width,695504
7,Fat-free mass,38483
7,Medication use (agents acting on the renin-angiotensin system),46185
7,Triglyceride levels in current drinkers [Asian],8553
7,Trunk fat percentage,55982
7,Diacylglycerol_34:1_[M+H-H2O]1+ levels,12098
7,1-stearoyl-2-arachidonoyl-gpc (18:0/20:4) levels,2010
7,"""Type 2 diabetes, strict (exclude DM1)""",8541
7,Metabolite levels [Serine],16165
7,Protein quantitative trait loci [TIG2],43936
7,Arm predicted mass (left),64394
7,Heel broadband ultrasound attenuation (right),10373
7,Palmar fascial fibromatosis [Dupuytren],1768
7,Ischemic heart diseases,233
7,Spherical equivalent [EA],29
7,Protein quantitative trait loci (liver) [FABP3],4
7,Never | smoking status,21280
7,Metabolic syndrome,10062
7,Respiratory diseases,1448
7,Hypertrophic cardiomyopathy,1922
7,Serum metabolite concentrations in chronic kidney disease [Lysophosphatidylcholine with acyl residue C18:1],4
7,Inflammatory skin disease [Psoriasis],338
7,Mouth ulcers,26616
7,Fasting blood glucose (BMI interaction),1484
7,Creutzfeldt-Jakob disease (sporadic),1276
7,LDL cholesterol levels x short total sleep time interaction (2df test) [EA],87
7,Bitter beverage consumption,36337
7,Insomnia [Female],20537
7,Rosiglitazone | treatment/medication code,1034
7,Sicca syndrome [Sjögren],2021
7,Skin cancer,1658
7,CD80 on CD62L+ plasmacytoid Dendritic Cell,500
7,CCR2 on plasmacytoid Dendritic Cell,120
7,Frequency of tiredness / lethargy in last 2 weeks,1
7,Serum metabolite levels [3-methoxytyrosine],5823
7,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [women],217
7,"""Dislocation, sprain and strain of joints and ligaments of elbow""",136
7,One or more previous psychiatric episodes with another health care provider | history of psychiatric care on admission,74
7,PR interval,18080
7,Body size at age 10,108844
7,Risk-taking tendency (4-domain principal component model),12240
7,Body mass index x sex x age interaction (4df test),7044
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-476 ms],3668
7,Fed-up feelings,565
7,Urinary metabolite levels in chronic kidney disease [epiandrosterone sulfate],726
7,Other disorders of ear,8
7,Simvastatin | treatment/medication code,46
7,Lansoprazole | treatment/medication code,4
7,Apolipoprotein B levels,119271
7,Gamma glutamyl transpeptidase,66695
7,Leisure sedentary behaviour (television watching),2616
7,Body fat percentage and HDL-C (pairwise),1919
7,Vertical cup-disc ratio (adjusted for vertical disc diameter),1699
7,Glomerular filtration rate in diabetes,271
7,Diovan 40mg capsule | treatment/medication code,146
7,Atenolol | treatment/medication code,46
7,Haemoglobin concentration,29078
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-466 ms],3668
7,Hydroxocobalamin | treatment/medication code,1110
7,Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event),1193
7,malignant neoplasm of male genital organs (controls excluding all cancers),386
7,"""Injuries to unspecified part of trunk, limb or body region""",19
7,Protein quantitative trait loci (liver) [DDB1],18
7,Body mass index,381462
7,DHEAS levels [women],14501
7,Inguinal hernia,13315
7,Participant wanted to stop early | completion status of test,239
7,Urinary metabolite levels in chronic kidney disease [X - 23656],2267
7,Serum levels of protein COLGALT1,1034
7,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant II (Nose), Segment 11]",306
7,Monobrow,185
7,Coffee consumption (cups per day),91356
7,HDL cholesterol levels x short total sleep time interaction (2df test),11462
7,Pulse wave arterial stiffness index,911
7,Electrocardiogram morphology (amplitude at temporal datapoints) [396 ms],1832
7,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction),1792
7,Type 2 diabetes (adjusted for BMI),2750
7,Completion of the aide-memoire,461
7,Mytonic disorders,29
7,Body mass index and systolic blood pressure (bivariate analysis),184
7,Retinal nerve fibre layer thickness or ganglion cell inner plexiform layer thickness (MTAG),413
7,Systolic blood pressure [Japanese],1352
7,"""Cholelithiasis, broad definition with cholecystitis""",17738
7,Relative age voice broke,1842
7,Transplant-related mortality after unrelated donor allogeneic hematopoietic cell transplantation (recipient effect),2032
7,Electrocardiogram morphology (amplitude at temporal datapoints) [398 ms],1832
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-20 ms],2280
7,Other disorders of urethra and urinary system,970
7,Irritable mood,859
7,Total cholesterol levels [EA],784
7,Parabacteroides abundance in stool,28
7,Smoking cessation (MTAG),7806
7,Hip index,15652
7,Electrocardiogram morphology (amplitude at temporal datapoints) [146 ms],43480
7,First line medication for Crohns disease,1667
7,Dried fruit intake,4088
7,Waist-to-hip ratio adjusted for body mass index [EA],15746
7,Urinary metabolite levels in chronic kidney disease [X - 23668],2267
7,Diseases of the ear and mastoid process,401
7,Paraoxonase activity [Serum Arylesterase activity],178
7,Protein quantitative trait loci (liver) [UCHL3],7
7,Chronic lower respiratory diseases,37
7,SSC-A on monocyte,13
7,Breast cancer,44593
7,Major depressive disorder (MTAG),5738
7,Systolic blood pressure [East Asian],2311
7,Electrocardiogram morphology (amplitude at temporal datapoints) [122 ms],1043
7,"Gynecologic disease (multivariate analysis) [endometriosis, uterine cervical cancer]",39
7,Eudaimonic well-being,256
7,HIgh-sensitivity cardiac troponin T levels (high vs low),158
7,Autism spectrum disorder (MTAG),193
7,Ever had same-sex intercourse,72
7,Amyotrophic lateral sclerosis,24
7,"LDL cholesterol levels in current smokers [African, trans-ethnic]",2
7,Heart rate response to recovery post exercise (50 sec),3330
7,Home location - north co-ordinate (rounded),470
7,Attention deficit hyperactivity disorder (MTAG),293
7,X-11787 levels,285
7,General cognitive ability,10242
7,Lymphocyte percentage,176769
7,Bone ultrasound measurement (broadband ultrasound attenuation) [female],1190
7,Fasting blood glucose adjusted for BMI,3784
7,Heart rate,4022
7,Protein quantitative trait loci (liver) [CYP3A5],2
7,Serum levels of protein RARRES2,43044
7,Episodic memory (pairs-matching),99
7,Urate levels [East Asian],11164
7,3mm weak meridian (left),7127
7,Electrocardiogram morphology (amplitude at temporal datapoints) [158 ms],1043
7,Psoriasis or type 2 diabetes (trans-disease meta-analysis),656
7,Hypothyroidism or myxedema,25449
7,Medication use (drugs affecting bone structure and mineralization),1999
7,Fish- and plant-related diet [female],465
7,Other heart diseases,109
7,Neutrophill percentage,143824
7,Cardiac dysrhythmias,1073
7,Neurological blood protein biomarker levels [ADAM 22],464
7,IgG glycosylation patterns [IgG1_G1N],789
7,Regular attendance at a pub or social club,108
7,Brain region volumes [right thalamus proper],141
7,"LDL cholesterol levels x smoking (current vs non smokers) interaction (1df test) [African, trans-ethnic]",2
7,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),24798
7,Diacylglycerol_34:3_[M+H-H2O]1+ levels,7340
7,Waist-hip ratio [EA],1645
7,Birth weight of first child,3075
7,"Other chronic ischemic heart disease, unspecified",46
7,Estrone levels,730
7,Electrocardiogram morphology (amplitude at temporal datapoints) [130 ms],1043
7,Angina pectoris,358
7,Protein quantitative trait loci (liver) [FHL1],21
7,Malignant neoplasm of skin (controls excluding all cancers),356
7,Vigorous physical activity,8738
7,"Serum metabolite levels [androstenediol (3alpha, 17alpha) monosulfate (3]",588
7,Distal/Left-sided colorectal cancer,61
7,Response to citalopram treatment [EA + AA - Vision\hearing],34
7,Plasminogen activator inhibitor type 1 levels (PAI-1),15394
7,Depressed affect,8554
7,OTU99_30 (Parasutterella) abundance,2738
7,Place of birth in uk - east co-ordinate,4593
7,Chronic obstructive pulmonary disease x ever smoker interaction (main effect),1049
7,Neurological blood protein biomarker levels [VWC2],134
7,Total body bone mineral density (age 45-60),1840
7,Cortical thickness (MOSTest),65234
7,Systemic lupus erythematosus [Hispanic],1243
7,Mean arterial pressure [Japanese],1410
7,Body mass index (joint analysis main effects and physical activity interaction),820
7,Sitting height ratio [EA],262
7,SLE (Finngen),3572
7,Electrocardiogram morphology (amplitude at temporal datapoints) [166 ms],1043
7,Fibroblastic disorders,2562
7,"Light diy (eg: pruning, watering the lawn) | types of physical activity in last 4 weeks",521
7,IgG glycosylation [IGP58],827
7,Heart rate variability traits (SDNN),436
7,Persistent mood disorders,18
7,Heel bone mineral density (bmd) (left),7208
7,Triglyceride levels x short total sleep time interaction (2df test) [EA],2741
7,Inter-alpha-trypsin inhibitor heavy chain H4 measurement,636
7,TestASV_48 (Sutterella) prevalence,225
7,Electrocardiographic traits [QT interval],624
7,Protein quantitative trait loci (liver) [ARHGDIB],12
7,Amino acid levels [Serine],5964
7,Lipid metabolism phenotypes [VLDL-D],11445
7,Limited cutaneous systemic scleroderma [EA],2056
7,Acute lymphoblastic leukemia (childhood) [ETV6-RUNX1 positive],3647
7,"Blood protein levels [EPHA1, 3431_54_2]",1111
7,Coronary artery disease and triglyceride levels (multivariate analysis),434
7,Anxiety disorders [EA],758
7,Philtrum width,7838
7,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],45350
7,Chronic obstructive pulmonary disease x current smoker interaction (main effect),10425
7,IgD on IgD+ CD38dim B cell,4469
7,Non-alcoholic fatty liver disease histology (other) [Fibrosis],38
7,Alzheimer's disease or family history of Alzheimer's disease,14146
7,Spherical equivalent,23442
7,Body mass index (bmi),111207
7,Celiac disease,3291
7,"Blood pressure medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",9662
7,Hormone measurements [Dehydroepiandrosterone],693
7,Atrial fibrillation and flutter,2065
7,Eosinophill percentage,94302
7,Electrocardiogram morphology (amplitude at temporal datapoints) [18 ms],8805
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-100 ms],1073
7,Electrocardiogram morphology (amplitude at temporal datapoints) [118 ms],1043
7,Electrocardiogram morphology (amplitude at temporal datapoints) [354 ms],1547
7,Brain region volumes [left lateral ventricle],9166
7,Urinary metabolite levels in chronic kidney disease [X - 24353],22659
7,Low hand grip strength (60 years and older) (EWGSOP),6141
7,Frontotemporal dementia,4505
7,Childhood maltreatment,1010
7,Serum galactose-deficient IgA1 levels in IgA nephropathy,2378
7,Frequency of inability to cease drinking in last year,10
7,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),17527
7,Serum phosphate levels,60058
7,"Obstructive sleep apnea trait (apnea hypopnea index, change over time)",1525
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-468 ms],3668
7,Abdominal aortic calcification levels [EA],47
7,"Bone mineral density (paediatric, lower limb) [EA]",404
7,Sex hormone-binding globulin levels,323746
7,Psoriasis,5487
7,1-myristoyl-2-palmitoyl-gpc (14:0/16:0) levels,9733
7,Brain region volumes [cerebellar vermal lobules VI VII],105
7,Brain morphology (MOSTest),43718
7,Triglyceride levels [Trans-ethnic initial],14170
7,Leg fat mass (right),76047
7,Hypothyroidism,11741
7,Renal function-related traits (eGRFcrea),441
7,Cortical volume [Pars triangularis],410
7,Waist circumference adjusted for body mass index [women],217
7,Physical activity (Total log acceleration 8pm-10pm),20
7,Serum levels of protein SET,5
7,"Low platelets/platelet disorder | non-cancer illness code, self-reported",2
7,Cognitive ability,10658
7,"Liver, biliary or pancreas problem",2987
7,Serum levels of protein CCL11,863
7,Biomedical quantitative traits [BD-RT],1038
7,Medication use (drugs used in diabetes),10529
7,"HDL cholesterol levels [Asian initial, BMI unadjusted]",156
7,Sleep apnoea,97
7,Major coronary heart disease event excluding revascularizations,46
7,Pulse pressure,165030
7,Waist circumference adjusted for body mass index,146927
7,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],7898
7,CD123 on plasmacytoid Dendritic Cell,500
7,Diffuse cutaneous systemic sclerosis [EA],1925
7,Endometriosis [EA],1551
7,"Iron deficiency anaemia | non-cancer illness code, self-reported",535
7,Protein quantitative trait loci (liver) [HIBADH],43
7,Tonsillitis,94
7,Chronic obstructive pulmonary disease or high blood pressure (pleiotropy),13341
7,Bipolar disorder (MTAG),51344
7,Serum levels of protein CEL,617
7,PR segment duration,806
7,Metabolite levels (small molecules and protein measures) [Creatinine],479
7,Rhinocort 50micrograms nasal spray | treatment/medication code,3062
7,Spherical power (left),3491
7,"Red blood cell traits [EA, MCV]",1045
7,Facial morphology (segment 1),400
7,Breast milk fatty acid composition (maternal genotype effect) [monounsaturated fatty acid],57
7,"Blood protein levels [PILRA, 10816_150_3]",41198
7,Blood metabolite ratios [Metabolite ratio 1],3728
7,"Dark brown | hair colour (natural, before greying)",6561
7,Medication use (diuretics),2850
7,Bitter taste response [PROP],359
7,Carotid intima media thickness (mean-maximum),411
7,Hypertension,91445
7,Whole body fat-free mass,93183
7,Electrocardiogram morphology (amplitude at temporal datapoints) [202 ms],1043
7,Subjective wellbeing conditioned on average household income before tax (multi-trait conditioning and joint analysis),114
7,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [X-24327, X-24353]",22659
7,Injuries to the elbow and forearm,1190
7,Serum metabolite levels [N-acetylhistidine],3406
7,Factor VII activity,312
7,Large artery stroke (TOAST classification),50
7,CD127 on granulocyte,13
7,IgG glycosylation [IGP60],827
7,Protein quantitative trait loci [paraoxonase 1],114
7,Asthma,45443
7,Cutaneous malignant melanoma,11546
7,Fat-free mass [male],15185
7,Chronic obstructive pulmonary disease in non-current smokers,10425
7,Serum levels of protein ADAM22,1738
7,Daytime dozing / sleeping (narcolepsy),403
7,Cannabis use,328
7,Hippocampal tail volume,151
7,Sphingomyelin(34:0)_[M-CH3]1- levels,9600
7,Hand grip strength (left),118815
7,IgG glycosylation [IGP5],1462
7,Pediatric areal bone mineral density (radius vs spine & hip discordant skeletal phenotype) [EA],3696
7,Rotator cuff injury,921
7,Nontraumatic osteonecrosis of the femoral head,162
7,Other/unspecified reactive arthropathies,11
7,Alcohol use disorder,64
7,CAG-83 sp000435555 abundance in stool,27
7,Calcium levels,181649
7,Differential aging (frontal cortex),4505
7,Non-tuberculous mycobacterial pulmonary disease,9260
7,Paired immunoglobulin-like type 2 receptor beta levels,44372
7,White matter microstructure (fractional anisotropy) [Superior corona radiata],9166
7,"Asthma | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",3326
7,B cell acute lymphoblastic leukaemia (Philadelphia chromosome negative),3647
7,Hand grip strength (Mahalanobis distance),186
7,Liver enzyme levels (alanine transaminase),54423
7,Autoimmune diseases,2752
7,1-palmitoyl-2-docosahexaenoyl-gpc (16:0/22:6) levels,1804
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-22 ms],2827
7,Early-onset Parkinson's disease,1452
7,"Blood protein levels [PILRA, 6402_8_3]",18337
7,None of the above | vascular/heart problems diagnosed by doctor,26967
7,Leg fat mass (left),73510
7,Triacylglycerol_48:4_[M+NH4]1+ levels,7791
7,Hypertrophic cardiomyopathy (MTAG),1922
7,3mm strong meridian (left),7275
7,Bone ultrasound measurement (broadband ultrasound attenuation),1190
7,Hepatitis B virus-related hepatocellular carcinoma,2970
7,Glycemic traits [2-hPG],1348
7,QT dynamics during exercise,713
7,Estimated glomerular filtration rate,267842
7,Diffuse plaques (SNP x SNP interaction),1707
7,Multiple sclerosis,16169
7,"""Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8""",2800
7,"Number of operations, self-reported",992
7,Age-related hearing impairment [additive],4304
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-486 ms],3668
7,Cataracts [male],7
7,"Ground coffee (include espresso, filter etc) | coffee type",69
7,Chronotype,34891
7,Externalizing behaviour (multivariate analysis),45377
7,Triglycerides x physical activity interaction (2df test),8687
7,Serum uric acid levels [EA],11557
7,Glioblastoma (age-stratified) [Below median age-at-diagnosis],148
7,Bone ultrasound measurement (velocity of sound),1190
7,Glioma [males],493
7,Tobacco use disorder,298
7,Suicide attempt,60
7,Flucloxacillin | treatment/medication code,45
7,Platelet crit,181147
7,Brain region volumes [right pallidum],12568
7,White blood cell count [African],13
7,Chron's disease NAS,22
7,Other systemic involvement of connective tissue (FG),6038
7,Youthful appearance (self-reported),9175
7,SSC-A on plasmacytoid Dendritic Cell,500
7,Respiratory or ear-nose-throat disease,2613
7,Triglyceride levels x short total sleep time interaction (1df test) [EA],2741
7,Leisure sedentary behaviour (computer use),3921
7,BMI at 1.5 years old,336
7,"Gastritis/gastric erosions | non-cancer illness code, self-reported",447
7,"""Inguinal of femoral hernia, unilateral""",96
7,Protein quantitative trait loci (liver) [RPS19],10
7,Protein quantitative trait loci (liver) [PREP],19
7,Cardiovascular disease,76663
7,Depressive symptoms (MTAG),14143
7,Coffee intake,46499
7,Gallstone disease,2800
7,Blood metabolite levels [X-03056--N-[3-(2-Oxopyrrolidin-1-yl)propyl]acetamide],3728
7,Macular telangiectasia type 2,5964
7,Ease of skin tanning,7006
7,Rotator cuff syndrome,378
7,"""Convulsions, not elsewhere classified""",95
7,Metabolite levels (lipoprotein measures) [VLDL diameter],11613
7,Brain region volumes [total brain volume],141
7,Protein quantitative trait loci (liver) [AGRN],10
7,Protein quantitative trait loci (liver) [ME1],1
7,QT interval,13211
7,Metabolite levels (small molecules and protein measures) [Glucose],1316
7,C-reactive protein levels [BMI-adjusted],9590
7,Frailty index,336
7,CX3CR1 on CD14- CD16-,417
7,Indoleacetate levels,1449
7,Cataracts (operation),24
7,Phosphatidylcholine-2O_32:0_[M+H]1+ levels,8648
7,Dupuytren's disease,3709
7,Cannabis use disorder,479
7,Psoriasis [fixed],632
7,Medium VLDL particle concentration,11613
7,Intracranial aneurysm,1469
7,Protein quantitative trait loci (liver) [ACSM2B],43
7,Protein quantitative trait loci (liver) [PLEC],52
7,Coronary artery disease [additive model],46
7,Number of self-reported non-cancer illnesses,9887
7,Contracture of palmar fascia [dupuytren's disease],3008
7,Creatine kinase levels,2893
7,Frozen shoulder,711
7,Lymphocyte count,15007
7,Alzheimer's disease or HDL levels (pleiotropy),662
7,Phosphatidylcholine-O_32:0_[M+H]1+/Phosphatidylethanolamine-O_35:0_[M+H]1+ levels,11613
7,Waist-to-hip ratio adjusted for BMI (age <50) [women],1551
7,Gallbladder cancer,2990
7,"Fibromyalgia | non-cancer illness code, self-reported",1946
7,Potassium in urine,83
7,Systolic blood pressure,269348
7,"Blood pressure medication | medication for cholesterol, blood pressure or diabetes",3386
7,Calcium+vitamin d 500units tablet | treatment/medication code,1380
7,Oramorph 10mg/5ml oral solution | treatment/medication code,638
7,Paracetamol | treatment/medication code,167
7,1-stearoyl-2-linoleoyl-gpc (18:0/18:2) levels,2076
7,Cognitive ability (MTAG),5603
7,Systemic sclerosis [IcSSc],2130
7,Vitamin b12 preparation | treatment/medication code,979
7,Type 2 diabetes [East Asian],1014
7,Protein quantitative trait loci (liver) [DIABLO],496
7,"Muscle or soft tissue injuries | non-cancer illness code, self-reported",383
7,Other malignant neoplasms of skin (=non-melanoma skin cancer),356
7,Average daytime sound level of noise pollution,76
7,Morning person,28173
7,College or university degree | qualifications,122389
7,Peak insulin response [BMI adjusted],9714
7,"Waist circumference adjusted for BMI in active individuals [EA, men]",217
7,Carotid artery stenosis,29
7,Fibrinogen levels,59781
7,Sphingomyelin(34:1)_[M-CH3]1- levels,9600
7,Total body bone mineral density (age over 60),1916
7,Sphingomyelin_34:0_[M+H]1+ levels,11613
7,Overall health rating,6543
7,Diastolic blood pressure x smoking status (ever vs never) interaction (2df test),1161
7,"Blood protein levels [SEMA3E, 5363_51_3]",419
7,Clozapine-induced cytotoxicity [30x],23
7,Lymphocyte counts,720817
7,Central corneal thickness,63569
7,Fractured/broken bones in last 5 years,1211
7,Insulin levels adjusted for BMI,3649
7,Neck pain or shoulder pain,98
7,Wheeze or whistling in the chest in last year,370
7,"Serum metabolite levels [5alpha-androstan-3beta,17beta-diol disulfate]",588
7,"""Hypothyroidism, strict autoimmune""",162
7,Triglyceride levels x short total sleep time interaction (2df test),6423
7,Diverticular disease of intestine,9124
7,Urinary potassium excretion [EA],649
7,Hemorrhoids,388
7,"""Ulcerative colitis, NAS""",22
7,Depression,31252
7,3mm strong meridian (right),8395
7,Protein C levels,11235
7,RR interval (heart rate),3668
7,Serum galactose-deficient IgA1 levels,2192
7,Educational attainment (college completion),2961
7,Waist circumference adjusted for BMI in active individuals,1911
7,Alzheimer's disease,479
7,1-palmitoyl-2-oleoyl-gpc (16:0/18:1) levels,1634
7,LDL cholesterol levels in current drinkers,6603
7,"Blood protein levels [ACHE, 10980_11_3]",14952
7,Plasma homocysteine levels,1444
7,Back pain,1913
7,Urinary albumin-to-creatinine ratio [EA],1286
7,Other joint disorders,1834
7,"Systolic blood pressure [EA, initial]",139
7,Morningness,35036
7,Alcohol intake frequency.,24944
7,Total triglycerides levels,11235
7,"Pediatric areal bone mineral density (radius vs spine & hip discordant skeletal phenotype) [EA, female]",4482
7,Hirschsprung disease [European],189
7,Stroke (ischemic) [LVD],39
7,"Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event) [Recessive, Mixture cure model]",28
7,Body fat distribution (leg fat ratio),13613
7,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)",30799
7,Basophill percentage,30433
7,Proline levels,14925
7,Electrocardiogram morphology (amplitude at temporal datapoints) [100 ms],1043
7,Serum levels of protein NOG,617
7,"Adenosine 3',5'-cyclic monophosphate (camp) levels",439
7,Intelligence (MTAG),11969
7,N-acetyl-3-methylhistidine levels,1183
7,Whole body water mass,91989
7,Anthropometric traits (multi-trait analysis),298
7,Inflammatory skin disease [Opposed],50
7,Adult body size,46695
7,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),24320
7,Salt added to food,3910
7,Waist circumference adjusted for BMI in non-smokers [women],1702
7,Serum levels of protein FLNA,178
7,Age of smoking initiation,4282
7,Protein quantitative trait loci (liver) [ATIC],7
7,Sleep duration,47240
7,Essential hypertension,15408
7,Blood glucose levels,54400
7,Serum levels of protein PCOLCE,5066
7,Duration of walks,15306
7,Phosphatidylcholine-O_31:0_[M+H]1+/Phosphatidylethanolamine-O_34:0_[M+H]1+ levels,6242
7,Average weekly beer plus cider intake,108
7,"""Diseases of arteries, arterioles and capillaries (FINNGEN)""",46
7,Gut microbiota (bacterial taxa) [Eubacterium_ventriosum],10
7,Mood instability,5953
7,Diseases of the musculoskeletal system and connective tissue,1218
7,Acute graft versus host disease in bone marrow transplantation (donor effect),3340
7,Diacylglycerol_36:2_[M+H-H2O]1+ levels,11543
7,IgD on IgD+ CD38+ B cell,2809
7,IgG glycosylation patterns [IgG1 Bn],789
7,Length of time at current address,488
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-108 ms],1073
7,N-acetylhistidine levels,1411
7,Spontaneous preterm birth (maternal effect),14
7,Vertigo of central origin,11
7,Protein quantitative trait loci (liver) [ARHGDIA],12
7,Protein quantitative trait loci (liver) [CYP3A4],2
7,Lifetime smoking index,19046
7,Educational attainment (years of education) [conditional-joint],39183
7,Red blood cell (erythrocyte) count,46297
7,B-cell acute lymphoblastic leukaemia,3792
7,Mouth ulcers | mouth/teeth dental problems,4004
7,"Femoral neck bone geometry and menarche (age at onset) [AAM-W, EA]",304
7,Electrocardiogram morphology (amplitude at temporal datapoints) [104 ms],1043
7,Bone ultrasound measurement (velocity of sound) [male],910
7,Nonsuppurative otitis media,386
7,"""Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)""",22
7,Diabetic nephropathy (more control exclusions),15
7,Diacylglycerol_36:3_[M+NH4]1+ levels,11613
7,Urolithiasis,13422
7,Alcohol-induced chronic pancreatitis,825
7,Cortical thickness (min-P),12283
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-452 ms],3668
7,Peripheral atherosclerosis,56
7,"""Ischaemic heart disease, wide definition""",233
7,Serum levels of protein HSPB1,1582
7,Risk taking,6946
7,Systemic lupus erythematosus and Systemic sclerosis,2685
7,"Allergic disease (asthma, hay fever or eczema)",4631
7,Age-related hearing impairment (SNP x SNP interaction),1081
7,IgG sialylation phenotypes (multivariate analysis),789
7,Serum metabolite concentrations in chronic kidney disease [N-acetylhistidine],426
7,Triacylglyceride levels [TAG(54:6;0],2
7,High light scatter reticulocyte count,430110
7,Sum neutrophil eosinophil counts,60450
7,Caffeine consumption,69
7,Colon polyp,118
7,Cystic kidney disease,87
7,Waist circumference variance,2199
7,6mm weak meridian (left),14848
7,Soft tissue disorders,1714
7,Diastolic blood pressure [Japanese],1368
7,Subjective wellbeing conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis),133
7,Intrahepatic Cholestasis of Pregnancy (ICP),2800
7,"""Pain (limb, back, neck, head abdominally)""",182
7,Essential hypertension (time to event),2328
7,Metabolite levels [C9H14Ona],198
7,Serum uric acid levels [Japanese],24537
7,Protein quantitative trait loci (liver) [WARS],315
7,Obesity,2086
7,Malignant neoplasm of skin,356
7,Atopic dermatitis (moderate to severe) [general],103
7,"Intra-ocular pressure, goldmann-correlated (left)",8497
7,Verbal-numerical reasoning,5898
7,"Other exercises (eg: swimming, cycling, keep fit, bowling) | types of physical activity in last 4 weeks",4086
7,Hernia of abodminal wall,787
7,Glioblastoma (age-stratified) [Median age-at-diagnosis],328
7,Average evening sound level of noise pollution,76
7,"Irregular heart beat | non-cancer illness code, self-reported",62
7,Protein quantitative trait loci (liver) [TYMP],2
7,Birth weight (MTAG),26269
7,Facial morphology (segment 18),1261
7,Electrocardiogram morphology (amplitude at temporal datapoints) [328 ms],1547
7,"Stomach disorder | non-cancer illness code, self-reported",526
7,Venous thromboembolism (SNP x SNP interaction),13
7,"Abdominal aortic calcification levels [EA, Hispanic]",50
7,Protein quantitative trait loci (liver) [ACLY],4
7,Nonatopic asthma or type 2 diabetes,451
7,Acute lymphoblastic leukemia in childhood (B cell precursor),7294
7,"None of the above | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",3278
7,"Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma) [Lung Cancer]",729
7,"Diastolic blood pressure x alcohol consumption interaction (2df test) [AA, Asian, EA]",425
7,Caudate nucleus volume,1577
7,Taking other prescription medications,1315
7,Ever believed in un-real communications or signs,144
7,Ankylosing spondylitis,22
7,Diabetic retinopathy (more control exclusions),8
7,Spherical power (right),8455
7,Apolipoprotein A1 levels,228984
7,Bone ultrasound measurement (broadband ultrasound attenuation) [male],1190
7,Electrocardiogram morphology (amplitude at temporal datapoints) [336 ms],1547
7,Neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy),12
7,Kidney stones,22618
7,Fasting glucose,46813
7,"Bone mineral density (paediatric, skull)",4392
7,circulating leptin levels,8066
7,Serum levels of protein POGLUT1,9358
7,Chronic obstructive pulmonary disease in never smokers,1049
7,Corneal hysteresis (right),460
7,IgG galactosylation phenotypes (multivariate analysis),789
7,Protein quantitative trait loci (liver) [SERPINA1],2
7,Protein C levels [EA],6330
7,Serum metabolite concentrations in chronic kidney disease [Putrescine],3728
7,"""Diabetes, insuline treatment (Kela reimbursement)""",7187
7,Electrocardiogram morphology (amplitude at temporal datapoints) [334 ms],1547
7,Brain region volumes [cerebellar vermal lobules VIII X],729
7,DHEAS levels,726
7,Pancreatitis,718
7,Degenerative rotator cuff disease surgery,43
7,Bioavailable testosterone levels,68277
7,Activated & secreting CD4 regulatory T cell %CD4+ T cell,943
7,"High cholesterol | non-cancer illness code, self-reported",1653
7,Metabolic traits [caffeine/quinate + 3 other traits],77
7,Non-oily fish intake,11404
7,Triglyceride levels [BMI unadjusted],11601
7,NADPH--cytochrome P450 reductase measurement,24583
7,3mm weak meridian (right),11478
7,Bone properties (heel) [BUA],380
7,Hip circumference adjusted for BMI,50593
7,Serum metabolite levels (CMS) [M_VLDL_L],8648
7,"Hip circumference [EA,women]",782
7,DNA methylation Hannum age acceleration,3234
7,Psoriatic arthropathies,124
7,Lobe attachment (rater-scored or self-reported),1514
7,Hip bone size,5139
7,Number of days/week of moderate physical activity 10+ minutes,3265
7,Age started wearing glasses or contact lenses,303
7,Bitter taste perception [PROP paper],338
7,Protein quantitative trait loci (liver) [MGMT],5
7,Mosaic loss of chromosome Y (Y chromosome dosage),53116
7,Immature reticulocyte fraction,51779
7,Coagulation factor IXab measurement,8721
7,Plasma homocysteine levels (post-methionine load test),5882
7,TPE interval (resting) [women],1314
7,Fracture of radius and ulna,1164
7,Total protein levels x insomnia interaction,415
7,Glimepiride | treatment/medication code,373
7,Blood pressure [Pulse Pressure],139
7,Autoimmune traits (pleiotropy),3445
7,"Waist circumference adjusted for BMI in active individuals [EA,women]",1702
7,Inflammatory bowel disease and other gastroenteritis and colitis,3719
7,2'-o-methylcytidine levels,1554
7,Electrocardiogram morphology (amplitude at temporal datapoints) [320 ms],1547
7,Neurofibrillary tangles,372
7,"Blood protein levels [EA, Semaphorin-3E]",13
7,Ulcerative colitis [EA],23636
7,Birth weight,114950
7,Primary biliary cirrhosis,8038
7,Age of smoking initiation (MTAG),32646
7,Leukocyte telomere length,9337
7,Blood urea nitrogen levels,23455
7,Phosphatidylcholine_32:0_[M+H]1+/Phosphatidylethanolamine_35:0_[M+H]1+/Phosphatidate_37:1_[M+NH4]1+ levels,8648
7,Total body bone mineral density (age 0-15),6066
7,Blood metabolite levels [X-12063],22659
7,Electrocardiogram morphology (amplitude at temporal datapoints) [16 ms],8805
7,"Cholelithiasis/gall stones | non-cancer illness code, self-reported",2972
7,Celiac disease or Rheumatoid arthritis,913
7,Escherichia abundance in stool,274
7,Electrocardiogram morphology (amplitude at temporal datapoints) [200 ms],1043
7,Body fat distribution (arm fat ratio) [males],1247
7,Prostate-specific antigen levels,240
7,Mean platelet (thrombocyte) volume,160189
7,Chronic lymphocytic leukemia,9369
7,Fish oil (including cod liver oil) | mineral and other dietary supplements,112
7,Protein quantitative trait loci (liver) [SH3BGRL],15
7,Protein quantitative trait loci (liver) [RMDN3],12
7,Eosinophil percentage of granulocytes,37369
7,Moderate to vigorous physical activity levels,11821
7,Left-handedness,3985
7,IgG glycosylation patterns [IgG1_G1Nn],789
7,Facial morphology (segment 45),286
7,Protein quantitative trait loci (liver) [GGH],349
7,Filtered coffee intake,69
7,Medication use (antiglaucoma preparations and miotics),17
7,Diastolic blood pressure (cigarette smoking interaction),46
7,White matter microstructure (axial diusivities) [Inferior fronto-occipital fasciculus],25
7,Bipolar I disorder,24667
7,High cholesterol,14122
7,Sedentary behaviour duration,855
7,"Bone mineral density (paediatric, lower limb)",404
7,Ever had prolonged loss of interest in normal activities,8
7,Dehydroepiandrosterone sulphate levels,28710
7,HDL cholesterol levels [EA],2588
7,Pattern 4 | hair/balding pattern,8592
7,Anxiety,1423
7,Electrocardiogram morphology (amplitude at temporal datapoints) [150 ms],1043
7,Estradiol levels,2178
7,TPE interval (resting) [men],1389
7,Systolic blood pressure (cigarette smoking interaction),185
7,Stable angina pectoris,96
7,"Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio)",69
7,Number of triplets attempted (right),37
7,Alzheimer's disease (cognitive decline),24
7,Protein quantitative trait loci (liver) [PRSS1],22
7,Diabetes mellitus,12264
7,Cortical thickness,113993
7,Waist-to-hip ratio adjusted for body mass index,5083
7,IgG glycosylation patterns [IgG1 BG1n/G1n],789
7,Doctor diagnosed hayfever or allergic rhinitis,1882
7,Peak expiratory flow (pef),554
7,QRS duration [EA],715
7,"Malignant melanoma | cancer code, self-reported",257
7,Esophageal adenocarcinoma,470
7,Gut microbiota abundance (genus Eubacterium coprostanoligenes group id.11375),34
7,Cognitive performance,17229
7,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),9686
7,Arm fat mass (right),76483
7,Electrocardiogram morphology (amplitude at temporal datapoints) [308 ms],1547
7,Electrocardiogram morphology (amplitude at temporal datapoints) [324 ms],1547
7,Aspartate aminotransferase platelet ratio index in high alcohol intake,617
7,Angina,76
7,Protein quantitative trait loci (liver) [KRT18],52
7,Threonate levels,96
7,Total body bone mineral density,4243
7,HDL cholesterol x physical activity interaction (2df test),3402
7,Type 2 diabetes or prostate cancer (pleiotropy),2260
7,Allergic rhinitis,993
7,Nervous feelings,881
7,N-formylanthranilic acid levels,106
7,Ever suffered mental distress preventing usual activities,4542
7,Serum metabolite levels (CMS) [S_VLDL_TG],8648
7,"Estimated glomerular filtration rate (creatinine, CKDi25)",816
7,"Blood protein levels [EA, Insulin-like growth factor I]",248
7,"LDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test) [African, trans-ethnic]",92
7,Intercellular adhesion molecule 1 (red blood cell fatty acid level interaction) [DPA_N6],16
7,Arthropathic psoriasis,52
7,Protein quantitative trait loci (liver) [CORO1B],52
7,Tissue-type plasminogen activator measurement,442
7,Serum levels of protein IL5RA,2584
7,IgG glycosylation [IGP69],156
7,Dizziness and giddiness (light-headedness and vertigo),57
7,Subjective wellbeing conditioned on cognitive performance (multi-trait conditioning and joint analysis),117
7,Autism spectrum disorder or schizophrenia,23306
7,Insulin-like growth factor 1 levels,218712
7,CD80 on plasmacytoid Dendritic Cell,500
7,Spherical equivalent or myopia (age of diagnosis),4308
7,"Whooping cough / pertussis | non-cancer illness code, self-reported",1204
7,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Hispanic],8553
7,Coagulation Factor X measurement,5132
7,Electrocardiogram morphology (amplitude at temporal datapoints) [204 ms],1043
7,Diaphragmatic hernia,787
7,Hematological and biochemical traits [fasting blood glucose],1348
7,Biological medication for rheuma,22
7,Parkinson's disease or first degree relation to individual with Parkinson's disease,90304
7,Type 2 diabetes [conditional],8422
7,Sphingomyelin_38:1_[M+H]1+ levels,11613
7,Waist-hip ratio,172917
7,Diacylglycerol_44:7_[M+H-H2O]1+ levels,11613
7,Trunk fat-free mass,92576
7,"Bone mineral density (paediatric, skull) [EA]",4392
7,Serum levels of protein CNTNAP2,711
7,Stroke [EA],160
7,Takayasu arteritis,177
7,Occlusion and stenosis of precerebral arteries,48
7,"Blood protein levels [CNTNAP2, 6965_19_3]",1
7,Mean arterial pressure [East Asian],10602
7,"Blood protein levels [GPNMB, 8289_8_3]",42072
7,Impedance of arm (right),70630
7,"Waist-to-hip ratio adjusted for body mass index [EA, women]",5072
7,Nonatopic asthma and/or BMI,1821
7,"Blood protein levels [CHST12, 6626_81_3]",1331
7,Protein quantitative trait loci (liver) [LRG1],737
7,Hard cardiovascular diseases,48
7,Retinal nerve fibre layer (RNFL) thickness,28
7,Late-onset Alzheimer's disease,9364
7,Blood metabolite levels [androsterone sulfate],5068
7,Cerebrospinal fluid biomarker levels [Semaphorin-3E],1552
7,Insulin-related traits (multivariate analysis),3851
7,Varicose veins of lower extremity,4350
7,Nephrolithiasis,629
7,Estimated glomerular filtration rate [EA],599
7,Simvador 10mg tablet | treatment/medication code,413
7,Pulse wave reflection index,75
7,CD14- CD16- Absolute Count,13
7,Serum levels of protein C1GALT1C1,1491
7,Plavix 75mg tablet | treatment/medication code,3125
7,Pediatric areal bone mineral density (radius),10375
7,"For short-sightedness, i.e. only or mainly for distance viewing such as driving, cinema etc (called 'myopia') | reason for glasses/contact lenses",172
7,Alcohol consumption,20984
7,Glycated hemoglobin levels,57870
7,Hemoglobin,73231
7,Electrocardiogram morphology (amplitude at temporal datapoints) [134 ms],1043
7,"Serum metabolite levels [5alpha-androstan-3beta,17alpha-diol disulfate]",138
7,Physically abused by family as a child,318
7,Suffer from 'nerves',127
7,Highest math class taken (MTAG) [MTAG],88188
7,Diacylglycerol_36:3_[M+H-H2O]1+ levels,11613
7,Vertex-wise sulcal depth,142044
7,Electrocardiogram morphology (amplitude at temporal datapoints) [144 ms],43480
7,"""Hypothyroidism,  other/unspecified""",29176
7,Diverticulosis and diverticulitis,9740
7,Disturbance of activity and attention,7628
7,Cheese intake,3115
7,Electrocardiogram morphology (amplitude at temporal datapoints) [10 ms],4
7,Protein quantitative trait loci (liver) [PRELP],3
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-98 ms],1073
7,Immune reponse to smallpox (secreted IL-1beta) [AA],137
7,Myeloproliferative neoplasms,2409
7,Protein quantitative trait loci (liver) [SPTAN1],892
7,Place of birth in uk - north co-ordinate,428
7,Subjective well-being (MTAG),143
7,Later onset COPD,9
7,Calculus of kidney,11321
7,Blood metabolite levels [X-18601],11822
7,Cigarettes smoked per day (MTAG),12011
7,Cyclizine | treatment/medication code,194
7,LDL levels x fish oil supplementation interaction (2df),355
7,"""Psoriatic arthropathies, ICD10""",22
7,Asthma (mode),27
7,Body fat percentage,83218
7,Smoking initiation (ever regular vs never regular) [Conditioned on chr7:69484366],1169
7,Protein quantitative trait loci (liver) [EIF2B1],129
7,1-palmitoyl-2-arachidonoyl-gpc (16:0/20:4n6) levels,1720
7,CCR2 on CD62L+ plasmacytoid Dendritic Cell,120
7,Digit length ratio,12
7,HDL cholesterol levels,240333
7,Facial morphology (segment 9),7838
7,Direct bilirubin levels,9424
7,Waist-hip ratio and HDL-C (pairwise),6893
7,Neonatal cytokine/chemokine levels (fetal genetic effect) [CCL24],1362
7,Pork consumption,658
7,Protein quantitative trait loci (liver) [TGM2],9
7,Protein quantitative trait loci (liver) [PYCARD],31
7,CD86 on granulocyte,13
7,"Blood protein levels [SFRP4, 9284_25_3]",92
7,Fish- and plant-related diet,3
7,Age completed full time education,6687
7,Blood metabolite levels [epiandrosterone sulfate],10677
7,Executive inhibition (Stroop WIT and CIT) in attention deficit hyperactivity disorder [Stroop WIT],6491
7,Electrocardiogram morphology (amplitude at temporal datapoints) [314 ms],1547
7,CD127 on CD8+ T cell,177
7,Ismn - isosorbide mononitrate | treatment/medication code,451
7,HDL cholesterol levels in never smokers [African],400
7,LDL cholesterol levels [Trans-ethnic initial],831
7,Migraine and/or systolic blood pressure,438
7,Urinary metabolite levels in chronic kidney disease [andro steroid monosulfate C19H28O6S (1],693
7,Educational attainment (years of education),282544
7,Mean platelet volume,798032
7,Brain region volumes [left pallidum],12260
7,Electrocardiogram morphology (amplitude at temporal datapoints) [98 ms],1043
7,Facial morphology (segment 54),1179
7,Electrocardiogram morphology (amplitude at temporal datapoints) [318 ms],1547
7,High blood pressure | illnesses of mother,796
7,Refractory celiac disease type II,791
7,Electrocardiogram morphology (amplitude at temporal datapoints) [312 ms],1547
7,Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN) [NW-EA],172
7,Schizophrenia (MTAG),92863
7,Osteoporosis,3539
7,Forearm bone mineral density,769
7,Heart rate response to recovery post exercise (20 sec),5188
7,Triglyceride levels x long total sleep time interaction (2df test),5995
7,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),3931
7,Endothelial growth factor levels [HGF],119
7,Other psoriatic arthropathies,22
7,"Blood pressure measurement (cold pressor test) [MAP, Time 0]",3406
7,"Waist circumference adjusted for body mass index [EA, men]",19900
7,6mm strong meridian (left),6809
7,Whole body fat mass,79348
7,Hormone measurements [Cortisol:DHEAS ratio],693
7,Avoided activities or situations because of previous stressful experience in past month,881
7,Chronic kidney disease [CKD],597
7,Glucuronate levels,5
7,Autoimmune thyroid disease,7205
7,"2,3-dihydroxy-2-methylbutyrate levels",8498
7,Serum metabolite levels (CMS) [Glc],1386
7,Sensorineural hearing loss,2
7,Coffee consumption,99975
7,Frontotemporal dementia with GRN mutation,4505
7,Family history of Alzheimer's disease,15288
7,Caffeine consumption from coffee or tea,44621
7,Invasive breast cancer [mixed effect],4220
7,Electrocardiogram morphology (amplitude at temporal datapoints) [394 ms],1832
7,None of the above | qualifications,1991
7,Hematological parameters [RBC],5066
7,Serum levels of protein EPHB6,1236
7,LDL levels x fish oil supplementation interaction (1df),355
7,"Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, Asian, EA]",824
7,Medication use (salicylic acid and derivatives),71
7,Fybogel mebeverine sachet | treatment/medication code,9
7,Vitiligo,7
7,Serum uric acid levels,76844
7,"Blood protein levels [GPNMB, 8240_207_3]",42437
7,Endometriosis,4059
7,"Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA, women]",1702
7,Triglyceride levels in current drinkers [EA],10005
7,Gut bacterial pathway abundance (P105.PWY..TCA.cycle.IV..2.oxoglutarate.decarboxylase.),898
7,Morning vs. evening chronotype,8210
7,Melanoma,445
7,Homeostasis model assessment of beta-cell function,1487
7,HDL cholesterol levels x long total sleep time interaction (2df test) [EA],29
7,Granulocyte percentage of myeloid white cells,85445
7,Chronic obstructive pulmonary disease x ever smoker interaction (2df),10425
7,Eosinophill count,75749
7,"Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA, women]",1702
7,IgG glycosylation patterns [IgG1 Bn/Fn total],789
7,Serum levels of protein IL7,617
7,"Other (e.g. cornflakes, frosties) | cereal type",4480
7,Number of incorrect matches in round,6433
7,Leg fat percentage (right),52078
7,IgG N-glycosylation phenotypes (multivariate analysis),2251
7,Corneal resistance factor (right),1831
7,Colorectal cancer,7040
7,Ingesting alcohol or a recreational or illicit drug | methods of self-harm used,174
7,Hearing difficulty/problems with background noise,403
7,Malignant neoplasm of prostate,410
7,"None of the above | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",3404
7,Electrocardiogram morphology (amplitude at temporal datapoints) [142 ms],1043
7,Worry too long after an embarrassing experience,1443
7,Serum metabolite levels [16a-hydroxy DHEA 3-sulfate],588
7,Apple intake,479
7,High density lipoprotein cholesterol levels,131268
7,Bitter non-alcoholic beverage consumption,37823
7,Morning/evening person (chronotype),15218
7,Meat-related diet [female],7012
7,Myeloproliferative diseases (CML excluded),2388
7,Electrocardiogram morphology (amplitude at temporal datapoints) [296 ms],1547
7,Medication use (antimigraine preparations),438
7,Phenylacetylglutamine levels,2
7,Electrocardiogram morphology (amplitude at temporal datapoints) [164 ms],1043
7,Leukocyte telomere length [East Asian],8027
7,Citramalate levels,3959
7,Electrocardiogram morphology (amplitude at temporal datapoints) [290 ms],1547
7,Life satisfaction,4422
7,Fasting plasma glucose [Non diabetics],1386
7,Arm fat-free mass (left),63597
7,"Hypertension | non-cancer illness code, self-reported",35267
7,Other abdominal problem,961
7,Beta-alanine levels,239
7,Large artery stroke (CCS and TOAST classification),48
7,C-reactive protein levels or HDL-cholesterol levels (pleiotropy),8111
7,Alcohol consumption (drinks per week),53749
7,Metabolite levels (lipoprotein measures) [Phospholipids in large LDL],613
7,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Hispanic],7898
7,Tacrolimus trough concentration in kidney transplant patients,453
7,SAPHO syndrome,323
7,Gout,16946
7,Plasmacytoid Dendritic Cell Absolute Count,417
7,Unspecified acute lower respiratory infection,42
7,Cognitive aspects of educational attainment,24422
7,Estrone-3-glucuronide levels,726
7,Keratinocyte cancer (MTAG),10733
7,Persistent chemotherapy-induced alopecia in breast cancer,467
7,Sjögren's syndrome,5823
7,Two-hour glucose,1923
7,Amyloid beta positivity,3018
7,"Bone mineral density (paediatric, total body less head) [EA]",769
7,Urate levels,281408
7,Word interpolation | fi3 ,605
7,Mean corpuscular hemoglobin concentration,153631
7,Retinoic acid receptor responder protein 2 levels,42660
7,Femur bone mineral density x serum urate levels interaction,1922
7,Fractures,4256
7,Electrocardiogram morphology (amplitude at temporal datapoints) [298 ms],1547
7,Electrocardiogram morphology (amplitude at temporal datapoints) [326 ms],1547
7,Diastolic blood pressure [East Asian],1278
7,Systolic blood pressure and diastolic blood pressure (bivariate analysis),184
7,Astigmatism angle (left),42242
7,None of the above | types of physical activity in last 4 weeks,5922
7,Electrocardiogram morphology (amplitude at temporal datapoints) [294 ms],1547
7,Pattern 2 | hair/balding pattern,1658
7,Waist-to-hip ratio adjusted for BMI in active individuals,1607
7,Fibrosis-4 index in high alcohol intake,617
7,Colorectal cancer x fine particulate matter exposure levels interaction,291
7,Other arthritis (FG),144
7,Protein quantitative trait loci (liver) [KRT8],52
7,Sarcoidosis,19583
7,Fasting insulin,19024
7,Glucose levels,29957
7,Potassium levels,1546
7,Electrocardiogram morphology (amplitude at temporal datapoints) [132 ms],1043
7,BMI in non-smokers,820
7,"Diastolic blood pressure [EA, initial]",1207
7,"LDL cholesterol levels [African, trans-ethnic]",92
7,X-12007 levels,473
7,Periventricular white matter hyperintensities,160
7,Subjective wellbeing conditioned on self-rated math ability (multi-trait conditioning and joint analysis),114
7,Tannerellaceae abundance in stool,28
7,"Triglyceride levels [Asian initial, BMI unadjusted]",10804
7,Vegetable consumption,156
7,Plasma free amino acid levels [His],22
7,Inflammatory bowel disease [EA],62341
7,Pediatric areal bone mineral density (radius vs spine & hip discordant skeletal phenotype),4482
7,Blood sugar levels,1432
7,Cortical surface area [Cuneus],291
7,Caffeine consumption from tea,36337
7,Bitter taste perception (multivariate analysis) [denatonium benzoate and quinine],43591
7,Schizophrenia [EA],8123
7,Smoking status (current vs never),442
7,Sum eosinophil basophil counts,41001
7,Serum urea levels,69328
7,Type 2 diabetes with other specified/multiple/unspecified complications,12466
7,Waist circumference adjusted for BMI (adjusted for smoking behaviour),4310
7,Glycated haemoglobin HbA1c levels adjusted for BMI,3896
7,Type 2 diabetes without complications,9268
7,Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis),3054
7,"Red blood cell traits [EA, Hgb]",559
7,Total body bone mineral density (age 30-45),8584
7,Electrocardiogram morphology (amplitude at temporal datapoints) [400 ms],1832
7,Hepatocyte growth factor levels,787
7,Protein quantitative trait loci (liver) [ACOT13],389
7,Protein quantitative trait loci (liver) [MLYCD],25
7,Interleukin-6 levels in non-alcoholic fatty liver disease x mastiha supplementation interaction,73
7,N-acetylglucosamine/n-acetylgalactosamine levels,3082
7,Fracture of forearm,1190
7,Systolic blood pressure x smoking status (ever vs never) interaction (2df test) [EA],1161
7,Electrocardiogram morphology (amplitude at temporal datapoints) [300 ms],1547
7,Body fat percentage and triglycerides (pairwise),1919
7,Neuropathic pain in head and neck cancer,97
7,Hyperglycemia in higher physical activity,58
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-448 ms],3668
7,Brain region volumes [right putamen],2181
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-106 ms],1073
7,"""Bronchitis, not specified as acute or chronic""",61
7,Sociability score,182
7,Height [AA],33
7,Lymphocyte percentage of white cells,206871
7,Total testosterone levels,108361
7,"Light brown | hair colour (natural, before greying)",2513
7,Time spent using computer,3789
7,IgG glycosylation patterns [IgG1 FBn/Bn total],789
7,IgG glycosylation patterns [IgG1 Fn/Bn],789
7,Johnsonella ignava abundance in stool,79
7,Hypertension [East Asian],1297
7,Cortical surface area [Pericalcarine],246
7,"""Endocrine, nutritional and metabolic diseases""",166
7,Coffee consumption [conditioned on rs4410790],23
7,"Blood protein levels [TPST1, 7928_183_3]",39067
7,Current | smoking status,60
7,Chronic obstructive pulmonary disease x current smoker interaction (2df),10425
7,Effects of heat and light,350
7,"Blood protein levels [EA, Insulin-like growth factor-binding protein 3]",248
7,Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy) [Hispanic],70
7,White matter microstructure (fractional anisotropy) [Splenium of corpus callosum],137
7,"""Asthma, hospital admissions , main diagnosis only""",15
7,Urinary calculus,10993
7,Schizophrenia,159039
7,Hip circumference adjusted for BMI [EA],15085
7,"""Diabetes, varying definitions""",10138
7,Oxalate (ethanedioate) levels,1105
7,Carotid intima media thickness,139
7,"Mania/bipolar disorder/manic depression | non-cancer illness code, self-reported",260
7,Waist circumference adjusted for BMI in active individuals [EA],1919
7,SSC-A on granulocyte,1946
7,Sensitivity / hurt feelings,1454
7,Age when periods started (menarche),990
7,Psoriatic and enteropathic arthropathies,54
7,Time spend outdoors in summer,6361
7,A levels/as levels or equivalent | qualifications,13994
7,Bone mineral density (spine),976
7,Ascending aorta maximum area,3764
7,Brain region volumes [left cerebellum white matter],1600
7,Tacrolimus trough concentration in kidney transplant patients [EA],12986
7,Electrocardiogram morphology (amplitude at temporal datapoints) [106 ms],1043
7,Butyrate (4:0) levels,1371
7,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],9588
7,Fresh fruit intake,10626
7,Protein quantitative trait loci (liver) [SEPT11],284
7,"Blood protein levels [SEMA3E, 10670_26_3]",423
7,FSC-A on granulocyte,13
7,Non-oily fish consumption,11176
7,Renal function-related traits (BUN),747
7,LDL cholesterol levels x long total sleep time interaction (2df test) [EA],51
7,Protein quantitative trait loci (liver) [ITIH4],54
7,Rheumatoid arthritis (ACPA-positive),4968
7,Calcaneus stiffness index,1017
7,Bone properties (heel) [BMD-DXA],1190
7,"Age hay fever, rhinitis or eczema diagnosed",712
7,Hepatocyte growth factor levels [EA],13
7,Epilepsy,123
7,Waist circumference adjusted for BMI in non-smokers,3931
7,Lifetime number of sexual partners,16546
7,Neuroticism score,8885
7,Bipolar disorder or major depressive disorder,6045
7,Uterine fibroids,721
7,3mm cylindrical power angle (left),138
7,Enterococcus A abundance in stool,4
7,Stool frequency,4280
7,Belittlement by partner or ex-partner as an adult,710
7,Prostate cancer [EA],241
7,Latanoprost | treatment/medication code,13
7,Adiponectin levels,24923
7,Pulse pressure [East Asian],3537
7,Atrial fibrillation [EA],5312
7,Serum levels of protein PRSS2,112
7,"Stomach cancer | cancer code, self-reported",50
7,Gut microbiota (bacterial taxa) [Unclassified Acidaminococcaceae],35
7,Triglyceride levels,309320
7,Age at suicide,219
7,Secondary polycythaemia,5
7,Systemic lupus erythematosus [EA],2268
7,Ankle spacing width (left),27271
7,Cognitive traits (MTAG),3443
7,Large artery stroke,121
7,Serum levels of protein SERPINE1,172
7,"Bone mineral density (paediatric, total body less head)",10220
7,C-type lectin domain family 5 member A levels,15462
7,Electrocardiogram morphology (amplitude at temporal datapoints) [156 ms],1043
7,Cannabis use disorder [EA],479
7,Atopic dermatitis (moderate to severe) [additive],474
7,Neutralising antibody response to interferon beta therapy in multiple sclerosis in patients positive for neutralising antibodies (antibody titre; IFNβ-1a intramuscular),288
7,"Unclassifiable | non-cancer illness code, self-reported",9
7,Asthma (only as main-diagnosis),15
7,Coronary artery disease,105635
7,Adolescent idiopathic scoliosis,64955
7,Balding type 1,11608
7,White matter microstructure (mode of anisotropy) [Superior corona radiata],9952
7,Electrocardiogram morphology (amplitude at temporal datapoints) [152 ms],1043
7,Electrocardiogram morphology (amplitude at temporal datapoints) [182 ms],1043
7,Pulse rate,5722
7,Smoking behaviour (cigarettes smoked per day),2388
7,Bone mineral density (hip),100
7,"Hayfever, allergic rhinitis or eczema | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",3863
7,Cancer (pleiotropy),6725
7,Glioblastoma (age-stratified) [Above median age-at-diagnosis],673
7,"Systolic blood pressure x alcohol consumption interaction (2df test) [AA, Asian, EA]",425
7,Alcohol usually taken with meals,1444
7,O levels/gcses or equivalent | qualifications,209
7,Fruit consumption,18271
7,Mean reticulocyte volume,178992
7,DNA methylation PhenoAge acceleration,9739
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-442 ms],3668
7,Anxiety [AA],481
7,"Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [Asian, EA]",890
7,Glomerular filtration rate in type 2 diabetes,479
7,"""Ulcerative colitis (strict definition, all Crohn cases excluded)""",22
7,Mean corpuscular volume,645383
7,Protein quantitative trait loci (liver) [CORO1A],1871
7,QRS duration [European],703
7,Cataract,40
7,Noninfective enteritis and colitis,22
7,Systemic sclerosis,8448
7,Serum alkaline phosphatase levels,344305
7,Wrist | fractured bone site(s),910
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-470 ms],3668
7,Immune reponse to smallpox (secreted IL-12p40) [EA],340
7,Antihypertensive medication - note that there are other indications,1735
7,"Gout | non-cancer illness code, self-reported",8648
7,HDL cholesterol levels in current drinkers [EA],11997
7,Glomerular filtration rate,3801
7,Spinal canal stenosis,850
7,Fructosamine levels,429
7,Protein quantitative trait loci (liver) [SAR1A],17
7,Facial morphology (segment 28),10485
7,Estimated glomerular filtration rate in diabetes,555
7,Smoking initiation (ever regular vs never regular) [Conditioned on chr7:1870794],769
7,White matter microstructure (fractional anisotropy) [Uncinate fasciculus],7
7,Protein quantitative trait loci (liver) [AGT],49
7,Ulcerative colitis,73914
7,Subcortical volume (min-P),12625
7,Glycine levels [conditional],5804
7,Cholelithiasis or gall stones,2976
7,DHEAS levels [men],726
7,Statin medication,875
7,Plantar fascial fibromatosis,777
7,Coronary artery disease or large artery stroke,92
7,Waist-to-hip ratio adjusted for BMI (additive genetic model),76072
7,Platelet-derived growth factor subunit B levels,5643
7,Sphingomyelin_42:1_[M+H]1+ levels,7726
7,Heart rate increase in response to exercise,3602
7,Hip circumference variance,2071
7,None of the above | pain type(s) experienced in last month,414
7,Feeling nervous,875
7,Age-related hearing impairment (high frequency) [EA],55
7,Aromatic-L-amino-acid decarboxylase levels,10309
7,Cortical surface area,137252
7,Abdominal hernia,2236
7,"Blood protein levels [DBNL, 9755_19_3]",1512
7,"Neurological, eye or psychiatric disease",4389
7,Circulating leptin levels or type 2 diabetes,1418
7,Protein quantitative trait loci (liver) [APRT],103
7,Endometrial cancer (endometrioid histology),9
7,HDL cholesterol levels [Trans-ethnic initial],22600
7,Butter/spreadable butter | spread type,1536
7,Moyamoya disease,793
7,Restless legs syndrome,1207
7,Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder,198
7,C-reactive protein and white blood cell count [CRP],192
7,Longest period of depression,6
7,Insomnia,45333
7,Fasting blood glucose,12525
7,Sleep duration (short sleep),4569
7,Neuropsychiatric disorders,492
7,Glycemic traits [FPG],1348
7,Depakote 250mg e/c tablet | treatment/medication code,67
7,Urinary albumin excretion (no hypertensive medication),69
7,Alzheimer's disease (APOE e4 interaction),8423
7,Autoimmune traits,11126
7,Male puberty timing (early vs. average onset facial hair),3183
7,"None of the above | medication for pain relief, constipation, heartburn",2832
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-104 ms],1073
7,Nevus count or cutaneous melanoma,1924
7,Protein quantitative trait loci (liver) [HMOX1],10
7,"""UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)""",22
7,Myeloid white cell count,16716
7,Macular thickness,29253
7,Chlamydia trachomatis pGP3 antibody levels,4847
7,Facial morphology (jaw protrusion 2),11691
7,"Serum metabolite levels [5alpha-androstan-3alpha,17beta-diol monosulfate (1]",588
7,Protein quantitative trait loci (liver) [SBDS],2000
7,Osteoarthritis,1321
7,Platelet count,1705635
7,Fibrinogen [EA],6934
7,High blood pressure | vascular/heart problems diagnosed by doctor,34557
7,"Blood protein levels [EA, Trypsin-2]",215
7,Neurociticism,10893
7,Cerebrospinal fluid biomarker levels [Transmembrane glycoprotein NMB],4434
7,Impedance of whole body,137758
7,Electrocardiogram morphology (amplitude at temporal datapoints) [92 ms],1043
7,Hypertensive diseases,5801
7,"""Crohn disease (strict definition, require KELA, min 2 HDR)""",22
7,Leisure-time exercise behaviour,3
7,Pediatric bone mineral content (radius),13178
7,Liver enzyme levels (alkaline phosphatase),97050
7,Electrocardiogram morphology (amplitude at temporal datapoints) [352 ms],1547
7,Trunk fat mass,87342
7,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Asian],8553
7,Electrocardiogram morphology (amplitude at temporal datapoints) [288 ms],1547
7,Electrocardiogram morphology (amplitude at temporal datapoints) [190 ms],1043
7,Pancreatic cancer,264
7,Cancer,155
7,Creatinine (enzymatic) in urine,53051
7,Lung cancer prognosis in former smokers,5152
7,Sex hormone levels [DHEAS],1674
7,Urinary metabolite levels in chronic kidney disease [16a-hydroxy DHEA 3-sulfate],693
7,Sex hormone-binding globulin levels adjusted for BMI,239240
7,Basal cell carcinoma,8950
7,Blood protein levels [NRCAM],725
7,Protein quantitative trait loci (liver) [HSPH1],9
7,Electrocardiogram morphology (amplitude at temporal datapoints) [160 ms],1043
7,Argininate levels,1438
7,Blood metabolite levels [caffeine],69
7,Gut microbiota (beta diversity),126
7,Distance between home and job workplace,72
7,Psychological over-eating or binge-eating | mental health problems ever diagnosed by a professional,84
7,Electrocardiogram morphology (amplitude at temporal datapoints) [12 ms],4
7,Protein quantitative trait loci (liver) [DPP7],110
7,Prostate cancer,99004
7,Gamma glutamyl transferase levels,113672
7,Smoking status (ever vs never smokers),45938
7,Triglyceride levels [EA],12626
7,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],10123
7,Erythritol levels,3225
7,Waist-to-hip ratio adjusted for BMI [women],782
7,Testicular germ cell tumor,32316
7,White matter microstructure (mode of anisotropy) [Posterior corona radiata ],9166
7,"Blood metabolite levels [1,5-anhydroglucitol (1,5-AG]",473
7,Medication use (antithrombotic agents),71
7,Sexual orientation,88
7,"Smoking initiation (ever regular vs never regular) [Conditioned on chr7:133840652, chr7:133589846]",325
7,Neutrophil count,882547
7,No | hearing difficulty/problems,4437
7,IgG glycosylation [IGP67],789
7,Other erythrocyte phenotypes [RBC],15484
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-474 ms],3668
7,Brain region volumes [left thalamus proper],317
7,Acute upper respiratory infections,251
7,Platelet-derived growth factor subunit A levels,6469
7,Glioblastoma [males],493
7,Ever sought or received professional help for mental distress,3342
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-460 ms],3668
7,Immunoglobulin light chain (AL) amyloidosis,279
7,Glomerular filtration rate [Japanese],149
7,Alcoholic chronic pancreatitis,724
7,Immunodeficiency with predominantly antibody defects,29
7,Urate levels [women],10403
7,Brain region volumes [left entorhinal],6037
7,"Systolic blood pressure, automated reading",20302
7,"Heel bone mineral density (bmd) t-score, automated (left)",6345
7,Urinary metabolite levels in chronic kidney disease [glyco-beta-muricholate],726
7,Coffee consumed,69
7,Intraocular pressure,50909
7,Haematocrit percentage,48468
7,Primary tooth development (number of teeth),4918
7,Serum levels of protein CROT,1134
7,"""Fracture of lower leg, including ankle""",1667
7,Forns index in high alcohol intake,617
7,Serum levels of protein THPO,1524
7,Vitamin d product | treatment/medication code,622
7,Protein quantitative trait loci (liver) [LIPA],5
7,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],24798
7,"Pulse rate, automated reading",44924
7,Number of days/week of vigorous physical activity 10+ minutes,7482
7,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [glyco-beta-muricholatemtauro-beta-muricholate, X-23157]",726
7,"Hip circumference adjusted for BMI [EA, women]",17004
7,Arm fat-free mass (right),73354
7,"No, never | tinnitus",1676
7,Other bones | fractured bone site(s),808
7,Malignant neoplasm of prostate (controls excluding all cancers),352
7,Average weekly red wine intake,359
7,"Other professional qualifications eg: nursing, teaching | qualifications",498
7,Attention deficit hyperactivity disorder (inattention symptoms),101
7,Medication use (calcium channel blockers),45639
7,Body fat distribution (trunk fat ratio) [females],13613
7,Cystatin C levels,118065
7,"Hayfever/allergic rhinitis | non-cancer illness code, self-reported",31010
7,Pilonidal cyst,1013
7,IgG glycosylation [IGP70],791
7,Protein quantitative trait loci (liver) [PSMD1],17
7,Amyotrophic lateral sclerosis [survival],133
7,White matter growth,7081
7,Diastolic blood pressure x smoking status (ever vs never) interaction (2df test) [EA],1161
7,Immune reponse to smallpox (secreted IL-10) [AA],72
7,Ulcerative rectosigmoiditis,22
7,Epstein-Barr virus EA-D antibody levels,2
7,Depression | mental health problems ever diagnosed by a professional,4542
7,"""Artrosis, including avohilmo""",2624
7,"Waist circumference adjusted for body mass index [EA,women]",2105
7,Celiac disease and Rheumatoid arthritis,943
7,Nonatopic asthma,1246
7,Imodium 2mg capsule | treatment/medication code,139
7,"""Femoral hernia, unilateral""",96
7,Atrial fibrillation,35754
7,"Bone mineral density (paediatric, upper limb) [EA]",8658
7,"""Coxarthrosis,""",416
7,Fat-free mass [female],22282
7,Fracture at wrist and hand level,1556
7,Neurological blood protein biomarker levels [CPA2],2428
7,Heart rate variability traits (RMSSD),476
7,3mm weak meridian angle (left),138
7,"Blood metabolite levels [5alpha-androstan-3beta,17beta-diol disulfate]",5068
7,Second line medication for Crohns disease,3861
7,Cutaneous melanoma or hair colour,2409
7,Pulse pressure x alcohol consumption interaction (2df test) [EA],139
7,Facial morphology (segment 60),57
7,Systemic connective tissue disorders,3794
7,IgG glycosylation patterns [IgG1_G1N/IgG1_G1],789
7,Worry too long after embarrassment,1478
7,Betamethasone | treatment/medication code,1095
7,"Diabetes | non-cancer illness code, self-reported",755
7,HDL cholesterol levels x long total sleep time interaction (2df test),11399
7,Smoking initiation,11042
7,N-glycan levels [plasma glycan peak 60],801
7,"1,5-anhydroglucitol levels [EA]",659
7,Osteoporosis nos,910
7,"Atrial fibrillation | non-cancer illness code, self-reported",858
7,Bone mineral density (trunk),404
7,Atrial fibrillation/atrial flutter,883
7,Systemic lupus erythematosus [AA],1243
7,Nicotine dependence,18
7,IgG glycosylation patterns [IgG1_G0N],789
7,Longest period spent worried or anxious,88
7,"""Atherosclerosis, excluding cerebral, coronary and PAD""",64
7,Serum levels of protein TBL2,214
7,I needed less sleep than usual | manifestations of mania or irritability,128
7,Electrocardiogram morphology (amplitude at temporal datapoints) [184 ms],1043
7,C-reactive protein,61004
7,Eotaxin levels,863
7,Hypospadias,14821
7,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA],12455
7,"Schizophrenia, schizoaffective disorder or bipolar disorder",1803
7,Body fat distribution (arm fat ratio) [females],1247
7,White | bread type,2556
7,Glycemic traits [1-hPG],1348
7,Cellulitis and abscess of arm/hand,140
7,Tea consumption,21262
7,Forced expiratory volume in 1-second (fev1),23430
7,"""Disorders of gallbladder, biliary tract and pancreas""",2949
7,Comparative body size at age 10,6115
7,Retinal vein occlusion (central or branch),309
7,Cardiorespiratory fitness slope,124
7,Protein quantitative trait loci (liver) [MYO1B],2
7,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [AA],7898
7,Asthma [conditional],831
7,Heart rate response to exercise,1374
7,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant II (Nose), Segment 45]",510
7,Parental extreme longevity (95 years and older),6790
7,Body fat distribution (arm fat ratio),1247
7,Alcohol consumption [quantile transformation],570
7,"Blood protein levels [ADAM22, 7933_75_3]",463
7,Prednisolone product | treatment/medication code,173
7,High light scatter reticulocyte percentage of red cells,325859
7,Monocyte count,1006364
7,Myocardial infarction,3377
7,Distal bite,3700
7,Self-reported risk-taking behaviour,191
7,Hypertriglyceridemia,16645
7,HDL cholesterol levels in current drinkers,11997
7,Estimated glomerular filtration rate in non-diabetics,11322
7,COVID-19 (very severe respiratory confirmed vs population) RELEASE 5,582
7,Barrett's esophagus or esophageal adenocarcinoma x sex interaction (2df test),470
7,Disorder of the sleep-wake schedule,12
7,White blood cell count [Japanese],13
7,C-C motif chemokine 24 levels,25607
7,A body shape index,32846
7,Ever smoked,20369
7,Facial morphology (segment 61),325
7,Major depressive disorder (ICD-10 coded),3457
7,CCL24 levels,1637
7,Systolic blood pressure x educational attainment (some college) interaction (2df),109
7,Hand grip strength,20646
7,"Pulse pressure [EA, initial]",436
7,Sagittal craniosynostosis,680
7,"""Crohn disease (strict definition, all UC cases excluded)""",22
7,Electrocardiogram morphology (amplitude at temporal datapoints) [186 ms],1043
7,Electrocardiogram morphology (amplitude at temporal datapoints) [110 ms],1043
7,"Cholecystitis | non-cancer illness code, self-reported",28
7,CD45RA on naive CD4+ T cell,457
7,Protein quantitative trait loci (liver) [UGT1A1],2
7,Crohn's disease [EA],46108
7,Total body bone mineral density [European],2891
7,Neuroticism (MTAG),192
7,Furosemide | treatment/medication code,308
7,Sjögren's syndrome [EA],1263
7,Ankle | fractured bone site(s),1439
7,Total cerebellar volume (excluding Crus I vermis),92
7,Atopic dermatitis,1751
7,Electrocardiogram morphology (amplitude at temporal datapoints) [116 ms],1043
7,Ever believed in an un-real conspiracy against self,210
7,Lumbar spine bone mineral density,7942
7,Pediatric areal bone mineral density (radius) [Females],7886
7,Electrocardiogram morphology (amplitude at temporal datapoints) [108 ms],1043
7,Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis),3341
7,Brain region volumes [left cerebellum exterior],62
7,Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor,453
7,"Waist-hip ratio [EA, women]",1555
7,"Waist-to-hip ratio adjusted for BMI in active individuals [EA, women]",1702
7,Electrocardiogram morphology (amplitude at temporal datapoints) [86 ms],1043
7,"""Hypertension, essential""",1157
7,Posterior cortical atrophy and Alzheimer's disease,329
7,Diverticular disease,9740
7,Iron status biomarkers (iron levels),11177
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-26 ms],2827
7,White matter hyperintensity volume x hypertension interaction (2df),181
7,"Osteoporosis | non-cancer illness code, self-reported",1353
7,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test) [EA],1161
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-110 ms],1073
7,Venous thromboembolism,395
7,Cetobacterium A abundance in stool,44
7,Acute tubulo-interstitial nephritis,11
7,Basal metabolic rate,63800
7,"""Lichen planus, including avohilmo""",129
7,Any gastric operation,62
7,"Pulse pressure x alcohol consumption interaction (2df test) [AA, EA]",139
7,Smoking initiation (ever regular vs never regular),38598
7,Worrier / anxious feelings,8748
7,Cholelithiasis,48759
7,Biological sex,14264
7,Irritability,8246
7,Muesli | cereal type,4918
7,Heart rate response to recovery post exercise (30 sec),3518
7,Type 2 diabetes [Japanese],1980
7,Hippocampal volume,100
7,"""Ankylosing spondylitis, strict definition""",79
7,Hair color,7714
7,Noncognitive aspects of educational attainment,8685
7,Carotid intima media thickness (mean) [men],399
7,Protein quantitative trait loci (liver) [FSCN1],4
7,Protein quantitative trait loci (liver) [S100A13],16
7,Positive affect,5028
7,Mean sphered cell volume,186772
7,Blood metabolite levels [serine],5964
7,Vesicular integral-membrane protein VIP36 measurement,1077
7,IgG glycosylation [IGP71],789
7,"Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)",280
7,Coronary artery disease or ischemic stroke,44
7,Protein quantitative trait loci (liver) [SPRYD4],2
7,Comparative height size at age 10,63150
7,Pediatric areal bone mineral density (radius vs spine & hip discordant skeletal phenotype) [female],4482
7,Bone mineral density (total hip) [females],1038
7,Time spent watching television (tv),3357
7,Putamen volume,2181
7,"Osteoporosis, osteopenia and pathological fracture",910
7,PR interval [Hispanic/Latino],399
7,Other diseases of pleura,89
7,"""Inflammatory bowel disease, strict (require KELA)""",22
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-450 ms],3668
7,"Heel broadband ultrasound attenuation, direct entry",13645
7,Iron status biomarkers (ferritin levels),1195
7,IgG glycosylation [IGP59],827
7,Iridocyclitis,22
7,Colorectal cancer or advanced adenoma,10105
7,Interleukin-18 levels,2523
7,Metabolic biomarkers (multivariate analysis),10833
7,Protein quantitative trait loci (liver) [LDHB],54
7,Serum levels of protein SFRP4,92
7,Hypertrophy of breast,99
7,High density lipoprotein cholesterol levels [EA],12700
7,Gallbladder disease,2972
7,Nonatopic asthma and/or waist-to-hip ratio adjusted for BMI,1083
7,Prostate cancer [European],233
7,Subjective wellbeing conditioned on highest math class (multi-trait conditioning and joint analysis),114
7,Stroke | illnesses of mother,46
7,Paget's disease,6891
7,Brain region volumes [left ventral DC],141
7,Reticulocyte fraction of red cells,226816
7,Wholemeal or wholegrain | bread type,4843
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-112 ms],1073
7,Systemic sclerosis [dcSSc],2130
7,None of the above | mouth/teeth dental problems,1854
7,"Blood protein levels [VWC2, 11121_56_3]",78
7,Diabetic retinopathy,42
7,Intrinsic epigenetic age acceleration,141
7,"Fracture shoulder / scapula | non-cancer illness code, self-reported",14
7,Worry,4
7,Type 2 diabetes,311958
7,Subcortical volume (MOSTest),47921
7,Neutrophil-to-lymphocyte ratio,51063
7,Electrocardiographic traits (multivariate),1063
7,"Blood metabolite ratios [indoleacetate/N2,N2-dimethylguanosine]",1218
7,Lactate dehydrogenase levels,2592
7,Bone mineral density (total hip),1038
7,Glomerular filtration rate in non diabetics (creatinine),13402
7,Mean arterial pressure x alcohol consumption interaction (2df test) [EA],640
7,TPE interval (resting),1330
7,"Blood protein levels [CROT, 13929_27_3]",1134
7,Body fat percentage and type 2 diabetes (pairwise),1452
7,Electrocardiogram morphology (amplitude at temporal datapoints) [102 ms],1043
7,Total cholesterol levels [Trans-ethnic initial],831
7,Protein quantitative trait loci (liver) [TTN],24
7,Ganglion cell inner plexiform layer (GCIPL) thickness,391
7,Acute lymphoblastic leukemia (B-cell precursor) [males],3647
7,Average 16-hour sound level of noise pollution,76
7,Intraocular pressure and central corneal thickness (multi-trait analysis) [EA],14929
7,Glaucoma (multi-trait analysis),11038
7,Facial morphology (columella inclination),126
7,Smoking behaviour (cigarette pack-years),781
7,Smoking initiation (ever regular vs never regular) [Conditioned on chr7:133589846],290
7,Differential aging in older adults (frontal cortex),4505
7,Schizophrenia [Chinese],353
7,B cell acute lymphoblastic leukaemia (normal cytogenetics),3647
7,Serum metabolite levels [N('1)-acetylspermidine],1765
7,Injuries to the wrist and hand,125
7,Cataract | eye problems/disorders,6
7,Heart rate response to exercise [females],1374
7,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Asian],1992
7,"Blood metabolite ratios [androsterone sulfate/4-androsten-3beta,17beta-diol disulfate 2]",10677
7,"Paracetamol | medication for pain relief, constipation, heartburn",2952
7,IgG glycosylation patterns [IgG1_G0Nn],789
7,IgG glycosylation [IGP63],789
7,"Abdominal hernia | non-cancer illness code, self-reported",332
7,Osteoarthritis (hip),5
7,White blood cell count (basophil),4554
7,Longevity (age >90th survival percentile),161
7,Number of sexual partners,19131
7,Glaucoma (primary open-angle),7551
7,"Other disorders of synovium, tendon, and bursa",621
7,Plasmacytoid Dendritic Cell %Dendritic Cell,417
7,IgG glycosylation patterns [IgG1 BG0n/G0n],789
7,"Cellulitis | non-cancer illness code, self-reported",443
7,"Blood protein levels [GPNMB, 8606_39_3]",49
7,Plasma free amino acid levels (adjusted for one other PFAA) [Ser (adjusted for Gly],13191
7,"""Systemic lupus erythematosus, unspecified""",3333
7,"Talking therapies, such as psychotherapy, counselling, group therapy or cbt | activities undertaken to treat depression",4571
7,Protein quantitative trait loci (liver) [FUCA1],456
7,Melusin levels,395
7,Serum metabolite levels [andro steroid monosulfate C19H28O6S (1)*],588
7,Systolic blood pressure [EA],139
7,Liver enzyme levels (gamma-glutamyl transferase),32438
7,Bilirubin levels,17762
7,Electrocardiogram morphology (amplitude at temporal datapoints) [140 ms],2070
7,White matter microstructure (mode of anisotropy) [Retrolenticular part of internal capsule],11562
7,Papulosquamous disorders,1147
7,Adventurousness,19027
7,Femur bone mineral density x serum urate levels interaction [male],6802
7,Phosphatidylcholine-O_34:1_[M+H]1+/Phosphatidylcholine-P_34:0_[M+H]1+/Phosphatidylethanolamine-O_37:1_[M+H]1+ levels,11613
7,Electrocardiogram morphology (amplitude at temporal datapoints) [128 ms],1043
7,Leprosy,3837
7,Acute lymphoblastic leukemia (childhood),25771
7,Fluid intelligence score,5925
7,Systolic blood pressure x smoking status (ever vs never) interaction (2df test),1161
7,Asthma (more control exclusions),27
7,Hip circumference,74932
7,Leg fat percentage (left),57191
7,"Svt / supraventricular tachycardia | non-cancer illness code, self-reported",356
7,Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease),789
7,Blood metabolite ratios [X-12095--N1-methyl-3-pyridone-4-carboxamide/X-12844],573
7,Salad / raw vegetable intake,5534
7,Heel bone mineral density (bmd),14549
7,Medication use (HMG CoA reductase inhibitors),15401
7,Serum levels of protein COCH,617
7,"Blood protein levels [EPHB6, 9261_14_3]",618
7,Staphylococcus A fleurettii abundance in stool,105
7,Age-related hearing impairment (MTAG),2532
7,Serum levels of protein PTN,406
7,Electrocardiogram morphology (amplitude at temporal datapoints) [168 ms],1043
7,Logical memory (delayed recall) in mild cognitive impairment,241
7,Lamb consumption,11064
7,Cortical surface area [Lingual],15729
7,Heel bone mineral density variance,1793
7,CAG-269 sp002372935 abundance in stool,62
7,Serine/threonine-protein kinase 4 levels,58
7,White blood cell count,1294963
7,Heel bone mineral density,474191
7,LDL cholesterol levels x long total sleep time interaction (2df test),8008
7,Forced vital capacity (fvc),25484
7,Job involves mainly walking or standing,581
7,Interstitial lung disease endpoints,4759
7,CCR2 on granulocyte,13
7,Self-reported math ability,24168
7,Age at menopause,33282
7,Serum levels of protein AOC1,8907
7,Age at first birth,19648
7,Time to complete round,3597
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-456 ms],3668
7,Getting up in morning,1016
7,Electrocardiogram morphology (amplitude at temporal datapoints) [304 ms],1547
7,Atopic asthma,1588
7,Bitter taste perception (phenylthiocarbamide) in obesity with metabolic syndrome,338
7,Protein quantitative trait loci (liver) [CLTC],52
7,Brain region volumes [right cerebellum exterior],62
7,Asthma (childhood onset),6213
7,Waist-to-hip ratio adjusted for body mass index [women],5072
7,Gut microbiota relative abundance (bacterial taxa) [Actinobacteriia],105
7,CAG-83 sp002392625 abundance in stool,9
7,Non-glioblastoma glioma,148
7,Smoking status,22275
7,Sulfatase-modifying factor 2 levels,4736
7,Mean time to correctly identify matches,5898
7,6mm strong meridian (right),6850
7,Disorders of lipoprotein metabolism and other lipidaemias,829
7,Protein quantitative trait loci (liver) [IGHG2],228
7,Sleep disorders (combined),73
7,Medication use (vasodilators used in cardiac diseases),32
7,QRS duration,4073
7,Hypertensive diseases (excluding secondary),10488
7,Body mass index and type 2 diabetes (pairwise),581
7,Blood metabolite levels [X-12844],510
7,Metformin | treatment/medication code,528
7,Zolmitriptan | treatment/medication code,445
7,Carotid intima media thickness (maximum),395
7,Cortical volume [Pericalcarine],144
7,Alcohol dependence symptom count [additive],11
7,Diabetes diagnosed by doctor,7700
7,Mean arterial pressure,21618
7,Polycythaemia vera,2388
7,IgD on transitional B cell,2809
7,Prevalent atrial fibrillation,1411
7,Protein quantitative trait loci (liver) [CCDC58],118
7,Protein quantitative trait loci (liver) [PLD3],5
7,Coronary revascularization (ANGIO or CABG),10728
7,"Heel quantitative ultrasound index (qui), direct entry (left)",9708
7,Albumin-globulin ratio,1420
7,P wave duration,700
7,Ultradistal forearm bone mineral density,1392
7,Body fat percentage [female],130
7,Labyrinthitis,647
7,Crohn disease,22
7,Household income (MTAG),21638
7,Total bilirubin levels,8549
7,Plasma free amino acid levels (adjusted for one other PFAA) [Ser (adjusted for Gln],13191
7,Mean corpuscular haemoglobin concentration,8932
7,Electrocardiogram morphology (amplitude at temporal datapoints) [154 ms],1043
7,Ischemic heart disease,330
7,Bone mineral density,1102
7,Low density lipoprotein cholesterol levels,221060
7,Pediatric areal bone mineral density (radius) [females],4468
7,"N,n,n-trimethyl-alanylproline betaine (tmap) levels",3245
7,Systemic sclerosis [EA],3686
7,"Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, Asian, EA]",824
7,Multiple myeloma (hyperdiploidy) [HD vs. controls],279
7,Ischemic stroke (large artery atherosclerosis),94
7,Platelet-to-lymphocyte ratio,42116
7,Ophthalmic complications in type 2 diabetes,1698
7,Heel bone mineral density x serum urate levels interaction [female],2258
7,White matter microstructure (fractional anisotropy) [Inferior fronto-occipital fasciculus],365
7,Acute lymphoblastic leukemia (B-cell precursor),3647
7,Peak expiratory flow,38713
7,Urinary albumin excretion,1293
7,Percentage of invited food questionnaires completed,110
7,Mild cognitive impairment,5
7,Serum 25-Hydroxyvitamin D level variance,36406
7,Average total household income before tax,10170
7,"Red blood cell traits [EA, RBCC]",5066
7,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test),1161
7,Bipolar disorder vs major depressive disorder (ordinary least squares (OLS)),741
7,"Systolic blood pressure x alcohol consumption interaction (2df test) [AA, EA]",139
7,Fracture of upper limb,1164
7,Treatment or medication use - peppermint oil product (UKB data field 20003_1140865414),157
7,"""Disorders of sclera, cornea, iris and ciliary body""",22
7,Mean corpuscular hemoglobin,330105
7,Waist-to-hip ratio adjusted for BMI in active individuals [EA],12270
7,Diacylglycerol_34:2_[M+NH4]1+ levels,11613
7,Feeling miserable,2141
7,Cortical surface area [Rostral Anterior Cingulate],145
7,Chronic obstructive pulmonary disease,21710
7,Resting heart rate,16708
7,Plasminogen activator inhibitor 1 measurement,512
7,Heart rate response to recovery post exercise,5178
7,Serum levels of protein B4GALT7,9320
7,Cortical surface area (visual PC2) [EA],274
7,Ischemic stroke,2180
7,Urinary albumin-to-creatinine ratio in diabetes,156
7,"Hypothyroidism/myxoedema | non-cancer illness code, self-reported",7387
7,Atrial fibrillation and flutter with reimbursement,1202
7,Had menopause,516
7,BMI (adjusted for smoking behaviour),2838
7,Imdur 60mg durule | treatment/medication code,935
7,Schizophrenia or bipolar disorder [SCZ or BP vs. controls],11903
7,Serum levels of protein CHST12,1331
7,3-methylhistidine levels,1441
7,Serum metabolite levels [epiandrosteronesulfate],730
7,Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis),472
7,Alcohol use disorder [EA],38
7,Corneal structure,18790
7,Alanine aminotransferase levels,233216
7,Carotid intima media thickness (mean),411
7,Metabolic syndrome [TG],12098
7,Serum levels of protein EPHA1,662
7,Electrocardiogram morphology (amplitude at temporal datapoints) [192 ms],1043
7,Male puberty timing (late vs. average onset facial hair),3183
7,Osteoarthritis of the hip or knee,935
7,Eczema,1794
7,Aspartate aminotransferase levels in non-alcoholic fatty liver disease,1333
7,Brain region volumes [right ventral DC],141
7,Ulcerative ileocolitis,81
7,Electroencephalogram traits [alphaCz],1977
7,"""Type 2 diabetes, definitions combined""",8467
7,Basophill count,3673
7,Haemmorrhoids and perianal venous thrombosis,312
7,Obesity due to excess calories,2080
7,"Medication use (adrenergics, inhalants)",567
7,Smoking initiation (ever regular vs never regular) (MTAG),94958
7,Age at menopause (last menstrual period),20936
7,Pulse pressure [Japanese],1368
7,Amlodipine | treatment/medication code,46
7,Instant coffee intake,69
7,Alcohol consumption x traumatic event in childhood (felt hated by family member) interaction,37
7,Feeling worry,4475
7,Vertex-wise cortical surface area,89702
7,Plasma free amino acid levels (adjusted for one other PFAA) [Thr (adjusted for Ser],13191
7,Chronic kidney disease [eGFRcrea],13192
7,Fasting plasma glucose,4178
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-96 ms],1073
7,Male puberty timing (age at voice breaking MTAG),5952
7,Serum metabolite levels [androsterone sulfate],588
7,Blood pressure traits (multi-trait analysis) [Het],522
7,Hydroxyasparagine levels,393
7,Facial morphology (segment 22),93
7,Glycine levels,17892
7,Urinary sodium excretion [EA],8618
7,Basophil percentage of white cells,56860
7,Serum levels of protein PIP,3303
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-478 ms],3668
7,Electrocardiogram morphology (amplitude at temporal datapoints) [350 ms],1547
7,Bone properties (heel) [VOS],289
7,Response to antiepileptic mood-stabilizing treatment in bipolar disorder,180
7,Cognitive performance (MTAG) [MTAG],33856
7,Serum levels of protein ACHE,15052
7,Plasma free amino acid levels [Ser],10348
7,Citrobacter A abundance in stool,5
7,LDL cholesterol x physical activity interaction (2df test),9005
7,Plasma free amino acid levels (adjusted for one other PFAA) [Ser (adjusted for Phe],13191
7,"Intra-ocular pressure, corneal-compensated (left)",1172
7,Heart failure and antihypertensive medication,1439
7,Peripheral artery disease in non diabetes,48
7,Inflammatory bowel disease,26524
7,Total PHF-tau (SNP x SNP interaction),23703
7,Vertex-wise cortical thickness,110178
7,"Asthma | non-cancer illness code, self-reported",3261
7,Urinary albumin-to-creatinine ratio,39037
7,"Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma) [All Cancers]",729
7,Childhood asthma with severe exacerbations,361
7,Serum creatinine levels,48551
7,Impedance of arm (left),105891
7,Electrocardiogram morphology (amplitude at temporal datapoints) [120 ms],1043
7,Difficulty not smoking for 1 day,838
7,Serum immune biomarker levels [YKL-40],3156
7,"Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",139
7,Waist-to-hip ratio adjusted for BMI,222273
7,Pattern 1 | hair/balding pattern,6916
7,Blood protein levels [DCN],70
7,Neutrophil percentage of granulocytes,87158
7,"Blonde | hair colour (natural, before greying)",8426
7,CD45 on CD33- HLA DR+,500
7,Hydrocele,152
7,Photic sneeze reflex,19
7,Idiopathic pulmonary fibrosis,15658
7,Diacylglycerol_34:2_[M+H-H2O]1+ levels,11613
7,Diacylglycerol_36:4_[M+H-H2O]1+ levels,11613
7,Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test),3192
7,Extremely high intelligence,4589
7,Serum metabolite levels [orotate],928
7,Protein quantitative trait loci (liver) [ECI1],153
7,Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe mucosal involvement,614
7,"Blood protein levels [EA, Aspartate aminotransferase, cytoplasmic]",90
7,Aspartate aminotransferase levels,165170
7,Pyridoxate levels,11880
7,Electrocardiogram morphology (amplitude at temporal datapoints) [174 ms],1043
7,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)",917
7,Serum levels of protein TMEM106B,4505
7,Sex hormone-binding globulin levels [Men + Women],4201
7,White matter microstructure (mode of anisotropy) [Genu of corpus callosum],185
7,Number of children fathered,16
7,Incremental insulin,3649
7,Serum 25-Hydroxyvitamin D levels,261650
7,Body fat distribution (leg fat ratio) [males],11634
7,Acceptance of an invitation to participate in a mental health questionnaire,5370
7,"Blood protein levels [EA, Retinoic acid receptor responder protein 2]",30140
7,Chronic kidney disease,1408
7,Breast cancer (estrogen-receptor negative),760
7,Shoulder lesions,259
7,Fasciitis,3008
7,Ease of getting up in the morning,1239
7,Hay fever and/or eczema,2263
7,Other systemic involvement of connective tissue,3794
7,Vitamin D levels,1080
7,Electrocardiogram morphology (amplitude at temporal datapoints) [138 ms],1043
7,Glioblastoma [females],148
7,Electrocardiogram morphology (amplitude at temporal datapoints) [292 ms],1547
7,Pediatric bone mineral content (femoral neck),669
7,Electrocardiogram morphology (amplitude at temporal datapoints) [114 ms],1043
7,Protein quantitative trait loci (liver) [GYG2],542
7,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),90
7,Sunburns,7676
7,Plasma free amino acid levels (adjusted for twenty other PFAAs) [Ser],13191
7,Diabetes or endocrine disease,15600
7,Electrocardiogram morphology (amplitude at temporal datapoints) [124 ms],1043
7,Serum levels of protein SEMA3E,1147
7,Arthrosis,2501
7,Asthma or allergic disease (pleiotropy),826
7,T wave morphology restitution during exercise (MTAG),713
7,Ebbinghaus illusion (underestimation),2024
7,Neurofibrillary tangles (SNP x SNP interaction),21241
7,Advanced age-related macular degeneration [EA],103555
7,Stroke,2007
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-484 ms],3668
7,Electrocardiogram morphology (amplitude at temporal datapoints) [20 ms],4
7,Systemic lupus erythematosus,45038
7,CD62L on CD62L+ plasmacytoid Dendritic Cell,417
7,malignant neoplasm of male genital organs,386
7,Age at first sexual intercourse,75386
7,"Blood protein levels [CPA4, 9267_2_3]",3007
7,Heart rate response to recovery post exercise (10 sec),3510
7,Reaction time,3645
7,Triglyceride levels [African American],320
7,White matter microstructure (axial diusivities) [Superior corona radiata],9952
7,Protein quantitative trait loci (liver) [MACROD1],59
7,Intrahepatic Cholestasis of Pregnancy (ICP)  (more control exclusions),2800
7,Miserableness,7681
7,Psoriasis vulgaris,97
7,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) [subset analysis]",43693
7,DNA methylation-estimated plasminogen activator inhibitor-1 levels,979
7,Migraine and/or pulse pressure,438
7,Hematocrit,234080
7,"Forced expiratory volume in 1-second (fev1), best measure",26336
7,Osteoarthritis (hip) [Male-specifc],635
7,"Urticaria | non-cancer illness code, self-reported",827
7,Brain region volumes [right inferior lateral ventricle],8
7,"Blood protein levels [EA, Leucine carboxyl methyltransferase 1]",10
7,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),10123
7,Usual walking pace,6633
7,Age asthma diagnosed,11450
7,Experiencing mood swings,5030
7,Protein quantitative trait loci (liver) [APOB],370
7,Number of triplets attempted (left),44
7,Neutrophil percentage of white cells,224284
7,Body mass index (joint analysis main effects and smoking interaction),2838
7,Systemic lupus erythematosus [Chinese],416
7,Buprenorphine | treatment/medication code,636
7,"""Ulcerative colitis (strict definition, require KELA)""",22
7,Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in secretors,12
7,Circulating chemerin levels [European],174929
7,Serum total protein level,98453
7,Monocyte percentage,30384
7,Postprandial triglyceride levels,8600
7,Relative age of first facial hair,6108
7,Cortical surface area [Pars Triangularis],1393
7,Left–right brain asymmetry,680
7,Childhood ear infection,4932
7,Insomnia symptoms (never/rarely vs. sometimes/usually),8252
7,Triglycerides [Hispanic],8039
7,Facial morphology (segment 26),8710
7,Hand grip strength (right),70637
7,Diseases of the respiratory system,11530
7,HDL cholesterol [AA],426
7,White matter microstructure (fractional anisotropy) [Posterior limb of internal capsule],220
7,Skin colour,13349
7,Bone mineral density [Conditional on rs917727],7836
7,Secreting CD4 regulatory T cell %CD4+ T cell,943
7,Response to fenofibrate [VLDL diameter],2265
7,Doctor diagnosed tuberculosis,451
7,Multiple myeloma,5346
7,Worry/vulnerability (special factor of neuroticism),1426
7,QT dynamics during exercise [female],713
7,"Encephalitis | non-cancer illness code, self-reported",53
7,Lung function (FEV1),31799
7,Electrocardiogram morphology (amplitude at temporal datapoints) [302 ms],1547
7,Ribulonate/xylulonate levels,97
7,Carpal tunnel syndrome,8533
7,"Diastolic blood pressure, automated reading",41391
7,Plasma free amino acid levels (adjusted for one other PFAA) [Ser (adjusted for Asn],13191
7,TB-LM or TBLH-BMD (pleiotropy),698
7,Mood swings,3748
7,Subjective wellbeing conditioned on educational attainment (multi-trait conditioning and joint analysis),117
7,Immature fraction of reticulocytes,127144
7,Brain region volumes [cerebellar vermal lobules I V],25482
7,Stem cell factor levels,178
7,DNA methylation variation (age effect),1880
7,Pappalysin-1 levels,1371
7,Eosinophil percentage of white cells,226221
7,Pursuit maintenance gain in psychotic disorders [African],11198
7,Waist circumference,67422
7,"Coffee consumption [conditioned on rs4410790, rs1349140]",51
7,Pulse pressure [EA],2540
7,Asthma (only as main-diagnosis) (more control exclusions),15
7,Iron status biomarkers (transferrin saturation),10132
7,Urea levels,2460
7,Body mass index (joint analysis main effects and physical activity interaction) [EA],2018
7,Xalacom 0.005%/0.5% eye drops | treatment/medication code,277
7,IgG glycosylation [IGP6],827
7,"""Type 1 diabetes, strict (exclude DM2)""",355
7,Glomerular filtration rate (creatinine),25074
7,Bread intake,10626
7,Blood metabolite levels [X12063 levels],13268
7,SSC-A on CD14+ monocyte,13
7,Electrocardiogram morphology (amplitude at temporal datapoints) [178 ms],1043
7,Smoking cessation,1520
7,Type 2 diabetes [EA],410
7,Interleukin-1 receptor type 2 measurement,64
7,Escherichia flexneri abundance in stool,274
7,Spondylopathies (FG),22
7,"Scleroderma/systemic sclerosis | non-cancer illness code, self-reported",11909
7,Electrocardiogram morphology (amplitude at temporal datapoints) [330 ms],1547
7,IgG glycosylation [IGP62],789
7,Osteoarthritis (with total knee replacement),6180
7,acne vulgaris,101
7,White matter microstructure (radial diusivities) [Retrolenticular part of internal capsule],559
7,Crohn's disease of large intestine,22
7,Odoribacter laneus abundance in stool,9
7,Acute and subacute iridocyclitis,22
7,Granulocyte count,30220
7,Hypothyroidism nos,2523
7,Aspartate aminotransferase to alanine aminotransferase ratio,30314
7,Ankle spacing width,64532
7,Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis),4382
7,"Waist circumference adjusted for body mass index [EA, women]",2675
7,Rate of cognitive decline in Alzheimer's disease [GEE model],212
7,PDL-1 on monocyte,30
7,Heel bone mineral density (bmd) (right),15877
7,IgG glycosylation [IGP46],827
7,Heel bone mineral density T score,178594
7,"Blood protein levels [AOC1, 6209_2_3]",2092
7,Other disorders of tympanic membrane,385
7,Other and unspecified dermatitis,333
7,Ulcerative proctitis,199
7,Feeling tense,4469
7,HDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test) [African],428
7,Metabolite levels [FPG],1348
7,Serum metabolite levels [epiandrosterone sulfate],588
7,IBD patients in KELA-register,22
7,Graves' disease,419
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-24 ms],97916
7,Tacrolimus trough concentration in kidney transplant patients [AA],12651
7,Age at first live birth,4723
7,Electrocardiogram morphology (amplitude at temporal datapoints) [126 ms],1043
7,White matter microstructure (radial diusivities) [Corticospinal tract ],17
7,Homocysteine levels,27559
7,Leg fat-free mass (left),57848
7,OTU99_55 (Barnesiella) abundance,9371
7,Electrocardiogram morphology (amplitude at temporal datapoints) [176 ms],1043
7,Arrhythmia,2554
7,Body fat distribution (leg fat ratio) [females],13613
7,Brown vs. black hair color,2388
7,Blood pressure [DBP],640
7,Neuroticism conditioned on self-rated math ability (multi-trait conditioning and joint analysis),480
7,Gamma-glutamyl-alpha-lysine levels,1385
7,Meat-related diet,11855
7,Past tobacco smoking,21071
7,Ankle spacing width (right),45691
7,COVID-19 (hospitalized vs population) RELEASE 5,552
7,Blood pressure traits (multi-trait analysis) [Hom],2585
7,Metopic nonsyndromic craniosynostosis,670
7,Serum levels of protein DBNL,1512
7,Glycemic traits (pleiotropy),217
7,Bone mineral density (pelvis),41
7,Haemorrhoidal disease,16418
7,Myeloproliferative diseases,2388
7,CD33- HLA DR+ Absolute Count,417
7,Global electrical heterogeneity phenotypes [SAI QRST],271
7,Acisoga levels,702
7,Cataracts [female],7
7,Age-related disease endophenotypes,8111
7,Scavenger receptor cysteine-rich domain-containing group B protein levels,11458
7,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),9588
7,Intelligence,23107
7,"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment",2791
7,Serum levels of protein CCL5,617
7,Coronary atherosclerosis (time to event),28
7,Arm fat percentage (right),36836
7,Umbilical hernia,787
7,Electrocardiogram morphology (amplitude at temporal datapoints) [306 ms],1547
7,Bone ultrasound measurement (velocity of sound) [female],1190
7,Bacteroides faecis abundance in stool,24
7,Well-being spectrum (multivariate analysis),9770
7,White matter microstructure (mode of anisotropy) [Fornix (column and body],9166
7,Neuritic plaques (SNP x SNP interaction),793
7,Medication use (glucocorticoids),1031
7,Protein quantitative trait loci (liver) [GNMT],114
7,Longevity,582
7,Cognitive decline rate in late mild cognitive impairment [EA],30
7,Follicular cysts of skin and subcutaneous tissue,48
7,Stroke [LVD],34
7,"Heel quantitative ultrasound index (qui), direct entry",14487
7,"Blood protein levels [HSPB1, 11103_24_3]",1458
7,Other cataract,33
7,Eosinophil counts,855540
7,Depressive symptoms,33370
7,Birth length (MTAG),2413
7,Serum levels of protein MANF,11009
7,Electrocardiogram morphology (amplitude at temporal datapoints) [392 ms],1832
7,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],6424
7,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test),1161
7,"Black | hair colour (natural, before greying)",2842
7,High light scatter reticulocyte percentage,18410
7,Thalamus volume,237
7,Language performance in older adults (adjusted for episodic memory),30
7,Carotid plaque,139
7,Large artery stroke (CCSp classification)j,50
7,Serum albumin levels,202020
7,Non-albumin protein levels,27099
7,Cerebral aneurysm,1721
7,Hypertension [Japanese],1297
7,CD123 on CD62L+ plasmacytoid Dendritic Cell,500
7,Body mass index (age <50),7044
7,Cardiac arrhytmias,1397
7,"Cholesterol lowering medication | medication for cholesterol, blood pressure or diabetes",90
7,Acne (severe),101
7,"Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",139
7,Waist-hip index,49368
7,Leg predicted mass (right),58824
7,White blood cell (leukocyte) count,76828
7,Cortical surface area (min-P),4985
7,"Heel bone mineral density (bmd) t-score, automated",14487
7,Waist circumference adjusted for BMI (adjusted for smoking behaviour) [women],1702
7,Protein quantitative trait loci (liver) [COQ9],35
7,Executive function (trail making test B),4205
7,Myopia (pathological),4573
7,Sphingomyelin_36:1_[M+H]1+ levels,11613
7,Diseases of middle ear and mastoid,670
7,Electrocardiogram morphology (amplitude at temporal datapoints) [196 ms],1043
7,CD14+ CD16- monocyte Absolute Count,13
7,Mosquito bite size,1105
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-454 ms],3668
7,Job involves heavy manual or physical work,749
7,Electrocardiogram morphology (amplitude at temporal datapoints) [84 ms],1043
7,Senile cataract,257
7,Takeaway meals | type of meals eaten,1
7,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),8171
7,Urate levels [men],10633
7,Lifetime anxiety disorder [EA],4531
7,Self-reported math ability (MTAG) [MTAG],72395
7,vWF levels,11238
7,Bitter taste perception (6-n-propylthiouracil) in obesity with metabolic syndrome,338
7,"Cholesterol lowering medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",1508
7,Electrocardiogram morphology (amplitude at temporal datapoints) [-114 ms],1073
7,Microalbumin in urine,28
7,Ischemic stroke (large artery atherosclerosis) [CCSp],30
7,Testosterone levels,19813
7,vWF levels [EA],23018
7,Pulmonary fibrosis,14473
7,Creatinine levels,159152
7,Iris characteristics [Crypts],126
7,Itch intensity from mosquito bite,929
7,"Dupuytren's contracture | non-cancer illness code, self-reported",777
7,"Migraine | non-cancer illness code, self-reported",234
7,Crohn's disease of small interstine,22
7,Large artery stroke (CCS or TOAST classification),50
7,"""Ulcerative colitis (strict definition, require KELA, min 2 HDR)""",22
7,Mucosal proctocolitis,22
7,Bipolar disorder,35485
7,Low testosterone levels,4281
7,"Blood protein levels [PCOLCE, 11237_49_3]",5066
7,Bitter taste perception [PROP],317
7,Triglyceride levels x short total sleep time interaction (2df test) [Hispanic/Latino],215
7,Diabetic nephropathy,8
7,Waist-to-hip ratio adjusted for BMI in active individuals [women],1702
7,Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],139
7,Metabolite levels [CE 20:4],2782
7,Bone mineral density (hip) and hip bone size,5139
7,Metabolic traits [androsterone sulfate + 2 other traits],730
7,Cervical cancer,489
7,Cardiovascular diseases (excluding rheumatic etc),46
7,Nicotine glucouronidation,15
7,Oily fish consumption,658
7,Waist circumference adjusted for body mass index [EA],15713
7,Mean spheric corpuscular volume,106443
7,Arm fat mass (left),75454
7,"Sphingomyelin (d18:1/20:0, d16:1/22:0) levels",22
7,Serum levels of protein CXCL9,36
7,Serum levels of protein HTN1,98376
7,Protein quantitative trait loci (liver) [BPNT1],1174
7,Electrocardiogram morphology (amplitude at temporal datapoints) [194 ms],1043
7,Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis),1335
7,Coronary atherosclerosis,358
7,Protein quantitative trait loci (liver) [RAB7A],52
7,Monocyte percentage of white cells,244819
7,"Forced expiratory volume in 1-second (fev1), predicted percentage",181
7,"LDL cholesterol levels x smoking (current vs non smokers) interaction (2df test) [African, trans-ethnic]",94
7,Chemerin levels,46009
7,Bipolar disorder or body mass index,2051
7,White matter hyperintensities,10153
7,Serum levels of protein HGF,536
7,Electrocardiogram morphology (amplitude at temporal datapoints) [316 ms],1547
7,Bitter taste perception [PROP solution],338
7,T cell lymphocyte profile difference (90 days post influenza vaccination),141
8,Sex hormone-binding globulin levels adjusted for BMI,198840
8,Waist-to-hip ratio adjusted for body mass index [women],2404
8,Urinary metabolite levels in chronic kidney disease [1-methylxanthine],298
8,Corticobasal degeneration,346
8,Protein quantitative trait loci (liver) [ADHFE1],879
8,Major depressive disorder,1595
8,Electrocardiogram morphology (amplitude at temporal datapoints) [74 ms],2
8,Peptic ulcer disease,22719
8,Serum levels of protein COLEC12,7744
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-34 ms],6423
8,Chin dimples,680
8,Heart rate response to exercise,898
8,Smoking x traumatic event in childhood (sexually molested) interaction,776
8,Protein quantitative trait loci (liver) [ACTR3],5
8,Gamma glutamyl transpeptidase,23338
8,Serous invasive ovarian cancer,804
8,Breast cancer (early onset),148
8,Ever unenthusiastic/disinterested for a whole week,1
8,White blood cell count,492494
8,"High cholesterol | non-cancer illness code, self-reported",8159
8,Atorvastatin | treatment/medication code,1756
8,Total cholesterol levels,269047
8,Never | smoking status,2864
8,C-reactive protein levels [BMI-adjusted],2822
8,Serum metabolite levels (CMS) [L_HDL_P],1511
8,Electrocardiogram morphology (amplitude at temporal datapoints) [18 ms],136
8,Cortical volume [Insula],10
8,Average total household income before tax,951
8,Gut microbiota abundance (k_Bacteria.p_Bacteroidetes.c_Bacteroidia.o_Bacteroidales.f_Rikenellaceae.g_Alistipes.s_Alistipes_sp_AP11),43
8,Spontaneous preterm birth (maternal effect),6
8,Nevus count or cutaneous melanoma,1000
8,Mean platelet (thrombocyte) volume,98404
8,Electrocardiogram morphology (amplitude at temporal datapoints) [230 ms],7043
8,Serum uric acid levels [Japanese],18048
8,Facial morphology (segment 2),7492
8,Electrocardiogram morphology (amplitude at temporal datapoints) [124 ms],2
8,Ankle spacing width,158732
8,"""Hypothyroidism, strict autoimmune""",5264
8,Cholesterol [HDL],1711
8,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [AA],1518
8,Eczema or dermatitis,427
8,Central serous retinopathy [Japanese],736
8,Blood metabolite levels [1-methylxanthine],298
8,Cancer within the respiratory system,40
8,Electrocardiogram morphology (amplitude at temporal datapoints) [86 ms],2
8,White blood cell count (basophil),28060
8,Protein quantitative trait loci (liver) [GCLC],83
8,Apolipoprotein A1 levels,79454
8,Fasciitis,26026
8,Osteoarthrosis nos,19186
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-16 ms],2587
8,Electrocardiogram morphology (amplitude at temporal datapoints) [234 ms],2
8,Cholesteryl ester_20:3_[M+NH4]1+ levels,1856
8,Cognitive ability (MTAG),16445
8,Ovarian cancer [Serious invasive],804
8,Serum metabolite levels (CMS) [MUFA],1778
8,Total cholesterol levels [BMI unadjusted],188
8,Matrix metalloproteinase-1 levels,81
8,Protein quantitative trait loci (liver) [GPX4],3
8,Body fat percentage,78314
8,Malignant neoplasm of urinary organs,24375
8,Serum metabolite levels (CMS) [XS_VLDL_TG],1778
8,"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment",681
8,Protein quantitative trait loci (liver) [LRRC59],34
8,Gut microbiota (beta diversity) [Unifrac metric],799
8,Number of sexual partners,13975
8,Liver enzyme levels (gamma-glutamyl transferase),21046
8,Bisphosphonate-related osteonecrosis of the jaw in cancer (i.v. bisphosphonate),2327
8,"Blood protein levels [CA1, 4969_2_1]",7162
8,Nonalcoholic fatty liver disease,2069
8,Menopause (age at onset) [japanese],2718
8,Seretide 50 evohaler | treatment/medication code,987
8,Myeloperoxidase levels,162
8,Fish- and plant-related diet,50861
8,LDL cholesterol levels,74904
8,Natural Killer T %T cell,42750
8,Spherical equivalent (joint analysis main effects and education interaction) [European ancestry],124
8,Serum metabolite levels [hexanoylglutamine],353
8,"LDL cholesterol levels [Asian initial, BMI unadjusted]",221
8,Electrocardiogram morphology (amplitude at temporal datapoints) [262 ms],2
8,Serum levels of protein WISP1,3846
8,Cereal intake,374
8,Diabetes or endocrine disease,1970
8,Electrocardiogram morphology (amplitude at temporal datapoints) [196 ms],2
8,Diacylglycerol(34:1)_[M+H-H2O]1+ levels,1674
8,Total cholesterol levels [Hispanic],351
8,Electrocardiogram morphology (amplitude at temporal datapoints) [208 ms],2
8,Total triglycerides levels,5385
8,Creatinine levels,147105
8,Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis),31538
8,Cholesterol [TG],1711
8,Central serous retinopathy,736
8,Testosterone levels,34675
8,"Dark brown | hair colour (natural, before greying)",23232
8,Peak expiratory flow (pef),25731
8,"Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA, women]",1215
8,Hedonic well-being,133
8,OTU99_19 (Bacteria) prevalence,25
8,Water intake,13
8,Abnormal serum enzyme levels,8
8,Age started wearing glasses or contact lenses,16931
8,Erythritol levels,240
8,Sphingomyelin_42:3_[M+H]1+ levels,1823
8,Serum levels of protein CA1,6187
8,"Bladder problem (not cancer) | non-cancer illness code, self-reported",224
8,White blood cell count [Hispanic/Latino],124
8,Alanine aminotransferase levels,79148
8,Whole body water mass,142600
8,Gamma-glutamyl hydrolase measurement,9820
8,Tumor necrosis factor receptor superfamily member 10C levels,851
8,Serum metabolite levels (CMS) [L_VLDL_L],379
8,Serum metabolite levels (CMS) [M_VLDL_FC],375
8,Verbal-numerical reasoning,1099
8,Carotid intima media thickness,1773
8,Spontaneous abortion,21
8,Electrocardiogram morphology (amplitude at temporal datapoints) [260 ms],2
8,"Lipid metabolism phenotypes [HDL-C.by.NMR, whole]",1511
8,Electrocardiogram morphology (amplitude at temporal datapoints) [190 ms],2
8,Protein quantitative trait loci (liver) [ACTR2],5
8,Brain morphology (min-P),32817
8,Cholelithiasis with other cholecystitis,1896
8,Fat-free mass [male],5746
8,Phosphatidylcholine_34:3_[M+H]1+/Phosphatidylethanolamine_37:3_[M+H]1+/Phosphatidate_39:4_[M+NH4]1+ levels,1511
8,LDL cholesterol levels in current drinkers,1346
8,Autism spectrum disorder (MTAG),440
8,Pancreas iron content,6
8,Bioavailable testosterone levels,50350
8,Vertex-wise cortical surface area,110839
8,Autoimmune diseases,16700
8,Smoking cessation,1268
8,Serum metabolite levels (CMS) [Remnant_C],379
8,Serum uric acid levels [EA],417
8,"""Type 2 diabetes, strict (exclude DM1)""",708
8,Non-glioblastoma glioma [males],37
8,Brain region volumes [left insula],10
8,Type 2 diabetes,364449
8,Lipoprotein (a) levels,4138
8,Basophil percentage of granulocytes,713
8,Triglyceride to HDL cholesterol ratio,380
8,Triglycerides x physical activity interaction (2df test),3229
8,Femur bone mineral density x serum urate levels interaction,664
8,Follicular lymphoma,1076
8,High light scatter reticulocyte count,154134
8,Waist circumference adjusted for body mass index,225895
8,Comparative height size at age 10,71209
8,"Systolic blood pressure x alcohol consumption interaction (2df test) [AA, EA]",760
8,Metabolic syndrome [TG],1823
8,Chronic back pain,1020
8,Benign neoplasm: Colon (controls excluding all cancers),99
8,Brain region volumes [right insula],10
8,Electrocardiogram morphology (amplitude at temporal datapoints) [88 ms],2
8,Psoriasis,2091
8,Worry too long after embarrassment,43289
8,Brain region volumes [left pallidum],24348
8,6mm weak meridian (right),21563
8,Systemic lupus erythematosus and Systemic sclerosis,3234
8,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction) [women],1215
8,Serum metabolite levels (CMS) [S_VLDL_PL],1778
8,Myopia (pathological),564
8,Alanine transaminase levels,188
8,6mm regularity index (left),1
8,Smoking behaviour (cigarettes smoked per day) [Conditioned on chr8:42578059],3348
8,Impedance of leg (left),137463
8,5-hydroxyindoleacetate levels,933
8,Smoking status (current vs mixed),767
8,Sphingomyelin_38:1_[M+H]1+ levels,1800
8,Serum metabolite levels [S_HDL_TG],1856
8,Fasting blood insulin,351
8,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA],77
8,Protein quantitative trait loci (liver) [QARS],83
8,Unstable angina (intermediate coronary syndrome),7
8,Electrocardiogram morphology (amplitude at temporal datapoints) [254 ms],2
8,Longevity,754
8,Executive function (trail making test B),3317
8,Abdominal aortic aneurysm,267
8,1-palmitoyl-2-arachidonoyl-gpc (16:0/20:4n6) levels,311
8,Systolic blood pressure,613090
8,Reticulocyte fraction of red cells,71100
8,Cognitive aspects of educational attainment,23997
8,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],2592
8,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [AA],1792
8,Other chronic nonalcoholic liver disease,229
8,"Blood protein levels [DEFB1, 6629_3_3]",810
8,Age-related hearing impairment [additive],25722
8,Impedance of whole body,117240
8,3-hydroxy-1-methylpropylmercapturic acid levels in smokers [AA],1147
8,malignant neoplasm of male genital organs,1268
8,Type 2 diabetes [EA],616
8,Diplopia and disorders of binocular vision,256
8,Cortical surface area [Transverse Temporal],18632
8,A levels/as levels or equivalent | qualifications,8602
8,General anaesthetic | anaesthetics administered during delivery,319
8,Hip circumference [EA],177
8,Other/unspecified reactive arthropathies,42
8,Age at first sexual intercourse,139122
8,Liver enzyme levels (alanine transaminase),58374
8,Retinal detachment,896
8,Serum metabolite levels [L_VLDL_CE],375
8,Metabolic syndrome (multivariate analysis),374
8,Plasma lactate levels [EA],165
8,Adiposity [WC],42
8,Autoimmune traits,4973
8,Triacylglycerol_45:4_[M+NH4]1+ levels,1813
8,Serum metabolite levels (CMS) [M_VLDL_CE],227
8,Serum levels of protein CXCL5,78
8,Endometriosis or depression (pleiotropy),58
8,Highest math class taken (MTAG) [MTAG],113839
8,Automobile speeding propensity,19627
8,Urate levels [men],7882
8,Serum total protein level,256686
8,1-ribosyl-imidazoleacetate levels,7549
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-46 ms],6423
8,Leg fat-free mass (right),127531
8,Electrocardiogram morphology (amplitude at temporal datapoints) [110 ms],7043
8,Hypertension (SNP x SNP interaction),1078
8,Protein quantitative trait loci (liver) [FTH1],109
8,Rheumatoid arthritis [EA],253
8,Atopic dermatitis (moderate to severe) [additive],8
8,Malignant neoplasm of brain,37
8,Serum levels of protein GFRA2,4394
8,Triglycerides [Hispanic],2196
8,Breast cancer | illnesses of adopted mother,1387
8,Serum levels of protein EDAR,78
8,Chronic obstructive pulmonary disease or resting heart rate (pleiotropy),86
8,Protein quantitative trait loci (liver) [FGA],157
8,Facial morphology (segment 4),36
8,Electrocardiogram morphology (amplitude at temporal datapoints) [182 ms],2
8,Educational attainment (years of education),177633
8,Mean arterial pressure,40992
8,Blood metabolite levels [Aspartic acid / Acetylcarnitine],15163
8,Insomnia,6655
8,"Blood protein levels [EA, GDNF family receptor alpha-2]",1850
8,X-24295 levels,150
8,Protein quantitative trait loci (liver) [VAPA],34
8,Serum metabolite levels (CMS) [Gly],182
8,Persistent hepatitis B virus infection,272
8,Number of cigarettes previously smoked daily,2570
8,Urinary albumin excretion (no hypertensive medication),787
8,Reactive arthropathies,58
8,Suffer from 'nerves',21409
8,Neutrophill count,48792
8,Type 2 diabetes with other specified/multiple/unspecified complications,26131
8,Serum metabolite levels (CMS) [S_VLDL_P],1778
8,"Acute lymphoblastic leukemia (childhood) [ETV6-RUNX1 positive, Northern European]",1347
8,Oxybutynin | treatment/medication code,183
8,6mm regularity index (right),6
8,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Hispanic],1770
8,Urinary metabolites [Formate/succinate ratio],298
8,Waist-hip ratio and LDL-C (pairwise),310
8,Eubacterium Q abundance in stool,15
8,Modified Stumvoll Insulin Sensitivity Index (BMI interaction),10
8,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),4321
8,Sphingomyelin_36:2_[M+H]1+ levels,1800
8,"Blood protein levels [NOV, 2737_22_2]",3904
8,Duration screen displayed,509
8,Serum metabolite levels (CMS) [L_VLDL_FC],375
8,"Blood protein levels [HRSP12, 14636_25_3]",895
8,Vertical cup-disc ratio (adjusted for vertical disc diameter),352
8,Hemoglobin levels,88698
8,Mean corpuscular haemoglobin,82584
8,Age cataract diagnosed,892
8,Superficial cellulitis and abscess,9404
8,"Diastolic blood pressure, automated reading",28969
8,"Forced expiratory volume in 1-second (fev1), best measure",27619
8,Blood metabolite ratios [lysine/glutaroyl carnitine],3339
8,Relative wall thickness,499
8,Natural Killer T Absolute Count,42750
8,Intrahepatic Cholestasis of Pregnancy (ICP),5488
8,Body fat percentage and HDL-C (pairwise),522
8,Protein quantitative trait loci (liver) [SUCLA2],206
8,Electrocardiogram morphology (amplitude at temporal datapoints) [180 ms],2
8,Spherical equivalent (joint analysis main effects and education interaction),228
8,Electrocardiogram morphology (amplitude at temporal datapoints) [138 ms],2
8,Electrocardiogram morphology (amplitude at temporal datapoints) [104 ms],2
8,Fourth [trochlear] nerve palsy,3
8,Osteoarthritis (hip) [additive],1031
8,Tissue-type plasminogen activator measurement,223
8,Fasting blood glucose [additive],330
8,Fasting blood glucose adjusted for BMI,51
8,Protein quantitative trait loci (liver) [CLIC1],5
8,Mean corpuscular hemoglobin concentration,393932
8,Lipid metabolism phenotypes [M-VLDL-PL],1845
8,Fish- and plant-related diet [male],3036
8,Serum metabolite levels (CMS) [L_VLDL_PL],1511
8,Serum levels of protein IL7,2506
8,Bone mineral density (hip) [trochanter],34
8,Unilateral cleft lip and palate,1
8,Lumbar spine bone mineral density (trabecular),920
8,White matter hyperintensity volume (adjusted for hypertension),27185
8,Serum metabolite levels [S_VLDL_PL],1778
8,"Forced vital capacity (fvc), best measure",9371
8,Serum metabolite levels (CMS) [L_VLDL_P],1511
8,"Blood protein levels [PRELP, 5675_6_3]",1376
8,"Hip circumference adjusted for BMI [EA,men]",1020
8,Serum levels of protein DKK4,78
8,Protein quantitative trait loci (liver) [FDXR],3
8,Hypothyroidism,54306
8,Diastolic blood pressure x smoking status (ever vs never) interaction (2df test) [EA],14893
8,"Bone mineral density (paediatric, skull)",2505
8,Feeling miserable,1055
8,QRS duration,644
8,Relative age of first facial hair,477
8,Blood sugar levels,70
8,Cardiovascular diseases (excluding rheumatic etc),75
8,"Adult diffuse glioma (IDH mutation, 1p/19q non-codeleted)",62
8,"Orofacial clefts [Meta-All, NSCLO]",1
8,Electrocardiogram morphology (amplitude at temporal datapoints) [148 ms],13466
8,Waist-to-hip ratio adjusted for BMI x sex interaction,1215
8,Serum 25-Hydroxyvitamin D level variance,742
8,Femur bone mineral density x serum urate levels interaction [female],210
8,Acute ischemic stroke x type 2 diabetes interaction,2
8,Predicted visceral adipose tissue,22155
8,Leg fat percentage (right),41075
8,Betnovate cream | treatment/medication code,293
8,Electrocardiogram morphology (amplitude at temporal datapoints) [96 ms],2
8,Acne (severe),6814
8,Skeletal age [boys],10623
8,Breast cancer (estrogen-receptor negative),1444
8,Phosphatidylcholine-O_34:3_[M+H]1+/Phosphatidylcholine-P_34:2_[M+H]1+/Phosphatidylethanolamine-P_37:2_[M+H]1+ levels,2093
8,Fractional shortening,499
8,Non-glioblastoma glioma [females],37
8,Electrocardiogram morphology (amplitude at temporal datapoints) [66 ms],2
8,"Black | hair colour (natural, before greying)",16716
8,Bone mineral density [Cortical vBMD],77
8,Protein quantitative trait loci (liver) [S100A6],8
8,Lifetime number of sexual partners,20116
8,None of the above | vascular/heart problems diagnosed by doctor,78438
8,Coronary atherosclerosis,13370
8,Triacylglyceride levels [TAG(52:3;0],1856
8,Youthful appearance (self-reported),1280
8,Protein quantitative trait loci (liver) [RAB21],34
8,Vascular endothelial growth factor levels,234
8,Kidney volume,653
8,Total protein levels x insomnia interaction,517
8,Atopic asthma,999
8,"Number of decayed, missing and filled tooth surfaces or use of dentures",349
8,Functional digestive disorders,607
8,Testicular germ cell tumor,3002
8,Anxiety/tension (special factor of neuroticism),9939
8,Blood metabolite levels [Alanine / Aspartic acid],15163
8,Fish- and plant-related diet [female],47317
8,Cutaneous malignant melanoma,1000
8,"Serum metabolite levels [N1,N12-diacetylspermine]",946
8,"""Malignant neoplasm of breast, HER-positive""",269
8,4-chlorobenzoic acid levels,627
8,Lymphocyte count,7702
8,"Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)",267
8,Nontoxic multinodular goitre,3763
8,Triglyceride levels in current drinkers [AA],1518
8,Glycine levels [conditional],389
8,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),3055
8,Serum levels of protein CTSA,78
8,Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease),54
8,Waist-to-hip ratio adjusted for BMI,195920
8,White matter microstructure (radial diusivities) [Body of corpus callosum],42783
8,Mouth ulcers | mouth/teeth dental problems,2650
8,Galectin-3-binding protein measurement,1116
8,Meat-related diet [male],347
8,Mean reticulocyte volume,212895
8,3-ureidopropionate levels,850
8,Benign neoplasm of colon,214
8,Educational attainment (MTAG) [MTAG],160481
8,Serum metabolite levels [5oxoproline],27565
8,"Heel quantitative ultrasound index (qui), direct entry (right)",13598
8,Metabolic syndrome,7504
8,Acceptance of an invitation to wear a physical activity monitor,1973
8,Urinary metabolite levels in chronic kidney disease [N-acetylputrescine],298
8,Paracetamol | treatment/medication code,658
8,Serum levels of protein HPSE,78
8,Heel bone mineral density,597610
8,Gastric cancer,40040
8,Gastroduodenal ulcer,24366
8,"Diastolic blood pressure x alcohol consumption interaction (2df test) [AA, EA]",2156
8,Otitis media and eustachian tube disorders,331
8,Electrocardiogram morphology (amplitude at temporal datapoints) [114 ms],2
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-78 ms],2357
8,Prostate-specific antigen levels (conditioned on lead SNPs) [conditional on Round 1 SNPs],4539
8,"""Inguinal hernia, bilateral""",983
8,Factor VIII levels,903
8,Electrocardiogram morphology (amplitude at temporal datapoints) [2 ms],274
8,White blood cell count [Japanese],47
8,Barrett's esophagus or esophageal adenocarcinoma x sex interaction (2df test),19
8,Ascending aorta maximum area,46850
8,Phospholipase D3 measurement,2013
8,High-grade serous ovarian cancer,804
8,Electrocardiogram morphology (amplitude at temporal datapoints) [168 ms],13466
8,Rate of cognitive decline in mild cognitive impairment (time interaction),861
8,Tuberculosis [Russian],1191
8,Dyslipidemia,267
8,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)",50633
8,"Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",2146
8,"Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",1086
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-176 ms],1183
8,malignant neoplasm of male genital organs (controls excluding all cancers),1266
8,Ganglion cell inner plexiform layer (GCIPL) thickness,818
8,Menarche (age at onset) [japanese],381
8,Facial morphology [right exocanthion-left cheilion distance],68
8,Protein quantitative trait loci (liver) [RAC1],5
8,Plasma free amino acid levels (adjusted for one other PFAA) [Arg (adjusted for Asn],402
8,Fasting glucose adjusted for BMI,109
8,Diacylglycerol_34:1_[M+NH4]1+ levels,281
8,Electrocardiogram morphology (amplitude at temporal datapoints) [144 ms],2
8,Cystatin C levels,136060
8,White | bread type,4865
8,Malignant neoplasm of prostate (controls excluding all cancers),1260
8,Serum metabolite levels [XXL_VLDL_CE],375
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-12 ms],274
8,"Blood clot in the leg (dvt) | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",81
8,Adventurousness,18552
8,Lipid traits (pleiotropy) (HIPO component 1),291
8,Total body bone mineral density (age 45-60),2624
8,Depression,28804
8,Endometriosis,250
8,Ever addicted to prescription or over-the-counter medication,283
8,Serum levels of protein TNFRSF10B,191
8,Carotid intima media thickness (mean),970
8,Triglyceride levels in HIV infection [African American],175
8,Serum metabolite levels (CMS) [XXL_VLDL_CE],375
8,Serum metabolite levels (CMS) [TotFA],1511
8,Diacylglycerol_44:7_[M+H-H2O]1+ levels,1800
8,Peripheral artery disease,3004
8,COPD,631
8,Waist circumference adjusted for BMI (adjusted for smoking behaviour),1099
8,Securon 40mg tablet | treatment/medication code,97
8,Orofacial clefts,7
8,"Forced expiratory volume in 1-second (fev1), predicted",81537
8,Hypothyroidism (congenital or acquired),8153
8,Tuberculosis,1191
8,Lung adenocarcinoma [East Asian],217
8,Gamma glutamyl transferase levels,49816
8,Hyperplasia of prostate,9143
8,Leprosy,14686
8,TPE interval (resting),11783
8,"Blood metabolite levels [X-04499--3,4-dihydroxybutyrate]",3789
8,Phosphatidylcholine-O_37:2_[M+H]1+/Phosphatidylcholine-P_37:1_[M+H]1+/Phosphatidylethanolamine-O_40:2_[M+H]1+ levels,1836
8,Inter-alpha-trypsin inhibitor heavy chain H3 measurement,223
8,Malignant neoplasm of digestive organs,84
8,Isovolumetric relaxation time,55
8,Electrocardiogram morphology (amplitude at temporal datapoints) [252 ms],2
8,A body shape index,104180
8,Red blood cell (erythrocyte) count,80641
8,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,1789
8,Serum metabolite concentrations in chronic kidney disease [6-oxopiperidine-2-carboxylate],7365
8,Angina | vascular/heart problems diagnosed by doctor,1511
8,Allergy,1005
8,COPD (mode),631
8,Myopia (age of diagnosis),222
8,Serum levels of protein PAPLN,81
8,Phlebitis and thrombophlebitis,78
8,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),3339
8,"Blood protein levels [CETP, 7131_207_3]",1376
8,White blood cell count [Monocytes],182
8,Protein quantitative trait loci (liver) [ACOX1],28
8,Male infertility,9
8,Pepsinogen I/II ratio,10690
8,Platelet-to-lymphocyte ratio,54521
8,Ankle spacing width (right),53353
8,Lymphocyte percentage,35447
8,"Blood protein levels [CA3, 3799_11_2]",5532
8,Serum metabolite levels (CMS) [VLDL_C],2235
8,Phlebitis and thrombophlebitis of lower extremities,78
8,Pancreatic cancer [EA],9
8,Any mental disorder,6
8,Metabolic traits [5-oxoproline],21960
8,Glaucoma,3242
8,Neuroticism (MTAG),61
8,"Orofacial clefts [Meta-All, NSCL/P]",19
8,"None of the above | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",229
8,Protein quantitative trait loci (liver) [PRDX3],5
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-32 ms],6596
8,TNF-related apoptosis-inducing ligand receptor 2 levels,1627
8,Prostate-specific antigen levels,1402
8,Feeling worry,722
8,Serum metabolite levels [N-acetylputrescine],343
8,Fosinopril | treatment/medication code,35
8,Fludrocortisone | treatment/medication code,9
8,College or university degree | qualifications,90023
8,Serum metabolite levels [glutarylcarnitine (C5-DC],995
8,Serum levels of protein DEFB1,1163
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-76 ms],2358
8,Triglycerides x physical activity interaction (2df test) [EA],259
8,Obstructive sleep apnea trait (minimum oxyhemoglobin saturation across sleep episode),24
8,Alcohol intake frequency.,2880
8,Phospholipid levels in large HDL,68
8,Cancer (pleiotropy),70
8,Total cerebellar volume (excluding Crus I vermis),43611
8,Abdominal hernia,560
8,Attention deficit hyperactivity disorder (MTAG),28
8,Inguinal hernia,19297
8,Serum metabolite levels (CMS) [S_VLDL_TG],2090
8,Birth weight (MTAG),558
8,DNA methylation-estimated plasminogen activator inhibitor-1 levels,200
8,Hip index,51265
8,Hernia,959
8,Facial morphology (segment 60),259
8,HDL cholesterol levels in current drinkers [Hispanic],1820
8,Cholelithiasis or gall stones,1896
8,"Blood pressure medication | medication for cholesterol, blood pressure or diabetes",7846
8,HDL cholesterol levels [HIspanic],1518
8,"Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA, women]",1101
8,Subjective well-being (MTAG),326
8,Urinary sodium excretion [EA],60
8,Triacylglycerol(53:2)_[M+NH4]1+ levels,1657
8,Anxiety,3125
8,Diverticulosis,4886
8,Immune response to smallpox vaccine (IL-6) [AA],555
8,Serum levels of protein CCDC50,1933
8,"Intra-ocular pressure, goldmann-correlated (left)",54
8,Systolic blood pressure [Japanese],7691
8,Serum levels of protein PENK,2190
8,Medication use (glucocorticoids),1870
8,Heart failure and antihypertensive medication,59
8,Morning person,23678
8,Current | smoking status,9147
8,Serum levels of protein POFUT2,974
8,Prostate cancer [EA],79
8,Protein quantitative trait loci (liver) [NUTF2],5
8,Presence of cardiac and vascular implants and grafts,15303
8,Blood protein levels in cardiovascular risk,3421
8,"""Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified""",2777
8,Hypercholesterolemia,1507
8,"Waist-hip ratio [EA, women]",1241
8,"Vesicoureteral reflux [recessive, male]",4237
8,Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],2697
8,Protein quantitative trait loci (liver) [EIF3E],115
8,Tuberculosis (SNP x SNP interaction),240
8,Erectile dysfunction,62
8,White matter microstructure (fractional anisotropy) [Body of corpus callosum],42625
8,TNF-related activation-induced cytokine levels,3344
8,N1-methylinosine levels,3439
8,Brain region volumes [right cerebellum exterior],583
8,Bone disorder,2154
8,"Adult diffuse glioma (IDH mutation, 1p/19q codeletion)",59
8,Angina,1511
8,Naramig 2.5mg tablet | treatment/medication code,278
8,Kidney injury molecule 1 levels,280
8,"Lipid metabolism phenotypes [APOB.assay, whole]",267
8,"""Female infertility, cervigal, vaginal, other or unspecified origin""",405
8,Medication use (beta blocking agents),15851
8,Cholesterol_[M+H-H2O]1+ levels,1800
8,Polycystic ovary syndrome,2658
8,Coronary revascularization (ANGIO or CABG),2856
8,"Lipid metabolism phenotypes [HDL-C.assay, whole]",1511
8,X-24813 levels,771
8,Body mass index (joint analysis main effects and smoking interaction),142
8,"Lapatinib-induced hepatotoxicity [Maximum ALT, Conditioned on HLA- DRB1*07:01]",123
8,Dermatitis and eczema,19
8,Malignant neoplasm of stomach,22548
8,Cholesteryl ester_18:0_[M+NH4]1+ levels,1800
8,G_Sutterella prevalence,13
8,1-stearoyl-2-oleoyl-gpc (18:0/18:1) levels,165
8,Serum metabolite levels [6-oxopiperidine-2-carboxylate],19720
8,Skeletal age,10623
8,Optic disc area,305
8,Type 2 diabetes and end-stage kidney disease,35
8,Smoking initiation,14430
8,Sleep duration,15264
8,HDL cholesterol levels x short total sleep time interaction (2df test),2732
8,Blood protein levels [GDNF family receptor alpha-2],400
8,Iron status biomarkers (transferrin levels),298
8,Platelet crit,76737
8,"Blood protein levels [EVA1C, 7008_13_3]",1376
8,HDL cholesterol levels in current drinkers,4022
8,Colon cancer,205
8,Age started hormone-replacement therapy (hrt),7046
8,Triglyceride levels in current drinkers [Asian],1770
8,Waist-to-hip ratio adjusted for BMI in active individuals [women],1101
8,Age at menopause (last menstrual period),865
8,Hodgkin's lymphoma,540
8,Cortical surface area (MOSTest),882
8,Irritability,60347
8,Osteoarthritis; localized,7943
8,Total bilirubin levels,11134
8,Sphingomyelin_36:1_[M+H]1+ levels,1800
8,Ulcerative colitis [EA],7
8,Malignant neoplasm of prostate,1323
8,Diacylglycerol_36:1_[M+H-H2O]1+ levels,1813
8,Sphingomyelin_35:1_[M+H]1+ levels,1800
8,Mean time to correctly identify matches,241
8,Hypertrophy of breast,297
8,Metabolite levels (lipoprotein measures) [Triglycerides in very small VLDL],267
8,IgA nephropathy,4207
8,IgA nephropathy [East Asian],1896
8,Diacylglycerol_32:2_[M+H-H2O]1+ levels,1800
8,Electrocardiogram morphology (amplitude at temporal datapoints) [6 ms],274
8,Stool frequency,41208
8,White blood cell (leukocyte) count,34466
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-186 ms],1183
8,Serum metabolite levels [Gly],182
8,Protein quantitative trait loci (liver) [UCHL3],83
8,Survival in breast cancer (estrogen-receptor positive),702
8,"Fracture clavicle / collar bone | non-cancer illness code, self-reported",117
8,Blood metabolite levels [1-methylurate],298
8,Electrocardiogram morphology (amplitude at temporal datapoints) [152 ms],2
8,3mm strong meridian (right),11218
8,Chronic obstructive pulmonary disease,1291
8,"Lipid metabolism phenotypes [HDL-C.assay, fasting]",1511
8,Psychotic experience (distressing),28
8,Blue cheese intake,14
8,Yes | final attempt correct,35
8,Cannabis dependence symptom count [EA],12
8,Estrogen level change in anastrozole-treated breast cancer [estradiol],1
8,"""Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8""",3554
8,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) [subset analysis]",1345
8,Electrocardiogram morphology (amplitude at temporal datapoints) [194 ms],2
8,"Muscle/soft tissue problem | non-cancer illness code, self-reported",1
8,Interleukin-18 levels,8080
8,Triacylglycerol(52:2)_[M+NH4]1+ levels,1657
8,N-acetylglucosamine/n-acetylgalactosamine levels,229
8,Parkinson's disease,33793
8,"""Systemic lupus erythematosus, unspecified""",20788
8,Non-melanoma skin cancer,3154
8,"Allergic disease (asthma, hay fever or eczema)",2080
8,Triglyceride levels [Indian],3551
8,Pattern 3 | hair/balding pattern,256
8,Lung adenocarcinoma,539
8,Frequency of friend/family visits,225
8,Retinal detachments and defects,203
8,Electrocardiogram morphology (amplitude at temporal datapoints) [112 ms],2
8,Electrocardiogram morphology (amplitude at temporal datapoints) [158 ms],2
8,Left unilateral cleft lip and palate,1
8,Remission after SSRI treatment in MDD or neuroticism,9002
8,Body mass index,335241
8,Atrial fibrillation/atrial flutter,48119
8,Cerebrospinal fluid biomarker levels [Fibroblast growth factor 17],570
8,Atrial fibrillation,94366
8,Electrocardiogram morphology (amplitude at temporal datapoints) [120 ms],2
8,Electrocardiogram morphology (amplitude at temporal datapoints) [186 ms],7043
8,Papillary thyroid cancer,834
8,Age-related disease endophenotypes,1778
8,Phosphatidylcholine_40:10_[M+OAc]1- levels,285
8,Glioma [females],37
8,Protein quantitative trait loci (liver) [UGT2B15],46
8,Educational attainment (years of education) [conditional-joint],57473
8,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Hispanic],1792
8,Total body bone mineral density (age over 60),244
8,Public transport | types of transport used (excluding work),613
8,Obesity due to excess calories,79
8,Bring up phlegm/sputum/mucus on most days,1066
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-24 ms],233
8,Protein quantitative trait loci (liver) [CTSC],5
8,Electrocardiogram morphology (amplitude at temporal datapoints) [210 ms],2
8,"Blood protein levels [IL7, 14049_17_3]",2506
8,"Pulse rate, automated reading",1214
8,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),4374
8,LDL cholesterol levels [EA],1520
8,Sphingomyelin_32:1_[M+H]1+ levels,1823
8,C-reactive protein levels or total cholesterol levels (pleiotropy),351
8,Thyrotoxicosis with toxic single thyroid nodule,47
8,Miserableness,13109
8,Circulating plasma alpha-Klotho levels,2556
8,Lymphocyte-to-monocyte ratio,12947
8,Trunk fat percentage,29439
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-28 ms],6596
8,Calceos chewable tablet | treatment/medication code,857
8,Particulate matter air pollution (pm10); 2007,1779
8,Other malignant neoplasms of skin (=non-melanoma skin cancer) (controls excluding all cancers),1186
8,Glomerular filtration rate,811
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-110 ms],14
8,Electrocardiogram morphology (amplitude at temporal datapoints) [174 ms],2
8,Carotid intima media thickness [cIMT],7146
8,Lysophosphatidylcholine_16:1_[M+H]1+/Lysophosphatidylethanolamine_19:1_[M+H]1+ levels,1511
8,Serum levels of protein LST1,4263
8,Serum metabolite levels [XS_VLDL_TG],1778
8,Raw vegetable consumption,1282
8,Facial morphology (segment 18),1335
8,Non-cardia gastric cancer,9401
8,Fenofibrate | treatment/medication code,1340
8,Diacylglycerol_36:2_[M+NH4]1+ levels,1511
8,White matter microstructure (radial diusivities) [Sagittal stratum],37
8,"""Hypertension, essential""",72
8,Electrocardiogram morphology (amplitude at temporal datapoints) [220 ms],7043
8,Serum metabolite concentrations in chronic kidney disease [1-arachidonoyl-GPI],1312
8,Serum metabolite levels (CMS) [M_VLDL_PL],1511
8,Endometrial endometrioid carcinoma,154
8,Electrocardiogram morphology (amplitude at temporal datapoints) [0 ms],274
8,Hypospadias,252
8,Protein quantitative trait loci (liver) [EIF4A1],115
8,Brown vs. black hair color,16260
8,3mm weak meridian (left),23897
8,Interleukin-1 receptor-like 1 measurement,7200
8,Blood trace element (Zn levels),8034
8,"Mean arterial pressure x alcohol consumption interaction (2df test) [EA, Hispanic]",5738
8,Serum metabolite levels (CMS) [VLDL_D],1823
8,"Icd10: i64 stroke, not specified as haemorrhage or infarction | underlying (primary) cause of death",124
8,Total cholesterol levels in medium HDL,141
8,Ensifer abundance in stool,167
8,Nervous feelings,25811
8,High cholesterol,8662
8,Heel broadband ultrasound attenuation (left),55390
8,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],4445
8,Problematic alcohol use (MTAG),749
8,Invasive epithelial ovarian cancer,804
8,Electrocardiogram morphology (amplitude at temporal datapoints) [258 ms],2
8,Protein quantitative trait loci (liver) [SERPINA1],7
8,Diverticulosis and diverticulitis,4866
8,Cortical surface area [Superior Temporal],31315
8,Spherical equivalent,14457
8,Hypertensive diseases,4098
8,Salivary metabolite levels [3-ureidopropionate],666
8,Length of mobile phone use,21570
8,Systemic lupus erythematosus [AA],2253
8,Serum metabolite levels (CMS) [SFA],1856
8,"""Hypothyroidism, strict autoimmune, 3 medication purchases required""",2725
8,Diastolic blood pressure [EA],3904
8,Serum metabolite levels [S_VLDL_TG],2090
8,Ejection fraction,499
8,None of the above | vitamin and mineral supplements,165
8,Other obstetric trauma,15
8,Human milk oligosaccharide concentration (lacto-N-fucopentaose III),5
8,Risk taking,14180
8,Serum levels of protein CETP,1297
8,Fractional exhaled nitric oxide (childhood) [EA],136
8,Electrocardiogram morphology (amplitude at temporal datapoints) [58 ms],2
8,Back problem,1033
8,Protein quantitative trait loci (liver) [EPHX2],6451
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-82 ms],2357
8,von Willebrand factor A domain-containing protein 1 measurement,718
8,White matter microstructure (radial diusivities) [Uncinate fasciculus],37
8,Neurofibrillary tangles (SNP x SNP interaction),6461
8,Triglyceride levels in HIV infection [EA],162
8,Urinary metabolites [2.159 ppm/3.324 ppm],298
8,Major depressive disorder vs ADHD (ordinary least squares (OLS)),28
8,"""Abnormal findings on examination of blood, without diagnosis""",9
8,Total cholesterol levels [Trans-ethnic initial],44188
8,Electrocardiogram morphology (amplitude at temporal datapoints) [106 ms],7043
8,Anti-cytomegalovirus IgG levels,3400
8,Longest period of unenthusiasm / disinterest,225
8,Alzheimer's disease in APOE e4+ carriers,728
8,"Sciatica | non-cancer illness code, self-reported",294
8,Hydroxychloroquine | treatment/medication code,310
8,Protein quantitative trait loci (liver) [KATNAL2],34
8,Serum p2 prostate specific antigen levels,5
8,"HDL cholesterol levels [Asian initial, BMI unadjusted]",3668
8,Fruit consumption,2848
8,Serum levels of protein LRP12,858
8,Serum metabolite levels [M_VLDL_CE],227
8,Bone mineral accretion in asthma (oral corticosteroid dose interaction),50
8,Protein quantitative trait loci (liver) [SULT1A1],38
8,Eosinophil percentage of granulocytes,4027
8,Serum uric acid levels,97315
8,Plasma free amino acid levels (adjusted for twenty other PFAAs) [Orn],467
8,Spherical power (right),262
8,Phosphatidylcholine_34:0_[M+H]1+/Phosphatidylethanolamine_37:0_[M+H]1+/Phosphatidate_39:1_[M+NH4]1+ levels,1511
8,Age at first live birth,701
8,Ischemic heart diseases,279
8,Breakfast cereal skipping frequency,206
8,"Heel bone mineral density (bmd) t-score, automated (right)",13598
8,Waist-to-hip ratio adjusted for BMI (age >50) [women],1215
8,"""Inguinal or femoral hernia, bilateral""",1011
8,Percent liver fat,257
8,Spine | fractured bone site(s),20
8,"Blood protein levels [FUT10, 7156_2_3]",32967
8,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test) [EA],18764
8,Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia,7457
8,Left inferior frontal gyrus (orbital part) cortical thickness [EA],436
8,Getting up in morning,5240
8,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),79
8,Autism spectrum disorder or schizophrenia,9113
8,Neuroticism score,36911
8,Plasma plasminogen activator levels,8309
8,Fasting blood glucose (BMI interaction),361
8,Eubacterium R coprostanoligenes abundance in stool,97
8,Chorioretinal inflammation,1
8,Schizophrenia vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),40357
8,Osteoarthritis (hip),9019
8,Major coronary heart disease event,2457
8,Bullous dermatoses,24
8,Electrocardiogram morphology (amplitude at temporal datapoints) [156 ms],2
8,Blood metabolite levels [glutaroyl carnitine],1415
8,Heart rate response to exercise [females],918
8,"For short-sightedness, i.e. only or mainly for distance viewing such as driving, cinema etc (called 'myopia') | reason for glasses/contact lenses",262
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-84 ms],2357
8,Sum basophil neutrophil counts,34134
8,Leisure sedentary behaviour (television watching),10498
8,Metabolic traits [TG],1800
8,Body fat percentage and triglycerides (pairwise),805
8,"""Early lumbar disc prolapse, operated""",1031
8,Ovarian cancer [All invasive],804
8,Electrocardiogram morphology (amplitude at temporal datapoints) [140 ms],2
8,C-reactive protein levels or LDL-cholesterol levels (pleiotropy),828
8,Phosphatidylcholine-O_36:2_[M+H]1+/Phosphatidylcholine-P_36:1_[M+H]1+/Phosphatidylethanolamine-P_39:1_[M+H]1+ levels,2105
8,Crohn's disease [EA],1677
8,Triglyceride levels [EA],3757
8,"Sphingomyelin (d18:1/22:1, d18:2/22:0, d16:1/24:1) levels",8
8,Glaucoma (primary angle closure) [Asian],748
8,Low-grade serous and serous borderline ovarian cancer,137
8,Hip circumference adjusted for BMI,76491
8,"Systolic blood pressure [EA, initial]",22345
8,Protein quantitative trait loci (liver) [HNRNPR],5291
8,Serum levels of protein ST3GAL1,270
8,Rheumatoid arthritis,28280
8,Age when periods started (menarche),39208
8,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],4047
8,C-reactive protein,2431
8,Other non-epithelial cancer of skin,1219
8,Height [Conditioned on rs7460090],596
8,Electrocardiogram morphology (amplitude at temporal datapoints) [4 ms],274
8,Electrocardiogram morphology (amplitude at temporal datapoints) [118 ms],2
8,Red blood cell count,714521
8,Serum levels of protein GGH,6901
8,3mm weak meridian (right),51285
8,Mosaic loss of chromosome Y (Y chromosome dosage),7880
8,Serum metabolite levels (CMS) [M_VLDL_TG],1856
8,CD40 ligand levels,80
8,Disorders of lipoprotein metabolism and other lipidaemias,229
8,Deep venous thrombosis,81
8,Protein quantitative trait loci (liver) [DUSP3],83
8,Electrocardiogram morphology (amplitude at temporal datapoints) [146 ms],2
8,"Blood protein levels [CTSB, 8007_19_3]",14361
8,Metabolic disorders,335
8,Glioma,249
8,Blood protein levels [APOA4],174
8,Eosinophil percentage of white cells,84567
8,Sitting height,113423
8,Serum metabolite levels [VLDL_TG],1511
8,Serum metabolite levels [S_VLDL_P],1778
8,Takayasu arteritis,5144
8,Lung cancer,232
8,Low myopia,175
8,Left eye only | ever had cataract surgery,19
8,Contracture of palmar fascia [dupuytren's disease],18885
8,Had menopause,925
8,Allergic sensitization,56
8,Ascorbate (vitamin c) levels,225
8,Dentures | mouth/teeth dental problems,10844
8,"Multiple myeloma | cancer code, self-reported",200
8,"Lipid metabolism phenotypes [HDL-C.by.NMR, fasting]",1511
8,Cannabis use,1566
8,"Adult diffuse triple positive glioma (IDH and TERT mutations, 1p19q codeletion)",59
8,Immature fraction of reticulocytes,123885
8,Hippocampal volume in normal cognition,1472
8,"Non-hodgkins lymphoma | cancer code, self-reported",574
8,Cleft lip with or without cleft palate,41
8,Electrocardiogram morphology (amplitude at temporal datapoints) [76 ms],2
8,Parental longevity (father's age at death or father's attained age),1728
8,Total PHF-tau (SNP x SNP interaction),33000
8,Skin colour,9792
8,Diastolic blood pressure x alcohol consumption interaction (2df test) [EA],15449
8,Eczema,2544
8,"Blood protein levels [COLEC12, 5457_5_2]",14361
8,O levels/gcses or equivalent | qualifications,5164
8,Other chronic obstructive pulmonary disease,631
8,Cholesteryl ester_16:1_[M+NH4]1+ levels,1562
8,Immunoglobulin light chain (AL) amyloidosis (liver involvement),84
8,Periodontal disease related phenotype (PCT3),4
8,Blood metabolite levels [X-12100--hydroxytryptophan],1084
8,Glomerular filtration rate (creatinine),728
8,Pediatric asthma,873
8,Phosphatidylcholine-2O_32:0_[M+H]1+ levels,1800
8,Triacylglycerol_52:1_[M+NH4]1+ levels,1511
8,Protein quantitative trait loci (liver) [LTF],521
8,Ever smoked,314
8,Migraine without aura and triptan purchases,50
8,Asthma,19676
8,Nontoxic uninodular goiter,2729
8,Colorectal cancer,5969
8,Angina pectoris,4329
8,Ebbinghaus illusion (overestimation),32
8,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test),16938
8,"Forced expiratory volume in 1-second (fev1), predicted percentage",13228
8,Schizophrenia vs ADHD (ordinary least squares (OLS)),4025
8,Nasopharyngeal carcinoma (SNP x SNP interaction),157
8,Plasma free amino acid levels (adjusted for one other PFAA) [Arg (adjusted for Gln],402
8,Myocardial fractal dimension (slice 6),429
8,Spondylolisthesis/Spondylolysis,392
8,OTU97_19 (Bacteria) prevalence,25
8,Volume level set by participant (right),6
8,Asthma (childhood onset),5681
8,Systemic lupus erythematosus [Chinese],2760
8,Electrocardiogram morphology (amplitude at temporal datapoints) [188 ms],7043
8,Body mass index (joint analysis main effects and physical activity interaction) [EA],142
8,Cytokine network levels (multivariate analysis),78
8,"""Benign neoplasm: Skin, unspecified""",32
8,Other benign neoplasms of uterus (controls excluding all cancers),6
8,Leg fat-free mass (left),129046
8,Electrocardiogram morphology (amplitude at temporal datapoints) [166 ms],7043
8,"Smoking initiation (ever regular vs never regular) [Conditioned on chr8:93048104, chr8:92733282]",33
8,Carotenoid levels [Beta Cryptoxanthin],6
8,Corneal hysteresis (left),16125
8,Clobetasone | treatment/medication code,94
8,Recombination measurement [Hotspot usage],24
8,Triglyceride levels,214836
8,Corneal endothelial cell size variation coefficient,27754
8,Total cholesterol levels [EA],2089
8,Diastolic blood pressure [Japanese],7691
8,Balding type 1,4002
8,Nitrogen dioxide air pollution; 2007,1295
8,Glomerular filtration rate in non diabetics (creatinine),653
8,Non-small cell lung cancer,434
8,Endometrial cancer,308
8,Sciatica caused by lumbar disc herniation (treated with microdiscectomy),1020
8,Diacylglycerol_36:3_[M+NH4]1+ levels,1511
8,Protein quantitative trait loci (liver) [CTH],5
8,Barrett's esophagus,41814
8,White blood cell types [monocyte count],491
8,"Blood protein levels [DEFA1, 9250_87_3]",154
8,Otitis media,316
8,Serum levels of protein VEGFA,237
8,Pediatric areal bone mineral density (concordant skeletal phenotype) [female],43
8,Lifetime smoking index,16593
8,Malignant neoplasm of bladder,48750
8,6mm strong meridian (left),48134
8,Alcohol consumption x experiences in childhood (felt loved by family member) interaction,391
8,Average weekly beer plus cider intake,32
8,Sinemet-62.5 tablet | treatment/medication code,92
8,Platelet count,569391
8,Schizophrenia [EA],1935
8,Serum metabolite levels [M_VLDL_TG],1856
8,Eosinophill percentage,52630
8,Facial morphology (columella inclination),2955
8,Usual walking pace,2615
8,Pancreas fat,6
8,Protein quantitative trait loci (liver) [NDUFAB1],2
8,Systolic blood pressure (cigarette smoking interaction),19755
8,Dupuytren's disease,33624
8,Hand grip strength,4824
8,Serum metabolite levels [TG_PG],1511
8,Serum metabolite levels (CMS) [L_HDL_PL],1511
8,Malignant neoplasm of digestive organs (controls excluding all cancers),84
8,"Alcohol use disorder [AA, women]",18
8,Response to lurasidone in schizophrenia [EA],2
8,Electrocardiogram morphology (amplitude at temporal datapoints) [116 ms],2
8,Menopause (age at onset),6157
8,Alpha-galactosidase A measurement,4479
8,Respiratory or ear-nose-throat disease,1161
8,"""Disorders of gallbladder, biliary tract and pancreas""",3795
8,Triglyceride levels in current drinkers [Hispanic],1770
8,Dorsopathies,118
8,Spirochaetia abundance in stool,5
8,Smoking initiation (ever regular vs never regular),20465
8,"Heel bone mineral density (bmd) t-score, automated",129020
8,Hand grip strength (left),1081
8,Regular attendance at a religious group,5581
8,Diabetes mellitus,1170
8,Vertical cup-disc ratio (multi-trait analysis),472
8,Type 2 diabetes with ophthalmic manifestations,70
8,5-oxoproline levels,282
8,Electrocardiogram morphology (amplitude at temporal datapoints) [248 ms],2
8,Sodium in urine,6843
8,Time spent using computer,10342
8,Serum metabolite levels (CMS) [XL_VLDL_C],375
8,Topiramate | treatment/medication code,751
8,Electrocardiogram morphology (amplitude at temporal datapoints) [10 ms],683
8,Electrocardiogram morphology (amplitude at temporal datapoints) [198 ms],2
8,Triacylglycerol_51:3_[M+NH4]1+ levels,1556
8,Electrocardiogram morphology (amplitude at temporal datapoints) [222 ms],7043
8,Sodium bicarbonate | treatment/medication code,391
8,Protein quantitative trait loci (liver) [AGT],20
8,Protein quantitative trait loci (liver) [SND1],34
8,"Triglyceride levels [Asian initial, BMI unadjusted]",3897
8,Triacylglycerol_51:2_[M+NH4]1+ levels,1645
8,Neurociticism,6257
8,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],4857
8,Electrocardiogram morphology (amplitude at temporal datapoints) [228 ms],7043
8,Cardiovascular disease risk factors [HDL],1823
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-6 ms],274
8,Protein quantitative trait loci (liver) [CFL1],5
8,"Blonde | hair colour (natural, before greying)",23283
8,Length of menstrual cycle,452
8,Inflammatory bowel disease,790
8,Smoking initiation (ever regular vs never regular) [Conditioned on chr8:10763655],417
8,Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes [AA],13
8,Neutrophil count,346587
8,Dilated cardiomyopathy (MTAG),6833
8,CD8dim Natural Killer T %lymphocyte,7223
8,"Smoking initiation (ever regular vs never regular) [Conditioned on chr8:93190014, chr8:93048104, chr8:92733282]",15965
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-92 ms],3554
8,Primary open-angle glaucoma,2046
8,Sleeplessness / insomnia,640
8,Protein quantitative trait loci (liver) [PARVA],5
8,Keratoconus,11733
8,Facial ageing,851
8,Crohn's disease,2691
8,HDL cholesterol levels [BMI unadjusted],3449
8,"Heart/cardiac problem | non-cancer illness code, self-reported",183
8,Choline phosphate levels,33
8,Direct low density lipoprotein cholesterol levels,59598
8,Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis),29838
8,Cortical thickness,51752
8,Smoking status (current vs never),767
8,Intracranial aneurysm,17173
8,"""Malignant neoplasm of breast, HER2-negative (controls excluding all cancers)""",262
8,Gut microbiota (bacterial taxa) [OTU10032 unclassified Enterobacteriaceae Species-level OTU],234
8,Cortical surface area,82281
8,Body fat distribution (trunk fat ratio) [females],1190
8,Nectin-2 levels,235
8,Prostate cancer [Japanese and Latin American],81
8,Electrocardiogram morphology (amplitude at temporal datapoints) [72 ms],2
8,Electrocardiogram morphology (amplitude at temporal datapoints) [256 ms],2
8,Response to interferon beta therapy,55
8,Body mass index [EA],142
8,Myopia (severe),492
8,Electrocardiogram morphology (amplitude at temporal datapoints) [154 ms],2
8,Electrocardiogram morphology (amplitude at temporal datapoints) [200 ms],2
8,Medication use (thyroid preparations),63122
8,Leg fat percentage (left),59625
8,Experiencing mood swings,6286
8,"Blood protein levels [CTSB, 3061_61_2]",14361
8,"""Persons encountering health services for other counselling and medical advice, not elsewhere classified""",33209
8,Corneal curvature,873
8,Hip circumference adjusted for BMI [EA],2346
8,Phosphatidylcholine-O_34:2_[M+H]1+/Phosphatidylcholine-P_34:1_[M+H]1+/Phosphatidylethanolamine-O_37:2_[M+H]1+ levels,1826
8,"Blood protein levels [EA, Carbonic anhydrase 13]",794
8,"""Gonarthrosis,primary""",44
8,Electrocardiogram morphology (amplitude at temporal datapoints) [242 ms],2
8,Smoking initiation (ever regular vs never regular) (MTAG),88456
8,Waist-hip index,82906
8,Ulcerative colitis,6663
8,Urinary metabolite levels in chronic kidney disease [5-acetylamino-6-amino-3-methyluracil],298
8,Serum metabolite levels (CMS) [XL_VLDL_L],379
8,Colorectal polyp and colorectal cancer (MTAG) [Colorectal polyp],616
8,Protein quantitative trait loci (liver) [ATIC],83
8,Plateletcrit,131320
8,"Bone mineral density (paediatric, skull) [EA]",2505
8,"""Rheumatoid arthritis , including avohilmo""",10312
8,Coagulation factor Xa measurement,267
8,Adenine levels,58
8,Metabolite levels (small molecules and protein measures) [Glycine],254
8,Metabolic syndrome [HDL],1548
8,Other specified/unspecified systemic involvement of connective tissue,6524
8,"Blood metabolite ratios [X-04499--3,4-dihydroxybutyrate/C-glycosyltryptophan]",3745
8,Protein quantitative trait loci (liver) [EIF2B1],1
8,High light scatter reticulocyte percentage of red cells,101414
8,Blood metabolite levels [X-14625],21960
8,Daytime nap,23307
8,Triglyceride levels [Hispanic],1525
8,Ease of skin tanning,4322
8,OTU99_35 (Ruminococcus) prevalence,1605
8,Cystic kidney disease,12
8,Spherical equivalent [EA],170
8,Electrocardiogram morphology (amplitude at temporal datapoints) [82 ms],2
8,Osteoarthrosis,24877
8,TPE interval (resting) [women],767
8,Sphingomyelin_39:1_[M+H]1+ levels,1826
8,Serum levels of protein SELPLG,537
8,"Cellulitis and abscess of leg, except foot",8423
8,Neutrophil percentage of granulocytes,1515
8,Major depressive disorder (unexposed to adversity),1045
8,Waist circumference adjusted for BMI (adjusted for smoking behaviour) [women],1215
8,X-23308 levels,315
8,Glycated hemoglobin levels,75020
8,Tumor necrosis factor receptor 2 levels,15332
8,Levothyroxine sodium | treatment/medication code,31875
8,Creutzfeldt-Jakob disease (variant),874
8,Recent worrying too much about different things,486
8,Atopic dermatitis (moderate to severe) [general],612
8,Cortical surface area (min-P),9003
8,SSC-A on monocyte,41906
8,Blood glucose levels,28375
8,Type 1 diabetes,4798
8,Body fat distribution (leg fat ratio) [females],800
8,CD64 on monocyte,10
8,Electrocardiogram morphology (amplitude at temporal datapoints) [100 ms],2
8,Time to complete round,4953
8,Triglyceride levels in current drinkers,2919
8,Mild influenza (H1N1) infection,288
8,"Adenosine 3',5'-cyclic monophosphate (camp) levels",255
8,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Asian],259
8,Chronic kidney disease [eGFRcrea],663
8,Optic disc area [EA],101
8,Osteoarthritis of the hip (hospital diagnosed),42783
8,Breast cancer,15251
8,Liver injury in anti-tuberculosis drug treatment [recessive],377
8,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction),77
8,Number of days/week walked 10+ minutes,207
8,Body mass index and triglycerides (pairwise),522
8,Pancreas volume,6
8,Injury of eye and orbit,21
8,Electrocardiogram morphology (amplitude at temporal datapoints) [202 ms],2
8,Monocyte percentage of white cells,56300
8,Serum levels of protein RRM2B,9302
8,Systemic sclerosis [EA],1083
8,"Pulse pressure x alcohol consumption interaction (2df test) [Asian, EA]",1457
8,"Prolapsed disc/slipped disc | non-cancer illness code, self-reported",1096
8,Chronic obstructive pulmonary disease [conditional on rs9329170],230
8,Serum levels of protein PDGFD,78
8,Homeostasis model assessment of insulin resistance in less-fat diet,31
8,Protein quantitative trait loci (liver) [SBDS],18
8,Macular thickness,19429
8,Apolipoprotein B levels,177399
8,Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis),28320
8,"Hip circumference adjusted for BMI [EA, women]",1020
8,Dosulepin | treatment/medication code,337
8,Myocardial infarction,13235
8,Tense / 'highly strung',36599
8,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test) [EA],18764
8,Type 2 diabetes or prostate cancer (pleiotropy),866
8,Diacylglycerol_38:5_[M+H-H2O]1+ levels,267
8,Sphingomyelin_40:0_[M+H]1+ levels,1849
8,Depressive symptoms,4529
8,Phosphatidylcholine-O_44:5_[M+H]1+/Phosphatidylcholine-P_44:4_[M+H]1+ levels,205
8,Protein quantitative trait loci (liver) [ALDH16A1],25
8,Processed meat consumption,15888
8,Cancer,183
8,Multiple myeloma,30
8,Electrocardiogram morphology (amplitude at temporal datapoints) [224 ms],7043
8,Diastolic blood pressure [East Asian],6666
8,N-acetyl-beta-alanine levels,1723
8,Birth weight of first child,383
8,Systolic blood pressure x smoking status (current vs non-current) interaction (1df test) [African],40
8,Neutrophil percentage of white cells,83206
8,Diffuse plaques (SNP x SNP interaction),1214
8,Serum metabolite levels (CMS) [S_VLDL_C],1856
8,Varicose veins of lower extremity,2434
8,Metabolically unhealthy in normal weight,1711
8,Disc problem,1033
8,Erosive tooth wear (severe vs non-severe) [male],968
8,Metformin | treatment/medication code,51
8,"""Hypothyroidism, levothyroxin purchases""",8984
8,"Hayfever, allergic rhinitis or eczema | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",1081
8,Phosphatidylcholine_36:7_[M+OAc]1-/Phosphatidylserine_40:6_[M-H]1- levels,285
8,"""Atopic  dermatitis, strict definition""",388
8,Colorectal cancer (controls excluding all cancers),84
8,Electrocardiogram morphology (amplitude at temporal datapoints) [60 ms],2
8,Peptic ulcer (excl. esophageal),22548
8,General cognitive ability,20943
8,Body size at age 10,31538
8,Sensitivity / hurt feelings,39861
8,"Blood protein levels [RRM2B, 8854_59_3]",4704
8,Lumbar spine bone mineral density,4694
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-184 ms],1183
8,Female infertility,379
8,Coronary artery disease,34199
8,Triglyceride levels x short total sleep time interaction (2df test),3660
8,Cholecystitis,3790
8,White matter microstructure (radial diusivities) [Genu of corpus callosum],39274
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-182 ms],1183
8,Other heart diseases,81
8,"""Diabetes, insuline treatment (Kela reimbursement)""",51
8,Body fat distribution (arm fat ratio) [females],21833
8,Rectal cancer,70
8,Facial morphology (columella size),5341
8,Vestibular neuritis,8
8,Protein quantitative trait loci (liver) [RSU1],5
8,Sum neutrophil eosinophil counts,34090
8,Ribitol levels,390
8,Serum metabolite levels (CMS) [M_VLDL_P],1511
8,Prostate cancer [conditional],6
8,"Heel bone mineral density (bmd) t-score, automated (left)",80610
8,Sunburns,802
8,6mm strong meridian (right),11302
8,Palmar fascial fibromatosis [Dupuytren],30062
8,Serum levels of protein SCARA5,1548
8,"Lipid metabolism phenotypes [TG.by.NMR, fasting]",1856
8,Lipid traits [Triglycerides],1856
8,Serum metabolite levels (CMS) [S_HDL_TG],1856
8,Chylomicron and largest VLDL particle concentration,335
8,Optic cup area,274
8,Vitamin a | treatment/medication code,183
8,Migraine,32
8,Diffuse large B cell lymphoma,97
8,Thyroid problem (not cancer),72993
8,Free thyroxine concentration,551
8,Serum metabolite levels (CMS) [S_VLDL_L],2083
8,Glycine levels,1954
8,Electrocardiogram morphology (amplitude at temporal datapoints) [160 ms],2
8,Arm fat-free mass (left),102100
8,Urinary albumin excretion,269
8,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],3359
8,Cholesteryl ester(20:3)_[M+NH4]1+ levels,1674
8,Alcohol use disorder (total score),46
8,Glycated haemoglobin HbA1c levels adjusted for BMI,68
8,Other and unspecified dermatitis,19
8,Fibrinogen levels,126840
8,Waist-to-hip ratio adjusted for body mass index [EA],1275
8,Drive faster than motorway speed limit,160
8,Electrocardiogram morphology (amplitude at temporal datapoints) [162 ms],2
8,Ankle spacing width (left),56911
8,Age-related macular degeneration,2509
8,"Helicobacter pylori | non-cancer illness code, self-reported",349
8,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),5961
8,"Waist-to-hip ratio adjusted for body mass index [EA, women]",2404
8,Adiponectin levels,732
8,"Blood protein levels [ST3GAL1, 5657_28_3]",363
8,"""Ischaemic heart disease, wide definition""",184
8,LDL cholesterol levels [Asian],150
8,Nontoxic nodular goiter,125
8,Protein quantitative trait loci (liver) [ME1],19
8,Fasting glucose,20090
8,"Systolic blood pressure x alcohol consumption interaction (2df test) [EA, Hispanic]",5946
8,Diisocyanate-induced asthma,400
8,Maximum habitual alcohol consumption,1699
8,(N(1) + N(8))-acetylspermidine levels,3577
8,1-carboxyethylvaline levels,180
8,Serum metabolite levels [4-acetamidobutanoate],343
8,"Blood protein levels [EA, Tumor necrosis factor receptor superfamily member EDAR]",75
8,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),79
8,Serum levels of protein SPTLC2,1
8,Hypertension,141915
8,Ever used hormone-replacement therapy (hrt),818
8,Serum levels of protein PRDX3,3982
8,Insomnia [Female],3331
8,Triglyceride levels [conditional on round 2],111
8,Parental longevity (father's attained age),142
8,HDL cholesterol,83663
8,acne vulgaris,10796
8,Coronary artery bypass grafting,2801
8,Serum metabolite levels [M_VLDL_FC],2231
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-36 ms],13834
8,Other intervertebral disc disorders,1031
8,Protein quantitative trait loci (liver) [SDS],29
8,Serum levels of protein FCN3,122
8,Morningness,12992
8,Non-albumin protein levels,51991
8,Colorectal cancer [East Asian],985
8,Left-handedness,629
8,2-hydroxyadipate levels,219
8,Vertex-wise sulcal depth,155250
8,Basal metabolic rate,67005
8,"""Cholelithiasis, broad definition with cholecystitis""",3300
8,Bone mineral density (hip),5466
8,Serum levels of protein ASPH,1760
8,Serum metabolite levels [L_VLDL_C],375
8,"Intra-ocular pressure, corneal-compensated (left)",275
8,Erythrocyte cadmium concentration in never smokers,63026
8,Serum urea levels,5529
8,Pulse pressure x alcohol consumption interaction (2df test) [EA],10634
8,vWF levels,661
8,Serum levels of protein COCH,78
8,Protein quantitative trait loci (liver) [AP1B1],34
8,Macrophage colony stimulating factor levels,2
8,Hands-free device/speakerphone use with mobile phone in last 3 month,24217
8,Bendroflumethiazide | treatment/medication code,15604
8,"Disorders of muscle, ligament, and fascia",18063
8,Age-related hearing impairment (MTAG),8097
8,"Sphingomyelin (d18:2/16:0, d18:1/16:1) levels",1954
8,Protein quantitative trait loci (liver) [CAPNS1],394
8,Distance between home and job workplace,77
8,Protein quantitative trait loci (liver) [FN3K],11
8,Cognitive performance (MTAG) [MTAG],55515
8,KELA_REIMBURSEMENT_202,3811
8,Facial morphology (segment 1),6519
8,Phosphatidylcholine_34:1_[M+H]1+/Phosphatidylethanolamine_37:1_[M+H]1+/Phosphatidate_39:2_[M+NH4]1+ levels,1511
8,Glycemic traits (pregnancy) [FCP],245
8,Left ventricular global circumferential strain,410
8,Dickkopf-related protein 1 levels,78
8,"Infective/viral hepatitis | non-cancer illness code, self-reported",142
8,Height,641860
8,Snoring,262322
8,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Asian],1777
8,"""Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium""",240
8,Esophageal disorder,29
8,Medication use (antithrombotic agents),2195
8,Direct bilirubin levels,26032
8,Epilepsy,2489
8,Serum metabolite levels (CMS) [HDL_TG],1856
8,Electrocardiogram morphology (amplitude at temporal datapoints) [134 ms],6425
8,Hypertension [East Asian],7717
8,Serum metabolite levels (CMS) [VLDL_TG],1511
8,Diaphragmatic hernia,3154
8,Waist circumference adjusted for body mass index [EA],85
8,Protein quantitative trait loci (liver) [TTN],521
8,Urticaria,922
8,Age completed full time education,2589
8,Gut microbiota (bacterial taxa) [OTU10032 unclassified Enterobacteriaceae],34
8,"Cholesterol, total",95844
8,Total cholesterol levels [conditional],10903
8,Positive affect,4846
8,Basophill percentage,11358
8,Prolapsed or slipped disc,1033
8,Triglyceride levels in chylomicrons and largest VLDL,227
8,Eosinophil counts,291701
8,Serum metabolite levels (CMS) [S_VLDL_FC],1856
8,Sphingomyelin_36:0_[M+H]1+ levels,1800
8,Problematic alcohol use,1814
8,Pulmonary function decline [FEV1/FVC decline in asthmatics],1186
8,Triacylglycerol(52:3)_[M+NH4]1+ levels,1683
8,OTU97_34 (Ruminococcus) prevalence,1605
8,Cannabis use disorder [EA],69
8,General risk tolerance (MTAG),80499
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-96 ms],3554
8,Respiratory diseases,1143
8,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],1770
8,Triacylglycerol_50:4_[M+NH4]1+ levels,1546
8,Headache,1065
8,Nasal polyps,1874
8,Waist circumference adjusted for BMI in non-smokers,1020
8,"Cholesterol lowering medication | medication for cholesterol, blood pressure or diabetes",3229
8,Diacylglycerol_36:3_[M+H-H2O]1+ levels,1511
8,Cerebrospinal fluid t-tau:AB1-42 ratio,403
8,Serum metabolite levels [MUFA],267
8,Body mass index [Male],58
8,C-reactive protein levels or triglyceride levels (pleiotropy),19245
8,Facial morphology (segment 63),2266
8,Essential hypertension (time to event),374
8,Alcohol consumption,86
8,Diacylglycerol(36:2)_[M+H-H2O]1+ levels,1657
8,Triacylglycerol_53:3_[M+NH4]1+ levels,1580
8,Sweet biscuits intake,671
8,"Emphysema imaging phenotypes [Perc15, All]",333
8,Cerebrospinal fluid sTREM-2 levels,40
8,"""Pain (limb, back, neck, head abdominally)""",14
8,Migraine without aura,5164
8,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)",30348
8,Subcortical volume (min-P),26146
8,HDL cholesterol levels in current drinkers [AA],1820
8,Bilirubin levels,35151
8,Metabolic biomarkers (multivariate analysis),27912
8,No | hearing difficulty/problems,25705
8,"""Type 2 diabetes, wide definition""",522
8,Cannabis dependence symptom count,12
8,Autoimmune thyroid disease,70029
8,Serum metabolite levels (CMS) [Serum_TG],1890
8,Urinary albumin-to-creatinine ratio,4251
8,Frequency of needing morning drink of alcohol after heavy drinking session in last year,59
8,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),3076
8,Body mass index (bmi),84550
8,Leg predicted mass (right),127826
8,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],5583
8,Childhood body mass index,1155
8,Epithelial ovarian cancer,1724
8,Triacylglycerol_52:3_[M+NH4]1+ levels,1511
8,"Atopic dermatitis [EA, fixed effects]",646
8,Menopause (age at onset) [Japanese],381
8,Atrial fibrillation [EA],35116
8,White matter microstructure (radial diusivities) [Fornix (cres) / Stria terminalis],23693
8,IgD- CD38dim B cell %lymphocyte,39274
8,Triacylglycerol_52:5_[M+NH4]1+ levels,1525
8,Trunk fat-free mass,109536
8,Cholelithiasis,14501
8,Serum levels of protein CELA1,1021
8,"Blood protein levels [LRP12, 7744_10_3]",858
8,Delta-5 desaturase activity response to n3-polyunsaturated fat supplement,42
8,"Parental longevity (combined parental attained age, Martingale residuals)",814
8,Facial morphology (segment 48),802
8,Haemoglobin concentration,47796
8,HDL cholesterol levels x long total sleep time interaction (2df test),3313
8,Metabolite levels (lipoprotein measures) [Triglycerides in small VLDL],1845
8,Thyroid cancer,2902
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-100 ms],3540
8,Phosphatidylcholine-O_36:1_[M+H]1+/Phosphatidylcholine-P_36:0_[M+H]1+/Phosphatidylethanolamine-O_39:1_[M+H]1+ levels,1826
8,Type 2 diabetes [conditional],545
8,Body mass index and HDL-C (pairwise),522
8,Neuroticism,288695
8,HDL cholesterol levels,95109
8,Hearing difficulty/problems with background noise,7507
8,Adult diffuse glioma (IDH mutation only),62
8,Left atrial active emptying fraction,249
8,Medication use (diuretics),54533
8,Electrocardiogram morphology (amplitude at temporal datapoints) [236 ms],7043
8,Hirschsprung disease,172
8,Stem cell factor levels,366
8,Peripheral arterial disease x type 2 diabetes interaction,358
8,Rheumatoid arthritis [AA],69
8,Heel bone mineral density T score,140171
8,Serum levels of protein DNAJB12,23714
8,"Heel broadband ultrasound attenuation, direct entry",108822
8,Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test),1215
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-22 ms],233
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-90 ms],2371
8,Number of incorrect matches in round,2825
8,Triglyceride levels x long total sleep time interaction (2df test),2205
8,Schizophrenia vs bipolar disorder (ordinary least squares (OLS)),688
8,Serum metabolite levels [VLDL_C],2235
8,Estradiol plasma levels (breast cancer),243
8,Cerebrospinal fluid beta-site APP cleaving enzyme levels,78
8,Response to serotonin-norepinephrine reuptake inhibitors (responders vs non-responders),62
8,Electrocardiogram morphology (amplitude at temporal datapoints) [12 ms],409
8,Blond vs. brown/black hair color,20304
8,"Heavy diy (eg: weeding, lawn mowing, carpentry, digging) | types of physical activity in last 4 weeks",1727
8,LDL cholesterol levels x short total sleep time interaction (2df test),2385
8,Low density lipoprotein cholesterol levels,363619
8,Overall health rating,10631
8,Basophil count,134288
8,"Hypertension | non-cancer illness code, self-reported",78053
8,Phosphatidylcholine-O_32:0_[M+H]1+/Phosphatidylethanolamine-O_35:0_[M+H]1+ levels,1663
8,Time to smoke first cigarette in the morning,742
8,Pancreatic cancer,401
8,Serum thyroid-stimulating hormone levels,693
8,Benign neoplasm of breast,50
8,Surgical necrotising enterocolitis in extremely premature birth,4
8,Electrocardiogram morphology (amplitude at temporal datapoints) [246 ms],2
8,Mouth breathing,2
8,Smoking cessation (MTAG),2540
8,Ankle-brachial index [Caribbean],1144
8,Liver enzyme levels (alkaline phosphatase),51364
8,Serum levels of protein CTSB,15998
8,White matter microstructure (fractional anisotropy) [Inferior fronto-occipital fasciculus],37567
8,Diacylglycerol_36:2_[M+H-H2O]1+ levels,1616
8,HDL cholesterol [Hispanic],175
8,Triacylglycerol_52:2_[M+NH4]1+ levels,1527
8,Smoking status (ever vs never smokers),29863
8,CD8dim Natural Killer T %T cell,7223
8,Urinary metabolite levels in chronic kidney disease [1-methylurate],298
8,Fat-free mass,6498
8,Serum metabolite levels [2-hydroxystearate],464
8,"""Malignant neoplasm of breast, HER-positive (controls excluding all cancers)""",266
8,Plasma free amino acid levels (adjusted for twenty other PFAAs) [Arg],1464
8,Childhood sunburn occasions,29876
8,Cellulitis and abscess of arm/hand,8940
8,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],4374
8,Cholesterol ester levels in medium HDL,1518
8,Fibrosis-4 index in high alcohol intake,81
8,"Deep venous thrombosis (dvt) | non-cancer illness code, self-reported",81
8,Paralytic ileus,397
8,Gut microbiota relative abundance (bacterial taxa) [Lentisphaerae],36
8,Thyroid stimulating hormone levels,1663
8,Comparative body size at age 10,9802
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-104 ms],1449
8,Benign neoplasm of breast (controls excluding all cancers),52
8,Urate levels,322314
8,Bipolar disorder (MTAG),133187
8,Protein quantitative trait loci (liver) [RPL30],4856
8,3mm cylindrical power angle (left),398
8,Protein quantitative trait loci (liver) [HAO1],99
8,Serum metabolite levels [5-acetylamino-6-formylamino-3-methyluracil],343
8,Vertex-wise cortical thickness,107612
8,Fibroblastic disorders,30114
8,Pulmonary arterial hypertension,438
8,Smoking initiation (ever regular vs never regular) [Conditioned on chr8:27425349],192
8,Celiac disease or Rheumatoid arthritis,82
8,Response to paliperidone in schizophrenia (negative Marder score) [GLM],13
8,Essential hypertension,27841
8,Statin medication,44693
8,Mental and behavioural disorders due to opioids,20
8,Home location at assessment - north co-ordinate (rounded),137
8,1-stearoyl-2-arachidonoyl-gpc (18:0/20:4) levels,213
8,Pericarditis,25
8,Bone mineral density (hip) and hip bone size,2
8,Triglycerides,141831
8,Sum eosinophil basophil counts,5821
8,Urinary tract infection frequency,22719
8,Duodenal ulcer,47085
8,Immature reticulocyte fraction,34827
8,Malignant neoplasm of stomach (controls excluding all cancers),22548
8,Carotid intima media thickness (mean) [men],826
8,C-reactive protein levels or HDL-cholesterol levels (pleiotropy),2434
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-98 ms],1197
8,Electrocardiogram morphology (amplitude at temporal datapoints) [192 ms],2
8,Protein quantitative trait loci (liver) [TAGLN2],5
8,Lymphocyte counts,411188
8,Age of smoking initiation (MTAG),8938
8,Schizophrenia (MTAG),105987
8,Leg fat mass (right),36538
8,Granulocyte percentage of myeloid white cells,24116
8,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Hispanic],1777
8,Offspring birth weight,6269
8,Metabolic syndrome (bivariate traits) [HDLC-WC],451
8,Body fat distribution (leg fat ratio),800
8,"""Other dorsopathies, not elsewhere classified""",94
8,Glaucoma (primary open-angle) [NPG],52
8,Bilateral cleft lip and palate,11
8,Serum levels of protein FGL1,34846
8,Impedance of arm (left),63970
8,Cerebrospinal fluid biomarker levels [R-spondin-2],1066
8,Self-rated health,346
8,Depressive symptoms (MTAG),326
8,Hypertension [Japanese],7691
8,Pattern 1 | hair/balding pattern,3829
8,Urinary metabolite levels in chronic kidney disease [5-acetylamino-6-formylamino-3-methyluracil],298
8,"""Type 2 diabetes, definitions combined""",610
8,Bumetanide | treatment/medication code,504
8,Disorders of breast,297
8,Electrocardiogram morphology (amplitude at temporal datapoints) [132 ms],2
8,Serum metabolite levels [M_VLDL_PL],1511
8,High blood pressure | vascular/heart problems diagnosed by doctor,57241
8,Number of cigarettes currently smoked daily (current cigarette smokers),2620
8,Diacylglycerol_34:3_[M+H-H2O]1+ levels,1800
8,Serum metabolite levels [L_VLDL_PL],1511
8,"Angina | non-cancer illness code, self-reported",1511
8,Serum immune biomarker levels [YKL-40],143
8,Doctor diagnosed copd (chronic obstructive pulmonary disease),43
8,Phosphatidylcholine levels [PC(16:0;0-16:0;0],15281
8,"Blood protein levels [UNC5D, 5140_56_3]",716
8,Protein quantitative trait loci (liver) [CNN3],5
8,Diverticular disease,4828
8,Highest math class taken,43118
8,Waist circumference,24835
8,Electrocardiogram morphology (amplitude at temporal datapoints) [170 ms],13466
8,Plays computer games,24494
8,Endometrial cancer (endometrioid histology),158
8,Triacylglycerol_53:2_[M+NH4]1+ levels,1631
8,Arm fat percentage (left),43173
8,Sphingomyelin_38:2_[M+H]1+ levels,1826
8,Phosphatidylcholine-O_36:4_[M+H]1+/Phosphatidylcholine-P_36:3_[M+H]1+ levels,1613
8,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [4-acetamidobutanoate, allo-threonine, N-acetylputrescine]",298
8,Protein quantitative trait loci (liver) [NNT],111
8,Serum levels of protein CST7,78
8,"""Diabetes, insuline treatment (Kela reimbursement) (more control exclusions)""",51
8,Diastolic blood pressure (cigarette smoking interaction),19755
8,Citramalate levels,5528
8,Breast size,834
8,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [women],1101
8,Left ventricular internal dimension in systole,499
8,Daytime dozing / sleeping (narcolepsy),155
8,Cancer (pleiotropy)(bidirectional),92
8,"Blood protein levels [ASPH, 6998_106_3]",35
8,Protein quantitative trait loci (liver) [CYP3A5],18
8,Femur bone mineral density x serum urate levels interaction [male],990
8,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),5583
8,Serum metabolite levels [VLDL_D],1823
8,Left ventricular internal dimension in diastole,499
8,Eosinophilic esophagitis,156
8,6mm weak meridian (left),26940
8,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Hispanic],1820
8,"""Hypothyroidism,  other/unspecified""",2641
8,Graves' disease,3148
8,Estimated glomerular filtration rate in non-diabetics,544
8,Early age-related macular degeneration,606
8,Protein quantitative trait loci (liver) [ABHD14B],83
8,White matter microstructure (fractional anisotropy) [Sagittal stratum],37
8,"""Diseases of arteries, arterioles and capillaries (FINNGEN)""",15
8,Oily fish intake,4963
8,Haematocrit percentage,36943
8,White matter microstructure (mode of anisotropy) [Average across all tracts],766
8,Late-onset myasthenia gravis,514
8,Protein quantitative trait loci (liver) [TYMP],5
8,Time spent watching television (tv),15670
8,Urea levels,3645
8,Electrocardiogram morphology (amplitude at temporal datapoints) [238 ms],7043
8,"Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",5160
8,"Systolic blood pressure x alcohol consumption interaction (2df test) [Asian, EA]",3556
8,Serum metabolite levels (CMS) [XL_VLDL_CE],375
8,Platelet-derived growth factor subunit B levels,81
8,FEV1,27350
8,Severe gastric atrophy,9401
8,"Blood protein levels [RMDN1, 7096_30_3]",19023
8,Triglyceride levels x smoking (current vs non smokers) interaction (2df test),338
8,Paget's disease,561
8,Plasminogen activator inhibitor 1 measurement,78
8,Hematocrit,195452
8,Hypothyroidism or myxedema,80607
8,High density lipoprotein cholesterol levels [EA],3549
8,Body mass index (joint analysis main effects and physical activity interaction),142
8,Protein quantitative trait loci (liver) [PABPC1],34
8,Hip bone size,2
8,Mean platelet volume,426687
8,C-reactive protein levels,51383
8,Parkinson's disease or first degree relation to individual with Parkinson's disease,26134
8,"Waist circumference adjusted for body mass index [EA,women]",1300
8,Thyroid hormone levels [TSH - Females],409
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-80 ms],2357
8,Colchicine | treatment/medication code,1459
8,Systemic lupus erythematosus or rheumatoid arthritis [same effect],3234
8,Type 2 diabetes [Lean],51
8,Triglyceride levels [Trans-ethnic initial],5569
8,Corneal resistance factor (left),19478
8,Serum levels of protein PRELP,1297
8,X-24686 levels,114
8,Haemorrhoidal disease,115209
8,Left | usual side of head for mobile phone use,14864
8,"Blood protein levels [RRM2B, 8925_25_3]",4704
8,Pork consumption,3852
8,Caffeine consumption from coffee or tea,310
8,"Waist-to-hip ratio adjusted for BMI in active individuals [EA, women]",1110
8,Serum metabolite levels [XXL_VLDL_C],375
8,Blood metabolite levels [levulinate (4-oxovalerate],67
8,"Fracture lower leg / ankle | non-cancer illness code, self-reported",166
8,Protein quantitative trait loci (liver) [RMDN3],2
8,Brain morphology (MOSTest),93818
8,Heel broadband ultrasound attenuation (right),16685
8,Feeling tense,3125
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-188 ms],1183
8,Early-onset Parkinson's disease,169
8,Had major operations,339
8,Nifedipine | treatment/medication code,16
8,White matter microstructure (mean diusivities) [Genu of corpus callosum],39274
8,Body fat distribution (trunk fat ratio),800
8,Diacylglycerol_34:1_[M+H-H2O]1+ levels,2093
8,Celiac disease and Rheumatoid arthritis,137
8,Prostate cancer [European],1508
8,"Blood protein levels [GFRA2, 2515_14_3]",1151
8,Protein quantitative trait loci (liver) [FLNA],5
8,Mean arterial pressure [Japanese],7124
8,Glucose levels,19352
8,Impedance of leg (right),156193
8,Monocyte percentage,18911
8,Facial morphology (segment 3),5616
8,Serum metabolite levels [2-hydroxypalmitate],728
8,Protein quantitative trait loci (liver) [GSTK1],114
8,Protein quantitative trait loci (liver) [FKBP1A],5
8,Serum levels of protein TOM1L1,86
8,Systemic sclerosis,10016
8,Kawasaki disease,18182
8,Fasting triglyceride levels,1511
8,Spherical power (left),1138
8,Type 2 diabetes [Japanese],529
8,"Emphysema imaging phenotypes [%LAA-950, All]",327
8,Male puberty timing (age at voice breaking MTAG),205
8,Keratitis and keratoconjunctivitis in other diseases classified elsewhere,49
8,Cortical surface area [Pars Opercularis],67478
8,Disorders of lipoid metabolism,3432
8,"Blood protein levels [FAM163A, 6260_14_3]",1376
8,None of the above | pain type(s) experienced in last month,152
8,"Heel quantitative ultrasound index (qui), direct entry",129020
8,Heel bone mineral density (bmd),129890
8,Worry,3915
8,Protein quantitative trait loci (liver) [ARHGDIB],5
8,Unilateral cleft lip,1
8,5-methylthioadenosine (mta) levels,2243
8,Serum metabolite levels (CMS) [TG_PG],1511
8,Protein quantitative trait loci (liver) [SHMT2],156
8,Alcohol consumption x traumatic event in childhood (felt hated by family member) interaction,6
8,White matter microstructure (radial diusivities) [Corticospinal tract ],2318
8,Serum levels of protein LGMN,1933
8,"Schizophrenia, schizoaffective disorder or bipolar disorder",5
8,Mean arterial pressure [East Asian],6779
8,Whole body fat-free mass,129268
8,Supervision of high-risk pregnancy,20
8,Fresh fruit intake,38
8,3mm regularity index (left),12
8,Multiple sclerosis,57963
8,Blood metabolite levels [Aspartic acid],15163
8,Pre-treatment viral load in HIV-1 infection,1230
8,Serum metabolite levels [L_VLDL_TG],1511
8,Mean arterial pressure x alcohol consumption interaction (2df test) [EA],4240
8,Triglycerides-Blood Pressure (TG-BP),1886
8,Serum metabolite levels [M_VLDL_C],227
8,Fasting plasma glucose [Non diabetics],51
8,Protein quantitative trait loci (liver) [KCTD12],5
8,Glucuronate levels,88
8,Metabolite levels,2166
8,Guilty feelings,43671
8,Total testosterone levels,111915
8,HDL cholesterol levels [Trans-ethnic initial],4882
8,Scavenger receptor class A member 5 measurement,2932
8,Multisite chronic pain,4732
8,White matter microstructure (axial diusivities) [Superior fronto-occipital fasciculus],963
8,High density lipoprotein cholesterol levels [Hispanic],1813
8,Lipid traits [HDL],1711
8,Triacylglycerol_50:3_[M+NH4]1+ levels,1532
8,Oily fish consumption,3852
8,Colorectal cancer [EA],414
8,Retinal detachment or retinal break,406
8,Syntrophorhabdia abundance in stool,152
8,Job involves heavy manual or physical work,86
8,Medication use (drugs used in diabetes),1671
8,Bone mineral density [spine],1698
8,Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis),20003
8,Chronic diseases of tonsils and adenoids,2703
8,Serum metabolite levels [XL_VLDL_L],379
8,Prostate cancer [Japanese],83
8,Phosphatidylinositol_34:2_[M-H]1- levels,285
8,Peripheral arterial disease (traffic-related air pollution interaction) [AA],71
8,Protein quantitative trait loci (liver) [CAPN2],5
8,Basophil percentage of white cells,36755
8,"Heel quantitative ultrasound index (qui), direct entry (left)",84271
8,CD86 on granulocyte,110
8,Cardiac Troponin-T levels [Continuous Variable],125
8,Serum metabolite levels (CMS) [ApoB],2050
8,"Blood protein levels [GNS, 8314_71_3]",6993
8,"""Vasculitis limited to skin, not elsewhere classified""",40
8,Obesity [Overweight],82
8,Estrone levels,24387
8,Glaucoma (multi-trait analysis),3492
8,Smoking behaviour (cigarette pack-years),2598
8,Intrinsic epigenetic age acceleration,68
8,Systemic lupus erythematosus,107007
8,Nose morphology,5872
8,Percent mammographic density,1203
8,White blood cell count (neutrophil),383
8,Sphingomyelin_42:2_[M+H]1+ levels,1856
8,Gut microbiota (functional units) [PWY-5873_ubiquinol-7_biosynthesis_(eukaryotic],441
8,Protein quantitative trait loci (liver) [CES2],1
8,Intelligence (MTAG),47570
8,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],4812
8,Phosphatidylcholine-O_34:1_[M+H]1+/Phosphatidylcholine-P_34:0_[M+H]1+/Phosphatidylethanolamine-O_37:1_[M+H]1+ levels,1817
8,"Leukaemia | cancer code, self-reported",856
8,Risk-taking tendency (4-domain principal component model),685
8,Spherical equivalent or myopia (age of diagnosis),28465
8,Bipolar disorder,45909
8,Noncognitive aspects of educational attainment,25314
8,Ulcer of esophagus,585
8,Schizophrenia [South Asian],2721
8,"Total cholesterol levels [Asian initial, BMI unadjusted]",221
8,"""Asthma, including avohilmo""",40
8,LDL cholesterol levels in current drinkers [EA],1346
8,Alanine transaminase levels in high alcohol intake,366
8,Serum levels of protein CA8,1408
8,hemolysis of donated blood (cold-storage),8
8,Alcohol dependence (drinking more than intended) [EA],2
8,Breast milk fatty acid composition (maternal genotype effect) [capric acid],2
8,Mitochondrial DNA copy number,3715
8,Triglycerides [AA],83
8,Logical memory (immediate recall) in mild cognitive impairment,63
8,Triacylglycerol_53:5_[M+NH4]1+ levels,1525
8,Serum metabolite levels [L_VLDL_P],1511
8,Systemic lupus erythematosus [EA],2760
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-8 ms],1349
8,"Blood protein levels [CA8, 11390_24_3]",1408
8,Bipolar disorder lithium response (categorical) or schizophrenia,908
8,Serum metabolite levels [methionine sulfoxide],1260
8,Salad / raw vegetable intake,247
8,Brain region volumes [cerebellar vermal lobules VIII X],39
8,Nonsyndromic cleft lip with or without cleft palate,1
8,Irritable mood,8487
8,Fibrinogen [EA],42139
8,Arm fat-free mass (right),109076
8,White matter hyperintensity volume,10129
8,Serum levels of protein CPQ,2641
8,"Blood protein levels [ANGPT1, 2811_27_1]",211
8,"""Other diabetes, wide definition""",718
8,Ventolin 100micrograms inhaler | treatment/medication code,853
8,Nummular dermatitis,19
8,Aspartate aminotransferase to alanine aminotransferase ratio,1051
8,Serum levels of protein SOST,2588
8,Arm predicted mass (left),112533
8,Serum levels of protein SFTPC,1259
8,Sphingomyelin_34:0_[M+H]1+ levels,1800
8,Frontal fibrosing alopecia,286
8,Iron  | vitamin and/or mineral supplement use,482
8,Sleep duration (short sleep),1394
8,Triglyceride levels in small VLDL,1845
8,Glycated hemoglobin levels [conditional],471
8,Serous borderline ovarian cancer,137
8,Autism and educational attainment (MTAG),129
8,Selenium product | treatment/medication code,164
8,Cancer of urinary organs (incl. kidney and bladder),9
8,Electrocardiogram morphology (amplitude at temporal datapoints) [102 ms],2
8,Self-reported math ability (MTAG) [MTAG],47363
8,Autism spectrum disorder,41237
8,Feeling nervous,3169
8,Cognitive decline rate in late mild cognitive impairment,127
8,Osteoprotegerin levels [Sex-combined],992
8,Leg predicted mass (left),128203
8,Methotrexate | treatment/medication code,1386
8,hemolysis of donated blood (osmotic),483
8,Salt added to food,2353
8,"Light brown | hair colour (natural, before greying)",134
8,Phosphatidylcholine_40:5_[M+H]1+ levels,1525
8,Waist-to-hip ratio adjusted for body mass index,165
8,"Overweight, obesity and other hyperalimentation",28941
8,Triacylglycerol_56:6_[M+NH4]1+ levels,1582
8,Basophill count,7724
8,Obstructive sleep apnea trait (apnea hypopnea index),190
8,Monobrow,375
8,Paralytic strabismus,83
8,Serum levels of protein MANBA,1933
8,Ovarian cancer,137
8,Postprandial triglyceride levels,1511
8,"Intra-ocular pressure, corneal-compensated (right)",1716
8,Alzheimer's disease or fasting insulin levels (pleiotropy),728
8,"""COPD, hospital admissions""",631
8,Serum metabolite levels [L_VLDL_FC],375
8,Triacylglycerol_46:4_[M+NH4]1+ levels,1849
8,Blood pressure traits (multi-trait analysis) [Het],2088
8,Cannabis use disorder,1021
8,Thyrotoxicosis,758
8,Depressed affect,467
8,Serum metabolite levels [XL_VLDL_CE],375
8,"Blood pressure medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",13877
8,Skin cancer,1358
8,Colon polyp,338
8,Glaucoma (low intraocular pressure),52
8,Insomnia symptoms (never/rarely vs. usually),817
8,Phosphatidylcholine_34:4_[M+H]1+/Phosphatidylethanolamine_37:4_[M+H]1+/Phosphatidate_39:5_[M+NH4]1+ levels,1511
8,Brain region volumes [left cerebellum exterior],302
8,Age of smoking initiation,192
8,White matter hyperintensity volume x hypertension interaction (2df),23821
8,Pattern 4 | hair/balding pattern,2009
8,"Stress-related phenotypes (multivariate analysis) [mental health and PTSD symptom scores; plasma levels of DHEA-S, GABA, NPY and SHBG]",9537
8,Headache | pain type(s) experienced in last month,899
8,"Blood protein levels [SCARA5, 10419_1_3]",1376
8,Triglyceride levels [Asian],1675
8,Refractive error,44164
8,Electrocardiogram morphology (amplitude at temporal datapoints) [128 ms],6425
8,Total body bone mineral density,2491
8,Nitrogen dioxide air pollution; 2010,1542
8,Nitromin 400micrograms cfc-free spray | treatment/medication code,196
8,Protein quantitative trait loci (liver) [S100A9],1851
8,Breakfast skipping,206
8,Electrocardiogram morphology (amplitude at temporal datapoints) [240 ms],2
8,Hemoglobin concentration,177829
8,Birth weight,17431
8,Cerebrospinal fluid AB1-42 levels,30
8,Motion sickness,602
8,Coagulation Factor X measurement,267
8,Right unilateral cleft lip and palate,1
8,Lung function (FVC),135175
8,Cooked vegetable consumption,15775
8,Serum metabolite levels (CMS) [L_VLDL_TG],1511
8,Diacylglycerol_34:0_[M+H-H2O]1+ levels,1813
8,Phosphatidylglycerol-O_38:0_[M+NH4]1+ levels,1856
8,Malignant neoplasm of brain (controls excluding all cancers),37
8,IgM levels,396
8,Current tobacco smoking,688
8,Allergic rhinitis,1123
8,Psoriasis or type 2 diabetes (trans-disease meta-analysis),51
8,Electrocardiogram morphology (amplitude at temporal datapoints) [178 ms],2
8,Intelligence,31150
8,Methionine sulfone levels,1169
8,Nap during day,19126
8,"Lipid metabolism phenotypes [TG.assay, whole]",267
8,Bone mineral density (spine),5017
8,"Light diy (eg: pruning, watering the lawn) | types of physical activity in last 4 weeks",7
8,Hair color,25493
8,Sphingomyelin_38:2_[M+OAc]1- levels,358
8,Serum levels of protein GNS,4355
8,Alcohol use disorder,310
8,Tea consumption,166
8,Otosclerosis,70
8,Androstenedione levels,95309
8,Mean spheric corpuscular volume,135102
8,Gastric ulcer,20973
8,"Blood protein levels [EA, Cathepsin B]",7379
8,Microalbuminuria,72
8,Protein quantitative trait loci (liver) [LIPA],3327
8,Seroxat 20mg tablet | treatment/medication code,202
8,Maternal smoking around birth,397
8,Fed-up feelings,10401
8,Venous thromboembolism,3011
8,Frailty index,3894
8,"Aspirin | medication for pain relief, constipation, heartburn",307
8,Glycemic traits (pleiotropy),51
8,Granulocyte count,33898
8,Bipolar I disorder,82306
8,Varicose veins,2362
8,Mouth ulcers,2610
8,"Light smokers, at least 100 smokes in lifetime",669
8,High-sensitivity cardiac troponin T levels,548
8,Metabolite levels [Hex2Cer d18:2/16:0],169
8,Medication use (antimigraine preparations),83
8,Malignant lymphoma,14
8,Total body bone mineral density [European],2491
8,Hemoglobin A1c levels,120752
8,Serum phosphate levels,66221
8,Trunk fat mass,31148
8,Factor VIII levels [EA],297
8,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [AA],1518
8,Malignant neoplasm of skin (controls excluding all cancers),1186
8,Interstitial lung disease endpoints,137
8,Glyceryl trinitrate product | treatment/medication code,267
8,Systolic blood pressure x smoking status (ever vs never) interaction (2df test) [EA],14893
8,Electrocardiogram morphology (amplitude at temporal datapoints) [214 ms],7043
8,Prostate cancer | illnesses of father,229
8,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],5982
8,Chronic lymphocytic leukemia,784
8,"Pediatric areal bone mineral density (concordant skeletal phenotype) [EA, female]",43
8,Electrocardiogram morphology (amplitude at temporal datapoints) [84 ms],2
8,Cholelithiasis and cholecystitis,3686
8,High density lipoprotein cholesterol levels,48887
8,"Blood protein levels [FGL1, 5581_28_3]",33537
8,Gut microbiota (beta diversity),8070
8,Diseases of the respiratory system,961
8,Triacylglycerol_53:4_[M+NH4]1+ levels,1542
8,Protein quantitative trait loci (liver) [MACF1],393
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-4 ms],274
8,Liver volume,310
8,Protein quantitative trait loci (liver) [SEPT7],5
8,Alzheimer's disease,19537
8,Body mass index [Japanese],5537
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-108 ms],1449
8,Gastroesophageal reflux disease,842
8,Urate levels [women],404
8,3mm weak meridian angle (left),398
8,Type 2 diabetes without complications,51
8,Serum levels of protein DKK1,78
8,"""Superficial injury of abdomen, lower back and pelvis""",3
8,Estimated glomerular filtration rate,238234
8,Osteoarthritis (with total hip replacement),1157
8,Protein quantitative trait loci (liver) [ABAT],392
8,Protein quantitative trait loci (liver) [HP],177
8,Electrocardiogram morphology (amplitude at temporal datapoints) [98 ms],2
8,Central corneal thickness,44642
8,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),4445
8,Antihypertensive medication - note that there are other indications,5612
8,Past tobacco smoking,635
8,Protein quantitative trait loci (liver) [EMILIN2],177
8,Dentures,349
8,Other benign neoplasm of uterus: Other parts/unspecified (controls excluding all cancers),2
8,Systolic blood pressure x alcohol consumption interaction (2df test) [EA],21699
8,Serum metabolite levels [S-1-pyrroline-5-carboxylate],7225
8,"Systolic blood pressure, automated reading",47632
8,Heel bone mineral density x serum urate levels interaction [female],8443
8,Nose morphology [Nasolabial angle],6318
8,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Asian],2622
8,Osteoprotegerin levels [Female-specific],992
8,Hyperthyroidism or thyrotoxicosis,609
8,Processed meat intake,15061
8,Dried fruit intake,1727
8,Hypertriglyceridemia,1911
8,Protein quantitative trait loci (liver) [HIBADH],28
8,Protein quantitative trait loci (liver) [MTPN],5
8,CAG-273 sp003507395 abundance in stool,8169
8,Serum metabolite levels (CMS) [XXL_VLDL_C],375
8,None of the above (group 2) | illnesses of father,77
8,Alzheimer's disease (late onset),5319
8,Gastric atrophy,9401
8,Blood protein levels [90K Protein],1133
8,"""Other or unspecified ileus, impaction or obstruction""",4
8,Peak expiratory flow,10939
8,Standing height,162655
8,"Fatty acid-binding protein, adipocyte levels",937
8,CD80 on granulocyte,1458
8,Non-glioblastoma glioma,74
8,Blood metabolite levels [4-acetamidobutanoate],183
8,Lung function (FEV1/FVC),322450
8,Cardiovascular disease risk factors [TRIG],1823
8,Serevent 25mcg inhaler | treatment/medication code,59
8,Pure hypercholesterolaemia,335
8,CD64 on CD14+ CD16- monocyte,10
8,Electrocardiogram morphology (amplitude at temporal datapoints) [206 ms],2
8,LDL cholesterol,233918
8,Self-reported math ability,33618
8,Serum levels of protein CREG1,1933
8,Nicotine dependence,4038
8,Other malignant neoplasms of skin (=non-melanoma skin cancer),1186
8,Retinal nerve fibre layer (RNFL) thickness,9330
8,Estimated glomerular filtration rate [EA],2434
8,Sphingomyelin(42:4)_[M+H]1+ levels,1778
8,Protein quantitative trait loci (liver) [HYOU1],14
8,Chronotype,30372
8,Prostate cancer,45544
8,Phosphatidylcholine-O_35:1_[M+H]1+/Phosphatidylcholine-P_35:0_[M+H]1+/Phosphatidylethanolamine-O_38:1_[M+H]1+ levels,1813
8,Colorectal cancer or advanced adenoma,1725
8,Glioma [males],37
8,Total amyloid (SNP x SNP interaction),233
8,Facial morphology [left alare-labiale superius distance],331
8,Diastolic blood pressure x smoking status (ever vs never) interaction (2df test),7655
8,Low density lipoprotein cholesterol levels [EA],41302
8,Triglyceride levels [Japanese],1711
8,Height [EA],3060
8,Maximum habitual alcohol consumption [EA],1699
8,Type 2 diabetes [DGI+FUSION+WTCCC],102
8,Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio),3
8,Snoring [adjusted for BMI],61918
8,Serum albumin levels,167367
8,Neutrophil-to-lymphocyte ratio,12827
8,Phosphatidylcholine_32:0_[M+H]1+/Phosphatidylethanolamine_35:0_[M+H]1+/Phosphatidate_37:1_[M+NH4]1+ levels,1599
8,"Blood protein levels [SFTPC, 5738_25_3]",1376
8,Colorectal cancer [colorectal cancer],104
8,Retinal nerve fibre layer thickness or ganglion cell inner plexiform layer thickness (MTAG),9941
8,Triglyceride levels [BMI unadjusted],3658
8,Serum creatinine levels,62919
8,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) [Modelling analysis]",3433
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-2 ms],274
8,Electrocardiogram morphology (amplitude at temporal datapoints) [250 ms],2
8,Protein quantitative trait loci (liver) [PLD3],60
8,Diacylglycerol(36:1)_[M+H-H2O]1+ levels,1657
8,Diabetes diagnosed by doctor,400
8,Age at menopause,2359
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-18 ms],868
8,Protein quantitative trait loci (liver) [IGHG2],258
8,Protein quantitative trait loci (liver) [LCP1],5
8,Diabetes,22440
8,Metabolic syndrome (bivariate traits) [BP-HDLC],1511
8,Schizophrenia,313188
8,Diacylglycerol_34:2_[M+H-H2O]1+ levels,1548
8,Hypothyroidism and >3 levothyroxin purchases,8984
8,Late-onset Alzheimer's disease,1711
8,"Medication use (adrenergics, inhalants)",1902
8,HDL cholesterol levels [AA],1792
8,Protein quantitative trait loci (liver) [PFN1],5
8,Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count) [Infliximab],2
8,Intrahepatic Cholestasis of Pregnancy (ICP)  (more control exclusions),5488
8,Carotid intima media thickness (mean-maximum),1744
8,Serum levels of protein LGALS3BP,1114
8,Insulin product | treatment/medication code,790
8,Serum metabolite levels [XXL_VLDL_FC],375
8,Attention deficit hyperactivity disorder,28
8,Cancer of bronchus; lung,40
8,Electrocardiogram morphology (amplitude at temporal datapoints) [216 ms],2
8,Bladder cancer,71903
8,Basal cell carcinoma,6970
8,Disorders of the thyroid gland,1476
8,White blood cell count (monocyte),589
8,Zinc product | treatment/medication code,367
8,"Blood protein levels [CPQ, 9394_19_3]",9
8,Myeloid white cell count,45504
8,Corneal resistance factor (right),16268
8,Inflammatory bowel disease [EA],2582
8,Medication use (antiglaucoma preparations and miotics),538
8,Electrocardiogram morphology (amplitude at temporal datapoints) [218 ms],2
8,High density lipoprotein cholesterol levels [East Asian],1856
8,Acceptance of an invitation to participate in a mental health questionnaire,3539
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-14 ms],1719
8,Simvastatin | treatment/medication code,3663
8,Methylmalonate (mma) levels,88
8,Pulse wave arterial stiffness index,380
8,Attention deficit hyperactivity disorder or cannabis use,81
8,SSC-A on granulocyte,24
8,Cortical surface area [Rostral Middle Frontal],10
8,Obesity (extreme),16781
8,Hypothyroidism nos,21887
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-38 ms],13834
8,Whole body fat mass,41018
8,Electrocardiogram morphology (amplitude at temporal datapoints) [142 ms],6425
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-20 ms],2065
8,Serum levels of protein DEFA1,1031
8,Alcohol consumption (drinks per week),459
8,Time spend outdoors in summer,1310
8,Fasting blood insulin (BMI interaction),310
8,Well-being spectrum (multivariate analysis),61807
8,Cholesterol efflux capacity,1856
8,Asthma and hay fever,991
8,Protein quantitative trait loci (liver) [GCSH],344
8,Serum metabolite levels [HDL_TG],1856
8,Malignant neoplasm of bladder (controls excluding all cancers),25593
8,Glaucoma (high intraocular pressure),245
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-10 ms],1176
8,"Waist circumference adjusted for body mass index [EA, women]",1215
8,"Blood protein levels [TNFRSF10B, 7693_13_3]",191
8,Electrocardiogram morphology (amplitude at temporal datapoints) [176 ms],2
8,Body mass (lean),8945
8,Medication use (agents acting on the renin-angiotensin system),41322
8,3mm strong meridian (left),22762
8,Sjögren's syndrome,3618
8,Serum levels of protein NOV,3904
8,Epirubicin-induced leukopenia,992
8,Never smoked | tobacco smoking,2445
8,Lipid traits [TG],1711
8,Serum metabolite levels (CMS) [L_VLDL_C],375
8,Apolipoprotein A-I measurement,335
8,Red cell distribution width,920470
8,Protein quantitative trait loci (liver) [PSMD4],76243
8,Mean corpuscular haemoglobin concentration,52666
8,Osteoporosis,2318
8,"None of the above | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",1336
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-106 ms],1449
8,Abdominal and pelvic pain,405
8,X-11787 levels,15139
8,Arm fat mass (right),47292
8,Red blood cell (erythrocyte) distribution width,162030
8,Glaucoma (primary open-angle),5477
8,Body mass index variance,227
8,Bisphosphonate-related osteonecrosis of the jaw,2327
8,Poultry intake,2121
8,Malignant neoplasm,450
8,Interleukin-1 receptor type 2 measurement,267
8,Serum metabolite levels (CMS) [M_VLDL_C],1738
8,Serum metabolite levels [M_VLDL_L],1823
8,Brain region volumes [cerebellar vermal lobules I V],302
8,Differentiated thyroid cancer,834
8,White matter microstructure (fractional anisotropy) [Retrolenticular part of internal capsule],37
8,Protein quantitative trait loci (liver) [CNN2],5
8,Duodenitis,22569
8,Cholesteryl ester_18:1_[M+NH4]1+ levels,1800
8,Aspirin | treatment/medication code,333
8,Serum 25-Hydroxyvitamin D levels,55196
8,Hemoglobin,116487
8,HDL cholesterol levels in current drinkers [Asian],2320
8,Pulse pressure x alcohol consumption interaction (2df test) [AA],481
8,Serum levels of protein SPINK9,741
8,Delta-6 desaturase activity response to n3-polyunsaturated fat supplement,435
8,White matter microstructure (mean diusivities) [Sagittal stratum],37
8,Barrett's esophagus  or Esophageal adenocarcinoma,36483
8,B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio,25984
8,Osteoarthrosis (time to event),6013
8,Glutamine levels,2267
8,Height [AA],7866
8,Nose size,3762
8,Smoking status,17034
8,Uterine fibroids,17755
8,Rapid automised naming of letters,330
8,Number of days/week of moderate physical activity 10+ minutes,1949
8,Glaucoma (primary angle closure),1043
8,Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in secretors,1
8,Electrocardiogram morphology (amplitude at temporal datapoints) [8 ms],26441
8,Serum metabolite levels [L_HDL_PL],1511
8,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) [women],1215
8,Barrett's esophagus  or Esophageal adenocarcinoma [female],262
8,Interleukin-10 levels,290
8,Protein quantitative trait loci (liver) [GALT],82
8,"""Atopic dermatitis, strict definition with reimbursement""",388
8,Mood instability,31382
8,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),5379
8,Nonatopic asthma,998
8,Keratinocyte cancer (MTAG),2748
8,"Asthma | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",1161
8,Protein quantitative trait loci (liver) [HSPA8],34
8,"Cholelithiasis/gall stones | non-cancer illness code, self-reported",1919
8,Salicylate levels,530
8,Iron status biomarkers (ferritin levels),1446
8,Obesity [Obesity class I],82
8,Body fat distribution (arm fat ratio),21833
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-86 ms],2357
8,Smoking behaviour (cigarettes smoked per day),9417
8,Cortical thickness (MOSTest),3541
8,Alcohol intake versus 10 years previously,2061
8,General anaesthetic | anaesthetics administered post delivery,524
8,Homeostasis model assessment of insulin resistance,55
8,Phosphatidylcholine-O_31:0_[M+H]1+/Phosphatidylethanolamine-O_34:0_[M+H]1+ levels,1800
8,Arm predicted mass (right),107137
8,Electrocardiogram morphology (amplitude at temporal datapoints) [150 ms],7043
8,Smoking behaviour (cigarettes smoked per day) [Conditioned on chr8:27442127],70
8,Two-hour glucose,396
8,Ezetimibe | treatment/medication code,267
8,Prozac 20mg capsule | treatment/medication code,1429
8,Phosphatidylcholine_32:1_[M+H]1+/Phosphatidylethanolamine_35:1_[M+H]1+/Phosphatidate_37:2_[M+NH4]1+ levels,1511
8,Waist-hip ratio [EA],154
8,Atopic dermatitis,4473
8,Cognitive performance,25314
8,Serum levels of protein FAM163A,1297
8,Self-reported risk-taking behaviour,2034
8,"None of the above | medication for cholesterol, blood pressure or diabetes",295
8,Glycemic traits (pregnancy) [FPG],245
8,Phenyllactate (pla) levels,703
8,High density lipoprotein cholesterol levels [Indian],5407
8,"Diastolic blood pressure x alcohol consumption interaction (2df test) [EA, Hispanic]",11639
8,Diacylglycerol(34:0)_[M+H-H2O]1+ levels,1657
8,Right | usual side of head for mobile phone use,14603
8,Coffee intake,6244
8,"""Type 2 diabetes, definitions combined, including avohilmo""",697
8,Serum levels of protein TNC,1259
8,Other appendicitis,4
8,Medication use (calcium channel blockers),63914
8,Weight,198406
8,"Blood protein levels [WISP1, 13692_154_3]",359
8,Low tan response,804
8,Cutaneous squamous cell carcinoma,804
8,Emphysema distribution in smoking [ratio950],38
8,Neuropsychiatric disorders,2
8,Protein quantitative trait loci (liver) [ENO1],14
8,Protein quantitative trait loci (liver) [RNH1],5
8,Intraocular pressure,33497
8,Electrocardiogram morphology (amplitude at temporal datapoints) [126 ms],6425
8,"Blood protein levels [PENK, 9076_25_3]",1971
8,White matter microstructure (fractional anisotropy) [Superior longitudinal fasciculus],37
8,Cholesterol [total cholesterol],188
8,Sex hormone-binding globulin levels,263589
8,Serum metabolite levels [S_VLDL_FC],1856
8,"Intra-ocular pressure, goldmann-correlated (right)",1786
8,Serum metabolite levels [Serum_TG],1890
8,Back pain | pain type(s) experienced in last month,531
8,Protein quantitative trait loci (liver) [GMFB],34
8,Lyrica 25mg capsule | treatment/medication code,111
8,Monocyte count [EA],111
8,Yes | hearing difficulty/problems,25705
8,Phosphatidylcholine-O_44:5_[M+OAc]1-/Phosphatidylcholine-P_44:4_[M+OAc]1- levels,205
8,Urinary metabolite levels in chronic kidney disease [X - 12410],298
8,Essential tremor,4
8,None of the above | types of physical activity in last 4 weeks,38
8,Pulse pressure [EA],7565
8,LDL cholesterol x physical activity interaction (2df test),3074
8,Phosphatidylcholine-O_32:1_[M+H]1+/Phosphatidylcholine-P_32:0_[M+H]1+/Phosphatidylethanolamine-O_35:1_[M+H]1+ levels,1826
8,Malignant neoplasm of breast,262
8,Myo-inositol levels,101
8,Electrocardiogram morphology (amplitude at temporal datapoints) [184 ms],7043
8,Heel bone mineral density (bmd) (right),14079
8,Triglyceride levels [AA],1545
8,Fasting blood proinsulin levels,51
8,Alcohol use disorder (consumption score),165
8,HDL cholesterol levels in current drinkers [EA],4022
8,"Blood protein levels [TNC, 4155_3_2]",1376
8,Pituitary hypofunction,386
8,Cigarettes smoked per day (MTAG),3453
8,Serum levels of protein EVA1C,1259
8,Chlamydia trachomatis momp D antibody levels,487
8,"Fracture fibula | non-cancer illness code, self-reported",73
8,Externalizing behaviour (multivariate analysis),99689
8,Nitrogen dioxide air pollution; 2006,1295
8,Fasting insulin adjusted for BMI,223
8,Fat-free mass [female],3370
8,Malignant neoplasm of skin,1186
8,Ease of getting up in the morning,739
8,Telmisartan | treatment/medication code,137
8,"Ground coffee (include espresso, filter etc) | coffee type",153
8,HDL cholesterol levels [EA],2487
8,Ras-related protein Rab-2A measurement,14935
8,Heel bone mineral density (bmd) (left),73313
8,Leg fat mass (left),43858
8,Sphingomyelin_40:2_[M+H]1+ levels,1836
8,Mental retardation,158
8,Serum metabolite levels [L_VLDL_L],379
8,Mean sphered cell volume,143443
8,Haemophilus D sp001679485 abundance in stool,1964
8,Resistin levels,162
8,Urinary bladder cancer,18
8,Electrocardiogram morphology (amplitude at temporal datapoints) [244 ms],2
8,Blood metabolite levels [Aspartic acid / Citrulline],15163
8,Diacylglycerol_33:1_[M+H-H2O]1+ levels,1800
8,Myocardial fractal dimension (slice 5),429
8,Myopia,367
8,Walking for pleasure (not as a means of transport) | types of physical activity in last 4 weeks,38
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-30 ms],6596
8,Leisure sedentary behaviour (computer use),3125
8,Malignant neoplasm of breast (controls excluding all cancers),262
8,Waist circumference adjusted for BMI in non-smokers [women],1215
8,Alpha-tocopherol levels,213
8,"Prostate cancer [conditioned, East Asian]",12
8,Optic disc size,23169
8,Sphingomyelin_34:2_[M+H]1+ levels,1800
8,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test),19247
8,DNA methylation variation (age effect),15838
8,Appendicular lean mass,549099
8,"Liver, biliary or pancreas problem",4833
8,Sphingomyelin_41:2_[M+H]1+ levels,1836
8,"Age-related diseases, mortality and associated endophenotypes",1778
8,"Dupuytren's contracture | non-cancer illness code, self-reported",247
8,Left ventricular end-systolic volume,410
8,Vitamin D levels,2423
8,Blood metabolite levels [5-oxoproline],21960
8,Atrial fibrillation and flutter,985
8,N-acetylleucine levels,2439
8,Smoking initiation (ever regular vs never regular) [Conditioned on chr8:92733282],396
8,"Blood protein levels [GGH, 9370_69_3]",2851
8,Left ventricular ejection fraction,775
8,Renal cell carcinoma,70
8,Protein quantitative trait loci (liver) [NPC2],102
8,Protein quantitative trait loci (liver) [SEPT11],2
8,HDL cholesterol x physical activity interaction (2df test),1573
8,Waist-to-hip ratio adjusted for body mass index [Women],83
8,Infectious mononucleosis,36
8,Mean corpuscular volume,1097638
8,Hay fever and/or eczema,1164
8,Alcohol consumption (drinks per week) (MTAG),3804
8,Urate levels [East Asian],42
8,Serum metabolite levels [5-acetylamino-6-amino-3-methyluracil],343
8,Protein quantitative trait loci (liver) [RBP1],5
8,A gas fire that you use regularly in winter time | gas or solid-fuel cooking/heating,5
8,Waist-hip ratio,72150
8,Arm fat mass (left),44957
8,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],500
8,Banana intake,2988
8,Forced expiratory volume in 1-second (fev1),43827
8,"Hypothyroidism/myxoedema | non-cancer illness code, self-reported",66543
8,Bile acid(DCA)_[M-H]1- levels,1896
8,Gallstone disease,3193
8,Protein quantitative trait loci (liver) [EPHX1],862
8,Thyroid hormone levels [TSH],409
8,Estrogen level change in anastrozole-treated breast cancer [estrone and estradiol],1
8,Cardiorespiratory fitness slope,31012
8,Serum metabolite levels (CMS) [M_VLDL_L],1823
8,Stable angina pectoris,1766
8,Sphingomyelin_32:2_[M+H]1+ levels,1582
8,Low myopia vs hyperopia,334
8,Protein quantitative trait loci (liver) [GALE],59
8,Proinsulin levels,51
8,Nonsyndromic cleft lip with cleft palate,51672
8,Mean corpuscular hemoglobin,584453
8,Systolic blood pressure [East Asian],6585
8,Life satisfaction,584
8,Gut bacterial pathway abundance (PWY.6353..purine.nucleotides.degradation.II..aerobic.),1042
8,Place of birth in uk - east co-ordinate,164
8,Cancer of bladder,24375
8,None of the above | qualifications,6774
8,Rosuvastatin | treatment/medication code,646
8,Joint mobility (Beighton score),3689
8,Hyperopia,236
8,Cerebrospinal fluid biomarker levels [3-hydroxy-3-methylglutaryl-coenzyme A reductase],166
8,"""Dental caries, including avohilmo""",225
8,Gtn - glyceryl trinitrate | treatment/medication code,322
8,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test) [African],69
8,Childhood ear infection,384
8,Facial morphology (segment 10),105
8,Electrocardiogram morphology (amplitude at temporal datapoints) [14 ms],409
8,Electrocardiogram morphology (amplitude at temporal datapoints) [130 ms],2
8,Cheese intake,25338
8,Serum levels of protein RIDA,969
8,Impedance of arm (right),82979
8,"Smoking initiation (ever regular vs never regular) [Conditioned on chr8:27344719, chr8:27425349]",669
8,Atopic dermatitis [random effects],646
8,Glaucoma | eye problems/disorders,205
8,Rate of cognitive decline in Alzheimer's disease [GEE model],147
8,Protein quantitative trait loci (liver) [PSMD3],25
8,Medication use (HMG CoA reductase inhibitors),100806
8,"Pulse pressure [EA, initial]",3910
8,Bone mineral density,2347
8,Nicotine metabolite ratio in current smokers,91
8,White matter microstructure (fractional anisotropy) [Anterior corona radiata],37
8,General factor of neuroticism,41645
8,Triacylglycerol_56:5_[M+NH4]1+ levels,1527
8,Triglycerides [EA],2189
8,HDL cholesterol [AA],216
8,Blood metabolite ratios [4-acetamidobutanoate/N1-methyladenosine],298
8,Phosphatidylcholine-O_38:2_[M+H]1+/Phosphatidylcholine-P_38:1_[M+H]1+ levels,1823
8,COVID-19 (hospitalized vs population),337
8,Mood swings,32431
8,Obesity,28941
8,Protein quantitative trait loci (liver) [DECR1],76243
8,Protein quantitative trait loci (liver) [DCN],226
8,Medication use (salicylic acid and derivatives),2111
8,Tumor necrosis factor receptor superfamily member 10A levels,2125
8,Interleukin-6 levels in HIV infection [Hispanic/Latino],228
8,Serum metabolite levels (CMS) [XXL_VLDL_FC],375
8,Serum metabolite levels [1-methylxanthine],343
8,Protein quantitative trait loci (liver) [MYO1B],19
8,"Cholesterol lowering medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",2367
8,Triglycerides [East Asian],1845
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-94 ms],1197
8,Metabolically unhealthy in obesity,1956
8,Sphingomyelin_34:1_[M+H]1+ levels,2087
8,Facial morphology (philtrum length),61
8,Resting heart rate,153
8,Angiopoietin-1 receptor levels,5704
8,Trunk predicted mass,106287
8,Fasting insulin,1129
8,Triglyceride levels in current drinkers [EA],1770
8,Brugada syndrome,1599
8,Serum metabolite levels [XL_VLDL_C],375
8,Place of birth in uk - north co-ordinate,434
8,High myopia,236
8,Adult diffuse glioma (IDH mutation),59
8,Attention function,3
8,Serum alkaline phosphatase levels,212159
8,Asthma (adult onset),1985
8,Bone ultrasound measurement (broadband ultrasound attenuation),1266
8,"Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) [AA, women]",285
8,"Cellulitis and abscess of foot, toe",8785
8,Eosinophill count,23978
8,Ossification of the posterior longitudinal ligament of the spine,32791
8,Albumin-globulin ratio,4941
8,Hydroxyasparagine levels,451
8,X-13728 levels,202
8,Triacylglycerol_52:4_[M+NH4]1+ levels,1511
8,Mammographic density (non-dense area),291
8,Left ventricle diastolic internal dimension,410
8,Electrocardiogram morphology (amplitude at temporal datapoints) [136 ms],2
8,Monocyte count,342637
8,Use of sun/uv protection,23756
8,Protein quantitative trait loci (liver) [CCDC58],440
8,Brain region volumes [left cerebellum white matter],559
8,Minocycline | treatment/medication code,419
8,Neonatal cytokine/chemokine levels (fetal genetic effect) [IL-4],129
8,Serum levels of protein SFRP1,386
8,Protein quantitative trait loci (liver) [ECI2],83
8,Extraversion,22704
8,Osteoprotegerin levels,6120
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-88 ms],2357
8,None of the above | attendance/disability/mobility allowance,3088
8,Hyperlipidemia,3636
8,Stopping prescribed medication | methods of self-harm used,68
8,"Orofacial clefts [Meta-All, NSCLP]",1
8,Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis),27978
8,Serum metabolite levels [5-oxoproline],14078
8,Type 2 diabetes (adjusted for BMI),656
8,Vitamin D insufficiency,345
8,Bulimia nervosa (incl. atypical),6
8,Haemorrhagic disorder due to circulating anticoagulants,171
8,Primary biliary cholangitis,2
8,Schizophrenia and type 2 diabetes,6
8,Vitiligo,12024
8,Subcortical volume (MOSTest),108798
8,Malignant neoplasm of urinary organs (controls excluding all cancers),25593
8,Mental health study participation (completed survey),3199
8,Household income (MTAG),17390
8,Osteoarthritis,1489
8,vWF levels [EA],661
8,Other acquired deformities of musculoskeletal system and connective tissue,723
8,Bilateral oophorectomy (both ovaries removed),18
8,Electrocardiogram morphology (amplitude at temporal datapoints) [108 ms],7043
8,Femoral neck bone mineral density,2302
8,Advanced age-related macular degeneration [EA],606
8,Serum metabolite levels [S_VLDL_L],2083
8,Previous | smoking status,688
8,None of the above (group 2) | illnesses of adopted father,86
8,Prostate cancer (early onset),148
8,Duodenal ulcer [Additive],9401
8,Age at first birth,86262
8,High light scatter reticulocyte percentage,5673
8,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),1020
8,Phosphatidylcholine-O_37:1_[M+H]1+/Phosphatidylcholine-P_37:0_[M+H]1+/Phosphatidylethanolamine-O_40:1_[M+H]1+ levels,1861
8,Reticulocyte count,118323
8,Electrocardiogram morphology (amplitude at temporal datapoints) [232 ms],7043
8,Reticulocyte percentage,4509
8,Facial morphology (segment 45),913
8,Serum metabolite levels (CMS) [L_VLDL_CE],375
8,Non-small cell lung cancer [East Asian],217
8,Hip circumference,52086
8,"Osteoporosis-related phenotypes [LS BMD, women]",2588
8,Smoking behavior,2598
8,Electrocardiogram morphology (amplitude at temporal datapoints) [-26 ms],233
8,Chitinase-3-like protein 1 levels,267
8,Frontotemporal dementia,172
8,Depression medications,16
8,Pulse pressure,358419
8,Idiopathic pulmonary fibrosis,9457
8,Electrocardiogram morphology (amplitude at temporal datapoints) [212 ms],7043
8,Metabolic syndrome (bivariate traits) [TG-GLUC],51
8,LDL cholesterol levels x long total sleep time interaction (2df test),548
8,Age-related hearing impairment (SNP x SNP interaction),573
8,Serum levels of protein FUT10,32967
8,"""Malignant neoplasm of breast, HER2-negative""",559
8,Psychoticism,58
8,Electrocardiogram morphology (amplitude at temporal datapoints) [172 ms],2
8,Paracetamol of NSAID medication,5
8,Cardiovascular disease,143947
8,Switched memory B cell %lymphocyte,39274
8,Hand grip strength (right),17483
8,HDL cholesterol levels [Asian],2318
8,White matter microstructure (radial diusivities) [Posterior limb of internal capsule],934
8,Urinary albumin-to-creatinine ratio [EA],768
8,Phospholipid levels in chylomicrons and largest VLDL,375
8,Visceral adipose tissue volume,5
8,Menarche (age at onset),40710
8,Osteoarthritis of the hip or knee,23211
8,Platelet distribution width,365795
8,Diastolic blood pressure,312565
8,Worrier / anxious feelings,38620
8,Episodal and paroxysmal disorders,13002
8,Follicular lymphoma (controls excluding all cancers),1055
8,"Urinary metabolites (H-NMR features) [2.1875, Unknown]",298
8,Systolic blood pressure x smoking status (ever vs never) interaction (2df test),13080
8,QT interval,11538
8,Phosphatidylcholine-O_31:2_[M+H]1+/Phosphatidylcholine-P_31:1_[M+H]1+/Phosphatidylethanolamine-O_34:2_[M+H]1+ levels,1800
8,Lipoprotein lipase levels,1312
8,Fasting blood glucose,634
8,Fluid intelligence score,68
8,Hyperkinetic disorders (excl. ADHD),3
8,HDL Cholesterol - Triglycerides (HDLC-TG),2196
8,Arm fat percentage (right),42558
8,Neutrophill percentage,51157
8,"""SLE, strict definition""",5820
8,Vegetable consumption,870
8,"Blood protein levels [EA, Integrin alpha-I: beta-1 complex]",75
8,"Lipid metabolism phenotypes [VLDL.medium, fasting]",1856
8,Asthma or allergic disease (pleiotropy),1223
8,Family history of Alzheimer's disease,1697
8,Cataracts (operation),220
8,Fasting plasma glucose [tFPG],116
8,Serum metabolite levels [M_VLDL_P],1511
8,3mm strong meridian angle (right),398
8,"""Diabetes, varying definitions""",749
8,Diacylglycerol_36:4_[M+H-H2O]1+ levels,1525
8,Ascending aorta minimum area,3221
8,"""Disorders of thyroid, IBD co-morbidities""",125
8,Electrocardiogram morphology (amplitude at temporal datapoints) [90 ms],2
8,Male-pattern baldness,27248
8,LDL cholesterol levels [Trans-ethnic initial],44033
8,Alzheimer's disease or family history of Alzheimer's disease,2868
8,Hemorrhoids,450
8,Broad depression or schizophrenia,3303
8,Hirschsprung disease [East Asian],600
8,Lymphocyte percentage of white cells,70075
8,Cognitive traits (MTAG),3496
8,Serum metabolite levels [S_VLDL_C],1856
8,Insulin-related traits (multivariate analysis),51
8,Electrocardiogram morphology (amplitude at temporal datapoints) [68 ms],2
8,Blood pressure [Pulse Pressure],3661
8,"Asthma | non-cancer illness code, self-reported",1161
8,"Fracture patella / knee | non-cancer illness code, self-reported",212
8,Orofacial clefts [EA],11
8,Pallidum volume,24218
8,PR interval,13202
8,Sphingomyelin_40:1_[M+H]1+ levels,1861
8,Pyridoxate levels,504
8,Corneal hysteresis (right),1254
8,"Response to statin therapy [HDL, sum]",154
8,Sensitivity to environmental stress and adversity,44
8,Insulin-like growth factor 1 levels,100544
8,Diabetes | illnesses of mother,51
8,Morning/evening person (chronotype),9165
8,Age first had sexual intercourse,18358
8,Nitrogen dioxide air pollution; 2005,1295
8,Serum levels of protein MMP7,114
8,Electrocardiogram morphology (amplitude at temporal datapoints) [164 ms],7043
8,Fasting plasma glucose,128
8,Prochlorperazine | treatment/medication code,90
8,Protein quantitative trait loci (liver) [HNRNPH3],3
8,Calcium levels,383998
8,Aspartate aminotransferase levels,114722
8,Triacylglycerol_46:5_[M+NH4]1+ levels,1836
8,Total cholesterol levels in HDL,3336
8,"Diabetes | non-cancer illness code, self-reported",179
8,Morning vs. evening chronotype,338
8,Mitochondrial DNA levels,466
8,Colorectal cancer or advanced adenoma [conditioned on lead SNPs in LD],104
8,Blood urea nitrogen levels,32148
8,Brain region volumes [right pallidum],24348
8,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [AA],1820
8,Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals,35
8,1-stearoyl-2-linoleoyl-gpc (18:0/18:2) levels,68
8,Sex hormone-binding globulin levels [Men + Women],71
8,Cleft lip with or without cleft palate [EA],15
8,Gallbladder disease,1896
8,Nicotine dependence symptom count [AA],243
8,Heel bone mineral density (MTAG),3510
8,Often | worked with pesticides,1079
8,Electrocardiogram morphology (amplitude at temporal datapoints) [20 ms],136
8,Obesity (early onset extreme),227
8,Glioblastoma (age-stratified) [Below median age-at-diagnosis],37
8,Natural Killer T %lymphocyte,42750
8,Biological sex,28090
8,Electrocardiogram morphology (amplitude at temporal datapoints) [226 ms],7043
8,Forced vital capacity (fvc),11295
8,"""Other chronic obstructive pulmonary disease , including avohilmo""",631
8,Protein quantitative trait loci (liver) [LRG1],9
8,Estrogen level change in anastrozole-treated breast cancer [estrone],1
8,Adolescent idiopathic scoliosis,26774
8,Adult body size,66287
8,Neuroticism conditioned on self-rated math ability (multi-trait conditioning and joint analysis),30870
8,Nonalcoholic fatty liver disease (imputed),18764
8,Fear of minor pain,472
8,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)",333
8,Heart rate response to exercise [males],3695
8,Urinary metabolite levels in chronic kidney disease [4-acetamidobutanoate],298
8,"Diabetic neuropathy/ulcers | non-cancer illness code, self-reported",9
8,Electrocardiogram morphology (amplitude at temporal datapoints) [204 ms],2
9,Eczema,27989
9,Serum levels of protein RIPK2,15409
9,Risk-taking tendency (4-domain principal component model),1457
9,Ease of getting up in the morning,2422
9,Triglycerides [EA],570
9,Ventolin 100micrograms inhaler | treatment/medication code,391
9,"Depression | non-cancer illness code, self-reported",142
9,Granulocyte count,33946
9,Body fat percentage [male],13510
9,Male puberty timing (age at voice breaking MTAG),1135
9,IgG glycosylation patterns [IgG1_G0FN],1196
9,Electrocardiogram morphology (amplitude at temporal datapoints) [148 ms],1042
9,"Seen doctor (gp) for nerves, anxiety, tension or depression",123
9,Malignant neoplasm,952
9,"HDL cholesterol levels [Asian initial, BMI unadjusted]",570
9,Medication use (glucocorticoids),2260
9,Low density lipoprotein cholesterol levels [Hispanic],891
9,Electrocardiogram morphology (amplitude at temporal datapoints) [146 ms],1042
9,Congestive heart failure; nonhypertensive,1000
9,Blood protein levels [PECAM1],2759
9,Sphingomyelin_43_2_[M+OAc]1- levels,32
9,IgG glycosylation patterns [IgG1_G1FN/IgG1_G0FN],1196
9,Dentate gyrus granule cell layer volume,153
9,Protein quantitative trait loci (liver) [HEXB],110
9,6-oxopiperidine-2-carboxylate levels,34
9,"Black | hair colour (natural, before greying)",18707
9,IgG glycosylation patterns [IgG2 G0n],1247
9,Blood protein levels [E-selectin],3154
9,Heart disease | illnesses of father,1906
9,Serum levels of protein DPEP2,891
9,Optic cup area [EA],1000
9,Rosiglitazone | treatment/medication code,403
9,Gut microbiota (bacterial taxa) [k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Lachnospiraceae|g__Blautia|s__Ruminococcus_obeum],172
9,Smoking cessation,55542
9,Predicted visceral adipose tissue,25058
9,IgG glycosylation [IGP37],5334
9,Haemoglobin concentration,30068
9,Parental longevity (combined parental age at death),1000
9,Unstable angina (intermediate coronary syndrome),1303
9,Phosphatidylcholine_40:5_[M+H]1+ levels,542
9,Childhood asthma (age<16) (more control exclusions),474
9,Cortical surface area [Lingual],729
9,Protein quantitative trait loci (liver) [GART],15
9,Cathepsin L1 levels,2868
9,Total hippocampal volume,100
9,Smoking initiation (ever regular vs never regular) [Conditioned on chr9:81444104],10
9,Menopause (age at onset),24131
9,Obesity-related traits [TSH ],1361
9,"Forced vital capacity (fvc), best measure",46034
9,Serum levels of protein ICAM5,1782
9,Neural proliferation differentiation and control protein 1 levels,165
9,Protein levels in obesity [ATS13],20114
9,"Blood protein levels [EA, A disintegrin and metalloproteinase with thrombospondin motifs 13]",19450
9,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [H],761
9,Cardiometabolic and hematological traits [HDL],78
9,Cses or equivalent | qualifications,36
9,Modic changes,21
9,Multiple consecutive miscarriage,8
9,Schizophrenia,12193
9,Congenital malformations of the circulatory system,99
9,Age-related macular degeneration,3483
9,Protein quantitative trait loci (liver) [PGD],4278
9,Feeling guilty,383
9,Proheparin-binding EGF-like growth factor levels,446
9,Gut microbiota relative abundance (bacterial taxa) [Peptoniphilaceae],176
9,Neuritic plaque [Case/control],15
9,White blood cell count,788784
9,Nasopharyngeal carcinoma,743
9,PR interval,1686
9,Serum levels of protein SEPT10,4551
9,White matter microstructure (mean diusivities) [Splenium of corpus callosum],1487
9,Neuroticism (MTAG),521
9,Blood metabolite ratios [DSGEGDFXAEGGGVR/ADpSGEGDFXAEGGGVR],672
9,High blood pressure | illnesses of adopted siblings,3229
9,Smokes on most or all days | tobacco smoking,4642
9,ABO blood group (B vs non-B),666
9,Serum levels of protein KIN,891
9,Neurofibrillary tangles (SNP x SNP interaction),7355
9,Serum metabolite levels [ADpSGEGDFXAEGGGVR*],1772
9,Other/unspecified dorsalgia,9
9,Blond vs. brown/black hair color,30333
9,Mental health study participation (completed survey),21964
9,Childhood asthma with severe exacerbations,1957
9,Aspirin | treatment/medication code,1303
9,Red blood cell count [Asian],581
9,"""Coxarthrosis, primary""",1066
9,Self-reported allergy,307
9,Global electrical heterogeneity phenotypes [SVG magnitude],167
9,Chronotype,59066
9,Electrocardiogram morphology (amplitude at temporal datapoints) [214 ms],3272
9,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],2289
9,Parental longevity (father's age at death),2000
9,Interleukin-6 receptor subunit beta measurement,4982
9,Blood protein levels [von Willebrand factor],1314
9,Prolargin levels,88
9,Mosaic loss of chromosome Y (Y chromosome dosage),1921
9,"""Type 2 diabetes, wide definition""",173
9,Blood pressure traits (multi-trait analysis) [Het],90
9,Longest period of unenthusiasm / disinterest,9
9,Protein quantitative trait loci (liver) [AGXT],18
9,Platelet count,791806
9,OTU99_16 (Faecalibacterium) abundance,2298
9,Serum levels of protein TPST2,891
9,Liver fibrosis severity in HIV/hepatitis C co-infection,277
9,Hemoglobin levels [Asian],581
9,Facial morphology [left endocanthion-subnasale distance],166
9,Triglyceride levels,191903
9,Chymotrypsin C levels,4091
9,"Blood protein levels [CNTFR, 14101_2_3]",12746
9,Orofacial clefts,6278
9,Galectin-4 levels,891
9,Urinary metabolite levels in chronic kidney disease [3-methylglutarylcarnitine (2],277
9,Doctor diagnosed chronic bronchitis,764
9,Protein quantitative trait loci (liver) [LGALS1],72
9,Gamma-glutamyl-alpha-lysine levels,666
9,Response to antipsychotic treatment in schizophrenia,626
9,"Blood protein levels [EA, Carbohydrate sulfotransferase 15]",795
9,Experiencing mood swings,573
9,Morning person,57369
9,Skin colour,50313
9,"Intra-ocular pressure, goldmann-correlated (left)",16046
9,Coronary artery disease in diabetes,1303
9,Mucinous ovarian carcinoma,219
9,Height [EA],117
9,End-stage coagulation [FX],299
9,STROKE,990
9,Childhood steroid-sensitive nephrotic syndrome,266
9,Interleukin-6 levels,1130
9,Both gained and lost some weight during the episode | weight change during worst episode of depression,27
9,Protein quantitative trait loci (liver) [A2M],28
9,IgG N-glycosylation phenotypes (multivariate analysis),10668
9,Birth weight,95147
9,Serum albumin levels,87630
9,"Intra-ocular pressure, corneal-compensated (left)",627
9,Other diseases of liver,59
9,Macular thickness,29737
9,Crohn's disease [EA],17244
9,Pancreatic cancer,2555
9,Serum levels of protein TEK,4355
9,Coronary atherosclerosis,2000
9,Electrocardiogram morphology (amplitude at temporal datapoints) [144 ms],1415
9,Migraine without aura,153
9,Monocyte count [EA],318
9,Securon 40mg tablet | treatment/medication code,16
9,Well-being spectrum (multivariate analysis),21837
9,Low density lipoprotein cholesterol levels,97964
9,"Blood protein levels [EA, Endoglin]",3863
9,Serum levels of protein FCN2,920
9,"Blood protein levels [CETP, 7131_207_3]",259
9,"Angina | non-cancer illness code, self-reported",1015
9,Serum levels of protein ICAM1,891
9,Depressive symptoms x dependent stressful life events interaction (1df test),26
9,Atopic dermatitis (moderate to severe) [general],3044
9,Statin medication,1937
9,Electrocardiogram morphology (amplitude at temporal datapoints) [150 ms],1042
9,Autoimmune traits (pleiotropy),239
9,Coxarthrosis [arthrosis of hip](FG),859
9,Asthma onset (childhood vs adult),391
9,Sum basophil neutrophil counts,42077
9,Electrocardiogram morphology (amplitude at temporal datapoints) [142 ms],1042
9,Zolmitriptan | treatment/medication code,6336
9,Alpha-galactosidase A measurement,1292
9,Externalizing behaviour (multivariate analysis),63553
9,"Parental longevity (combined parental attained age, Martingale residuals)",1000
9,Granulocyte percentage of myeloid white cells,50491
9,Follistatin levels,3529
9,Lymphocyte percentage of white cells,112314
9,"Melanomas of skin, dx or hx",23019
9,Body mass index [Japanese],13313
9,Carotid plaque burden,1000
9,Serum metabolite levels [sarcosine],1235
9,Hypothyroidism [eMERGE],1179
9,Endometriosis of pelvic peritoneum,713
9,Sequelae of injuries of neck and trunk,3
9,"""Asthma, including avohilmo""",546
9,Blood metabolite levels [ADpSGEGDFXAEGGGVR],672
9,"Icd10: c71.9 brain, unspecified | underlying (primary) cause of death",1460
9,Serum levels of protein CTSV,128
9,Skin changes due to chronic exposure to nonionizing radiation,302
9,Response to risperidone in schizophrenia,297
9,Glycine levels,400
9,Pioglitazone | treatment/medication code,1632
9,Acute pancreatitis,3565
9,Serum levels of protein CASC4,1619
9,Time from waking to first cigarette,525
9,Cognitive performance,66896
9,Atopic asthma,23747
9,Urate levels [women],6462
9,"Gut microbiota (bacterial taxa, rank normal transformation method) [G_unclassified_P_Firmicutes_RNT]",17376
9,Serum levels of protein CNTFR,12122
9,Ovarian cancer in BRCA1 mutation carriers,789
9,Serum levels of protein GSN,2363
9,Co-enzyme q10/ubiquinone/bio-quinone/coenzyme q10 | treatment/medication code,58
9,Smoking initiation (ever regular vs never regular) [Conditioned on chr9:3025368],42
9,Total PHF-tau (SNP x SNP interaction),87693
9,Mean platelet (thrombocyte) volume,84046
9,Age completed full time education,1173
9,Total cholesterol levels [Hispanic],1619
9,"Migraine | non-cancer illness code, self-reported",138
9,Depressive episodes in bipolar disorder,59
9,General pain for 3+ months,21
9,Serum levels of protein ABO,4091
9,Cataracts [conditional],1000
9,Suggestive for eosinophilic asthma,391
9,Radiation-related disorders of the skin and subcutaneous tissue,302
9,Protein quantitative trait loci (liver) [HSPA9],110
9,Waist circumference adjusted for body mass index [EA],128
9,Candida albicans stimulated MMP-1 levels,207
9,Metabolite levels [HexCer d16:1/22:0],14
9,Nevus count [Han & Eskin random effects],34202
9,Coronary artery disease in individuals without type 2 diabetes,979
9,Biological sex,10249
9,Creatinine levels,95170
9,Serum metabolite levels [2'-O-methylcytidine],18033
9,Corneal resistance factor (right),23061
9,None of the above (group 1) | illnesses of father,1074
9,Dermatitis and eczema,80
9,Triacylglycerol_46:2_[M+NH4]1+ levels,9
9,N-acetylglucosamine/n-acetylgalactosamine levels,892
9,Bitter alcoholic beverage consumption,80
9,Platelet distribution width,195900
9,Meat-related diet,63930
9,Cataracts,9961
9,Pattern 4 | hair/balding pattern,3340
9,Hashimoto thyroiditis,1099
9,Monobrow,1304
9,Freckling,343
9,Electrocardiogram morphology (amplitude at temporal datapoints) [-112 ms],12
9,Differentiated thyroid cancer,1179
9,Glycosuria in pregnancy (maternal genotype effect),448
9,Smoking initiation (ever regular vs never regular),24856
9,Pork intake,26863
9,Other malignant neoplasms of skin (=non-melanoma skin cancer) (controls excluding all cancers),15266
9,Glaucoma suspect,554
9,Serum metabolite levels [N-formylmethionine],7719
9,6mm strong meridian (left),2849
9,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Hispanic],672
9,CD40 on CD14+ CD16- monocyte,1454
9,Mitochondrial DNA copy number,76
9,Facial morphology (segment 48),19
9,Diastolic blood pressure,118515
9,Serum levels of protein IL27RA,3839
9,Medication use (calcium channel blockers),15893
9,Leisure sedentary behaviour (television watching),8357
9,Brain region volumes [cerebellar vermal lobules VI VII],168
9,Electrocardiogram morphology (amplitude at temporal datapoints) [-28 ms],158
9,TestASV_20 (Phascolarctobacterium) prevalence,110
9,Intake of sugar added to coffee,95
9,Pediatric autoimmune diseases,14535
9,Simvastatin | treatment/medication code,2194
9,Protein quantitative trait loci (liver) [KATNAL2],6693
9,Fat-free mass [male],394
9,Sum eosinophil basophil counts,43763
9,Physical activity,8363
9,Serum levels of protein TLL1,4091
9,HLA DR+ CD8+ T cell Absolute Count,3103
9,Gallstone disease,1883
9,CD25 on B cell,1171
9,Osteoarthritis (with total hip replacement),1467
9,Major coronary heart disease event,1000
9,Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined),796
9,vWF levels [EA],1504
9,Caffeine consumption from tea,124
9,Male puberty timing (early vs. average onset voice breaking),137
9,Lung function (FVC),146762
9,Budesonide+formoterol | treatment/medication code,1036
9,Glioblastoma (age-stratified) [Median age-at-diagnosis],1519
9,Depression (broad),117
9,Hematological parameters [PLT],197
9,"Blood protein levels [ENG, 4908_6_1]",2708
9,Electrocardiogram morphology (amplitude at temporal datapoints) [138 ms],1042
9,HDL cholesterol x physical activity interaction (2df test),548
9,Protein quantitative trait loci (liver) [CYP2A6],61
9,Mean corpuscular hemoglobin [Asian],519
9,Allergic asthma (mode),554
9,"Cholesterol lowering medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",2596
9,Smoking cessation [Conditioned on chr9:136467344],448
9,Asthma-related pneumonia,392
9,Facial morphology (columella size),198
9,Thyroid volume in Hashimoto’s thyroiditis,60
9,Crohn's disease,36273
9,Water intake,34539
9,Varicose veins,4192
9,Stable angina pectoris,1263
9,Polycystic ovary syndrome (adjusted for age),1368
9,Previous | smoking status,1964
9,Serum levels of protein FCN1,1282
9,Serum alkaline phosphatase levels,177900
9,Glycated hemoglobin levels,19112
9,Benign neoplasm: Cranial nerves (controls excluding all cancers),1171
9,"Glaucoma | non-cancer illness code, self-reported",2381
9,Basophil percentage of granulocytes,753
9,Nevus count [fixed effects],38
9,Type 1 diabetes,2481
9,Pulse rate,7863
9,Corneal hysteresis (right),22486
9,"Gynecologic disease (multivariate analysis) [uterine fibroid, ovarian cancer]",38
9,Ethylmalonate levels,171
9,Protein quantitative trait loci (liver) [ACSS3],16
9,Feeling hurt,6323
9,Eosinophilic esophagitis,10192
9,Pediatric bone mineral content (radius) [males],717
9,Keratoconus,5114
9,N-glycan levels [plasma glycan peak 67],1947
9,Platelet reactivity measurement (collagen-epinephrine),672
9,"Number of operations, self-reported",762
9,"""Primary open-angle glaucoma, strict""",2216
9,Vitamin K-dependent protein S measurement,396
9,Age of smoking initiation (MTAG),13023
9,IgG glycosylation [IGP13],5334
9,Coronary artery disease and LDL cholesterol levels (multivariate analysis),290
9,N-acetylhistidine levels,3223
9,Age first had sexual intercourse,174
9,Plasma anti-thyroglobulin and anti-thyroid peroxidase levels (bivariate analysis) [women],165
9,Amyotrophic lateral sclerosis (sporadic),8073
9,"Blood protein levels [KLRG1, 10548_35_3]",8052
9,Life satisfaction,2978
9,Neurological disease,153
9,Ankle spacing width (right),24939
9,Hip circumference adjusted for BMI [EA],12060
9,Clinical laboratory measurements [alkaline phosphatase],1455
9,Disorders of the thyroid gland,5199
9,Coronary revascularization (ANGIO or CABG),1000
9,Cerebrospinal fluid t-tau:AB1-42 ratio,281
9,IgG glycosylation patterns [IgG4_G2F],5334
9,"Waist circumference [EA, women]",57
9,Sphingomyelin_42:2_[M+H]1+ levels,432
9,Galectin-3-binding protein measurement,4091
9,"""Ulcerative colitis (strict definition, require KELA)""",2048
9,"Blood protein levels [GSN, 4775_34_3]",81
9,"Atrial fibrillation | non-cancer illness code, self-reported",1145
9,Malignant neoplasm of breast (controls excluding all cancers),966
9,Ulcerative colitis,71985
9,"Blood protein levels [ADAMTS13, 3175_51_5]",20017
9,Gut microbiota abundance (k_Bacteria.p_Actinobacteria.c_Actinobacteria.o_Coriobacteriales.f_Coriobacteriaceae.g_Collinsella.s_Collinsella_aerofaciens),1619
9,Femur bone mineral density x serum urate levels interaction [male],717
9,Brain region volumes [right cerebellum white matter],112
9,Sensitivity to environmental stress and adversity,13728
9,Neuroticism score,14994
9,Femur bone mineral density x serum urate levels interaction [female],90
9,Ascorbic acid 3-sulfate levels,22
9,Hypertensive diseases,6782
9,Schizophrenia vs ADHD (ordinary least squares (OLS)),17994
9,Influenza A (H1N1) infection,4510
9,Cardiac arrest,990
9,"Blood protein levels [EA, Intercellular adhesion molecule 2]",795
9,Help-seeking from a GP,283
9,Cortical surface area [Postcentral],100
9,Brain region volumes [right postcentral],50
9,"""Coxarthrosis, primary, with hip surgery""",926
9,Immune reponse to smallpox (secreted IFN-alpha) [AA],956
9,Serum metabolite levels [leucylalanine],955
9,Infantile hypertrophic pyloric stenosis,676
9,Tumor biomarkers [CEA],2899
9,IgG glycosylation patterns [IgG2_G2F],1196
9,Threonate levels,167
9,Hay fever and/or eczema,30325
9,Type 2 diabetes or prostate cancer (pleiotropy),13195
9,"Blood protein levels [Angiopoietin-1 receptor, soluble]",3332
9,Protein quantitative trait loci (liver) [PSMD14],350
9,Autism spectrum disorder or schizophrenia,631
9,"Waist circumference adjusted for body mass index [EA, men]",276
9,"Blood protein levels [EA, Platelet glycoprotein 4]",795
9,Goiter,1099
9,Protein quantitative trait loci (liver) [RAB7A],18
9,Electrocardiogram morphology (amplitude at temporal datapoints) [-108 ms],12
9,IBD patients in KELA-register,1817
9,Nontoxic diffuse goitre,1179
9,Educational attainment (years of education) [conditional-joint],37151
9,"Peripheral vascular disease, unspecified",990
9,Programmed cell death 1 ligand 2 levels,606
9,Procedures for purposes other than remedying health state,160
9,"""Type 2 diabetes, definitions combined, including avohilmo""",101
9,Protein quantitative trait loci (liver) [LCP1],50
9,Hippocampal subfield CA4 volume,153
9,Infant length,13
9,IgA nephropathy [EA],14716
9,Protein quantitative trait loci (liver) [CES2],5307
9,Cholelithiasis and cholecystitis,1883
9,Electrocardiogram morphology (amplitude at temporal datapoints) [160 ms],1042
9,Serum metabolite concentrations in chronic kidney disease [Histidine],19
9,Cutaneous malignant melanoma,28178
9,Peripheral artery disease,6114
9,Nontoxic nodular goiter,1179
9,"""Endomtriosis ASRM stages 1,2""",725
9,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)",188
9,Electrocardiogram morphology (amplitude at temporal datapoints) [136 ms],1042
9,General factor of neuroticism,3806
9,Estradiol levels,2200
9,Serum levels of protein COL15A1,1085
9,Spherical equivalent [EA],1292
9,Congenital iodine-deficiency syndrome/hypothyroidism,984
9,Cataracts (operation),29
9,Serum levels of protein PTGR1,4397
9,Hydroxycarbamide | treatment/medication code,10296
9,Neuroticism conditioned on self-rated math ability (multi-trait conditioning and joint analysis),2765
9,Educational attainment,216
9,Time to complete round,1016
9,"Smoking cessation [Conditioned on chr9:136461851, chr9:136473572, chr9:136467344]",229
9,Melanoma,92294
9,Triglycerides,78441
9,Serum levels of protein GFRAL,4091
9,Brain region volumes [right isthmus cingulate],1500
9,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),1310
9,Drug-induced liver injury (isoniazid-containing anti-tuberculosis drugs),4
9,Protein quantitative trait loci (liver) [PTGR1],7829
9,Whole body fat mass,44713
9,Leg fat percentage (right),77194
9,Diabetes,2856
9,Hematological and biochemical traits [ALP],1489
9,Smoking status (current vs mixed),571
9,Hernia,631
9,Atrial fibrillation and flutter,1250
9,Waist circumference [EA],57
9,Birth weight (MTAG),19244
9,Circumscribed brain atrophy,47
9,Body mass index (SNP x SNP interaction),131
9,Blood protein levels [PECAM-1],5057
9,"Pulmonary embolism +/- dvt | non-cancer illness code, self-reported",891
9,Alzheimer's disease biomarkers [ptau],36
9,Motor neuron disease,22
9,Refractive error,65880
9,Haemorrhoidal disease,42241
9,Heel bone mineral density (bmd) (left),1433
9,Blood sugar levels,362
9,"Heel quantitative ultrasound index (qui), direct entry (left)",668
9,Chron's disease NAS,477
9,Childhood body mass index,160
9,Overall survival in osteosarcoma,200
9,Neurological blood protein biomarker levels [gal-8],1563
9,Serum levels of protein PNPLA2,1455
9,"Allergy, hypersensitivity or anaphylaxis",391
9,"""Thyrotoxicosis, other and/or unspecified""",42
9,Adult body size,56034
9,Number of days/week of vigorous physical activity 10+ minutes,7479
9,Non-accidental death in close genetic family,1000
9,Hypersomnia (HLA-DQB1*06:02 negative),889
9,White | bread type,121
9,Fish- and plant-related diet,9088
9,Myeloproliferative neoplasms,30745
9,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],302
9,Eye color traits [Eye color phototype score],3006
9,Protein quantitative trait loci (liver) [AMBP],453
9,"Thyroid cancer (Papillary, radiation-related)",1179
9,Childhood asthma (age<16),474
9,Maximum frequency of taking cannabis,28
9,Electrocardiogram morphology (amplitude at temporal datapoints) [-110 ms],12
9,Neuroblastoma (1p deletion),1265
9,Electrocardiogram morphology (amplitude at temporal datapoints) [154 ms],1042
9,Total cholesterol levels [EA],1461
9,CD25 on IgD- CD38- B cell,367
9,Arm fat mass (left),35410
9,IgG glycosylation patterns [IgG4_G2F/IgG4_G1F],5334
9,Gastroesophageal reflux disease,1304
9,White blood cell count (monocyte),785
9,End-stage coagulation [FVIII],672
9,Cytokine levels [VEGF-A],86
9,Protein quantitative trait loci (liver) [HNRNPH3],121
9,Facial skin colour (CIELAB index L* value),37
9,Metabolite levels [CE 16:0],44
9,Protein quantitative trait loci (liver) [ABRACL],15
9,Blood protein levels [Hepatocyte growth factor receptor],795
9,LDL cholesterol levels x long total sleep time interaction (2df test),795
9,Personality dimensions [Openness],28
9,Frequency of needing morning drink of alcohol after heavy drinking session in last year,49
9,Electrocardiogram morphology (amplitude at temporal datapoints) [184 ms],4687
9,Low tan response,4037
9,Brainstem volume,112
9,Malaria [additive],184
9,Peripheral vascular disease,1881
9,Blue vs. green eyes,3006
9,Facial pigmentation measurement (UV light),1364
9,Serum metabolite levels [3-methylglutaconate],278
9,Urinary sodium excretion [EA],109
9,Myopia (age of diagnosis),4970
9,IgG glycosylation [IGP39],5334
9,"""Sleep apnoea, including avohilmo""",569
9,Cardiometabolic and hematological traits [PLT],1413
9,Cereal intake,19109
9,IgG fucosylation phenotypes (multivariate analysis),5334
9,Alcohol consumption (drinks per week),4012
9,Asthma-related acute respiratory infections,391
9,Pattern 2 | hair/balding pattern,333
9,Modified Stumvoll Insulin Sensitivity Index (BMI interaction),2
9,Protein quantitative trait loci (liver) [RAC2],50
9,Cutaneous nevi,22834
9,Menarche (age at onset),54208
9,Ankle spacing width (left),23230
9,Metabolic disorders,1891
9,Smoking initiation (ever regular vs never regular) [Conditioned on chr9:134334588],1282
9,Other arthropathies,207
9,Hypothyroidism nos,6708
9,Nontoxic multinodular goiter,1179
9,"Cholesterol, total",12601
9,Disorders of lipoprotein metabolism and other lipidaemias,1891
9,Creatinine (enzymatic) in urine,854
9,Caudate nucleus volume,16
9,COVID-19 (RELEASE 5),2200
9,Migraine,624
9,Hyperlipidemia,2033
9,Protein quantitative trait loci (liver) [ENTPD5],7
9,Facial ageing,17085
9,"Heel quantitative ultrasound index (qui), direct entry",18756
9,"Umbilical hernia | non-cancer illness code, self-reported",4159
9,IgG glycosylation patterns [IgG4_G2FS1],5334
9,Spherical power (right),1442
9,"""Endomtriosis ASRM stages 3,4""",780
9,Advanced age-related macular degeneration [EA],3471
9,Hematocrit [Asian],581
9,Usual walking pace,1526
9,"Vocal cord polyp | non-cancer illness code, self-reported",1363
9,Sociability score,1366
9,Facial morphology (segment 2),266
9,Hip circumference,35163
9,Sulfhydryl oxidase 2 measurement,4671
9,"""Inflammatory bowel disease, strict (require KELA)""",1854
9,Vitiligo,3289
9,Status post-ami,1000
9,Blood protein levels [CD209 antigen],1314
9,Leg predicted mass (left),68742
9,Sensitivity / hurt feelings,5941
9,Left atrial total emptying fraction,1358
9,Pediatric bone mineral density (spine) [Males],63
9,Lobe attachment (rater-scored or self-reported),53
9,Prostate-specific antigen levels,44740
9,Loneliness,14918
9,DNA methylation-estimated plasminogen activator inhibitor-1 levels,528
9,Protein quantitative trait loci (liver) [LGALS3BP],129
9,Time spend outdoors in summer,8107
9,Hypothyroidism or myxedema,7224
9,IgG glycosylation patterns [IgG1_G2FS1/IgG1_G1FS1],5334
9,Asthma (adult onset),3155
9,Asthma and hay fever,446
9,Mean corpuscular hemoglobin concentration,166832
9,Proinsulin levels (early-phase conversion),1297
9,Metabolite levels (lipoprotein measures) [Total cholesterol in very large HDL],570
9,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],485
9,Thyroid hormone levels [FT4-Males],976
9,Serum metabolite concentrations in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C44:4],19
9,Insulin-like growth factor-binding protein-like 1 levels,1448
9,Monocyte differentiation antigen CD14 measurement,891
9,Gastrointestinal infection,891
9,Inflammatory biomarkers [IL-6],1130
9,Heel bone mineral density,178391
9,Neutrophil-to-lymphocyte ratio,2610
9,Protein quantitative trait loci [TNFA],1455
9,Protein quantitative trait loci (liver) [TOMM70],1
9,HDL cholesterol levels [EA],3925
9,Factor VIII levels [conditional],1190
9,Colorectal cancer (alcohol consumption interaction) [Light-to-moderate drinkers],4073
9,"Chronic lymphocytic | cancer code, self-reported",75
9,Cutaneous melanoma or hair colour,20143
9,"Diastolic blood pressure, automated reading",5708
9,Nicotine dependence,491
9,Serum levels of protein CD109,891
9,Protein quantitative trait loci (liver) [LUM],164
9,Pyridoxate levels,200
9,Anthropometric traits [height],363
9,Estimated glomerular filtration rate [EA],478
9,"Blood protein levels [CNTFR, 2711_6_2]",138
9,Protein quantitative trait loci (liver) [CORO1A],27
9,Glaucoma (low intraocular pressure),2808
9,Blood protein levels [P-Selectin],795
9,Ovarian cancer [All invasive],224
9,Impedance of arm (right),90888
9,Multiple sclerosis,5133
9,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)",2442
9,Baclofen | treatment/medication code,74
9,"""Type 2 diabetes, strict (exclude DM1)""",193
9,Type 2 diabetes [conditional],12564
9,Platelet-to-lymphocyte ratio,15333
9,Pure hypercholesterolaemia,1891
9,Age started wearing glasses or contact lenses,1008
9,Dicloflex 25mg e/c tablet | treatment/medication code,1572
9,Serum levels of protein TFPI,299
9,Impedance of leg (right),93670
9,Photic sneeze reflex,89
9,Ability to confide in someone,6998
9,Vertex-wise cortical thickness,82977
9,Urinary metabolite levels in chronic kidney disease [2'-O-methylcytidine],18152
9,Pulse wave arterial stiffness index,872
9,Serum levels of protein FAM3D,1619
9,Benign neoplasm of brain and other parts of central nervous system (controls excluding all cancers),990
9,"Osteoarthritis | non-cancer illness code, self-reported",14
9,Bipolar disorder or body mass index,57
9,Feeling miserable,23
9,Balding type 1,23093
9,Diabetes mellitus,1085
9,Plays computer games,3330
9,Persons with potential health hazards related to family and personal history and certain conditions influencing health status,1000
9,Seroxat 20mg tablet | treatment/medication code,10
9,"Eye color [EA, discovery]",3510
9,"Long-standing illness, disability or infirmity",9259
9,"Intra-ocular pressure, goldmann-correlated (right)",3702
9,"Number of decayed, missing and filled tooth surfaces or use of dentures",10057
9,"Larynx/throat cancer | cancer code, self-reported",724
9,Serum levels of protein ICAM2,1782
9,Chronic kidney disease,545
9,Fracture of vertebral column without mention of spinal cord injury,203
9,Identify largest number | fi2 ,86
9,Chronic airway obstruction,9235
9,Fat-free mass,11476
9,Insomnia symptoms (never/rarely vs. sometimes/usually),7839
9,Arm fat-free mass (right),74651
9,Lead levels in blood,70
9,Other disorders of veins,90
9,Protein quantitative trait loci (liver) [HBG1],15
9,Vertex-wise sulcal depth,75809
9,Bioavailable testosterone levels,35115
9,Serum levels of protein EVA1C,973
9,Protein quantitative trait loci [Tenascin],259
9,Electrocardiogram morphology (amplitude at temporal datapoints) [186 ms],4687
9,Medication use (HMG CoA reductase inhibitors),11726
9,Fasting insulin,5001
9,Benign neoplasm: Cranial nerves,1171
9,Metabolic syndrome,1701
9,Serum levels of protein VEGFA,288
9,Labour and delivery complicated by umbilical cord complications,19
9,Body fat distribution (leg fat ratio) [females],10659
9,"Blood protein levels [DPP7, 8346_9_3]",15722
9,Autoimmune traits,1944
9,Serum levels of protein KDR,891
9,Protein quantitative trait loci (liver) [NIPSNAP1],76
9,"""Atopic dermatitis, strict definition with reimbursement""",80
9,Age at first birth,890
9,C-reactive protein,29946
9,"""Hypothyroidism,  other/unspecified""",5102
9,Dupuytren's disease,156
9,Reticulocyte fraction of red cells,94846
9,LDL cholesterol levels [BMI unadjusted],1489
9,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction),135
9,None of the above | pain type(s) experienced in last month,27307
9,HDL cholesterol levels in current drinkers,2275
9,"Light brown | hair colour (natural, before greying)",3751
9,Thrombin generation potential phenotypes [Lag Time],299
9,Protein quantitative trait loci [DC-SIGN],1455
9,Heel bone mineral density (MTAG),53
9,Asthma,72675
9,"Loneliness, isolation",6874
9,Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis),3598
9,Obesity [Obesity class I],57
9,Takayasu arteritis,42
9,Age at first sexual intercourse,40482
9,IgG glycosylation [IGP26],5334
9,Phlebitis and thrombophlebitis of lower extremities,1455
9,HDL cholesterol levels [BMI unadjusted],655
9,"Blood protein levels [PTGDS, 10514_5_3]",4026
9,"Systolic blood pressure, automated reading",15278
9,Serum metabolite levels (CMS) [Gly],586
9,"Blood protein levels [QSOX2, 8397_147_3]",1105
9,Lodine 200mg tablet | treatment/medication code,3594
9,Receptor for advanced glycosylation end products levels,1396
9,Endothelial growth factor levels [sTie-2],4355
9,Sunburns,469
9,Metabolic biomarkers (multivariate analysis),46853
9,Fibrosis-4 index in high alcohol intake,527
9,Primary open angle glaucoma,1572
9,"Aging traits (healthspan, parental lifespan or longevity) (multivariate analysis)",990
9,Asthma (only as main-diagnosis),637
9,"Smoking cessation [Conditioned on chr9:136473572, chr9:136467344]",408
9,Medication use (thyroid preparations),11460
9,Protein quantitative trait loci [FCN2],277
9,Childhood onset type 2 diabetes,340
9,Glioblastoma [females],1519
9,Malignant neoplasm of endocrine gland,1179
9,Body fat distribution (leg fat ratio) [males],2956
9,Knee pain | pain type(s) experienced in last month,410
9,Cortical surface area (visual PC2) [EA],669
9,Forns index in high alcohol intake,197
9,Smoking cessation (MTAG),28017
9,Depressive symptoms (MTAG),12003
9,Sleeplessness / insomnia,7738
9,Place of birth in uk - north co-ordinate,1056
9,Testicular germ cell cancer,192
9,Platelet endothelial cell adhesion molecule levels,6018
9,Electrocardiogram morphology (amplitude at temporal datapoints) [212 ms],3645
9,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),485
9,Cholelithiasis or gall stones,1883
9,Benign neoplasm of skin,7483
9,"Blood protein levels [C5, 2381_52_4]",5989
9,Macular telangiectasia type 2,3766
9,IgG glycosylation patterns [IgG2 G1n],1247
9,Gestational diabetes (for exclusion),276
9,Type 2 diabetes [South Asian],106
9,Crowding of teeth,16
9,Eosinophill count,86625
9,Male puberty timing (late vs. average onset facial hair),1222
9,Optic disc size,8056
9,Mitochondrial DNA levels,2772
9,Electrocardiogram morphology (amplitude at temporal datapoints) [170 ms],1042
9,Lipoprotein phospholipase A2 activity in cardiovascular disease,282
9,Rheumatoid arthritis [ACPA+ cases vs. all controls],2235
9,Autoimmune thyroid disease,1980
9,Thyroid hormone levels [FT4],8319
9,Irritable bowel syndrome [women],51
9,Glioblastoma (age-stratified) [Above median age-at-diagnosis],1519
9,Subcortical volume (min-P),6250
9,Duodenal ulcer [Recessive],3148
9,Chronic lymphocytic leukemia,1006
9,HDL cholesterol levels x short total sleep time interaction (2df test),1801
9,Cortical surface area (min-P),700
9,Metabolic traits [SM-8 + 3 other traits],1177
9,Body mass index in physically active individuals,305
9,Skin pigmentation traits [Skin color],426
9,Duration to first press of snap-button in each round,10871
9,Difficulty not smoking for 1 day,639
9,Gamma glutamyl transpeptidase,19246
9,Serum levels of protein C5,5989
9,Autoimmune diseases,26907
9,vWF levels in ischaemic stroke and hyperhomocysteinaemia,1455
9,"Blood protein levels [CCL21, 2516_57_3]",165
9,Metastasis at diagnosis in osteosarcoma [EA],272
9,Beclomist 50micrograms nasal spray | treatment/medication code,126
9,Facial morphology (segment 38),40
9,Eye color traits [Eye color],3006
9,White matter microstructure (radial diusivities) [Genu of corpus callosum],1569
9,Cortical surface area (MOSTest),2323
9,Glaucoma (primary open-angle) [Japanese discovery],1101
9,"Facial morphology (factor 17, height of vermillion upper lip)",191
9,Subiculum volume,197
9,Protein quantitative trait loci (liver) [TNC],97
9,White matter microstructure (mean diusivities) [Genu of corpus callosum],1569
9,Cholecystitis,1804
9,Smoking behaviour (cigarettes smoked per day) [Conditioned on chr9:136502369],605
9,"Blood protein levels [FCN2, 3313_21_2]",62
9,Maximum workload during fitness test,30
9,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) [subset analysis]",15833
9,Serum levels of protein NCMAP,33148
9,Forced vital capacity (fvc),61148
9,Pulmonary embolism with or without deep venous thrombosis,2580
9,Serum levels of protein EPHA4,4982
9,Prostate cancer [EA],595
9,Waist circumference [BMI_pooled],122
9,Interleukin-12p70 levels,36
9,Appendicular lean mass,408182
9,Serum metabolite levels [ADpSGEGDFXAEGGGVR],672
9,acne vulgaris,1660
9,Arthrosis,4088
9,"Peripheral nerve disorder | non-cancer illness code, self-reported",836
9,Lung cancer | illnesses of father,48
9,Protein quantitative trait loci (liver) [CAPN2],16
9,LDL cholesterol x physical activity interaction (2df test),891
9,Beef intake,64516
9,Hypothyroidism and >3 levothyroxin purchases,4421
9,Electrocardiogram morphology (amplitude at temporal datapoints) [198 ms],4687
9,Lipid traits [TC],1489
9,Serum metabolite levels [glycosyl-N-palmitoyl-sphingosine (d18:1/16:0],1833
9,Glioma (high-grade),802
9,Muscle strain,86
9,Apolipoprotein A1 levels,49265
9,Medication use (salicylic acid and derivatives),3160
9,Lung volume,2287
9,"Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)",1891
9,Morning vs. evening chronotype,1182
9,Depressive symptoms x dependent stressful life events interaction (2df test),26
9,Midgestational circulating levels of PBDEs [BDE-28],18
9,Prostate cancer,94433
9,Primary biliary cholangitis,13536
9,Insomnia symptoms (never/rarely vs. usually),7723
9,HDL cholesterol x physical activity interaction (2df test) [EA],1798
9,Serum levels of protein CCL28,891
9,Electrocardiogram morphology (amplitude at temporal datapoints) [-24 ms],158
9,Rate of cognitive decline in Alzheimer's disease [GEE model],297
9,Cortical surface area,64955
9,Peak expiratory flow,4463
9,CD25 on CD24+ CD27+ B cell,1171
9,Coronary artery disease or large artery stroke,1662
9,Protein quantitative trait loci [sTie-1],3910
9,Circulatory disease nec,991
9,Smoking behaviour (cigarettes smoked per day),829
9,Type 2 diabetes,212273
9,Body fat percentage,134986
9,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Asian],485
9,Blood protein levels [Vascular endothelial growth factor receptor 3],795
9,Barrett's esophagus,407
9,Diltiazem | treatment/medication code,218
9,Bone mineral density (hip) and age at menarche,803
9,Self-reported math ability (MTAG) [MTAG],47567
9,Sleep duration,30782
9,High light scatter reticulocyte percentage,13092
9,Beta-trace protein levels [EA],2935
9,Circulating fibroblast growth factor 23 levels [EA],1203
9,"Fracture shoulder / scapula | non-cancer illness code, self-reported",2262
9,"Paracetamol | medication for pain relief, constipation, heartburn",1883
9,"Gut microbiota (bacterial taxa, rank normal transformation method) [O_Rhodospirillales_RNT]",875
9,Waist circumference adjusted for BMI in active individuals [women],51
9,Body fat percentage [female],13510
9,Lymphocyte percentage,83849
9,Factor VIII levels,1157
9,Medication use (antihistamines for systemic use),667
9,"None of the above | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",28792
9,Lifetime smoking index,11149
9,"Other chronic ischemic heart disease, unspecified",1000
9,Pattern 1 | hair/balding pattern,3144
9,DNA methylation GrimAge acceleration,187
9,Nonatopic asthma,456
9,Latanoprost | treatment/medication code,467
9,Domperidone | treatment/medication code,203
9,Response to montelukast in asthma (change in FEV1),164
9,Protein quantitative trait loci (liver) [TAGLN],72
9,Aspartate aminotransferase to alanine aminotransferase ratio,13273
9,"Heel quantitative ultrasound index (qui), direct entry (right)",6046
9,Carbamazepine | treatment/medication code,86
9,Obesity [Obesity class II],57
9,Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis),3910
9,Gut microbiota (beta diversity) [Jaccard metric],512
9,Serum levels of protein CD200,891
9,Schizophrenia vs bipolar disorder (ordinary least squares (OLS)),34
9,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event) [Cox proportional hazards regression model],9
9,Dipeptidyl peptidase 2 levels,15452
9,Urinary metabolite levels in chronic kidney disease [3-methylglutarate/2-methylglutarate],277
9,Suffering from nerves,709
9,Vitamin D levels,16062
9,ABO blood group (A vs non-A),1452
9,Pappalysin-1 levels,176
9,Pancreas fat,891
9,Waist-to-hip ratio adjusted for body mass index [EA],259
9,CTACK levels,12026
9,Serum levels of protein ADGRF5,4091
9,"""Amyloidosis, other/unspecified""",622
9,Ischemic stroke (large artery atherosclerosis),41
9,Pulse pressure,194484
9,"""Hypothyroidism, strict autoimmune""",5090
9,Total cholesterol levels [Trans-ethnic initial],1951
9,Brain region volumes [cerebellar vermal lobules I V],1182
9,Femur bone mineral density x serum urate levels interaction,956
9,Motion sickness,163
9,Ovarian cancer [Serious invasive],224
9,Pre-treatment viral load in HIV-1 infection,3677
9,Graves' disease,3148
9,Glaucoma (multi-trait analysis),15226
9,Urinary metabolite levels in chronic kidney disease [2'-O-methyluridine],18152
9,Electrocardiogram morphology (amplitude at temporal datapoints) [-148 ms],1006
9,Venous thromboembolism (SNP x SNP interaction),662
9,Any other type of psychosis or psychotic illness | mental health problems ever diagnosed by a professional,131
9,Mean arterial pressure,28496
9,Serum phosphate levels,33169
9,Heel bone mineral density T score,70361
9,Ascorbate (vitamin c) levels,434
9,Serum levels of protein PTGDS,4026
9,"Blood pressure medication | medication for cholesterol, blood pressure or diabetes",80
9,Schizophrenia (MTAG),138
9,"Blood protein levels [SEPT10, 12690_33_3]",8052
9,Waist circumference adjusted for BMI in non-smokers,260
9,Insomnia,28152
9,Smoking initiation,12766
9,Trunk predicted mass,135668
9,Electrocardiogram morphology (amplitude at temporal datapoints) [156 ms],1042
9,Nasal or sinus disorder,391
9,Remission after SSRI treatment in MDD or neuroticism,28
9,Protein quantitative trait loci (liver) [EML4],86
9,Waist circumference adjusted for body mass index [women],51
9,Able to confide,7854
9,Time spent watching television (tv),4918
9,Gliclazide | treatment/medication code,115
9,Serum levels of protein LIFR,891
9,"Blood protein levels [CDH5, 2819_23_2]",2357
9,Mild influenza (H1N1) infection,4510
9,Hidradenitis suppurativa,349
9,Serum levels of protein PEAR1,4091
9,"""Diabetes, insuline treatment (Kela reimbursement) (more control exclusions)""",855
9,Response to tolvaptan in hepatic ascites (body weight gain),77
9,Leg fat-free mass (right),72911
9,Lung adenocarcinoma,10138
9,Angitil sr 90 m/r capsule | treatment/medication code,136
9,"Medication use (adrenergics, inhalants)",2672
9,"Heel bone mineral density (bmd) t-score, automated (right)",6046
9,Gut microbiota abundance (k_Bacteria.p_Actinobacteria.c_Actinobacteria.o_Coriobacteriales.f_Coriobacteriaceae.g_Collinsella),1619
9,Coronary artery disease in type 1 diabetes,1218
9,Fibroblastic disorders,102
9,Central corneal thickness,34882
9,Protein quantitative trait loci (liver) [CFL2],9
9,Serum levels of protein IL3RA,4982
9,"Blood protein levels [ROBO4, 9232_1_3]",2357
9,Hypertensive diseases (excluding secondary),14363
9,Serum levels of protein RGMA,5457
9,Electrocardiogram morphology (amplitude at temporal datapoints) [192 ms],4687
9,Atorvastatin | treatment/medication code,1906
9,Protein quantitative trait loci (liver) [APRT],373
9,Endometriosis [EA],634
9,Hydroxyasparagine levels,1588
9,Length of menstrual cycle,1156
9,Ascending aorta maximum area,1389
9,Azorhizobium abundance in stool,111
9,Weight,206745
9,Electrocardiogram morphology (amplitude at temporal datapoints) [74 ms],9359
9,"Forced expiratory volume in 1-second (fev1), predicted",54245
9,Medication use (agents acting on the renin-angiotensin system),10160
9,Obesity-related traits [IL6 ],1283
9,Pancreas volume,891
9,Glioblastoma [males],1519
9,"""Other diabetes, wide definition""",874
9,Waist-hip ratio,128644
9,Worry too long after embarrassment,14271
9,Soluble E-selectin levels,3052
9,Electrocardiogram morphology (amplitude at temporal datapoints) [22 ms],1884
9,Cataract,1029
9,Gamma glutamyl transferase levels,58635
9,Tumor necrosis factor receptor 2 levels,778
9,"Blood protein levels [EA, Toll-like receptor 4:Lymphocyte antigen 96 complex]",909
9,Protein quantitative trait loci (liver) [SH3BGRL],72
9,Direct low density lipoprotein cholesterol levels,28526
9,A levels/as levels or equivalent | qualifications,8591
9,Brain region volumes [cerebellar vermal lobules VIII X],1182
9,Serum carcinoembryonic antigen levels,910
9,Left–right brain asymmetry,1164
9,Thioalkalivibrionaceae abundance in stool,357
9,Facial morphology (segment 7),96
9,Coagulation factor Xa measurement,527
9,Glucocorticoid-induced osteonecrosis,88
9,Hypromellose product | treatment/medication code,71
9,Birth length (MTAG),19277
9,Liver enzyme levels [ALP],2733
9,"N,n,n-trimethyl-alanylproline betaine (tmap) levels",1517
9,Cadherin-5 levels,5826
9,Spherical equivalent (joint analysis main effects and education interaction),1271
9,Alzheimer's disease biomarkers [tau],36
9,Intraocular pressure,66363
9,Blood protein levels [Programmed cell death 1 ligand 2],1017
9,Sleep disorders (combined),1928
9,Electrocardiogram morphology (amplitude at temporal datapoints) [-116 ms],12
9,Hypothyroidism,18559
9,Testicular cancer,913
9,Gallbladder disease,1883
9,Benign neoplasm of unspecified sites,302
9,Gut microbiota (bacterial taxa) [OTU10032 unclassified Enterobacteriaceae],59
9,Glucose levels,30039
9,Thyroxine product | treatment/medication code,8265
9,Osteoarthritis (hip) [additive],1176
9,Medication use (beta blocking agents),1480
9,Waist circumference adjusted for BMI in active individuals [men],134
9,Leg fat-free mass (left),66645
9,Medication use (vasodilators used in cardiac diseases),1976
9,Osteoarthritis of the hip or knee,1158
9,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction),51
9,Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications,12853
9,interferon-related traits [IFNalpha_STAT4_of_CD56pCD16p],12735
9,Electrocardiogram morphology (amplitude at temporal datapoints) [216 ms],3272
9,Positive affect,3109
9,Serum levels of protein MINPP1,4091
9,Type 2 diabetes [Japanese],2650
9,Quinine | treatment/medication code,772
9,Glomerular filtration rate,517
9,Parental extreme longevity (95 years and older),20
9,Retinal nerve fibre layer (RNFL) thickness,2
9,Neuroticism,75802
9,Major depressive disorder,18552
9,Relative age voice broke,1161
9,Serum levels of protein LYVE1,3364
9,Stroke,1970
9,Corneal curvature,181
9,Contracture of palmar fascia [dupuytren's disease],99
9,Total protein levels x insomnia interaction,179
9,Cholesteryl ester_22:5_[M+NH4]1+ levels,43
9,Protein quantitative trait loci (liver) [RHOC],16
9,"Hip circumference adjusted for BMI [EA, women]",12850
9,6mm strong meridian (right),2906
9,Nontoxic multinodular goitre,1179
9,Apolipoprotein B levels,62020
9,Sex hormone-binding globulin levels adjusted for BMI,149008
9,Eosinophill percentage,69577
9,Protein quantitative trait loci [Cadherin-5],4091
9,Gut microbiota relative abundance (bacterial taxa) [Peptoniphilus],176
9,Candida albicans stimulated IL-8 levels,5
9,Inflammatory bowel disease,50014
9,Psoriasis,12061
9,Keratinocyte cancer (MTAG),17998
9,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [2-methylmalonylcarnitine(C4-DC), succinylcarnitine(C4-DC), X-24699]",41636
9,Glaucoma (primary open-angle) [NPG],1577
9,Asthma/COPD (KELA code 203),391
9,Fibroblast growth factor 23 levels,1645
9,Cortical surface area [Lateral Occipital],661
9,Neuritic plaques (SNP x SNP interaction),130
9,Protein quantitative trait loci (liver) [DDB1],21
9,Hard cardiovascular diseases,1000
9,Colorectal cancer,5827
9,Serum levels of protein OBP2B,3454
9,Bilirubin levels,21559
9,Cooked vegetable intake,8057
9,Myeloproliferative disease,10212
9,IgG glycosylation patterns [IgG4 FGS1/(FG+FGS1],6801
9,Moderate to vigorous physical activity levels,2508
9,IgG glycosylation [IgG1G2],5334
9,Psoriasis or type 2 diabetes (trans-disease meta-analysis),762
9,Coronary artery disease,34459
9,Erythritol levels,2102
9,"""Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system (controls excluding all cancers)""",990
9,Arm predicted mass (left),90474
9,Protein quantitative trait loci (liver) [HSPH1],243
9,Actinic keratosis,302
9,Electrocardiogram morphology (amplitude at temporal datapoints) [78 ms],9359
9,Loneliness (MTAG),7013
9,White matter microstructure (fractional anisotropy) [Splenium of corpus callosum],1569
9,Serum levels of protein GLCE,891
9,Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis),3227
9,CD25 on IgD+ CD38+ B cell,1171
9,Endometrial cancer,468
9,Lymphocyte counts,403004
9,Rheumatoid arthritis (ACPA-positive),47249
9,Melanomas of skin,23019
9,Non-glioblastoma glioma,3096
9,Asthma (mode),704
9,Menarche (age at onset) [japanese],165
9,Ankle spacing width,61143
9,Aspartate aminotransferase platelet ratio index in high alcohol intake,527
9,Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia,563
9,Serum levels of protein FAM3B,891
9,Adenocarcinoma,191
9,Parkinson's disease,146
9,Anxiety score x vitamin D PRS interaction,61
9,Protein quantitative trait loci (liver) [TTN],91
9,Elevated serum carcinoembryonic antigen levels,2899
9,IgG glycosylation patterns [IgG2_G2FS1/IgG2_G1FS1],5334
9,Electrocardiogram morphology (amplitude at temporal datapoints) [210 ms],3645
9,Parental longevity (both parents in top 10%),1000
9,Lung function (FEV1),481
9,Electrocardiogram morphology (amplitude at temporal datapoints) [164 ms],1415
9,Pursuit maintenance gain,323
9,Serum levels of protein ASPN,33409
9,"Heel broadband ultrasound attenuation, direct entry",13344
9,IgG glycosylation patterns [IgG2_G2Fn],1196
9,"Yes, because of illness | major dietary changes in the last 5 years",1218
9,Cortical volume [Postcentral],50
9,Gut microbiota abundance (genus Oxalobacter id.2978),20
9,Factor VIII levels [EA],1157
9,Serum levels of protein CHST12,891
9,Metabolite levels,281
9,Cerebrovascular diseases (FINNGEN),990
9,Immunological or systemic disorder,391
9,Brain region volumes [left cerebellum exterior],13
9,IgA nephropathy,14716
9,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)",4979
9,Waist circumference adjusted for body mass index,115947
9,Cancer of brain,1460
9,"Bone mineral density (paediatric, lower limb)",1433
9,Phytosterol levels [campesterol],1130
9,IgG glycosylation patterns [IgG1_G0FNn],1196
9,"Blood protein levels [OLFM1, 5703_26_3]",195
9,Total cholesterol levels,64994
9,Fish- and plant-related diet [male],9036
9,Headache | pain type(s) experienced in last month,3632
9,Leisure sedentary behaviour (computer use),3338
9,Inflammatory skin disease [Psoriasis],640
9,Iritis,717
9,Normotensive glaucoma,1589
9,P-selectin glycoprotein ligand 1 levels,155
9,Participation in an health questionnaire (not invited vs invited),34
9,Comparative body size at age 10,13016
9,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),2021
9,Glaucoma | eye problems/disorders,2440
9,Major coronary heart disease event excluding revascularizations,1000
9,"Red blood cell traits [EA, MCV]",643
9,Heart disease | illnesses of mother,990
9,Cigarettes smoked per day (current),196
9,Adolescent idiopathic scoliosis,31595
9,Serum levels of protein AMY2B,891
9,Electrocardiogram morphology (amplitude at temporal datapoints) [202 ms],3645
9,Acute lymphoblastic leukemia (childhood),1039
9,Shoulder impingement syndrome,7
9,Cognitive ability (MTAG),16061
9,White matter microstructure (radial diusivities) [Splenium of corpus callosum],1569
9,Blood protein levels [TIE2],6750
9,Monoclonal gammopathy of undetermined significance,126
9,Lung function (FEV1/FVC),138593
9,Sex hormone-binding globulin levels,207836
9,Electrocardiogram morphology (amplitude at temporal datapoints) [236 ms],12094
9,Heel bone mineral density (bmd),18255
9,"""Disorders of gallbladder, biliary tract and pancreas""",5539
9,Alcohol consumption (drinks per week) (MTAG),5002
9,Electrocardiogram morphology (amplitude at temporal datapoints) [76 ms],9359
9,"Thyroid cancer | cancer code, self-reported",1179
9,Type 2 diabetes [EA],1124
9,Low density lipoprotein cholesterol levels [EA],891
9,Protein quantitative trait loci (liver) [PYCARD],50
9,Blood cell traits (multivariate analysis),30
9,Dentures,10057
9,Irritability,16
9,Age at last live birth,72
9,Lifetime anxiety disorder [EA],156
9,Haemorrhagic disorder due to circulating anticoagulants,78
9,Neutrophil percentage of white cells,77337
9,Electrocardiogram morphology (amplitude at temporal datapoints) [196 ms],4687
9,Type 2 diabetes with ophthalmic complications,122
9,"Blood protein levels [EA, Tenascin]",655
9,General cognitive ability,1841
9,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),2289
9,"None of the above | medication for cholesterol, blood pressure or diabetes",990
9,Nevus count or cutaneous melanoma,84855
9,Childhood sunburn occasions,1738
9,Serum levels of protein SELP,891
9,interferon-related traits [IFNalpha_STAT4_of_CD56brightCD16n],11822
9,IgG glycosylation patterns [IgG2_G1FN/IgG2_G0FN],1247
9,Serum levels of protein SVEP1,806
9,Disorders of choroid and retina,192
9,Serum levels of protein HFE2,5457
9,Osteoarthritis (hip),5128
9,Nose size,344
9,Protein quantitative trait loci (liver) [CA1],15
9,Serum levels of protein QSOX2,2724
9,HDL cholesterol levels [Trans-ethnic initial],1190
9,Fasciitis,99
9,Body mass index,476825
9,Depression,12676
9,Angina pectoris,3256
9,Blood protein levels [SELE],2759
9,Electrocardiogram morphology (amplitude at temporal datapoints) [208 ms],4687
9,"Insomnia | non-cancer illness code, self-reported",410
9,Glioma [females],1519
9,Tourette syndrome,507
9,"Blood protein levels [IL11RA, 3814_63_1]",24203
9,"Bone mineral density (paediatric, total body less head)",1433
9,Age-related hearing impairment (SNP x SNP interaction),9518
9,Serum levels of protein SEMA6B,4091
9,Methylmalonate (mma) levels,8603
9,Glaucoma (primary angle closure),1587
9,Smoking x traumatic event in childhood (sexually molested) interaction,2522
9,"Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA, men]",134
9,D-dimer levels in HIV infection,52
9,Epithelial ovarian cancer,2099
9,Chronic lower respiratory diseases,659
9,Coagulation Factor VIII measurement,5164
9,Leprosy,1392
9,Something else not mentioned | behavioural and miscellaneous addictions,370
9,LDL cholesterol levels in current drinkers [EA],761
9,High light scatter reticulocyte percentage of red cells,114416
9,Frequency of tiredness / lethargy in last 2 weeks,13135
9,Mean spheric corpuscular volume,79602
9,College or university degree | qualifications,34751
9,Myocardial infarction,19145
9,Protein quantitative trait loci (liver) [DDX3X],55
9,Protein quantitative trait loci (liver) [ARG1],15
9,Back pain | pain type(s) experienced in last month,40
9,Worry,16062
9,Urinary metabolite levels in chronic kidney disease [2-methylmalonylcarnitine (C4-DC],41564
9,Leg fat percentage (left),63139
9,Respiratory or ear-nose-throat disease,2302
9,Place of birth in uk - east co-ordinate,374
9,Male puberty timing (early vs. average onset facial hair),137
9,Fasting plasma glucose,2587
9,HLA DR+ T cell%lymphocyte,3103
9,Brain region volumes [X3rd ventricle],532
9,Menarche (age at onset) [EA],458
9,Cleft lip with or without cleft palate,847
9,Brain region volumes [left isthmus cingulate],52
9,Protein quantitative trait loci (liver) [SEPT11],13
9,Lamb/mutton intake,22778
9,Current | smoking status,30868
9,Early-onset Parkinson's disease,886
9,Senile cataract,213
9,Juvenile Open Angle Glaucoma,2216
9,Diabetes | illnesses of mother,122
9,Anxiety score x vitamin D PRS interaction (COJO adjusted),61
9,Bipolar disorder and schizophrenia,37
9,Right eye | which eye(s) affected by astigmatism,42
9,Protein quantitative trait loci (liver) [RMDN3],5
9,C-reactive protein levels,93254
9,Impedance of arm (left),93066
9,Blood metabolite levels [Methylmalonylcarnitine],43663
9,"Blood protein levels [SUMF1, 6941_11_3]",23774
9,Time spent using computer,5865
9,"Blood protein levels [COL15A1, 8974_172_3]",723
9,Stem cell factor levels,2104
9,"""Hypertension, essential""",220
9,Mean time to correctly identify matches,10877
9,Oxalate (ethanedioate) levels,207
9,Clopidogrel | treatment/medication code,1000
9,No | breathing problems during period of job,5
9,Highest math class taken,27658
9,Smoking initiation (ever regular vs never regular) [Conditioned on chr9:11161799],94
9,HLA DR+ T cell%T cell,3103
9,Glomerular filtration rate in non diabetics (creatinine),545
9,Glycemic traits (pleiotropy),24
9,"Deep venous thrombosis (dvt) | non-cancer illness code, self-reported",1910
9,"Cholesterol lowering medication | medication for cholesterol, blood pressure or diabetes",2634
9,Serum levels of protein SEMA6A,4982
9,Serum levels of protein SIAE,101
9,Electrocardiogram morphology (amplitude at temporal datapoints) [-106 ms],12
9,Electrocardiogram morphology (amplitude at temporal datapoints) [-122 ms],12
9,Self-reported math ability,37027
9,Hemoglobin levels,202948
9,Worry too long after an embarrassing experience,6603
9,CD25 on naive-mature B cell,1171
9,Electrocardiogram morphology (amplitude at temporal datapoints) [166 ms],1415
9,"Polycythaemia vera | non-cancer illness code, self-reported",10313
9,Diabetes diagnosed by doctor,2818
9,Body mass index (joint analysis main effects and physical activity interaction) [EA],304
9,Vascular endothelial growth factor levels,408
9,Chronic kidney disease [eGFRcrea],545
9,Serum immune biomarker levels [YKL-40],111
9,IgG glycosylation patterns [IgG4_G2Fn],5334
9,Electrocardiogram morphology (amplitude at temporal datapoints) [24 ms],1884
9,Gut microbiota abundance (k_Bacteria.p_Actinobacteria.c_Actinobacteria.o_Coriobacteriales.f_Coriobacteriaceae),1619
9,Length of mobile phone use,696
9,Dipyridamole | treatment/medication code,103
9,"Body mass index (joint analysis main effects and physical activity interaction) [EA, men]",5
9,Mean corpuscular hemoglobin,316172
9,ADAMTS13 levels,15168
9,Educational attainment (years of education),163043
9,Serum metabolite levels [2'-O-methyluridine],18979
9,"Hayfever, allergic rhinitis or eczema | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",28725
9,Hip index,6239
9,Essential hypertension,874
9,DNA methylation Hannum age acceleration,2821
9,Diaphragmatic hernia,749
9,"Blood protein levels [PDCD1LG2, 3004_67_2]",582
9,"Urinary metabolites (H-NMR features) [1.2975, Unknown]",1130
9,Body mass index in physically active individuals [men],55
9,Early age at menarche,42
9,Cyst of kidney,3
9,Nicorandil | treatment/medication code,1015
9,Subarachnoid hemorrhage,1121
9,"""Diseases of arteries, arterioles and capillaries (FINNGEN)""",990
9,Bipolar disorder or major depressive disorder,3979
9,Protein quantitative trait loci (liver) [MYO1B],38
9,Other and unspecified hydrocephalus,18
9,Protein quantitative trait loci (liver) [HGD],15
9,Body fat distribution (trunk fat ratio),13615
9,ABO blood group (AB vs non-AB),3187
9,Cognitive aspects of educational attainment,65212
9,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),14864
9,Insulin disposition index,1455
9,Mood swings,131
9,Protein quantitative trait loci (liver) [C11orf54],15
9,Multiple myeloma,304
9,Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis),2732
9,Malignant neoplasm of thyroid gland (controls excluding all cancers),1179
9,Neuronal pentraxin-1 measurement,1753
9,Protein quantitative trait loci (liver) [LBP],7
9,Sum neutrophil eosinophil counts,34591
9,Coronary artery bypass grafting,1000
9,Vertical cup-disc ratio (multi-trait analysis),5905
9,Restless legs syndrome,270
9,Open-angle glaucoma and optic cup area [EA],132
9,Waist-to-hip ratio adjusted for BMI,138390
9,E-selectin levels,31791
9,White matter microstructure (axial diusivities) [Superior longitudinal fasciculus],6249
9,"Hypertension | non-cancer illness code, self-reported",25462
9,High density lipoprotein cholesterol levels [East Asian],570
9,Breast cancer [conditional],1639
9,Plasma thyroid-stimulating hormone levels,1179
9,4-chlorobenzoic acid levels,965
9,Metastasis at diagnosis in osteosarcoma,272
9,Cipralex 5mg tablet | treatment/medication code,134
9,Cerebrospinal fluid biomarker levels [Dipeptidyl peptidase 2],13900
9,Polycythemia vera,10212
9,Serum levels of protein SEMG1,9761
9,Glutathione peroxidase in non-alcoholic fatty liver disease x mastiha supplementation interaction,83
9,Acute lymphoblastic leukemia (B-cell precursor),285
9,"Blood protein levels [EVA1C, 7008_13_3]",259
9,Suicidality,599
9,Anthropometric traits (multi-trait analysis),363
9,Blood metabolite levels [2-Hydroxyisovalerylcarnitine / Leucine|Isoleucine],41564
9,Spherical equivalent (joint analysis main effects and education interaction) [European ancestry],1271
9,Serum levels of protein DPP7,15722
9,Nasal polyps,1050
9,Other appendicitis,23
9,Cerebrospinal P-tau181p levels,36
9,Protein quantitative trait loci (liver) [BLVRB],23
9,Serum urea levels,39813
9,None of the above | qualifications,12166
9,"""Hypothyroidism, levothyroxin purchases""",4421
9,Irritable bowel syndrome,7774
9,Eye color (saturation),1563
9,Serum levels of protein L1CAM,891
9,Serum levels of protein ENG,4982
9,Arm fat percentage (left),63120
9,Arthrotec 50 tablet | treatment/medication code,2499
9,IgG glycosylation patterns [IgG2_G1F],1247
9,Barrett's esophagus  or Esophageal adenocarcinoma,120
9,Protein quantitative trait loci (liver) [AMACR],33
9,Malaria [heterogeneous],126
9,Subclinical trait of interstitial lung disease (basilar peel-core ratio of high attentuation areas on CT scan),9
9,Thrombomodulin modified thrombin generation parameter (endogenous thrombin potential),3
9,Blood metabolite levels [Methylmalonylcarnitine / Propionylcarnitine],41564
9,Coronary artery disease or ischemic stroke,1662
9,Endometriosis,3618
9,Heart failure and coronary heart disease,1000
9,Cholesterol levels,388
9,Hot drink temperature,135
9,Tissue factor levels,4982
9,SARS-CoV-2 infection,1100
9,A disintegrin and metalloproteinase with thrombospondin motifs 13 levels,7167
9,Inflammatory biomarkers (multivariate analysis),1693
9,Protein levels in obesity [sE-Selectin],672
9,Salt added to food,2945
9,Serum levels of protein C1GALT1C1,1619
9,Asthma (time to onset),391
9,Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event),96
9,Alcohol consumption (drinks per week) [Conditioned on chr9:109345993],3
9,Eosinophil percentage of white cells,128445
9,Protein quantitative trait loci (liver) [EIF2S3],1513
9,Serum levels of protein CXCL5,1891
9,Irritable mood,562
9,Protein quantitative trait loci (liver) [S100A8],122
9,Primary dental caries (decayed and filled teeth),45
9,Mood instability,16
9,Obsessive-compulsive traits,11
9,Electrocardiogram morphology (amplitude at temporal datapoints) [188 ms],4687
9,Cardiac dysrhythmias,988
9,Levothyroxine sodium | treatment/medication code,3420
9,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [3-hydroxy-3-methylglutarate, 3-methylglutaconate, 3-methylglutarate, 2-methylglutarate, 3-methylglutarylcarnitine]",277
9,Bacillus velezensis abundance in stool,40
9,Beef consumption,24038
9,"Forced expiratory volume in 1-second (fev1), best measure",24322
9,"""Asthma, hospital admissions , main diagnosis only""",1056
9,Brain-derived neurotrophic factor levels,1131
9,Spondin-1 levels,91
9,Menopause (age at onset) [Japanese],130
9,Average weekly beer plus cider intake,70
9,Interstitial lung disease,65
9,Male puberty timing (late vs. average onset voice breaking),137
9,Platelet crit,76060
9,"2,3-dihydroxy-2-methylbutyrate levels",3658
9,Blood protein levels [Neurogenic locus notch homolog protein 1],3068
9,Estimated glomerular filtration rate in non-diabetics,958
9,High-grade serous ovarian cancer,1361
9,Urethritis and urethral syndrome,238
9,Malignant neoplasm of endocrine gland (controls excluding all cancers),1179
9,Anal and rectal conditions,990
9,Salphingitis and oophoritis,64
9,Lymphocyte count,32227
9,Non-albumin protein levels,2307
9,ABO blood group (O vs non-O),3132
9,Chronic obstructive pulmonary disease x ever smoker interaction (2df),713
9,Electrocardiogram morphology (amplitude at temporal datapoints) [190 ms],1415
9,Serum levels of protein JAG1,891
9,Other disorders of circulatory system,1129
9,Cigarettes smoked per day (MTAG),17816
9,Forced expiratory volume in 1-second (fev1),77940
9,Cholelithiasis,9765
9,"""Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system""",990
9,Asthma (age of onset),862
9,Parkinson's disease (age at diagnosis),134
9,Cognitive performance (MTAG) [MTAG],35998
9,Liver enzyme levels (alanine transaminase),9997
9,"Dark brown | hair colour (natural, before greying)",27305
9,Electrocardiogram morphology (amplitude at temporal datapoints) [182 ms],373
9,Disorders of lipoid metabolism,2033
9,Peripheral atherosclerosis,990
9,Platelet count [conditional on round 4],241
9,Worrier / anxious feelings,2274
9,Blood protein levels [Cadherin-5],3068
9,Spinal canal stenosis,21
9,Pro-interleukin-16 levels,3
9,Serum total protein level,138127
9,Type 2 diabetes (adjusted for BMI),4166
9,BMI (adjusted for smoking behaviour) [women],57
9,Infant head circumference (MTAG),15347
9,Serum levels of protein PDCD1LG2,1461
9,Heart failure and antihypertensive medication,2171
9,Heart attack | vascular/heart problems diagnosed by doctor,1015
9,Bisoprolol | treatment/medication code,1204
9,Asthma-related infections,487
9,Waist circumference adjusted for BMI in active individuals [EA],51
9,Electrocardiogram morphology (amplitude at temporal datapoints) [-118 ms],12
9,Intelligence (MTAG),22691
9,Urate levels,152844
9,CD25 on IgD- CD38dim B cell,1171
9,Metabolite levels (lipoprotein measures) [Free cholesterol in very large HDL],1883
9,Urinary magnesium excretion,2562
9,Raw vegetable consumption,9156
9,Spherical equivalent or myopia (age of diagnosis),5230
9,"Yes, but not in the last year | ever been injured or injured someone else through drinking alcohol",507
9,Educational attainment (college completion),36
9,Overall health rating,16385
9,Melanoma x citrus consumption interaction (2df),22830
9,Blood metabolite levels [indolelactate],13483
9,Shingles,951
9,"Pulmonary function (smoking interaction) [FEV1/FVC, Ever-smoking]",2254
9,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),260
9,Lamb consumption,23143
9,"Blonde | hair colour (natural, before greying)",33686
9,Composite immunoglobulin trait (IgA/IgM),31
9,Regular attendance at a pub or social club,150
9,LDL cholesterol levels x short total sleep time interaction (2df test),795
9,Depressed affect,9664
9,Daytime dozing / sleeping (narcolepsy),101
9,IgG glycosylation patterns [IgG1_G2F],1247
9,Ebbinghaus illusion (overestimation),290
9,Often | worked with materials containing asbestos,381
9,Acute lymphoblastic leukemia in childhood (B cell precursor),285
9,"""Diabetes, insuline treatment (Kela reimbursement)""",939
9,ABO blood group (AB vs O),3246
9,High serum lipase activity,4091
9,Systemic mastocytosis,405
9,Protein quantitative trait loci (liver) [ACO1],29
9,Whole body fat-free mass,103491
9,"""Ischaemic heart disease, wide definition""",1000
9,Brain region volumes [right hippocampus],197
9,Pulse pressure [Japanese],47
9,Mean sphered cell volume,80146
9,CD25 on IgD+ CD24- B cell,1171
9,Protein quantitative trait loci (liver) [FGA],113
9,Benign neoplasms (controls excluding all cancers),106
9,Free cholesterol levels in medium HDL [conditioned on 885 SNPs],3662
9,Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test),287
9,Ischemic heart disease,1000
9,Spleen volume,712
9,Thyroid hormone levels [FT4-Females],976
9,Vasomotor and allergic rhinitis,1448
9,Hypertension [Japanese],470
9,Plateletcrit,151580
9,Colon polyp,1130
9,Lipid metabolism phenotypes [Tot-C/Est-C],570
9,"Joint pain | non-cancer illness code, self-reported",161
9,Ovarian cancer,319
9,"Blood protein levels [CELA1, 6107_3_3]",259
9,Mean platelet volume,335422
9,Serum levels of protein SERPINE2,3994
9,Cardioplen xl 5mg m/r tablet | treatment/medication code,855
9,Asthma (moderate or severe),446
9,Coronary heart disease x type 2 diabetes interaction,1303
9,"Blood protein levels [TNC, 4155_3_2]",259
9,Neutrophil level response to clozapine in treatment-resistant schizophrenia,9
9,"Hip circumference adjusted for BMI [EA,men]",12060
9,A body shape index,319
9,"""Atherosclerosis, excluding cerebral, coronary and PAD""",1303
9,"LDL cholesterol levels [Asian initial, BMI unadjusted]",761
9,Gut microbiota relative abundance (bacterial taxa) [Eubacterium_ruminantium],14
9,Bone mineral density (spine),1677
9,Serum levels of protein MANF,17286
9,Birth weight of first child,1659
9,Atherosclerosis of the extremities,990
9,High density lipoprotein cholesterol levels,30210
9,Age at menopause (last menstrual period),23894
9,Brain region volumes [left hippocampus],197
9,Asthma [AA],36
9,Neutrophil count,508624
9,Retinal vascular fractal density,1292
9,Protein quantitative trait loci (liver) [FHL1],72
9,Alcohol consumption,80
9,Acceptance of an invitation to participate in a mental health questionnaire,22381
9,Serum levels of protein CD163,2491
9,"Blood protein levels [EA, CD109 antigen]",3863
9,Electrocardiogram morphology (amplitude at temporal datapoints) [206 ms],3645
9,"Cholelithiasis/gall stones | non-cancer illness code, self-reported",1883
9,Metabolically unhealthy in normal weight,130
9,Leg fat mass (left),43513
9,Protein quantitative trait loci (liver) [PBDC1],1916
9,Ferritin levels,983
9,Heart failure,990
9,Myopia,1323
9,Smoking status (ever vs never smokers),25885
9,Youthful appearance (self-reported),17567
9,Early-onset schizophrenia,7401
9,Feeling nervous,1766
9,HDL cholesterol levels in current drinkers [Asian],471
9,Serum levels of protein GOLM1,1619
9,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA],135
9,Waist circumference adjusted for BMI in active individuals,51
9,Hip circumference adjusted for BMI,83360
9,Light-intensity physical activity duration,8363
9,"""Crohn disease (strict definition, all UC cases excluded)""",20805
9,Serum levels of protein SUMF1,5451
9,Myopia (pathological),454
9,Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis),2969
9,Knee osteoarthritis,416
9,"Waist-to-hip ratio adjusted for body mass index [EA, women]",124
9,Triacylglycerol_46:1_[M+NH4]1+ levels,9
9,Circulating plasma alpha-Klotho levels,10912
9,Type 2 diabetes without complications,372
9,Total testosterone levels,69500
9,Standing height,197183
9,Mean corpuscular haemoglobin,18507
9,Neutrophill count,43689
9,Immature reticulocyte fraction,37483
9,Insulinogenic index,1985
9,Becotide 50 inhaler | treatment/medication code,359
9,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),2562
9,Disorders of external ear,633
9,Phlebitis and thrombophlebitis (not including DVT),116
9,Hemoglobin A1c levels,142520
9,Electrocardiogram morphology (amplitude at temporal datapoints) [200 ms],4691
9,Trans-epidermal water loss,241
9,"Disorders of muscle, ligament, and fascia",105
9,Skin cancer,29572
9,Rheumatoid arthritis,152097
9,Doctor diagnosed asthma,1930
9,Coagulation Factor X measurement,824
9,Spherical equivalent,5143
9,Heme oxygenase 1 measurement,891
9,HDL cholesterol [Hispanic],277
9,"Waist circumference adjusted for BMI in active individuals [EA, men]",134
9,Type 2 diabetes [additive model],122
9,General anaesthetic | anaesthetics administered during delivery,161
9,Angiotensin-converting enzyme activity,1489
9,2'-o-methylcytidine levels,18152
9,Hand grip strength (left),70615
9,Coronary artery calcification,3161
9,Extremely high intelligence,1357
9,Obstructive sleep apnea trait (apnea hypopnea index),120
9,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],2559
9,Serum levels of protein GNS,1619
9,Presence of cardiac and vascular implants and grafts,1000
9,Other and/or unspecified nontoxic goitre,1179
9,Diffuse plaques (SNP x SNP interaction),772
9,Gut microbiota relative abundance (bacterial taxa) [Butyricicoccus_pullicaecorum],8
9,Cutaneous squamous cell carcinoma,44477
9,Diverticulosis,1455
9,Chronic obstructive pulmonary disease x current smoker interaction (2df),717
9,Psoriasis [fixed],158
9,HDL cholesterol levels,127488
9,CD5 levels,185
9,Serum levels of protein AGER,1396
9,Serum levels of protein CCL25,891
9,Platelet-derived growth factor subunit B levels,446
9,Bone mineral density (hip) and hip bone size,40041
9,Hemoglobin,149086
9,Neurociticism,15882
9,Ascending aorta minimum area,1389
9,"High cholesterol | non-cancer illness code, self-reported",5271
9,Phlebitis and thrombophlebitis,1455
9,Hippocampal volume,197
9,Thyrotoxicosis,42
9,Electrocardiogram morphology (amplitude at temporal datapoints) [-114 ms],12
9,Subjective well-being (MTAG),15661
9,Leg fat mass (right),42525
9,Leg predicted mass (right),73165
9,Gut microbiota abundance (genus Allisonella id.2174),534
9,Metformin | treatment/medication code,182
9,Testicular germ cell tumor,1050
9,Arrhythmia,1256
9,Malignant neoplasm of thyroid gland,1179
9,Diseases of the respiratory system,407
9,Post bronchodilator FEV1,225
9,Cataracts [male],29
9,Thyroid cancer,26332
9,Vertex-wise cortical surface area,64069
9,HLA DR+ CD4+ T cell %lymphocyte,3103
9,Urinary metabolite levels in chronic kidney disease [3-methylglutaconate],277
9,HDL cholesterol levels in current drinkers [EA],2275
9,Protein levels in obesity [FCN2],277
9,Pipecolate levels,1224
9,Type 2 diabetes [DGI+FUSION+WTCCC],122
9,Lung function (FVC) [conditioned on rs10858246],11361
9,"Total cholesterol levels [Asian initial, BMI unadjusted]",1331
9,Oral cavity cancer,1191
9,Cardiac problem,1171
9,Serum levels of protein POFUT2,259
9,Serum levels of protein FAM163A,990
9,Household income (MTAG),13680
9,"Urinary metabolites (H-NMR features) [5.1825, Unknown]",672
9,Red blood cell traits (multivariate analysis),1846
9,Smoking x traumatic event in childhood (felt hated by family member) interaction,485
9,Unstable angina pectoris,2311
9,Invasive epithelial ovarian cancer,1361
9,Electrocardiogram morphology (amplitude at temporal datapoints) [168 ms],1042
9,LDL cholesterol levels [Trans-ethnic initial],779
9,Obesity-related traits [TFM],406
9,Cortical thickness (MOSTest),18191
9,Monocyte count,202676
9,Never | smoking status,22411
9,"""Myocardial infarction, strict""",1000
9,Protein quantitative trait loci (liver) [VDAC2],193
9,Body mass index (joint analysis main effects and smoking interaction) [women],57
9,ABO blood group (B vs O),3132
9,Noncognitive aspects of educational attainment,23450
9,Reticulocyte percentage,6890
9,Headache,3607
9,Serum lipase activity,4091
9,Electrocardiogram morphology (amplitude at temporal datapoints) [204 ms],3645
9,Soluble levels of adhesion molecules [P-Selectin],672
9,Protein quantitative trait loci (liver) [CCDC58],206
9,"""Type 2 diabetes, definitions combined""",2702
9,"Forced expiratory volume in 1-second (fev1), predicted percentage",1275
9,HDL cholesterol levels [Asian],302
9,Vitamin b12 preparation | treatment/medication code,20
9,"Blood protein levels [SVEP1, 11109_56_3]",23
9,LDL cholesterol,45306
9,Trunk fat mass,68410
9,"Blood protein levels [ADGRF5, 6409_57_3]",2357
9,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],302
9,Protein quantitative trait loci (liver) [LTF],81
9,Job involves heavy manual or physical work,12131
9,Intelligence,59946
9,Basophil percentage of white cells,44743
9,Body mass index (joint analysis main effects and smoking interaction),307
9,Thrombotic microangiopathy,6
9,IgG glycosylation patterns [IgG4_G2n],5334
9,Bipolar disorder,697
9,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 measurement",4458
9,Dyslipidemia,891
9,Serum levels of protein MBL2,1455
9,Past tobacco smoking,1299
9,"""Atopic  dermatitis, strict definition""",80
9,"Tinnitus / tiniitis | non-cancer illness code, self-reported",132
9,Atenolol | treatment/medication code,1218
9,CAG-552 abundance in stool,147
9,Atopic dermatitis,1086
9,Electrocardiogram morphology (amplitude at temporal datapoints) [124 ms],1042
9,Electrocardiogram morphology (amplitude at temporal datapoints) [-4 ms],261
9,Protein quantitative trait loci (liver) [RBP1],88
9,Ankle injury,24
9,Immune response to measles-mumps-rubella vaccine [IFN gamma response],12
9,HDL cholesterol levels x long total sleep time interaction (2df test),82
9,Chin dimples,1152
9,"Small intestine/small bowel cancer | cancer code, self-reported",439
9,Educational attainment (MTAG) [MTAG],112851
9,Mean reticulocyte volume,274759
9,Waist circumference,36954
9,Arm fat-free mass (left),72075
9,Facial morphology (segment 3),1059
9,Iron status biomarkers (ferritin levels),1145
9,Metabolite levels [LDL],1489
9,"Blood protein levels [PRELP, 5675_6_3]",259
9,Neutrophil percentage of granulocytes,35541
9,Butter/spreadable butter | spread type,22973
9,Diseases of the musculoskeletal system and connective tissue,654
9,Age at menopause,29206
9,Aspartate aminotransferase levels,185846
9,Medication use (drugs used in diabetes),24954
9,"Asthma | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",21087
9,Monocyte percentage,47739
9,Nonsyndromic cleft lip with cleft palate,2092
9,Facial morphology (segment 44),2287
9,Fat-free mass [female],225
9,Alcohol consumption (drinkers vs non-drinkers),77
9,Comparative height size at age 10,84449
9,Serum levels of protein ICAM4,1782
9,Kallikrein-10 levels,136
9,Palmar fascial fibromatosis [Dupuytren],99
9,Haematocrit percentage,31353
9,Pneumonia,9162
9,Protein quantitative trait loci (liver) [DCN],72
9,Serum levels of protein ROBO4,4982
9,3mm weak meridian (left),4418
9,Snoring,3878
9,Smoking behaviour (cigarette pack-years),605
9,Distance between home and job workplace,92
9,"Ecg, phase time",30
9,Serum levels of protein TIE1,5710
9,Body fat distribution (trunk fat ratio) [females],10659
9,Basophil count,65246
9,GIP levels in response to oral glucose tolerance test (120 minutes),891
9,Lipid traits [LDL],1489
9,Intercellular adhesion molecule 2 levels,891
9,6mm weak meridian (right),716
9,Myo-inositol levels,54
9,Faecalicatena sp001517425 abundance in stool,17
9,Number of treatments/medications taken,10
9,Blood metabolite ratios [ADpSGEGDFXAEGGGVR/X-14304--leucylalanine],672
9,Serum levels of protein CD274,860
9,Arthropathy in ulcerative colitis,59
9,Breast cancer,20685
9,Cancer,2003
9,"Psoriasis | non-cancer illness code, self-reported",2897
9,Adventurousness,4537
9,Car/motor vehicle | transport type for commuting to job workplace,410
9,Mean diameter of LDL particles,718
9,Brain region volumes [Brain stem],112
9,Minimum ankle–brachial index,756
9,X-11612 levels,74
9,IgG glycosylation patterns [IgG1 G0n],1196
9,Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS)),24594
9,Corneal structure,6224
9,Protein AMBP levels,4679
9,Polycystic ovary syndrome (adjusted for age and BMI),1368
9,Doctor diagnosed hayfever or allergic rhinitis,790
9,1-palmitoyl-2-arachidonoyl-gpc (16:0/20:4n6) levels,1802
9,"Aspirin | medication for pain relief, constipation, heartburn",1303
9,Electrocardiogram morphology (amplitude at temporal datapoints) [220 ms],3272
9,Arm predicted mass (right),76239
9,Glioma,7813
9,Inguinal hernia,1719
9,Healthspan,990
9,Age at voice drop,137
9,Cortical surface area [Superior Frontal],7
9,Venous thromboembolism,21093
9,Direct bilirubin levels,25916
9,"""Cholelithiasis, broad definition with cholecystitis""",4484
9,"Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)",1282
9,Knee pain,280
9,Prostaglandin E synthase 2 measurement,213
9,DNA methylation PhenoAge acceleration,30
9,Total amyloid (SNP x SNP interaction),76
9,Atrial fibrillation,9229
9,Heart disease | illnesses of siblings,990
9,Brain region volumes [left putamen],444
9,Coronary heart disease,8897
9,Hypercholesterolemia,2194
9,Cardiovascular diseases (excluding rheumatic etc),1196
9,Ovarian cancer in BRCA2 mutation carriers,470
9,Current tobacco smoking,25402
9,Gelsolin measurement,4463
9,Blood protein levels [VEGFR-2],891
9,Angina | vascular/heart problems diagnosed by doctor,1015
9,Prothrombin measurement,299
9,Electrocardiogram morphology (amplitude at temporal datapoints) [152 ms],1042
9,Allergy,1189
9,Joint disorder,208
9,"Blood protein levels [SVEP1, 11178_21_3]",23
9,Ankylosing spondylitis [EA],11299
9,Serum creatinine levels,42273
9,Serum metabolite levels [indolelactate],12822
9,Electrocardiogram morphology (amplitude at temporal datapoints) [158 ms],1415
9,Glioblastoma (age-stratified) [Below median age-at-diagnosis],1519
9,Ischemic heart diseases,1000
9,Use of sun/uv protection,302
9,Insomnia [Male],28
9,Glucuronate levels,15799
9,Body mass index (bmi),109671
9,Mean corpuscular haemoglobin concentration,10441
9,Total cholesterol levels [BMI unadjusted],2144
9,COVID-19 (hospitalized vs population),1100
9,Migraine and/or diastolic blood pressure,62
9,Parental lifespan,1000
9,Ethyl beta-glucopyranoside levels,745
9,Serum levels of protein C5;C6,5989
9,"Blood protein levels [EA, Hemojuvelin]",3861
9,Electrocardiogram morphology (amplitude at temporal datapoints) [172 ms],1042
9,"Blood protein levels [EA, E-Selectin]",1405
9,CD14+ CD16- monocyte Absolute Count,677
9,End-stage coagulation [vWF],6676
9,Medication use (antimigraine preparations),481
9,Basophill percentage,74
9,Protein quantitative trait loci (liver) [SERPINF1],72
9,Ulcerative colitis [EA],17263
9,Cognitive ability,1357
9,Glioblastoma,1519
9,Ever smoked,11234
9,Miserableness,218
9,Squamous cell lung carcinoma [East Asian],526
9,Hand grip strength,3696
9,LDL cholesterol levels [EA],761
9,Brain region volumes [left cerebellum white matter],112
9,Electrocardiogram morphology (amplitude at temporal datapoints) [128 ms],1042
9,"Gut microbiota (bacterial taxa, hurdle binary method) [G_Ruminococcus_HB]",217
9,Longitudinal alcohol consumption [mean],408
9,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA],51
9,General risk tolerance (MTAG),13359
9,Thyroid stimulating hormone levels,8822
9,Hand grip strength (right),30157
9,Noninfective enteritis and colitis,8827
9,Myocardial infarction (early onset),1000
9,Electrocardiogram morphology (amplitude at temporal datapoints) [-124 ms],12
9,Severe influenza A (H1N1) infection,4491
9,"Blood protein levels [EA, Basal Cell Adhesion Molecule]",3068
9,Electrocardiogram morphology (amplitude at temporal datapoints) [140 ms],1042
9,Impedance of whole body,98740
9,Trunk fat-free mass,133209
9,Average weekly red wine intake,71
9,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [men],134
9,Protein quantitative trait loci (liver) [PON1],91
9,"Waist circumference adjusted for body mass index [EA,women]",22
9,CAG-110 abundance in stool,6
9,Highest math class taken (MTAG) [MTAG],70857
9,Nap during day,18032
9,Neutrophill percentage,40522
9,IgG glycosylation [IGP24],5334
9,Gram negative septicemia,49
9,Insomnia [Female],18774
9,Glaucoma (primary open-angle),24193
9,Electrocardiogram morphology (amplitude at temporal datapoints) [176 ms],4687
9,Impedance of leg (left),89409
9,Glomerular filtration rate (creatinine),1870
9,Asthma (childhood onset),4659
9,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],2021
9,"Blood protein levels [OBP2B, 5680_54_3]",2357
9,"Retinal problem | non-cancer illness code, self-reported",192
9,Brain region volumes [left ventral DC],7
9,Luteine | treatment/medication code,5700
9,Eye color (brightness),1563
9,Guilty feelings,323
9,Metabolite levels [SM d18:2/24:0],446
9,Type 2 diabetes with other specified/multiple/unspecified complications,235
9,Arm fat mass (right),38387
9,Diabetes or endocrine disease,9294
9,Protein quantitative trait loci (liver) [ACSM2B],6489
9,"""Diabetes, varying definitions""",520
9,Age when periods started (menarche),26686
9,Blood glucose levels,30900
9,Whole body water mass,105529
9,Glutamine levels,8318
9,Tonsillectomy,1782
9,Fasting blood glucose,3517
9,Number of cigarettes previously smoked daily,605
9,Parental longevity (father's attained age),1000
9,Menarche and menopause (age at onset) [age at menarche],20
9,Symptoms and signs involving emotional state,10
9,Daytime nap,61659
9,Glaucoma (high intraocular pressure),2129
9,Oily fish intake,1417
9,Urinary magnesium-to-creatinine ratio,2562
9,Aortic aneurysm,623
9,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [women],51
9,Body size at age 10,11835
9,"""Diseases of arteries, arterioles and capillaries""",1008
9,Serum levels of protein TNC,1249
9,Neurofibrillary tangles [EA],13
9,Protein quantitative trait loci (liver) [SPTAN1],6
9,Eye color,1563
9,"Blood protein levels [Tyrosine-protein kinase receptor Tie-1, soluble]",4707
9,Tumor necrosis factor receptor 1 levels,1000
9,Pulmonary embolism,206
9,Periodontitis,471
9,Medication use (opioids),15583
9,Retinal nerve fibre layer thickness or ganglion cell inner plexiform layer thickness (MTAG),24191
9,Major depressive disorder (MTAG),6050
9,Pancreatic cancer [EA],1455
9,"""UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)""",1987
9,Squamous cell lung carcinoma,1052
9,Brain region volumes [right ventral DC],7
9,LDL cholesterol levels in current drinkers,1309
9,"Urinary metabolites (H-NMR features) [2.0525, Unknown]",672
9,IgG glycosylation [IGP53],5334
9,Non-glioblastoma glioma [males],1519
9,"Blood protein levels [SEMA4D, 5737_61_3]",2432
9,Serum levels of protein INSR,891
9,Protein quantitative trait loci [sE-Selectin],891
9,Respiratory diseases,459
9,Squamous cell carcinoma,24506
9,Asthma or allergic disease (pleiotropy),2730
9,Optic cup area,3690
9,Electrocardiogram morphology (amplitude at temporal datapoints) [-22 ms],158
9,Blood metabolite levels [2-Hydroxyisovalerylcarnitine],41564
9,Basal metabolic rate,84335
9,Lung function (FVC) [adults],1578
9,Tobacco use disorder,605
9,Nonalcoholic fatty liver disease (imputed),155
9,IgG glycosylation [IGP57],5334
9,Chronic obstructive pulmonary disease x current smoker interaction (main effect),717
9,Anxiety,16779
9,Type 1 diabetes with ophthalmic complications,2234
9,Primary open-angle glaucoma,2216
9,Parent of origin effect on receptive language ability (paternal),5
9,FEV1,113978
9,Cortical thickness,85493
9,Rheumatoid arthritis [all cases vs. all controls],2235
9,Smoking behavior [smoking cessation],605
9,Vascular dementia,810
9,Cotinine and 3'-hydroxycotinine levels in current smokers,130
9,Triacylglycerol_49:4_[M+NH4]1+ levels,1
9,Serum metabolite levels [2-hydroxyphenylacetate],27298
9,Colorectal cancer or advanced adenoma,2561
9,Hematological and biochemical traits [Ht],1489
9,"Blood protein levels [EA, Vascular endothelial growth factor receptor 2]",795
9,Serum levels of protein CD36,4091
9,Glioma [males],1519
9,Monocyte Absolute Count,633
9,Glaucoma (primary angle closure) [Asian],1587
9,Facial morphology (segment 57),423
9,Malaria [dominant],184
9,Blood protein levels [Ficolin-1],538
9,White blood cell count (basophil),519
9,Blood protein levels in cardiovascular risk,10009
9,"Blood protein levels [TEK, 3773_15_4]",2621
9,Familial squamous cell lung carcinoma,812
9,Serum levels of protein IGF1R,891
9,IgG glycosylation patterns [IgG2_G1Fn],1196
9,Brain region volumes [X4th ventricle],13
9,Fresh fruit intake,16960
9,IgG glycosylation [IGP17],5873
9,Electrocardiogram morphology (amplitude at temporal datapoints) [102 ms],9359
9,White blood cell (leukocyte) count,34179
9,Morning/evening person (chronotype),7155
9,Thyroid hormone levels [TSH],1242
9,Sodium in urine,1634
9,Estimated glomerular filtration rate in diabetes,433
9,"Blood protein levels [EA, Ficolin-2]",43
9,Gout,12
9,Red cell distribution width,661373
9,Red blood cell (erythrocyte) distribution width,73754
9,"Blood protein levels [GOLM1, 8983_7_3]",1517
9,Thyroid problem (not cancer),8230
9,Average total household income before tax,13864
9,Morningness,33717
9,"Hypothyroidism/myxoedema | non-cancer illness code, self-reported",3267
9,Serum IgA levels,424
9,Albumin-globulin ratio,5654
9,Migraine - clinic-based,153
9,Father's age at death,1000
9,Anaemias,105
9,Antihypertensive medication - note that there are other indications,797
9,Complement component C8 gamma chain measurement,9747
9,Other non-epithelial cancer of skin,602
9,vWF levels,2255
9,Heel broadband ultrasound attenuation (left),428
9,"Sphingomyelin (d18:1/20:0, d16:1/22:0) levels",68
9,Meat-related diet [female],22897
9,Liver enzyme levels (alkaline phosphatase),21122
9,Electrocardiogram morphology (amplitude at temporal datapoints) [194 ms],4687
9,Trunk fat percentage,56466
9,Age asthma diagnosed,391
9,3-hydroxyisobutyrate levels,1317
9,Serum levels of protein MET,1782
9,IgG glycosylation patterns [IgG1 Galactosylation],1247
9,Persons with potential health hazards related to communicable diseases,12
9,Serum levels of protein BID,23
9,Verbal-numerical reasoning,7877
9,Ischemic stroke,2551
9,Brown vs. black hair color,13918
9,Lung function (FEV1/FVC) [adults],1466
9,Problematic alcohol use (MTAG),1042
9,Serum levels of protein ACE,891
9,Mean corpuscular volume,371583
9,Monocyte percentage of white cells,114956
9,Aerodigestive squamous cell cancer (pleiotropy),286
9,Serum levels of protein FLT4,891
9,"Hayfever/allergic rhinitis | non-cancer illness code, self-reported",391
9,Facial pigmentation measurement (polar light),1364
9,Polycystic ovary syndrome,8480
9,IgG glycosylation patterns [IgG2_G1F/IgG2_G0F],1247
9,Relative age of first facial hair,6594
9,Free cholesterol levels in very large HDL,1883
9,6mm weak meridian (left),385
9,Hematocrit,337365
9,Childhood ear infection,3151
9,3mm strong meridian (left),1126
9,Blood protein levels [OX-2 membrane glycoprotein],795
9,"Blood protein levels [EA, Cadherin-5]",795
9,Antenatal screening,112
9,Height,651600
9,Alanine aminotransferase levels,84697
9,Body fat distribution (leg fat ratio),13615
9,Blood protein levels [Insulin receptor],1405
9,IgG glycosylation patterns [IgG1_G2Fn],1247
9,CD20 on IgD+ CD38- B cell,31
9,Angiopoietin-1 receptor levels,10943
9,Vertical cup-disc ratio,5114
9,Electrocardiogram morphology (amplitude at temporal datapoints) [118 ms],11123
9,"Blood protein levels [CD36, 2973_15_2]",2357
9,IgG glycosylation patterns [IgG1_G1F/IgG1_G0F],1196
9,White blood cell count [Monocytes],967
9,Very large HDL particle concentration,281
9,"Nasal polyps | non-cancer illness code, self-reported",391
9,Cortical thickness [Insula],669
9,Blood urea nitrogen levels,15827
9,Fibrinogen levels,3717
9,Global electrical heterogeneity phenotypes [SAI QRST],167
9,Resting heart rate,3240
9,Electrocardiogram morphology (amplitude at temporal datapoints) [174 ms],1415
9,Folate pathway vitamin levels [plasma homocysteine],91
9,Electrocardiogram morphology (amplitude at temporal datapoints) [-150 ms],1006
9,Nervous feelings,1062
9,Protein quantitative trait loci (liver) [RBMX],7
9,Serum levels of protein CEL,7617
9,Sleep apnoea,588
9,Pulmonary heart disease,1097
9,Serum levels of protein SPINK2,299
9,Serum levels of protein TMEM106A,108
9,Nonorganic sleeping disorders,5
9,Basal cell carcinoma,40951
9,Blood metabolite ratios [C-glycosyltryptophan/succinylcarnitine],41564
9,3mm strong meridian (right),2771
9,Physical activity (Total log acceleration),8363
9,Serum levels of protein FAM177A1,1619
9,Chronic obstructive pulmonary disease,841
9,Household income,12232
9,IgG glycosylation [IGP36],5334
9,Serous invasive ovarian cancer,1361
9,Serum levels of protein CETP,990
9,Percent liver fat,393
9,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),302
9,Myeloid white cell count,31518
9,Body fat distribution (trunk fat ratio) [males],2956
9,von Willebrand factor measurement,2394
9,Red blood cell (erythrocyte) count,55158
9,IgG glycosylation [IGP38],5334
9,Allergic rhinitis,2119
9,Total body bone mineral density [European],1367
9,Fasting glucose,11736
9,Peripheral artery disease in ever smokers,2396
9,"Blood protein levels [IL3RA, 13744_37_3]",2357
9,Waist-to-hip ratio adjusted for body mass index,259
9,Protein quantitative trait loci (liver) [SPRYD4],18
9,Ankylosing spondylitis,11299
9,Chronic obstructive pulmonary disease in non-current smokers,717
9,"Intra-ocular pressure, corneal-compensated (right)",627
9,Choline phosphate levels,441
9,Pediatric asthma,287
9,Protein quantitative trait loci (liver) [OAT],133
9,Brain region volumes [left postcentral],50
9,Smoking status,11280
9,Serum levels of protein CD34,34081
9,Testosterone levels,14556
9,Serum metabolite concentrations in chronic kidney disease [2'-O-methylcytidine],8541
9,Feeling lonely,2946
9,High-density lipoprotein 3 cholesterol levels,281
9,High blood pressure | vascular/heart problems diagnosed by doctor,2117
9,Protein quantitative trait loci (liver) [SBDS],138
9,Electrocardiogram morphology (amplitude at temporal datapoints) [-120 ms],12
9,Gut microbiota relative abundance (bacterial taxa) [Butyricicoccus],8
9,Parkinson's disease or first degree relation to individual with Parkinson's disease,14124
9,Duration of strenuous sports,7
9,COVID-19 (covid vs negative),3238
9,Heel broadband ultrasound attenuation (right),8294
9,Corneal hysteresis (left),19443
9,Urea levels,891
9,Symptoms in placebo-treated COVID-19 outpatients at risk of severe disease (time to remission),139
9,Alanine transaminase levels in high alcohol intake,2293
9,Regular attendance at a gym or sports club,54
9,High cholesterol,5726
9,Coronary angiopasty,1000
9,Blood protein levels [CDH1],891
9,"Diabetes | non-cancer illness code, self-reported",2827
9,Inflammatory bowel disease [EA],20673
9,Immature fraction of reticulocytes,95290
9,Arm fat percentage (right),85453
9,Thrombosis,1455
9,Alanine transaminase levels,2137
9,Medication use (antiglaucoma preparations and miotics),5289
9,Atrial fibrillation [EA],998
9,Cytokine network levels (multivariate analysis),1705
9,Chronic heart failure,1242
9,Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease),481
9,Stappia abundance in stool,125
9,Hair color,62849
9,Depressive symptoms,28735
9,Calcium levels,45671
9,"Pulse rate, automated reading",22460
9,"Blood protein levels [TIE1, 2844_53_2]",2357
9,Other diseases of upper respiratory tract,1907
9,"Blood protein levels [CD274, 5060_62_3]",860
9,Arthropathy nos,293
9,N1-methyl-2-pyridone-5-carboxamide levels,213
9,HDL cholesterol,80765
9,Sleep end time,1428
9,Electrocardiogram morphology (amplitude at temporal datapoints) [224 ms],3272
9,Fruit consumption,5554
9,"Allergic disease (asthma, hay fever and/or eczema) (age of onset)",1673
9,Electrocardiogram morphology (amplitude at temporal datapoints) [126 ms],1042
9,Diverticulosis and diverticulitis,1455
9,"Blood clot in the leg (dvt) | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",1455
9,Systemic lupus erythematosus [Chinese],269
9,Varicose veins of lower extremity,359
9,Carboplatin drug response (IC50),179
9,Tense / 'highly strung',136
9,Systemic atrophies primarly affecting the central nervous system,39
9,Diverticular disease,442
9,Non-small cell lung cancer,11406
9,Asthma (only as main-diagnosis) (more control exclusions),637
9,Gynoid bone mass,59
9,Male-pattern baldness,83462
9,Estimated glomerular filtration rate,58586
9,ADAMTS13 activity [Conditional on rs41314453 and rs10456544],3425
9,Angina,1015
9,Osteoarthritis,3808
9,Smoking status (current vs never),574
9,Alcohol usually taken with meals,1355
9,Serum levels of protein C8G,30561
9,Dentures | mouth/teeth dental problems,1487
9,Other malignant neoplasms of skin (=non-melanoma skin cancer),1668
9,Serum levels of protein CHST15,3238
9,Medication use (antithrombotic agents),4563
9,Waist-to-hip ratio adjusted for body mass index [women],259
9,Body mass index (joint analysis main effects and physical activity interaction),304
9,"""Endocrine, nutritional and metabolic diseases""",5075
9,"Red blood cell traits [EA, RBCC]",672
9,Osteoarthritis of the hip or knee (with total joint replacement),276
9,Gut microbiota (bacterial taxa) [k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Lachnospiraceae|g__Blautia],169
9,Insulin-like growth factor 1 levels,86780
9,"Blood protein levels [ABO, 9253_52_3]",20017
9,Total bilirubin levels,51891
9,Serum levels of protein ADAMTS13,22288
9,Serum metabolite concentrations in chronic kidney disease [2'-O-methyluridine],8541
9,Motor neuron disease (with DMD),22
9,"""Articial joint operation, menisceal resection""",95
9,Circulating leptin levels or type 2 diabetes,50
9,Protein quantitative trait loci (liver) [HSD17B4],18
9,Cancer of brain and nervous system,1460
9,Diseases of the skin and subcutaneous tissue,55
9,Electrocardiogram morphology (amplitude at temporal datapoints) [-26 ms],158
9,COVID-19 (RELEASE 4),1100
9,Lactate dehydrogenase levels,2063
9,Neck/shoulder pain for 3+ months,771
9,"Heart attack/myocardial infarction | non-cancer illness code, self-reported",1015
9,Mean corpuscular volume [Asian],587
9,Longevity (100 years and older) [EA],197
9,"Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction) [Dilation, amyloid positive]",28
9,Zolpidem | treatment/medication code,1588
9,Maternal smoking around birth,605
9,Hypertension,24038
9,Gut bacterial pathway abundance (LACTOSECAT.PWY..lactose.and.galactose.degradation.I),891
9,Hip shape (DXA scan) [hip shape mode 2],425
9,Feeling worry,3286
9,Asthma [conditional],606
9,"Blood protein levels [SEMG1, 7115_5_3]",8052
9,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],761
9,Thyroid nodules,289
9,Midgestational circulating levels of PCBs (fetal genetic effect) [PCB187],9
9,IgG glycosylation patterns [IgG4_G2FS1/IgG4_G1FS1],5334
9,Electrocardiogram morphology (amplitude at temporal datapoints) [180 ms],4687
9,Ulcerative colitis or Crohn's disease [UC vs. CD],713
9,Malignant neoplasm of skin,1672
9,Femoral neck bone mineral density,2394
9,Diabetes | illnesses of siblings,122
9,Low vWF levels,1612
9,Malaria,1951
9,White matter microstructure (mode of anisotropy) [Anterior limb of internal capsule],60
9,Red blood cell count,602324
9,Blood metabolite levels [succinylcarnitine],32978
9,Gut microbiota abundance (k_Bacteria.p_Actinobacteria.c_Actinobacteria.o_Coriobacteriales),1619
9,UBA1611 abundance in stool,535
9,Open-angle glaucoma,1572
9,Leiomyoma of uterus (controls excluding all cancers),183
9,Eye or eyelid problem,2518
9,White blood cell count (neutrophil),206
9,Eosinophil counts,446358
9,Serum levels of protein CCL27,12026
9,"Blood protein levels [EA, Annexin A1]",395
9,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],1170
9,Asthma-related pneumonia or sepsis,370
9,Blood protein levels [VEGFA],74
9,Waist circumference adjusted for body mass index [men],134
9,Thrombomodulin levels,5325
9,None of the above | vascular/heart problems diagnosed by doctor,1629
9,"""Ulcerative colitis (strict definition, all Crohn cases excluded)""",3154
9,IgG glycosylation patterns [IgG2 Galactosylation],1196
9,Frequency of depressed mood in last 2 weeks,2757
9,BMI (adjusted for smoking behaviour),307
9,"Colon cancer/sigmoid cancer | cancer code, self-reported",83
9,Liver enzyme levels (gamma-glutamyl transferase),2393
9,Intracranial aneurysm,4909
9,Number of days/week of moderate physical activity 10+ minutes,2551
9,Faecalicatena lactaris abundance in stool,1455
9,Serum levels of protein IL6ST,891
9,Flixonase 50micrograms aqueous nasal spray | treatment/medication code,844
9,"Heel bone mineral density (bmd) t-score, automated (left)",827
9,Diverticular disease of intestine,57
9,"Blood protein levels [EA, Protein jagged-1]",795
9,Fludrocortisone | treatment/medication code,540
9,Protein quantitative trait loci (liver) [COQ9],1
9,Low high density lipoprotein cholesterol levels,78
9,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),1573
9,Other osteochondropathies,7943
9,Lung function (FVC) [EA],105
9,Heel bone mineral density x serum urate levels interaction [female],10
9,Reticulocyte count,246022
9,OTU97_27 (Bacteroides) prevalence,2272
9,Blood protein levels [VWF],1868
9,Systemic lupus erythematosus,10271
9,Infantile hypertrophic pyloric stenosis [EA],676
9,Leiomyoma of uterus,183
9,No | breathing problems improved/stopped away from workplace or on holiday,509
9,Gastric parietal cell autoantibody levels in type 1 diabetes,1130
9,LDL cholesterol levels,31688
9,Serum levels of protein IL11RA,12177
9,Acute insulin response (insulin secretion adjusted),8420
9,Hematological and biochemical traits [Hb],1489
9,Serum levels of protein CD209,1533
9,Facial skin colour (CIELAB index b* value),37
9,Protein quantitative trait loci (liver) [SDS],31
9,Protein quantitative trait loci (liver) [HRG],86
9,Hemorrhoids,36855
9,Amyotrophic lateral sclerosis,48168
9,Cystatin C levels,99121
9,Lymphocyte-to-monocyte ratio,31784
9,Electrocardiogram morphology (amplitude at temporal datapoints) [222 ms],3272
9,Freckles,37
9,Brain region volumes [right cerebellum exterior],13
9,Offspring birth weight,3391
9,Brain morphology (min-P),5059
9,Serum levels of protein ISLR2,6601
9,Protein quantitative trait loci (liver) [PSMD5],1395
9,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant I (Philtrum), Segment 16]",906
9,CD25 on memory B cell,1171
9,Hemoglobin concentration,197233
9,"""Hypothyroidism, strict autoimmune, 3 medication purchases required""",5060
9,"Blood clot in the lung | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",891
9,Number of sexual partners,636
9,ABO blood group (A vs O),4173
9,Frequency of tenseness / restlessness in last 2 weeks,54
9,Deep venous thrombosis,4982
9,Malignant neoplasm of skin (controls excluding all cancers),14775
9,Eosinophil percentage of granulocytes,41879
9,Multisite chronic pain,17113
9,Kidney volume,28000
9,"Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)",1000
9,Feeling fed-up,625
9,Non-melanoma skin cancer,14683
9,Blood protein levels [HGF],1868
9,Glaucoma,20605
9,1-palmitoyl-2-stearoyl-gpc (16:0/18:0) levels,346
9,Intralaminar thalamic nuclei volume,112
9,Creatine kinase levels,9227
9,Free thyroxine concentration,4278
9,Total cerebellar volume (excluding Crus I vermis),710
9,"Blood protein levels [FCN2, 13717_15_3]",277
9,Diabetes | illnesses of father,122
9,Cortical surface area [Pericalcarine],509
9,Protein quantitative trait loci (liver) [PRDX3],227
9,Fosinopril | treatment/medication code,233
9,Brain morphology (MOSTest),32859
9,Warfarin | treatment/medication code,1449
9,Uterine fibroids,2726
9,Serum levels of protein CELA1,990
9,BMI in non-smokers,307
9,Serum levels of protein DSG2,4091
9,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),2559
9,Ease of skin tanning,5917
9,Allergic asthma (mode) (more control exclusions),554
9,Hip bone size,729
9,Systolic blood pressure [Puberty],122
9,Total body bone mineral density,1367
9,IgG glycosylation [IGP40],5334
9,Hypothyroidism (congenital or acquired),4421
9,"Liver, biliary or pancreas problem",1883
9,Electrocardiogram morphology (amplitude at temporal datapoints) [-20 ms],158
9,Phosphatidylcholine levels [PC(16:0;0-16:1;0],9
9,Wheeze or whistling in the chest in last year,2965
9,HLA DR+ CD4+ T cell Absolute Count,3103
9,Body mass index [EA],304
9,Getting up in morning,1924
9,Reaction time,22595
9,"Blood protein levels [C8G, 14708_59_3]",8052
9,Nitrolingual 400micrograms spray | treatment/medication code,8820
9,"""Coxarthrosis,""",897
9,Magnesium levels,94
9,Heel bone mineral density (bmd) (right),6536
9,Spherical power (left),2896
9,Lung cancer,191
9,Total body bone mineral density (MTAG),53
9,Protein quantitative trait loci (liver) [PEA15],72
9,Body mass index in physically active individuals [EA],55
9,"Urinary metabolites (H-NMR features) [5.2625, Unknown]",4091
9,Vertical cup-disc ratio (adjusted for vertical disc diameter),1612
9,Carotid plaque,1396
9,"Blood protein levels [POFUT2, 6042_52_3]",259
9,Hyperthyroidism,1179
9,OTU97_15 (Parasutterella) abundance,25
9,Waist circumference adjusted for BMI (adjusted for smoking behaviour),130
9,Protein quantitative trait loci (liver) [HBD],15
9,High light scatter reticulocyte count,299945
9,"Asthma | non-cancer illness code, self-reported",23257
9,Adolescent idiopathic scoliosis [Japanese],194
9,Polycystic ovarian syndrome,1498
9,Celiac disease or Rheumatoid arthritis,22589
9,Subcortical volume (MOSTest),38767
9,Rheumatoid arthritis [EA],44145
9,Ganglion cell inner plexiform layer (GCIPL) thickness,24191
9,Serum levels of protein CDH5,4982
9,Menarche (age at onset) [Japanese],130
9,Metabolic syndrome [HDL],570
9,Serum galactose-deficient IgA1 levels in IgA nephropathy,285
9,Protein quantitative trait loci (liver) [COTL1],50
9,Waist-hip index,52684
9,Mouth ulcers,581
9,Interleukin-1 receptor-like 1 measurement,891
9,Had menopause,1168
9,Electrocardiogram morphology (amplitude at temporal datapoints) [218 ms],3272
9,Corneal hysteresis,82
9,Serum uric acid levels,40742
9,DNA methylation variation (age effect),9085
9,Fractures,1433
9,High density lipoprotein cholesterol levels [EA],2446
9,Serum metabolite levels [Gly],404
9,Nasal polyp,391
9,Ankle-brachial index,1396
9,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant O (Nose + Philtrum), Segment 2]",166
9,Snoring [adjusted for BMI],1574
9,"Peripheral vascular disease | non-cancer illness code, self-reported",380
9,Seretide 50 evohaler | treatment/medication code,446
9,Protein quantitative trait loci (liver) [SERPINA1],4
9,Serum levels of protein F10,598
9,Bipolar I disorder,489
9,Airway responsiveness in chronic obstructive pulmonary disease [Continuous PC20],30
9,Benign neoplasm of brain and other parts of central nervous system,990
9,Serum thyroid-stimulating hormone levels,1113
9,"Blood protein levels [EA, Interleukin-27 receptor subunit alpha]",3068
9,Protein quantitative trait loci (liver) [FBP2],645
9,Corneal resistance factor (left),18144
9,Automobile speeding propensity,1239
9,Serum 25-Hydroxyvitamin D levels,70419
9,Serum levels of protein SFTPC,1101
9,Electrocardiogram morphology (amplitude at temporal datapoints) [162 ms],1042
9,Soluble ICAM-1,2673
9,"Blood protein levels [CCL27, 2192_63_10]",24203
9,Sitting height,141657
9,"Allergic disease (asthma, hay fever or eczema)",4553
9,Chronic sinusitis,730
9,Electrocardiogram morphology (amplitude at temporal datapoints) [178 ms],4687
9,Endometriosis of ovary,811
9,Asthma (more control exclusions),684
9,Coagulation factor levels [Conditioned on rs687289],1612
9,Blood protein levels [E-Selectin],795
9,Cerebral aneurysm,1796
9,3mm weak meridian (right),1495
9,Serum levels of protein BCAM,4091
9,"Heel bone mineral density (bmd) t-score, automated",18756
9,Peak expiratory flow (pef),23996
9,"""Hypothyroidism, drug reimbursement""",1179
9,Alzheimer's disease or HDL levels (pleiotropy),570
9,Current eye infection,3560
9,Cardiovascular disease,11409
9,Lung function (FEV1) [adults],1578
9,Bread intake,1334
9,Serum levels of protein NOG,158
9,Broad depression or schizophrenia,407
9,Beer/cider intake,3
9,Systolic blood pressure,343854
9,"""Ulcerative colitis (strict definition, require KELA, min 2 HDR)""",1887
9,Smoking initiation (ever regular vs never regular) (MTAG),18842
9,"Blood protein levels [EA, Vascular endothelial growth factor receptor 3]",3068
9,Citramalate levels,300
9,Abdominal aortic aneurysm,3563
9,"Ecg, load",30
10,Response to antidepressants (non-treatment-resistant vs treatment-resistant depression),7682
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-98 ms],13674
10,Antihypertensive medication - note that there are other indications,27878
10,N-acetylglucosamine/n-acetylgalactosamine levels,3810
10,Response to clopidogrel therapy [Amish],8534
10,Nonischemic cardiomyopathy,351
10,Primary tooth development (number of teeth),1935
10,White matter microstructure (mean diusivities) [Anterior limb of internal capsule],299
10,Nonsyndromic cleft lip with cleft palate,3163
10,Retinol levels,379
10,Electrocardiogram morphology (amplitude at temporal datapoints) [242 ms],1597
10,Cardiomyopathy,351
10,TPE interval (resting),45
10,Serum metabolite levels [X-12092],31184
10,Blood protein levels [Mannose-binding protein C],206
10,White matter microstructure (radial diusivities) [Anterior corona radiata],15256
10,Dried fruit intake,9503
10,Protein quantitative trait loci (liver) [TPM3],21
10,Vertical cup-disc ratio,61980
10,"Urinary metabolites (H-NMR features) [2.8625, Trimethylamine]",31775
10,"Urinary metabolites (H-NMR features) [2.8775, Trimethylamine]",31775
10,Betamethasone | treatment/medication code,651
10,Estrogen receptor status in HER2 negative breast cancer,54
10,Sex hormone-binding globulin levels adjusted for BMI,263221
10,White matter microstructure (radial diusivities) [Superior longitudinal fasciculus],2458
10,Educational attainment (college completion),1253
10,Serum levels of protein AGGF1,253
10,Started insulin within one year diagnosis of diabetes,125
10,Type 1 diabetes without complications,149
10,Creon e/c granules in capsule | treatment/medication code,17
10,Cognitive performance (MTAG) [MTAG],86981
10,Leg predicted mass (right),155480
10,Distal/Left-sided colorectal cancer,1828
10,"Blood protein levels [PLAU, 4158_54_2]",5147
10,malignant neoplasm of male genital organs,218
10,"Melanomas of skin, dx or hx",2801
10,Sebaceous cyst,161
10,Home location at assessment - east co-ordinate (rounded),965
10,Protein quantitative trait loci (liver) [GLUL],436
10,Subclinical trait of interstitial lung disease (percentage of high attenuation areas on CT scan) [Chinese],30
10,Schizophrenia (MTAG),219008
10,Total amyloid (SNP x SNP interaction),2478
10,Spondylopathies,385
10,Lamb consumption,66
10,Electrocardiogram morphology (amplitude at temporal datapoints) [40 ms],7
10,Protein quantitative trait loci (liver) [EPHA6],13
10,Low-grade serous and serous borderline ovarian cancer,2707
10,"Adrenocortical insufficiency/addison's disease | non-cancer illness code, self-reported",503
10,Latent autoimmune diabetes,266
10,"""Moderate visual impairment, binocular""",1059
10,"2,3-dihydroxy-2-methylbutyrate levels",44
10,Heart rate response to exercise [males],374
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-2 ms],8929
10,Heart rate response to recovery post exercise (50 sec),123
10,Frequency of tenseness / restlessness in last 2 weeks,101
10,"Blood protein levels [FAS, 9459_7_3]",188
10,"Hearing loss, difficulty in hearing",7
10,LDL cholesterol,16515
10,Diabetes or endocrine disease,3984
10,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],5545
10,"Skin aging measurement [Additive, wrinkles under eyes, East Asian]",862
10,Double-edged eyelids,144
10,White matter hyperintensity burden [EA],6254
10,Erythritol levels,865
10,Acylcarnitine levels [Propionylcarnitine],188
10,Graves' disease,226
10,"""Malignant neoplasm of breast, HER-positive""",249
10,Human milk oligosaccharide concentration (fucosyllacto-N-hexaose),1
10,Wholemeal or wholegrain | bread type,92
10,Serum metabolite levels [1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1)*],25
10,"Blood protein levels [CSGALNACT2, 10772_21_3]",670
10,Gout (combined type),3810
10,"Sarcoidosis | non-cancer illness code, self-reported",4052
10,Lung adenocarcinoma,3478
10,"""Asthma, hospital admissions , main diagnosis only""",39
10,CD25 on memory B cell,47
10,Heme oxygenase 1 measurement,8
10,Cisplatin-induced hearing loss in childhood cancer,2
10,White matter hyperintensity volume (adjusted for hypertension) [MR-MEGA],1021
10,Threonate levels,184
10,Protein quantitative trait loci (liver) [PSMD14],68
10,Hemoglobin levels,106130
10,CD4 on CD39+ CD4+ T cell,30917
10,Mean sphered cell volume,170075
10,Electrocardiogram morphology (amplitude at temporal datapoints) [2 ms],8929
10,Arm fat-free mass (right),169712
10,Interleukin-2 receptor subunit alpha levels,7575
10,Blood metabolite levels [X-13548],177
10,Asthma or allergic disease (pleiotropy),683
10,Psoriasis or type 2 diabetes (trans-disease meta-analysis),25100
10,Nervous feelings,73318
10,Heel broadband ultrasound attenuation (right),12697
10,Nonsyndromic cleft lip with or without cleft palate x sex interaction (2df test),581
10,Marginal zone lymphoma or multiple sclerosis,403
10,"Blood protein levels [ITIH2, 9326_33_3]",490
10,Lung cancer,2695
10,Hirschsprung disease [East Asian],3521
10,"Brain haemorrhage | non-cancer illness code, self-reported",523
10,Mean arterial pressure,93698
10,Systolic blood pressure [Japanese],22458
10,Electrocardiogram morphology (amplitude at temporal datapoints) [210 ms],10512
10,Whole body water mass,181910
10,Pneumococcal meningitis x streptococcus pneumoniae genotype cluster interaction [cluster 8],954
10,Apolipoprotein Levels [APOA2],147
10,White matter hyperintensities,82
10,C-C motif chemokine 17 levels,60
10,Thalamus volume,14536
10,CD39+ CD8+ T cell %CD8+ T cell,30962
10,Direct bilirubin levels,37264
10,"Light brown | hair colour (natural, before greying)",969
10,CD25 on CD24+ CD27+ B cell,47
10,Gut microbiota (bacterial taxa) [k__Bacteria|p__Firmicutes|c__Negativicutes|o__Selenomonadales|f__Veillonellaceae|g__Dialister],40
10,Acetylcarnitine (c2) levels,5
10,"Systolic blood pressure, automated reading",67332
10,Rheumatoid arthritis [East Asian],2833
10,Serum metabolite levels [dihydroorotate],1118
10,Pancreas volume,1008
10,"None of the above | medication for cholesterol, blood pressure or diabetes",1166
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-86 ms],849
10,Electrocardiogram morphology (amplitude at temporal datapoints) [262 ms],1597
10,Caffeine consumption from coffee,193
10,Neuritic plaques (SNP x SNP interaction),659
10,Blood cell traits (multivariate analysis),2141
10,Hot drink temperature,15191
10,Place of birth in uk - north co-ordinate,1029
10,Cardiac problem,4494
10,Electrocardiogram morphology (amplitude at temporal datapoints) [220 ms],1597
10,Blood metabolite levels [acetylcarnitine],188
10,Offspring birth weight,14016
10,Cortical surface area [Precentral],3680
10,Vigorous physical activity,982
10,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,40
10,Gut microbiota (bacterial taxa) [Clostridium_cellulolyticum],42
10,"""Early lumbar disc prolapse, operated""",7046
10,"Rectal cancer | cancer code, self-reported",320
10,Triglyceride levels [Asian],40
10,Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals,20
10,Cancer (pleiotropy)(bidirectional),112
10,Electrocardiogram morphology (amplitude at temporal datapoints) [22 ms],168
10,Both eyes | which eye(s) affected by hypermetropia (long sight),18
10,Apolipoprotein A1 levels,93835
10,3-hydroxy-3-methylglutarate levels,331
10,Carotid intima media thickness,15
10,Bowel cancer | illnesses of adopted mother,154
10,Activated partial thromboplastin time,89
10,Nonalcoholic fatty liver disease (imputed),15255
10,Leg fat percentage (right),48543
10,College or university degree | qualifications,42846
10,Glaucoma (primary angle closure),391
10,Pulse pressure [EA],23757
10,Sarcoidosis,6648
10,Optic nerve head parameters (multi-trait analysis) [EA],1062
10,Serum levels of protein CAPN2,2608
10,Serum levels of protein HS3ST1,697
10,"Gout | non-cancer illness code, self-reported",188
10,Pancreatic cancer,240
10,"Weight, manual entry",128
10,Renal or urological disease,330
10,Triglyceride levels,161027
10,Ischemic stroke,10002
10,CD20 on switched memory B cell,1247
10,Total cholesterol levels [EA],676
10,"Asthma | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",3513
10,"Forced vital capacity (fvc), best measure",48197
10,Leg fat mass (left),66790
10,Urate levels [East Asian],7526
10,Bioavailable testosterone levels,173190
10,Arm fat mass (right),20448
10,Electrocardiographic traits (multivariate),809
10,"Blood protein levels [FGFBP3, 11219_95_3]",1075
10,Secreting CD4 regulatory T cell %CD4+ T cell,194
10,Sinemet-62.5 tablet | treatment/medication code,3
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-18 ms],22988
10,Breast size,7316
10,Activated & secreting CD4 regulatory T cell %CD4+ T cell,795
10,Mean corpuscular haemoglobin concentration,3924
10,Risedronate sodium | treatment/medication code,339
10,Waist-hip index,41559
10,Usual walking pace,21557
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-144 ms],6155
10,Waist-to-hip ratio adjusted for body mass index [women],3533
10,Migraine and/or systolic blood pressure,2708
10,Trunk fat percentage,47766
10,Body mass index [recessive model],4101
10,"""Atopic dermatitis, strict definition with reimbursement""",130
10,Brain region volumes [left hippocampus],1077
10,Serum levels of protein AP4M1,253
10,Cutaneous malignant melanoma,5414
10,"""Type 1 diabetes, wide definition, subgroup 1""",149
10,Dysphagia,1
10,Cholelithiasis and cholecystitis,20104
10,PR interval,50979
10,Smoking initiation,67081
10,Cardiovascular diseases (excluding rheumatic etc),23819
10,Chronic obstructive pulmonary disease,3983
10,Melanocytic naevi of scalp and neck (controls excluding all cancers),1422
10,Age-related hearing impairment (SNP x SNP interaction),86
10,Lobe attachment (rater scored),30
10,Hip circumference [EA],39131
10,Non-small cell lung cancer [East Asian],861
10,Atrial fibrillation and flutter,17764
10,Caffeine consumption from coffee or tea,5114
10,General episode | hospital episode type,2657
10,Pantoprazole | treatment/medication code,931
10,Urate levels [AA],827
10,"Prolapsed disc/slipped disc | non-cancer illness code, self-reported",2286
10,T cell lymphocyte profile difference (90 days post influenza vaccination),123
10,Indapamide | treatment/medication code,118
10,Urate levels,259968
10,Gallstone disease,20284
10,Thyroid problem (not cancer),7729
10,Serum levels of protein ITIH1,760
10,Cocaine dependence [Symptom count],3515
10,Thoracic aortic aneurysms [genotyped],320
10,Degeneration of macula and posterior pole of retina,1059
10,3mm weak meridian angle (right),16
10,Modified Stumvoll Insulin Sensitivity Index (BMI interaction),2
10,Type 2 diabetes [additive model],2383
10,Total PHF-tau (SNP x SNP interaction),60922
10,Mean arterial pressure [East Asian],24818
10,Serum uric acid levels [EA],1279
10,Uric acid levels,617
10,High-sensitivity cardiac troponin I concentration (MTAG),351
10,Acceptance of an invitation to participate in a mental health questionnaire,884
10,Gut microbiota relative abundance (Oscillospira),27
10,"Diastolic blood pressure, automated reading",35317
10,Leg fat-free mass (left),154785
10,Ankle spacing width (left),3103
10,Soluble interleukin-2 receptor subunit alpha [EA],147
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-6 ms],2965
10,"Type 2 diabetes | non-cancer illness code, self-reported",119
10,Type 2 diabetes [Lean],119
10,Attention deficit hyperactivity disorder,1304
10,White matter microstructure (mean diusivities) [Average across all tracts],2458
10,"High cholesterol | non-cancer illness code, self-reported",744
10,Mosaic loss of chromosome Y (Y chromosome dosage),32
10,Self-reported math ability,27510
10,"Heel bone mineral density (bmd) t-score, automated",23244
10,CD25 on naive-mature B cell,228
10,"Bursitis | non-cancer illness code, self-reported",32
10,Other type of milk | type milk consumed,181
10,"""Disorders of sclera, cornea, iris and ciliary body""",5
10,Alzheimer's disease or fasting glucose levels (pleiotropy),84
10,Highest math class taken,31227
10,Hippocampal subfield CA1 volume,1366
10,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],9424
10,Metabolic biomarkers (multivariate analysis),18512
10,Epithelial ovarian cancer [CCOC],192
10,Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis),319
10,Adiponectin levels,64
10,Genitourinary diseases,9
10,"Daytime sleep phenotypes [daytime resting, weekdays]",29
10,Metabolite levels [TMAu],31184
10,Interleukin-12p70 levels,6134
10,Neuroblastoma (11q deletion),1357
10,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test),1017
10,Serum metabolite levels (CMS) [IDL_L],49
10,Gelsolin measurement,12
10,Breast cancer,52876
10,Venous thromboembolism,10151
10,"Infant, child and juvenile death in continuous marriage (proportion of children died <15 years)",1520
10,Dermovate cream | treatment/medication code,1027
10,Sleeping too much,115
10,Sunburns,12550
10,Triglyceride levels x short total sleep time interaction (2df test),5541
10,Putamen volume,3243
10,Advanced age-related macular degeneration [EA],3083
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-134 ms],5057
10,Serum metabolite levels [N-methylpipecolate],48401
10,Conductive and sensorineural hearing loss,7
10,Facial morphology (segment 9),197
10,Dentate gyrus molecular layer volume,1366
10,"Pulse pressure x alcohol consumption interaction (2df test) [EA, Hispanic]",254
10,Asthma (mode),3
10,Lifetime number of sexual partners,72460
10,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),93526
10,Gonarthrosis,242
10,Wet age-related macular degeneration,1059
10,Protein quantitative trait loci (liver) [UCHL3],68
10,Sum eosinophil basophil counts,23144
10,Insomnia [Female],23536
10,Cathepsin L1 levels,185
10,Serum metabolite levels [X-12093],31184
10,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [X-12093, X-12112, X-23776, X-24809, X-24983]",31775
10,"Diverticular disease/diverticulitis | non-cancer illness code, self-reported",5919
10,"Blood protein levels [FAS, 5392_73_2]",188
10,Systolic blood pressure (alcohol consumption interaction) [Oz alcohol/week],271
10,Electrocardiogram morphology (amplitude at temporal datapoints) [42 ms],232
10,Type 1 diabetes,21984
10,Prostate cancer [EA],593
10,High blood pressure | illnesses of father,261
10,Mood instability,151
10,Hypothyroidism,11945
10,"""Migraine, single triptan purchase ok & required. ICD-code if available is included""",2585
10,None of the above (group 2) | illnesses of mother,249
10,Age-related macular degeneration (whether dry or wet),1059
10,CD25 on IgD+ CD24+ B cell,47
10,Total body bone mineral density,4271
10,Psoriasis,36759
10,Glycine levels,6512
10,Diabetes diagnosed by doctor,4507
10,CD39 on CD39+ activated CD4 regulatory T cell,33264
10,Use of sun/uv protection,2305
10,Response to oxaliplatin,532
10,Injuries to the shoulder and upper arm,27
10,Cotinine glucuronidation,1926
10,White matter hyperintensity volume x hypertension interaction (2df),5433
10,Cortical surface area [Lingual],2813
10,Body fat percentage and fasting glucose (pairwise),119
10,Myoglobin levels,351
10,Orofacial clefts,4874
10,White matter microstructure (mean diusivities) [Anterior corona radiata],15256
10,A levels/as levels or equivalent | qualifications,13847
10,Skin pigmentation,117
10,Protein quantitative trait loci (liver) [ALDH7A1],21
10,Protein quantitative trait loci (liver) [CTSS],3
10,Red cell distribution width,560303
10,Cleft lip with or without cleft palate,4874
10,Cognitive ability (MTAG),18271
10,Electrocardiogram morphology (amplitude at temporal datapoints) [202 ms],2342
10,Colorectal polyp and colorectal cancer (MTAG) [Colorectal polyp],631
10,Body mass index (joint analysis main effects and smoking interaction) [men],119
10,White blood cell (leukocyte) count,91002
10,Cardiorespiratory fitness slope,748
10,Protein quantitative trait loci (liver) [EXD1],55
10,Pioglitazone | treatment/medication code,119
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-132 ms],5057
10,Blood protein levels [Proto-oncogene tyrosine-protein kinase receptor Ret],3057
10,Prostate cancer [European],1707
10,Basophil percentage of granulocytes,36428
10,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)",72751
10,Urinary metabolite levels in chronic kidney disease [X - 12093],31775
10,Urinary albumin-to-creatinine ratio [EA],5543
10,"Heel quantitative ultrasound index (qui), direct entry (left)",1460
10,Neurociticism,377
10,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],167
10,"Cholesterol lowering medication | medication for cholesterol, blood pressure or diabetes",119
10,Vaccenic acid (18:1n-7) levels [EA],25
10,Brain region volumes [left isthmus cingulate],23833
10,Incident atrial fibrillation,5790
10,Waist-to-hip ratio adjusted for BMI (additive genetic model),532
10,Solpadol capsule | treatment/medication code,172
10,CD25 on IgD- CD24- B cell,228
10,N-trimethyl 5-aminovalerate levels,19
10,"Blood protein levels [VWA2, 7128_9_3]",3270
10,Scalp hair shape,210
10,Atrial fibrillation and flutter with reimbursement,8515
10,Smoking initiation (ever regular vs never regular) [Conditioned on chr10:104640052],2566
10,Seropositive rheumatoid arthritis,697
10,Ferrous sulphate | treatment/medication code,206
10,Stromal cell-derived factor 2 measurement,25
10,Asthma-related infections,3
10,Well-being spectrum (multivariate analysis),25449
10,Peak expiratory flow x sex interaction,6311
10,Externalizing behaviour (multivariate analysis),72189
10,Cholelithiasis or gall stones,6323
10,Protein quantitative trait loci (liver) [GSN],305
10,Age-related diseases and mortality,846
10,Diabetic hypoglycemia,119
10,Protein quantitative trait loci (liver) [ATIC],83
10,Arm fat percentage (left),43930
10,Post-traumatic stress disorder,1320
10,Physiological aging rate,37
10,Glycated haemoglobin HbA1c levels adjusted for BMI,664
10,Extraversion,299
10,Electrocardiogram morphology (amplitude at temporal datapoints) [128 ms],75
10,Disease-related mortality after unrelated donor allogeneic hematopoietic cell transplantation (donor effect),48
10,Optic disc area,45798
10,Birth weight,99867
10,Worrier / anxious feelings,66380
10,CD28 on CD39+ CD8+ T cell,14624
10,Serum levels of protein SPOCK2,4528
10,"""Diabetes, varying definitions""",4400
10,Alcohol consumption x experiences in childhood (felt loved by family member) interaction,716
10,Time spent outdoors in winter,1979
10,Blood metabolite levels [carnitine],617
10,Topiramate | treatment/medication code,261
10,Diseases of sebaceous glands,132
10,Vascular endothelial growth factor levels,18374
10,Factor VII activity or levels,5931
10,"Blood protein levels [DKK1, 3535_84_1]",134
10,Frequency of needing morning drink of alcohol after heavy drinking session in last year,128
10,Congenital malformations of the urinary system,90
10,Electrocardiogram morphology (amplitude at temporal datapoints) [34 ms],7
10,Optic disc parameters,16981
10,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),6221
10,Autoimmune traits,5142
10,Alzheimer's disease in APOE e4- carriers,109
10,Protein quantitative trait loci (liver) [ENO3],5
10,Blepharochalasis,16
10,Protein quantitative trait loci (liver) [MACROD1],6
10,Number of sexual partners,81017
10,Essential hypertension,33988
10,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),3417
10,Fasting glucose,4717
10,"""Type 2 diabetes, definitions combined, including avohilmo""",24139
10,Metabolite levels [asymmetric dimethylarginine],17795
10,Overall health rating,2994
10,Chronic kidney disease [eGFRcrea],1986
10,Interleukin-1 receptor type 2 measurement,3996
10,Facial morphology (segment 5),299
10,Left-handedness,1532
10,Smoking cessation (MTAG),12089
10,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) [Modelling analysis]",95615
10,Metformin | treatment/medication code,4475
10,Other joint disorders,230
10,Palmar fascial fibromatosis [Dupuytren],25
10,Electrocardiogram morphology (amplitude at temporal datapoints) [172 ms],45
10,UBA1417 sp003531055 abundance in stool,5
10,Open-angle glaucoma and vertical cup-disc ratio,1216
10,Protein quantitative trait loci (liver) [AOC3],53
10,Percent mammographic density,359
10,Dermatologic disease,875
10,Warfarin maintenance dose,25229
10,Arsenic metabolism [MMA%],13897
10,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction) [women],48021
10,Mean corpuscular hemoglobin concentration,446165
10,Sex hormone-binding globulin levels,289421
10,"Urinary metabolites (H-NMR features) [2.8825, Trimethylamine]",17795
10,Celiac disease,1924
10,Malignant neoplasm of prostate (controls excluding all cancers),218
10,Alcohol intake frequency.,898
10,Left atrial active emptying fraction,984
10,Diprobase cream | treatment/medication code,953
10,Protein quantitative trait loci (liver) [ALDH4A1],10
10,Creatinine levels,214639
10,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),9424
10,"Pulmonary function (smoking interaction) [FEV1/FVC, Ever-smoking]",2788
10,Metabolite levels [carnitine],188
10,CD25 on IgD+ CD38dim B cell,212
10,Subjective well-being (MTAG),600
10,Age-related macular degeneration [EA],1059
10,Protein quantitative trait loci (liver) [SBDS],72
10,Total cholesterol levels,299181
10,Fibrosis-4 index in high alcohol intake,6131
10,Neurological blood protein biomarker levels [N-CDase],2823
10,Left ventricular end-systolic volume,702
10,Malignant neoplasm of digestive organs,355
10,Serum levels of protein GNLY,1394
10,Serum levels of protein C8G,65
10,Beef consumption,35
10,Basophil count,123500
10,Statin medication,2383
10,Protein levels in obesity [a1-Antichymotrypsin],53
10,Smoking status (ever vs never smokers),120187
10,Femur bone mineral density x serum urate levels interaction [male],2060
10,Impedance of leg (right),117304
10,HDL cholesterol x physical activity interaction (2df test),676
10,"""UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)""",984
10,Neuroticism (MTAG),881
10,"Deep venous thrombosis (dvt) | non-cancer illness code, self-reported",1772
10,Lysophosphatidylcholine_16:1_[M+H]1+/Lysophosphatidylethanolamine_19:1_[M+H]1+ levels,25
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-14 ms],22988
10,Diverticular disease of intestine,819
10,Metabolite levels [Hex2Cer d18:2/16:0],493
10,Behcet's disease,615
10,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],1765
10,CD28 on CD39+ CD4+ T cell,14896
10,"""Hypothyroidism,  other/unspecified""",1487
10,Disc problem,619
10,Risk-taking tendency (4-domain principal component model),38946
10,"""Malignant neoplasm of breast, HER-positive (controls excluding all cancers)""",249
10,Infant head circumference (MTAG),94
10,Major coronary heart disease event,47
10,Crohn's disease [EA],85156
10,Raw vegetable consumption,5252
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-108 ms],13721
10,"Blood protein levels [ARL3, 12571_14_3]",8816
10,CD28 on CD39+ activated CD4 regulatory T cell,14624
10,Urate levels [men],3662
10,Waist circumference [EA],39131
10,Blood metabolite levels [X-12092],31184
10,Biological sex,7341
10,Ear-nose-throat disorder,176
10,Phosphatidylcholine_36:0_[M+H]1+/Phosphatidylethanolamine_39:0_[M+H]1+/Phosphatidate_41:1_[M+NH4]1+ levels,396
10,Bipolar ii disorder | bipolar and major depression status,381
10,Serum levels of protein ITIH2,507
10,Brain region volumes [right entorhinal],32
10,Other diseases of intestines,331
10,Acute lymphoblastic leukemia (adolescents and young adults),28
10,Age of smoking initiation (MTAG),69107
10,Youthful appearance (self-reported),7551
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-136 ms],5057
10,Central corneal thickness,5175
10,Heart rate response to exercise,374
10,Unspecified diabetes,119
10,Cerebrospinal fluid p-tau levels in mild cognitive impairment,32
10,Inguinal hernia,108
10,Retinal nerve fibre layer thickness or ganglion cell inner plexiform layer thickness (MTAG),17181
10,Standing height,274521
10,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA],149
10,Bread intake,921
10,"Blood protein levels [MBL2, 3000_66_1]",286
10,Prostate cancer | illnesses of father,1991
10,Left atrial total emptying fraction,556
10,Type 2 diabetes with ophthalmic manifestations,124
10,CD39+ CD4+ T cell %CD4+ T cell,14941
10,Pulse pressure [East Asian],22378
10,Ischemic heart disease,383
10,Coffee consumption,6124
10,Carotid plaque burden,1254
10,Alcohol use disorder (total score),237
10,Malignant neoplasm of breast,335
10,"Smoking initiation (ever regular vs never regular) [Conditioned on chr10:103186838, chr10:104403310, chr10:104852121, chr10:103960351, chr10:104640052]",1253
10,"""Cardiomyopathies, Primary/intrinsic""",496
10,Obstructive sleep apnea trait (minimum oxyhemoglobin saturation across sleep episode),222
10,Decline in glucose metabolism in posterior cingulate cortex,262
10,Hip bone size,67
10,"Orofacial clefts [Meta-All, NSCL/P]",1259
10,Cardiorespiratory fitness (vo2 max),748
10,Diabetes,4572
10,QT interval (ambient particulate matter interaction),209
10,Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy) [EA],241
10,Asthma (moderate or severe),235
10,Bone properties (heel) [BUA],191
10,"Waist circumference [EA, men]",119
10,Intelligence (MTAG),19000
10,Systolic blood pressure [EA],23584
10,Low testosterone levels,5709
10,Beef intake,4692
10,White matter microstructure (mean diusivities) [Superior fronto-occipital fasciculus],2946
10,Serum levels of protein FGFBP3,1772
10,Granulocyte percentage of myeloid white cells,31918
10,Cortical surface area,119649
10,Blood metabolite levels [3-dehydrocarnitine],44208
10,Current | smoking status,78877
10,Monobrow,239
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-120 ms],781
10,Carotid intima media thickness (mean-maximum),121
10,Body mass index [men],119
10,Verbal-numerical reasoning,2123
10,Bipolar disorder or major depressive disorder,24110
10,Vertex-wise sulcal depth,132707
10,"Blonde | hair colour (natural, before greying)",43180
10,Lung adenocarcinoma [East Asian],898
10,Interleukin-2 receptor subunit alpha measurement,147
10,Ebbinghaus illusion (overestimation),123
10,Asthma (more control exclusions),3
10,Pulmonary function [FEV1],2876
10,White matter hyperintensity burden,6254
10,Weight,460286
10,Cardiac arrhytmias,6723
10,Optic nerve measurement (cup-to-disc ratio),11123
10,Serum metabolite levels [N('1)-acetylspermidine],241
10,Allergy,35
10,Other retinal disorders,2118
10,Blood protein levels in cardiovascular risk,8416
10,Age first had sexual intercourse,10006
10,Extremely high intelligence,312
10,Blood metabolite levels [X-03056--N-[3-(2-Oxopyrrolidin-1-yl)propyl]acetamide],413
10,Lung function (FEV1/FVC),218136
10,Hypertrophic cardiomyopathy,8196
10,Immune reponse to smallpox (secreted IL-1beta) [AA],40
10,Serum uric acid levels [Japanese],11337
10,Blood metabolite levels [X-02249],2186
10,Serum metabolite levels [andro steroid monosulfate C19H28O6S (1)*],7102
10,Medication use (HMG CoA reductase inhibitors),3894
10,CD25++ CD4+ T cell %CD4+ T cell,795
10,1-stearoyl-2-linoleoyl-gpc (18:0/18:2) levels,349
10,Thymus and reactivation regulated chemokine levels,60
10,Palmitoleic acid (16:1n-7) levels,151714
10,Serum levels of protein HAAO,8925
10,Medical abortion,3626
10,"""Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium""",248
10,Hemoglobin concentration,166936
10,Dorsopathies,6721
10,Lateral ventricular volume in normal aging,3762
10,Corneal structure,299
10,Adverse response to drug [Dihydropyridine derivatives [C08CA]],16
10,Diastolic blood pressure (long-term average),26389
10,C-reactive protein levels [BMI-adjusted],2608
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-4 ms],8929
10,Electrocardiogram morphology (amplitude at temporal datapoints) [212 ms],10512
10,Protein quantitative trait loci (liver) [ACAT2],3770
10,None of the above | types of physical activity in last 4 weeks,1251
10,Haemorrhoidal disease,464
10,Blood protein levels [Creatine phosphokinase],1474
10,Serevent 25mcg inhaler | treatment/medication code,789
10,Serum levels of protein PCDHA7,697
10,CD25 on switched memory B cell,228
10,"Heel quantitative ultrasound index (qui), direct entry",23244
10,Electrocardiogram morphology (amplitude at temporal datapoints) [10 ms],2302
10,"Eczema/dermatitis | non-cancer illness code, self-reported",617
10,Waist-to-hip ratio adjusted for body mass index,149
10,Intrahepatic Cholestasis of Pregnancy (ICP)  (more control exclusions),780
10,"""Hypothyroidism, levothyroxin purchases""",867
10,Alcohol misuse (trauma interaction) [AA],103
10,Other disorders of eyelid,16
10,N-acetyl-beta-alanine levels,6354
10,Inflammatory biomarkers (multivariate analysis),6112
10,CD25 on CD39+ secreting CD4 regulatory T cell,118
10,Height [Conditioned on rs2145998],210
10,Serum levels of protein CXCL5,6131
10,Electrocardiogram morphology (amplitude at temporal datapoints) [254 ms],1691
10,Subcortical volume (min-P),11987
10,Electrocardiogram morphology (amplitude at temporal datapoints) [38 ms],7
10,Cardiovascular disease,68662
10,Optic disc size,99848
10,Urinary metabolite levels in chronic kidney disease [X - 24809],31775
10,"Long-standing illness, disability or infirmity",6608
10,Serum metabolite levels [1-methylhistamine],265
10,Waist circumference adjusted for body mass index [EA],48628
10,Proheparin-binding EGF-like growth factor levels,12854
10,Serum levels of protein EDAR,4194
10,Pattern 1 | hair/balding pattern,17673
10,3mm weak meridian (left),32778
10,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],167
10,Serum levels of protein NOG,7136
10,Serum levels of protein DTX1,96
10,Blood metabolite levels [palmitoleate (16:1n7],25
10,Systolic blood pressure (long-term average),35015
10,White matter hyperintensity volume,7582
10,Permanent tooth development,1484
10,"Red blood cell traits [EA, MCH]",655
10,"Blood protein levels [ITIH1, 7955_195_3]",490
10,Hemoglobin A1c levels [Hispanic/Latino],44
10,Metabolically unhealthy in normal weight,22473
10,"""Type 2 diabetes, definitions combined""",3992
10,White matter microstructure in first episode schizophrenia (left posterior cingulate cortex),30
10,Smoking x traumatic event in childhood (sexually molested) interaction,9
10,Trunk fat-free mass,201687
10,DNA methylation PhenoAge acceleration,2623
10,BRCA1/2-negative high-risk breast cancer,218
10,Heart rate response to recovery post exercise,374
10,Ulcerative colitis [EA],42265
10,Factor VII activity,5909
10,Second line medication for Crohns disease,5
10,Paget's disease,994
10,Distance between home and job workplace,242
10,"Blood clot in the lung | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",1266
10,Esophageal cancer and gastric cancer [ESCC],4069
10,Protein quantitative trait loci (liver) [HSP90AB2P],122
10,Electrocardiogram morphology (amplitude at temporal datapoints) [28 ms],7
10,Telomere length,5919
10,Walking pace,22313
10,"Talking therapies, such as psychotherapy, counselling, group therapy or cbt | activities undertaken to treat depression",5426
10,Serum levels of protein CDNF,1415
10,Blood protein levels [Calcium/calmodulin-dependent protein kinase type 1],825
10,Ankylosing spondylitis [EA],467
10,Varicose veins,1508
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-154 ms],1098
10,Unspecified diabetes with ketoacidosis,48
10,Other disorders of ear,7
10,Atrial fibrillation,58120
10,General risk tolerance (MTAG),103436
10,Impedance of leg (left),143134
10,White matter microstructure (mode of anisotropy) [Cingulate gyrus],5478
10,Cardiac dysrhythmias,2361
10,Electrocardiogram morphology (amplitude at temporal datapoints) [200 ms],2342
10,Serum metabolite levels [N-acetyltaurine],6678
10,Electrocardiogram morphology (amplitude at temporal datapoints) [14 ms],918
10,Fasting insulin,328
10,Seretide 50 evohaler | treatment/medication code,46
10,Phenylacetylglutamine levels,60
10,Leg fat mass (right),41353
10,Electrocardiogram morphology (amplitude at temporal datapoints) [188 ms],2342
10,Testicular germ cell tumor,395
10,Type 2 diabetes and end-stage kidney disease,296
10,Acute lymphoblastic leukemia (childhood) [ETV6-RUNX1 positive],359
10,Diabetes related eye disease | eye problems/disorders,119
10,Ulcerative proctitis,19
10,Adolescent idiopathic scoliosis,52389
10,Total cholesterol levels [Trans-ethnic initial],2002
10,Prolapsed or slipped disc,570
10,Basophil percentage of white cells,60510
10,Pulse pressure,287523
10,Protein quantitative trait loci (liver) [PBLD],15924
10,Corneal hysteresis (left),1706
10,"Blood protein levels [MINPP1, 5586_66_3]",765
10,Gut microbiota (bacterial taxa) [k__Bacteria|p__Firmicutes|c__Negativicutes|o__Selenomonadales|f__Veillonellaceae|g__Dialister|s__Dialister_invisus],38
10,Rheumatoid arthritis,23809
10,"None of the above | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",27855
10,Age started wearing glasses or contact lenses,11969
10,Type 2 diabetes without complications,3992
10,"Blood protein levels [ITIH5, 8233_2_3]",312
10,"Skin, hair and eye pigmentation (multivariate analysis)",35
10,Leg fat percentage (left),60463
10,Blood protein levels [Calpastatin],825
10,Glucosamine | mineral and other dietary supplements,914
10,Dentate gyrus granule cell layer volume,6798
10,Bipolar disorder (MTAG),100864
10,Aspartate aminotransferase to alanine aminotransferase ratio,14806
10,Gastrointestinal event in colchicine-treated recent myocardial infarction (time to event),586
10,Femur total bone mineral density x gut microbiota (﻿genus Lactococcus) interaction,147
10,Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded),438
10,Immune response to smallpox vaccine (IL-6) [AA],116
10,Protein quantitative trait loci (liver) [RNASE2],20
10,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)",959
10,Type 2 diabetes [non-obese],119
10,Risky sexual behaviors in alcohol dependence [AA],58
10,Neutrophil count,643343
10,Major depressive disorder (MTAG),47303
10,Forns index in high alcohol intake,6112
10,Body mass index (bmi),109638
10,"Pulse pressure x alcohol consumption interaction (2df test) [Asian, EA]",7820
10,Autoimmune traits (pleiotropy),1964
10,Mitochondrial heteroplasmy measurement,2542
10,Chronic obstructive pulmonary disease x ever smoker interaction (2df),2862
10,Inflammatory bowel disease (early onset),765
10,1-palmitoyl-2-docosahexaenoyl-gpc (16:0/22:6) levels,31
10,Sleep apnoea,43
10,Basal cell carcinoma,6438
10,Type 2 diabetes (adjusted for BMI),8067
10,3mm strong meridian (left),30965
10,Spherical power (right),11184
10,X-15245 levels,820
10,Platelet thrombus formation [AA],745
10,Femoral neck bone mineral density,7437
10,"Age-related diseases, mortality and associated endophenotypes",384
10,Placenta growth factor levels,6
10,Hip circumference adjusted for BMI,33305
10,Electrocardiogram morphology (amplitude at temporal datapoints) [238 ms],1691
10,Urokinase plasminogen activator surface receptor levels,4296
10,Blood metabolite levels [X-11469],2186
10,Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid),339
10,Age cataract diagnosed,182
10,Blood pressure [Mean Arterial Pressure],24774
10,Benign neoplasm of breast,100
10,Risky sexual behaviors (alcohol dependence interaction),89
10,Total cerebellar volume (excluding Crus I vermis),6
10,6mm strong meridian (left),18195
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-138 ms],5057
10,Alzheimer's disease,167
10,Chronic obstructive pulmonary disease [conditional on rs721917],1005
10,Mean corpuscular hemoglobin,1224874
10,Chronic obstructive pulmonary disease-related biomarkers [SP-D],2507
10,Ease of getting up in the morning,2864
10,Facial morphology (segment 20),192
10,Blood metabolite ratios [myristate (14:0)/myristoleate (14:1n5],25
10,Vitiligo,8886
10,"Systolic blood pressure x alcohol consumption interaction (2df test) [Asian, EA]",7820
10,Arsenic metabolism [principal component 2 of arsenic species],33773
10,White matter microstructure (axial diusivities) [Fornix (column and body],3773
10,Glomerular filtration rate (creatinine),7442
10,Myocardial infarction (early onset),329
10,OTU99_9 (Alistipes) abundance,156
10,HDL cholesterol levels,129575
10,Electrocardiogram morphology (amplitude at temporal datapoints) [226 ms],1597
10,Electrocardiogram morphology (amplitude at temporal datapoints) [208 ms],10512
10,"Blood protein levels [PNLIPRP1, 6627_25_3]",76
10,Serum levels of protein PCBD1,773
10,Processed meat intake,116
10,Platelet distribution width,190516
10,Waist circumference adjusted for body mass index,184027
10,Electrocardiogram morphology (amplitude at temporal datapoints) [6 ms],2302
10,Platelet aggregation [epinephrine],4349
10,White matter microstructure (axial diusivities) [Average across all tracts],2458
10,Fibrinogen gamma chain measurement,124
10,Hemoglobin A1c levels,151176
10,Serum levels of protein SRL,1055
10,Urinary metabolite levels in chronic kidney disease [X - 24983],31775
10,Facial morphology (segment 45),7794
10,"Atrial fibrillation | non-cancer illness code, self-reported",7244
10,Age-related macular degeneration,9531
10,Corneal resistance factor (right),2065
10,Healthspan,119
10,Catechol sulfate levels,200
10,Current tobacco smoking,233
10,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) [subset analysis]",30056
10,Multiple sclerosis,13250
10,Lymphocyte-to-monocyte ratio,47541
10,"Blood protein levels [RET, 3220_40_2]",3057
10,"Diabetes | non-cancer illness code, self-reported",4967
10,Blood metabolite levels [X-11787],1679
10,CD25 on IgD- CD38- B cell,139
10,High cholesterol,500
10,Neuroticism conditioned on self-rated math ability (multi-trait conditioning and joint analysis),312
10,"Blood protein levels [ENTPD1, 7999_23_3]",12670
10,Nonatopic asthma or type 2 diabetes,889
10,"Blood protein levels [EA, Nidogen-1]",93
10,Serum levels of protein SURF1,65
10,Age at last episode of depression,92
10,Dehydroepiandrosterone sulphate levels,5633
10,Immature fraction of reticulocytes,365924
10,Bilirubin levels,36372
10,Serum levels of protein ADAM12,11879
10,"Heel bone mineral density (bmd) t-score, automated (left)",2957
10,Estimated glomerular filtration rate [EA],3515
10,Cancer diagnosed by doctor,249
10,Serum metabolite levels (CMS) [MUFA_FA],25
10,Facial morphology (segment 62),11
10,CD39+ activated CD4 regulatory T cell Absolute Count,28605
10,HDL cholesterol levels in current drinkers [EA],676
10,Headache,2874
10,Urinary albumin excretion (no hypertensive medication),499
10,Serum levels of protein LRRC24,253
10,Serum metabolite levels [myristoleate (14:1n5],25
10,CD25++ CD45RA+ CD4 not regulatory T cell %T cell,313
10,CD25 on resting CD4 regulatory T cell,170
10,Retention of urine,155
10,Carbohydrate,11
10,Detrusitol 1mg tablet | treatment/medication code,5
10,Male-pattern baldness,40729
10,Electrocardiogram morphology (amplitude at temporal datapoints) [240 ms],1597
10,Atopic asthma,1952
10,Diacylglycerol_36:3_[M+H-H2O]1+ levels,6075
10,Dilated cardiomyopathy (MTAG),2440
10,Serum metabolite concentrations in chronic kidney disease [Carnitine (free],188
10,Midgestational cytokine/chemokine levels (maternal genetic effect) [sIL2R-alpha],110
10,Blood metabolite levels [myristoleate (14:1n5],25
10,Systolic blood pressure (cigarette smoking interaction),25445
10,Atopic dermatitis,3988
10,Cerebrospinal fluid sTREM-2 levels,1427
10,Amyotrophic lateral sclerosis,2705
10,"Dry eyes | non-cancer illness code, self-reported",665
10,Estimated glomerular filtration rate in non-diabetics,24462
10,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],4287
10,Male puberty timing (age at voice breaking MTAG),12210
10,Electrocardiogram morphology (amplitude at temporal datapoints) [160 ms],45
10,"Blood protein levels [IL15RA, 14054_17_3]",553
10,"Polymyalgia rheumatica | non-cancer illness code, self-reported",18
10,High light scatter reticulocyte percentage of red cells,507010
10,Arsenic metabolism [principal component 1 of arsenic species],16074
10,Previous | smoking status,73727
10,Warfarin maintenance dose (adjusted for clinical factors) [AA],9820
10,Depressed affect,151
10,Serum levels of protein DKK4,157
10,Mitochondrial DNA levels,23590
10,Blood protein levels [SFTPD],31149
10,High blood pressure | illnesses of mother,15532
10,Leukocyte telomere length,2899
10,Multisite chronic pain,8555
10,"Blood protein levels [ADAM12, 4420_7_2]",693
10,Electrocardiogram morphology (amplitude at temporal datapoints) [158 ms],45
10,"Ground coffee (include espresso, filter etc) | coffee type",16130
10,Serum levels of protein RET,3874
10,Lung function (FVC),127593
10,Gastric cancer,8151
10,C-reactive protein,13217
10,Osteoarthritis (with total hip replacement),5074
10,Asthma (only as main-diagnosis) (more control exclusions),39
10,Follicular lymphoma or rheumatoid arthritis,52
10,Coagulation factor Xa measurement,6543
10,Receptor for advanced glycosylation end products levels,1182
10,"Blood protein levels [EA, Neutrophil collagenase]",2041
10,Childhood maltreatment,135
10,Breast cancer in BRCA2 mutation carriers,498
10,Physical activity,3782
10,"""Hypothyroidism, strict autoimmune""",1487
10,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs (controls excluding all cancers),40
10,Brain region volumes [right fusiform],15
10,Injury of muscle and tendon at shoulder and upper arm level,27
10,Cortical thickness (MOSTest),43149
10,Unstable angina pectoris,23052
10,Back problem,6800
10,Mitochondrial DNA copy number,5925
10,Macular telangiectasia type 2,4998
10,Fasting insulin (dietary factor interaction) [Carbohydrate],21
10,Hearing aid user,568
10,Asthma/COPD (KELA code 203),39
10,Serum levels of protein GALNT10,24
10,Protein quantitative trait loci (liver) [AKR7A3],775
10,Benign neoplasm: Sigmoid colon (controls excluding all cancers),76
10,Sum neutrophil eosinophil counts,35534
10,Electrocardiogram morphology (amplitude at temporal datapoints) [198 ms],8915
10,Low density lipoprotein cholesterol levels [EA],2324
10,White matter hyperintensity volume [MR-MEGA],3416
10,Protein quantitative trait loci (liver) [IGHG2],282
10,Triglyceride levels in current drinkers [Asian],159
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-106 ms],13357
10,Phosphatidylcholine_36:0_[M+OAc]1- levels,396
10,Arrhythmia,3268
10,"Appendicitis | non-cancer illness code, self-reported",744
10,"Blood protein levels [NRP1, 5542_22_2]",516
10,Cognitive aspects of educational attainment,33283
10,Brain region volumes [right pallidum],3243
10,Hyperplasia of prostate,2274
10,"Yes, because of illness | major dietary changes in the last 5 years",119
10,Heel bone mineral density x serum urate levels interaction,8
10,"Allergic disease (asthma, hay fever or eczema)",54818
10,Serum levels of protein SMPD1,6512
10,Electrocardiogram morphology (amplitude at temporal datapoints) [18 ms],918
10,White matter microstructure (fractional anisotropy) [Superior corona radiata],3185
10,Angioedema in response to angiotensin-converting enzyme inhibitor and/or angiotensin receptor blocker,806
10,"Bladder problem (not cancer) | non-cancer illness code, self-reported",12
10,Peripheral arterial disease (traffic-related air pollution interaction) [AA],9
10,Body mass index and fasting glucose (pairwise),119
10,Iris color (a* coordinate),10
10,Fibrinogen levels,22806
10,Glaucoma,12723
10,"Heel broadband ultrasound attenuation, direct entry",19484
10,Thyroid stimulating hormone levels,48
10,Plateletcrit,147540
10,Sitting height,224367
10,Hydroxyasparagine levels,2842
10,Type 2 diabetes [South Asian],100
10,Feeling worry,73015
10,Optic disc area [EA],12723
10,Electrocardiogram morphology (amplitude at temporal datapoints) [258 ms],1691
10,Gastroesophageal reflux disease,5031
10,Eczema or dermatitis,1540
10,Number of unenthusiastic/disinterested episodes,1
10,Sex hormone-binding globulin levels [Men + Women],6512
10,Interstitial lung disease,5104
10,Pregnancy hypertension,301
10,"Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test) [Asian, EA]",4045
10,"""Diabetes, several complications""",119
10,Vaccenic acid (18:1n-7) levels,25
10,Forced expiratory volume in 1-second (fev1),93348
10,Insulin product | treatment/medication code,119
10,Noninfective enteritis and colitis,867
10,Blood metabolite levels [margarate (17:0],25
10,Arthritis (juvenile idiopathic),340
10,Phosphatidylcholine_36:1_[M+H]1+/Phosphatidylethanolamine_39:1_[M+H]1+/Phosphatidate_41:2_[M+NH4]1+ levels,396
10,Eosinophill count,67332
10,Thyroid cancer,2707
10,Electrocardiogram morphology (amplitude at temporal datapoints) [260 ms],1597
10,Brain region volumes [left cerebellum exterior],6
10,Systolic blood pressure,827433
10,Age at menopause,68801
10,Hand grip strength (right),50545
10,3mm strong meridian (right),28854
10,Age completed full time education,6622
10,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],5734
10,Had menopause,516
10,Electrocardiogram morphology (amplitude at temporal datapoints) [234 ms],1597
10,Autoimmune diseases,1503
10,Reaction time,708
10,Acute pancreatitis,187
10,Gamma glutamyl transpeptidase,75728
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-130 ms],5057
10,6mm weak meridian (right),20535
10,Allopurinol | treatment/medication code,748
10,Blood protein levels [Neutral ceramidase],736
10,Esophageal cancer,4069
10,Left ventricular ejection fraction,1356
10,"Blood protein levels [GFRA1, 3314_74_2]",280
10,Mean platelet volume,345636
10,Number of incorrect matches in round,32225
10,Left atrial minimum volume,984
10,Electrocardiogram morphology (amplitude at temporal datapoints) [236 ms],1691
10,Ebbinghaus illusion (underestimation),28
10,Xenical 120mg capsule | treatment/medication code,25
10,Smoking behavior [CPD],42
10,Salbutamol | treatment/medication code,1
10,FEV1,32744
10,Serum alkaline phosphatase levels,357620
10,Nonatopic asthma,228
10,Crohn's disease and psoriasis [same-effect analysis],1098
10,Electrocardiogram morphology (amplitude at temporal datapoints) [222 ms],1597
10,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),903
10,Pre-treatment viral load in HIV-1 infection,223
10,Type 2 diabetes [AA],19
10,Clopidogrel active metabolite levels,11769
10,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],5545
10,Asthma [conditional],601
10,Liver enzyme levels (gamma-glutamyl transferase),72563
10,"Blood protein levels [UROS, 11248_43_3]",3530
10,Sodium levels,37254
10,PCA3 expression level,1968
10,Chin dimples,506
10,Non-small cell lung cancer,1680
10,Contracture of palmar fascia [dupuytren's disease],11
10,"Liver, biliary or pancreas problem",6510
10,"Heel quantitative ultrasound index (qui), direct entry (right)",2968
10,White matter microstructure (mode of anisotropy) [Retrolenticular part of internal capsule],2983
10,Hip index,8610
10,Protein quantitative trait loci (liver) [HAL],271
10,Hypothyroidism (congenital or acquired),1104
10,"Blood protein levels [RBP4, 7831_39_3]",405
10,Cardiac troponin-I levels,21972
10,Epithelial ovarian cancer,4289
10,"Blood protein levels [FAS, 6248_68_3]",188
10,"Blood protein levels [GDI2, 2647_66_2]",3906
10,"Seen doctor (gp) for nerves, anxiety, tension or depression",628
10,Lung volume,3982
10,"Blood protein levels [C10orf54, 14123_34_3]",653
10,Asthma and attention deficit hyperactivity disorder,104
10,Electrocardiogram morphology (amplitude at temporal datapoints) [70 ms],11
10,Menarche (age at onset),30263
10,Adventurousness,22094
10,Triglyceride levels in current drinkers,5734
10,Serum levels of protein APOL1,7961
10,Urinary metabolite levels in chronic kidney disease [N-methylpipecolate],30640
10,"Blood protein levels [KAZALD1, 7144_234_3]",5147
10,Blood metabolite levels [propionylcarnitine],617
10,Bipolar disorder,58856
10,Hand grip strength,23571
10,Neutrophil-to-lymphocyte ratio,25262
10,None of the above | qualifications,7261
10,3-hydroxypropylmercapturic acid levels in smokers [Japanese],1396
10,D-dimer measurement,124
10,CAG-776 abundance in stool,105
10,Red blood cell count,1076000
10,Adult body size,45713
10,"""Diabetes, insuline treatment (Kela reimbursement)""",4534
10,None of the above | pain type(s) experienced in last month,1831
10,Leukocyte telomere length [East Asian],599
10,Folate pathway vitamin levels [Plasma Vitamin B12],136
10,Stroke,2614
10,Adult onset asthma or type 2 diabetes,2310
10,"Dark brown | hair colour (natural, before greying)",11360
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-12 ms],2841
10,"""Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8""",918
10,Acute pharyngitis,116
10,Fibroblastic disorders,57
10,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],9696
10,C-reactive protein levels,37944
10,"Blood protein levels [DUSP13, 6525_17_3]",4463
10,Protein quantitative trait loci (liver) [MVD],3770
10,Medication use (thyroid preparations),12023
10,"Blood pressure medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",27541
10,Colorectal cancer [East Asian],1518
10,Metabolite levels (small molecules and protein measures) [Glutamine],568
10,Self-rated health,206
10,Mild influenza (H1N1) infection,109
10,I was more restless than usual | manifestations of mania or irritability,25
10,Monocyte count,787570
10,Total body bone mineral density [European],3619
10,"""Appendicitis, broad definition""",1109
10,Atorvastatin | treatment/medication code,107
10,Ex-smoker | tobacco smoking,72085
10,Proteinuria,1186
10,Amias 2mg tablet | treatment/medication code,839
10,Metabolite levels [SM],533
10,Immune reponse to smallpox (secreted IL-1beta) [EA],607
10,TestASV_9 (Alistipes) abundance,156
10,Balding,181
10,Clozapine-to-N-desmethylclozapine metabolic ratio in schizophrenia,7383
10,Cortical surface area (MOSTest),33364
10,N6-methyllysine levels,31775
10,Mean arterial pressure x alcohol consumption interaction (2df test) [EA],886
10,Psychotic experience,81
10,Hypothyroidism and >3 levothyroxin purchases,867
10,Thrombin-induced platelet aggregation,60
10,Interferon alpha levels in systemic lupus erythematosus [EA],69
10,"Waist circumference adjusted for body mass index [EA,women]",48418
10,Diseases of the skin and subcutaneous tissue,2007
10,Blood pressure [Diastolic],21957
10,Atrial fibrillation [Japanese],899
10,Self-reported allergy,39
10,Protein quantitative trait loci (liver) [ACAD11],68
10,1-palmitoyl-2-arachidonoyl-gpc (16:0/20:4n6) levels,101
10,Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease,12
10,Educational attainment (MTAG) [MTAG],165540
10,Serum levels of protein UROS,3530
10,CD25++ CD45RA+ CD4 not regulatory T cell %CD4+ T cell,313
10,Metabolic traits [carnitine],617
10,Protein quantitative trait loci (liver) [GALE],68
10,Type 2 diabetes [South Asians],165
10,CXCL5 levels,4574
10,Electrocardiogram morphology (amplitude at temporal datapoints) [228 ms],1597
10,Height [AA],51250
10,White matter microstructure (axial diusivities) [Anterior limb of internal capsule],1587
10,"Number of operations, self-reported",3232
10,Serum levels of protein LILRB4,4863
10,Glycemic traits (pregnancy) [2HPG],1013
10,Systolic blood pressure change trajectory,171
10,Age at death,217
10,Body fat percentage and type 2 diabetes (pairwise),1708
10,Urinary metabolite levels in chronic kidney disease [X - 23776],31184
10,Lymphocyte percentage,56626
10,Diabetic retinopathy,1671
10,"Monocyte differentiation antigen CD14, soluble measurement",749
10,"Urinary metabolite levels in chronic kidney disease [N1,N12-diacetylspermine]",466
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-122 ms],781
10,Secreting CD4 regulatory T cell Absolute Count,625
10,Serum levels of protein PPY,485
10,Systemic lupus erythematosus [EA],582
10,Protein quantitative trait loci (liver) [RAB14],20
10,Feeling tense,21024
10,Brain region volumes [right putamen],2233
10,CD39 on CD39+ CD8+ T cell,14624
10,Fish- and plant-related diet [male],3403
10,Brain region volumes [right caudate],3683
10,"Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",297
10,White matter microstructure (radial diusivities) [Anterior limb of internal capsule],299
10,Protein quantitative trait loci (liver) [AKR1C3],55
10,Monocyte percentage of white cells,159270
10,Zinc | mineral and other dietary supplements,5163
10,"Blood protein levels [ASAH2, 3212_30_3]",1224
10,Protein quantitative trait loci (liver) [COQ9],188
10,Rino clenil 50micrograms nasal spray | treatment/medication code,575
10,Corneal resistance factor,299
10,Electrocardiogram morphology (amplitude at temporal datapoints) [24 ms],168
10,Protein quantitative trait loci (liver) [HSP90AB1],55
10,Urinary metabolite levels in chronic kidney disease [4-ureidobutyrate],59
10,Cigarettes smoked per day (MTAG),7166
10,Insomnia symptoms (never/rarely vs. sometimes/usually),3038
10,"Blood protein levels [EA, Proto-oncogene tyrosine-protein kinase receptor Ret]",1063
10,Cystatin C levels,110725
10,Protein levels in obesity [Calpastatin],8228
10,Migraine and/or pulse pressure,2302
10,High density lipoprotein cholesterol levels [EA],1143
10,6mm regularity index (right),26
10,Renal underexcretion gout,9591
10,Spherical equivalent (joint analysis main effects and education interaction),5680
10,Dengue shock syndrome,4069
10,SAPHO syndrome,213
10,Myopia (age of diagnosis),10551
10,A body shape index,32229
10,Serum levels of protein ARL3,8816
10,Serum levels of protein IL15RA,1365
10,Life satisfaction,959
10,X-23639 levels,554
10,Gut microbiota (functional units) [PWY-6395_superpathway_of_seleno-compound_metabolism],20
10,Brain region volumes [right cerebellum exterior],3585
10,Melanocytic naevi of scalp and neck,1422
10,Chronic obstructive pulmonary disease x ever smoker interaction (main effect),2788
10,Nonsyndromic cleft lip,504
10,Body mass index (joint analysis main effects and smoking interaction),119
10,None of the above | mouth/teeth dental problems,42
10,Left planum temporale grey matter volume,16
10,Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes [AA],30
10,Low tan response,28
10,Hirschsprung disease,44863
10,Intraocular pressure,35170
10,Gamma glutamyl transferase levels,176084
10,DNA methylation Hannum age acceleration,8137
10,Left ventricular global circumferential strain,351
10,Estrogen receptor status in breast cancer,249
10,Insomnia symptoms (never/rarely vs. usually),3038
10,CD39+ activated CD4 regulatory T cell %CD4 regulatory T cell,30645
10,Brain region volumes [right precentral],3240
10,Protein quantitative trait loci (liver) [ABAT],10
10,Wheeze or whistling in the chest in last year,38
10,CD25 on IgD+ CD38- B cell,212
10,Protein quantitative trait loci (liver) [ORM2],16
10,CD25 on IgD+ CD24- B cell,212
10,Menopause (age at onset) [japanese],633
10,"Age hay fever, rhinitis or eczema diagnosed",50451
10,Survival in sporadic amyotrophic lateral sclerosis,2948
10,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) [5 degree of freedom test]",420
10,Protein quantitative trait loci (liver) [FKBP4],55
10,Chronotype,32348
10,Mean corpuscular hemoglobin [Asian],28995
10,None of the above | mineral and other dietary supplements,4547
10,Glycated hemoglobin levels,7882
10,Heel bone mineral density (bmd) (right),2903
10,"Blood protein levels [SPOCK2, 5491_12_3]",4648
10,Interleukin-2 receptor antagonist levels,1156
10,Muesli | cereal type,24
10,"""Collapsed vertebra, not elsewhere classified""",6
10,Carotid intima media thickness [Age-sex-adjusted],9
10,Obesity,4
10,Arsenic metabolism [DMA%],8266
10,Homocysteine levels,12575
10,"""Other dorsopathies, not elsewhere classified""",6923
10,Fasting blood glucose (BMI interaction),226
10,"Atopic dermatitis [EA, fixed effects]",14
10,Plasma factor V levels in venous thrombosis,65
10,Self-reported math ability (MTAG) [MTAG],36945
10,Cortical surface area (global PC1) [EA],7261
10,Serum levels of protein CAMK1,697
10,Heart rate response to recovery post exercise (10 sec),123
10,"""Type 2 diabetes, wide definition""",3992
10,Salad / raw vegetable intake,3439
10,Schizophrenia vs type 2 diabetes,119
10,Glaucoma (primary open-angle),26899
10,Trunk predicted mass,197571
10,Cancer (pleiotropy),6074
10,Protein quantitative trait loci (liver) [CP],28
10,Vertical cup-disc ratio (multi-trait analysis),19209
10,None of the above | vascular/heart problems diagnosed by doctor,32150
10,Myopia,7271
10,Leprosy,471
10,Electrocardiogram morphology (amplitude at temporal datapoints) [0 ms],8929
10,Pulse wave arterial stiffness index,118
10,Immune response to smallpox vaccine (IL-6) [Hispanic],54
10,Body mass index [Japanese],30746
10,Adenine levels,1448
10,Help-seeking from a GP,151
10,Dilated cardiomyopathy,351
10,Male puberty timing (late vs. average onset facial hair),56
10,"""Sleep apnoea, including avohilmo""",43
10,Insulin-like growth factor 1 levels,128330
10,Hypothyroidism or myxedema,7858
10,Serum levels of protein GSTO1,7575
10,Alzheimer's disease or family history of Alzheimer's disease,5887
10,Clostridium S felsineum abundance in stool,76
10,Serum levels of protein CCL17,60
10,Noncognitive aspects of educational attainment,92117
10,Ascending aorta minimum area,34736
10,Facial attractiveness (female raters),908
10,Breast cancer [conditional],102
10,6mm strong meridian (right),29411
10,Mild age-related type 2 diabetes,119
10,Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in non-secretors,244
10,Phospholipid levels (plasma) [levels],25
10,Benign prostatic hyperplasia and lower urinary tract symptoms,18909
10,Serum metabolite levels [glycocholenate sulfate*],3580
10,"Systolic blood pressure x alcohol consumption interaction (2df test) [EA, Hispanic]",205
10,Vogt-Koyanagi-Harada syndrome,240
10,Spherical equivalent or myopia (age of diagnosis),56836
10,Sleeplessness / insomnia,27532
10,Schizophrenia [EA],34785
10,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),4446
10,White matter microstructure (radial diusivities) [Average across all tracts],2458
10,Spontaneous other cephalic | delivery methods,152
10,Gabapentin | treatment/medication code,284
10,Breast cancer | illnesses of mother,472
10,"Chickenpox | non-cancer illness code, self-reported",423
10,Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis),310
10,Doctor diagnosed asthma,217
10,"Autism, asperger's or autistic spectrum disorder | mental health problems ever diagnosed by a professional",624
10,Fasting glucose adjusted for BMI,28
10,Influenza A (H1N1) infection,14
10,Alanine aminotransferase levels,575577
10,Blood pressure [Pulse Pressure],23767
10,Retinopathy x type 2 diabetes interaction,376
10,Urinary albumin-to-creatinine ratio in diabetes,876
10,6mm asymmetry index (left),1931
10,Aortic vascular smooth muscle cell calcification in response to osteogenic stimuli [calcification (osteogenic media],137
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-22 ms],1248
10,Type 2 diabetes [obese],119
10,Getting up in morning,2922
10,Whole body fat mass,62056
10,"Hypothyroidism/myxoedema | non-cancer illness code, self-reported",7891
10,Glaucoma (primary angle closure) [Asian],391
10,Triglycerides [EA],6261
10,Severe insulin-deficient type 2 diabetes,119
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-96 ms],13674
10,Neuropsychiatric disorders,23767
10,Left ventricular global radial strain,351
10,Glucosuria (moderate to severe),119
10,Serum metabolite levels (CMS) [IDL_FC],49
10,Waist circumference adjusted for BMI (adjusted for smoking behaviour) [women],48021
10,Stable angina pectoris,44785
10,"Non-infective hepatitis | non-cancer illness code, self-reported",355
10,Vertical cup-disc ratio (adjusted for vertical disc diameter),16907
10,Urate levels [women],2238
10,Liver enzyme levels [ALP],8821
10,Brain region volumes [total brain volume],14536
10,Macular degeneration (senile) of retina nos,1059
10,Benign neoplasm: Sigmoid colon,76
10,X-21733 levels,353
10,Inflammatory biomarkers [hsCRP-IL6 pattern prefenofibrate],147
10,"Cholesterol lowering medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",119
10,"Disorders of muscle, ligament, and fascia",36
10,Glycerophospholipid levels [lysoPhosphatidylcholine acyl C16:1],25
10,Mean platelet (thrombocyte) volume,139512
10,Multiple myeloma,355
10,Reticulocyte percentage,80393
10,Nasopharyngeal carcinoma (SNP x SNP interaction),2232
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-84 ms],781
10,Electrocardiogram morphology (amplitude at temporal datapoints) [232 ms],1597
10,5-methylthioadenosine (mta) levels,382
10,CAG-776 sp000438195 abundance in stool,105
10,Type 2 diabetes [DGI+FUSION+WTCCC],2648
10,White matter hyperintensity volume (adjusted for hypertension),6533
10,Ascorbic acid 3-sulfate levels,1257
10,Serum metabolite levels [propyl 4-hydroxybenzoate sulfate],2432
10,Age-related macular degeneration (extreme sampling),1059
10,Protein quantitative trait loci (liver) [MGMT],264
10,Fatty acid(16:1)_[M-H]1- levels,50
10,Cannabis dependence symptom count [AA],30
10,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)",23956
10,CD25 on CD39+ CD4+ T cell,30962
10,CD39 on CD39+ CD4+ T cell,31234
10,Basal metabolic rate,177646
10,Scoliosis,590
10,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],676
10,Urinary metabolite levels in chronic kidney disease [diacetylspermidine],385
10,"Blood protein levels [DKK4, 3365_7_2]",134
10,Heel bone mineral density (bmd),23291
10,CD25++ CD45RA- CD4 not regulatory T cell Absolute Count,625
10,Non-hodgkin's lymphoma in HIV infection,48
10,Aloe vera product | treatment/medication code,3
10,Cutaneous melanoma or hair colour,12600
10,Menorrhagia,4674
10,FSC-A on Natural Killer T,1523
10,Malignant neoplasm of prostate,218
10,B cell acute lymphoblastic leukaemia (hyperdiploid negative),209
10,Diverticular disease,7561
10,Hay fever and/or eczema,53670
10,"Blood pressure [EA, MAP, Age 50-59]",49815
10,"Systolic blood pressure [EA, initial]",24866
10,Daytime dozing / sleeping (narcolepsy),838
10,IgA levels,61
10,Gut microbiota abundance (genus Ruminococcaceae UCG013 id.11370),8
10,Age high blood pressure diagnosed,22598
10,Number of self-reported cancers,2774
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-152 ms],1098
10,Protein quantitative trait loci (liver) [DHTKD1],1225
10,Serum metabolite ratios in chronic kidney disease [Valine/Propionylcarnitine],188
10,Serum levels of protein C10orf54,1306
10,Electrocardiogram morphology (amplitude at temporal datapoints) [246 ms],1691
10,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA],210
10,Serum metabolite levels [palmitoleate (16:1n7],25
10,"Pulse rate, automated reading",71933
10,Rheumatoid arthritis (ACPA-positive),1508
10,Morning person,2176
10,Ovarian cancer [All invasive],3768
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-116 ms],781
10,Pentraxin-related protein PTX3 levels,269
10,Interleukin-27 levels,9966
10,Protein quantitative trait loci (liver) [FDPS],3770
10,Fractures,382
10,Blond vs. brown/black hair color,42942
10,Mean arterial pressure [Japanese],22445
10,Electrocardiogram morphology (amplitude at temporal datapoints) [216 ms],10512
10,"""Excessive, freguent and irrelgular menstruation""",1482
10,"Other (e.g. cornflakes, frosties) | cereal type",5367
10,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) [women],2833
10,"Blood protein levels [SIRT2, 5030_52_1]",490
10,Mild to moderate chronic kidney disease,170
10,Depressive symptoms,24833
10,Body mass index and coronary artery disease (pairwise),22789
10,Blood metabolite levels [X-14473],7383
10,Percent liver fat,560
10,Hypertension [East Asian],23358
10,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)",30255
10,Atrial fibrillation/atrial flutter,12721
10,Prostate-specific antigen levels (conditioned on lead SNPs) [conditional on Round 1 SNPs],17733
10,Hypospadias,17
10,Non-albumin protein levels,7896
10,Dental caries [DMFS2],386
10,Heart disease | illnesses of mother,218
10,Mental disorder (without autoimmune disease),655
10,Age-related hearing impairment [additive],575
10,Primary biliary cirrhosis,5773
10,Coagulation Factor X measurement,6278
10,Protein quantitative trait loci (liver) [HMGCS1],3770
10,Colorectal cancer,44330
10,Schizophrenia vs ADHD (ordinary least squares (OLS)),37746
10,Lymphocyte count,12011
10,Protein quantitative trait loci (liver) [WARS],578
10,Essential hypertension (time to event),3608
10,Facial morphology (segment 34),243
10,Facial pigmentation measurement (UV light),28
10,Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid),6112
10,Plasma factor VII activating protease levels,151
10,Mood swings,151
10,Automobile speeding propensity,192
10,Pattern 4 | hair/balding pattern,15689
10,Age when periods started (menarche),7616
10,Smoking behaviour (cigarettes smoked per day),2649
10,HDL cholesterol levels in current drinkers,835
10,Colon polyp,354
10,Miserableness,168
10,Diabetes mellitus in pregnancy,119
10,CD25 on CD39+ activated CD4 regulatory T cell,14680
10,Serum levels of protein C1QC,123
10,Electrocardiogram morphology (amplitude at temporal datapoints) [16 ms],918
10,Serum levels of protein MINPP1,765
10,"Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",297
10,Serum metabolite levels [acetylcarnitine (C2],181
10,Periventricular white matter hyperintensities,4309
10,Platelet crit,123063
10,Serum levels of protein GFRA1,280
10,Platelet-to-lymphocyte ratio,14087
10,"Medication use (adrenergics, inhalants)",3052
10,Inflammatory bowel disease [Adult],3393
10,Type 2 diabetes [Japanese],5802
10,Serum levels of protein SIRT2,735
10,Femur bone mineral density x serum urate levels interaction [female],1248
10,Duration to first press of snap-button in each round,12
10,Smoking initiation (ever regular vs never regular) (MTAG),101872
10,Plasma pyridoxal phosphate to pyridoxal ratio,31775
10,Medication use (beta blocking agents),46509
10,Place of birth in uk - east co-ordinate,137
10,"Osteomyelitis | non-cancer illness code, self-reported",69
10,Fatty acid desaturase activity (adipose tissue) [SCD],25
10,Frequency of stair climbing in last 4 weeks,66162
10,Brain region volumes [right hippocampus],5006
10,Ankylosing spondylitis,931
10,Dry age-related macular degeneration (includes geographic atrophy),1059
10,"""Hypertension complicating pregnancy, childbirth, and the puerperium""",301
10,Pancreas fat,153
10,Serum levels of protein CDH7,65
10,Granulocyte count,35336
10,Average weekly beer plus cider intake,3743
10,Liver enzyme levels (alkaline phosphatase),80098
10,Malignant neoplasm of digestive organs (controls excluding all cancers),355
10,Achilles tendon injury,4040
10,DNA methylation GrimAge acceleration,482
10,Facial pigmentation measurement (polar light),28
10,Mean reticulocyte volume,367968
10,"Urinary metabolites (H-NMR features) [2.7125, Unknown]",31775
10,Heart disease | illnesses of father,1042
10,Hypertensive diseases,26077
10,Body mass index and systole blood pressure (pairwise),23362
10,Non-glioblastoma glioma,5151
10,Relative brain age,1446
10,CD39+ CD8+ T cell Absolute Count,30962
10,Serum levels of protein MMP8,697
10,Activated & secreting CD4 regulatory T cell Absolute Count,625
10,Plasma clozapine-norclozapine ratio in treatment-resistant schizophrenia,7383
10,Medication use (calcium channel blockers),82762
10,Dorsalgia,5695
10,Protein quantitative trait loci [CAMK1],619
10,Fluid intelligence score,8212
10,Systolic blood pressure x alcohol consumption interaction (2df test) [EA],868
10,Electrocardiogram morphology (amplitude at temporal datapoints) [26 ms],168
10,Vitamin D levels,27666
10,Asthma (childhood onset),6999
10,Fractures (paediatric),320
10,Eosinophil percentage of white cells,69254
10,Ease of skin tanning,17009
10,C-X-C motif chemokine 1 levels,6112
10,"Mean arterial pressure x alcohol consumption interaction (2df test) [AA, EA]",562
10,Hirschsprung disease [European],3521
10,CD25++ CD4+ T cell Absolute Count,625
10,TPE interval (resting) [women],45
10,Medication use (glucocorticoids),42
10,Glucuronate levels,125
10,Diverticulosis,7055
10,Total protein levels x insomnia interaction,1973
10,Diabetes | illnesses of mother,4291
10,Electrocardiogram morphology (amplitude at temporal datapoints) [92 ms],351
10,Diastolic blood pressure [EA],444
10,Blood urea nitrogen levels,74443
10,Positive affect,1322
10,Personality traits in bipolar disorder [TCI-ST1],672
10,Urinary albumin excretion,2112
10,Gut microbiota (bacterial taxa) [Lactobacillales order],100
10,QRS complex (Cornell) [EA],7
10,Total testosterone levels,293420
10,Impedance of whole body,86766
10,QRS duration [EA],925
10,interleukin 15 receptor subunit alpha levels,81
10,Protein quantitative trait loci (liver) [PSMD3],68
10,Left atrial maximum volume,984
10,Immature reticulocyte fraction,122884
10,"Cardiac hypertrophy [additive, recessive]",2758
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-104 ms],849
10,"""Abnormal blood-pressure reading, without diagnosis""",1157
10,"Allergy, hypersensitivity or anaphylaxis",39
10,Triglyceride levels x loop diuretics use interaction,29
10,Hearing difficulty/problems with background noise,102
10,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),6410
10,Mean corpuscular haemoglobin,163835
10,Chronic obstructive pulmonary disease in never smokers,2788
10,Ascorbate (vitamin c) levels,1899
10,Blood metabolite levels [X-02269],2186
10,CD25++ CD45RA- CD4 not regulatory T cell %CD4+ T cell,625
10,"""Inflammatory bowel disease, strict (require KELA)""",878
10,Leg | fractured bone site(s),248
10,Dorea abundance in stool,62
10,Intracranial aneurysm,22982
10,Eosinophil counts,455193
10,Estimated glomerular filtration rate,361335
10,Ankle spacing width,29266
10,Time to complete round,2782
10,Corrected insulin response,2024
10,Freckles,2970
10,Ewing sarcoma,507
10,Body mass index (change over time) in gastrointestinal cancer,12
10,Cytokine levels [VEGF-A],6131
10,Type 2 diabetes [conditional],23299
10,Time spent watching television (tv),5530
10,Lodine 200mg tablet | treatment/medication code,526
10,Cerebral aneurysm,7
10,Amyotrophic lateral sclerosis (sporadic),150
10,Flax oil tablet | treatment/medication code,6
10,Blood metabolite levels [X-12093],31184
10,Heart rate response to recovery post exercise (30 sec),516
10,Childhood sunburn occasions,28
10,Myo-inositol levels,827
10,Iron product | treatment/medication code,531
10,Gtn 400micrograms spray | treatment/medication code,285
10,Bacterial infection,294
10,Drive faster than motorway speed limit,199
10,Hypertrophic cardiomyopathy (MTAG),7845
10,CD25++ CD45RA- CD4 not regulatory T cell %T cell,625
10,"None of the above | medication for pain relief, constipation, heartburn",276
10,Vertex-wise cortical thickness,157455
10,"Hayfever, allergic rhinitis or eczema | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",26372
10,Neuroblastoma or malignant cutaneous melanoma,2603
10,Fresh fruit intake,4062
10,Protein quantitative trait loci (liver) [ECHDC3],1021
10,Corrected insulin response adjusted for insulin sensitivity index,921
10,C-reactive protein levels or HDL-cholesterol levels (pleiotropy),6131
10,Medication use (vasodilators used in cardiac diseases),43757
10,6mm weak meridian (left),32589
10,Rheumatoid arthritis [conditional on rs3134883],244
10,White matter microstructure (axial diusivities) [Posterior limb of internal capsule],3773
10,"Fracture foot | non-cancer illness code, self-reported",296
10,Simvador 10mg tablet | treatment/medication code,525
10,Serum levels of protein NID1,65
10,Serum levels of protein LIPN,4247
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-94 ms],13425
10,White matter microstructure (radial diusivities) [Fornix (column and body],3773
10,Other/unspecified seropositiverheumatoid arthritis,686
10,Pulmonary function [FEV1/FVC],2788
10,Blood metabolite levels [X-11381],617
10,Serum levels of protein CRTAC1,286
10,C_Clostridia abundance,72
10,Liver enzyme levels [ALT],14942
10,Brain region volumes [left insula],3448
10,Total hippocampal volume,6798
10,Type 2 diabetes or prostate cancer (pleiotropy),10830
10,FSC-A on Natural Killer,1674
10,Electrocardiogram morphology (amplitude at temporal datapoints) [248 ms],1691
10,Essential tremor,665
10,Chronic obstructive pulmonary disease x current smoker interaction (2df),2862
10,"Blood protein levels [NRP1, 3214_3_2]",456
10,"Nasal polyps | non-cancer illness code, self-reported",45
10,Platelet aggregation [ephinephrine low 1],71
10,Spherical equivalent,21035
10,Brain morphology (min-P),11116
10,"Diastolic blood pressure [EA, initial]",24866
10,DVT of lower extremities and pulmonary embolism,1668
10,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),1765
10,CD25 on CD45RA+ CD4 not regulatory T cell,313
10,Emotional dysregulation [Males],169
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-100 ms],13357
10,Lobe attachment (rater-scored or self-reported),399
10,Metabolic traits [SM-13],4731
10,Anorexia nervosa,10720
10,Electrocardiogram morphology (amplitude at temporal datapoints) [214 ms],10512
10,Pulmonary heart disease,1326
10,Cystic kidney disease,101
10,Protein quantitative trait loci (liver) [POLR2H],15
10,"Chronic fatigue syndrome | non-cancer illness code, self-reported",25
10,Coronary artery disease,204071
10,White blood cell count,982788
10,Apolipoprotein B levels,10938
10,CD25 on CD39+ CD4 regulatory T cell,14680
10,Heel bone mineral density T score,75872
10,Arm fat mass (left),30163
10,Neutrophill count,125514
10,Heart disease | illnesses of siblings,2608
10,Renal cell carcinoma,2458
10,Electrocardiogram morphology (amplitude at temporal datapoints) [256 ms],1691
10,Problematic alcohol use,443
10,General factor of neuroticism,151
10,Protein quantitative trait loci (liver) [PSMD13],68
10,Body mass index (joint analysis main effects and physical activity interaction),8618
10,Number of treatments/medications taken,1152
10,Alopecia areata,626
10,Reticulocyte fraction of red cells,239564
10,Triglycerides x physical activity interaction (2df test),6261
10,Refractive error,96388
10,Accelerometer-based physical activity measurement (average acceleration),3768
10,Urinary microalbumin levels,1186
10,Left–right brain asymmetry,16
10,High light scatter reticulocyte count,571642
10,Household income (MTAG),11830
10,"Smoking initiation (ever regular vs never regular) [Conditioned on chr10:104852121, chr10:103960351, chr10:104640052]",28410
10,Electrocardiogram morphology (amplitude at temporal datapoints) [196 ms],8915
10,Ulcerative colitis,15080
10,"For short-sightedness, i.e. only or mainly for distance viewing such as driving, cinema etc (called 'myopia') | reason for glasses/contact lenses",852
10,White matter microstructure (mean diusivities) [Superior longitudinal fasciculus],2458
10,Serum albumin levels,30623
10,Blood protein levels [CXCL5],32658
10,Cancer,2956
10,Cortical surface area [total],10324
10,Prostate-specific antigen levels (conditioned on lead SNPs) [conditional on Round 2 SNPs],45
10,"Type 2 diabetes [South Asians, East Asians]",165
10,Age at first live birth,172
10,Regular attendance at a pub or social club,24
10,Leg predicted mass (left),155703
10,Heart failure,5450
10,Average weekly red wine intake,589
10,Thoracic aortic aneurysms [fine-mapped],311
10,"Arthritis (nos) | non-cancer illness code, self-reported",16
10,Protein quantitative trait loci (liver) [AGXT2],13
10,Electrocardiogram morphology (amplitude at temporal datapoints) [194 ms],2342
10,Hip bone mineral density and total body fat mass (bivariate analysis),1050
10,"""Seropositive rheumatoid arthritis, wide""",697
10,"Blood protein levels [EA, Neutral ceramidase]",526
10,HDL cholesterol,62568
10,Age at first sexual intercourse,118024
10,Trunk fat mass,73925
10,"Blood protein levels [LILRB4, 6453_70_3]",1613
10,Heart rate response to recovery post exercise [males],374
10,Other cataract,988
10,Time spend outdoors in summer,2363
10,Bladder neck obstruction,278
10,B cell acute lymphoblastic leukaemia (normal cytogenetics),209
10,Morning/evening person (chronotype),364
10,BMI in non-smokers [men],119
10,Calcium levels,99142
10,Atrial fibrillation [EA],22942
10,Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS)),965
10,Diastolic blood pressure [East Asian],2330
10,Pulmonary embolism with or without deep venous thrombosis,1266
10,Intrahepatic Cholestasis of Pregnancy (ICP),780
10,Age-related macular degeneration (MTAG),92
10,Crisp intake,1
10,Keratoconus,10690
10,"Forced expiratory volume in 1-second (fev1), predicted percentage",11356
10,Childhood gender nonconformity,1861
10,Spherical power (left),9122
10,Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA],1331
10,High-sensitivity cardiac troponin T levels (MTAG),351
10,"Other professional qualifications eg: nursing, teaching | qualifications",106
10,Glomerular filtration rate,31986
10,Intracranial volume,18039
10,Platelet reactivity in response to clopidogrel treatment,14748
10,Subcortical volume (MOSTest),88627
10,Metabolite levels [Caprolactam],17795
10,"Blood protein levels [GSTO1, 12436_84_3]",7575
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-24 ms],230
10,DVT of lower extremities,1668
10,Body mass index x sex x age interaction (4df test),84
10,Smoking status,81191
10,Pulse pressure x alcohol consumption interaction (2df test) [EA],7892
10,Comparative body size at age 10,2115
10,Disorders of the thyroid gland,1338
10,Childhood onset type 2 diabetes,719
10,Osteoarthritis of the hip or knee (with total joint replacement),61
10,Protein quantitative trait loci (liver) [AGT],24
10,Blood metabolite levels [stearate (18:0],25
10,Dentate gyrus molecular layer volume (corrected for total hippocampal volume),6798
10,Carpal tunnel syndrome,5080
10,Hematological or dermatological disease,366
10,Acisoga levels,4642
10,Bone fracture in osteoporosis,243
10,Headache | pain type(s) experienced in last month,2118
10,Sodium in urine,10540
10,"Waist-to-hip ratio adjusted for body mass index [EA, women]",3533
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-8 ms],2670
10,Butyrate (4:0) levels,1533
10,Age spots,25
10,"Red blood cell traits [EA, MCV]",34209
10,White matter microstructure (mode of anisotropy) [Superior corona radiata],3382
10,Albuminuria,1186
10,"""Endocrine, nutritional and metabolic diseases""",131
10,Resistance to Mycobacterium tuberculosis infection,138
10,Protein quantitative trait loci (liver) [TXNL1],31
10,Neutrophil percentage of white cells,141055
10,Factor VII activity [EA],5909
10,Serum metabolite levels [arginine],26430
10,Oily fish consumption,4001
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-124 ms],5057
10,Serum metabolite levels [carnitine],1809
10,Electrocardiogram morphology (amplitude at temporal datapoints) [218 ms],1597
10,Finngen Rheumatological endpoints,265
10,Serum levels of protein VWA2,7233
10,Certain disorders involving the immune mechanism,2741
10,Type 2 diabetes [Punjabi Sikhs],165
10,Blood metabolite levels [hexanoylcarnitine],188
10,Gout [EA],188
10,Haematocrit percentage,48061
10,von Willebrand factor A domain-containing protein 2 measurement,5486
10,Meat-related diet,78
10,Glucosamine/chondroitin  | vitamin and/or mineral supplement use,42
10,Lung function (low FEV1 vs high FEV1),88
10,Serum levels of protein REG1A,6957
10,Urinary albumin-to-creatinine ratio,10757
10,Instant coffee | coffee type,6543
10,Warfarin | treatment/medication code,2016
10,"Type 2 diabetes [South Asian, East Asian, Europeans]",165
10,Platelet count,692122
10,Impedance of arm (right),46928
10,Red blood cell (erythrocyte) count,86525
10,"Blood protein levels [PNLIPRP2, 6957_14_3]",396
10,Open wound of neck,709
10,Colorectal cancer (controls excluding all cancers),111
10,Heart rate response to recovery post exercise (20 sec),20
10,Body size at age 10,13083
10,Tense / 'highly strung',19164
10,"Pulse pressure [EA, initial]",23536
10,Crohn's disease,91133
10,Optic disc area [Asian],8607
10,Direct low density lipoprotein cholesterol levels,32962
10,Diverticulosis and diverticulitis,6453
10,Progranulin levels,2143
10,Glucosuria,119
10,Menopause (age at onset),5350
10,CD3 on CD39+ activated CD4 regulatory T cell,13981
10,C-X-C motif chemokine 16 levels,956
10,Heart rate response to recovery post exercise (40 sec),516
10,Electrocardiogram morphology (amplitude at temporal datapoints) [36 ms],7
10,Electrocardiogram morphology (amplitude at temporal datapoints) [44 ms],7
10,Aspartate aminotransferase levels,236963
10,Facial ageing,5201
10,CD25 on CD45RA- CD4 not regulatory T cell,625
10,6mm asymmetry index (right),1816
10,"Osteopenia | non-cancer illness code, self-reported",760
10,Asthma (only as main-diagnosis),39
10,QRS complex (Sokolow-Lyon) [EA],123
10,Liver enzyme levels (alanine transaminase),78008
10,Feeling nervous,73055
10,Balding type 1,17746
10,Circulating leptin levels or type 2 diabetes,1308
10,Serum levels of protein FAM174A,338
10,Electrocardiogram morphology (amplitude at temporal datapoints) [20 ms],918
10,Electrocardiogram morphology (amplitude at temporal datapoints) [126 ms],75
10,Health satisfaction,161
10,CD25 on IgD- CD27- B cell,212
10,Educational attainment (years of education),139275
10,Eosinophill percentage,37188
10,CD25 on IgD+ CD38+ B cell,212
10,"Red blood cell traits [EA, Hgb]",222
10,Alzheimer's disease (late onset),167
10,Autism spectrum disorder or schizophrenia,39886
10,Colorectal cancer or advanced adenoma,8270
10,Hippocampal subfield CA4 volume,6798
10,Cortical surface area [Posterior Cingulate],6798
10,No | hearing difficulty/problems,373
10,Protein quantitative trait loci (liver) [MAP4],99
10,Meralgia paraesthetica,5
10,HDL cholesterol levels x short total sleep time interaction (2df test),5757
10,Cortical thickness,96315
10,Brain region volumes [right insula],3486
10,High blood pressure | vascular/heart problems diagnosed by doctor,32169
10,Serum levels of protein RIPK2,2017
10,Phlebitis and thrombophlebitis,1772
10,Benign neoplasms (controls excluding all cancers),2582
10,Disc degeneration (lumbar),1509
10,Diseases of male genital organs,19
10,Alanine transaminase levels in high alcohol intake,15891
10,Brain region volumes [left putamen],3243
10,Serum metabolite levels [propionylcarnitine (C3],181
10,Protein quantitative trait loci [MBL],195
10,Age-related hearing impairment (MTAG),634
10,Protein quantitative trait loci (liver) [TAGLN],131
10,"Urinary metabolites (H-NMR features) [2.8725, Trimethylamine]",142
10,Planum temporale asymmetry index,16
10,Optic cup area [EA],11571
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-88 ms],849
10,Type 2 diabetes [All Punjabi],165
10,Irritability,64
10,Eosinophil percentage of granulocytes,14430
10,"Urinary metabolites (H-NMR features) [2.8675, Trimethylamine]",31775
10,Leg fat-free mass (right),157592
10,"Squamous cell carcinoma | cancer code, self-reported",171
10,Sex hormone-binding globulin levels [Women],6512
10,Progesterone levels,22298
10,High light scatter reticulocyte percentage,84499
10,Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis),889
10,Acenocoumarol maintenance dosage,6184
10,Colorectal cancer [EA],287
10,Photic sneeze reflex,587
10,Olanzapine | treatment/medication code,103
10,Diastolic blood pressure x alcohol consumption interaction (2df test) [EA],868
10,CD39+ resting CD4 regulatory T cell %CD4 regulatory T cell,14495
10,"Intra-ocular pressure, goldmann-correlated (left)",1665
10,Chronic obstructive pulmonary disease in non-current smokers,2862
10,Serum metabolite ratios in chronic kidney disease [Lysophosphatidylcholine with acyl residue C16:0/Lysophosphatidylcholine with acyl residue C16:1],25
10,Triglycerides,81435
10,Testosterone levels,72547
10,Monocyte percentage,31567
10,LDL cholesterol levels [Trans-ethnic initial],1095
10,Clinically amyopathic dermatomyositis [Japanese],2021
10,Spherical equivalent [EA],6797
10,Serum prostate-specific antigen levels,2186
10,Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis),806
10,Systolic blood pressure x smoking status (ever vs never) interaction (2df test),960
10,Age-related hearing impairment [recessive],260
10,Chlamydia trachomatis momp D antibody levels,71
10,Brown vs. black hair color,969
10,Esophageal squamous cell carcinoma,4069
10,hemolysis of donated blood (osmotic),444
10,Arthrosis,242
10,"Kidney/renal cell cancer | cancer code, self-reported",202
10,Co-amilofruse | treatment/medication code,152
10,Myocardial infarction,94121
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-140 ms],5057
10,Protein quantitative trait loci (liver) [PRTN3],228
10,Cancer (pleiotropy) [subset analysis],249
10,High density lipoprotein cholesterol levels,27657
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-110 ms],13721
10,Impedance of arm (left),61770
10,Depressive symptoms (MTAG),721
10,Breast cancer (estrogen-receptor negative),502
10,Serum levels of protein PNLIPRP1,144
10,CD40 on monocytes,146
10,Protein quantitative trait loci (liver) [CRK],189
10,Protein quantitative trait loci (liver) [GPX4],68
10,Bronchial neuroendocrine tumor,2
10,Hypertension [Japanese],22560
10,CD3 on HLA DR+ CD4+ T cell,477
10,Frailty index,137
10,Electrocardiogram morphology (amplitude at temporal datapoints) [170 ms],45
10,Insulin-degrading enzyme measurement,803
10,Pediatric autoimmune diseases,3058
10,CD39 on granulocyte,5238
10,Blood metabolite levels [butyrylcarnitine],188
10,Autism spectrum disorder (MTAG),886
10,Coronary atherosclerosis,360
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-128 ms],5057
10,Thrombin measurement,5879
10,Ankle spacing width (right),711
10,Other maternal disorders predominantly related to pregnancy,165
10,Otosclerosis,239
10,Reticulocyte count,443883
10,Educational attainment (years of education) [conditional-joint],37833
10,Electrocardiogram morphology (amplitude at temporal datapoints) [8 ms],2355
10,Spleen volume,1798
10,Crohn disease,976
10,"""Malignant neoplasm of breast, HER2-negative""",335
10,MGMT methylation in smokers,115
10,Colorectal cancer (diet interaction) [Processed meat],222
10,Motion sickness,184
10,Protein quantitative trait loci (liver) [BHMT],11
10,Serum metabolite levels [X-11787],34114
10,"""Hypertension, essential""",25550
10,High-sensitivity cardiac troponin I concentration,18053
10,Protein quantitative trait loci (liver) [ACLY],1718
10,Serum metabolite levels (CMS) [IDL_C],49
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-90 ms],849
10,Blood metabolite levels [X-12798],188
10,Nasal polyp,39
10,Type 2 diabetes with peripheral circulatory complications,119
10,Bowel cancer | illnesses of adopted father,115
10,Body mass index and type 2 diabetes (pairwise),119
10,Medication use (diuretics),9566
10,"Urinary metabolites (H-NMR features) [1.7775, Unknown]",17795
10,Undefined dementia,6
10,Cortical surface area [Insula],5516
10,Urinary metabolite levels in chronic kidney disease [X - 16087],2186
10,B-cell acute lymphoblastic leukaemia,5572
10,X-24295 levels,473
10,Neutrophil percentage of granulocytes,13492
10,Comparative height size at age 10,197504
10,Frequency of other exercises in last 4 weeks,685
10,Serum levels of protein KAZALD1,5355
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-10 ms],2670
10,Glucose levels,1933
10,Heart rate increase in response to exercise,516
10,Birth length (MTAG),2353
10,Insulin-related traits [IR],141
10,Bone properties (heel) [VOS],191
10,Protein quantitative trait loci (liver) [PLD3],134
10,CD4 regulatory T cell %T cell,133
10,"Insulin | medication for cholesterol, blood pressure or diabetes",119
10,Past tobacco smoking,39420
10,Birth weight (MTAG),25857
10,Childhood ear infection,850
10,White matter microstructure (global fractional anisotropy),1830
10,"Asthma [EA, adjusted for allergy status]",329
10,Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels) [S-DCT/S-CT ratio],7495
10,Urinary metabolite levels in chronic kidney disease [X - 12112],31184
10,Serum levels of protein GDI2,3720
10,Morningness,1095
10,Phlebitis and thrombophlebitis of lower extremities,1772
10,Year ended full time education,3201
10,"Metabolite levels [Gln, His]",568
10,"""Malignant neoplasm of breast, HER2-negative (controls excluding all cancers)""",335
10,B cell acute lymphoblastic leukaemia (Philadelphia chromosome negative),209
10,CD39 on CD39+ secreting CD4 regulatory T cell,30917
10,Hand grip strength (left),85959
10,Creatinine (enzymatic) in urine,3866
10,Abdominal aortic aneurysm,2608
10,Corneal resistance factor (left),2311
10,Disease progression in age-related macular degeneration,1059
10,Type 2 diabetes with ketoacidosis,12
10,Lifespan [females],3728
10,Salt added to food,17264
10,"Soluble interleukin-2 receptor subunit alpha [EA, conditioned on rs7911500]",942
10,Fish- and plant-related diet [female],5940
10,Cooked vegetable intake,720
10,Disorders of lens,995
10,Venous thromboembolism (SNP x SNP interaction),1648
10,Homeostasis model assessment of insulin resistance in less-fat diet,59
10,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test) [African],335
10,Type 2 diabetes [Indo-European South Asians],239
10,Intelligence,25447
10,Arsenic metabolism [percent dimethylarsinate],44589
10,Trimethylamine levels,31775
10,Propionibacterium freudenreichii abundance in stool,784
10,White matter microstructure (radial diusivities) [Posterior corona radiata ],321
10,Serum creatinine levels,86212
10,Arm predicted mass (left),181464
10,Blood metabolite levels [X-11261],188
10,"""Type 1 diabetes, wide definition""",268
10,High blood pressure | illnesses of siblings,1246
10,Diabetic nephropathy,96
10,Tuberculosis (SNP x SNP interaction),722
10,Clinical laboratory measurements [glucose levels],119
10,Blue badge | attendance/disability/mobility allowance,44
10,"""Diabetes, insuline treatment (Kela reimbursement) (more control exclusions)""",4505
10,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Asian],159
10,Serum levels of protein EBI3,697
10,Serum levels of protein C11orf87,96
10,"Vertigo | non-cancer illness code, self-reported",316
10,Unruptured cerebral aneurysm,7
10,Corneal hysteresis (right),307
10,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction),149
10,"Hayfever/allergic rhinitis | non-cancer illness code, self-reported",27
10,Hematocrit,288941
10,DNA methylation variation (age effect),12334
10,Peak expiratory flow,18362
10,Urea levels,23665
10,Acute lymphoblastic leukemia (childhood),4741
10,Fasting blood glucose,1213
10,"Ventouse, vacuum extraction | delivery methods",354
10,Non-invasive ventilation,4
10,Type 2 diabetes [Obese],2359
10,Pulmonary surfactant-associated protein D levels,9151
10,Hip circumference,61875
10,Snoring,137
10,Urinary metabolite levels in chronic kidney disease [dimethylmalonic acid],6345
10,Lipid traits (pleiotropy) (HIPO component 1),94
10,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test) [African],743
10,Hypothyroidism nos,535
10,Retinal nerve fibre layer (RNFL) thickness,17216
10,Lumbar spine bone mineral density,2216
10,CD25++ CD4+ T cell %T cell,1011
10,Cardiomyopathy (excluding other),496
10,Waist-hip ratio,124285
10,Pulse pressure [Japanese],22445
10,Uterine fibroids,15345
10,"Heel bone mineral density (bmd) t-score, automated (right)",2968
10,Electrocardiogram morphology (amplitude at temporal datapoints) [224 ms],1597
10,Serum metabolite levels [Carnitine],188
10,Biliary atresia,12050
10,CD39+ resting CD4 regulatory T cell %resting CD4 regulatory T cell,14298
10,Pork consumption,4001
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-114 ms],781
10,"Aging traits (healthspan, parental lifespan or longevity) (multivariate analysis)",119
10,Type 2 diabetes [EA],5951
10,Arm predicted mass (right),219537
10,Cortical thickness (min-P),7230
10,Heel broadband ultrasound attenuation (left),2489
10,Dermatitis and eczema,625
10,Simvastatin | treatment/medication code,119
10,"Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1) [BDRPRED, EA]",1217
10,Thyroxine product | treatment/medication code,226
10,Prostate cancer,93082
10,"Black | hair colour (natural, before greying)",7403
10,3mm weak meridian (right),33493
10,Coronary heart disease,4433
10,Proteinase-activated receptor 1 levels,6112
10,Gut microbiota relative abundance (bacterial taxa) [Clostridium_xylanovorans],850
10,Facial morphology (segment 1),165
10,Protein quantitative trait loci (liver) [GSTO1],2268
10,Pediatric asthma,42
10,Lymphocyte counts,524891
10,Serum phosphate levels,57927
10,Serum urea levels,82404
10,Vertex-wise cortical surface area,71636
10,Brain connectivity [Strength - L-transverse temporal],2435
10,"Fracture wrist / colles fracture | non-cancer illness code, self-reported",115
10,Serum levels of protein CDHR3,253
10,Depression (broad),284
10,Diastolic blood pressure,472029
10,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),9696
10,Ever smoked,37096
10,Electrocardiogram morphology (amplitude at temporal datapoints) [244 ms],1691
10,Meningioma,3768
10,Acute lymphoblastic leukemia (B-cell precursor),5013
10,Total body bone mineral density (MTAG),357
10,Electrocardiogram morphology (amplitude at temporal datapoints) [250 ms],1691
10,Prostate-specific antigen levels,7074
10,Upper eyelid sagging severity,436
10,Idiopathic dilated cardiomyopathy,351
10,Non-melanoma skin cancer,6
10,Unspecified dementia,6
10,Neuroticism,67960
10,Medication use (agents acting on the renin-angiotensin system),84368
10,"Orofacial clefts [Meta-All, NSCLP]",1259
10,Body fat percentage,81876
10,Urinary albumin excretion [UACR],1186
10,Daytime nap,1595
10,Metabolic traits [SM-6 + 94 other traits],25
10,Myopia (pathological),263
10,Serum levels of protein ATF6,14
10,Mean arterial pressure (long-term average),35015
10,Eczema,57771
10,Bipolar I disorder,14714
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-142 ms],5057
10,White matter microstructure (fractional anisotropy) [Fornix (column and body],3773
10,"Macular degeneration | non-cancer illness code, self-reported",972
10,Malignant neoplasm,249
10,Gut microbiota (bacterial taxa) [Bacilli class],100
10,Sensorineural hearing loss,7
10,Alcohol consumption (drinks per week) (MTAG),14806
10,Corneal curvature,34547
10,Bipolar disorder (body mass index interaction),63
10,Asthma (adult onset),564
10,Protein quantitative trait loci (liver) [EIF3K],45
10,CD28 on CD39+ secreting CD4 regulatory T cell,30645
10,Breast cancer | illnesses of siblings,243
10,Sitting height ratio [AA],84
10,Activity variability during wake,50
10,Coronary artery disease or large artery stroke,23536
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-16 ms],23467
10,Hypertrophy of breast,91
10,Late-onset Alzheimer's disease,451
10,Heel bone mineral density,200938
10,Worry,82423
10,Forced vital capacity (fvc),106367
10,Never smoked | tobacco smoking,72085
10,Childhood body mass index,27
10,CD39+ CD8+ T cell %T cell,30962
10,"Blood protein levels [C10orf54, 11531_24_3]",653
10,Home location - east co-ordinate (rounded),7
10,Ever taken cannabis,40577
10,White matter microstructure (mean diusivities) [Fornix (column and body],3773
10,Urinary sodium excretion [EA],10437
10,"Blood protein levels [PSAP, 6207_10_3]",1613
10,Nasal polyps,1001
10,Left eye | which eye(s) affected by hypermetropia (long sight),1024
10,White matter microstructure (mean diusivities) [Superior corona radiata],323
10,"Urinary metabolites (H-NMR features) [1.8025, Unknown]",31775
10,Brain region volumes [left supramarginal],524
10,"Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)",26744
10,Leisure sedentary behaviour (television watching),7853
10,CD20 on IgD- CD38dim B cell,1247
10,Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels) [S-CT concentration],7495
10,Dipyridamole | treatment/medication code,300
10,Skin colour,15381
10,CD39+ activated CD4 regulatory T cell %activated CD4 regulatory T cell,30319
10,"""Atopic  dermatitis, strict definition""",130
10,Hippocampal tail volume,6798
10,"""Type 2 diabetes, strict (exclude DM1)""",3992
10,Fed-up feelings,141
10,Phospholipid levels (plasma) [proportions],245
10,Monocyte differentiation antigen CD14 measurement,137
10,Highest math class taken (MTAG) [MTAG],105929
10,Triglyceride levels x long total sleep time interaction (2df test),6103
10,Diabetes | illnesses of father,2633
10,"""Disorders of gallbladder, biliary tract and pancreas""",10021
10,Fruit consumption,3567
10,Androgen levels [serum testosterone],6272
10,Hippocampal subfield CA3 volume,5006
10,Serum levels of protein CSGALNACT2,670
10,Low myopia vs hyperopia,787
10,Fasting insulin adjusted for BMI,845
10,Age-related macular degeneration (geographic atrophy),1059
10,Sporadic pituitary adenoma,148
10,CD39+ CD4+ T cell %T cell,14941
10,Proteinuria (moderate to severe),1186
10,Senile cataract,995
10,Logical memory (delayed recall) in normal cognition,45
10,Optic cup area,30069
10,Lung function (FEV1),28532
10,"Allergic disease (asthma, hay fever and/or eczema) (age of onset)",51321
10,Birth weight of first child,9398
10,Serum 25-Hydroxyvitamin D levels,122090
10,Serum levels of protein GRN,2105
10,Blood metabolite ratios [androsterone sulfate/epiandrosterone sulfate],4957
10,"Asthma | non-cancer illness code, self-reported",3504
10,Waist-to-hip ratio adjusted for body mass index [EA],149
10,Clonidine | treatment/medication code,366
10,Cholesteryl ester_16:1_[M+NH4]1+ levels,25
10,Serum levels of protein VEGFA,6131
10,Serum levels of protein C15orf48,253
10,Arthropathies,230
10,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),14808
10,Glaucoma (multi-trait analysis),12884
10,QT interval,10967
10,Cortical volume [Precentral],919
10,Prostate-specific antigen levels (conditioned on lead SNPs) [conditional on Round 3 SNPs],63
10,Iron status biomarkers (ferritin levels),222
10,Protein quantitative trait loci (liver) [EMILIN2],56
10,Chronic lymphocytic leukemia,22943
10,Lifetime smoking index,60730
10,Triglyceride levels in current drinkers [EA],5575
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-26 ms],230
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-82 ms],781
10,Protein quantitative trait loci (liver) [TARS],55
10,Serum levels of protein CCL22,60
10,"Blood protein levels [EA, Interleukin-15 receptor subunit alpha]",326
10,Serum metabolite levels [5-dodecenoate (12:1n7],25
10,Alzheimer disease and age of onset [between families],899
10,Cataracts (operation),7
10,Body mass index variance,363
10,Diabetes | illnesses of siblings,119
10,Glycemic traits (pleiotropy),849
10,Cataracts,21550
10,Serum levels of protein PLAU,5147
10,"Sphingomyelin (d18:1/20:1, d18:2/20:0) levels",392
10,Age stroke diagnosed,67
10,Gestational diabetes (for exclusion),119
10,Two-hour glucose challenge,107
10,"""Asthma, including avohilmo""",3
10,Sum basophil neutrophil counts,39443
10,"Blood protein levels [IL15RA, 3445_53_2]",553
10,Body mass index [women],602
10,Electrocardiogram morphology (amplitude at temporal datapoints) [30 ms],7
10,Coronary revascularization (ANGIO or CABG),2558
10,Blood glucose levels,5973
10,Language functional connectivity,3905
10,CD25 on secreting CD4 regulatory T cell,118
10,"Pulmonary function (smoking interaction) [FEV1, Ever-smoking]",88
10,Age at last live birth,144
10,Homeostasis model assessment of insulin resistance (dietary factor interaction) [Carbohydrate],21
10,Protein quantitative trait loci (liver) [SERPINF1],3
10,Gut microbiota abundance (family Peptostreptococcaceae id.2042),1327
10,Minocycline | treatment/medication code,894
10,Diastolic blood pressure (cigarette smoking interaction),25445
10,LDL cholesterol levels,10511
10,CD39+ secreting CD4 regulatory T cell Absolute Count,30002
10,Chronic obstructive pulmonary disease x current smoker interaction (main effect),2862
10,HDL cholesterol levels [Trans-ethnic initial],9318
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-126 ms],5057
10,Average total household income before tax,4431
10,Triglyceride levels [Trans-ethnic initial],11880
10,Microalbuminuria,519
10,Blood protein levels [IL2RA],1111
10,Levothyroxine sodium | treatment/medication code,1350
10,Depression,2073
10,"Diastolic blood pressure x alcohol consumption interaction (2df test) [AA, EA]",552
10,Feeling miserable,151
10,Type 2 diabetes [Conditioned],54
10,Response to temozolomide,13777
10,Serum levels of protein DUSP13,4463
10,Serum levels of protein FAS,564
10,"""Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified""",815
10,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event) [Cox proportional hazards regression model],117
10,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [acisoga, diacetylspermidine, N1, N12-diacetylspermine, X-23656, X-23668]",466
10,Acute respiratory distress syndrome in sepsis,600
10,Systolic blood pressure (alcohol consumption interaction) [drinks/week],271
10,Sudden cardiac arrest in coronary artery disease,17
10,Protein quantitative trait loci (liver) [CALD1],1
10,Attention deficit hyperactivity disorder (MTAG),1462
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-28 ms],3879
10,"Hypertension | non-cancer illness code, self-reported",24328
10,Other viral diseases,3
10,Gut microbiota abundance (genus Romboutsia id.11347),1327
10,Coronary artery bypass grafting,173
10,Prevalent atrial fibrillation,569
10,Diabetic nephropathy (more control exclusions),119
10,Hypertrophic cardiomyopathy (sarcomere negative),351
10,Femur bone mineral density x serum urate levels interaction,391
10,Appendicular lean mass,666560
10,Fish- and plant-related diet,5862
10,Serum levels of protein DKK1,157
10,Protein quantitative trait loci (liver) [OGDH],177
10,Eremiobacterota abundance in stool,3
10,Granulins levels,3385
10,Never | smoking status,64082
10,"Abdominal hernia | non-cancer illness code, self-reported",102
10,CD39+ secreting CD4 regulatory T cell %secreting CD4 regulatory T cell,29338
10,White matter integrity (mean diffusivity),2458
10,"Meniere's disease | non-cancer illness code, self-reported",248
10,CD25 on IgD+ B cell,228
10,Laterality in neovascular age-related macular degeneration,1057
10,"Blood protein levels [EA, Calcium/calmodulin-dependent protein kinase type 1]",11
10,Acylcarnitine levels [Acetylcarnitine],188
10,CD39+ secreting CD4 regulatory T cell %CD4 regulatory T cell,30645
10,Narcolepsy,272
10,Glycine levels [conditional],5819
10,Serum levels of protein NRP1,912
10,Experiencing mood swings,3
10,Neutrophill percentage,46297
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-32 ms],3879
10,"Blood protein levels [CDNF, 4962_52_1]",1420
10,Electrocardiogram morphology (amplitude at temporal datapoints) [64 ms],2932
10,Blood metabolite ratios [carnitine/X-12798],188
10,Octanoylcarnitine (c8) levels,56
10,Ascending aorta distensibility,99
10,Diabetes mellitus,8850
10,Acute appendicitis,965
10,Fybogel orange s/f granules | treatment/medication code,332
10,Suggestive for eosinophilic asthma,39
10,Arm fat-free mass (left),184807
10,Alanine transaminase levels,1842
10,Sex hormone-binding globulin levels [Men],6512
10,Nap during day,280
10,BMI in non-smokers,119
10,Other intervertebral disc disorders,5921
10,Optic nerve measurement (disc area),37269
10,Acute lymphoblastic leukemia in childhood (B cell precursor),5572
10,"""Hypothyroidism, strict autoimmune, 3 medication purchases required""",1487
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-20 ms],1018
10,Response to tamoxifen in breast cancer,17
10,Paclitaxel-induced cytotoxicity,51
10,Cholelithiasis,40679
10,Red blood cell (erythrocyte) distribution width,25394
10,"""Other diabetes, wide definition""",3992
10,Cerebrospinal fluid t-tau:AB1-42 ratio,2213
10,Rheumatoid arthritis [EA],1564
10,Disorders of vestibular function (Vertigo),1914
10,Pulse pressure x alcohol consumption interaction (2df test) [AA],77
10,"""Malignant neoplasm of breast, HER-negative""",115
10,Total body bone mineral density (age over 60),170
10,Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],4045
10,Hodgkin's lymphoma,492
10,CD25 on CD4+ T cell,625
10,QRS duration [European],789
10,Smoking initiation (ever regular vs never regular) [Conditioned on chr10:106460460],105
10,Bone mineral density (hip) and hip bone size,67
10,Gout,8455
10,Esophageal cancer and gastric cancer [Total gastric],4082
10,Mean spheric corpuscular volume,114473
10,Basophill percentage,40611
10,"""Cholelithiasis, broad definition with cholecystitis""",10023
10,"Blood protein levels [NPPB, 10387_1_3]",490
10,Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder,3490
10,Sleep duration,4942
10,Yes | hearing difficulty/problems,373
10,N-acetylhistidine levels,563
10,Upper cheek morphology,79
10,Myeloid white cell count,35142
10,Lymecycline | treatment/medication code,2221
10,Kidney cancer,37
10,Creatine kinase levels,47216
10,Prothrombin time,6745
10,Smoking initiation (ever regular vs never regular),127842
10,Cataracts [conditional],2225
10,Cerebrospinal fluid biomarker levels [Neutral ceramidase],1056
10,Metabolic syndrome,6996
10,Depressive symptoms (stressful life events interaction),1099
10,Deep venous thrombosis,1772
10,CD25 on B cell,228
10,White matter microstructure (radial diusivities) [Superior corona radiata],189
10,Body mass index,690504
10,Ascending aorta maximum area,35498
10,Glomerular filtration rate in non diabetics (creatinine),7272
10,Electrocardiogram morphology (amplitude at temporal datapoints) [4 ms],8929
10,Type 2 diabetes with other specified/multiple/unspecified complications,3992
10,Allergic rhinitis [Latino],11
10,Height,669711
10,Keratinocyte cancer (MTAG),708
10,Water intake,3266
10,"Blood protein levels [LIPN, 8097_77_3]",3834
10,Longest period of unenthusiasm / disinterest,40
10,Mammographic density (non-dense area),193
10,Height [EA],6784
10,Proliferative diabetic retinopathy,119
10,Amino-terminal enhancer of split measurement,22
10,Fasciitis,97
10,Allergic rhinitis,26019
10,Nodular sclerosis Hodgkin lymphoma,270
10,4-chlorobenzoic acid levels,2027
10,CD25 on IgD- CD38dim B cell,228
10,Diseases of appendix,1109
10,B cell lymphocyte profile difference (7 days post influenza vaccination),477
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-118 ms],781
10,Dickkopf-related protein 1 levels,8114
10,Uric acid levels [Obese],1807
10,Diastolic blood pressure x smoking status (ever vs never) interaction (2df test),960
10,Acylcarnitine levels [Carnitine],555
10,Serum metabolite levels [Palmitoleate (16:1n7],25
10,"Soluble interleukin-2 receptor subunit alpha [EA, conditioned on rs7911500, rs791590 and rs8177757]",47
10,3mm cylindrical power angle (right),16
10,Paracetamol of NSAID medication,263
10,Schizophrenia,579471
10,Asthma,44652
10,Fibrinogen [EA],5931
10,Gallbladder disease,6332
10,2-hydroxyadipate levels,358
10,Craniofacial microsomia,116
10,Respiratory or ear-nose-throat disease,9102
10,Electrocardiogram morphology (amplitude at temporal datapoints) [252 ms],1691
10,Current | alcohol drinker status,225
10,CD4 on CD39+ secreting CD4 regulatory T cell,30917
10,Arm fat percentage (right),42820
10,Inflammatory bowel disease and other gastroenteritis and colitis,1456
10,Respiratory diseases,2723
10,Protein quantitative trait loci (liver) [FGA],3
10,Systemic lupus erythematosus,65412
10,"Urinary metabolites (H-NMR features) [2.8575, Trimethylamine]",31775
10,Brain region volumes [left superior parietal],5972
10,"Blood protein levels [EA, Mannose-binding protein C]",1035
10,Waist-hip ratio and HDL-C (pairwise),94
10,Neovascular age-related macular degeneration,2458
10,Type 2 diabetes with coma,119
10,Hair color,75755
10,Other and unspecified dermatitis,681
10,Low density lipoprotein cholesterol levels,79895
10,"Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)",51321
10,Melanoma,7709
10,Fat-free mass,10587
10,Heel bone mineral density (bmd) (left),4185
10,White matter microstructure (fractional anisotropy) [Anterior corona radiata],275
10,Amlodipine | treatment/medication code,2512
10,Peripheral artery disease,238
10,Coronary artery aneurysm in Kawasaki disease,222
10,Chronic lymphocytic leukemia (time to first treatment),36
10,Primary tooth development (time to first tooth eruption),1484
10,Nevus count or cutaneous melanoma,10973
10,CD39+ CD4+ T cell Absolute Count,14941
10,Waist circumference,53367
10,Insomnia,8516
10,Isotard 25xl m/r tablet | treatment/medication code,2124
10,Hair shape,91
10,Celiac disease and Rheumatoid arthritis,409
10,CD25++ CD8+ T cell %T cell,625
10,High myopia,2070
10,Urolithiasis,3096
10,Alcohol consumption,24
10,Protein quantitative trait loci (liver) [AKR1C2],27
10,Hypertension,175467
10,Type 2 diabetes,350177
10,Liver volume,10619
10,SSC-A on Natural Killer,1674
10,"Obstructive sleep apnea trait (apnea hypopnea index, change over time)",52
10,Waist-to-hip ratio adjusted for BMI,198693
10,Angina pectoris,44865
10,Back pain | pain type(s) experienced in last month,7315
10,"Rheumatic fever | non-cancer illness code, self-reported",412
10,Benign neoplasm of breast (controls excluding all cancers),100
10,"Smoking initiation (ever regular vs never regular) [Conditioned on chr10:106929313, chr10:106460460]",169
10,White matter microstructure (radial diusivities) [Superior fronto-occipital fasciculus],500
10,Thoracic aortic aneurysms [index],211
10,Protein quantitative trait loci (liver) [FHL1],12
10,Inflammatory bowel disease [EA],109054
10,Serum levels of protein AAGAB,14790
10,Vegetarian alternatives intake,66643
10,Protein quantitative trait loci (liver) [PSMB6],35
10,Alcohol consumption (drinks per week),1476
10,Proinsulin levels,119
10,CD25 on unswitched memory B cell,47
10,Gut microbiota (bacterial taxa) [Alistipes_putredinis],5
10,T cell lymphocyte profile difference,33
10,Chronic obstructive pulmonary disease or resting heart rate (pleiotropy),12029
10,Ventolin 100micrograms inhaler | treatment/medication code,39
10,Electrocardiogram morphology (amplitude at temporal datapoints) [32 ms],7
10,Peak height velocity [boys],2
10,Bipolar disorder or attention deficit hyperactivity disorder,3833
10,Blood pressure [Systolic],21957
10,Two-hour glucose,119
10,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test),1017
10,Diabetic retinopathy (more control exclusions),1178
10,Mean corpuscular volume,1656142
10,Cognitive performance,23542
10,Macular thickness,12914
10,CD39+ resting CD4 regulatory T cell Absolute Count,14495
10,Cognitive traits (MTAG),2239
10,Rapid alternating stimulus test for letters/numbers,1669
10,Protein quantitative trait loci (liver) [FKBP1A],305
10,Hemoglobin,145602
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-92 ms],13425
10,"Lung cancer | cancer code, self-reported",1444
10,Systolic blood pressure [East Asian],23640
10,Total bilirubin levels,24379
10,Parkinson's disease or first degree relation to individual with Parkinson's disease,3940
10,CD4 regulatory T cell %CD4+ T cell,308
10,Neuroticism score,349
10,LDL cholesterol levels in current drinkers,4176
10,Optic disc radius,33534
10,Disorders of breast,91
10,"Pulmonary embolism +/- dvt | non-cancer illness code, self-reported",1266
10,"Carpal tunnel syndrome | non-cancer illness code, self-reported",109
10,Lymphocyte percentage of white cells,96997
10,Medication use (drugs used in diabetes),32578
10,Arsenic metabolism [percent monomethylarsonate],44589
10,Parkinson's disease,1802
10,Primary biliary cholangitis,2189
10,Mammographic density (dense area),2101
10,Monoclonal gammopathy of undetermined significance,12
10,Emphysema distribution in smoking [ratio950],17
10,General cognitive ability,29132
10,Insulin-related traits (multivariate analysis),9009
10,Migraine,8372
10,1-stearoyl-2-arachidonoyl-gpc (18:0/20:4) levels,30
10,Brain region volumes [cerebellar vermal lobules VIII X],1769
10,Age-related macular degeneration (wet),1229
10,Protein quantitative trait loci (liver) [GLDC],8
10,Haemoglobin concentration,45921
10,CD8 on CD39+ CD8+ T cell,16021
10,Dentures | mouth/teeth dental problems,1633
10,Lipoma of skin and subcutaneous tissue,2458
10,Platelet-derived growth factor subunit B levels,7701
10,Multivitamins +/- minerals | vitamin and mineral supplements,5178
10,Malignant neoplasm of breast (controls excluding all cancers),335
10,CD25 on CD28+ CD4+ T cell,625
10,Serum levels of protein KRT23,487
10,Oxalate (ethanedioate) levels,201
10,Lysophosphatidylethanolamine levels [LPE(20:4;0],44
10,Multiple delivery,8
10,Serum total protein level,32974
10,"Forced expiratory volume in 1-second (fev1), predicted",58035
10,Subcutaneous adipose tissue [women],7985
10,Atenolol | treatment/medication code,1166
10,"""Malignant neoplasm of breast, HER-negative (controls excluding all cancers)""",302
10,Morganella abundance in stool,133
10,Protein quantitative trait loci (liver) [TPM4],158
10,Fat-free mass [female],7315
10,Naratriptan | treatment/medication code,187
10,QRS duration,2528
10,Homeostasis model assessment of beta-cell function (dietary factor interaction) [n-6 PUFA],51
10,Anxiety/tension (special factor of neuroticism),72056
10,Oily fish intake,3788
10,Primary sclerosing cholangitis,764
10,Protein quantitative trait loci (liver) [PKM],305
10,Serum levels of protein HBEGF,6112
10,Serum levels of protein PSAP,4863
10,Inflammatory bowel disease,95627
10,Whole body fat-free mass,176989
10,Serum metabolite levels [3-hydroxy-2-ethylpropionate],12553
10,Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis),872
10,Serum levels of protein ASAH2,2323
10,Degeneration of macula and posterior pole,1059
10,Warfarin maintenance dose [Brazilian],3340
10,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],361
10,Body mass index (age>50),84
10,Psoriasis vulgaris,15764
10,Extrinsic epigenetic age acceleration,14115
10,Anthropometric traits (multi-trait analysis),2580
10,"Blood protein levels [MSMB, 10620_21_3]",1970
10,"Smoking initiation (ever regular vs never regular) [Conditioned on chr10:104403310, chr10:104852121, chr10:103960351, chr10:104640052]",1471
10,Fractured/broken bones in last 5 years,191
10,Triglyceride levels x short total sleep time interaction (2df test) [EA],361
10,Chronic lower respiratory diseases,39
10,Lysophosphatidylcholine(16:1)_[M+H]1+/Lysophosphatidylethanolamine(19:1)_[M+H]1+ levels,25
10,Hypertensive diseases (excluding secondary),26462
10,Neurofibrillary tangles (SNP x SNP interaction),13254
10,"Cholelithiasis/gall stones | non-cancer illness code, self-reported",6383
10,Age-related macular degeneration (choroidal neovascularisation),1059
10,Disorders of choroid and retina,1059
10,Chronic kidney disease,275
10,"Blood protein levels [CRTAC1, 5632_6_3]",101
10,Predicted visceral adipose tissue,34541
10,"Blood protein levels [EA, Inorganic pyrophosphatase]",2578
10,Age-related macular degeneration (CNV vs. GA),1059
10,"Intra-ocular pressure, goldmann-correlated (right)",2419
10,Migraine and/or diastolic blood pressure,2708
10,Metabolite levels (Pyroglutamine),19
10,Major depressive disorder,7787
10,Brain region volumes [left caudate],3345
10,"Blood clot in the leg (dvt) | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",1772
10,Pattern 2 | hair/balding pattern,2224
10,Serum levels of protein MBL2,293
10,"Risky sexual behaviors (alcohol dependence interaction) [EA, men]",175
10,Melanomas of skin,2801
10,Blood metabolite levels [citrulline],11753
10,Brain region volumes [grey matter],2738
10,"None of the above | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",2371
10,CD25 on transitional B cell,212
10,Serum metabolite levels [X-06226],28
10,"Cholesterol, total",24791
10,Mean corpuscular volume [Asian],28502
10,Basophill count,9448
10,"Serum metabolite levels [N1,N12-diacetylspermine]",915
10,Exudative age-related macular degeneration,1229
10,Degenerative macular diseases,999
10,Gliclazide | treatment/medication code,149
10,White blood cell count (basophil),12677
10,Nonsyndromic cleft lip with or without cleft palate,3042
10,Macular degeneration | eye problems/disorders,972
10,Body fat percentage [male],2302
10,Rapid automised naming and rapid alternating stimulus test performance,1669
10,OTU97_9 (Alistipes) abundance,156
10,Cataracts [female],4767
10,Progesterone levels [men],22298
10,Triacylglycerol_59:12_[M+NH4]1+ levels,11864
10,"Fracture neck of femur / hip | non-cancer illness code, self-reported",909
10,Rheumatoid arthritis [conditional on rs71508903],4072
10,Problematic alcohol use (MTAG),12274
10,Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis),635
10,Type 2 diabetes with ophthalmic complications,119
10,Brain morphology (MOSTest),27510
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-112 ms],13357
10,"Blood pressure medication | medication for cholesterol, blood pressure or diabetes",4814
10,Leiomyoma of uterus (controls excluding all cancers),2571
10,Snoring [adjusted for BMI],1315
10,Complement C2 measurement,89
10,Type 2 diabetes with renal complications,119
10,Serum uric acid levels,85426
10,Autoimmune thyroid disease,7105
10,IBD patients in KELA-register,878
10,Oramorph 10mg/5ml oral solution | treatment/medication code,9090
10,Methylmalonate (mma) levels,3169
10,Bisacodyl | treatment/medication code,2122
10,Diffuse plaques (SNP x SNP interaction),1835
10,Age at menopause (last menstrual period),1079
10,Ever had prostate specific antigen (psa) test,155
10,Peak expiratory flow (pef),85605
10,Early age-related macular degeneration,1059
10,Coagulation Factor V measurement,219
10,"Forced expiratory volume in 1-second (fev1), best measure",21207
10,Age at first birth,7761
10,Serum levels of protein NPPB,482
10,"Blood protein levels [PCBD1, 11313_100_3]",773
10,Serum metabolite levels (CMS) [IDL_P],49
10,Left ventricular internal dimension in diastole,5974
10,Electrocardiogram morphology (amplitude at temporal datapoints) [-30 ms],3879
10,X-23308 levels,5825
10,Tumor necrosis factor receptor superfamily member 6 levels,3278
10,Protein quantitative trait loci (liver) [TMSB4X],158
10,Leiomyoma of uterus,321
10,"Soluble interleukin-2 receptor subunit alpha [EA, conditioned on on rs7911500, rs791590, rs8177757 and rs10905716]",147
10,Protein quantitative trait loci (liver) [IGHG4],17
10,Relative age of first facial hair,22994
10,Mild obesity-related type 2 diabetes,962
10,Blood metabolite levels [X-11247],11367
10,Benign neoplasms,2582
10,Electrocardiogram morphology (amplitude at temporal datapoints) [230 ms],1597
10,Vitamin B levels in ischemic stroke [Vitamin B12],116
11,Depression,58101
11,Respiratory diseases,34152
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C38:4],12763
11,Anxiety/tension (special factor of neuroticism),904
11,Electrocardiogram morphology (amplitude at temporal datapoints) [38 ms],4805
11,Age at first birth,4697
11,"Diastolic blood pressure [EA, initial]",1384
11,Eubacterium F sp000434115 abundance in stool,3144
11,Diabetes | illnesses of father,659
11,"Blood protein levels [CLMP, 10440_26_3]",380
11,Colorectal cancer,59449
11,"Blood protein levels [EA, Plasma protease C1 inhibitor]",19506
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with diacyl residue sum C40:4],12139
11,Triacylglycerol_55:8_[M+NH4]1+ levels,2120
11,Asthma (moderate or severe),984
11,Serum metabolite levels [VLDL_D],2275
11,Mammographic density (dense area),4166
11,Serum levels of protein TMEM132C,253
11,Intestinal infection due to protozoa,729
11,Hip circumference adjusted for BMI [EA],2895
11,Two-hour glucose,2281
11,"Blood protein levels [NTM, 10907_116_3]",66
11,Desulfobacterota A abundance in stool,15
11,Cholelithiasis and cholecystitis,12763
11,Statin medication,15693
11,Celiac disease or Rheumatoid arthritis,19937
11,Pork consumption,29226
11,Cutaneous mastocytosis,9120
11,Medication use (antihistamines for systemic use),952
11,"Blood protein levels [EA, Dickkopf-related protein 3]",97
11,Electrocardiogram morphology (amplitude at temporal datapoints) [404 ms],144
11,Fatty acid(20:4)_[M-H]1- levels,24777
11,Serum metabolite levels [arachidonoylcholine],14654
11,HDL cholesterol [Hispanic],2892
11,Triacylglycerol_52:3_[M+NH4]1+ levels,2120
11,Sphingomyelin_34:1_[M+H]1+ levels,2120
11,Spine bone mineral density and alcohol drinking [males],430
11,Diastolic blood pressure [EA],207
11,Glaucoma (primary angle closure),1444
11,Cardiovascular disease,156050
11,Change in serum metabolite levels [FAw3_FA],12763
11,Phosphatidylcholine_40:4_[M+H]1+/Phosphatidylethanolamine_43:4_[M+H]1+ levels,12763
11,Triacylglycerol(48:3)_[M+NH4]1+ levels,3087
11,Vitamin E levels,2120
11,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),45085
11,Electrocardiogram morphology (amplitude at temporal datapoints) [414 ms],8598
11,"Blood protein levels [CTSC, 13730_18_3]",1194
11,Current tobacco smoking,9858
11,Renal function-related traits (urea),4686
11,Serum metabolite levels (CMS) [L_VLDL_PL],2275
11,"Other exercises (eg: swimming, cycling, keep fit, bowling) | types of physical activity in last 4 weeks",2610
11,Blood protein levels [MMP3],2164
11,"""Hyperlipidaemia, other/unspecified""",2120
11,IgG N-glycosylation phenotypes (multivariate analysis),523
11,Medication use (beta blocking agents),29017
11,Cholesteryl ester_15:0_[M+NH4]1+ levels,12763
11,Sphingomyelin_38:2_[M+H]1+ levels,14446
11,Phosphatidylcholine-O_44:5_[M+H]1+/Phosphatidylcholine-P_44:4_[M+H]1+ levels,14883
11,Metabolite levels [LPC 20:4],12763
11,Forced vital capacity (fvc),144161
11,Serum metabolite levels (CMS) [ApoB],2275
11,Phosphatidylcholine-O_34:2_[M+H]1+/Phosphatidylcholine-P_34:1_[M+H]1+/Phosphatidylethanolamine-O_37:2_[M+H]1+ levels,2120
11,"Bursitis | non-cancer illness code, self-reported",395
11,Endometriosis or endometrial cancer (pleiotropy),789
11,Brugada syndrome,787
11,Protein quantitative trait loci (liver) [CSRP1],25
11,Serum 25-Hydroxyvitamin D levels,712049
11,Phosphatidylcholine-P_38:6_[M+H]1+ levels,12763
11,Serum metabolite levels [PUFA],2275
11,Pulse pressure x alcohol consumption interaction (2df test) [EA],1821
11,Suicidality,308
11,Diabetes (gestational),251
11,Smoking initiation (ever regular vs never regular),34421
11,Corneal endothelial cell size variation coefficient,14065
11,Triglyceride levels [EA],12240
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C40:1],12763
11,Electrocardiogram morphology (amplitude at temporal datapoints) [348 ms],12780
11,Inguinal hernia,6146
11,Serum metabolite levels (CMS) [SFA],2275
11,"Serum metabolite levels [N6,N6,N6-trimethyllysine]",1850
11,Diacylglycerol(34:0)_[M+H-H2O]1+ levels,3087
11,Serum metabolite levels [N-acetyltyrosine],1905
11,Natural Killer T %T cell,232
11,Other coagulation defects,782
11,Brain region volumes [CSF],185
11,Lifetime smoking index,9525
11,Heel bone mineral density (bmd) (left),57676
11,Type 2 diabetes or prostate cancer (pleiotropy),13850
11,Odorant perception (&beta;-ionone),8143
11,Serum levels of protein MMP7,173
11,Nonsyndromic cleft lip,521
11,Gout [Japanese],1182
11,"Blood clot in the lung | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",131
11,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test) [EA],1088
11,"Blood protein levels [NELL1, 6544_33_3]",93
11,1-stearoyl-2-docosahexaenoyl-gpc (18:0/22:6) levels,28
11,Serum levels of protein PGLYRP1,24
11,Waist circumference adjusted for body mass index,221750
11,malignant neoplasm of male genital organs (controls excluding all cancers),6398
11,Disorders of lens,1323
11,"""Ulcerative colitis (strict definition, require KELA)""",10568
11,"""Type 1 diabetes, strict (exclude DM2)""",846
11,"Blood protein levels [APOA1, 2750_3_2]",32
11,C-reactive protein levels or LDL-cholesterol levels (pleiotropy),14474
11,Non-small cell lung cancer,1518
11,Sex hormone-binding globulin levels adjusted for BMI,359144
11,Colon polyp,2890
11,"""Type 2 diabetes, definitions combined""",4949
11,High light scatter reticulocyte percentage,43326
11,Age-related hearing impairment (MTAG),26843
11,Femur bone mineral density x serum urate levels interaction,921
11,Water intake,3783
11,Postinflammatory pulmonary fibrosis,75
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with diacyl residue sum C38:4],12763
11,Phospholipase D3 measurement,1471
11,Cholesteryl ester_14:0_[M+NH4]1+ levels,12763
11,Psychiatric diseases,96
11,Protein quantitative trait loci (liver) [ATOX1],25
11,Lysophosphatidylcholine levels [LPC(20:4;0],12429
11,Urticaria,13040
11,Phosphatidylglycerol(34:0)_[M-H]1- levels,12014
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C42:1/Phosphatidylcholine with acyl-alkyl residue sum C36:2],12139
11,Electrocardiogram morphology (amplitude at temporal datapoints) [360 ms],12780
11,Triacylglycerol_49:2_[M+NH4]1+ levels,2144
11,Change in serum metabolite levels (CMS) [FAw3_FA],12763
11,Cholesteryl ester_18:3_[M+NH4]1+ levels,14883
11,Sphingomyelin_32:1_[M+H]1+ levels,2120
11,Serum metabolite levels [Remnant_C],2275
11,Serum metabolite levels (CMS) [XS_VLDL_TG],2275
11,Brain region volumes [left basal forebrain],274
11,Protein quantitative trait loci (liver) [CYP3A4],1717
11,Urinary metabolite levels in chronic kidney disease [dimethylmalonic acid],21089
11,Serum metabolite levels (CMS) [FAw3],12807
11,Tea intake,2217
11,Cholesteryl ester(16:1)_[M+NH4]1+ levels,3087
11,Serum levels of protein B3GALT2,1379
11,Hernia of abodminal wall,270
11,Chronic lymphocytic leukemia or systemic lupus erythematosus,47
11,Electrocardiogram morphology (amplitude at temporal datapoints) [162 ms],17
11,Mean arterial pressure [East Asian],10428
11,Serum metabolite levels (CMS) [XS_VLDL_P],2275
11,Doctor diagnosed asthma,874
11,Neurological diseases,457
11,Nexium 20mg tablet | treatment/medication code,185
11,Low testosterone levels,610
11,Electrocardiogram morphology (amplitude at temporal datapoints) [258 ms],17
11,"Cortical brain region measurements (area, volume and thickness) [right rostral middle frontal (area]",8
11,Pulse pressure [EA],3445
11,Sphingolipid levels [SM 16:1],2552
11,"""Atopic  dermatitis, strict definition""",3389
11,Other malignant neoplasms of skin (=non-melanoma skin cancer) (controls excluding all cancers),589
11,Infantile hypertrophic pyloric stenosis,31210
11,Serum levels of protein MRAP,2286
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C38:4],12763
11,Metformin | treatment/medication code,51573
11,Dementia in Alzheimer disease,13486
11,Sphingomyelin(34:1)_[M-CH3]1- levels,11909
11,Body mass index and triglycerides (pairwise),1378
11,Bone ultrasound measurement (velocity of sound),1648
11,Serum metabolite levels [L_VLDL_L],2275
11,Colorectal cancer (controls excluding all cancers),2747
11,White matter microstructure (axial diusivities) [Superior longitudinal fasciculus],73
11,Obesity [Obesity class II],1025
11,Tuberculosis [binary model],1030
11,Electrocardiogram morphology (amplitude at temporal datapoints) [146 ms],17
11,Smoking cessation (MTAG),15513
11,Brain region volumes [cerebellar vermal lobules I V],13445
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with diacyl residue sum C36:4],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C38:5/Lysophosphatidylcholine with acyl residue C20:3],12763
11,Serum levels of protein TMEM132A,9018
11,Glycerophospholipid levels [Phosphatidylcholine acyl-alkyl C36:5],12763
11,Systolic blood pressure [EA],1929
11,Diacylglycerol_33:1_[M+H-H2O]1+ levels,2144
11,Cortical volume [Cuneus],39
11,Lung function (FVC),346174
11,LDL cholesterol x physical activity interaction (2df test),12503
11,Serum omega-6 to omega-3 polyunsaturated fatty acid ratio in metabolic syndrome,12763
11,Lysophosphatidylcholine-O_18:2_[M+H]1+/Lysophosphatidylcholine-P_18:1_[M+H]1+ levels,12763
11,Phosphatidylethanolamine_34:0_[M-H]1- levels,12763
11,Serum levels of protein PDE11A,8768
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:3/Sphingomyelin with acyl residue sum C16:1],11815
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C38:4],12763
11,CD20 on memory B cell,4906
11,Matrix metalloproteinase-12 levels,7582
11,Serum metabolite levels (CMS) [XXL_VLDL_PL],2275
11,Electrocardiogram morphology (amplitude at temporal datapoints) [-122 ms],22
11,Electrocardiogram morphology (amplitude at temporal datapoints) [192 ms],17
11,Electrocardiogram morphology (amplitude at temporal datapoints) [372 ms],17
11,Low myopia,6
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C38:4/Phosphatidylcholine with acyl-alkyl residue sum C44:4],12763
11,Ultradistal forearm bone mineral density,1099
11,Phosphatidylcholine-O_35:1_[M+H]1+/Phosphatidylcholine-P_35:0_[M+H]1+/Phosphatidylethanolamine-O_38:1_[M+H]1+ levels,2120
11,Sphingomyelin_39:2_[M+H]1+ levels,2120
11,Smoking status (current vs mixed),682
11,Electrocardiogram morphology (amplitude at temporal datapoints) [-72 ms],628
11,Nitrogen dioxide air pollution; 2007,945
11,Serum metabolite levels (CMS) [L_VLDL_L],2275
11,N-acetylhistidine levels,1159
11,Response to inhaled glucocorticoid treatment in asthma (change in FEV1),94
11,Gut microbiota (bacterial taxa) [k__Bacteria|p__Firmicutes|c__Negativicutes|o__Selenomonadales|f__Acidaminococcaceae],169
11,Protein quantitative trait loci (liver) [LDHB],25
11,Oily fish consumption,29226
11,Phosphatidylcholine levels [PC(18:0;0-20:4;0],14336
11,"Intra-ocular pressure, corneal-compensated (right)",26476
11,"""Endocrine, nutritional and metabolic diseases""",734
11,"""Malignant neoplasm of breast, HER-positive""",58
11,"Serum metabolite levels [1,2-dipalmitoyl-GPC (16:0/16:0]",12327
11,N-acetylglucosamine/n-acetylgalactosamine levels,25987
11,Serum levels of protein GLTPD2,10726
11,Impedance of leg (right),137068
11,Myeloperoxidase levels,8592
11,Serum metabolite levels (CMS) [XXL_VLDL_CE],2275
11,X-11612 levels,681
11,Intelligence,87608
11,Alcohol use disorder (consumption score),64412
11,Well-being spectrum (multivariate analysis),120283
11,Unspecified lump in breast,3420
11,Serum levels of protein CNTN5,275
11,Ease of skin tanning,130261
11,Cystatin C levels,277809
11,Plasma omega-6 polyunsaturated fatty acid levels (adrenic acid),12763
11,Facial morphology (lower lip thickness 1),1354
11,Cholesteryl ester(20:5)_[M+NH4]1+ levels,12456
11,"Waist circumference [EA, men]",11561
11,Serum metabolite levels (CMS) [M_VLDL_C],2275
11,Urinary potassium levels,42
11,Graves' disease,48
11,Accelerometer-based physical activity measurement (average acceleration),70
11,Light vs. dark hair color,6080
11,Sun-seeking behavior,36637
11,Gout,77783
11,"Blood protein levels [CASC4, 8838_10_3]",28374
11,Anthropometric traits (multi-trait analysis),2122
11,Fracture of forearm,712
11,Lymphoid leukaemia,266
11,Body mass index (joint analysis main effects and smoking interaction),41635
11,Red cell distribution width,918245
11,HDL cholesterol levels in current drinkers [Asian],3640
11,Skin cancer,17602
11,6mm strong meridian (right),43086
11,None of the above | pain type(s) experienced in last month,3647
11,"Blood protein levels [SPON1, 5496_49_3]",1889
11,Digit length ratio,481
11,IgE levels,303
11,Estimated glomerular filtration rate in non-diabetics,5740
11,Disruptive behavior disorder and attention deficit hyperactivity disorder,5671
11,Glycerophospholipid levels [Phosphatidylcholine acyl-alkyl C36:3],12763
11,Phosphatidylcholine levels [PC(16:0;0-22:4;0],13183
11,Phosphatidylglycerol-O_40:1_[M+NH4]1+ levels,2120
11,Blood metabolite levels [1-linoleoylglycerol (1-monolinolein],4040
11,Phosphatidylcholine-O_36:4_[M+OAc]1-/Phosphatidylcholine-P_36:3_[M+OAc]1-/Phosphatidylserine-O_40:3_[M-H]1- levels,12763
11,Glycerophospholipid levels [Phosphatidylcholine diacyl C34:3],12763
11,Electrocardiogram morphology (amplitude at temporal datapoints) [334 ms],12780
11,Duodenal ulcer,3034
11,Protein quantitative trait loci (liver) [AK1],8448
11,Heart rate response to recovery post exercise (10 sec),2917
11,Acute myeloid leukemia (all cytogenetic sub-types),2584
11,"Eye trauma | non-cancer illness code, self-reported",7759
11,Serum levels of protein GKN2,788
11,Esophageal disorder,1102
11,Creatine kinase M-type:Creatine kinase B-type heterodimer measurement,71
11,General factor of neuroticism,58458
11,Phosphatidate(41:2)_[M+H]1+ levels,11043
11,Serum metabolite levels (CMS) [VLDL_D],2275
11,"Systolic blood pressure, automated reading",62095
11,Basal metabolic rate,137453
11,Noninflammatory disorders of female genital tract,4897
11,Blood protein levels [Interstitial collagenase],1652
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C38:4/Phosphatidylcholine with acyl-alkyl residue sum C36:3],12763
11,BMI (adjusted for smoking behaviour) [men],1031
11,Glucose homeostasis traits [DI],40
11,Iron status biomarkers [sTfR],38946
11,Phosphatidylinositol levels [PI(18:0;0-20:4;0],12139
11,Serum metabolite levels (CMS) [XL_VLDL_TG],15038
11,Electrocardiogram morphology (amplitude at temporal datapoints) [416 ms],8598
11,Electrocardiogram morphology (amplitude at temporal datapoints) [84 ms],25359
11,Current | smoking status,10275
11,Impedance of whole body,182847
11,CD20 on unswitched memory B cell,4906
11,Serum metabolite levels [1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1)*],12327
11,Phosphatidylcholine-O_30:1_[M+H]1+/Phosphatidylcholine-P_30:0_[M+H]1+/Phosphatidylethanolamine-O_33:1_[M+H]1+ levels,2120
11,"""Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis""",33
11,Retinal detachment,320
11,Resting CD4 regulatory T cell Absolute Count,23
11,Blood urea nitrogen levels,140780
11,Able to confide,32330
11,Phosphatidylcholine_35:2_[M+H]1+/Phosphatidylethanolamine_38:2_[M+H]1+/Phosphatidate_40:3_[M+NH4]1+ levels,12763
11,Sarcoidosis,7641
11,Atopic asthma,16695
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C40:5],12763
11,High density lipoprotein cholesterol levels [Hispanic],2275
11,Skin pigmentation traits [Skin color],431
11,Triglyceride levels x long total sleep time interaction (2df test),13149
11,Triacylglycerol_56:5_[M+NH4]1+ levels,14883
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C40:4],12613
11,"""Diabetes, varying definitions""",9615
11,Lateral thalamic nuclei volume,3947
11,Smoking initiation (ever regular vs never regular) [Conditioned on chr11:46393574],1062
11,CD20 on IgD- CD38- B cell,4790
11,"Migraine | non-cancer illness code, self-reported",2037
11,Previous | smoking status,760
11,"Blood protein levels [MMP7, 2789_26_2]",173
11,Cigarettes smoked per day (MTAG),22220
11,Glycerophospholipid levels [Phosphatidylcholine acyl-alkyl C44:5],12763
11,"Blood protein levels [PCSK7, 4459_68_2]",30526
11,Serum levels of protein CRTAM,577
11,Phosphatidylserine(42:7)_[M+OAc]1- levels,11043
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:1/Phosphatidylcholine with diacyl residue sum C36:5],12763
11,P wave duration,12763
11,Venous thromboembolism,2356
11,"Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event) [Recessive, Mixture cure model]",87
11,Hernia,745
11,Hypertension,244070
11,Adolescent idiopathic scoliosis,162034
11,Allergic rhinitis,19766
11,"Asthma | non-cancer illness code, self-reported",47609
11,NHDL cholesterol to HDL cholesterol ratio,3029
11,Factor VII activity or levels,10818
11,"Eye color [EA, discovery]",577
11,Mouth ulcers | mouth/teeth dental problems,80
11,Sphingomyelin_42:3_[M+H]1+ levels,14447
11,Phosphatidylcholine(40:4)_[M+OAc]1-/Phosphatidylserine(44:3)_[M-H]1- levels,12014
11,Glycerophospholipid levels [Phosphatidylcholine diacyl C40:4],12763
11,Phosphatidylcholine levels [PC(18:0;0-22:5;0],12139
11,Serum metabolite levels (CMS) [TG_PG],43934
11,Medication use (HMG CoA reductase inhibitors),42520
11,Cholesteryl ester levels [CE(20:4;0],13075
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C36:4],12763
11,Urine pH measurement,1515
11,Non-glioblastoma glioma [females],4382
11,CD8+ Natural Killer T %lymphocyte,232
11,"Ankylosing spondylitis | non-cancer illness code, self-reported",193
11,Blue vs. green eyes,569
11,Schizophrenia (MTAG),155620
11,Immature reticulocyte fraction,87559
11,Immunoglobulin light chain (AL) amyloidosis,995
11,Urinary metabolite levels in chronic kidney disease [N-acetyltyrosine],962
11,Distance between home and job workplace,145
11,"Blood protein levels [DKK3, 3607_71_1]",1216
11,Blood protein levels [Cell adhesion molecule-related/down-regulated by oncogenes],1210
11,"Blood protein levels [EA, Contactin-5]",173
11,HDL cholesterol levels in current drinkers,48529
11,Iron status biomarkers (ferritin levels),30788
11,C-reactive protein,6710
11,Electrocardiogram morphology (amplitude at temporal datapoints) [102 ms],25359
11,Sodium in urine,38172
11,Serum levels of protein RELT,10914
11,Polycystic ovary syndrome (indeterminate subtype),1241
11,Smoking behavior [smoking initiation],869
11,Serum levels of protein CAT,1178
11,Type 1 diabetes with ketoacidosis,1692
11,Protein quantitative trait loci (liver) [ANP32A],675
11,Diacylglycerol(36:2)_[M+NH4]1+ levels,3087
11,Neurological disease,129
11,Complement factor H-related protein 3 levels,2
11,Triglyceride levels in small VLDL,4183
11,"Long-standing illness, disability or infirmity",8751
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:4/Phosphatidylcholine with diacyl residue sum C36:2],12763
11,DNA methylation variation (age effect),23978
11,Migraine and/or pulse pressure,3196
11,Diacylglycerol(36:1)_[M+H-H2O]1+ levels,3087
11,Triacylglycerol(54:2)_[M+NH4]1+ levels,16011
11,Serum metabolite levels [HDL_TG],2923
11,C-reactive protein levels or total cholesterol levels (pleiotropy),1711
11,Acute insulin response,40
11,AP-2 complex subunit alpha-2 measurement,14720
11,Phosphatidylethanolamine-O_38:5_[M-H]1-/Phosphatidylethanolamine-P_38:4_[M-H]1- levels,12763
11,Mean platelet (thrombocyte) volume,292257
11,Electrocardiogram morphology (amplitude at temporal datapoints) [248 ms],2666
11,Sphingomyelin_40:1_[M+H]1+ levels,2230
11,Diffuse plaques (SNP x SNP interaction),2193
11,"Osteoporosis, osteopenia and pathological fracture",8875
11,Obesity [Overweight],1025
11,Bone disorder,2957
11,Diacylglycerol(34:1)_[M+H-H2O]1+ levels,3087
11,Tuberculosis,316
11,Endoplasmic reticulum lectin 1 measurement,1258
11,Corneal structure,236
11,"Cardiomyopathy | non-cancer illness code, self-reported",196
11,LDL cholesterol,152744
11,Serum phosphate levels,57407
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C42:2],12139
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C38:5],12763
11,"Blood protein levels [SAA1, 4336_2_1]",408
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:3/Sphingomyelin with acyl residue sum C18:1],11815
11,Triacylglycerol_55:9_[M+NH4]1+ levels,2120
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C36:4],12763
11,Sphingomyelin(34:2)_[M+H]1+ levels,3087
11,"Light smokers, at least 100 smokes in lifetime",203
11,Neuroticism,458755
11,Time spend outdoors in summer,28723
11,6mm weak meridian (right),43423
11,Osteoarthrosis,7233
11,Granulocyte count,87906
11,Glucuronate levels,8188
11,Blood metabolite levels [arachidonate (20:4n6],12139
11,Triacylglycerol_51:2_[M+NH4]1+ levels,2120
11,Sphingolipid levels [Sphingomyeline C16:1],12763
11,Phosphatidylcholine-O_34:3_[M+H]1+/Phosphatidylcholine-P_34:2_[M+H]1+/Phosphatidylethanolamine-P_37:2_[M+H]1+ levels,2120
11,Postprandial triglyceride levels,2120
11,Serum metabolite levels [dihomo-linolenate (20:3n3 or n6],929
11,Cardiac arrhytmias,186
11,Electrocardiogram morphology (amplitude at temporal datapoints) [202 ms],17
11,Leisure sedentary behaviour (computer use),16637
11,Phosphatidylcholine-O_38:4_[M+OAc]1-/Phosphatidylcholine-P_38:3_[M+OAc]1-/Phosphatidylserine-P_42:0_[M-H]1- levels,12763
11,Phosphatidylinositol-O(33:0)_[M-H]1- levels,12014
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C40:1],12763
11,Blood protein levels [Plasma protease C1 inhibitor],18786
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C32:3/Phosphatidylcholine with diacyl residue sum C34:4],12465
11,Triglycerides [Hispanic],4016
11,Sphingomyelin(34:1)_[M+H]1+ levels,3087
11,Invasive breast cancer [fixed effect],4658
11,Sex hormone levels [LH],1250
11,"Diastolic blood pressure x alcohol consumption interaction (2df test) [AA, Asian, EA]",533
11,"Hypertension | non-cancer illness code, self-reported",89946
11,Ischemic heart disease,7792
11,Sphingomyelin(39:1)_[M+H]1+ levels,3087
11,Help-seeking from a GP,1034
11,Protein quantitative trait loci (liver) [ME1],198
11,Total triglycerides levels,10668
11,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 measurement",4761
11,Cholesteryl ester(16:0)_[M+NH4]1+ levels,15215
11,Triacylglycerol(56:4)_[M+NH4]1+ levels,11485
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with diacyl residue sum C36:5],12763
11,Mean time to correctly identify matches,18012
11,"Forced vital capacity (fvc), best measure",181209
11,Alcohol consumption (drinks per week) [Conditioned on chr11:113424042],1121
11,"Blood protein levels [BDNF, 2421_7_3]",200
11,Added milk to filtered coffee,11
11,Triacylglyceride levels [TAG(50:3;0],2120
11,Body mass index and systole blood pressure (pairwise),2220
11,Spontaneous dizygotic twinning,1241
11,Diabetic maculopathy (more control exclusions),846
11,Waist circumference adjusted for body mass index [women],16
11,Phosphatidylcholine(38:5)_[M+H]1+/Phosphatidylethanolamine(41:5)_[M+H]1+/Phosphatidate(43:6)_[M+NH4]1+ levels,12014
11,College or university degree | qualifications,49519
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with diacyl residue sum C38:5],12763
11,Triacylglycerol_50:3_[M+NH4]1+ levels,2120
11,Glycerophospholipid levels [Phosphatidylcholine diacyl C42:4],12763
11,Phosphatidylcholine levels [PC(18:1;0-20:4;0],13610
11,"Insulin | medication for cholesterol, blood pressure or diabetes",1313
11,Bone properties (heel) [VOS],1783
11,White matter microstructure (mean diusivities) [Posterior limb of internal capsule],1512
11,Inflammatory biomarkers [ESR],152
11,Eosinophil percentage of white cells,335913
11,Alzheimer's disease or fasting glucose levels (pleiotropy),6443
11,Brain-derived neurotrophic factor levels,36593
11,Serum metabolite concentrations in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C38:5],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C36:5],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C40:5],12763
11,Leprosy,6628
11,Coffee consumption,5325
11,Phosphatidylcholine-O_31:2_[M+H]1+/Phosphatidylcholine-P_31:1_[M+H]1+/Phosphatidylethanolamine-O_34:2_[M+H]1+ levels,14358
11,Electrocardiogram morphology (amplitude at temporal datapoints) [34 ms],4805
11,Facial morphology (segment 30),121
11,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Asian],36378
11,Serum metabolite levels [N-acetyl-aspartyl-glutamate (NAAG],60603
11,Electrocardiogram morphology (amplitude at temporal datapoints) [364 ms],12780
11,"Heel quantitative ultrasound index (qui), direct entry (left)",48802
11,"Forced expiratory volume in 1-second (fev1), best measure",156550
11,Malignant neoplasm of breast (controls excluding all cancers),1115
11,Hypertensive Heart Disease,1525
11,Multiple myeloma (IgH translocation) [t11;14 vs. controls],995
11,Protein quantitative trait loci [SAA],657
11,Atrial fibrillation and flutter with reimbursement,58
11,Chronic obstructive pulmonary disease x ever smoker interaction (2df),148
11,Rubella-specific interleukin-6 secretion,229
11,Palmitoleic acid (16:1n-7) levels,26690
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:1/Phosphatidylcholine with acyl-alkyl residue sum C40:5],12763
11,Alcohol consumption x experiences in childhood (felt loved by family member) interaction,5968
11,Lysophosphatidylethanolamine-P_20:0_[M-H]1- levels,12763
11,Urinary metabolite levels in chronic kidney disease [Alanine],5638
11,"Diverticular disease/diverticulitis | non-cancer illness code, self-reported",827
11,Lofepramine | treatment/medication code,9234
11,Diacylglycerol_36:2_[M+NH4]1+ levels,2230
11,Protein quantitative trait loci (liver) [SERPINA3],316
11,Frequency of stair climbing in last 4 weeks,101
11,Digit length ratio (left hand) [EA],481
11,Calcium levels,352072
11,Uterine fibroids,47180
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:5/Sphingomyelin with acyl residue sum C24:0],12763
11,Serum metabolite levels [glycosyl-N-(2-hydroxynervonoyl)-sphingosine (d18:1/24:1(2OH))*],396
11,White matter microstructure (mean diusivities) [Inferior fronto-occipital fasciculus],216
11,"Subcortical brain region volumes [Caudate, EA]",81
11,Influenza A (H1N1) infection,3
11,Electrocardiogram morphology (amplitude at temporal datapoints) [228 ms],17
11,Serum metabolite levels [1-palmitoyl-2-stearoyl-GPC (16:0/18:0],24565
11,Aspartate aminotransferase to alanine aminotransferase ratio,4646
11,Phosphatidylglycerol(35:3)_[M-H]1- levels,12014
11,Serum metabolite levels (CMS) [EstC],12139
11,Pattern 1 | hair/balding pattern,15349
11,Urate levels [South Asian],1132
11,Myopia (age of diagnosis),2667
11,Smoking cessation,1099
11,Nitrogen dioxide air pollution; 2006,1005
11,Childhood body mass index,1162
11,Chronic obstructive pulmonary disease or coronary artery disease (pleiotropy),95
11,Electrocardiogram morphology (amplitude at temporal datapoints) [210 ms],17
11,ILD related to systemic autoimmune disease,75
11,Phosphatidylcholine_36:7_[M+OAc]1-/Phosphatidylserine_40:6_[M-H]1- levels,12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:3/Hydroxysphingomyelin with acyl residue sum C22:2],12763
11,Triacylglyceride levels [TAG(56:6;0],12763
11,Electrocardiogram morphology (amplitude at temporal datapoints) [430 ms],8598
11,Benign neoplasms (controls excluding all cancers),3571
11,"Blood protein levels [SMPD1, 10818_36_3]",848
11,Smoking behaviour (cigarettes smoked per day),16021
11,Number of treatments/medications taken,12376
11,Phosphatidate(34:2)_[M-H]1- levels,12014
11,Eosinophill count,141474
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C40:4],12763
11,Triacylglyceride levels [TAG(56:5;0],13183
11,Phosphatidylcholine-O(34:1)_[M+H]1+/Phosphatidylcholine-P(34:0)_[M+H]1+/Phosphatidylethanolamine-O(37:1)_[M+H]1+ levels,3087
11,Protein quantitative trait loci (liver) [OAT],822
11,Triacylglycerol(50:4)_[M+NH4]1+ levels,3087
11,Serum levels of protein SIAE,45
11,Mean corpuscular volume,1657508
11,LDL cholesterol levels,80278
11,Phosphatidylethanolamine levels [PE(18:0;0-18:2;0],12763
11,Fatty acid(18:4)_[M-H]1- levels,12763
11,Phosphatidylglycerol_34:0_[M-H]1- levels,12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C38:4/Sphingomyelin with acyl residue sum C16:0],13183
11,Metabolite levels [PC 34:2],12763
11,3mm strong meridian (left),45400
11,Nevus count or cutaneous melanoma,14542
11,Lung cancer,10480
11,Postoperative survival time in hepatocellular carcinoma,2430
11,Sudden cardiac arrest [Recessive],371
11,"Malignant melanoma | cancer code, self-reported",600
11,Serum levels of protein BMP6,205
11,Cotinine glucuronidation,49
11,Total body bone mineral density (age over 60),13792
11,N-formylanthranilic acid levels,4195
11,Diabetes or endocrine disease,68900
11,Insomnia,132066
11,Phosphatidylcholine-ether levels [PCO(18:1;0-20:3;0],11815
11,Hemoglobin,172552
11,Serum metabolite concentrations in chronic kidney disease [Lysophosphatidylcholine with acyl residue C20:4],12763
11,Total body bone mineral density (age 45-60),7367
11,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test),1088
11,Doctor diagnosed bronchiectasis,677
11,"Blood protein levels [JAM3, 2998_53_2]",625
11,Blood protein levels [IL18],323
11,"""Primary coxarthrosis, bilateral""",23
11,Nonatopic asthma,28069
11,Phosphatidylserine-O_42:6_[M+H]1+ levels,12139
11,"Blood protein levels [ANGPTL3, 10391_1_3]",2120
11,Serum metabolite levels [PUFA_FA],12763
11,Serum metabolite levels [M_VLDL_L],2275
11,"Blood protein levels [ESAM, 2981_9_3]",1034
11,"Smoking initiation (ever regular vs never regular) [Conditioned on chr11:112984491, chr11:112912811]",513
11,Alcohol consumption (heavy vs. light/non-drinkers),12564
11,Average weekly red wine intake,18071
11,Body mass index (joint analysis main effects and physical activity interaction) [EA],86280
11,Mean reticulocyte volume,518528
11,"Heel bone mineral density (bmd) t-score, automated",110833
11,Mean corpuscular haemoglobin,183917
11,Glycemic traits (pregnancy) [FPG],258
11,CD16-CD56 on HLA DR+ Natural Killer,232
11,Lateral ventricular volume in normal aging,48
11,"For short-sightedness, i.e. only or mainly for distance viewing such as driving, cinema etc (called 'myopia') | reason for glasses/contact lenses",6
11,Rheumatic heart disease,62
11,Cognitive performance,78329
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with diacyl residue sum C40:4],11815
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C42:1/Phosphatidylcholine with acyl-alkyl residue sum C36:3],12139
11,Electrocardiogram morphology (amplitude at temporal datapoints) [366 ms],12780
11,Clomipramine | treatment/medication code,116
11,Medication use (calcium channel blockers),108932
11,Glycated hemoglobin levels,72831
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C44:4/Phosphatidylcholine with acyl-alkyl residue sum C44:5],11815
11,Hip circumference,175310
11,Pipecolate levels,6723
11,Serum metabolite levels [1-stearoyl-2-linoleoyl-GPI (18:0/18:2],1062
11,White matter hyperintensity volume x hypertension interaction (2df),2810
11,Idiopathic pulmonary fibrosis,1277
11,Platelet count,2172658
11,Glaucoma (primary open-angle),102263
11,Red blood cell fatty acid levels [DPA-n3],12238
11,Smoking status (ever vs never smokers),34962
11,Serum metabolite levels [1linoleoylglycerophosphoethanolamine],12763
11,Serum metabolite levels [M_HDL_TG],2275
11,Number of sexual partners,1299
11,Age-related diseases and mortality,2664
11,Birth weight of first child,4476
11,Heavy menstrual bleeding,1241
11,Desulfovibrionales abundance in stool,15
11,Phosphatidylethanolamine_39:4_[M-H]1- levels,12763
11,Serum metabolite levels [UnSat],12763
11,Arm predicted mass (right),102641
11,Cataracts,10326
11,Phosphatidylcholine_38:7_[M+OAc]1-/Phosphatidylserine_42:6_[M-H]1- levels,12763
11,Adult diffuse glioma (IDH mutation),4029
11,Neurological blood protein biomarker levels [SMPD1],848
11,Hydroxyasparagine levels,2850
11,Serum levels of protein TIRAP,213
11,"Umbilical hernia | non-cancer illness code, self-reported",156
11,Irritability,1003
11,Menarche (age at onset) [japanese],132
11,Type 1 diabetes,58438
11,Hypothyroidism nos,33982
11,Lysophosphatidylethanolamine levels [LPE(18:2;0],12763
11,Metabolite levels [PC 36:2],12613
11,Phosphatidylcholine-O(39:1)_[M+H]1+/Phosphatidylethanolamine-P(39:0)_[M+H]1+ levels,3087
11,Serum metabolite levels [3beta-hydroxy-5-cholestenoate],2239
11,Depression (broad),1048
11,"Blood protein levels [EA, Interleukin-25]",95
11,Life satisfaction,67696
11,Phosphatidylcholine levels [PC(16:1;0-18:2;0],15197
11,"None of the above | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",47943
11,Trunk fat percentage,216489
11,"Hayfever, allergic rhinitis or eczema | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",33344
11,Feeling guilty,12380
11,Warfarin | treatment/medication code,154
11,Acute lymphoblastic leukemia (childhood),2250
11,Multiple gestation,55
11,Childhood ear infection,90
11,Phosphatidylinositol_36:0_[M+H]1+ levels,12763
11,"Blood protein levels [C1R, 3285_23_2]",38492
11,Protein quantitative trait loci (liver) [C11orf54],21229
11,Fasting insulin,1378
11,Protein quantitative trait loci (liver) [CTSD],24
11,Multisite chronic pain,1029
11,Glycemic traits [FPG],251
11,Electrocardiogram morphology (amplitude at temporal datapoints) [374 ms],17
11,BMI in non-smokers,41624
11,Neurofibrillary tangles (SNP x SNP interaction),27313
11,Cataracts [conditional],55696
11,Fatty acid(20:3)_[M-H]1- levels,8191
11,Lysophosphatidylcholine_22:6_[M+H]1+ levels,12763
11,Serum metabolite levels [1-palmitoyl-2-arachidonoyl-GPC (16:0/20:4n6],15528
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with diacyl residue sum C40:5],12763
11,3-methylhistidine levels,1461
11,Electrocardiogram morphology (amplitude at temporal datapoints) [-100 ms],254
11,Gout vs asymptomatic hyperuricemia,1797
11,Percent mammographic density,202
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C40:5],12613
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:4/Phosphatidylcholine with acyl-alkyl residue sum C36:2],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with diacyl residue sum C42:4],12238
11,None of the above | qualifications,36823
11,Arm fat-free mass (left),113478
11,Postprandial triglyceride response to high fat diet meal [AUC],2120
11,Triacylglycerol_54:4_[M+NH4]1+ levels,2120
11,Malaria [dominant],42
11,Phosphatidylcholine-O_34:2_[M+OAc]1-/Phosphatidylcholine-P_34:1_[M+OAc]1-/Phosphatidylserine-O_38:1_[M-H]1- levels,12613
11,Phosphatidylcholine(38:4)_[M+OAc]1-/Phosphatidylserine(42:3)_[M-H]1- levels,12014
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C36:4],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C38:5/Sphingomyelin with acyl residue sum C24:0],12763
11,Lipoprotein-associated phospholipase A2 activity and mass [Activity concentrations],2120
11,White matter microstructure (mode of anisotropy) [Posterior limb of internal capsule],1551
11,Breast cancer | illnesses of siblings,91
11,Protein quantitative trait loci (liver) [CAST],25
11,Nasal polyps,12763
11,"Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",2699
11,Serum metabolite levels [L_VLDL_C],2923
11,Retinal vascular fractal density,2682
11,Body mass index (joint analysis main effects and physical activity interaction) [men],1192
11,Protein quantitative trait loci (liver) [FDXR],6
11,Inflammatory bowel disease,50251
11,Lung adenocarcinoma,11239
11,Worry too long after embarrassment,36858
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C40:5/Phosphatidylcholine with acyl-alkyl residue sum C36:2],12613
11,Nonatopic asthma or type 2 diabetes,12763
11,Sphingomyelin(44:9)_[M+H]1- levels,11043
11,Electrocardiogram morphology (amplitude at temporal datapoints) [438 ms],8598
11,Worry/vulnerability (special factor of neuroticism),6122
11,Diacylglycerol_34:1_[M+H-H2O]1+ levels,2120
11,Quinate levels,458
11,Smoking initiation (ever regular vs never regular) (MTAG),123164
11,Serum levels of protein TMX3,10074
11,High-density lipoprotein 3 cholesterol levels,12228
11,Electrocardiogram morphology (amplitude at temporal datapoints) [466 ms],8598
11,Morning/evening person (chronotype),11583
11,Hemoglobin A1c levels,374763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:5/Phosphatidylcholine with acyl-alkyl residue sum C36:2],12763
11,Protein quantitative trait loci (liver) [ATP6V1E1],55
11,Cutaneous squamous cell carcinoma,1358
11,Past tobacco smoking,2583
11,Body fat distribution (arm fat ratio) [females],14261
11,Lysophosphatidylethanolamine_18:2_[M-H]1- levels,12613
11,Electrocardiogram morphology (amplitude at temporal datapoints) [116 ms],25376
11,"Tongue cancer | cancer code, self-reported",18435
11,Electrocardiogram morphology (amplitude at temporal datapoints) [-108 ms],731
11,"""Type 1 diabetes, wide definition, subgroup 1""",846
11,Brain region volumes [left lateral ventricle],1101
11,Brain region volumes [right cuneus],72
11,Alcohol consumption x traumatic event in childhood (felt hated by family member) interaction,2
11,"Hematology traits [AA, HCT]",845
11,"Subcortical brain region volumes [Putamen, EA]",8739
11,Body fat percentage [male],66696
11,Provencibacterium abundance in stool,11180
11,Sphingomyelin(41:1)_[M+H]1+ levels,3087
11,Body mass index (SNP x SNP interaction),779
11,Diabetic background retinopathy,846
11,DVT of lower extremities and pulmonary embolism,853
11,"Rosacea | non-cancer illness code, self-reported",190
11,Skin pigmentation,821
11,Reticulocyte count,370324
11,Apolipoprotein A1 levels,587937
11,HLA DR+ CD8+ T cell %T cell,2476
11,Stable angina pectoris,18314
11,Autoimmune diseases,42069
11,Sphingomyelin_35:1_[M+H]1+ levels,2120
11,"""Type1 diabetes, definitions combined""",846
11,Verbal-numerical reasoning,1727
11,"""Malignant neoplasm of breast, HER2-negative (controls excluding all cancers)""",1163
11,Chronic obstructive pulmonary disease (severe),400
11,Acute lymphoblastic leukemia (childhood) [ETV6-RUNX1 positive],2250
11,Protein quantitative trait loci (liver) [STARD10],591
11,"""Malignant neoplasm of breast, HER-positive (controls excluding all cancers)""",58
11,Metabolite levels [Glycerolphosphocholine],12238
11,Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded),3734
11,Galectin-3 levels,581
11,Very low density lipoprotein cholesterol levels,2120
11,"""Malignant neoplasm of breast, HER-negative""",58
11,Plasma thyroid-stimulating hormone levels,132
11,Triglycerides,532390
11,BMI (adjusted for smoking behaviour),41635
11,C-reactive protein levels [BMI-adjusted],19157
11,Blood metabolite ratios [arachidonate (20:4n6)/dihomo-linolenate (20:3n3 or n6],12139
11,Interleukin-6 receptor subunit beta measurement,1673
11,Metabolite levels [TAG 54:5],2120
11,OTU99_4 (Alistipes) abundance,49
11,Serum levels of protein PDGFD,80
11,Eosinophil counts,1408680
11,Metabolite levels [CE 16:0],12139
11,Phosphatidylcholine-O_36:3_[M+OAc]1-/Phosphatidylcholine-P_36:2_[M+OAc]1-/Phosphatidylserine-O_40:2_[M-H]1- levels,12763
11,Triacylglycerol(56:7)_[M+NH4]1+ levels,12014
11,Phosphatidylserine_36:1_[M+H]1+/Phosphatidylglycerol_36:3_[M+NH4]1+ levels,12763
11,Chronic obstructive pulmonary disease x current smoker interaction (main effect),672
11,"Blood protein levels [BMP6, 8459_10_3]",249
11,Glioblastoma,454
11,White matter microstructure (axial diusivities) [External capsule ],216
11,Language functional connectivity,135
11,Crohn's disease [EA],24671
11,Gondoic acid (20:1n-9) levels,12228
11,Breast milk fatty acid composition (maternal genotype effect) [arachidonic acid],11758
11,Basal cell carcinoma,52591
11,Cholesteryl ester levels [CE(16:0;0],12139
11,Serum metabolite levels [MUFA_FA],12763
11,Walking for pleasure (not as a means of transport) | types of physical activity in last 4 weeks,7378
11,"Intra-ocular pressure, goldmann-correlated (right)",45116
11,White blood cell (leukocyte) count,112254
11,Metabolite levels [TAG 54:2],2120
11,Urate levels [East Asian],956
11,Blood sugar levels,947
11,Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid) [Conditioned on rs174547],12763
11,Interleukin-18 levels,17822
11,Phosphatidylcholine-O_36:2_[M+H]1+/Phosphatidylcholine-P_36:1_[M+H]1+/Phosphatidylethanolamine-P_39:1_[M+H]1+ levels,14883
11,Serum levels of protein CST6,23326
11,Sphingomyelin_40:2_[M+H]1+ levels,2120
11,TestASV_4 (Alistipes) abundance,49
11,"""Disorders of thyroid, IBD co-morbidities""",243
11,Phosphatidylcholine-O_38:4_[M+H]1+/Phosphatidylcholine-P_38:3_[M+H]1+ levels,14883
11,"Heel bone mineral density (bmd) t-score, automated (left)",28291
11,Hip circumference [EA],12058
11,Bone properties (heel) [BUA],1783
11,Matrix metalloproteinase-10 levels,4870
11,Serum levels of protein CDON,1157
11,Curve progression in adolescent idiopathic scoliosis,700
11,"N,n,n-trimethyl-alanylproline betaine (tmap) levels",301
11,Left-handedness,23833
11,Serum metabolite levels [1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6)*],12327
11,Gallstone disease,12763
11,Electrocardiogram morphology (amplitude at temporal datapoints) [422 ms],8598
11,Serum metabolite levels [Serum_TG],2275
11,White wine intake,924
11,Urate levels [Urate],1797
11,"""Universal eryhrodermia, KELA reimbursement""",23
11,Change in serum metabolite levels (CMS) [DHA_FA],12763
11,Neuroticism conditioned on self-rated math ability (multi-trait conditioning and joint analysis),47925
11,Phosphatidylcholine_35:3_[M+H]1+/Phosphatidylethanolamine_38:3_[M+H]1+/Phosphatidate_40:4_[M+NH4]1+ levels,12763
11,Triacylglycerol(54:4)_[M+NH4]1+ levels,3087
11,"Blood protein levels [CDH12, 8329_166_3]",38492
11,Arm predicted mass (left),111116
11,Mean arterial pressure x alcohol consumption interaction (2df test) [EA],3982
11,Phosphatidylcholine(37:4)_[M+H]1+/Phosphatidylethanolamine(40:4)_[M+H]1+/Phosphatidate(42:5)_[M+NH4]1+ levels,12014
11,E-selectin levels,484
11,IgM levels,266
11,Insulin-like growth factor 1 levels,500789
11,Metabolite levels [SM d18:2/22:0],26609
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C32:0/Phosphatidylcholine with diacyl residue sum C34:3],12763
11,Leg fat-free mass (right),115391
11,Phosphatidylcholine-O_42:6_[M+OAc]1-/Phosphatidylcholine-P_42:5_[M+OAc]1- levels,12763
11,Phosphatidylcholine-2O_32:0_[M+H]1+ levels,2120
11,Colorectal cancer x fine particulate matter exposure levels interaction,9728
11,Hypertrophic cardiomyopathy (sarcomere positive),51
11,Coagulation defects,1021
11,Electrocardiogram morphology (amplitude at temporal datapoints) [214 ms],17
11,Cholesterol levels,6
11,Neutrophil count,864259
11,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],12306
11,Gastroesophageal reflux disease,18724
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with diacyl residue sum C42:1],12763
11,Bezafibrate | treatment/medication code,2120
11,Phosphatidylcholine_34:1_[M+H]1+/Phosphatidylethanolamine_37:1_[M+H]1+/Phosphatidate_39:2_[M+NH4]1+ levels,2120
11,Macular thickness,8403
11,Heel bone mineral density variance,1040
11,Sex hormone-binding globulin levels,482695
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C38:2/Phosphatidylcholine with acyl-alkyl residue sum C40:5],12763
11,Serum metabolite levels [arachidonate204n6],12139
11,Metabolite levels [TAG 58:11],12139
11,Body mass index [men],1192
11,Blood metabolite levels [X-03094],2120
11,Cooked vegetable consumption,3686
11,Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda based profile),995
11,White matter microstructure (mode of anisotropy) [Average across all tracts],666
11,Educational attainment (years of education),209066
11,Ceramide_42:1_[M+OAc]1- levels,12763
11,Sphingomyelin_38:2_[M+OAc]1- levels,2813
11,Corneal hysteresis (right),17316
11,Mean arterial pressure [Japanese],4454
11,Protein quantitative trait loci (liver) [EIF2B1],1452
11,Phosphatidylcholine_37:3_[M+OAc]1-/Phosphatidylserine_41:2_[M-H]1- levels,3503
11,Type 1 diabetes with other specified/multiple/unspecified complications,846
11,Diabetic hypoglycemia,846
11,Metabolic syndrome (bivariate traits) [TG-GLUC],8437
11,Lysophosphatidylcholine_20:4_[M+H]1+ levels,14883
11,Phosphatidylcholine_36:2_[M+OAc]1-/Phosphatidylserine_40:1_[M-H]1- levels,12763
11,Triacylglycerol(51:2)_[M+NH4]1+ levels,3087
11,Serum metabolite levels [Acetylcarnitine],1989
11,Endometriosis,3557
11,Epidermal growth factor levels,3931
11,Serum metabolite levels [LA],2923
11,"Melanomas of skin, dx or hx",589
11,Protein quantitative trait loci (liver) [SOD2],324
11,Cerebrospinal fluid biomarker levels [VPS10 domain-containing receptor SorCS2],255
11,Family history of Alzheimer's disease,27360
11,Body fat percentage and fasting glucose (pairwise),2537
11,Oily fish intake,35423
11,Cholesteryl ester_20:3_[M+NH4]1+ levels,14978
11,Phosphatidylinositol_35:2_[M-H]1- levels,12763
11,Serum metabolite levels (CMS) [M_VLDL_FC],15038
11,"Ibuprofen (e.g. nurofen) | medication for pain relief, constipation, heartburn",1501
11,Arthrosis,2489
11,Serum metabolite levels [Gp],2275
11,Serum metabolite levels [palmitoyl-linoleoyl-glycerol (16:0/18:2) [2]*],531
11,Protein quantitative trait loci (liver) [TMSB10],25
11,Bone mineral density (hip) and hip bone size,69
11,"Waist circumference adjusted for body mass index [EA, men]",7669
11,Liver enzyme levels (alanine transaminase),151666
11,Sphingomyelin_36:2_[M+H]1+ levels,14259
11,Cortical thickness,174530
11,Cholesterol ester levels in medium VLDL,569
11,Diacylglycerol(34:3)_[M+H-H2O]1+ levels,3087
11,Pigment spots (darkness),275
11,Systolic blood pressure and diastolic blood pressure (bivariate analysis),47
11,LDL cholesterol levels in current drinkers [EA],12620
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C32:0/Phosphatidylcholine with diacyl residue sum C34:2],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C38:5],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with diacyl residue sum C38:4],12763
11,Hallux valgus (acquired),72991
11,Male puberty timing (age at voice breaking MTAG),6033
11,Serum levels of protein THYN1,1331
11,Prostate cancer [European],1650
11,Chronic Coagulation defects,1557
11,"""Malignant neoplasm of breast, HER-negative (controls excluding all cancers)""",74
11,Anorexia nervosa,218
11,Serum levels of protein SMPD1,848
11,Metabolite levels [Glc],136
11,Bipolar disorder,136706
11,Walking pace,67189
11,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],54978
11,Phosphatidylethanolamine_36:2_[M-H]1- levels,12763
11,Metabolite levels [LPE 20:4],12139
11,"Blood protein levels [SERPING1, 4479_14_2]",38492
11,Cerebral aneurysm,9126
11,Phosphatidylcholine(40:5)_[M+H]1+ levels,11043
11,Diacylglycerol_42:7_[M+H-H2O]1+ levels,2120
11,Lymphocytic leukemia,282
11,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],14878
11,Phosphatidylcholine levels [PC(16:0;0-20:5;0],12763
11,Vertex-wise sulcal depth,206448
11,Serum metabolite levels [3b-hydroxy-5-cholenoic acid],907
11,Length of menstrual cycle,8775
11,Brain region volumes [X3rd ventricle],5137
11,Metabolic traits [alpha-hydroxyisovalerate + 6 other traits],5957
11,Inflammatory bowel disease [EA],39504
11,Serum metabolite levels [cerotoylcarnitine (C26)*],2430
11,Calcaneus stiffness index,3366
11,Sphingomyelin_34:0_[M+H]1+ levels,2120
11,Polycystic ovary syndrome,5904
11,Electrocardiogram morphology (amplitude at temporal datapoints) [352 ms],12780
11,Impedance of arm (right),171700
11,"""Hypothyroidism,  other/unspecified""",33822
11,Breast cancer (early onset),359
11,Serum levels of protein CTSD,1542
11,Sphingolipid levels [levels],916
11,Metabolite levels [TAG 56:3],2120
11,Ascending aorta minimum area,2762
11,Emergencia abundance in stool,111
11,Skin pigmentation traits [phototype score],589
11,High-sensitivity cardiac troponin I concentration (MTAG),4248
11,Serum metabolite levels (CMS) [XL_HDL_C],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C44:4/Phosphatidylcholine with acyl-alkyl residue sum C44:6],11815
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C36:4],12763
11,1-carboxyethylvaline levels,538
11,Benign neoplasm: Caecum (controls excluding all cancers),212
11,Total bilirubin levels,50383
11,Electrocardiogram morphology (amplitude at temporal datapoints) [440 ms],8598
11,Serum metabolite levels [asparagine],17360
11,Neutrophill percentage,56724
11,TB-LM or TBLH-BMD (pleiotropy),8462
11,Systolic blood pressure x alcohol consumption interaction (2df test) [AA],169
11,Serum levels of protein C1QTNF5,810
11,"Blood protein levels [KIAA1549L, 11145_72_3]",376
11,Prostate cancer,112094
11,Relative age voice broke,5509
11,Educational attainment (years of education) [conditional-joint],121531
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with acyl-alkyl residue sum C38:5],12763
11,Triglycerides-Blood Pressure (TG-BP),10355
11,"Mean arterial pressure x alcohol consumption interaction (2df test) [AA, EA]",737
11,Serum metabolite levels [S_VLDL_TG],2275
11,Phosphatidylcholine-O_39:0_[M+H]1+/Phosphatidylethanolamine-O_42:0_[M+H]1+ levels,2120
11,"Red | hair colour (natural, before greying)",2502
11,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),12550
11,Low density lipoprotein cholesterol levels [EA],15059
11,Glycerophospholipid levels [Phosphatidylcholine diacyl C40:5],12763
11,Metabolic syndrome [GLU],264
11,"""Cardiomyopathies, Primary/intrinsic""",266
11,Serum metabolite levels [glycocholenate sulfate*],2239
11,Childhood onset type 2 diabetes,281
11,"Schizophrenia, bipolar disorder and depression (combined)",213
11,Platelet endothelial cell adhesion molecule levels,859
11,Smoking behaviour (cigarette pack-years),9536
11,Hemoglobin levels,121719
11,Interleukin-1 receptor-like 1 measurement,1179
11,Red blood cell (erythrocyte) count,116445
11,Monobrow,10549
11,CD20 on transitional B cell,9851
11,Triacylglycerol_54:2_[M+NH4]1+ levels,2120
11,Electrocardiogram morphology (amplitude at temporal datapoints) [-28 ms],241
11,Maximum habitual alcohol consumption,112
11,Dimethylamine levels,106
11,Electrocardiogram morphology (amplitude at temporal datapoints) [156 ms],17
11,Time spent watching television (tv),42431
11,Phosphatidylserine-P_42:1_[M+H]1+/Phosphatidylglycerol-P_42:6_[M+NH4]1+ levels,12763
11,Phosphatidylcholine_40:6_[M+OAc]1-/Phosphatidylserine_44:5_[M-H]1- levels,12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C42:5],12613
11,Fibrinogen levels,24616
11,"Gut microbiota (bacterial taxa, hurdle binary method) [G_Dialister_HB]",638
11,Smoking initiation (ever regular vs never regular) [Conditioned on chr11:132098205],47
11,Sum basophil neutrophil counts,100451
11,Household income (MTAG),29528
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C32:2/Phosphatidylcholine with diacyl residue sum C34:4],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:5/Phosphatidylcholine with diacyl residue sum C38:3],12763
11,Arterial stiffness index,1567
11,Autism and major depressive disorder (MTAG),1003
11,Serum metabolite levels [stearidonate (18:4n3],12427
11,Serum metabolite levels [L_VLDL_P],2275
11,Electrocardiogram morphology (amplitude at temporal datapoints) [338 ms],12780
11,Red blood cell (erythrocyte) distribution width,120117
11,Prostate-specific antigen levels,230
11,Ascorbic acid 3-sulfate levels,719
11,Kidney stones,2135
11,Peripheral artery disease,4250
11,Femur bone mineral density x serum urate levels interaction [female],427
11,None of the above | attendance/disability/mobility allowance,105
11,Intraocular pressure,417771
11,Morningness,165673
11,Optic disc area,9093
11,Unspecified diffuse connective tissue disease,9577
11,Red blood cell fatty acid levels [OA],12763
11,Serum metabolite levels [1-stearoyl-2-arachidonoyl-GPE (18:0/20:4],12429
11,"Dark brown | hair colour (natural, before greying)",109131
11,Electrocardiogram morphology (amplitude at temporal datapoints) [458 ms],8598
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:4/Phosphatidylcholine with diacyl residue sum C38:3],12763
11,Triglyceride levels in HIV infection [EA],1940
11,Nicotine dependence and major depression (severity of comorbidity),110
11,Osteoarthritis (with total knee replacement),150
11,Attention deficit hyperactivity disorder (MTAG),105
11,Type 2 diabetes [EA],4433
11,Myoglobin levels,4565
11,Ceramide_40:1_[M-H]1- levels,12613
11,HDL cholesterol [additive],2703
11,Atopic dermatitis,73509
11,Osteoarthritis of the hip or knee,5842
11,"Cholesterol lowering medication | medication for cholesterol, blood pressure or diabetes",2382
11,Salbutamol | treatment/medication code,854
11,Malignant neoplasm,90
11,Hypothyroidism,138882
11,Breast milk fatty acid composition (infant genotype effect) [arachidonic acid],11758
11,Alanine transaminase levels,15386
11,Free thyroxine concentration,41603
11,Total cholesterol levels [conditional],11949
11,Serum metabolite levels (CMS) [ApoA1],41659
11,3mm strong meridian (right),42077
11,Provencibacterium massiliense abundance in stool,11180
11,Electrocardiogram morphology (amplitude at temporal datapoints) [-74 ms],628
11,Serum metabolite levels [SFA],2275
11,None of the above (group 2) | illnesses of father,444
11,Protein quantitative trait loci (liver) [LASP1],25
11,Nervous feelings,16250
11,Phosphatidylcholine levels [PC(16:0;0-20:4;0],12983
11,Biological sex,48542
11,Electrocardiogram morphology (amplitude at temporal datapoints) [122 ms],25376
11,Serum metabolite levels [beta-citrylglutamate],15158
11,Sphingomyelin(36:2)_[M+H]1+ levels,3087
11,"Body mass index (joint analysis main effects and physical activity interaction) [EA, women]",5590
11,QT dynamics during exercise,13200
11,Endometriosis or depression (pleiotropy),680
11,Blood protein levels [Macrophage metalloelastase],475
11,Sphingomyelin(38:0)_[M+H]1+ levels,3087
11,Protein quantitative trait loci (liver) [CCDC58],166
11,6mm cylindrical power angle (right),15
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C36:5],12763
11,Electrocardiogram morphology (amplitude at temporal datapoints) [104 ms],25359
11,Mental health study participation (completed survey),950
11,Ascending aorta maximum area,2828
11,Cholesteryl ester(18:1)_[M+NH4]1+ levels,3087
11,Serum metabolite levels [VLDL_C],2275
11,Fractured/broken bones in last 5 years,1045
11,Gamma glutamyl transferase levels,222391
11,Lysophosphatidylethanolamine levels [LPE(20:4;0],12139
11,Glycerophospholipid levels [Phosphatidylcholine diacyl C38:5],12763
11,Serum metabolite levels [TG_PG],43934
11,Aortic root size,1122
11,Facial depth [Upper facial depth],216
11,HVEM on CD45RA- CD4+ T cell,376
11,Electrocardiogram morphology (amplitude at temporal datapoints) [180 ms],17
11,"""Persons encountering health services for other counselling and medical advice, not elsewhere classified""",4
11,Depressed affect,10554
11,Sleep duration,60104
11,Diacylglycerol_38:6_[M+H-H2O]1+ levels,12763
11,Serum metabolite levels [1-stearoyl-GPC (18:0],12427
11,Electrocardiogram morphology (amplitude at temporal datapoints) [290 ms],12780
11,Rheumatoid arthritis [EA],32381
11,Snoring [adjusted for BMI],1700
11,"Blood protein levels [MMP3, 2788_55_1]",1880
11,Umbilical hernia,541
11,"Body mass index [EA, men]",516
11,Serum metabolite levels [XL_VLDL_P],2275
11,Small VLDL particle concentration,5975
11,Serum metabolite levels (CMS) [SM],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with diacyl residue sum C36:5],12763
11,None of the above | vascular/heart problems diagnosed by doctor,82769
11,Sphingomyelin_41:2_[M+H]1+ levels,2120
11,Phosphatidylinositol levels [PI(18:0;0-18:1;0],1005
11,White blood cell count (basophil),9543
11,Aplastic and other anaemias,42
11,Phosphatidylcholine_35:4_[M+OAc]1-/Phosphatidylserine_39:3_[M-H]1- levels,12763
11,Serum levels of protein QPCT,2531
11,Electrocardiogram morphology (amplitude at temporal datapoints) [332 ms],12815
11,Corrected insulin response,235
11,Bipolar disorder vs major depressive disorder (ordinary least squares (OLS)),449
11,Plasminogen activator inhibitor type 1 levels (PAI-1),196
11,Serum metabolite levels [palmitoyl-linoleoyl-glycerol (16:0/18:2) [1]*],531
11,Electrocardiogram morphology (amplitude at temporal datapoints) [296 ms],17
11,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Asian],12151
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with diacyl residue sum C40:5],12763
11,Blood metabolite levels [1-arachidonoylglycerophosphoethanolamine],12763
11,Triglyceride levels in current drinkers [EA],12347
11,Obesity due to excess calories,2842
11,"Acute lymphoblastic leukemia (childhood) [ETV6-RUNX1 positive, Northern European]",2250
11,Home location at assessment - north co-ordinate (rounded),439
11,"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment",3034
11,Metabolite levels [Cer d18:1/24:1],13746
11,Mixed hyperlipidaemia,2120
11,Serum levels of protein MMP8,2388
11,Cysteinylglycine levels,5006
11,Other nutritional deficiencies,1246
11,CD39 on monocyte,140
11,Protein quantitative trait loci (liver) [EMILIN2],522
11,Alzheimer's disease in APOE e4- carriers,11297
11,Body mass index (joint analysis main effects and physical activity interaction),86230
11,Fat-free mass [male],30461
11,Phosphatidylinositol_38:4_[M+NH4]1+ levels,12763
11,Femoral neck section modulus,9243
11,Entropion and trichiasis of eyelid,235
11,Age-related hearing impairment (SNP x SNP interaction),1869
11,Seropositive rheumatoid arthritis,138
11,Lung function (FEV1/FVC),521935
11,Phosphatidylethanolamine(34:2)_[M+H]1+ levels,12014
11,Serum metabolite ratios in chronic kidney disease [Lysophosphatidylcholine with acyl residue C18:1/Lysophosphatidylcholine with acyl residue C20:4],12763
11,Blood protein levels [Spondin-1],1318
11,Electrocardiogram morphology (amplitude at temporal datapoints) [346 ms],12780
11,Eosinophill percentage,159566
11,"""Hypothyroidism, strict autoimmune, 3 medication purchases required""",33822
11,Serum metabolite levels (CMS) [S_VLDL_C],2275
11,Phosphatidylcholine-O_31:0_[M+H]1+/Phosphatidylethanolamine-O_34:0_[M+H]1+ levels,2120
11,CXADR-like membrane protein levels,679
11,Mild influenza (H1N1) infection,3
11,Phosphatidylethanolamine_38:3_[M-H]1- levels,12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with diacyl residue sum C40:4],12763
11,BMI (adjusted for smoking behaviour) [women],1031
11,Benign neoplasms,4601
11,Cooked vegetable intake,847
11,Bladder cancer,1054
11,Phosphatidylcholine-O_37:2_[M+H]1+/Phosphatidylcholine-P_37:1_[M+H]1+/Phosphatidylethanolamine-O_40:2_[M+H]1+ levels,2120
11,Long QT syndrome,426
11,Blood protein levels [MMP-10],29
11,Electrocardiogram morphology (amplitude at temporal datapoints) [178 ms],17
11,Cheese intake,98715
11,Systemic lupus erythematosus [EA],27368
11,Body mass index [Japanese],42754
11,White matter microstructure (axial diusivities) [Anterior limb of internal capsule],1709
11,Fish- and plant-related diet [female],408
11,Diastolic blood pressure [Japanese],1576
11,Place of birth in uk - north co-ordinate,1445
11,Other maternal disorders predominantly related to pregnancy,136
11,Mean corpuscular hemoglobin,1138449
11,Diacylglycerol_38:4_[M+H-H2O]1+ levels,12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C36:4],12763
11,Electrocardiogram morphology (amplitude at temporal datapoints) [136 ms],25376
11,Electrocardiogram morphology (amplitude at temporal datapoints) [442 ms],8598
11,"Serum metabolite levels [sphingomyelin (d18:1/20:2, d18:2/20:1, d16:1/22:2)*]",12327
11,Bipolar disorder vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),449
11,Severe influenza A (H1N1) infection,29402
11,Renal cell carcinoma,3186
11,Electrocardiographic traits [QT interval],767
11,"""UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)""",854
11,Serum metabolite levels (CMS) [XXL_VLDL_C],2275
11,Natural Killer T %lymphocyte,232
11,Omacor 1g capsule | treatment/medication code,36
11,Fasting glucose,93168
11,Blood metabolite levels [dihomo-linolenate (20:3n3 or n6],2723
11,Otosclerosis,29499
11,Intrinsic epigenetic age acceleration,10426
11,Basophil percentage of granulocytes,3723
11,Serum metabolite levels [XS_VLDL_TG],2275
11,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [N-acetylkynurenine, N-acetylphenylalanine, N-acetyltryptophan, N-acetyltyrosine]",962
11,Chloride levels,910
11,Subjective well-being (MTAG),1208
11,Liver enzyme levels (alkaline phosphatase),90225
11,Phosphatidylinositol levels [PI(18:0;0-18:2;0],13183
11,Urate levels [AA],32662
11,Complement C1r subcomponent measurement,18446
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C38:6],12763
11,3mm weak meridian (left),28594
11,Red blood cell count [Pomak],1272
11,Metabolite levels [LPC 20:3],2723
11,Diverticular disease,2600
11,Intelligence (MTAG),38336
11,Phosphatidylcholine_32:2_[M+OAc]1-/Phosphatidylserine_36:1_[M-H]1- levels,12763
11,Phosphatidylinositol-O_36:0_[M-H]1- levels,12763
11,Serum metabolite levels [adrenate (22:4n6],12429
11,Spherical power (right),45384
11,Autoimmune traits (pleiotropy),16320
11,Diastolic blood pressure [East Asian],10622
11,Salicylate levels,343
11,Serum levels of protein DKK3,194
11,Body fat percentage or coronary artery disease (MTAG),70
11,Serum levels of protein LRRC4C,12
11,QT interval,52239
11,Serum metabolite levels (CMS) [XS_VLDL_L],12763
11,Serum metabolite levels [N-acetylphenylalanine],1279
11,Epilepsy [GGE],1027
11,"""Diabetes, insuline treatment (Kela reimbursement) (more control exclusions)""",3437
11,Electrocardiogram morphology (amplitude at temporal datapoints) [240 ms],2666
11,Retinal detachments and defects,1211
11,Selective IgA deficiency,1717
11,Electrocardiogram morphology (amplitude at temporal datapoints) [330 ms],17
11,Gut microbiota (bacterial taxa) [k__Bacteria|p__Bacteroidetes|c__Bacteroidia|o__Bacteroidales|f__Bacteroidaceae|g__Bacteroides|s__Bacteroides_xylanisolvens],10
11,Migraine without aura,1
11,Lung disease severity in cystic fibrosis,6781
11,Lipid traits (pleiotropy) (HIPO component 2),61425
11,Guilty feelings,19583
11,Plays computer games,28691
11,Osteoarthritis (hip) [additive],11453
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with diacyl residue sum C36:6],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with diacyl residue sum C36:4],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C38:5/Phosphatidylcholine with acyl-alkyl residue sum C38:3],12763
11,Triacylglycerol_52:1_[M+NH4]1+ levels,2120
11,Serum metabolite levels (CMS) [Serum_TG],2275
11,Triacylglycerol_54:5_[M+NH4]1+ levels,2120
11,Non-small cell lung cancer [East Asian],759
11,Serum levels of protein TCN1,210
11,Brain region volumes [left pericalcarine],72
11,Thiazide-induced adverse metabolic effects in hypertensive patients [AA-triglyceride response],28
11,HOMA-B (corrected for HOMA-IR),6
11,Systemic sclerosis,49977
11,Bioavailable testosterone levels,41512
11,Phosphatidylethanolamine_37:3_[M-H]1- levels,12763
11,Phosphatidylcholine-O(36:3)_M+H]1+/Phosphatidylcholine-P(36:2)_M+H]1+ levels,11043
11,Metabolite levels [TAG 54:3],2120
11,"Blonde | hair colour (natural, before greying)",139320
11,Phosphatidylcholine-O(40:5)_[M+H]1+/Phosphatidylcholine-P(40:4)_[M+H]1+ levels,12014
11,Serum metabolite levels (CMS) [XL_VLDL_P],2275
11,Dermatitis and eczema,1222
11,Protein quantitative trait loci (liver) [MAP4],25
11,Alzheimer's disease (late onset),111672
11,Medication use (antiglaucoma preparations and miotics),67546
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C32:2/Phosphatidylcholine with acyl-alkyl residue sum C36:3],11815
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C40:5],12763
11,Phosphatidylethanolamine-ether levels [PEO(16:1;0-20:4;0],12238
11,Electrocardiogram morphology (amplitude at temporal datapoints) [-110 ms],731
11,Atrial fibrillation/atrial flutter,2121
11,Protein quantitative trait loci (liver) [NME8],236
11,Triacylglycerol_48:3_[M+NH4]1+ levels,2120
11,Endometriosis of uterus,1241
11,High fasting blood glucose,246
11,Prevotella bivia abundance in stool,303
11,Retinal breaks without detachment,111
11,Parkinson's disease,10357
11,Hematocrit,391378
11,Celiac disease,55453
11,Leg fat mass (left),246733
11,Testosterone levels,24206
11,Iron status biomarkers (total iron binding capacity),25090
11,Metabolic syndrome [TG],2120
11,"Stomach cancer | cancer code, self-reported",1555
11,Endometriosis of ovary,1241
11,Phosphatidylcholine_40:7_[M+OAc]1-/Phosphatidylserine_44:6_[M-H]1- levels,3826
11,Human herpes virus 7 U14 antibody levels,763
11,Ulcerative colitis,17139
11,Primary sclerosing cholangitis,25361
11,Hyperthyroidism,299
11,Complement C1r subcomponent-like protein measurement,18446
11,Phosphatidylcholine_32:2_[M+H]1+/Phosphatidylethanolamine_35:2_[M+H]1+/Phosphatidate_37:3_[M+NH4]1+ levels,12763
11,Phosphatidylcholine(40:5)_[M+OAc]1-/Phosphatidylserine(44:4)_[M-H]1- levels,11043
11,Coronary artery disease or large artery stroke,2120
11,Migraine,10294
11,Hypertriglyceridemia [KARE],2881
11,1-palmitoyl-2-linoleoyl-gpc (16:0/18:2) levels,2689
11,Body mass (lean) [ALM-ABS],3068
11,Sphingomyelin(42:3)_[M+H]1+ levels,3087
11,3mm weak meridian angle (right),15
11,Phosphatidylcholine_30:0_[M+H]1+/Phosphatidylethanolamine_33:0_[M+H]1+/Phosphatidate_35:1_[M+NH4]1+ levels,2120
11,Phosphatidylcholine_35:1_[M+H]1+/Phosphatidylethanolamine_38:1_[M+H]1+/Phosphatidate_40:2_[M+NH4]1+ levels,2120
11,Home location - east co-ordinate (rounded),13
11,Electrocardiogram morphology (amplitude at temporal datapoints) [340 ms],17
11,Alcohol consumption (drinks per week) (MTAG),126095
11,Blood metabolite levels [docosapentaenoate (n3 DPA; 22:5n3],12671
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C42:5],12763
11,Getting up in morning,11575
11,Height [EA],11967
11,Ebbinghaus illusion (underestimation),142
11,Health precaution | why reduced smoking,112
11,Serum urea levels,64349
11,Phosphatidylcholine_34:4_[M+OAc]1-/Phosphatidylserine_38:3_[M-H]1- levels,12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C38:4],12763
11,Phospholipid levels (plasma) [levels],13449
11,IgE grass sensitization,865
11,Fibrosis-4 index in high alcohol intake,9137
11,Mammographic density (non-dense area),2525
11,Chronic lower respiratory diseases,854
11,Abdominal hernia,636
11,Electrocardiogram morphology (amplitude at temporal datapoints) [174 ms],17
11,Cerebrospinal fluid biomarker levels [cAMP-dependent protein kinase catalytic subunit alpha],12
11,Iron status biomarkers (transferrin levels),12939
11,Severe diabetic retinopathy in type 2 diabetes,10709
11,"Medication use (adrenergics, inhalants)",20926
11,Phosphatidylethanolamine-O(38:6)_[M+H]1+/Phosphatidylcholine-P(35:5)_[M+H]1+ levels,11043
11,Leg fat-free mass (left),145022
11,Pulse pressure [East Asian],2207
11,"Mean arterial pressure x alcohol consumption interaction (2df test) [AA, Asian, EA]",533
11,Diacylglycerol_39:2_[M+NH4]1+ levels,2120
11,White matter microstructure (mean diusivities) [Superior fronto-occipital fasciculus],216
11,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),23398
11,Medication use (thyroid preparations),135960
11,Vertical cup-disc ratio,44210
11,Cathepsin D levels,15833
11,Total testosterone levels,98353
11,Phosphatidylethanolamine_37:2_[M-H]1- levels,12763
11,"None of the above | medication for cholesterol, blood pressure or diabetes",34084
11,"Non-hodgkins lymphoma | cancer code, self-reported",9497
11,Phosphatidylcholine_38:2_[M+H]1+/Phosphatidylethanolamine_41:2_[M+H]1+ levels,3378
11,Serum metabolite levels (CMS) [L_VLDL_TG],2275
11,Years since last cervical smear test,1241
11,Facial morphology (lip thickness 1),1354
11,Urate levels,495929
11,Respiratory or ear-nose-throat disease,13022
11,Triacylglyceride levels [TAG(51:3;0],2120
11,Urinary metabolite levels in chronic kidney disease [17alpha-hydroxypregnanolone glucuronide],7780
11,Phosphatidylcholine-O_37:1_[M+H]1+/Phosphatidylcholine-P_37:0_[M+H]1+/Phosphatidylethanolamine-O_40:1_[M+H]1+ levels,2230
11,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA],258
11,Other diabetic retinopathy,846
11,Symmetrical dimethylarginine levels,125
11,Smoking status (heavy vs never),1127
11,Feeling miserable,8117
11,Serum metabolite concentrations in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:4],25526
11,Serum metabolite levels (CMS) [Ile],2275
11,"Pulse rate, automated reading",191692
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C40:1],12763
11,"Blood protein levels [EA, Serum amyloid A-1 protein]",5640
11,Metabolite levels [DAG 34:2],2120
11,Ramipril | treatment/medication code,13811
11,Pure hyperglyceridaemia,2192
11,Alzheimer's disease (cognitive decline),487
11,Other respiratory diseases principally affecting the interstitium,75
11,Protein quantitative trait loci (liver) [PTMA],25
11,Protein quantitative trait loci (liver) [HEXB],7
11,Alzheimer's disease,62746
11,Neuroticism (MTAG),46301
11,Phosphatidylinositol(38:4)_[M-H]1- levels,14717
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with acyl-alkyl residue sum C38:4],12763
11,Serum metabolite levels [linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1]*],12327
11,Serum metabolite levels [taurocholenate sulfate],3237
11,Whole body fat mass,250339
11,"Osteoporosis | non-cancer illness code, self-reported",8962
11,Pappalysin-1 levels,13137
11,Sphingomyelin(36:0)_[M-CH3]1- levels,3087
11,Hiatus hernia,738
11,Dexamethasone+hypromellose 0.1%/0.5% eye drops | treatment/medication code,248
11,Free cholesterol levels in large HDL,120605
11,Type 2 diabetes [Japanese],4713
11,Glycerophospholipid levels [Phosphatidylcholine diacyl C36:4],12763
11,Serum metabolite levels [eicosapentaenoateEPA205n3],12763
11,Arm fat mass (right),232246
11,Serum levels of protein SPON1,3042
11,Triacylglycerol_53:4_[M+NH4]1+ levels,2120
11,Gout (combined type),2922
11,"Mania, hypomania, bipolar or manic-depression | mental health problems ever diagnosed by a professional",206
11,White matter microstructure (axial diusivities) [Average across all tracts],216
11,Electrocardiogram morphology (amplitude at temporal datapoints) [216 ms],17
11,Sjögren's syndrome,8540
11,Systolic blood pressure x alcohol consumption interaction (2df test) [EA],16992
11,Phosphatidylethanolamine_38:5_[M-H]1- levels,12763
11,Serum levels of protein CDH12,19246
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C38:5],12763
11,Leg fat percentage (right),222669
11,Waist circumference adjusted for body mass index [EA],9891
11,CD20 on switched memory B cell,4790
11,Diabetic retinopathy (more control exclusions),846
11,Interleukin-10 levels [AA],2059
11,Metabolically unhealthy in obesity,2703
11,Restless legs syndrome,33
11,Smoking status,13309
11,Electrocardiogram morphology (amplitude at temporal datapoints) [450 ms],8598
11,Ovarian cyst,2445
11,T wave morphology restitution during recovery from exercise (MTAG),17
11,Primary biliary cholangitis,64917
11,Total cholesterol levels,296231
11,Comparative height size at age 10,117635
11,Phosphatidylcholine_40:4_[M+OAc]1-/Phosphatidylserine_44:3_[M-H]1- levels,12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with diacyl residue sum C34:4],12763
11,Phosphatidylcholine(39:6)_[M+OAc]1-/Phosphatidylserine(43:5)_[M-H]1- levels,10995
11,Diabetic ketoacidosis,846
11,Red blood cell fatty acid levels [DGLA],13183
11,Phosphatidylcholine-O_18:1_[M+H]1+/Phosphatidylcholine-P_18:0_[M+H]1+ levels,2120
11,Waist-to-hip ratio adjusted for body mass index [women],1223
11,Hemoglobin A1c levels [Hispanic/Latino],42
11,Metabolite levels [PC],12139
11,Cholesteryl ester_20:5_[M+NH4]1+ levels,14883
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with diacyl residue sum C36:5],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:3/Lysophosphatidylcholine with acyl residue C20:4],12763
11,Electrocardiogram morphology (amplitude at temporal datapoints) [350 ms],12780
11,Glycerophospholipid levels [Phosphatidylcholine acyl-alkyl C38:5],12763
11,Frequency of depressed mood in last 2 weeks,620
11,Hyperthyroidism or thyrotoxicosis,85
11,Renal cell carcinoma [Western European],1062
11,Electrocardiogram morphology (amplitude at temporal datapoints) [172 ms],17
11,Serum metabolite levels [1-stearoyl-2-arachidonoyl-GPI (18:0/20:4],13489
11,Phosphatidylcholine-O_38:2_[M+H]1+/Phosphatidylcholine-P_38:1_[M+H]1+ levels,2120
11,Cardiovascular diseases (excluding rheumatic etc),81
11,Type 2 diabetes [AA],3472
11,"Insulin | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",846
11,"""Dental caries, including avohilmo""",44
11,Blood pressure [Pulse Pressure],141
11,Alopecia areata,8275
11,Non-albumin protein levels,49424
11,Vaccenic acid (18:1n-7) levels [EA],12228
11,CD20 on IgD- CD38dim B cell,4906
11,Phosphatidylcholine_35:3_[M+OAc]1-/Phosphatidylserine_39:2_[M-H]1- levels,12763
11,Serum levels of protein POMC,24692
11,Fluid intelligence score,31113
11,Leg fat mass (right),223683
11,Leg predicted mass (left),144354
11,TNF-alpha gene expression levels in non-alcoholic fatty liver disease x mastiha supplementation interaction,142
11,Serum metabolite levels [VLDL_TG],2275
11,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)",88564
11,Sphingolipid levels [Sphingomyeline C18:1],12763
11,Phosphatidylethanolamine-O_36:5_[M+H]1+/Phosphatidylethanolamine-P_36:4_[M+H]1+ levels,26937
11,Sitting height,211554
11,Protein quantitative trait loci [IL18],407
11,"Hip circumference adjusted for BMI [EA, women]",1204
11,Disability living allowance | attendance/disability/mobility allowance,99
11,Cholelithiasis,33976
11,Metabolic biomarkers (multivariate analysis),171292
11,Electrocardiogram morphology (amplitude at temporal datapoints) [424 ms],8598
11,Age first had sexual intercourse,4008
11,"Blood protein levels [TMEM132A, 7871_16_3]",3014
11,Electrocardiogram morphology (amplitude at temporal datapoints) [206 ms],17
11,Nap during day,14387
11,Mood swings,13078
11,Phosphatidylinositol levels [PI(18:0;0-20:3;0],11815
11,Phosphatidylcholine(37:4)_[M+H]1+/Phosphatidylethanolamine(40:3)_[M+H]1+ levels,11043
11,Triacylglyceride levels [Total_TAG],2120
11,Food allergy,865
11,malignant neoplasm of male genital organs,6449
11,Glaucoma (primary angle closure) [Asian],508
11,Protein quantitative trait loci (liver) [COL18A1],60
11,Serum levels of protein CRISPLD2,24
11,Serum metabolite levels [XL_HDL_P],12763
11,Body mass index and type 2 diabetes (pairwise),4757
11,Serum uric acid levels [EA],5711
11,Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda/kappa based profile),995
11,Body mass index in physically inactive individuals [EA],485
11,Other insterstitial pulmonary diseases,75
11,Urinary albumin-to-creatinine ratio [Caribbean Hispanic],42
11,3mm strong meridian angle (right),15
11,Plasminogen activator inhibitor-1 (PAI-1) levels,46
11,Proinsulin levels,7806
11,Phosphatidylcholine_39:6_[M+OAc]1- levels,12763
11,Skimmed | milk type used,67728
11,Any mental disorder,2474
11,Heart failure and antihypertensive medication,2120
11,Diabetic maculopathy,1692
11,Cortical surface area (MOSTest),865
11,Immunoglobulin M against phosphorylcholine (IgM anti-PC) levels,266
11,Lamb consumption,367
11,Phosphatidylethanolamine-O_38:6_[M-H]1-/Phosphatidylethanolamine-P_38:5_[M-H]1- levels,12763
11,Body mass index [women],5540
11,Serum metabolite levels (CMS) [TotFA],2275
11,Serum levels of protein APOA5,2120
11,Type 1 diabetes with ophthalmic complications,846
11,Lipid traits [TG],5406
11,Anal and rectal polyp,1785
11,Serum levels of protein MMP19,581
11,White matter microstructure (axial diusivities) [Posterior limb of internal capsule],1551
11,Cortical surface area [Pars Orbitalis],19
11,Eosinophil percentage of granulocytes,79086
11,Primary biliary cirrhosis,33754
11,Headache | pain type(s) experienced in last month,1781
11,"""Hypothyroidism, levothyroxin purchases""",2861
11,Triacylglyceride levels [TAG(56:4;0],2122
11,Serum metabolite levels [MUFA],2275
11,Serum levels of protein CTSC,1355
11,Phosphatidylglycerol_34:1_[M+H]1+ levels,2120
11,Cortical surface area [Pars Triangularis],49
11,UBA1407 abundance in stool,23
11,Resting heart rate,62373
11,Alcohol consumption (drinks per week),166001
11,Glycerophospholipid levels [Phosphatidylcholine acyl-alkyl C44:6],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with diacyl residue sum C36:5],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C42:4/Phosphatidylcholine with acyl-alkyl residue sum C38:3],11815
11,Serum metabolite levels [1-palmitoyl-2-linoleoyl-GPE (16:0/18:2],15453
11,Phosphatidylcholine levels [PC(17:0;0-20:4;0],12763
11,Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis),4664
11,Cortical surface area (min-P),624
11,Protein levels in obesity [Contactin-5],295
11,"Blood protein levels [CHST1, 7803_4_3]",248
11,Other derangement of joint,186
11,Protein quantitative trait loci (liver) [TTN],7
11,Fatty acid(22:6)_[M-H]1- levels,12763
11,Serum levels of protein A4GALT,6935
11,Diacylglycerol_34:3_[M+H-H2O]1+ levels,2120
11,Phosphatidylethanolamine-P_38:6_[M+H]1+ levels,2120
11,Serum metabolite levels [etiocholanolone glucuronide],3182
11,1-stearoyl-2-linoleoyl-gpc (18:0/18:2) levels,1083
11,Bone mineral density,4130
11,Varicose veins,26297
11,Morning person,33550
11,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),43159
11,Mosaic loss of chromosome Y (Y chromosome dosage),113628
11,Age when periods started (menarche),74181
11,Diacylglycerol_36:3_[M+NH4]1+ levels,14259
11,Sphingomyelin_37:1_[M+H]1+ levels,2120
11,Homeostasis model assessment of beta-cell function,122
11,Electrocardiogram morphology (amplitude at temporal datapoints) [408 ms],144
11,Problematic alcohol use (MTAG),66874
11,Change in serum metabolite levels [LA_FA],12763
11,Noncognitive aspects of educational attainment,155602
11,Phosphatidate(43:4)_[M-H]1- levels,12014
11,Serum levels of protein CTSF,12598
11,Metabolite levels [LPC 20:5],12139
11,Triacylglycerol(53:2)_[M+NH4]1+ levels,3087
11,Triacylglycerol_56:7_[M+NH4]1+ levels,12613
11,Serum metabolite levels [palmitoleoyl-linoleoyl-glycerol (16:1/18:2) [1]*],531
11,Major depressive disorder vs anorexia nervosa (ordinary least squares (OLS)),169
11,Systolic blood pressure x educational attainment (some college) interaction (2df),66
11,Skin colour,106472
11,"Seen doctor (gp) for nerves, anxiety, tension or depression",14245
11,Lysophosphatidylethanolamine_20:2_[M-H]1- levels,12613
11,Diacylglycerol_34:2_[M+NH4]1+ levels,2651
11,Triacylglycerol(51:4)_[M+NH4]1+ levels,3087
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C40:6],12763
11,Metabolite levels [SM d18:2/24:0],12533
11,HbA2 levels,4441
11,Distal bite,3439
11,Ever had hysterectomy (womb removed),1241
11,Pediatric asthma,291
11,Phosphatidylethanolamine_35:2_[M-H]1- levels,12763
11,Serum metabolite levels (CMS) [XL_HDL_P],12763
11,Electrocardiogram morphology (amplitude at temporal datapoints) [324 ms],12815
11,Laryngeal squamous cell carcinoma,13673
11,CD8dim Natural Killer T %T cell,232
11,Menopause (age at onset),2680
11,Serum levels of protein FJX1,371
11,Attention deficit hyperactivity disorder,116
11,"Blood protein levels [CRTAM, 7968_15_3]",59
11,3mm strong meridian angle (left),164
11,CAG-877 sp000433455 abundance in stool,175
11,Blood pressure [DBP],48
11,Bone mineral density (spine),6826
11,Essential hypertension,73060
11,Insomnia [Female],74821
11,Phosphatidylcholine_33:2_[M+H]1+/Phosphatidylethanolamine_36:2_[M+H]1+/Phosphatidate_38:3_[M+NH4]1+ levels,12763
11,Smoking initiation (ever regular vs never regular) [Conditioned on chr11:113994505],1121
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:4/Phosphatidylcholine with acyl-alkyl residue sum C36:2],12763
11,HDL Cholesterol - Triglycerides (HDLC-TG),6825
11,None of the above | types of physical activity in last 4 weeks,5361
11,Serum metabolite levels [XXL_VLDL_CE],2275
11,"Blood protein levels [EA, Calpain I]",1198
11,Blood protein levels [Endothelial cell-selective adhesion molecule],1111
11,Caudate nucleus volume,82
11,Electrocardiogram morphology (amplitude at temporal datapoints) [176 ms],17
11,Ease of getting up in the morning,8081
11,HDL cholesterol levels,638476
11,Myocardial infarction,32181
11,Bipolar disorder [Japanese],12550
11,HDL cholesterol levels [Trans-ethnic initial],36889
11,Participation in an health questionnaire (not invited vs invited),37004
11,HDL cholesterol levels x long total sleep time interaction (2df test),26220
11,Serum lipopolysaccharide activity,21053
11,Serum metabolite levels (CMS) [L_VLDL_P],2275
11,Sphingomyelin_36:1_[M+H]1+ levels,2120
11,Body mass index (joint analysis main effects and smoking interaction) [women],1031
11,Phosphatidylethanolamine-ether levels [PEO(16:1;0-18:2;0],12763
11,Metabolite levels [adrenate],12613
11,Lysophosphatidylethanolamine-O_18:1_[M-H]1-/Lysophosphatidylethanolamine-P_18:0_[M-H]1- levels,12238
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C38:5/Phosphatidylcholine with acyl-alkyl residue sum C36:2],12763
11,Triglyceride levels [Japanese],2703
11,Total protein levels x insomnia interaction,479
11,Corneal hysteresis (left),666
11,Electrocardiogram morphology (amplitude at temporal datapoints) [-114 ms],477
11,Digit length ratio (left hand),481
11,Unspecified diabetic retinopathy,846
11,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) [Modelling analysis]",254
11,CD8+ Natural Killer T Absolute Count,232
11,Pulmonary fibrosis,75
11,Disorders of lipoid metabolism,5691
11,Immature fraction of reticulocytes,298983
11,Hay fever and/or eczema,34095
11,Urea levels,42663
11,Diacylglycerol(36:3)_[M+H-H2O]1+ levels,15101
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C42:5/Phosphatidylcholine with acyl-alkyl residue sum C44:3],12763
11,Metabolite levels [LPC 22:6],12763
11,Electrocardiogram morphology (amplitude at temporal datapoints) [120 ms],25376
11,Brain morphology (min-P),16151
11,"""Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified""",1713
11,Educational attainment (college completion),828
11,Optic disc size,4391
11,Diabetes | illnesses of siblings,927
11,High blood pressure | illnesses of siblings,2359
11,Triglyceride levels,660942
11,Body mass index (age <50),12228
11,Major depressive disorder,41865
11,Phosphatidylinositol_36:2_[M+H]1+ levels,12763
11,Serum metabolite levels [FAw3],12807
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with diacyl residue sum C40:4],12763
11,Electrocardiogram morphology (amplitude at temporal datapoints) [434 ms],8598
11,Cortical surface area [Parahippocampal],678
11,Triacylglycerol_52:5_[M+NH4]1+ levels,2120
11,KDEL motif-containing protein 2 measurement,3005
11,Menorrhagia,1241
11,Metabolic syndrome (bivariate traits) [BP-GLUC],235
11,6mm weak meridian angle (right),15
11,Protein quantitative trait loci (liver) [EIF4A2],37
11,Subcortical volume (min-P),16151
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C42:4],12238
11,Phosphatidylethanolamine_38:4_[M-H]1- levels,12763
11,Relative age of first facial hair,2253
11,Systolic blood pressure x smoking status (ever vs never) interaction (2df test),953
11,TestASV_21 (Ruminococcaceae) abundance,70
11,Cardiovascular diseases,41
11,"Sphingomyelin (d18:1/18:1, d18:2/18:0) levels",8
11,Response to metformin in type 2 diabetes (glycemic),36003
11,Body fat distribution (leg fat ratio),12911
11,Metabolite levels [PC aa C36:3/PC aa C36:4],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C40:5],12763
11,Uterine fibroids (MTAG),6218
11,Obesity (early onset extreme),3174
11,Urinary metabolite levels in chronic kidney disease [N-acetylphenylalanine],962
11,Timoptol 0.25% eye drops | treatment/medication code,113
11,Lipid metabolism phenotypes [Val/serum TG],2923
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C42:4/Phosphatidylcholine with acyl-alkyl residue sum C38:2],12763
11,Ankle spacing width,122719
11,"Forced expiratory volume in 1-second (fev1), predicted",75847
11,Systolic blood pressure [East Asian],9083
11,Vitamin B12 levels,953
11,Mean corpuscular volume [Conditioned on rs334],76
11,High light scatter reticulocyte percentage of red cells,289191
11,Hypertension [Japanese],3021
11,Serum metabolite levels (CMS) [L_HDL_P],43934
11,"""Hypertension, essential""",2666
11,Sphingomyelin_40:0_[M+H]1+ levels,2230
11,Triacylglycerol(51:3)_[M+NH4]1+ levels,3087
11,Place of birth in uk - east co-ordinate,1639
11,Free cholesterol levels in small VLDL,1038
11,HDL cholesterol x physical activity interaction (2df test),19087
11,Phosphatidylethanolamine(38:5)_[M-H]1- levels,12014
11,Serum metabolite levels (CMS) [PUFA_FA],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:2/Lysophosphatidylcholine with acyl residue C20:4],12763
11,Lipoprotein (a) - cholesterol levels,84
11,Serum metabolite levels [S_VLDL_C],2275
11,Serum metabolite levels [M_VLDL_CE],2275
11,Protein quantitative trait loci (liver) [FERMT2],13
11,Body fat percentage,518265
11,Red blood cell fatty acid levels [DTA],12613
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C36:4],12763
11,Metabolite levels [PC 40:6],12763
11,Serum metabolite levels [1-stearoyl-2-linoleoyl-GPE (18:0/18:2)*],12327
11,"1,5-anhydroglucitol (1,5-ag) levels",2883
11,Electrocardiogram morphology (amplitude at temporal datapoints) [304 ms],12780
11,"Blood protein levels [MMP1, 4924_32_1]",2225
11,Heel broadband ultrasound attenuation (right),41139
11,Intracranial aneurysm,2971
11,Phosphatidylcholine-O(32:0)_[M+H]1+/Phosphatidylethanolamine-O(35:0)_[M+H]1+ levels,3087
11,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),718
11,Phlebitis and thrombophlebitis of lower extremities,157
11,Aortic aneurysm,144
11,C-reactive protein levels or HDL-cholesterol levels (pleiotropy),12763
11,Depressive symptoms,120332
11,Dimethyl sulfone levels,2053
11,Neutrophil-to-lymphocyte ratio,7391
11,Phosphatidylcholine(38:3)_[M+OAc]1-/Phosphatidylserine(42:2)_[M-H]1- levels,11043
11,"Gout | non-cancer illness code, self-reported",10671
11,Hereditary deficiency of other clotting factors,1419
11,Fasting triglyceride levels,2120
11,Electrocardiogram morphology (amplitude at temporal datapoints) [198 ms],17
11,Serum levels of protein MMP12,1715
11,White matter microstructure (fractional anisotropy) [Fornix (column and body],1088
11,Electrocardiogram morphology (amplitude at temporal datapoints) [-104 ms],254
11,Electrocardiogram morphology (amplitude at temporal datapoints) [300 ms],17
11,Feeling lonely,41376
11,Offspring birth weight,26965
11,Lysophosphatidylcholine_18:2_[M+OAc]1-/Lysophosphatidylserine_22:1_[M-H]1- levels,12613
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C40:5],12763
11,Lipid or lipoprotein levels [Triglycerides],2120
11,Local histogram emphysema pattern [Moderate Centrilobular],1430
11,Protein quantitative trait loci (liver) [C4B],487
11,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],1074
11,Mean corpuscular hemoglobin [Pomak],1272
11,White matter microstructure (axial diusivities) [Inferior fronto-occipital fasciculus],216
11,Basal metabolic rate variance,107
11,Reaction time,23639
11,Facial ageing,25803
11,Phosphatidate(45:6)_[M-H]1- levels,72088
11,Serum metabolite ratios in chronic kidney disease [Lysophosphatidylcholine with acyl residue C20:3/Lysophosphatidylcholine with acyl residue C20:4],12763
11,Endometriosis [EA],1241
11,Serum metabolite levels [1-(1-enyl-palmitoyl)-2-oleoyl-GPC (P-16:0/18:1)*],12529
11,Benign prostatic hyperplasia and lower urinary tract symptoms,3734
11,3-hydroxypropylmercapturic acid levels in smokers [Japanese],586
11,Heart rate,12238
11,Serum metabolite levels (CMS) [FAw6],15791
11,Haematocrit percentage,122468
11,Phosphatidylcholine(36:3)_[M+OAc]1-/Phosphatidylserine(40:2)_[M-H]1- levels,12461
11,Phosphatidylcholine_32:1_[M+H]1+/Phosphatidylethanolamine_35:1_[M+H]1+/Phosphatidate_37:2_[M+NH4]1+ levels,2120
11,Diacylglycerol_34:2_[M+H-H2O]1+ levels,14259
11,Phosphatidylcholine_36:4_[M+OAc]1-/Phosphatidylserine_40:3_[M-H]1- levels,12763
11,Glycerophospholipid levels [Phosphatidylcholine acyl-alkyl C42:5],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C38:4],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:5/Phosphatidylcholine with diacyl residue sum C36:6],12763
11,Malignant neoplasm of digestive organs,2747
11,CD6 levels,420
11,Breast cancer | illnesses of mother,58
11,Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis),49386
11,Phosphatidylcholine(34:2)_[M+H]1+/Phosphatidylethanolamine(37:2)_[M+H]1+/Phosphatidate(39:3)_[M+NH4]1+ levels,12014
11,Phosphatidylcholine(40:6)_[M+OAc]1-/Phosphatidylserine(44:5)_[M-H]1- levels,12014
11,3mm weak meridian (right),41859
11,Serum metabolite levels (CMS) [S_VLDL_TG],2275
11,Type 2 diabetes with other specified/multiple/unspecified complications,4991
11,Sphingomyelin(34:0)_[M-CH3]1- levels,3087
11,Alanine aminotransferase levels,210297
11,Apolipoprotein A-I measurement,15053
11,Prothrombin measurement,2419
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C40:1],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with diacyl residue sum C36:4],12763
11,Coronary heart disease,2342
11,Sickle cell anemia (haemolysis),15470
11,Type 2 diabetes (adjusted for BMI),9261
11,Serum metabolite levels [M_VLDL_P],2275
11,Age of smoking initiation (MTAG),14455
11,Cancer (pleiotropy) [subset analysis],2216
11,"Omeprazole (e.g. zanprol) | medication for pain relief, constipation, heartburn",2894
11,Protein quantitative trait loci (liver) [HBD],105
11,"Blood protein levels [CHRDL2, 6086_15_3]",249
11,Smoking initiation (ever regular vs never regular) [Conditioned on chr11:27679916],116
11,"LDL cholesterol levels [Asian initial, BMI unadjusted]",12228
11,Leisure sedentary behaviour (television watching),35458
11,"""Type 2 diabetes, wide definition""",2834
11,High density lipoprotein cholesterol levels [East Asian],2499
11,Serum metabolite levels (CMS) [Gp],2275
11,Glycated haemoglobin HbA1c levels adjusted for BMI,126
11,White blood cell count (monocyte),120
11,"Bone mineral density (paediatric, skull) [EA]",10116
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C40:4/Phosphatidylcholine with acyl-alkyl residue sum C36:3],12139
11,Electrocardiogram morphology (amplitude at temporal datapoints) [140 ms],25376
11,Duration to first press of snap-button in each round,15340
11,IBD patients in KELA-register,7565
11,Heme oxygenase 1 measurement,12936
11,Chagas cardiomyopathy in Tripanosoma cruzi seropositivity,3321
11,"Adult diffuse glioma (IDH mutation, 1p/19q non-codeleted)",4029
11,Medial thalamic nuclei volume,543
11,Other arrhytmias,68
11,Electrocardiogram morphology (amplitude at temporal datapoints) [154 ms],17
11,"Bone mineral density (paediatric, total body less head)",8462
11,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),13799
11,Phosphatidylcholine_34:3_[M+OAc]1-/Phosphatidylserine_38:2_[M-H]1- levels,12613
11,Phosphatidylcholine(35:4)_[M+H]1+/Phosphatidylethanolamine(38:4)_[M+H]1+/Phosphatidate(40:5)_[M+NH4]1+ levels,12461
11,Yes | hearing difficulty/problems,5717
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C38:3/Lysophosphatidylcholine with acyl residue C20:4],12763
11,Leg fat percentage (left),213949
11,Meningioma,3694
11,Allergic sensitization,1719
11,Central retinal vein equivalent,309
11,IgA nephropathy,2916
11,Biological sex (age adjusted),42
11,Body mass index,2219105
11,Vitamin D insufficiency,70117
11,Phosphatidylethanolamine_38:2_[M-H]1- levels,12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C44:6],12763
11,Factor VII activity,11488
11,Allergic conjunctivitis,17601
11,"""Ulcerative colitis (strict definition, all Crohn cases excluded)""",865
11,Perceptual and visual search speed (trail making test A),195
11,Body mass index in physically active individuals,86332
11,Lactate dehydrogenase levels,52388
11,Sensitivity to environmental stress and adversity,24929
11,Fatty acid(22:5)_[M-H]1- levels,24777
11,Serum metabolite concentrations in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C38:5],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C36:5],12763
11,Whole body fat-free mass,128736
11,Ex-smoker | tobacco smoking,1172
11,Allergic asthma (mode) (more control exclusions),865
11,Coronary artery bypass grafting,675
11,Reductil 10mg capsule | treatment/medication code,9
11,Phosphatidylethanolamine-O_38:3_[M-H]1-/Phosphatidylethanolamine-P_38:2_[M-H]1- levels,12763
11,Cholesteryl ester(20:4)_[M+NH4]1+ levels,15101
11,Serum levels of protein APOA2,38145
11,"Diabetes | non-cancer illness code, self-reported",18733
11,Squamous cell carcinoma,1178
11,Prostate cancer [EA],65
11,Estrogen level change in anastrozole-treated breast cancer,74
11,Interstitial lung abnormalities,35
11,Systemic lupus erythematosus,173874
11,Low density lipoprotein cholesterol levels,288472
11,Lysophosphatidylethanolamine_18:2_[M+H]1+ levels,12613
11,Phosphatidylinositol_36:3_[M-H]1- levels,12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with diacyl residue sum C42:4],12613
11,HDL cholesterol levels [BMI unadjusted],2703
11,Cataracts (operation),4400
11,"Blood protein levels [EA, Catalase]",2673
11,CD16-CD56 on Natural Killer,675
11,Spine bone size,150
11,Serum metabolite concentrations in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C44:6],12238
11,Serum metabolite levels (CMS) [M_VLDL_P],15038
11,Feeling nervous,8964
11,Immune reponse to smallpox (secreted IL-12p40) [EA],714
11,"Blood protein levels [CD59, 11514_196_3]",2489
11,Other spirochaetal diseases,1148
11,Protein quantitative trait loci (liver) [CTSL],55
11,Desulfovibrionaceae abundance in stool,15
11,LDL cholesterol levels x long total sleep time interaction (2df test),11815
11,Phosphatidylcholine levels [PC(18:0;0-18:2;0],12763
11,"None of the above | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",3525
11,Allopurinol | treatment/medication code,10495
11,Chronic obstructive pulmonary disease,802
11,Chronic bronchitis and chronic obstructive pulmonary disease [EA],292
11,Major coronary heart disease event,590
11,Ezetimibe | treatment/medication code,2120
11,Neuritic plaques (SNP x SNP interaction),799
11,"Deep venous thrombosis (dvt) | non-cancer illness code, self-reported",33
11,Mean diameter of HDL particles,15192
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C38:5/Sphingomyelin with acyl residue sum C24:0],12763
11,Pizotifen | treatment/medication code,1057
11,Matrix metalloproteinase-1 levels,6372
11,Cholesteryl ester levels [CE(20:5;0],16245
11,Serum metabolite levels (CMS) [S_HDL_TG],15038
11,No | hearing difficulty/problems,5717
11,Lactadherin measurement,13369
11,Phosphatidylcholine-O_33:3_[M+H]1+/Phosphatidylcholine-P_33:2_[M+H]1+/Phosphatidylethanolamine-O_36:3_[M+H]1+ levels,12613
11,Cortical volume [Insula],504
11,Severe diabetic background retinopathy,846
11,Number of self-reported non-cancer illnesses,865
11,Nifedipine | treatment/medication code,773
11,Post bronchodilator FEV1/FVC ratio,1443
11,Prozac 20mg capsule | treatment/medication code,143
11,Electrocardiogram morphology (amplitude at temporal datapoints) [142 ms],17
11,Electrocardiogram morphology (amplitude at temporal datapoints) [244 ms],17
11,Fat-free mass,37688
11,Angiopoietin-1 receptor levels,73
11,Phosphatidylethanolamine-O_36:4_[M-H]1-/Phosphatidylethanolamine-P_36:3_[M-H]1- levels,12763
11,Latent autoimmune diabetes vs. type 2 diabetes,846
11,Heart attack | vascular/heart problems diagnosed by doctor,95
11,Glomerular filtration rate (creatinine),57923
11,Type 2 diabetes,657597
11,Peak expiratory flow (pef),16273
11,Bendroflumethiazide | treatment/medication code,20866
11,Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid),12763
11,Phosphatidylethanolamine-O_36:5_[M-H]1-/Phosphatidylethanolamine-P_36:4_[M-H]1- levels,12139
11,Sphingomyelin(42:0)_[M+OAc]1- levels,2703
11,Diacylglycerol(36:4)_[M+H-H2O]1+ levels,3087
11,Diverticulosis and diverticulitis,2666
11,Triacylglycerol_49:3_[M+NH4]1+ levels,2120
11,Protein quantitative trait loci (liver) [GRPEL1],152
11,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],53386
11,Serum metabolite levels (CMS) [VLDL_C],2275
11,Cardiomyopathy (excluding other),266
11,Protein quantitative trait loci (liver) [UCHL3],1
11,Testicular germ cell tumor,62718
11,LDL cholesterol levels in current drinkers,12620
11,Serum docosahexaenoic fatty acid concentration in metabolic syndrome,12763
11,Medication use (vasodilators used in cardiac diseases),4379
11,1-carboxyethylphenylalanine levels,823
11,CD4+CD8+ T cell Absolute Count,80
11,Other/unspecified seropositiverheumatoid arthritis,131
11,"Atopic dermatitis [EA, fixed effects]",8679
11,Wheeze or whistling in the chest in last year,17951
11,Red blood cell fatty acid levels [LA],12763
11,Osteoporosis,29069
11,Phosphatidylcholine_38:6_[M+OAc]1-/Phosphatidylserine_42:5_[M-H]1- levels,12763
11,Serum levels of protein TREM2,24031
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C42:5/Phosphatidylcholine with acyl-alkyl residue sum C44:4],12238
11,Lymphocyte count,11144
11,Brainstem volume,2144
11,Electrocardiogram morphology (amplitude at temporal datapoints) [40 ms],4805
11,Electrocardiogram morphology (amplitude at temporal datapoints) [432 ms],8598
11,Longitudinal brain connectivity change (transitivity),3930
11,White matter microstructure (mean diusivities) [Hippocampus ],216
11,Electrocardiogram morphology (amplitude at temporal datapoints) [150 ms],17
11,Monocyte count,830721
11,Prothrombin time,23013
11,Serum amyloid A-2 protein measurement,2624
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with diacyl residue sum C40:5],12763
11,Schizophrenia [EA],29557
11,Estimated glomerular filtration rate [EA],21770
11,Circulating vasoactive peptide levels [ADM],4781
11,Protein quantitative trait loci (liver) [CIITA],675
11,"Blood protein levels [MMP10, 10479_18_3]",741
11,Frequency of solarium/sunlamp use,103
11,Electrocardiogram morphology (amplitude at temporal datapoints) [158 ms],17
11,Eating disorders,2
11,Systolic blood pressure,841329
11,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],12151
11,Metabolite levels [C20:4],13829
11,Serum levels of protein MMP1,3342
11,"""Other noninflammatory disorders of uterus, except cervix""",1241
11,Lamb/mutton intake,454
11,Electrocardiogram morphology (amplitude at temporal datapoints) [-34 ms],144
11,Fasting plasma glucose,915
11,Peak insulin response,40
11,Hematology traits [ALB/GLB],13673
11,Self-reported math ability,96115
11,Sphingomyelin(36:1)_[M+H]1+ levels,3087
11,Brain region volumes [right caudate],683
11,White matter microstructure (axial diusivities) [Anterior corona radiata],216
11,Enterococcus A abundance in stool,16
11,Hair color,224631
11,Comparative body size at age 10,26990
11,Phosphatidylcholine levels [PC(16:0;0-22:5;0],12763
11,Forced expiratory volume in 1-second (fev1),152800
11,Arm fat mass (left),226794
11,Atopic march,1388
11,Obesity and other hyperalimentation,1895
11,Thyroid hormone levels [TSH],299
11,Serum amyloid A-1 protein measurement,2598
11,Brain region volumes [left parahippocampal],543
11,"Risky sexual behaviors (alcohol dependence interaction) [EA, men]",373
11,Carotid intima media thickness (mean-maximum),85
11,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)",24864
11,Serum metabolite levels [1-arachidonylglycerol (20:4],24565
11,Phosphatidate(39:1)_[M+H]1+ levels,12014
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:2/Sphingomyelin with acyl residue sum C16:1],12763
11,Serum metabolite levels [L_HDL_PL],41659
11,"Blood protein levels [CST6, 14711_27_3]",11962
11,"Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [Asian, EA]",2772
11,Number of alcoholic drinks required to feel an effect (long-term average),5973
11,Femur bone mineral density x serum urate levels interaction [male],1437
11,Serum metabolite levels [L_VLDL_CE],2275
11,"Blood protein levels [SWAP70, 13552_7_3]",1776
11,Blood metabolite levels [X-12990--docosapentaenoic acid (n6-DPA],892
11,Viral meningitis,556
11,"Heart attack/myocardial infarction | non-cancer illness code, self-reported",95
11,Renal function-related traits (sCR),11
11,Serum metabolite concentrations in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:5],12763
11,A levels/as levels or equivalent | qualifications,34559
11,"Blood protein levels [NXPH2, 9511_61_3]",2120
11,"Eczema/dermatitis | non-cancer illness code, self-reported",1172
11,Asthma/COPD (KELA code 203),2319
11,Pulse wave arterial stiffness index,828
11,"Basal cell carcinoma | cancer code, self-reported",704
11,Urinary sodium levels,42
11,Serum levels of protein FAM189A2,97
11,Monocyte percentage of white cells,205145
11,Sum eosinophil basophil counts,124886
11,Asthma (age of onset),15347
11,Dried fruit intake,41533
11,Vitamin D levels [Age 6],9782
11,Phosphatidylcholine_36:5_[M+H]1+/Phosphatidylethanolamine_39:5_[M+H]1+/Phosphatidate_41:6_[M+NH4]1+ levels,12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C30:0/Phosphatidylcholine with diacyl residue sum C34:3],12763
11,White | bread type,14004
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C38:4],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C38:6],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C40:5],12763
11,Electrocardiogram morphology (amplitude at temporal datapoints) [236 ms],2666
11,Type 1 diabetes with neurological complications,846
11,"Blood protein levels [CTSD, 5508_62_3]",1312
11,Tanning,2123
11,Disorders of lipoprotein metabolism and other lipidaemias,590
11,Nontoxic multinodular goitre,267
11,"Psoriasis | non-cancer illness code, self-reported",153
11,QT dynamics during exercise [male],17
11,Triglycerides [EA],14764
11,Waist circumference,224503
11,Ankle spacing width (left),37950
11,Glycerophospholipid levels [Phosphatidylcholine diacyl C34:4],12763
11,Medication use (antithrombotic agents),4604
11,Serum metabolite levels [S_VLDL_FC],2275
11,Cortical surface area (visual PC2) [EA],1527
11,Electrocardiogram morphology (amplitude at temporal datapoints) [184 ms],17
11,Hand grip strength,35650
11,Positive affect,98149
11,Triacylglycerol(56:6)_[M+NH4]1+ levels,12014
11,Phosphatidylinositol(36:0)_[M+OAc]1- levels,12461
11,Serum metabolite levels (CMS) [XL_HDL_PL],12763
11,"Blood protein levels [POMC, 2558_51_3]",28374
11,Atrial fibrillation [EA],562
11,Electrocardiogram morphology (amplitude at temporal datapoints) [200 ms],17
11,Vaccenic acid (18:1n-7) levels,12228
11,Sunburns,19187
11,Birth weight,54473
11,Phosphatidylcholine-ether levels [PCO(18:0;0-20:4;0],12238
11,Serum metabolite levels [1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0)*],12595
11,Malignant lymphoma,17780
11,Serum metabolite levels [oleoyl-linoleoyl-glycerol (18:1/18:2) [1]],531
11,P wave terminal force [AA],546
11,Cataract | eye problems/disorders,749
11,"Pulse pressure x alcohol consumption interaction (2df test) [Asian, EA, Hispanic]",1927
11,Protein quantitative trait loci (liver) [CYP3A5],1717
11,Immunoglobulin light chain (AL) amyloidosis (serum Ig lambda profile),995
11,Doctor diagnosed hayfever or allergic rhinitis,865
11,Lipid traits (pleiotropy) (HIPO component 1),56292
11,Urinary albumin-to-creatinine ratio,12250
11,PR interval,27224
11,Hip circumference adjusted for BMI,92665
11,Schizophrenia or bipolar disorder [SCZ or BP vs. controls],14335
11,Metabolite levels [LPE 18:2],12613
11,Triacylglycerol_50:4_[M+NH4]1+ levels,2120
11,Serum metabolite levels (CMS) [M_VLDL_CE],2275
11,Triglyceride levels [additive],2703
11,Venous thromboembolism [Conditioned on rs1799963],2286
11,Triacylglycerol_48:4_[M+NH4]1+ levels,2327
11,Endometrial cancer,662
11,Triacylglycerol 56:2 levels,2120
11,"Systolic blood pressure [EA, initial]",183
11,"Blood protein levels [LRRC4C, 9369_174_3]",12
11,Red blood cell count,1410631
11,C-reactive protein levels,375524
11,CD20 on IgD+ CD38+ B cell,9851
11,Phosphatidylcholine_40:8_[M+OAc]1-/Phosphatidylserine_44:7_[M-H]1- levels,12763
11,"Light brown | hair colour (natural, before greying)",83833
11,Hypertriglyceridemia,17756
11,Triglycerides x physical activity interaction (2df test),2070
11,Glaucoma (high intraocular pressure),2743
11,C-X-C motif chemokine 16 levels,1780
11,"""Coagulation defects, purpura and other haemorrhagic conditions""",386
11,Follicular lymphoma [CLL/SLL],266
11,Keratinocyte cancer (MTAG),14715
11,Lysophosphatidylcholine-2O_18:0_[M+H]1+ levels,12763
11,Ibuprofen | treatment/medication code,1501
11,Skin pigmentation (conditioned on rs1426654 and rs35397),338
11,Other abnormal uterine and caginal bleeding,1241
11,Body fat distribution (arm fat ratio),23661
11,Bilirubin levels,45912
11,Vitamin C levels,12763
11,Serum metabolite levels (CMS) [ApoB_ApoA1],2275
11,Cholesteryl ester_17:1_[M+NH4]1+ levels,2120
11,Triacylglycerol(52:5)_[M+NH4]1+ levels,3087
11,"Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)",2272
11,Metabolite levels [FPG],251
11,"""Type 1 diabetes, wide definition""",846
11,Conduct disorder (symptom count),60
11,"""Hypothyroidism, strict autoimmune""",32990
11,Diabetes,7407
11,Triacylglycerol(52:2)_[M+NH4]1+ levels,3087
11,Phosphatidylglycerol-O_38:0_[M+NH4]1+ levels,2120
11,Severity of nausea and vomiting of pregnancy,816
11,Metabolite levels (small molecules and protein measures) [Glucose],260
11,White blood cell types [basophil count],1377
11,Asthma (adult onset),49359
11,"Waist-to-hip ratio adjusted for body mass index [EA, women]",47842
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C34:3/Phosphatidylcholine with acyl-alkyl residue sum C36:5],12763
11,Blood protein levels [Soluble transferrin receptor],22775
11,"Hypothyroidism/myxoedema | non-cancer illness code, self-reported",36450
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C36:5],12763
11,Electrocardiogram morphology (amplitude at temporal datapoints) [436 ms],8598
11,Coronary revascularization (ANGIO or CABG),675
11,Waist-hip ratio [EA],5426
11,Cortical volume [Pericalcarine],937
11,Facial morphology (segment 7),472
11,Craniofacial microsomia,125
11,"Systolic blood pressure x alcohol consumption interaction (2df test) [AA, EA]",450
11,Pemphigus vulgaris,62
11,Serum levels of protein IL1RL1,57
11,Pre-treatment viral load in HIV-1 infection,4177
11,Self-reported allergy,865
11,Never | smoking status,11775
11,Electrocardiogram morphology (amplitude at temporal datapoints) [-112 ms],731
11,Baclofen | treatment/medication code,17
11,Gout vs. Hyperuricemia,14
11,Lymphocyte percentage of white cells,295651
11,Waist-to-hip ratio adjusted for BMI,548572
11,Phosphatidylcholine_42:4_[M+OAc]1- levels,12763
11,Serum levels of protein B3GAT3,32118
11,Hypertensive diseases,7176
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C44:6],11815
11,Pediatric autoimmune diseases,895
11,Iron deficiency anemia,422
11,Creatine kinase levels,49533
11,Cutaneous melanoma or hair colour,16863
11,Overall health rating,36144
11,"Diastolic blood pressure x alcohol consumption interaction (2df test) [EA, Hispanic]",790
11,Phosphatidylcholine_35:4_[M+H]1+/Phosphatidylethanolamine_38:4_[M+H]1+/Phosphatidate_40:5_[M+NH4]1+ levels,12763
11,Lysophosphatidylcholine_20:3_[M+OAc]1- levels,3378
11,Irregular menses,1241
11,Cholesteryl ester_18:0_[M+NH4]1+ levels,2120
11,Serum levels of protein FCN2,3328
11,Type 2 diabetes and end-stage kidney disease,168
11,Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid),42750
11,Body mass index in physically active individuals [EA],86190
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C38:5/Phosphatidylcholine with acyl-alkyl residue sum C36:3],12763
11,White matter microstructure (mode of anisotropy) [Cingulate gyrus],1390
11,Smoking initiation,7469
11,Serum levels of protein SCGB3A1,3781
11,Atrial fibrillation and flutter,807
11,Serum levels of protein NCAM1,482
11,Phosphatidylglycerol_35:3_[M-H]1- levels,12763
11,Electrocardiogram morphology (amplitude at temporal datapoints) [412 ms],8598
11,Total body bone mineral density,39938
11,Meat-related diet,367
11,IgG glycosylation [IGP41],2584
11,Luteinizing hormone levels in polycystic ovary syndrome,1241
11,Cataracts [male],1332
11,Protein quantitative trait loci (liver) [NPC2],87
11,Monomax xl 60mg m/r tablet | treatment/medication code,105
11,Electrocardiogram morphology (amplitude at temporal datapoints) [220 ms],17
11,Electrocardiogram morphology (amplitude at temporal datapoints) [166 ms],17
11,Electrocardiogram morphology (amplitude at temporal datapoints) [298 ms],17
11,Glucose levels,19529
11,Phosphatidylcholine-O(36:4)_[M+H]1+/Phosphatidylcholine-P(36:3)_[M+H]1+ levels,63475
11,Non-glioblastoma glioma,9545
11,Triglyceride levels in small HDL,2413
11,Triacylglycerol_52:2_[M+NH4]1+ levels,2120
11,Photic sneeze reflex,3239
11,"Blood protein levels [BDNF, 14047_78_3]",200
11,Osteoarthritis of the hand,828
11,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test),1088
11,"Hayfever/allergic rhinitis | non-cancer illness code, self-reported",865
11,White matter microstructure (radial diusivities) [Anterior corona radiata],216
11,Nonatopic asthma or fasting glucose levels,12763
11,Phosphatidylcholine_32:0_[M+OAc]1- levels,12763
11,Phosphatidylserine(35:2)_[M+OAc]1- levels,12014
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:3/Lysophosphatidylcholine with acyl residue C16:0],12139
11,Serum omega-3 polyunsaturated fatty acid concentration in metabolic syndrome,12873
11,Mastocytosis,9120
11,Body mass index and HDL-C (pairwise),1378
11,Number of self-reported cancers,589
11,Digit length ratio (right hand),481
11,DNA methylation (parent-of-origin) [KvDMR 10-11-12],142
11,Interstitial lung abnormalities [EA],35
11,Fasting plasma glucose [Fasting glucose],4
11,Fed-up feelings,12637
11,Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis),47623
11,Cholesteryl ester_22:6_[M+NH4]1+ levels,12763
11,Phosphatidylcholine(36:3)_[M+H]1+/Phosphatidylethanolamine(39:3)_[M+H]1+/Phosphatidate(41:4)_[M+NH4]1+ levels,11043
11,Triacylglycerol(54:3)_[M+NH4]1+ levels,15101
11,Triacylglycerol_48:2_[M+NH4]1+ levels,2120
11,Electrocardiogram morphology (amplitude at temporal datapoints) [126 ms],17
11,Urolithiasis,12852
11,Haemorrhoidal disease,45470
11,Cerebrospinal fluid biomarker levels [Cystatin-M],2651
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C40:4],12139
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C42:5],11815
11,Glycemic traits (pregnancy) [1HPG],258
11,Drive faster than motorway speed limit,35
11,Itch intensity from mosquito bite,34
11,Cognitive performance (MTAG) [MTAG],108938
11,Adult onset asthma or fasting glucose levels,12763
11,Metabolically unhealthy in normal weight,2703
11,BRCA1 mutation in breast cancer [adjusted],36668
11,Phosphatidylinositol_36:2_[M-H]1- levels,12763
11,6mm weak meridian (left),44664
11,Electrocardiogram morphology (amplitude at temporal datapoints) [168 ms],17
11,High myopia,12
11,Breast cancer,136698
11,Medication use (drugs used in diabetes),51302
11,Average weekly champagne plus white wine intake,12763
11,Felodipine | treatment/medication code,947
11,Osteoarthritis (hip),19346
11,"Age hay fever, rhinitis or eczema diagnosed",2054
11,Glycerophospholipid levels [lysoPhosphatidylcholine acyl C20:3],2723
11,Female genital prolapse,4021
11,Ischemic heart diseases,590
11,"""Disorders of plasma-protein metabolism, not elsewhere classified""",513
11,Protein quantitative trait loci (liver) [HBG1],22
11,Loneliness,41659
11,Obesity [Obesity class I],6875
11,Vertex-wise cortical surface area,172330
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with diacyl residue sum C38:5],12763
11,"Blood protein levels [TFRC, 8795_48_3]",28374
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C44:6],12763
11,Electrocardiogram morphology (amplitude at temporal datapoints) [284 ms],17
11,Cholesteryl ester(17:1)_[M+NH4]1+ levels,3087
11,LDL cholesterol levels [BMI adjusted],11432
11,Myeloid white cell count,85788
11,Vitiligo,22147
11,Glycerophospholipid levels [Phosphatidylcholine acyl-alkyl C36:2],12763
11,Platelet-to-lymphocyte ratio,94352
11,Phosphatidylcholine-O_35:4_[M+OAc]1-/Phosphatidylcholine-P_35:3_[M+OAc]1- levels,12763
11,Electrocardiogram morphology (amplitude at temporal datapoints) [232 ms],2666
11,Diacylglycerol_36:5_[M+H-H2O]1+ levels,2120
11,Sarcoidosis [EA],6999
11,Cutaneous mastocytosis (childhood),9120
11,Metabolite levels (lipoprotein measures) [Triglycerides in small VLDL],2120
11,Sphingomyelin(40:0)_[M+OAc]1- levels,2703
11,Plakophilin-2 measurement,1198
11,"Appendicitis | non-cancer illness code, self-reported",17
11,General cognitive ability,66520
11,Electrocardiogram morphology (amplitude at temporal datapoints) [292 ms],12780
11,"Intra-ocular pressure, goldmann-correlated (left)",38881
11,&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels,250
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C32:1/Phosphatidylcholine with acyl-alkyl residue sum C36:3],12139
11,Serum metabolite levels [1-arachidonoyl-GPI (20:4)*],12327
11,Triacylglycerol_51:3_[M+NH4]1+ levels,2120
11,Fetal hemoglobin levels,152
11,Sodium levels,131
11,Evening primrose oil product | treatment/medication code,720
11,"Cholesterol, total",117954
11,Serum CC16 levels,7495
11,"Loneliness, isolation",31403
11,Tonsillectomy,36416
11,Height [AA],516
11,Inflammatory bowel disease and other gastroenteritis and colitis,865
11,BMI in smokers,1040
11,Red vs. brown/black hair color,1602
11,Corrected insulin response adjusted for insulin sensitivity index,299
11,Electrocardiogram morphology (amplitude at temporal datapoints) [-32 ms],144
11,Electrocardiogram morphology (amplitude at temporal datapoints) [186 ms],17
11,"Waist-hip ratio [EA, women]",22
11,Mean sphered cell volume,334442
11,Cholesteryl ester_16:0_[M+NH4]1+ levels,14883
11,"Blood protein levels [B3GAT3, 6897_38_3]",32118
11,High blood pressure | illnesses of mother,2478
11,Impedance of arm (left),161611
11,Diffuse diseases of connective tissue,9577
11,Cortical surface area [Lingual],1352
11,Chronic obstructive pulmonary disease x current smoker interaction (2df),672
11,Mumps,170
11,6mm regularity index (right),6
11,Electrocardiographic traits (multivariate),14367
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C36:5],12763
11,Arm fat-free mass (right),102814
11,"""Other diabetes, wide definition""",3590
11,Neurological blood protein biomarker levels [CTSC],3241
11,Age diabetes diagnosed,741
11,Type 2 diabetes [Conditioned],573
11,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],849
11,Started insulin within one year diagnosis of diabetes,846
11,Obstructive sleep apnea trait (apnea hypopnea index) [Hispanic],265
11,Adult body size,204226
11,Phosphatidylcholine-ether levels [PCO(18:1;0-18:2;0],12613
11,Phosphatidylethanolamine-O_40:6_[M+H]1+/Phosphatidylethanolamine-P_40:5_[M+H]1+ levels,14883
11,Phosphatidylcholine-O_40:6_[M+H]1+/Phosphatidylcholine-P_40:5_[M+H]1+ levels,14883
11,Levothyroxine sodium | treatment/medication code,16860
11,CD20 on IgD+ CD38- B cell,4906
11,Triacylglycerol_51:4_[M+NH4]1+ levels,2120
11,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),865
11,Electrocardiogram morphology (amplitude at temporal datapoints) [118 ms],17
11,Serum metabolite levels [Glc],136
11,Hip bone size,69
11,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) [subset analysis]",49911
11,Depressive symptoms (MTAG),34066
11,Alcohol usually taken with meals,33604
11,Phosphatidylcholine_31:2_[M+H]1+/Phosphatidylethanolamine_34:2_[M+H]1+/Phosphatidate_36:3_[M+NH4]1+ levels,12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C40:1],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:4/Phosphatidylcholine with diacyl residue sum C36:3],12763
11,Serum levels of protein KDELC2,2981
11,Interstitial lung disease,374
11,"Blood protein levels [PRCP, 5722_78_3]",2688
11,BMI in non-smokers [women],1031
11,Carotid intima media thickness (mean),85
11,Protein quantitative trait loci (liver) [TMSB4X],25
11,Triacylglycerol_58:8_[M+NH4]1+ levels,12613
11,Glycerophospholipid levels [Phosphatidylcholine diacyl C32:0],12763
11,Diastolic blood pressure x smoking status (ever vs never) interaction (2df test) [EA],3800
11,Phosphatidylcholine(36:4)_[M+H]1+/Phosphatidylethanolamine(39:4)_[M+H]1+/Phosphatidate(41:5)_[M+NH4]1+ levels,861
11,Mucosal proctocolitis,854
11,Smoking initiation (ever regular vs never regular) [Conditioned on chr11:112912811],378
11,Serum alkaline phosphatase levels,425398
11,Chronic obstructive pulmonary disease-related biomarkers [CC16],20899
11,Phosphatidylcholine-ether levels [PCO(16:0;0-20:4;0],12986
11,Electrocardiogram morphology (amplitude at temporal datapoints) [114 ms],25376
11,Malignant neoplasm of prostate (controls excluding all cancers),5675
11,Total cholesterol levels in HDL,590
11,Headache,11621
11,Bone mineral density [spine],3930
11,Phosphatidylethanolamine-O_36:3_[M-H]1-/Phosphatidylethanolamine-P_36:2_[M-H]1- levels,12763
11,Isobutyrylcarnitine (c4) levels,1103
11,Blood protein levels [CD30-L],1322
11,Electrocardiogram morphology (amplitude at temporal datapoints) [302 ms],17
11,Brain region volumes [right pallidum],43722
11,"Blood protein levels [PLEKHA7, 12731_12_3]",1386
11,Medication use (antihypertensives),3557
11,Type 2 diabetes [DGI+FUSION+WTCCC],4308
11,Phosphatidylinositol_36:0_[M-H]1- levels,12763
11,Body mass index (joint analysis main effects and smoking interaction) [men],1031
11,HVEM on Effector Memory CD4+ T cell,376
11,Cancer (pleiotropy),1032
11,Standard tea intake,19
11,Leukocyte telomere length,67468
11,Metabolic traits [SM-3 + 152 other traits],12763
11,Body mass index (bmi),462355
11,Phosphatidylcholine-O_38:1_[M+H]1+/Phosphatidylcholine-P_38:0_[M+H]1+/Phosphatidylethanolamine-P_41:0_[M+H]1+ levels,2120
11,Phosphatidylinositol_34:0_[M+H]1+ levels,12763
11,Hypercholesterolemia,6218
11,Serum metabolite levels (CMS) [M_VLDL_L],2275
11,Osteoarthritis of the hip or knee (with total joint replacement),431
11,Triacylglycerol_53:2_[M+NH4]1+ levels,2120
11,Serum metabolite levels [oleoyl-linoleoyl-glycerol (18:1/18:2) [2]],531
11,"""Endomtriosis ASRM stages 3,4""",1241
11,Background diabetic retinopathy,846
11,Other anaemias,192
11,Insulin levels adjusted for BMI,136
11,Immune reponse to smallpox (secreted IL-2) [AA],20
11,Hodgkin's lymphoma,2066
11,Diacylglycerol_36:3_[M+H-H2O]1+ levels,14259
11,Serum metabolite levels [1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (P-18:0/20:4)*],12003
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C32:3/Phosphatidylcholine with diacyl residue sum C36:5],12613
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:1/Phosphatidylcholine with diacyl residue sum C34:4],12763
11,Reticulocyte percentage,4151
11,Caffeine consumption from tea,2199
11,Primary tooth development (time to first tooth eruption),615
11,Electrocardiogram morphology (amplitude at temporal datapoints) [378 ms],17
11,Orange intake,1
11,Phosphatidylcholine-ether levels [PCO(16:0;0-20:3;0],2573
11,Phosphatidylcholine levels [PC(16:0;0-18:2;0],12763
11,Phosphatidylinositol_34:2_[M-H]1- levels,12763
11,Externalizing behaviour (multivariate analysis),50129
11,Electrocardiogram morphology (amplitude at temporal datapoints) [-56 ms],2322
11,Eye color [green eyes],704
11,Myopia,3543
11,Serum metabolite levels (CMS) [Remnant_C],2275
11,Glucose homeostasis traits [AIRg],40
11,Serum albumin levels,143396
11,Electrocardiogram morphology (amplitude at temporal datapoints) [306 ms],12815
11,Liver enzyme levels (gamma-glutamyl transferase),14406
11,Protein quantitative trait loci (liver) [GALE],64
11,Urinary sodium excretion [EA],1462
11,Protein quantitative trait loci [IL-17E],378
11,Diacylglycerol_38:5_[M+H-H2O]1+ levels,12763
11,Phosphatidylcholine levels [PC(18:1;0-18:2;0],12763
11,Diacylglycerol(32:2)_[M+H-H2O]1+ levels,3087
11,Myocardial fractal dimension (slice 6),451
11,Electrocardiogram morphology (amplitude at temporal datapoints) [454 ms],8598
11,Malignant neoplasm of breast,1115
11,Triacylglycerol_47:4_[M+NH4]1+ levels,2120
11,Triacylglycerol(53:3)_[M+NH4]1+ levels,3087
11,Atrial fibrillation,2707
11,Triglyceride levels [conditional on round 4],864
11,Food allergy [including GERA cohort],854
11,Paroxysmal tachycardia,220
11,White blood cell count,987553
11,Lymphocyte counts,853417
11,HDL cholesterol levels [Asian],3640
11,Phosphatidylcholine-O_18:0_[M+H]1+/Lysophosphatidylethanolamine_21:0_[M+H]1+ levels,12763
11,Age asthma diagnosed,16272
11,Leiomyoma of uterus,3906
11,Serum metabolite levels [S_VLDL_P],2275
11,Protein quantitative trait loci (liver) [TSN],25
11,Vitamin D levels (dietary vitamin D intake interaction),35136
11,Highest math class taken,60678
11,Late-onset Alzheimer's disease,39039
11,Phosphatidylethanolamine_40:6_[M-H]1- levels,12763
11,Glycerophospholipid levels [Phosphatidylcholine acyl-alkyl C40:5],12763
11,Neutrophill count,131654
11,1-ribosyl-imidazoleacetate levels,3088
11,Electrocardiogram morphology (amplitude at temporal datapoints) [448 ms],8598
11,Maternal care for other conditions predominantly related to pregnancy,145
11,Diastolic blood pressure,724862
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C40:3/Phosphatidylcholine with acyl-alkyl residue sum C40:5],12763
11,Serum metabolite levels (CMS) [HDL_C],41659
11,Migraine and/or systolic blood pressure,1676
11,Triiodothyronine/thyroxine ratio,504
11,Eosinophilic esophagitis,142
11,Food allergy [excluding GERA cohort],854
11,Alzheimer's disease/dementia | illnesses of siblings,29
11,Lysophosphatidylcholine(20:4)_[M+H]1+ levels,12014
11,Urinary metabolite levels in chronic kidney disease [pregnanediol-3-glucuronide],7780
11,"High cholesterol | non-cancer illness code, self-reported",1843
11,Brain connectivity [connectivity pattern],1125
11,Immunoglobulin light chain (AL) amyloidosis (heart involvement),995
11,"Smoking initiation (ever regular vs never regular) [Conditioned on chr11:122023187, chr11:121530888]",772
11,Triglyceride levels in HIV infection [African American],2684
11,Facial morphology (lower lip thickness 2),1354
11,Frequency of needing morning drink of alcohol after heavy drinking session in last year,12
11,Urinary albumin-to-creatinine ratio [EA],6624
11,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Hispanic],12139
11,"Blood protein levels [APLP2, 10627_87_3]",3712
11,Insulin disposition index,275
11,White matter microstructure (mean diusivities) [Anterior limb of internal capsule],216
11,Bone mineral density (total hip),228
11,"Blood protein levels [NTM, 8428_102_3]",66
11,Delta-6 desaturase activity,27699
11,Metabolic syndrome,106047
11,Bipolar disorder or major depressive disorder,36390
11,Retinal nerve fibre layer thickness or ganglion cell inner plexiform layer thickness (MTAG),14964
11,"Blood protein levels [MASP1, 8091_16_3]",38492
11,"Mean arterial pressure x alcohol consumption interaction (2df test) [Asian, EA, Hispanic]",768
11,Cystic fibrosis severity [p.Phe508del/p.Phe508del only],2160
11,Change in serum metabolite levels [DHA],892
11,Shingles,30
11,High density lipoprotein cholesterol levels [EA],53875
11,Phosphatidylinositol_35:0_[M-H]1- levels,12763
11,Phosphatidylinositol_38:0_[M-H]1- levels,12763
11,Serum levels of protein C1R,18446
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with diacyl residue sum C38:5],12763
11,Triacylglycerol_57:11_[M+NH4]1+ levels,12763
11,Vertical cup-disc ratio (adjusted for vertical disc diameter),13430
11,Triacylglycerol_53:3_[M+NH4]1+ levels,14883
11,Vertex-wise cortical thickness,151819
11,Osteoporosis nos,8638
11,Phosphatidylethanolamine-O_40:4_[M-H]1-/Phosphatidylethanolamine-P_40:3_[M-H]1- levels,642
11,Visual disturbances and blindness,34
11,Peripheral vascular disease,104
11,Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid),82073
11,A body shape index,93531
11,LDL cholesterol levels [Trans-ethnic initial],15566
11,"Forced expiratory volume in 1-second (fev1), predicted percentage",48551
11,HVEM on CD4+ T cell,376
11,Serum levels of protein DMKN,2436
11,Serum metabolite levels [S_VLDL_PL],2923
11,Electrocardiogram morphology (amplitude at temporal datapoints) [234 ms],2666
11,"Blood protein levels [CDON, 4541_49_2]",1157
11,An7 abundance in stool,117
11,TestASV_31 (Ruminococcus) prevalence,19
11,Protein quantitative trait loci (liver) [TXNL1],1
11,Age completed full time education,35975
11,Change in serum metabolite levels [DHA_FA],12763
11,Serum metabolite levels [XL_HDL_PL],54422
11,Body mass index and fasting glucose (pairwise),2663
11,Cholesteryl ester(20:3)_[M+NH4]1+ levels,3087
11,Phosphatidylcholine-O_36:1_[M+H]1+/Phosphatidylcholine-P_36:0_[M+H]1+/Phosphatidylethanolamine-O_39:1_[M+H]1+ levels,2120
11,Chronic obstructive pulmonary disease in non-current smokers,672
11,Autoimmune traits,48
11,Phosphatidylcholine-O_32:1_[M+H]1+/Phosphatidylcholine-P_32:0_[M+H]1+/Phosphatidylethanolamine-O_35:1_[M+H]1+ levels,14259
11,Blood metabolite levels [alpha-hydroxyisovalerate],5957
11,Serum levels of protein ANGPTL3,2120
11,Low HDL-cholesterol levels,6303
11,Diisocyanate-induced asthma,746
11,Serum levels of protein SWAP70,1776
11,Low urine pH,1515
11,"Blood protein levels [LYVE1, 3206_4_2]",556
11,Open wound of forearm,25
11,Protein quantitative trait loci (liver) [NARS],4
11,Glomerular filtration rate in non diabetics (creatinine),35887
11,Coronary artery disease,144858
11,Suffering from nerves,41603
11,Brown vs. black hair color,71134
11,Alcohol use disorder,21727
11,Phosphatidylcholine_36:5_[M+OAc]1-/Phosphatidylserine_40:4_[M-H]1- levels,12763
11,Natural Killer T Absolute Count,232
11,Stroke,1512
11,"Diastolic blood pressure x alcohol consumption interaction (2df test) [AA, EA]",1187
11,Freckles,431
11,Oleic acid (18:1n-9) levels,26690
11,Diacylglycerol_38:3_[M+H-H2O]1+ levels,12238
11,Triacylglycerol_56:6_[M+NH4]1+ levels,12763
11,Endometriosis or migraine [random effect],1241
11,Certain infectious and parasitic diseases,86
11,Gut microbiota (functional units) [GO:0045087|BP|03|innate immune response],10
11,"Blood protein levels [ARL11, 12433_8_3]",32
11,Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis),49988
11,Hypothyroidism or myxedema,87719
11,Glycerophospholipid levels [lysoPhosphatidylcholine acyl C20:4],12763
11,Metabolite levels [PC 34:3],12763
11,Adverse cardiovascular outcome x beta blockers interaction in hypertension,69
11,Cholesteryl ester_16:1_[M+NH4]1+ levels,2120
11,Electrocardiogram morphology (amplitude at temporal datapoints) [-30 ms],241
11,Neurociticism,51780
11,Longevity,26456
11,Serum 25-Hydroxyvitamin D levels [AA + Hispanic],14436
11,Phosphatidylserine_40:3_[M+H]1+/Phosphatidylglycerol_40:5_[M+NH4]1+ levels,12238
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C40:5/Phosphatidylcholine with acyl-alkyl residue sum C44:4],12763
11,Diastolic blood pressure (cigarette smoking interaction),13154
11,Phosphatidylcholine-O(34:3)_[M+H]1+/Phosphatidylethanolamine-P(37:2)_[M+H]1+ levels,2703
11,Serum levels of protein KIAA1549L,825
11,Bitter alcoholic beverage consumption,35269
11,Serum metabolite levels [oleoyl-arachidonoyl-glycerol (18:1/20:4) [1]*],12327
11,Phosphatidylcholine_34:0_[M+H]1+/Phosphatidylethanolamine_37:0_[M+H]1+/Phosphatidate_39:1_[M+NH4]1+ levels,2120
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C38:5],12763
11,Serum metabolite levels (CMS) [M_LDL_PL],2275
11,Serum metabolite levels [S_HDL_TG],2275
11,"Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test) [Asian, EA]",1611
11,"""Type 2 diabetes, definitions combined, including avohilmo""",5452
11,Circulatory disease nec,98
11,Urinary creatinine levels,42
11,Waist-to-hip ratio adjusted for body mass index [EA],34818
11,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],12952
11,Electrocardiogram morphology (amplitude at temporal datapoints) [456 ms],8598
11,Bilateral oophorectomy (both ovaries removed),3454
11,Eumovate cream | treatment/medication code,2237
11,Eye color [eye color],569
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:5/Phosphatidylcholine with acyl-alkyl residue sum C38:0],12763
11,Abdominal aortic aneurysm,2438
11,Cortical surface area [Postcentral],100
11,Serum immune biomarker levels [log(CRP],239
11,Carotid intima media thickness (maximum),70
11,Protein quantitative trait loci (liver) [GATM],16
11,Putamen volume,18309
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:5/Sphingomyelin with acyl residue sum C16:0],12763
11,Migraine with aura and/or diastolic blood pressure,1567
11,Hypertension [East Asian],3580
11,"Blood protein levels [APOA5, 11318_20_3]",2120
11,Cortical surface area [Insula],49
11,Sphingomyelin levels [SM(36:2;2],12238
11,Phosphatidylcholine-O_34:1_[M+H]1+/Phosphatidylcholine-P_34:0_[M+H]1+/Phosphatidylethanolamine-O_37:1_[M+H]1+ levels,2120
11,Phosphatidylcholine_38:5_[M+H]1+/Phosphatidylethanolamine_41:5_[M+H]1+/Phosphatidate_43:6_[M+NH4]1+ levels,12763
11,Phosphatidylinositol_38:4_[M-H]1- levels,12238
11,Urokinase plasminogen activator surface receptor levels,1673
11,Peptococcia abundance in stool,8
11,Bone ultrasound measurement (broadband ultrasound attenuation),1849
11,Serum 25-Hydroxyvitamin D level variance,41668
11,Full cream | milk type used,41502
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C44:6],12139
11,Arm fat percentage (left),239903
11,Experiencing mood swings,8372
11,Electrocardiogram morphology (amplitude at temporal datapoints) [288 ms],12780
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C42:5],13183
11,Plasma amyloid beta peptide concentrations (ABx-40),1215
11,General risk tolerance (MTAG),25852
11,Weight,423428
11,"Local histogram emphysema pattern [Moderate Centrilobular, EA]",1430
11,Metabolite levels [thyroxine],168
11,High density lipoprotein cholesterol levels,431338
11,Apolipoprotein B levels,160872
11,Phosphatidylglycerol_36:0_[M-H]1- levels,12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C44:3/Phosphatidylcholine with acyl-alkyl residue sum C44:6],11815
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C32:0/Phosphatidylcholine with acyl-alkyl residue sum C36:3],12139
11,Serum metabolite levels [linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2]*],12327
11,Waist Circumference - Triglycerides (WC-TG),6825
11,Serum metabolite levels [dopamine 3-O-sulfate],7412
11,Icd10: j84.1 other interstitial pulmonary diseases with fibrosis | underlying (primary) cause of death,1901
11,Male puberty timing (early vs. average onset voice breaking),362
11,Lysophosphatidylcholine_16:1_[M+H]1+/Lysophosphatidylethanolamine_19:1_[M+H]1+ levels,2120
11,Highest math class taken (MTAG) [MTAG],144603
11,Direct bilirubin levels,42455
11,Lysophosphatidylcholine-O_16:1_[M+H]1+/Lysophosphatidylcholine-P_16:0_[M+H]1+ levels,14259
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C30:0/Phosphatidylcholine with diacyl residue sum C32:2],12763
11,Serum metabolite levels (CMS) [XXL_VLDL_P],66876
11,Diabetes diagnosed by doctor,16073
11,Phosphatidylcholine-O(36:5)_[M+H]1+/Phosphatidylcholine-P(36:4)_[M+H]1+ levels,15101
11,Cholesterol efflux capacity (ABCA-1 dependent assay),2120
11,Cutaneous mastocytosis (adult),9120
11,Spondin-1 levels,10159
11,Age started wearing glasses or contact lenses,7100
11,Metabolite levels [TAG 52:5],2120
11,Other and unspecified coagulation defects,833
11,Ischemic stroke,2138
11,Gut microbiota abundance (genus Ruminococcus1 id.11373),358
11,Sphingomyelin_42:1_[M+H]1+ levels,2120
11,Electrocardiogram morphology (amplitude at temporal datapoints) [246 ms],2666
11,Migraine with aura and/or systolic blood pressure,1567
11,Diaphragmatic hernia,1411
11,Soluble E-selectin levels,261
11,Protein quantitative trait loci (liver) [TGM2],4
11,Crohn's disease,22785
11,Lung function (FEV1),35028
11,Mean arterial pressure,40511
11,Number of fluid intelligence questions attempted within time limit,14400
11,Sphingomyelin(32:1)_[M+H]1+ levels,3087
11,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test) [EA],3935
11,Total body bone mineral density (MTAG),1165
11,Global electrical heterogeneity phenotypes [SAI QRST],2126
11,"B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)",168
11,Serum metabolite levels [alphahydroxyisovalerate],5957
11,Trunk fat-free mass,107615
11,Body mass index variance,869
11,Triacylglyceride levels [TAG(52:4;0],2120
11,Serum metabolite levels [M_VLDL_TG],2275
11,"Blood protein levels [OAF, 6414_8_3]",329
11,"Blood clot in the leg (dvt) | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",54
11,Self-reported math ability (MTAG) [MTAG],117204
11,Alzheimer's disease (onset between ages 58 and 79),3367
11,Infantile hypertrophic pyloric stenosis [EA],28221
11,Phosphatidylcholine(38:3)_[M+H]1+/Phosphatidylethanolamine(41:3)_[M+H]1+/Phosphatidate(43:4)_[M+NH4]1+ levels,12014
11,Serum metabolite levels [HDL_D],54422
11,High blood pressure | vascular/heart problems diagnosed by doctor,79760
11,Serum metabolite levels (CMS) [XS_VLDL_FC],15686
11,"Diastolic blood pressure, automated reading",40295
11,Haemoglobin concentration,84031
11,Triacylglycerol(53:4)_[M+NH4]1+ levels,3087
11,Malignant neoplasm of prostate,6640
11,Serum metabolite levels (CMS) [LA_FA],892
11,"Sphingomyelin (d18:1/20:0, d16:1/22:0) levels",2001
11,Senile cataract,2683
11,Never smoked | tobacco smoking,1172
11,"Waist circumference [EA, women]",335
11,Response to Vitamin E supplementation [alpha-TOH],2120
11,Metabolic syndrome (bivariate traits) [HDLC-GLUC],235
11,Sleep duration (long sleep),650
11,Electrocardiogram morphology (amplitude at temporal datapoints) [280 ms],17
11,Colorectal cancer [East Asian],12488
11,Factor VII activity [EA],11488
11,Phosphatidylcholine_36:6_[M+OAc]1-/Phosphatidylserine_40:5_[M-H]1- levels,12763
11,Blood metabolite levels [eicosapentaenoate (EPA; 20:5n3],12139
11,Phosphatidylethanolamine-O_40:6_[M-H]1-/Phosphatidylethanolamine-P_40:5_[M-H]1- levels,12763
11,Serum metabolite levels [1-arachidonoyl-GPA (20:4],12427
11,Lipoprotein-associated phospholipase A2 activity and mass [activity],9526
11,Depression x maternal smoking during pregnancy interaction [Dominant model],1912
11,Corneal curvature,1894
11,3mm weak meridian angle (left),1235
11,Phosphatidylcholine levels [PC(18:0;0-20:2;0],892
11,Electrocardiogram morphology (amplitude at temporal datapoints) [124 ms],17
11,Reticulocyte fraction of red cells,225857
11,Cerebrospinal fluid sTREM-2 levels,29056
11,Blood protein levels [MMP-1],2225
11,Conjunctivitis,17307
11,Serum levels of protein CHRDL2,1858
11,Spherical power (left),7020
11,Sphingomyelin_40:3_[M+H]1+ levels,2120
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C40:5/Lysophosphatidylcholine with acyl residue C20:3],11815
11,Triacylglyceride levels [TAG(54:3;0],2120
11,Electrocardiogram morphology (amplitude at temporal datapoints) [418 ms],8598
11,Serum 25-Hydroxyvitamin D levels x season interaction,6857
11,Benzoate levels,20
11,Obesity,3132
11,Fasting glucose adjusted for BMI,12422
11,Arm fat percentage (right),213602
11,Alzheimer's disease in APOE e4+ carriers,3633
11,Psoriasis vulgaris,7853
11,QRS duration [EA],12763
11,Sphingomyelin(36:1)_[M-CH3]1- levels,3087
11,"Headaches (not migraine) | non-cancer illness code, self-reported",295
11,Major coronary event in darapladib-treated cardiovascular disease (time to event),58
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:1/Phosphatidylcholine with diacyl residue sum C38:4],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with diacyl residue sum C38:4],12763
11,Neuroticism score,66343
11,Triglyceride levels [BMI unadjusted],3029
11,Serum metabolite levels [L_VLDL_FC],2275
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C38:5],12763
11,CD8dim Natural Killer T %lymphocyte,232
11,Protein quantitative trait loci (liver) [TPM4],25
11,Electrocardiogram morphology (amplitude at temporal datapoints) [208 ms],17
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:1/Phosphatidylcholine with diacyl residue sum C38:5],12763
11,Systemic mastocytosis,9120
11,Sphingomyelin(42:4)_[M+H]1+ levels,3087
11,Phosphatidylethanolamine-O_38:4_[M-H]1-/Phosphatidylethanolamine-P_38:3_[M-H]1- levels,642
11,Electrocardiogram morphology (amplitude at temporal datapoints) [128 ms],17
11,Amyloid A serum levels,16717
11,Blond vs. brown/black hair color,83444
11,Body mass index (joint analysis main effects and physical activity interaction) [women],5540
11,Diacylglycerol(36:3)_[M+NH4]1+ levels,3087
11,Phosphatidylcholine(40:8)_[M+H]1+ levels,75489
11,"Asthma | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",47796
11,Serum metabolite levels [eicosapentaenoate (EPA; 20:5n3],20976
11,Serum metabolite levels [S_VLDL_L],2275
11,Serum metabolite levels (CMS) [L_VLDL_C],2923
11,Electrocardiogram morphology (amplitude at temporal datapoints) [344 ms],17
11,Electrocardiogram morphology (amplitude at temporal datapoints) [282 ms],17
11,Vertical cup-disc ratio (multi-trait analysis),16232
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:1/Phosphatidylcholine with diacyl residue sum C36:4],12763
11,Otorrhea,8462
11,Unspecified diabetes,846
11,Sodium valproate | treatment/medication code,481
11,Benign neoplasm of colon,16456
11,Fatty acid(22:4)_[M-H]1- levels,24777
11,Phosphatidylcholine-O_40:6_[M+OAc]1-/Phosphatidylcholine-P_40:5_[M+OAc]1- levels,12763
11,Phosphatidylinositol(36:3)_[M-H]1- levels,64404
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with diacyl residue sum C42:1],11815
11,Hematological and biochemical traits [HDL],2881
11,Uric acid levels,15533
11,Angina pectoris,8772
11,Triacylglycerol_52:4_[M+NH4]1+ levels,2120
11,Mean corpuscular haemoglobin concentration,19163
11,"Blood protein levels [C1QTNF5, 7810_20_3]",810
11,Protein quantitative trait loci (liver) [LUM],203
11,Alcohol use disorder [EA],108
11,Hypertrophic cardiomyopathy,142
11,Muscular dystrophy,19
11,Worry too long after an embarrassing experience,59602
11,Waist-hip index,127359
11,Phosphatidylcholine_33:2_[M+OAc]1-/Phosphatidylserine_37:1_[M-H]1- levels,12763
11,Phosphatidylserine(44:6)_[M+OAc]1- levels,11043
11,Metabolite levels [TAG 56:10],2120
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with diacyl residue sum C34:4],12763
11,Neuroblastoma (11q deletion),744
11,Serum levels of protein PYY,1472
11,Heart failure and hypertrophic cardiomyopathy,405
11,Blood metabolite levels [adrenate (22:4n6],12763
11,Serum metabolite levels (CMS) [M_VLDL_PL],4894
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:4/Lysophosphatidylcholine with acyl residue C20:3],12139
11,Electrocardiogram morphology (amplitude at temporal datapoints) [446 ms],8598
11,"Blood protein levels [CTSF, 9212_22_3]",12598
11,Electrocardiogram morphology (amplitude at temporal datapoints) [32 ms],4805
11,Hematuria,768
11,Sphingomyelin_36:2_[M+OAc]1- levels,2552
11,Obstructive sleep apnea trait (average oxyhemoglobin saturation across sleep episode),38
11,Coronary artery disease [additive model],925
11,"Blood protein levels [TCN1, 11232_46_3]",132
11,Gestational diabetes (for exclusion),136
11,Glycemic traits (multi-trait analysis),136
11,I can only hear on the right side | hearing test done,2
11,Waist-to-hip ratio adjusted for body mass index,33595
11,Blood protein levels [Beta-endorphin],10562
11,Whole body water mass,144706
11,Electrocardiogram morphology (amplitude at temporal datapoints) [426 ms],8598
11,Cadherin-related family member 5 levels,5667
11,Serum uric acid levels [Japanese],6052
11,"""Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)""",1222
11,Musculoskeletal disorder or trauma,1364
11,CD4-CD8- Natural Killer T %lymphocyte,232
11,Lumbar spine bone mineral density,14838
11,Alcohol use disorder (total score),11270
11,Other non-epithelial cancer of skin,9048
11,Glycerophospholipid levels [Phosphatidylcholine diacyl C36:3],12139
11,Serum metabolite levels [L_VLDL_TG],2275
11,Lifetime number of sexual partners,1102
11,Age at menopause (last menstrual period),1241
11,Cholesteryl ester(14:0)_[M+NH4]1+ levels,884
11,Electrocardiogram morphology (amplitude at temporal datapoints) [320 ms],52
11,Amyotrophic lateral sclerosis (sporadic),68
11,Risk-taking tendency (4-domain principal component model),44353
11,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)",3977
11,Ganglion cell inner plexiform layer (GCIPL) thickness,14743
11,"Heel quantitative ultrasound index (qui), direct entry (right)",63342
11,"""Disorders of gallbladder, biliary tract and pancreas""",13963
11,Electrocardiogram morphology (amplitude at temporal datapoints) [138 ms],25376
11,One or more previous psychiatric episodes with this health care provider | history of psychiatric care on admission,2286
11,Multiple myeloma (IgH translocation) [t11;14 vs non t11;14],995
11,1-palmitoyl-2-docosahexaenoyl-gpc (16:0/22:6) levels,49
11,"Number of decayed, missing and filled tooth surfaces or use of dentures",50
11,Myopia (pathological),10
11,Blood metabolite levels [1-arachidonoylglycerophosphoinositol],12763
11,Urate levels [women],26783
11,Spherical equivalent or myopia (age of diagnosis),36386
11,Low tan response,7186
11,Cancer diagnosed by doctor,654
11,Protein quantitative trait loci (liver) [CYP2E1],20
11,Protein quantitative trait loci (liver) [LGMN],55
11,Electrocardiogram morphology (amplitude at temporal datapoints) [310 ms],52
11,Blood protein levels in cardiovascular risk,17013
11,Worrier / anxious feelings,39939
11,Left | usual side of head for mobile phone use,41659
11,Sleep duration (short sleep),3545
11,White blood cell count [Pomak],1272
11,Phosphatidylcholine-O(38:4)_[M+H]1+/Phosphatidylcholine-P(38:3)_[M+H]1+ levels,12014
11,Urate levels [men],27036
11,Triglyceride levels in current drinkers [Asian],12151
11,Electrocardiogram morphology (amplitude at temporal datapoints) [464 ms],8598
11,Migraine and/or diastolic blood pressure,1567
11,"Pulse pressure x alcohol consumption interaction (2df test) [AA, EA]",977
11,Glycemic traits [1-hPG],251
11,Educational attainment (MTAG) [MTAG],187347
11,Phosphatidylcholine(36:5)_[M+OAc]1-/Phosphatidylserine(40:4)_[M-H]1- levels,12014
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:4/Sphingomyelin with acyl residue sum C24:0],12763
11,Pattern 4 | hair/balding pattern,29343
11,Diacylglycerol_36:1_[M+H-H2O]1+ levels,2120
11,"""Ulcerative colitis (strict definition, require KELA, min 2 HDR)""",854
11,Acute graft versus host disease in bone marrow transplantation (recipient effect),30
11,Adverse response to radiation therapy,149
11,Providencia abundance in stool,16
11,Fatty acid desaturase activity (adipose tissue) [D5D],12238
11,Appendicular lean mass,578862
11,Ever had bowel cancer screening,8159
11,Sphingomyelin(38:1)_[M+H]1+ levels,3087
11,"Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)",4255
11,Proliferative diabetic retinopathy,1692
11,Electrocardiogram morphology (amplitude at temporal datapoints) [252 ms],2666
11,Electrocardiogram morphology (amplitude at temporal datapoints) [242 ms],2666
11,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [beta-citrylglutamate, saccharopine]",1305
11,Had menopause,1241
11,Obesity-related traits [TG ],442
11,"Hip circumference [EA,women]",832
11,Serum levels of protein NELL1,97
11,Fractional shortening,271
11,Mother's age at death,54
11,Electrocardiogram morphology (amplitude at temporal datapoints) [188 ms],17
11,Protein quantitative trait loci (liver) [ARHGDIA],3
11,"Hemoglobin levels [HbF, Sardinian]",2534
11,Oleic acid (18:1n-9) levels [EA],13927
11,Serum metabolite concentrations in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C38:4],12763
11,Serum metabolite levels (CMS) [UnSat],12763
11,Time spent using computer,16654
11,Anxiety,22180
11,Hypertensive heart and/or renal disease,1174
11,Blood protein levels [NCAM],444
11,Breast cancer (survival) [ER -ve],61
11,Chronic lymphocytic leukemia,11362
11,Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid),39591
11,Glycerophospholipid levels [Phosphatidylcholine diacyl C38:4],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C38:6],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:5/Phosphatidylcholine with acyl-alkyl residue sum C34:1],12763
11,Serum levels of protein MMP10,2281
11,Urinary metabolite levels in chronic kidney disease [beta-citrylglutamate],1305
11,"Blood protein levels [EA, Matrilysin]",131
11,Frequency of unenthusiasm / disinterest in last 2 weeks,1127
11,Human milk oligosaccharide concentration (lacto-N-fucopentaose III),12
11,Total cholesterol levels [EA],17531
11,Prostate cancer | illnesses of father,443
11,LDL cholesterol levels x short total sleep time interaction (2df test),12139
11,IgA levels,2723
11,Red blood cell traits [MCHC],3459
11,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [women],16
11,Electrocardiogram morphology (amplitude at temporal datapoints) [222 ms],17
11,Malaria [additive],42
11,Electrocardiogram morphology (amplitude at temporal datapoints) [132 ms],17
11,Asthma,365476
11,Daytime nap,14500
11,Miserableness,4962
11,Heel bone mineral density (bmd) (right),74203
11,Allergy,18831
11,Triacylglycerol(54:5)_[M+NH4]1+ levels,3087
11,Sphingolipid d18:1/d18:2 ratio,3482
11,Folate pathway vitamin levels [Plasma Vitamin B12],43
11,Irritable mood,13514
11,Body size at age 10,109705
11,Glycerophospholipid levels [Phosphatidylcholine acyl-alkyl C36:4],12763
11,Cycle | types of transport used (excluding work),17573
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C38:4],12763
11,Electrocardiogram morphology (amplitude at temporal datapoints) [238 ms],2666
11,Metabolite levels [TAG 52:3],4020
11,Cardiomyopathy,232
11,Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in non-secretors,126
11,Optic cup area,31209
11,Pulse pressure,399689
11,Varicose veins of lower extremity,4764
11,Butter/spreadable butter | spread type,10954
11,Thyrotoxicosis,299
11,Electrocardiogram morphology (amplitude at temporal datapoints) [182 ms],17
11,Corneal hysteresis,306
11,Sporadic neuroblastoma [European American],25
11,Protein quantitative trait loci (liver) [IGHG3],11
11,Melanoma,11306
11,HDL cholesterol levels in current drinkers [EA],51346
11,Pulse rate,6294
11,Leg predicted mass (right),119456
11,Phosphatidylinositol_38:4_[M+H]1+ levels,12763
11,Antihypertensive medication - note that there are other indications,9202
11,Serum levels of protein CD59,2489
11,Visual disturbances,34
11,Electrocardiogram morphology (amplitude at temporal datapoints) [170 ms],17
11,For just reading/near work as you are getting older (called 'presbyopia') | reason for glasses/contact lenses,15
11,Systolic blood pressure (cigarette smoking interaction),13154
11,Lymphocyte-to-monocyte ratio,32065
11,Cholesterol_[M+H-H2O]1+ levels,17970
11,Pollen allergy,865
11,Glioma,17292
11,Salbutamol product | treatment/medication code,574
11,Serum metabolite levels [3-methoxytyramine sulfate],8573
11,Triglyceride levels [Indian],5307
11,Low hand grip strength (60 years and older) (EWGSOP),1554
11,Asthma and allergy,854
11,"""Disorders of ocular muscles, binocular movement, accommodation and refraction""",78
11,Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count) [Etanercept],6
11,Menarche (age at onset),286240
11,Fatty acid desaturase activity (serum) [D5D],14961
11,Asthma (childhood onset),54917
11,Triacylglycerol_58:9_[M+NH4]1+ levels,12763
11,Sphingomyelin(40:2)_[M-CH3]1- levels,9188
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with diacyl residue sum C38:5],12763
11,Childhood asthma (age<16) (more control exclusions),854
11,Male puberty timing (late vs. average onset voice breaking),1351
11,Brain region volumes [left cerebellum exterior],3414
11,Cortical surface area [Pericalcarine],1285
11,Magnesium levels,106
11,Electrocardiogram morphology (amplitude at temporal datapoints) [194 ms],17
11,Conductive hearing loss,8
11,Other reason | reason for reducing amount of alcohol drunk,1
11,Mean corpuscular hemoglobin concentration,413900
11,Blood glucose levels,48455
11,Electrocardiogram morphology (amplitude at temporal datapoints) [316 ms],12815
11,Frailty index,1127
11,Type 2 diabetes [non-obese],2154
11,Serum metabolite concentrations in chronic kidney disease [1-arachidonoyl-GPC (20:4n6],405
11,Triacylglycerol_52:6_[M+NH4]1+ levels,12763
11,Phosphatidylcholine-O(40:6)_[M+H]1+/Phosphatidylcholine-P(40:5)_[M+H]1+ levels,12014
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C38:6],12763
11,Serum metabolite levels [1-(1-enyl-palmitoyl)-GPC (P-16:0)*],12427
11,"Blood protein levels [EA, Proprotein convertase subtilisin/kexin type 7]",10837
11,Psoriasis or type 2 diabetes (trans-disease meta-analysis),3979
11,Phosphatidylinositol(34:2)_[M-H]1- levels,12014
11,"Systolic blood pressure x alcohol consumption interaction (2df test) [Asian, EA, Hispanic]",1750
11,Quantitative traits [TG],5998
11,Hematological or dermatological disease,1935
11,Potassium levels,1380
11,Complement factor B measurement,1561
11,Other and unspecified anaemias,192
11,Other heart diseases,100
11,Adult onset asthma and/or waist-to-hip ratio adjusted for BMI,25898
11,Phosphatidylcholine-O_38:5_[M+H]1+/Phosphatidylcholine-P_38:4_[M+H]1+ levels,14883
11,Phosphatidylcholine_35:2_[M+OAc]1-/Phosphatidylserine_39:1_[M-H]1- levels,12763
11,"Heavy diy (eg: weeding, lawn mowing, carpentry, digging) | types of physical activity in last 4 weeks",17342
11,Serum levels of protein PRCP,2562
11,Electrocardiogram morphology (amplitude at temporal datapoints) [254 ms],2666
11,Renal underexcretion gout,3184
11,Fenofibrate | treatment/medication code,2120
11,Serum uric acid levels [dominant],296
11,Peak expiratory flow,27227
11,"Body mass index [EA, women]",5540
11,Interleukin-1 receptor type 2 measurement,3122
11,Phosphatidylcholine_36:3_[M+H]1+/Phosphatidylethanolamine_39:3_[M+H]1+/Phosphatidate_41:4_[M+NH4]1+ levels,12238
11,Phosphatidylinositol(36:4)_[M-H]1- levels,12014
11,Glycerophospholipid levels [Phosphatidylcholine diacyl C36:5],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C32:0/Phosphatidylcholine with diacyl residue sum C36:2],12763
11,Medication use (drugs affecting bone structure and mineralization),18615
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C34:0/Phosphatidylcholine with acyl-alkyl residue sum C36:2],12763
11,"""Atopic dermatitis, strict definition with reimbursement""",1864
11,Matrix metalloproteinase-7 levels,1305
11,Triacylglyceroloxid(53:3)_[M+NH4]1+ levels,884
11,Blood cell traits (multivariate analysis),84
11,SSC-A on Natural Killer T,315
11,Vertigo,159
11,Very large HDL particle concentration,13183
11,Problematic alcohol use,21007
11,Serum metabolite levels [1arachidonoylglycerophosphoethanolamine],12763
11,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),12952
11,Medication use (salicylic acid and derivatives),14759
11,1-stearoyl-2-oleoyl-gpc (18:0/18:1) levels,1079
11,Potassium in urine,731
11,Cholesteryl ester_18:1_[M+NH4]1+ levels,2120
11,"LDL cholesterol levels x smoking (current vs non smokers) interaction (2df test) [African, trans-ethnic]",84
11,Electrocardiogram morphology (amplitude at temporal datapoints) [380 ms],17
11,Triglyceride levels x short total sleep time interaction (2df test),14561
11,HDL cholesterol levels [EA],43004
11,Phosphatidylglycerol(36:0)_[M-H]1- levels,11043
11,Serum metabolite levels [ApoB_ApoA1],2275
11,Electrocardiogram morphology (amplitude at temporal datapoints) [-66 ms],628
11,Waist circumference adjusted for BMI in active individuals [EA],258
11,Phospholipid levels in small VLDL,24
11,Thyroid problem (not cancer),68942
11,Lysophosphatidylethanolamine_22:4_[M-H]1- levels,13655
11,Phosphatidylethanolamine-O(38:4)_[M-H]1-/Phosphatidylcholine-O(35:4)_[M-H]1-/Phosphatidylcholine-P(35:3)_[M-H]1- levels,12014
11,Protein quantitative trait loci [Soluble transferrin receptor],22775
11,Lymphocyte percentage,181794
11,Non-Hodgkin's lymphoma,18729
11,Triacylglycerol(50:3)_[M+NH4]1+ levels,3087
11,Coronary atherosclerosis,975
11,Serum metabolite levels (CMS) [S_VLDL_PL],2923
11,Brain region volumes [left insula],543
11,Basophil percentage of white cells,38190
11,Triacylglycerol_54:7_[M+NH4]1+ levels,12763
11,Serum levels of protein TFRC,20866
11,Glycerophospholipid levels [Phosphatidylcholine acyl-alkyl C40:4],12763
11,Galactonate levels,564
11,Body fat percentage and type 2 diabetes (pairwise),2007
11,Bone ultrasound measurement (velocity of sound) [female],1648
11,SAPHO syndrome,1632
11,White matter microstructure (mean diusivities) [Average across all tracts],216
11,Breast cancer (male),58
11,Subpleural-predominant interstitial lung abnormalities [EA],35
11,Spherical equivalent,99208
11,Gondoic acid (20:1n-9) levels [EA],12228
11,Phosphatidylinositol(36:2)_[M-H]1- levels,12014
11,Standing height,354829
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C40:4],12613
11,Brain region volumes [white matter],1750
11,Allergic asthma (mode),865
11,Blood protein levels [Interleukin-25],138
11,Electrocardiogram morphology (amplitude at temporal datapoints) [164 ms],17
11,Colorectal cancer [EA],15241
11,Serum uric acid levels,45406
11,Brain region volumes [left pallidum],33199
11,Triacylglyceride levels [TAG(52:3;0],2120
11,Serum levels of protein TAC3,7028
11,"Type 1 diabetes | non-cancer illness code, self-reported",2263
11,Family history of certain disabilities and chronic diseases leading to disablement,222
11,Incremental insulin,136
11,Brain region volumes [left inferior parietal],50
11,Syntrophorhabdaceae abundance in stool,32
11,Cognitive ability (MTAG),37385
11,acne vulgaris,28275
11,Serum metabolite levels (CMS) [L_HDL_PL],44582
11,"""Cholelithiasis, broad definition with cholecystitis""",8996
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with diacyl residue sum C40:5],12763
11,Fetal hemoglobin levels [African],12728
11,Serum metabolite levels (CMS) [HDL_TG],2923
11,Serum metabolite levels (CMS) [S_VLDL_L],2275
11,Malaria,9352
11,Adventurousness,11940
11,Triacylglycerol_58:7_[M+NH4]1+ levels,12613
11,Serum levels of protein JAM3,625
11,Vasomotor and allergic rhinitis,863
11,Electrocardiogram morphology (amplitude at temporal datapoints) [328 ms],52
11,Glaucoma (multi-trait analysis),83330
11,Phosphatidylcholine_34:3_[M+H]1+/Phosphatidylethanolamine_37:3_[M+H]1+/Phosphatidate_39:4_[M+NH4]1+ levels,15172
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C44:5],12763
11,Trunk fat mass,202062
11,"Number of operations, self-reported",7216
11,Mitochondrial DNA levels,13301
11,Cataract,4437
11,"""Thyrotoxicosis, other and/or unspecified""",265
11,Protein quantitative trait loci (liver) [CKB],207
11,Lymphoma [LYM],12656
11,Phosphatidylcholine_37:5_[M+H]1+/Phosphatidylethanolamine_40:5_[M+H]1+/Phosphatidate_42:6_[M+NH4]1+ levels,12763
11,Phosphatidylcholine(33:2)_[M+H]1+/Phosphatidylethanolamine(36:2)_[M+H]1+/Phosphatidate(38:3)_[M+NH4]1+ levels,11043
11,"""Type 1 diabetes, strict definition, subgroup 1""",846
11,"""Type 2 diabetes, strict (exclude DM1)""",4949
11,"2,3-dihydroxy-2-methylbutyrate levels",3186
11,Facial morphology (segment 1),306
11,"Blood protein levels [MMP10, 8479_4_3]",741
11,"Blood protein levels [ESAM, 7841_84_3]",1034
11,"Blood protein levels [PDGFD, 9341_1_3]",80
11,Breast cancer (estrogen-receptor negative),36299
11,Heel bone mineral density,476013
11,Fruit consumption,57079
11,Galectin-3-binding protein measurement,13199
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C44:6],12763
11,Metabolite levels [DAG 36:2],2120
11,Change in serum metabolite levels (CMS) [DHA],892
11,Febrile seizures (MMR vaccine-related),31
11,Status post-ami,6
11,Acne (severe) [fixed effect model],53106
11,"Ground coffee (include espresso, filter etc) | coffee type",11886
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C42:1/Phosphatidylcholine with acyl-alkyl residue sum C42:3],11815
11,High-sensitivity cardiac troponin T levels (MTAG),4248
11,Hernia abdominopelvic cavity,754
11,Retinal detachments and breaks,111
11,Obesity-related traits [GLU ],40
11,Electrocardiogram morphology (amplitude at temporal datapoints) [224 ms],17
11,Acne (severe),57742
11,Waist-hip ratio,406809
11,Fasting blood glucose adjusted for BMI,9480
11,Subcortical volume (MOSTest),50938
11,Cutaneous malignant melanoma,9512
11,Bone ultrasound measurement (broadband ultrasound attenuation) [female],782
11,DNA methylation Hannum age acceleration,4897
11,Diabetes | illnesses of mother,3373
11,"""Ischaemic heart disease, wide definition""",590
11,White matter microstructure (axial diusivities) [Posterior corona radiata ],73
11,Renal function-related traits (BUN),11
11,Femoral neck bone mineral density,30773
11,Male puberty timing (late vs. average onset facial hair),1713
11,Gamma glutamyl transpeptidase,61207
11,Triacylglycerol_56:8_[M+NH4]1+ levels,12763
11,Serum metabolite levels [N-acetyltryptophan],1905
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C38:5],12763
11,Serum metabolite levels (CMS) [S_VLDL_CE],2275
11,Serum metabolite levels [Trehalose],26632
11,Electrocardiogram morphology (amplitude at temporal datapoints) [256 ms],2666
11,Coffee intake,2567
11,Haemolytic anaemias,2158
11,Bone mineral density (hip),15030
11,Alcohol intake frequency.,30533
11,Body mass index [EA],86230
11,High density lipoprotein cholesterol levels [conditional on round 4],12743
11,Phosphatidylinositol_38:5_[M-H]1- levels,12238
11,Diacylglycerol(44:6)_[M+H-H2O]1+ levels,3087
11,Brain region volumes [right putamen],9290
11,Serum metabolite levels [docosapentaenoate (n3 DPA; 22:5n3],12427
11,Cortical surface area [Fusiform],591
11,Doxazosin | treatment/medication code,2816
11,Cholesteryl ester levels [CE(22:6;0],892
11,Angina,95
11,Corneal resistance factor,306
11,Serum metabolite levels [linoleoyl-linoleoyl-glycerol (18:2/18:2) [1]*],531
11,DNA methylation (parent-of-origin) [H19-ICR-CpG02],4668
11,Sex hormone levels [FSH],1241
11,Phosphatidylcholine(35:3)_[M+H]1+/Phosphatidylethanolamine(38:3)_[M+H]1+/Phosphatidate(40:4)_[M+NH4]1+ levels,12014
11,Sphingomyelin(42:2)_[M+OAc]1- levels,6043
11,Hypothyroidism and >3 levothyroxin purchases,2861
11,"Mean arterial pressure x alcohol consumption interaction (2df test) [EA, Hispanic]",1584
11,Sphingomyelin(32:1)_[M-CH3]1- levels,442
11,Serum levels of protein SERPINA5,2286
11,Risk taking,18
11,Electrocardiogram morphology (amplitude at temporal datapoints) [212 ms],17
11,Phosphatidate(43:6)_[M-H]1- levels,10995
11,Follicular lymphoma,15757
11,"Allergy, hypersensitivity or anaphylaxis",16383
11,Triacylglycerol_46:5_[M+NH4]1+ levels,2120
11,Serum metabolite levels (CMS) [Glc],136
11,N-glycan levels [DG13],2782
11,Gut microbiota relative abundance (bacterial taxa) [Synergistaceae],306
11,Body fat distribution (arm fat ratio) [males],12911
11,Phosphatidylcholine_37:6_[M+OAc]1-/Phosphatidylserine_41:5_[M-H]1- levels,12613
11,Triacylglycerol_58:10_[M+NH4]1+ levels,12763
11,Atorvastatin | treatment/medication code,860
11,Response to serotonin reuptake inhibitors in major depressive disorder [Response],2858
11,"Pulse pressure x alcohol consumption interaction (2df test) [AA, Asian, EA, Hispanic]",1750
11,Sphingomyelin_36:0_[M+H]1+ levels,2120
11,Estimated glomerular filtration rate in diabetes,51
11,Erosive tooth wear (severe vs non-severe) [male],114
11,Serum metabolite levels (CMS) [DHA],12807
11,Phosphatidylcholine_38:3_[M+H]1+/Phosphatidylethanolamine_41:3_[M+H]1+/Phosphatidate_43:4_[M+NH4]1+ levels,2991
11,Heel bone mineral density (bmd),115630
11,Sphingomyelin_39:1_[M+H]1+ levels,2120
11,Acceptance of an invitation to participate in a mental health questionnaire,571
11,Serum metabolite levels (CMS) [M_VLDL_TG],2275
11,Blood metabolite levels [1-arachidonoylglycerophosphocholine],12763
11,Phosphatidylcholine_38:6_[M+H]1+/Phosphatidylethanolamine_41:6_[M+H]1+ levels,12763
11,"Intra-ocular pressure, corneal-compensated (left)",41408
11,Type 1 diabetes with renal complications,1305
11,Cannabis use,1127
11,"Other (e.g. cornflakes, frosties) | cereal type",1125
11,Serum metabolite levels (CMS) [VLDL_TG],2275
11,Urinary metabolite levels in chronic kidney disease [X - 22834],7780
11,Insulin product | treatment/medication code,1313
11,Tense / 'highly strung',2987
11,Average total household income before tax,74
11,Albumin-globulin ratio,25409
11,Eczema,55157
11,Nonalcoholic fatty liver disease (imputed),2780
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C42:5],13205
11,Lung adenocarcinoma [East Asian],759
11,Electrocardiogram morphology (amplitude at temporal datapoints) [-36 ms],144
11,Sicca syndrome [Sjögren],6
11,Total body bone mineral density (age 30-45),18305
11,Phosphatidylcholine(38:4)_[M+H]1+/Phosphatidylethanolamine(41:4)_[M+H]1+ levels,12014
11,Sensitivity / hurt feelings,18644
11,Cholesteryl ester_22:5_[M+NH4]1+ levels,13183
11,Hyperlipidemia,8394
11,Matrix metalloproteinase-3 levels,6004
11,Cardiac muscle measurement [Relative wall thickness],123
11,Valvular heart disease including rheumatic fever,62
11,T wave morphology restitution during recovery from exercise,17
11,Wilms tumor,20
11,Percentage of invited food questionnaires completed,14452
11,Alzheimer's disease or HDL levels (pleiotropy),3367
11,Rectal cancer,1563
11,Cereal intake,1272
11,Thyrotoxicosis with toxic multinodular goitre,299
11,"Skin, hair and eye pigmentation (multivariate analysis)",464
11,Number of incorrect matches in round,125
11,Desulfovibrionia abundance in stool,15
11,Chronic obstructive pulmonary disease or resting heart rate (pleiotropy),46386
11,Predicted visceral adipose tissue,65808
11,Direct low density lipoprotein cholesterol levels,53963
11,Timolol 0.25% eye drops | treatment/medication code,2557
11,Matrix metalloproteinase levels,6162
11,Peptic ulcer disease,3627
11,White matter microstructure (mean diusivities) [Anterior corona radiata],216
11,"Blood protein levels [NCAM1, 4498_62_2]",39
11,"Pulse pressure [EA, initial]",16851
11,Triglyceride levels [Asian],12240
11,Phosphatidylcholine_38:9_[M+OAc]1-/Phosphatidylserine_42:8_[M-H]1- levels,12763
11,"Bone mineral density (paediatric, skull)",10116
11,Blood protein levels [Serum amyloid A-1 protein],9235
11,Moyamoya disease,1022
11,Unstable angina pectoris,2128
11,Processed meat intake,1800
11,Childhood asthma (age<16),854
11,Chronic kidney disease,35879
11,Blood protein levels [APOA4],65918
11,Phosphatidylethanolamine_34:2_[M-H]1- levels,12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C38:2/Phosphatidylcholine with acyl-alkyl residue sum C40:4],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:5/Phosphatidylcholine with acyl-alkyl residue sum C36:3],12763
11,Corneal resistance factor (right),40490
11,"Cholesterol lowering medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",4348
11,Electrocardiogram morphology (amplitude at temporal datapoints) [226 ms],2666
11,Femur total bone mineral density x gut microbiota (﻿genus Lactococcus) interaction,5
11,Serum total protein level,230965
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C36:4],12763
11,White matter microstructure (axial diusivities) [Splenium of corpus callosum],2456
11,Urinary metabolite levels in chronic kidney disease [N-acetyl-aspartyl-glutamate (NAAG],37538
11,Methylmalonate (mma) levels,108
11,"Body mass index in physically active individuals [EA,women]",878
11,Electrocardiogram morphology (amplitude at temporal datapoints) [36 ms],4805
11,Serum levels of protein NTM,353
11,"""Malignant neoplasm of breast, HER2-negative""",1115
11,"Blood protein levels [MMP10, 3743_1_2]",741
11,Serum metabolite levels [M_VLDL_PL],2275
11,Pure hypercholesterolaemia,590
11,Brain region volumes [right insula],591
11,Electrocardiogram morphology (amplitude at temporal datapoints) [152 ms],17
11,Red blood cell fatty acid levels [ALA],12613
11,Fatty acid desaturase activity (serum) [D6D],892
11,Diastolic blood pressure x alcohol consumption interaction (2df test) [EA],2115
11,Phospholipid levels (plasma) [proportions],2120
11,Sphingomyelin(37:1)_[M+H]1+ levels,3087
11,CD8+ Natural Killer T %T cell,232
11,"Lymphoid leukemia, chronic",266
11,Bipolar disorder lithium response (categorical) or schizophrenia,18
11,Protein quantitative trait loci (liver) [USP5],49
11,"Total cholesterol levels [Asian initial, BMI unadjusted]",12228
11,Metabolite levels [DAG 36:1],2120
11,"Aging traits (healthspan, parental lifespan or longevity) (multivariate analysis)",3593
11,Salt added to food,1676
11,Thrombin measurement,2385
11,Hot drink temperature,42901
11,Sphingomyelin_34:2_[M+H]1+ levels,14259
11,Phosphatidylcholine_35:5_[M+OAc]1-/Phosphatidylserine_39:4_[M-H]1- levels,12613
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with diacyl residue sum C36:4],12763
11,Benign neoplasm: Colon (controls excluding all cancers),12613
11,Type 2 diabetes [conditional],9038
11,Serum metabolite levels [XS_VLDL_P],2275
11,Brown vs. non-brown hair color,6080
11,Benign neoplasm: Colon,12613
11,Malignant neoplasm of skin (controls excluding all cancers),589
11,Protein quantitative trait loci (liver) [TXN],25
11,Phosphatidylcholine-O_32:0_[M+H]1+/Phosphatidylethanolamine-O_35:0_[M+H]1+ levels,2120
11,Total amyloid (SNP x SNP interaction),18
11,Neuroblastoma,13250
11,Bipolar disorder (MTAG),67317
11,Diacylglycerol_44:7_[M+H-H2O]1+ levels,2120
11,"Blood protein levels [UBASH3B, 12558_3_3]",2880
11,Adrenomedullin levels,12959
11,Rosuvastatin | treatment/medication code,2356
11,Keratoconus,21226
11,Cognitive aspects of educational attainment,149906
11,Eczema or dermatitis,2919
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C38:5/Phosphatidylcholine with acyl-alkyl residue sum C44:4],12763
11,Non-melanoma skin cancer,9391
11,Sphingomyelin_42:2_[M+H]1+ levels,2120
11,Waist-to-hip ratio adjusted for BMI (additive genetic model),3106
11,Retinal nerve fibre layer (RNFL) thickness,649
11,Stool frequency,2227
11,Thyroid stimulating hormone levels,511
11,Skin pigmentation traits [Fitzpatrick phototype score],589
11,Protein quantitative trait loci (liver) [ISOC2],52
11,Serum levels of protein OLR1,48
11,Vitamin D levels [Age 14],18565
11,Phosphatidylethanolamine-O_34:3_[M-H]1-/Phosphatidylethanolamine-P_34:2_[M-H]1- levels,12763
11,Phosphatidylethanolamine-O_38:6_[M+H]1+/Phosphatidylethanolamine-P_38:5_[M+H]1+ levels,14883
11,Phosphatidylcholine-O_36:4_[M+H]1+/Phosphatidylcholine-P_36:3_[M+H]1+ levels,14883
11,"Blood protein levels [EA, Tumor necrosis factor receptor superfamily member 19L]",6351
11,Electrocardiogram morphology (amplitude at temporal datapoints) [428 ms],8598
11,"Blood protein levels [IL25, 4137_57_2]",329
11,Metabolite levels [TAG 58:10],12139
11,Blond vs non-blond hair color,6080
11,Diabetic retinopathy,1692
11,Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid) [Conditioned on rs174547],892
11,Electrocardiogram morphology (amplitude at temporal datapoints) [204 ms],17
11,Male-pattern baldness,49474
11,Cholesteryl ester(18:3)_[M+NH4]1+ levels,15101
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C40:1],12763
11,Serum metabolite levels [TotFA],2275
11,"Heel bone mineral density (bmd) t-score, automated (right)",63342
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:2/Lysophosphatidylcholine with acyl residue C20:4],12763
11,Aortic valve stenosis,12763
11,Other malignant neoplasms of skin (=non-melanoma skin cancer),589
11,Breast size,863
11,Serum metabolite levels (CMS) [S_VLDL_P],2275
11,Electrocardiogram morphology (amplitude at temporal datapoints) [148 ms],17
11,Gut microbiota relative abundance (bacterial taxa) [Synergistales],306
11,Electrocardiogram morphology (amplitude at temporal datapoints) [160 ms],17
11,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),53978
11,Age-related hearing impairment [additive],5444
11,Age at first sexual intercourse,38198
11,Triacylglycerol_53:5_[M+NH4]1+ levels,2120
11,Electrocardiogram morphology (amplitude at temporal datapoints) [286 ms],12780
11,Body mass index in physically active individuals [women],878
11,Vitamin B levels in ischemic stroke [Vitamin B12],36
11,Retinal vascular fractal dimension,205
11,Corticosteroid-induced adrenal suppression (peak cortisol < 500 nmol/L),80
11,T wave morphology restitution during exercise (MTAG),17
11,Metabolite levels,14883
11,Sociability score,23581
11,Phosphatidylethanolamine-O_40:5_[M-H]1-/Phosphatidylethanolamine-P_40:4_[M-H]1- levels,12763
11,Triacylglycerol_54:3_[M+NH4]1+ levels,14259
11,Serum metabolite concentrations in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:4],12763
11,"HDL cholesterol levels [Asian initial, BMI unadjusted]",2275
11,Triglyceride levels [Filipino],2187
11,Beta thalassemia/hemoglobin E disease,2387
11,Benign neoplasm: Caecum,212
11,Electrocardiogram morphology (amplitude at temporal datapoints) [-64 ms],628
11,Electrocardiogram morphology (amplitude at temporal datapoints) [406 ms],144
11,Triglyceride levels in very small VLDL,18753
11,Rosacea symptom severity,11391
11,Feeling hurt,24436
11,Cataracts [female],1332
11,Diacylglycerol_36:2_[M+H-H2O]1+ levels,14883
11,Phosphatidylcholine-O_38:5_[M+OAc]1-/Phosphatidylcholine-P_38:4_[M+OAc]1-/Phosphatidylserine-O_42:4_[M-H]1- levels,12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:2/Hydroxysphingomyelin with acyl residue sum C22:2],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:4/Sphingomyelin with acyl residue sum C24:0],12763
11,Electrocardiogram morphology (amplitude at temporal datapoints) [308 ms],12815
11,Electrocardiogram morphology (amplitude at temporal datapoints) [322 ms],12780
11,Triglycerides [AA],5738
11,Diacylglycerol(34:2)_[M+H-H2O]1+ levels,3087
11,Blood protein levels [Proprotein convertase subtilisin/kexin type 7],14682
11,Electrocardiogram morphology (amplitude at temporal datapoints) [326 ms],52
11,General symptoms and signs,158
11,Feeling worry,12083
11,Glycemic traits (pleiotropy),21695
11,Adult onset asthma or type 2 diabetes,12763
11,Phosphatidylcholine(38:6)_[M+H]1+/Phosphatidylethanolamine(41:6)_[M+H]1+ levels,12014
11,Stem cell factor levels,14733
11,Ocular pain,241
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C38:4/Phosphatidylcholine with acyl-alkyl residue sum C36:2],12763
11,Amlodipine | treatment/medication code,2855
11,Metabolite levels [TAG 52:4],2120
11,Phosphatidylinositol levels [Total_PI],1005
11,Angina | vascular/heart problems diagnosed by doctor,95
11,Corticosteroid-induced adrenal suppression (peak cortisol < 350 nmol/L),80
11,Triacylglycerol 56:6 levels,12763
11,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Hispanic],12228
11,Blood metabolite ratios [3-(4-hydroxyphenyl)lactate/alpha-hydroxyisovalerate],6068
11,Diacylglycerol_34:0_[M+H-H2O]1+ levels,2120
11,Serum metabolite levels [N-acetylkynurenine (2],1905
11,Hemoglobin concentration,203537
11,Neutrophil percentage of granulocytes,48738
11,Phosphatidylcholine-ether levels [PCO(18:1;0-20:4;0],12139
11,Triacylglycerol(58:9)_[M+NH4]1+ levels,12014
11,Blood metabolite levels [stearidonate (18:4n3],13183
11,Electrocardiogram morphology (amplitude at temporal datapoints) [460 ms],8598
11,Optic cup area [EA],9802
11,Phosphatidylinositol_36:4_[M-H]1- levels,12763
11,Electrocardiogram morphology (amplitude at temporal datapoints) [-98 ms],254
11,Phosphatidylcholine(45:0)_[M-H]1- levels,3087
11,Serum metabolite levels [arachidonate (20:4n6],17321
11,Electrocardiogram morphology (amplitude at temporal datapoints) [474 ms],8598
11,Subjective well-being,17139
11,Triacylglycerol_46:4_[M+NH4]1+ levels,2120
11,Ventolin 100micrograms inhaler | treatment/medication code,478
11,Asthma and allergy (more control exclusions),854
11,Osteoarthritis,329
11,Electrocardiogram morphology (amplitude at temporal datapoints) [376 ms],17
11,Total PHF-tau (SNP x SNP interaction),47964
11,Serum metabolite levels [1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4)*],12564
11,Phosphatidylcholine(32:0)_[M+H]1+/Phosphatidylethanolamine(35:0)_[M+H]1+/Phosphatidate(37:1)_[M+NH4]1+ levels,15101
11,Serum metabolite levels [dihydroorotate],1308
11,Frequency of tiredness / lethargy in last 2 weeks,1175
11,Endometriosis of pelvic peritoneum,1241
11,CD4-CD8- Natural Killer T Absolute Count,232
11,Basophill percentage,281
11,DVT of lower extremities,417
11,Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia,50
11,Valvular operations,62
11,Refractive error,129068
11,Phosphatidylcholine_40:7_[M+H]1+ levels,12763
11,Glycerophospholipid levels [Phosphatidylcholine diacyl C36:2],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C38:5],12763
11,Smoking status (current vs never),1120
11,Febrile seizures [Overall],31
11,Neurological blood protein biomarker levels [TMPRSS5],2322
11,Metabolic disorders,590
11,Neurological blood protein biomarker levels [CNTN5],295
11,CAG-495 abundance in stool,65
11,Medication use (agents acting on the renin-angiotensin system),117408
11,Fresh fruit intake,69026
11,Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis),50042
11,Serum levels of protein TPST2,29951
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C36:5],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C40:5],12613
11,Serum metabolite levels (CMS) [FAw3_FA],12807
11,"Black | hair colour (natural, before greying)",93541
11,Blood metabolite levels [1-eicosatrienoylglycerophosphocholine],2723
11,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],855
11,"Angina | non-cancer illness code, self-reported",95
11,Height,1244286
11,Serum creatinine levels,155237
11,Phosphatidylinositol_36:2_[M+NH4]1+ levels,12763
11,Serum levels of protein MMP3,1880
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C32:0/Phosphatidylcholine with diacyl residue sum C36:3],12139
11,Electrocardiogram morphology (amplitude at temporal datapoints) [452 ms],8598
11,Oleic acid (18:1n-9) levels [Chinese],13927
11,Triacylglycerol(52:4)_[M+NH4]1+ levels,3087
11,Melanomas of skin,589
11,Age cataract diagnosed,381
11,Chronic obstructive pulmonary disease or high blood pressure (pleiotropy),183
11,Facial morphology (segment 9),150
11,Electrocardiogram morphology (amplitude at temporal datapoints) [130 ms],17
11,Granulocyte percentage of myeloid white cells,62528
11,Total cholesterol levels [Trans-ethnic initial],36896
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C38:6],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C42:1],12139
11,Triacylglycerol_45:4_[M+NH4]1+ levels,2120
11,Total body bone mineral density (age 0-15),8543
11,Electrocardiogram morphology (amplitude at temporal datapoints) [110 ms],17
11,White matter microstructure (axial diusivities) [Cingulate gyrus],216
11,Phosphatidylcholine_34:2_[M+OAc]1-/Phosphatidylserine_38:1_[M-H]1- levels,12763
11,Glycerophospholipid levels [Phosphatidylcholine diacyl C34:2],12763
11,Serum metabolite levels [L_HDL_P],41659
11,Oral cavity and pharyngeal cancer,31340
11,Skin changes due to chronic exposure to nonionizing radiation,589
11,Crohn's disease of small interstine,1509
11,Electrocardiogram morphology (amplitude at temporal datapoints) [260 ms],17
11,Sum neutrophil eosinophil counts,89709
11,Phosphatidylcholine-O_36:5_[M+OAc]1-/Phosphatidylcholine-P_36:4_[M+OAc]1-/Phosphatidylserine-O_40:4_[M-H]1- levels,12763
11,Electrocardiogram morphology (amplitude at temporal datapoints) [356 ms],12780
11,Trunk predicted mass,113435
11,Systolic blood pressure [Japanese],2977
11,Serum metabolite levels (CMS) [L_VLDL_FC],2275
11,Homocysteine levels,1210
11,Protein quantitative trait loci (liver) [LAMP2],63
11,"Allergic disease (asthma, hay fever or eczema)",79827
11,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],34493
11,Phosphatidylcholine_37:4_[M+H]1+/Phosphatidylethanolamine_40:4_[M+H]1+/Phosphatidate_42:5_[M+NH4]1+ levels,12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:4/Phosphatidylcholine with diacyl residue sum C36:1],12763
11,"Blood protein levels [CAT, 3488_64_2]",2553
11,Electrocardiogram morphology (amplitude at temporal datapoints) [444 ms],8598
11,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),9558
11,DNA methylation (variation) [H19-ICR],4668
11,Medication use (glucocorticoids),1063
11,"""Seropositive rheumatoid arthritis, wide""",131
11,"Systolic blood pressure x alcohol consumption interaction (2df test) [Asian, EA]",1140
11,Cerebrospinal fluid biomarker levels [Serum amyloid A-1 protein],723
11,Protein quantitative trait loci (liver) [BPNT1],119
11,Electrocardiogram morphology (amplitude at temporal datapoints) [230 ms],17
11,Electrocardiogram morphology (amplitude at temporal datapoints) [342 ms],17
11,High light scatter reticulocyte count,525568
11,Celiac disease and Rheumatoid arthritis,17230
11,Retinal detachment or retinal break,1294
11,LDL cholesterol levels [EA],14767
11,Phosphatidylcholine(38:2)_[M+H]1+/Phosphatidylethanolamine(41:2)_[M+H]1+ levels,4753
11,Serum metabolite levels (CMS) [XL_HDL_CE],12763
11,Phosphatidylcholine-O_38:6_[M+OAc]1-/Phosphatidylcholine-P_38:5_[M+OAc]1-/Phosphatidylserine-P_42:1_[M-H]1- levels,12763
11,Carotenoid and tocopherol levels [alpha-tocopherol],4040
11,Serum levels of protein CGA;FSHB,1250
11,Ceramide_42:1_[M+H]1+ levels,2526
11,Gut microbiota relative abundance (bacterial taxa) [Synergistia],306
11,Arthropathies,57
11,Autism spectrum disorder or schizophrenia,50530
11,Major depressive disorder (MTAG),63476
11,Immunological or systemic disorder,16288
11,Time to complete round,729
11,Type 1 diabetes without complications,846
11,Electrocardiogram morphology (amplitude at temporal datapoints) [-26 ms],241
11,Psoriasis [EA],104
11,"Self-injury such as self-cutting, scratching or hitting, etc. | methods of self-harm used",11
11,Microalbumin in urine,2
11,FEV1,166503
11,Snoring,17027
11,Nonatopic asthma and/or BMI,14938
11,Usual walking pace,67477
11,Phosphatidylcholine(36:2)_[M+H]1+/Phosphatidylethanolamine(39:2)_[M+H]1+/Phosphatidate(41:3)_[M+NH4]1+ levels,12014
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C32:0/Phosphatidylcholine with acyl-alkyl residue sum C36:2],12763
11,"Blood pressure medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",33925
11,Diacylglycerol_44:6_[M+H-H2O]1+ levels,14259
11,Brain region volumes [left caudate],81
11,Protein quantitative trait loci (liver) [DPP7],41
11,Fasting blood proinsulin levels,44750
11,Lectin-like oxidized LDL receptor 1 levels,12658
11,Phosphatidylcholine_38:4_[M+OAc]1-/Phosphatidylserine_42:3_[M-H]1- levels,12763
11,Triacylglycerol_54:6_[M+NH4]1+ levels,12763
11,Phosphatidylcholine-O_44:5_[M+OAc]1-/Phosphatidylcholine-P_44:4_[M+OAc]1- levels,12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C38:6],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:4/Phosphatidylcholine with acyl-alkyl residue sum C36:3],12763
11,Butyrate (4:0) levels,2678
11,N-acetylphenylalanine levels,862
11,Serum levels of protein CLMP,380
11,Diabetes | illnesses of adopted father,223
11,Protein quantitative trait loci (liver) [RMDN3],63
11,Electrocardiogram morphology (amplitude at temporal datapoints) [196 ms],17
11,Creatinine levels,323581
11,Forns index in high alcohol intake,9137
11,Serum metabolite levels (CMS) [HDL_D],56697
11,"Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",2699
11,Leiomyoma of uterus (controls excluding all cancers),2616
11,Serum levels of protein OAF,999
11,Sphingomyelin(41:2)_[M-CH3]1- levels,442
11,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],12347
11,Serum levels of protein MASP1,19246
11,Electrocardiogram morphology (amplitude at temporal datapoints) [358 ms],12780
11,"Heel broadband ultrasound attenuation, direct entry",111220
11,Rheumatoid arthritis (ACPA-positive),36319
11,Serum metabolite levels [L_VLDL_PL],2275
11,"Mean arterial pressure x alcohol consumption interaction (2df test) [Asian, EA]",1960
11,Protein levels in obesity [SAA],657
11,High blood pressure | illnesses of father,57
11,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),52100
11,Bipolar I disorder,76179
11,Waist circumference [EA],16987
11,Phosphatidylcholine(33:3)_[M+H]1+/Phosphatidylethanolamine(36:3)_[M+H]1+/Phosphatidate(38:4)_[M+NH4]1+ levels,12014
11,Serum levels of protein CCL25,16263
11,Metabolite levels [CE 20:4],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C44:6],12763
11,Monocyte percentage,60355
11,"Blood protein levels [APLP2, 7915_31_3]",3419
11,"""Excessive, freguent and irrelgular menstruation""",1241
11,DNA methylation PhenoAge acceleration,8
11,Cortical surface area [Middle Temporal],49
11,Co-proxamol | treatment/medication code,237
11,HDL cholesterol,433555
11,Platelet distribution width,442642
11,Lysophosphatidylethanolamine_20:4_[M-H]1- levels,12763
11,Serum metabolite levels [1-stearoyl-2-linoleoyl-GPC (18:0/18:2)*],12327
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C38:0/Phosphatidylcholine with acyl-alkyl residue sum C38:6],12763
11,"Blood protein levels [FOLH1, 5478_50_2]",14909
11,Triglyceride to HDL cholesterol ratio,3029
11,"""Migraine, single triptan purchase ok & required. ICD-code if available is included""",1567
11,Serum metabolite levels [deoxycarnitine],2394
11,Neuronal pentraxin-1 measurement,663
11,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test) [African],105
11,Nonatopic asthma and/or waist-to-hip ratio adjusted for BMI,14340
11,Phosphatidylserine_40:5_[M+H]1+/Phosphatidylglycerol_40:7_[M+NH4]1+ levels,12763
11,Spleen volume,337
11,Ever smoked,11897
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C38:4],12763
11,Parental longevity (father's attained age),6608
11,Serum levels of protein LYVE1,1252
11,Blood protein levels [MMP-12],1372
11,Oxalate (ethanedioate) levels,1220
11,"""Diabetes, several complications""",846
11,Malaria [heterogeneous],42
11,Vitamin a | treatment/medication code,224
11,Smoking x traumatic event in childhood (sexually molested) interaction,10
11,Triglycerides [East Asian],2499
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C32:0/Phosphatidylcholine with diacyl residue sum C38:3],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C38:4],12763
11,Childhood sunburn occasions,8812
11,Uterine prolapse,4319
11,Total cholesterol levels [Hispanic],1086
11,Electrocardiogram morphology (amplitude at temporal datapoints) [218 ms],17
11,Triacylglycerol_56:4_[M+NH4]1+ levels,14358
11,Platelet crit,242251
11,Serum metabolite levels (CMS) [PUFA],2275
11,Severe non-proliferative background diabetic retinopathy,846
11,Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid),12671
11,Metabolite levels (lipid measures) [other polyunsaturated fatty acids than 18:2],12763
11,Serum levels of protein CASC4,31115
11,Serum metabolite levels [1-arachidonoyl-GPC (20:4n6)*],20222
11,Hand grip strength (right),75545
11,Alzheimer disease and age of onset [between families],18
11,Cortical surface area [Cuneus],72
11,Alzheimer's disease or family history of Alzheimer's disease,63508
11,Serum levels of protein DVL2,18446
11,Smoking initiation (ever regular vs never regular) [Conditioned on chr11:64133552],6431
11,Age at voice drop,1299
11,CD8dim Natural Killer T Absolute Count,232
11,CAG-877 abundance in stool,175
11,Protein quantitative trait loci (liver) [SH3BGRL],25
11,Apolipoprotein A-IV levels,3076
11,Serum metabolite concentrations in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:5],12763
11,Protein levels in obesity [FCN2],1654
11,Cathepsin L1 levels,229
11,Multiple sclerosis,120637
11,Insomnia symptoms (never/rarely vs. usually),22798
11,Phosphatidylcholine_36:2_[M+H]1+/Phosphatidylethanolamine_39:2_[M+H]1+/Phosphatidate_41:3_[M+NH4]1+ levels,12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C44:5],12763
11,"Heel quantitative ultrasound index (qui), direct entry",110833
11,Hearing function [PC2],561
11,Lipitor 10mg tablet | treatment/medication code,4404
11,Sex hormone levels [Progesterone],7740
11,"Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",2699
11,Surgery on leg arteries (other than for varicose veins),917
11,Gynecologic disease (multivariate analysis) [uterine fibroid],423
11,Fasting blood glucose,60446
11,Alcohol consumption,39187
11,Cholesteryl ester_18:2_[M+NH4]1+ levels,14757
11,"Blood protein levels [APOA2, 7127_3_3]",32118
11,Metabolite levels [PC 36:4],15315
11,Electrocardiogram morphology (amplitude at temporal datapoints) [362 ms],12780
11,"""Diabetes, insuline treatment (Kela reimbursement)""",3495
11,Serum metabolite ratios in chronic kidney disease [Lysophosphatidylcholine with acyl residue C16:0/Lysophosphatidylcholine with acyl residue C20:4],12763
11,White matter microstructure (mean diusivities) [Cingulate gyrus],216
11,Spherical equivalent [EA],123
11,Subpleural-predominant interstitial lung abnormalities,35
11,Electrocardiogram morphology (amplitude at temporal datapoints) [368 ms],17
11,Fractures,11205
11,Mean spheric corpuscular volume,196152
11,Phosphatidylcholine_34:2_[M+H]1+/Phosphatidylethanolamine_37:2_[M+H]1+/Phosphatidate_39:3_[M+NH4]1+ levels,12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C36:4],12763
11,Metabolite levels [CE 20:5],12139
11,"Blood pressure medication | medication for cholesterol, blood pressure or diabetes",63628
11,Electrocardiogram morphology (amplitude at temporal datapoints) [144 ms],25376
11,"Blood protein levels [SPON1, 4297_62_3]",1521
11,"Duodenal ulcer | non-cancer illness code, self-reported",3231
11,Sphingomyelin_33:1_[M+H]1+ levels,2120
11,Serum levels of protein UBASH3B,2880
11,Blond vs. brown hair color,6251
11,Diacylglycerol(34:2)_[M+NH4]1+ levels,5659
11,"Pulmonary embolism +/- dvt | non-cancer illness code, self-reported",131
11,3mm cylindrical power angle (right),15
11,Low myopia vs hyperopia,6
11,Glomerular filtration rate,109945
11,Leukocyte telomere length [East Asian],31296
11,Serum metabolite concentrations in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C38:4],12763
11,Serum metabolite levels [docosapentaenoate (n6 DPA; 22:5n6],11949
11,Serum metabolite levels [M_VLDL_FC],2275
11,Age-related nuclear cataracts,569
11,Basophill count,50
11,Urate levels in overweight individuals [men],9154
11,Phosphatidylcholine_33:3_[M+H]1+/Phosphatidylethanolamine_36:3_[M+H]1+/Phosphatidate_38:4_[M+NH4]1+ levels,12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C44:5],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with acyl-alkyl residue sum C40:1],12763
11,"Otosclerosis | non-cancer illness code, self-reported",25910
11,Serum metabolite levels [M_VLDL_C],2275
11,Triacylglycerol_50:2_[M+NH4]1+ levels,2120
11,Other retinal disorders,846
11,Diacylglycerol_36:4_[M+H-H2O]1+ levels,2120
11,Vitamin d product | treatment/medication code,2490
11,Eye length [Uyghur],183
11,CD20 on CD24+ CD27+ B cell,4790
11,Cholesteryl ester(18:2)_[M+NH4]1+ levels,3087
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C38:4/Sphingomyelin with acyl residue sum C24:0],12763
11,"Triglyceride levels [Asian initial, BMI unadjusted]",2275
11,Serum metabolite levels (CMS) [L_VLDL_CE],2275
11,Sphingomyelin(40:1)_[M-CH3]1- levels,2703
11,Triacylglycerol(52:1)_[M+NH4]1+ levels,3087
11,Disorders of choroid and retina,957
11,Phlebitis and thrombophlebitis,119
11,Pulmonary embolism with or without deep venous thrombosis,112
11,Hepatitis,6
11,Schizophrenia,314471
11,Neutrophil percentage of white cells,220667
11,Neuropsychiatric disorders,17798
11,Serum metabolite levels [ApoB],2275
11,Simvastatin | treatment/medication code,659
11,Low high density lipoprotein cholesterol levels,7254
11,Serum metabolite levels [XL_VLDL_PL],2275
11,Pulmonary heart disease,2419
11,Cancer,1158
11,Birth weight (MTAG),2978
11,Other disorders of circulatory system,98
11,Serum levels of protein HGF,24
11,Phosphatidylcholine_40:9_[M+OAc]1-/Phosphatidylserine_44:8_[M-H]1- levels,12238
11,Glycerophospholipid levels [Phosphatidylcholine diacyl C40:6],12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C36:3],2573
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C38:4/Sphingomyelin with acyl residue sum C24:0],12763
11,Amiodarone | treatment/medication code,4554
11,Electrocardiogram morphology (amplitude at temporal datapoints) [250 ms],2666
11,hemolysis of donated blood (osmotic),4013
11,Sphingomyelin(36:0)_[M+H]1+ levels,3087
11,Feeling tense,880
11,Triacylglycerol(50:2)_[M+NH4]1+ levels,3087
11,"Cholesterol, total [Hispanic]",531
11,Renin levels,2651
11,"Blood protein levels [MMP12, 4496_60_2]",1660
11,Metabolite risk score for predicting weight gain,642
11,Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis),47980
11,Phosphatidylinositol-O_36:1_[M+H]1+ levels,12763
11,Diastolic blood pressure x smoking status (ever vs never) interaction (2df test),3800
11,Urate levels in overweight individuals,10951
11,Phosphatidylethanolamine_36:3_[M-H]1- levels,12763
11,Number of vehicles in household,456
11,Cerebrospinal fluid t-tau:AB1-42 ratio,961
11,Genitourinary diseases,1259
11,Inflammatory biomarkers [IL18],407
11,Abnormal findings on diagnostic imaging of lung,75
11,Hip index,61684
11,Metabolic syndrome [HDL],20524
11,Blood metabolite levels [1-linoleoylglycerophosphoethanolamine],12763
11,High cholesterol,28693
11,Phosphatidylcholine_52:4_[M+OAc]1- levels,12763
11,Phosphatidate(40:5)_[M+OAc]1-/Phosphatidylglycerol(39:5)_[M-H]1- levels,12014
11,"Blood protein levels [AMICA1, 8232_90_3]",10480
11,Prostate cancer (early onset),3467
11,Diseases of the musculoskeletal system and connective tissue,667
11,Medication use (diuretics),70959
11,Serum levels of protein FOLH1,14923
11,Electrocardiogram morphology (amplitude at temporal datapoints) [462 ms],8598
11,"Blood protein levels [SERPING1, 13710_6_3]",38492
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C42:0/Phosphatidylcholine with acyl-alkyl residue sum C44:6],2723
11,Body fat distribution (trunk fat ratio),12911
11,Circulating leptin levels or type 2 diabetes,2381
11,Serum metabolite concentrations in chronic kidney disease [N-acetyl-aspartyl-glutamate],2077
11,Triacylglycerol(52:3)_[M+NH4]1+ levels,3087
11,Diabetes mellitus in pregnancy,136
11,Feeling fed-up,30868
11,Colorectal cancer or advanced adenoma,17567
11,Triglyceride levels in current drinkers,12347
11,Heel bone mineral density T score,219074
11,Metabolite levels [CE 18:3],13265
11,Sphingomyelin(34:0)_[M+H]1+ levels,3087
11,Serum levels of protein ESAM,2068
11,"Systolic blood pressure x alcohol consumption interaction (2df test) [AA, Asian, EA, Hispanic]",737
11,"""Type 1 diabetes, strict definition""",846
11,Serum metabolite levels [XL_VLDL_TG],2275
11,Electrocardiogram morphology (amplitude at temporal datapoints) [-106 ms],254
11,Protein quantitative trait loci (liver) [ECI2],1
11,Use of sun/uv protection,43291
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C38:5/Sphingomyelin with acyl residue sum C16:0],12763
11,Metabolite levels [PC 38:5],16245
11,Electrocardiogram morphology (amplitude at temporal datapoints) [294 ms],12780
11,Diacylglycerol(36:2)_[M+H-H2O]1+ levels,15101
11,Hearing difficulty/problems with background noise,3508
11,X-15245 levels,2002
11,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test) [African],629
11,Electrocardiogram morphology (amplitude at temporal datapoints) [318 ms],52
11,Severe malaria [Heterozygous],42
11,Red blood cell fatty acid levels [GLA],12238
11,Aspartate aminotransferase platelet ratio index in high alcohol intake,18463
11,Phosphatidylcholine_34:4_[M+H]1+/Phosphatidylethanolamine_37:4_[M+H]1+/Phosphatidate_39:5_[M+NH4]1+ levels,12763
11,Serum metabolite levels (CMS) [MUFA_FA],12763
11,Electrocardiogram morphology (amplitude at temporal datapoints) [100 ms],25359
11,Central corneal thickness,16071
11,Serum metabolite concentrations in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:3],11815
11,Serum metabolite levels (CMS) [M_HDL_TG],2275
11,Phosphatidate_34:2_[M-H]1- levels,12763
11,Cholesterol [TG],6147
11,3mm cylindrical power angle (left),511
11,"""Endomtriosis ASRM stages 1,2""",1273
11,Serum levels of protein ADAMTS6,692
11,Renal function-related traits (eGRFcrea),11
11,Ulcerative colitis [EA],25267
11,"Age-related diseases, mortality and associated endophenotypes",31925
11,Fat-free mass [female],11561
11,Serum metabolite levels (CMS) [LA],3815
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with diacyl residue sum C38:4],12763
11,"Peripheral vascular disease | non-cancer illness code, self-reported",322
11,"Pernicious anaemia | non-cancer illness code, self-reported",78
11,Local histogram emphysema pattern [normal],1305
11,White matter microstructure (mode of anisotropy) [Body of corpus callosum],580
11,Mean corpuscular hemoglobin concentration [AA],845
11,Episodic memory (pairs-matching),125
11,Smoking initiation (ever regular vs never regular) [Conditioned on chr11:121530888],48
11,Deep venous thrombosis,33
11,Protein quantitative trait loci (liver) [PEA15],3
11,Red blood cell fatty acid levels [AA],12763
11,"Systolic blood pressure x alcohol consumption interaction (2df test) [EA, Hispanic]",1853
11,Phosphatidylinositol-O(36:0)_[M-H]1-/Phosphatidylglycerol(37:0)_[M+OAc]1- levels,11043
11,Sphingomyelin_32:2_[M+H]1+ levels,2552
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with diacyl residue sum C38:5],12763
11,Serum metabolite levels (CMS) [XS_VLDL_PL],2923
11,Malignant neoplasm of skin,589
11,Lipid metabolism phenotypes [LA/PUFA],12807
11,Serum metabolite levels [DHA],12807
11,Phosphatidylcholine_38:8_[M+OAc]1-/Phosphatidylserine_42:7_[M-H]1- levels,12763
11,Impedance of leg (left),157986
11,White blood cell count (neutrophil),480
11,Blood protein levels [Interleukin-18 (IL-18],407
11,Body mass index [Male],1123
11,Electrocardiogram morphology (amplitude at temporal datapoints) [370 ms],17
11,Celluvisc 1% single-use eye drops | treatment/medication code,176
11,Protein quantitative trait loci (liver) [TPP1],4
11,Plateletcrit,368599
11,Suffer from 'nerves',40717
11,Phosphatidylcholine-O(38:5)_[M+H]1+/Phosphatidylcholine-P(38:4)_[M+H]1+ levels,12014
11,Serum metabolite levels [FAw3_FA],12807
11,Serum metabolite levels [1-stearoyl-2-arachidonoyl-GPC (18:0/20:4],15883
11,Wholemeal or wholegrain | bread type,15853
11,Ankle spacing width (right),43377
11,Pattern 3 | hair/balding pattern,1073
11,Triglycerides [Filipino],246
11,Ebbinghaus illusion (overestimation),1623
11,Serum metabolite levels [S_VLDL_CE],2275
11,4-chlorobenzoic acid levels,1098
11,White matter microstructure (mean diusivities) [External capsule ],216
11,Cholesteryl ester(18:0)_[M+NH4]1+ levels,3087
11,Protein quantitative trait loci (liver) [LGALS1],17
11,Serum metabolite levels (CMS) [DHA_FA],12807
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with diacyl residue sum C40:5],12613
11,Electrocardiogram morphology (amplitude at temporal datapoints) [312 ms],52
11,Actinic keratosis,589
11,"Blood protein levels [FAM189A2, 5699_19_3]",93
11,Disorders of the thyroid gland,48
11,Delta-5 desaturase activity response to n3-polyunsaturated fat supplement,12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C38:5],12763
11,Serum levels of protein PCSK7,6175
11,Type 1 diabetes with coma,846
11,CD16-CD56 on Natural Killer T,675
11,Electrocardiogram morphology (amplitude at temporal datapoints) [382 ms],17
11,Gut microbiota (bacterial taxa) [Lactobacillales order],29
11,Loneliness (MTAG),42212
11,Serum metabolite levels [DHA_FA],12807
11,Basophil count,175696
11,Aspartate aminotransferase levels,453845
11,Sphingomyelin_34:2_[M+OAc]1- levels,12327
11,Serum levels of protein FNDC5,2886
11,Metabolite levels [PC 38:4],13369
11,Electrocardiogram morphology (amplitude at temporal datapoints) [420 ms],8598
11,Urinary albumin excretion,3705
11,Parkinson's disease or first degree relation to individual with Parkinson's disease,2151
11,Sphingomyelin(41:2)_[M+H]1+ levels,3087
11,"Diastolic blood pressure x alcohol consumption interaction (2df test) [Asian, EA]",1908
11,Serum levels of protein SFTPB,75
11,Electrocardiogram morphology (amplitude at temporal datapoints) [314 ms],52
11,Myocardial fractal dimension (slice 3),7
11,Protein quantitative trait loci (liver) [ARG1],11
11,Protein quantitative trait loci (liver) [ALDH16A1],6
11,Stearic acid (18:0) levels,12763
11,C-reactive protein levels or triglyceride levels (pleiotropy),12959
11,Estimated glomerular filtration rate,510416
11,Essential hypertension (time to event),20851
11,Glycerophospholipid levels [Phosphatidylcholine acyl-alkyl C38:4],12763
11,Serum metabolite levels [ApoA1],41659
11,Lysophosphatidylcholine_20:4_[M+OAc]1- levels,12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C44:5],12139
11,Metabolite levels [TAG 54:4],12763
11,Hand grip strength (left),69204
11,Nitrogen dioxide air pollution; 2005,963
11,Body fat distribution (leg fat ratio) [females],12911
11,Phosphatidylcholine_40:5_[M+H]1+ levels,12763
11,Phosphatidylcholine_36:3_[M+OAc]1-/Phosphatidylserine_40:2_[M-H]1- levels,12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:1/Phosphatidylcholine with diacyl residue sum C40:5],12613
11,Rheumatoid arthritis,41665
11,Special screening examination for neoplasms,527
11,Febrile seizures (MMR vaccine-unrelated),31
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C42:3/Phosphatidylcholine with acyl-alkyl residue sum C44:6],12763
11,Serum metabolite levels (CMS) [MUFA],15038
11,Corneal resistance factor (left),13197
11,Diabetes mellitus,12898
11,Asthma or allergic disease (pleiotropy),14399
11,Dermatologic disease,6928
11,Bring up phlegm/sputum/mucus on most days,2819
11,Ipratropium | treatment/medication code,790
11,Caffeine consumption from coffee,1182
11,Cholelithiasis with other cholecystitis,3146
11,Sphingomyelin_41:0_[M+H]1+ levels,2120
11,Asthma [conditional],29
11,Skin and soft tissue infections,9458
11,Phosphatidylcholine_37:5_[M+OAc]1-/Phosphatidylserine_41:4_[M-H]1- levels,12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C34:4/Phosphatidylcholine with diacyl residue sum C38:3],12763
11,Non-glioblastoma glioma [males],4382
11,Polycystic ovary syndrome (adjusted for age),1871
11,Protein quantitative trait loci (liver) [RAB14],1
11,Youthful appearance (self-reported),50121
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C42:5],12763
11,"Blood protein levels [RELT, 5115_31_3]",10893
11,Serum metabolite levels (CMS) [XL_VLDL_PL],2275
11,"Carpal tunnel syndrome | non-cancer illness code, self-reported",2032
11,Vitamin levels [Vitamin E alpha tocopherol],2120
11,Vitamin b-complex deficiencies,737
11,"Allergic disease (asthma, hay fever and/or eczema) (age of onset)",3097
11,Caffeine consumption from coffee or tea,9084
11,Phosphatidylcholine_37:6_[M+H]1+/Phosphatidylethanolamine_40:6_[M+H]1+/Phosphatidate_42:7_[M+NH4]1+ levels,12613
11,Electrocardiogram morphology (amplitude at temporal datapoints) [354 ms],12780
11,N-glycan levels [plasma glycan peak 17],1673
11,Ischemic stroke (large artery atherosclerosis),2218
11,Interstitial lung disease endpoints,472
11,Electrocardiogram morphology (amplitude at temporal datapoints) [134 ms],17
11,Gut bacterial pathway abundance (PWY.6147..6.hydroxymethyl.dihydropterin.diphosphate.biosynthesis.I),11
11,Atopic dermatitis [random effects],20
11,Arthrotec tablet | treatment/medication code,7
11,HDL cholesterol levels x short total sleep time interaction (2df test),26220
11,Phosphatidylcholine_32:0_[M+H]1+/Phosphatidylethanolamine_35:0_[M+H]1+/Phosphatidate_37:1_[M+NH4]1+ levels,14883
11,Phosphatidylethanolamine-O_38:5_[M+H]1+/Phosphatidylethanolamine-P_38:4_[M+H]1+ levels,15017
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:5/Sphingomyelin with acyl residue sum C24:1],12763
11,Inflammatory skin disease [Atopic dermatitis],865
11,Diacylglycerol_32:2_[M+H-H2O]1+ levels,2120
11,Gynecologic disease,6218
11,Radiation-related disorders of the skin and subcutaneous tissue,548
11,CD4-CD8- Natural Killer T %T cell,232
11,Fasting blood glucose (BMI interaction),22734
11,Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid),40519
11,Phosphatidylcholine_44:5_[M+OAc]1- levels,12238
11,Phosphatidylinositol(36:1)_[M+OAc]1- levels,11043
11,Cerebrospinal fluid biomarker levels [Proprotein convertase subtilisin/kexin type 7],29218
11,Phosphatidylcholine levels [PC(18:0;0-20:5;0],13116
11,Phosphatidylcholine-O_40:5_[M+H]1+/Phosphatidylcholine-P_40:4_[M+H]1+ levels,14883
11,Phosphatidylcholine_40:6_[M+H]1+/Phosphatidylethanolamine_43:6_[M+H]1+ levels,12763
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C36:4/Phosphatidylcholine with acyl-alkyl residue sum C36:3],12763
11,Phosphatidylcholine(40:6)_[M+H]1+/Phosphatidylethanolamine(43:6)_[M+H]1+ levels,12014
11,Cardiovascular disease risk factors [TRIG],6409
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:3/Sphingomyelin with acyl residue sum C16:0],12139
11,Irritable bowel syndrome,2361
11,ST2 protein levels,1448
11,Brain region volumes [right lateral ventricle],1088
11,Age-related disease endophenotypes,14883
11,Age at menopause,113134
11,Chronotype,91256
11,Fish- and plant-related diet,16581
11,Brain morphology (MOSTest),65212
11,Lacunar stroke,21836
11,Mood instability,11940
11,"Blood protein levels [CST6, 3303_23_2]",11962
11,"""Spirochaetal infections, other/unspecified""",1148
11,Lysophosphatidylcholine_16:0_[M+H]1+/Lysophosphatidylethanolamine_19:0_[M+H]1+ levels,2230
11,Blood protein levels [MMP-7],448
11,"Blood protein levels [CNTN5, 3299_29_2]",295
11,Automobile speeding propensity,35
11,Body mass index x sex x age interaction (4df test),12228
11,Diverticulosis,2666
11,Total body bone mineral density [European],37907
11,Asthma onset (childhood vs adult),16695
11,Phosphatidylcholine_37:4_[M+OAc]1-/Phosphatidylserine_41:3_[M-H]1- levels,12763
11,Autoimmune thyroid disease,7140
11,Fibrinogen [EA],8251
11,Serum metabolite levels (CMS) [S_VLDL_FC],2275
11,Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease),422
11,Psoriasis,23758
11,Triglyceride levels [Trans-ethnic initial],14503
11,Heel broadband ultrasound attenuation (left),36715
11,Brain region volumes [left putamen],9290
11,Insulin-related traits (multivariate analysis),8839
11,IgG glycosylation [IGP1],2584
11,Pattern 2 | hair/balding pattern,796
11,"Blood protein levels [MMP8, 9172_69_3]",187
11,Hip pain | pain type(s) experienced in last month,22
11,Vitamin D levels,215733
11,Lung function (forced vital capacity) [EA],22557
11,Serum metabolite levels (CMS) [XL_HDL_L],12139
11,"""Pain (limb, back, neck, head abdominally)""",4632
11,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Hispanic],12139
11,Osteoarthritis (with total hip replacement),13503
11,Duration walking for pleasure,20752
11,Serum levels of protein AMH,2886
11,Cerebrospinal fluid levels of Alzheimer's disease-related proteins [Matrix metalloproteinase-3],1880
11,Thumb osteoarthritis severity (hand Klsum),16322
11,Hypertensive diseases (excluding secondary),13400
11,Serum levels of protein APLP2,8102
11,Type 2 diabetes without complications,2834
11,Systolic blood pressure x smoking status (ever vs never) interaction (2df test) [EA],3800
11,Major coronary heart disease event excluding revascularizations,590
11,Blood pressure [Mean Arterial Pressure],320
11,Electrocardiogram morphology (amplitude at temporal datapoints) [-96 ms],254
11,Electrocardiogram morphology (amplitude at temporal datapoints) [190 ms],17
11,Worry,7371
11,BRCA1 mutation in breast cancer,20011
11,"Trans fatty acid levels [Cis/trans-18:2, EA]",11815
11,HDL cholesterol x physical activity interaction (2df test) [EA],4636
11,Body mass index in physically inactive individuals,804
11,Odorant perception [Cinnamon naming problem],984
11,Electrocardiogram morphology (amplitude at temporal datapoints) [336 ms],17
11,Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid),43354
11,Balding type 1,21898
11,Serum metabolite levels [1arachidonoylglycerophosphocholine],12763
11,Glaucoma,41328
11,Cortical surface area,205616
11,Serum metabolite levels (CMS) [HDL2_C],12671
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C40:5/Phosphatidylcholine with acyl-alkyl residue sum C36:3],12139
11,Adrenoogenital disorders,3814
11,NADPH--cytochrome P450 reductase measurement,1198
11,Fructosamine levels [AA],183
11,"""Cardiomyopathy, Hypertrophic obstructive""",180
11,Male puberty timing (early vs. average onset facial hair),362
11,Pioglitazone | treatment/medication code,435
11,Mean platelet volume,1553967
11,Sphingomyelin_38:1_[M+H]1+ levels,2120
11,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C38:4/Lysophosphatidylcholine with acyl residue C20:3],11815
11,6mm strong meridian (left),44839
11,"""Inflammatory bowel disease, strict (require KELA)""",7689
11,HVEM on Central Memory CD4+ T cell,376
11,Gliclazide | treatment/medication code,58
12,Systemic lupus erythematosus,38159
12,Brain region volumes [right cerebellum exterior],27597
12,Tea intake,39454
12,Electrocardiogram morphology (amplitude at temporal datapoints) [292 ms],542
12,Seropositive rheumatoid arthritis,510
12,Migraine without aura,7294
12,Leisure sedentary behaviour (computer use),1109
12,CD27 on unswitched memory B cell,529
12,Serum levels of protein NOG,77
12,Back problem,20
12,Getting up in morning,17018
12,Low testosterone levels,26785
12,Drinking behavior,3215
12,Retinal vascular fractal density,2241
12,"""Gonarthrosis, primary, with knee surgery""",682
12,"Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA, women]",16263
12,"Blood protein levels [MANSC4, 9578_263_3]",3640
12,"""Haemangioma, any site (controls excluding all cancers)""",114
12,Facial morphology (brow ridge protrusion 2),248
12,Electrocardiogram morphology (amplitude at temporal datapoints) [336 ms],84
12,Estradiol levels,54
12,"""Ischaemic Stroke, excluding all haemorrhages""",79
12,Intralaminar thalamic nuclei volume,3778
12,Bacteroides A abundance in stool,372
12,Sum basophil neutrophil counts,68461
12,Total PHF-tau (SNP x SNP interaction),40326
12,"Systolic blood pressure x alcohol consumption interaction (2df test) [AA, EA, Hispanic]",1072
12,Leg predicted mass (right),108062
12,Urinary albumin excretion,3929
12,Serum levels of protein PTPN4,3130
12,Nasal polyps,41603
12,Arm predicted mass (left),121971
12,Electrocardiogram morphology (amplitude at temporal datapoints) [134 ms],19535
12,Protein quantitative trait loci (liver) [S100A8],710
12,Serum levels of protein DVL2,2460
12,Metabolite levels [C4],3748
12,Budesonide+formoterol | treatment/medication code,383
12,Sarcoidosis [EA],452
12,Chronic heart failure,74
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-376 ms],71
12,Protein quantitative trait loci (liver) [AMACR],26
12,"""Malignant neoplasm of breast, HER2-negative (controls excluding all cancers)""",36
12,Insomnia symptoms (never/rarely vs. usually),27099
12,Sleep duration,48681
12,Odorant perception [Licorice intensity],6418
12,Electrocardiogram morphology (amplitude at temporal datapoints) [2 ms],166
12,Lymphocyte counts,1224004
12,Waist-to-hip ratio adjusted for BMI in active individuals [women],15932
12,Systolic blood pressure [EA],537
12,Gamma glutamyl transferase levels,170366
12,Neutrophill count,164169
12,Type 2 diabetes [EA],2557
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-60 ms],202
12,Hematological and biochemical traits [GGT],260
12,Acute lymphoblastic leukemia in childhood (B cell precursor),1487
12,Birth weight,13968
12,Serum levels of protein CPQ,1781
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-164 ms],71
12,Lipoprotein phospholipase A2 activity in cardiovascular disease,69
12,"Forced expiratory volume in 1-second (fev1), predicted",188092
12,"""Type 1 diabetes, wide definition""",21056
12,Arthrosis,607
12,Hematological parameters [PLT],327
12,Chronic back pain,15
12,Other diseases of intestines,8
12,Cataracts [female],4596
12,Mean spheric corpuscular volume,313777
12,Itch intensity from mosquito bite adjusted by bite size,1686
12,Urinary metabolite levels in chronic kidney disease [X - 19913],695
12,Electrocardiogram morphology (amplitude at temporal datapoints) [386 ms],125
12,Bitter taste perception [Caffeine],32325
12,"Metabolite levels [Gln, Glc]",3535
12,2-hydroxyisobutyrate levels,3320
12,Mean arterial pressure [East Asian],2627
12,"Fracture skull / head | non-cancer illness code, self-reported",1278
12,Electrocardiographic traits [QRS duration],268
12,"""Malignant neoplasm of breast, HER-negative (controls excluding all cancers)""",36
12,Sleep apnoea,2
12,Spherical equivalent or myopia (age of diagnosis),21469
12,"Blood protein levels [LYZ, 4920_10_1]",26152
12,Feeling worry,9401
12,"""Diabetes, insuline treatment (Kela reimbursement) (more control exclusions)""",3626
12,Serum levels of protein FUT5,2220
12,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [women],2723
12,"Basal cell carcinoma | cancer code, self-reported",161
12,Electrocardiogram morphology (amplitude at temporal datapoints) [80 ms],1300
12,White matter microstructure (fractional anisotropy) [Fornix (column and body],66
12,Educational attainment (years of education),422249
12,Hot drink temperature,5914
12,Ease of skin tanning,4609
12,Other non-epithelial cancer of skin,12033
12,High blood pressure | illnesses of mother,2624
12,Diclofenac sodium+misoprostol | treatment/medication code,575
12,Non-melanoma skin cancer,322
12,Osteoarthritis of the hip or knee (with total joint replacement),91
12,Lung function (FEV1/FVC),385202
12,Brain region volumes [total brain volume],22659
12,Electrocardiogram morphology (amplitude at temporal datapoints) [98 ms],19535
12,Heel bone mineral density (bmd) (right),3739
12,Electrocardiogram morphology (amplitude at temporal datapoints) [42 ms],202
12,Lung function (FEV1) and waist circumference adjusted for BMI [East Asian],47
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-114 ms],71
12,"Glaucoma [AA, prevalent]",13
12,Protein quantitative trait loci (liver) [KATNAL2],8
12,HDL cholesterol,255929
12,Insulinogenic index,4458
12,Tissue-type plasminogen activator levels,16791
12,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test) [African],217
12,"Red blood cell traits [EA, Hgb]",446
12,Prevalent atrial fibrillation,122
12,DNA methylation variation (age effect),5499
12,Atopic asthma,35011
12,Electrocardiogram morphology (amplitude at temporal datapoints) [260 ms],2409
12,Age-related hearing impairment (SNP x SNP interaction),2315
12,Heel broadband ultrasound attenuation (right),4907
12,Lung function (FVC) [EA],776
12,Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive),488
12,Lung cancer in ever smokers,160
12,Weight,325321
12,Blood protein levels in cardiovascular risk,4404
12,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Asian],5905
12,Coagulation Factor VIII measurement,2457
12,"""Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified""",1575
12,No | ever been injured or injured someone else through drinking alcohol,86
12,Protein quantitative trait loci (liver) [GATD3A],13
12,Educational attainment (college completion),82774
12,Neutrophil percentage of granulocytes,23465
12,Age started wearing glasses or contact lenses,20302
12,Platelet crit,205504
12,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),2856
12,Creatine kinase M-type:Creatine kinase B-type heterodimer measurement,1222
12,Green tea consumption,260
12,Pulse pressure x alcohol consumption interaction (2df test) [EA],537
12,Parkinson's disease [EA],594
12,Atrial fibrillation [EA],37341
12,Electrocardiogram morphology (amplitude at temporal datapoints) [22 ms],166
12,Lectin-like oxidized LDL receptor 1 levels,1877
12,Electrocardiogram morphology (amplitude at temporal datapoints) [238 ms],125
12,Metabolite levels [betaine],525
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-100 ms],71
12,Gut microbiota relative abundance (bacterial taxa) [Aestuariispira_insulae],7
12,Urate levels [East Asian],26360
12,"Systolic blood pressure x alcohol consumption interaction (2df test) [AA, EA]",4580
12,Platelet count [EA],659
12,Basophill count,1188
12,Electrocardiogram morphology (amplitude at temporal datapoints) [148 ms],35349
12,Medication use (antihypertensives),616
12,6-oxopiperidine-2-carboxylate levels,961
12,Electrocardiogram morphology (amplitude at temporal datapoints) [330 ms],626
12,Breast Cancer in BRCA1 mutation carriers,89
12,Brown vs. non-brown hair color,120
12,Heart disease | illnesses of mother,302
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-110 ms],71
12,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],1709
12,"Blood protein levels [SULF2, 8305_18_3]",8944
12,Serum alpha1-antitrypsin levels,4180
12,Doctor diagnosed tuberculosis,302
12,Immune reponse to smallpox (secreted TNF-alpha) [AA],521
12,Coxarthrosis [arthrosis of hip](FG),236
12,Vitamin e  | vitamin and/or mineral supplement use,49
12,Uterine fibroids,66488
12,Diabetic ketoacidosis,13107
12,Electrocardiogram morphology (amplitude at temporal datapoints) [312 ms],626
12,Yoghurt consumption,260
12,"""Seropositive rheumatoid arthritis, wide""",581
12,Nose morphology [Profile nasal angle],150
12,Urinary sodium excretion [EA],36
12,Metabolite levels (small molecules and protein measures) [Phenylalanine],572
12,3mm weak meridian (left),3329
12,CD4 on resting CD4 regulatory T cell,1180
12,Protein quantitative trait loci (liver) [S100A9],710
12,Electrocardiogram morphology (amplitude at temporal datapoints) [254 ms],125
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-116 ms],71
12,Elusimicrobiota abundance in stool,26
12,Cardiac dysrhythmias,177
12,Pulse pressure [East Asian],742
12,"Waist-to-hip ratio adjusted for body mass index [EA, men]",2850
12,Systolic blood pressure (long-term average),1055
12,Physical activity (moderate intensity activity duration),616
12,Spinal stenosis,133
12,"""Stroke, excluding SAH""",69
12,Electrocardiogram morphology (amplitude at temporal datapoints) [8 ms],62
12,Educational attainment,32421
12,Waist circumference adjusted for body mass index,163738
12,Frequency of tenseness / restlessness in last 2 weeks,12782
12,Serum metabolite levels [X-12456],957
12,"Blood protein levels [CLEC12A, 11187_11_3]",5114
12,Electrocardiogram morphology (amplitude at temporal datapoints) [334 ms],84
12,Methylsuccinoylcarnitine levels,3969
12,Motion sickness,169
12,"Diastolic blood pressure x alcohol consumption interaction (2df test) [AA, Asian, EA]",69
12,Cheese intake,35562
12,Bioavailable testosterone levels,54502
12,Direct bilirubin levels,50810
12,Renal overload gout,426
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-30 ms],2332
12,3mm cylindrical power (left),583
12,Fasting blood insulin,859
12,Broad depression or schizophrenia,29
12,Direct low density lipoprotein cholesterol levels,44392
12,Total protein levels x insomnia interaction,4849
12,Blood metabolite levels [1-arachidonoylglycerophosphoethanolamine],957
12,Total cholesterol levels [EA],6439
12,Serum levels of protein NUDT16L1,1169
12,Hydroxocobalamin | treatment/medication code,245
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-316 ms],71
12,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],5247
12,COVID-19 (hospitalized vs population),28151
12,Sphingomyelin_36:1_[M+H]1+ levels,4664
12,Medication use (drugs used in diabetes),8823
12,Serum levels of protein TKT,70458
12,Cortical surface area (global PC1) [EA],82
12,Protein quantitative trait loci (liver) [EIF3K],6
12,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test),19510
12,Waist-to-hip ratio adjusted for BMI [male],1205
12,Pulmonary function [FEV1/FVC],4790
12,Activated partial thromboplastin time,2259
12,C-reactive protein [HA women],3452
12,Serum levels of protein HSP90B1,8013
12,Serum immune biomarker levels [YKL-40],228
12,Mean corpuscular volume [Asian],20
12,Cerebrospinal fluid biomarker levels [Lysozyme C],24179
12,"""Hypertension, essential""",5070
12,Urinary metabolites [2-hydroxyisobutyrate],3320
12,IgD- CD27- B cell %B cell,803
12,Gliclazide | treatment/medication code,180
12,Total amyloid (SNP x SNP interaction),113
12,Optic disc area,1
12,Chronic lymphocytic leukemia,29106
12,Body mass index and HDL-C (pairwise),19664
12,SSC-A on monocyte,26255
12,Serum levels of protein CD300C,4774
12,Migraine,25477
12,Serum uric acid levels,30709
12,Vertex-wise cortical thickness,214364
12,"Intra-ocular pressure, goldmann-correlated (right)",4266
12,Nontoxic multinodular goitre,49
12,"Systolic blood pressure x alcohol consumption interaction (2df test) [AA, Asian, EA, Hispanic]",69
12,Human papilloma virus 16 negative oropharyngeal cancer,8
12,High light scatter reticulocyte count,1042012
12,O levels/gcses or equivalent | qualifications,61687
12,Nasal polyp,20999
12,Obesity [Overweight],487
12,"""Articial joint operation, menisceal resection""",439
12,CD4 on activated & secreting CD4 regulatory T cell,1180
12,C-reactive protein levels or total cholesterol levels (pleiotropy),6235
12,Chloride levels,6624
12,"Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) [AA, men]",2850
12,Childhood body fatness,1955
12,Differentiated thyroid cancer,295
12,"Heel quantitative ultrasound index (qui), direct entry (right)",3337
12,Serum metabolite levels [gamma-glutamylglutamine],2820
12,Interleukin-1 receptor-like 2 measurement,6056
12,Statin-induced myopathy (severe),957
12,"Mean arterial pressure x alcohol consumption interaction (2df test) [Asian, EA]",1935
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-76 ms],71
12,Follistatin levels,2940
12,"Metabolite levels (small molecules and protein measures) [Histidine, conditioned]",1976
12,Catechol O-methyltransferase measurement,3181
12,Plasma free amino acid levels (adjusted for one other PFAA) [Phe (adjusted for Pro],255
12,Acne,10
12,Estimated glomerular filtration rate,82240
12,Surgery on leg arteries (other than for varicose veins),1151
12,Electrocardiogram morphology (amplitude at temporal datapoints) [14 ms],62
12,Bitter taste perception (multivariate analysis) [sucrose octaacetate and caffeine],135456
12,None of the above | mineral and other dietary supplements,5611
12,Myocardial fractal dimension (slice 4),104
12,Tumor necrosis factor levels,546
12,Malignant neoplasm of small intestine (controls excluding all cancers),125
12,PR interval [Hispanic/Latino],71
12,"""Sleep apnoea, including avohilmo""",11
12,Serum C-reactive protein concentration in non-obese individuals,6235
12,Pediatric asthma,21687
12,Methotrexate clearance (acute lymphoblastic leukemia),1446
12,Left bundle-branch block,58
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-40 ms],202
12,Gtn - glyceryl trinitrate | treatment/medication code,57
12,Protelos 2g sachets | treatment/medication code,260
12,Circulatory disease nec,436
12,Large proline-rich protein BAG6 levels,47
12,Protein quantitative trait loci (liver) [CTH],1
12,Adult onset asthma and/or BMI,22482
12,Educational attainment (years of education) [conditional-joint],206941
12,Blood glucose levels,26653
12,High light scatter reticulocyte percentage,64542
12,Medication use (agents acting on the renin-angiotensin system),38120
12,Allopurinol | treatment/medication code,18382
12,"Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)",5589
12,Asthma or allergic disease (pleiotropy),22714
12,HDL cholesterol levels x long total sleep time interaction (2df test),13330
12,Left–right brain asymmetry,20376
12,Serum metabolite levels (CMS) [Gln],3535
12,"Bone disorder | non-cancer illness code, self-reported",112
12,Testicular cancer,1708
12,Vitamin D levels,11073
12,Fasting blood insulin (BMI interaction),448
12,Hematological and biochemical traits [CK],1106
12,White matter microstructure (mode of anisotropy) [Fornix (column and body],66
12,Temperament (bipolar disorder) [Hyperthymic],78
12,Disorders of lens,9180
12,Central corneal thickness,4605
12,Systolic blood pressure [East Asians],667
12,Other disorders of circulatory system,436
12,Menarche (age at onset),43366
12,Bilirubin levels [Indirect bilirubin],2720
12,Protein quantitative trait loci (liver) [SERPINA3],2466
12,Other/unspecified rheumatoid arthritis,581
12,Central Memory CD4+ T cell Absolute Count,446
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-314 ms],71
12,Maximum heart rate during fitness test,84
12,Response to statins (LDL cholesterol change),882
12,Lung function (FEV1),22487
12,Trochanter size,45412
12,Salad / raw vegetable intake,19373
12,Cortical surface area [total],21707
12,Electrocardiogram morphology (amplitude at temporal datapoints) [212 ms],125
12,Protein quantitative trait loci [Lysozyme],24776
12,Bipolar disorder vs autism spectrum disorder (ordinary least squares (OLS)),871
12,Benign neoplasm: Duodenum (controls excluding all cancers),657
12,"Bone mineral density (paediatric, total body less head)",136
12,Electrocardiogram morphology (amplitude at temporal datapoints) [16 ms],166
12,HDL cholesterol levels in current drinkers [EA],15750
12,Galectin-3 levels,5917
12,Blood metabolite ratios [isoleucine/X-11529],957
12,Metabolite levels [C18-DC:C20-OH],615
12,Multiple sclerosis,210784
12,QRS duration,40983
12,Body fat distribution (leg fat ratio) [females],71835
12,Hemoglobin,214355
12,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],14871
12,Protein quantitative trait loci (liver) [MMAB],23278
12,Optic cup area,1822
12,Drive faster than motorway speed limit,5022
12,Bipolar disorder (MTAG),5642
12,Ever addicted to alcohol,42
12,Comparative height size at age 10,142770
12,Electrocardiogram morphology (amplitude at temporal datapoints) [60 ms],19718
12,Seronegative rheumatoid arthritis,581
12,HDL cholesterol levels [EA],17263
12,"Waist-to-hip ratio adjusted for BMI in non-smokers [AA, men]",2850
12,Metabolite levels,3535
12,Breast cancer | illnesses of mother,458
12,Coronary heart disease x type 2 diabetes interaction,29
12,Varicose veins,25023
12,Driving (hours per day),14804
12,"Liver, biliary or pancreas problem",3703
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-96 ms],71
12,Age at menopause,57620
12,Serum metabolite levels [imidazole lactate],1177
12,"""Type 1 diabetes, strict definition""",21603
12,Coronary atherosclerosis,9255
12,Blood metabolite levels [1-arachidonoylglycerophosphoinositol],1017
12,Serum metabolite levels (CMS) [Phe],595
12,Diastolic blood pressure [Japanese],685
12,Protein quantitative trait loci (liver) [RAB14],40
12,Cathepsin L1 levels,973
12,Myopia,6591
12,Brain region volumes [left basal forebrain],431
12,"Diastolic blood pressure x alcohol consumption interaction (2df test) [EA, Hispanic]",299
12,Urinary metabolite levels in chronic kidney disease [X - 24546],828
12,Smoking status (ever vs never smokers),38901
12,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) [subset analysis]",11075
12,Serum levels of protein LRIG3,718
12,Electrocardiogram morphology (amplitude at temporal datapoints) [30 ms],264
12,Depressive symptoms (MTAG),15581
12,"Age hay fever, rhinitis or eczema diagnosed",22173
12,"""Diseases of arteries, arterioles and capillaries""",116
12,Disorders of the thyroid gland,7439
12,Age high blood pressure diagnosed,474
12,Adenocarcinoma,1289
12,Ginkgo forte tablet | treatment/medication code,238
12,"""Malignant neoplasm of breast, HER-positive (controls excluding all cancers)""",36
12,Acceptance of an invitation to participate in a mental health questionnaire,21932
12,Brain region volumes [right amygdala],2157
12,Dried fruit intake,553
12,Serum levels of protein NTN4,2553
12,Serum levels of protein THPO,446
12,Myositis,107
12,Depression,20830
12,Femur bone mineral density x serum urate levels interaction [female],7773
12,Electrocardiogram morphology (amplitude at temporal datapoints) [178 ms],28515
12,Clinical laboratory measurements [bilirubin levels],1050
12,B cell lymphocyte profile difference (1 day post influenza vaccination),194
12,Anxiety/tension (special factor of neuroticism),106
12,Inguinal hernia,402
12,"Blood protein levels [NUDT16L1, 12497_29_3]",86
12,Electrocardiogram morphology (amplitude at temporal datapoints) [206 ms],125
12,"Waist circumference adjusted for body mass index [EA, women]",16793
12,Cholelithiasis or gall stones,6238
12,Serum levels of protein BAG4,957
12,Sulfhydryl oxidase 2 measurement,517
12,T cell Absolute Count,446
12,Electrocardiogram morphology (amplitude at temporal datapoints) [298 ms],697
12,Diabetes diagnosed by doctor,925
12,"Blood metabolite levels [4-androsten-3beta,17beta-diol disulfate 2]",957
12,Mean time to correctly identify matches,44921
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-174 ms],273
12,"Blood protein levels [DVL2, 13575_40_3]",2460
12,Serum levels of protein CNTN1,196
12,Benign prostatic hyperplasia and lower urinary tract symptoms,173
12,Daytime dozing / sleeping (narcolepsy),167
12,Laryngeal squamous cell carcinoma,117
12,Facial skin colour (CIELAB index L* value),5
12,Estimated glomerular filtration rate in diabetes,2
12,Protein quantitative trait loci (liver) [SEPT11],4
12,Primary biliary cholangitis,29137
12,Glaucoma (multi-trait analysis),16802
12,Serum metabolite levels (CMS) [His],4215
12,Electrocardiogram morphology (amplitude at temporal datapoints) [50 ms],1425
12,"HDL cholesterol levels [Asian initial, BMI unadjusted]",465
12,HDL cholesterol levels [BMI unadjusted],241
12,Brain region volumes [right posterior cingulate],52
12,Frequency of light diy in last 4 weeks,19
12,Head circumference (infant),60538
12,Low HDL-cholesterol levels,442
12,"Blood protein levels [METAP2, 3170_6_1]",267
12,"Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",1150
12,Systolic blood pressure x smoking status (ever vs never) interaction (2df test) [EA],10489
12,Glycated hemoglobin levels,97613
12,Mean sphered cell volume,356302
12,Urate levels in overweight individuals,2856
12,"Dark brown | hair colour (natural, before greying)",10944
12,Eye color [EA],760
12,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),877
12,Narrowest width of the femoral neck,12081
12,Frequency of tiredness / lethargy in last 2 weeks,5856
12,Urinary albumin-to-creatinine ratio [EA],3936
12,Cardiovascular diseases (excluding rheumatic etc),446
12,Serum levels of protein LDHB,1412
12,"Blood protein levels [TMEM132C, 7173_141_3]",395
12,Homeostasis model assessment of insulin resistance,407
12,Electrocardiogram morphology (amplitude at temporal datapoints) [224 ms],125
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-74 ms],71
12,Oily fish intake,710
12,Metabolic traits [SM-10 + 59 other traits],1050
12,Nonalcoholic fatty liver disease (imputed),3468
12,Nasopharyngeal carcinoma (SNP x SNP interaction),654
12,Pelvic organ prolapse,125
12,LDL cholesterol,67435
12,Coronary artery disease,114221
12,Salt added to food,28353
12,Electrocardiogram morphology (amplitude at temporal datapoints) [166 ms],9384
12,Frequency of friend/family visits,252
12,General cognitive ability,52261
12,Chronic obstructive pulmonary disease,24680
12,Had menopause,2114
12,Cardiovascular disease risk factors [GGT],4341
12,Oily fish consumption,710
12,Primary tooth development (time to first tooth eruption),2444
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-394 ms],7
12,Oral cavity and pharyngeal cancer,36717
12,Ischemic stroke,5641
12,Metabolite levels (small molecules and protein measures) [Glutamine],3535
12,SSC-A on CD14+ monocyte,26255
12,Coronary angiopasty,581
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-172 ms],71
12,Prostate-specific antigen levels,4781
12,Electrocardiogram morphology (amplitude at temporal datapoints) [54 ms],20758
12,Hearing difficulty/problems with background noise,6426
12,Red blood cell fatty acid levels [OA],9051
12,"Number of decayed, missing and filled tooth surfaces or use of dentures",863
12,Electrocardiogram morphology (amplitude at temporal datapoints) [226 ms],125
12,Diastolic blood pressure (long-term average),551
12,Blood metabolite levels [X12063 levels],1033
12,Number of self-reported non-cancer illnesses,446
12,Serum levels of protein TMEM132C,549
12,HOMA-B (corrected for HOMA-IR),80
12,Glomerular filtration rate (creatinine),6101
12,Asthma onset (childhood vs adult),4265
12,Age at menopause (last menstrual period),8759
12,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) [men],2850
12,Varicose veins of lower extremity,1046
12,Urinary metabolite levels in chronic kidney disease [trans-urocanate],954
12,Facial skin colour (CIELAB index b* value),140
12,Electrocardiogram morphology (amplitude at temporal datapoints) [124 ms],19750
12,Protein levels in obesity [40 S ribosomal protein SA],3535
12,Diastolic blood pressure [East Asian],1015
12,Serum levels of protein PRCP,1650
12,Serpin A12 levels,296
12,C-X-C motif chemokine 16 levels,530
12,Detrusitol 1mg tablet | treatment/medication code,1072
12,Gut microbiota (functional units) [GO:0009231|BP|04|riboflavin biosynthetic process],700
12,CD27 on switched memory B cell,529
12,Lymphocyte percentage,126280
12,Body mass index in physically active individuals,2079
12,"Pediatric dental caries (decayed, missing and filled teeth >5)",49
12,Cognitive performance (MTAG) [MTAG],195143
12,Medication use (thyroid preparations),45838
12,High density lipoprotein cholesterol levels [conditional on round 2],6979
12,Medication use (glucocorticoids),42628
12,Moyamoya disease,1260
12,Waist circumference adjusted for body mass index [women],2723
12,Blood protein levels [Complement C1q subcomponent],2074
12,Serum levels of protein FAM189A2,1186
12,Electrocardiogram morphology (amplitude at temporal datapoints) [38 ms],202
12,Allergic rhinitis,121184
12,Asthma (childhood onset),155631
12,Hip index,42645
12,"Neurological, eye or psychiatric disease",4025
12,"Fractional excretion of metabolites in chronic kidney disease [Butyrylcarnitine, Isobutyrylcarnitine]",3786
12,Blood protein levels [Alkaline phosphatase],8
12,Chronic periodontitis (localised),106
12,Body fat percentage and triglycerides (pairwise),14532
12,Gut microbiota abundance (genus Streptococcus id.1853),16304
12,"Black | hair colour (natural, before greying)",2871
12,"""Pulmonary heart disease, diseases of pulmonary circulation""",339
12,Glaucoma (primary open-angle),720
12,"Heel bone mineral density (bmd) t-score, automated",13809
12,Electrocardiogram morphology (amplitude at temporal datapoints) [126 ms],35349
12,Serum metabolite levels [methylsuccinate],3095
12,Home location - north co-ordinate (rounded),2744
12,BMI (adjusted for smoking behaviour),2220
12,"Blood protein levels [RECQL, 11431_235_3]",762
12,HLA DR on monocyte,103
12,"""Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium""",521
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-382 ms],7
12,Male-pattern baldness,121042
12,Urate levels,291425
12,CD4 on naive CD4+ T cell,1621
12,E-selectin levels,5177
12,Chronic kidney disease [eGFRcrea],1458
12,"Heart failure/pulmonary odema | non-cancer illness code, self-reported",723
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-160 ms],71
12,Visual disturbances,122
12,Platelet count,1759613
12,Type 2 diabetes,503618
12,Autoimmune traits (pleiotropy),21535
12,Electrocardiogram morphology (amplitude at temporal datapoints) [146 ms],19660
12,Blood metabolite levels [X-12456],957
12,Vitamin B12 deficiency anaemia,446
12,Exudative age-related macular degeneration,2521
12,Vertical cup-disc ratio,3352
12,Low myopia vs hyperopia,1455
12,Urinary metabolite levels in chronic kidney disease [taurocholenate sulfate],1017
12,Serum metabolite levels [X-12063],1515
12,Attention deficit hyperactivity disorder or cannabis use,760
12,3-hydroxybutyrate + 3-aminoisobutyrate levels,1207
12,"Red blood cell traits [EA, MCH]",246
12,"Blood protein levels [C1RL, 9348_1_3]",292
12,Sex hormone-binding globulin levels adjusted for BMI,433034
12,4-chlorobenzoic acid levels,4315
12,Autoimmune diseases,13794
12,Spherical equivalent (joint analysis main effects and education interaction),2206
12,Body fat distribution (arm fat ratio),2486
12,Alcohol consumption (max-drinks),443
12,Electrocardiogram morphology (amplitude at temporal datapoints) [24 ms],166
12,Triglyceride levels x long total sleep time interaction (2df test),14869
12,Bitter taste perception [quinine],147851
12,SARS-CoV-2 infection,27378
12,Electrocardiogram morphology (amplitude at temporal datapoints) [108 ms],36232
12,Duration to first press of snap-button in each round,50118
12,"Diastolic blood pressure x alcohol consumption interaction (2df test) [Asian, EA]",2472
12,"Blood protein levels [EA, Lysosomal protective protein]",1237
12,QRS complex (12-leadsum) [EA],208
12,Placenta praevia,116
12,Lysophosphatidylcholine levels [LPC(14:0;0],1
12,Hand osteoarthritis severity (hand Klsum),23073
12,Ankle spacing width (right),12211
12,Tildiem 60mg m/r tablet | treatment/medication code,611
12,Atrial fibrillation and flutter,926
12,Dentures,863
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-8 ms],62
12,Intelligence,99508
12,Rheumatoid arthritis [EA],20158
12,Diabetes or endocrine disease,25110
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-24 ms],2170
12,Fracture of forearm,3444
12,Atrial fibrillation and flutter with reimbursement,551
12,Electrocardiogram morphology (amplitude at temporal datapoints) [6 ms],166
12,Body mass index,621966
12,Depressive symptoms,45507
12,Aortic root size,150
12,HDL cholesterol levels [Trans-ethnic initial],38233
12,Impedance of whole body,152715
12,Plasma free amino acid levels (adjusted for one other PFAA) [Gln (adjusted for Gly],2337
12,Heart rate response to beta blockers [AA],9003
12,"Blood protein levels [PKN1, 12562_1_3]",2460
12,"Long-standing illness, disability or infirmity",714
12,Brain region volumes [right inferior parietal],2354
12,Serum metabolite levels [3-aminoisobutyrate],1177
12,Cortical surface area [Inferior parietal],914
12,Serum metabolite levels [Deoxycarnitine],17
12,Mitochondrial DNA copy number,30160
12,Spondylopathies,59325
12,CD4 on secreting CD4 regulatory T cell,1180
12,Electrocardiogram morphology (amplitude at temporal datapoints) [194 ms],125
12,Chronic mountain sickness,1061
12,Aerodigestive squamous cell cancer (pleiotropy),153
12,Corneal curvature,317
12,Other embolism and thrombosis,40
12,High density lipoprotein cholesterol levels,197935
12,High altitude adaptation,5903
12,Blood metabolite levels [2-hydroxyisobutyrate],4382
12,Gut microbiota (functional units) [PWY-7528_L-methionine_salvage_cycle_I_(bacteria_and_plants],2807
12,Alcohol consumption (drinkers vs non-drinkers),260
12,Dorsalgia,11
12,Prostate cancer (early onset),6679
12,Psychological resilience (outcome-based) in high deployment stress exposure,126
12,Waist-hip ratio and systolic blood pressure (pairwise),2850
12,Electrocardiogram morphology (amplitude at temporal datapoints) [258 ms],2409
12,Lipid traits (pleiotropy) (HIPO component 1),4087
12,Major depressive disorder (MTAG),1532
12,Metabolic biomarkers (multivariate analysis),31209
12,Serum levels of protein H6PD,1755
12,Electrocardiogram morphology (amplitude at temporal datapoints) [138 ms],19660
12,Triglycerides [EA],17731
12,"Hip circumference [EA,women]",2737
12,Barrett's esophagus  or Esophageal adenocarcinoma [male],855
12,Glomerular filtration rate (cystatin C),446
12,Electrocardiogram morphology (amplitude at temporal datapoints) [300 ms],626
12,Dorea phocaeense abundance in stool,592
12,Eczema,99172
12,Blood metabolite levels [gamma-glutamylglutamine],3535
12,Ankle spacing width,32239
12,Gonarthrosis,2634
12,"""Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)""",2432
12,IgE levels,1924
12,Citramalate levels,123
12,Benign paroxysmal vertigo,14
12,Diastolic blood pressure x alcohol consumption interaction (2df test) [EA],4359
12,Retinal detachment,872
12,"Blood protein levels [SELPLG, 11266_8_3]",1978
12,Electrocardiogram morphology (amplitude at temporal datapoints) [120 ms],19535
12,Brain region volumes [left entorhinal],1989
12,Physical activity (Total log acceleration 6am-8am),1830
12,Brugada syndrome,202
12,Other intervertebral disc disorders,10
12,Menopause (age at onset),40785
12,Smoking initiation (ever regular vs never regular) (MTAG),93382
12,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction) [men],14838
12,Testicular germ cell tumor,16470
12,Serum levels of protein CTSA,3226
12,Serum levels of protein IDUA,1781
12,Alcohol use disorder (consumption score) [EA],435
12,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)",100417
12,Keratinocyte cancer (MTAG),11411
12,BMI (adjusted for smoking behaviour) [women],2220
12,Serum levels of protein SCIN,3130
12,Tuberculosis (SNP x SNP interaction),926
12,Primary tooth development (number of teeth),1343
12,Vertex-wise sulcal depth,305404
12,Amyotrophic lateral sclerosis (sporadic),1995
12,Bipolar I disorder,10294
12,Aspartate aminotransferase to alanine aminotransferase ratio,97779
12,"""Type 1 diabetes, wide definition, subgroup 1""",22049
12,Pulse pressure [East Asians],653
12,Malignant neoplasm of skin (controls excluding all cancers),161
12,Metabolite levels [Cer d18:2/16:0],77
12,Protein quantitative trait loci (liver) [KRT18],21
12,Bitter taste perception [caffeine],37408
12,Leg fat percentage (right),68105
12,Waist circumference adjusted for BMI (adjusted for smoking behaviour),29572
12,Reduction in HbA1c levels in response to sulfonylureas treatment in type 2 diabetes,3712
12,AR-C124910XX levels in individuals with acute coronary syndromes treated with ticagrelor,1037
12,Non-glioblastoma glioma,508
12,Response to alcohol consumption (flushing response),438
12,Left-handedness,22149
12,Eosinophill percentage,105342
12,Electrocardiogram morphology (amplitude at temporal datapoints) [136 ms],19535
12,Serum metabolite levels [hexadecanedioate],2878
12,None of the above (group 1) | illnesses of siblings,446
12,Body size at age 10,71846
12,Disorders of lipoid metabolism,6294
12,Chronic obstructive pulmonary disease [conditional on rs7307510],849
12,"Number of operations, self-reported",158
12,Age first had sexual intercourse,21125
12,Left ventricular end-diastolic volume,885
12,Photic sneeze reflex,5062
12,Birth weight (MTAG),1726
12,Body fat percentage [female],106
12,Overall health rating,271
12,Ease of getting up in the morning,25579
12,Metabolite levels (lipoprotein measures) [HDL diameter],111
12,Brain region volumes [left amygdala],589
12,Gut microbiota (bacterial taxa) [OTU10032 unclassified Enterobacteriaceae Species-level OTU],627
12,Frequency of needing morning drink of alcohol after heavy drinking session in last year,206
12,Electrocardiogram morphology (amplitude at temporal datapoints) [248 ms],125
12,Ischemic stroke (small artery occlusion) [CCSp],2842
12,CD4+CD8+ T cell %T cell,3587
12,Corneal resistance factor (right),897
12,Electrocardiogram morphology (amplitude at temporal datapoints) [316 ms],84
12,Serum levels of protein CREG1,9721
12,Electrocardiogram morphology (amplitude at temporal datapoints) [100 ms],19750
12,Electrocardiogram morphology (amplitude at temporal datapoints) [58 ms],19875
12,Electrocardiogram morphology (amplitude at temporal datapoints) [90 ms],35349
12,Serum metabolite levels [Gln],3535
12,"Spinal cord disorder | non-cancer illness code, self-reported",76
12,Alcohol consumption (drinkers vs non-drinkers) [East Asian],1367
12,Endometrial cancer (endometrioid histology),567
12,Protein quantitative trait loci (liver) [NIPSNAP1],271
12,Subcortical volume (min-P),20916
12,Serum levels of protein SULF2,2940
12,Paracetamol | treatment/medication code,3485
12,Facial morphology (segment 30),1123
12,Chronic kidney disease [eGFRcys],474
12,Parental lifespan,474
12,Plasma free amino acid levels (adjusted for one other PFAA) [Phe (adjusted for Gln],255
12,Protein quantitative trait loci (liver) [ACO2],996
12,Glycemic traits [2-hPG],226
12,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,19
12,Serum metabolite levels [His],4215
12,Electrocardiogram morphology (amplitude at temporal datapoints) [132 ms],19535
12,Ibuprofen | treatment/medication code,3701
12,"""Other noninflammatory disorders of uterus, except cervix""",1918
12,Antihypertensive medication - note that there are other indications,2747
12,Daytime nap,1518
12,Sleep duration (oversleepers),38
12,Immature reticulocyte fraction,140627
12,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],11751
12,Urinary metabolite levels in chronic kidney disease [X - 16654],1017
12,Serum levels of protein TXNRD1,1222
12,Brain region volumes [right medial orbitofrontal],346
12,Pulse pressure [EA],1074
12,Electrocardiogram morphology (amplitude at temporal datapoints) [128 ms],36357
12,"Psoriasis | non-cancer illness code, self-reported",446
12,Internar derangement of knee,60462
12,"Aging traits (healthspan, parental lifespan or longevity) (multivariate analysis)",2322
12,Advanced age-related macular degeneration [EA],558
12,Tetralogy of Fallot,474
12,Colorectal cancer (aspirin and/or NSAID use interaction),1
12,Protein quantitative trait loci (liver) [RAB7A],36
12,Corneal structure,303
12,Early-onset Parkinson's disease,610
12,Urinary metabolite levels in chronic kidney disease [glycocholenate sulfate],957
12,Low density lipoprotein cholesterol levels,248893
12,Hernia of abodminal wall,113
12,Peripheral artery disease in non diabetes,419
12,Leg pain when walking normally,19
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-70 ms],71
12,Brain region volumes [left lateral ventricle],66
12,Protein quantitative trait loci (liver) [HGD],32
12,Composite immunoglobulin trait (IgA x IgG/IgM),92
12,Time spent watching television (tv),84553
12,Bitter taste perception (multivariate analysis) [sucrose octaacetate and quinine],135456
12,Factor VIII levels [EA],1600
12,Total bilirubin levels [conditional on round 3],160
12,Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals,203
12,Neurociticism,24858
12,Ebbinghaus illusion (overestimation),253
12,"Adenosine 3',5'-cyclic monophosphate (camp) levels",167
12,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),21071
12,HDL cholesterol levels,418704
12,Facial morphology (segment 1),12338
12,Serum levels of protein CD300A,4774
12,None of the above (group 1) | illnesses of adopted mother,46004
12,Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease),7677
12,"Heel quantitative ultrasound index (qui), direct entry",13806
12,Bone mineral density (hip),6388
12,Hip circumference [EA],2901
12,Total hippocampal volume,6483
12,Adventurousness,28283
12,Alcohol intake frequency.,67301
12,Serum levels of protein NAAA,9712
12,"Blood pressure medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",9187
12,Ulcerative colitis [EA],884
12,"Mean arterial pressure x alcohol consumption interaction (2df test) [AA, Asian, EA]",606
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-12 ms],62
12,White matter microstructure (axial diusivities) [Fornix (column and body],66
12,Heart rate increase in response to exercise,325
12,LDL cholesterol levels x short total sleep time interaction (2df test),5522
12,Squamous cell carcinoma,158
12,"Systolic blood pressure [EA, initial]",1141
12,3mm cylindrical power angle (right),260
12,CD4+CD8+ T cell %leukocyte,3587
12,Blood metabolite levels [phenylalanine],595
12,Electrocardiogram morphology (amplitude at temporal datapoints) [296 ms],626
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-180 ms],273
12,Hip circumference,99219
12,Electrocardiogram morphology (amplitude at temporal datapoints) [72 ms],1300
12,Electrocardiogram morphology (amplitude at temporal datapoints) [182 ms],125
12,Urinary metabolites [1.345 ppm/7.664 ppm],3582
12,"""Coxarthrosis, primary""",169
12,Plateletcrit,289441
12,Estimated glomerular filtration rate in non-diabetics,4843
12,Hip circumference adjusted for BMI,290300
12,Whole body fat-free mass,167054
12,Electrocardiographic traits [PR interval],268
12,Heel bone mineral density (bmd) (left),2699
12,Pulse pressure [Japanese],644
12,Total cerebellar volume (excluding Crus I vermis),20682
12,"Blood protein levels [TAPBPL, 6364_7_3]",16566
12,Other diseases of upper respiratory tract,3034
12,"""Malignant neoplasm of breast, HER-negative""",36
12,Spherical power (right),8937
12,Retinal nerve fibre layer thickness or ganglion cell inner plexiform layer thickness (MTAG),583
12,Lumbar spine bone mineral density,31283
12,Menopause (age at onset) [japanese],240
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-78 ms],71
12,Taking other prescription medications,446
12,Sweet taste preference,260
12,Erosive tooth wear (severe vs non-severe) [male],37
12,Female genital prolapse,105
12,Atopic march,18
12,Reaction time,64725
12,"Waist circumference adjusted for BMI in active individuals [EA,women]",17321
12,Serum levels of protein FJX1,1781
12,"Cellulitis | non-cancer illness code, self-reported",923
12,Biomedical quantitative traits [waist-hip ratio],226
12,Addison's disease,446
12,Nabumetone | treatment/medication code,460
12,Fibroblastic disorders,8
12,Never | smoking status,29220
12,Body mass index and coronary artery disease (pairwise),424
12,Psoriasis [fixed],260
12,Atrial fibrillation,77339
12,Autoimmune traits,21022
12,Age when periods started (menarche),12548
12,Rizatriptan | treatment/medication code,2690
12,Disorders of breast,452
12,Serum levels of protein C1RL,4898
12,Schizophrenia,534724
12,Cigarettes smoked per day (MTAG),8843
12,Diffuse plaques (SNP x SNP interaction),4094
12,Spontaneous coronary artery dissection,5783
12,Primary sclerosing cholangitis,948
12,"""Coxarthrosis,""",171
12,Youthful appearance (self-reported),1308
12,Angiostatin measurement,4774
12,Identify largest number | fi2 ,7605
12,Lung function (FVC) [adults],1460
12,Glyceryl trinitrate | treatment/medication code,147
12,Serum levels of protein TMEM132B,44
12,Myopia (age of diagnosis),8300
12,Colorectal cancer or advanced adenoma,44431
12,Platelet-to-lymphocyte ratio,126672
12,Metabolite levels [Cer d18:2/24:1],3920
12,Phosphorus levels,2449
12,CD4 on Central Memory CD4+ T cell,1180
12,Hematological and biochemical traits [ALT],212
12,Velopharyngeal dysfunction,49
12,Fish consumption,345
12,Hypothyroidism or myxedema,28313
12,"Serum metabolite levels [androstenediol (3beta,17beta) disulfate (2]",844
12,White matter microstructure (mean diusivities) [Fornix (column and body],66
12,Basal metabolic rate variance,18253
12,Intracranial aneurysm,10552
12,Blood metabolite levels [X-11529],957
12,"Subcortical brain region volumes [Hippocampus, EA]",4525
12,"Blood protein levels [LRIG3, 3322_52_2]",287
12,Protein quantitative trait loci (liver) [HSPD1],996
12,Essential hypertension,40828
12,"""Other diabetes, wide definition""",3007
12,Serum metabolite levels [taurocholenate sulfate],3732
12,Serum levels of protein HNRNPM,8109
12,Protein quantitative trait loci (liver) [PSAP],31
12,Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel,323
12,Crohn's disease [EA],2964
12,Blood sugar levels,158
12,PR interval,32574
12,Age completed full time education,41097
12,Oleic acid (18:1n-9) levels [Chinese],5713
12,Sclerostin levels,592
12,Serum levels of protein CHST11,232
12,"Blood protein levels [PZP, 6580_29_3]",86
12,Facial morphology (segment 28),242
12,"Spine arthritis/spondylitis | non-cancer illness code, self-reported",40
12,Colon polyp,17038
12,Serum metabolite levels [ethylmalonate],9014
12,Type 1 diabetes with ophthalmic complications,22049
12,von Willebrand factor measurement,5038
12,Factor VIII levels,3271
12,Heart failure and antihypertensive medication,3441
12,Medication use (beta blocking agents),2058
12,Nonsyndromic cleft lip with cleft palate,44738
12,Subjective well-being (MTAG),4458
12,Worry too long after an embarrassing experience,19545
12,Serum levels of protein HTN3,64585
12,6mm strong meridian (left),5881
12,Ankylosing spondylitis [EA],2605
12,Electrocardiogram morphology (amplitude at temporal datapoints) [188 ms],125
12,Naratriptan | treatment/medication code,292
12,Protein quantitative trait loci (liver) [AK2],10
12,Hand grip strength (right),52143
12,"Blood protein levels [EA, CMRF35-like molecule 6]",4209
12,"HDL cholesterol levels [Asian initial, BMI adjusted]",18
12,Romboutsia ilealis abundance in stool,6
12,"Hip circumference adjusted for BMI [EA, women]",62705
12,Waist-to-hip ratio adjusted for BMI in non-smokers [women],15409
12,"Blood protein levels [APOF, 12370_30_3]",25294
12,Protein quantitative trait loci (liver) [TOMM70],2319
12,Serum metabolite levels [X-13429],1515
12,Dehydroepiandrosterone sulphate levels,721
12,Restless legs syndrome in migraine without aura,67
12,"""Rheumatoid arthritis , including avohilmo""",581
12,Beta-2 microglubulin plasma levels,446
12,"""Malignant neoplasm of breast, HER-positive""",36
12,Reticulocyte count,998890
12,Skin cancer,12581
12,Hippocampal volume,8817
12,"Mean arterial pressure x alcohol consumption interaction (2df test) [AA, EA]",1637
12,Other disorders of veins,1021
12,Smoking cessation (MTAG),1214
12,Serum levels of protein CXCL11,446
12,Fish intake frequency,530
12,Parental longevity (both parents in top 10%),2371
12,Testosterone levels,27997
12,Heel bone mineral density (bmd),10433
12,Spherical power (left),9273
12,"""Hypothyroidism, strict autoimmune, 3 medication purchases required""",23095
12,Cholelithiasis,16537
12,Serum metabolite levels [4-hydroxyphenylpyruvate],9486
12,Electrocardiogram morphology (amplitude at temporal datapoints) [26 ms],368
12,Serum metabolite levels [deoxycarnitine],1156
12,Brain region volumes [right cerebellum white matter],1772
12,Protein quantitative trait loci (liver) [SELENBP1],174
12,Heart rate response to exercise [males],71
12,Vertical cup-disc ratio (multi-trait analysis),9803
12,Average total household income before tax,17735
12,"Paracetamol | medication for pain relief, constipation, heartburn",3485
12,"Pneumonia | non-cancer illness code, self-reported",38
12,Serum levels of protein GCH1,1445
12,Travatan 40micrograms/ml eye drops | treatment/medication code,742
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-98 ms],71
12,Dorsopathies,15
12,Depressed affect,10896
12,"Waist circumference adjusted for body mass index [EA,women]",17584
12,White blood cell count (lymphocyte),504
12,Ceramide_42:2_[M+H-H2O]1+ levels,6167
12,malignant neoplasm of male genital organs,5937
12,Bacteroides sp002160055 abundance in stool,150
12,Irritable mood,11202
12,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 measurement",2988
12,N-glycan levels [DG7],9896
12,"Sjogren's syndrome/sicca syndrome | non-cancer illness code, self-reported",3167
12,Hyperopia,1455
12,Proheparin-binding EGF-like growth factor levels,132
12,Systolic blood pressure x smoking status (ever vs never) interaction (2df test),10536
12,Well-being spectrum (multivariate analysis),39701
12,3-hydroxyoctanoate levels,1940
12,Benign neoplasm: Duodenum,657
12,Triglyceride levels x short total sleep time interaction (2df test),15
12,Bitter taste perception (multivariate analysis) [caffeine and sucrose octaacetate],37408
12,Back pain | pain type(s) experienced in last month,9385
12,Stroke,1056
12,Glucose levels,8550
12,C-reactive protein levels [HIS],2682
12,Diastolic blood pressure [East Asians],736
12,Number of incorrect matches in round,374
12,"Blood pressure [EA, MAP, Age 40-49]",537
12,Lamb consumption,262
12,Other malignant neoplasms of skin (=non-melanoma skin cancer) (controls excluding all cancers),161
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-82 ms],71
12,Age at first sexual intercourse,49504
12,Verbal-numerical reasoning,56746
12,Serum phosphate levels,80622
12,"Asthma | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",42707
12,Diseases of the musculoskeletal system and connective tissue,193
12,Serum levels of protein CTSH,7931
12,Serum C-reactive protein concentration,6235
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-176 ms],1406
12,Blood metabolite levels [octadecanedioate],5397
12,Change in serum metabolite levels [S_HDL_TG],19
12,Eubacterium R coprostanoligenes abundance in stool,14
12,T cell lymphocyte profile difference (7 days post influenza vaccination),121
12,Depression score x vitamin D interaction,23
12,Gamma glutamyl transpeptidase,55767
12,Osteoarthritis,71007
12,Caffeine consumption from tea,38363
12,Coronary artery disease and triglyceride levels (multivariate analysis),4519
12,"Oesophagitis/barretts oesophagus | non-cancer illness code, self-reported",5556
12,Medication use (salicylic acid and derivatives),4713
12,Metabolite levels (small molecules and protein measures) [Histidine],4215
12,Mean arterial pressure [East Asians],653
12,Cerebrovascular diseases,89
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-162 ms],71
12,Spleen volume,15845
12,Serum levels of protein CTSO,1781
12,Total body bone mineral density,19043
12,Thoracic-to-hip circumference ratio [males],241
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-190 ms],273
12,Leflunomide | treatment/medication code,109
12,White matter microstructure (mode of anisotropy) [Splenium of corpus callosum],66
12,Previous | smoking status,446
12,Mean arterial pressure (long-term average),537
12,SSC-A on myeloid Dendritic Cell,103
12,Aspartate aminotransferase levels,375243
12,"Hip circumference adjusted for BMI [EA,men]",2252
12,Home location - east co-ordinate (rounded),546
12,Febrile seizures [Overall],872
12,Type 2 diabetes [conditional],23931
12,"Heel broadband ultrasound attenuation, direct entry",17104
12,Celiac disease and Rheumatoid arthritis,420
12,Odorant perception [Licorice naming problem],6418
12,Bone mineral density (hip) and hip bone size,1210
12,"Blood protein levels [KLRB1, 10809_14_3]",4906
12,Type 2 diabetes [AA],118
12,Microalbuminuria,2284
12,Tumor necrosis factor receptor 1 levels,267
12,Parental longevity (father's age at death),474
12,None of the above | pain type(s) experienced in last month,3765
12,Myopia (pathological),455
12,Heel bone mineral density x serum urate levels interaction [female],122
12,Gout (combined type),345
12,Prolapsed or slipped disc,30
12,Hippocampal subfield CA4 volume,2498
12,COVID-19 (critical illness vs population),56448
12,Cardiometabolic and hematological traits [PLT],1370
12,Small vessel stroke (CCSp classification),508
12,Vestibular neuronitis,280
12,Number of treatments/medications taken,519
12,Phenylalanine levels,14283
12,Serum levels of protein TAPBPL,14347
12,N-glycan levels [GP13],4619
12,"Blood protein levels [CLEC4C, 9094_5_3]",2674
12,Hip shape (DXA scan) [hip shape mode 1],492
12,Electrocardiogram morphology (amplitude at temporal datapoints) [36 ms],202
12,Autoimmune thyroid disease,31639
12,Calcium levels,59446
12,"Blonde | hair colour (natural, before greying)",73769
12,Pattern 1 | hair/balding pattern,25523
12,Femur bone mineral density x serum urate levels interaction,6385
12,Blood metabolite levels [betaine],525
12,"Waist-to-hip ratio adjusted for BMI in active individuals [EA, women]",16181
12,Left eye | which eye(s) affected by hypermetropia (long sight),1937
12,Hypertension [East Asian],752
12,Global electrical heterogeneity phenotypes [QRS-T angle],103
12,Ascorbate (vitamin c) levels,901
12,"Blood protein levels [CHST11, 7779_86_3]",29
12,1-carboxyethylphenylalanine levels,6171
12,Urinary metabolites [3-aminoisobutyrate],1458
12,Electrocardiogram morphology (amplitude at temporal datapoints) [160 ms],19535
12,Complement C1r subcomponent measurement,3385
12,Childhood sunburn occasions,954
12,Parental longevity (father's age at death or father's attained age),446
12,White matter microstructure (mode of anisotropy) [Posterior limb of internal capsule],98
12,Serum levels of protein SMPD1,1781
12,Menarche (age at onset) [japanese],240
12,Brainstem volume,16932
12,Bipolar disorder or major depressive disorder,15714
12,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test) [EA],18257
12,Monoclonal gammopathy of undetermined significance,296
12,Serum metabolite levels [glycodeoxycholate sulfate],844
12,Brain region volumes [X3rd ventricle],66
12,Lymphocyte percentage of white cells,272523
12,Waist-hip index,103354
12,"""Type1 diabetes, definitions combined""",21603
12,Electrocardiogram morphology (amplitude at temporal datapoints) [102 ms],19535
12,Serum metabolite levels [1-arachidonoyl-GPE (20:4n6)*],740
12,Thyroid peroxidase antibody positivity,474
12,Blood protein levels [Plexin-C1],165
12,Protein quantitative trait loci (liver) [MT1H],72
12,Lung function (FEV1) and waist to hip ratio adjusted for BMI [East Asian],61
12,Self-rated health,37
12,Crohn's disease,14663
12,Hypercholesterolemia,6294
12,Electrocardiogram morphology (amplitude at temporal datapoints) [310 ms],626
12,Impedance of leg (right),103496
12,Urinary albumin-to-creatinine ratio,8650
12,N-glycan levels [DG11],9238
12,Lifetime number of sexual partners,1458
12,Adult-onset Still disease,581
12,Coronary artery disease and LDL cholesterol levels (multivariate analysis),9794
12,Mean platelet (thrombocyte) volume,283112
12,Morning/evening person (chronotype),22006
12,Adiponectin levels,4586
12,Heart rate response to recovery post exercise (20 sec),576
12,Vitamin b compound tablet | treatment/medication code,65
12,"""Benign neoplasm: Pituitary gland, craniopharyngeal duct (controls excluding all cancers)""",39
12,QT interval,28623
12,Apolipoprotein A1 levels,361054
12,Lactate dehydrogenase levels,2771
12,Systolic blood pressure x educational attainment (some college) interaction (2df),1162
12,Blood pressure [Systolic],821
12,Urinary metabolite levels in chronic kidney disease [X - 14662],575
12,Sensitivity to environmental stress and adversity,47633
12,"Cholesterol lowering medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",6167
12,"Serum metabolite levels [androstenediol (3alpha, 17alpha) monosulfate (3]",1480
12,Codeine or tramadol medication,54
12,Pancreas fat,503
12,Sudden idiopathic hearing loss,378
12,Sodium levels,278
12,Lung function (FEV1) and body mass index [East Asian],18081
12,Serum metabolite levels [pyroglutamine*],1177
12,"Blood protein levels [SERPINA9, 7266_4_3]",2460
12,"Blood protein levels [C1R, 3285_23_2]",2460
12,Gut microbiota (bacterial taxa) [k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Lachnospiraceae|g__Lachnospiraceae_noname|s__Lachnospiraceae_bacterium_1_1_57FAA],342
12,"""Other bursitis, not elsewhere classified""",20
12,"Blood protein levels [EA, Plexin-C1]",88
12,Waist-hip ratio [male],9
12,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),25395
12,Psoriasis or type 2 diabetes (trans-disease meta-analysis),26097
12,C-reactive protein levels or triglyceride levels (pleiotropy),975
12,Low tan response,180
12,Electrocardiogram morphology (amplitude at temporal datapoints) [322 ms],542
12,"Hip circumference [EA, men]",164
12,Pediatric autoimmune diseases,25800
12,Total body bone mineral density (age 45-60),9514
12,Waist circumference adjusted for BMI in active individuals [EA],29402
12,Respiratory or ear-nose-throat disease,27102
12,Response to fenofibrate (adiponectin levels) [Response],2594
12,Colorectal cancer [East Asian],2136
12,Serum metabolite levels [glutamine],6355
12,Brain region volumes [right entorhinal],1989
12,Myocardial fractal dimension (slice 5),104
12,Migraine and/or diastolic blood pressure,82
12,Smoking initiation (ever regular vs never regular),97615
12,LDL cholesterol levels,32207
12,"Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)",37959
12,Low density lipoprotein cholesterol levels [EA],6439
12,Left ventricle diastolic internal dimension,446
12,Electrocardiogram morphology (amplitude at temporal datapoints) [196 ms],125
12,Haematocrit percentage,42551
12,Asthma [conditional],25923
12,Snoring [adjusted for BMI],25879
12,Bipolar disorder vs anorexia nervosa (ordinary least squares (OLS)),851
12,Electrocardiogram morphology (amplitude at temporal datapoints) [332 ms],84
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-168 ms],71
12,Serum levels of protein SMIM13,35
12,Positive affect,25111
12,Snoring,46334
12,Heel bone mineral density T score,235320
12,"Sphingomyelin (d18:1/22:1, d18:2/22:0, d16:1/24:1) levels",324
12,Serum levels of protein MANSC1,1886
12,Protein quantitative trait loci (liver) [PLD3],126
12,Male puberty timing (early vs. average onset facial hair),52
12,Other and unspecified corneal deformities and disorders,15
12,Self-reported math ability,177156
12,Electrocardiogram morphology (amplitude at temporal datapoints) [152 ms],28592
12,Body mass index and triglycerides (pairwise),18898
12,Smoking behaviour (cigarettes smoked per day),692
12,Cortical volume [Global],1039
12,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],2998
12,Ischemic stroke (large artery atherosclerosis) [EA],453
12,Graves' disease,405
12,High blood pressure | vascular/heart problems diagnosed by doctor,66299
12,Brinzolamide | treatment/medication code,1196
12,Serum levels of protein C1R,2460
12,Remission after SSRI treatment in MDD or neuroticism,419
12,Facial morphology (segment 13),47
12,Insomnia,96260
12,Dyslipidemia,4283
12,Tofu consumption,260
12,C-reactive protein levels [BMI-adjusted],5534
12,Electrocardiogram morphology (amplitude at temporal datapoints) [170 ms],19875
12,IgD- CD27- B cell Absolute Count,803
12,Cardiac arrhytmias,68
12,Subcortical volume (MOSTest),48611
12,Electrocardiogram morphology (amplitude at temporal datapoints) [114 ms],19875
12,PR interval [Hispanic],71
12,Non-albumin protein levels,15775
12,Serum levels of protein LYZ,26152
12,Trunk predicted mass,187108
12,Bipolar disorder vs ADHD (ordinary least squares (OLS)),8602
12,Serum levels of protein RHOD,957
12,Serum levels of protein ICAM2,509
12,Cancer (pleiotropy),141
12,Waist circumference adjusted for BMI in active individuals,29477
12,Dentate gyrus molecular layer volume,6611
12,Hypospadias (moderate to severe),20864
12,"Hayfever, allergic rhinitis or eczema | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",38955
12,Fasting insulin,22041
12,CD27 on CD24+ CD27+ B cell,529
12,Hippurate levels,6620
12,Serum levels of protein CASC4,5658
12,Mood instability,1203
12,Atrial fibrillation [Japanese],64
12,"Retinal artery/vein occlusion | non-cancer illness code, self-reported",234
12,Goiter,91
12,"Systolic blood pressure x alcohol consumption interaction (2df test) [Asian, EA]",299
12,Neutrophill percentage,127265
12,"Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)",7277
12,Other coagulation defects,120
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-182 ms],273
12,Serum levels of protein PLXNC1,292
12,"Energy expenditure [Women, Lean]",148
12,Gut microbiota abundance (genus Faecalibacterium id.2057),27
12,Lymphocyte count,9210
12,Spherical equivalent (joint analysis main effects and education interaction) [European ancestry],872
12,"Systolic blood pressure x alcohol consumption interaction (2df test) [EA, Hispanic]",2007
12,Serum levels of protein B4GALT2,670
12,PR interval [AA],189
12,Vertigo,80
12,Body fat distribution (leg fat ratio),15056
12,Mean arterial pressure x alcohol consumption interaction (2df test) [EA],2426
12,Systolic blood pressure (cigarette smoking interaction),1417
12,Metabolic traits [glutamine + 7 other traits],3535
12,Breast cancer (estrogen-receptor negative),1184
12,Protein quantitative trait loci (liver) [ANXA6],49
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-186 ms],273
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-338 ms],71
12,Red blood cell count,940813
12,Lysophosphatidylethanolamine_22:6_[M-H]1- levels,6075
12,Electrocardiogram morphology (amplitude at temporal datapoints) [306 ms],626
12,Facial morphology (segment 9),2682
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-20 ms],822
12,"Mean arterial pressure x alcohol consumption interaction (2df test) [EA, Hispanic]",1456
12,Waist-hip ratio,191100
12,Amygdala volume,11762
12,"Heel bone mineral density (bmd) t-score, automated (left)",1927
12,Electrocardiogram morphology (amplitude at temporal datapoints) [304 ms],626
12,Phospholipase D3 measurement,3069
12,Unspecified monoarthritis,34842
12,Arm fat mass (right),79792
12,Red blood cell (erythrocyte) distribution width,168374
12,Major coronary heart disease event,1353
12,Body mass index (joint analysis main effects and physical activity interaction) [EA],1846
12,Natto consumption,260
12,Other/unspecified seropositiverheumatoid arthritis,510
12,Cortical surface area (global PC1),254
12,Electrocardiogram morphology (amplitude at temporal datapoints) [250 ms],125
12,Intraocular pressure,12192
12,Past tobacco smoking,22307
12,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),64121
12,Doctor diagnosed asthma,5001
12,"Diabetes | non-cancer illness code, self-reported",925
12,"Blood protein levels [CNTN1, 2974_61_2]",196
12,Alzheimer's disease (cognitive decline),84
12,Intestinal malabsorption (non-celiac),446
12,Adverse response to drug [Macrolides [J01FA]],140
12,Phlebitis and thrombophlebitis (not including DVT),306
12,Body fat percentage and HDL-C (pairwise),16813
12,Mean corpuscular hemoglobin concentration,385456
12,Major depressive disorder,47490
12,Serum levels of protein CD7,4216
12,Gallstone disease,6167
12,Parkinson's disease or first degree relation to individual with Parkinson's disease,4202
12,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [5-hydroxyhexanoate, ethylmalonate, N-formylmethionine, triacetate lactone]",3131
12,"Chronic obstructive airways disease/copd | non-cancer illness code, self-reported",462
12,Response to statin therapy,957
12,Varicose veins of other sites,780
12,Electrocardiogram morphology (amplitude at temporal datapoints) [338 ms],84
12,Electrocardiogram morphology (amplitude at temporal datapoints) [220 ms],125
12,Electrocardiogram morphology (amplitude at temporal datapoints) [234 ms],125
12,Vertical cup-disc ratio (adjusted for vertical disc diameter),7200
12,Preeclampsia (maternal genotype effect),419
12,Cortical surface area [Superior Parietal],249
12,LDL cholesterol levels [Trans-ethnic initial],4930
12,CD14- CD16- Absolute Count,103
12,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),5247
12,Urate levels [Urate],2940
12,Blood metabolite ratios [betaine/pyroglutamine],1207
12,Hyperlipidemia,6294
12,Electrocardiogram morphology (amplitude at temporal datapoints) [172 ms],19875
12,Electrocardiogram morphology (amplitude at temporal datapoints) [246 ms],8967
12,"High cholesterol | non-cancer illness code, self-reported",13720
12,B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio,4216
12,"Blood protein levels [LAG3, 9950_229_3]",774
12,Urinary metabolite levels in chronic kidney disease [3-aminoisobutyrate],1207
12,STROKE,553
12,Survival in progressive supranuclear palsy,481
12,Protein quantitative trait loci (liver) [IGHM],298
12,Actinic keratosis,147
12,Fibrinogen levels,38814
12,Lifetime smoking index,35151
12,Insomnia [Female],94415
12,Glioma,1426
12,HATA volume,2113
12,Atorvastatin | treatment/medication code,1221
12,Blood urea nitrogen levels,68555
12,Irritability,10896
12,Homocysteine levels,4458
12,Serum levels of protein CLEC6A,8170
12,Ceramide_42:2_[M+H]1+ levels,4555
12,Serum levels of protein CST5,57341
12,Red blood cell (erythrocyte) count,133267
12,Diastolic blood pressure (cigarette smoking interaction),1417
12,Coeliac disease,470
12,Invasive breast cancer [mixed effect],103
12,Colorectal cancer,132307
12,Cognitive ability (MTAG),94335
12,Coffee consumption,38362
12,acne vulgaris,3932
12,Fish- and plant-related diet [female],710
12,Serum C-reactive protein concentration in visceral obesity (waist circumference),4664
12,Serum metabolite levels [carotene diol (1],47
12,Endometrial cancer,682
12,Serum levels of protein SERPINA9,2341
12,Permanent tooth development,249
12,"Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",616
12,Bitter alcoholic beverage consumption,3315
12,CHKCI006 sp900018345 abundance in stool,592
12,Co-amilofruse | treatment/medication code,184
12,Electrocardiogram morphology (amplitude at temporal datapoints) [4 ms],166
12,Stool frequency,42
12,Age of smoking initiation (MTAG),22991
12,Inflammatory skin disease [Psoriasis],25183
12,Myocardial infarction,19970
12,Metabolite levels [LPE 20:4],957
12,Heart disease | illnesses of father,419
12,CD4 on CD4+ T cell,1626
12,Serum levels of protein DGKB,670
12,Folic acid or folate (vit b9) | vitamin and mineral supplements,344
12,"Prolapsed disc/slipped disc | non-cancer illness code, self-reported",30
12,Educational attainment (MTAG) [MTAG],289503
12,Mouth ulcers,2834
12,Fluid intelligence score,8869
12,Total bilirubin levels,46663
12,Response to SSRI in MDD or conscientiouness,681
12,Serum levels of protein CAPN1;CAPNS1,1259
12,Bilirubin levels [Total bilirubin],2720
12,Mammographic density (non-dense area),46
12,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),15815
12,Cholesteryl ester_17:0_[M+NH4]1+ levels,5051
12,Gallbladder disease,6149
12,Sphingomyelin_36:2_[M+OAc]1- levels,4664
12,Sitting height,239563
12,GDP-fucose protein O-fucosyltransferase 1 measurement,1270
12,Colorectal cancer [EA],932
12,Blood metabolite levels [X-11538],1017
12,"Systolic blood pressure x alcohol consumption interaction (2df test) [AA, Asian, EA]",537
12,Heart rate variability traits (RMSSD) [Hispanic],75
12,White matter microstructure (fractional anisotropy) [Splenium of corpus callosum],66
12,Anxiety,280
12,Lung function (FEV1) [adults],1460
12,Loneliness,13803
12,Osteoarthritis of the hand,21956
12,Sociability score,9731
12,Dilzem sr 60mg long acting m/r capsule | treatment/medication code,2286
12,Mitochondrial DNA levels,1736
12,Electrocardiogram morphology (amplitude at temporal datapoints) [326 ms],542
12,Pulmonary embolism,319
12,Electrocardiogram morphology (amplitude at temporal datapoints) [228 ms],125
12,Brain region volumes [left insula],121
12,Medial thalamic nuclei volume,66
12,"""Hypothyroidism,  other/unspecified""",26198
12,Protein quantitative trait loci (liver) [GARS],2864
12,Heel broadband ultrasound attenuation (left),880
12,Insomnia symptoms (never/rarely vs. sometimes/usually),873
12,Adverse response to drug [Acetic acid derivatives and related substances [M01AB]],812
12,Global electrical heterogeneity phenotypes [SVG magnitude],103
12,Myeloid white cell count,67416
12,Schizophrenia vs bipolar disorder (ordinary least squares (OLS)),12255
12,Haemorrhoidal disease,4278
12,"1,5-anhydroglucitol (1,5-ag) levels",2771
12,T wave morphology restitution during exercise,125
12,Electrocardiogram morphology (amplitude at temporal datapoints) [186 ms],125
12,Sum eosinophil basophil counts,41783
12,Cutaneous squamous cell carcinoma,720
12,Serum levels of protein BPIFA2,63895
12,Electrocardiogram morphology (amplitude at temporal datapoints) [104 ms],20418
12,Itch intensity from mosquito bite,3886
12,Interleukin-27 levels,2174
12,None of the above | vitamin and mineral supplements,4230
12,Cutaneous malignant melanoma,2156
12,Xenical 120mg capsule | treatment/medication code,3066
12,Attention deficit hyperactivity disorder,316
12,T wave morphology restitution during recovery from exercise (MTAG),130
12,C-reactive protein,61847
12,Breast cancer,39699
12,Medial temporal lobe substructure volumes [right Brodmann area 36],9439
12,Blood metabolite levels [X-13429],1017
12,"""Coxarthrosis, primary, with hip surgery""",571
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-54 ms],202
12,Electrocardiogram morphology (amplitude at temporal datapoints) [12 ms],62
12,Household income (MTAG),87074
12,Gamma-glutamyl hydrolase measurement,10369
12,Other joint disorders,60704
12,Rocuronium dose requirement in breast cancer surgery,2233
12,Diastolic blood pressure [EA],18011
12,Serum metabolite levels [glycochenodeoxycholate glucuronide (1],2878
12,Protein quantitative trait loci (liver) [CNN3],4186
12,"Blood protein levels [COCH, 7227_75_3]",1297
12,Parental longevity (father's attained age),518
12,Corneal resistance factor (left),171
12,COVID-19 (very severe respiratory confirmed vs population) RELEASE 5,58499
12,"Hypothyroidism/myxoedema | non-cancer illness code, self-reported",22141
12,T-cell surface glycoprotein CD4 levels,1674
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-6 ms],166
12,Heart rate response to recovery post exercise (50 sec),329
12,Electrocardiogram morphology (amplitude at temporal datapoints) [192 ms],125
12,"Allergic disease (asthma, hay fever and/or eczema) (age of onset)",37959
12,"Pulse pressure [EA, initial]",655
12,Wheeze or whistling in the chest in last year,1179
12,Electrocardiogram morphology (amplitude at temporal datapoints) [0 ms],166
12,Glomerular filtration rate,1911
12,Hemoglobin A1c levels,31353
12,"Blood protein levels [ENDOU, 5656_53_3]",2690
12,Type 1 diabetes without complications,21445
12,Peripheral artery disease,1519
12,"Blood protein levels [DHFR, 9823_2_3]",1671
12,Alanine transaminase levels,158
12,Hard cardiovascular diseases,474
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-32 ms],167
12,Agouti-related protein levels,73
12,Pyridoxal levels,7
12,"Forced expiratory volume in 1-second (fev1), best measure",92858
12,Arthropathies,1428
12,Inflammatory bowel disease,12477
12,Thyroxine product | treatment/medication code,446
12,Cortical surface area [Superior Frontal],668
12,Prostate cancer | illnesses of father,5527
12,Urinary metabolite levels in chronic kidney disease [X - 21470],957
12,Serum levels of protein CCL28,2998
12,Central retinal vein equivalent,583
12,Response to olanzapine in schizophrenia,405
12,"Eye color [EA, discovery]",19
12,Allergic sensitization,2358
12,Red blood cell fatty acid levels [LA],10735
12,Diabetes mellitus,3537
12,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant I (Philtrum), Segment 37]",1799
12,Chronic pancreatitis,262
12,Fibrinogen [EA],14228
12,Cortical surface area,204912
12,Chronic diseases of tonsils and adenoids,2987
12,Spine bone size,1038
12,Serum levels of protein SCGB1A1,670
12,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],1227
12,Glucosamine product | treatment/medication code,305
12,Hippocampal subfield CA1 volume (corrected for total hippocampal volume),52
12,Body mass index (joint analysis main effects and physical activity interaction),1846
12,"Diastolic blood pressure, automated reading",78400
12,"Asthma | non-cancer illness code, self-reported",42146
12,Nonsyndromic cleft lip,3082
12,Inflammatory bowel disease [EA],3488
12,T wave morphology restitution during exercise (MTAG),125
12,High blood pressure | illnesses of siblings,446
12,"Allergy, hypersensitivity or anaphylaxis",2098
12,Serum levels of protein MGAT2,1781
12,PDL-1 on CD14- CD16-,103
12,Stroke [ischemic stroke],58
12,Sodium in urine,36
12,Other disorders of liver,61
12,Medication use (anilides),5783
12,"""Atopic dermatitis, strict definition with reimbursement""",397
12,Electrocardiogram morphology (amplitude at temporal datapoints) [34 ms],202
12,Von Willebrand disease,102
12,"Spontaneous pneumothorax/recurrent pneumothorax | non-cancer illness code, self-reported",103
12,Electrocardiogram morphology (amplitude at temporal datapoints) [216 ms],125
12,Serum total protein level,125698
12,Blood pressure [MAP],580
12,"Blood protein levels [MANSC1, 9557_5_3]",1886
12,Immune reponse to smallpox (secreted IFN-alpha) [AA],293
12,G_Alloprevotella abundance,28
12,Basal metabolic rate,159508
12,Hip circumference adjusted for BMI [EA],75483
12,"Hypertension | non-cancer illness code, self-reported",65151
12,Medication use (HMG CoA reductase inhibitors),12892
12,"Ibuprofen (e.g. nurofen) | medication for pain relief, constipation, heartburn",3485
12,Intracranial volume,177
12,Blood metabolite ratios [glutamine/histidine],3436
12,"Blood protein levels [EA, Cathepsin Z]",1237
12,Serum metabolite levels [alpha-tocopherol],47
12,Facial morphology (segment 5),104
12,Chorioretinal inflammation,11
12,Osteoarthritis (with total knee replacement),9331
12,Icd10: g12.2 motor neuron disease | underlying (primary) cause of death,506
12,3mm weak meridian angle (right),260
12,Estimated glomerular filtration rate [EA],3129
12,White matter microstructure (global fractional anisotropy),123
12,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction),16014
12,Leg fat mass and leg lean mass (pleiotropy),14644
12,Whole body fat mass,89579
12,Cortical surface area [Inferior Parietal],1101
12,Systolic blood pressure x alcohol consumption interaction (2df test) [EA],3229
12,Often | worked with pesticides,1521
12,Methotrexate pharmacokinetics (acute lymphoblastic leukemia),1086
12,CD4 on Effector Memory CD4+ T cell,1180
12,Injuries to the thorax,511
12,Pork consumption,710
12,Plasma free amino acid levels [Leu],29
12,Electrocardiogram morphology (amplitude at temporal datapoints) [150 ms],35349
12,Metabolite levels [C3/C4],3131
12,Chronic obstructive pulmonary disease or high blood pressure (pleiotropy),1046
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-178 ms],273
12,Brain region volumes [right inferior lateral ventricle],5
12,Type 1 diabetes,454899
12,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test) [EA],17690
12,"Blood pressure medication | medication for cholesterol, blood pressure or diabetes",3589
12,Sphingomyelin_36:2_[M+H]1+ levels,4664
12,Protein quantitative trait loci (liver) [AK3],18
12,Ebbinghaus illusion (underestimation),35
12,Oxalate (ethanedioate) levels,4854
12,Migraine and/or pulse pressure,3485
12,Serum uric acid levels [EA],2811
12,Height [female],1041
12,Vitamin E levels,127
12,Electrocardiogram morphology (amplitude at temporal datapoints) [204 ms],125
12,Physical activity (Principal component 2),1830
12,Serum levels of protein HBEGF,132
12,Fruit consumption,426
12,Essential hypertension (time to event),7
12,Medication use (calcium channel blockers),23799
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-84 ms],71
12,Unspecified diabetes without complications,60
12,Loose teeth | mouth/teeth dental problems,11948
12,Arm fat percentage (right),50293
12,Primary biliary cirrhosis,12020
12,Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event),46
12,DVT of lower extremities,254
12,Adcal 600mg chewable tablet | treatment/medication code,636
12,Osteoarthritis of the hip (with total joint replacement),447
12,Serum creatinine levels,27913
12,Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis),37778
12,Electrocardiogram morphology (amplitude at temporal datapoints) [92 ms],19750
12,Cognitive function,2808
12,Glycemic traits [1-hPG],2125
12,Erythritol levels,1777
12,Neurological disease,3485
12,White blood cell count (eosinophil),584
12,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),327
12,Alcohol consumption x traumatic event in childhood (felt hated by family member) interaction,36
12,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test),4166
12,Electrocardiogram morphology (amplitude at temporal datapoints) [106 ms],20418
12,Serum metabolite levels [1-linoleoyl-GPG (18:2)*],2771
12,Yes | breathing problems responsible for leaving job,69
12,Agoraphobia | mental health problems ever diagnosed by a professional,6615
12,Amyotrophic lateral sclerosis,3829
12,Brain region volumes [right hippocampus],2041
12,QRS duration [EA],274
12,Light vs. dark hair color,120
12,Serum levels of protein COCH,77
12,Malignant neoplasm of skin,161
12,Tonsillectomy,7286
12,Monocyte percentage,13532
12,"Blood protein levels [HNRNPM, 12783_29_3]",4070
12,C-reactive protein and white blood cell count [CRP],4664
12,Facial morphology (forehead protrusion 1),248
12,Protein quantitative trait loci (liver) [ME1],534
12,"Light brown | hair colour (natural, before greying)",1188
12,Protein levels in obesity [CATZ],1781
12,Fat-free mass,9158
12,"""Gonarthrosis,primary""",269
12,Serum C-reactive protein concentration in low fat diet,4664
12,Electrocardiogram morphology (amplitude at temporal datapoints) [118 ms],19535
12,Peritonsillar abscess,3350
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-38 ms],306
12,White blood cell count (basophil),12755
12,Mean corpuscular hemoglobin,852065
12,Total cholesterol levels [Trans-ethnic initial],7210
12,College or university degree | qualifications,116041
12,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),2856
12,Waist-to-hip ratio adjusted for BMI (age >50) [women],2175
12,Urinary metabolite levels in chronic kidney disease [X - 21467],1017
12,Panic disorder,348
12,CD4+ T cell Absolute Count,446
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-4 ms],166
12,Number of vehicles in household,54
12,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)",85447
12,Standing height,351102
12,Alcohol consumption (drinks per week),11338
12,Height [Conditioned on rs11107116],2104
12,Cortical surface area [Pericalcarine],253
12,Electrocardiogram morphology (amplitude at temporal datapoints) [20 ms],166
12,Protein quantitative trait loci (liver) [BPNT1],7
12,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),6090
12,Nonatopic asthma and/or BMI,22482
12,Endometriosis,18520
12,Diastolic blood pressure x smoking status (ever vs never) interaction (2df test) [EA],9539
12,Complement C1s subcomponent measurement,3948
12,Serum levels of protein GGH,1781
12,Processed meat consumption,229
12,Serum levels of protein PKN1,2460
12,Beta electroencephalogram power,4
12,"Type 2 diabetes | non-cancer illness code, self-reported",63
12,Electrocardiogram morphology (amplitude at temporal datapoints) [158 ms],28502
12,Waist circumference adjusted for BMI in non-smokers [women],14734
12,Electrocardiogram morphology (amplitude at temporal datapoints) [78 ms],1300
12,Polyarthropathies,446
12,"Red blood cell traits [EA, RBCC]",328
12,Bipolar disorder,28313
12,HDL cholesterol levels [BMI adjusted],47899
12,Serum C-reactive protein concentration in visceral obesity (waist-hip ratio),6235
12,Exhaled nitric oxide levels,17319
12,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) [5 degree of freedom test]",851
12,Childhood asthma (age<16),161
12,Gut microbiota relative abundance (bacterial taxa) [Aestuariispira],7
12,Variation in diet,14403
12,Barrett's esophagus,111
12,"For short-sightedness, i.e. only or mainly for distance viewing such as driving, cinema etc (called 'myopia') | reason for glasses/contact lenses",872
12,"""Haemangioma and lymphangioma, any site (controls excluding all cancers)""",114
12,Insulin-like growth factor 1 levels,243136
12,Finger osteoarthritis,21956
12,Electrocardiogram morphology (amplitude at temporal datapoints) [86 ms],19750
12,Amlodipine | treatment/medication code,6020
12,Ganglion cell inner plexiform layer (GCIPL) thickness,583
12,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction) [women],877
12,Shoulder lesions,15
12,Electrocardiogram morphology (amplitude at temporal datapoints) [214 ms],125
12,Morning vs. evening chronotype,7307
12,"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment",21603
12,CD4 on monocyte,7972
12,Latent autoimmune diabetes vs. type 2 diabetes,446
12,Protein quantitative trait loci (liver) [SERPINF1],24
12,Serum 25-Hydroxyvitamin D levels,124315
12,White blood cell (leukocyte) count,83305
12,Blood protein levels [CMRF35-like molecule 6],5693
12,Abdominal aortic aneurysm,3461
12,Lichen simplex chronicus and prurigo,1656
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-170 ms],71
12,Epithelial ovarian cancer,5277
12,Neutrophil count,581223
12,Body fat distribution (trunk fat ratio),88624
12,Glycine levels,4020
12,Ascending aorta maximum area,3369
12,Electrocardiogram morphology (amplitude at temporal datapoints) [244 ms],8967
12,Protein quantitative trait loci (liver) [CLIC1],4186
12,Matrix metalloproteinase-1 levels,16678
12,Subcutaneous adipose tissue,299
12,"""Malignant neoplasm of breast, HER2-negative""",772
12,Diabetes mellitus in pregnancy,140
12,Body fat percentage or coronary artery disease (MTAG),4216
12,Serum levels of protein INHBB,2940
12,Hippocampal volume [EA],2483
12,Pulse rate,2324
12,Eosinophil counts [EA],433
12,Heart rate response to recovery post exercise (40 sec),329
12,Protein quantitative trait loci (liver) [LRRK2],12
12,Cortical surface area (MOSTest),11094
12,Urate levels [women],20156
12,"Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",1766
12,Osteoarthrosis,276
12,Relative age of first facial hair,14180
12,6mm strong meridian (right),20320
12,Medication use (antihistamines for systemic use),1990
12,Depressive symptoms (binary sum-score),2112
12,Respiratory diseases,27062
12,Triglyceride levels [Trans-ethnic initial],17595
12,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],15750
12,Waist circumference [EA],2357
12,Celiac disease or Rheumatoid arthritis,474
12,Plasma plasminogen activator levels,16730
12,Bitter taste perception [Quinine],150181
12,C-reactive protein measurement,5917
12,"""Ischaemic heart disease, wide definition""",474
12,Gamma glutamyl transferase levels in low alcohol consumption,5917
12,Serum levels of protein UGP2,1412
12,Headache [allelic],328
12,Circulating plasma alpha-Klotho levels,2500
12,Facial morphology (segment 7),399
12,Osteoarthritis; localized,276
12,Protein quantitative trait loci (liver) [UGDH],4
12,Leg fat-free mass (left),120765
12,"Medication use (anti-inflammatory and antirheumatic products, non-steroids)",6554
12,Serum metabolite levels [isobutyrylglycine],6147
12,CD4 on CD4 regulatory T cell,1180
12,Excessive alcohol consumption,1362
12,Diastolic blood pressure [Hispanic],467
12,Comparative body size at age 10,45931
12,Sensitivity / hurt feelings,9978
12,Cancer (pleiotropy) [subset analysis],5832
12,Risk-taking tendency (4-domain principal component model),106
12,Serum levels of protein CTSZ,1781
12,"""Postprocedural musculoskeletal disorders, not elsewhere classified""",12
12,Serum albumin levels,103814
12,Electrocardiogram morphology (amplitude at temporal datapoints) [140 ms],19660
12,Medication use (vasodilators used in cardiac diseases),3185
12,"Blood protein levels [SCIN, 12684_5_3]",2460
12,Serum levels of protein RPIA,1259
12,Metformin | treatment/medication code,216
12,Body mass index [Japanese],14965
12,"""Hypothyroidism, levothyroxin purchases""",446
12,Osteoarthritis of the hip or knee,7377
12,Serum levels of protein PPT1,1445
12,Serum metabolite concentrations in chronic kidney disease [Butyrylcarnitine / Isobutyrylcarnitine],3131
12,Atenolol | treatment/medication code,446
12,HLA DR on CD14+ monocyte,103
12,"""Excessive, freguent and irrelgular menstruation""",191
12,Electrocardiogram morphology (amplitude at temporal datapoints) [262 ms],125
12,Smoking initiation,63973
12,"Other professional qualifications eg: nursing, teaching | qualifications",60551
12,Electrocardiogram morphology (amplitude at temporal datapoints) [130 ms],20758
12,Leg predicted mass (left),123297
12,"""Diabetes, insuline treatment (Kela reimbursement)""",23440
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-16 ms],3640
12,"None of the above | medication for pain relief, constipation, heartburn",3809
12,Glaucoma (primary open-angle) [European],424
12,QRS duration [European],271
12,Biological sex,153498
12,Electrocardiogram morphology (amplitude at temporal datapoints) [112 ms],19535
12,Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis),14996
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-56 ms],202
12,Electrocardiogram morphology (amplitude at temporal datapoints) [318 ms],84
12,Curvature of spine,339
12,Whooping cough,15
12,Venous thromboembolism,64434
12,Bitter taste perception (multivariate analysis) [quinine and sucrose octaacetate],147851
12,Leg fat percentage (left),76490
12,Hashimoto thyroiditis,6849
12,N-glycan levels [GP15],4619
12,Waist circumference adjusted for body mass index [East Asian],822
12,Cutaneous melanoma or hair colour,511
12,Broad depression or bipolar disorder,29
12,Hip circumference variance,14804
12,Age asthma diagnosed,13114
12,Aortic aneurysm,2622
12,Deep venous thrombosis,1605
12,Arthritis (juvenile idiopathic),446
12,Allergic asthma (mode),96
12,Ankylosing spondylitis,36471
12,Bilirubin levels,80880
12,Waist-to-hip ratio adjusted for body mass index [women],37819
12,Electrocardiogram morphology (amplitude at temporal datapoints) [176 ms],28515
12,Offspring birth weight,9985
12,"Blood protein levels [HSP90B1, 6393_63_3]",4070
12,Lung cancer,3752
12,HLA DR on CD14+ CD16- monocyte,103
12,Psoriasis,152789
12,HDL cholesterol levels x short total sleep time interaction (2df test),19181
12,Mean corpuscular haemoglobin,111116
12,Type 2 diabetes [Japanese],1484
12,Osteoarthritis (with total hip replacement),631
12,Body mass index (joint analysis main effects and smoking interaction),2220
12,"Body mass index in physically active individuals [EA,women]",2079
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-28 ms],2621
12,Brain structure [Intracranial volume],164
12,Brain region volumes [right lateral ventricle],66
12,Appendicular lean mass,840385
12,Leisure sedentary behaviour (television watching),27407
12,KELA_REIMBURSEMENT_202,446
12,"Other chronic ischemic heart disease, unspecified",446
12,Benign neoplasm of colon,30
12,"""Primary gonarthrosis, bilateral""",15
12,Lentimicrobiaceae abundance in stool,4
12,Doctor diagnosed hayfever or allergic rhinitis,3143
12,Complement C1r subcomponent-like protein measurement,5628
12,Serum levels of protein VWF,2274
12,Blood metabolite levels [butyrylcarnitine],3969
12,Renal cell carcinoma,3489
12,Periodontal disease-related phenotype (Socransky),300
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-112 ms],71
12,Schizophrenia [EA],26547
12,Electrocardiogram morphology (amplitude at temporal datapoints) [62 ms],20476
12,Esophageal cancer,1940
12,Plasma free amino acid levels (adjusted for one other PFAA) [Gln (adjusted for Ser],2337
12,Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer,1518
12,Waist-to-hip ratio adjusted for BMI in non-smokers,877
12,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test) [African],217
12,Blood metabolite levels [kynurenine],446
12,Hypothyroidism nos,27898
12,Cataracts,13504
12,"Blood protein levels [EA, Lysozyme C]",10082
12,"Blood protein levels [ART4, 6576_1_3]",43912
12,Hypertensive diseases,4780
12,Serum metabolite levels [beta-hydroxyisovalerate],9486
12,Other reason | reason for reducing amount of alcohol drunk,632
12,Male puberty timing (age at voice breaking MTAG),226
12,Periodontal disease related phenotype (PCT5),215
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-150 ms],202
12,CAG-632 abundance in stool,78
12,Heart rate response to recovery post exercise [males],5807
12,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],2856
12,Gout,39181
12,Serum metabolite levels [glycocholenate sulfate*],3732
12,"Yes, but not in the last year | ever been injured or injured someone else through drinking alcohol",39
12,Glaucoma,242
12,Electrocardiogram morphology (amplitude at temporal datapoints) [208 ms],125
12,Blood metabolite levels [X-12063],957
12,Lamb/mutton intake,1040
12,St john's wort/hypericum [ctsu] | treatment/medication code,85
12,Chronic obstructive pulmonary disease or resting heart rate (pleiotropy),177
12,Leg fat mass (right),77771
12,Statin medication,6221
12,Stem cell factor levels,1213
12,C-reactive protein [AA women],887
12,Plasma free amino acid levels (adjusted for one other PFAA) [Phe (adjusted for Gly],255
12,Alfacalcidol | treatment/medication code,305
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-94 ms],71
12,Electrocardiogram morphology (amplitude at temporal datapoints) [110 ms],20418
12,Pregnancy hypertension,521
12,Osteoarthritis (hip) [additive],509
12,"""Hypertension complicating pregnancy, childbirth, and the puerperium""",521
12,Brain region volumes [Brain stem],25502
12,Electrocardiogram morphology (amplitude at temporal datapoints) [144 ms],19875
12,Cerebrospinal fluid biomarker levels [X-linked interleukin-1 receptor accessory protein-like 2],1580
12,"""Disorders of gallbladder, biliary tract and pancreas""",6138
12,Ulcerative colitis,4255
12,Femur bone mineral density x serum urate levels interaction [male],1844
12,Medication use (drugs affecting bone structure and mineralization),1150
12,Pemphigus foliaceus,938
12,Kashin-Beck disease,1935
12,Mitochondrial heteroplasmy measurement,491
12,High light scatter reticulocyte percentage of red cells,472838
12,Chronotype,78863
12,Waist circumference adjusted for body mass index [EA],59593
12,"Body mass index [EA, women]",1846
12,Mood swings,780
12,Type 1 diabetes with other specified/multiple/unspecified complications,446
12,Protein quantitative trait loci (liver) [PYCARD],31
12,Tea consumption,39409
12,Hay fever and/or eczema,97999
12,Arm fat-free mass (right),180761
12,Cholelithiasis and cholecystitis,4664
12,Electrocardiogram morphology (amplitude at temporal datapoints) [28 ms],264
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-2 ms],166
12,Home location at assessment - east co-ordinate (rounded),546
12,Serum levels of protein FCN3,599
12,Smoking status,9999
12,Intrinsic epigenetic age acceleration,23915
12,Electrocardiogram morphology (amplitude at temporal datapoints) [88 ms],20633
12,Electrocardiogram morphology (amplitude at temporal datapoints) [94 ms],19750
12,Electrocardiogram morphology (amplitude at temporal datapoints) [56 ms],20758
12,Pre-treatment viral load in HIV-1 infection,1262
12,Senile cataract,9180
12,Obesity,2486
12,Facial morphology (segment 3),1170
12,Serum levels of protein LARGE1,1781
12,High-sensitivity C-reactive protein levels in HIV infection,2891
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-188 ms],273
12,Serum levels of protein PEBP1,242
12,MAP/microtubule affinity-regulating kinase 3 measurement,332
12,Medication use (antithrombotic agents),246
12,DNA methylation-estimated plasminogen activator inhibitor-1 levels,130
12,Diabetes | illnesses of father,39
12,Mean platelet volume,798171
12,Electrocardiogram morphology (amplitude at temporal datapoints) [96 ms],19750
12,Body mass index (bmi),183589
12,Breast size,2004
12,"None of the above | medication for cholesterol, blood pressure or diabetes",1551
12,Hypothyroidism and >3 levothyroxin purchases,446
12,"None of the above | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",446
12,Allergic asthma (mode) (more control exclusions),96
12,T wave morphology restitution during recovery from exercise,130
12,Hypertension,160182
12,Monocyte count,404805
12,Electrocardiogram morphology (amplitude at temporal datapoints) [180 ms],9182
12,"""Hypothyroidism, drug reimbursement""",446
12,"Waist circumference adjusted for body mass index [EA, men]",5573
12,Blood pressure [Mean Arterial Pressure],1129
12,"Blood protein levels [PMEL, 6472_40_3]",1097
12,Electrocardiogram morphology (amplitude at temporal datapoints) [10 ms],62
12,Pneumoconiosis in silica exposure,81
12,Gut microbiota relative abundance (bacterial taxa) [Blautia_stercoris],53
12,Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis),51
12,Longest period of depression,1
12,Mean corpuscular volume,1236809
12,Parental longevity (combined parental age at death),513
12,Forced vital capacity (fvc),103425
12,Serum metabolite ratios in chronic kidney disease [Butyrylcarnitine / Isobutyrylcarnitine/Isovalerylcarnitine / 2-Methylbutyrylcarnitine / Valerylcarnitine],3131
12,Migraine without aura and/or pulse pressure,3485
12,Complement component C8 gamma chain measurement,9
12,Cerebrospinal AB1-42 levels in normal cognition,8
12,Angina pectoris,3120
12,Serum levels of protein MDH1,1222
12,CD27 on memory B cell,686
12,Protein quantitative trait loci (liver) [ALDOA],8
12,Intracranial trauma,10
12,Serum levels of protein COL1A1,10905
12,"Pulse rate, automated reading",49842
12,Ossification of the posterior longitudinal ligament of the spine,2478
12,Urinary metabolite levels in chronic kidney disease [glycodeoxycholate sulfate],840
12,Two-hour glucose,4543
12,Electrocardiogram morphology (amplitude at temporal datapoints) [190 ms],125
12,Response to esketamine in treatment resistant depression,42
12,Lateral ventricular volume in normal aging,60
12,Serum levels of protein APOF,25700
12,NT-proBNP levels in acute coronary syndrome,4216
12,Pulse wave arterial stiffness index,1496
12,Serum metabolite ratios in chronic kidney disease [Propionylcarnitine/Butyrylcarnitine / Isobutyrylcarnitine],3131
12,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),24979
12,"None of the above | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",91746
12,Energy intake [Men],421
12,Glucosamine | mineral and other dietary supplements,243
12,Serum levels of protein PSAP,1423
12,Obstructive sleep apnea (BMI adjusted),2
12,"Cholesterol, total",33312
12,Systolic blood pressure,370987
12,Waist circumference variance,14532
12,(N(1) + N(8))-acetylspermidine levels,986
12,Myeloproliferative neoplasms,446
12,QRS complex (Sokolow-Lyon) [EA],104
12,Psoriasis vulgaris,25700
12,Heel bone mineral density (MTAG),6744
12,Cortical thickness (MOSTest),13849
12,Serum levels of protein CTSD,1781
12,Lysophosphatidylethanolamine_20:4_[M-H]1- levels,6075
12,LDL cholesterol levels in current drinkers [EA],5307
12,Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy) [EA],134
12,Facial ageing,166
12,Basal cell carcinoma,12265
12,Headaches for 3+ months,3485
12,"Cholesterol lowering medication | medication for cholesterol, blood pressure or diabetes",6167
12,Highest math class taken,106265
12,"Diastolic blood pressure x alcohol consumption interaction (2df test) [AA, EA]",1677
12,"Forced vital capacity (fvc), best measure",145145
12,Gut microbiota abundance (family Streptococcaceae id.1850),16304
12,Disorders of sweat glands,1532
12,Vitamin b12  | vitamin and/or mineral supplement use,1302
12,Bacteroides A plebeius A abundance in stool,372
12,Malignant neoplasm of testis (controls excluding all cancers),885
12,Gastric cancer,676
12,"Allergic disease (asthma, hay fever or eczema)",81703
12,High density lipoprotein cholesterol levels [EA],82223
12,Creatinine levels,173533
12,Thyroid problem (not cancer),30840
12,A levels/as levels or equivalent | qualifications,85493
12,"Blood protein levels [VWF, 3050_7_2]",1671
12,Metabolic traits [SM-1 + 12 other traits],3969
12,Glucuronate levels,3200
12,No | hearing difficulty/problems,11268
12,None of the above | vascular/heart problems diagnosed by doctor,51300
12,Tafenoquine efficacy in P. vivax malaria (recurrence by 4 months),62
12,Extraversion,106
12,Sum neutrophil eosinophil counts,67342
12,Waist-to-hip ratio adjusted for BMI in active individuals [EA],15979
12,Cortical thickness,177511
12,Electrocardiogram morphology (amplitude at temporal datapoints) [66 ms],19750
12,Urinary metabolite levels in chronic kidney disease [glycochenodeoxycholate glucuronide (1],1017
12,Serum levels of protein VEGFC,1755
12,Serum levels of protein PMEL,1097
12,Gout vs. Hyperuricemia,260
12,Progressive supranuclear palsy,405
12,Renal function-related traits (sCR),174
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-48 ms],202
12,"""Diabetes, varying definitions""",2408
12,Electrocardiogram morphology (amplitude at temporal datapoints) [222 ms],125
12,Disc problem,30
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-58 ms],202
12,Hematocrit,545862
12,Hemoglobin concentration,439665
12,Theophylline levels,3792
12,Electrocardiogram morphology (amplitude at temporal datapoints) [48 ms],1210
12,Body fat distribution (arm fat ratio) [females],2486
12,Serum metabolite levels [pregnenolone sulfate],844
12,Type 2 diabetes without complications,1742
12,Electrocardiogram morphology (amplitude at temporal datapoints) [230 ms],125
12,Fractured/broken bones in last 5 years,20175
12,Blood pressure [Diastolic],895
12,Ventolin 100micrograms inhaler | treatment/medication code,2137
12,Bilirubin levels [Direct bilirubin],2720
12,"Bone mineral density (paediatric, lower limb)",136
12,"Blood protein levels [PEBP1, 4276_10_2]",242
12,DVT of lower extremities and pulmonary embolism,206
12,Nevus count [fixed effects],823
12,Systolic blood pressure x sodium interaction (2df test),255
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-10 ms],62
12,Diastolic blood pressure,587080
12,Neutrophil-to-lymphocyte ratio,126533
12,Sphingomyelin_38:2_[M+OAc]1- levels,4664
12,Serum levels of protein PZP,1447
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-14 ms],62
12,Protein quantitative trait loci (liver) [FERMT2],6
12,Brain structure [Mean bilateral hippocampal volume],2042
12,Fasting plasma glycodeoxycholate 3-O-glucuronide concentration,957
12,Metabolite levels (small molecules and protein measures) [Alanine],574
12,Electrocardiogram morphology (amplitude at temporal datapoints) [218 ms],125
12,Bitter taste perception (multivariate analysis) [quinine and denatonium benzoate],147851
12,Serum levels of protein AMY1A,153594
12,Walking for pleasure (not as a means of transport) | types of physical activity in last 4 weeks,58860
12,Osteoarthritis (hip),16137
12,Metabolite levels [beta aminoisobutyric acid],4380
12,Other arthropathies,604
12,Blood metabolite levels [tetradecanedioate],1017
12,Lipoprotein (a) levels,1194
12,Malignant neoplasm of testis,947
12,Hair color,98423
12,Waist-to-hip ratio adjusted for BMI (additive genetic model),58659
12,Atrial fibrillation/atrial flutter,23171
12,Serum levels of protein C1QTNF5,4273
12,Non-oily fish intake,3503
12,Plasma free amino acid levels [Phe],1761
12,Blond vs. brown hair color,120
12,Noncognitive aspects of educational attainment,61364
12,"Blood protein levels [EA, NKG2-D type II integral membrane protein]",8470
12,"""Type 1 diabetes, strict definition, subgroup 1""",21603
12,Malignant neoplasm of prostate (controls excluding all cancers),6010
12,Colorectal or endometrial cancer [same direction],446
12,Free thyroxine concentration,957
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-72 ms],71
12,"""Atopic  dermatitis, strict definition""",397
12,Serum levels of protein LAG3,774
12,Procollagen galactosyltransferase 1 measurement,446
12,Diabetes | illnesses of siblings,39
12,Facial wrinkles (forehead) [women],33
12,Waist-to-hip ratio adjusted for BMI,451662
12,Impedance of leg (left),97406
12,Urate levels [men],5948
12,High cholesterol,5100
12,Heart rate response to recovery post exercise (30 sec),329
12,Cerebrospinal fluid biomarker levels [Dipeptidyl peptidase 1],13
12,Asthma,411979
12,Bitter taste perception (multivariate analysis) [caffeine and quinine],37408
12,Cognitive aspects of educational attainment,33502
12,"Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) [EA, men]",2789
12,Ischemic heart diseases,509
12,White matter microstructure (radial diusivities) [Posterior limb of internal capsule],66
12,Alcohol dependence (age at onset),1843
12,Nap during day,1053
12,Hypertension [Japanese],69
12,"Blood protein levels [DGKB, 12895_28_3]",2460
12,Pancreatic ductal adenocarcinoma,9031
12,Height [AA],849
12,Heart rate response to recovery post exercise (10 sec),329
12,Electrocardiogram morphology (amplitude at temporal datapoints) [200 ms],125
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-384 ms],7
12,Autism spectrum disorder or schizophrenia,61275
12,Waist-to-hip ratio adjusted for BMI in active individuals,15932
12,KDEL motif-containing protein 2 measurement,1431
12,Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis),24478
12,Raw vegetable consumption,6962
12,1-stearoyl-2-linoleoyl-gpc (18:0/18:2) levels,1009
12,Hand grip strength,85563
12,Gastroesophageal reflux disease,89238
12,vWF levels [EA],18657
12,Brain region volumes [left cerebellum exterior],27124
12,Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer,3610
12,Fasting plasma glycochenodeoxycholate 3-O-glucuronide concentration,957
12,"Blood protein levels [LAG3, 5099_14_3]",774
12,Ever addicted to illicit or recreational drugs,204
12,Dark chocolate intake,7
12,Serum levels of protein LUM,6
12,Testicular germ cell cancer,4381
12,ADHD vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),10545
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-22 ms],822
12,CD25 on naive-mature B cell,240
12,Cirrhosis,618
12,Electrocardiographic traits (multivariate),301
12,Cognitive performance,37629
12,Waist circumference adjusted for BMI (adjusted for smoking behaviour) [men],14838
12,"Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA, men]",2723
12,"Systolic blood pressure, automated reading",32057
12,Alcohol-associated liver disease in light drinkers,5974
12,Lactate dehydrogenase levels in statin users,1412
12,Ethylmalonate levels,3969
12,"""Artrosis, including avohilmo""",401
12,"Blood protein levels [PTPN4, 14254_27_3]",2460
12,Childhood asthma (age<16) (more control exclusions),161
12,Rheumatoid arthritis,50447
12,Impedance of arm (right),173077
12,Behcet's disease,7031
12,Urinary metabolite levels in chronic kidney disease [methylsuccinate],3131
12,Facial morphology [pronasale-right alare distance],104
12,Heart rate variability traits (RMSSD),4193
12,Balding type 1,38620
12,Finger osteoarthritis severity (hand Klsum),23073
12,Lymphocyte-to-monocyte ratio,9954
12,Serum levels of protein SELPLG,1978
12,"""Cholelithiasis, broad definition with cholecystitis""",6029
12,Fibroblast growth factor 23 levels,259
12,Argininate levels,158
12,Eosinophil percentage of white cells,162172
12,Macular thickness,63445
12,High myopia,2775
12,Liver enzyme levels (gamma-glutamyl transferase),36066
12,IgG glycosylation [IGP41],6713
12,None of the above | qualifications,89748
12,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [glycochenodeoxycholate glucuronide, glycodeoxycholate sulfate, glycolithocholate sulfate, taurolithocholate 3-sulfate, X-14626, X-16654, X-22520, X-22834]",1017
12,Plasma PCSK9 levels,84
12,Corneal hysteresis (left),2
12,"""Type 2 diabetes, definitions combined""",8166
12,Optic disc size,4753
12,Medication use (antimigraine preparations),6431
12,Ever smoked,1833
12,Hippocampal subfield CA3 volume,2165
12,"Pulse pressure x alcohol consumption interaction (2df test) [Asian, EA]",537
12,Visual disturbances and blindness,122
12,C-C motif chemokine 3 levels,446
12,Serum levels of protein DCN,111
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-36 ms],104
12,Brain region volumes [left rostral anterior cingulate],52
12,Hypothyroidism,33325
12,Body fat percentage and LDL-C (pairwise),14532
12,"""Hypothyroidism, strict autoimmune""",25008
12,HDL cholesterol levels [Asian],11751
12,UBA644 abundance in stool,295
12,I can only hear on the left side | hearing test done,1158
12,Electrocardiogram morphology (amplitude at temporal datapoints) [256 ms],125
12,Multisite chronic pain,15
12,Type 1 diabetes with peripheral circulatory complications,27
12,Response to cytidine analogues (gemcitabine),3
12,Self-reported math ability (MTAG) [MTAG],243070
12,Age at first birth,87483
12,Coronary heart disease (SNP X SNP interaction),3369
12,"Heel bone mineral density (bmd) t-score, automated (right)",3337
12,Prostate cancer [EA],616
12,Serum metabolite concentrations in chronic kidney disease [ethylmalonate],671
12,P wave duration [AA],155
12,Electrocardiogram morphology (amplitude at temporal datapoints) [210 ms],125
12,Cystatin C levels,167669
12,Serum levels of protein SMPDL3A,9712
12,Spherical equivalent,11781
12,Hippocampal subfield CA1 volume,2165
12,Serum levels of protein DHFR,707
12,Body mass index and systole blood pressure (pairwise),1850
12,CD4 on CD28+ CD4+ T cell,1180
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-80 ms],71
12,"Ecg, heart rate",84
12,Heart rate reached safety level | completion status of test,152
12,Osteoarthrosis (time to event),164
12,Obese vs. thin,1955
12,Coronary artery disease [recessive model],66
12,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],6090
12,Platelet-derived growth factor subunit B levels,2998
12,Problematic alcohol use,3364
12,CD27 on IgD- CD38+ B cell,803
12,Place of birth in uk - north co-ordinate,12744
12,Metabolic syndrome (multivariate analysis),8142
12,3mm weak meridian (right),19525
12,Gamma-glutamyl-alpha-lysine levels,502
12,Red cell distribution width,1050961
12,Neuroticism,98611
12,Presubiculum volume,1958
12,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction) [women],14734
12,Basophil count,84693
12,Ever suffered mental distress preventing usual activities,7723
12,malignant neoplasm of male genital organs (controls excluding all cancers),5969
12,Phospholipid levels (plasma) [levels],358
12,Mean reticulocyte volume,707839
12,Bacteroides clarus abundance in stool,4313
12,Headache | pain type(s) experienced in last month,45265
12,Electrocardiogram morphology (amplitude at temporal datapoints) [154 ms],19875
12,Body mass index [women],1846
12,White matter microstructure (mode of anisotropy) [Retrolenticular part of internal capsule],72
12,Cerebrospinal T-tau levels [Controls],89
12,Serum metabolite levels [tetradecanedioate],2878
12,CD64 on CD14+ CD16+ monocyte,474
12,Waist circumference adjusted for BMI in non-smokers,29572
12,FEV1,90890
12,Alanine aminotransferase levels,495966
12,Body mass index [EA],1846
12,White blood cell count,1050883
12,Fulminant type 1 diabetes,11489
12,Adult body size,49552
12,"""Type 2 diabetes, strict (exclude DM1)""",7468
12,Urinary metabolites [2-Hydroxyisobutyrate concentration],4382
12,LDL cholesterol levels in current drinkers,5307
12,Schizophrenia or bipolar disorder [SCZ or BP vs. controls],851
12,Pattern 3 | hair/balding pattern,1034
12,Waist-to-hip ratio adjusted for body mass index [EA],37832
12,Mean arterial pressure [Japanese],692
12,Other malignant neoplasms of skin (=non-melanoma skin cancer),161
12,Renal underexcretion gout,413
12,Celiac disease,5004
12,Birth weight of first child,19195
12,Cholelithiasis with other cholecystitis,2449
12,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [glycochenodeoxycholate sulfate, glycocholenate sulfate, X-14658, X-21448, X-21467]",1017
12,"""Diabetes, several complications""",39
12,Electrocardiogram morphology (amplitude at temporal datapoints) [174 ms],19458
12,Electrocardiogram morphology (amplitude at temporal datapoints) [74 ms],20418
12,Bone mineral density (spine),9419
12,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction) [men],2850
12,Alzheimer's disease or HDL levels (pleiotropy),110
12,Low vWF levels,1833
12,Liver enzyme levels (alkaline phosphatase),73819
12,Ascending aorta minimum area,18415
12,"Sphingomyelin (d18:1/24:1, d18:2/24:0) levels",1133
12,Plasma free amino acid levels (adjusted for one other PFAA) [Gln (adjusted for Asn],2337
12,Diabetes | illnesses of mother,3285
12,Lung function (FEV1) [EA],776
12,Barrett's esophagus  or Esophageal adenocarcinoma,966
12,Electrocardiogram morphology (amplitude at temporal datapoints) [40 ms],202
12,Total cholesterol levels,199356
12,Vitamin C levels,8014
12,N-glycan levels [DG9],5277
12,Serum metabolite levels (CMS) [M_LDL_P],5917
12,Protein quantitative trait loci (liver) [DLST],2005
12,Neuritic plaques (SNP x SNP interaction),906
12,"Heart attack/myocardial infarction | non-cancer illness code, self-reported",446
12,Serum levels of protein CST2,84312
12,Electrocardiogram morphology (amplitude at temporal datapoints) [164 ms],28592
12,Creatine kinase levels,10868
12,LDL cholesterol levels [EA],8156
12,Sleeplessness / insomnia,1435
12,Serum metabolite levels [betaine],962
12,Barrett's esophagus or esophageal adenocarcinoma x sex interaction (2df test),855
12,Electrocardiogram morphology (amplitude at temporal datapoints) [340 ms],84
12,Hodgkin's lymphoma,2008
12,Fibrosis-4 index in high alcohol intake,256
12,Cerebrospinal fluid biomarker levels [Complement C1r subcomponent],37
12,Heart rate,9450
12,HDL cholesterol levels in current drinkers [Asian],5905
12,Levothyroxine sodium | treatment/medication code,22471
12,Peripheral atherosclerosis,705
12,Leg fat mass (lean adjusted),14644
12,Trunk fat percentage,43160
12,Brain region volumes [left cerebellum white matter],1271
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-88 ms],71
12,Other heart diseases,508
12,Systemic mastocytosis,61
12,Body fat percentage,107577
12,Alcohol consumption,12410
12,Hypothyroidism (congenital or acquired),446
12,Venous thromboembolism (SNP x SNP interaction),184
12,Plasma free amino acid levels (adjusted for one other PFAA) [Met (adjusted for Phe],255
12,Triglycerides,143316
12,Peak expiratory flow,46131
12,Hypertensive diseases (excluding secondary),3313
12,"Body mass index [Japanese, Male]",2801
12,Lactate dehydrogenase levels in off-statin users,1412
12,Angina,6167
12,Dentate gyrus granule cell layer volume,2498
12,Facial morphology (brow ridge protrusion 1),248
12,Fluticasone | treatment/medication code,277
12,Protein quantitative trait loci (liver) [HSPA8],8
12,Pulse pressure,179726
12,Brain region volumes [cerebellar vermal lobules I V],34385
12,Serum levels of protein ADAM23,2017
12,Brain region volumes [left inferior lateral ventricle],11833
12,Electrocardiogram morphology (amplitude at temporal datapoints) [68 ms],22907
12,Miserableness,1161
12,Birth length (MTAG),1412
12,"Blood protein levels [TMEM132D, 13416_8_3]",84
12,Episodal and paroxysmal disorders,14
12,Immature fraction of reticulocytes,237161
12,Whole body water mass,166680
12,Gut microbiota (bacterial taxa) [Bacilli class],2155
12,Diabetes,2143
12,Low density lipoprotein cholesterol levels (on statin treatment),882
12,Response to statins (LDL cholesterol percent change),882
12,Heart rate response to recovery post exercise,19933
12,Liver enzyme levels (alanine transaminase),233589
12,Externalizing behaviour (multivariate analysis),84043
12,Trunk fat-free mass,180293
12,Protein quantitative trait loci (liver) [GCN1],996
12,Electrocardiogram morphology (amplitude at temporal datapoints) [116 ms],35689
12,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) [women],18221
12,Clomipramine | treatment/medication code,280
12,"""Endomtriosis ASRM stages 3,4""",1551
12,None of the above (group 1) | illnesses of father,461
12,Serum levels of protein GPI,2510
12,Electrocardiogram morphology (amplitude at temporal datapoints) [320 ms],626
12,Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test),20036
12,Systolic blood pressure [East Asian],3409
12,Serum metabolite levels [X-11529],1515
12,"""Appendicitis, broad definition""",3202
12,Metabolite levels [Glycochenodeoxycholic acid 3-glucuronide],1050
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-26 ms],456
12,PR interval in Tripanosoma cruzi seropositivity,244
12,White matter microstructure (fractional anisotropy) [Superior corona radiata],66
12,Serum levels of protein LTA;LTB,1145
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-374 ms],71
12,Nose size,2921
12,Medication use (diuretics),32294
12,Serum levels of protein CLEC12A,12746
12,N-glycan levels [FUC-A],4619
12,"Urinary metabolites (H-NMR features) [0.8875, Unknown]",3131
12,Heart rate response to exercise,2304
12,Protein quantitative trait loci (liver) [IGLL5],23
12,Electrocardiogram morphology (amplitude at temporal datapoints) [294 ms],84
12,Infant length,164
12,Plasma free amino acid levels (adjusted for twenty other PFAAs) [Gln],7259
12,Urinary metabolite levels in chronic kidney disease [4-hydroxyphenylpyruvate],3320
12,"Urinary metabolites (H-NMR features) [1.3625, 2-Hydroxyisobutyrate]",3320
12,Insomnia [AA],73
12,Inverse distance to the nearest major road,16
12,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction),30001
12,Heel bone mineral density,531011
12,Lung function (FVC),387859
12,Skin flushing frequency,10535
12,Leg fat-free mass (right),108530
12,Cholecystitis,5659
12,Spherical equivalent [EA],708
12,Serum polyunsaturated fatty acid concentration x sex interaction in metabolic syndrome [omega-3 PUFA],142
12,General glucose level in pregnancy (gestational week 30-32),7
12,Vitiligo,86766
12,Amino acid levels [Glutamine],3535
12,Walking pace,19966
12,IgA levels [Recessive],446
12,Serum uric acid levels [Japanese],236
12,Glioblastoma,288
12,Plasma free amino acid levels (adjusted for one other PFAA) [Phe (adjusted for Ser],255
12,"""Benign neoplasm: Pituitary gland, craniopharyngeal duct""",39
12,Migraine with aura and/or pulse pressure,3485
12,Schizophrenia vs ADHD (ordinary least squares (OLS)),62228
12,Childhood body mass index,4441
12,Plasma free amino acid levels (adjusted for one other PFAA) [Gln (adjusted for Pro],2337
12,Confectionary intake,950
12,Blood metabolite levels [X-11491],957
12,Serum metabolite levels [X-14626],1050
12,Childhood obesity [EA],324
12,Usual walking pace,32856
12,Forns index in high alcohol intake,6391
12,Plasma free amino acid levels (adjusted for twenty other PFAAs) [Phe],1852
12,Electrocardiogram morphology (amplitude at temporal datapoints) [252 ms],125
12,Metabolic traits [CRP],4458
12,CD27 on IgD+ CD24+ B cell,529
12,Plasma free amino acid levels (adjusted for one other PFAA) [Phe (adjusted for Asn],255
12,Pappalysin-1 levels,474
12,Hemorrhoids,36
12,Insomnia [Male],141
12,Metabolic syndrome,6965
12,Pattern 4 | hair/balding pattern,42516
12,Impedance of arm (left),144434
12,Glomerular filtration rate in non diabetics (creatinine),3974
12,Adolescent idiopathic scoliosis,103305
12,Pulmonary heart disease,319
12,Plasma free amino acid levels (adjusted for one other PFAA) [Gln (adjusted for Phe],2337
12,Feeling hurt,11356
12,Infant head circumference (MTAG),60538
12,Coffee intake,39368
12,Urinary albumin excretion (no hypertensive medication),3929
12,Acute graft versus host disease in bone marrow transplantation (recipient effect),978
12,Facial morphology (segment 12),365
12,Glycemic traits [FPG],226
12,Major depressive disorder vs ADHD (ordinary least squares (OLS)),158
12,Allergy,60374
12,Eosinophil percentage of granulocytes,23477
12,"Blood protein levels [EA, N-acylethanolamine-hydrolyzing acid amidase]",7108
12,Cerebral aneurysm,2039
12,Body mass index in physically active individuals [women],2079
12,Second line medication for Crohns disease,446
12,Rice/oat/vegetable milk | type milk consumed,1590
12,Electrocardiogram morphology (amplitude at temporal datapoints) [18 ms],166
12,Age at first live birth,22204
12,"Waist-hip ratio [EA, women]",3235
12,"Stroke [ischemic stroke, EA]",58
12,Onycholysis,21
12,Urinary incontinence,30
12,Bipolar disorder lithium response (categorical) or schizophrenia,31439
12,Serum metabolite ratios in chronic kidney disease [Carnitine (free)/Butyrylcarnitine / Isobutyrylcarnitine],3131
12,Arm predicted mass (right),139340
12,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],2856
12,"Forced expiratory volume in 1-second (fev1), predicted percentage",1559
12,Butyricimonas sp900258545 abundance in stool,5601
12,Non-oily fish consumption,886
12,Serum metabolite levels [octadecanedioate],844
12,COVID-19 (hospitalized vs population) RELEASE 5,57448
12,Waist circumference adjusted for BMI (adjusted for smoking behaviour) [women],14734
12,Total body bone mineral density [European],21229
12,Electrocardiogram morphology (amplitude at temporal datapoints) [64 ms],20418
12,Electrocardiogram morphology (amplitude at temporal datapoints) [70 ms],4457
12,BMI (adjusted for smoking behaviour) [men],2220
12,CD4 on CD39+ activated CD4 regulatory T cell,1180
12,Malignant neoplasm of small intestine,125
12,Coronary artery disease or large artery stroke,474
12,Menorrhagia,175
12,Percent mammographic density,216
12,Worry too long after embarrassment,83
12,Automobile speeding propensity,55981
12,Alcohol consumption (drinks per week) (MTAG),24288
12,Electrocardiogram morphology (amplitude at temporal datapoints) [156 ms],19750
12,Electrocardiogram morphology (amplitude at temporal datapoints) [46 ms],327
12,Metabolite levels [ALT],241
12,Serum CC16 levels,862
12,Protein quantitative trait loci (liver) [CS],996
12,Gut microbiota (functional units) [PWY-7527_L-methionine_salvage_cycle_III],2807
12,Lipoprotein-associated phospholipase A2 activity and mass [activity],254
12,Gut microbiota (beta diversity),210
12,Uterine prolapse,87
12,Platelet distribution width,407225
12,Diseases of middle ear and mastoid,3125
12,Serum levels of protein CTSC,1781
12,Persons encountering health services for examination and investigation,36
12,Stroke [EA],58
12,"Medication use (adrenergics, inhalants)",46423
12,Serum alkaline phosphatase levels,395682
12,Fish- and plant-related diet,13743
12,Amias 2mg tablet | treatment/medication code,401
12,"Fracture radius | non-cancer illness code, self-reported",45
12,Interleukin-2 receptor subunit beta measurement,446
12,Mammographic density (dense area),1004
12,Cerebrospinal fluid t-tau levels in normal cognition,89
12,Coronary artery disease or ischemic stroke,474
12,"Blood protein levels [PLXNC1, 4564_2_2]",180
12,Serum levels of protein MGP,21956
12,Alcohol dependence or heroin dependence or methamphetamine dependence,146
12,Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],881
12,Brain region volumes [CSF],107
12,Facial morphology (segment 35),289
12,"""Other (seronegative) rheumatoid arthritis, wide""",581
12,Serum metabolite concentrations in chronic kidney disease [glycochenodeoxycholate glucuronide],100
12,Family history of other specific disorders,41
12,Arm fat mass (left),65838
12,Sphingomyelin_38:2_[M+H]1+ levels,4664
12,Cortical volume [Inferior parietal],654
12,Plakophilin-2 measurement,531
12,Meat-related diet,2715
12,Electrocardiogram morphology (amplitude at temporal datapoints) [168 ms],542
12,Serum levels of protein TMEM132D,88
12,C-reactive protein levels or LDL-cholesterol levels (pleiotropy),73765
12,Reticulocyte percentage,58016
12,Sex hormone-binding globulin levels [Men + Women],957
12,Body mass index variance,1955
12,Umbilical hernia,232
12,Small intestine neuroendocrine tumor,377
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-158 ms],71
12,Cancer diagnosed by doctor,3
12,Vertex-wise cortical surface area,212725
12,Tumor necrosis factor receptor 2 levels,446
12,Childhood onset systemic lupus erythematosus,93
12,Electrocardiogram morphology (amplitude at temporal datapoints) [240 ms],125
12,Neuropathic pain,44
12,Malignant neoplasm of breast,36
12,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),81162
12,Bone disorder,1177
12,Cortical surface area (min-P),6925
12,Lymphocyte Absolute Count,446
12,White matter microstructure (mode of anisotropy) [Posterior corona radiata ],446
12,Neutrophil percentage of white cells,227197
12,Serum levels of protein CLEC1B,7331
12,Arm fat-free mass (left),129713
12,"Gout | non-cancer illness code, self-reported",18382
12,BMI in non-smokers,2191
12,Marginal zone lymphoma or rheumatoid arthritis,2152
12,Arthrotec tablet | treatment/medication code,1173
12,Blood metabolite levels [glutamine],3535
12,Type 2 diabetes with ketoacidosis,133
12,Arrhythmia,317
12,Schizophrenia (MTAG),268171
12,Vitamin D insufficiency,954
12,"Blood protein levels [CASQ1, 11263_57_3]",2460
12,"Parental longevity (combined parental attained age, Martingale residuals)",446
12,Serum metabolite levels [X-11538],4716
12,Hair shape,92
12,Heart attack | vascular/heart problems diagnosed by doctor,446
12,Electrocardiogram morphology (amplitude at temporal datapoints) [44 ms],202
12,"""Migraine, single triptan purchase ok & required. ICD-code if available is included""",3485
12,Serum metabolite levels [1-methylimidazoleacetate],1139
12,Fat-free mass [male],672
12,Cerebrovascular diseases (FINNGEN),474
12,Serum levels of protein PTHLH,1093
12,Reticulocyte fraction of red cells,486259
12,Headache,47699
12,Heart rate response to recovery post exercise [females],5807
12,Electrocardiogram morphology (amplitude at temporal datapoints) [82 ms],19750
12,Etoposide drug response (IC50),298
12,Haemorrhage in early pregnancy,219
12,Brown vs. black hair color,1188
12,Neuroticism (MTAG),51
12,Electrocardiogram morphology (amplitude at temporal datapoints) [264 ms],125
12,Immune reponse to smallpox (secreted IL-2) [EA],20
12,Alcohol intake versus 10 years previously,2715
12,Hallux valgus (acquired),373
12,CD45RA- CD4+ T cell Absolute Count,474
12,"Pulse pressure x alcohol consumption interaction (2df test) [AA, EA, Hispanic]",1631
12,"Yes, because of illness | major dietary changes in the last 5 years",58
12,Heart failure,518
12,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),29572
12,Type 2 diabetes with other specified/multiple/unspecified complications,2140
12,Body mass index (joint analysis main effects and smoking interaction) [women],2220
12,Electrocardiogram morphology (amplitude at temporal datapoints) [302 ms],542
12,Global electrical heterogeneity phenotypes [SVG elevation],104
12,Milk consumption,260
12,Ischemic heart disease,7536
12,"Sphingomyelin (d18:2/16:0, d18:1/16:1) levels",538
12,Hippocampal tail volume,2113
12,Serum sclerostin levels,599
12,Renal function-related traits (BUN),226
12,Serum levels of protein HPSE,1445
12,"Waist-to-hip ratio adjusted for BMI in non-smokers [EA, men]",2789
12,"Migraine | non-cancer illness code, self-reported",3485
12,Hippocampal sclerosis of aging [recessive],710
12,Metabolite levels [C18:1-DC],615
12,Granulocyte percentage of myeloid white cells,28256
12,Serum urea levels,44838
12,Serum levels of protein TPI1,69800
12,Montelukast product | treatment/medication code,13320
12,CD4+CD8+ T cell Absolute Count,3587
12,Left eye only | ever had cataract surgery,6419
12,"Waist circumference [EA, women]",2357
12,Serum levels of protein NELL1,1186
12,"""Other dorsopathies, not elsewhere classified""",10
12,Knee osteoarthritis,83346
12,"""Type 1 diabetes, strict (exclude DM2)""",21603
12,"""Type 2 diabetes, definitions combined, including avohilmo""",6805
12,Femoral neck bone mineral density,7554
12,Obesity (extreme),1955
12,Electrocardiogram morphology (amplitude at temporal datapoints) [328 ms],613
12,FSC-A on monocyte,103
12,P-selectin glycoprotein ligand 1 levels,10692
12,Serum levels of protein CST1,57341
12,Trunk fat mass,101380
12,Obesity [Obesity class II],2486
12,Serum levels of protein CASQ1,2460
12,Dermatitis and eczema,3009
12,Protein quantitative trait loci (liver) [PIPOX],30
12,Cardiovascular diseases,505
12,"""Haemangioma, any site""",114
12,Hedonic well-being,62
12,Participation in an health questionnaire (not invited vs invited),264
12,Electrocardiogram morphology (amplitude at temporal datapoints) [242 ms],8842
12,Urea levels,6634
12,Alcohol drinking status (current drinker vs non-current drinker),260
12,HDL cholesterol x physical activity interaction (2df test),6870
12,HDL cholesterol levels in current drinkers,15750
12,Protein quantitative trait loci (liver) [ACADS],5005
12,Heart rate variability traits (SDNN),903
12,P wave duration,161
12,Refractive error,79652
12,hemolysis of donated blood (osmotic),82559
12,HDL cholesterol x physical activity interaction (2df test) [EA],3207
12,"Mania/bipolar disorder/manic depression | non-cancer illness code, self-reported",5373
12,Distance between home and job workplace,1539
12,"""Stroke, including SAH""",86
12,Mean arterial pressure,114934
12,Bitter taste perception (multivariate analysis) [caffeine and denatonium benzoate],37408
12,Time spent using computer,3506
12,Body fat distribution (trunk fat ratio) [females],131666
12,Monocyte percentage of white cells,142801
12,Serum levels of protein GXYLT1,19515
12,Hand grip strength (left),49482
12,CD27 on IgD- CD38- B cell,803
12,Hypertrophy of breast,261
12,Other obstetric trauma,48
12,Alcohol dependence symptom count,183
12,Biscuit cereal (e.g. weetabix) | cereal type,14
12,Protein quantitative trait loci [Alkaline phosphatase],8
12,Schizophrenia vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),74855
12,Forced expiratory volume in 1-second (fev1),85902
12,Finngen Rheumatological endpoints,1121
12,Gonarthrosis [arthrosis of knee](FG),2397
12,Weight [male],503
12,Idiopathic polyneuropathy,580
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-46 ms],202
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-86 ms],71
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-34 ms],166
12,Predicted visceral adipose tissue,40874
12,"Blood protein levels [TPI1, 4309_59_3]",69800
12,Peak expiratory flow (pef),57766
12,Blood protein levels [Complement C1r subcomponent],2074
12,Chronic lower respiratory diseases,104
12,Electrocardiogram morphology (amplitude at temporal datapoints) [76 ms],20758
12,Amino acid levels [Phenylalanine],595
12,Carbomers | treatment/medication code,6
12,Hemoglobin levels,165638
12,3mm strong meridian (right),18831
12,Systolic blood pressure [Japanese],685
12,Temporal lobe volume,500
12,Sleep disorders (combined),2
12,Highest math class taken (MTAG) [MTAG],308950
12,Apolipoprotein B levels,121326
12,Basophill percentage,7424
12,Ankle spacing width (left),386
12,Haemmorrhoids and perianal venous thrombosis,36
12,Osteoporosis,20699
12,Electrocardiogram morphology (amplitude at temporal datapoints) [142 ms],19875
12,PR segment duration,104
12,Unspecified diabetes,6
12,Morningness,34984
12,Mosaic loss of chromosome Y (Y chromosome dosage),10109
12,Bitter taste perception (multivariate analysis) [quinine and caffeine],147851
12,Coronary revascularization (ANGIO or CABG),1377
12,Retinal vascular caliber [Retinal venular caliber],446
12,Polycystic ovary syndrome,47264
12,Mosquito bite size,1767
12,Brain morphology (min-P),26464
12,Electrocardiogram morphology (amplitude at temporal datapoints) [122 ms],19750
12,Electrocardiogram morphology (amplitude at temporal datapoints) [84 ms],19535
12,Endometriosis of ovary,1551
12,Colorectal polyp,96
12,Type 2 diabetes (adjusted for BMI),83738
12,Asthma (adult onset),51951
12,N-acetylglucosamine/n-acetylgalactosamine levels,9809
12,Serum levels of protein IDS,1781
12,"""Endocrine, nutritional and metabolic diseases""",2831
12,Monobrow,1183
12,Empathy quotient,4
12,Sunburns,1608
12,Life satisfaction,11631
12,Brain morphology (MOSTest),142909
12,"Mean arterial pressure x alcohol consumption interaction (2df test) [AA, EA, Hispanic]",1459
12,Asthma (moderate or severe),15919
12,Cardiovascular disease,101101
12,Chained arithmetic | fi8 ,60723
12,Severe influenza A (H1N1) infection,3017
12,"Serum metabolite levels [bilirubin (E,Z or Z,E)*]",844
12,Cholecystitis without cholelithiasis,61
12,Serum levels of protein CTSF,1781
12,Presubiculum volume (corrected for total hippocampal volume),52
12,RR interval (heart rate),700
12,Brain region volumes [right superior parietal],90
12,Intelligence (MTAG),171074
12,COVID-19 (RELEASE 5),61064
12,Flavonifractor sp900199495 abundance in stool,2972
12,Waist circumference,74966
12,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant I (Philtrum), Segment 18]",1799
12,Body mass index in physically active individuals [EA],2079
12,Serum levels of protein CRP,4619
12,Heart rate variability traits (pvRSA/HF),1785
12,"Heel quantitative ultrasound index (qui), direct entry (left)",1023
12,"Sphingomyelin (d18:1/20:0, d16:1/22:0) levels",947
12,Serum levels of protein PSMA7,1412
12,Electrocardiogram morphology (amplitude at temporal datapoints) [32 ms],264
12,Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded),125
12,"Disorders of fluid, electrolyte, and acid-base balance",13
12,Alopecia areata,44389
12,Meniscus derangement,60506
12,Coronary heart disease,4089
12,Cathepsin D levels,1781
12,LDL cholesterol x physical activity interaction (2df test) [EA],4184
12,Fat-free mass [female],3090
12,"Body mass index (joint analysis main effects and physical activity interaction) [EA, women]",1846
12,"""Haemangioma and lymphangioma, any site""",114
12,CD27 on IgD- CD38dim B cell,117
12,Gut microbiota relative abundance (bacterial taxa) [Eggerthella_sinensis],15
12,C-reactive protein levels,138082
12,Prostate cancer,119827
12,CD4 on CD45RA+ CD4+ T cell,1180
12,Blond vs non-blond hair color,120
12,Serum prostate-specific antigen levels,39
12,Blond vs. brown/black hair color,41292
12,General risk tolerance (MTAG),56566
12,Other  prurigo,1511
12,Serum levels of protein ENDOU,2690
12,"Parkinsons disease | non-cancer illness code, self-reported",502
12,Electrocardiogram morphology (amplitude at temporal datapoints) [236 ms],125
12,Electrocardiogram morphology (amplitude at temporal datapoints) [308 ms],542
12,Height,1270341
12,Granulocyte count,68035
12,Feeling miserable,10896
12,Skin colour,7864
12,Waist-hip ratio [EA],1786
12,Fasting glucose,13348
12,Plasma free amino acid levels [Gln],4674
12,Bread intake,9700
12,Hip bone size,1210
12,Spinal canal stenosis,83
12,White matter microstructure (fractional anisotropy) [Posterior limb of internal capsule],66
12,vWF levels,20687
12,Triglyceride levels,224148
12,A body shape index,39178
12,Stable angina pectoris,3802
12,"Liver failure/cirrhosis | non-cancer illness code, self-reported",2507
12,Blood metabolite levels [pyroglutamine],1207
12,Electrocardiogram morphology (amplitude at temporal datapoints) [52 ms],1425
12,"Diastolic blood pressure [EA, initial]",1327
12,Interstitial lung disease endpoints,581
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-166 ms],273
12,CCR2 on CD14- CD16-,103
12,Malignant neoplasm of breast (controls excluding all cancers),36
12,Cheft hard palate NOS,5
12,Eosinophil counts,890963
12,Basophil percentage of granulocytes,5737
12,Serum levels of protein KLRB1,4906
12,Problematic alcohol use (MTAG),6656
12,Blood metabolite levels [hexadecanedioate],1017
12,Aspartate aminotransferase to alanine aminotransferase ratio x alcohol consumption interaction,226
12,Squamous cell lung carcinoma,153
12,1-(1-enyl-palmitoyl)-2-oleoyl-gpc (p-16:0/18:1) levels,118
12,Medication use (antidepressants),53
12,Protein quantitative trait loci (liver) [ACSS3],24
12,Eosinophill count,113345
12,Electrocardiogram morphology (amplitude at temporal datapoints) [162 ms],19750
12,Waist circumference adjusted for BMI in non-smokers [men],2850
12,Serum levels of protein CTSS,1445
12,Idiopathic osteonecrosis of the femoral head,164
12,"Thyroid goitre | non-cancer illness code, self-reported",181
12,Hippocampal fissure volume,52
12,Serum metabolite levels [butyrylcarnitine],16121
12,Acute appendicitis,2987
12,Electrocardiogram morphology (amplitude at temporal datapoints) [198 ms],125
12,Cerebrospinal fluid t-tau:AB1-42 ratio,507
12,Chin dimples,53
12,White matter microstructure (mode of anisotropy) [Sagittal stratum],66
12,Worry,11058
12,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA],29826
12,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA],16014
12,Leg fat mass (left),81525
12,Neurofibrillary tangles (SNP x SNP interaction),29886
12,Depressive symptoms x herpes simplex 1 infection interaction [dominant],209
12,Obesity [Obesity class I],2486
12,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [taurocholenate sulfate, X-24669]",1017
12,Chronic Coagulation defects,108
12,Total testosterone levels,123586
12,Atopic dermatitis,36688
12,Yes | hearing difficulty/problems,11708
12,Protein quantitative trait loci (liver) [KRT2],9108
12,6mm weak meridian (left),4060
12,Nevus count or cutaneous melanoma,4981
12,Brain region volumes [left postcentral],225
12,CD4 on activated CD4 regulatory T cell,1180
12,TMED109 abundance in stool,153
12,"For long-sightedness, i.e. for distance and near, but particularly for near tasks like reading (called 'hypermetropia') | reason for glasses/contact lenses",583
12,Cortical surface area [Isthmus Cingulate],16
12,Basophil percentage of white cells,19999
12,Subiculum volume,6278
12,Composite immunoglobulin trait (IgA/IgG),47816
12,Serum levels of protein TP53I13,1049
12,Serum metabolite levels [2-hydroxyphenylacetate],9442
12,"""Type 2 diabetes, wide definition""",1634
12,Receptor for advanced glycosylation end products levels,4477
12,Electrocardiogram morphology (amplitude at temporal datapoints) [266 ms],2284
12,Urinary metabolite levels in chronic kidney disease [ethylmalonate],3131
12,White matter microstructure (radial diusivities) [Fornix (column and body],66
12,Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder,37
12,Neuroticism conditioned on self-rated math ability (multi-trait conditioning and joint analysis),38054
12,3mm strong meridian (left),18791
12,Serum metabolite levels [butyrylcarnitine (C4],9176
12,Experiencing mood swings,745
12,Brain region volumes [left hippocampus],2041
12,Electrocardiogram morphology (amplitude at temporal datapoints) [388 ms],125
12,Unstable angina pectoris,418
12,Gestational diabetes (for exclusion),39
12,Brain region volumes [left lateral occipital],66
12,"Red blood cell traits [EA, PCV]",361
12,Non-obstructive azoospermia,25
12,Albumin-globulin ratio,46603
12,"Blood protein levels [MGP, 6520_87_3]",43912
12,"Blood protein levels [NTN4, 3327_27_1]",2553
12,Psoriasis [EA],24210
12,Merdibacter massiliensis abundance in stool,551
12,Electrocardiogram morphology (amplitude at temporal datapoints) [-184 ms],273
12,Colorectal cancer [Han Chinese],48
12,Blood cell traits (multivariate analysis),8
12,Two-hour glucose in pregnancy (gestational week 30-32),7
12,Number of sexual partners,32347
12,"Blood protein levels [CLEC1B, 4332_6_2]",3002
12,Haemoglobin concentration,74073
12,Diseases of appendix,3202
12,Keratoconus,649
12,Blood metabolite levels [X-14626],1017
12,Blood pressure [Pulse Pressure],655
12,Alcohol dependence,472
12,Plavix 75mg tablet | treatment/medication code,1446
12,"""Diseases of arteries, arterioles and capillaries (FINNGEN)""",524
12,Bladder cancer,9026
12,Waist-to-hip ratio adjusted for body mass index,37832
12,Morning person,76872
12,Gout [Japanese],796
12,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [women],16001
12,Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis),15512
12,Arm fat percentage (left),43164
12,General factor of neuroticism,5441
12,6mm weak meridian (right),19159
12,Cortical thickness (min-P),410
12,"Pulse pressure x alcohol consumption interaction (2df test) [AA, EA]",311
12,Bendroflumethiazide | treatment/medication code,73
12,Body mass index (joint analysis main effects and physical activity interaction) [women],1846
12,Mouth ulcers | mouth/teeth dental problems,103
12,Electrocardiogram morphology (amplitude at temporal datapoints) [202 ms],125
12,Achilles tendinitis,126
12,Diastolic blood pressure x smoking status (ever vs never) interaction (2df test),10550
12,Soluble VCAM-1 levels,10290
12,1-palmitoyl-2-linoleoyl-gpc (16:0/18:2) levels,1245
12,Nonatopic asthma,25868
12,"Waist-to-hip ratio adjusted for body mass index [EA, women]",37879
12,Low hand grip strength (60 years and older) (EWGSOP),43804
12,Sex hormone-binding globulin levels,606863
12,Cardiorespiratory fitness slope,1784
12,Malignant neoplasm of prostate,6275
12,Coagulation factor levels,1671
12,Brain region volumes [left inferior parietal],66
12,Serum levels of protein RECQL,80
12,Resting heart rate,8546
12,"Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA, women]",15022
12,Worrier / anxious feelings,11112
12,Neuroticism score,11176
12,Parkinson's disease,7551
12,Cognitive ability,6999
12,Epilepsy,1180
12,Sudden cardiac arrest [Recessive],262
13,Skin colour,11702
13,Acute upper respiratory infections,63
13,Apolipoprotein B levels,14182
13,Malignant neoplasm of bronchus and lung,2
13,"Heel broadband ultrasound attenuation, direct entry",2277
13,White matter hyperintensity volume x hypertension interaction (2df),629
13,Electrocardiogram morphology (amplitude at temporal datapoints) [164 ms],75
13,Symptoms involving skin and other integumentary tissue,56
13,Nonsyndromic cleft lip with or without cleft palate,41
13,Trunk fat mass,40078
13,End-stage coagulation [Fibrin lag time],7
13,Macular thickness,2466
13,LDL cholesterol levels [Trans-ethnic initial],655
13,Uterine fibroids,14584
13,Disorders of lipoprotein metabolism and other lipidaemias,7136
13,"Bone mineral density (paediatric, upper limb)",393
13,Coronary artery calcification in type 2 diabetes (excluding prevalent cardiovascular disease),1236
13,Heart failure and coronary heart disease,163
13,Eosinophil counts,170996
13,Depression,12192
13,"Hip circumference adjusted for BMI [EA, women]",145
13,Cognitive performance (MTAG) [MTAG],4461
13,Factor VII activity [EA],856
13,Educational attainment (years of education) [conditional-joint],7567
13,Atopic asthma,4225
13,Myocarditis,98
13,High blood pressure | vascular/heart problems diagnosed by doctor,4899
13,Maximum habitual alcohol consumption,340
13,Age at first birth,359
13,Type 1 diabetes,3296
13,Ankle spacing width,5600
13,Daytime nap,151
13,Regular attendance at a religious group,162
13,Alcohol consumption (drinks per week) (MTAG),1578
13,Hernia,43
13,Hair color,29772
13,"Dark brown | hair colour (natural, before greying)",10972
13,"Pulse rate, automated reading",5636
13,Spells in hospital,199
13,Hip circumference [EA],27
13,Matrix metalloproteinase-12 levels,7
13,Hypothyroidism and >3 levothyroxin purchases,324
13,Number of self-reported non-cancer illnesses,1382
13,Atrial fibrillation,16346
13,Ankle spacing width (left),4653
13,Total body bone mineral density (MTAG),513
13,Protein quantitative trait loci (liver) [RSU1],4
13,Age-related macular degeneration,1687
13,Circulating odd-numbered chain saturated fatty acid levels (C19:0),473
13,Smoking initiation (ever regular vs never regular) (MTAG),7814
13,Total body bone mineral density [European],506
13,Menarche (age at onset),30892
13,Pulse pressure,31456
13,Arm predicted mass (right),22602
13,"Blood pressure medication | medication for cholesterol, blood pressure or diabetes",583
13,Corneal endothelial cell density,272
13,Autoimmune diseases,2570
13,Brain region volumes [left precentral],71
13,Waist circumference adjusted for body mass index,6903
13,Spherical equivalent,7947
13,Protein quantitative trait loci (liver) [DCN],1
13,Neutrophil count,113297
13,Serum levels of protein PLG,2171
13,Medication use (agents acting on the renin-angiotensin system),23753
13,Body fat percentage or coronary artery disease (MTAG),8
13,Asthma (childhood onset),10698
13,Electrocardiogram morphology (amplitude at temporal datapoints) [46 ms],417
13,Brain region volumes [cerebellar vermal lobules VI VII],259
13,Varicose veins,4350
13,Non-lobar intracerebral hemorrhage (MTAG),290
13,Hepatitis,587
13,"Intra-ocular pressure, goldmann-correlated (left)",482
13,Electrocardiogram morphology (amplitude at temporal datapoints) [216 ms],75
13,Electrocardiogram morphology (amplitude at temporal datapoints) [208 ms],75
13,Fasting blood insulin (BMI interaction),75
13,"""Diabetes, insuline treatment (Kela reimbursement) (more control exclusions)""",47
13,Stroke,9502
13,Blood metabolite levels [X-12244--N-acetylcarnosine],1054
13,Attention deficit hyperactivity disorder,1171
13,Yes | hearing difficulty/problems,150
13,Year ended full time education,166
13,Hydroxychloroquine | treatment/medication code,547
13,Osteoporosis,506
13,Gut microbiota abundance (family Bifidobacteriaceae id.433),8
13,Granulocyte percentage of myeloid white cells,5379
13,Haematocrit percentage,4793
13,Benign neoplasm: other/unspecified salivary gland (controls excluding all cancers),51
13,"Atrial fibrillation | non-cancer illness code, self-reported",50
13,Smoking behaviour (cigarette pack-years),48
13,6mm weak meridian (left),3182
13,Blood protein levels [Coagulation Factor VII],271
13,3mm strong meridian (left),3239
13,Hand grip strength (right),692
13,Hippocampal atrophy [Hippocampal volume],200
13,Refractive error,16344
13,Glucuronate levels,1198
13,Average weekly beer plus cider intake,1128
13,Type 2 diabetes [Punjabi Sikhs],52
13,Immunodeficiency with predominantly antibody defects,543
13,Neuroticism conditioned on self-rated math ability (multi-trait conditioning and joint analysis),254
13,Alverine | treatment/medication code,14
13,Brain morphology (min-P),1670
13,Medication use (drugs affecting bone structure and mineralization),615
13,Hydroxyasparagine levels,191
13,Facial morphology (segment 20),90
13,Hip bone size,3125
13,Had menopause,1349
13,Reaction time,472
13,Facial morphology (segment 2),61
13,Myocardial fractal dimension (slice 4),36
13,Electrocardiogram morphology (amplitude at temporal datapoints) [260 ms],75
13,Sum eosinophil basophil counts,17965
13,Glomerular filtration rate,2432
13,Serum levels of protein PIR,2171
13,Insomnia [Male],815
13,Glutamine levels,489
13,Electrocardiogram morphology (amplitude at temporal datapoints) [14 ms],417
13,Serum levels of protein CALB1,2171
13,"Blood pressure medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",320
13,Chronic lymphocytic leukemia or multiple sclerosis,361
13,Beef intake,3
13,Bricanyl 250mcg inhaler | treatment/medication code,534
13,epithelial cell adhesion molecule levels,32
13,Mood swings,1953
13,Protein quantitative trait loci [Esterase D],412
13,Neurofibrillary tangles (SNP x SNP interaction),2592
13,Diffuse plaques (SNP x SNP interaction),1190
13,Electrocardiogram morphology (amplitude at temporal datapoints) [226 ms],75
13,Frequency of tiredness / lethargy in last 2 weeks,13
13,Hematocrit,80713
13,Facial morphology (segment 1),625
13,Lymphocyte counts,87531
13,Morning/evening person (chronotype),1916
13,Breast cancer,141
13,"""Malignant neoplasm of breast, HER2-negative""",2
13,Platelet count,363106
13,Serum levels of protein TDO2,4762
13,Number of incorrect matches in round,619
13,Medication use (vasodilators used in cardiac diseases),20
13,A levels/as levels or equivalent | qualifications,159
13,"Other chronic ischemic heart disease, unspecified",502
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-108 ms],75
13,Body mass index [Japanese],27
13,Systemic lupus erythematosus or rheumatoid arthritis [same effect],9859
13,Cholelithiasis or gall stones,170
13,Electrocardiogram morphology (amplitude at temporal datapoints) [236 ms],75
13,Initial pursuit acceleration in psychotic disorders [African],360
13,Methanobrevibacter B abundance in stool,211
13,Life satisfaction,2990
13,"""Endocrine, nutritional and metabolic diseases""",324
13,Mean time to correctly identify matches,206
13,Percent mammographic density,22
13,Alcohol consumption x experiences in childhood (felt loved by family member) interaction,107
13,Idiopathic pulmonary fibrosis,262
13,Bone mineral density [Cortical vBMD],423
13,Visual field defects,3
13,Heart attack | vascular/heart problems diagnosed by doctor,8
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-12 ms],417
13,"""Hypertension, essential""",174
13,Protein quantitative trait loci (liver) [CYP1A2],3
13,"Pancreatitis | non-cancer illness code, self-reported",538
13,Agouti-related protein levels,1806
13,Strenuous sports or other exercises,5597
13,"Bowel / intestinal obstruction | non-cancer illness code, self-reported",51
13,Asthma (more control exclusions),708
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-172 ms],2001
13,5-hydroxyindoleacetate levels,59
13,Postoperative survival time in hepatocellular carcinoma,58
13,Water intake,7727
13,College or university degree | qualifications,3060
13,Cerebrospinal fluid t-tau:AB1-42 ratio,1356
13,Electrocardiogram morphology (amplitude at temporal datapoints) [266 ms],75
13,Waist circumference,13092
13,Frequency of friend/family visits,963
13,Spherical power (left),8808
13,Blood protein levels [Glypican-5],609
13,Urolithiasis,5550
13,Hand grip strength,35
13,Angina | vascular/heart problems diagnosed by doctor,8
13,Normal facial asymmetry (angle of surface orientation score) [≥14 yr],107
13,Home location at assessment - north co-ordinate (rounded),18
13,"Hip circumference [EA, men]",692
13,6mm weak meridian (right),2704
13,Interstitial lung disease,262
13,Metabolite levels [Proline],72
13,Retinal arteriolar tortuosity,1006
13,"None of the above | medication for pain relief, constipation, heartburn",79
13,Coagulation Factor X measurement,6994
13,Colorectal polyp and colorectal cancer (MTAG) [Colorectal polyp],121
13,Lifetime smoking index,333
13,Homeostasis model assessment of insulin resistance,2
13,Bone mineral density [spine],109
13,Thiopurine-induced leukopenia in inflammatory bowel disease,6294
13,Self-reported math ability,4923
13,Electrocardiographic traits (multivariate),5756
13,Comparative body size at age 10,9750
13,Protein quantitative trait loci (liver) [GCLC],1567
13,Pneumococcal meningitis x streptococcus pneumoniae antigen allele interaction [pspC-9],80
13,Tissue factor levels,1194
13,Protein quantitative trait loci (liver) [DDB1],28
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-162 ms],2001
13,Gut microbiota relative abundance (bacterial taxa) [Clostridium_xylanovorans],34
13,UBA737 sp002451855 abundance in stool,18
13,Vertex-wise cortical surface area,13495
13,Protein quantitative trait loci (liver) [DUSP3],1567
13,Haemorrhoidal disease,656
13,N-acetylglucosamine/n-acetylgalactosamine levels,1144
13,Fluid intelligence score,74
13,Fat-free mass,4592
13,Spleen volume,1402
13,Electrocardiogram morphology (amplitude at temporal datapoints) [246 ms],75
13,Age at first sexual intercourse,13371
13,Electrocardiogram morphology (amplitude at temporal datapoints) [8 ms],417
13,DTU024 sp002411105 abundance in stool,95
13,Fibroblast growth factor 23 levels,1239
13,Electrocardiogram morphology (amplitude at temporal datapoints) [218 ms],249
13,Protein quantitative trait loci (liver) [UCHL3],1713
13,Cheese intake,195
13,Corneal hysteresis (right),183
13,Protein quantitative trait loci (liver) [ACO1],12
13,QRS duration [European],56
13,"Blood protein levels [CRLF2, 13694_24_3]",2171
13,Heel bone mineral density (bmd) (left),4758
13,Birth weight (MTAG),1668
13,Intelligence,778
13,Chronic venous insufficiency [cvi],243
13,Aspartate aminotransferase levels,23798
13,Platelet-to-lymphocyte ratio,11437
13,Vertex-wise cortical thickness,35364
13,Leisure sedentary behaviour (computer use),1283
13,Actinic keratosis,88
13,"""Pulmonary eosinophilia, not elsewhere classified""",108
13,BMI (adjusted for smoking behaviour),27
13,Protein quantitative trait loci (liver) [S100A9],14
13,Protein quantitative trait loci (liver) [SEPT7],4
13,Gout,1665
13,Duration to first press of snap-button in each round,182
13,Protein quantitative trait loci (liver) [ALDH5A1],21
13,Predicted visceral adipose tissue,7308
13,Lung function (FEV1/FVC),31932
13,Thiopurine-induced early leukopenia in Crohn's disease,3147
13,Sum neutrophil eosinophil counts,6582
13,Previous | smoking status,1130
13,Diverticulosis,69
13,Hip circumference,14066
13,"Blood protein levels [TOR1AIP1, 10606_34_3]",2171
13,"Disc problem | non-cancer illness code, self-reported",159
13,Low tan response,8487
13,Metabolic biomarkers (multivariate analysis),33607
13,3mm strong meridian (right),3431
13,Adcal-d3 1.5g/10micrograms chewable tablet | treatment/medication code,83
13,"None of the above | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",158
13,Protein quantitative trait loci (liver) [ECI1],278
13,"Back problem | non-cancer illness code, self-reported",119
13,Small (125ml) | size of red wine glass drunk,11
13,Spinal canal stenosis,33
13,Essential hypertension,1277
13,Atrial fibrillation/atrial flutter,124
13,Other diseases of upper respiratory tract,73
13,Normal facial asymmetry (angle of surface orientation score),107
13,Gastroesophageal reflux disease,5436
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-22 ms],3118
13,Lysophosphatidylethanolamine levels [LPE(18:2;0],2449
13,No | hearing difficulty/problems,187
13,Vertical cup-disc ratio (adjusted for vertical disc diameter),1755
13,Snoring [adjusted for BMI],1632
13,Dupuytren's disease,467
13,Childhood body mass index,54
13,Left-handedness,774
13,Electrocardiogram morphology (amplitude at temporal datapoints) [270 ms],75
13,Alanine aminotransferase levels,56986
13,Heel broadband ultrasound attenuation (left),1885
13,Job involves heavy manual or physical work,304
13,Serum metabolite levels [succinylcarnitine (C4-DC],1234
13,Acute appendicitis,240
13,Electrocardiogram morphology (amplitude at temporal datapoints) [142 ms],17058
13,"Forced expiratory volume in 1-second (fev1), best measure",33229
13,Aprovel 75mg tablet | treatment/medication code,249
13,Benign prostatic hyperplasia and lower urinary tract symptoms,2501
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-98 ms],75
13,Neuroticism,12001
13,Restless legs syndrome,566
13,Diastolic blood pressure (alcohol consumption interaction) [Oz alcohol/week],19
13,Cortical surface area,13120
13,"Blood protein levels [EA, Glypican-5]",663
13,Diabetes mellitus,75
13,Body fat percentage,90052
13,Serum levels of protein MAP2K2,16899
13,Direct bilirubin levels,2715
13,3mm weak meridian (right),3272
13,Endometrial cancer (endometrioid histology),21
13,Leg fat mass (left),52454
13,Impedance of leg (right),8640
13,Disorders of lipoid metabolism,2783
13,Bendroflumethiazide | treatment/medication code,317
13,Facial morphology (nose protrusion),81
13,Endozoicomonadaceae abundance in stool,4
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-170 ms],2001
13,Parkinson's disease or first degree relation to individual with Parkinson's disease,921
13,Lung function (FVC),31606
13,Body mass index (bmi),85587
13,Cortical surface area [Pericalcarine],1371
13,Protein quantitative trait loci (liver) [UGT1A1],2268
13,Diverticular disease of intestine,134
13,Type 2 diabetes,20188
13,Place of birth in uk - east co-ordinate,487
13,Brinzolamide | treatment/medication code,895
13,Childhood sunburn occasions,941
13,Neurociticism,728
13,Electrocardiogram morphology (amplitude at temporal datapoints) [282 ms],75
13,"Hypertension | non-cancer illness code, self-reported",5498
13,Brown vs. black hair color,3119
13,Periventricular white matter hyperintensities,260
13,"""Asthma, including avohilmo""",708
13,Leg fat mass,2
13,Balding type 1,1347
13,Electrocardiogram morphology (amplitude at temporal datapoints) [144 ms],75
13,Gliclazide | treatment/medication code,75
13,"Acute infective polyneuritis/guillain-barre syndrome | non-cancer illness code, self-reported",98
13,Barnesiellaceae abundance in stool,227
13,Age when periods started (menarche),5441
13,Nasopharyngeal carcinoma (SNP x SNP interaction),780
13,Medication use (beta blocking agents),122
13,Nevus count or cutaneous melanoma,681
13,Bifidobacterium kashiwanohense abundance in stool,195
13,Myeloproliferative neoplasms,1357
13,Arm fat-free mass (right),13436
13,Crohn's disease [EA],4253
13,Inflammatory bowel disease,6746
13,"""Asthma, hospital admissions , main diagnosis only""",708
13,Household income,5047
13,Serum levels of protein RHOD,2517
13,HDL cholesterol,747
13,Whole body fat-free mass,48405
13,Gut microbiota (functional units) [PWY-3001_superpathway_of_L-isoleucine_biosynthesis_I],519
13,Ever smoked,1378
13,Arm fat percentage (left),36318
13,"Blood protein levels [EA, Carboxypeptidase B2]",1694
13,X-11787 levels,676
13,Periodontal disease-related phenotype (Socransky),230
13,Cortical thickness (MOSTest),218
13,Adolescent idiopathic scoliosis,26747
13,Mean arterial pressure,4239
13,Thrombin-activatable fibrinolysis inhibitor activation peptide,2689
13,Protein quantitative trait loci [TAFI],2171
13,Heel broadband ultrasound attenuation (right),2985
13,Keratoconus,429
13,Vitamin B12 levels,57
13,Cortical volume [Pericalcarine],93
13,Protein quantitative trait loci (liver) [LASP1],1639
13,Thyroid stimulating hormone levels,322
13,Electrocardiogram morphology (amplitude at temporal datapoints) [212 ms],75
13,Mean reticulocyte volume,175717
13,Serum urea levels,3452
13,Attention deficit hyperactivity disorder (MTAG),685
13,"Blood protein levels [F7, 3184_25_2]",1194
13,Time spend outdoors in summer,1678
13,Well-being spectrum (multivariate analysis),2846
13,Prostate-specific antigen levels (conditioned on lead SNPs) [conditional on Round 1 SNPs],92
13,"Self-injury such as self-cutting, scratching or hitting, etc. | methods of self-harm used",140
13,Sex hormone-binding globulin levels adjusted for BMI,112978
13,Sum basophil neutrophil counts,6545
13,Ever believed in an un-real conspiracy against self,195
13,Protein quantitative trait loci (liver) [GALE],71
13,Electrocardiogram morphology (amplitude at temporal datapoints) [256 ms],75
13,Direct low density lipoprotein cholesterol levels,7523
13,Cognitive aspects of educational attainment,181
13,Serum metabolite levels [N-acetylcarnosine],630
13,Body mass index [age 1-17],27
13,Platelet distribution width,159572
13,Leg predicted mass (right),19265
13,Lymphocyte percentage,17443
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-174 ms],2001
13,None of the above | vascular/heart problems diagnosed by doctor,4949
13,BRCA2 mutation in breast cancer,133
13,Electrocardiogram morphology (amplitude at temporal datapoints) [200 ms],249
13,Liver enzyme levels (alanine transaminase),32577
13,"Blood protein levels [KIAA2013, 6538_90_3]",2891
13,Vitiligo,521
13,1-methyl-5-imidazoleacetate levels,973
13,"""Type 2 diabetes, definitions combined""",187
13,Aortic aneurysm,257
13,3mm asymmetry index (right),5
13,B cell lymphocyte profile difference,168
13,Protein quantitative trait loci (liver) [IARS2],13
13,Longest period of depression,9
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-176 ms],2001
13,Protein quantitative trait loci (liver) [MYO1B],5
13,"Orofacial clefts [Meta-All, NSCLP]",26
13,Eosinophill percentage,28629
13,Protein quantitative trait loci (liver) [RNASE2],628
13,High cholesterol,2904
13,Corneal resistance factor (left),230
13,QRS complex (12-leadsum) [EA],4149
13,Obesity [Obesity class II],4197
13,"Other exercises (eg: swimming, cycling, keep fit, bowling) | types of physical activity in last 4 weeks",163
13,Coronary artery bypass grafting,65
13,"""Cluster headache, wide""",115
13,Peritonsillar abscess,57
13,Electrocardiogram morphology (amplitude at temporal datapoints) [244 ms],75
13,"Blood protein levels [TDO2, 9880_33_3]",2171
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-154 ms],2001
13,Bone mineral density (spine),1518
13,Electrocardiogram morphology (amplitude at temporal datapoints) [204 ms],75
13,Protein quantitative trait loci (liver) [RHOA],1567
13,Nasal polyps,408
13,Serum levels of protein TOM1L1,2498
13,Body fat distribution (trunk fat ratio) [females],59
13,Estimated glomerular filtration rate [EA],82
13,Electrocardiogram morphology (amplitude at temporal datapoints) [252 ms],75
13,Thyroid problem (not cancer),4183
13,Electrocardiogram morphology (amplitude at temporal datapoints) [138 ms],75
13,Coagulation factor Xa measurement,3526
13,Electrocardiogram morphology (amplitude at temporal datapoints) [118 ms],17058
13,Fasting plasma glucose,506
13,Aortic root size,365
13,Osteoarthritis,910
13,Protein quantitative trait loci (liver) [MAP4],1
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-158 ms],2001
13,Red cell distribution width,381914
13,Trunk predicted mass,46328
13,Paceibacteria abundance in stool,49
13,Age started wearing glasses or contact lenses,9519
13,Calcium carbonate+cholecalciferol 1.25g/200iu tablet | treatment/medication code,4
13,Platelet crit,11815
13,"Medication use (adrenergics, inhalants)",6856
13,"Blood protein levels [CLN5, 8874_53_3]",2755
13,White matter microstructure (fractional anisotropy) [Genu of corpus callosum],1766
13,LDL cholesterol x physical activity interaction (2df test),632
13,Bilirubin levels,17
13,Asthma (adult onset),20829
13,Protein quantitative trait loci (liver) [HINT1],1567
13,Hypertensive diseases (excluding secondary),83
13,Protein quantitative trait loci (liver) [NIPSNAP1],4
13,"Heel bone mineral density (bmd) t-score, automated (right)",3042
13,Alzheimer's disease (cognitive decline),20
13,Gamma glutamyl transpeptidase,5095
13,Serum levels of protein APLN,2171
13,Tumor necrosis factor ligand superfamily member 13B levels,21
13,Bipolar disorder,15993
13,High light scatter reticulocyte count,60957
13,Achilles tendon injury,55
13,T wave morphology restitution during recovery from exercise (MTAG),75
13,Electrocardiogram morphology (amplitude at temporal datapoints) [238 ms],75
13,Nucleated red blood cell count,3
13,Heel bone mineral density x serum urate levels interaction [female],3
13,Red blood cell (erythrocyte) distribution width,70298
13,"Hypothyroidism/myxoedema | non-cancer illness code, self-reported",2077
13,Electrocardiogram morphology (amplitude at temporal datapoints) [272 ms],75
13,P-cresol sulfate levels,33
13,Nonsyndromic cleft lip with cleft palate,121
13,Rheumatoid arthritis,28672
13,Basal metabolic rate,50783
13,Serum albumin levels,5255
13,Thiopurine-induced alopecia in inflammatory bowel disease,3147
13,Peak expiratory flow,1825
13,Migraine and/or pulse pressure,55
13,Body mass index [EA],27
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-100 ms],6482
13,Knee osteoarthritis,506
13,Protein quantitative trait loci (liver) [COQ9],262
13,Smoking initiation (ever regular vs never regular) [Conditioned on chr13:80191873],45
13,Vertical cup-disc ratio,4610
13,Antihypertensive medication - note that there are other indications,18083
13,Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis),1246
13,Serum levels of protein F7,525
13,Protein quantitative trait loci (liver) [PREP],9
13,"5,6-dihydrothymine levels",714
13,Oxalate (ethanedioate) levels,170
13,Acute respiratory distress syndrome in sepsis,342
13,Ease of getting up in the morning,2755
13,Male-pattern baldness,2002
13,Urea levels,807
13,Prostate cancer,1752
13,DHEAS levels [men],149
13,Electrocardiogram morphology (amplitude at temporal datapoints) [136 ms],75
13,Family history of malignant neoplasm,11
13,Temporomandibular joint disorder [Hispanic women],4
13,Nephrolithiasis,963
13,Basophil percentage of white cells,264
13,Fybogel mebeverine sachet | treatment/medication code,98
13,Protein quantitative trait loci (liver) [GGT5],4
13,"Cancer of larynx, pharynx, nasal cavities",573
13,Peptic ulcer disease,868
13,Total cerebellar volume (excluding Crus I vermis),198
13,CD62L- monocyte %monocyte,22
13,Mean corpuscular hemoglobin,239842
13,Brain morphology (MOSTest),5252
13,Waist-to-hip ratio adjusted for BMI,12309
13,Respiratory diseases,3974
13,Rheumatoid arthritis [AA],155
13,Endometrial cancer,63
13,hemolysis of donated blood (osmotic),6
13,Choline phosphate levels,2
13,Height,334786
13,Parkinson's disease,1258
13,"Heart attack/myocardial infarction | non-cancer illness code, self-reported",8
13,Factor VII levels,1194
13,None of the above | pain type(s) experienced in last month,639
13,Demyelenating diseases of the central nervous system,454
13,Electrocardiogram morphology (amplitude at temporal datapoints) [224 ms],75
13,Reticulocyte fraction of red cells,10317
13,"Black | hair colour (natural, before greying)",3119
13,Electrocardiogram morphology (amplitude at temporal datapoints) [284 ms],75
13,Essential hypertension (time to event),583
13,Protein quantitative trait loci (liver) [LONP1],4
13,"Thyroid problem (not cancer) | non-cancer illness code, self-reported",1
13,KELA_REIMBURSEMENT_202,9892
13,Glycated hemoglobin levels,15262
13,Inflammatory bowel disease [EA],4351
13,Serum levels of protein CPB2,2184
13,Nucleated red blood cell percentage,3
13,A painkiller | substance of prescription or over-the-counter medication addiction,1903
13,Colorectal cancer,2876
13,Mitochondrial DNA copy number,2063
13,Coronary artery aneurysm in Kawasaki disease,194
13,Chronic obstructive pulmonary disease,80
13,Electrocardiogram morphology (amplitude at temporal datapoints) [134 ms],75
13,Treponema D abundance in stool,64
13,Irritable mood,8
13,"Forced expiratory volume in 1-second (fev1), predicted",33177
13,Whole body fat mass,42203
13,Serum levels of protein IFNA10,2498
13,Blood protein levels [F7],1194
13,Electrocardiogram morphology (amplitude at temporal datapoints) [210 ms],75
13,Benign neoplasm: other/unspecified salivary gland,51
13,Alcohol intake frequency.,857
13,Protein quantitative trait loci (liver) [C4B],10
13,Hypertensive diseases,249
13,Depressed affect,299
13,"""Other diabetes, wide definition""",33
13,White matter hyperintensity volume,629
13,Bleeding gums | mouth/teeth dental problems,157
13,Arm fat percentage (right),36093
13,Long QT syndrome,69
13,Neutrophil percentage of white cells,31818
13,Spherical power (right),9383
13,Nasopharyngeal carcinoma,1779
13,BRCA2 mutation in breast cancer [adjusted],712
13,Electrocardiogram morphology (amplitude at temporal datapoints) [34 ms],417
13,Electrocardiogram morphology (amplitude at temporal datapoints) [160 ms],75
13,Rate of ventricular enlargement,320
13,Eosinophill count,29436
13,"Diabetes | non-cancer illness code, self-reported",137
13,Craniofacial microsomia [left-side-affected],7
13,Immune reponse to smallpox (secreted IL-1beta) [EA],55
13,Optic nerve head parameters (multi-trait analysis) [EA],5707
13,HDL cholesterol levels,13471
13,Arm fat mass (right),34204
13,Monocyte percentage,6274
13,Bone mineral density (hip) and hip bone size,3125
13,Autoimmune traits,2795
13,Pulse wave arterial stiffness index,1430
13,Protein quantitative trait loci (liver) [KRT18],23
13,Intracranial aneurysm,783
13,Colorectal cancer or advanced adenoma,1158
13,"""Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified""",449
13,Electrocardiogram morphology (amplitude at temporal datapoints) [156 ms],75
13,Hot drink temperature,27
13,Barnesiella abundance in stool,227
13,QT dynamics during exercise [female],61
13,Forced vital capacity (fvc),2555
13,General risk tolerance (MTAG),2512
13,General factor of neuroticism,1531
13,Waist-hip index,1564
13,Ascorbate (vitamin c) levels,9
13,Diverticulitis,31
13,Ulcer of oesophagus,5
13,"Blood protein levels [GPC5, 4991_12_1]",587
13,Obesity-related traits [Weight z-score change ],112
13,Serum metabolite levels [glycodeoxycholate sulfate],12
13,Age-related cognitive decline (attention/processing speed) (slope of z-scores),4973
13,Hypothyroidism,4894
13,Ulcerative colitis,981
13,Arterial stiffness,173
13,Irritability,8
13,Pre-treatment viral load in HIV-1 infection,62
13,Neutrophil percentage of granulocytes,18344
13,Mean corpuscular volume,313312
13,"Asthma | non-cancer illness code, self-reported",3994
13,Heel bone mineral density (bmd),4082
13,Strenuous sports | types of physical activity in last 4 weeks,184
13,Glucose levels,1794
13,Occasionally | tobacco smoking,13
13,Budesonide+formoterol | treatment/medication code,205
13,Glycated hemoglobin levels in type 1 diabetes,17
13,Cholelithiasis,303
13,Autism and major depressive disorder (MTAG),730
13,Fracture at wrist and hand level,4
13,Eosinophil percentage of white cells,57459
13,"""Hypothyroidism, strict autoimmune, 3 medication purchases required""",2687
13,Vertical cup-disc ratio (multi-trait analysis),1801
13,Disorders of the thyroid gland,324
13,Diabetes diagnosed by doctor,60
13,Anti-Epstein-Barr virus IgG seropositivity,1722
13,Protein quantitative trait loci (liver) [LTF],295
13,Protein quantitative trait loci (liver) [RAB11B],1567
13,Serum levels of protein PCDH9,236
13,"""Appendicitis, broad definition""",368
13,Height [AA],460
13,Myopia (age of diagnosis),9468
13,TB-LM or TBLH-BMD (pleiotropy),393
13,Terbutaline | treatment/medication code,24
13,High density lipoprotein cholesterol levels,51
13,Mean spheric corpuscular volume,84899
13,Irritable bowel syndrome,768
13,Morning vs. evening chronotype,2755
13,Leiomyoma of uterus (controls excluding all cancers),677
13,Time spent using computer,1373
13,"Intra-ocular pressure, corneal-compensated (right)",772
13,6mm strong meridian (left),2872
13,Conduct disorder (symptom count),59
13,Protein quantitative trait loci (liver) [GATM],30
13,Electrocardiogram morphology (amplitude at temporal datapoints) [230 ms],75
13,Late-onset Alzheimer's disease [liability model],18
13,Arm fat-free mass (left),41073
13,Urinary calculus,766
13,malignant neoplasm of female genital organs (controls excluding all cancers),16
13,Glaucoma (multi-trait analysis),2169
13,Protein quantitative trait loci [MAPKAPK3],2498
13,Protein quantitative trait loci [Coagulation Factor VII],1194
13,"Blood protein levels [POSTN, 6645_53_3]",239
13,Comparative height size at age 10,57914
13,Aspartate aminotransferase to alanine aminotransferase ratio,221
13,Serum 25-Hydroxyvitamin D levels,43
13,Electrocardiogram morphology (amplitude at temporal datapoints) [280 ms],75
13,Protein quantitative trait loci (liver) [IGHA1],141
13,3mm weak meridian (left),3547
13,Chin dimples,16
13,Electrocardiogram morphology (amplitude at temporal datapoints) [240 ms],75
13,Cognitive traits (MTAG),19
13,Hypothyroidism (congenital or acquired),324
13,Medication use (HMG CoA reductase inhibitors),2913
13,Insomnia [Female],5132
13,Lymphocyte count,3533
13,Sunburns,712
13,"Tennis elbow / lateral epicondylitis | non-cancer illness code, self-reported",315
13,Cognitive ability,107
13,Cigarettes smoked per day (MTAG),179
13,Appendicular lean mass,154208
13,Respiratory or ear-nose-throat disease,3870
13,"Blood protein levels [EA, MAP kinase-activated protein kinase 3]",4518
13,Lymphocyte-to-monocyte ratio,2021
13,Serum levels of protein CD96,1998
13,Primary tooth development (number of teeth),733
13,Psoriasis,17894
13,Fasting blood glucose (BMI interaction),506
13,"Skin aging measurement [Dominant, size of pigmented spots on cheek, East Asian]",11
13,Menopause (age at onset),6158
13,Colon polyp,570
13,Electrocardiogram morphology (amplitude at temporal datapoints) [186 ms],75
13,Highest math class taken (MTAG) [MTAG],21003
13,"Smoking initiation (ever regular vs never regular) [Conditioned on chr13:100648356, chr13:100546450]",1458
13,Glomerular filtration rate (creatinine),201
13,Place of birth in uk - north co-ordinate,154
13,Cerebrospinal fluid biomarker levels [Periostin],192
13,Time to complete round,431
13,Serum levels of protein ESD,412
13,Asthma (time to childhood onset) x early life tobacco smoke interaction,59
13,Cystatin C levels,85304
13,Levothyroxine sodium | treatment/medication code,1911
13,FEV1,868
13,Hypertrophic cardiomyopathy (sarcomere negative),163
13,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)",17055
13,Medication use (drugs used in diabetes),2311
13,Electrocardiogram morphology (amplitude at temporal datapoints) [166 ms],75
13,Overall health rating,3484
13,Serum levels of protein MIF,2498
13,Sudden cardiac arrest [Recessive],178
13,Procreative management,5
13,Hemoglobin,18321
13,White blood cell (leukocyte) count,21103
13,Psychroserpens abundance in stool,1030
13,Extremely high intelligence,6
13,PR interval,24463
13,Impedance of whole body,8899
13,Thiopurine-induced severe alopecia in inflammatory bowel disease,3147
13,Blood glucose levels,3611
13,Facial morphology (segment 11),731
13,Serum levels of protein TNFRSF19,643
13,Total body bone mineral density (age 30-45),506
13,Household income (MTAG),718
13,Birth length (MTAG),1457
13,Salt added to food,1128
13,Insomnia symptoms (never/rarely vs. sometimes/usually),1360
13,Icd10: i25.1 atherosclerotic heart disease | underlying (primary) cause of death,44
13,Youthful appearance (self-reported),555
13,Mean platelet volume,211366
13,"""Inflammatory bowel disease, strict (require KELA)""",2903
13,Intraocular pressure,5467
13,Rheumatoid arthritis [EA],18741
13,Gamma glutamyl transferase levels,30871
13,Serum phosphate levels,2000
13,Blood urea nitrogen levels,10603
13,Serum levels of protein F10,432
13,Electrocardiogram morphology (amplitude at temporal datapoints) [10 ms],417
13,"Waist-hip ratio [EA, men]",8
13,Multiple sclerosis,1193
13,Total protein levels x insomnia interaction,302
13,Cerebrospinal fluid biomarker levels [S-formylglutathione hydrolase],413
13,Angina pectoris,93
13,Peak expiratory flow (pef),2025
13,Prothrombin time,3012
13,"Blood protein levels [EA, Coagulation Factor VII]",2211
13,Medication use (diuretics),1545
13,Leg fat percentage (left),61648
13,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),2245
13,Glaucoma,165
13,Low vWF levels,124
13,Monocyte percentage of white cells,64028
13,Brain region volumes [right vessel],195
13,Breast milk fatty acid composition (maternal genotype effect) [capric acid],760
13,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)",2241
13,Amlodipine | treatment/medication code,741
13,CCR7 on naive CD4+ T cell,23
13,Number of treatments/medications taken,707
13,Squamous cell carcinoma,573
13,Pulse wave peak to peak time,79
13,Body mass index [age 8],27
13,Neutrophill count,27135
13,"Allergic disease (asthma, hay fever or eczema)",5315
13,Protein Z-dependent protease inhibitor measurement,24149
13,Lumbar spine bone mineral density (integral),122
13,Electrocardiogram morphology (amplitude at temporal datapoints) [36 ms],417
13,Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis),226
13,Effects of other external causes,3
13,"Blood pressure measurement (low sodium intervention) [SBP, response to intervention]",2269
13,Coronary atherosclerosis,842
13,Protein quantitative trait loci (liver) [PSME1],984
13,Multisite chronic pain,712
13,Corneal resistance factor (right),183
13,Stable angina pectoris,20
13,Low density lipoprotein cholesterol levels,16349
13,Asthma (only as main-diagnosis),708
13,TNF-related activation-induced cytokine levels,506
13,Average total household income before tax,1243
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-4 ms],417
13,Oily fish consumption,272
13,Calceos chewable tablet | treatment/medication code,68
13,Positive affect,3017
13,Estimated glomerular filtration rate,13306
13,Protein quantitative trait loci [GPC5],576
13,Electrocardiogram morphology (amplitude at temporal datapoints) [38 ms],417
13,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],2245
13,Urinary potassium excretion [EA],287
13,Ease of skin tanning,8569
13,Externalizing behaviour (multivariate analysis),8715
13,Leg fat percentage (right),54445
13,Past tobacco smoking,1353
13,Worry too long after an embarrassing experience,4848
13,Serum levels of protein RAET1E,2498
13,Lysophosphatidylcholine_17:2_[M+H]1+/Lysophosphatidylethanolamine_20:2_[M+H]1+ levels,329
13,Electrocardiogram morphology (amplitude at temporal datapoints) [254 ms],75
13,Electrocardiogram morphology (amplitude at temporal datapoints) [268 ms],75
13,Educational attainment (years of education),21900
13,Phospholipid levels (plasma) [levels],27
13,Gut microbiota abundance (order Bifidobacteriales id.432),8
13,Serum levels of protein TOR1AIP1,2498
13,Impedance of arm (right),6852
13,Arthritis (juvenile idiopathic),506
13,Cortical surface area (visual PC2) [EA],111
13,Inguinal hernia,252
13,Calcium | mineral and other dietary supplements,506
13,Allergic march (atopic dermatitis to allergic rhinitis),1
13,Thrombin-activatable fibrinolysis inhibitor levels,3134
13,Hypercholesterolemia,2783
13,Ebbinghaus illusion (overestimation),64
13,Metoclopramide | treatment/medication code,11
13,Nodular sclerosis Hodgkin lymphoma,13088
13,Age at menopause,8896
13,"Alcohol use disorder (consumption score) [EA, women]",22010
13,Venous thromboembolism (SNP x SNP interaction),154
13,Basophil count,9395
13,Impedance of leg (left),8816
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-24 ms],3118
13,Corneal structure,205
13,Nicotine product | treatment/medication code,47
13,Metabolite levels [CE 14:0],4
13,Serum levels of protein ALPI,2498
13,Total amyloid (SNP x SNP interaction),174
13,Edema,38
13,Chlamydia trachomatis PorB antibody levels,173
13,DVT of lower extremities and pulmonary embolism,145
13,Plateletcrit,47452
13,Red blood cell (erythrocyte) count,11332
13,Myopia,990
13,"Blood protein levels [EA, S-formylglutathione hydrolase]",46
13,Lung cancer,704
13,Eczema,4530
13,"Blood protein levels [ALPI, 10463_23_3]",2891
13,Cortical surface area [Cuneus],256
13,Cardiac problem,8
13,Triglyceride levels,23313
13,"Heel quantitative ultrasound index (qui), direct entry (right)",3042
13,Protein quantitative trait loci (liver) [NUCB1],148
13,Electrocardiogram morphology (amplitude at temporal datapoints) [32 ms],417
13,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) [EA],110
13,Orofacial clefts,21
13,Bone mineral density (hip),506
13,Shoulder impingement or rotator cuff tear,211
13,Fed-up feelings,8
13,Diclofenac sodium+misoprostol | treatment/medication code,611
13,"""Cluster headache, wide,, including avohilmo""",132
13,Time spent watching television (tv),1316
13,Fasting plasma glucose [Non diabetics],506
13,Academic attainment (science),35
13,Leg predicted mass (left),19626
13,For a 'squint' or 'turn' in an eye since childhood (called 'strabismus') | reason for glasses/contact lenses,9
13,"Blood protein levels [B3GALTL, 5727_35_3]",6749
13,Montelukast product | treatment/medication code,208
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-114 ms],6407
13,Liver enzyme levels (gamma-glutamyl transferase),2538
13,Insulin-related traits (multivariate analysis),109
13,Electrocardiogram morphology (amplitude at temporal datapoints) [6 ms],417
13,Protein quantitative trait loci (liver) [HEBP1],15
13,Longest period of unenthusiasm / disinterest,7
13,Total body bone mineral density,1076
13,Cortical surface area (min-P),1115
13,Nocturnal enuresis,758
13,"Blood protein levels [EA, Macrophage migration inhibitory factor]",2597
13,Pediatric asthma,2913
13,Corneal resistance factor,555
13,Medication use (salicylic acid and derivatives),97
13,Fasting blood glucose,1009
13,"Blood protein levels [CALB1, 9918_23_3]",2171
13,Initial pursuit acceleration in psychotic disorders,360
13,Sporadic miscarriage,13
13,Protein quantitative trait loci (liver) [CSTA],15
13,Imodium 2mg capsule | treatment/medication code,252
13,X-12101 levels,299
13,Non-muscle-invasive bladder cancer tumour size,121
13,Endometrial endometrioid carcinoma,21
13,Systemic lupus erythematosus,4877
13,"Blood protein levels [EA, Dual specificity mitogen-activated protein kinase kinase 2]",10830
13,White blood cell count (basophil),1025
13,Neurological blood protein biomarker levels [GPC5],672
13,3mm cylindrical power (right),42
13,Electrocardiogram morphology (amplitude at temporal datapoints) [40 ms],417
13,Electrocardiogram morphology (amplitude at temporal datapoints) [220 ms],75
13,"Blood protein levels [CPB2, 3518_54_2]",2171
13,"Blood protein levels [PCDH9, 10558_26_3]",270
13,Breast milk fatty acid composition (maternal genotype effect) [palmitic acid],117
13,Diffuse large B-cell lymphoma or multiple sclerosis,361
13,Serum total protein level,9638
13,End-stage coagulation [FVII:C],4422
13,Pattern 2 | hair/balding pattern,321
13,Immunoglobulin light chain (AL) amyloidosis (serum Ig lambda profile),71
13,Electrocardiogram morphology (amplitude at temporal datapoints) [214 ms],75
13,White blood cell count,138220
13,Serum levels of protein B3GLCT,6683
13,Arm predicted mass (left),38479
13,Social science traits (pleiotropy) (HIPO component 1),5190
13,Sleeplessness / insomnia,1383
13,C-reactive protein,470
13,"Chronic obstructive airways disease/copd | non-cancer illness code, self-reported",93
13,Malignant neoplasm of breast (controls excluding all cancers),6
13,Preeclampsia (fetal genotype effect),133
13,Depression (broad),7003
13,Age at menopause (last menstrual period),3005
13,For just reading/near work as you are getting older (called 'presbyopia') | reason for glasses/contact lenses,995
13,White matter hyperintensities,249
13,Facial morphology [nasion-pronasale distance],16
13,Varicose veins of lower extremity,225
13,Adventurousness,499
13,Use of sun/uv protection,54
13,Blood protein levels [Dual specificity mitogen-activated protein kinase kinase 2],499
13,Behcet's disease,915
13,Femur bone mineral density x serum urate levels interaction [female],136
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-10 ms],417
13,Total PHF-tau (SNP x SNP interaction),18353
13,Electrocardiogram morphology (amplitude at temporal datapoints) [278 ms],75
13,Bipolar I disorder,7192
13,Snoring,2168
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-116 ms],6407
13,Testosterone levels,312
13,Electrocardiogram morphology (amplitude at temporal datapoints) [242 ms],75
13,"Angina | non-cancer illness code, self-reported",8
13,"Asthma | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",3994
13,Educational attainment (MTAG) [MTAG],17264
13,Cortical thickness,13111
13,Asthma (only as main-diagnosis) (more control exclusions),708
13,Chronic bronchitis,265
13,Lumbar spine bone mineral density (trabecular),122
13,"""Diabetes, insuline treatment (Kela reimbursement)""",47
13,Protein quantitative trait loci (liver) [AK4],4
13,Lung cancer | illnesses of father,47
13,Chronic kidney disease [eGFRcrea],201
13,Cognitive performance,181
13,"Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)",506
13,OTU97_109 (Paraprevotella) prevalence,3
13,"Blood protein levels [POSTN, 3457_57_1]",416
13,Coronary angiopasty,94
13,Hemoglobin A1c levels,29310
13,Leg fat-free mass (left),19473
13,Electrocardiogram morphology (amplitude at temporal datapoints) [2 ms],417
13,Self-reported math ability (MTAG) [MTAG],8300
13,"Allergic disease (asthma, hay fever and/or eczema) (age of onset)",506
13,Factor VII activity,1094
13,Hip index,272
13,"Labyrinthitis | non-cancer illness code, self-reported",130
13,Leisure sedentary behaviour (television watching),1162
13,Hirschsprung disease,1
13,Reticulocyte count,51156
13,Electrocardiogram morphology (amplitude at temporal datapoints) [250 ms],75
13,"Blood protein levels [PLG, 4151_6_2]",2171
13,"""Cholelithiasis, broad definition with cholecystitis""",146
13,Gtn 400micrograms spray | treatment/medication code,13
13,Electrocardiogram morphology (amplitude at temporal datapoints) [276 ms],75
13,Creatinine levels,53377
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-164 ms],2001
13,Factor VII,1194
13,Hypertrophic cardiomyopathy (sarcomere positive),72
13,Protein quantitative trait loci (liver) [LYPLAL1],146
13,Biological sex,616
13,"Sphingomyelin (d18:2/24:1, d18:1/24:2) levels",6
13,Eosinophil percentage of granulocytes,19876
13,White | bread type,1081
13,"None of the above | medication for cholesterol, blood pressure or diabetes",579
13,Creatine kinase levels,252
13,Noncognitive aspects of educational attainment,2456
13,Never | smoking status,2321
13,Endovascular or surgical operations to intracerebral aneurysms,196
13,Immature fraction of reticulocytes,49529
13,"No, never | tinnitus",1114
13,Nervous feelings,109
13,Serum levels of protein PARP11,159
13,Protein quantitative trait loci (liver) [COL14A1],23
13,Gut microbiota abundance (genus Bifidobacterium id.436),8
13,Hay fever and/or eczema,4125
13,Triglyceride levels [Trans-ethnic initial],790
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-90 ms],75
13,Angina,8
13,Citramalate levels,1271
13,Granulocyte count,6561
13,High light scatter reticulocyte percentage of red cells,9263
13,Colorectal polyp and colorectal cancer (MTAG) [Colorectal cancer],121
13,Type 2 diabetes (adjusted for BMI),47
13,Liver enzyme levels (alkaline phosphatase),4336
13,"Heel quantitative ultrasound index (qui), direct entry",4063
13,Ascending aorta minimum area,138
13,Other joint disorders,4
13,Type 2 diabetes [conditional],76
13,Electrocardiogram morphology (amplitude at temporal datapoints) [202 ms],75
13,Arm fat mass (left),34650
13,Cortical thickness (min-P),555
13,Neutrophill percentage,25528
13,Moderate to vigorous physical activity levels,219
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-156 ms],2001
13,Ever had prostate specific antigen (psa) test,1265
13,Total cholesterol levels,17274
13,Thiopurine-induced severe leukopenia in inflammatory bowel disease,3147
13,Medication use (calcium channel blockers),1223
13,Protein levels in obesity [MP2K2],456
13,Protein quantitative trait loci (liver) [PRDX5],1713
13,Cerebrospinal P-tau181p levels,86
13,Leg fat-free mass (right),19795
13,QRS duration,350
13,Migraine and/or diastolic blood pressure,55
13,Trigger finger,70
13,Ascending aorta maximum area,138
13,Age-related hearing impairment (SNP x SNP interaction),246
13,acne vulgaris,70
13,Epilepsy and lamotrigine-induced maculopapular eruptions,74
13,Protein quantitative trait loci (liver) [KRT8],23
13,Optic cup area [EA],1428
13,Gut microbiota (bacterial taxa) [Gammaproteobacteria class],33
13,Idiopathic downbeat nystagmus,6
13,Weight,97444
13,Fasting glucose,1678
13,"Blood protein levels [CCL25, 14068_29_3]",2171
13,Insomnia symptoms (never/rarely vs. usually),1348
13,Fracture of neck of femur,100
13,Presence of cardiac and vascular implants and grafts,104
13,Body fat percentage [European],36
13,Major depressive disorder (MTAG),3575
13,P-selectin levels,816
13,Non-albumin protein levels,2491
13,Fish- and plant-related diet,272
13,Longevity,102
13,Breast milk fatty acid composition (maternal genotype effect) [docosapentaenoic-n6],4
13,Protein quantitative trait loci (liver) [ACSM2A],4
13,Protein quantitative trait loci (liver) [MACROD1],1713
13,Electrocardiogram morphology (amplitude at temporal datapoints) [234 ms],75
13,QT dynamics during exercise,61
13,Nonsyndromic cleft palate,73
13,"Sphingomyelin (d18:1/20:0, d16:1/22:0) levels",57
13,Myocardial infarction,23297
13,Protein quantitative trait loci (liver) [PSMB6],192
13,Adult body size,37318
13,"""Hypothyroidism, strict autoimmune""",2412
13,Apolipoprotein A1 levels,22275
13,Blood sugar levels,357
13,"Light brown | hair colour (natural, before greying)",3133
13,Monocyte count,98937
13,Urate levels,43823
13,Mosaic loss of chromosome Y (Y chromosome dosage),2033
13,Hyperlipidemia,2783
13,Age-related hearing impairment [additive],1657
13,Cognitive ability (MTAG),362
13,Lung adenocarcinoma (survival time) in never smokers [EA],105
13,Femur bone mineral density x serum urate levels interaction [male],120
13,Smoking initiation (ever regular vs never regular) [Conditioned on chr13:38172867],266
13,Electrocardiogram morphology (amplitude at temporal datapoints) [248 ms],75
13,Forced expiratory volume in 1-second (fev1),19169
13,Autoimmune thyroid disease,830
13,Relative age of first facial hair,195
13,PR segment duration,11355
13,Bioavailable testosterone levels,602
13,Venous thromboembolism,145
13,Smoking status,1100
13,Electrocardiogram morphology (amplitude at temporal datapoints) [16 ms],417
13,White matter microstructure (axial diusivities) [Splenium of corpus callosum],542
13,Gut microbiota (bacterial taxa) [Clostridium_jejuense],93
13,Electrocardiogram morphology (amplitude at temporal datapoints) [274 ms],75
13,"Bone mineral density (paediatric, total body less head)",393
13,Mood instability,483
13,Smoking initiation (ever regular vs never regular) [Conditioned on chr13:100546450],494
13,Rapid response to perioperative phenylephrine (change in mean arterial pressure),272
13,"""Type 2 diabetes, strict (exclude DM1)""",187
13,Serum levels of protein SERPINA10,33594
13,Impedance of arm (left),8362
13,3-hydroxypropylmercapturic acid levels in smokers [Japanese],1481
13,"Heel quantitative ultrasound index (qui), direct entry (left)",4604
13,Sodium in urine,2358
13,Type 2 diabetes [EA],33
13,Systolic blood pressure,114803
13,Smoking status (ever vs never smokers),3600
13,Serum uric acid levels,5412
13,"Heel bone mineral density (bmd) t-score, automated",4063
13,"Blood protein levels [PIR, 13634_209_3]",2171
13,Metformin | treatment/medication code,106
13,Electrocardiogram morphology (amplitude at temporal datapoints) [262 ms],75
13,Birth weight,29708
13,DNA methylation variation (age effect),2222
13,Tetralogy of Fallot,154
13,Protein quantitative trait loci (liver) [PSMD11],26
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-94 ms],6482
13,"Diastolic blood pressure, automated reading",1029
13,DHEAS levels,149
13,Major coronary heart disease event excluding revascularizations,16
13,Spherical equivalent or myopia (age of diagnosis),9307
13,Prostate-specific antigen levels,681
13,Asthma (mode),708
13,Kidney stones,962
13,Schizophrenia,6611
13,Nitrogen dioxide air pollution; 2010,1326
13,Facial morphology (segment 5),243
13,X-24431 levels,37
13,Glaucoma (primary open-angle),1366
13,Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded),688
13,Distance between home and job workplace,49
13,Whole body water mass,47438
13,Getting up in morning,1949
13,Doctor diagnosed chronic bronchitis,238
13,Protein quantitative trait loci (liver) [EIF2B1],544
13,Diverticulosis and diverticulitis,69
13,Facial morphology (nose size),81
13,Hypertension,41484
13,Insulin-like growth factor 1 levels,31616
13,Age completed full time education,579
13,"Helicobacter pylori | non-cancer illness code, self-reported",113
13,Diabetes,37
13,Cortical volume [Cuneus],93
13,Waist circumference [EA],27
13,"""Coxarthrosis, primary""",139
13,Unswitched memory B cell Absolute Count,110
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-88 ms],75
13,Intelligence (MTAG),940
13,Total body bone mineral density (age 0-15),393
13,Trimethoprim | treatment/medication code,85
13,Lachnoanaerobaculum saburreum abundance in stool,19
13,Unprescribed medication (more than once) | substances taken for depression,6
13,Hard cardiovascular diseases,55
13,Coronary atherosclerosis (time to event),16
13,Heel bone mineral density,100871
13,Sex hormone-binding globulin levels,94797
13,Central corneal thickness,833
13,Gynoid fat mass,2
13,Ischemic stroke,10248
13,Optic disc size,3919
13,Risk-taking tendency (4-domain principal component model),422
13,"""Myocardial infarction, strict""",25
13,Hemoglobin concentration,32967
13,Depressive symptoms,5373
13,Usual walking pace,1599
13,Diabetic retinopathy,1048
13,Home location at assessment - east co-ordinate (rounded),5
13,Red blood cell count,156832
13,"None of the above | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",7108
13,Neuroticism score,2504
13,General cognitive ability,1478
13,Alcohol consumption (drinks per week),1332
13,Protein quantitative trait loci (liver) [ACAT2],2
13,C-reactive protein levels,14617
13,Major depressive disorder,3632
13,Captopril | treatment/medication code,270
13,Participation in an health questionnaire (not invited vs invited),126
13,Urinary sodium excretion [EA],5005
13,Myeloid white cell count,6597
13,Total testosterone levels,3707
13,Bipolar disorder or major depressive disorder,2205
13,Total cholesterol levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder,39
13,Hypothyroidism nos,797
13,Blond vs. brown/black hair color,10964
13,Smoking initiation (ever regular vs never regular),8329
13,Cleft lip with or without cleft palate,74
13,Thiopurine-induced acute severe leukopenia in inflammatory bowel disease,3147
13,Blood protein levels [IL23A],1194
13,Statin medication,7599
13,Serum levels of protein POSTN,905
13,Blood protein levels [Carboxypeptidase B2],4302
13,Ischemic heart disease,585
13,Protein quantitative trait loci (liver) [GCLM],13
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-178 ms],2001
13,Heel bone mineral density (bmd) (right),3172
13,Vitamin b6 preparation | treatment/medication code,307
13,Allergic rhinitis,506
13,"Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)",8
13,Serum alkaline phosphatase levels,62973
13,Peripheral artery disease,1491
13,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),2307
13,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],2307
13,"Blood protein levels [POSTN, 6650_20_3]",239
13,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) [subset analysis]",6462
13,Sitting height,72703
13,Corneal hysteresis (left),65
13,Electrocardiogram morphology (amplitude at temporal datapoints) [12 ms],417
13,High light scatter reticulocyte percentage,304
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-106 ms],75
13,Tumor necrosis factor receptor superfamily member 13B levels,21
13,Urinary albumin-to-creatinine ratio [EA],674
13,Hemoglobin levels,6907
13,Bone disorder,506
13,Trunk fat percentage,58930
13,Educational attainment (college completion),271
13,Electrocardiogram morphology (amplitude at temporal datapoints) [178 ms],75
13,"Anxiety/panic attacks | non-cancer illness code, self-reported",1295
13,Protein quantitative trait loci (liver) [LDHB],1
13,"Blood protein levels [APLN, 6622_90_3]",2171
13,"LDL cholesterol levels [Asian initial, BMI unadjusted]",1087
13,Oily fish intake,303
13,Lung function (FEV1),1009
13,Arterial stiffness index,79
13,Homeostasis model assessment of insulin resistance in more-fat diet,2
13,Myopia (pathological),5754
13,Pattern 4 | hair/balding pattern,1539
13,Bone mineral density,929
13,"""Type 2 diabetes, definitions combined, including avohilmo""",181
13,Diseases of appendix,561
13,Primary biliary cirrhosis,1101
13,Protein quantitative trait loci (liver) [ACSL5],16
13,Leg fat mass (right),24069
13,Photic sneeze reflex,595
13,Otosclerosis,339
13,Protein quantitative trait loci (liver) [LUM],1
13,Feeling nervous,102
13,Two-hour glucose,603
13,X-24686 levels,596
13,Protein quantitative trait loci (liver) [PON1],4853
13,LDL cholesterol levels [BMI adjusted],1365
13,Facial morphology (segment 14),1119
13,Acute sinusitis,63
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-6 ms],417
13,Lumbar spine bone mineral density,549
13,"Heavy diy (eg: weeding, lawn mowing, carpentry, digging) | types of physical activity in last 4 weeks",806
13,Body mass index,327360
13,Electrocardiogram morphology (amplitude at temporal datapoints) [222 ms],75
13,Chronotype,4075
13,Age of smoking initiation (MTAG),553
13,Electrocardiogram morphology (amplitude at temporal datapoints) [198 ms],174
13,Childhood maltreatment,217
13,"""Inguinal hernia, bilateral""",43
13,"Systolic blood pressure, automated reading",35198
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-104 ms],6482
13,Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis),28
13,Waist-to-hip ratio adjusted for BMI in non-smokers [EA],110
13,Immature reticulocyte fraction,46093
13,Medication use (thyroid preparations),1525
13,Protein quantitative trait loci (liver) [CFL2],1567
13,Cutaneous malignant melanoma,740
13,Chlamydia trachomatis momp D antibody levels,765
13,Autism,36
13,Mean sphered cell volume,81631
13,Modified Stumvoll Insulin Sensitivity Index (BMI interaction),163
13,Total body bone mineral density (age over 60),125
13,Body size at age 10,8432
13,CD16-CD56 on Natural Killer T,37
13,Highest math class taken,9462
13,Estimated glomerular filtration rate in non-diabetics,150
13,Protein quantitative trait loci (liver) [PRDX4],75
13,Keratinocyte cancer (MTAG),3858
13,Ischemic heart diseases,16
13,Placenta growth factor levels,609
13,SAPHO syndrome,327
13,"""Malignant neoplasm of breast, HER-positive (controls excluding all cancers)""",2
13,Neutrophil-to-lymphocyte ratio,3046
13,Serum levels of protein CRLF2,2498
13,Mean corpuscular hemoglobin concentration,54386
13,Coagulation factor VII measurement,2902
13,Pork consumption,272
13,Haemoglobin concentration,5245
13,"Bone mineral density (paediatric, upper limb) [EA]",393
13,Electrocardiogram morphology (amplitude at temporal datapoints) [168 ms],75
13,Pattern 3 | hair/balding pattern,92
13,Age first had sexual intercourse,11618
13,Monoclonal gammopathy of undetermined significance,4795
13,6mm strong meridian (right),2874
13,Electrocardiogram morphology (amplitude at temporal datapoints) [30 ms],417
13,Electrocardiogram morphology (amplitude at temporal datapoints) [158 ms],75
13,Malignant neoplasm of breast,2
13,Depressive symptoms (MTAG),2169
13,Type 2 diabetes with other specified/multiple/unspecified complications,47
13,Electrocardiogram morphology (amplitude at temporal datapoints) [258 ms],75
13,"Schizophrenia | non-cancer illness code, self-reported",17
13,Waist-hip ratio,13788
13,Meconium ileus in cystic fibrosis,493
13,Corneal hysteresis,372
13,QRS duration [EA],69
13,Trunk fat-free mass,46268
13,Rheumatoid arthritis (ACPA-positive),1924
13,"Cholelithiasis/gall stones | non-cancer illness code, self-reported",260
13,Coronary revascularization (ANGIO or CABG),16
13,"""Hypothyroidism, levothyroxin purchases""",324
13,CCL4 levels,271
13,Cardiovascular disease,36553
13,Hip circumference adjusted for BMI,29682
13,Low hand grip strength (60 years and older) (EWGSOP),1402
13,"""Deaf mutism, not elsewhere classified""",198
13,6mm cylindrical power (right),71
13,Diastolic blood pressure,12962
13,6-oxopiperidine-2-carboxylate levels,96
13,Mitochondrial heteroplasmy measurement,335
13,Pancreatic cancer [EA],196
13,"""Cluster headache, strict""",132
13,Serum creatinine levels,9840
13,"Heel bone mineral density (bmd) t-score, automated (left)",4613
13,QT interval,331
13,White matter hyperintensity volume (adjusted for hypertension),414
13,Tonsillectomy,117
13,"Hayfever, allergic rhinitis or eczema | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",4773
13,Local histogram emphysema pattern [Panlobular],556
13,Age cataract diagnosed,12
13,Electrocardiogram morphology (amplitude at temporal datapoints) [28 ms],417
13,Medication use (antithrombotic agents),97
13,Hip circumference adjusted for BMI [EA],145
13,"Retinal artery/vein occlusion | non-cancer illness code, self-reported",312
13,Psoriasis [EA],10142
13,Basal cell carcinoma,7732
13,Femur bone mineral density x serum urate levels interaction,225
13,Electrocardiogram morphology (amplitude at temporal datapoints) [232 ms],75
13,Major coronary heart disease event,16
13,"Forced vital capacity (fvc), best measure",33532
13,Protein quantitative trait loci (liver) [EPHX1],2268
13,"Red | hair colour (natural, before greying)",3194
13,Pancreatic cancer,1722
13,Electrocardiogram morphology (amplitude at temporal datapoints) [228 ms],75
13,"Blood protein levels [CD96, 9560_56_3]",2171
13,Insomnia,9068
13,Generalized skin eruption due to drugs and medicaments,664
13,"Osteoporosis | non-cancer illness code, self-reported",506
13,Protein quantitative trait loci (liver) [SERPINA1],19
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-96 ms],75
13,LDL cholesterol,9030
13,Smoking initiation,655
13,"Intra-ocular pressure, goldmann-correlated (right)",458
13,"Other renal/kidney problem | non-cancer illness code, self-reported",217
13,Headache | pain type(s) experienced in last month,328
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-160 ms],2001
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-2 ms],417
13,Protein quantitative trait loci (liver) [AK1],984
13,Morning person,6769
13,Coronary artery disease,86148
13,Standing height,114043
13,"Blood protein levels [TNFRSF19, 5131_15_3]",643
13,"Nasal polyps | non-cancer illness code, self-reported",1564
13,Triglyceride levels x fish oil supplementation interaction (1df),672
13,Breast cancer (estrogen-receptor negative),12
13,Body fat distribution (leg fat ratio) [females],59
13,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),373
13,Diabetes or endocrine disease,3945
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-168 ms],2001
13,Waist-to-hip ratio adjusted for body mass index,582
13,Diseases of the larynx and vocal cords,21
13,Calcium levels,18612
13,Nap during day,62
13,Primary biliary cholangitis,1313
13,Cutaneous melanoma or hair colour,225
13,Protein quantitative trait loci (liver) [CTH],10
13,Electrocardiogram morphology (amplitude at temporal datapoints) [264 ms],75
13,Optic cup area,4294
13,Alcohol consumption x traumatic event in childhood (felt hated by family member) interaction,638
13,"""Disorders of gallbladder, biliary tract and pancreas""",146
13,"Gut microbiota (bacterial taxa, rank normal transformation method) [G_unclassified_F_Porphyromonadaceae_RNT]",176
13,Total body bone mineral density (age 45-60),542
13,Experiencing mood swings,302
13,OTU97_56 (Ruminococcaceae) prevalence,147
13,Pattern 1 | hair/balding pattern,58
13,Interleukin-17D levels,12103
13,Angiostatin measurement,727
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-8 ms],417
13,Sporadic pituitary adenoma,271
13,"""Hypothyroidism,  other/unspecified""",408
13,Peripheral arterial disease (traffic-related air pollution interaction) [AA],133
13,Mean platelet (thrombocyte) volume,50136
13,Corneal curvature,2232
13,Cortical surface area (MOSTest),6043
13,Episodic memory (pairs-matching),430
13,Electrocardiogram morphology (amplitude at temporal datapoints) [44 ms],417
13,Abdominal aortic aneurysm,142
13,Hypothyroidism or myxedema,5192
13,Psoriasis or type 2 diabetes (trans-disease meta-analysis),218
13,None of the above | qualifications,1406
13,Factor VII activity [AA],1094
13,Electrocardiogram morphology (amplitude at temporal datapoints) [-166 ms],2001
13,A body shape index,1115
13,Neuritic plaques (SNP x SNP interaction),231
13,"Seen doctor (gp) for nerves, anxiety, tension or depression",6762
13,Brain region volumes [right pars triangularis],1477
13,Diverticular disease,143
13,"""Diabetes, varying definitions""",37
13,"""Ischaemic heart disease, wide definition""",16
13,Heel bone mineral density T score,49115
13,Circulating plasma alpha-Klotho levels,916
13,Blood protein levels [S-formylglutathione hydrolase],420
13,Vertex-wise sulcal depth,12963
13,Wholemeal or wholegrain | bread type,360
13,Electrocardiogram morphology (amplitude at temporal datapoints) [154 ms],75
13,"Fracture pelvis | non-cancer illness code, self-reported",794
13,Alendronate sodium | treatment/medication code,506
13,Protein quantitative trait loci (liver) [CAPN2],4
13,Hand grip strength (left),692
13,Atrial fibrillation [EA],214
13,Electrocardiogram morphology (amplitude at temporal datapoints) [42 ms],417
13,Autism spectrum disorder-related traits [ASD paternal model],12
13,Mean corpuscular haemoglobin,15339
13,Lymphocyte percentage of white cells,37114
13,"Blonde | hair colour (natural, before greying)",10964
13,Ankle spacing width (right),5113
13,Cerebrospinal fluid biomarker levels [Epidermal growth factor receptor],24
13,Plasma free amino acid levels [Lys],22
13,Morningness,4082
13,Factor VII activity or levels,1094
13,Advanced age-related macular degeneration [EA],653
13,Leprosy,2745
13,Rate of cognitive decline in Alzheimer's disease [GEE model],400
13,Ulcerative colitis [EA],270
13,Electrocardiogram morphology (amplitude at temporal datapoints) [0 ms],417
13,Home location - north co-ordinate (rounded),26
13,LDL cholesterol levels,2791
13,Candidiasis,5
13,Serum levels of protein GPC5,64
13,Internar derangement of knee,4
13,Protein quantitative trait loci (liver) [TPM4],1
13,Crohn's disease,15202
13,"Orofacial clefts [Meta-All, NSCL/P]",26
13,Asthma,80489
13,Ultradistal forearm bone mineral density,513
13,Protein quantitative trait loci (liver) [WARS],10
13,Triglycerides,9280
13,Leiomyoma of uterus,677
13,Body mass index (joint analysis main effects and smoking interaction),27
14,Neuroticism (MTAG),6953
14,6mm weak meridian (left),11102
14,Rheumatoid arthritis,21303
14,Dried fruit intake,893
14,Sleep activity levels,40
14,"Obesity-related traits [Dinner intake, adj EER ]",135
14,Electrocardiogram morphology (amplitude at temporal datapoints) [284 ms],236
14,High density lipoprotein cholesterol levels [conditional],55430
14,"Sphingomyelin (d18:1/20:0, d16:1/22:0) levels",1269
14,Blood metabolite levels [X-10510],388
14,Body mass index (joint analysis main effects and physical activity interaction) [EA],10
14,Smoking cessation (MTAG),44700
14,Serum levels of protein PNP,4779
14,Serum levels of protein AXIN2,8671
14,Neuroticism score,16283
14,IgG levels,21378
14,"""Inflammatory disorders of male genital organs, not elsewhere classified""",1307
14,Electrocardiogram morphology (amplitude at temporal datapoints) [344 ms],275
14,Age-related macular degeneration,923
14,High blood pressure | illnesses of mother,3253
14,Mean arterial pressure,1203
14,Serum levels of protein CDC42BPA,269
14,Serum levels of protein ICOS,574
14,Glucose levels,15816
14,Serum levels of protein ARG1,33588
14,Eosinophill percentage,72494
14,Pre-treatment viral load in HIV-1 infection,2008
14,Insomnia,11
14,Psoriasis,21298
14,Myopia,1295
14,Blue vs. green eyes,420
14,Other disorders of metabolism,50
14,IgG N-glycosylation phenotypes (multivariate analysis),17930
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-124 ms],275
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-120 ms],275
14,Serum levels of protein WNT5A,261
14,Usual walking pace,3989
14,Respiratory or ear-nose-throat disease,2576
14,Leg fat mass (right),15439
14,Plasma free amino acid levels [Asn],3051
14,Serum levels of protein KMT2C,243
14,Vertex-wise sulcal depth,170272
14,Brain region volumes [left precuneus],15552
14,Nicotine dependence symptom count [AA],25247
14,Brain region volumes [right pallidum],1230
14,Hand grip strength (right),13185
14,Ankle spacing width (right),2031
14,"""Gonarthrosis, primary, with knee surgery""",20
14,Leg fat percentage (left),20871
14,Ezetimibe | treatment/medication code,9
14,Gastritis and duodenitis,4
14,"Age-related diseases, mortality and associated endophenotypes",5651
14,Primary biliary cirrhosis,897
14,Iris characteristics [Pigmented Ring],420
14,Electrocardiogram morphology (amplitude at temporal datapoints) [364 ms],275
14,Heart disease | illnesses of father,50
14,1-arachidonoyl-gpc (20:4n6) levels,1575
14,Contracture of palmar fascia [dupuytren's disease],2203
14,"Blood protein levels [EA, Kallistatin]",469
14,4-chlorobenzoic acid levels,11
14,Smoking status,37727
14,Systolic blood pressure x smoking status (ever vs never) interaction (2df test) [African],63
14,Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis),7358
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-30 ms],4630
14,Renal cell carcinoma,552
14,Atopic asthma,937
14,Sphingomyelin(32:1)_[M+H]1+ levels,853
14,Headache | pain type(s) experienced in last month,450
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-96 ms],275
14,vWF levels [EA],5565
14,"Blood protein levels [GOT1, 4912_17_1]",5464
14,Heart rate response to recovery post exercise (40 sec),517
14,Aspartate aminotransferase to alanine aminotransferase ratio,2227
14,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C32:2/Phosphatidylcholine with acyl-alkyl residue sum C34:1],2310
14,Gut microbiota (bacterial taxa) [Clostridium_spiroforme],387
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-110 ms],275
14,Monocyte percentage of white cells,114638
14,Insulin-like growth factor 1 levels,247491
14,Age-related hearing impairment [additive],767
14,Body mass index (joint analysis main effects and smoking interaction),10
14,Forced vital capacity (fvc),20486
14,Plasma free amino acid levels (adjusted for one other PFAA) [Phe (adjusted for Asn],1636
14,Electrocardiogram morphology (amplitude at temporal datapoints) [304 ms],285
14,Femur bone mineral density x serum urate levels interaction,64
14,Youthful appearance (self-reported),74481
14,Standing height,161679
14,Acisoga levels,1464
14,"Rosacea | non-cancer illness code, self-reported",7
14,Cortical volume [Pericalcarine],7094
14,"Blood protein levels [SERPINA4, 14105_5_3]",1705
14,"Serum metabolite levels [sphingomyelin (d18:2/21:0, d16:2/23:0)*]",369
14,Adherence to a Japanese dietary pattern,107
14,"Forced vital capacity (fvc), best measure",15726
14,Low myopia vs hyperopia,3073
14,Post bronchodilator FEV1/FVC ratio,754
14,Serum levels of protein TNFSF12,469
14,Gut microbiota (bacterial taxa) [Unclassified Acidaminococcaceae],8699
14,Chronic obstructive pulmonary disease (moderate to severe),338
14,"Blood protein levels [LGMN, 7840_64_3]",68
14,Protein quantitative trait loci (liver) [RBP1],16
14,Cortical thickness [Middletemporal],145
14,3mm asymmetry angle (left),7
14,Testosterone levels,23121
14,Aspartate aminotransferase levels,170415
14,1-palmitoyl-2-palmitoleoyl-gpc (16:0/16:1) levels,5182
14,Cortical surface area [Inferior Temporal],1961
14,Hydrocortisone product | treatment/medication code,893
14,Cholelithiasis and cholecystitis,50
14,Immunity deficiency,818
14,Nonsyndromic cleft lip,298
14,Inflammatory bowel disease [EA],8943
14,Normotensive glaucoma,3073
14,Uveal melanoma with any chromosomal aberration,3674
14,Sphingomyelin_39:1_[M+H]1+ levels,388
14,Age at first live birth,828
14,Type 2 diabetes or prostate cancer (pleiotropy),61
14,Serum levels of protein DLK1,1978
14,Serum levels of protein UQCC3,633
14,Yeast infection,923
14,Protein quantitative trait loci (liver) [FBP1],32
14,IgG glycosylation patterns [IgG1_G0FN/IgG1_G0N],9645
14,Serum levels of protein AP1G2,2855
14,Intrahepatic Cholestasis of Pregnancy (ICP)  (more control exclusions),50
14,Gastroesophageal reflux disease,17509
14,Sitting height,83881
14,Haematocrit percentage,12078
14,Pulse rate,8925
14,Nontoxic multinodular goitre,1941
14,Facial wrinkles (crow's feet) [men],1161
14,Body fat distribution (leg fat ratio),182
14,Neutrophill count,40328
14,Serum levels of protein PTPRN2,1814
14,Feeling nervous,12841
14,N-glycan levels [plasma glycan peak 20],3164
14,Thyroid stimulating hormone levels,209
14,Hard cardiovascular diseases,117
14,All-cause Heart Failure,84
14,Cardiovascular diseases (excluding rheumatic etc),31
14,High light scatter reticulocyte count,304066
14,"Heel broadband ultrasound attenuation, direct entry",27073
14,Pork consumption,138
14,Serum levels of protein RNASE2,1148
14,Blood protein levels [Angiogenin],4419
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-24 ms],5287
14,Heart rate variability traits (RMSSD),254
14,Cortical thickness [Middle Temporal],234
14,Type 1 diabetes with ketoacidosis,9
14,"""Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified""",1
14,Age at first birth,8249
14,Basal cell carcinoma,2410
14,"Blood protein levels [CTSA, 3179_51_2]",518
14,"""Type1 diabetes, definitions combined""",93
14,Type 2 diabetes [conditional],20324
14,Serum levels of protein WARS,17027
14,Glaucoma (primary open-angle) [Japanese discovery],2941
14,"""Other chronic obstructive pulmonary disease , including avohilmo""",25
14,Cardiac arrhytmias,4
14,Cortisol levels (plasma),4752
14,Serum levels of protein TNFSF11,8671
14,Brain morphology (min-P),8619
14,Large artery stroke,1257
14,Electrocardiogram morphology (amplitude at temporal datapoints) [308 ms],521
14,Heart rate increase in response to exercise,517
14,IgG glycosylation [IGP65],243
14,Atrovent 20micrograms inhaler | treatment/medication code,1656
14,Walking pace,4184
14,Facial ageing,74687
14,Impedance of whole body,61294
14,"Blood protein levels [EA, Alpha-1-antitrypsin]",1976
14,Dimethylglycine levels,1152
14,Bladder problem (not cancer),380
14,Current eye infection,37
14,Chronic obstructive pulmonary disease or resting heart rate (pleiotropy),9105
14,IgG glycosylation patterns [IgG1 BG1S1/(BG1+BG1S1],10035
14,IgG glycosylation patterns [IgG1_G1S1/IgG1_G1],15284
14,Retinal nerve fibre layer thickness or ganglion cell inner plexiform layer thickness (MTAG),23050
14,White matter hyperintensity volume,8166
14,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],301
14,Brain region volumes [left pallidum],1230
14,Olmesartan | treatment/medication code,788
14,Body mass index in physically active individuals,70
14,Intralaminar thalamic nuclei volume,6314
14,Corneal curvature,5940
14,"Light brown | hair colour (natural, before greying)",817
14,Eye color [eye color],420
14,Cortical surface area [Pericalcarine],7436
14,Red blood cell (erythrocyte) count,41207
14,Nose size,273
14,Sebaceous cyst,69740
14,Lymphocyte-to-monocyte ratio,17973
14,Chronic obstructive pulmonary disease,1168
14,"Blood protein levels [MRPL33, 13453_2_3]",6963
14,N-glycan levels [DG1],2817
14,Serum levels of protein KLK13,1014
14,Olecranon bursitis,12
14,Serum phosphate levels,46328
14,Serum levels of protein KLRG1,8838
14,Metabolite levels [Hex2Cer d16:1/16:0],1473
14,Fibrinogen [EA],388
14,vWF levels,6138
14,Brain region volumes [right pericalcarine],21599
14,6mm weak meridian (right),3548
14,Waist-hip ratio,70403
14,Waist circumference adjusted for body mass index,73392
14,Plasma free amino acid levels (adjusted for one other PFAA) [His (adjusted for Asn],1636
14,BMI in non-smokers [women],10
14,Cognitive aspects of educational attainment,5824
14,3-hydroxy-1-methylpropylmercapturic acid levels in smokers [Japanese],224
14,White matter microstructure (fractional anisotropy) [Fornix (column and body],2751
14,C-reactive protein,1921
14,Coffee consumption,122
14,"Atopic dermatitis [EA, fixed effects]",32133
14,Serum metabolite levels [palmitoyl dihydrosphingomyelin (d18:0/16:0)*],739
14,Serum metabolite concentrations in chronic kidney disease [Asparagine],1057
14,Language functional connectivity,234
14,Diastolic blood pressure,47521
14,Marginal zone lymphoma or multiple sclerosis,1140
14,Electrocardiogram morphology (amplitude at temporal datapoints) [348 ms],275
14,Medication use (calcium channel blockers),664
14,Eosinophil cationic protein levels,2530
14,"Blood protein levels [EA, Alpha-1-antichymotrypsin complex]",148
14,Heel bone mineral density,384047
14,Antihypertensive medication - note that there are other indications,14323
14,CD25 on IgD+ CD38+ B cell,1556
14,Initial pursuit acceleration [African],8
14,Hemoglobin A1c levels,75774
14,Heart rate response to recovery post exercise (50 sec),517
14,Medication use (agents acting on the renin-angiotensin system),34587
14,"Hepatitis | non-cancer illness code, self-reported",3669
14,Serum levels of protein ENTPD5,17478
14,Serum levels of protein SLURP1,8671
14,Plasma free amino acid levels (adjusted for twenty other PFAAs) [Asn],7137
14,Lactobacillus B salivarius abundance in stool,28
14,Age-related hearing impairment (SNP x SNP interaction),40624
14,Granulocyte count,15201
14,Brain region volumes [left lateral occipital],3702
14,Blood protein levels [Galectin-3],10329
14,Albumin-globulin ratio,5636
14,Serum levels of protein SLC14A2,269
14,Oily fish intake,120
14,Hemoglobin concentration,120376
14,Mean spheric corpuscular volume,85803
14,Body fat percentage,40086
14,IgG glycosylation patterns [IgG1 GS1/(G0+G+GS1],14146
14,"Anal fissure | non-cancer illness code, self-reported",1866
14,Cathepsin L1 levels,394
14,Sphingomyelin(44:9)_[M+H]1- levels,1128
14,Iron status biomarkers (ferritin levels),22
14,Hypertensive diseases (excluding secondary),17
14,Coronary artery disease,291344
14,Lung function (FEV1/FVC),181485
14,Serum levels of protein SMOC1,769
14,C-reactive protein and white blood cell count [CRP],886
14,HDL cholesterol levels in current drinkers,275
14,Phosphatidylinositol-O(36:0)_[M-H]1-/Phosphatidylglycerol(37:0)_[M+OAc]1- levels,2863
14,Serum alpha-fetoprotein levels,1811
14,Diabetes,281
14,Composite immunoglobulin trait (IgA/IgM),1571
14,Iron status biomarkers (total iron binding capacity),269
14,Pediatric asthma,322
14,Electrocardiogram morphology (amplitude at temporal datapoints) [354 ms],275
14,Gut bacterial pathway abundance (PYRIDNUCSYN.PWY..NAD.biosynthesis.I..from.aspartate.),92
14,Other diseases of upper respiratory tract,1
14,Gestational diabetes only,212
14,Subjective well-being,661
14,"Blood protein levels [SEMG2, 6373_54_3]",597
14,Serum metabolite ratios in chronic kidney disease [Hydroxysphingomyelin with acyl residue sum C14:1/Hydroxysphingomyelin with acyl residue sum C16:1],388
14,Electrocardiogram morphology (amplitude at temporal datapoints) [64 ms],275
14,Plasma free amino acid levels (adjusted for one other PFAA) [Trp (adjusted for Asn],1636
14,Endometriosis,127
14,Protein quantitative trait loci (liver) [ANP32A],32
14,Retinal nerve fibre layer (RNFL) thickness,22765
14,Atrial fibrillation [EA],5264
14,Serum levels of protein DCP1B,243
14,Moderate to vigorous physical activity levels,374
14,Levothyroxine sodium | treatment/medication code,937
14,Alcohol use disorder,10301
14,Eosinophil percentage of white cells,156307
14,Serum albumin levels,92866
14,Spherical equivalent (joint analysis main effects and education interaction) [European ancestry],3738
14,Alcohol consumption in current drinkers,4484
14,Serum levels of protein AMELX,633
14,Ascending aorta maximum area,738
14,Metabolite levels [SM d16:1/20:0],870
14,Ankylosing spondylitis [EA],997
14,Sphingomyelin_32:1_[M+H]1+ levels,388
14,Serum levels of protein MED1,106
14,Mastocytosis,116
14,Cholesterol levels,4
14,Sum neutrophil eosinophil counts,8210
14,Ulcerative colitis [EA],7106
14,Cortical thickness [Banks of the Superior Temporal Sulcus],225
14,Peak expiratory flow,60970
14,MAP/microtubule affinity-regulating kinase 3 measurement,8533
14,Impedance of arm (right),29892
14,"Malaria | non-cancer illness code, self-reported",12999
14,Serum levels of protein MRPL33,512
14,Sphingomyelin_39:1_[M+OAc]1- levels,388
14,Red blood cell count,372406
14,Platelet crit,27944
14,Total body bone mineral density [European],1102
14,IgG glycosylation patterns [IgG1_G1FN/IgG1_G1N],15464
14,Protein quantitative trait loci (liver) [S100A11],27
14,Mastopathy,72
14,Electrocardiogram morphology (amplitude at temporal datapoints) [332 ms],10
14,Vitamin D levels,27112
14,Chronic obstructive pulmonary disease [conditional on rs72699855],238
14,Neuroticism conditioned on self-rated math ability (multi-trait conditioning and joint analysis),12507
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-20 ms],657
14,Rectal cancer,2428
14,HDL cholesterol x physical activity interaction (2df test),275
14,Protein quantitative trait loci (liver) [S100A4],4
14,Mean platelet volume,505139
14,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)",71007
14,A body shape index,10443
14,Whole body fat mass,18715
14,"""Hypothyroidism, strict autoimmune""",2652
14,"Blood protein levels [MGAT2, 6909_40_3]",8421
14,Mean platelet (thrombocyte) volume,90545
14,Oxalate (ethanedioate) levels,1192
14,Waist-hip index,9826
14,Proximal colorectal cancer,506
14,Electrocardiogram morphology (amplitude at temporal datapoints) [346 ms],275
14,Platelet count,597609
14,Basal metabolic rate,65531
14,Blood protein levels [Kallistatin],2031
14,"Serum metabolite levels [sphingomyelin (d18:1/21:0, d17:1/22:0, d16:1/23:0)*]",369
14,Electrocardiogram morphology (amplitude at temporal datapoints) [362 ms],275
14,Phospholipid levels (plasma) [levels],2404
14,Autism spectrum disorder or schizophrenia,42779
14,Highest math class taken (MTAG) [MTAG],112186
14,Serum levels of protein AGER,5723
14,Balding type 1,12605
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-28 ms],4630
14,Electrocardiogram morphology (amplitude at temporal datapoints) [306 ms],521
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-134 ms],275
14,"Blood protein levels [SERPINA12, 6551_94_3]",314
14,Serum levels of protein CD27,106
14,Radiation-induced brain injury in nasopharyngeal carcinoma,5201
14,Well-being spectrum (multivariate analysis),24705
14,Comparative height size at age 10,79787
14,Vertex-wise cortical surface area,107289
14,Cortical surface area [Supramarginal],7160
14,Autoimmune traits,17919
14,Sphingomyelin_36:0_[M+H]1+ levels,388
14,Brain region volumes [CSF],247
14,Body mass index (joint analysis main effects and physical activity interaction) [women],10
14,Sum eosinophil basophil counts,5252
14,"Blood protein levels [AP1G2, 12714_38_3]",182
14,Serum levels of protein GC,633
14,Mean corpuscular hemoglobin concentration,165431
14,Trunk fat mass,20993
14,Optic disc size,18867
14,"Red blood cell traits [EA, MCH]",1668
14,Plasma free amino acid levels (adjusted for one other PFAA) [Orn (adjusted for Asn],1636
14,Morning person,1241
14,IgG glycosylation patterns [IgG1_G1N(20)/IgG2_G1N(20],325
14,Other keratitis,46
14,Fibrinogen levels,1643
14,Lumbar spine bone mineral density,1121
14,"Blood protein levels [ANG, 4874_3_1]",1147
14,Protein quantitative trait loci (liver) [ACADM],16
14,Electrocardiographic traits [HR],275
14,Electrocardiogram morphology (amplitude at temporal datapoints) [52 ms],275
14,Cardiac murmurs and other cardiac sounds,57
14,Cutis laxa senilis,18
14,Protein quantitative trait loci (liver) [CSTA],8
14,Age-related diseases and mortality,5651
14,Myeloid white cell count,15201
14,X-23308 levels,1484
14,Chronotype,34386
14,Blood protein levels [Ectonucleoside triphosphate diphosphohydrolase 5],31769
14,Autoimmune hyperthyroidism,2531
14,Plasma free amino acid levels (adjusted for one other PFAA) [Ser (adjusted for Asn],1636
14,Waist-to-hip ratio adjusted for body mass index [East Asian],838
14,Arthritis (juvenile idiopathic),737
14,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)",57
14,Serum levels of protein GOT1,5460
14,Brain region volumes [left cuneus],6244
14,Age completed full time education,6331
14,Urine 6-bromotryptophan levels in chronic kidney disease,42
14,Snoring,413
14,Venous thromboembolism (SNP x SNP interaction),101
14,Tobacco use disorder,36633
14,White matter microstructure (radial diusivities) [Fornix (column and body],2751
14,"Blood protein levels [HTATIP2, 7753_21_3]",518
14,Cortical surface area [Lateral occipital],3458
14,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) [subset analysis]",2546
14,Systolic blood pressure night-to-day ratio in hypertension,6
14,"Hypothyroidism/myxoedema | non-cancer illness code, self-reported",22896
14,Alcohol consumption (drinks per week) (MTAG),6178
14,Completion of the aide-memoire,2698
14,LDL cholesterol x physical activity interaction (2df test),1550
14,Electrocardiogram morphology (amplitude at temporal datapoints) [298 ms],285
14,Electrocardiogram morphology (amplitude at temporal datapoints) [342 ms],10
14,Adult body size,59719
14,Cortical surface area [Entorhinal],11343
14,6mm strong meridian (right),6277
14,Rheumatoid arthritis [East Asian],5477
14,Myocardial fractal dimension (slice 3),4630
14,Phosphatidylcholine-O_32:1_[M+OAc]1-/Phosphatidylcholine-P_32:0_[M+OAc}1-/Phosphatidylserine-O_36:0_[M-H]1- levels,2310
14,CD4 on naive CD4+ T cell,5880
14,"Asthma | non-cancer illness code, self-reported",1576
14,Heart rate variability traits (SDNN),266
14,Adolescent idiopathic scoliosis,13867
14,Colorectal cancer or advanced adenoma,890
14,Sphingomyelin_40:3_[M+H]1+ levels,388
14,Liver enzyme levels (gamma-glutamyl transferase),784
14,Body mass index,329597
14,LDL cholesterol levels,16340
14,Frozen shoulder,1558
14,Mitochondrial DNA copy number,2410
14,"Red blood cell traits [EA, MCV]",202
14,Sphingomyelin(39:1)_[M+H]1+ levels,280
14,Educational attainment (college completion),139
14,Serum levels of protein TIGAR,106
14,Serum 25-Hydroxyvitamin D level variance,1499
14,Inflammatory skin disease [Psoriasis],405
14,IgG glycosylation patterns [IgG1 BGS1/(BG0+BG+BGS1],5880
14,Trunk fat percentage,15651
14,Waist-to-hip ratio adjusted for BMI (additive genetic model),1494
14,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C32:2/Hydroxysphingomyelin with acyl residue sum C22:2],2404
14,Oily fish consumption,138
14,Lifetime smoking index,38107
14,Bipolar disorder (MTAG),98115
14,"Asthma | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",4386
14,Heart rate,619
14,Phosphatidylethanolamine-O_34:1_[M-H]1-/Phosphatidylethanolamine-P_34:0_[M-H]1- levels,2310
14,Ectonucleoside triphosphate diphosphohydrolase 5 levels,27967
14,Electrocardiogram morphology (amplitude at temporal datapoints) [66 ms],275
14,Facial morphology (segment 17),1066
14,Serum levels of protein RNASE4,1822
14,Other benign neoplasm of uterus: Other parts/unspecified,509
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-348 ms],528
14,Loperamide | treatment/medication code,138
14,"None of the above | illness, injury, bereavement, stress in last 2 years",222
14,IgG glycosylation [IGP60],243
14,Bacteroides thetaiotaomicron abundance in stool,93
14,Tinnitus,2772
14,Obsessive compulsive disorder vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),750
14,Relative age of first facial hair,7809
14,Prostate cancer [EA],209
14,Sphingomyelin(32:1)_[M-CH3]1- levels,133
14,Trunk predicted mass,55382
14,Juvenile Open Angle Glaucoma,3073
14,Cortical volume [Cuneus],779
14,Allergy,598
14,Menarche (age at onset) [japanese],310
14,Cortical surface area [Fusiform],10861
14,Bipolar disorder lithium response (continuous) or schizophrenia,28060
14,Lung function (FVC),115063
14,"Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event) [Recessive, Mixture cure model]",2696
14,"""Disorders of thyroid, IBD co-morbidities""",2612
14,Self-reported allergy,636
14,Migraine and/or diastolic blood pressure,4819
14,Financial reasons | reason former drinker stopped drinking alcohol,286
14,Serum total protein level,97370
14,Leg fat percentage (right),20276
14,Overall health rating,2552
14,Gamma glutamyl transferase levels [conditional on round 3],1209
14,"Blood protein levels [RNASE4, 5644_60_3]",834
14,Normal facial asymmetry (angle of surface orientation score),890
14,Gut microbiota relative abundance (bacterial taxa) [Clostridium_celerecrescens],9
14,Mean corpuscular hemoglobin,458200
14,Weight,129567
14,Lymphocyte percentage,50730
14,Platelet-to-lymphocyte ratio,20119
14,Respiratory diseases,2843
14,Hair morphology traits [Hair color],420
14,Electrocardiogram morphology (amplitude at temporal datapoints) [72 ms],275
14,Parkinson's disease,29972
14,Leg fat-free mass (right),68431
14,Electrocardiogram morphology (amplitude at temporal datapoints) [350 ms],275
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-132 ms],275
14,"Bilirubin (z,z) levels",11
14,Systolic blood pressure,303027
14,Gut microbiota abundance (k_Bacteria.p_Firmicutes.c_Negativicutes),43
14,Heel bone mineral density (bmd) (right),26607
14,Resting heart rate,5804
14,Nicotine dependence symptom count,25247
14,Cortical thickness (min-P),2298
14,IgG monosialylation phenotypes (multivariate analysis),8914
14,Strenuous sports or other exercises,3024
14,IgG glycosylation patterns [IgG1 Fn/Bn],5269
14,CD25 on transitional B cell,1556
14,Protein quantitative trait loci (liver) [MYO1B],8
14,Glycerophospholipid levels [Phosphatidylcholine acyl-alkyl C32:2],2404
14,"Stomach disorder | non-cancer illness code, self-reported",256
14,"Hip circumference [EA, men]",29
14,Protein quantitative trait loci (liver) [SERPINH1],7
14,CD20- CD38- B cell %B cell,28
14,Ease of skin tanning,420
14,Autism spectrum disorder (MTAG),839
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-116 ms],275
14,"Muscle/soft tissue problem | non-cancer illness code, self-reported",294
14,Lysophosphatidylethanolamine_20:0_[M-H]1- levels,25
14,Disease-related mortality after unrelated donor allogeneic hematopoietic cell transplantation (donor effect),29773
14,IgG glycosylation patterns [IgG1_G0N],4962
14,Metabolite levels [Cer d16:1/20:0],1225
14,"""Gonarthrosis,primary""",20
14,"Serum metabolite levels [sphingomyelin (d17:1/16:0, d18:1/15:0, d16:1/17:0)*]",369
14,Cognitive traits (MTAG),71
14,Antineutrophil cytoplasmic antibody-associated vasculitis,29
14,Protein quantitative trait loci (liver) [CORO1A],6
14,Serum levels of protein MAX,12978
14,"Dark brown | hair colour (natural, before greying)",19669
14,Systolic blood pressure [East Asian],14504
14,IgG glycosylation patterns [IgG1_G1Nn],11313
14,Cortical surface area [Cuneus],5975
14,X-11787 levels,31401
14,IgG glycosylation patterns [IgG2_G0F/IgG2_G0],16332
14,Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis),12912
14,Vertical cup-disc ratio,8199
14,Alteration of consciousness,664
14,Plasma free amino acid levels (adjusted for one other PFAA) [Asn (adjusted for Ser],1636
14,Cholecystitis without cholelithiasis,464
14,Severe exacerbations in childhood asthma,42
14,Spherical power (left),4447
14,Home location - north co-ordinate (rounded),481
14,Dermatologic disease,921
14,Irritable mood,26
14,Venous thromboembolism,10700
14,Age when periods started (menarche),3906
14,Cortical surface area [Precuneus],7360
14,Arm fat-free mass (left),77843
14,Trauma exposure,141
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-118 ms],275
14,DNA-(apurinic or apyrimidinic site) lyase levels,181
14,Wet age-related macular degeneration,111
14,Asthma/COPD (KELA code 203),1
14,Neuropsychiatric disorders,839
14,Prostate cancer,30984
14,"Bone mineral density (paediatric, lower limb) [EA]",862
14,Recurrence-free survival in non-muscle-invasive bladder cancer,59
14,Number of treatments/medications taken,9965
14,Serum levels of protein LGALS3,11656
14,White blood cell count (basophil),1583
14,Pattern 4 | hair/balding pattern,4700
14,Able to confide,1153
14,Other heart diseases,213
14,Serum levels of protein SERPINA5,185
14,Eosinophill count,60820
14,Phosphatidylglycerol-O_34:0_[M-H]1- levels,388
14,"""Type 1 diabetes, wide definition, subgroup 1""",73
14,Spherical equivalent,10567
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-122 ms],275
14,Tuberculosis,234
14,"N-glycan levels [GP1, men]",141
14,White blood cell count,469095
14,Reticulocyte count,238483
14,Guilty feelings,10247
14,Hypertension,54810
14,Mytonic disorders,59
14,Cyclizine | treatment/medication code,85
14,BMI (adjusted for smoking behaviour),10
14,Cardiovascular disease,31724
14,Neurofibrillary tangles (SNP x SNP interaction),25262
14,Gallbladder disease,25
14,Narcolepsy,1168
14,Vitamin e product | treatment/medication code,93
14,Body mass index [women],151
14,PR interval,42831
14,IgG glycosylation patterns [IgG1 G1S1/(G1+G1S1],15284
14,1-myristoyl-2-palmitoyl-gpc (14:0/16:0) levels,209
14,"N-glycan levels [GP1, women]",2449
14,IgM levels,513
14,General pain for 3+ months,1916
14,Leisure/social activities: Sports club or gym,2154
14,GCA-900199385 sp900320755 abundance in stool,14
14,Bronchiectasis,50
14,Waist-hip ratio [EA],25
14,Serum metabolite levels [5-bromotryptophan],42
14,C-reactive protein levels,48056
14,IgD on IgD+ CD38-  B cell,1556
14,CAG-495 abundance in stool,30
14,Serum levels of protein FAM177A1,2938
14,Electrocardiogram morphology (amplitude at temporal datapoints) [58 ms],275
14,Serum levels of protein KRT5,269
14,Chin dimples,251
14,"Black | hair colour (natural, before greying)",858
14,Serum levels of protein MMP14,680
14,Non-small cell lung cancer,6134
14,Morning/evening person (chronotype),18211
14,Heel bone mineral density T score,182210
14,High cholesterol,2106
14,Varicose veins,157
14,Self-reported math ability (MTAG) [MTAG],71636
14,"Blood protein levels [GNPNAT1, 13954_9_3]",5591
14,Serum levels of protein RAB31,269
14,Serum levels of protein FBN3,633
14,Emphysema,50
14,Estimated glomerular filtration rate in non-diabetics,9245
14,Hepatitis,136
14,Serum levels of protein SERPINA1,1499
14,Menopause (age at onset),3618
14,Fasciitis,2216
14,Corneal resistance factor (right),714
14,Serum levels of protein COL9A2,633
14,IgG glycosylation patterns [IgG2_G0],13116
14,HDL cholesterol levels in current drinkers [EA],275
14,Schizophrenia,190879
14,Serum levels of protein HBE1,47301
14,Daytime nap,709
14,Wheeze or whistling in the chest in last year,4165
14,Serum metabolite levels [1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0)*],909
14,White | bread type,186
14,Metabolite levels (5-HIAA/ MHPG Ratio),55
14,Cortical surface area (MOSTest),17870
14,"Forced expiratory volume in 1-second (fev1), best measure",12810
14,Acute lymphoblastic leukemia (childhood) [ETV6-RUNX1 positive],859
14,Serum levels of protein STX2,269
14,"For short-sightedness, i.e. only or mainly for distance viewing such as driving, cinema etc (called 'myopia') | reason for glasses/contact lenses",278
14,Peak expiratory flow (pef),103
14,Intelligence (MTAG),47748
14,P-selectin glycoprotein ligand 1 levels,179
14,Subclinical trait of interstitial lung disease (basilar peel-core ratio of high attentuation areas on CT scan) [AA],9
14,Leg fat-free mass (left),58562
14,Serum levels of protein RNF165,8642
14,Serum levels of protein RNASE1,1056
14,Angina pectoris,100
14,Osteoprotegerin levels,25
14,Fat-free mass,4850
14,Prostate-specific antigen levels,249
14,"Blood protein levels [SERPINA3, 2879_9_2]",545
14,Electrocardiogram morphology (amplitude at temporal datapoints) [338 ms],275
14,Cortical volume [Banksts],59
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-32 ms],4630
14,"Heel quantitative ultrasound index (qui), direct entry",28763
14,3mm weak meridian (right),11895
14,Home location at assessment - north co-ordinate (rounded),448
14,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),10151
14,General risk tolerance (MTAG),47977
14,Femoral neck bone mineral density,20918
14,Mean arterial pressure [East Asian],14504
14,Hematocrit,190215
14,Serum levels of protein EPHB3,33588
14,Spleen volume,639
14,"Blood protein levels [GSK3A GSK3B, 3236_12_2]",922
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-130 ms],275
14,Femur bone mineral density x serum urate levels interaction [male],92
14,IgG glycosylation [IGP63],243
14,Intelligence,17384
14,Lung function (FEV1) [adults],29805
14,Heel broadband ultrasound attenuation (left),22310
14,White blood cell (leukocyte) count,68893
14,"Allergy, hypersensitivity or anaphylaxis",1407
14,OTU99_108 (Cytophagales) prevalence,3858
14,Serum levels of protein CDHR1,269
14,Electrocardiogram morphology (amplitude at temporal datapoints) [80 ms],275
14,"""Malignant neoplasm of breast, HER2-negative""",194
14,Serum levels of protein NRXN3,643
14,"""Diabetes, insuline treatment (Kela reimbursement) (more control exclusions)""",73
14,Heel broadband ultrasound attenuation (right),23982
14,Impedance of leg (left),36729
14,Reticulocyte percentage,13992
14,Mood disorders,258
14,Metabolite levels [Cer d16:1/18:0],1225
14,Alzheimer's disease (cognitive decline),182
14,Sphingomyelin levels [SM(34:0;2],1683
14,Composite immunoglobulin trait (IgA x IgG/IgM),519
14,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C32:1/Phosphatidylcholine with acyl-alkyl residue sum C34:1],2310
14,"""Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8""",25
14,Self-reported math ability,63482
14,3mm strong meridian (right),4744
14,Sensitivity to environmental stress and adversity,1881
14,Nonalcoholic fatty liver disease (imputed),185
14,Body fat distribution (trunk fat ratio),182
14,Protein quantitative trait loci (liver) [USP5],1
14,Hemoglobin,126823
14,Advanced age-related macular degeneration [EA],473
14,Asthma,18709
14,None of the above | vascular/heart problems diagnosed by doctor,17223
14,Cardiac dysrhythmias,4930
14,Haemoglobin concentration,26531
14,Electrocardiogram morphology (amplitude at temporal datapoints) [60 ms],275
14,Hematological or dermatological disease,1009
14,Protein quantitative trait loci (liver) [SND1],817
14,Place of birth in uk - north co-ordinate,2787
14,Metabolite levels [SM 14:0],2701
14,Cognitive function,61
14,Hip index,11451
14,Urinary metabolite levels in chronic kidney disease [X - 24330],4308
14,Protein quantitative trait loci (liver) [GNPNAT1],12668
14,Celiac disease,1620
14,N-glycan levels [FUC-C],974
14,Serum levels of protein COCH,244
14,Educational attainment (years of education),200685
14,Spherical equivalent [EA],174
14,Worry,9602
14,Digit length ratio (left hand),322
14,Chronic diseases of tonsils and adenoids,93
14,Nonsyndromic cleft lip with or without cleft palate [All],26
14,Chronic bronchitis/emphysema | illnesses of father,25
14,Household income (MTAG),45572
14,Total testosterone levels,125726
14,Frequency of stair climbing in last 4 weeks,10149
14,Metabolite levels [HexCer d16:1/22:0],1473
14,Whole body water mass,67928
14,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),301
14,"Age hay fever, rhinitis or eczema diagnosed",947
14,IgD on IgD+ CD24- B cell,1941
14,"""Type 1 diabetes, wide definition""",79
14,Cortical volume [Lateral orbitofrontal],43
14,Serum 25-Hydroxyvitamin D levels,210094
14,Mitochondrial DNA levels,3043
14,Gut microbiota relative abundance (bacterial taxa) [Erysipelothrix],85
14,Herpesviral [herpes simplex] infections,2278
14,Body mass index and systole blood pressure (pairwise),60
14,Free thyroxine concentration,260
14,"""Diabetes, varying definitions""",130
14,Serum levels of protein KCNE2,8671
14,Mood instability,9283
14,"Blood protein levels [EA, Angiogenin]",3152
14,Iron deficiency anemias,12
14,Red cell distribution width,513544
14,Serum metabolite levels [2-hydroxyglutarate],8109
14,Major coronary heart disease event excluding revascularizations,117
14,IgG glycosylation patterns [IgG1_G2n],243
14,Cardiorespiratory fitness (vo2 max),10
14,Broad depression or major depressive disorder (recurrent),4227
14,"Urticaria | non-cancer illness code, self-reported",282
14,Phosphatidylcholine-O_37:2_[M+H]1+/Phosphatidylcholine-P_37:1_[M+H]1+/Phosphatidylethanolamine-O_40:2_[M+H]1+ levels,388
14,Osteoporosis,972
14,Cigarettes smoked per day (MTAG),43147
14,Apolipoprotein B levels,67973
14,Complement C1r subcomponent measurement,18059
14,Total protein levels x insomnia interaction,2155
14,Height,792909
14,Type 1 diabetes,4763
14,Plasma cortisol levels (morning),1931
14,Differentiated thyroid cancer,1869
14,Ischemic heart diseases,128
14,Heel bone mineral density (bmd) (left),21523
14,Central corneal thickness,2238
14,Smoking initiation (ever regular vs never regular) [Conditioned on chr14:79563654],1
14,CD4 on CD4+ T cell,2664
14,IgG glycosylation patterns [IgG1 FG0n total/G0n],9645
14,Endometrial endometrioid carcinoma,3610
14,DNA methylation variation (age effect),2549
14,"Response to statin therapy [chol, diff]",633
14,Severe depression | illnesses of adopted mother,47
14,Hypothyroidism nos,18154
14,Nonsyndromic cleft palate,1105
14,Serum levels of protein PRB4,633
14,Mild influenza (H1N1) infection,929
14,Blood metabolite ratios [X-13215/X-13671],613
14,Plasma free amino acid levels (adjusted for one other PFAA) [Met (adjusted for Asn],1636
14,"2,3-dihydroxy-2-methylbutyrate levels",1979
14,Sphingolipid levels [SM 14:0Mol%],388
14,Neutrophil percentage of white cells,66074
14,OTU97_95 (Cytophagales) prevalence,3858
14,SPARC-related modular calcium-binding protein 1 measurement,1753
14,Frequency of unenthusiasm / disinterest in last 2 weeks,1106
14,Serum levels of protein NID2,1196
14,Cortical surface area [Pars Orbitalis],344
14,Type 2 diabetes with other specified/multiple/unspecified complications,59
14,QRS duration [EA],4630
14,Average weekly spirits intake,1091
14,Major depressive disorder or stress-related disorder,1726
14,Serum metabolite levels [N-acetylasparagine],1003
14,Sphingomyelin levels [SM(38:1;2],388
14,"Cholelithiasis/gall stones | non-cancer illness code, self-reported",25
14,Diseases of sebaceous glands,69740
14,Protein biomarker [Galectin-3],32596
14,Methylmalonate (mma) levels,4206
14,Primary biliary cholangitis,8610
14,Sphingolipid levels [levels],388
14,Cognitive ability,839
14,Fed-up feelings,12151
14,Fruit consumption,893
14,Primary tooth development (time to first tooth eruption),82
14,IgG monogalactosylation phenotypes (multivariate analysis),8914
14,IgG glycosylation patterns [IgG1_G2],6540
14,Protein levels in obesity [Kallistatin],987
14,Electrocardiogram morphology (amplitude at temporal datapoints) [82 ms],275
14,Liver enzyme levels (alanine transaminase),25871
14,N-glycan levels [GP10],974
14,Inosine levels,5011
14,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),74
14,Leg predicted mass (left),59557
14,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:5/Phosphatidylcholine with acyl-alkyl residue sum C38:5],2310
14,"""Cholelithiasis, broad definition with cholecystitis""",25
14,Family history of other specific disorders,8
14,Mood swings,11175
14,Electrocardiogram morphology (amplitude at temporal datapoints) [56 ms],275
14,Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count) [Adalimumab],267
14,Depression,45696
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-22 ms],657
14,"N-glycan levels [A2, women]",864
14,Obesity [WHR],24
14,Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis),6953
14,Trunk fat-free mass,60813
14,Severe influenza A (H1N1) infection,847
14,Alzheimer's disease or family history of Alzheimer's disease,7134
14,Eosinophil percentage of granulocytes,3649
14,Experiencing mood swings,6627
14,Hearing difficulty/problems with background noise,30236
14,Ras-related protein Rab-2A measurement,3565
14,IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis),8671
14,Total body bone mineral density (age 0-15),862
14,Electrocardiographic traits (multivariate),316
14,Sphingomyelin_38:1_[M+H]1+ levels,388
14,"Bronchiectasis | non-cancer illness code, self-reported",604
14,IgG glycosylation patterns [IgG1 FG1n total/G1n],15406
14,"Hayfever, allergic rhinitis or eczema | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",8342
14,Arm fat percentage (right),38465
14,Brain region volumes [right putamen],1230
14,Nonsyndromic cleft lip with cleft palate,602
14,Serum levels of protein PPP1R14B,633
14,Thyrotoxicosis,2612
14,Aphakia,17
14,Ascending aorta minimum area,738
14,Cognitive performance (MTAG) [MTAG],55438
14,Smoking initiation (ever regular vs never regular) (MTAG),10624
14,Neutrophil count,216327
14,Atrial fibrillation,20423
14,High blood pressure | illnesses of siblings,12015
14,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C32:2/Sphingomyelin with acyl residue sum C16:1],2404
14,Electrocardiogram morphology (amplitude at temporal datapoints) [70 ms],275
14,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C32:0/Phosphatidylcholine with acyl-alkyl residue sum C32:1],2310
14,"Blood protein levels [RNASE2, 8394_56_3]",1255
14,"Serum metabolite levels [sphingomyelin (d17:2/16:0, d18:2/15:0)*]",369
14,Sex hormone-binding globulin levels adjusted for BMI,137229
14,Takayasu arteritis,1901
14,Female genital prolapse,26
14,Other metabolic disorders,25
14,Diacylglycerol_38:3_[M+H-H2O]1+ levels,493
14,IgG glycosylation patterns [IgG1_G1n],15406
14,Subcortical volume (min-P),5488
14,Astigmatism angle (left),3083
14,Psychological wellbeing index 12 (lack of enjoying daily life),15
14,Pancreas volume,93
14,High light scatter reticulocyte percentage of red cells,145168
14,Putamen volume,3831
14,Optic cup area,7229
14,"""Thyrotoxicosis, other and/or unspecified""",2710
14,"Blood protein levels [WNT5A, 13268_45_3]",545
14,Insulin-related traits (multivariate analysis),3350
14,Benign neoplasm of colon,18
14,Acute inflammation of orbit,84
14,Blood protein levels [SERPINA1],250
14,Multisite chronic pain,30859
14,QRS duration [European],4390
14,IgG glycosylation patterns [IgG2_G0n],12068
14,"Other exercises (eg: swimming, cycling, keep fit, bowling) | types of physical activity in last 4 weeks",2596
14,Lobe attachment (rater scored),177
14,White matter microstructure (mode of anisotropy) [Hippocampus ],850
14,Metabolite levels [S1P d16:1],1225
14,Blood metabolite ratios [X-08402/cholesterol],388
14,Smoking status (current vs never),54
14,"Serum metabolite levels [sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2)*]",369
14,1-(1-enyl-palmitoyl)-2-arachidonoyl-gpc (p-16:0/20:4) levels,6
14,B cell acute lymphoblastic leukaemia (normal cytogenetics),20
14,Protein quantitative trait loci (liver) [CLIC4],340
14,"Rheumatism, unspecified and fibrositis",146
14,Crohn's disease [EA],10335
14,Olmetec 10mg tablet | treatment/medication code,784
14,Optic cup area [EA],2246
14,Glaucoma | eye problems/disorders,3759
14,Age-related hearing impairment (MTAG),767
14,Getting up in morning,3611
14,Direct low density lipoprotein cholesterol levels,26575
14,Immunoglobulin measurement (zinc sulfate turbidity test),5636
14,"Blood protein levels [EA, Inosine-5'-monophosphate dehydrogenase 2]",2448
14,Electrocardiogram morphology (amplitude at temporal datapoints) [296 ms],285
14,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),1445
14,Benign neoplasm: Sigmoid colon,86
14,Neurociticism,13439
14,Hemoglobin levels,102223
14,IgG glycosylation patterns [IgG1 Bn],9645
14,Protein quantitative trait loci [ENTP5],17726
14,Breast cancer (estrogen-receptor negative),213
14,Corneal hysteresis (left),516
14,Serum levels of protein CEND1,633
14,Coronary artery bypass grafting,89
14,Suffering from nerves,11058
14,Serum levels of protein CUEDC2,662
14,"Liver, biliary or pancreas problem",25
14,Colorectal cancer [EA],98
14,"Waist circumference [EA, men]",26
14,Leukocyte telomere length [East Asian],3882
14,Hair color [hair color],420
14,Left-handedness,208
14,Eczema or dermatitis,7358
14,Kynurenine levels,1269
14,Walk | types of transport used (excluding work),1272
14,"Gut microbiota (bacterial taxa, hurdle binary method) [G_Coprococcus_HB]",39
14,Arm predicted mass (right),55627
14,Hip bone size,1371
14,TNF-related apoptosis-inducing ligand levels,50
14,Pallidum volume,1230
14,Metabolite levels [Cer d16:1/24:0],2095
14,Guanosine levels,2457
14,Dentate gyrus granule cell layer volume (corrected for total hippocampal volume),234
14,Protein quantitative trait loci (liver) [CES2],353
14,Average monthly spirits intake,21
14,Snoring [adjusted for BMI],105
14,Protein quantitative trait loci (liver) [CNN2],6
14,None of the above | qualifications,1251
14,Serpin A12 levels,2144
14,IgG glycosylation [IGP58],243
14,Serum metabolite concentrations in chronic kidney disease [Phosphatidylcholine with diacyl residue sum C28:1],388
14,Ulcerative colitis,547
14,Protein quantitative trait loci (liver) [CPQ],8
14,Serum levels of protein SHISA3,8671
14,Life satisfaction,8819
14,Serum levels of protein SERPINA4,2028
14,Medication use (thyroid preparations),1300
14,Phosphatidylcholine_43:0_[M+H]1+ levels,2474
14,White matter hyperintensity volume (adjusted for hypertension),1340
14,Leisure sedentary behaviour (television watching),661
14,Menopause (age at onset) [Japanese],71
14,IgD on IgD+ CD38dim B cell,1556
14,Skin cancer,682
14,Metabolite levels,243
14,Hair color,61700
14,Essential hypertension,4415
14,Vitamin d product | treatment/medication code,882
14,Non-melanoma skin cancer,732
14,Reasoning,12
14,Smoking initiation (ever regular vs never regular) [Conditioned on chr14:98597552],10
14,IgG glycosylation patterns [IgG1_G1],15406
14,Early onset COPD,25
14,Primary open-angle glaucoma,3256
14,Blond vs. brown hair color,420
14,N-glycan levels [GP1],141
14,Bipolar disorder or major depressive disorder,14152
14,Serum levels of protein CD84,633
14,No | ever had corneal graft surgery,420
14,3mm regularity index (left),7
14,Phosphatidylcholine-O_36:5_[M+OAc]1-/Phosphatidylcholine-P_36:4_[M+OAc]1-/Phosphatidylserine-O_40:4_[M-H]1- levels,2310
14,Atrial fibrillation/atrial flutter,3747
14,Serum levels of protein MAVS,8743
14,Brain region volumes [left lateral ventricle],2751
14,Cardiac dysrhythmias (time to event),275
14,Initial pursuit acceleration,8
14,Waist-to-hip ratio adjusted for BMI,81738
14,Chronic obstructive pulmonary disease x ever smoker interaction (2df),601
14,Coagulation Factor VIII measurement,6587
14,Metabolite levels [SM d16:1/22:0],2095
14,Protein quantitative trait loci (liver) [ASAH1],147
14,IgG glycosylation patterns [IgG1 Fn total],15406
14,Body mass index (bmi),70391
14,Nose morphology [Nasal ala length],1117
14,Gut microbiota relative abundance (bacterial taxa) [Lentisphaerae],192
14,Total bilirubin levels,534
14,Heart failure and bmi 25plus,84
14,Serum levels of protein PILRA,8773
14,Height [AA],1698
14,"Serum metabolite levels [sphingomyelin (d18:1/19:0, d19:1/18:0)*]",369
14,Benign neoplasm: Sigmoid colon (controls excluding all cancers),86
14,IgG glycosylation [IGP11],243
14,"Forced expiratory volume in 1-second (fev1), predicted",81783
14,Hippocampal subfield CA1 volume (corrected for total hippocampal volume),234
14,Smoking initiation,643
14,White matter microstructure (axial diusivities) [Fornix (column and body],2751
14,IgG glycosylation patterns [IgG2 FG0n total/G0n],16332
14,"Blood protein levels [PNP, 10039_32_3]",1157
14,"Blood protein levels [RNASE1, 7211_2_3]",764
14,Extremely high intelligence,839
14,BMI in non-smokers,10
14,Electrocardiogram morphology (amplitude at temporal datapoints) [288 ms],246
14,Protein quantitative trait loci (liver) [LRG1],42
14,Total PHF-tau (SNP x SNP interaction),74936
14,"Blood protein levels [EA, Galectin-3]",8643
14,Hypothyroidism or myxedema,5211
14,Metabolite levels [Cer d16:1/22:0],1225
14,"Disorders of muscle, ligament, and fascia",777
14,Fibulin-5 measurement,538
14,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],275
14,Estradiol levels,89
14,Phosphatidylcholine-O_35:1_[M+H]1+/Phosphatidylcholine-P_35:0_[M+H]1+/Phosphatidylethanolamine-O_38:1_[M+H]1+ levels,388
14,Direct bilirubin levels,2770
14,"Blood protein levels [SERPINA1, 3580_25_8]",1499
14,Frequency of friend/family visits,70
14,"Blood protein levels [EA, Alpha-1-antichymotrypsin]",148
14,Pulse wave arterial stiffness index,282
14,Neurological blood protein biomarker levels [FLRT2],247
14,Erythritol levels,12631
14,Gamma glutamyl transpeptidase,6178
14,Hyperthyroidism or thyrotoxicosis,2612
14,Hyperthyroidism,1505
14,Protein quantitative trait loci (liver) [RAB14],483
14,Malignant neoplasm of breast (controls excluding all cancers),194
14,Malignant neoplasm of breast,194
14,Duration of vigorous activity,397
14,Serum metabolite concentrations in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C32:1],2404
14,Cortical surface area [Lingual],7182
14,Serum levels of protein SUSD2,633
14,Electrocardiogram morphology (amplitude at temporal datapoints) [78 ms],275
14,Psoriasis or type 2 diabetes (trans-disease meta-analysis),405
14,"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment",2409
14,Granulocyte percentage of myeloid white cells,23772
14,Cognitive ability (MTAG),45458
14,Hip circumference adjusted for BMI [EA],9298
14,Suffer from 'nerves',12546
14,Serum levels of protein MMRN2,1814
14,Light vs. dark hair color,172
14,Metabolite levels [Cer d16:1/24:1],1225
14,Intrahepatic Cholestasis of Pregnancy (ICP),50
14,Kawasaki disease,39722
14,Schizophrenia [EA],33954
14,Metabolite levels [SM d16:1/16:0],2095
14,Electrocardiogram morphology (amplitude at temporal datapoints) [312 ms],285
14,Goiter,3124
14,Prozac 20mg capsule | treatment/medication code,606
14,IgG glycosylation patterns [IgG1_G1N],9645
14,6mm strong meridian (left),6515
14,Blood metabolite levels [X-13671],1293
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-128 ms],275
14,Leukocyte count in ischemic stroke,204
14,Medication use (glucocorticoids),58
14,Varicose veins of lower extremity,18
14,Lung adenocarcinoma,6414
14,"Blood protein levels [GZMB, 14041_13_3]",1217
14,Urinary metabolite levels in chronic kidney disease [glutamate],1154
14,HDL cholesterol levels x loop diuretics use interaction [African],1
14,3mm strong meridian (left),6656
14,Optic nerve head parameters (multi-trait analysis) [EA],4660
14,Myocardial fractal dimension (slice 4),4653
14,Eye color [green eyes],420
14,Metabolite levels [Cer d16:1/23:0],1225
14,Waldenström macroglobulinemia / lymphoplasmacytic lymphoma,32
14,Non-oily fish consumption,195
14,FEV1,39071
14,Schizophrenia (MTAG),208349
14,"N-glycan levels [GP10, women]",974
14,Serum levels of protein EVI2B,2435
14,"""Type 1 diabetes, strict (exclude DM2)""",93
14,Neutrophill percentage,37095
14,Hippurate levels,1905
14,Brain region volumes [right lateral orbitofrontal],806
14,Pancreatic cancer,12464
14,Age at menopause (last menstrual period),2596
14,Gamma glutamyl transferase levels in low alcohol consumption,432
14,Number of children ever born,306
14,Hepatocyte growth factor levels,140
14,Low density lipoprotein cholesterol levels,86110
14,Serum alkaline phosphatase levels,136831
14,Sodium in urine,3408
14,Protein quantitative trait loci (liver) [SERPINA3],597
14,"Blood protein levels [CHGA, 11184_51_3]",20
14,Morningness,21125
14,Atrial fibrillation and flutter with reimbursement,3587
14,Comparative body size at age 10,268
14,Phosphatidylcholine-O_36:1_[M+H]1+/Phosphatidylcholine-P_36:0_[M+H]1+/Phosphatidylethanolamine-O_39:1_[M+H]1+ levels,388
14,Other and unspecified disorders of adult personality and behauviour,27
14,Thyroid problem (not cancer),23618
14,Forced expiratory volume in 1-second (fev1),15790
14,"""Primary open-angle glaucoma, strict""",3246
14,Electrocardiogram morphology (amplitude at temporal datapoints) [352 ms],275
14,"Bone mineral density (paediatric, total body less head) [EA]",862
14,Serum metabolite concentrations in chronic kidney disease [Hydroxysphingomyelin with acyl residue sum C14:1],388
14,Rosacea symptom severity,118
14,Basophill count,8367
14,Thyrotoxicosis with toxic multinodular goitre,1956
14,Phosphatidylcholine-O_30:1_[M+H]1+/Phosphatidylcholine-P_30:0_[M+H]1+/Phosphatidylethanolamine-O_33:1_[M+H]1+ levels,388
14,Blood glucose levels,17305
14,IgG glycosylation patterns [IgG1_G0Nn],4962
14,"Glaucoma | non-cancer illness code, self-reported",3073
14,Ankylosing spondylitis,997
14,Co-amilozide | treatment/medication code,29
14,3mm asymmetry angle (right),7
14,CAG-390 sp003523225 abundance in stool,23953
14,Serum levels of protein IGFL4,8671
14,Plasma free amino acid levels (adjusted for one other PFAA) [Gln (adjusted for Asn],1636
14,Electrocardiogram morphology (amplitude at temporal datapoints) [336 ms],285
14,Other benign neoplasm of uterus: Other parts/unspecified (controls excluding all cancers),509
14,Change in serum metabolite levels (CMS) [VLDL_C],132
14,"None of the above | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",1193
14,Posterior thalamic nuclei volume,100
14,Serum creatinine levels,54325
14,IgG sialylation phenotypes (multivariate analysis),8914
14,Basophil percentage of granulocytes,1026
14,Peak insulin response (BMI and insulin secretion adjusted),4
14,Waist circumference adjusted for body mass index [EA],20159
14,Serum levels of protein AMBN,8671
14,Serum levels of protein SERPINA3,545
14,N-glycan levels [A2],141
14,Other orthopaedic follow-up care,19
14,Triglyceride levels,27231
14,Back problem,3481
14,Hip shape (DXA scan) [hip shape mode 1],189
14,Pattern 1 | hair/balding pattern,3452
14,Fluid intelligence score,73
14,Late-onset Alzheimer's disease,3594
14,Waist circumference [EA],225
14,Serum metabolite levels [1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1)*],909
14,"Blood protein levels [SERPINA11, 9002_36_3]",729
14,Sphingomyelin_40:2_[M+OAc]1- levels,388
14,Dothiepin | treatment/medication code,337
14,P wave terminal force,228
14,Monocyte percentage,31252
14,Adventurousness,848
14,"Blood protein levels [FLRT2, 13122_19_3]",236
14,Electrocardiogram morphology (amplitude at temporal datapoints) [68 ms],275
14,IgG galactosylation phenotypes (multivariate analysis),8914
14,"Nervous breakdown | non-cancer illness code, self-reported",611
14,Glaucoma (low intraocular pressure),3048
14,Waist circumference,12944
14,Plasma free amino acid levels (adjusted for one other PFAA) [Asn (adjusted for Gln],1636
14,Lifetime number of sexual partners,147
14,Electrocardiogram morphology (amplitude at temporal datapoints) [294 ms],521
14,Glaucoma (multi-trait analysis),4739
14,Sphingomyelin_33:1_[M+H]1+ levels,388
14,"""Malignant neoplasm of breast, HER2-negative (controls excluding all cancers)""",194
14,Alcohol consumption (drinks per week),6278
14,Serum levels of protein TREML4,8671
14,Serum levels of protein C6orf226,633
14,C-reactive protein levels [BMI-adjusted],148
14,Help-seeking from a GP,9770
14,Externalizing behaviour (multivariate analysis),50944
14,Neutrophil-to-lymphocyte ratio,20503
14,Dupuytren's disease,1867
14,Facial morphology (segment 11),105
14,"Body mass index (joint analysis main effects and physical activity interaction) [EA, women]",10
14,Educational attainment (MTAG) [MTAG],131868
14,Leg fat mass (left),14922
14,Cortical surface area [Banks of the Superior Temporal Sulcus],225
14,Electrocardiogram morphology (amplitude at temporal datapoints) [300 ms],285
14,Thyroid hormone levels [TSH],2958
14,Photic sneeze reflex,238
14,IgG glycosylation patterns [IgG1 BG1n/G1n],9645
14,Protein quantitative trait loci (liver) [GSTZ1],12216
14,Thyroid cancer,4115
14,Retinal vascular fractal density,1037
14,Hodgkin's lymphoma,304
14,Cortical surface area (visual PC2) [EA],258
14,N-glycan levels [DG10],974
14,Autism and major depressive disorder (MTAG),839
14,Verbal-numerical reasoning,3221
14,Serum levels of protein IGFL1,8671
14,Paget's disease,862
14,Urinary albumin-to-creatinine ratio [EA],638
14,Hearing aid user,767
14,Lobe attachment (rater-scored or self-reported),457
14,Spontaneous abortion,9
14,Major depressive disorder (MTAG),24474
14,Heel bone mineral density (bmd),28275
14,Mammographic density (dense area),315
14,None of the above | types of physical activity in last 4 weeks,14
14,Serum levels of protein LRRC52,37657
14,"Blood protein levels [FAM177A1, 8039_41_3]",2018
14,"Parental longevity (combined parental attained age, Martingale residuals)",12089
14,IgG glycosylation [IGP61],243
14,Vaspin levels,354
14,COPD (mode),25
14,Triglycerides [EA],87
14,Estimated glomerular filtration rate,51259
14,Systemic lupus erythematosus,10635
14,Brain region volumes [left inferior parietal],3702
14,Sphingomyelin_33:1_[M+OAc]1- levels,388
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-26 ms],4630
14,Pattern 2 | hair/balding pattern,1325
14,Protein quantitative trait loci (liver) [EMILIN2],7
14,Non-glioblastoma glioma,15
14,Lymphocyte percentage of white cells,88161
14,Sphingomyelin levels [SM(32:1;2],2103
14,Glycerophospholipid levels [Phosphatidylcholine acyl-alkyl C32:1],2404
14,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:4/Phosphatidylcholine with acyl-alkyl residue sum C36:5],2404
14,Diacylglycerol_44:6_[M+H-H2O]1+ levels,388
14,"Body mass index in physically active individuals [EA,women]",10
14,Reticulocyte fraction of red cells,165222
14,Hay fever and/or eczema,4446
14,LDL cholesterol,14119
14,"Subcortical brain region volumes [Putamen, EA]",1230
14,Angioedema in response to angiotensin-converting enzyme inhibitor,1190
14,HDL cholesterol levels,80386
14,Fasting glucose,36564
14,Alanine aminotransferase levels,29675
14,Age started wearing glasses or contact lenses,3382
14,Ankle spacing width,34839
14,Ebbinghaus illusion (overestimation),946
14,Mosaic loss of chromosome Y,240
14,Electrocardiogram morphology (amplitude at temporal datapoints) [314 ms],10
14,"""Disorders of gallbladder, biliary tract and pancreas""",25
14,Cortical surface area (visual PC2),3775
14,Serum levels of protein RNASE6,2288
14,Serum levels of protein CCNC,633
14,Feeling hurt,1691
14,Asthma (childhood onset),5715
14,Cognitive performance,6017
14,Total amyloid (SNP x SNP interaction),48
14,FSC-A on CD8+ T cell,5
14,Hypokalaemia,14
14,Cataracts,1596
14,Phosphatidylinositol-O_36:0_[M-H]1- levels,2310
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-106 ms],275
14,Amyotrophic lateral sclerosis,21708
14,Hypothyroidism,39416
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-114 ms],275
14,Mean sphered cell volume,114993
14,Cortical surface area,57504
14,"Hypertension | non-cancer illness code, self-reported",1563
14,Rheumatoid arthritis [EA],322
14,"Blood protein levels [NID2, 3633_70_5]",954
14,Age of smoking initiation (MTAG),758
14,Acute lymphoblastic leukemia (B-cell precursor),859
14,Plateletcrit,95756
14,Mean reticulocyte volume,186621
14,Galectin-3 levels,166820
14,General factor of neuroticism,13009
14,Body mass index [Japanese],1942
14,Metabolite levels [Cer d16:1/16:0],2095
14,Serum levels of protein SERPINA11,516
14,Causalgia,11
14,"Abdominal hernia | non-cancer illness code, self-reported",65
14,"Seen doctor (gp) for nerves, anxiety, tension or depression",10549
14,A levels/as levels or equivalent | qualifications,395
14,Plasma free amino acid levels (adjusted for one other PFAA) [Asn (adjusted for Phe],1636
14,Obesity (early onset extreme),280
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-108 ms],303
14,Never | smoking status,47
14,Protein quantitative trait loci (liver) [FNTA],2
14,Arm fat-free mass (right),54245
14,Lymphocyte count,52659
14,Insomnia [Female],1300
14,Serum levels of protein CTSH,1501
14,Serum levels of protein MCFD2,56785
14,Ankle spacing width (left),14
14,IgG glycosylation patterns [IgG1 BG0n/G0n],5351
14,"Blood protein levels [SERPINA10, 13119_26_3]",5464
14,Low tan response,420
14,"Serum metabolite levels [sphingomyelin (d18:1/14:0, d16:1/16:0)*]",369
14,Parkinson's disease or first degree relation to individual with Parkinson's disease,19426
14,Non-albumin protein levels,14118
14,Diacylglycerol_42:7_[M+H-H2O]1+ levels,388
14,IgG glycosylation [IGP46],243
14,HDL cholesterol levels [Trans-ethnic initial],275
14,Apolipoprotein A1 levels,71868
14,Refractive error,25880
14,Serum levels of protein ANG,5431
14,Doctor diagnosed hayfever or allergic rhinitis,805
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-98 ms],275
14,Pyelonephritis,193
14,Sweets intake,20
14,Noncognitive aspects of educational attainment,3606
14,Uterine fibroids,3882
14,Protein quantitative trait loci (liver) [ME1],21
14,Migraine,1378
14,Leukocyte telomere length,10146
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-112 ms],275
14,N-acetylhistidine levels,11648
14,Facial morphology (segment 53),352
14,Smoking status (ever vs never smokers),353
14,Care involving use of rehabilitation procedures,27
14,N-glycan levels [DG6],1948
14,Liver enzyme levels (alkaline phosphatase),4254
14,Knee pain | pain type(s) experienced in last month,6664
14,Age cataract diagnosed,216
14,Urinary creatinine levels,131
14,Arm predicted mass (left),49984
14,Inflammatory bowel disease,4163
14,LDL cholesterol levels [Trans-ethnic initial],1445
14,P wave duration,316
14,Serum levels of protein ATG5,33588
14,IgD on IgD+ CD24+ B cell,1586
14,IgD on unswitched memory B cell,1556
14,Catechol O-methyltransferase measurement,180
14,Mumps,65
14,Body size at age 10,15367
14,Bone mineral density (hip) and hip bone size,1371
14,Caudate nucleus volume,2648
14,Lymphocyte counts,357656
14,Depressive symptoms (MTAG),15224
14,Problematic alcohol use,10301
14,Serum levels of protein ASPRV1,1843
14,"Peptic ulcer | non-cancer illness code, self-reported",122
14,Length of mobile phone use,288
14,Aortic stiffness,147
14,Phosphatidylcholine-O_31:0_[M+H]1+/Phosphatidylethanolamine-O_34:0_[M+H]1+ levels,388
14,Frequency of tenseness / restlessness in last 2 weeks,79
14,High density lipoprotein cholesterol levels [EA],87
14,Mean corpuscular volume,461476
14,Depressive symptoms,23702
14,Worrier / anxious feelings,9056
14,Cystatin C levels,26492
14,Vitamin C levels,694
14,Childhood maltreatment,141
14,Phosphatidylcholine-O_18:0_[M+OAc]1- levels,25
14,Serum levels of protein SERPINA12,541
14,Protein quantitative trait loci (liver) [ACSM2B],13
14,"Blood protein levels [LGALS3, 3066_12_1]",11656
14,Serum metabolite levels [dopamine 3-O-sulfate],1877
14,Electrocardiogram morphology (amplitude at temporal datapoints) [62 ms],275
14,Total cholesterol levels [EA],1841
14,Carpal tunnel syndrome,80
14,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 measurement",28
14,"""COPD, hospital admissions""",25
14,Urate levels,142913
14,IgG glycosylation patterns [IgG1 FBn/Bn total],15406
14,Keratinocyte cancer (MTAG),732
14,Phosphatidylcholine-O_38:6_[M+OAc]1-/Phosphatidylcholine-P_38:5_[M+OAc]1-/Phosphatidylserine-P_42:1_[M-H]1- levels,2310
14,Menopause (age at onset) [japanese],2029
14,"N-glycan levels [DG1, men]",325
14,Protein quantitative trait loci (liver) [TNC],51
14,Response to paliperidone in schizophrenia (CGI-S score) [MLM],415
14,Serum levels of protein ACP2,33588
14,Cancer (pleiotropy) [subset analysis],176
14,Mosaic loss of chromosome Y (Y chromosome dosage),3422
14,Type 2 diabetes,105280
14,Parachlamydiales abundance in stool,2809
14,Parent of origin effect on language impairment (paternal),18333
14,Smoking initiation (ever regular vs never regular),4659
14,Multiple sclerosis,14952
14,Other chronic obstructive pulmonary disease,25
14,Appendicular lean mass,324178
14,Low density lipoprotein cholesterol levels [EA],5611
14,"Blood protein levels [CGREF1, 6257_56_3]",954
14,Systolic blood pressure (cigarette smoking interaction),3292
14,Gamma glutamyl transferase levels,47248
14,"Heel bone mineral density (bmd) t-score, automated (right)",26607
14,"Blood protein levels [RNASE6, 5646_20_3]",2288
14,Waist circumference adjusted for BMI (adjusted for smoking behaviour),10151
14,Mood disorders (more control exclusions),324
14,"Bone mineral density (paediatric, lower limb)",862
14,Sphingomyelin_39:2_[M+H]1+ levels,388
14,Electrocardiogram morphology (amplitude at temporal datapoints) [334 ms],285
14,Glaucoma,20105
14,Red blood cell (erythrocyte) distribution width,37538
14,Statin medication,4475
14,Diastolic blood pressure response to thiazide and thiazide-like diuretics in hypertension [EA],84
14,Bipolar disorder,470
14,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),275
14,Bone mineral density [spine],213
14,"Fracture skull / head | non-cancer illness code, self-reported",763
14,Number of self-reported non-cancer illnesses,220
14,Eosinophil counts,685830
14,Monocyte count,226598
14,Otosclerosis,19970
14,Benign neoplasm of other parts of digestive system,4658
14,Serum levels of protein FLRT2,239
14,Glaucoma (primary angle closure) [Asian],215
14,Cholelithiasis,75
14,Macular thickness,73503
14,Memory B cell %B cell,83
14,Nevus count or cutaneous melanoma,6182
14,Spherical equivalent (joint analysis main effects and education interaction),3738
14,Coronary atherosclerosis,693
14,C-reactive protein (red blood cell fatty acid level interaction) [EDA],209
14,"Psoriasis | non-cancer illness code, self-reported",378
14,Protein quantitative trait loci (liver) [FGG],32
14,Branched-chain amino acid levels (Isoleucine),2698
14,"Body mass index [EA, women]",141
14,Coronary angiopasty,56
14,6mm regularity index (right),8
14,Brain region volumes [left putamen],1256
14,P wave duration [EA],316
14,Atopic dermatitis [random effects],32133
14,Vitiligo,2434
14,Serum levels of protein SCGB1C2,8671
14,Serum levels of protein SEMG2,1978
14,Colon adenocarcinoma,93
14,"Heel bone mineral density (bmd) t-score, automated",28763
14,Pediatric areal bone mineral density (radius) [Females],1983
14,Creatine kinase levels,11838
14,Atrial fibrillation and flutter,11262
14,"Heel bone mineral density (bmd) t-score, automated (left)",21502
14,"Allergic disease (asthma, hay fever and/or eczema) (age of onset)",4861
14,Serum metabolite levels [1-(1-enyl-palmitoyl)-2-oleoyl-GPC (P-16:0/18:1)*],909
14,No | hearing difficulty/problems,767
14,Gut microbiota (bacterial taxa) [Proteobacteria phylum],790
14,Serum levels of protein RLN1,15756
14,Taking other prescription medications,9446
14,"Rubella / german measles | non-cancer illness code, self-reported",267
14,Red blood cell traits [MCH],782
14,White matter microstructure (axial diusivities) [Hippocampus ],846
14,Cortical surface area [Banksts],153
14,Protein quantitative trait loci (liver) [UGT2B15],202
14,Gastrointestinal diseases,50
14,Left–right brain asymmetry,4009
14,Autoimmune thyroid disease,946
14,Rosuvastatin | treatment/medication code,741
14,Body mass index in physically active individuals [women],10
14,Cutaneous melanoma or hair colour,26021
14,Hand grip strength (left),15415
14,Nucleus accumbens volume,3690
14,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),1820
14,"Blood protein levels [ENTPD5, 4437_56_3]",17268
14,Complement C1s subcomponent measurement,20183
14,Urinary metabolite levels in chronic kidney disease [nonenedioate (C9:1-DC],3834
14,Protein quantitative trait loci (liver) [FGA],32
14,Brain region volumes [right inferior lateral ventricle],176
14,Glaucoma (primary open-angle),37505
14,Lysophosphatidylcholine-O_16:1_[M+H]1+/Lysophosphatidylcholine-P_16:0_[M+H]1+ levels,2454
14,Serum levels of protein GNPNAT1,5591
14,Impedance of leg (right),41722
14,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],1445
14,"Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)",4861
14,Ceramide levels [N24S16],388
14,Zinc  | vitamin and/or mineral supplement use,6
14,Yes | hearing difficulty/problems,767
14,Serum levels of protein SIGLEC8,269
14,Facial morphology (segment 18),4326
14,IgG glycosylation patterns [IgG1 FG2n total/G2n],15406
14,Serum levels of protein GZMB,1217
14,Phosphatidylglycerol-O_38:0_[M-H]1- levels,388
14,Testicular germ cell tumor,12010
14,Highest math class taken,48006
14,Brain region volumes [left pericalcarine],3702
14,Thyrotoxicosis with or without goiter,2612
14,Electrocardiogram morphology (amplitude at temporal datapoints) [316 ms],285
14,Escitalopram | treatment/medication code,6
14,Skin colour,21043
14,Male-pattern baldness,9785
14,N-acetylglucosamine/n-acetylgalactosamine levels,5435
14,IgG glycosylation [IGP51],243
14,Carbimazole | treatment/medication code,1559
14,Sphingomyelin_40:2_[M+H]1+ levels,388
14,Sex hormone-binding globulin levels,198863
14,Immunoglobulin G measurement,17744
14,Number of stillbirths in continuous marriage,159
14,Allergic rhinitis,1475
14,Abandon | final attempt correct,246
14,"Malabsorption/coeliac disease | non-cancer illness code, self-reported",613
14,"Blood protein levels [RNASE3, 5741_55_3]",1559
14,Eczema,51042
14,Total cholesterol levels,52118
14,Hip circumference adjusted for BMI,76759
14,Current tobacco smoking,29764
14,Composite immunoglobulin trait (IgG/IgM),17748
14,Serum levels of protein DEFB131,9174
14,Total body bone mineral density,1102
14,Serum metabolite levels [3-methoxytyramine sulfate],4011
14,Serum levels of protein B4GAT1,1814
14,Cortical thickness [Cuneus],4122
14,Fresh fruit intake,912
14,"""Other diabetes, wide definition""",73
14,Electrocardiogram morphology (amplitude at temporal datapoints) [328 ms],10
14,Major depressive disorder,11389
14,"Hyperthyroidism/thyrotoxicosis | non-cancer illness code, self-reported",2612
14,Epilim 100mg crushable tablet | treatment/medication code,585
14,Ptosis of eyelid,35
14,Gut bacterial pathway abundance (PWY.6612..superpathway.of.tetrahydrofolate.biosynthesis),1018
14,Electrocardiogram morphology (amplitude at temporal datapoints) [54 ms],275
14,IgG glycosylation patterns [IgG1 Bn/Fn total],9645
14,Arm fat mass (right),36814
14,3mm weak meridian (left),5223
14,Autoimmune diseases,591
14,Triacylglycerol_46:5_[M+NH4]1+ levels,388
14,High density lipoprotein cholesterol levels,46852
14,Type 1 diabetes without complications,85
14,Systemic sclerosis,71
14,Spherical equivalent or myopia (age of diagnosis),15242
14,Protein quantitative trait loci (liver) [PHYH],182
14,Peripheral artery disease,1148
14,Gut microbiota abundance (k_Bacteria.p_Firmicutes.c_Negativicutes.o_Selenomonadales),43
14,Daytime dozing / sleeping (narcolepsy),24
14,Deoxycarnitine levels,3623
14,Metabolite levels (small molecules and protein measures) [Histidine],1192
14,Serum levels of protein ERMAP,269
14,Male puberty timing (age at voice breaking MTAG),6006
14,IgG glycosylation patterns [IgG1_G1F/IgG1_G1],15406
14,Predicted visceral adipose tissue,8580
14,Bilirubin levels,14436
14,"""Diabetes, insuline treatment (Kela reimbursement)""",73
14,Brain morphology (MOSTest),20855
14,Mitral valve prolapse,4630
14,Serum levels of protein CTBS,9174
14,Bioavailable testosterone levels,18912
14,Blood metabolite levels [asparagine],3502
14,Cutaneous mastocytosis (adult),116
14,Pattern 3 | hair/balding pattern,48
14,Positive affect,21918
14,Diabetes or endocrine disease,7562
14,Prolapsed or slipped disc,2128
14,"Eye color [EA, discovery]",420
14,Blood metabolite levels [X-08402],388
14,"Serum metabolite levels [sphingomyelin (d18:1/22:1, d18:2/22:0, d16:1/24:1)*]",369
14,Phosphatidylcholine-O_38:2_[M+H]1+/Phosphatidylcholine-P_38:1_[M+H]1+ levels,388
14,P wave terminal force [EA],228
14,Electrocardiogram morphology (amplitude at temporal datapoints) [356 ms],275
14,Serum levels of protein CGREF1,21
14,Schizophrenia vs ADHD (ordinary least squares (OLS)),35806
14,Feeling worry,7846
14,Serum levels of protein NCF2,269
14,Cutaneous mastocytosis,116
14,Phosphatidylcholine-O(36:5)_[M+H]1+/Phosphatidylcholine-P(36:4)_[M+H]1+ levels,172
14,Smoking x traumatic event in childhood (sexually molested) interaction,44
14,Electrocardiogram morphology (amplitude at temporal datapoints) [340 ms],10
14,Breast cancer,27545
14,Plasma free amino acid levels (adjusted for one other PFAA) [Ala (adjusted for Asn],1636
14,Protein quantitative trait loci (liver) [PNP],3450
14,Subcutaneous adipose tissue [women],393
14,Sphingomyelin_36:1_[M+OAc]1- levels,388
14,Serum levels of protein CTSA,469
14,Black vs. blond hair color,420
14,Time spent using computer,12037
14,Brain region volumes [right precuneus],14989
14,Arrhythmia,680
14,IgG glycosylation patterns [IgG1_G0n],11941
14,Plasma free amino acid levels (adjusted for one other PFAA) [Tyr (adjusted for Asn],1636
14,Cortical thickness [Pericalcarine],2292
14,Body mass index [EA],282
14,Intraocular pressure,13840
14,Cortical surface area [Lateral Occipital],3852
14,IgG glycosylation patterns [IgG1 GS1/(G+GS1],10256
14,Serum levels of protein GALK1,269
14,Unstable angina pectoris,132
14,Mean corpuscular haemoglobin concentration,8520
14,Periodontal disease-related phenotype (Socransky),265
14,"Cholesterol, total",1550
14,TB-LM or TBLH-BMD (pleiotropy),862
14,"Blood protein levels [SMOC1, 13118_5_3]",368
14,Serum 25-Hydroxyvitamin D levels x season interaction,1499
14,Hippocampal tail volume (corrected for total hippocampal volume),234
14,Coronary revascularization (ANGIO or CABG),120
14,Cortical volume [Supramarginal],7094
14,Fractures,1102
14,Colon adenocarcinoma (controls excluding all cancers),100
14,Serum levels of protein CHGA,216
14,Body mass index (joint analysis main effects and smoking interaction) [women],10
14,Protein quantitative trait loci (liver) [ORM2],26
14,Blood protein levels in cardiovascular risk,20063
14,Pulse pressure,54845
14,"Bone mineral density (paediatric, total body less head)",862
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-104 ms],275
14,Smoking cessation,38059
14,IgG glycosylation patterns [IgG2_G2/IgG2_G1],14767
14,Immature reticulocyte fraction,37761
14,"Mania/bipolar disorder/manic depression | non-cancer illness code, self-reported",1013
14,Plasma free amino acid levels (adjusted for one other PFAA) [Thr (adjusted for Asn],1636
14,Electrocardiogram morphology (amplitude at temporal datapoints) [292 ms],246
14,IgG glycosylation patterns [IgG1_G0],11941
14,IgG glycosylation patterns [IgG1_G2FS1/IgG1_G2S1],16079
14,Sphingomyelin_40:3_[M+OAc]1- levels,388
14,"Ecg, heart rate",514
14,Stress-related phenotypes (multivariate analysis) [mental health and PTSD symptom scores],139
14,IgG glycosylation patterns [IgG1 Fucosylation],9645
14,Interleukin-6 receptor subunit beta measurement,5274
14,CD25 on IgD+ CD24- B cell,1556
14,IgG fucosylation phenotypes (multivariate analysis),8914
14,Sphingomyelin_37:1_[M+H]1+ levels,388
14,QT interval,7423
14,Methionine sulfoxide levels,315
14,Facial morphology (segment 56),33
14,UBP9 abundance in stool,137
14,"""Ischaemic heart disease, wide definition""",106
14,"""Type 1 diabetes, strict definition""",97
14,White matter hyperintensity volume x hypertension interaction (2df),4565
14,Urinary albumin excretion,697
14,Phosphatidylethanolamine-ether levels [PEO(18:1;0-18:2;0],207
14,Electrocardiogram morphology (amplitude at temporal datapoints) [302 ms],285
14,Myopia (age of diagnosis),4327
14,Serum levels of protein ISM2,8671
14,Glycerophospholipid levels [Phosphatidylcholine acyl-alkyl C36:5],2404
14,Alcohol consumption,667
14,Electrocardiogram morphology (amplitude at temporal datapoints) [320 ms],285
14,Protein delta homolog 1 levels,611
14,Brain region volumes [right cuneus],5012
14,F_Rikenellaceae abundance,1337
14,B-cell acute lymphoblastic leukaemia,602
14,Glaucoma (primary angle closure),215
14,Disorders of the thyroid gland,982
14,Sleep duration,21406
14,HDL cholesterol,29416
14,Gut microbiota (bacterial taxa) [Unclassified Erysipelotrichaceae],601
14,Electrocardiogram morphology (amplitude at temporal datapoints) [286 ms],236
14,"Blood protein levels [FUT8, 8244_16_3]",518
14,Electrocardiogram morphology (amplitude at temporal datapoints) [460 ms],9
14,Diffuse plaques (SNP x SNP interaction),5511
14,Breast cancer (male),1681
14,"N-glycan levels [A2, men]",325
14,Pulmonary artery enlargement in chronic obstructive pulmonary disease,762
14,Bone mineral density (hip),21
14,Asthma or allergic disease (pleiotropy),937
14,Major coronary heart disease event,95
14,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),1445
14,"""Hypothyroidism, strict autoimmune, 3 medication purchases required""",2147
14,Number of days/week walked 10+ minutes,987
14,Distance between home and job workplace,70
14,IgG glycosylation [IGP59],243
14,IgG glycosylation [IGP42],243
14,Platelet distribution width,135505
14,Uveal melanoma with epithelioid cells,3674
14,High blood pressure | vascular/heart problems diagnosed by doctor,24646
14,Decline in glucose metabolism in posterior cingulate cortex,913
14,Serum metabolite levels [sphingomyelin (d18:2/23:1)*],369
14,Colorectal cancer,1411
14,Protein quantitative trait loci (liver) [FLNA],6
14,Gut microbiota abundance (genus Ruminococcaceae UCG009 id.11366),6
14,Serum levels of protein CEACAM1,47117
14,IgG glycosylation patterns [IgG1_G2F/IgG1_G2],15406
14,Fat-free mass [male],29741
14,IgG glycosylation patterns [IgG1 FG2n/G2n],11313
14,Protein quantitative trait loci (liver) [SERPINF1],32
14,Vertical cup-disc ratio (multi-trait analysis),48330
14,Sphingomyelin_41:2_[M+H]1+ levels,388
14,"Blood protein levels [NRXN3, 5111_15_3]",636
14,Brain region volumes [left lingual],3702
14,Serum levels of protein GALNT16,18
14,Systemic lupus erythematosus [Hispanic],517
14,Sphingomyelin_32:1_[M+OAc]1- levels,388
14,Birth weight,26402
14,Heel bone mineral density (MTAG),80591
14,Ganglion cell inner plexiform layer (GCIPL) thickness,15398
14,Mean corpuscular haemoglobin,88868
14,Neutrophil percentage of granulocytes,3512
14,Myocardial infarction,1859
14,Waist-to-hip ratio adjusted for body mass index [East Asian women],838
14,Blond vs non-blond hair color,172
14,dCTP pyrophosphatase 1 measurement,48
14,Primary tooth development (number of teeth),5600
14,CD27 on unswitched memory B cell,1556
14,Body fat distribution (trunk fat ratio) [males],182
14,Nervous feelings,6702
14,Cortical volume [Precuneus],7094
14,"""Hypothyroidism,  other/unspecified""",2491
14,"Blood protein levels [COCH, 7227_75_3]",220
14,Brown vs. non-brown hair color,172
14,Cholelithiasis or gall stones,25
14,Cortical volume [Fusiform],1403
14,Interleukin-10 levels in non-alcoholic fatty liver disease x mastiha supplementation interaction,2456
14,Pulse pressure [EA],509
14,"""Congenital malformations of eyelid, lacrimal apparatus and orbit""",151
14,Colon polyp,784
14,Body mass index (joint analysis main effects and physical activity interaction),68
14,Serum levels of protein NGFR,633
14,More irritable than usual during worst period of anxiety,65
14,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),47061
14,Electrocardiogram morphology (amplitude at temporal datapoints) [290 ms],246
14,Spherical power (right),4437
14,Bullous pemphigoid,22
14,Sodium levels,4634
14,Cortical thickness (MOSTest),13567
14,"Intra-ocular pressure, goldmann-correlated (right)",6824
14,Acute lymphoblastic leukemia (childhood),1732
14,Serum levels of protein GSK3A;GSK3B,243
14,Body fat distribution (leg fat ratio) [females],182
14,Phosphatidylglycerol-O_40:0_[M-H]1- levels,388
14,Fat-free mass [female],3310
14,Phosphatidylcholine-O_32:1_[M+H]1+/Phosphatidylcholine-P_32:0_[M+H]1+/Phosphatidylethanolamine-O_35:1_[M+H]1+ levels,2310
14,Gut microbiota (functional units) [P562-PWY_myo-inositol_degradation_I],207
14,"""Heart failure, not strict""",84
14,Electrocardiogram morphology (amplitude at temporal datapoints) [326 ms],10
14,Vertex-wise cortical thickness,49463
14,Arm fat mass (left),26095
14,Protein quantitative trait loci [Angiogenin],3028
14,Two-hour glucose,275
14,"Pulse rate, automated reading",40851
14,Plasma free amino acid levels (adjusted for one other PFAA) [Asn (adjusted for Gly],1636
14,Electrocardiogram morphology (amplitude at temporal datapoints) [366 ms],275
14,"Cerebrospinal fluid biomarker levels [ATP synthase subunit beta, mitochondrial]",6
14,IgG glycosylation patterns [IgG1_G0F/IgG1_G0],15406
14,Glycated hemoglobin levels,8502
14,Serum levels of protein GPHB5,8671
14,Ease of getting up in the morning,2901
14,RR interval (heart rate),325
14,"Blonde | hair colour (natural, before greying)",40418
14,LDL cholesterol levels in current drinkers,1445
14,Subcortical volume (MOSTest),6065
14,Water intake,493
14,Urinary sodium excretion [EA],3745
14,Protein quantitative trait loci (liver) [SERPINC1],27
14,White matter microstructure (fractional anisotropy) [Hippocampus ],379
14,Basophil count,41252
14,Blond vs. brown/black hair color,31229
14,Eye color [Blue eye color],420
14,Electrocardiogram morphology (amplitude at temporal datapoints) [322 ms],521
14,Triacylglycerol_45:4_[M+NH4]1+ levels,388
14,Place of birth in uk - east co-ordinate,28
14,Basophil percentage of white cells,12507
14,Metabolite levels [SM d16:1/18:0],2095
14,QRS duration,18291
14,Doctor diagnosed emphysema,639
14,Type 1 diabetes with ophthalmic complications,103
14,"Blood protein levels [WARS, 9870_17_3]",17066
14,Protein Z-dependent protease inhibitor measurement,6391
14,Electrocardiogram morphology (amplitude at temporal datapoints) [318 ms],285
14,"""Myocardial infarction, strict""",89
14,Heel bone mineral density x serum urate levels interaction [female],57
14,Triglycerides,37300
14,Brain region volumes [left accumbens area],3945
14,Cancer (pleiotropy),579
14,"Hip circumference adjusted for BMI [EA, women]",9298
14,Broad depression or schizophrenia,28338
14,Sensitivity / hurt feelings,2391
14,Plasma free amino acid levels (adjusted for one other PFAA) [Lys (adjusted for Asn],1636
14,Electrocardiogram morphology (amplitude at temporal datapoints) [310 ms],521
14,"Blood protein levels [GALNT16, 8923_94_3]",18
14,Smoking behaviour (cigarette pack-years),42546
14,Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis),6953
14,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],1445
14,Serum levels of protein UCHL1,269
14,Digit length ratio (left hand) [EA],322
14,Serum urea levels,10439
14,Montelukast product | treatment/medication code,1320
14,Sphingomyelin_36:1_[M+H]1+ levels,388
14,Problematic alcohol use (MTAG),40276
14,Creatinine levels,54957
14,Atopic dermatitis,30587
14,Cortical thickness,47199
14,Plasma free amino acid levels (adjusted for one other PFAA) [Asn (adjusted for Pro],1636
14,Brain region volumes [right accumbens area],3251
14,IgG glycosylation [IGP6],243
14,Digit length ratio,322
14,"Medication use (adrenergics, inhalants)",118
14,Number of sexual partners,48827
14,Risk taking,42999
14,Serum uric acid levels,20859
14,Medication use (drugs used in diabetes),2365
14,Metabolite levels [HexCer d16:1/16:0],2841
14,Sociability score,369
14,Serum metabolite concentrations in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C32:2],2404
14,"Blood protein levels [DLK1, 6496_60_3]",597
14,Ceramide_40:1_[M-H]1- levels,388
14,Whole body fat-free mass,67190
14,Thyrotoxicosis with diffuse goitre,2498
14,Immune reponse to smallpox (secreted IFN-alpha) [EA],4493
14,Serum metabolite levels [1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4)*],909
14,Cortical thickness [Banksts],63
14,High light scatter reticulocyte percentage,46817
14,Blood urea nitrogen levels,8386
14,"Heel quantitative ultrasound index (qui), direct entry (right)",26607
14,Basophill percentage,8800
14,Obesity [Overweight],10
14,IgD on IgD+ B cell,1556
14,Cutaneous mastocytosis (childhood),116
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-126 ms],275
14,Arm fat percentage (left),49303
14,"Blood protein levels [GZMB, 4133_54_2]",1217
14,Protein quantitative trait loci (liver) [FGB],32
14,"Allergic disease (asthma, hay fever or eczema)",5237
14,High-sensitivity cardiac troponin I concentration,881
14,Rheumatoid arthritis (ACPA-positive),805
14,Calcium levels,106800
14,Risk-taking tendency (4-domain principal component model),761
14,Digit length ratio (right hand),322
14,Personal history of certain other diseases,291
14,Metabolic biomarkers (multivariate analysis),17408
14,White matter microstructure (mean diusivities) [Fornix (column and body],2751
14,Blood protein levels [MB],435
14,Crohn's disease,2424
14,Cortical volume [Lingual],779
14,Type 1 diabetes with other specified/multiple/unspecified complications,79
14,"Waist circumference adjusted for body mass index [EA, men]",10290
14,Cortical volume [Lateral occipital],7094
14,Serum levels of protein SIGLEC10,39318
14,Body mass index in physically active individuals [EA],10
14,Vertical cup-disc ratio (adjusted for vertical disc diameter),45157
14,"Heel quantitative ultrasound index (qui), direct entry (left)",20238
14,Leg predicted mass (right),68643
14,Frequency of tiredness / lethargy in last 2 weeks,1647
14,Protein quantitative trait loci (liver) [AKR1B1],3
14,Composite immunoglobulin trait (IgA/IgG),513
14,Participant wanted to stop early | completion status of test,881
14,Monobrow,420
14,Phosphatidylcholine-2O_32:0_[M+H]1+ levels,388
14,Diabetes mellitus,272
14,Neuritic plaques (SNP x SNP interaction),14
14,Graves' disease,21966
14,Rheumatic heart disease [IGHV4-61*02 lead SNP],15205
14,Serum levels of protein RNASE3,2842
14,Electrocardiogram morphology (amplitude at temporal datapoints) [368 ms],275
14,Protein quantitative trait loci (liver) [HAL],72
14,Medial thalamic nuclei volume,197
14,Educational attainment (years of education) [conditional-joint],27029
14,Impedance of arm (left),43815
14,Depressed affect,13372
14,Biscuit cereal (e.g. weetabix) | cereal type,3332
14,"N-glycan levels [DG1, women]",2676
14,Heart rate response to recovery post exercise (30 sec),517
14,Plasma free asparagine levels,1636
14,Systolic blood pressure x sodium interaction (1df test) [recessive model],35
14,Inverse distance to the nearest major road,44
14,Burn and corrosion of head and neck,14
14,Neuroticism,58158
14,Immunoglobulin G index levels in multiple sclerosis,18059
14,Obesity [Obesity class I],10
14,Hand grip strength,6488
14,IgG glycosylation [IGP2],243
14,"Serum metabolite levels [sphingomyelin (d18:1/20:0, d16:1/22:0)*]",369
14,"""Disorders of plasma-protein metabolism, not elsewhere classified""",25
14,Endometrial cancer,3610
14,Age at menopause,20747
14,Cortical surface area (min-P),3936
14,Corneal resistance factor (left),5688
14,Acute lymphoblastic leukemia in childhood (B cell precursor),859
14,"Blood protein levels [SERPINA4, 3449_58_2]",1705
14,Pediatric bone mineral density (femoral neck),4176
14,IgD on IgD+ CD38+ B cell,1556
14,Serum levels of protein FXYD4,2031
14,"Bladder problem (not cancer) | non-cancer illness code, self-reported",380
14,"Ground coffee (include espresso, filter etc) | coffee type",1163
14,Medication use (HMG CoA reductase inhibitors),17127
14,Placenta growth factor levels,71767
14,Feeling fed-up,12218
14,White blood cell types [monocyte count],562
14,Hip circumference [EA],85
14,College or university degree | qualifications,61219
14,Electrocardiogram morphology (amplitude at temporal datapoints) [-100 ms],275
14,IgG digalactosylation phenotypes (multivariate analysis),243
14,BMI (adjusted for smoking behaviour) [women],10
14,Serum levels of protein MGAT2,8484
14,COPD,25
14,Disc problem,1143
14,Protein quantitative trait loci (liver) [ACADS],104
14,Femur bone mineral density x serum urate levels interaction [female],1395
14,Psoriasis vulgaris,1550
14,Narcolepsy with cataplexy,634
14,Anaphylactic shock nos,1109
14,Urolithiasis,9490
14,Alzheimer's disease (late onset),1308
14,Glycerophospholipid levels [Phosphatidylcholine diacyl C28:1],388
14,Chronic obstructive pulmonary disease x current smoker interaction (2df),601
14,Betahistine | treatment/medication code,36
14,Hip circumference,15520
14,"Blood protein levels [EA, Inosine-5'-monophosphate dehydrogenase 1]",2570
14,Urinary metabolite levels in chronic kidney disease [X - 21792],408
14,Electrocardiogram morphology (amplitude at temporal datapoints) [324 ms],246
14,Age at first sexual intercourse,16878
14,Serum metabolite levels [leucylglycine],12520
14,Medication use (antiglaucoma preparations and miotics),6025
14,Sensorineural hearing loss,651
14,Electrocardiogram morphology (amplitude at temporal datapoints) [330 ms],10
14,Nap during day,678
14,Menarche (age at onset),28153
14,"Systolic blood pressure, automated reading",50549
14,White matter hyperintensities,1561
14,Biological sex,1425
14,Age first had sexual intercourse,3635
14,Cranial base width,478
14,Immature fraction of reticulocytes,121364
14,Total body bone mineral density (MTAG),80591
14,"Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)",458
14,Body fat percentage or coronary artery disease (MTAG),275
14,Sphingomyelin_38:1_[M+OAc]1- levels,388
14,Mood [affective] disorders,258
14,"Thyroid problem (not cancer) | non-cancer illness code, self-reported",49
14,Smoking behaviour (cigarettes smoked per day),43013
14,IgG glycosylation patterns [IgG1_G2N/IgG1_G1N],15002
14,Sum basophil neutrophil counts,8822
14,Metabolite levels [SM d16:1/24:1],2095
14,Creon e/c granules in capsule | treatment/medication code,710
14,Factor VIII levels [EA],3016
14,Serum metabolite levels [asparagine],3244
14,IgD on transitional B cell,1556
14,Spontaneous vertex | delivery methods,41
14,Home location - east co-ordinate (rounded),6
14,Anxiety,12507
14,General cognitive ability,14558
14,Body fat distribution (leg fat ratio) [males],182
14,Citramalate levels,1703
14,Average total household income before tax,225
14,Cerebrospinal fluid t-tau levels in normal cognition,6361
14,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)",94863
14,Glaucoma (high intraocular pressure),12171
14,IgG glycosylation patterns [IgG1_G1NS1/IgG1_G1N],10035
14,Cortical surface area [Lateral Orbitofrontal],276
14,Brown vs. black hair color,420
15,Phosphatidylcholine-ether levels [PCO(18:2;0-18:1;0],53228
15,Corneal resistance factor (left),5989
15,Advanced age-related macular degeneration [EA],322
15,Asthma (only as main-diagnosis),1148
15,Free thyroxine concentration,1070
15,Externalizing behaviour score,105
15,Cigarettes smoked per day (current),8386
15,Body mass index in physically active individuals [EA],9407
15,Adverse response to chemotherapy (amenorrhea) in breast cancer,1592
15,Hair morphology traits [Hair color],427
15,Brain region volumes [left supramarginal],304
15,Glucose levels,12403
15,Body fat distribution (trunk fat ratio) [females],3503
15,High blood pressure | illnesses of siblings,3839
15,Levothyroxine sodium | treatment/medication code,942
15,Obesity-related traits [Sleep duration ],1431
15,Heme oxygenase 1 measurement,575
15,Birth weight of first child,26040
15,"Blood protein levels [NMB, 9321_400_3]",14138
15,Left ventricle wall thickness,7013
15,Electrocardiogram morphology (amplitude at temporal datapoints) [86 ms],216
15,Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in secretors,32
15,Spontaneous vertex | delivery methods,10
15,"""Diabetes, insuline treatment (Kela reimbursement)""",2028
15,Serum metabolite levels [TotCho],310
15,Serum metabolite levels [1-palmitoyl-GPE (16:0],445
15,Aminopeptidase N levels,169
15,HDL cholesterol levels x short total sleep time interaction (2df test),581
15,Cortical surface area [Precentral],314
15,Metabolic syndrome (bivariate traits) [HDLC-GLUC],334
15,Malignant neoplasm of skin (controls excluding all cancers),5
15,Multiple sclerosis,6528
15,Primary open-angle glaucoma,6918
15,Phosphatidylcholine(37:6)_[M+H]1+/Phosphatidylethanolamine(40:6)_[M+H]1+/Phosphatidate(42:7)_[M+NH4]1+ levels,326
15,Serum metabolite levels [XL_HDL_TG],334
15,"Skin aging measurement [Additive, crow's feet, East Asian]",21
15,Cotinine and 3'-hydroxycotinine levels in current smokers,7673
15,Serum metabolite levels [Creatine],16803
15,Body mass index (joint analysis main effects and physical activity interaction) [EA],9407
15,Serum uric acid levels [Japanese],33561
15,Glucoma-related operations,594
15,Hyperopia,2158
15,Electrocardiogram morphology (amplitude at temporal datapoints) [20 ms],7694
15,Eye color traits [RS123 cohort],427
15,Cortical surface area [Rostral Middle Frontal],84
15,Asthma (childhood onset),37118
15,Subcortical volume (min-P),4657
15,Serum metabolite levels (CMS) [ApoA1],334
15,Serum metabolite levels [M_LDL_TG],635
15,Mean sphered cell volume,212717
15,Waist circumference adjusted for BMI in active individuals,4639
15,Abdominal and pelvic pain,524
15,Brown vs. black hair color,5704
15,BMI (adjusted for smoking behaviour) [women],9407
15,Spherical equivalent,8469
15,Global electrical heterogeneity phenotypes [SAI QRST],728
15,Protein quantitative trait loci (liver) [PCCB],1007
15,Serum lipopolysaccharide activity,161
15,"""Coxarthrosis, primary, with hip surgery""",12
15,Triglycerides,86848
15,Ulcerative colitis,32966
15,Body size at age 10,13362
15,Chronic obstructive pulmonary disease x current smoker interaction (2df),7893
15,Facial morphology (nose roundness 3),96
15,High density lipoprotein cholesterol levels [East Asian],547
15,Body mass index in physically active individuals [women],9407
15,Serum levels of protein FGF7,18382
15,Serum metabolite levels (CMS) [S_VLDL_FC],334
15,"Eye color (brightness) [conditional on rs16891982, rs12203592, rs10809826, rs1800404, rs12913832 and rs1426654]",191
15,Skin pigmentation traits [Skin sensitivity to sun (high-medium to low-medium],427
15,Platelet distribution width,314496
15,Ever smoked,971
15,Diffuse plaques (SNP x SNP interaction),207
15,IgA nephropathy,110
15,UBA6398 abundance in stool,194
15,Iris heterochromicity,76
15,Menarche (age at onset),135768
15,Birth weight,14065
15,Essential hypertension,60063
15,Urinary metabolite levels in chronic kidney disease [inosine],12600
15,"Forced expiratory volume in 1-second (fev1), best measure",52599
15,Spherical power (left),5570
15,Coronary artery bypass grafting,10139
15,Leisure sedentary behaviour (television watching),1217
15,Chronic bronchitis/emphysema | illnesses of siblings,7673
15,Nontoxic single thyroid nodule,12480
15,Electrocardiogram morphology (amplitude at temporal datapoints) [264 ms],10179
15,Time to smoke first cigarette in the morning,7539
15,Age at first birth,1527
15,Malignant neoplasm of bronchus and lung,7539
15,Attention deficit hyperactivity disorder or intracranial volume (pleiotropy),645
15,Current cigarettes per day in chronic obstructive pulmonary disease,8642
15,Malignant neoplasm of skin,41
15,3mm cylindrical power (right),215
15,Sex hormone-binding globulin levels [Men + Women],13
15,Atopic asthma,27064
15,Male puberty timing (age at voice breaking MTAG),3798
15,"Hypertension | non-cancer illness code, self-reported",50424
15,Childhood asthma (age<16) (more control exclusions),710
15,Any mental disorder,470
15,Hay fever and/or eczema,43112
15,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test) [EA],20143
15,Body fat percentage [male],7818
15,Cytokine network levels (multivariate analysis),999
15,Attention deficit hyperactivity disorder or putamen volume (pleiotropy),653
15,Benign neoplasm of colon,427
15,Chronic obstructive pulmonary disease x current smoker interaction (main effect),7893
15,Forced expiratory volume in 1-second (fev1),54138
15,"Cys-gly, oxidized levels",8299
15,Age-related hearing impairment [EA],678
15,Antihypertensive medication - note that there are other indications,4339
15,Phosphatidylethanolamine(36:4)_[M-H]1- levels,634
15,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)",38902
15,Leg predicted mass (right),42803
15,Sertraline | treatment/medication code,303
15,Physically abused by family as a child,474
15,Rosacea symptom severity,427
15,Protein quantitative trait loci (liver) [PCCA],1007
15,Parental longevity (father's attained age),10991
15,HDL cholesterol levels x long total sleep time interaction (2df test) [EA],2352
15,Phosphatidylcholine_35:6_[M+H]1+/Phosphatidylethanolamine_38:6_[M+H]1+/Phosphatidate_40:7_[M+NH4]1+ levels,997
15,Fruit consumption,221
15,Lagophthalmos,4
15,Impedance of leg (right),61236
15,Alcohol consumption (drinks per week),18783
15,Gut microbiota (bacterial taxa) [Enterobacteriaceae family],1249
15,Serum metabolite levels [LDL_D],334
15,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),8067
15,Cotinine levels in current smokers,7673
15,"Smoking behaviour (cigarettes smoked per day) [Conditioned on chr15:78911181, chr15:78906177, chr15:78849779, chr15:78908565, chr15:78814046]",10046
15,Sum neutrophil eosinophil counts,56215
15,Urinary albumin-to-creatinine ratio [EA],50519
15,Renal function and chronic kidney disease [eGFRcrea],53228
15,"Heel quantitative ultrasound index (qui), direct entry",43939
15,Chronic lower respiratory diseases,8660
15,Breakfast cereal skipping frequency,455
15,Total PHF-tau (SNP x SNP interaction),87398
15,Hip circumference,29036
15,Age-related hearing impairment (SNP x SNP interaction),9956
15,Bipolar disorder or body mass index,2228
15,Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis),1073
15,Diseases of the musculoskeletal system and connective tissue,8
15,Alcohol consumption (drinks per week) (MTAG),1701
15,Vertex-wise cortical surface area,96917
15,"Blood protein levels [ANXA2, 4961_17_1]",351
15,Age when periods started (menarche),113705
15,Systemic sclerosis,22433
15,Leg fat mass (left),36583
15,Unstable angina pectoris,13714
15,Serum metabolite levels [S_VLDL_C],334
15,"Epidural or caudal, and spinal anaesthetic | anaesthetics administered during delivery",105
15,C-reactive protein levels,48014
15,Serum levels of protein NEO1,5509
15,Lung cancer | illnesses of mother,7458
15,Neutrophill count,100464
15,Verbal-numerical reasoning,2204
15,Triglyceride levels in current drinkers,688
15,"Blood protein levels [NTRK3, 2658_27_1]",143
15,"""Cardiomyopathy, Hypertrophic obstructive""",252
15,Chronic obstructive pulmonary disease (severe),1879
15,Age first had sexual intercourse,5299
15,Crohn's disease,2578
15,Serum levels of protein ISLR2,8301
15,White matter hyperintensities,2208
15,Lipid traits [HDL],148
15,Sensitivity / hurt feelings,1589
15,Serum metabolite levels [MUFA],362
15,Electrocardiogram morphology (amplitude at temporal datapoints) [76 ms],216
15,High light scatter reticulocyte percentage,7026
15,Cheese intake,4398
15,Neuroticism conditioned on self-rated math ability (multi-trait conditioning and joint analysis),1073
15,"Peritonitis | non-cancer illness code, self-reported",804
15,Serum metabolite levels (CMS) [Serum_C],334
15,Femur bone mineral density x serum urate levels interaction [female],31
15,"Liver failure/cirrhosis | non-cancer illness code, self-reported",91
15,Cleft lip with or without cleft palate,10321
15,"""Non-small cell lung cancer, squamous (controls excluding all cancers)""",10392
15,Low HDL-cholesterol levels,522
15,Keratoconus,1071
15,Sodium in urine,302
15,Household income (MTAG),47941
15,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],8138
15,Lymphocyte count,75335
15,Electrocardiogram morphology (amplitude at temporal datapoints) [154 ms],887
15,Multivitamins capsule | treatment/medication code,1350
15,Blood metabolite levels [1-stearoylglycerophosphoethanolamine],635
15,N-acetylglucosamine/n-acetylgalactosamine levels,2
15,Cotinine glucuronidation,10
15,Fibrinogen levels,107192
15,Medication use (diuretics),35778
15,Presence of cardiac and vascular implants and grafts,816
15,Parental lifespan,11466
15,Serum metabolite levels (CMS) [S_LDL_PL],433
15,Total cholesterol levels [BMI unadjusted],327
15,Change in serum metabolite levels (CMS) [FAw6_FA],310
15,Serum uric acid levels [EA],6954
15,"Thyroid goitre | non-cancer illness code, self-reported",12020
15,"""Gonarthrosis, primary, with knee surgery""",4797
15,Fasting blood glucose (BMI interaction),430
15,Other disorders of glucose regulation and pancreatic internal secretion,2240
15,Anxiety,99
15,"Heel bone mineral density (bmd) t-score, automated (right)",841
15,Protein quantitative trait loci (liver) [IGKC],21
15,Bacterial meningitis,105
15,Monoclonal gammopathy of undetermined significance,14
15,"Emphysema imaging phenotypes [%LAA-950, All]",4570
15,Acceptance of an invitation to participate in a mental health questionnaire,32411
15,High blood pressure | vascular/heart problems diagnosed by doctor,49203
15,Urinary metabolite levels in chronic kidney disease [adenosine],15085
15,Serum metabolite levels (CMS) [XL_HDL_FC],334
15,Serum metabolite levels [M_HDL_PL],310
15,Lung cancer,84920
15,Serum albumin levels [EA],10481
15,Thoracic aortic aneurysms and dissections,1326
15,Phosphatidylethanolamine_36:4_[M-H]1- levels,997
15,Urolithiasis,73
15,Hematocrit,382148
15,Ease of skin tanning,11462
15,DNA methylation GrimAge acceleration,1180
15,"Red blood cell traits [EA, Hgb]",1724
15,Total cholesterol levels [Trans-ethnic initial],408
15,Metabolite levels [LPE 18:0],162
15,Attention deficit hyperactivity disorder or cannabis use,572
15,X-24686 levels,110
15,Chronotype,2761
15,Serum metabolite levels [1-oleoyl-GPE (18:1],861
15,Skin pigmentation traits [Skin sensitivity to sun],446
15,Monobrow,829
15,Electrocardiogram morphology (amplitude at temporal datapoints) [72 ms],216
15,Eye color traits [Eye color phototype score],749
15,Alzheimer's disease or family history of Alzheimer's disease,14608
15,Smoking status (heavy vs light),10557
15,Non-small cell lung cancer,19041
15,Serum metabolite levels (CMS) [XS_VLDL_TG],334
15,Phosphatidylcholine_35:4_[M+H]1+/Phosphatidylethanolamine_38:4_[M+H]1+/Phosphatidate_40:5_[M+NH4]1+ levels,997
15,Heart rate,360
15,DHEAS levels,6778
15,Pediatric autoimmune diseases,643
15,Hypertrophic scar,203
15,Glycemic traits (multi-trait analysis),23365
15,Waist-to-hip ratio adjusted for BMI (additive genetic model),81502
15,Thyroid volume [goiter],11811
15,Fasting blood proinsulin levels,430
15,"Blood pressure medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",39893
15,"Forced expiratory volume in 1-second (fev1), predicted percentage",10284
15,Protein quantitative trait loci (liver) [CYP3A5],921
15,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],688
15,"Other professional qualifications eg: nursing, teaching | qualifications",825
15,Schizophrenia,236592
15,Myeloid white cell count,34804
15,Electrocardiogram morphology (amplitude at temporal datapoints) [-118 ms],359
15,Serum metabolite levels [1-stearoyl-2-arachidonoyl-GPE (18:0/20:4],445
15,Eye color (saturation),1411
15,Carpal tunnel syndrome,326
15,Serum metabolite levels (CMS) [XS_VLDL_C],334
15,Serum metabolite levels [L_HDL_FC],362
15,HDL cholesterol levels [Asian],282
15,Skin colour,31099
15,"Heel bone mineral density (bmd) t-score, automated (left)",1094
15,Emphysema distribution in smoking [diff950],2719
15,Waist-to-hip ratio adjusted for BMI,272987
15,Nontoxic diffuse goitre,8506
15,Facial morphology (segment 2),272
15,Peak velocity of the mitral A-wave,2953
15,Trauma exposure,3839
15,Triglycerides [EA],11247
15,Cystatin C levels,180982
15,Joint disorder,3459
15,Chitinase-3-like protein 1 levels,125
15,In situ neoplasms,11
15,"Caffeine metabolism (plasma 1,3,7-trimethylxanthine (caffeine) level)",2808
15,Hypothyroidism nos,1051
15,Serum metabolite levels (CMS) [L_LDL_PL],334
15,Phosphatidylethanolamine(40:7)_[M-H]1- levels,326
15,Lung function (FVC),179635
15,Fat-free mass,25258
15,"Body mass index in physically active individuals [EA,women]",9407
15,Chronic obstructive pulmonary disease [conditional on rs55676755],1732
15,Electrocardiogram morphology (amplitude at temporal datapoints) [-174 ms],6177
15,Relative age of first facial hair,3519
15,Chloride levels,20625
15,Ever stopped smoking for 6+ months,10261
15,High density lipoprotein cholesterol levels [EA],9826
15,Chronic obstructive pulmonary disease in ever smokers,7721
15,Gamma glutamyl transferase levels,52296
15,"Aging traits (healthspan, parental lifespan or longevity) (multivariate analysis)",11466
15,Pattern 3 | hair/balding pattern,1072
15,"Blood protein levels [EA, Annexin A2]",413
15,Noncognitive aspects of educational attainment,219
15,Diastolic blood pressure,628628
15,Neutrophil percentage of white cells,193311
15,Estradiol levels [men],11036
15,Total testosterone levels,116727
15,Butyrate (4:0) levels,3978
15,Electrocardiogram morphology (amplitude at temporal datapoints) [194 ms],887
15,Phosphatidylcholine_37:5_[M+H]1+/Phosphatidylethanolamine_40:5_[M+H]1+/Phosphatidate_42:6_[M+NH4]1+ levels,635
15,Protein quantitative trait loci (liver) [MTPN],40
15,Cerebrospinal fluid AB1-42 levels,29
15,"""Disorders of gallbladder, biliary tract and pancreas""",6
15,Mean corpuscular hemoglobin concentration,297072
15,Protein quantitative trait loci (liver) [EMILIN2],1196
15,Irritability,11
15,Toxic multinodular goiter,12572
15,"Systolic blood pressure [EA, initial]",25204
15,A body shape index,46788
15,Heel bone mineral density (bmd) (right),28842
15,Skin cancer,204
15,Smoking behavior,15078
15,Opioid dependence,12
15,Frequency of friend/family visits,2
15,Optic disc area,8
15,Fasting glucose,44994
15,Standing height,173678
15,Serum metabolite levels (CMS) [HDL2_C],334
15,Phosphatidylethanolamine_35:2_[M-H]1- levels,635
15,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],13204
15,Colorectal cancer,4058
15,Keloid,5741
15,"Blood protein levels [EA, Death-associated protein kinase 2]",571
15,Creatine kinase levels,27913
15,Smoking status (ever vs never smokers),6611
15,Diabetes or endocrine disease,23351
15,Heel broadband ultrasound attenuation (left),2489
15,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Asian],310
15,Chin dimples,1094
15,Electrocardiogram morphology (amplitude at temporal datapoints) [62 ms],216
15,Phosphatidylethanolamine_34:1_[M-H]1- levels,945
15,Electrocardiogram morphology (amplitude at temporal datapoints) [8 ms],18
15,Umbilical hernia,308
15,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [AA],310
15,Type 2 diabetes [conditional],24147
15,Blood metabolite levels [isovalerylcarnitine],8311
15,Heel bone mineral density x serum urate levels interaction [female],18
15,Coronary artery disease [additive model],2177
15,Gut microbiota (beta diversity),191
15,Urate levels [East Asian],788
15,"Eye and/or adnexal cancer | cancer code, self-reported",415
15,Asthma and hay fever,266
15,Systolic blood pressure,447799
15,Age at menopause,180507
15,Apolipoprotein B levels,82343
15,Protein quantitative trait loci [IL-16],1336
15,"Response to tocilizumab in rheumatoid arthritis [CSJC , EA, RF-]",546
15,Hydroxycarbamide | treatment/medication code,420
15,Doctor diagnosed asthma,894
15,None of the above | qualifications,41
15,Systolic blood pressure x alcohol consumption interaction (2df test) [EA],20854
15,Self-reported math ability,5481
15,"Ground coffee (include espresso, filter etc) | coffee type",302
15,Aortic root size,1891
15,Electrocardiogram morphology (amplitude at temporal datapoints) [280 ms],1594
15,Primary biliary cholangitis,1801
15,Cardiomyopathy,219
15,"Smoking behaviour (cigarettes smoked per day) [Conditioned on chr15:78908565, chr15:78814046]",7673
15,Atrial fibrillation and flutter,622
15,Refractive error,81080
15,Bipolar disorder (MTAG),112300
15,Metabolic biomarkers (multivariate analysis),22456
15,Vertex-wise cortical thickness,106393
15,Serum metabolite levels [XS_VLDL_FC],334
15,Background retinopathy and retinal vascular changes,3
15,Triglyceride levels [Trans-ethnic initial],10911
15,Spinal canal stenosis,705
15,Serum metabolite levels [1-stearoyl-GPE (18:0],445
15,Protein quantitative trait loci (liver) [VAPB],1362
15,Allergy,266
15,Phosphatidylcholine(33:2)_[M+H]1+/Phosphatidylethanolamine(36:2)_[M+H]1+/Phosphatidate(38:3)_[M+NH4]1+ levels,326
15,A painkiller | substance of prescription or over-the-counter medication addiction,6
15,Myocardial infarction,65709
15,"Age-related diseases, mortality and associated endophenotypes",620
15,Neuropathic pain in head and neck cancer,323
15,Electrocardiogram morphology (amplitude at temporal datapoints) [12 ms],18
15,Time from waking to first cigarette,7760
15,Triglyceride levels in very large HDL,1563
15,Metabolite levels [Glycerophospho-N-Palmitoyl Ethanolamine],635
15,Sodium levels,396
15,Cholesterol [HDL],608
15,Cataracts,577
15,Malignant neoplasm of other connective and soft tissue (controls excluding all cancers),94
15,CTACK levels,4
15,Malignant neoplasm of respiratory system and intrathoracic organs,7539
15,Brain region volumes [right lateral orbitofrontal],570
15,Basal cell carcinoma,2457
15,Facial morphology (segment 11),1787
15,Aortic aneurysm,1160
15,Urinary tract infection frequency,1844
15,Serum metabolite levels (CMS) [XL_HDL_L],334
15,Serum metabolite levels (CMS) [FAw6_FA],334
15,Cerebrospinal fluid AB1-42 levels [Controls],76
15,Geminocystis abundance in stool,106
15,"Number of decayed, missing and filled tooth surfaces or use of dentures",9624
15,Gout,5868
15,Brain region volumes [left precentral],84
15,"Body mass index (joint analysis main effects and physical activity interaction) [EA, women]",9407
15,Metabolite levels,845
15,Chronic parodontitis,170
15,Low tan response,427
15,Systolic blood pressure [East Asian],3690
15,Pulse rate,5363
15,"Hayfever/allergic rhinitis | non-cancer illness code, self-reported",21756
15,"""Non-small cell lung cancer, squamous""",11336
15,Triglyceride levels in current drinkers [Asian],310
15,Pro-cathepsin H levels,10819
15,Kidney injury molecule 1 levels,881
15,Electrocardiogram morphology (amplitude at temporal datapoints) [158 ms],887
15,"Waist circumference [EA, men]",1684
15,Serum metabolite levels (CMS) [S_VLDL_P],334
15,Morningness,1150
15,Brain region volumes [right postcentral],70
15,Total protein levels x insomnia interaction,48
15,Urinary albumin-to-creatinine ratio,135366
15,Sensitivity to environmental stress and adversity,2583
15,Serum metabolite levels [HDL_D],635
15,Mood disorders,482
15,Persons encountering health services for examination and investigation,46
15,Granulocyte percentage of myeloid white cells,27183
15,Brain morphology (MOSTest),8855
15,Ischemic stroke,3026
15,1-carboxyethylvaline levels,2165
15,Cognitive function,56
15,Hand grip strength (left),13100
15,Depressed affect,1465
15,IgE levels,197
15,Singulair 10mg tablet | treatment/medication code,1009
15,Overall health rating,1388
15,"Blood protein levels [PDIA3, 7832_181_3]",32043
15,Early onset COPD,7602
15,Serum metabolite levels (CMS) [IDL_CE],334
15,6mm cylindrical power (left),215
15,Filtered coffee intake,455
15,Arm fat percentage (left),51088
15,Phosphatidylethanolamine(36:4)_[M+H]1+ levels,634
15,Central retinal vein equivalent,91
15,Facial morphology (segment 15),148
15,Hernia of abodminal wall,52
15,Nicorandil | treatment/medication code,340
15,Exfoliation syndrome,399
15,Decubitus ulcer,60
15,Direct low density lipoprotein cholesterol levels,34832
15,Heart disease | illnesses of father,3494
15,Central corneal thickness,15491
15,Cardiac arrhytmias,1106
15,Vertical cup-disc ratio (multi-trait analysis),903
15,"Lymphoid leukemia, chronic",664
15,Delivery,54
15,Protein quantitative trait loci (liver) [CPT2],7
15,Amlodipine | treatment/medication code,5964
15,"Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA, men]",2501
15,Iron status biomarkers (total iron binding capacity),2302
15,Interleukin-16 levels,1336
15,QRS duration,1742
15,Syncope and collapse,99
15,Hypothyroidism or myxedema,933
15,"Squamous cell carcinoma [adjusted for rs16891982, rs12203592, rs1126809, rs12916300, rs4268748, rs6059655, rs62246017, rs6791479, rs4455710, rs74664507]",117
15,HDL cholesterol levels [Trans-ethnic initial],282
15,Atrial fibrillation and flutter with reimbursement,73
15,Protein quantitative trait loci (liver) [HINT1],18
15,Diverticulosis,84238
15,"Mean arterial pressure x alcohol consumption interaction (2df test) [AA, EA]",2771
15,Fasting glucose adjusted for BMI,471
15,Attention deficit hyperactivity disorder (inattention symptoms),187
15,Urinary potassium excretion [EA],302
15,Lung function (FEV1/FVC),340378
15,same-sex sexual behaviour,3296
15,"Asthma | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",10638
15,"Disorders of muscle, ligament, and fascia",3520
15,Phosphatidylethanolamine_36:2_[M-H]1- levels,635
15,Serum metabolite levels (CMS) [MUFA_FA],362
15,Lung function (FEV1) and waist to hip ratio adjusted for BMI [East Asian],321
15,Cataract,222
15,Tryptophan betaine levels,136
15,Hemoglobin concentration,280899
15,Low density lipoprotein cholesterol levels,96294
15,Iris color (L* coordinate),152
15,Adventurousness,2982
15,Peak expiratory flow (pef),9759
15,White blood cell count (eosinophil),84
15,Corneal astigmatism,854
15,Type 1 diabetes nephropathy [ESRD vs. non-ESRD],20
15,Retinal vascular fractal dimension,427
15,High blood pressure | illnesses of mother,3718
15,Phosphatidylcholine_40:7_[M+OAc]1-/Phosphatidylserine_44:6_[M-H]1- levels,1319
15,"Triglyceride levels [Asian initial, BMI unadjusted]",432
15,High myopia,5336
15,Heel bone mineral density (bmd) (left),524
15,Home location - north co-ordinate (rounded),31
15,Brain imaging measurements [Imaging-derived phenotype a2009s_lh_S_central_area],84
15,BMI in non-smokers,9407
15,Vitamin D levels,12604
15,Atrophy of salivary gland,965
15,Systolic blood pressure x smoking status (ever vs never) interaction (2df test),17889
15,Serum alkaline phosphatase levels,66815
15,Eosinophill count,76574
15,Coronary heart disease,10392
15,Spine bone size,1928
15,Serum metabolite levels [IDL_FC],635
15,Current | smoking status,590
15,Hemoglobin levels,173770
15,Water intake,7222
15,Osteoarthritis (hip),2587
15,"Blood protein levels [DUT, 9995_6_3]",138
15,Serum metabolite levels (CMS) [XS_VLDL_P],334
15,Cortical thickness (min-P),214
15,"Hair colour (natural, before greying): Black (UKB data field 1747_5)",16
15,Hemoglobin A1c levels,302329
15,Venous thromboembolism (SNP x SNP interaction),724
15,Osteoarthritis of the hand,629
15,Stroke [cohort study],457
15,Cortical volume [Postcentral],43
15,Smoking behaviour (cigarettes smoked per day),58412
15,Cylindrical power (right),427
15,Respiratory or ear-nose-throat disease,8876
15,HDL cholesterol levels in current drinkers,688
15,Oily fish consumption,763
15,Frequency of difficulty controlling worry during worst period of anxiety,100
15,"Unclassifiable | non-cancer illness code, self-reported",7
15,Type 1 diabetes,12519
15,Cancer of bronchus; lung,5966
15,Asthma [conditional],7766
15,"Vasculitis | non-cancer illness code, self-reported",83
15,Type 2 diabetes or prostate cancer (pleiotropy),20523
15,DNA methylation variation (age effect),690
15,Electrocardiogram morphology (amplitude at temporal datapoints) [266 ms],1594
15,Renal function-related traits (sCR),341
15,Gut microbiota (bacterial taxa) [OTU15355 Dialister Species-level OTU],13
15,Serum levels of protein MILR1,15
15,Menopause (age at onset),45703
15,"""Disorders of thyroid, IBD co-morbidities""",11811
15,Serum metabolite levels (CMS) [VLDL_D],486
15,Serum metabolite levels (CMS) [TotFA],310
15,C-reactive protein levels or LDL-cholesterol levels (pleiotropy),122
15,Protein quantitative trait loci (liver) [CYP3A4],912
15,Phosphatidate(39:1)_[M+H]1+ levels,50
15,Activated partial thromboplastin time,15
15,Mitochondrial DNA levels,27
15,Red cell distribution width,628595
15,Narcolepsy,1429
15,Hand grip strength,14512
15,Neutrophil-to-lymphocyte ratio,23951
15,Asthma (moderate or severe),878
15,Simvastatin | treatment/medication code,3802
15,Self-reported math ability (MTAG) [MTAG],64718
15,Major depressive disorder vs ADHD (ordinary least squares (OLS)),572
15,Pneumothorax,6620
15,Total cholesterol levels,55221
15,Lifetime smoking index,9190
15,Chronic bronchitis and chronic obstructive pulmonary disease,4172
15,Sleep duration,840
15,Pulse pressure [EA],2348
15,Depression (broad),154
15,"Blood protein levels [RGMA, 5483_1_3]",13
15,Seborrhoeic keratosis,9
15,Protein quantitative trait loci (liver) [APRT],4
15,Urinary albumin excretion,50674
15,Dentures,9304
15,High cholesterol,1948
15,2'-deoxyuridine levels,75
15,Other aneurysm,9242
15,Arm fat-free mass (right),47387
15,Thyrotoxicosis,11811
15,Body mass index and systole blood pressure (pairwise),17767
15,"Blood protein levels [MTHFS, 14107_1_3]",4625
15,Unspecified monoarthritis,340
15,Serum metabolite levels [XS_VLDL_TG],334
15,"Lipid metabolism phenotypes [IDL.total, whole]",334
15,Cytokine network levels (multivariate analysis) [conditioned on rs11639051],333
15,Neuroticism score,825
15,Coffee consumption,34328
15,Hand grip strength (right),38697
15,Coronary revascularization (ANGIO or CABG),6372
15,Electrocardiogram morphology (amplitude at temporal datapoints) [130 ms],887
15,Diverticulosis and diverticulitis,2010
15,Electrocardiogram morphology (amplitude at temporal datapoints) [-124 ms],359
15,Chronic kidney disease,106914
15,Had menopause,34224
15,Blood metabolite levels [isobutyrylcarnitine],64942
15,Urinary sodium excretion,302
15,Intelligence,20996
15,UBA1409 abundance in stool,845
15,Cerebrospinal fluid t-tau:AB1-42 ratio,4156
15,"Blood protein levels [CTSH, 8644_46_3]",1662
15,Insomnia,49245
15,Electrocardiogram morphology (amplitude at temporal datapoints) [-106 ms],2887
15,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),580
15,vWF levels,220
15,Gynecologic disease (multivariate analysis) [uterine fibroid],18
15,Angina | vascular/heart problems diagnosed by doctor,16950
15,Caffeine consumption from tea,309
15,"Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)",1326
15,Hydroxyasparagine levels,616
15,Job involves heavy manual or physical work,132
15,Alpha-tocopherol levels,92
15,Nontoxic nodular goiter,11888
15,Pattern 1 | hair/balding pattern,37091
15,Glycated hemoglobin levels,7117
15,"""Complications of other internal prosthetic devices, implants and grafts""",594
15,Electrocardiogram morphology (amplitude at temporal datapoints) [116 ms],1103
15,Eye color traits [Eye color (dark],749
15,Eosinophilic esophagitis,1826
15,Inflammatory biomarkers (multivariate analysis),1332
15,Electrocardiogram morphology (amplitude at temporal datapoints) [74 ms],216
15,Waist circumference adjusted for body mass index [non-East Asian],1814
15,Electrocardiogram morphology (amplitude at temporal datapoints) [144 ms],887
15,Epilepsy and lamotrigine-induced maculopapular eruptions,125
15,"""Type 2 diabetes, definitions combined, including avohilmo""",2105
15,"For short-sightedness, i.e. only or mainly for distance viewing such as driving, cinema etc (called 'myopia') | reason for glasses/contact lenses",731
15,Serum metabolite levels [L_HDL_PL],635
15,Phosphatidylcholine_33:2_[M+H]1+/Phosphatidylethanolamine_36:2_[M+H]1+/Phosphatidate_38:3_[M+NH4]1+ levels,969
15,Other specified and unspecified disorders of lens,594
15,Protein quantitative trait loci (liver) [FDXR],44
15,Cortical volume [Rostral middle frontal],64
15,Maximum cranial width,28
15,White blood cell count (basophil),22759
15,Respiratory diseases,11351
15,Trunk fat mass,23709
15,Interstitial lung disease,11617
15,HLA DR+ Natural Killer  %CD3- lymphocyte,1708
15,High-density lipoprotein 3 cholesterol levels,380
15,Total amyloid (SNP x SNP interaction),10
15,Liver enzyme levels (alanine transaminase),44639
15,Haemoglobin concentration,111218
15,Fish- and plant-related diet,646
15,Tea consumption,302
15,Malignant neoplasm of endocrine gland,419
15,Lymphocyte percentage of white cells,287285
15,Comparative body size at age 10,11506
15,"Red blood cell traits [EA, MCV]",11625
15,Chronic obstructive pulmonary disease x ever smoker interaction (2df),7804
15,"""Non-small cell lung cancer, adenocarcinoma""",7539
15,Neurociticism,3276
15,White matter microstructure (fractional anisotropy) [Posterior limb of internal capsule],160
15,Parental longevity (mother's age at death or mother's attained age),6274
15,"""Myocardial infarction, strict""",5391
15,Male puberty timing (late vs. average onset facial hair),409
15,Cataracts (operation),19
15,General risk tolerance (MTAG),11822
15,Medication use (drugs used in diabetes),70060
15,See own gp | actions taken following self-harm,2019
15,Metabolic syndrome,18265
15,Persantin 25mg tablet | treatment/medication code,1846
15,Oropharynx cancer and human papilloma virus 16 negative oropharyngeal cancer,13915
15,Haemorrhoidal disease,1349
15,Red blood cell traits [Hgb],326
15,Doctor diagnosed hayfever or allergic rhinitis,143
15,Paroxetine | treatment/medication code,14
15,Fimbriimonadia abundance in stool,6
15,Glomerular filtration rate in non diabetics (creatinine),77519
15,Thyroid hormone levels [TSH],15894
15,Intrinsic epigenetic age acceleration,1648
15,Triglyceride levels in current drinkers [EA],688
15,Electrocardiogram morphology (amplitude at temporal datapoints) [112 ms],216
15,Protein quantitative trait loci (liver) [IGHV3OR16-9],21
15,Cognitive performance,18544
15,Two-hour glucose,9252
15,Systemic lupus erythematosus [EA],11333
15,Hypertensive diseases,3839
15,Hypertension [Japanese],1758
15,Triglycerides x physical activity interaction (2df test),300
15,Blood protein levels [Annexin A2],504
15,Autism spectrum disorder or schizophrenia,33793
15,Medication use (beta blocking agents),31651
15,Cognitive aspects of educational attainment,40363
15,Atrial fibrillation,22937
15,Endometriosis,3123
15,Brain region volumes [left postcentral],70
15,Back pain,318
15,"Asthma | non-cancer illness code, self-reported",10739
15,Electrocardiogram morphology (amplitude at temporal datapoints) [282 ms],1594
15,3mm weak meridian (right),11895
15,Emphysema,17510
15,Hypertrophic disorders of skin,203
15,Stem cell factor levels,437
15,Nonsyndromic cleft palate,79555
15,Serum metabolite levels [S_LDL_TG],362
15,Skin reflectance (Melanin index),1553
15,Serum levels of protein SERPINE2,999
15,Spontaneous dizygotic twinning,65
15,Macular thickness,48644
15,"Medication use (adrenergics, inhalants)",9105
15,Metabolic traits [succinylcarnitine],6567
15,Eye color (brightness),2289
15,Black vs. red hair color,612
15,Mean corpuscular volume,793486
15,Neutrophil count,329308
15,Bilirubin levels,7143
15,Glucuronate levels,2431
15,Percentage of invited food questionnaires completed,1039
15,Protein quantitative trait loci (liver) [COL18A1],9
15,"Number of decayed, missing and filled tooth surfaces",351
15,Electrocardiogram morphology (amplitude at temporal datapoints) [96 ms],216
15,V9D3004 abundance in stool,22
15,Reproduciblity of spirometry measurement using ers/ats criteria,50
15,LDL cholesterol levels,30791
15,Glaucoma (primary open-angle),10505
15,Myopia (pathological),659
15,Height,415436
15,Phospholipid levels (plasma) [levels],310
15,Bullous keratopathy,55
15,Monocyte percentage of white cells,168374
15,Daytime dozing / sleeping (narcolepsy),16570
15,Peripheral artery disease in non diabetes,15299
15,Varicose veins,3064
15,Depression,696
15,Carcinoma in situ of skin,5
15,Blond vs. brown/black hair color,31821
15,Body mass index [EA],9407
15,Risk-taking tendency (4-domain principal component model),4338
15,Motion sickness,4426
15,Phosphatidylcholine_33:1_[M+H]1+/Phosphatidylethanolamine_36:1_[M+H]1+/Phosphatidate_38:2_[M+NH4]1+ levels,635
15,Serum metabolite levels (CMS) [IDL_P],334
15,Systolic blood pressure [Pre-puberty],608
15,"Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio)",302
15,Actinic keratosis,5
15,"High cholesterol | non-cancer illness code, self-reported",914
15,Serum metabolite levels (CMS) [HDL_D],635
15,Protein quantitative trait loci (liver) [RAB14],277
15,"Skin aging measurement [Additive, crow's feet]",21
15,Educational attainment (MTAG) [MTAG],118383
15,Serum metabolite levels [homoarginine],58265
15,Sphingomyelin_34:1_[M+H]1+ levels,12719
15,"Risky sexual behaviors (alcohol dependence interaction) [AA, men]",4463
15,Serum metabolite levels (CMS) [L_HDL_CE],870
15,"Metabolite levels (lipoprotein measures) [Triglycerides in very large HDL, conditioned]",635
15,Serum metabolite levels (CMS) [PUFA],310
15,Sum eosinophil basophil counts,10063
15,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test),20143
15,6mm strong meridian (right),14526
15,Longevity (100 years and older) [EA],1222
15,Electrocardiogram morphology (amplitude at temporal datapoints) [-120 ms],359
15,Candida albicans stimulated CCL3 levels,85
15,Rosuvastatin | treatment/medication code,5
15,Eosinophil percentage of white cells,125813
15,Schizophrenia [EA],51628
15,"""Other chronic obstructive pulmonary disease , including avohilmo""",7602
15,BMI (smoking interaction),8750
15,Insomnia [Male],1348
15,Serum metabolite levels (CMS) [L_HDL_P],334
15,Cigarettes smoked per day (MTAG),23631
15,Systemic lupus erythematosus,13391
15,Obesity [Overweight],9511
15,Non-albumin protein levels,17181
15,Craniofacial microsomia,14944
15,Medication use (vasodilators used in cardiac diseases),7581
15,Electrocardiogram morphology (amplitude at temporal datapoints) [156 ms],887
15,CD33dim HLA DR+ CD11b- %CD33dim HLA DR+,1721
15,DNA methylation PhenoAge acceleration,1024
15,Serum metabolite levels (CMS) [DHA],362
15,Corneal ulcer,327
15,Radiation-related disorders of the skin and subcutaneous tissue,5
15,Urate levels [men],16837
15,Serum metabolite levels (CMS) [XS_VLDL_FC],334
15,Electrocardiogram morphology (amplitude at temporal datapoints) [88 ms],216
15,Facial morphology (segment 31),78
15,Insulin-related traits (multivariate analysis),477
15,Iron status biomarkers (transferrin saturation),2302
15,Brain morphology (min-P),1711
15,Lysophosphatidylcholine_15:0_[M+H]1+/Lysophosphatidylethanolamine_18:0_[M+H]1+ levels,997
15,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],8067
15,Direct bilirubin levels,4668
15,Diabetes,35525
15,Height [AA],1440
15,Cortical surface area [Superior Parietal],444
15,Low myopia vs hyperopia,1305
15,Serum metabolite levels (CMS) [L_LDL_L],635
15,Vertigo,35
15,"Intra-ocular pressure, corneal-compensated (right)",111
15,Tanning,427
15,Brain imaging measurements [Imaging-derived phenotype a2009s_rh_S_central_area],84
15,Phosphatidylethanolamine levels [Total_PE],364
15,Alcohol use disorder,164
15,Rheumatoid arthritis [EA],1115
15,Soya with calcium | type milk consumed,84
15,Disorders of lens,1175
15,Tea intake,309
15,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),660
15,Venous thromboembolism,84
15,Endometriosis or depression (pleiotropy),7
15,Hip circumference adjusted for BMI,112749
15,Atopic dermatitis,8758
15,"Blood protein levels [SCG3, 7957_2_3]",4645
15,Hematological and biochemical traits [sCr],504
15,Alanine aminotransferase levels,116697
15,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),32359
15,None of the above (group 1) | illnesses of father,3472
15,Dentures | mouth/teeth dental problems,15973
15,Alcohol intake frequency.,1093
15,Electrocardiogram morphology (amplitude at temporal datapoints) [164 ms],887
15,Blue vs. brown eyes,580
15,Major coronary heart disease event excluding revascularizations,7780
15,Oily fish intake,393
15,Diabetes mellitus,2698
15,CD34 on Hematopoietic Stem Cell,810
15,Plasma clozapine levels in treatment-resistant schizophrenia,302
15,Ganglion cell inner plexiform layer (GCIPL) thickness,59
15,Other arrhytmias,25
15,Tobacco use disorder,10615
15,Leg fat percentage (left),50364
15,Mean platelet (thrombocyte) volume,241257
15,Smoking status (current vs never),265
15,Serum metabolite levels (CMS) [IDL_C],334
15,Protein quantitative trait loci (liver) [COQ9],30
15,"Systolic blood pressure, automated reading",52352
15,Platelet crit,42072
15,Hernia,7768
15,Asthma (only as main-diagnosis) (more control exclusions),1148
15,Serum metabolite levels [IDL_P],334
15,Serum metabolite levels (CMS) [FAw6],310
15,Waist-to-hip ratio adjusted for body mass index,14161
15,Number of self-reported non-cancer illnesses,7813
15,"Systolic blood pressure x alcohol consumption interaction (2df test) [AA, EA]",12874
15,Spherical power (right),4728
15,Perceived skin darkness,427
15,Asthma or allergic disease (pleiotropy),643
15,Number of attempts,18650
15,Yes | hearing difficulty/problems,26050
15,Phosphatidylcholine_37:6_[M+H]1+/Phosphatidylethanolamine_40:6_[M+H]1+/Phosphatidate_42:7_[M+NH4]1+ levels,997
15,Cortical surface area [Pars Opercularis],236
15,Mycoplasmataceae abundance in stool,6
15,Body mass index [Japanese],5607
15,Cortical thickness,32848
15,Electrocardiogram morphology (amplitude at temporal datapoints) [-108 ms],2887
15,Osteoarthritis,58233
15,Waist circumference adjusted for body mass index [men],2501
15,Medication use (antithrombotic agents),1758
15,Time spent using computer,421
15,Endometrial endometrioid carcinoma,479
15,Vertical cup-disc ratio,580
15,HDL cholesterol levels [HIspanic],282
15,"Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [Asian, EA]",8697
15,Electrocardiogram morphology (amplitude at temporal datapoints) [152 ms],887
15,Protein quantitative trait loci (liver) [SERPINA1],60
15,Abnormal findings on diagnostic imaging of lung,7539
15,Nevus count or cutaneous melanoma,427
15,Major depressive disorder (MTAG),4537
15,Bitter alcoholic beverage consumption,103
15,Myopia (age of diagnosis),1282
15,Serum metabolite levels (CMS) [L_HDL_TG],334
15,HDL cholesterol levels in current drinkers [Asian],310
15,"Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)",19991
15,Father still alive,7760
15,Nontoxic multinodular goitre,11849
15,Type 2 diabetes [Obese],5948
15,Electrocardiogram morphology (amplitude at temporal datapoints) [128 ms],1103
15,"Intra-ocular pressure, corneal-compensated (left)",108
15,Male puberty timing (early vs. average onset facial hair),409
15,Home location at assessment - north co-ordinate (rounded),29
15,Balding type 1,36984
15,Mean arterial pressure x alcohol consumption interaction (2df test) [EA],16551
15,Duration to first press of snap-button in each round,248
15,Serum levels of protein SPINT1,433
15,HLA DR+ Natural Killer %Natural Killer,1721
15,Nasopharyngeal carcinoma (SNP x SNP interaction),304
15,Protein quantitative trait loci (liver) [CES2],6
15,Heel bone mineral density T score,60024
15,Chronic bronchitis/emphysema | illnesses of father,7641
15,Testicular cancer,1258
15,Blood metabolite levels [HWESASXX],889
15,"Medication use (anti-inflammatory and antirheumatic products, non-steroids)",30930
15,Other and/or unspecified nontoxic goitre,11849
15,Local histogram emphysema pattern [normal],4232
15,Estimated glomerular filtration rate in diabetes,2083
15,Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test),759
15,"Blood protein levels [EA, Lactadherin]",1421
15,Serum metabolite levels [IDL_TG],635
15,Parkinson's disease,333
15,Adult body size,56584
15,Blood glucose levels,28329
15,Vegetable consumers,3711
15,Bitter non-alcoholic beverage consumption,302
15,HDL cholesterol [Hispanic],488
15,Squamous cell carcinoma,533
15,Age-related hearing impairment,678
15,Body mass index in physically active individuals,9382
15,DNA methylation-estimated plasminogen activator inhibitor-1 levels,12722
15,Hyperplasia of prostate,137
15,Intraocular pressure and central corneal thickness (multi-trait analysis) [EA],352
15,Chronic obstructive pulmonary disease x current smoker interaction (1df),10092
15,Parental longevity (both parents in top 10%),7673
15,Eye color [green eyes],427
15,Serum levels of protein OLFM3,999
15,Skin pigmentation traits [Skin sensitivity to sun (high to low],427
15,Phosphatidylethanolamine(34:2)_[M+H]1+ levels,634
15,"""Alcohol use disorder, ICD-based""",8
15,Endometrial cancer,12513
15,"Emphysema/chronic bronchitis | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",8037
15,Malignant neoplasm,4432
15,"Heel quantitative ultrasound index (qui), direct entry (left)",2770
15,"Skin pigmentation [conditional on rs16891982, rs12203592, rs10809826, rs1800404, rs12913832 and rs1426654]",185
15,Gut microbiota relative abundance (bacterial taxa) [Clostridium_xylanovorans],24
15,Comparative height size at age 10,82271
15,Body fat percentage,60120
15,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction),2587
15,Other malignant neoplasms of skin (=non-melanoma skin cancer),41
15,Male-pattern baldness,63337
15,Gallstone disease,889
15,Chronic obstructive pulmonary disease,48325
15,Angina,12400
15,Breast cancer,64772
15,Serum creatinine levels,103013
15,Miserableness,951
15,Hair morphology traits [Hair color (light],427
15,Ever self-harmed,77
15,Hyperthyroidism,21283
15,Brain region volumes [X4th ventricle],1541
15,Estradiol levels,7663
15,Dissection of aorta,1215
15,Aspartate aminotransferase levels,130737
15,Diacylglycerol_38:5_[M+H-H2O]1+ levels,97701
15,Ascending aorta maximum area,10490
15,Gut microbiota (bacterial taxa) [Enterobacteriales order],1249
15,Follistatin levels,465
15,Serum levels of protein ANXA2,351
15,Serum metabolite levels (CMS) [EstC],310
15,"Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)",10942
15,"Osteoarthritis (hand, severe)",1323
15,Serum metabolite levels [L_HDL_P],334
15,Neuroticism (MTAG),1101
15,Keratitis,321
15,Body mass index (bmi),113364
15,Bendroflumethiazide | treatment/medication code,25914
15,Insomnia symptoms (never/rarely vs. sometimes/usually),1366
15,"15-year breast cancer-specific survival (ER positive, PR positive, and HER2 negative)",263
15,Parkinson's disease or first degree relation to individual with Parkinson's disease,181
15,Postprandial triglyceride response,362
15,Photic sneeze reflex,18
15,Low myopia,226
15,Iron status biomarkers (ferritin levels),14706
15,Serum metabolite levels (CMS) [LA_FA],362
15,Malignant neoplasm of thyroid gland (controls excluding all cancers),467
15,Total cholesterol levels in HDL,731
15,Serum metabolite levels (CMS) [M_HDL_PL],310
15,Anal and rectal conditions,576
15,Renal function-related traits (BUN),507
15,Electrocardiogram morphology (amplitude at temporal datapoints) [-20 ms],29868
15,"Heel broadband ultrasound attenuation, direct entry",24045
15,Nonatopic asthma and/or waist-to-hip ratio adjusted for BMI,7766
15,Phosphatidylethanolamine levels [PE(18:0;0-20:4;0],364
15,Mycoplasmatales abundance in stool,6
15,Life satisfaction,183
15,Estimated glomerular filtration rate [EA],30735
15,Hypertrophic cardiomyopathy (MTAG),6177
15,Feeling nervous,152
15,Serum 25-Hydroxyvitamin D levels x season interaction,825
15,Cortical volume [Supramarginal],64
15,Prospective memory result,18650
15,Arm fat percentage (right),64865
15,Phosphatidylethanolamine_40:6_[M-H]1- levels,945
15,Electrocardiogram morphology (amplitude at temporal datapoints) [106 ms],216
15,Electrocardiogram morphology (amplitude at temporal datapoints) [122 ms],216
15,Hair color [hair color],427
15,C-reactive protein levels [BMI-adjusted],133
15,Mean arterial pressure,61877
15,Peripheral artery disease,9405
15,Nap during day,16945
15,Impedance of arm (left),49406
15,Corneal structure,2821
15,Retinal nerve fibre layer (RNFL) thickness,2240
15,Caffeine consumption,455
15,Agoraphobia | mental health problems ever diagnosed by a professional,1127
15,Feeling hurt,1701
15,Bipolar disorder vs anorexia nervosa (ordinary least squares (OLS)),22469
15,"Blood protein levels [NEO1, 8900_28_3]",5856
15,Blood metabolite levels [succinylcarnitine],6635
15,Metabolic syndrome [HDL],334
15,Insomnia symptoms (never/rarely vs. usually),5275
15,Airflow obstruction [Smokers],7760
15,Basophill count,25085
15,Arm predicted mass (left),49067
15,Cortical surface area [Pericalcarine],2053
15,Electrocardiogram morphology (amplitude at temporal datapoints) [204 ms],887
15,Relative hand skill in reading disability,293
15,Serum metabolite levels [S_VLDL_FC],334
15,FEV1,25929
15,Lung cancer | illnesses of father,7673
15,None of the above | vitamin and mineral supplements,9681
15,Autoimmune traits (pleiotropy),2355
15,Childhood sunburn occasions,1604
15,Anthropometric traits (multi-trait analysis),693
15,Coronary artery disease or ischemic stroke,6256
15,Creatinine levels,306590
15,Serum levels of protein SCG3,4777
15,"""Hypertension, essential""",3718
15,Electrocardiogram morphology (amplitude at temporal datapoints) [124 ms],216
15,Uterine fibroids,8546
15,"Blood pressure medication | medication for cholesterol, blood pressure or diabetes",23704
15,Leg fat-free mass (right),43253
15,Eosinophill percentage,27647
15,Serum metabolite levels (CMS) [LDL_TG],1792
15,Ulcerative colitis [Children],320
15,Tumor necrosis factor levels,567
15,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant IV (Upper face), Segment 59]",262
15,Feeling fed-up,4211
15,Rheumatoid arthritis (ACPA-positive),1873
15,Serum metabolite levels (CMS) [IDL_FC],635
15,In situ neoplasms (controls excluding all cancers),5
15,Asthma,46409
15,"Blood protein levels [CSK, 3363_31_4]",27085
15,Triglyceride levels [Hispanic/Latino],64
15,Restless legs syndrome,24094
15,Pneumonia,7384
15,Fibroblastic disorders,52
15,Fagerstrӧm test for nicotine dependence,7539
15,High density lipoprotein cholesterol levels,27246
15,Urinary sodium excretion [EA],302
15,Serum metabolite levels (CMS) [L_HDL_PL],635
15,Serum metabolite levels (CMS) [XL_HDL_TG],334
15,Follicle stimulating hormone levels [FSH],479
15,Clonidine | treatment/medication code,356
15,Central retinal arteriolar equivalent,91
15,Hematological and biochemical traits [HDL],232
15,Adolescent idiopathic scoliosis,46821
15,Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in non-secretors,105
15,Exfoliation syndrome [Japanese],399
15,Serum metabolite levels [LDL_TG],635
15,Dupuytren's disease,2304
15,"Intra-ocular pressure, goldmann-correlated (right)",1163
15,Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications,1096
15,Electrocardiogram morphology (amplitude at temporal datapoints) [102 ms],216
15,Serum metabolite levels (CMS) [XS_VLDL_CE],334
15,Electrocardiogram morphology (amplitude at temporal datapoints) [16 ms],18
15,Type 2 diabetes [EA],8158
15,Serum albumin levels,67004
15,Relative age voice broke,1655
15,Leisure/social activities: Sports club or gym,813
15,Serum metabolite levels (CMS) [PC],310
15,Electrocardiogram morphology (amplitude at temporal datapoints) [98 ms],216
15,Breakfast skipping,455
15,Age started wearing glasses or contact lenses,755
15,"None of the above | medication for pain relief, constipation, heartburn",1241
15,Childhood body mass index,19
15,Educational attainment (years of education),56459
15,Chronic obstructive pulmonary disease or resting heart rate (pleiotropy),6717
15,Smoking behavior [CPD],7900
15,Electrocardiogram morphology (amplitude at temporal datapoints) [172 ms],887
15,Serum metabolite levels (CMS) [XL_HDL_C],362
15,Serum metabolite levels (CMS) [L_LDL_P],277
15,Parental longevity (father's age at death),22838
15,Pattern 2 | hair/balding pattern,4710
15,Cigarettes smoked per day (past),7602
15,Phosphatidylethanolamine_36:3_[M-H]1- levels,997
15,Hard cardiovascular diseases,8173
15,Serum metabolite levels (CMS) [HDL3_C],334
15,Spleen volume,754
15,"Eye color [conditional on rs16891982, rs12203592, rs10809826, rs1800404, rs12913832 and rs1426654]",6
15,Glomerular filtration rate (creatinine),118913
15,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test),20143
15,Lercanidipine | treatment/medication code,4700
15,Serum metabolite levels (CMS) [XS_VLDL_PL],310
15,HOMA-B (corrected for HOMA-IR),530
15,Subcortical volume (MOSTest),1103
15,Brain connectivity [Strength - R-banks of the superior temporal sulcus],817
15,Neutrophill percentage,90904
15,Phosphatidylethanolamine_34:2_[M-H]1- levels,997
15,"Total cholesterol levels [Asian initial, BMI unadjusted]",432
15,Getting up in morning,1565
15,Immunological or systemic disorder,724
15,Gestational age at birth (maternal effect),118
15,Protein quantitative trait loci (liver) [LRRK2],87
15,Opioid dependence [EA],12
15,Intracranial aneurysm,11835
15,Facial ageing,14303
15,Waist circumference adjusted for BMI in non-smokers [women],1791
15,Previous | smoking status,1143
15,Language functional connectivity,1418
15,Electrocardiogram morphology (amplitude at temporal datapoints) [114 ms],1103
15,Smoking initiation (ever regular vs never regular) (MTAG),36587
15,Body fat percentage [female],1180
15,Serum metabolite levels (CMS) [SFA],362
15,Clozapine concentration in schizophrenia,302
15,"Other | hair colour (natural, before greying)",427
15,Serum metabolite levels (CMS) [TotCho],310
15,Liver enzyme levels (alkaline phosphatase),10481
15,Polyarhtrosis,1585
15,Fed-up feelings,497
15,Hearing difficulty/problems with background noise,23662
15,Basophil count,253128
15,High light scatter reticulocyte percentage of red cells,46434
15,Serum metabolite levels [cytidine],2822
15,Serum metabolite levels (CMS) [XL_HDL_PL],362
15,Serum metabolite levels (CMS) [M_HDL_P],310
15,Serum metabolite levels (CMS) [XL_HDL_P],362
15,"""Diabetes, insuline treatment (Kela reimbursement) (more control exclusions)""",2028
15,Cereal intake,455
15,Blood metabolite levels [cystathionine],101
15,Blood pressure [Mean Arterial Pressure],25204
15,Reticulocyte count,127892
15,Urokinase-type plasminogen activator levels,10084
15,Allopurinol | treatment/medication code,1851
15,Cortical surface area [Postcentral],140
15,Calcaneal bone ultrasound measurement (speed of sound),527
15,Serum metabolite levels (CMS) [S_VLDL_C],334
15,Gamma glutamyl transferase levels in low alcohol consumption,153
15,"Light brown | hair colour (natural, before greying)",6496
15,Inflammatory bowel disease,1826
15,Gtn 400micrograms spray | treatment/medication code,31
15,Eosinophil percentage of granulocytes,10743
15,Lipoprotein phospholipase A2 activity in cardiovascular disease,6033
15,2-hydroxyglutarate levels,3207
15,Type 2 diabetes with other specified/multiple/unspecified complications,2112
15,Skin pigmentation traits [Skin sensitivity to sun phototype score],427
15,Electrocardiogram morphology (amplitude at temporal datapoints) [94 ms],216
15,Total cerebellar volume (excluding Crus I vermis),11836
15,Electrocardiogram morphology (amplitude at temporal datapoints) [262 ms],10179
15,Blautia A sp002159835 abundance in stool,248
15,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Hispanic],282
15,Dislocation of lens,594
15,Cardiorespiratory fitness (800m run time),5
15,Body fat distribution (leg fat ratio),3503
15,Waist circumference adjusted for BMI (adjusted for smoking behaviour) [women],1791
15,Handedness in dyslexia,342
15,White matter microstructure (mean diusivities) [Corticospinal tract ],1152
15,"Allergic disease (asthma, hay fever or eczema)",81756
15,Serum levels of protein IL16,1336
15,Protein quantitative trait loci (liver) [MPO],1082
15,Methylmalonate (mma) levels,326
15,Medication use (antiglaucoma preparations and miotics),445
15,"Pulse pressure [EA, initial]",1265
15,Electrocardiogram morphology (amplitude at temporal datapoints) [90 ms],216
15,Alcohol dependence,8
15,"Smoking behaviour (cigarettes smoked per day) [Conditioned on chr15:78849779, chr15:78908565, chr15:78814046]",7539
15,Trunk fat-free mass,94785
15,CD33dim HLA DR+ CD11b- Absolute Count,1721
15,Ginkgo forte tablet | treatment/medication code,264
15,Bowel cancer | illnesses of adopted mother,113
15,Number of twin births,614
15,Rheumatoid arthritis,8437
15,Phosphatidylethanolamine_38:6_[M-H]1- levels,997
15,Serum metabolite levels [XL_HDL_L],334
15,Intelligence (MTAG),21537
15,Chronic kidney disease [eGFRcrea],53701
15,Appendicular lean mass,437731
15,Serum metabolite levels [succinylcarnitine (C4-DC],8072
15,Lifetime number of sexual partners,1348
15,Serum metabolite levels (CMS) [IDL_L],442
15,Carcinoma in situ of skin of other and unspecified parts of face,66
15,Cataracts [female],97
15,"2,3-dihydroxy-2-methylbutyrate levels",50
15,Mean corpuscular hemoglobin,476647
15,Externalizing behaviour (multivariate analysis),10200
15,Electrocardiogram morphology (amplitude at temporal datapoints) [-182 ms],6177
15,Chronic obstructive pulmonary disease in never smokers,182
15,"""Asthma, including avohilmo""",857
15,Electrocardiogram morphology (amplitude at temporal datapoints) [84 ms],216
15,BMI in non-smokers [women],9407
15,Fat-free mass [male],12136
15,Electrocardiogram morphology (amplitude at temporal datapoints) [146 ms],887
15,Fibrinogen [EA],6030
15,Cortical volume [Pars opercularis],60
15,Coffee consumed,330
15,Serum metabolite levels [TotPG],310
15,White matter microstructure (radial diusivities) [Posterior limb of internal capsule],160
15,"Hair colour (natural, before greying): Blonde (UKB data field 1747_1)",16
15,Mean spheric corpuscular volume,155553
15,Blood urea nitrogen levels,12244
15,Aspartate aminotransferase to alanine aminotransferase ratio,2388
15,Cortical thickness [Postcentral],997
15,Protein quantitative trait loci (liver) [ABAT],30
15,Dilated cardiomyopathy (MTAG),23885
15,3mm strong meridian (right),17833
15,Skin pigmentation traits [Phototype score],446
15,Electrocardiogram morphology (amplitude at temporal datapoints) [108 ms],216
15,Gut microbiota relative abundance (bacterial taxa) [Acidaminococcus],133
15,Leg predicted mass (left),52161
15,Severe coronary stenosis (young age of onset interaction),524
15,Serum metabolite levels (CMS) [M_LDL_TG],635
15,BMI (adjusted for smoking behaviour),9407
15,Optic disc size,2418
15,Electrocardiogram morphology (amplitude at temporal datapoints) [118 ms],1103
15,Neuropsychiatric disorders,1348
15,Medication use (thyroid preparations),1211
15,Resting heart rate,546
15,"Yes, now most or all of the time | tinnitus",56
15,Coffee consumption (cups per day),3452
15,Sunburn type,287
15,Electrocardiogram morphology (amplitude at temporal datapoints) [174 ms],887
15,Serum metabolite levels [IDL_PL],334
15,Urine pH measurement,454
15,TestASV_37 (Ruminococcaceae) abundance,23
15,Body mass index (joint analysis main effects and smoking interaction),18157
15,Smoking cessation (MTAG),18289
15,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA],4926
15,Diastolic blood pressure x smoking status (ever vs never) interaction (2df test) [EA],17889
15,Uveal melanoma,427
15,Number of sexual partners,1503
15,Carcinoma in situ of skin (controls excluding all cancers),5
15,Pulmonary artery enlargement in chronic obstructive pulmonary disease,6411
15,Lymphocyte counts,773277
15,Serum phosphate levels,28771
15,Reticulocyte percentage,21575
15,Mean arterial pressure [East Asian],8789
15,Other non-epithelial cancer of skin,25
15,Proinsulin levels,397
15,Diastolic blood pressure (cigarette smoking interaction),39324
15,Diastolic blood pressure x alcohol consumption interaction (2df test) [EA],9864
15,Serum metabolite levels [S_HDL_TG],334
15,"""Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified""",643
15,Use of antiglaucoma preparations and miotics,570
15,Serum metabolite levels (CMS) [S_VLDL_L],334
15,Ischemic heart disease,10653
15,Smoking initiation,29259
15,Frequency of tiredness / lethargy in last 2 weeks,11010
15,"Smoking behaviour (cigarettes smoked per day) [Conditioned on chr15:78243579, chr15:78836288, chr15:78812098, chr15:78911181, chr15:78906177, chr15:78849779, chr15:78908565, chr15:78814046]",9035
15,Forced vital capacity (fvc),90449
15,Presence of other functional implants,594
15,High density lipoprotein cholesterol levels [Hispanic],605
15,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event) [Cox proportional hazards regression model],24
15,Serum 25-Hydroxyvitamin D levels,64383
15,Urate levels [women],1730
15,"Skin, hair and eye pigmentation (multivariate analysis)",2295
15,Acne (severe),174
15,Lysophosphatidylethanolamine levels [LPE(16:0;0],326
15,Total cholesterol levels [East Asian],583
15,Small cell lung carcinoma,16902
15,Smoking status,401
15,Electrocardiogram morphology (amplitude at temporal datapoints) [134 ms],216
15,"Diabetes | non-cancer illness code, self-reported",16
15,Glomerular filtration rate,53235
15,Biological sex,17468
15,Heel bone mineral density (bmd),42618
15,Ankle spacing width (right),3269
15,Serum metabolite levels [2-stearoyl-GPE (18:0)*],445
15,Malignant neoplasm of other connective and soft tissue,94
15,Aplastic anemia,2
15,Glaucoma (multi-trait analysis),7121
15,Diacylglycerol_44:7_[M+H-H2O]1+ levels,12719
15,HDL cholesterol levels in current drinkers [Hispanic],310
15,Reticulocyte fraction of red cells,58677
15,Endometrial cancer (endometrioid histology),3717
15,Waist circumference [EA],1684
15,Serum metabolite levels (CMS) [L_LDL_FC],635
15,Red blood cell (erythrocyte) count,112771
15,"""COPD, hospital admissions""",7602
15,Hair morphology traits [Hair color (blond],427
15,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],660
15,Serum metabolite levels [FAw6],310
15,Mean time to correctly identify matches,207
15,Highest math class taken,44213
15,Airflow obstruction in ever smokers,7602
15,"Dark brown | hair colour (natural, before greying)",43193
15,Metformin | treatment/medication code,12672
15,Microalbuminuria,2050
15,"Blood protein levels [CTSH, 8465_52_3]",1429
15,Pre-treatment viral load in HIV-1 infection,52
15,Thyroid cancer,897
15,Serum urea levels,23827
15,"Pulse pressure x alcohol consumption interaction (2df test) [AA, EA]",3919
15,Mood swings,929
15,Sex hormone-binding globulin levels,219983
15,Atenolol | treatment/medication code,3953
15,Disorders of lipoid metabolism,4174
15,Lymphocytic leukemia,1012
15,Drinking water intake,302
15,Hematological and biochemical traits [ALP],27
15,Response to antipsychotic treatment [risperidone-hip circumference],12
15,Serum metabolite concentrations in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C42:3],64
15,Self-reported allergy,643
15,Spherical equivalent [EA],1067
15,Cancer (pleiotropy),274
15,Neonatal cytokine/chemokine levels (maternal genetic effect) [CCL24],5
15,Ebbinghaus illusion (overestimation),125
15,3mm weak meridian angle (left),49
15,Lung cancer in ever smokers,15212
15,Arm fat-free mass (left),48304
15,Serum metabolite levels (CMS) [L_HDL_C],635
15,Serum metabolite levels [XS_VLDL_P],334
15,Sleep duration (short sleep),104
15,3mm cylindrical power angle (left),49
15,Mean platelet volume,728273
15,Diastolic blood pressure x smoking status (ever vs never) interaction (2df test),17889
15,Peak expiratory flow,82647
15,Caffeine consumption from coffee,3073
15,SAPHO syndrome,2853
15,Urea levels,4358
15,Triglycerides [East Asian],301
15,Hepatitis,303
15,Serum metabolite levels [L_HDL_L],334
15,Paget's disease,25
15,Mortality,7740
15,Chronic periodontitis,14
15,Brown vs. non-brown hair color,4544
15,Coronary artery disease,135103
15,"Body mass index [EA, women]",9407
15,Waist circumference,30153
15,Worrier / anxious feelings,1159
15,Carotid atherosclerosis in HIV infection [common cIMT],259
15,Rate of cognitive decline in mild cognitive impairment (time interaction),9543
15,Abdominal aortic aneurysm,7519
15,Waist circumference adjusted for BMI (adjusted for smoking behaviour),10211
15,"Waist circumference adjusted for BMI in active individuals [EA, men]",2501
15,Asthma (mode),643
15,Immature fraction of reticulocytes,31151
15,Often | worked with materials containing asbestos,13263
15,"Pulmonary function (smoking interaction) [FEV1/FVC, Pack-years]",348
15,Stable angina pectoris,18151
15,Leg fat percentage (right),48859
15,Serum metabolite levels [N4-acetylcytidine],2822
15,"""Other diabetes, wide definition""",2678
15,Asthma-related infections,638
15,Amblyopia ex anopsia,37
15,Educational attainment (years of education) [conditional-joint],44895
15,Serum levels of protein NMB,14138
15,Serum metabolite levels [L_HDL_CE],334
15,Lipid metabolism phenotypes [XL-HDL-TG],362
15,Depressive symptoms (MTAG),492
15,Smoking initiation (ever regular vs never regular) [Conditioned on chr15:47685010],716
15,Type 2 diabetes [Japanese],775
15,Malignant neoplasm of endocrine gland (controls excluding all cancers),470
15,Bipolar disorder lithium response (categorical) or schizophrenia,14551
15,Prostate cancer,25962
15,Systolic blood pressure x smoking status (ever vs never) interaction (2df test) [EA],17889
15,Hemoglobin,253253
15,High light scatter reticulocyte count,103755
15,Eye color [Eye color],580
15,"Polymyalgia rheumatica | non-cancer illness code, self-reported",980
15,Lobe attachment (rater-scored or self-reported),841
15,TPE interval (resting) [men],889
15,Hair morphology traits [Hair color (black],427
15,Colorectal cancer [EA],274
15,Protein quantitative trait loci (liver) [JAK3],213
15,Aerodigestive squamous cell cancer (pleiotropy),7673
15,Left atrial active emptying fraction,1142
15,Current tobacco smoking,583
15,Glomerular filtration rate [3-measure Model],22071
15,Chronic obstructive pulmonary disease in non-current smokers,7893
15,Age at menopause (last menstrual period),39323
15,None of the above | vascular/heart problems diagnosed by doctor,67970
15,Body fat distribution (trunk fat ratio),3503
15,Height [Conditioned on rs5742915],594
15,Serum metabolite levels [SFA],362
15,Knee osteoarthritis,13015
15,"Diastolic blood pressure, automated reading",78196
15,Corneal resistance factor (right),6165
15,Dehydroepiandrosterone sulphate levels,6778
15,"Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) [Asian, EA]",9368
15,Crohn's disease [EA],496
15,Electrocardiogram morphology (amplitude at temporal datapoints) [-114 ms],359
15,Electrocardiogram morphology (amplitude at temporal datapoints) [-176 ms],6177
15,Total cholesterol levels [EA],522
15,Serum metabolite levels (CMS) [L_HDL_FC],362
15,Cortical surface area [Superior parietal],70
15,Gene methylation in lung tissue,76
15,Gut microbiota (beta diversity) [Unifrac metric],3
15,Calcium levels,144466
15,Public transport | types of transport used (excluding work),3856
15,Late-onset Alzheimer's disease,2365
15,Barrett's esophagus  or Esophageal adenocarcinoma,1203
15,Distance between home and job workplace,54
15,Multisite chronic pain,8269
15,"Allergy, hypersensitivity or anaphylaxis",22644
15,Cortical surface area,108345
15,Protein quantitative trait loci (liver) [SOD2],352
15,Essential tremor,143
15,"""Ischaemic heart disease, wide definition""",6957
15,Glaucoma suspect,528
15,Other signs and symptoms in breast,13
15,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),10211
15,Difficulty not smoking for 1 day,7602
15,Waist circumference adjusted for body mass index [EA],15393
15,Cardiac problem,10925
15,Contracture of palmar fascia [dupuytren's disease],3531
15,Heart disease | illnesses of adopted siblings,554
15,Hip circumference adjusted for BMI [EA],2387
15,White matter microstructure (radial diusivities) [Corticospinal tract ],531
15,Light vs. dark hair color,4544
15,Urinary potassium to creatinine ratio,40281
15,Asthma onset (childhood vs adult),643
15,Serum levels of protein RAB27A,876
15,Anal and rectal polyp,576
15,Electrocardiogram morphology (amplitude at temporal datapoints) [18 ms],11972
15,Potassium in urine,302
15,Protein quantitative trait loci (liver) [MCEE],313
15,Blond vs non-blond hair color,4544
15,Chronic bronchitis,12517
15,Tyrosine-protein kinase receptor TYRO3 levels,31589
15,Coronary artery disease or large artery stroke,6256
15,Electrocardiogram morphology (amplitude at temporal datapoints) [170 ms],887
15,CD14- CD16+ monocyte %monocyte,1721
15,Senile cataract,1331
15,High blood pressure | illnesses of father,3839
15,Schizophrenia vs ADHD (ordinary least squares (OLS)),970
15,Black vs. blond hair color,612
15,Myo-inositol levels,2570
15,Sphingomyelin_34:0_[M+H]1+ levels,12719
15,"None of the above | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",31477
15,Standard tea intake,302
15,Diabetes diagnosed by doctor,20869
15,Liver enzyme levels (gamma-glutamyl transferase),21023
15,Phosphatidylcholine(35:4)_[M+H]1+/Phosphatidylethanolamine(38:4)_[M+H]1+/Phosphatidate(40:5)_[M+NH4]1+ levels,634
15,3mm strong meridian (left),13178
15,Obesity [Obesity class I],9511
15,Medication use (HMG CoA reductase inhibitors),3494
15,Serum metabolite levels [succinylcarnitine],10505
15,Serum metabolite levels (CMS) [MUFA],362
15,Ankle spacing width (left),1738
15,White matter hyperintensity volume,2319
15,Geobacter C abundance in stool,2951
15,CD28+ CD45RA+ CD8+ T cell Absolute Count,26
15,Sum basophil neutrophil counts,58699
15,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)",65860
15,Body mass index [women],9407
15,Arm fat mass (left),58977
15,Influenza and pneumonia,8168
15,None of the above (group 1) | illnesses of mother,3718
15,Psychiatric diseases,466
15,Serum metabolite levels (CMS) [S_LDL_TG],362
15,Serum metabolite levels (CMS) [HDL_TG],362
15,Protein quantitative trait loci (liver) [ELAVL1],29
15,Red blood cell (erythrocyte) distribution width,67015
15,Goiter,9289
15,Platelet-derived growth factor subunit B levels,1167
15,Serum levels of protein MFGE8,4733
15,Glaucoma (exfoliation),400
15,Coffee intake,302
15,Carcinoma in situ of skin of other and unspecified parts of face (controls excluding all cancers),26
15,Electrocardiogram morphology (amplitude at temporal datapoints) [162 ms],887
15,Palmar fascial fibromatosis [Dupuytren],52
15,Serum levels of protein FUT10,7
15,Eosinophil counts,450032
15,Townsend deprivation index at recruitment,5924
15,"Blood protein levels [TYRO3, 13668_44_3]",12380
15,Ankle spacing width,40821
15,Serum levels of protein PPBP,3374
15,Corneal hysteresis (right),1010
15,Serum metabolite levels [1-palmitoyl-2-linoleoyl-GPE (16:0/18:2],445
15,Electrocardiogram morphology (amplitude at temporal datapoints) [-206 ms],359
15,Pulse pressure,131538
15,Positive affect,9224
15,Frozen shoulder,2363
15,Skin pigmentation traits [Skin color],427
15,Average weekly beer plus cider intake,302
15,Chronic obstructive pulmonary disease [conditional on rs1441358],347
15,Serum metabolite levels [PC],310
15,Phosphatidylcholine_30:1_[M-H]-/Phosphatidylethanolamine_33:1_[M-H]1- levels,32
15,Total body bone mineral density,8790
15,Corneal curvature,27206
15,Brain region volumes [right supramarginal],807
15,HDL cholesterol,28909
15,Mean reticulocyte volume,409381
15,Triglyceride levels x long total sleep time interaction (2df test),725
15,Highest math class taken (MTAG) [MTAG],134488
15,Hypertension [East Asian],6994
15,Waist circumference adjusted for BMI in non-smokers [men],1791
15,"Cholesterol, total",4722
15,Electrocardiogram morphology (amplitude at temporal datapoints) [190 ms],887
15,Rheumatoid arthritis [conditional on rs7170107],860
15,Autoimmune thyroid disease,1051
15,Periodontal disease related phenotype (PCT5),49
15,Monocyte count,435926
15,Urinary creatinine levels,33402
15,Daytime nap,19853
15,IgD on IgD+ CD38+ B cell,64363
15,Platelet-to-lymphocyte ratio,25218
15,Morning person,1122
15,Serum metabolite levels (CMS) [PUFA_FA],362
15,Serum metabolite levels [1-palmitoyl-2-oleoyl-GPE (16:0/18:1],445
15,Urate levels,230912
15,Coronary artery disease and total cholesterol levels (multivariate analysis),22433
15,"Diastolic blood pressure x alcohol consumption interaction (2df test) [Asian, EA]",6216
15,"Cholesterol lowering medication | medication for cholesterol, blood pressure or diabetes",3718
15,Alzheimer's disease (late onset),2071
15,Marinilabiliaceae abundance in stool,35
15,Chronic obstructive pulmonary disease (moderate to severe),1879
15,Asthma (adult onset),2343
15,Age at first sexual intercourse,15834
15,Weight,109002
15,Trunk predicted mass,93533
15,Thyrotoxicosis with toxic multinodular goitre,8092
15,Heart failure [EA],1003
15,Age at loss of ambulation in Duchenne muscular dystrophy,321
15,Cognitive ability,7739
15,Leg fat mass (right),29811
15,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Hispanic],310
15,Pulmonary artery enlargement and chronic obstructive pulmonary disease,4232
15,HDL cholesterol levels [BMI unadjusted],608
15,Mood [affective] disorders,486
15,Cystitis,41
15,Homoarginine levels,40281
15,Nonsyndromic cleft lip with cleft palate,29888
15,acne vulgaris,9135
15,Electrocardiogram morphology (amplitude at temporal datapoints) [-112 ms],359
15,Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis),1073
15,Angina pectoris,29244
15,Sex hormone-binding globulin levels adjusted for BMI,204805
15,Serum levels of protein PDIA3,33397
15,Malignant neoplasm of respiratory system and intrathoracic organs (controls excluding all cancers),7539
15,Guilty feelings,1987
15,Maternal smoking around birth,10124
15,P wave terminal force,5133
15,"N,n,n-trimethyl-alanylproline betaine (tmap) levels",2873
15,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),688
15,"Pulse rate, automated reading",12920
15,Nicotine dependence,16852
15,Neuroticism,24705
15,Ewing sarcoma,7082
15,Nonatopic asthma,873
15,Frontal fibrosing alopecia,174
15,Waist-hip index,56626
15,Inflammatory bowel disease [Children],320
15,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Asian],310
15,No | hearing difficulty/problems,26050
15,Neuritic plaques (SNP x SNP interaction),5120
15,Phospholipid levels in very small VLDL,45
15,Body mass index (joint analysis main effects and physical activity interaction) [women],9407
15,Lymphocyte-to-monocyte ratio,94104
15,Father's age at death,7673
15,Waist circumference adjusted for BMI in active individuals [EA],4710
15,Estrone levels,1241
15,Glomerular filtration rate [Japanese],307
15,Vitamin D insufficiency,969
15,Nervous feelings,152
15,General factor of neuroticism,1797
15,Attention deficit hyperactivity disorder [males],580
15,Educational attainment (college completion),119
15,Rectal cancer,274
15,Breast cancer [East Asian],4546
15,"For long-sightedness, i.e. for distance and near, but particularly for near tasks like reading (called 'hypermetropia') | reason for glasses/contact lenses",311
15,"Eye color [EA, discovery]",220
15,Lactulose product | treatment/medication code,301
15,Any gastric operation,59
15,Cortical surface area [Superior Temporal],5
15,Chronic bronchitis/emphysema | illnesses of mother,7539
15,Height [Conditioned on rs16942341],874
15,Serum 25-Hydroxyvitamin D level variance,364
15,"Smoking behaviour (cigarettes smoked per day) [Conditioned on chr15:78906177, chr15:78849779, chr15:78908565, chr15:78814046]",7602
15,Axial length,1719
15,Moxonidine | treatment/medication code,244
15,Serum metabolite levels (CMS) [M_HDL_TG],362
15,Phosphatidylcholine_33:3_[M+H]1+/Phosphatidylethanolamine_36:3_[M+H]1+/Phosphatidate_38:4_[M+NH4]1+ levels,997
15,Serum levels of protein SLC5A8,334
15,Medication use (agents acting on the renin-angiotensin system),67002
15,PR interval,138708
15,Serum metabolite levels [creatine],57905
15,Basophil percentage of granulocytes,20608
15,Bitter beverage consumption,302
15,Age completed full time education,12569
15,Serum metabolite levels [5-hydroxylysine],16172
15,Personality disorders (more control exclusions),1348
15,Phosphatidylethanolamine(38:5)_[M-H]1- levels,326
15,"Hair colour (natural, before greying): Dark brown (UKB data field 1747_4)",279
15,Montelukast product | treatment/medication code,335
15,Bipolar disorder vs major depressive disorder (ordinary least squares (OLS)),4011
15,Serum uric acid levels,21197
15,Electrocardiogram morphology (amplitude at temporal datapoints) [284 ms],1594
15,Electrocardiogram morphology (amplitude at temporal datapoints) [274 ms],1594
15,Fasting blood glucose,397
15,Protein quantitative trait loci (liver) [SAMHD1],60
15,Estimated glomerular filtration rate,492811
15,Lung function (FEV1),605
15,Brain region volumes [right precentral],84
15,Pro-interleukin-16 levels,3678
15,Cholesterol efflux capacity,635
15,Chronic obstructive pulmonary disease x ever smoker interaction (main effect),182
15,Basophil percentage of white cells,97196
15,Waist circumference adjusted for BMI in active individuals [men],2501
15,Never | smoking status,5140
15,Serum metabolite levels [XS_VLDL_PL],310
15,Thyroid problem (not cancer),933
15,Retinal nerve fibre layer thickness or ganglion cell inner plexiform layer thickness (MTAG),2259
15,Body mass index (joint analysis main effects and physical activity interaction),11542
15,Cardiovascular disease,105146
15,"Local histogram emphysema pattern [Severe Centrilobular, EA]",3616
15,Cancer within the respiratory system,3530
15,Post bronchodilator FEV1,492
15,"Caffeine metabolism (plasma 1,3-dimethylxanthine (theophylline) level)",1394
15,Protein quantitative trait loci (liver) [EIF3M],262
15,Psoriatic and enteropathic arthropathies,150
15,Suicide attempt severity [AA],242
15,Electrocardiogram morphology (amplitude at temporal datapoints) [92 ms],216
15,Whole body fat-free mass,115590
15,Skin pigmentation,1122
15,Phosphatidylethanolamine_38:5_[M-H]1- levels,997
15,Voxel-wise structural brain imaging measurements [left central sulcus peak voxel],70
15,BMI in smokers,8750
15,Depressive symptoms,8421
15,Lactadherin measurement,5730
15,Arm fat mass (right),35921
15,Serum metabolite levels [L_HDL_TG],334
15,Other diseases of upper respiratory tract,643
15,Fasting blood glucose adjusted for BMI,430
15,Wheeze or whistling in the chest in last year,643
15,Exhaled carbon monoxide levels [EA],4522
15,Celiac disease,41056
15,Time spend outdoors in summer,10030
15,Coronary angiopasty,6777
15,COPD (mode),7602
15,Red blood cell count,844687
15,HDL cholesterol levels [EA],9536
15,"Heel bone mineral density (bmd) t-score, automated",43939
15,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [AA],282
15,Childhood maltreatment,1348
15,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant I (Philtrum), Segment 33]",111
15,Phosphatidylcholine_31:2_[M+H]1+/Phosphatidylethanolamine_34:2_[M+H]1+/Phosphatidate_36:3_[M+NH4]1+ levels,997
15,Corneal hysteresis (left),1065
15,Serum levels of protein CTSH,1997
15,Idiopathic pulmonary fibrosis,12911
15,Sunburns,1033
15,Glycine levels,877
15,"Lipid metabolism phenotypes [HDL-C.assay, fasting]",334
15,Urinary albumin excretion (no hypertensive medication),42201
15,Impedance of whole body,125409
15,Obstructive chronic bronchitis,7539
15,Age-related disease endophenotypes,620
15,"Body composition traits [M, Hip circumference]",2008
15,Serum metabolite levels [XL_HDL_P],362
15,Versican core protein levels,515
15,Number of treatments/medications taken,405
15,Non-glioblastoma glioma,2768
15,Electrocardiogram morphology (amplitude at temporal datapoints) [14 ms],18
15,Blood trace element (Zn levels),9485
15,3mm weak meridian (left),13581
15,Emphysema distribution in smoking [ratio950],2129
15,Anxiety x vitamin D PRS interaction (COJO adjusted),37
15,Serum metabolite levels [ApoA1],334
15,Neutralising antibody response to interferon beta therapy in multiple sclerosis in patients positive for neutralising antibodies (antibody titre; IFNβ-1a intramuscular),40
15,Renal function-related traits (eGRFcrea),341
15,Metabolite levels (small molecules and protein measures) [Creatinine],40281
15,Serum metabolite levels (CMS) [FreeC],528
15,Serum metabolite levels (CMS) [LDL_D],334
15,Triglyceride levels x short total sleep time interaction (2df test),225
15,Cortical volume [Superior parietal],43
15,Colon polyp,9730
15,Later onset COPD,7673
15,Hip circumference [EA],1818
15,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [men],2501
15,Serum metabolite levels (CMS) [IDL_PL],334
15,Age-related macular degeneration,1797
15,Diacylglycerol_38:6_[M+H-H2O]1+ levels,997
15,Post bronchodilator FEV1/FVC ratio,4590
15,Accelerometer-based physical activity measurement (fraction of time with accelerations >425 milli-gravities),1355
15,Bipolar disorder,107054
15,"Blood protein levels [FGF7, 4487_1_1]",14105
15,Heart disease | illnesses of mother,8716
15,Keratinocyte cancer (MTAG),514
15,Electrocardiogram morphology (amplitude at temporal datapoints) [148 ms],216
15,Serum metabolite levels (CMS) [S_VLDL_CE],334
15,Lung function (FEV1/FVC) [conditioned on rs10851839],16
15,Neutrophil percentage of granulocytes,23586
15,Left ventricular mass to end-diastolic volume ratio,7013
15,Asthma (more control exclusions),1513
15,Familial lung cancer,7602
15,Electrocardiogram morphology (amplitude at temporal datapoints) [192 ms],887
15,Mean corpuscular haemoglobin,85774
15,White blood cell count (monocyte),1477
15,Gamma glutamyl transpeptidase,10481
15,COVID-19 (RELEASE 5),5
15,Parkinson's disease (age of onset),103
15,Estimated glomerular filtration rate in non-diabetics,79915
15,Serum metabolite levels (CMS) [Serum_TG],334
15,Serum metabolite levels (CMS) [Remnant_C],334
15,"Lipid metabolism phenotypes [IDL.total, fasting]",334
15,Hair morphology traits [Hair color phototype score],427
15,Serum metabolite levels [Remnant_C],334
15,Triglyceride levels,35279
15,Glomerular filtration rate [EA],29605
15,Immature reticulocyte fraction,9757
15,Protein quantitative trait loci (liver) [CYB5A],4
15,Low testosterone levels,1471
15,Phosphatidylethanolamine_38:4_[M-H]1- levels,997
15,Facial morphology (segment 24),106
15,HDL cholesterol levels,121884
15,Walking pace,1675
15,Protein quantitative trait loci (liver) [HP],1136
15,Brain region volumes [white matter],2181
15,Vertical cup-disc ratio (adjusted for vertical disc diameter),612
15,Waist circumference adjusted for BMI in active individuals [women],2501
15,Metabolic traits [SM-17 + 8 other traits],8130
15,Ascending aorta minimum area,10497
15,Statin medication,2885
15,"Hip circumference adjusted for BMI [EA, women]",1803
15,"Blood protein levels [IL16, 2774_10_3]",1336
15,Serum metabolite levels [L_LDL_TG],635
15,T cell lymphocyte profile difference,55
15,"Hayfever, allergic rhinitis or eczema | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",46709
15,Aspirin | treatment/medication code,2771
15,Schizophrenia [male],19022
15,Mean diameter of VLDL particles,1488
15,Electrocardiogram morphology (amplitude at temporal datapoints) [-26 ms],1891
15,Heel broadband ultrasound attenuation (right),741
15,Electrocardiogram morphology (amplitude at temporal datapoints) [150 ms],216
15,Phosphatidylcholine(33:3)_[M+H]1+/Phosphatidylethanolamine(36:3)_[M+H]1+/Phosphatidate(38:4)_[M+NH4]1+ levels,326
15,Femoral neck bone mineral density,762
15,Sleep (1/3-day periodicity),53
15,Offspring birth weight,77870
15,Other peripheral nerve disorders,356
15,Inverse distance to the nearest major road,20
15,Electrocardiogram morphology (amplitude at temporal datapoints) [100 ms],216
15,"""Non-small cell lung cancer, adenocarcinoma (controls excluding all cancers)""",7539
15,Body fat distribution (arm fat ratio),3084
15,Colorectal cancer or advanced adenoma,1479
15,Immune reponse to smallpox (secreted IFN-alpha) [EA],25
15,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],282
15,Cortical volume [Precentral],64
15,Sitting height,97485
15,Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis),1021
15,"Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",3999
15,"Malignant neoplasm of rectum, rectosigmoid junction, and anus",274
15,Protein quantitative trait loci (liver) [C4B],3
15,Electrocardiogram morphology (amplitude at temporal datapoints) [-28 ms],13253
15,"Local histogram emphysema pattern [normal, EA]",4232
15,"Blood protein levels [IGDCC4, 9793_145_3]",398
15,Hypertension,148838
15,Non-small cell lung cancer (controls excluding all cancers),7539
15,Systemic lupus erythematosus and Systemic sclerosis,14145
15,Urinary metabolite levels in chronic kidney disease [succinylcarnitine (C4-DC],7394
15,Basophill percentage,19729
15,Serum metabolite levels (CMS) [IDL_TG],1429
15,Electrocardiogram morphology (amplitude at temporal datapoints) [120 ms],216
15,Eye color traits [Eye color],749
15,Leisure sedentary behaviour (computer use),92
15,Cortical volume [Pars triangularis],43
15,Triglyceride levels in IDL,9
15,Cognitive ability (MTAG),24533
15,Eczema,37277
15,6mm strong meridian (left),11826
15,Serum metabolite levels [L_HDL_C],635
15,Skin changes due to chronic exposure to nonionizing radiation,5
15,3-hydroxypropylmercapturic acid levels in smokers [Japanese],26
15,Pre bronchodilator FEV1,61798
15,COPD,7602
15,Fasting plasma glucose,551
15,C-reactive protein levels or HDL-cholesterol levels (pleiotropy),635
15,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],282
15,Eye color (hue),76
15,Cognitive performance (MTAG) [MTAG],38630
15,Ramipril | treatment/medication code,16132
15,TPE interval (resting),869
15,Facial morphology (segment 53),725
15,Serum metabolite levels [dihydroorotate],3487
15,Serum immune biomarker levels [YKL-40],291
15,1-ribosyl-imidazoleacetate levels,1577
15,Electrocardiogram morphology (amplitude at temporal datapoints) [-122 ms],359
15,Squamous cell lung carcinoma,13651
15,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction) [men],10211
15,Male sexual orientation,3240
15,Feeling miserable,1973
15,"Hip circumference adjusted for BMI [EA,men]",1803
15,Bipolar disorder or major depressive disorder,195
15,Pattern 4 | hair/balding pattern,39832
15,Impedance of arm (right),30134
15,CD33dim HLA DR+ CD11b+ %CD33dim HLA DR+,1721
15,Hypertrophic cardiomyopathy,6226
15,Eye color [Blue eye color],427
15,Malignant neoplasm of thyroid gland,456
15,Colorectal cancer (aspirin and/or NSAID use interaction) [Case only],257
15,Serum metabolite levels [S_VLDL_PL],334
15,Iris color,1070
15,Hypothyroidism,2322
15,Optic cup area,777
15,Electrocardiogram morphology (amplitude at temporal datapoints) [10 ms],18
15,"Electron transfer flavoprotein subunit alpha, mitochondrial measurement",1384
15,Peptac liquid | treatment/medication code,160
15,Bipolar I disorder,56216
15,Serum levels of protein IGDCC4,367
15,Completion of the aide-memoire,42
15,"""Cysts of oral region, not elsewhere classified""",110
15,Plateletcrit,93736
15,Diseases of the respiratory system,643
15,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test) [EA],20143
15,Blood metabolite levels [1-palmitoylglycerophosphoethanolamine],945
15,Cardiac dysrhythmias,200
15,"Heel quantitative ultrasound index (qui), direct entry (right)",841
15,Protein quantitative trait loci (liver) [IGHG2],21
15,Waist-to-hip ratio adjusted for body mass index [EA],14741
15,Electrocardiogram morphology (amplitude at temporal datapoints) [24 ms],7694
15,Pediatric asthma,553
15,Attention deficit hyperactivity disorder,653
15,Serum metabolite levels (CMS) [TotPG],310
15,Severe influenza A (H1N1) infection,2
15,Past tobacco smoking,13254
15,Lymphocyte percentage,156903
15,Local histogram emphysema pattern [Panlobular],5008
15,Hypertensive diseases (excluding secondary),3839
15,Diisocyanate-induced asthma,427
15,Suicide,11
15,Psoriasis,184
15,Parental longevity (combined parental age at death),8847
15,Schizophrenia (MTAG),143574
15,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction) [women],1791
15,Waist circumference adjusted for body mass index [women],2501
15,Low hand grip strength (60 years and older) (EWGSOP),2638
15,Skin pigmentation traits [Skin color phototype score],427
15,"Red | hair colour (natural, before greying)",427
15,"Leg claudication/ intermittent claudication | non-cancer illness code, self-reported",227
15,Electrocardiogram morphology (amplitude at temporal datapoints) [54 ms],216
15,Intraocular pressure,31868
15,Apolipoprotein A1 levels,48381
15,Esophageal cancer,624
15,Serum metabolite levels [M_HDL_TG],362
15,Body fat percentage or coronary artery disease (MTAG),2771
15,Serum metabolite levels [HDL_TG],362
15,Triglyceride levels in very small VLDL [conditioned on 885 SNPs],4
15,Hair color,49177
15,Height [EA],1097
15,Sleeplessness / insomnia,13496
15,Alzheimer's disease or diastolic blood pressure (pleiotropy),2643
15,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) [subset analysis]",1935
15,Electrocardiogram morphology (amplitude at temporal datapoints) [182 ms],887
15,Pulmonary function [FEV1/FVC],691
15,LDL cholesterol,30062
15,"""Diabetes, varying definitions""",2109
15,Osteoarthritis of the hip or knee,11113
15,"""Primary open-angle glaucoma, strict""",6774
15,Lipoprotein (a) levels,170
15,Type 2 diabetes,734696
15,Average weekly red wine intake,19330
15,Kidney stones,344
15,"Aspirin | medication for pain relief, constipation, heartburn",2771
15,"Parental longevity (combined parental attained age, Martingale residuals)",10021
15,Insulin-like growth factor 1 levels,242480
15,Hyperlipidemia,4174
15,Cutaneous malignant melanoma,618
15,HDL cholesterol levels in current drinkers [EA],353
15,Electrocardiogram morphology (amplitude at temporal datapoints) [110 ms],216
15,Tumor biomarkers [AFP],77646
15,Electrocardiogram morphology (amplitude at temporal datapoints) [52 ms],216
15,Inflammatory bowel disease [EA],1061
15,Instant coffee | coffee type,12460
15,Place of birth in uk - north co-ordinate,271
15,"""Thyrotoxicosis, other and/or unspecified""",11811
15,Stroke,457
15,Electrocardiogram morphology (amplitude at temporal datapoints) [104 ms],216
15,Blue vs. green eyes,580
15,Spine | fractured bone site(s),46
15,Well-being spectrum (multivariate analysis),10847
15,Oxalate (ethanedioate) levels,8642
15,Exfoliation glaucoma or exfoliation syndrome,1642
15,Subjective well-being (MTAG),115
15,Protein quantitative trait loci (liver) [CALR],250
15,Other malignant neoplasms of skin (=non-melanoma skin cancer) (controls excluding all cancers),5
15,Chronic obstructive pulmonary disease in current smokers,7602
15,Hip index,10621
15,Creatinine (enzymatic) in urine,40624
15,Pollinosis,307
15,White | bread type,1174
15,Caffeine consumption from coffee or tea,2315
15,Serum metabolite levels (CMS) [XS_VLDL_L],334
15,Protein quantitative trait loci (liver) [KRT10],6
15,Granulocyte count,32861
15,Number of cigarettes previously smoked daily,17824
15,Eye color [discovery],236
15,Platelet-derived growth factor BB levels,1320
15,Iris color (a* coordinate),489
15,HDL cholesterol levels in current drinkers [AA],310
15,Waist circumference adjusted for BMI (adjusted for smoking behaviour) [men],10211
15,Phosphatidylcholine-O_34:1_[M+H]1+/Phosphatidylcholine-P_34:0_[M+H]1+/Phosphatidylethanolamine-O_37:1_[M+H]1+ levels,13048
15,Whole body water mass,126560
15,Serum levels of protein WFDC1,999
15,Protein levels in obesity [IL-16],1336
15,"Mean arterial pressure x alcohol consumption interaction (2df test) [Asian, EA]",2771
15,"Age hay fever, rhinitis or eczema diagnosed",251
15,Bioavailable testosterone levels,117850
15,"Angina | non-cancer illness code, self-reported",14742
15,Total bilirubin levels,7854
15,Spherical equivalent (joint analysis main effects and education interaction) [European ancestry],5118
15,Waist circumference adjusted for body mass index [East Asian],1814
15,Myopia,1802
15,C-reactive protein levels or total cholesterol levels (pleiotropy),159
15,Body mass index,291409
15,Spherical equivalent (joint analysis main effects and education interaction),5554
15,White blood cell count,563217
15,Lung function (FEV1/FVC) variance,7539
15,"Allergic disease (asthma, hay fever and/or eczema) (age of onset)",19991
15,"""Type 2 diabetes, strict (exclude DM1)""",2105
15,Lean body mass,1814
15,Blood protein levels [IL16],1336
15,Cortical surface area (MOSTest),1025
15,Year ended full time education,105
15,Corneal resistance factor,18
15,General cognitive ability,23345
15,Smoking cessation,54781
15,Basal metabolic rate,43615
15,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],5727
15,Mother still alive,7539
15,Number in household,271
15,Serum metabolite levels [VLDL_D],486
15,Electrocardiogram morphology (amplitude at temporal datapoints) [140 ms],216
15,Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified),7718
15,Irritable bowel syndrome,1
15,"None of the above | medication for cholesterol, blood pressure or diabetes",22372
15,Whole body fat mass,28027
15,Haematocrit percentage,85815
15,"""Glaucoma, exfoliation""",570
15,"Waist circumference adjusted for body mass index [EA,women]",1803
15,Male puberty timing (early vs. average onset voice breaking),409
15,Serum metabolite levels [PUFA],310
15,College or university degree | qualifications,547
15,White matter microstructure (mode of anisotropy) [Anterior limb of internal capsule],241
15,Knee pain | pain type(s) experienced in last month,1653
15,Cortical surface area (min-P),165
15,Age started oral contraceptive pill,62
15,Protein quantitative trait loci (liver) [TAGLN2],40
15,Ventolin 100micrograms inhaler | treatment/medication code,643
15,Other special examinations and investigations of persons without complaint or reported diagnosis,16
15,Waist circumference adjusted for body mass index,146214
15,Mammographic density (non-dense area),1904
15,"Forced expiratory volume in 1-second (fev1), predicted",33012
15,Percent mammographic density,85
15,Platelet count,539277
15,Pork consumption,763
15,"Other chronic ischemic heart disease, unspecified",7970
15,Diffusing capacity of carbon monoxide [EA],10095
15,Vertex-wise sulcal depth,138623
15,Multivitamin+mineral preparations | treatment/medication code,222
15,"Local histogram emphysema pattern [Moderate Centrilobular, EA]",4322
15,Predicted visceral adipose tissue,9901
15,Place of birth in uk - east co-ordinate,6465
15,Testicular germ cell tumor,13648
15,Electrocardiogram morphology (amplitude at temporal datapoints) [78 ms],216
15,Cortical thickness (MOSTest),266
15,Serum metabolite levels (CMS) [VLDL_C],442
15,Asthma-related acute respiratory infections,638
15,Growth/differentiation factor 15 measurement,8
15,"Waist circumference adjusted for body mass index [EA, men]",12724
15,Smoking behaviour (cigarettes smoked per day) [Conditioned on chr15:78814046],10069
15,Monocyte percentage,97867
15,Simple and unspecified goiter,11691
15,Waist circumference adjusted for BMI in non-smokers,2478
15,Electrocardiogram morphology (amplitude at temporal datapoints) [132 ms],216
15,"Energy expenditure [Men, Overweight/Obese]",25
15,Coronary atherosclerosis,16132
15,Atrial fibrillation [EA],8085
15,Body mass index (joint analysis main effects and smoking interaction) [women],9407
15,Childhood asthma (age<16),691
15,Diseases of the skin and subcutaneous tissue,80
15,Ischemic heart diseases,6374
15,6mm cylindrical power (right),427
15,Pseudoexfoliation syndrome,594
15,Phosphatidylethanolamine levels [PE(18:0;0-18:2;0],362
15,Hormone measurements [Oestradiol],993
15,Body fat distribution (arm fat ratio) [males],1793
15,Serum metabolite levels (CMS) [M_HDL_L],635
15,Cortical surface area [Pars Triangularis],84
15,Atrial fibrillation/atrial flutter,227
15,Time to complete round,181
15,Juvenile Open Angle Glaucoma,6348
15,Serum metabolite levels [1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)*],640
15,"HDL cholesterol levels [Asian initial, BMI unadjusted]",408
15,"Blonde | hair colour (natural, before greying)",40184
15,"Waist circumference adjusted for BMI in active individuals [EA,women]",1791
15,Electrocardiogram morphology (amplitude at temporal datapoints) [160 ms],887
15,"""Type 2 diabetes, definitions combined""",2105
15,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [women],2501
15,Length of menstrual cycle,632
15,Voxel-wise structural brain imaging measurements [right central sulcus peak voxel],70
15,Spherical equivalent or myopia (age of diagnosis),4994
15,Youthful appearance (self-reported),8267
15,Glaucoma,2328
15,"""Asthma, hospital admissions , main diagnosis only""",643
15,Mean corpuscular haemoglobin concentration,11477
15,Thyroid volume [thyroid volume],11811
15,Pyridoxate levels,1469
15,Central corneal thickness [conditional],1600
15,Heel bone mineral density,284221
15,Age-related hearing impairment [additive],764
15,"Blood protein levels [ISLR2, 8528_74_3]",2775
15,Pulse wave arterial stiffness index,122
15,Electrocardiogram morphology (amplitude at temporal datapoints) [-22 ms],29868
15,Eye color [Brown eye color],427
15,Potassium levels,30677
15,Electrocardiogram morphology (amplitude at temporal datapoints) [22 ms],7694
15,Serum metabolite levels [1-arachidonoyl-GPE (20:4n6)*],445
15,Number of cigarettes currently smoked daily (current cigarette smokers),8386
15,Cardiovascular diseases (excluding rheumatic etc),3839
15,Ease of getting up in the morning,1465
15,"Light diy (eg: pruning, watering the lawn) | types of physical activity in last 4 weeks",88
15,Testosterone levels,25116
15,"Light smokers, at least 100 smokes in lifetime",7653
15,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],10100
15,Femur bone mineral density x serum urate levels interaction [male],201
15,Cytokine levels [PDGF-BB],999
15,"Intra-ocular pressure, goldmann-correlated (left)",5810
15,Serum metabolite levels [XS_VLDL_CE],334
15,Serum levels of protein RGMA,32
15,Joint mobility (Beighton score),1209
15,Iron status biomarkers (iron levels),2302
15,Relative carbohydrate intake,302
15,Disease progression in age-related macular degeneration (adjusted for baseline),121
15,Malignant neoplasm of bronchus and lung (controls excluding all cancers),7539
15,Adult onset asthma and/or waist-to-hip ratio adjusted for BMI,8286
15,Mean diameter of HDL particles,2910
15,Iris color (b* coordinate),811
15,Electrocardiogram morphology (amplitude at temporal datapoints) [-116 ms],359
15,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),8138
15,Spontaneous coronary artery dissection,1299
15,Low urine pH,454
15,Triglyceride levels [EA],888
15,Mean diameter of LDL particles,2398
15,Waist-hip ratio [EA],746
15,Chronic lymphocytic leukemia,41203
15,Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease,8386
15,Diverticular disease,2010
15,6mm weak meridian (left),26627
15,Age-related macular degeneration (SNP x mitochondrial G12771A interaction),3303
15,Blood metabolite ratios [propionylcarnitine/isovalerylcarnitine],8311
15,Parental lifespan [EA],7653
15,Electrocardiogram morphology (amplitude at temporal datapoints) [-110 ms],359
15,Phosphatidylcholine_35:3_[M+H]1+/Phosphatidylethanolamine_38:3_[M+H]1+/Phosphatidate_40:4_[M+NH4]1+ levels,969
15,Serum metabolite levels [XL_HDL_PL],362
15,Skin pigmentation traits [Fitzpatrick phototype score],427
15,Protein quantitative trait loci (liver) [PRDX3],26
15,Chronic airway obstruction,7539
15,Local histogram emphysema pattern [Moderate Centrilobular],4322
15,Leg fat-free mass (left),43344
15,Metabolic syndrome (multivariate analysis),1989
15,"""Ulcerative colitis (strict definition, require KELA, min 2 HDR)""",6
15,Insomnia [Female],12256
15,Body fat distribution (arm fat ratio) [females],2490
15,Asthma/COPD (KELA code 203),3288
15,Cutaneous melanoma or hair colour,554
15,Serum metabolite levels (CMS) [HDL_C],334
15,Smoking behaviour (cigarette pack-years),15696
15,Alzheimer's disease or HDL levels (pleiotropy),7137
15,Eye color,2289
15,Major depressive disorder,9867
15,"Osteopenia | non-cancer illness code, self-reported",941
15,Smoking initiation (ever regular vs never regular),41678
15,Medication use (calcium channel blockers),42255
15,Essential hypertension (time to event),25929
15,"Diastolic blood pressure [EA, initial]",25204
15,"Smoking behaviour (cigarettes smoked per day) [Conditioned on chr15:78812098, chr15:78911181, chr15:78906177, chr15:78849779, chr15:78908565, chr15:78814046]",18388
15,3mm cylindrical power (left),427
15,Trunk fat percentage,27465
15,Lipid traits [HDL-C],286
15,Lung adenocarcinoma,33260
15,Lipid traits (pleiotropy) (HIPO component 1),10630
15,Age of smoking initiation (MTAG),4967
15,Liver volume,2400
15,Major coronary heart disease event,6387
15,Serum metabolite levels [isovalerylcarnitine (C5],9024
15,Serum metabolite levels [XS_VLDL_C],334
15,Cutaneous squamous cell carcinoma,207
15,Impedance of leg (left),64102
15,Bladder cancer [Japanese],884
15,Blood metabolite ratios [10-undecenoate (11:1n1)/X-11438],346
15,Nasobec aqueous 50micrograms nasal spray | treatment/medication code,16
15,Autoimmune traits,942
15,"Blood protein levels [GLCE, 7808_5_3]",2588
15,Skin pigmentation (conditioned on rs1426654 and rs35397),286
15,Serum metabolite levels [1-stearoyl-2-linoleoyl-GPE (18:0/18:2)*],445
15,Serum total protein level,114814
15,A levels/as levels or equivalent | qualifications,986
15,Brain region volumes [left superior parietal],72
15,Electrocardiogram morphology (amplitude at temporal datapoints) [126 ms],1103
15,Blond vs. brown hair color,580
15,Serum metabolite levels [XS_VLDL_L],334
15,Triglyceride levels [Asian],227
15,Other disorders of ear,768
15,Total body bone mineral density [European],8815
15,"Forced vital capacity (fvc), best measure",105585
15,Phosphatidylcholine_33:4_[M+H]1+/Phosphatidylethanolamine_36:4_[M+H]1+/Phosphatidate_38:5_[M+NH4]1+ levels,1530
15,Local histogram emphysema pattern [Severe Centrilobular],3616
15,High-sensitivity cardiac troponin I concentration,6099
15,"Waist circumference adjusted for body mass index [EA, women]",1783
15,"Blood protein levels [MFGE8, 4455_89_2]",4011
15,Sphingomyelin_33:1_[M+H]1+ levels,1201
15,Osteoarthritis (hip) [additive],860
15,HDL cholesterol levels x long total sleep time interaction (2df test),626
15,Zantac 75 tablet | treatment/medication code,101
15,Hot drink temperature,302
15,Cortical surface area [Transverse Temporal],84
15,Waist-hip ratio,320710
15,Fasciitis,3490
15,6mm weak meridian (right),12685
15,Other chronic obstructive pulmonary disease,7602
15,Protein quantitative trait loci (liver) [EIF4A1],262
15,Melanoma,188
15,"Blistering/desquamating skin disorder | non-cancer illness code, self-reported",106
15,Inguinal hernia,60
15,Chronic obstructive pulmonary disease [conditional on rs10152300],4073
15,Sphingomyelin_35:1_[M+H]1+ levels,1972
15,Reaction time,470
15,Serum metabolite levels (CMS) [L_HDL_L],870
15,Serum metabolite levels (CMS) [L_LDL_TG],1429
15,vascular endothelial growth factor D levels,1404
15,Neurofibrillary tangles (SNP x SNP interaction),15803
15,Number of unsuccessful stop-smoking attempts,7602
15,Serum metabolite levels [Serum_C],334
15,"Thyroid problem (not cancer) | non-cancer illness code, self-reported",4662
15,Left-handedness,3813
15,Age-related macular degeneration (SNP x mitochondrial A4917G interaction),250
15,"Metabolite levels (lipoprotein measures) [HDL diameter, conditioned]",830
15,"Estimated glomerular filtration rate (creatinine, CKDi25)",285
15,"Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [Asian, EA]",16607
15,Sphingomyelin_34:2_[M+H]1+ levels,12719
15,Serum metabolite levels (CMS) [M_LDL_L],635
15,Spinal stenosis,848
15,Serum metabolite levels (CMS) [S_HDL_TG],334
15,Infant length,874
15,Serum levels of protein MTHFS,6944
15,Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis),910
15,Thyroid hormone levels [TSH - Males],12107
15,Hypospadias,315
15,Serum metabolite levels [1-stearoyl-2-oleoyl-GPE (18:0/18:1],861
15,"Parkinson's disease (familial, age at onset)",260
15,Moderate to vigorous physical activity levels,627
15,Type 2 diabetes (adjusted for BMI),41100
15,"Blood protein levels [EA, Interleukin-16]",1664
15,Refractive astigmatism,427
15,Parental longevity (father's age at death or father's attained age),13228
15,HLA DR+ Natural Killer Absolute Count,1708
15,Chronic obstructive pulmonary disease x ever smoker interaction (1df),6274
15,C-reactive protein,12867
15,Frailty index,59316
15,Peripheral artery disease in ever smokers,17663
15,Arm predicted mass (right),46393
15,White blood cell (leukocyte) count,89858
15,Body fat distribution (leg fat ratio) [females],3503
15,Bipolar disorder vs ADHD (ordinary least squares (OLS)),1259
15,Protein quantitative trait loci (liver) [PLD3],3790
15,Medication use (glucocorticoids),1197
15,Participation in an health questionnaire (not invited vs invited),6138
15,Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis),1021
15,Serum metabolite levels (CMS) [SM],635
15,Cardiovascular disease risk factors [HDL],310
15,Systolic blood pressure (cigarette smoking interaction),39324
15,Allergic rhinitis,67464
15,5-hydroxyindoleacetate levels,19030
15,Electrocardiographic traits (multivariate),2502
15,Serum metabolite levels (CMS) [S_VLDL_PL],334
15,Protein quantitative trait loci (liver) [FTH1],2
15,Protein quantitative trait loci (liver) [TNC],26
15,Meniere's disease,39
15,Protein quantitative trait loci (liver) [PBDC1],15
15,QT interval,11358
15,Number of vehicles in household,9825
15,"Black | hair colour (natural, before greying)",6372
15,Serum metabolite levels (CMS) [S_LDL_P],433
15,Other renal tubulo-interstitial diseases,16
15,Attention deficit hyperactivity disorder (MTAG),370
15,Problematic alcohol use (MTAG),377
15,Cortical surface area [Supramarginal],336
15,Eye color [eye color],427
15,Metabolite levels [LPE 16:0],1635
15,Testosterone to estradiol ratio,2330
15,Lysophosphatidylethanolamine_16:0_[M-H]1- levels,945
15,Resting oxygen saturation in chronic osbtructive pulmonary disease (pulse oxymetry) [AA],37
15,Use of sun/uv protection,1527
15,"Gout | non-cancer illness code, self-reported",3898
15,"Hypothyroidism/myxoedema | non-cancer illness code, self-reported",926
15,"Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA, women]",1783
15,Vitiligo,4947
15,Nontoxic multinodular goiter,11849
15,Red vs. brown/black hair color,427
15,Barrett's esophagus,1528
15,Serum metabolite levels [TotFA],310
15,Metabolite levels (lipoprotein measures) [Triglycerides in very large HDL],334
16,Musculoskeletal disorder or trauma,26045
16,Body fat distribution (arm fat ratio) [males],19112
16,Chronic kidney disease,1280
16,Gut microbiota presence (genus Lachnospiraceae UCG 010 id.11330),744
16,Imdur 60mg durule | treatment/medication code,179
16,Metabolic syndrome,48380
16,"Hip circumference [EA,women]",216034
16,Sum neutrophil eosinophil counts,7756
16,White matter microstructure (mode of anisotropy) [Superior corona radiata],795
16,Serum levels of protein SPARCL1,479
16,Electrocardiogram morphology (amplitude at temporal datapoints) [20 ms],416
16,Type 1 diabetes,785176
16,Leg predicted mass (left),377527
16,Serum metabolite levels [XS_VLDL_C],931
16,Blood osmolality (transformed sodium),2384
16,Other insterstitial pulmonary diseases,379
16,Hepatitis B,86
16,Phosphatidylcholine(38:2)_[M+H]1+/Phosphatidylethanolamine(41:2)_[M+H]1+ levels,6916
16,Never | smoking status,62611
16,Thyroid hormone levels [FT4-Males],3679
16,BMI in non-smokers [women],1084
16,Non-oily fish intake,1084
16,Didronel 200mg tablet | treatment/medication code,1615
16,"Cholesterol lowering medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",2278
16,Pulse wave reflection index,82
16,Congenital left-sided heart lesions [EA],12
16,Zirtek 10mg tablet | treatment/medication code,4337
16,Sleep apnoea,1093
16,Other papulosquamous disorders,103
16,Light vs. dark hair color,23733
16,Fed-up feelings,1978
16,Obesity,171296
16,Systolic blood pressure x smoking status (ever vs never) interaction (2df test) [EA],34739
16,Electrocardiogram morphology (amplitude at temporal datapoints) [108 ms],3918
16,Diverticulosis and diverticulitis,1235
16,Attention deficit hyperactivity disorder or intracranial volume (pleiotropy),701
16,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),1376
16,Serum metabolite levels [M_HDL_C],931
16,Electrocardiogram morphology (amplitude at temporal datapoints) [24 ms],416
16,Mental and behavioural disorders due to alcohol,188
16,Facial morphology [pronasale-labiale superius distance],7929
16,Electrocardiogram morphology (amplitude at temporal datapoints) [182 ms],21594
16,Serum levels of protein NAGPA,1953
16,Electrocardiogram morphology (amplitude at temporal datapoints) [164 ms],20509
16,Brain region volumes [right lateral ventricle],809
16,Glaucoma (primary open-angle),1250
16,Multiple sclerosis,98311
16,Heel bone mineral density,418789
16,Hip circumference [EA],237644
16,Body mass index in physically active individuals [men],214202
16,"Forced expiratory volume in 1-second (fev1), best measure",81268
16,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),5624
16,Inguinal hernia,6484
16,"Allergic disease (asthma, hay fever and/or eczema) (age of onset)",1215
16,Serum metabolite levels (CMS) [S_VLDL_P],2107
16,Hypospadias,1015
16,Adiponectin levels (BMI-adjusted),132
16,Cutaneous melanoma or hair colour,36402
16,Apolipoprotein A-I measurement,14604
16,Urinary metabolite levels in chronic kidney disease [3-hydroxyindolin-2-one sulfate],82823
16,Electrocardiogram morphology (amplitude at temporal datapoints) [162 ms],19603
16,Glomerular filtration rate in diabetics (creatinine),816
16,Phosphatidylcholine_32:1_[M+H]1+/Phosphatidylethanolamine_35:1_[M+H]1+/Phosphatidate_37:2_[M+NH4]1+ levels,1763
16,Cardiometabolic and hematological traits [MCH],52
16,"Gut microbiota (bacterial taxa, rank normal transformation method) [G_Butyricicoccus_RNT]",1573
16,Electrocardiogram morphology (amplitude at temporal datapoints) [296 ms],384
16,Acidobacteriales abundance in stool,35
16,Periodontitis,137
16,Regional enteritis,289
16,Sleep disorders (combined),1093
16,"Blood protein levels [HP, 3054_3_2]",639
16,Hip shape (DXA scan) [hip shape mode 1],78
16,Worry too long after embarrassment,48
16,Household income (MTAG),229810
16,Essential hypertension,27063
16,LDL cholesterol levels in current drinkers,5063
16,Electrocardiogram morphology (amplitude at temporal datapoints) [148 ms],4098
16,Body mass index (age <50),1084
16,Ovarian dysfunction,179
16,Depressive symptoms (SSRI exposure interaction),3
16,Birth weight,5994
16,CAG-177 sp003538135 abundance in stool,528
16,Body mass index [women],208959
16,Hair morphology traits [Hair color (light],24067
16,"Long-standing illness, disability or infirmity",10525
16,Plasma haptoglobin levels in type 2 diabetes,376
16,Alcohol use disorder,2048
16,Mean platelet volume,517331
16,Chloride levels,2555
16,HDL cholesterol x physical activity interaction (2df test),79972
16,Iron status biomarkers (ferritin levels),37111
16,Cortical surface area,292288
16,Protein quantitative trait loci (liver) [HINT2],759
16,Cortical surface area (min-P),2241
16,Lipoprotein-associated phospholipase A2 activity and mass [Mass concentrations],931
16,BMI in smokers,1084
16,Physical activity (Total log acceleration 10pm-12am),6
16,"""Aneurysms, operations, SAH""",38239
16,Asthma (more control exclusions),6894
16,Serum metabolite levels (CMS) [IDL_PL],931
16,Red blood cell traits [MCH],2536
16,Fasting glucose,76186
16,Electrocardiogram morphology (amplitude at temporal datapoints) [192 ms],53812
16,Depressive symptoms,3650
16,Serum levels of protein PNLIPRP1,2984
16,Heart failure,1084
16,Gut microbiota presence (genus Anaerostipes id.1991),72
16,Subcortical volume (min-P),73525
16,Hip index,171121
16,Type 2 diabetes [EA],3944
16,"""Hypothyroidism, strict autoimmune""",2299
16,CD11c on granulocyte,1352
16,Serum levels of protein APOL1,5745
16,Breast cancer (male),63
16,Phospholipid levels (plasma) [levels],6047
16,Body mass index and triglycerides (pairwise),5643
16,Waist circumference adjusted for BMI (adjusted for smoking behaviour) [women],45570
16,Schizophrenia [EA],18174
16,Cataracts,17070
16,Electrocardiogram morphology (amplitude at temporal datapoints) [92 ms],1991
16,Bone mineral accretion in asthma (oral corticosteroid dose interaction),818
16,Serum uric acid levels [EA],201
16,Gut microbiome composition (winter) [genus_Bifidobacterium],82
16,Irritable mood,45219
16,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],72059
16,Serum levels of protein CCL17,5133
16,Response to fenofibrate (HDL cholesterol levels),931
16,Serum metabolite levels [3-hydroxyhexanoate],216
16,Keratoconus,1115
16,Pork intake,172
16,Electrocardiogram morphology (amplitude at temporal datapoints) [218 ms],19617
16,Vitamin D levels,4054
16,Dyslipidemia,1645
16,Autoimmune thyroid disease,492
16,Electrocardiogram morphology (amplitude at temporal datapoints) [236 ms],28519
16,Malignant neoplasm of skin (controls excluding all cancers),14584
16,Serum metabolite levels [M_HDL_CE],931
16,Fruit consumption,7307
16,Phosphatidylcholine_31:2_[M+H]1+/Phosphatidylethanolamine_34:2_[M+H]1+/Phosphatidate_36:3_[M+NH4]1+ levels,5737
16,Ascending aorta minimum area,7484
16,Impedance of leg (right),472281
16,"Chickenpox | non-cancer illness code, self-reported",516
16,Electrocardiogram morphology (amplitude at temporal datapoints) [314 ms],384
16,6mm strong meridian angle (left),10
16,Morning person,19912
16,"Red blood cell traits [EA, MCH]",2638
16,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test) [EA],35121
16,Age of smoking initiation (MTAG),87506
16,Age-related hearing impairment (high frequency) [EA],23968
16,Serum metabolite levels (CMS) [XL_VLDL_CE],1136
16,"Blood protein levels [NPW, 9986_14_3]",4450
16,Feeling fed-up,1580
16,Phosphatidylcholine_36:3_[M+H]1+/Phosphatidylethanolamine_39:3_[M+H]1+/Phosphatidate_41:4_[M+NH4]1+ levels,1927
16,Juvenile myoclonic epilepsy,46056
16,Serum creatinine levels,41776
16,Electrocardiogram morphology (amplitude at temporal datapoints) [214 ms],19617
16,Atopic dermatitis,8985
16,Phosphatidylcholine_40:4_[M+OAc]1-/Phosphatidylserine_44:3_[M-H]1- levels,5700
16,High cholesterol,714
16,White matter hyperintensity volume x hypertension interaction (2df),799
16,Warfarin maintenance dose [Brazilian],28899
16,"Black | hair colour (natural, before greying)",26108
16,Electrocardiogram morphology (amplitude at temporal datapoints) [114 ms],3918
16,Corneal hysteresis,2202
16,"""SLE, strict definition""",54
16,Serum metabolite levels [indolepropionate],15
16,Systemic lupus erythematosus,167859
16,Electrocardiogram morphology (amplitude at temporal datapoints) [232 ms],28519
16,Leg fat-free mass (left),377456
16,CD4 on monocyte,1868
16,Wheeze or whistling in the chest in last year,6610
16,Serum metabolite levels [Remnant_C],2107
16,Electrocardiogram morphology (amplitude at temporal datapoints) [84 ms],1991
16,Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications,89
16,"""Hypothyroidism, levothyroxin purchases""",102
16,TestASV_16 (Bacteroides) abundance,21
16,Fish- and plant-related diet [male],993
16,C-reactive protein,7211
16,Hypo-HDL-cholesterolemia [KARE],767
16,Lymphocyte-to-monocyte ratio,3225
16,Resting heart rate,1095
16,Mean corpuscular hemoglobin,1927960
16,Hip circumference variance,219196
16,Hip circumference adjusted for BMI [EA],228903
16,Educational attainment (years of education) [conditional-joint],264768
16,LDL cholesterol levels [Trans-ethnic initial],6172
16,Blood metabolite levels [3-phenylpropionate (hydrocinnamate],5070
16,Asthma and hay fever,6465
16,DNA methylation variation (age effect),2848
16,Pulse wave arterial stiffness index,243
16,Electrocardiogram morphology (amplitude at temporal datapoints) [208 ms],21838
16,"Pulse rate, automated reading",105841
16,Red blood cell (erythrocyte) distribution width,73642
16,Positive affect,842
16,Testosterone levels,238625
16,Carotenoid levels [Beta carotene],1405
16,Optic disc parameters,67
16,"Cholesterol, total",93886
16,Coronary atherosclerosis,36451
16,Serum urea levels,180287
16,Vertex-wise cortical surface area,266085
16,HDL cholesterol levels in HIV infection [EA],651
16,Breast milk fatty acid composition (maternal genotype effect) [polyunsaturated FA-6/polyunsaturated FA-3],236
16,Glycine levels,29637
16,Parental lifespan,1611
16,Total cholesterol levels [Trans-ethnic initial],6172
16,"Smoking initiation (ever regular vs never regular) [Conditioned on chr16:72950468, chr16:72574550]",6127
16,Carotenoid levels [Lutein],1405
16,Cylindrical power (right),10
16,Body mass index,4514382
16,Serum metabolite levels (CMS) [M_HDL_TG],1525
16,"Metabolite levels [Phe, Tyr]",5059
16,Serum metabolite levels (CMS) [L_HDL_P],931
16,Serum metabolite levels (CMS) [XL_HDL_C],931
16,Pulse pressure x alcohol consumption interaction (2df test) [EA],946
16,Serum metabolite levels (CMS) [XL_HDL_P],931
16,Freckles,12299
16,Diastolic blood pressure,621768
16,Time spent outdoors in winter,41328
16,"Waist-hip ratio [EA, women]",1084
16,High light scatter reticulocyte percentage,33662
16,HLA DR+ CD4+ T cell Absolute Count,1285
16,CAG-177 sp002438685 abundance in stool,528
16,Electrocardiogram morphology (amplitude at temporal datapoints) [98 ms],1991
16,Age at adiposity rebound,1084
16,Neuropsychiatric disorders,295
16,White matter microstructure (fractional anisotropy) [Fornix (column and body],809
16,Attendance allowance | attendance/disability/mobility allowance,205
16,Blood urea nitrogen levels,143986
16,Bendroflumethiazide | treatment/medication code,23728
16,"Blood protein levels [EA, Haptoglobin]",10127
16,Estimated glomerular filtration rate [EA],232
16,Cerebrospinal fluid t-tau:AB1-42 ratio,57
16,Renal function-related traits (urea),139
16,Hydroxycholesterol_[M+H-2H2O]1+ levels,22
16,Arm fat percentage (right),334745
16,Pre-treatment viral load in HIV-1 infection,2175
16,Forced vital capacity (fvc),69115
16,"""Primary gonarthrosis, bilateral""",1084
16,Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in non-secretors,329
16,Obesity [adults],1127
16,Bone mineral density (hip),39
16,Chronic obstructive pulmonary disease or coronary artery disease (pleiotropy),34171
16,Core binding factor acute myeloid leukemia,15692
16,Appendicular lean mass,628452
16,Chronic obstructive pulmonary disease x current smoker interaction (2df),34049
16,Electrocardiogram morphology (amplitude at temporal datapoints) [174 ms],19603
16,Age started wearing glasses or contact lenses,9117
16,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],5624
16,Body mass index [age 1-17],1084
16,Periodontal disease-related phenotype (Socransky),2168
16,Thyroid volume [thyroid volume],238
16,Human milk oligosaccharide concentration (lacto-N-fucopentaose III),333
16,Breast cancer [all races combined],21
16,HLA DR on B cell,308
16,Lacunar stroke,183
16,"""Crohn disease (strict definition, all UC cases excluded)""",50
16,Systolic blood pressure,391983
16,Brown vs. black hair color,12299
16,Coagulation factor Xa measurement,5274
16,Arm predicted mass (right),404169
16,Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid),5700
16,Lysophosphatidylethanolamine_18:0_[M-H]1- levels,931
16,Glomerulonephritis,232
16,"""Crohn disease (strict definition, require KELA, min 2 HDR)""",50
16,Myopia (age of diagnosis),64667
16,Colon polyp,9649
16,Lysophosphatidylethanolamine_22:4_[M-H]1- levels,1911
16,"Blood protein levels [FTH1 FTL, 3031_66_1]",639
16,Serum metabolite levels [S-1-pyrroline-5-carboxylate],147
16,White blood cell count,516504
16,Age when periods started (menarche),50070
16,Serum metabolite levels (CMS) [XS_VLDL_PL],931
16,Electrocardiogram morphology (amplitude at temporal datapoints) [160 ms],20573
16,Mean corpuscular hemoglobin [AA],448
16,"Blood protein levels [EA, C-C motif chemokine 17]",1633
16,"Lipid metabolism phenotypes [HDL-C.assay, whole]",1525
16,Eczema or dermatitis,1364
16,Superficial injury of forearm,262
16,Blond vs. brown hair color,12299
16,"Blood protein levels [AGRP, 2813_11_2]",51856
16,"Heel bone mineral density (bmd) t-score, automated (left)",47607
16,HLA DR on HLA DR+ CD4+ T cell,2399
16,HLA DR+ CD8+ T cell %T cell,1285
16,Other heart diseases,1293
16,Serum metabolite levels (CMS) [XS_VLDL_CE],931
16,Alcohol consumption (drinks per week),479003
16,Alzheimer's disease (late onset),19474
16,Colorectal cancer or advanced adenoma,9611
16,Brain region volumes [left caudate],209413
16,"Red | hair colour (natural, before greying)",414160
16,"Heel quantitative ultrasound index (qui), direct entry",69700
16,Smoking initiation (ever regular vs never regular) [Conditioned on chr16:17570220],167
16,Age at loss of ambulation in Duchenne muscular dystrophy [EA],53
16,Alzheimer's disease (cognitive decline),19
16,White matter microstructure (radial diusivities) [Cingulate gyrus],2498
16,Heel bone mineral density (bmd),69293
16,Trunk fat-free mass,446105
16,Sodium valproate | treatment/medication code,160
16,T cell lymphocyte profile difference,147
16,Electrocardiogram morphology (amplitude at temporal datapoints) [-40 ms],34
16,Response to amphetamines [SF1],38
16,Obesity and other hyperalimentation,1084
16,HLA DR on CD33dim HLA DR+ CD11b+,1205
16,Waist circumference adjusted for BMI (adjusted for smoking behaviour),45570
16,Total protein levels x insomnia interaction,1506
16,"Dark brown | hair colour (natural, before greying)",43283
16,Cataract,9692
16,Corneal hysteresis (left),1119
16,Hemoglobin levels in non-alcoholic fatty liver disease x mastiha supplementation interaction,329
16,BRCA1/2-negative high-risk breast cancer,20
16,3-hydroxyoctanoate levels,5
16,Low density lipoprotein cholesterol levels,138554
16,Body mass index [men],214202
16,QT dynamics during exercise [male],8297
16,Aspartate aminotransferase to alanine aminotransferase ratio,1359
16,Age-related hearing impairment (MTAG),2435
16,Renal function and chronic kidney disease [eGFRcrea],816
16,Low calorie drink intake,1
16,Medication use (thyroid preparations),97465
16,Variation in diet,57594
16,Vertex-wise sulcal depth,313133
16,Eosinophilic esophagitis (pediatric),388
16,Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid) [Conditioned on rs16966952],7112
16,Worry too long after an embarrassing experience,35
16,Eosinophill count,104401
16,"Blood protein levels [EA, Heparin cofactor 2]",6745
16,Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis),4500
16,Total cholesterol levels in HDL,733
16,Serum levels of protein PDILT,2
16,Melanoma,96714
16,Male puberty timing (early vs. average onset facial hair),12841
16,Serum metabolite levels [gamma-glutamyl-alpha-lysine],6739
16,Chronic diseases of tonsils and adenoids,4956
16,HDL cholesterol levels in HIV infection [African American],903
16,Serum levels of protein MMP7,232
16,Triglyceride levels in current drinkers [EA],518
16,Forced expiratory volume in 1 second x sex interaction,305
16,Lysophosphatidylethanolamine_20:0_[M-H]1- levels,931
16,Crohn's disease of small interstine,50
16,Plays computer games,17946
16,CD3 on Naive CD4+ T cell,13291
16,Electrocardiogram morphology (amplitude at temporal datapoints) [320 ms],384
16,Coagulation Factor X measurement,5274
16,Atrial fibrillation [Japanese],89
16,Facial morphology [right exocanthion-left cheilion distance],99
16,Waist-hip index,85018
16,Vitamin B12 deficiency anaemia,3448
16,Serum metabolite levels (CMS) [S_VLDL_PL],2107
16,Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test),588
16,Metabolite levels,6441
16,Cutaneous squamous cell carcinoma,24598
16,Autism spectrum disorder or schizophrenia,43076
16,Pediatric asthma,6341
16,Electrocardiogram morphology (amplitude at temporal datapoints) [204 ms],19667
16,"None of the above | medication for pain relief, constipation, heartburn",2032
16,High density lipoprotein cholesterol levels [Indian],4299
16,Aspartate transaminase levels in high alcohol intake,1960
16,Serum metabolite levels [glutaroylcarnitine],7010
16,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),1104
16,"Seen doctor (gp) for nerves, anxiety, tension or depression",1143
16,Ischemic stroke (small-vessel),183
16,"Overweight, obesity and other hyperalimentation",149263
16,Sodium levels,2555
16,Arm fat-free mass (left),410267
16,Serum metabolite levels [indoleacetylglutamine],10849
16,Gallstone disease,2875
16,Fasting insulin,2168
16,Feeling hurt,471
16,KELA_REIMBURSEMENT_202,45
16,Calcium levels,126945
16,Fasciitis,8513
16,Right planum temporale grey matter volume,62
16,Migraine and/or pulse pressure,63513
16,Whole body water mass,430788
16,Male puberty timing (early vs. average onset voice breaking),828
16,6mm weak meridian (left),969
16,Electrocardiogram morphology (amplitude at temporal datapoints) [294 ms],384
16,Eubacterium I ramulus A abundance in stool,327
16,Electrocardiogram morphology (amplitude at temporal datapoints) [216 ms],19700
16,Mean corpuscular hemoglobin [conditional on round 7],7186
16,Chlamydia trachomatis momp D antibody levels,2335
16,Mood instability,5480
16,Serum metabolite levels (CMS) [S_HDL_TG],2107
16,Serum metabolite levels (CMS) [L_HDL_L],2107
16,Serum metabolite levels [L_HDL_FC],931
16,Actonel 5mg tablet | treatment/medication code,281
16,Skin pigmentation traits [Fitzpatrick phototype score],24067
16,Refractive error,107082
16,Obesity [Overweight],219675
16,Immature fraction of reticulocytes,241893
16,Serum levels of protein TPPP2,21410
16,Urinary metabolite levels in chronic kidney disease [X - 18889 ],20111
16,Electrocardiogram morphology (amplitude at temporal datapoints) [248 ms],20490
16,Leiomyoma of uterus (controls excluding all cancers),14858
16,Urinary sodium excretion [EA],2105
16,Urinary metabolites [3.594 ppm/1.067 ppm],1573
16,Circulating fibroblast growth factor 23 levels [EA],54
16,Electrocardiogram morphology (amplitude at temporal datapoints) [226 ms],19617
16,Vascular endothelial growth factor levels,1265
16,Persistent mood disorders,153
16,Mental and behavioural disorders due to psychoctive substance use,188
16,Switch to non-stimulant treatment in ADHD,270
16,White matter microstructure (fractional anisotropy) [Superior corona radiata],795
16,Any mental disorder,52
16,Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count) [Infliximab],248
16,Electrocardiogram morphology (amplitude at temporal datapoints) [116 ms],24106
16,"Heel broadband ultrasound attenuation, direct entry",59916
16,White | bread type,1084
16,Lung function (forced vital capacity) [EA],312
16,Cerebrospinal fluid biomarker levels [Haptoglobin],414
16,Facial morphology (segment 19),251
16,White matter microstructure (mode of anisotropy) [Posterior limb of internal capsule],809
16,White matter hyperintensities,35
16,Childhood body mass index,31008
16,Malignant neoplasm of skin,14549
16,Female genital prolapse,104
16,Protein quantitative trait loci (liver) [FAHD1],127
16,Bone mineral density [hip],53
16,Facial ageing,33854
16,Sex hormone-binding globulin levels,844132
16,Cerebrospinal fluid sTREM-2 levels,1152
16,Body mass index [Female],63
16,Allergic conjunctivitis,37
16,General cognitive ability,375535
16,Body mass index (joint analysis main effects and physical activity interaction) [EA],219834
16,Asthma (adult onset),21203
16,Corneal resistance factor,2216
16,Estimated glomerular filtration rate in non-diabetics,3639
16,Electrocardiogram morphology (amplitude at temporal datapoints) [336 ms],578
16,Viral hepatitis,127
16,Total cholesterol levels [BMI unadjusted],2345
16,Heel bone mineral density (bmd) (left),10137
16,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),5680
16,Serum levels of protein SRL,679
16,Allergic asthma (mode),218
16,Aspartate aminotransferase levels,65542
16,Forced expiratory volume in 1-second (fev1),103563
16,QT dynamics during exercise,8857
16,"Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)",1215
16,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),858
16,Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid),5737
16,Glomerular filtration rate (creatinine),12611
16,Sleep apnea syndrome,992
16,Asthma (only as main-diagnosis) (more control exclusions),6828
16,Left–right brain asymmetry,4304
16,Headache | pain type(s) experienced in last month,34390
16,Electrocardiogram morphology (amplitude at temporal datapoints) [316 ms],384
16,Disease progression to choroidal neovascularization form in age-related macular degeneration,1318
16,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Asian],518
16,Serum metabolite levels [XS_VLDL_P],931
16,Eosinophil percentage of white cells,196558
16,Lactose-free | type of special diet followed,6189
16,Radiation-related disorders of the skin and subcutaneous tissue,12299
16,Blood metabolite levels [scyllo-inositol],1573
16,Red blood cell traits (multivariate analysis),3635
16,Major depressive disorder (MTAG),699
16,Gut bacterial pathway abundance (PWY.5088..L.glutamate.degradation.VIII..to.propanoate.),193
16,Digit length ratio (right hand),2
16,Systemic mastocytosis,4788
16,Non-albumin protein levels,182960
16,LDL cholesterol levels [Asian],5480
16,Electrocardiogram morphology (amplitude at temporal datapoints) [82 ms],1991
16,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test),1084
16,Obesity due to excess calories,1093
16,Serum levels of protein AIF1,858
16,"Sphingomyelin (d18:2/16:0, d18:1/16:1) levels",1074
16,Alcohol consumption x experiences in childhood (felt loved by family member) interaction,160
16,"Rectal prolapse | non-cancer illness code, self-reported",266
16,Number of incorrect matches in round,49939
16,Pulse rate,23212
16,"Lipid metabolism phenotypes [HDL.total, whole]",1461
16,Lysophosphatidylcholine_15:0_[M+H]1+/Lysophosphatidylethanolamine_18:0_[M+H]1+ levels,1136
16,Phosphatidylcholine-O_34:1_[M+H]1+/Phosphatidylcholine-P_34:0_[M+H]1+/Phosphatidylethanolamine-O_37:1_[M+H]1+ levels,2224
16,Serum metabolite levels (CMS) [HDL_D],931
16,Fish- and plant-related diet [female],1084
16,Thyroid function,238
16,Brugada syndrome,258
16,Cancer (pleiotropy),20140
16,Blood metabolite levels [indolepropionate],5068
16,Electrocardiogram morphology (amplitude at temporal datapoints) [230 ms],28519
16,Contactin-1 levels,14769
16,"Hematology traits [AA, RBC]",448
16,Serum levels of protein GABARAPL2,13656
16,Respiratory diseases,9295
16,Primary biliary cirrhosis,13592
16,Serum metabolite levels [M_HDL_TG],1525
16,Lipoprotein-associated phospholipase A2 activity and mass [mass],931
16,Theta electroencephalogram power,287
16,Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid),5737
16,Job involves mainly walking or standing,7855
16,6mm strong meridian (right),2019
16,Atrial fibrillation,3353
16,Electrocardiogram morphology (amplitude at temporal datapoints) [104 ms],3918
16,"Blood protein levels [CCL17, 3519_3_2]",271
16,CAG-269 sp001915995 abundance in stool,865
16,"""Benign neoplasm of colon, rectum, anus and anal canal (controls excluding all cancers)""",240
16,Enteroscipio abundance in stool,50
16,Hereditary retinal dystrophy,49
16,Coffee intake,1084
16,Serum metabolite levels [VLDL_C],931
16,HLA DR on HLA DR+ T cell,2399
16,Electrocardiogram morphology (amplitude at temporal datapoints) [78 ms],1991
16,Smoking behaviour (cigarettes smoked per day),31349
16,Medication use (antithrombotic agents),48844
16,Gamma glutamyl transpeptidase,21526
16,Electrocardiogram morphology (amplitude at temporal datapoints) [88 ms],1927
16,Salt added to food,4773
16,FSC-A on plasmacytoid Dendritic Cell,224
16,6mm asymmetry index (left),10
16,Suggestive for eosinophilic asthma,6621
16,Serum metabolite levels (CMS) [M_VLDL_CE],931
16,"""Gonarthrosis, primary, with knee surgery""",1093
16,Black vs. non-black hair color,11
16,Psoriasis,233436
16,Methanobacterium B abundance in stool,114
16,White matter microstructure (axial diusivities) [Average across all tracts],19
16,Leisure sedentary behaviour (television watching),223831
16,Serum metabolite levels (CMS) [TG_PG],16320
16,Barrett's esophagus,457
16,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Asian],714
16,Leg lean mass,1084
16,Multiple myeloma,35610
16,Worry,54976
16,"Body mass index in physically active individuals [EA,women]",1084
16,Pulmonary mycobacterium avium complex disease [East Asian],6776
16,Response to tofacitinib treatment (herpes zoster),958
16,Serum metabolite levels (CMS) [L_HDL_FC],931
16,Glioblastoma,25169
16,Serum 25-Hydroxyvitamin D levels,259321
16,Walking pace,229834
16,CD127 on CD45RA+ CD4+ T cell,13048
16,Body mass index (adult),1084
16,Blood protein levels [Alpha-2 Globulin],1560
16,Serum levels of protein HPSE,614
16,Cataracts (operation),9629
16,"Hayfever/allergic rhinitis | non-cancer illness code, self-reported",6555
16,Full cream | milk type used,1084
16,"Age-related diseases, mortality and associated endophenotypes",2032
16,Glomerular filtration rate (cystatin C),816
16,Response to opioid analgesics in cancer (pain decrease),121
16,Serum metabolite levels (CMS) [IDL_L],931
16,"Blood protein levels [HBZ, 6919_3_3]",1803
16,CAG-177 sp003514385 abundance in stool,528
16,"Intra-ocular pressure, goldmann-correlated (left)",2340
16,Metabolite levels (small molecules and protein measures) [Glycoprotein acetyls],639
16,Help-seeking from a GP,478
16,Sum eosinophil basophil counts,68943
16,Worrier / anxious feelings,36598
16,Hair morphology traits [Hair color (red],24346
16,Leprosy,8741
16,HLA DR on HLA DR+ Natural Killer,1205
16,Obesity [obesity],1084
16,Waist circumference variance,219196
16,Atrial fibrillation and flutter,1898
16,Cannabis use (age at onset),334
16,Sick sinus syndrome,208
16,Penicillin v | treatment/medication code,17
16,Platelet-to-lymphocyte ratio,9317
16,Reticulocyte percentage,19717
16,Skin colour saturation,2498
16,HLA DR+ CD4+ T cell %lymphocyte,1285
16,Serum metabolite levels [L_VLDL_CE],931
16,Serum levels of protein IGFBP6,232
16,Vitiligo (non-segmental),1790
16,None of the above | pain type(s) experienced in last month,11522
16,Blood metabolite levels [succinylcarnitine],5579
16,Serum metabolite levels (CMS) [L_LDL_C],2107
16,Phosphatidylcholine-O(34:3)_[M+H]1+/Phosphatidylethanolamine-P(37:2)_[M+H]1+ levels,1485
16,Total bone mineral density x gut microbiota (﻿genus Dialister) interaction,13
16,Protein quantitative trait loci (liver) [CTSD],15
16,Medication use (salicylic acid and derivatives),90270
16,Serum metabolite levels (CMS) [XL_HDL_L],931
16,Heel bone mineral density (MTAG),741
16,Myocardial infarction,2968
16,"""Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)""",2526
16,Automobile speeding propensity,228
16,Electrocardiogram morphology (amplitude at temporal datapoints) [126 ms],1927
16,"Liver/biliary/pancreas problem | non-cancer illness code, self-reported",8
16,"""Malignant neoplasm of breast, HER2-negative""",76
16,B cell lymphocyte profile difference,9
16,Carotenoid and tocopherol levels [beta-carotene],1405
16,Blood protein levels [SFTPD],258
16,Age at menopause,55799
16,Stem cell factor levels,101857
16,Electrocardiogram morphology (amplitude at temporal datapoints) [228 ms],28519
16,Gut microbiota (beta diversity),5957
16,Modified Stumvoll Insulin Sensitivity Index (BMI interaction),432
16,White matter microstructure (mode of anisotropy) [Retrolenticular part of internal capsule],815
16,Interleukin-10 levels [AA],10
16,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test),35121
16,Cannabis use,196439
16,Glycosuria in pregnancy (maternal genotype effect),6047
16,Comparative height size at age 10,431872
16,Sitting height,214374
16,Body mass index (age>50),1084
16,Interleukin-4 receptor subunit alpha levels,2485
16,Doctor diagnosed hayfever or allergic rhinitis,533
16,Electrocardiogram morphology (amplitude at temporal datapoints) [96 ms],1991
16,Phosphatidylcholine_40:8_[M+OAc]1-/Phosphatidylserine_44:7_[M-H]1- levels,1499
16,Waist-to-hip ratio adjusted for BMI [women],724
16,Calculus of kidney,790
16,Self-reported math ability,293109
16,CD11c on monocyte,1160
16,Facial pigmentation measurement (UV light),126137
16,Leg fat mass (left),329785
16,Glucosamine product | treatment/medication code,13129
16,Vitamin K-dependent protein S measurement,5274
16,"""Asthma, including avohilmo""",6828
16,Serine protease 27 levels,6100
16,Epithelial ovarian cancer,170
16,Spherical equivalent [EA],9
16,Low tan response,4233
16,Caudate nucleus volume,214824
16,Male puberty timing (late vs. average onset voice breaking),828
16,HLA DR+ CD8+ T cell Absolute Count,1285
16,Job involves heavy manual or physical work,1124
16,Electrocardiogram morphology (amplitude at temporal datapoints) [324 ms],384
16,Prostate-specific antigen levels,855
16,Broad depression or schizophrenia,1651
16,Systolic blood pressure [East Asian],931
16,Serum metabolite levels (CMS) [S_VLDL_CE],931
16,Electrocardiogram morphology (amplitude at temporal datapoints) [180 ms],17676
16,Trunk fat mass,316076
16,Serum metabolite levels [carotene diol (1],398
16,Insomnia,95148
16,Cortical thickness,316299
16,Cholesteryl ester(20:3)_[M+NH4]1+ levels,6916
16,Phosphatidylcholine-O_32:1_[M+H]1+/Phosphatidylcholine-P_32:0_[M+H]1+/Phosphatidylethanolamine-O_35:1_[M+H]1+ levels,2107
16,"""Other diabetes, wide definition""",4045
16,Lung function (FEV1/FVC) [adults],532
16,Nonsyndromic cleft palate,1440
16,Mouth ulcers | mouth/teeth dental problems,1614
16,Cardiovascular diseases (excluding rheumatic etc),1084
16,Beef intake,1166
16,"""Artrosis, including avohilmo""",993
16,Serum metabolite levels (CMS) [Gly],109
16,Protein quantitative trait loci (liver) [APRT],18
16,Medication use (HMG CoA reductase inhibitors),60960
16,Medial thalamic nuclei volume,830
16,Body fat percentage,1049500
16,Youthful appearance (self-reported),37065
16,Melanomas of skin,20470
16,Autism spectrum disorder (MTAG),331
16,Restless legs syndrome,865
16,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),1272
16,HLA DR on CD14- CD16+ monocyte,1205
16,Kawasaki disease or immunoglobulin A vasculitis (pleiotropy),185
16,Crohn's disease vs ulcerative colitis (ordinary least squares (OLS)),1104
16,Nasopharyngeal carcinoma,683
16,High light scatter reticulocyte count,613375
16,Number of self-reported cancers,12363
16,Cholesteryl ester transfer protein levels,2483
16,Serum levels of protein NPW,4450
16,Metabolite levels (lipid measures) [ratio of bis-allylic bonds to double bonds in lipids],1499
16,Monocyte count [conditional on round 4],55
16,Eosinophil percentage of granulocytes,55306
16,Smoking behaviour (cigarette pack-years),16455
16,Electrocardiographic traits (multivariate),8437
16,Age at first birth,11007
16,CD11c on CD62L+ myeloid Dendritic Cell,23912
16,Creatinine levels,329380
16,Urinary haptoglobin levels in type 2 diabetes,376
16,Getting up in morning,2378
16,Diastolic blood pressure x smoking status (ever vs never) interaction (2df test) [EA],1032
16,Cortical thickness [Superior parietal],609
16,I needed less sleep than usual | manifestations of mania or irritability,200
16,Electrocardiogram morphology (amplitude at temporal datapoints) [-12 ms],33
16,Lipid traits [HDL],4417
16,QT dynamics during exercise [female],8857
16,Unprescribed medication (more than once) | substances taken for anxiety,13893
16,Glomerular filtration rate in diabetes [EA],715
16,Brown vs. non-brown hair color,23733
16,Waist circumference,1051162
16,Urea levels,74948
16,Phosphatidylcholine_33:2_[M+H]1+/Phosphatidylethanolamine_36:2_[M+H]1+/Phosphatidate_38:3_[M+NH4]1+ levels,5737
16,Plasma homocysteine levels,22778
16,Haptoglobin levels,1314
16,Ebbinghaus illusion (overestimation),226
16,Brain region volumes [right caudate],769
16,Home location - north co-ordinate (rounded),242
16,Limited cutaneous systemic scleroderma [EA],163
16,"For short-sightedness, i.e. only or mainly for distance viewing such as driving, cinema etc (called 'myopia') | reason for glasses/contact lenses",10
16,Headache,34022
16,Femoral neck bone mineral density,14680
16,Bilirubin levels,231130
16,Electrocardiogram morphology (amplitude at temporal datapoints) [138 ms],19520
16,Electrocardiogram morphology (amplitude at temporal datapoints) [246 ms],19584
16,Urinary metabolite levels in chronic kidney disease [picolinate],20987
16,Fresh fruit intake,1554
16,Exudative age-related macular degeneration,767
16,Impedance of whole body,175123
16,In situ neoplasms (controls excluding all cancers),3152
16,Electrocardiogram morphology (amplitude at temporal datapoints) [118 ms],3918
16,Ovarian cancer-related tumor marker CA 125 levels,3277
16,"Atopic dermatitis [EA, fixed effects]",71
16,DHEAS levels,1085
16,"""Mental and behavioural disorders due to alcohol, excluding acute intoxication""",186
16,HDL cholesterol levels in current drinkers [Hispanic],144
16,Vertex-wise cortical thickness,341579
16,Serum levels of protein VOPP1,1525
16,Body mass index [AA and Sub-Saharan],926
16,White matter microstructure (mode of anisotropy) [Posterior corona radiata ],4079
16,"Mitral regurgitation / incompetence | non-cancer illness code, self-reported",455
16,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [women],518
16,White matter microstructure (axial diusivities) [Inferior fronto-occipital fasciculus],776
16,"""Disorders of thyroid, IBD co-morbidities""",238
16,Protein quantitative trait loci (liver) [HNRNPH3],66
16,Leg fat percentage (left),303658
16,Glucosuria,10565
16,"""Asthma, hospital admissions , main diagnosis only""",6828
16,"Pulse pressure x alcohol consumption interaction (2df test) [Asian, EA]",939
16,Dupuytren's disease,33804
16,Electrocardiogram morphology (amplitude at temporal datapoints) [198 ms],19667
16,"Forced expiratory volume in 1-second (fev1), predicted percentage",88600
16,Ease of getting up in the morning,4698
16,Antihypertensive medication - note that there are other indications,5059
16,Extreme obesity with alveolar hypoventilation,1084
16,Monoclonal gammopathy of undetermined significance,36
16,Serum metabolite levels [1-dihomo-linolenylglycerol (20:3],485
16,Obstructive sleep apnea,1093
16,Fat-free mass,76238
16,Serum levels of protein HAVCR2,2099
16,Puberty onset (genital enlargement),828
16,Kidney volume,1508
16,Electrocardiogram morphology (amplitude at temporal datapoints) [298 ms],384
16,Retinal nerve fibre layer (RNFL) thickness,19
16,Thyroid autoantibody positivity (anti-thyroglobulin (TgAb) and/or anti-thyroid peroxidase  (TPOAb) levels),26
16,Relative age voice broke,12285
16,Phosphatidylcholine_32:2_[M+H]1+/Phosphatidylethanolamine_35:2_[M+H]1+/Phosphatidate_37:3_[M+NH4]1+ levels,6668
16,Type 2 diabetes without complications,4045
16,LDL cholesterol levels [BMI unadjusted],2345
16,6mm strong meridian (left),986
16,3mm weak meridian (left),966
16,Colorectal cancer [East Asian],132
16,Protein quantitative trait loci (liver) [ALDH5A1],57
16,"Blood protein levels [EA, Hemoglobin]",6530
16,Coffee consumption,1197
16,Electrocardiogram morphology (amplitude at temporal datapoints) [322 ms],384
16,Serum metabolite levels [12-HETE],634
16,Gut microbiota (bacterial taxa) [Faecalicoccus],17
16,Neurociticism,49043
16,Neutrophil count,194599
16,BMI at 7 years old,1093
16,"None of the above | medication for cholesterol, blood pressure or diabetes",1889
16,Liver volume,1084
16,Protein quantitative trait loci (liver) [LBP],86
16,Breast cancer (early onset),63
16,Substance dependence,28
16,Ease of skin tanning,307298
16,Platelet crit,277712
16,Skin sensitivity to sun,24067
16,Aortic root size,34049
16,Cognitive performance (MTAG) [MTAG],273506
16,Childhood asthma (age<16),3440
16,Diacylglycerol_36:2_[M+NH4]1+ levels,971
16,Serum metabolite levels (CMS) [Tyr],2086
16,Kidney injury molecule 1 levels,232
16,Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid) [Conditioned on rs16966952],7112
16,Blood metabolite levels [lysine],6028
16,Body fat percentage variance,1101
16,Serum metabolite levels [S_VLDL_CE],931
16,High myopia,10
16,"HDL cholesterol levels [Asian initial, BMI unadjusted]",79304
16,Blood metabolite ratios [linoleate (18:2n6)/dihomo-linolenate (20:3n3 or n6],5737
16,Urinary metabolite levels in chronic kidney disease [cysteinylglycine disulfide],20953
16,Prevalent atrial fibrillation,208
16,Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis),46
16,High density lipoprotein cholesterol levels [AA],6697
16,High density lipoprotein cholesterol levels [TransMeta],1477
16,3mm strong meridian (right),2036
16,"Body mass index (joint analysis main effects and physical activity interaction) [EA, men]",1084
16,Serum metabolite levels (CMS) [HDL_TG],931
16,Glomerular filtration rate,557
16,A body shape index,69411
16,"Waist circumference [EA, women]",218144
16,High light scatter reticulocyte percentage of red cells,211452
16,Red cell distribution width,1528403
16,Atrial fibrillation/atrial flutter,253
16,Advanced age-related macular degeneration [EA],1718
16,"Red blood cell traits [MCV, AA]",198
16,Lipid metabolism phenotypes [LA/PUFA],1499
16,LDL cholesterol levels x short total sleep time interaction (2df test),2032
16,White matter hyperintensity volume (adjusted for hypertension),337
16,Verbal-numerical reasoning,220221
16,Pancreas volume,7291
16,Sugar-sweetened beverage consumption,1084
16,Hematological and biochemical traits [HDL],767
16,Serum levels of protein WFDC1,255
16,Primary biliary cholangitis,125102
16,Mean corpuscular volume,3415957
16,FEV1,128804
16,Basophil percentage of white cells,22124
16,Lateral ventricular volume in normal aging,779
16,Electrocardiogram morphology (amplitude at temporal datapoints) [-14 ms],33
16,Liver fibrosis in non-alcoholic fatty liver disease,39882
16,Mean sphered cell volume,1002080
16,Electrocardiogram morphology (amplitude at temporal datapoints) [154 ms],1927
16,Depressive symptoms (MTAG),1963
16,Low high density lipoprotein cholesterol levels,1525
16,"Blood protein levels [SRL, 10940_25_3]",679
16,Thyrotoxicosis with diffuse goitre,238
16,Enduring personality changes,9
16,Cholesteryl ester_18:3_[M+NH4]1+ levels,1499
16,Average weekly spirits intake,1084
16,Type 2 diabetes [obese],1084
16,Phosphatidylcholine_34:1_[M+H]1+/Phosphatidylethanolamine_37:1_[M+H]1+/Phosphatidate_39:2_[M+NH4]1+ levels,773
16,Protein quantitative trait loci (liver) [EIF2B1],260
16,Chronic heart failure,206
16,Atopic dermatitis (moderate to severe) [general],92
16,UBA1206 sp000433115 abundance in stool,2
16,First fracture in long-term childhood cancer survivors (time to event),11253
16,Phosphatidylcholine_36:3_[M+OAc]1-/Phosphatidylserine_40:2_[M-H]1- levels,1499
16,Lysophosphatidylcholine levels [Total_LPC],43
16,Metabolite levels (small molecules and protein measures) [Glycine],118
16,Optic disc area [EA],67
16,Digit length ratio (left hand),2
16,Crohn's disease,451664
16,Basal cell carcinoma,58992
16,Body size at age 10,269132
16,BMI in non-smokers [men],203655
16,Intake of total sugars,993
16,Femur bone mineral density x serum urate levels interaction [male],3842
16,Urinary uromodulin levels,1538
16,"Blood protein levels [WFDC1, 9316_67_3]",255
16,Protein quantitative trait loci (liver) [MAP4],224
16,Esophageal cancer (squamous cell),23042
16,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction),54989
16,Total cholesterol levels,151823
16,CD127 on CD28+ CD4+ T cell,13048
16,Oily fish consumption,3216
16,Electrocardiogram morphology (amplitude at temporal datapoints) [310 ms],384
16,Osteoporosis,6516
16,"Blood protein levels [CTRB1, 5671_1_3]",2185
16,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],1376
16,Arrhythmia,465
16,Low myopia vs hyperopia,145
16,Serum metabolite levels [S_VLDL_FC],931
16,Serum metabolite levels (CMS) [ApoB_ApoA1],931
16,Other demyelinating diseases of the central nervous system,125
16,Granulocyte percentage of myeloid white cells,14603
16,Squamous cell carcinoma [adjusted for rs4268748],12013
16,"Metabolite levels (lipoprotein measures) [Total cholesterol in HDL, conditioned]",1461
16,Body mass index and bone mineral density (pleiotropy),1084
16,Incident atrial fibrillation,208
16,BMI (adjusted for smoking behaviour) [women],203655
16,High density lipoprotein cholesterol levels [EA],77369
16,Serum albumin levels,48095
16,Obese vs. thin,1093
16,Fish- and plant-related diet,1148
16,Phosphatidylcholine_34:4_[M+H]1+/Phosphatidylethanolamine_37:4_[M+H]1+/Phosphatidate_39:5_[M+NH4]1+ levels,971
16,Body fat percentage [men],1075
16,Protein quantitative trait loci (liver) [QPRT],1439
16,Intelligence (MTAG),252726
16,Red blood cell (erythrocyte) count,396599
16,Basophil percentage of granulocytes,6874
16,Serum metabolite levels [L_HDL_CE],1136
16,Subcutaneous adipose tissue,1084
16,Stroke (ischemic) [CS],208
16,CD20 on IgD+ CD38dim B cell,173
16,Chronic obstructive pulmonary disease or resting heart rate (pleiotropy),4
16,CCR7 on naive CD4+ T cell,13048
16,Oxalate (ethanedioate) levels,2104
16,Thyrotoxic periodic paralysis,6
16,Triacylglycerol_56:5_[M+NH4]1+ levels,5700
16,N-acetylhistidine levels,3261
16,Electrocardiogram morphology (amplitude at temporal datapoints) [76 ms],1991
16,Yes | hearing difficulty/problems,1363
16,Cortical surface area [Rostral Middle Frontal],529
16,Mouth ulcers,565
16,Nevus count or cutaneous melanoma,51671
16,Obesity related asthma,1093
16,Diacylglycerol_34:1_[M+NH4]1+ levels,931
16,Serum metabolite levels (CMS) [Gp],479
16,Non-melanoma skin cancer,36487
16,Stable angina pectoris,79769
16,High blood pressure | vascular/heart problems diagnosed by doctor,75526
16,White matter integrity (fractional anisotropy),8910
16,Skimmed | milk type used,1084
16,Postoperative survival time in hepatocellular carcinoma,2776
16,Insomnia symptoms (never/rarely vs. usually),303
16,Cardioembolic stroke (CCSp classification),1038
16,Acceptance of an invitation to participate in a mental health questionnaire,10
16,Electrocardiogram morphology (amplitude at temporal datapoints) [194 ms],53812
16,Family history of malignant neoplasm,13
16,Cardiac arrhytmias,1488
16,Phosphatidylcholine_38:4_[M+OAc]1-/Phosphatidylserine_42:3_[M-H]1- levels,5700
16,Cholelithiasis,2736
16,Body mass index (bmi),654030
16,Hypertensive diseases,2964
16,Black vs. red hair color,9436
16,General factor of neuroticism,3719
16,Serum levels of protein TPSB2,9039
16,"Forced vital capacity (fvc), best measure",53651
16,Serum metabolite levels [Lysine],7223
16,Brain region volumes [right paracentral],776
16,Abdominal subcutaneous adipose tissue volume,1084
16,Monocyte percentage of white cells,341998
16,Monocyte count,592390
16,Smoking initiation (ever regular vs never regular),149150
16,Brain region volumes [right middle temporal],1115
16,Protein quantitative trait loci (liver) [GOT2],24
16,"Blood protein levels [SPARCL1, 4467_49_2]",639
16,Metabolic traits [glutaroyl carnitine/lysine + 3 other traits],7010
16,BRCA1 mutation in breast cancer,63
16,Hand grip strength,636246
16,Platelet count,1426518
16,Response to erlotinib,93313
16,Arm fat mass (right),334050
16,Branched-chain amino acid levels (Isoleucine),1339
16,Cholesterol efflux capacity (cAMP stimulated assay),931
16,CD45 on HLA DR+ CD4+ T cell,1205
16,UBA2922 sp900313925 abundance in stool,387
16,Chronic central serous retinopathy,863
16,Migraine and/or systolic blood pressure,34049
16,Mental health study participation (completed survey),23
16,Spherical equivalent (joint analysis main effects and education interaction) [European ancestry],9
16,Glucosuria (moderate to severe),10565
16,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Asian],77260
16,Systolic blood pressure x alcohol consumption interaction (2df test) [EA],946
16,Photic sneeze reflex,85
16,Early-onset Parkinson's disease,1322
16,Lifetime number of sexual partners,17955
16,Freckling,11768
16,Disorders of the thyroid gland,198
16,"Adenosine 3',5'-cyclic monophosphate (camp) levels",781
16,Adiposity,1079
16,Serum levels of protein MPG,1332
16,Medication use (glucocorticoids),10491
16,Arm predicted mass (left),428368
16,Fatty acid desaturase activity (serum) [D6D],5737
16,Diabetes or endocrine disease,4825
16,Obesity (early onset extreme),2168
16,Lean mass index,1084
16,Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis),234
16,Protein quantitative trait loci (liver) [ACSM5],9192
16,"Blood pressure medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",26167
16,Streptacidiphilus abundance in stool,117
16,Birth weight of first child,33575
16,Asthma [conditional],2740
16,Electrocardiogram morphology (amplitude at temporal datapoints) [212 ms],19617
16,"Serum metabolite levels [N6,N6,N6-trimethyllysine]",11923
16,Rheumatoid arthritis [AA],166
16,Phosphatidylcholine-O_18:0_[M+OAc]1- levels,931
16,Protein quantitative trait loci (liver) [ALDH6A1],14
16,Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer,2416
16,Serum metabolite levels [XXL_VLDL_CE],931
16,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],858
16,Schizophrenia vs bipolar disorder (ordinary least squares (OLS)),119
16,Lactose intolerance,5
16,CD19 on switched memory B cell,197802
16,Other disorders of veins,2463
16,Body mass index in physically inactive individuals [EA],990
16,Body fat percentage [women],1075
16,Nasopharyngeal carcinoma (SNP x SNP interaction),251
16,Body mass index (joint analysis main effects and physical activity interaction) [men],214202
16,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Hispanic],76742
16,Serum levels of protein HP,7437
16,Mean corpuscular haemoglobin concentration,39711
16,Diverticular disease,355
16,interferon-related traits [IFNalpha_ABC_of_monocytes],53
16,Bipolar disorder or body mass index,427213
16,Telomere length [Punjabi Sikhs],5942
16,"""Type 2 diabetes, definitions combined, including avohilmo""",6600
16,Total body bone mineral density,745
16,White matter microstructure (fractional anisotropy) [Body of corpus callosum],1557
16,Type 2 diabetes nephropathy including microalbuminuria,984
16,"Blood protein levels [EA, Ferritin]",215
16,Hyperthyroidism,234
16,"Lipid metabolism phenotypes [APOA1.assay, fasting]",2107
16,Metabolic traits [SM-15 + 12 other traits],5737
16,Urinary metabolite levels in chronic kidney disease [X - 12714],80926
16,Electrocardiogram morphology (amplitude at temporal datapoints) [200 ms],19667
16,Protein quantitative trait loci (liver) [TARS],598
16,Usual walking pace,223760
16,Pubertal anthropometrics [Single Height],39095
16,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],78239
16,Papulosquamous disorders,3839
16,"Red blood cell traits [Hgb, AA]",198
16,Thyroid hormone levels [TSH - Males],238
16,Episodic memory (pairs-matching),19451
16,Serum metabolite levels (CMS) [TotPG],931
16,Protein quantitative trait loci (liver) [UCHL3],31
16,Serum metabolite levels (CMS) [S_VLDL_FC],931
16,Sex hormone-binding globulin levels adjusted for BMI,224728
16,Smoking initiation (ever regular vs never regular) [Conditioned on chr16:75766873],9822
16,"Heel bone mineral density (bmd) t-score, automated (right)",32542
16,Atrial fibrillation and flutter with reimbursement,1488
16,Relative sugar intake,1084
16,Other respiratory diseases principally affecting the interstitium,379
16,Other nutritional deficiencies,1084
16,Protein quantitative trait loci (liver) [SULT1A1],196225
16,White blood cell (leukocyte) count,9703
16,Primary sclerosing cholangitis,6516
16,"Waist-hip ratio [EA, men]",1084
16,Glomerular filtration rate in type 2 diabetes [EA],786
16,Protein quantitative trait loci (liver) [RBMX],149
16,"Body mass index [EA, women]",209945
16,Unspecified haematuria,3385
16,Liver enzyme levels (alkaline phosphatase),73877
16,Externalizing behaviour (multivariate analysis),174197
16,Serum metabolite levels [L_HDL_P],931
16,Corneal hysteresis (right),3042
16,Electrocardiogram morphology (amplitude at temporal datapoints) [290 ms],384
16,White matter microstructure (global fractional anisotropy),140
16,Hard cardiovascular diseases,8
16,Psychosis proneness (hypomanic personality scale),2898
16,Blood metabolite levels [X-11478],30
16,Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes [AA],136
16,Educational attainment (MTAG) [MTAG],461561
16,Body mass in chronic obstructive pulmonary disease [BMI],1084
16,Water intake,56591
16,Family history of Alzheimer's disease,21219
16,Sodium in urine,3687
16,Electrocardiogram morphology (amplitude at temporal datapoints) [278 ms],1948
16,"Mean arterial pressure x alcohol consumption interaction (2df test) [Asian, EA]",927
16,High density lipoprotein cholesterol levels [conditional on round 6],199
16,Smoking behaviour (maximum cigarettes in a 24 hour period),2048
16,Gut microbiota (bacterial taxa) [OTU10032 unclassified Enterobacteriaceae],1550
16,Wholemeal or wholegrain | bread type,1125
16,Cortical thickness [Insula],19
16,Eosinophill percentage,119192
16,Heel bone mineral density T score,226613
16,Gout,3862
16,Alzheimer's disease,1217
16,Serum metabolite levels [XL_HDL_CE],931
16,Systolic blood pressure (baseline),189
16,Idiopathic pulmonary fibrosis,395
16,Trunk predicted mass,440451
16,"Estimated glomerular filtration rate (creatinine, CKDi25)",1597
16,Childhood obesity [EA],3339
16,Adhesive capsulitis of shoulder,265
16,Height,841279
16,Body mass index (joint analysis main effects and physical activity interaction) [women],208959
16,"Asthma | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",10790
16,"""Diabetes, varying definitions""",4674
16,Phosphatidylcholine-O_34:3_[M+H]1+/Phosphatidylcholine-P_34:2_[M+H]1+/Phosphatidylethanolamine-P_37:2_[M+H]1+ levels,931
16,Neuroticism conditioned on self-rated math ability (multi-trait conditioning and joint analysis),46
16,Atrial fibrillation [EA],427
16,"Melanomas of skin, dx or hx",20470
16,Forceval capsule | treatment/medication code,11756
16,Mean corpuscular hemoglobin concentration [AA],448
16,Electrocardiogram morphology (amplitude at temporal datapoints) [120 ms],3918
16,"Malignant melanoma | cancer code, self-reported",22221
16,Glycated hemoglobin levels [conditional],2923
16,Total cholesterol levels [EA],2638
16,Gut microbiota relative abundance (bacterial taxa) [Eubacterium_eligens],1442
16,Vertical cup-disc ratio,211
16,UBA1777 sp900319835 abundance in stool,64
16,Reticulocyte count,476477
16,Serum metabolite levels (CMS) [XS_VLDL_L],931
16,Macular thickness,3640
16,Serum metabolite levels (CMS) [UnSat],2048
16,Malignant neoplasm of breast (controls excluding all cancers),76
16,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) [subset analysis]",282291
16,Mosaic loss of chromosome Y (Y chromosome dosage),102219
16,Neuroblastoma or malignant cutaneous melanoma,25796
16,Systemic lupus erythematosus [Chinese],22343
16,Skin pigmentation traits [Phototype score],24067
16,Thyroid stimulating hormone levels,1892
16,N-acetylglucosamine/n-acetylgalactosamine levels,155
16,Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid),5700
16,HLA DR+ CD8+ T cell %lymphocyte,1285
16,"Red blood cell traits [MCH, AA]",1010
16,Diacylglycerol_36:4_[M+NH4]1+ levels,1763
16,C-reactive protein levels [BMI-adjusted],17
16,Plateletcrit,507542
16,HDL cholesterol levels [Trans-ethnic initial],80848
16,Bipolar disorder [recessive],4301
16,Blood metabolite ratios [hexanoylcarnitine/octanoylcarnitine],5579
16,Serum metabolite levels [kynurenine],1308
16,Serum metabolite levels [Phenylacetate],79
16,Dihydrocodeine | treatment/medication code,25
16,Protein quantitative trait loci (liver) [HMOX1],14
16,Tanning,13782
16,Waist-to-hip ratio adjusted for BMI,510913
16,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),50637
16,Electrocardiogram morphology (amplitude at temporal datapoints) [222 ms],28519
16,Serum levels of protein TPSB2;TPSAB1,14139
16,Cortical thickness [Superior Parietal],795
16,Electrocardiogram morphology (amplitude at temporal datapoints) [312 ms],384
16,Schizophrenia (MTAG),117687
16,Alanine aminotransferase levels,47994
16,Serum levels of protein FTH1;FTL,2347
16,"""Alcohol use disorder, ICD-based""",188
16,Brain region volumes [left lateral ventricle],815
16,Lateral thalamic nuclei volume,78
16,Breast cancer in BRCA2 mutation carriers,63
16,Overall health rating,34408
16,Chronic obstructive pulmonary disease in non-current smokers,34049
16,"Body mass index (joint analysis main effects and physical activity interaction) [EA, women]",1084
16,Gut microbiota (bacterial taxa) [Lactobacillales order],53
16,Triglyceride levels x long total sleep time interaction (2df test),210
16,Systemic lupus erythematosus [anti-dsDNA +],7868
16,Mitochondrial DNA levels,19877
16,"Sphingomyelin (d18:1/22:1, d18:2/22:0, d16:1/24:1) levels",14967
16,Serum metabolite levels (CMS) [IDL_TG],1525
16,Serum metabolite levels (CMS) [XS_VLDL_P],931
16,Dickkopf-related protein 1 levels,1160
16,Uterine prolapse,188
16,Chronic obstructive pulmonary disease,278931
16,"Blonde | hair colour (natural, before greying)",38983
16,Urinary sodium excretion,2512
16,"Rodent ulcer | cancer code, self-reported",392
16,Serum metabolite levels (CMS) [ApoA1],931
16,Nontoxic multinodular goitre,348
16,"Red blood cell traits [RBC, AA]",198
16,Brain morphology (MOSTest),264058
16,Electrocardiogram morphology (amplitude at temporal datapoints) [178 ms],21774
16,Time to complete round,40970
16,Leg fat-free mass (right),376794
16,HDL cholesterol [Hispanic],1799
16,Parkinson's disease,86896
16,Urinary metabolites [1.257 ppm/1.067 ppm],5949
16,Gastric cancer,3867
16,Lateral ventricle temporal horn volume,238
16,"""Crohn disease (strict definition, require KELA)""",50
16,C-reactive protein levels or triglyceride levels (pleiotropy),1639
16,C-C motif chemokine 3 levels,9496
16,Cholesterol,2107
16,Albumin-globulin ratio,740
16,Waist circumference and related phenotypes [HDL cholesterol],733
16,Sex hormone levels [FAI],67
16,Co-codamol | treatment/medication code,87
16,Spherical power (left),42
16,Allergic rhinitis,232446
16,C-reactive protein levels,196051
16,Leiomyoma of uterus,14858
16,Serum levels of protein P4HB,943
16,Number of treatments/medications taken,1084
16,Breast cancer [conditional],22
16,Lung function (FVC),332250
16,Phosphatidylcholine_38:3_[M+H]1+/Phosphatidylethanolamine_41:3_[M+H]1+/Phosphatidate_43:4_[M+NH4]1+ levels,7355
16,White matter microstructure (fractional anisotropy) [Cingulate gyrus],2948
16,Flora pro-active/benecol | spread type,123
16,"""Endocrine, nutritional and metabolic diseases""",1084
16,Protein quantitative trait loci (liver) [HIBADH],97
16,Blood protein levels in cardiovascular risk,1610
16,Intracranial aneurysm,79522
16,Cancer,46432
16,Average weekly beer plus cider intake,1084
16,Place of birth in uk - east co-ordinate,885
16,Hypothyroidism (congenital or acquired),102
16,"Waist circumference [EA, men]",206773
16,"Body mass index [EA, men]",214202
16,Whole body fat mass,315146
16,Vertical cup-disc ratio (multi-trait analysis),1812
16,TPE interval (resting),2897
16,Urinary metabolite levels in chronic kidney disease [myo-inositol],1573
16,Gut microbiota presence (unknown genus id.1000005479),1071
16,"Ecg, heart rate",578
16,Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis),95
16,Alcohol consumption (heavy vs. light/non-drinkers),10
16,Highest math class taken (MTAG) [MTAG],396406
16,Serum metabolite levels [XL_HDL_FC],931
16,Cortical surface area [Entorhinal],1399
16,Thymus and reactivation regulated chemokine levels,900
16,Vitiligo,71350
16,Serum uric acid levels,22213
16,Serum metabolite levels [picolinate],7085
16,Cardiovascular diseases,1093
16,Early age-related macular degeneration,1272
16,Membrane-bound aminopeptidase P levels,246
16,Electrocardiogram morphology (amplitude at temporal datapoints) [348 ms],578
16,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test) [EA],1084
16,Butyrate (4:0) levels,1312
16,Menarche (age at onset),125295
16,Graves' disease,182588
16,Medication use (vasodilators used in cardiac diseases),36809
16,Glycerophospholipid levels [Phosphatidylcholine diacyl C38:3],5737
16,Cortical thickness [Superior temporal],609
16,Age-related hearing impairment (SNP x SNP interaction),106
16,Type 2 diabetes [Obese],1084
16,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) [women],518
16,Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis),46
16,Alcohol intake frequency.,308088
16,Cholesteryl ester_20:3_[M+NH4]1+ levels,7236
16,"""Diabetes, insuline treatment (Kela reimbursement)""",4036
16,HLA DR+ CD4+ T cell %T cell,1261
16,Physical activity,2091
16,6mm weak meridian (right),787
16,In situ neoplasms,3152
16,Blood glucose levels,4712
16,Psoriasis vulgaris,49590
16,Peak expiratory flow,49724
16,Immature reticulocyte fraction,337008
16,Sleep (number of episodes),616
16,"""Sleep apnoea, including avohilmo""",1368
16,Corneal structure,1073
16,Sum basophil neutrophil counts,7580
16,Systemic lupus erythematosus and Systemic sclerosis,8589
16,"Blood pressure medication | medication for cholesterol, blood pressure or diabetes",1836
16,Serum metabolite levels [HDL_TG],931
16,Cholesterol efflux capacity,931
16,Kidney function decline traits [eGFRchange noCKD],816
16,Serum metabolite levels [XL_HDL_PL],931
16,Cardiac dysrhythmias,208
16,Degenerative skin conditions and other dermatoses,12299
16,High density lipoprotein cholesterol levels,362116
16,No | major dietary changes in the last 5 years,45874
16,Response to Dalcetrapib treatment in acute coronary syndrome,632
16,Protein quantitative trait loci (liver) [COL6A3],57
16,Social science traits (pleiotropy) (HIPO component 1),277
16,Chronic obstructive pulmonary disease or high blood pressure (pleiotropy),78130
16,Systemic sclerosis [IcSSc],325
16,Epilepsy,1094
16,"Lipid metabolism phenotypes [HDL.total, fasting]",1461
16,Varicose veins of lower extremity,2843
16,Diseases of the respiratory system,356
16,Senile cataract,528
16,Smoking initiation (ever regular vs never regular) [Conditioned on chr16:49766772],108
16,Neutrophil percentage of white cells,54569
16,Serum metabolite levels [cysteinylglycine],11909
16,Neck circumference,1084
16,Number of sexual partners,5083
16,HDL cholesterol change in response to niacin in statin-treated individuals,931
16,Acisoga levels,2161
16,Educational attainment (college completion),9
16,Electrocardiogram morphology (amplitude at temporal datapoints) [202 ms],19667
16,Protein quantitative trait loci (liver) [HSPA4],598
16,Ischemic stroke,183
16,Mean corpuscular hemoglobin [Conditioned on esv2676630],231
16,Thyroid hormone levels [TSH],238
16,Blood metabolite levels [myo-inositol],1550
16,Cognitive ability (MTAG),214585
16,Cheese intake,206707
16,HDL cholesterol levels in current drinkers [Asian],77260
16,Arm fat percentage (left),332774
16,Serum metabolite levels (CMS) [SFA],1868
16,Serum metabolite levels [Gly],109
16,Hematological disease,28
16,Dementia with Lewy bodies,49692
16,"Icd10: c25.9 pancreas, unspecified | underlying (primary) cause of death",3169
16,Electrocardiogram morphology (amplitude at temporal datapoints) [318 ms],384
16,Protein quantitative trait loci (liver) [CPQ],1
16,Digit length ratio,2
16,Platelet distribution width,146301
16,Walk | types of transport used (excluding work),35313
16,"""Asthma, unspecified (mode)""",5785
16,Diabetes | illnesses of mother,659
16,Basophill percentage,993
16,Blood metabolite levels [phenyllactate (PLA],2352
16,Total bilirubin levels,300097
16,Blood protein levels [Ferritin],707
16,HDL cholesterol levels [Japanese],767
16,"Blood protein levels [GNPTG, 10666_7_3]",9340
16,Serum metabolite levels [L_HDL_C],931
16,Alzheimer disease and age of onset [within families],7
16,Neuroticism,158912
16,HDL cholesterol levels,677690
16,LDL cholesterol levels in current drinkers [EA],5063
16,Basophil count,49631
16,Serum metabolite levels [L_HDL_PL],931
16,"""Alcohol related diseases, tilastokeskus definition""",186
16,Body mass index in physically inactive individuals,990
16,dCTP pyrophosphatase 1 measurement,483
16,Creatinine (enzymatic) in urine,816
16,Protein quantitative trait loci (liver) [PLIN3],89
16,HDL cholesterol levels in current drinkers [AA],76598
16,Leg fat mass (right),321507
16,Gastroesophageal reflux disease,1322
16,Serum levels of protein APOA1,2242
16,Obesity-related traits [hip],955
16,"Carbonic anhydrase 5A,mitochondrial levels",3538
16,"Blood protein levels [CRISPLD2, 5691_2_3]",339
16,"""Malignant neoplasm of breast, HER2-negative (controls excluding all cancers)""",76
16,Protein quantitative trait loci (liver) [PEPD],3
16,Medication use (calcium channel blockers),78966
16,Serum metabolite levels [propyl 4-hydroxybenzoate sulfate],162036
16,"Ground coffee (include espresso, filter etc) | coffee type",92333
16,Heel bone mineral density (bmd) (right),32540
16,Abdominal aortic aneurysm,701
16,Venous thromboembolism,1307
16,"Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA, women]",518
16,Frequency of drinking alcohol,644
16,Optic cup area,1301
16,Borreliaceae abundance in stool,158
16,Normal facial asymmetry (angle of surface orientation score) [≥14 yr],36
16,Serum metabolite levels [dihomo-linolenate (20:3n3 or n6],6851
16,Hair color [red hair],11768
16,Free thyroxine concentration,1953
16,Haemorrhoidal disease,959
16,Malate levels,71
16,"Blood protein levels [APOL1, 11510_51_3]",639
16,Other Chron's disease,50
16,Warfarin | treatment/medication code,205
16,Early onset atrial fibrillation,47
16,Weight,1476992
16,Body mass index (joint analysis main effects and physical activity interaction),227656
16,Reported occurrences of cancer,11937
16,Serum metabolite levels [glutarylcarnitine (C5-DC],6739
16,Type 2 diabetes nephropathy,984
16,Anxiety,888
16,Body mass index and fasting glucose (pairwise),268
16,Smoking status,64617
16,Body mass index variance,170927
16,Electrocardiogram morphology (amplitude at temporal datapoints) [112 ms],3918
16,"Intra-ocular pressure, goldmann-correlated (right)",21610
16,Age-related disease endophenotypes,2015
16,Hypertensive diseases (excluding secondary),4031
16,Serum levels of protein PRSS2,2952
16,Mitochondrial DNA copy number,824
16,Electrocardiogram morphology (amplitude at temporal datapoints) [328 ms],962
16,Body mass index in physically active individuals [women],208959
16,Blood metabolite levels [glutaroyl carnitine],9245
16,Corneal resistance factor (right),19674
16,Asthma onset (childhood vs adult),2740
16,"Body mass index in physically inactive individuals [EA, men]",990
16,Hematocrit,674765
16,"Systolic blood pressure, automated reading",56087
16,Optic disc area,207
16,"Blood protein levels [CBLN1, 9313_27_3]",92
16,Crohn's disease [EA],93697
16,Extremely high intelligence,211280
16,Mean corpuscular volume [AA],448
16,Parkinson's disease progression (cognitive),58
16,Systolic blood pressure x smoking status (ever vs never) interaction (2df test),34739
16,Lamb consumption,214301
16,"Diabetes | non-cancer illness code, self-reported",16490
16,Carcinoma in situ of skin of other and unspecified parts of face (controls excluding all cancers),3152
16,Body fat mass,2048
16,CAG-177 sp002451755 abundance in stool,528
16,LDL cholesterol,23416
16,Urinary calculus,483
16,IgA nephropathy [EA],15456
16,College or university degree | qualifications,200897
16,Electrocardiogram morphology (amplitude at temporal datapoints) [210 ms],19700
16,Myo-inositol levels,1382
16,Pure non-grapefruit juice consumption,1084
16,Serum metabolite levels (CMS) [HDL2_C],931
16,Serum metabolite levels (CMS) [M_HDL_C],931
16,Ulcerative colitis [EA],26913
16,Cardiovascular disease,139683
16,CD11c on myeloid Dendritic Cell,24112
16,Metabolite levels (small molecules and protein measures) [Pyruvate],1219
16,White matter microstructure (fractional anisotropy) [Anterior corona radiata],24386
16,Chronic obstructive pulmonary disease x current smoker interaction (main effect),34049
16,Leg fat percentage (right),289160
16,Mean corpuscular hemoglobin concentration [Asian],1333
16,"Lipid metabolism phenotypes [HDL.large, whole]",1525
16,"Blepharitis / eyelid infection | non-cancer illness code, self-reported",59
16,White matter microstructure (radial diusivities) [Body of corpus callosum],1296
16,Phosphatidylcholine_34:0_[M+H]1+/Phosphatidylethanolamine_37:0_[M+H]1+/Phosphatidate_39:1_[M+NH4]1+ levels,1716
16,CAG-177 abundance in stool,528
16,Crohn's disease [Children],162
16,Testicular germ cell tumor,73631
16,Direct low density lipoprotein cholesterol levels,8176
16,Asthma (moderate or severe),6527
16,Serum levels of protein SERPIND1,1793
16,Electrocardiogram morphology (amplitude at temporal datapoints) [72 ms],1991
16,Serum metabolite levels (CMS) [L_HDL_C],931
16,Barrett's esophagus  or Esophageal adenocarcinoma,125
16,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [AA],76598
16,Type 2 diabetes (adjusted for BMI),4264
16,Asthma or allergic disease (pleiotropy),6555
16,Asthma (mode),6828
16,Serum metabolite levels [ApoA1],931
16,Protein quantitative trait loci (liver) [ACSS3],57
16,Captopril | treatment/medication code,535
16,Mean corpuscular volume [Conditioned on esv2676630],231
16,Nervous feelings,49905
16,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [AA],71570
16,Thyroid problem (not cancer),74646
16,"Hayfever, allergic rhinitis or eczema | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",7165
16,3mm strong meridian (left),2386
16,"Lipid metabolism phenotypes [HDL.mean.size, fasting]",1525
16,Colorectal cancer,11070
16,Inflammatory bowel disease [EA],168818
16,Pediatric autoimmune diseases,148440
16,Smoking status (ever vs never smokers),73011
16,"Sphingomyelin (d18:2/24:1, d18:1/24:2) levels",23899
16,Age first had sexual intercourse,43541
16,Urinary metabolite levels in chronic kidney disease [imidazole lactate],1960
16,Electrocardiogram morphology (amplitude at temporal datapoints) [110 ms],3918
16,Estimated glomerular filtration rate in diabetes,744
16,Childhood body fatness,1084
16,Serum metabolite levels [S_HDL_TG],2107
16,Heel bone mineral density x serum urate levels interaction [female],54
16,Protein quantitative trait loci (liver) [OTC],57
16,Nodular sclerosis Hodgkin lymphoma,7328
16,Preeclampsia (maternal genotype effect),1084
16,Serum levels of protein PRSS22,638
16,Body mass index (SNP x SNP interaction),976
16,Borreliales abundance in stool,158
16,Anatomical abnormatilies of kidney and ureters,495
16,Triglycerides,161859
16,Blood metabolite ratios [phenyllactate (PLA)/phenylalanine],14938
16,Electrocardiogram morphology (amplitude at temporal datapoints) [134 ms],1927
16,"""Diabetes, insuline treatment (Kela reimbursement) (more control exclusions)""",4036
16,Hypercholesterolemia,714
16,Crohn disease,348
16,Intelligence,537888
16,Carotid intima media thickness,4153
16,Major depressive disorder,1340
16,Bipolar disorder lithium response (categorical) or schizophrenia,289
16,HLA DR on myeloid Dendritic Cell,42
16,Diverticulosis,1207
16,Gastric cancer [East Asian],3867
16,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],5480
16,Serum levels of protein HBZ,1803
16,White matter hyperintensity volume,1576
16,Phosphatidylcholine(36:3)_[M+H]1+/Phosphatidylethanolamine(39:3)_[M+H]1+/Phosphatidate(41:4)_[M+NH4]1+ levels,6916
16,Hematology traits [RBC],173
16,Rheumatoid arthritis [EA],4738
16,Pork consumption,3216
16,Resting-state electroencephalogram vigilance [Slope index],3898
16,Serum levels of protein POMC,1057
16,Pelvic organ prolapse,104
16,Excessive sweating,427
16,Sleep duration (short sleep),5053
16,Systemic lupus erythematosus [Hispanic],9358
16,Other disorders of thyroid,1574
16,White matter microstructure (fractional anisotropy) [Posterior corona radiata ],795
16,Substance abuse (more control exclusions),188
16,Scalp hair shape,125
16,Hip circumference,543522
16,Hip circumference adjusted for BMI,463405
16,Angina pectoris,46207
16,Electrocardiogram morphology (amplitude at temporal datapoints) [176 ms],55919
16,Electrocardiogram morphology (amplitude at temporal datapoints) [172 ms],19603
16,Alcohol use disorder [EA],981
16,Blood metabolite levels [dihomo-linolenate (20:3n3 or n6],5737
16,Serum metabolite levels [phenyllactate (PLA],1027
16,Chronic obstructive pulmonary disease in ever smokers,34049
16,Electrocardiogram morphology (amplitude at temporal datapoints) [26 ms],416
16,Intrinsic epigenetic age acceleration,22
16,Schizophrenia,595276
16,Irritability,45003
16,White matter microstructure (fractional anisotropy) [Posterior limb of internal capsule],795
16,Zinc product | treatment/medication code,3961
16,Lysophosphatidylethanolamine-P_19:1_[M+H]1+ levels,1136
16,"Blood protein levels [NAGPA, 11208_15_3]",581
16,Response to antipsychotic treatment [Effect of Risperidone on CGI-S],533
16,Serum immune biomarker levels [YKL-40],372
16,"""Malignant neoplasm of breast, HER-negative""",76
16,Prostate cancer,29723
16,Leukocyte telomere length,42902
16,Triglyceride levels [Trans-ethnic initial],24586
16,Electrocardiogram morphology (amplitude at temporal datapoints) [184 ms],21594
16,A levels/as levels or equivalent | qualifications,1138
16,Bipolar disorder,2592
16,Blood metabolite levels [kynurenine],1319
16,"Blood protein levels [MPG, 12438_127_3]",1332
16,"Estimated glomerular filtration rate (creatinine, Rapid3)",995
16,Hypopituitarism,484
16,Metabolite levels (lipoprotein measures) [Total cholesterol in HDL],931
16,Stroke,183
16,DNA methylation Hannum age acceleration,38
16,Metformin | treatment/medication code,4674
16,Total PHF-tau (SNP x SNP interaction),34760
16,Haptoglobin measurement,109590
16,Body mass index in physically inactive individuals [men],990
16,Cataracts [male],12
16,Highest math class taken,268891
16,Juvenile arthritis (FINNGEN),31371
16,"""Diabetes, several complications""",34164
16,Renal function and chronic kidney disease [CKD],816
16,Crohn's disease [Adults],162
16,Able to confide,10111
16,Insulin-like growth factors [IGFBP-3],43211
16,Spherical power (right),44381
16,"Non-melanoma skin cancer | cancer code, self-reported",10684
16,Chronic lower respiratory diseases,52268
16,Diverticular disease of intestine,10380
16,"""Hypertension, essential""",2753
16,Fibrosis-4 index in high alcohol intake,2340
16,High-density lipoprotein 3 cholesterol levels,354
16,Cerebrospinal fluid α-synuclein levels,61
16,Psoriasis or type 2 diabetes (trans-disease meta-analysis),46231
16,Gamma glutamyl transferase levels,69590
16,Electrocardiogram morphology (amplitude at temporal datapoints) [100 ms],1991
16,Serum metabolite levels [S_VLDL_PL],2107
16,Cancer diagnosed by doctor,3256
16,Phosphatidylcholine_36:2_[M+H]1+/Phosphatidylethanolamine_39:2_[M+H]1+/Phosphatidate_41:3_[M+NH4]1+ levels,2229
16,Pattern 1 | hair/balding pattern,34577
16,Electrocardiogram morphology (amplitude at temporal datapoints) [166 ms],22417
16,Lumbar spine bone mineral density,13583
16,Periventricular white matter hyperintensities,16
16,None of the above | vascular/heart problems diagnosed by doctor,58621
16,Carotid intima media thickness (mean),4454
16,Electrocardiogram morphology (amplitude at temporal datapoints) [106 ms],1927
16,Cystic kidney disease,47
16,Procreative management,13
16,Contracture of palmar fascia [dupuytren's disease],8513
16,Nasal polyp,6683
16,Femur bone mineral density x serum urate levels interaction [female],58
16,Autoimmune traits,9345
16,Electrocardiogram morphology (amplitude at temporal datapoints) [242 ms],28486
16,Carcinoma in situ of skin (controls excluding all cancers),3152
16,"Blood protein levels [NQO1, 9837_60_3]",10445
16,Lean body mass,2096
16,"Hematology traits [AA, HGB]",448
16,Phosphatidylethanolamine_38:3_[M-H]1- levels,1499
16,Serum metabolite levels [phenylacetate],317
16,Protein quantitative trait loci (liver) [DHTKD1],57
16,HDL cholesterol,860021
16,Leg predicted mass (right),389658
16,Nap during day,11599
16,Serum metabolite levels [L_HDL_L],2107
16,Serum metabolite levels (CMS) [S_VLDL_L],931
16,Alcoholic chronic pancreatitis,1147
16,Obesity [Obesity class II],193595
16,Osteoarthritis,1702
16,Serum metabolite levels (CMS) [L_VLDL_CE],931
16,Non-glioblastoma glioma,535
16,Urate levels,322180
16,Smoking initiation,70578
16,Hand grip strength (right),301880
16,Type 2 diabetes with other specified/multiple/unspecified complications,4036
16,White matter microstructure (mode of anisotropy) [Fornix (column and body],795
16,"Lipid metabolism phenotypes [LDL.large, fasting]",1039
16,Levothyroxine sodium | treatment/medication code,103
16,Direct bilirubin levels,21675
16,Keratinocyte cancer (MTAG),21595
16,Serum phosphate levels,4865
16,HDL cholesterol [AA],789
16,BMI in smokers [women],1084
16,Electrocardiogram morphology (amplitude at temporal datapoints) [300 ms],384
16,Gonarthrosis [arthrosis of knee](FG),1093
16,Diffuse diseases of connective tissue,215
16,Choline phosphate levels,312
16,HDL cholesterol levels in current drinkers,77260
16,Body mass index [EA],228642
16,Facial morphology (segment 9),8302
16,"Blood protein levels [DPEP1, 8794_13_3]",15512
16,Length of time at current address,3906
16,Type 2 diabetes [additive model],1084
16,Crohn's disease and psoriasis [same-effect analysis],3428
16,Allergic asthma (mode) (more control exclusions),218
16,Other non-epithelial cancer of skin,19179
16,Interstitial lung disease endpoints,3666
16,hemolysis of donated blood (osmotic),2858
16,Low density lipoprotein cholesterol levels [EA],4874
16,Kidney stones,853
16,"Heel quantitative ultrasound index (qui), direct entry (right)",32542
16,Chronic kidney disease and serum creatinine levels [CKD],816
16,Cortical volume [Superior parietal],269
16,Protein quantitative trait loci (liver) [COL18A1],36
16,Reticulocyte fraction of red cells,242067
16,ADHD vs anorexia nervosa (ordinary least squares (OLS)),1057
16,Protein quantitative trait loci (liver) [RAB14],150
16,Serum levels of protein CDH11,188
16,Uterine fibroids,35076
16,HDL cholesterol levels x short total sleep time interaction (2df test),69149
16,Age completed full time education,8618
16,Diacylglycerol_34:3_[M+NH4]1+ levels,971
16,"Shingles | non-cancer illness code, self-reported",1016
16,"Asthma | non-cancer illness code, self-reported",12621
16,Electrocardiogram morphology (amplitude at temporal datapoints) [302 ms],384
16,Problematic alcohol use,1202
16,White matter microstructure (radial diusivities) [Posterior limb of internal capsule],795
16,Body fat distribution (trunk fat ratio),1084
16,Bipolar i disorder | bipolar and major depression status,405
16,"Total cholesterol levels [Asian initial, BMI unadjusted]",3297
16,Carcinoma in situ of skin of other and unspecified parts of face,3152
16,Hyperlipidemia,714
16,Cardioembolic stroke (CCSc classification),193
16,Impedance of arm (left),129093
16,Body fat percentage [female],1084
16,"Aging traits (healthspan, parental lifespan or longevity) (multivariate analysis)",2761
16,Diacylglycerol_34:2_[M+NH4]1+ levels,931
16,Major depressive disorder vs ADHD (ordinary least squares (OLS)),1005
16,Celiac disease,624
16,Hemoglobin levels,284919
16,Corneal resistance factor (left),3106
16,Heart failure and antihypertensive medication,1084
16,"Blood protein levels [TPSB2, 3403_1_2]",712
16,Urinary metabolite levels in chronic kidney disease [indoleacetylglutamine],30
16,Serum metabolite levels (CMS) [L_LDL_L],2107
16,Serum metabolite levels [XL_HDL_L],931
16,HLA DR+ T cell Absolute Count,1285
16,Allergy,533
16,Body mass index (joint analysis main effects and smoking interaction),253027
16,Lymphocyte percentage of white cells,68201
16,Subcortical volume (MOSTest),261973
16,Breast cancer | illnesses of siblings,63
16,Serum levels of protein ZG16B,2739
16,Body mass index [Male],15
16,Morning vs. evening chronotype,6
16,Glomerular filtration rate in non diabetics (creatinine),23561
16,Systemic lupus erythematosus [AA],6455
16,Basophill count,1911
16,Femur bone mineral density x serum urate levels interaction,1313
16,Male puberty timing (late vs. average onset facial hair),828
16,Blood protein levels [Tryptase beta-2],4661
16,Insomnia [Male],688
16,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction) [women],45570
16,"Allergy, hypersensitivity or anaphylaxis",23962
16,"""Asthma, unspecified (mode) (more control exclusions)""",5615
16,Male puberty timing (age at voice breaking MTAG),15852
16,White matter microstructure (mode of anisotropy) [Inferior fronto-occipital fasciculus],776
16,Sleep disorders,1634
16,HDL cholesterol levels [HIspanic],144
16,Ischemic stroke (cardioembolic),904
16,Phosphatidylcholine-O_18:0_[M+H]1+/Lysophosphatidylethanolamine_21:0_[M+H]1+ levels,1136
16,Lysophosphatidylcholine_20:3_[M+OAc]1- levels,1499
16,Chronic kidney disease [eGFRcrea],816
16,Optic disc size,586
16,HDL cholesterol levels [Asian],72059
16,Erythritol levels,4158
16,"Lipid metabolism phenotypes [HDL-C.by.NMR, fasting]",2107
16,Glycine levels [conditional],715
16,Ischemic heart disease,242
16,Protein quantitative trait loci (liver) [SPRYD4],14
16,Alzheimer's disease or family history of Alzheimer's disease,102792
16,Eczema,227004
16,Relative age of first facial hair,13801
16,Body mass index [Japanese],192353
16,"Diastolic blood pressure, automated reading",76033
16,Neutrophill count,25583
16,Electrocardiogram morphology (amplitude at temporal datapoints) [196 ms],19667
16,Phosphatidylcholine-O_32:0_[M+H]1+/Phosphatidylethanolamine-O_35:0_[M+H]1+ levels,1586
16,"Blood protein levels [ZG16B, 8310_6_3]",2739
16,Gut microbiota presence (family Bacteroidales S24 7group id.11173),1071
16,Menopause (age at onset),36229
16,Hodgkin's lymphoma,25156
16,6mm asymmetry angle (right),26301
16,Serum metabolite levels [HDL2_C],931
16,Arthrosis,1084
16,Bipolar disorder (MTAG),115985
16,Skin colour,212337
16,Lymphocyte percentage,13218
16,Medication use (diuretics),135824
16,Phosphatidylcholine(38:3)_[M+OAc]1-/Phosphatidylserine(42:2)_[M-H]1- levels,6916
16,Protein quantitative trait loci (liver) [PSMB5],14198
16,Sensitivity to environmental stress and adversity,883
16,Bumetanide | treatment/medication code,2261
16,Age-related diseases and mortality,17
16,Brain amyloid deposition (PET imaging),25
16,Facial pigmentation,12013
16,Electrocardiogram morphology (amplitude at temporal datapoints) [142 ms],21511
16,"Forced expiratory volume in 1-second (fev1), predicted",102657
16,Eosinophilic esophagitis,14884
16,"Lipid metabolism phenotypes [HDL-C.assay, fasting]",2107
16,Total body bone mineral density [European],745
16,Hepatitis,190
16,Feeling nervous,48021
16,Alcohol consumption (drinks per week) (MTAG),261976
16,Suffer from 'nerves',208280
16,Mean corpuscular hemoglobin [conditional on round 8],43299
16,Migraine and/or diastolic blood pressure,34049
16,"""Type 2 diabetes, wide definition""",4036
16,"Blood protein levels [PRSS22, 4534_10_2]",638
16,"""Thyrotoxicosis, other and/or unspecified""",238
16,Venous thromboembolism (SNP x SNP interaction),19086
16,Lipoprotein (a) levels,80295
16,Cognitive traits (MTAG),1062
16,Serum metabolite levels [1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0)*],3198
16,"Other (e.g. cornflakes, frosties) | cereal type",1084
16,Body mass index [discovery + validation],1084
16,Other and/or unspecified nontoxic goitre,245
16,Non-oily fish consumption,1084
16,Other disorders of optic [2nd] nerve and visual pathways,21
16,Respiratory or ear-nose-throat disease,14962
16,Diabetes | illnesses of father,1084
16,"""Malignant neoplasm of breast, HER-positive (controls excluding all cancers)""",76
16,Urinary metabolite levels in chronic kidney disease [furaneol sulfate],99883
16,Diastolic blood pressure [EA],14466
16,Serum metabolite levels [Gp],479
16,Serum metabolite levels [XS_VLDL_CE],931
16,Metabolite levels [Glycine],19351
16,Blood metabolite levels [X-13435],5579
16,Lysophosphatidylcholine_17:0_[M+H]1+/Lysophosphatidylethanolamine_20:0_[M+H]1+ levels,1209
16,Serum metabolite levels (CMS) [XL_HDL_CE],931
16,Vitamin C levels,239
16,Chronic renal failure,232
16,Neuronal pentraxin receptor levels,174
16,Brain volume in infants (white matter),3
16,Bioavailable testosterone levels,240506
16,Cortical thickness (MOSTest),814
16,Body mass index (age interaction),1084
16,Cognitive performance,241992
16,Lysophosphatidylcholine levels [LPC(16:0;0],43
16,"Fracture nose | non-cancer illness code, self-reported",9
16,Snoring,211061
16,4-chlorobenzoic acid levels,1512
16,Heart disease | illnesses of father,284
16,Hair color,89865
16,Feeling tense,48709
16,Other malignant neoplasms of skin (=non-melanoma skin cancer),14549
16,Electrocardiogram morphology (amplitude at temporal datapoints) [186 ms],19667
16,Response to statins (HDL cholesterol change),931
16,Body fat percentage [European men],1075
16,Type 2 diabetes [DGI+FUSION+WTCCC],1084
16,Serum levels of protein ANTXR1,931
16,Neuroblastoma (1p deletion),406
16,Brain morphology (min-P),73544
16,Insulin-like growth factor 1 levels,748526
16,"Pulmonary function (smoking interaction) [FEV1/FVC, Ever-smoking]",2024
16,Insomnia [Female],16065
16,Ear-nose-throat disorder,3265
16,Urolithiasis,1777
16,Benign neoplasm of skin,12417
16,"Hypertension | non-cancer illness code, self-reported",75498
16,Asthma (only as main-diagnosis),6828
16,Spironolactone | treatment/medication code,2023
16,Electrocardiogram morphology (amplitude at temporal datapoints) [292 ms],384
16,Inflammatory bowel disease [Adult],103
16,Renal function-related traits (eGRFcrea),232
16,Homocysteine levels,33228
16,Mean reticulocyte volume,1045717
16,"Light diy (eg: pruning, watering the lawn) | types of physical activity in last 4 weeks",221024
16,Ankle spacing width (right),255241
16,HDL Cholesterol - Triglycerides (HDLC-TG),733
16,CD127 on CD28+ CD45RA+ CD8+ T cell,13048
16,Sphingolipid levels [proportions],107
16,Nonatopic asthma,7990
16,Peritoneal adhesions (postoperative) (postinfection),1166
16,Qvar 50 inhaler | treatment/medication code,2596
16,Systemic lupus erythematosus [EA],7672
16,Electrocardiogram morphology (amplitude at temporal datapoints) [58 ms],2595
16,Glyceryl trinitrate product | treatment/medication code,76
16,Iron deficiency anemia,43
16,Knee osteoarthritis,26498
16,Daytime nap,244466
16,Neutrophil-to-lymphocyte ratio,2834
16,HDL cholesterol levels x long total sleep time interaction (2df test),37601
16,Tense / 'highly strung',48538
16,Joint mobility (Beighton score),3514
16,Body mass index (adult) [AA],1084
16,Gained weight | weight change during worst episode of depression,1084
16,White blood cell count (basophil),11627
16,White matter microstructure (fractional anisotropy) [Retrolenticular part of internal capsule],815
16,White matter microstructure (mode of anisotropy) [Body of corpus callosum],815
16,SSC-A on HLA DR+ T cell,1285
16,Asthma,121292
16,Cognitive ability,422066
16,Pulse pressure,302537
16,General risk tolerance (MTAG),24776
16,Electrocardiogram morphology (amplitude at temporal datapoints) [128 ms],1927
16,Electrocardiogram morphology (amplitude at temporal datapoints) [326 ms],384
16,"None of the above | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",835
16,"""Malignant neoplasm of breast, HER-negative (controls excluding all cancers)""",76
16,Meat-related diet,172
16,Myopia (pathological),89
16,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),78239
16,Neutrophill percentage,25095
16,Red blood cell traits [MCHC],2812
16,Serum levels of protein APOA5,931
16,Protein levels in obesity [Haptoglobin mixed],1314
16,Electrocardiogram morphology (amplitude at temporal datapoints) [276 ms],1948
16,"Blood pressure (smoking interaction) [SBP,Pack-years]",1926
16,Blood metabolite ratios [lysine/glutaroyl carnitine],7223
16,White matter microstructure (axial diusivities) [Fornix (column and body],809
16,Educational attainment (years of education),875749
16,Glycated hemoglobin levels,450063
16,Trunk fat percentage,313912
16,"""Type 2 diabetes, strict (exclude DM1)""",4045
16,"Lipid metabolism phenotypes [HDL-C.by.NMR, whole]",1525
16,Diastolic blood pressure x smoking status (ever vs never) interaction (2df test),1032
16,Liver enzyme levels (gamma-glutamyl transferase),7705
16,Beef consumption,1084
16,White matter microstructure (radial diusivities) [Fornix (column and body],809
16,Smoking initiation (ever regular vs never regular) [Conditioned on chr16:72574550],219
16,Thyrotoxicosis,238
16,Lung function (FEV1/FVC),233013
16,Serum metabolite levels (CMS) [Remnant_C],2107
16,Electrocardiogram morphology (amplitude at temporal datapoints) [-34 ms],302
16,Pattern 2 | hair/balding pattern,304
16,Pulse pressure [East Asian],1862
16,Electrocardiogram morphology (amplitude at temporal datapoints) [22 ms],416
16,Optic cup area [EA],103
16,Body mass index in physically active individuals,219301
16,Coronary artery disease,311729
16,Adult body size,313828
16,"Skin cancer | cancer code, self-reported",9672
16,"Basal cell carcinoma | cancer code, self-reported",19103
16,"Blood protein levels [WFIKKN1, 3191_50_2]",7711
16,3mm weak meridian (right),683
16,Obesity (extreme),4529
16,Serum metabolite levels [carotene diol (2],398
16,HDL cholesterol levels [BMI unadjusted],62888
16,Neuritic plaques (SNP x SNP interaction),3242
16,Cardioembolic stroke (CCS or TOAST classification),172
16,Electrocardiogram morphology (amplitude at temporal datapoints) [122 ms],3918
16,Hypothyroidism and >3 levothyroxin purchases,102
16,Spherical equivalent or myopia (age of diagnosis),536
16,Age-related hearing impairment (high frequency),23968
16,Glomerular filtration rate in type 2 diabetes,232
16,HLA DR+ T cell%T cell,1285
16,Energy expenditure [Women],1721
16,3mm cylindrical power (right),2263
16,Mean corpuscular hemoglobin concentration,1318727
16,Use of sun/uv protection,48376
16,Hair morphology traits [Hair color phototype score],24067
16,"Red blood cell traits [EA, MCHC]",1444
16,Attention deficit hyperactivity disorder (MTAG),576
16,Age-related macular degeneration,1970
16,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),19
16,Cognitive aspects of educational attainment,434470
16,Serum alkaline phosphatase levels,445457
16,Alzheimer's disease or LDL levels (pleiotropy),56462
16,LDL cholesterol levels in current drinkers [Asian],5063
16,Body mass index x sex x age interaction (4df test),1084
16,Phosphatidylcholine-O_34:3_[M+OAc]1-/Phosphatidylcholine-P_34:2_[M+OAc]1-/Phosphatidylserine-O_38:2_[M-H]1- levels,2224
16,Low testosterone levels,84
16,Serum metabolite levels (CMS) [S_VLDL_C],931
16,Triglyceride levels in current drinkers,518
16,Polycystic ovary syndrome,59
16,Protein quantitative trait loci (liver) [NPC2],2
16,Protein quantitative trait loci (liver) [DECR2],43544
16,Peak expiratory flow (pef),51332
16,Neuroticism (MTAG),298
16,Serum metabolite levels [XS_VLDL_L],931
16,Dentures,40728
16,Offspring birth weight,256025
16,PR interval,22818
16,Diabetes diagnosed by doctor,17096
16,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],73014
16,Triglyceride levels x short total sleep time interaction (2df test),1506
16,Vertical cup-disc ratio (adjusted for vertical disc diameter),150
16,Electrocardiogram morphology (amplitude at temporal datapoints) [124 ms],1927
16,"Red blood cell traits [MCHC, AA]",198
16,Interstitial lung disease,379
16,"""Gonarthrosis,primary""",1093
16,Serum metabolite levels (CMS) [XL_HDL_FC],931
16,Global electrical heterogeneity phenotypes [SAI QRST],769
16,Medication use (agents acting on the renin-angiotensin system),182647
16,CCR7 on naive CD8+ T cell,13048
16,Glycerophospholipid levels [lysoPhosphatidylcholine acyl C20:3],6894
16,Serum metabolite levels [lysine],6739
16,Noncognitive aspects of educational attainment,11440
16,N-acetyltaurine levels,329
16,Injury of nerves at forearm level,26
16,Metabolic syndrome [HDL],80678
16,"Other | hair colour (natural, before greying)",18684
16,Electrocardiogram morphology (amplitude at temporal datapoints) [240 ms],28519
16,Height adjusted BMI,1084
16,High density lipoprotein cholesterol levels [additive model],1039
16,Moxonidine | treatment/medication code,68
16,Squamous cell carcinoma,16782
16,Spherical equivalent,78020
16,Body fat percentage [male],220713
16,Alcohol usually taken with meals,357
16,High-sensitivity cardiac troponin I concentration,2066
16,Relative fat intake,1084
16,"Body mass index in physically inactive individuals [EA, women]",990
16,Systemic sclerosis,721
16,Malignant neoplasm of breast,76
16,White matter microstructure (mean diusivities) [Superior longitudinal fasciculus],2948
16,Lymphocyte count,4264
16,Electrocardiogram morphology (amplitude at temporal datapoints) [70 ms],1991
16,3-hydroxy-1-methylpropylmercapturic acid levels in smokers [AA],4
16,C-reactive protein levels or HDL-cholesterol levels (pleiotropy),82829
16,Cortical surface area (MOSTest),23884
16,Cholesteryl ester_14:0_[M+NH4]1+ levels,1461
16,Serum metabolite levels [S_VLDL_L],931
16,Digit length ratio (left hand) [EA],18
16,Impedance of arm (right),215606
16,Mean platelet (thrombocyte) volume,126314
16,3-hydroxypropylmercapturic acid levels in smokers [Japanese],193
16,Breast cancer (estrogen-receptor negative),2688
16,Electrocardiogram morphology (amplitude at temporal datapoints) [-10 ms],33
16,Tonsillectomy,267564
16,Morningness,19230
16,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Hispanic],71645
16,High blood pressure | illnesses of siblings,1154
16,Sleeplessness / insomnia,4715
16,Velopharyngeal dysfunction,4106
16,Lipid or lipoprotein levels [HDL cholesterol],1639
16,Urate levels [women],2022
16,"Other chronic ischemic heart disease, unspecified",112
16,Telmisartan | treatment/medication code,11
16,Risk-taking tendency (4-domain principal component model),18661
16,Adiponectin levels,1721
16,Protein quantitative trait loci (liver) [ADH7],59
16,Facial pigmentation measurement (polar light),126137
16,Serum levels of protein CPB1,7084
16,Blood metabolite levels [X-12556],22932
16,Bipolar disorder or major depressive disorder,3655
16,Doctor diagnosed asthma,7328
16,Nonsyndromic cleft lip with or without cleft palate,1427
16,Electrocardiogram morphology (amplitude at temporal datapoints) [274 ms],1948
16,Waist-to-hip ratio adjusted for body mass index [women],518
16,Sleep duration,19410
16,"High cholesterol | non-cancer illness code, self-reported",12731
16,Neuroblastoma (11q deletion),1474
16,Skin cancer,63117
16,Diabetes,19185
16,Arm fat-free mass (right),399952
16,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),45570
16,HDL cholesterol x physical activity interaction (2df test) [EA],733
16,Tuberculosis (SNP x SNP interaction),1204
16,Serum levels of protein NBL1,232
16,"Blood pressure measurement (high sodium and potassium intervention) [DBP, during intervention]",231
16,Renal failure,232
16,Red vs non-red hair color,36032
16,Predicted visceral adipose tissue,295085
16,Phosphatidylcholine_37:3_[M+OAc]1-/Phosphatidylserine_41:2_[M-H]1- levels,5700
16,Electrocardiogram morphology (amplitude at temporal datapoints) [206 ms],53812
16,Autoimmune diseases,7358
16,Spherical equivalent (joint analysis main effects and education interaction),9
16,Inflammatory bowel disease (early onset),214276
16,Monobrow,6616
16,Left-handedness,241608
16,"Blood protein levels [PNLIPRP1, 6627_25_3]",2185
16,Facial morphology [left alare-labiale superius distance],14273
16,Hematuria,480
16,Visceral adipose tissue volume,1084
16,Normal facial asymmetry (angle of surface orientation score),36
16,Mood swings,6365
16,CD19 on B cell,99229
16,Agouti-related protein levels,34279
16,Phosphatidylethanolamine(40:2)_[M-H]1- levels,6916
16,Phosphatidylcholine(38:3)_[M+H]1+/Phosphatidylethanolamine(41:3)_[M+H]1+/Phosphatidate(43:4)_[M+NH4]1+ levels,6916
16,"Oat cereal (e.g. ready brek, porridge) | cereal type",1084
16,Chronic obstructive pulmonary disease-related biomarkers [SP-D],236
16,Urinary metabolite levels in chronic kidney disease [X - 24339],16287
16,Pancreas fat,4132
16,BMI (adjusted for smoking behaviour),279663
16,Skin aging (microtopography measurement),10207
16,Waist-hip ratio,1097685
16,Atopic asthma,89710
16,Type 2 diabetes [conditional],34238
16,Total testosterone levels,265744
16,Hypothyroidism or myxedema,22864
16,Phosphatidylcholine_34:3_[M+H]1+/Phosphatidylethanolamine_37:3_[M+H]1+/Phosphatidate_39:4_[M+NH4]1+ levels,6755
16,Body fat percentage [European],1075
16,TPE interval (resting) [women],1991
16,"Blood protein levels [CTRB2, 5648_28_3]",5653
16,"Heart attack/myocardial infarction | non-cancer illness code, self-reported",1473
16,Average weekly red wine intake,547
16,Blood osmolality (transformed sodium) [EA],2384
16,Lipid metabolism phenotypes [HDL-C],931
16,Bone mineral density [hip BMD],236
16,CD3 on CD45RA+ CD4+ T cell,13118
16,Skin changes due to chronic exposure to nonionizing radiation,12299
16,Fat-free mass [female],1352
16,Serum metabolite levels [S_VLDL_C],931
16,Age at first live birth,89
16,HDL cholesterol [Yoruban],218
16,Glucuronate levels,888
16,Second line medication for Crohns disease,45
16,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),73014
16,Childhood sunburn occasions,35764
16,Metabolic biomarkers (multivariate analysis),285767
16,Neck or shoulder pain | pain type(s) experienced in last month,13967
16,Subjective well-being,158
16,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)",49648
16,"Hip circumference [EA, men]",204588
16,Serum levels of protein AGRP,47490
16,Impedance of leg (left),430409
16,Cardiovascular disease risk factors [HDL],733
16,Home location at assessment - north co-ordinate (rounded),176
16,"Blood protein levels [CDH11, 9604_14_3]",188
16,Urinary albumin-to-creatinine ratio,19478
16,acne vulgaris,7574
16,Ankle spacing width (left),45758
16,Monocyte percentage,229838
16,Multiple myeloma (survival),14694
16,Hemoglobin levels [African],8070
16,Nasal polyps,8077
16,Malignant neoplasm,2663
16,Brainstem volume,387
16,Brain region volumes [X3rd ventricle],815
16,Inflammatory bowel disease [Children],162
16,Granulocyte count,8539
16,CD127 on CD4+ T cell,13048
16,Muesli | cereal type,115964
16,"Cholesterol lowering medication | medication for cholesterol, blood pressure or diabetes",1611
16,Body fat percentage or coronary artery disease (MTAG),946
16,Protein quantitative trait loci (liver) [MACF1],1176
16,"Atrial fibrillation | non-cancer illness code, self-reported",702
16,Balding type 1,43551
16,Problematic alcohol use (MTAG),240240
16,Bone mineral density or leg lean mass (pleiotropy),1084
16,"Crohns disease | non-cancer illness code, self-reported",410
16,Electrocardiogram morphology (amplitude at temporal datapoints) [156 ms],19520
16,Whole body fat-free mass,421741
16,"Pulmonary function (smoking interaction) [FEV1/FVC, Pack-years]",34049
16,LDL cholesterol levels [EA],5480
16,"Lipid metabolism phenotypes [HDL.mean.size, whole]",1525
16,Ischemic stroke (cardioembolic) [CCSp],202
16,"""Benign neoplasm: Connective and other soft tissue of lower limb, including hip (controls excluding all cancers)""",58
16,Triglyceride levels,438735
16,"LDL cholesterol levels [Asian initial, BMI unadjusted]",2190
16,Melanoma x citrus consumption interaction (2df),3750
16,Serum levels of protein NQO1,10445
16,Mean arterial pressure [East Asian],931
16,LDL cholesterol x physical activity interaction (2df test),714
16,"Varicose veins | non-cancer illness code, self-reported",2000
16,Serum metabolite levels (CMS) [L_LDL_PL],2107
16,White matter microstructure (fractional anisotropy) [Superior longitudinal fasciculus],4305
16,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],1272
16,Pallidum volume,63
16,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)",267919
16,Electrocardiogram morphology (amplitude at temporal datapoints) [220 ms],19617
16,Metabolic syndrome (bivariate traits) [HDLC-WC],733
16,LDL cholesterol levels x short total sleep time interaction (2df test) [EA],963
16,Lipid traits [HDL-C],1036
16,Had menopause,24772
16,Serum metabolite levels [Tyr],2053
16,Morning/evening person (chronotype),5440
16,Caffeine consumption from coffee,1084
16,Brain region volumes [left cuneus],654
16,Chronic obstructive pulmonary disease [conditional on rs8044657],1134
16,Electrocardiogram morphology (amplitude at temporal datapoints) [330 ms],384
16,Serum levels of protein CNTN1,13120
16,Serum metabolite levels [succinylcarnitine (C4-DC],5343
16,Body mass index [age 8],1084
16,"Blood protein levels [CX3CL1, 2827_23_2]",1277
16,Hydrolysed wheat protein allergy,18
16,Asthma (corticosteroid response),44
16,Estrogen level change in anastrozole-treated breast cancer,15
16,Serum metabolite levels (CMS) [XS_VLDL_FC],2107
16,Age at voice drop,828
16,"Blood protein levels [HP, 7905_30_3]",639
16,Electrocardiogram morphology (amplitude at temporal datapoints) [-8 ms],33
16,HDL cholesterol levels in current drinkers [EA],77260
16,Electrocardiogram morphology (amplitude at temporal datapoints) [234 ms],28519
16,Fibrinogen [EA],10749
16,Hay fever and/or eczema,6610
16,Body mass index in physically inactive individuals [women],990
16,Shift pattern was worked for some (but not all) of job | day shifts worked,886
16,High density lipoprotein cholesterol levels [Hispanic],865
16,Composite immunoglobulin trait (IgA/IgM),331
16,Migraine,35027
16,Self-reported math ability (MTAG) [MTAG],359621
16,Apolipoprotein B levels,118806
16,Age started hormone-replacement therapy (hrt),11170
16,Age at menopause (last menstrual period),65252
16,Waist-to-hip ratio adjusted for body mass index [Women],14950
16,Serum levels of protein GNPTG,10858
16,Nonsyndromic cleft lip with cleft palate,1436
16,Nonalcoholic fatty liver disease,1093
16,Serum metabolite levels (CMS) [L_HDL_PL],931
16,"Yes, because of other reasons | major dietary changes in the last 5 years",1084
16,Response to tofacitinib treatment (herpes zoster)(time to event),1035
16,Metabolic syndrome (bivariate traits) [HDLC-GLUC],1136
16,Serum levels of protein CRISPLD2,59
16,HDL cholesterol levels [EA],72203
16,HLA DR+ T cell%lymphocyte,1285
16,"Age hay fever, rhinitis or eczema diagnosed",3054
16,Body fat percentage [European women],1075
16,1-palmitoyl-2-linoleoyl-gpc (16:0/18:2) levels,1963
16,Dietary macronutrient intake [Protein],2168
16,Triglycerides [EA],3033
16,Varicose veins,10131
16,"Blood protein levels [GABARAPL2, 12494_99_3]",13483
16,Simvastatin | treatment/medication code,3201
16,Diabetes mellitus,20699
16,Past tobacco smoking,10134
16,Smoking status (current vs never) [EA],16031
16,"""Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified""",2563
16,Childhood asthma (age<16) (more control exclusions),3440
16,"""Hypothyroidism, strict autoimmune, 3 medication purchases required""",2064
16,Financial reasons | reason former drinker stopped drinking alcohol,195
16,Waist circumference adjusted for body mass index,928894
16,Chronotype,21445
16,circulating leptin levels,9234
16,Serum cancer antigen 125 levels,1818
16,Protein quantitative trait loci (liver) [GPNMB],57
16,"Blood protein levels [TPSB2, 14696_45_3]",712
16,Eosinophil counts,1010651
16,Body mass index in physically active individuals [EA],220287
16,Age at first sexual intercourse,75873
16,Chronic obstructive pulmonary disease x ever smoker interaction (main effect),34049
16,Cystatin C levels,230857
16,LDL cholesterol levels x long total sleep time interaction (2df test),421
16,Serum levels of protein WFIKKN1,6923
16,Serum metabolite levels (CMS) [IDL_P],2107
16,Electrocardiogram morphology (amplitude at temporal datapoints) [150 ms],1927
16,"Eczema/dermatitis | non-cancer illness code, self-reported",1704
16,"""Lactose intolerance, other/unspecified""",5
16,Chronic obstructive pulmonary disease in never smokers,34049
16,Diacylglycerol_36:3_[M+NH4]1+ levels,971
16,Serum metabolite levels (CMS) [L_HDL_CE],1136
16,Oily fish intake,1151
16,Protein quantitative trait loci (liver) [NAMPT],1
16,Hemoglobin,413235
16,Electrocardiogram morphology (amplitude at temporal datapoints) [102 ms],3918
16,Mean corpuscular hemoglobin [conditional on round 5],7429
16,Serum levels of protein CX3CL1,177
16,White matter microstructure (axial diusivities) [Superior corona radiata],795
16,Feeling worry,48
16,Glioma,20027
16,Electrocardiogram morphology (amplitude at temporal datapoints) [158 ms],20509
16,CD3 on naive CD8+ T cell,13118
16,Brain region volumes [X4th ventricle],795
16,Serum levels of protein CGA;TSHB,238
16,Serum uric acid levels [Japanese],5484
16,Mean corpuscular haemoglobin,278163
16,Electrocardiogram morphology (amplitude at temporal datapoints) [144 ms],5068
16,Fatty acid(20:3)_[M-H]1- levels,1777
16,"""Obesity, other/unspecified""",1084
16,Small vessel stroke,569
16,Cigarettes smoked per day (MTAG),41200
16,Obesity [Obesity class I],219943
16,Metabolic syndrome (bivariate traits) [BP-HDLC],931
16,Myopia,10
16,Red blood cell traits [MCV],2536
16,Substance abuse,188
16,"Heel bone mineral density (bmd) t-score, automated",69700
16,Obesity [children],1084
16,Ascending aorta maximum area,10888
16,Basal metabolic rate variance,1084
16,"Body mass index (adult) [AA,Women]",1084
16,Electrocardiogram morphology (amplitude at temporal datapoints) [304 ms],384
16,Multisite chronic pain,13938
16,"Hypothyroidism/myxoedema | non-cancer illness code, self-reported",66514
16,CD45 on HLA DR+ T cell,1285
16,Plantar fascial disorders,1657
16,Cutaneous malignant melanoma,110704
16,Hair morphology traits [Hair color],24067
16,"Serum metabolite levels [cys-gly, oxidized]",13602
16,Heel broadband ultrasound attenuation (right),31693
16,Serum metabolite levels (CMS) [HDL_C],931
16,Adiponectin levels [Second stage],165
16,Drive faster than motorway speed limit,108
16,Actinic keratosis,24598
16,Rheumatoid arthritis (ACPA-positive),752
16,High density lipoprotein cholesterol levels [East Asian],865
16,Goiter,330
16,Inflammatory bowel disease,320144
16,Electrocardiogram morphology (amplitude at temporal datapoints) [190 ms],21838
16,Cortical thickness (min-P),814
16,Blood pressure [SBPLTA],622
16,Hip circumference [men],5643
16,"Blood protein levels [TPSAB1, 9409_11_3]",4788
16,Ascorbate (vitamin c) levels,148
16,Cortical surface area [Caudal Middle Frontal],261
16,Apolipoprotein A1 levels,420397
16,Hair color [hair color],11768
16,Intralaminar thalamic nuclei volume,7049
16,Serum metabolite levels [XL_HDL_C],931
16,Kidney function decline traits [eGFRchange overall],816
16,Serum metabolite levels [XL_HDL_P],931
16,Thyroid volume [goiter],16
16,Medication use (drugs used in diabetes),13053
16,"Lipid metabolism phenotypes [HDL.large, fasting]",1525
16,Carpal tunnel syndrome,1093
16,Lifetime smoking index,59586
16,Arm fat mass (left),306825
16,Haemoglobin concentration,134026
16,"Medication use (adrenergics, inhalants)",15303
16,Protein quantitative trait loci (liver) [IGHM],1069
16,Cardiovascular risk factors [HDL-cholesterol],931
16,Glomerular filtration rate in diabetes,232
16,Cardioembolic stroke (TOAST classification),193
16,Bitter alcoholic beverage consumption,4952
16,Blood protein levels [Haptoglobin],5609
16,Anthropometric traits (multi-trait analysis),4166
16,Doctor's advice | reason former drinker stopped drinking alcohol,333
16,Serum metabolite levels (CMS) [ApoB],931
16,Standing height,359580
16,Reaction time,11582
16,Serum metabolite levels [ApoB_ApoA1],931
16,Red vs. brown/black hair color,28
16,Subclinical trait of interstitial lung disease (basilar peel-core ratio of high attentuation areas on CT scan),20
16,Electrocardiogram morphology (amplitude at temporal datapoints) [250 ms],18499
16,Blood metabolite levels [X-11550],931
16,Experiencing mood swings,8633
16,Serum metabolite levels [HDL_C],931
16,Ulcerative colitis,98002
16,Estimated glomerular filtration rate,587021
16,Citramalate levels,1743
16,Warfarin dose variability,18643
16,"Blood protein levels [EA, Agouti-related protein]",35351
16,"None of the above | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",12663
16,Metabolic syndrome [Waist],1093
16,Low hand grip strength (60 years and older) (EWGSOP),7315
16,Asthma (time to onset),610
16,Red blood cell count,2648134
16,Electrocardiogram morphology (amplitude at temporal datapoints) [170 ms],21594
16,Brain region volumes [left entorhinal],618
16,Ankle spacing width,281958
16,Other malignant neoplasms of skin (=non-melanoma skin cancer) (controls excluding all cancers),14584
16,Serum levels of protein CBLN1,395
16,Relative carbohydrate intake,1084
16,Chronic lymphocytic leukemia,2354
16,Asthma (childhood onset),26143
16,Serum metabolite levels (CMS) [TotFA],1868
16,Place of birth in uk - north co-ordinate,61
16,Hypertension,141561
16,Caffeine consumption from tea,1084
16,Attention deficit hyperactivity disorder,576
16,Phosphatidylcholine_32:0_[M+H]1+/Phosphatidylethanolamine_35:0_[M+H]1+/Phosphatidate_37:1_[M+NH4]1+ levels,931
16,Depressed affect,183
16,Type 2 diabetes,992189
16,Parkinson's disease or first degree relation to individual with Parkinson's disease,151397
16,Diffuse plaques (SNP x SNP interaction),3796
16,Lamb/mutton intake,892
16,Warfarin maintenance dose,106593
16,White matter microstructure (radial diusivities) [Superior longitudinal fasciculus],2948
16,Fluid intelligence score,162954
16,"Lipid metabolism phenotypes [LDL.large, whole]",1039
16,"Blood protein levels [SERPIND1, 3316_58_1]",639
16,Immunological or systemic disorder,6610
16,"""Benign neoplasm of colon, rectum, anus and anal canal""",240
16,CD25 on IgD- CD24- B cell,136
16,Bone mineral density (spine),5457
16,Glaucoma (multi-trait analysis),39385
16,HLA DR on CD33dim HLA DR+ CD11b-,1205
16,Ever smoked,13717
16,Electrocardiogram morphology (amplitude at temporal datapoints) [146 ms],6089
16,Breast cancer | illnesses of mother,63
16,Adolescent idiopathic scoliosis,44989
16,Pulmonary function [FEV1/FVC],36073
16,CX3CL1 levels,7248
16,Haematocrit percentage,132494
16,Lysophosphatidylcholine_16:0_[M+H]1+/Lysophosphatidylethanolamine_19:0_[M+H]1+ levels,1136
16,"""Hypothyroidism,  other/unspecified""",406
16,Peripheral arterial disease (traffic-related air pollution interaction) [AA],1498
16,Electrocardiogram morphology (amplitude at temporal datapoints) [18 ms],416
16,Cylindrical power (left),10
16,Time spend outdoors in summer,210530
16,Annualised percent change of cerebrospinal fluid AB1-42 levels,743
16,Congenital malformations of the urinary system,47
16,"Number of decayed, missing and filled tooth surfaces or use of dentures",40728
16,Low HDL-cholesterol levels,767
16,Chronic obstructive pulmonary disease x ever smoker interaction (2df),34049
16,Urate levels [men],2022
16,Serum levels of protein CTRB2,6146
16,Alcohol use disorder (consumption score),2477
16,BMI in smokers [men],1084
16,Lysophosphatidylcholine levels [LPC(18:0;0],43
16,Carotid plaque,34049
16,Liver enzyme levels (alanine transaminase),20989
16,Electrocardiogram morphology (amplitude at temporal datapoints) [306 ms],384
16,Serum metabolite levels [beta-hydroxyisovalerate],1733
16,Type 2 diabetes [Japanese],946
16,Serum metabolite levels (CMS) [M_HDL_CE],931
16,Unspecified diffuse connective tissue disease,225
16,Breast cancer,53893
16,Caffeine consumption from coffee or tea,6830
16,Serum metabolite levels [M_VLDL_CE],931
16,Serum metabolite levels [HDL_D],931
16,Serum metabolite ratios in chronic kidney disease [Lysophosphatidylcholine with acyl residue C18:1/Lysophosphatidylcholine with acyl residue C20:3],5737
16,Differentiated thyroid cancer,238
16,Neutrophil percentage of granulocytes,44048
16,Waist circumference [EA],246124
16,Phosphatidylcholine_38:2_[M+H]1+/Phosphatidylethanolamine_41:2_[M+H]1+ levels,7355
16,Obesity [Obesity class III],1084
16,Osteoarthritis of the hip or knee,2186
16,Fibrinogen levels,60462
16,Diacylglycerol_38:3_[M+H-H2O]1+ levels,2100
16,No | hearing difficulty/problems,1363
16,Pattern 4 | hair/balding pattern,30791
16,Basal metabolic rate,439531
16,Statin medication,4674
16,Life satisfaction,849
16,Prostate cancer (advanced),289
16,Blond vs. brown/black hair color,12299
16,Body mass index (joint analysis main effects and smoking interaction) [women],203655
16,Serum levels of protein DPEP1,19864
16,Serum metabolite levels (CMS) [VLDL_C],931
16,Electrocardiogram morphology (amplitude at temporal datapoints) [140 ms],1927
16,Both eyes | ever had cataract surgery,803
16,Intracerebral hemorrhage,351
16,Hemoglobin concentration,381242
16,Medication use (beta blocking agents),42518
16,Fat-free mass [male],57546
16,Body fat percentage or heart failure (MTAG),1093
16,Abdominal and pelvic pain,1184
16,Skin pigmentation traits [Freckling phototype score],24312
16,Electrocardiogram morphology (amplitude at temporal datapoints) [168 ms],21594
16,Disorders of lipoid metabolism,714
16,Small (125ml) | size of red wine glass drunk,23
16,Body mass index (joint analysis main effects and smoking interaction) [men],203655
16,Body fat distribution (arm fat ratio) [females],27304
16,Plasma free amino acid levels (adjusted for twenty other PFAAs) [Gly],22673
16,Lymphocyte counts,604449
16,Walking for pleasure (not as a means of transport) | types of physical activity in last 4 weeks,84315
16,Electrocardiogram morphology (amplitude at temporal datapoints) [188 ms],21838
16,"Body mass index in physically active individuals [EA, men]",1084
16,CD3 on HLA DR+ T cell,1418
16,Glomerular filtration rate [EA],232
16,QT interval,72681
16,Hand grip strength (left),71166
16,"Allergic disease (asthma, hay fever or eczema)",15466
16,Gonarthrosis,1093
16,"Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)",242
16,"""Malignant neoplasm of breast, HER-positive""",76
16,Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer,201
16,"""Chronic periodontitis , including avohilmo""",22
16,Waist circumference adjusted for body mass index [EA],48571
16,Rheumatoid arthritis,51463
16,Serum total protein level,572341
16,Neuroticism score,50306
16,Response to trametinib,24524
16,Smoking cessation (MTAG),15953
16,Depression,5064
16,Electrocardiogram morphology (amplitude at temporal datapoints) [224 ms],19617
16,Subjective well-being (MTAG),331
16,Phosphatidylcholine_34:2_[M+H]1+/Phosphatidylethanolamine_37:2_[M+H]1+/Phosphatidate_39:3_[M+NH4]1+ levels,6668
16,Electrocardiogram morphology (amplitude at temporal datapoints) [244 ms],28486
16,IgA nephropathy,30928
16,HLA DR on plasmacytoid Dendritic Cell,3646
16,Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis),46
16,Hemoglobin A1c levels,330724
16,Myeloid white cell count,11268
16,Urate levels [East Asian],2586
16,Serum metabolite levels (CMS) [XL_HDL_PL],931
16,Benign neoplasm of colon,74
16,Essential hypertension (time to event),46
16,Tartronate (hydroxymalonate) levels,69
16,Hypothyroidism,46
16,C-reactive protein measurement,9
16,CAG-841 sp002479075 abundance in stool,1
16,Waist circumference adjusted for BMI in non-smokers,45570
16,LDL cholesterol levels,31552
16,Serum metabolite levels (CMS) [M_VLDL_C],931
16,Neurofibrillary tangles (SNP x SNP interaction),15778
16,Serum metabolite levels (CMS) [L_LDL_CE],2107
16,Phosphatidylcholine_35:2_[M+H]1+/Phosphatidylethanolamine_38:2_[M+H]1+/Phosphatidate_40:3_[M+NH4]1+ levels,5737
16,White matter microstructure (mean diusivities) [Fornix (column and body],809
16,Duration to first press of snap-button in each round,82
16,Protein quantitative trait loci (liver) [ACSM2B],10
16,Well-being spectrum (multivariate analysis),4722
16,BMI (adjusted for smoking behaviour) [men],213276
16,Participation in an health questionnaire (not invited vs invited),223156
16,"Light brown | hair colour (natural, before greying)",90682
16,Glycosuria in pregnancy (maternal and offspring genotype effect),6047
16,Central corneal thickness,11036
16,Serum metabolite levels (CMS) [XXL_VLDL_CE],931
16,Pancreatic cancer,234
16,Protein quantitative trait loci (liver) [VAPB],51
16,Phosphatidylcholine_36:4_[M+OAc]1-/Phosphatidylserine_40:3_[M-H]1- levels,5700
16,Sleep duration (long sleep),1166
16,6-oxopiperidine-2-carboxylate levels,3265
16,Sleep (1/2-day periodicity),960
16,Average total household income before tax,224819
16,Serum levels of protein CCL22,1631
16,Cardiorespiratory fitness (vo2 max),44
16,Serum levels of protein NCAM2,13120
16,Blood protein levels [HP],8474
16,Adventurousness,18874
16,Smoking initiation (ever regular vs never regular) [Conditioned on chr16:25351633],2918
16,Heel broadband ultrasound attenuation (left),38358
16,White matter microstructure (axial diusivities) [Posterior limb of internal capsule],809
16,Smoking initiation (ever regular vs never regular) (MTAG),101112
16,Mean spheric corpuscular volume,572500
16,"Waist-to-hip ratio adjusted for body mass index [EA, women]",2135
16,Serum metabolite levels [imidazole lactate],1027
16,Renal function-related traits (sCR),232
16,Waist-hip ratio [EA],1084
16,Electrocardiogram morphology (amplitude at temporal datapoints) [308 ms],384
16,Gluconate levels,268
16,BMI in non-smokers,203655
16,Comparative body size at age 10,292018
16,Asthma/COPD (KELA code 203),9598
16,Electrocardiogram morphology (amplitude at temporal datapoints) [136 ms],1927
16,Nodal modulator 1 levels,2048
16,Serum metabolite levels (CMS) [XS_VLDL_C],931
16,Intraocular pressure,223681
16,Electrocardiogram morphology (amplitude at temporal datapoints) [238 ms],26528
16,Metabolically unhealthy in normal weight,451
16,Gulonate levels,58
16,Anxiety/tension (special factor of neuroticism),40627
16,Alcohol consumption,21447
16,"Blood protein levels [APOL1, 11510_31_3]",639
16,"Heel quantitative ultrasound index (qui), direct entry (left)",47109
16,Otosclerosis,2178
16,"Ulcerative colitis | non-cancer illness code, self-reported",376
16,Body fat distribution (arm fat ratio),32611
16,Waist-to-hip ratio adjusted for BMI (additive genetic model),246532
16,Electrocardiogram morphology (amplitude at temporal datapoints) [94 ms],1991
16,Urticaria,4621
16,Neck pain or shoulder pain,1493
16,"""Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)""",50
16,Mean arterial pressure,52366
16,"""Type 2 diabetes, definitions combined""",4036
16,Dentures | mouth/teeth dental problems,247
16,Male-pattern baldness,34505
16,Carcinoma in situ of skin,16393
16,Alcohol use disorder (consumption score) [EA],955
16,Serum metabolite levels [S_VLDL_P],2107
16,Blood metabolite levels [X-12038],1525
16,Sunburns,31598
16,Biological sex,28004
16,Urinary metabolite levels in chronic kidney disease [prolylglycine],20953
16,Blood cell traits (multivariate analysis),2354
16,3-hydroxypropylmercapturic acid levels in smokers [Latino],453
16,CD127 on CD28- CD8+ T cell,331
16,None of the above | qualifications,281416
17,Strenuous sports or other exercises,3036
17,Haemorrhoidal disease,47681
17,Blood glucose levels,78689
17,"""Asthma, including avohilmo""",39146
17,Serum levels of protein FLRT1,6403
17,CCR7 on naive CD8+ T cell,188
17,Atopic march,36672
17,"Blood protein levels [ADM, 8518_55_3]",12863
17,"Blood protein levels [ARHGEF7, 13932_45_3]",12863
17,"Forced expiratory volume in 1-second (fev1), predicted",94171
17,White matter hyperintensity burden [EA],17589
17,Cataract | eye problems/disorders,3131
17,"Blood protein levels [VPS29, 14318_1_3]",12863
17,Immune reponse to smallpox (secreted IL-2) [AA],213
17,Serum metabolite levels [aspartylphenylalanine],3095
17,Maximum heart rate during fitness test,74
17,Leg fat mass (left),150868
17,"Blood protein levels [EPHB4, 3612_6_4]",12863
17,Serum levels of protein ECI2,6403
17,Serum levels of protein ASIP,6403
17,Thyroid volume in Hashimoto’s thyroiditis,1334
17,Brain region volumes [cerebellar vermal lobules I V],70
17,Electrocardiogram morphology (amplitude at temporal datapoints) [476 ms],22
17,Risk-taking tendency (4-domain principal component model),1420081
17,Serum levels of protein TAGLN2,12806
17,"Asthma | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",58226
17,"Blood protein levels [CLMP, 9585_80_3]",12863
17,Leg fat percentage (left),228465
17,Arm fat percentage (right),218737
17,"Blood protein levels [CTSH, 3737_6_3]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [30 ms],5073
17,Severe skin toxicity response to cetuximab in stage 3 colon cancer,128
17,Endometrial cancer (endometrioid histology),68986
17,Feeling guilty,1385740
17,Sensitivity / hurt feelings,1370568
17,High density lipoprotein cholesterol levels [EA],34138
17,Serum levels of protein TIMP2,4160
17,"Blood protein levels [ATP1B1, 13392_13_3]",12863
17,Skin cancer,85
17,Any mental disorder,12
17,Reticulocyte count,4293020
17,Alcohol use disorder (total score),1413800
17,Maximum habitual alcohol consumption,1354503
17,Malignant neoplasm of breast,13604
17,Diffuse plaques (SNP x SNP interaction),5224
17,Coronary artery disease [additive model],2191
17,Serum albumin levels,2902595
17,Serum levels of protein TUFT1,6403
17,Serum levels of protein PGM1,6403
17,Monocyte percentage,91935
17,Osteoprotegerin levels,6403
17,Sudden cardiac arrest [Recessive],85
17,Neutrophil percentage of white cells,1805132
17,Overall health rating,16133
17,Externalizing behaviour (multivariate analysis),109250
17,"Blood protein levels [DNAJB14, 8037_53_3]",12863
17,Serum levels of protein WDR1,6403
17,Sunburns,8865
17,Serum levels of protein PPIL2,6416
17,"Blood protein levels [ASCC1, 10647_18_3]",12863
17,"Blood protein levels [RNF146, 11401_181_3]",12863
17,Glycated haemoglobin HbA1c levels adjusted for BMI,22383
17,White matter microstructure (mean diusivities) [Posterior limb of internal capsule],11092
17,"Blood protein levels [NPTX1, 9256_78_3]",2648
17,"""Ischaemic heart disease, wide definition""",4385
17,Osteoarthritis,2253
17,Serum levels of protein ARHGEF7,6403
17,"Blood protein levels [NCR1, 5104_57_3]",12863
17,Monocyte chemoattractant protein-1 levels,1359
17,Electrocardiogram morphology (amplitude at temporal datapoints) [98 ms],125
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-54 ms],53
17,High density lipoprotein cholesterol levels,78548
17,Serum levels of protein MCEE,6403
17,C-X-C motif chemokine 16 levels,17074
17,"Blood protein levels [CYB5D2, 10924_258_3]",6457
17,CD28- CD4-CD8- T cell Absolute Count,691
17,Insomnia symptoms (never/rarely vs. usually),2146
17,Serum levels of protein SLC3A2,1429
17,Serum levels of protein ALDH1A3,6403
17,Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in secretors,219
17,Cerebrospinal fluid sTREM-2 levels,493
17,Systemic lupus erythematosus,137487
17,Alcohol consumption (drinks per week) (MTAG),1515077
17,"Blood protein levels [MFAP4, 5636_10_3]",12863
17,"Blood protein levels [LGALS9, 9197_4_3]",11311
17,Serum levels of protein DPP7,6403
17,Serum levels of protein FCRL2,6403
17,Trunk fat mass,152551
17,Testosterone levels [Testosterone],13885
17,Urea levels,27923
17,Serum levels of protein SULT4A1,6403
17,Intrinsic epigenetic age acceleration,4630
17,"Blood protein levels [KLRC3, 7795_14_3]",4975
17,Pace-maker,845
17,"Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA, women]",187
17,Electrocardiogram morphology (amplitude at temporal datapoints) [472 ms],22
17,White blood cell count (neutrophil),80090
17,Offspring birth weight,33590
17,Salad / raw vegetable intake,1433334
17,"Blood protein levels [ASAP2, 13518_5_3]",12863
17,"Light diy (eg: pruning, watering the lawn) | types of physical activity in last 4 weeks",9041
17,Serum levels of protein RBBP9,6403
17,Hair shape,119
17,"Mean arterial pressure x alcohol consumption interaction (2df test) [AA, EA]",98
17,High-grade serous ovarian cancer,921575
17,Serum levels of protein CST8,7393
17,Serum levels of protein KCNIP1,6424
17,Arrhythmia,391
17,"Allergic disease (asthma, hay fever or eczema)",64548
17,Mood swings,18371
17,Serum levels of protein PPIB,6403
17,Serum levels of protein CTNNB1,12806
17,"Blood protein levels [APOL1, 9506_10_3]",12863
17,Neuroticism score,1161538
17,Serum levels of protein PTPRH,6403
17,"Blood protein levels [SMR3A, 7838_27_3]",12863
17,Serum levels of protein MPO,2015
17,Serum levels of protein EQTN,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-82 ms],52
17,Prostate cancer,67941
17,Atopic asthma,40864
17,Leg fat-free mass (left),332779
17,Arm fat-free mass (left),238855
17,Glucuronate levels,2485
17,"Blood protein levels [PLCG1, 4563_61_2]",12863
17,Neck or shoulder pain | pain type(s) experienced in last month,145
17,DNA methylation GrimAge acceleration,19633
17,Headache | pain type(s) experienced in last month,1164078
17,"Blood protein levels [OLFM3, 11143_32_3]",12863
17,Leg fat percentage (right),193302
17,Hematoma volume in non-lobar spontaneous intracerebral hemorrhage,107
17,Ganglion cell inner plexiform layer (GCIPL) thickness,5196
17,Body mass index,2605954
17,Bipolar disorder,78550
17,Cortical volume [Global],880468
17,Serum levels of protein CDH6,6403
17,Osteoarthritis of the hip (hospital diagnosed),296
17,Ever smoked,267
17,Metformin | treatment/medication code,248
17,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],135
17,Presence of other devices,146
17,Cheese intake,52435
17,HDL cholesterol x physical activity interaction (2df test) [EA],31748
17,Serum levels of protein PSMA1,6403
17,Nonalcoholic fatty liver disease (imputed),34138
17,"Blood protein levels [GRAP2, 5265_12_3]",12863
17,"Blood protein levels [STK16, 3471_49_1]",12863
17,"Blood protein levels [CCL14, 2900_53_3]",2422
17,"Blood protein levels [HMGB3, 12775_6_3]",12863
17,Serum levels of protein CSTL1,6403
17,Serum levels of protein ASGR1,6403
17,Amyotrophic lateral sclerosis (sporadic),2620
17,Metabolite levels,677
17,Asthma or allergic disease (pleiotropy),45167
17,Systolic blood pressure x smoking status (ever vs never) interaction (2df test) [EA],15396
17,Serum levels of protein HBZ,6403
17,"Blood protein levels [FGFBP1, 9507_55_3]",12863
17,"Blood protein levels [LRRC37A2, 8897_3_3]",12863
17,Plasma t-tau levels,391
17,"""Dementia, including avohilmo""",1015
17,Soft tissue disorders,19
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-124 ms],52
17,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test),16027
17,Intertrochanteric region size,279
17,Serum levels of protein AHSP,6403
17,Chronic sinusitis,56
17,Generalized epilepsy [All GGE],10652
17,Hand grip strength (left),1161518
17,Hand grip strength (right),1194403
17,"Blood protein levels [SERPINA12, 6551_94_3]",12863
17,IgG galactosylation phenotypes (multivariate analysis),11095
17,Serum metabolite levels [1-methylhistamine],3015
17,6mm regularity index (right),146
17,Electrocardiogram morphology (amplitude at temporal datapoints) [108 ms],125
17,Mouth ulcers,37901
17,Electrocardiographic traits (multivariate),5258
17,Irritability,1176231
17,Serum levels of protein ACE2,6403
17,Brain region volumes [left insula],39792
17,"Blood protein levels [ELK1, 10006_25_3]",12863
17,"""Inflammatory bowel disease, strict (require KELA)""",37213
17,Serum levels of protein FST,6403
17,Hypothyroidism (congenital or acquired),8
17,Educational attainment (college completion),1456003
17,Lung function (FEV1) [EA],1269134
17,Serum levels of protein PFKFB3,6403
17,Serum levels of protein RAB35,6403
17,Serum levels of protein DHFR,6403
17,"Blood protein levels [EZR, 9753_17_3]",12863
17,"Blood protein levels [MUC1, 9176_3_3]",12863
17,Sleeplessness / insomnia,3272
17,Serum levels of protein HTR7,6367
17,"Blood protein levels [DHFR, 9823_2_3]",6403
17,Heart disease | illnesses of father,4221
17,Sum basophil neutrophil counts,1421526
17,A body shape index,137827
17,Serum levels of protein SRL,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [336 ms],4731
17,Serum levels of protein HSD17B1,6403
17,Juvenile Open Angle Glaucoma,257
17,Switched memory B cell %lymphocyte,352
17,Ankylosing spondylitis,113709
17,Serum total protein level,3271809
17,Total body bone mineral density [European],41497
17,Spherical equivalent [EA],3184
17,Mean arterial pressure,51471
17,Serum levels of protein SRXN1,6403
17,Serum levels of protein GHRL,6403
17,"Yes, because of other reasons | major dietary changes in the last 5 years",18296
17,Serum levels of protein TNFSF18,6460
17,Electrocardiogram morphology (amplitude at temporal datapoints) [330 ms],4731
17,"Blood protein levels [CXCL16, 2436_49_4]",2754
17,Sum eosinophil basophil counts,272435
17,Accelerometer-based physical activity measurement (average acceleration),1428268
17,White matter microstructure (axial diusivities) [Anterior corona radiata],1102778
17,Serum levels of protein RNF13,6403
17,"Blood protein levels [PDK1, 5227_60_3]",12863
17,"Blood protein levels [CLEC4A, 8853_2_3]",6403
17,Protein quantitative trait loci (liver) [CAPNS1],595
17,Blood protein levels [CCL18],1367
17,Serum levels of protein MLEC,6403
17,Alcohol usually taken with meals,516
17,Electrocardiogram morphology (amplitude at temporal datapoints) [184 ms],125
17,Serum levels of protein SCO1,6403
17,"Blood protein levels [ASGR1, 5452_71_3]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [28 ms],5073
17,"""Ulcerative colitis (strict definition, require KELA, min 2 HDR)""",25919
17,Dried fruit intake,1550
17,6mm asymmetry index (left),1864
17,Ovarian clear cell cancer,290
17,Nucleated red blood cell count,221
17,Electrocardiogram morphology (amplitude at temporal datapoints) [192 ms],125
17,Alcohol consumption (drinks per week),5454890
17,Waist circumference adjusted for body mass index [EA],4906
17,Red blood cell (erythrocyte) count,1768458
17,"Hypertension | non-cancer illness code, self-reported",92335
17,Youthful appearance (self-reported),1539
17,Serum levels of protein GPC1,6403
17,"Blood protein levels [RIC3, 11228_37_3]",12863
17,Diverticular disease,16405
17,Serum levels of protein TRIB2,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [292 ms],1182
17,Serum levels of protein ALDOC,579
17,Ischemic heart disease,2169
17,"Blood protein levels [SERPINF1, 7735_17_3]",4999
17,Serum levels of protein CD300C,2281
17,Cardiac arrhytmias,5371
17,Alfacalcidol | treatment/medication code,1840
17,Gonarthrosis [arthrosis of knee](FG),296
17,"Eczema/dermatitis | non-cancer illness code, self-reported",49
17,Protein quantitative trait loci (liver) [LMNA],202
17,Hemoptysis,87
17,Psoriatic and enteropathic arthropathies,16
17,Primary tooth development (time to first tooth eruption),52359
17,Serum levels of protein DDR2,6403
17,"Other exercises (eg: swimming, cycling, keep fit, bowling) | types of physical activity in last 4 weeks",10627
17,"Blood protein levels [CSNK2B, 11330_15_3]",12863
17,Lymphocyte count,151066
17,Serum levels of protein LGALS9,7094
17,"Blood protein levels [CTSB, 3061_61_2]",12863
17,"Blood protein levels [SLC5A5, 12826_5_3]",12863
17,Serum levels of protein KDR,6403
17,6mm cylindrical power (left),5196
17,Osteoporosis,522
17,Cutaneous malignant melanoma,285
17,Electrocardiogram morphology (amplitude at temporal datapoints) [118 ms],125
17,Drug-induced obesity,58
17,Invasive epithelial ovarian cancer,921037
17,Serum levels of protein MRPL58,6403
17,Atrial fibrillation and flutter with reimbursement,2784
17,Serum levels of protein TESC,6403
17,Fractional exhaled nitric oxide (childhood) [EA],5948
17,Total protein levels x insomnia interaction,295
17,Electrocardiogram morphology (amplitude at temporal datapoints) [176 ms],125
17,Electrocardiogram morphology (amplitude at temporal datapoints) [306 ms],1182
17,Protein quantitative trait loci (liver) [DHRS4],57
17,Lactobacillus B salivarius abundance in stool,51
17,Essential hypertension,61568
17,Ascending aorta minimum area,38952
17,Electrocardiogram morphology (amplitude at temporal datapoints) [326 ms],5913
17,Protein quantitative trait loci (liver) [ACSF2],4831
17,"Electron transfer flavoprotein subunit alpha, mitochondrial measurement",6403
17,"""Coxarthrosis, primary, with hip surgery""",1261
17,Electrocardiogram morphology (amplitude at temporal datapoints) [144 ms],149
17,Wears glasses or contact lenses,26
17,Urate levels,578444
17,Forns index in high alcohol intake,11398
17,Serum levels of protein GRIA4,6403
17,Serum levels of protein EBI3,6403
17,"Systolic blood pressure, automated reading",132593
17,Childhood asthma (age<16),40028
17,Blood protein levels [C-C motif chemokine 18],1001
17,CD28- CD8dim T cell %T cell,727
17,Serum metabolite levels [12-HETE],599
17,Parkinson's disease,13725718
17,Neurofibrillary tangles (SNP x SNP interaction),8342
17,Fibrosis-4 index in high alcohol intake,11415
17,Serum levels of protein MGAT4A,6403
17,"Blood protein levels [ACE2, 2805_6_2]",12863
17,4-chlorobenzoic acid levels,6076
17,Biological sex,2546
17,Prostate cancer | illnesses of father,290
17,Asthma (adult onset),1036
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-112 ms],52
17,Marginal zone lymphoma or multiple sclerosis,4496
17,Bronchitis,35738
17,Serum levels of protein TNFRSF12A,6403
17,Heel bone mineral density (bmd) (left),57080
17,Serum levels of protein NR1H2,6403
17,Natural Killer T %lymphocyte,580
17,Daytime dozing / sleeping (narcolepsy),1401920
17,"Blood protein levels [C20orf173, 7046_6_3]",12863
17,"Blood protein levels [GPD1L, 12420_10_3]",12863
17,"Blood protein levels [NPIPB3, 9954_2_3]",12863
17,"""Ulcerative colitis, NAS""",37409
17,Primary tooth development (number of teeth),4760
17,Serum levels of protein HTR2A,6403
17,Protein levels in obesity [LD78-beta],1001
17,Serum levels of protein PXYLP1,6403
17,CD33- HLA DR- Absolute Count,1044
17,Triglyceride levels in current drinkers,207
17,Educational attainment (years of education) [conditional-joint],975355
17,Serum levels of protein SERPINB1,6403
17,Serum levels of protein TPT1,6403
17,Serum levels of protein STX1B,6403
17,Pattern 4 | hair/balding pattern,212859
17,"Blood protein levels [HRC, 6584_1_3]",12863
17,"Blood protein levels [LRP2, 10618_190_3]",12863
17,Impedance of leg (right),358357
17,Serum levels of protein NUDT12,6403
17,Alzheimer's disease (late onset),1438
17,Serum levels of protein PPP1R3B,466
17,Morning vs. evening chronotype,47
17,"Blood protein levels [IL36A, 10928_7_3]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [318 ms],5913
17,"Blood protein levels [UCMA, 10977_55_3]",12863
17,"Blood protein levels [SLC25A18, 5280_68_5]",12863
17,Migraine and/or pulse pressure,5922
17,Serum levels of protein CRABP2,6403
17,Serum levels of protein UBE2G2,6403
17,Serum levels of protein DERL1,6403
17,Sex hormone levels [SHBG],351
17,Electrocardiogram morphology (amplitude at temporal datapoints) [226 ms],125
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-118 ms],52
17,Esophageal cancer (squamous cell),20839
17,Hip circumference adjusted for BMI,1604679
17,Left-handedness,1307322
17,Serum levels of protein ARFIP1,6403
17,Heel bone mineral density (bmd),119307
17,Viral infections characterized by skin and mucous membrane lesions,104
17,Electrocardiogram morphology (amplitude at temporal datapoints) [462 ms],22
17,Electrocardiogram morphology (amplitude at temporal datapoints) [74 ms],125
17,Hair color,72115
17,Unspecified monoarthritis,30312
17,Serum levels of protein PDE11A,6403
17,Serum levels of protein MUC1,12806
17,Serum levels of protein ENAH,6403
17,Cortical surface area [Insula],45904
17,Serum levels of protein GOSR2,6517
17,Feeling nervous,1414615
17,"Blood protein levels [C1orf185, 10667_78_3]",12863
17,"Blood protein levels [RCN2, 10645_72_3]",12863
17,"Blood protein levels [UBE2D4, 13475_10_3]",12863
17,Statin medication,32309
17,Cortical surface area [Pericalcarine],676
17,Waist circumference adjusted for BMI in active individuals [EA],270
17,Hydrocortisone product | treatment/medication code,7959
17,DNA methylation variation (age effect),757
17,FSC-A on plasmacytoid Dendritic Cell,1713
17,TPE interval (resting),59
17,Electrocardiogram morphology (amplitude at temporal datapoints) [210 ms],125
17,Alzheimer's disease (cognitive decline),8
17,Triglyceride levels,538302
17,"Blood protein levels [RLN2, 6621_10_3]",12863
17,Serum levels of protein CLK2,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [240 ms],8129
17,Electrocardiogram morphology (amplitude at temporal datapoints) [168 ms],125
17,Facial morphology (segment 44),82
17,Body fat mass,27
17,Type 2 diabetes (time to event),10720
17,Skin colour,51471
17,Childhood sunburn occasions,5847
17,Serum levels of protein CHKB,6403
17,Bipolar disorder or major depressive disorder,1522
17,Facial ageing,844
17,"Blood protein levels [AHSG, 3581_53_3]",12863
17,Malignant neoplasm of cervix uteri,47722
17,Serum levels of protein CNTNAP5,6403
17,Urate levels (BMI interaction) [Combined sex],163
17,Serum levels of protein GLTPD2,4169
17,Serum levels of protein LRRC37A2,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [180 ms],125
17,Paramax tablet | treatment/medication code,672
17,Malignant neoplasm of prostate,45
17,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),36745
17,Loneliness,1104934
17,Androgen levels [serum testosterone],3875
17,Serum levels of protein RBM28,6403
17,Serum levels of protein CNGA2,6403
17,Serum levels of protein SMOC1,6403
17,Serum levels of protein VPS29,6403
17,Serum levels of protein CXCL1,6403
17,Serum levels of protein ANGPTL3,6403
17,Serum levels of protein CD163,1895
17,"Blood protein levels [ICT1, 6380_23_3]",12863
17,Coronary atherosclerosis,15975
17,"Subcortical brain region volumes [Intracranial volume, EA]",2926000
17,Serum uric acid levels,26730
17,Serum levels of protein SYNGR3,6403
17,Serum levels of protein TNFRSF1B,6403
17,Vertex-wise cortical surface area,3008638
17,"Blood protein levels [CSF2RA, 10438_19_3]",12863
17,"Blood protein levels [SHBG, 7909_37_3]",17775
17,Protein quantitative trait loci [MCP-3],1300
17,Protein quantitative trait loci (liver) [ABAT],10
17,Serum levels of protein NRAS,6403
17,Impedance of whole body,1430173
17,Hormone measurements [SHBG],15165
17,Naive CD4+ T cell %T cell,11428
17,Serum levels of protein CTSH,6403
17,Ascending aorta maximum area,31499
17,Serum levels of protein RCAN1,6403
17,Serum levels of protein UBXN4,6403
17,Serum levels of protein SFN,6403
17,CD4-CD8- Natural Killer T %lymphocyte,1324
17,Intelligence (MTAG),1585114
17,Rheumatoid arthritis (ACPA-positive),57264
17,Drive faster than motorway speed limit,1174498
17,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),78796
17,Serum levels of protein AIF1,6403
17,"Blood protein levels [APOA5, 12908_15_3]",12863
17,"Blood protein levels [SF1, 12777_11_3]",12863
17,Forced vital capacity (fvc),1543816
17,"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment",145
17,Electrocardiogram morphology (amplitude at temporal datapoints) [218 ms],125
17,Diseases of the myoneural junction and muscle,3
17,White blood cell count [Neutrophils],22891
17,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],61875
17,Mean sphered cell volume,3189147
17,"Blood protein levels [CNP, 6609_22_3]",39537
17,"Blood protein levels [FLNA, 11108_16_3]",12863
17,"Blood protein levels [TUFT1, 5690_49_3]",6403
17,"Blood protein levels [GDF5, 2752_62_2]",12863
17,Serum levels of protein SNU13,6403
17,Serum levels of protein ALOX15B,2133
17,Electrocardiogram morphology (amplitude at temporal datapoints) [346 ms],22
17,Mytonic disorders,11
17,Serum levels of protein TAB1;MAP3K7,6403
17,Cleft lip with or without cleft palate,4764
17,6mm cylindrical power (right),5196
17,Serum levels of protein FGFRL1,6403
17,Feeling miserable,1576923
17,Fat-free mass,22032
17,Average weekly champagne plus white wine intake,5065
17,Serum levels of protein CETN2,6403
17,Serum levels of protein ERLIN1,6403
17,White blood cell (leukocyte) count,1152994
17,Depressive symptoms (MTAG),1107
17,"""Alzheimer’s disease, wide definition""",1015
17,Muscular dystrophy,267
17,"Blood protein levels [ALDH3A1, 11480_1_3]",2869
17,Atrial fibrillation and flutter,83925
17,von Willebrand factor A domain-containing protein 1 measurement,60804
17,Serum levels of protein TXNDC5,7684
17,Serum levels of protein EPHB4,6403
17,"Forced vital capacity (fvc), best measure",1938420
17,"Diastolic blood pressure [EA, initial]",2645
17,Cognitive traits (MTAG),5449
17,"Blood protein levels [HTR2A, 13556_28_3]",6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [478 ms],22
17,HDL cholesterol x physical activity interaction (1df test),71
17,Asthma (more control exclusions),10580
17,Periventricular white matter hyperintensities,24751
17,Neck circumference (BMI adjusted),293
17,Electrocardiogram morphology (amplitude at temporal datapoints) [198 ms],125
17,White blood cell count [African],21984
17,Deep white matter hyperintensities,16284
17,Serum levels of protein DDR1,6403
17,"Blood protein levels [PCDHGC3, 7859_21_3]",12863
17,"Blood protein levels [PDE2A, 5246_64_3]",12863
17,"Blood protein levels [TRIL, 6527_1_3]",12863
17,Subcutaneous adipose tissue [EA],18231
17,Serum levels of protein SLC6A14,6403
17,TPE interval (resting) [men],4682
17,Doctor diagnosed hayfever or allergic rhinitis,94
17,"Blood protein levels [AGA, 10435_2_3]",12863
17,"Blood protein levels [TNFRSF1B, 3152_57_1]",12863
17,Blood metabolite levels [citrate],804
17,Serum levels of protein DNAJC4,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [102 ms],125
17,"Blood protein levels [CA10, 13666_222_3]",104
17,Hypersensitivity angiitis,6
17,Right-handed | handedness (chirality/laterality),1165935
17,Hypertensive diseases,11198
17,Interleukin-6 receptor subunit beta measurement,2189
17,"Blood protein levels [GLTPD2, 7948_129_3]",3492
17,"Blood protein levels [SH2D1A, 4567_82_2]",12863
17,"Blood protein levels [ERLIN1, 8776_10_3]",6403
17,Gut microbiota relative abundance (bacterial taxa) [Victivallis_vadensis],907
17,CD3- lymphocyte %leukocyte,727
17,"""Benign neoplasm of colon, rectum, anus and anal canal (controls excluding all cancers)""",85
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-94 ms],52
17,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),16
17,White blood cell count [Hispanic/Latino],20873
17,Hypothyroidism,39883
17,Serum levels of protein LRPAP1,6403
17,"Blood protein levels [TESC, 12831_21_3]",6403
17,Serum levels of protein OLA1,6403
17,Serum levels of protein PNPLA2,6403
17,Facial morphology (segment 3),872
17,Brugada syndrome,789
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-120 ms],52
17,Eosinophil percentage of granulocytes,88549
17,Serum levels of protein RELB,6403
17,"Blood protein levels [TNFRSF11B, 8304_50_3]",12863
17,Blood protein levels [CCL16],1158
17,"Blood protein levels [APBB3, 13589_10_3]",6403
17,Heart attack | vascular/heart problems diagnosed by doctor,2268
17,Serum levels of protein FCRL4,6403
17,"Blood protein levels [EA, C-C motif chemokine 3]",2235
17,Protein quantitative trait loci (liver) [PYCARD],193
17,Idiopathic pulmonary fibrosis,1459438
17,Serum levels of protein ARRB1,6403
17,Serum levels of protein STK17B,6403
17,"Blood protein levels [GRP, 8400_74_3]",12863
17,Serum levels of protein MCF2L,6403
17,Serum levels of protein LIF,6403
17,"Blood protein levels [CMPK1, 4786_58_3]",12863
17,"Scleroderma/systemic sclerosis | non-cancer illness code, self-reported",1232
17,Phosphatidylinositol_38:0_[M-H]1- levels,3406
17,Hip shape (DXA scan) [hip shape mode 1],73
17,Hyperthyroidism,36
17,Human herpes virus 7 U14 antibody levels,14359
17,Moderate to vigorous physical activity duration,1176960
17,Serum levels of protein PDE3A,6403
17,Serum levels of protein LRP1B,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [242 ms],8129
17,"Blood protein levels [NXPH3, 6054_6_3]",12863
17,Serum metabolite concentrations in chronic kidney disease [N-formylanthranilic acid],154
17,Primary dental caries (decayed and filled teeth),26
17,Serum phosphate levels,3224483
17,Serum levels of protein TAX1BP3,6403
17,Serum levels of protein HS6ST1,6403
17,"Blood protein levels [SPARC, 14110_200_3]",12863
17,Nonsyndromic cleft lip with or without cleft palate [African],212
17,Serum levels of protein DEFB105B,6403
17,"""Cholelithiasis, broad definition with cholecystitis""",26
17,"Blood protein levels [SYNGR3, 13375_48_3]",6403
17,"Blood protein levels [CLCA1, 10496_11_3]",12863
17,COVID-19 (very severe respiratory confirmed vs population) RELEASE 5,3082
17,Serum levels of protein IL10RA,6403
17,Serum metabolite levels [Aspartylphenylalanine],184
17,Urinary albumin-to-creatinine ratio,135629
17,"Blood protein levels [CD300E, 10798_4_3]",12863
17,Serum levels of protein DYRK3,6403
17,"Blood protein levels [CXCL3 CXCL2, 3148_49_1]",12863
17,Protein quantitative trait loci (liver) [SPTAN1],25
17,Nap during day,1140391
17,Serum levels of protein ACAP2,6403
17,"Blood protein levels [COX7A2L, 9590_10_3]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [48 ms],5198
17,Waist-to-hip ratio adjusted for body mass index [EA],494
17,Motion sickness,774
17,Other diseases of gallbladder,4
17,Serum levels of protein CDCP1,6403
17,"Blood protein levels [NRAC, 13464_8_3]",12863
17,"Blood protein levels [GRB14, 13628_58_3]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-12 ms],1107
17,Serum levels of protein NHLRC3,6403
17,Macular thickness,2461124
17,Comparative height size at age 10,1326891
17,Serum levels of protein ERCC4,6460
17,"Blood protein levels [ARFGAP1, 11556_19_3]",12863
17,"Blood protein levels [MFAP3L, 8837_8_3]",12863
17,"Blood protein levels [TOR1AIP1, 9039_47_3]",12863
17,Asthma (mode),10063
17,White matter microstructure (axial diusivities) [Uncinate fasciculus],14722
17,"Blood protein levels [STAP1, 12510_3_3]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [446 ms],22
17,Protein quantitative trait loci (liver) [BHMT],1
17,Serum levels of protein LOC652493,6403
17,Bumetanide | treatment/medication code,3149
17,Angina,2769
17,Serum levels of protein DEFB121,6403
17,Pulse pressure [EA],1287
17,Nose morphology [Profile nasal angle],94
17,Parkinson's disease or first degree relation to individual with Parkinson's disease,1397048
17,"Blood protein levels [BACH1, 12451_62_3]",12863
17,C-reactive protein levels [BMI-adjusted],6378
17,"""Atopic dermatitis, strict definition with reimbursement""",1554
17,"Blood protein levels [LGALS3BP, 5000_52_1]",381
17,Amoxicillin | treatment/medication code,313
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-108 ms],198
17,IgG N-glycosylation phenotypes (multivariate analysis),22536
17,Serum levels of protein NEURL4,6403
17,Serum levels of protein BMP6,6403
17,Serum levels of protein SPOCK3,6403
17,"Blood protein levels [MIOX, 13498_1_3]",12863
17,"Blood protein levels [SERPINB1, 10737_96_3]",12863
17,Androgen levels [DHT levels],16402
17,Electrocardiogram morphology (amplitude at temporal datapoints) [42 ms],5073
17,"Blood protein levels [SRXN1, 14268_4_3]",12863
17,CD28- CD8+ T cell %CD8+ T cell,727
17,CD8dim Natural Killer T %lymphocyte,1044
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-84 ms],52
17,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],33188
17,Serum levels of protein AGA,6403
17,"Blood protein levels [EA, C-C motif chemokine 18]",2487
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-66 ms],53
17,Number of self-reported non-cancer illnesses,45420
17,Serum levels of protein TNFRSF11B,6403
17,Brain region volumes [right thalamus proper],23710
17,Cortical surface area [total],1464540
17,"Blood protein levels [FKBP6, 12529_32_3]",12863
17,Corneal resistance factor (left),20862
17,Asthma with severe exacerbations [Latino],62594
17,Serum levels of protein MAZ,6403
17,"Blood protein levels [C1QBP, 4967_1_1]",12863
17,"""Psoriasis (vulgaris), strict definition""",608
17,Electrocardiogram morphology (amplitude at temporal datapoints) [204 ms],125
17,Gastroesophageal reflux disease,435
17,Disorders of lipoid metabolism,2874
17,Chronotype,103310
17,Insomnia [Female],31968
17,Left-handed | handedness (chirality/laterality),62338
17,"Pulse rate, automated reading",48820
17,"Blood protein levels [SLC26A11, 13502_2_3]",6403
17,None of the above | vascular/heart problems diagnosed by doctor,68515
17,Serum immune biomarker levels [YKL-40],93
17,Loperamide | treatment/medication code,362
17,Non-albumin protein levels [TP],500
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-104 ms],2659
17,"Blood protein levels [LRRK2, 10990_21_3]",12863
17,Potassium levels,496
17,Smoking behaviour (cigarette pack-years),920
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-114 ms],52
17,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23
17,White blood cell count [EA],35573
17,Serum levels of protein EMID1,6403
17,"Blood protein levels [GSTP1, 13576_15_3]",12863
17,"Forced expiratory volume in 1-second (fev1), best measure",1518378
17,Metabolite levels [C14:1],3371
17,QRS complex (Cornell) [EA],2716
17,Free thyroxine concentration,125485
17,IgD on IgD+ CD38dim B cell,11451
17,Serum levels of protein NCMAP,6403
17,"Blood protein levels [MICALL2, 12891_1_3]",12863
17,"Blood protein levels [RFFL, 14186_13_3]",12863
17,Serum levels of protein SYTL4,6403
17,Serum levels of protein TBX22,466
17,"""Coxarthrosis, primary""",3265
17,Serum levels of protein UCMA,6403
17,Late-onset Alzheimer's disease,8922
17,Sodium in urine,826
17,Spherical equivalent (joint analysis main effects and education interaction) [European ancestry],481
17,Electrocardiogram morphology (amplitude at temporal datapoints) [356 ms],22
17,Electrocardiogram morphology (amplitude at temporal datapoints) [466 ms],22
17,Asthma onset (childhood vs adult),39109
17,Handedness (Left-handed vs. non-left-handed),42604
17,Serum levels of protein CD7,20531
17,"Blood protein levels [CD74, 8748_45_3]",6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [246 ms],8129
17,Serum levels of protein NDNF,6403
17,"Blood protein levels [DCTN2, 5879_51_3]",6460
17,Diastolic blood pressure [East Asian],1562
17,Diabetes | illnesses of father,290
17,Electrocardiogram morphology (amplitude at temporal datapoints) [448 ms],22
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-26 ms],125
17,Chronic obstructive pulmonary disease x current smoker interaction (2df),64101
17,Schizophrenia vs ADHD (ordinary least squares (OLS)),34499
17,"Blood protein levels [SPATA20, 11117_2_3]",21183
17,Reticulocyte percentage,27273
17,Serum levels of protein MIOX,6403
17,"Blood protein levels [CCL23, 3028_36_2]",3985
17,Volume depletion,15
17,Body fat percentage and LDL-C (pairwise),59709
17,Bioavailable testosterone levels,1666225
17,Serum levels of protein ETHE1,6403
17,"None of the above | medication for pain relief, constipation, heartburn",18686
17,Hypertensive diseases (excluding secondary),3116
17,Myocardial fractal dimension (slice 2),2763
17,Protein quantitative trait loci (liver) [BPNT1],1275
17,Blautia A sp900066145 abundance in stool,211
17,Electrocardiogram morphology (amplitude at temporal datapoints) [474 ms],22
17,Beef consumption,56
17,Blood protein levels [CCL4],1876
17,Serum levels of protein UBE2D4,6403
17,"Blood protein levels [TCTN2, 11433_11_3]",12863
17,"Blood protein levels [CCL4L1, 2781_63_2]",5587
17,Serum levels of protein SMR3A,6403
17,Blood protein levels [C-C motif chemokine 23],1234
17,Serum levels of protein DUSP4,6403
17,Serum levels of protein VSTM5,6403
17,"Blood protein levels [ELL, 11459_81_3]",12863
17,Blood protein levels [SHBG],3875
17,T cell lymphocyte profile difference (1 day post influenza vaccination),975
17,Protein levels in obesity [MIP-1a],1001
17,Electrocardiogram morphology (amplitude at temporal datapoints) [122 ms],149
17,Serum levels of protein KRTDAP,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [22 ms],5396
17,"Blood protein levels [LIPN, 8097_77_3]",12863
17,"Blood protein levels [SECTM1, 13093_6_3]",33394
17,"Blood protein levels [STX1A, 3766_51_4]",12863
17,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test),19042
17,"Blood protein levels [RNF41, 13411_21_3]",6403
17,Serum levels of protein CPM,6403
17,"Blood protein levels [EA, C-C motif chemokine 5]",3309
17,Protein quantitative trait loci [WFKN2],4569
17,Electrocardiogram morphology (amplitude at temporal datapoints) [82 ms],125
17,Self-rated health,1003
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-58 ms],53
17,Serum levels of protein ATP13A1,6403
17,Age asthma diagnosed,41214
17,Serum levels of protein SLC25A18,6403
17,Fibrinogen,2021
17,"Blood protein levels [PTPRR, 6361_49_3]",466
17,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)",13604
17,White matter microstructure (mode of anisotropy) [External capsule ],18010
17,Basophil percentage of white cells,35216
17,Neutrophil-to-lymphocyte ratio,1399553
17,Serum levels of protein DYNAP,6403
17,Serum levels of protein RASA1,6403
17,"Blood protein levels [LDOC1, 8378_3_4]",12863
17,"Blood protein levels [MAPK12, 5005_4_1]",12863
17,BRCA1 mutation in breast cancer [adjusted],3022
17,Electrocardiogram morphology (amplitude at temporal datapoints) [320 ms],5913
17,Serum levels of protein NCOA2,6403
17,Serum levels of protein MADCAM1,6403
17,"Ecg, heart rate",111
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-24 ms],125
17,Reticulocyte fraction of red cells,2275529
17,Lifetime number of sexual partners,1434939
17,Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis),866892
17,Serum levels of protein EFNA2,6403
17,Serum levels of protein GRAP,6403
17,"""Type 2 diabetes, definitions combined""",11632
17,HDL cholesterol levels x long total sleep time interaction (2df test) [EA],6038
17,"Blood protein levels [HDHD2, 13472_35_3]",6403
17,Retinal arteriolar caliber,1188
17,Luteine | treatment/medication code,951
17,Electrocardiogram morphology (amplitude at temporal datapoints) [80 ms],125
17,Cardiac pacemaker/device in situ,15
17,Plateletcrit,314864
17,Kidney injury molecule 1 levels,12348
17,"Blood protein levels [GRAMD1C, 8842_16_3]",12863
17,Serum levels of protein HSPA1L,6403
17,"Blood protein levels [EA, Non-receptor tyrosine-protein kinase TYK2]",120
17,Dentures,63963
17,Body fat distribution (trunk fat ratio) [females],26764
17,Non-albumin protein levels [conditional on round 2],10283
17,"Blood protein levels [BACH2, 12756_3_3]",12863
17,Bilateral cleft lip and palate,136
17,High light scatter reticulocyte count,5559609
17,Reaction time,14700
17,Serum levels of protein KCNG4,6403
17,Serum levels of protein TMX3,7684
17,"Blood protein levels [CDH6, 3591_51_3]",12863
17,Whole body fat-free mass,237227
17,"Hayfever/allergic rhinitis | non-cancer illness code, self-reported",35377
17,Serum levels of protein CLEC4A,6424
17,"Blood protein levels [CCL15, 3509_1_1]",4975
17,Chronic myeloid leukemia,1598
17,Serum levels of protein TSNARE1,6403
17,Cortical thickness [Superior temporal],37641
17,Citramalate levels,7808
17,"Blood protein levels [ADH5, 11369_23_3]",12863
17,"Blood protein levels [ENOX2, 13422_66_3]",12863
17,Serum levels of protein CMPK1,6403
17,Bone mineral density (spine),1219
17,Electrocardiogram morphology (amplitude at temporal datapoints) [104 ms],125
17,Benign neoplasm of skin,485
17,Interleukin-1 receptor type 2 measurement,88
17,Cervical cancer [Matched],38703
17,Alzheimer's disease or family history of Alzheimer's disease,90395
17,Brown vs. black hair color,18734
17,Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis),866892
17,Serum levels of protein IFIT2,6403
17,"Blood protein levels [DYNLRB1, 3845_51_2]",12863
17,Age at first sexual intercourse,14265
17,Serum levels of protein TMEM52B,6460
17,Place of birth in uk - north co-ordinate,6973
17,Electrocardiogram morphology (amplitude at temporal datapoints) [308 ms],1182
17,QT dynamics during exercise [female],96
17,HDL cholesterol levels in current drinkers,28331
17,Birth weight (MTAG),26661
17,IgD on IgD+ CD24- B cell,11451
17,"Blood protein levels [TAGLN2, 9201_13_3]",12863
17,Dermatitis and eczema,2868
17,"""Other dorsopathies, not elsewhere classified""",69
17,Serum levels of protein PLXDC2,6403
17,Serum levels of protein PDIA3,6403
17,"Blood protein levels [TPT1, 14072_9_3]",12863
17,"Blood protein levels [DDX23, 13946_8_3]",12863
17,"Blood protein levels [PPIB, 4718_5_2]",12863
17,Asthma-related acute respiratory infections,42578
17,Serum levels of protein MMEL1,6403
17,Serum metabolite levels [X-14208],2969
17,Alcohol use disorder (consumption score) [EA],3428
17,Total body bone mineral density,45669
17,vWF and FVIII levels,13590
17,Serum levels of protein DYNLRB1,6403
17,Serum levels of protein ASGR2,6367
17,"Blood protein levels [CLIC1, 5013_2_1]",6403
17,Serum levels of protein BACH2,6403
17,"""Other diabetes, wide definition""",12442
17,Mean arterial pressure [East Asian],2213
17,"Blood protein levels [CCL3, 3040_59_1]",1367
17,Serum levels of protein SFXN5,6403
17,Serum levels of protein NQO2,6403
17,"Blood protein levels [CRABP2, 11696_7_3]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [146 ms],149
17,Age at menopause,120354
17,Serum levels of protein TENM4,6403
17,Childhood asthma,15563
17,"Blood protein levels [ETHE1, 3847_56_2]",12863
17,Serum levels of protein LRTM2,6403
17,Hematology traits [ALB/GLB],502
17,Early cardiac repolarization,101
17,Neutrophil count,8946526
17,Waist-hip ratio,3351550
17,Glaucoma (multi-trait analysis),33213
17,Serum levels of protein DCP1A,6403
17,"Blood protein levels [CCNB1IP1, 9728_4_3]",12863
17,"Blood protein levels [FKBP2, 9339_204_3]",12863
17,Serum levels of protein BRF1,6403
17,Serum levels of protein FLT3,6403
17,B cell %lymphocyte,537
17,Body fat percentage,408197
17,Serum levels of protein NAGS,6403
17,Serum levels of protein OPCML,6403
17,"Blood protein levels [CTNNB1, 8424_269_3]",12863
17,"Blood protein levels [CD34, 9023_9_3]",12863
17,Serum levels of protein FUT9,6403
17,Hip bone size,3215
17,Serum levels of protein CDSN,453
17,Direct low density lipoprotein cholesterol levels,136860
17,Blood metabolite levels [X-14208--phenylalanylserine],2897
17,"Blood protein levels [CDH12, 10701_30_3]",12863
17,Serum levels of protein ACE,2897
17,"Blood protein levels [GDF11 MSTN, 2765_4_3]",5053
17,Electrocardiogram morphology (amplitude at temporal datapoints) [194 ms],125
17,Nose morphology [Nasal tip protrusion],94
17,Serum metabolite levels [p-cresol-glucuronide*],82
17,Monobrow,1434602
17,Medication use (calcium channel blockers),18669
17,Lymphocyte-to-monocyte ratio,1159050
17,Serum levels of protein LILRB3,6460
17,Serum levels of protein TEC,6403
17,"Blood protein levels [POFUT2, 6042_52_3]",12863
17,Serum levels of protein TNFSF12,12702
17,Neonatal cytokine/chemokine levels (fetal genetic effect) [CCL15],541
17,Intelligence,104691
17,Age-related hearing impairment [additive],26915
17,Fat-free mass [male],18368
17,Serum levels of protein COLGALT1,6403
17,Hypothyroidism or myxedema,13795
17,Refractive astigmatism,5196
17,"Blood protein levels [EA, WNT1-inducible-signaling pathway protein 1]",3809
17,Serum prostate-specific antigen levels,304
17,"""Malignant neoplasm of breast, HER-positive (controls excluding all cancers)""",725
17,"Heart attack/myocardial infarction | non-cancer illness code, self-reported",2391
17,Electrocardiogram morphology (amplitude at temporal datapoints) [58 ms],125
17,"Blood protein levels [KIF22, 12734_112_3]",12863
17,Serum levels of protein PSG2,6403
17,Age first had sexual intercourse,2523
17,ST2 protein levels,2119
17,Waist circumference adjusted for BMI (adjusted for smoking behaviour),160
17,Kidney volume,106
17,Serum levels of protein MT1F,6403
17,Serum levels of protein OLFM3,6403
17,Facial morphology (segment 49),2291
17,Electrocardiogram morphology (amplitude at temporal datapoints) [90 ms],1162
17,Electrocardiogram morphology (amplitude at temporal datapoints) [84 ms],125
17,Sitting height ratio,160
17,Lung function (FEV1),1460298
17,Birth weight,130427
17,HDL cholesterol levels,459644
17,Myocardial fractal dimension (slice 3),5073
17,Mean reticulocyte volume,4270485
17,Heel bone mineral density T score,1505225
17,Serum levels of protein CSN1S1,6403
17,"Blood protein levels [WFIKKN2, 3235_50_2]",5053
17,Electrocardiogram morphology (amplitude at temporal datapoints) [46 ms],5198
17,Disorders of the thyroid gland,4157
17,White matter microstructure (axial diusivities) [Inferior fronto-occipital fasciculus],36399
17,"Blood protein levels [JAM2, 2997_8_1]",12863
17,Two-hour glucose,4253
17,Securon 40mg tablet | treatment/medication code,594
17,Serum levels of protein EHD4,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [112 ms],125
17,Soluble VCAM-1 levels,156
17,T cell lymphocyte profile difference,18
17,Walking pace,13768
17,Guilty feelings,1143190
17,"Blood protein levels [RMI1, 13926_1_3]",12863
17,"Blood protein levels [TLR2, 3835_11_2]",12863
17,Distance between home and job workplace,73
17,Electrocardiogram morphology (amplitude at temporal datapoints) [128 ms],149
17,Type 2 diabetes,892669
17,Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis),769381
17,Serum levels of protein DNAJB14,6403
17,"Blood protein levels [SCARA3, 11292_13_3]",12863
17,Heel bone mineral density (bmd) (right),16698
17,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction),3425
17,Serum levels of protein CCL14,1719
17,Serum levels of protein ICOSLG,6403
17,Serum levels of protein STIM1,6403
17,"Blood protein levels [LMAN2, 7638_30_3]",12863
17,Asthma (only as main-diagnosis),8808
17,Cereal intake,1086
17,Electrocardiogram morphology (amplitude at temporal datapoints) [296 ms],1182
17,"Logmar, final (right)",5196
17,Serum levels of protein UGT2A2,6403
17,T wave morphology restitution during exercise,61
17,"Blood protein levels [EFNB1, 5746_37_3]",12863
17,"Blood protein levels [PCYOX1L, 5599_88_3]",12863
17,Protein quantitative trait loci (liver) [ME1],9
17,Sex hormone-binding globulin levels,1839035
17,Serum levels of protein OCRL,6403
17,Serum levels of protein NAT1,6403
17,"Blood protein levels [PRPF6, 9581_4_3]",12863
17,None of the above (group 1) | illnesses of mother,19487
17,Serum levels of protein AHSG,6403
17,Proinsulin levels,3543
17,Medium (175ml) | size of rose wine glass drunk,714
17,Dorsopathies,3
17,Bleomycin hydrolase levels,5932
17,Serum levels of protein TNFRSF10A,6403
17,"Blood protein levels [RRAS2, 12361_102_3]",12863
17,"Blood protein levels [PPA1, 5021_13_1]",12863
17,CD8dim T cell Absolute Count,1324
17,White matter microstructure (mode of anisotropy) [Cingulate gyrus],645
17,Monoclonal gammopathy of undetermined significance,304
17,Nonsyndromic cleft lip with or without cleft palate,233
17,Renal function-related traits (sCR),82
17,Rheumatoid arthritis,201848
17,Doctor diagnosed asthma,38053
17,"Paracetamol | medication for pain relief, constipation, heartburn",1415556
17,"Blood protein levels [ASGR2, 9474_22_3]",12863
17,"Blood protein levels [PFKFB3, 12456_5_3]",12863
17,Serum levels of protein SECTM1,27131
17,Blood protein levels [C-C motif chemokine 15],2697
17,"Rheumatic fever | non-cancer illness code, self-reported",1997
17,Crohn's disease [EA],58269
17,"Blood protein levels [GPR142, 12766_33_3]",12863
17,"Blood protein levels [MAP3K7 TAB1, 5259_2_3]",12863
17,"Blood protein levels [SHMT1, 12334_25_3]",21985
17,"Blood protein levels [MAPKAPK5, 8382_47_3]",12863
17,Thyrotoxic periodic paralysis,2454
17,Otosclerosis,491
17,Electrocardiogram morphology (amplitude at temporal datapoints) [156 ms],149
17,White matter microstructure (axial diusivities) [Posterior corona radiata ],587
17,"""Asthma, unspecified (mode) (more control exclusions)""",45
17,Eye color traits [CHS1],15409
17,Eczema,98902
17,Brain region volumes [right precuneus],120336
17,"Blood protein levels [IL22, 2778_10_2]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [52 ms],5198
17,Electrocardiogram morphology (amplitude at temporal datapoints) [50 ms],5198
17,Serum levels of protein KLRC3,7393
17,Cognitive ability (MTAG),1456117
17,Glomerular filtration rate,65537
17,White matter hyperintensity volume,96666
17,Type 2 diabetes or prostate cancer (pleiotropy),65368
17,Galectin-9 levels,11311
17,Serum levels of protein ISOC1,6403
17,"Blood protein levels [COPS2, 14029_42_3]",12863
17,"Blood protein levels [PKLR, 11203_97_3]",12863
17,Serum levels of protein HERC5,6403
17,Serum levels of protein ADM,6403
17,Gut microbiota relative abundance (bacterial taxa) [Murimonas_intestini],225
17,"Blood protein levels [CCL7, 4886_3_1]",1300
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-40 ms],53
17,Sum neutrophil eosinophil counts,1642823
17,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test) [EA],19042
17,Platelet-to-lymphocyte ratio,74849
17,"Other (e.g. cornflakes, frosties) | cereal type",12895
17,"Blood protein levels [KPNA2, 2860_19_2]",2097
17,Facial morphology (segment 26),15189
17,White matter microstructure (mean diusivities) [Genu of corpus callosum],11677
17,Calcaneus stiffness index,8823
17,"Red | hair colour (natural, before greying)",5196
17,Serum levels of protein IFNA2,6403
17,Brain region volumes [Brain stem],61
17,LDL cholesterol levels x long total sleep time interaction (2df test),31422
17,Serum levels of protein DAPK2,6403
17,"Blood protein levels [OCRL, 10011_65_3]",6403
17,Low myopia vs hyperopia,3888
17,Hernia,287
17,Ever had prostate specific antigen (psa) test,1011
17,Anthropometric traits (multi-trait analysis),844
17,Sitting height ratio [EA],411
17,Menopause (age at onset),116695
17,Total testosterone levels,1935599
17,"Blood protein levels [TNFRSF1A, 2654_19_1]",12863
17,Fractures,3314
17,Autoimmune thyroid disease,6630
17,Urolithiasis,1176
17,Gut microbiota relative abundance (bacterial taxa) [Murimonas],225
17,Feeling worry,1359293
17,Chronic obstructive pulmonary disease in non-current smokers,64101
17,Stable angina pectoris,6825
17,Serum levels of protein ANGPTL4,6403
17,Serum levels of protein KLK15,6403
17,White matter microstructure (mean diusivities) [Fornix (column and body],3428
17,Body fat distribution (arm fat ratio),2742
17,HLA DR+ Natural Killer %Natural Killer,1044
17,Electrocardiogram morphology (amplitude at temporal datapoints) [286 ms],1182
17,Serum levels of protein KPNA2,392
17,Neutrophil count [conditional on round 2],130
17,Schizophrenia [EA],67588
17,Low testosterone levels,1436039
17,"Blood protein levels [CLC, 11094_104_3]",12863
17,"Blood protein levels [SPACA3, 8076_4_3]",12863
17,"Blood protein levels [UBXN4, 9970_7_3]",12863
17,"""Malignant neoplasm of breast, HER2-negative (controls excluding all cancers)""",13604
17,"Blood protein levels [EA, C-C motif chemokine 14]",3381
17,Serum levels of protein CAMK1D,6460
17,"Blood protein levels [CST8, 10572_65_3]",4975
17,Serum levels of protein MYRF,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [342 ms],4731
17,Insulin-related traits (multivariate analysis),3462
17,"Blood protein levels [AMH, 4923_79_1]",12863
17,"Blood protein levels [ELL2, 11494_4_3]",12863
17,Sex hormone-binding globulin levels [Men + Women],16122
17,Serum levels of protein MPP6,6403
17,Serum levels of protein ELL,6403
17,Serum levels of protein RUFY1,6403
17,Metabolite levels [C12],991
17,Orofacial clefts,436
17,Anaemias,23
17,Eosinophil percentage of white cells,2003573
17,Peak expiratory flow,1534210
17,Serum levels of protein NDUFB4,6403
17,Serum levels of protein EFNB1,6403
17,"Blood protein levels [PMEL, 6472_40_3]",12863
17,"Carpal tunnel syndrome | non-cancer illness code, self-reported",1156
17,Serum levels of protein EDIL3,156
17,Miserableness,136802
17,Tense / 'highly strung',18033
17,Trouble falling asleep,1121092
17,"Blood protein levels [GRIA4, 10760_107_3]",12863
17,"Blood protein levels [KLK15, 6491_59_3]",12863
17,Serum levels of protein CCNB1IP1,6403
17,Albumin-globulin ratio,5822
17,B cell %CD3- lymphocyte,1044
17,Serum levels of protein ACBD7,6403
17,Hemoglobin A1c levels [Hispanic/Latino],119
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-60 ms],53
17,Lymphocyte counts,3508157
17,Snoring,2843740
17,Cortical thickness (MOSTest),29339
17,Hormone measurements [Testosterone],15165
17,Serum levels of protein TPM3,6460
17,"Blood protein levels [ERP44, 6064_4_3]",12863
17,"Blood protein levels [IFIT2, 9853_3_3]",12863
17,"Blood protein levels [ISOC1, 9816_37_3]",12863
17,"Diastolic blood pressure, automated reading",62350
17,"Blood protein levels [CCL5, 2523_31_3]",10049
17,"""Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere""",264
17,"Blood protein levels [EA, NAD-dependent protein deacetylase sirtuin-2]",459
17,Multiple sclerosis,190823
17,Serum levels of protein MSTN,12806
17,"Blood protein levels [GNRH1, 5627_53_3]",12863
17,Atrial fibrillation [EA],12942
17,"Blood protein levels [PENK, 9076_25_3]",12863
17,Serum levels of protein STAP1,6403
17,"Blood protein levels [CPN2, 6415_90_3]",12863
17,Serum levels of protein CCL7,864
17,Neurociticism,1430217
17,Serum levels of protein ZFYVE27,6403
17,CD3- lymphocyte %lymphocyte,1044
17,Electrocardiogram morphology (amplitude at temporal datapoints) [110 ms],125
17,Lipoprotein (a) levels,8939
17,C-C motif chemokine 16 levels,7957
17,Serum levels of protein CXCL2;CXCL3,6403
17,"Blood protein levels [PCDHB4, 10522_167_3]",12863
17,Bendroflumethiazide | treatment/medication code,97
17,Myocardial infarction,93043
17,"Blood protein levels [CD34, 11285_8_3]",12863
17,"Blood protein levels [RFESD, 13603_7_3]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-10 ms],6180
17,Serum levels of protein RAD51D,6403
17,"Sphingomyelin (d18:2/16:0, d18:1/16:1) levels",4607
17,Crohn's disease or systemic sclerosis,5548
17,Serum levels of protein NSDHL,6403
17,Serum levels of protein SLC22A16,6403
17,Age-related hearing impairment (SNP x SNP interaction),1566
17,General cognitive ability,1634394
17,Serum levels of protein HCAR2,6403
17,Serum levels of protein C20orf173,6403
17,"Blood protein levels [PRLR, 5114_65_3]",12863
17,"Blood protein levels [PSMD1, 10735_12_3]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [140 ms],125
17,Educational attainment (MTAG) [MTAG],1881984
17,Serum levels of protein ZPBP,6517
17,Serum levels of protein CPVL,6403
17,Serum levels of protein NPIPB3,6403
17,Chronic lower respiratory diseases,9319
17,Serum levels of protein LGMN,6403
17,SPARC-related modular calcium-binding protein 1 measurement,877
17,Serum levels of protein OCIAD1,6403
17,Serum levels of protein SIGLEC12,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-18 ms],1232
17,Theophylline levels,2045
17,Inguinal hernia,390
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-116 ms],52
17,Hip circumference [EA],22532
17,Serum levels of protein TWF1,6403
17,Serum levels of protein SPARC,6403
17,White matter microstructure (mean diusivities) [Superior corona radiata],11677
17,"Blood protein levels [NSDHL, 8038_41_3]",12863
17,6mm strong meridian (left),55696
17,Protein quantitative trait loci (liver) [ACTG1],3424
17,"Blood protein levels [CD7, 12008_3_3]",20214
17,Electrocardiogram morphology (amplitude at temporal datapoints) [224 ms],125
17,Large (250ml) | size of rose wine glass drunk,3187
17,Triglycerides [EA],247
17,Urokinase plasminogen activator surface receptor levels,994
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-16 ms],1107
17,Neck pain or shoulder pain,145
17,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),25265
17,TestASV_16 (Bacteroides) prevalence,11735
17,Serum levels of protein EBI3;IL27,6403
17,Serum levels of protein MGA,6403
17,Serum levels of protein EPHB2,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [290 ms],1182
17,Serum levels of protein MAP2K3,6403
17,"Blood protein levels [MUC1, 10623_19_3]",12863
17,BMI (adjusted for smoking behaviour),1104
17,Pulse pressure,330207
17,Alcohol consumption,1497584
17,Average total household income before tax,1174672
17,Serum levels of protein APBB1,6403
17,"Blood protein levels [SCO1, 7853_19_3]",12863
17,Serum levels of protein KCNA10,6403
17,Resting heart rate,1670
17,"Blood protein levels [PYY, 3727_35_1]",2302
17,Natural Killer %CD3- lymphocyte,1044
17,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs (controls excluding all cancers),48
17,Highest math class taken (MTAG) [MTAG],1876993
17,Smoking status,12315
17,HDL cholesterol levels [Trans-ethnic initial],37565
17,"Blood protein levels [PFN2, 13054_87_3]",12863
17,"Blood protein levels [SLITRK4, 7139_14_3]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-90 ms],52
17,Serum levels of protein SF1,6403
17,"Blood protein levels [UBC, 6647_55_3]",12863
17,3mm cylindrical power (left),5196
17,"Blood protein levels [DHX8, 11601_26_3]",466
17,DNA methylation Hannum age acceleration,11
17,Malignant neoplasm of skin (controls excluding all cancers),85
17,"""Haemangioma and lymphangioma, any site""",3
17,Serum levels of protein M6PR,6403
17,"Blood protein levels [CHIT1, 3600_2_3]",12863
17,Asthma and allergy,42565
17,Serum levels of protein CD8B,6416
17,Urate levels [men],28
17,Eosinophil counts,3941812
17,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],29012
17,Serum levels of protein OSCAR,6403
17,Serum levels of protein CD300E,8145
17,Frequency of consuming six or more units of alcohol,19531
17,"Blood protein levels [TNFRSF10A, 4832_75_2]",12863
17,6mm weak meridian (right),42892
17,Serum levels of protein CSH1;CSH2,6403
17,Colorectal cancer [East Asian],846
17,Electrocardiogram morphology (amplitude at temporal datapoints) [100 ms],125
17,Brainstem volume,61
17,Worry too long after an embarrassing experience,1385778
17,Smoking initiation (ever regular vs never regular),171409
17,Serum levels of protein CD58,6424
17,Serum levels of protein KLK13,6367
17,Corneal hysteresis (left),11793
17,Protein quantitative trait loci (liver) [SAT2],1247
17,Stromal cell-derived factor 2 measurement,6403
17,Serum levels of protein SEPT10,6403
17,"Blood protein levels [CD300E, 8287_17_3]",1742
17,Serum metabolite levels [3-Hydroxybutyrate],386
17,QRS duration,18107
17,White matter microstructure (axial diusivities) [External capsule ],1098778
17,White matter microstructure (radial diusivities) [Anterior limb of internal capsule],1147987
17,Serum levels of protein TREM2,6403
17,Serum levels of protein UPK3BL,6517
17,Basophill count,30968
17,"Blood protein levels [ADAM7, 10753_31_3]",12863
17,"Light brown | hair colour (natural, before greying)",15570
17,"Blood protein levels [HSPA1L, 12041_33_3]",12863
17,"Blood protein levels [IL31, 10455_196_3]",12863
17,Trunk fat percentage,139984
17,Ulcerative rectosigmoiditis,19898
17,Electrocardiogram morphology (amplitude at temporal datapoints) [36 ms],5073
17,Serum levels of protein SCARF1,6673
17,Serum levels of protein DSC1,6403
17,"Blood protein levels [EA, C-C motif chemokine 8]",2576
17,Enterococcus B abundance in stool,899
17,Protein quantitative trait loci (liver) [CRYM],31
17,Cortical surface area (min-P),58809
17,Serum levels of protein MSR1,6403
17,"Blood protein levels [CREBBP, 13614_6_3]",12863
17,"Blood protein levels [GOSR2, 10426_21_3]",12863
17,"Blood protein levels [MAGEA10, 13610_9_3]",12863
17,"Blood protein levels [PPP3R1, 3657_74_3]",12863
17,"Blood protein levels [mtb12, 15007_43_3]",6403
17,Serum levels of protein PUF60,6403
17,"Blood protein levels [HPGD, 4995_16_1]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [220 ms],125
17,Electrocardiogram morphology (amplitude at temporal datapoints) [60 ms],125
17,Spherical equivalent or myopia (age of diagnosis),88116
17,Serum levels of protein RRAS2,6403
17,"Dark brown | hair colour (natural, before greying)",46666
17,"Blood protein levels [UPK3BL, 6633_43_3]",12863
17,"Blood protein levels [VTN, 13125_45_3]",12863
17,Forced expiratory volume in 1-second (fev1),176939
17,Townsend deprivation index at recruitment,3097
17,Gout,154
17,Asthma-related infections,39772
17,Mosaic loss of chromosome Y (Y chromosome dosage),7370
17,Electrocardiogram morphology (amplitude at temporal datapoints) [18 ms],5396
17,"Blood protein levels [RPSA, 4957_1_2]",12863
17,Acisoga levels,4626
17,Microalbumin in urine,181
17,Blood metabolite levels [aspartylphenylalanine],2969
17,Serum levels of protein NAB1,6403
17,Peptic ulcer disease,335
17,Nutritional anaemias,23
17,Irritable mood,1468960
17,Serum levels of protein KIF22,6403
17,Serum levels of protein SERPINF1,9998
17,Serum levels of protein EZR,6403
17,Frequency of tenseness / restlessness in last 2 weeks,16233
17,Serum levels of protein HIST3H2A,6403
17,Serum levels of protein TP53,6403
17,Prostate-specific antigen levels,538
17,Lactococcus lactis abundance in stool,18
17,Insulin-like growth factor 1 levels,1816485
17,Neuroticism conditioned on self-rated math ability (multi-trait conditioning and joint analysis),769381
17,"Blood protein levels [IL1B, 3037_62_1]",12863
17,Serum levels of protein ZNF275,6403
17,Serum levels of protein C1QL1,6899
17,Serum levels of protein MDM2,6403
17,T cell %lymphocyte,1044
17,Neuroticism (MTAG),662
17,Adolescent idiopathic scoliosis,25360
17,Blond vs. brown/black hair color,27166
17,Morning person,71055
17,Cortical surface area (global PC1),2333358
17,Body mass index [Japanese],8865
17,X-15245 levels,12111
17,Serum levels of protein LY6G6C,6403
17,"Blood protein levels [TNFSF12, 5939_42_3]",20103
17,Serum levels of protein APMAP,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-8 ms],1107
17,Fractured/broken bones in last 5 years,1194
17,Body fat distribution (leg fat ratio),26764
17,Menarche (age at onset) [japanese],72359
17,White matter microstructure (axial diusivities) [Genu of corpus callosum],15534
17,"Blood protein levels [GBP6, 7818_101_3]",12863
17,"Blood protein levels [TAGLN2, 11636_33_3]",12863
17,None of the above | mouth/teeth dental problems,18764
17,Trunk fat-free mass,143515
17,"Blood protein levels [MPZL2, 9372_157_3]",12863
17,"Blood protein levels [CD96, 9735_44_3]",12863
17,Serum levels of protein RNF8,6403
17,"Fracture jaw | non-cancer illness code, self-reported",1317
17,Nabumetone | treatment/medication code,116
17,See own gp | actions taken following self-harm,442
17,Family history of malignant neoplasm,25
17,Electrocardiogram morphology (amplitude at temporal datapoints) [490 ms],22
17,Mean platelet volume,3829274
17,LDL cholesterol levels,73747
17,Brain region volumes [right insula],94826
17,Electrocardiogram morphology (amplitude at temporal datapoints) [334 ms],4731
17,"Blood protein levels [THRA, 12527_50_3]",12863
17,"Blood protein levels [TMCC3, 11294_7_3]",12863
17,Spherical power (left),51732
17,Dementia,1115
17,Electrocardiogram morphology (amplitude at temporal datapoints) [294 ms],1182
17,malignant neoplasm of male genital organs (controls excluding all cancers),45
17,Adventurousness,156931
17,Blood protein levels in cardiovascular risk,21969
17,Diabetic neuropathy in type 2 diabetes,13403
17,High blood pressure | vascular/heart problems diagnosed by doctor,105834
17,"Sex hormone-binding globulin levels [Men + Women, Conditional]",28879
17,Nasopharyngeal carcinoma (SNP x SNP interaction),8309
17,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),223
17,HDL cholesterol levels [EA],53404
17,"Blood protein levels [FAM210A, 14593_152_3]",12863
17,Cardiovascular diseases (excluding rheumatic etc),432
17,Systolic blood pressure x smoking status (ever vs never) interaction (2df test),12381
17,Serum levels of protein ALDH3A1,2869
17,Frequency of tiredness / lethargy in last 2 weeks,233
17,Protein quantitative trait loci (liver) [GGH],2212
17,Serum levels of protein GRN,1015
17,"Blood protein levels [EA, Dickkopf-related protein 4]",459
17,Feeling hurt,1428718
17,White matter microstructure (mean diusivities) [Anterior corona radiata],12264
17,"Pulse pressure [EA, initial]",5073
17,Serum urea levels,100535
17,Serum levels of protein ROR1,6403
17,"Blood protein levels [SMPDL3A, 4771_10_3]",12863
17,3mm strong meridian (right),38636
17,Serum levels of protein SPACA3,6403
17,Total amyloid (SNP x SNP interaction),2681
17,Atrial fibrillation/atrial flutter,18283
17,Sodium warfarin | treatment/medication code,1447
17,"Blood protein levels [EA, C-C motif chemokine 15]",1271
17,"Blood protein levels [C10orf35, 8220_15_3]",466
17,EGFR mutation-positive lung adenocarcinoma,8754
17,"""Hypothyroidism, strict autoimmune, 3 medication purchases required""",17217
17,Serum levels of protein THRA,6403
17,Time spent using computer,6333
17,Electrocardiogram morphology (amplitude at temporal datapoints) [88 ms],125
17,"""Malignant neoplasm of breast, HER2-negative""",13604
17,Serum levels of protein AXL,5927
17,Serum levels of protein CDC34,6403
17,Psoriatic arthropathies,16
17,Triglycerides,137825
17,Alcohol use disorder (consumption score),2831028
17,Bitter alcoholic beverage consumption,1278573
17,Serum levels of protein FAM210A,6403
17,"Blood protein levels [AXL, 10574_10_3]",4884
17,Diabetes mellitus,11923
17,Manlignant and unknown neoplasms of brain and nervous system,14526
17,Serum levels of protein ADAM7,6403
17,Serum levels of protein ATP1B1,6403
17,Serum levels of protein ESD,6403
17,Serum levels of protein POFUT2,6403
17,Serum levels of protein LDOC1,6403
17,Whole body water mass,253218
17,Leg predicted mass (left),322035
17,Serum levels of protein HSPA6,6403
17,Serum levels of protein FGF10,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [470 ms],22
17,Electrocardiogram morphology (amplitude at temporal datapoints) [468 ms],22
17,Diastolic blood pressure,686209
17,White matter microstructure (axial diusivities) [Superior longitudinal fasciculus],667809
17,"Blood protein levels [GAL3ST1, 8696_15_3]",12863
17,"Blood protein levels [JAK2, 11816_84_3]",12863
17,Fluid intelligence score,46027
17,Arm fat-free mass (right),162763
17,"Blood pressure medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",5651
17,"Blood protein levels [HERC5, 12934_1_3]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [38 ms],5073
17,"Intra-ocular pressure, goldmann-correlated (left)",1818
17,Lipoprotein-associated phospholipase A2 activity and mass [activity],4496
17,Benign neoplasm: Colon,85
17,TNF-related apoptosis-inducing ligand levels,50
17,Cholelithiasis and cholecystitis,26
17,White matter microstructure (radial diusivities) [Fornix (cres) / Stria terminalis],1225186
17,Lectin-like oxidized LDL receptor 1 levels,18586
17,Serum levels of protein ASTL,6403
17,Pattern 1 | hair/balding pattern,142255
17,Age asthma diagnosed by doctor,36175
17,Leg fat-free mass (right),343003
17,"High cholesterol | non-cancer illness code, self-reported",79740
17,Senile cataract,21956
17,White matter microstructure (global fractional anisotropy),921
17,Vitamin C levels,106
17,Acute lymphoblastic leukemia (childhood),17972
17,Depressed affect,1450354
17,Total cholesterol levels [EA],58320
17,Serum levels of protein SPHK2,6403
17,Serum levels of protein WFDC3,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [72 ms],125
17,Emotionally unstable personality disorder,30
17,"Blood protein levels [SLC6A14, 13053_6_3]",12863
17,Positive affect,445
17,"""Hypothyroidism, levothyroxin purchases""",8
17,Myopia,21174
17,White blood cell count (basophil),23143
17,Medication use (drugs used in diabetes),55533
17,Physical activity (Total log acceleration),1176960
17,"Blood protein levels [TGM1, 11242_33_3]",12863
17,"Blood protein levels [CCL8, 13748_4_3]",1306
17,"Blood protein levels [KISS1, 6606_61_3]",466
17,Hematological and biochemical traits [TP],529
17,Facial morphology [right alare-left cheilion distance],8
17,Phosphatidylcholine-O_44:5_[M+OAc]1-/Phosphatidylcholine-P_44:4_[M+OAc]1- levels,22891
17,Cortical surface area,1602141
17,"Blood protein levels [PLIN3, 14687_6_3]",12863
17,"Blood protein levels [UTS2, 6020_52_3]",12863
17,"Blood protein levels [CD300A, 5630_48_3]",2679
17,"Blood protein levels [MDM4, 13229_20_3]",12863
17,Protein quantitative trait loci [MIPb],280
17,OTU99_94 (Bacteroides) prevalence,30
17,"Cholesterol, total",261892
17,Myeloid white cell count,1664360
17,Weight,860589
17,Serum levels of protein IL36A,6403
17,For 'astigmatism' | reason for glasses/contact lenses,5196
17,"Blood protein levels [NHP2L1, 13602_6_3]",12863
17,Hair morphology traits [Hair color phototype score],5196
17,Ever heard an un-real voice,514
17,"Eye/eyelid problem | non-cancer illness code, self-reported",1366
17,Balding type 1,130156
17,Lung adenocarcinoma [East Asian],8865
17,"Blood protein levels [LGMN, 3622_33_4]",12863
17,Ankle spacing width,168869
17,"Heel broadband ultrasound attenuation, direct entry",72838
17,6mm strong meridian (right),53992
17,"Blood protein levels [ACP2, 9237_54_3]",12863
17,Serum levels of protein NTN1,2151
17,CCL23 levels,2089
17,Malignant neoplasm of skin,85
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-46 ms],53
17,Handedness (left-handed vs. right-handed),42604
17,Membrane-bound aminopeptidase P levels,39718
17,"Blood protein levels [GSTA1, 12446_49_3]",12863
17,"Blood protein levels [YWHAB,YWHAE,YWHAG,YWHAH,YWHAQ,YWHAZ,SFN, 4707_50_2]",12863
17,Basophill percentage,30698
17,CD28- CD8dim T cell Absolute Count,1305
17,"Blood protein levels [FAM3B, 5618_50_3]",12863
17,QT interval,25523
17,Predicted visceral adipose tissue,133961
17,Serum levels of protein AHSA1,6403
17,Serum levels of protein CDH3,6403
17,"Blood protein levels [DLK1, 8380_244_4]",6403
17,"Blood protein levels [MBD1, 14294_61_3]",12863
17,"Blood protein levels [PDIA3, 4719_58_2]",12863
17,"Blood protein levels [STX3, 7186_111_3]",12863
17,Mean corpuscular haemoglobin,237639
17,TPE interval (resting) [women],59
17,Serum uric acid levels [Japanese],174
17,Psoriasis vulgaris,32
17,Other and unspecified iron deficiency,23
17,Serum levels of protein RFESD,6403
17,"Blood protein levels [BMP6, 3736_60_3]",12863
17,"Blood protein levels [TMEM52B, 9778_45_3]",12863
17,Neuritic plaques (SNP x SNP interaction),1441
17,Serum levels of protein KLHL13,6403
17,"Blood protein levels [ANP32B, 4194_26_3]",12863
17,"Blood protein levels [SLC14A2, 12818_159_3]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [300 ms],1182
17,Serum uric acid levels [EA],518
17,Serum levels of protein SMAD3,6403
17,Serum levels of protein CD34,12806
17,Serum levels of protein SLITRK4,6403
17,For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia') | reason for glasses/contact lenses,4902
17,"Blood protein levels [ECI2, 12859_33_3]",12863
17,"Blood protein levels [OPCML, 3634_5_4]",12863
17,Arm predicted mass (right),162704
17,Cancer of brain and nervous system,13709
17,Vertical cup-disc ratio,758
17,Serum levels of protein C4orf32,332
17,Sphingolipid levels [levels],677
17,Cigarettes smoked per day (MTAG),26491
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-30 ms],42834
17,"Blood protein levels [TNFSF18, 2708_54_2]",12863
17,Serum levels of protein GPR135,6403
17,IgD+ B cell %Lymphocyte,436
17,"Angina | non-cancer illness code, self-reported",3546
17,Galectin-3-binding protein measurement,497
17,Myocardial fractal dimension (slice 4),5073
17,Childhood onset type 2 diabetes,5341
17,Serum levels of protein IL17RB,6403
17,"Blood protein levels [MPO, 2580_83_2]",2097
17,Neuronal pentraxin-1 measurement,2954
17,Serous invasive ovarian cancer,921575
17,Alzheimer's disease,66437
17,"Blood protein levels [CRABP1, 11967_23_3]",12863
17,"Blood protein levels [RBBP9, 10064_12_3]",6403
17,"Nervous breakdown | non-cancer illness code, self-reported",3831
17,"Blood protein levels [RBM28, 11927_3_3]",12863
17,CD28+ CD4-CD8- T cell %CD4-CD8- T cell,727
17,Cerebrospinal AB1-42 levels in normal cognition,247
17,Osteoarthrosis (time to event),2586351
17,Gamma-glutamyl hydrolase measurement,12745
17,Serum levels of protein TYMSOS,6403
17,White matter microstructure (axial diusivities) [Posterior thalamic radiation],15290
17,Standing height,603035
17,"Blood protein levels [FGF10, 2441_2_4]",12863
17,Duration to first press of snap-button in each round,14586
17,Body mass index (bmi),658823
17,Relapse in treatment-naive multiple sclerosis (time to event),716
17,"Blood protein levels [EA, C-C motif chemokine 4-like]",46
17,Heel bone mineral density,5190541
17,IgD+ CD24- B cell Absolute Count,37901
17,Pediatric asthma,18851
17,"Blood protein levels [GABBR2, 13948_50_3]",12863
17,"Blood protein levels [NUDC, 8887_21_3]",12863
17,"Logmar, final (left)",5196
17,Chin dimples,14608
17,Serum levels of protein TINF2,6403
17,Protein quantitative trait loci (liver) [CTSD],29
17,Serum levels of protein MAN2B2,6403
17,"Blood protein levels [EQTN, 11162_37_3]",12863
17,Serum levels of protein STK16,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [302 ms],1182
17,"Blood protein levels [MOB1A, 12426_19_3]",12863
17,"Blood protein levels [PPP1R3B, 12768_3_3]",466
17,Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test) [African],130
17,Serum levels of protein DEFA5,58
17,LDL cholesterol,154370
17,Systemic sclerosis,71717
17,Serum levels of protein PKLR,6403
17,Serum levels of protein TNFRSF11A,6403
17,Serum levels of protein SERPINI2,6403
17,Serum levels of protein CD63,6403
17,"Blood protein levels [OLFML3, 8660_33_3]",12863
17,"Blood protein levels [SCGN, 10894_25_3]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [250 ms],8129
17,Glucose levels,4703
17,"Percent glycated albumin [AA, initial]",390
17,Saccharofermentanaceae abundance in stool,24
17,Protein quantitative trait loci (liver) [ALDOA],6
17,Type 1 diabetes (age at diagnosis),35328
17,"Blood protein levels [SFXN5, 13729_26_3]",12863
17,Serum levels of protein TRH,6403
17,Unstable angina pectoris,617
17,Self-reported math ability (MTAG) [MTAG],1130426
17,C-C motif chemokine 4 levels,1959
17,Serum levels of protein YWHAQ;SFN;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ,6403
17,"Blood protein levels [RYK, 5583_62_3]",12863
17,Mitochondrial DNA copy number,8579
17,Hyperopia,811
17,Electrocardiogram morphology (amplitude at temporal datapoints) [460 ms],22
17,Electrocardiogram morphology (amplitude at temporal datapoints) [450 ms],22
17,Nervous feelings,1097473
17,"Blood protein levels [CDH3, 2643_57_2]",12863
17,"Blood protein levels [CHKB, 13117_232_3]",12863
17,"Blood protein levels [TAX1BP3, 12498_12_3]",12863
17,Single spontaneous delivery,4647
17,Meloxicam | treatment/medication code,878
17,Endometrial endometrioid carcinoma,290
17,"Medication use (adrenergics, inhalants)",69104
17,Cylindrical power (left),4902
17,Asthma-related pneumonia,42565
17,Adult onset asthma and/or BMI,12655
17,"Blood protein levels [GDF9, 3067_67_1]",12863
17,Diseases of the respiratory system,3082
17,Other cataract,3990
17,Electrocardiogram morphology (amplitude at temporal datapoints) [200 ms],125
17,Electrocardiogram morphology (amplitude at temporal datapoints) [182 ms],125
17,"Blood protein levels [NTN1, 9013_60_3]",319
17,Body fat distribution (trunk fat ratio),26764
17,Protein quantitative trait loci (liver) [SHMT1],35398
17,"Blood protein levels [PVRIG, 6464_40_3]",12863
17,Asthma and allergy (more control exclusions),42565
17,Serum levels of protein SLITRK1,6403
17,White matter microstructure (axial diusivities) [Fornix (column and body],3428
17,Exhaled nitric oxide levels,4141
17,Migraine without aura and/or pulse pressure,1661
17,Hemoglobin A1c levels,1992280
17,"Blood protein levels [HNRNPH1, 14309_8_3]",12863
17,"Blood protein levels [MPP6, 13490_1_3]",12863
17,Serum levels of protein NAPB,6403
17,CD28- CD8+ T cell Absolute Count,727
17,TPE interval (response to exercise),75
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-88 ms],52
17,Hypertension,250332
17,Lumbar spine bone mineral density,1485802
17,Apolipoprotein B levels,257600
17,"Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)",40491
17,Serum albumin levels [EA],3295
17,"Blood protein levels [CDH15, 5410_53_3]",12863
17,Medication use (HMG CoA reductase inhibitors),115828
17,Serum levels of protein COTL1,6403
17,Serum levels of protein GAA,4100
17,"Blood protein levels [KLK14, 3681_87_3]",12863
17,Impedance of arm (left),439634
17,Arm predicted mass (left),121757
17,3-hydroxy-1-methylpropylmercapturic acid levels in smokers [AA],215
17,"Hip circumference adjusted for BMI [EA, women]",3801
17,Atrial fibrillation,83851
17,IgD+ B cell Absolute Count,37901
17,Serum levels of protein SH2D3C,6403
17,Serum levels of protein UBC,6403
17,Serum levels of protein NBR1,6460
17,"Blood protein levels [ATP4B, 9994_217_3]",12863
17,Childhood asthma (age<16) (more control exclusions),40028
17,"Blood protein levels [PTPRH, 11222_62_3]",12863
17,Family history of Alzheimer's disease,15473
17,Serum metabolite levels [X-14304],3095
17,Serum levels of protein CDC25B,6460
17,C-C motif chemokine 3 levels,8298
17,Medication use (anilides),2812702
17,Serum levels of protein DKKL1,6403
17,Serum levels of protein GNRH1,6403
17,Serum levels of protein GBP6,6403
17,"Blood protein levels [C7, 2888_49_2]",12863
17,Neurological blood protein biomarker levels [CLM-1],5180
17,Electrocardiogram morphology (amplitude at temporal datapoints) [126 ms],149
17,3-hydroxypropylmercapturic acid levels in smokers [AA],215
17,Glaucoma (high intraocular pressure),143
17,Bilirubin levels,307339
17,White matter microstructure (fractional anisotropy) [Genu of corpus callosum],1458131
17,"Blood protein levels [CD27, 5412_53_3]",12863
17,"Blood protein levels [CLK2, 11327_56_3]",12863
17,"Blood protein levels [OCIAD1, 3635_76_4]",12863
17,"Blood protein levels [RAB5C, 14287_6_3]",12863
17,Serum levels of protein CCL5,20182
17,Urinary albumin-to-creatinine ratio [EA],2335
17,CD8dim Natural Killer T Absolute Count,1044
17,Angiotensin-converting enzyme inhibitor intolerance,109
17,hemolysis of donated blood (cold-storage),24
17,"Blood protein levels [EA, Breast cancer anti-estrogen resistance protein 3]",120
17,Serum levels of protein NRSN1,6403
17,"Blood protein levels [ASTL, 7993_23_3]",12863
17,"Blood protein levels [BMP15, 11129_66_3]",12863
17,"Blood protein levels [CTRL, 9229_9_3]",12863
17,"Blood protein levels [UBE3A, 11226_16_3]",12863
17,Serum levels of protein CBLN1,6403
17,Serum levels of protein ATP1B2,2080
17,Serum levels of protein SPINK5,6403
17,Osteoarthritis (hip) [additive],303
17,Macrovascular complications in type 2 diabetes,13403
17,"Waist circumference adjusted for body mass index [EA, men]",825
17,Serum levels of protein STAT6,6517
17,Blood metabolite levels [X-03056--N-[3-(2-Oxopyrrolidin-1-yl)propyl]acetamide],11375
17,"""Hypothyroidism, strict autoimmune""",17431
17,Gamma glutamyl transferase levels,241698
17,Diastolic blood pressure x smoking status (ever vs never) interaction (2df test),15396
17,Type 2 diabetes [conditional],53007
17,"Blood protein levels [CTXN3, 10467_58_3]",12863
17,"Blood protein levels [DIABLO, 3122_6_2]",12863
17,"Blood protein levels [M6PR, 10491_21_3]",12863
17,Serum levels of protein HMGCS1,6403
17,"Blood protein levels [GAA, 9385_4_3]",3050
17,"Blood protein levels [CETN2, 13078_3_3]",12863
17,"Blood protein levels [NLGN2, 9772_153_3]",1126
17,"Blood protein levels [GRN, 4992_49_1]",1015
17,Serum total protein level [EA],519
17,Serum levels of protein STOML2,6403
17,"Blood protein levels [DDX46, 14216_35_3]",12863
17,"Blood protein levels [WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2]",1959
17,Serum levels of protein ESRP1,6403
17,Blood metabolite levels [X-12441--12-hydroxyeicosatetraenoate (12-HETE],1235
17,"Blood protein levels [SIRT2, 5030_52_1]",13329
17,Serum levels of protein SLC3A1,6403
17,LDL cholesterol levels x short total sleep time interaction (2df test),1250
17,Cholelithiasis,52
17,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),33188
17,Optic disc size,12438
17,"Blood protein levels [CPM, 7768_10_3]",12863
17,"Blood protein levels [CXCL1, 2985_35_1]",12863
17,"Blood protein levels [FARS2, 13941_82_3]",12863
17,"Blood protein levels [MSR1, 3684_78_3]",12863
17,Antihypertensive medication - note that there are other indications,5985
17,Electrocardiogram morphology (amplitude at temporal datapoints) [304 ms],1182
17,Thyrotoxic hypokalemic periodic paralysis and Graves disease,1227
17,Previous | smoking status,193
17,Number of incorrect matches in round,2177
17,Lung cancer | illnesses of adopted father,275
17,Leiomyoma of uterus (controls excluding all cancers),85
17,Physical activity (overall physical activity time),2555706
17,Asthma (age of onset),80333
17,Serum levels of protein IL5,6403
17,Serum levels of protein MFAP4,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [14 ms],5073
17,"Blood protein levels [SPOCK3, 9906_21_3]",12863
17,"Blood protein levels [EA, OCIA domain-containing protein 1]",120
17,Serum levels of protein ATP2A3,6403
17,Treponema D abundance in stool,587
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-4 ms],1107
17,None of the above | pain type(s) experienced in last month,151
17,Electrocardiogram morphology (amplitude at temporal datapoints) [142 ms],149
17,Body fat distribution (leg fat ratio) [females],26764
17,Age at first birth,2984363
17,"Blood protein levels [CBLN1, 9313_27_3]",12863
17,Year ended full time education,1119132
17,Estradiol levels,17397
17,Levothyroxine sodium | treatment/medication code,4287
17,Systolic blood pressure [East Asian],2072
17,Serum levels of protein CD27,6403
17,Serum levels of protein APOH,466
17,Electrocardiogram morphology (amplitude at temporal datapoints) [222 ms],125
17,Iron deficiency anaemia secondary to blood loss (chronic),71
17,Other malignant neoplasms of skin (=non-melanoma skin cancer) (controls excluding all cancers),85
17,T wave morphology restitution during exercise (MTAG),61
17,Automobile speeding propensity,1433471
17,Serum levels of protein ADI1,6403
17,Serum levels of protein IL22RA2,6403
17,"Blood protein levels [CDKN2B, 9874_28_3]",12863
17,"Blood protein levels [RABEPK, 13599_15_3]",12863
17,Protein quantitative trait loci (liver) [PNPO],6503
17,Prostate cancer [European],221
17,"Blood protein levels [CCL16, 4913_78_1]",4975
17,Macrophage inflammatory protein 1b levels,34281
17,Cryptosporidiosis,1109
17,Serum levels of protein KIF3A,6403
17,Serum levels of protein DEAF1,6403
17,Vertex-wise sulcal depth,3086570
17,"Blood protein levels [MYRF, 8843_34_3]",12863
17,Leg predicted mass (right),321595
17,Autoimmune traits,11798
17,Male puberty timing (age at voice breaking MTAG),5492
17,Serum levels of protein SH2D1A,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [216 ms],125
17,Birth length (MTAG),26661
17,Length of mobile phone use,36081
17,Serum levels of protein FOXRED1,6403
17,"Blood protein levels [EA, Serine protease 27]",3809
17,"Blood protein levels [CSMD1, 9598_23_3]",12863
17,"Blood protein levels [JARID2, 12623_84_3]",12863
17,Migraine and/or systolic blood pressure,7656
17,"Blood protein levels [NCOA2, 14045_12_3]",12863
17,"""Hypertension, essential""",12775
17,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 levels,1302
17,Electrocardiogram morphology (amplitude at temporal datapoints) [484 ms],22
17,Body fat percentage or coronary artery disease (MTAG),4159
17,Serum levels of protein LRP2,6403
17,Serum levels of protein SHMT1,38191
17,"Blood protein levels [TNFRSF11A, 5424_55_3]",12863
17,Serum levels of protein APOA5,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [120 ms],149
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-44 ms],53
17,Smoking initiation (ever regular vs never regular) (MTAG),299145
17,Cataracts,20923
17,Serum levels of protein GABBR2,6403
17,Basal cell carcinoma,9948
17,Nonsyndromic cleft lip with or without cleft palate [EA],4180
17,"Blood protein levels [HTR6, 13561_5_3]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [298 ms],1182
17,Alpha-galactosidase A measurement,389
17,Venous thromboembolism (SNP x SNP interaction),420
17,Metabolic traits [aspartylphenylalanine],3095
17,"Blood protein levels [ADSL, 5023_23_1]",6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [324 ms],5913
17,Simvastatin | treatment/medication code,62146
17,Heart failure and antihypertensive medication,5032
17,Nonsyndromic cleft lip with cleft palate,7815
17,Serum levels of protein ELK1,6403
17,Angina pectoris,8823
17,CD4-CD8- Natural Killer T Absolute Count,1324
17,Scavenger receptor cysteine-rich type 1 protein M130 levels,5541
17,Type 2 diabetes (adjusted for BMI),2080
17,"Blood protein levels [STIM1, 8916_32_3]",12863
17,Congenital malformations of heart and great arteries,2538
17,Seborrheic dermatitis,171
17,"Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",125
17,Experiencing mood swings,1428764
17,Serum levels of protein COPS2,6403
17,"Blood protein levels [FLT3, 3437_80_3]",12863
17,"Blood protein levels [MCF2L, 13934_3_3]",6403
17,"""Ulcerative colitis (strict definition, all Crohn cases excluded)""",23288
17,Urinary metabolite levels in chronic kidney disease [N-formylanthranilic acid],402
17,Vertical cup-disc ratio (adjusted for vertical disc diameter),2050
17,Electrocardiogram morphology (amplitude at temporal datapoints) [174 ms],125
17,Facial morphology (forehead protrusion 1),2696
17,Physical activity,3840418
17,Electrocardiogram morphology (amplitude at temporal datapoints) [154 ms],149
17,Electrocardiogram morphology (amplitude at temporal datapoints) [76 ms],125
17,Bronchial hyperresponsiveness in asthma,35487
17,TB-LM or TBLH-BMD (pleiotropy),40958
17,"Blood protein levels [DAPK2, 4355_13_1]",12863
17,"Blood protein levels [RAD51L3, 12554_10_3]",12863
17,"Blood protein levels [ZP4, 7766_25_3]",12863
17,"Blood protein levels [IL5, 3741_4_3]",12863
17,Primary open-angle glaucoma,257
17,Leiomyoma of uterus,85
17,Lipid traits (pleiotropy) (HIPO component 1),12467
17,Insomnia,61275
17,Ethylmalonate levels,3228
17,Serum levels of protein BCAR3,12806
17,Blood metabolite levels [3-(4-hydroxyphenyl)lactate],192368
17,"Blood protein levels [SPINK5, 8028_22_3]",12863
17,"Blood protein levels [TMPRSS6, 11239_49_3]",12863
17,Serum levels of protein CTSB,6403
17,Other endophthalmitis,9
17,Hemoglobin levels,2862771
17,Serum levels of protein SLC5A5,6403
17,"Hayfever, allergic rhinitis or eczema | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",59535
17,"Blood protein levels [KLRC4, 10552_88_3]",12863
17,Well-being spectrum (multivariate analysis),3197
17,Number of treatments/medications taken,1697
17,Serum levels of protein FAM20A,1575
17,Group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP,156
17,Serum levels of protein SERPINF2,84
17,Serum levels of protein HDHD2,6403
17,Retinal vascular fractal density,5196
17,Gastrointestinal diseases,2076
17,"Blood protein levels [DUSP26, 8967_6_3]",6403
17,"""Disorders of plasma-protein metabolism, not elsewhere classified""",1491
17,Fracture of forearm,522
17,Activated partial thromboplastin time,411
17,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant I (Philtrum), Segment 35]",716
17,Other non-epithelial cancer of skin,85
17,Serum levels of protein SCMH1,6403
17,"Blood protein levels [DYRK3, 4359_87_1]",12863
17,Creatinine (enzymatic) in urine,5663
17,Bone mineral density (hip),15793
17,Serum levels of protein MFN1,6403
17,Serum levels of protein NMRAL1,6403
17,Heel broadband ultrasound attenuation (right),20453
17,"Blood protein levels [STAT6, 10372_18_3]",12863
17,"""Alzheimer disease, including avohilmo""",1855
17,Left–right brain asymmetry,143
17,Electrocardiogram morphology (amplitude at temporal datapoints) [186 ms],149
17,Electrocardiogram morphology (amplitude at temporal datapoints) [486 ms],22
17,Cognitive ability,1414287
17,Alcohol intake frequency.,1504063
17,"Blood protein levels [ADI1, 12457_10_3]",12863
17,"Blood protein levels [SHBG, 4929_55_1]",17775
17,"Blood protein levels [TPM3, 9890_8_3]",12863
17,Serum levels of protein XCL1,6403
17,"Blood protein levels [VWA2, 7128_9_3]",12863
17,"Blood protein levels [CD58, 10938_13_3]",12863
17,Serum levels of protein HRC,6403
17,Serum levels of protein FAM19A3,6403
17,"Black | hair colour (natural, before greying)",18436
17,"Blood protein levels [CLEC12B, 10837_131_3]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [44 ms],5073
17,Electrocardiogram morphology (amplitude at temporal datapoints) [158 ms],125
17,Cognitive performance (MTAG) [MTAG],959969
17,Serum levels of protein HHLA2,6403
17,Serum levels of protein SHBG,29510
17,Serum levels of protein NCR1,6403
17,Serum levels of protein HINT2,6403
17,Serum metabolite levels [leucylalanine],2744
17,"Blood protein levels [METTL1, 12514_16_3]",12863
17,Blood protein levels [Macrophage inflammatory protein-1b],280
17,"Blood protein levels [GPC1, 8697_38_3]",12863
17,Serum levels of protein RNF149,6403
17,Ribulonate/xylulonate levels,2728
17,Electrocardiogram morphology (amplitude at temporal datapoints) [248 ms],8129
17,Thyrotoxic hypokalemic periodic paralysis,2454
17,Electrocardiogram morphology (amplitude at temporal datapoints) [34 ms],5073
17,Serum levels of protein MDM4,6403
17,Multiple myeloma and monoclonal gammopathy,750
17,Rheumatoid arthritis [EA],37220
17,Chronic obstructive pulmonary disease x current smoker interaction (main effect),64101
17,"Blood protein levels [OOSP2, 7106_37_3]",12863
17,Serum levels of protein CCL18,1574
17,hemolysis of donated blood (osmotic),8351
17,Serum levels of protein CLCNKB,6403
17,Serum levels of protein SLC30A3,6517
17,Renal function-related traits (BUN),503
17,Total body bone mineral density (age over 60),399
17,Injuries to the elbow and forearm,522
17,Electrocardiogram morphology (amplitude at temporal datapoints) [166 ms],149
17,Gallstone disease,26
17,Retinal nerve fibre layer thickness or ganglion cell inner plexiform layer thickness (MTAG),186811
17,Urinary metabolites [histidine/τ-methylhistidine],65732
17,"Blood protein levels [PSMA1, 7880_9_3]",12863
17,Mean time to correctly identify matches,14895
17,Type 2 diabetes with other specified/multiple/unspecified complications,9107
17,"Waist-hip ratio [EA, women]",220
17,Serum levels of protein LMCD1,6403
17,Serum levels of protein CDKN2B,6403
17,"Blood protein levels [CLPB, 11860_3_3]",6403
17,Noncognitive aspects of educational attainment,1368
17,Feeling lonely,1861
17,Smoking status (ever vs never smokers),7056
17,Metabolic biomarkers (multivariate analysis),192815
17,"Blood protein levels [DSC1, 10882_12_3]",12863
17,Major depressive disorder,13339
17,Marginal zone lymphoma or systemic lupus erythematosus,19402
17,Cardiorespiratory fitness (800m run time),17
17,Serum levels of protein ADAMTS6,6403
17,"Blood protein levels [GPR135, 11465_4_3]",12863
17,"Blood protein levels [SFRP2, 7751_121_3]",12863
17,Serum levels of protein TNFSF11,6403
17,Medication use (drugs affecting bone structure and mineralization),2784
17,Alzheimer's disease or systolic blood pressure (pleiotropy),644
17,"Intra-ocular pressure, corneal-compensated (right)",257
17,Electrocardiogram morphology (amplitude at temporal datapoints) [354 ms],22
17,Disorders of breast,12
17,Platelet distribution width,480811
17,Basophil count,168416
17,Serum levels of protein OOSP2,6403
17,"Blood protein levels [CABP7, 7104_71_3]",12863
17,"Blood protein levels [DCP1A, 14008_22_3]",12863
17,Ovarian cancer [Serious invasive],29271
17,Serum levels of protein CCL8,3028
17,Pulse wave arterial stiffness index,516
17,Respiratory diseases,45288
17,Cortical surface area [Global],127830
17,Serum creatinine levels,191676
17,Serum levels of protein LRP1,6403
17,Serum metabolite levels [X-14205],2969
17,"Blood protein levels [LRPPRC, 10696_217_3]",12863
17,"None of the above | medication for cholesterol, blood pressure or diabetes",13865
17,Metabolite levels [Fischer's ratio],4253
17,Serum levels of protein EDN2,6403
17,Serum levels of protein YBX1,4194
17,"Blood protein levels [DYNAP, 10692_48_3]",12863
17,Alzheimer's disease or small vessel stroke,1564
17,QT dynamics during exercise,96
17,Electrocardiogram morphology (amplitude at temporal datapoints) [138 ms],125
17,Thyroid hormone levels [TSH],88
17,Corneal astigmatism,10392
17,Serum levels of protein DNAJB9,6403
17,Serum levels of protein GP1BA,10759
17,Serum levels of protein DUSP26,6460
17,"Blood protein levels [CALCOCO2, 12534_10_3]",10218
17,"Blood protein levels [ANGPTL1, 9092_33_3]",6403
17,Pork consumption,10639
17,Electrocardiogram morphology (amplitude at temporal datapoints) [134 ms],125
17,Malignant neoplasm of prostate (controls excluding all cancers),45
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-92 ms],52
17,Hand grip strength,1485566
17,Knee osteoarthritis,30006
17,"Blood protein levels [JAKMIP3, 9068_17_3]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [244 ms],8129
17,"Blood protein levels [RUFY1, 11425_31_3]",12863
17,"""UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)""",42958
17,Body fat percentage [European],2646
17,"Blood protein levels [MGA, 11587_5_3]",12863
17,Diastolic blood pressure [EA],4309
17,Serum levels of protein LRPPRC,6403
17,Serum levels of protein SMIM10,6403
17,Felt very upset when reminded of stressful experience in past month,1159
17,Serum levels of protein CASQ1,6403
17,Heel bone mineral density (MTAG),712
17,Protein quantitative trait loci (liver) [ADK],366
17,"Blood protein levels [RRM2B, 8854_59_3]",12863
17,Serum levels of protein FGFBP1,6403
17,"Blood protein levels [GPR64, 10767_52_3]",12863
17,"Blood protein levels [KCNA10, 13042_7_3]",12863
17,"Blood protein levels [ARFIP1, 13488_3_3]",12863
17,Non-albumin protein levels,1531125
17,Serum levels of protein STX8,2036
17,Serum levels of protein CADM3,6403
17,"Blood protein levels [CD47, 6653_58_3]",12863
17,Coronary revascularization (ANGIO or CABG),12805
17,"Blood protein levels [BRICD5, 6612_90_3]",12863
17,"Hip circumference [EA, men]",6267
17,"Blood protein levels [CCL23, 2913_1_2]",1307
17,Metabolite levels [C14:2],991
17,Protein quantitative trait loci (liver) [TOMM70],334
17,Primary biliary cholangitis,296408
17,Male-pattern baldness,4493927
17,Educational attainment (years of education),4445563
17,Chronic kidney disease,12040
17,Body size at age 10,25540
17,Calcium levels,426185
17,Salt added to food,6991
17,Osteoarthritis; localized,1432149
17,Serum levels of protein C2orf66,6403
17,"Blood protein levels [ERO1L, 7060_2_3]",12863
17,"Blood protein levels [GHRL, 6518_85_3]",12863
17,"Blood protein levels [RCAN1, 13465_5_3]",12863
17,Age at menopause (last menstrual period),118338
17,Serum metabolite levels [N6-acetyllysine],17727
17,"Blood protein levels [EA, C-C motif chemokine 3-like 1]",324
17,White matter microstructure (mean diusivities) [External capsule ],14
17,White matter microstructure (fractional anisotropy) [Average across all tracts],1414372
17,Respiratory or ear-nose-throat disease,41523
17,"Blood protein levels [AHSP, 9025_5_3]",12863
17,"Blood protein levels [STOML2, 6555_58_3]",12863
17,Cataracts [female],14714
17,Neurological blood protein biomarker levels [CLM-6],5220
17,Serum levels of protein ANGPTL1,6403
17,TNF-related activation-induced cytokine levels,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [32 ms],5073
17,Walking for pleasure (not as a means of transport) | types of physical activity in last 4 weeks,503
17,Electrocardiogram morphology (amplitude at temporal datapoints) [124 ms],149
17,Protein quantitative trait loci (liver) [C5],18
17,Asthma (time to onset),53587
17,Asthma with severe exacerbations,31885
17,"Blood protein levels [ZNF275, 9609_25_3]",12863
17,Serum levels of protein DPEP1,6403
17,Serum levels of protein TARDBP,6403
17,"""Artrosis, including avohilmo""",1161
17,Electrocardiogram morphology (amplitude at temporal datapoints) [78 ms],125
17,Asthma,973536
17,Lymphocyte percentage of white cells,3053824
17,Estimated glomerular filtration rate,511275
17,Caffeine consumption from coffee,8221
17,Serum levels of protein DMKN,6403
17,Serum levels of protein CSF3,6403
17,"Blood protein levels [CLEC4G, 10781_19_3]",12863
17,"Blood protein levels [TENM4, 11365_17_3]",12863
17,QT dynamics during recovery from exercise,1107
17,Neurological blood protein biomarker levels [CLEC10A],3331
17,Corneal endothelial cell size variation coefficient,393
17,Spherical equivalent,832064
17,Myocardial fractal dimension (slice 1),29218
17,"Blood protein levels [ACPL2, 6079_59_3]",12863
17,"Systolic blood pressure [EA, initial]",5295
17,Serum levels of protein MICALL2,6403
17,Thyrotoxicosis,2950
17,C-C motif chemokine 15 levels,17502
17,Nose morphology [Nasolabial angle],94
17,"Blood protein levels [EDN2, 12574_36_3]",12863
17,"Blood protein levels [HS6ST1, 5465_32_3]",12863
17,"Blood protein levels [TSNARE1, 7069_9_4]",12863
17,Leg fat mass (right),188597
17,Serum levels of protein LY96;TLR4,6403
17,Serum levels of protein YBX2,6403
17,"Blood protein levels [TWF1, 12871_10_3]",12863
17,QRS complex (Sokolow-Lyon) [EA],1065
17,Serum levels of protein RAB5C,6403
17,Chronic kidney disease [eGFRcrea],106
17,Electrocardiogram morphology (amplitude at temporal datapoints) [360 ms],22
17,Sleep duration,1520658
17,"Blood protein levels [ARRB1, 12643_4_3]",12863
17,Patellar tendinitis,40023
17,Natural Killer %lymphocyte,1771
17,Pulmonary emphysema [Chinese],41
17,Electrocardiogram morphology (amplitude at temporal datapoints) [92 ms],125
17,"Blood protein levels [MXRA7, 8005_1_3]",4421
17,Immature reticulocyte fraction,1584642
17,Electrocardiogram morphology (amplitude at temporal datapoints) [322 ms],4731
17,"Orofacial clefts [Meta-All, NSCL/P]",183
17,Hematology traits [Red cell distribution width],36
17,Electrocardiogram morphology (amplitude at temporal datapoints) [190 ms],125
17,Crohn's disease,149139
17,Highest math class taken,1577949
17,College or university degree | qualifications,1367685
17,Peak expiratory flow (pef),1401833
17,"Heel quantitative ultrasound index (qui), direct entry (right)",15788
17,"Constipation | non-cancer illness code, self-reported",3852
17,"Blood protein levels [EA, Interleukin-5]",3809
17,Serum levels of protein ABL2,6403
17,Serum levels of protein PCDH10,6403
17,Serum levels of protein GDA,6403
17,Serum levels of protein LPO,1217
17,"Blood protein levels [RAB26, 6997_32_3]",2097
17,White matter hyperintensity volume (adjusted for hypertension),5320
17,Cleft lip with or without cleft palate [EA],3648
17,Serum levels of protein ACP2,6403
17,Serum levels of protein TRIL,6403
17,Waist circumference adjusted for body mass index,316768
17,Worrier / anxious feelings,5604
17,Serum levels of protein HIF1A,6403
17,"Blood protein levels [SFN, 4829_43_6]",12863
17,"Blood protein levels [ADAMTS6, 6441_62_3]",12863
17,"Blood protein levels [ARF6, 12425_104_3]",12863
17,Serum levels of protein MFF,6403
17,"Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)",758
17,Uterine fibroids,107
17,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA],3425
17,"Blood protein levels [IL36G, 9117_4_3]",12863
17,Restless legs syndrome,7052
17,3mm weak meridian (left),17567
17,"Loneliness, isolation",2458
17,Mild influenza (H1N1) infection,1627
17,Oily fish intake,48769
17,Wheeze or whistling in the chest in last year,46351
17,Serum levels of protein CLIC1,6403
17,White matter microstructure (mean diusivities) [Retrolenticular part of internal capsule],3858
17,Ascorbic acid 3-sulfate levels,1713
17,CD24+ CD27+ B cell %lymphocyte,537
17,Alcohol consumption x experiences in childhood (felt loved by family member) interaction,1108
17,Protein quantitative trait loci (liver) [CCDC58],18
17,LDL cholesterol x physical activity interaction (2df test),58811
17,Alcohol consumption (heavy vs. light/non-drinkers),1296022
17,White matter integrity (mean diffusivity),1441252
17,Serum levels of protein TIGAR,6403
17,Serum levels of protein MAGEA10,6403
17,Serum levels of protein IL36G,6403
17,"Blood protein levels [BRF1, 5384_67_3]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [252 ms],8129
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-22 ms],1232
17,Serum levels of protein ARPC3,6403
17,Blood protein levels [CCL8],1433
17,Myeloperoxidase levels,34281
17,Serum levels of protein BMP15,6403
17,Serum levels of protein SEMA3A,6403
17,Brain region volumes [left transverse temporal],37197
17,"Blood protein levels [DEFB121, 5765_53_3]",12863
17,"Blood protein levels [LRTM2, 8906_60_3]",12863
17,Serum levels of protein GCNT4,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [282 ms],1182
17,Coxarthrosis [arthrosis of hip](FG),1430
17,Protein quantitative trait loci (liver) [STAT1],145
17,"Diabetes | non-cancer illness code, self-reported",248
17,Nonatopic asthma and/or BMI,34794
17,Diabetes or endocrine disease,17018
17,"Blood protein levels [Apoa1, 3748_74_1]",6460
17,"Blood protein levels [GPR68, 12503_5_3]",12863
17,"Blood protein levels [SULT4A1, 8357_43_3]",12863
17,Serum levels of protein SPSB1,6403
17,Vitamin e  | vitamin and/or mineral supplement use,5899
17,Depressive symptoms,1725
17,Femur bone mineral density x serum urate levels interaction,548
17,Cardiovascular diseases,239
17,High-sensitivity cardiac troponin I concentration,466
17,Electrocardiogram morphology (amplitude at temporal datapoints) [68 ms],125
17,Lung adenocarcinoma,8754
17,Subcortical volume (MOSTest),154409
17,HDL cholesterol levels in current drinkers [EA],78856
17,Serum levels of protein RABEPK,6403
17,Serum levels of protein NOG,12599
17,"Blood protein levels [MSTN, 14583_49_3]",12863
17,"Blood protein levels [RELB, 11464_9_3]",12863
17,Arm fat mass (right),108242
17,Serum levels of protein CLEC12B,6403
17,Serum levels of protein BLVRA,6403
17,Temporomandibular joint disorder [Hispanic women],41
17,White blood cell count,4607453
17,Fractional exhaled nitric oxide (childhood),27035
17,Serum 25-Hydroxyvitamin D levels,122783
17,Serum levels of protein CDH15,12806
17,Serum levels of protein NME2,9161
17,Photic sneeze reflex,269
17,Blood protein levels [C-C motif chemokine 14],1234
17,Iron deficiency anaemia,23
17,"Blood protein levels [AIF1, 2849_49_1]",12863
17,"Blood protein levels [HSD17B1, 4708_3_2]",12863
17,CD28- CD8dim T cell %CD8dim T cell,727
17,"Blood protein levels [IL27 EBI3, 2829_19_2]",12863
17,"Blood protein levels [ACE, 10714_7_3]",3095
17,"Blood protein levels [EFNA2, 10801_11_3]",12863
17,"Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event) [Co-Dominant, Mixture cure model]",125
17,Blood urea nitrogen levels,154093
17,Self-reported math ability,1266043
17,Serum levels of protein ARFGAP1,6403
17,Serum levels of protein RDH16,6403
17,Serum levels of protein HBD,6424
17,Serum levels of protein CLCA2,6403
17,"Blood protein levels [CDH11, 7763_25_3]",12863
17,"Blood protein levels [MGAT4A, 9392_43_3]",12863
17,"Blood protein levels [EA, Abelson tyrosine-protein kinase 2]",120
17,Electrocardiogram morphology (amplitude at temporal datapoints) [340 ms],4731
17,Brain region volumes [right medial orbitofrontal],2676
17,Aspartate aminotransferase to alanine aminotransferase ratio,2386
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-110 ms],198
17,Cardiometabolic and hematological traits [PLT],50
17,Past tobacco smoking,12097
17,Serum levels of protein EPHA5,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [316 ms],5913
17,"Blood protein levels [NAT1, 12632_14_3]",12863
17,Impedance of leg (left),256684
17,Blood protein levels [Ck-beta-8-1],1183
17,No | hearing difficulty/problems,24600
17,"Blood protein levels [BCAR3, 12634_79_3]",12863
17,"Blood protein levels [CSH1 CSH2, 13103_125_3]",12863
17,"Blood protein levels [RNMTL1, 9584_105_3]",12863
17,IBD patients in KELA-register,36128
17,Cerebrospinal fluid levels of Alzheimer's disease-related proteins [Angiotensin-converting enzyme],644
17,Protein quantitative trait loci (liver) [NUCB1],17
17,Serum levels of protein RNF122,6403
17,Serum levels of protein TMEM185A,6416
17,Serum levels of protein NRXN3,6403
17,"Blood protein levels [MSTN, 12077_32_3]",12863
17,"Blood protein levels [NCMAP, 14614_41_3]",12863
17,Serum levels of protein GPD1L,6403
17,"Blood protein levels [PBRM1, 12518_289_3]",6460
17,Serum levels of protein NOTUM,3364
17,Bacterial meningitis,266
17,Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test),592
17,Gout (combined type),90
17,Loneliness (MTAG),9096
17,IgM levels,40272
17,Serum levels of protein TCP11,6403
17,Serum levels of protein C5orf46,6403
17,Pattern 3 | hair/balding pattern,180129
17,"Blood protein levels [NSF, 13992_12_3]",12863
17,"Blood protein levels [USP21, 12681_63_3]",12863
17,Serum levels of protein MARCO,6403
17,Serum levels of protein ENOX2,6403
17,Schizophrenia vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),12040
17,Facial morphology (segment 7),47
17,Ease of getting up in the morning,1486689
17,"Blood protein levels [STK17B, 5249_31_3]",12863
17,Serum levels of protein GRAMD1C,6403
17,Preterm birth (maternal effect),891
17,"Intra-ocular pressure, corneal-compensated (left)",583
17,Metabolite levels (small molecules and protein measures) [Creatinine],76
17,UBA7102 sp002315655 abundance in stool,28
17,Cognitive aspects of educational attainment,3945794
17,Serum levels of protein TGM1,6460
17,Serum levels of protein CD96,6403
17,"Blood protein levels [RDH16, 12881_17_3]",12863
17,"Blood protein levels [ST8SIA4, 7038_45_3]",6460
17,"Blood protein levels [TNFRSF12A, 5138_50_3]",12863
17,Basal metabolic rate,371254
17,"Blood protein levels [ATP2A3, 13510_7_3]",12863
17,Immunoglobulin measurement (zinc sulfate turbidity test),634
17,"Waist-to-hip ratio adjusted for body mass index [EA, women]",1115
17,Waist-to-hip ratio adjusted for BMI,6275834
17,Serum levels of protein FARS2,6403
17,Serum levels of protein C8A;C8B;C8G,6403
17,Serum levels of protein PENK,6403
17,Effector Memory CD4-CD8- T cell Absolute Count,691
17,Male puberty timing (late vs. average onset facial hair),428
17,Brain region volumes [cerebellar vermal lobules VI VII],70
17,Migraine,901
17,Keratoconus,49284
17,No | major dietary changes in the last 5 years,1464622
17,"Blood protein levels [FOXRED1, 8017_23_3]",12863
17,"Blood protein levels [KIF1C, 9899_28_3]",12863
17,Abnormal spermatozoa,367
17,Corticobasal degeneration,2712351
17,Mitral valve prolapse,25859
17,Serum levels of protein CSNK2B,6403
17,Colorectal cancer,1889
17,Electrocardiogram morphology (amplitude at temporal datapoints) [162 ms],125
17,Dentures | mouth/teeth dental problems,33338
17,"Blood protein levels [ICOSLG, 5061_27_3]",12863
17,"Blood protein levels [TRH, 5659_11_3]",12863
17,6mm weak meridian (left),39047
17,Asthma-related pneumonia or sepsis,42565
17,"Blood protein levels [CD300C, 13406_161_3]",466
17,"Waist circumference adjusted for body mass index [EA,women]",169
17,Life satisfaction,419
17,Frequency of needing morning drink of alcohol after heavy drinking session in last year,50
17,GCA-900066135 sp900066135 abundance in stool,10
17,Glomerular filtration rate (creatinine),64452
17,Type 2 diabetes [EA],23367
17,Serum levels of protein PSMD9,6403
17,Brain region volumes [left rostral anterior cingulate],42834
17,"Blood protein levels [LRPAP1, 3640_14_3]",12863
17,CD4-CD8- T cell Absolute Count,691
17,"Blood protein levels [ADCYAP1, 4594_22_2]",12863
17,Other diseases of upper respiratory tract,3031
17,Mirtazapine | treatment/medication code,322
17,Ebbinghaus illusion (overestimation),509
17,Malignant neoplasm,1344
17,Monocyte count,1350703
17,Mean spheric corpuscular volume,3447359
17,Sex hormone-binding globulin levels adjusted for BMI,1827154
17,Serum levels of protein CDH2,6403
17,"""Primary open-angle glaucoma, strict""",257
17,"""Haemangioma and lymphangioma, any site (controls excluding all cancers)""",3
17,Lung function (FVC) [EA],24718
17,Serum levels of protein CRABP1,6517
17,Serum levels of protein GALNT2,6403
17,Brain region volumes [total brain volume],1425214
17,"Blood protein levels [PRSS27, 3624_3_4]",12863
17,"Blood protein levels [SCMH1, 12604_16_3]",12863
17,Yes | hearing difficulty/problems,21682
17,Electrocardiogram morphology (amplitude at temporal datapoints) [130 ms],149
17,Lung function (FEV1/FVC),406162
17,Low density lipoprotein cholesterol levels,635867
17,Medication use (diuretics),43146
17,Nonatopic asthma,40550
17,Serum levels of protein WFDC10B,6403
17,Serum levels of protein PRPF6,6403
17,"Cholesterol lowering medication | medication for cholesterol, blood pressure or diabetes",60521
17,"Blood protein levels [CCL3L1, 2783_18_2]",14230
17,Red blood cell (erythrocyte) distribution width,171704
17,IgG fucosylation phenotypes (multivariate analysis),11939
17,Urinary albumin excretion,2418
17,Serum total protein level [Japanese],519
17,Serum levels of protein SNRPF,6403
17,Height [Conditioned on rs2665838],17640
17,"Blood protein levels [IL10RA, 10344_334_3]",12863
17,"Blood protein levels [ST14, 10927_65_3]",12863
17,"Blood protein levels [VEGFA, 2597_8_3]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [328 ms],4731
17,HDL cholesterol x physical activity interaction (2df test),6007
17,Severe gingival inflammation,32
17,Serum levels of protein FTH1;FTL,6403
17,"Blood protein levels [GRAP, 12820_1_3]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [24 ms],5073
17,"Blood protein levels [NR1H2, 9016_12_3]",12863
17,Plays computer games,3944
17,Protein levels in obesity [PARC],1001
17,Android fat/gynoid fat ratio,109
17,Protein quantitative trait loci (liver) [LTF],749
17,HDL cholesterol,327495
17,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) [subset analysis]",118826
17,Serum levels of protein MFAP3L,6403
17,Hip bone mineral density and total body fat mass (bivariate analysis),5197
17,Serum levels of protein CCL23,7960
17,Disorders of lens,2761
17,"1,5-anhydroglucitol levels [EA]",21
17,HDL cholesterol levels x long total sleep time interaction (2df test),26533
17,Total PHF-tau (SNP x SNP interaction),28855
17,Serum levels of protein CDYL2,1715
17,"Blood protein levels [NAPB, 12655_30_3]",12863
17,"Blood protein levels [EA, C-C motif chemokine 16]",1127
17,GIP levels in response to oral glucose tolerance test (fasting),4913
17,Serum levels of protein DIABLO,6403
17,"Blood protein levels [ALOX15B, 12422_143_3]",2133
17,"Blood protein levels [EA, Serine/threonine-protein kinase 17B]",120
17,Kidney stones,177
17,Self-reported allergy,40825
17,Optic cup area,53729
17,Total body bone mineral density (MTAG),6367
17,Taking other prescription medications,35096
17,Serum levels of protein ANGPTL7,6403
17,"Blood protein levels [VTN, 8280_238_3]",12863
17,Serum levels of protein CDH12,6403
17,Protein quantitative trait loci (liver) [YARS],236
17,Serum levels of protein C10orf35,466
17,"Systolic blood pressure x alcohol consumption interaction (2df test) [AA, EA]",98
17,Granulocyte count,1639756
17,Microalbuminuria,60484
17,Cortical thickness (min-P),113999
17,"Cholesterol lowering medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",556
17,Electrocardiogram morphology (amplitude at temporal datapoints) [228 ms],125
17,Mean corpuscular hemoglobin concentration,792628
17,"Sitting height ratio [EA, men]",2860
17,Serum levels of protein IGFL3,6403
17,Neutrophill count,1794610
17,Intracerebral hemorrhage,2437
17,Femur bone mineral density x serum urate levels interaction [female],796
17,Serum levels of protein JAK2,6403
17,"Blood protein levels [EDDM3A, 9536_16_3]",12863
17,Impedance of arm (right),100488
17,"Blood protein levels [NME2, 4249_64_2]",9161
17,Electrocardiogram morphology (amplitude at temporal datapoints) [254 ms],8129
17,Serum levels of protein VTN,6403
17,Monocyte chemoattractant protein-2 levels,1300
17,Coffee intake,38687
17,Serum levels of protein FLNA,12806
17,"Blood protein levels [CAMK1D, 3418_12_2]",12863
17,"Blood protein levels [CDC25B, 12427_8_3]",12863
17,"Blood protein levels [IL13RA1, 2633_52_2]",12863
17,Cylindrical power (right),5196
17,White matter microstructure (mean diusivities) [Uncinate fasciculus],19042
17,"Blood protein levels [LILRB3, 11334_7_3]",6460
17,Serum levels of protein TRABD,6403
17,Serum levels of protein NTRK1,6403
17,Decreased low contrast letter acuity in multiple sclerosis,49
17,Ovarian cancer in BRCA1 mutation carriers,899614
17,High light scatter reticulocyte percentage of red cells,1844120
17,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)",42882
17,Vertex-wise cortical thickness,1500957
17,"Blood protein levels [DEAF1, 6369_82_3]",12863
17,"Blood protein levels [DPP7, 3608_12_5]",12863
17,"Blood protein levels [IL17RB, 5084_154_3]",12863
17,"Blood protein levels [MMEL1, 3627_71_4]",12863
17,"Blood protein levels [PKD2, 13486_9_3]",12863
17,Ventolin 100micrograms inhaler | treatment/medication code,35601
17,Serum levels of protein SELL,6403
17,Benign neoplasms (controls excluding all cancers),372
17,Restricted and repetitive behaviours in autism spectrum disorder [Repetitive use of objects],1087
17,Body mass index [Male],248
17,White matter microstructure (fractional anisotropy) [Retrolenticular part of internal capsule],35410
17,Electrocardiogram morphology (amplitude at temporal datapoints) [4 ms],1107
17,Tea intake,41320
17,Serum levels of protein CDC42BPB,6403
17,Serum levels of protein LGALS7B,6403
17,Neonatal cytokine/chemokine levels (fetal genetic effect) [CCL23],829
17,"Blood protein levels [TIGAR, 12476_50_3]",12863
17,CD28- CD4-CD8- T cell %T cell,691
17,Abnormal sputum,126
17,C-reactive protein and white blood cell count [WBC],22891
17,Aspartate aminotransferase levels,2660961
17,Blood metabolite levels [X-14189--leucylalanine],2969
17,"Blood protein levels [CASQ1, 11263_57_3]",12863
17,"Blood protein levels [DCUN1D5, 8760_10_3]",12863
17,"Blood protein levels [LMCD1, 9530_6_3]",12863
17,"Blood protein levels [MFF, 11157_35_3]",12863
17,"Blood protein levels [PCDH10, 8780_2_3]",12863
17,Allergic asthma (mode) (more control exclusions),41708
17,"Blood protein levels [SEC11C, 10658_28_3]",12863
17,Gut microbiota relative abundance (bacterial taxa) [Victivallales],907
17,Advanced age-related macular degeneration [EA],2311
17,Triglycerides x physical activity interaction (2df test),247
17,Corneal resistance factor,933
17,Allergic rhinitis,80713
17,Osteoprotegerin levels [Sex-combined],4493
17,White matter microstructure (radial diusivities) [Fornix (column and body],3428
17,Brain region volumes [right fusiform],27615
17,"Blood protein levels [TRADD, 13507_51_3]",6403
17,"Blood protein levels [UGT2A1, 8907_11_3]",12863
17,Serum levels of protein RRM2B,6403
17,Cortical surface area (global PC1) [EA],4707
17,Bowel problem,3075
17,"Blood protein levels [GCNT4, 10842_7_3]",12863
17,"Blood protein levels [TRIB2, 12363_70_3]",12863
17,Sitting height,1558750
17,Abnormal serum enzyme levels,476
17,Electrocardiogram morphology (amplitude at temporal datapoints) [350 ms],4753
17,Major coronary heart disease event,5785
17,"Jaundice (unknown cause) | non-cancer illness code, self-reported",572
17,Aplastic and other anaemias,48
17,Maximum cranial length,13
17,"""Benign neoplasm of colon, rectum, anus and anal canal""",85
17,Systolic blood pressure,3860570
17,Direct bilirubin levels,208587
17,Serum levels of protein SMPDL3A,6403
17,"Blood protein levels [C8A C8B C8G, 2429_27_4]",12863
17,"Blood protein levels [TMEM132B, 8890_9_3]",12863
17,Serum levels of protein RAB18,6403
17,Smoking behaviour (age at first cigarette),256
17,Protein quantitative trait loci (liver) [MDH2],619
17,Protelos 2g sachets | treatment/medication code,1068
17,Serum levels of protein CA10,21
17,Breast cancer,2720456
17,Low density lipoprotein cholesterol levels [EA],58320
17,Hair morphology traits [Hair color (black],5196
17,"""Hypothyroidism,  other/unspecified""",17122
17,Serum levels of protein ENTPD6,6424
17,Electrocardiogram morphology (amplitude at temporal datapoints) [314 ms],5913
17,Serum levels of protein GSTM3,6403
17,Body fat percentage and HDL-C (pairwise),3057
17,Calculus of kidney and ureter,76
17,Serum levels of protein C14orf180,6403
17,"Blood protein levels [FTH1 FTL, 3031_66_1]",12863
17,"Blood protein levels [SERPINF1, 9211_19_3]",4999
17,Serum levels of protein RNF146,6403
17,Serum levels of protein COX7A2L,6403
17,X-22162 levels,404
17,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),207
17,Waist-hip ratio [EA],286
17,Arthropathic psoriasis,16
17,Percentage of invited food questionnaires completed,61373
17,Serum levels of protein TCTN2,6403
17,"Blood protein levels [SMAD3, 10363_13_3]",12863
17,Age started wearing glasses or contact lenses,27350
17,Amlodipine | treatment/medication code,20974
17,Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive),494
17,Electrocardiogram morphology (amplitude at temporal datapoints) [132 ms],125
17,Protein quantitative trait loci (liver) [LGMN],47
17,Asthma (childhood onset),346406
17,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)",1362438
17,Comparative body size at age 10,63074
17,Electrocardiogram morphology (amplitude at temporal datapoints) [26 ms],5073
17,"Blood protein levels [TEX29, 10557_6_3]",6403
17,Other maternal disorders predominantly related to pregnancy,10
17,Myopia (age of diagnosis),9347
17,"Blood protein levels [MASP1, 3605_77_4]",12863
17,"Blood protein levels [NRSN1, 11654_77_3]",12863
17,Ankle spacing width (left),41884
17,Allergic asthma (mode),41648
17,"Blood protein levels [CSTL1, 6368_9_3]",12863
17,Serum levels of protein SCGN,6403
17,Protein quantitative trait loci (liver) [SPRYD4],87
17,von Willebrand factor A domain-containing protein 2 measurement,6403
17,"Blood protein levels [CDH2, 3797_1_1]",12863
17,"Blood protein levels [LOC652493, 6561_77_3]",12863
17,"Blood protein levels [CCL15, 14109_15_3]",4975
17,Blood protein levels [CCL13],380
17,Intraocular pressure,224510
17,Relative age of first facial hair,1369603
17,Glaucoma (primary open-angle),36594
17,Retinal nerve fibre layer (RNFL) thickness,189706
17,Pulmonary fibrosis,1136552
17,Cardiac problem,2041
17,Serum levels of protein PSMD1,12806
17,Serum levels of protein SIRT2,6869
17,"Blood protein levels [TNNT2, 5315_22_3]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [284 ms],1182
17,Electrocardiogram morphology (amplitude at temporal datapoints) [6 ms],1107
17,Femoral neck bone mineral density,23265
17,Strabismus [EA],5196
17,Cortical surface area [Fusiform],1549044
17,Serum levels of protein KIF1C,6403
17,"Blood protein levels [ROR1, 13400_13_3]",12863
17,"""Asthma, hospital admissions , main diagnosis only""",6065
17,Blood pressure [Pulse Pressure],5073
17,Serum levels of protein COX7A1,6403
17,"Blood protein levels [CCL18, 3044_3_2]",1367
17,Serum levels of protein ZPLD1,6403
17,Serum metabolite levels [[H]HWESASLLR[OH]],184
17,Testosterone levels,1423621
17,Serum levels of protein STAU2,6403
17,Serum levels of protein GAL3ST1,6403
17,Serum levels of protein PLCG1,6424
17,Serum levels of protein METTL1,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [152 ms],149
17,Memory B cell %lymphocyte,352
17,Varicose veins of lower extremity,117
17,Electrocardiogram morphology (amplitude at temporal datapoints) [208 ms],125
17,"Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",125
17,Serum levels of protein ECE1,12806
17,Serum levels of protein NLGN2,1126
17,Feeling tense,679
17,Serum levels of protein RMI1,6403
17,Serum levels of protein GRAP2,6403
17,"Blood protein levels [RNF8, 14663_44_3]",12863
17,"Blood protein levels [ROCK2, 13654_1_3]",12863
17,"Blood protein levels [SLC22A16, 9969_8_3]",12863
17,Serum levels of protein LEMD1,6403
17,Serum levels of protein MRPL14,6403
17,Type 1 diabetes,2275565
17,Coronary artery disease,300570
17,White matter hyperintensities,81040
17,"Blood protein levels [AZGP1, 9312_8_3]",12863
17,"Blood protein levels [EPHB2, 5077_28_3]",12863
17,"Blood protein levels [LGALS7, 9400_40_3]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-6 ms],1107
17,Chloride levels,1199
17,"Blood protein levels [NTN1, 6649_51_3]",308
17,Electrocardiogram morphology (amplitude at temporal datapoints) [178 ms],125
17,"""Organic, including symptomatic, mental disorders""",1516
17,"2,3-dihydroxy-2-methylbutyrate levels",1638
17,Urate levels [East Asian],64
17,"Blood protein levels [EA, Macrophage scavenger receptor types I and II]",120
17,"Allergic disease (asthma, hay fever and/or eczema) (age of onset)",78183
17,Serum levels of protein DDX46,6403
17,Serum levels of protein STX1A,6403
17,"""Type 2 diabetes, wide definition""",11632
17,Asthma/COPD (KELA code 203),45346
17,Serum levels of protein ERP44,6403
17,Serum levels of protein SPRN,6403
17,Serum levels of protein ADSL,6403
17,COVID-19 (hospitalized vs population),1361481
17,"Blood protein levels [EMC4, 13516_46_3]",12863
17,"Blood protein levels [NTRK1, 3477_63_2]",12863
17,Diverticulosis,18681
17,Gut microbiota relative abundance (bacterial taxa) [Lentisphaeria],907
17,"Blood protein levels [EA, UMP-CMP kinase]",3809
17,Electrocardiogram morphology (amplitude at temporal datapoints) [64 ms],125
17,Anxiety,21
17,Waist-hip index,1469336
17,"Blood protein levels [CSF3, 8952_65_3]",12863
17,"Blood protein levels [EVPL, 14019_73_3]",12863
17,Parkinson's disease | illnesses of mother,1357324
17,"Blood protein levels [MTPAP, 9028_5_3]",12863
17,IgD+ CD24+ B cell %lymphocyte,537
17,Cancer of brain,13100
17,Serum levels of protein ERO1A,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-122 ms],1187
17,Wrist | fractured bone site(s),2894
17,Depression,2112
17,Metabolic syndrome,28508
17,Height [AA],79710
17,Serum levels of protein TLR2,6403
17,"""Benign neoplasm: Colon, unspecified (controls excluding all cancers)""",85
17,Fracture of ribs,385
17,malignant neoplasm of male genital organs,176
17,"Allergy, hypersensitivity or anaphylaxis",227
17,Electrocardiogram morphology (amplitude at temporal datapoints) [66 ms],125
17,"Blood protein levels [DERL1, 13393_46_3]",6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-42 ms],53
17,Other anaemias,71
17,Diabetes diagnosed by doctor,10968
17,"Hip circumference adjusted for BMI [EA,men]",42364
17,Serum levels of protein GRB7,6403
17,"Blood protein levels [FUT9, 6991_24_3]",12863
17,Serum levels of protein IL22,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-96 ms],2513
17,ERO1-like protein beta measurement,50
17,Chronic diseases of tonsils and adenoids,28
17,Total cholesterol levels,495467
17,Serum levels of protein MMP13,6403
17,Serum levels of protein RLN2,6403
17,"Blood protein levels [ALDH1A3, 9835_16_3]",12863
17,"Blonde | hair colour (natural, before greying)",69533
17,"Blood protein levels [NUP210, 9819_110_3]",6403
17,Morning/evening person (chronotype),11521
17,Frequency of walking for pleasure in last 4 weeks,14828
17,"Glycated hemoglobin levels [HbA1c, Malay]",3881
17,Hypothyroidism nos,2878
17,Progressive supranuclear palsy,1414688
17,Immature fraction of reticulocytes,3342614
17,Relative age voice broke,1067777
17,Hip circumference adjusted for BMI [EA],74955
17,Serum levels of protein CD99L2,6403
17,Serum levels of protein GRB14,6403
17,Serum levels of protein PLIN3,6403
17,Whole body fat mass,152337
17,"Blood protein levels [AIFM1, 9522_3_3]",12863
17,Serum levels of protein CLCA1,6403
17,Orofacial clefts [EA],8
17,Cardiovascular disease,191945
17,C-reactive protein levels,384744
17,Eosinophill percentage,1123845
17,Electrocardiogram morphology (amplitude at temporal datapoints) [230 ms],125
17,Electrocardiogram morphology (amplitude at temporal datapoints) [454 ms],22
17,Serum levels of protein DHX8,187
17,Serum levels of protein CLMP,6403
17,Frequency of drinking alcohol,1421058
17,Smoking initiation (ever regular vs never regular) [Conditioned on chr17:44793283],8828
17,"Blood protein levels [NUDT12, 13947_371_3]",12863
17,Serum levels of protein RAB14,6403
17,T-Cell Immunoglobulin and Mucin domain 1 levels,156
17,Inflammatory skin disease [Psoriasis],209
17,Serum levels of protein VWA2,6403
17,"Blood protein levels [AHSA1, 11633_89_3]",12863
17,White matter microstructure (axial diusivities) [Superior fronto-occipital fasciculus],28566
17,"Blood protein levels [LRP1B, 11275_94_3]",12863
17,Spleen volume,6017
17,Serum levels of protein KIAA1024,6403
17,Serum levels of protein WNT3A,6403
17,White matter microstructure (axial diusivities) [Superior corona radiata],542
17,3mm index of best keratometry results (left),20
17,Serum levels of protein LIPN,6403
17,"Blood protein levels [RNF122, 11160_56_3]",12863
17,Serum levels of protein RFFL,6403
17,QRS duration [EA],3781
17,"Blood protein levels [PKN1, 12562_1_3]",12863
17,LDL cholesterol levels [Trans-ethnic initial],449
17,Chronic rhinosinusitis,178
17,"Blood protein levels [CLCNKB, 13683_18_3]",12863
17,Serum levels of protein ITGB2,6424
17,Alzheimer's disease or diastolic blood pressure (pleiotropy),644
17,"Blood protein levels [TIMP2, 2278_61_4]",1408
17,Platelet count,1773373
17,Household income,1433643
17,Corneal hysteresis,933
17,Hematological parameters [WBC],14203
17,Serum levels of protein HTATIP2,6403
17,"Blood protein levels [DNAJC4, 8653_132_3]",12863
17,"Blood protein levels [TLR4 LY96, 3647_49_4]",12863
17,Clopidogrel active metabolite levels,8
17,"Icd10: i25.9 chronic ischaemic heart disease, unspecified | underlying (primary) cause of death",66
17,Progranulin levels,1015
17,CCR7 on naive CD4+ T cell,188
17,PR interval in Tripanosoma cruzi seropositivity,55
17,Aortic root size,40335
17,Naive-mature B cell Absolute Count,37901
17,"Heel bone mineral density (bmd) t-score, automated",120028
17,"Blood protein levels [CNTNAP5, 9044_1_3]",12863
17,"Blood protein levels [KIF3A, 13961_18_3]",12863
17,"Blood protein levels [PDE11A, 5252_33_3]",12863
17,"Blood protein levels [SEMA3A, 3222_11_2]",12863
17,"Blood protein levels [TP53, 6152_111_3]",12863
17,Hypertension [East Asian],308
17,"""Articial joint operation, menisceal resection""",1084
17,Menarche (age at onset),1304989
17,FEV1,1693829
17,White matter microstructure (mean diusivities) [Body of corpus callosum],11677
17,"Blood protein levels [APBB1, 12822_34_3]",12863
17,"Blood protein levels [ECE1, 8767_44_3]",12863
17,"Blood protein levels [SH2D3C, 12704_26_3]",12863
17,Seretide 50 evohaler | treatment/medication code,12
17,Mitochondrial DNA levels,38330
17,Usual walking pace,47503
17,Cancer (pleiotropy),2540948
17,Serum levels of protein EVPL,6517
17,"Forced expiratory volume in 1-second (fev1), predicted percentage",44855
17,Neutrophill percentage,268222
17,Cataract,5672
17,Anthropometric traits [height],844
17,Primary open angle glaucoma,240
17,Telomere length,18846
17,Morningness,41822
17,Autoimmune traits (pleiotropy),37901
17,Leisure sedentary behaviour (television watching),43428
17,Ease of skin tanning,13345
17,Hearing difficulty/problems with background noise,6407
17,"Blood protein levels [FAM19A3, 7839_99_3]",6403
17,Serum levels of protein AZGP1,6403
17,C-C motif chemokine 17 levels,679
17,"Blood protein levels [GDA, 12667_2_3]",12863
17,Serum levels of protein NAP1L1,1226
17,CD28- CD4-CD8- T cell %CD4-CD8- T cell,727
17,Depression medications,8
17,Medication use (glucocorticoids),56201
17,Serum alkaline phosphatase levels,2132499
17,Serum levels of protein RYK,6403
17,"Blood protein levels [NMRAL1, 13988_67_3]",12863
17,Local histogram emphysema pattern [Severe Centrilobular],491
17,Arthrosis,1232
17,Serum levels of protein SMIM9,6403
17,Cleft lip with or without cleft palate [Asian],98
17,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),29012
17,Adult body size,246552
17,White matter microstructure (fractional anisotropy) [Anterior limb of internal capsule],3988246
17,Serum levels of protein CALCOCO2,10161
17,Serum metabolite levels [X-14189],2897
17,"Blood protein levels [GRB7, 11281_6_3]",12863
17,Haemoglobin concentration,1379612
17,Lymphocyte percentage,1652695
17,Solpadol capsule | treatment/medication code,11237
17,"Blood protein levels [PDE3A, 5254_69_3]",12863
17,3mm cylindrical power (right),5196
17,Serum metabolite levels [N-formylanthranilic acid],1167
17,Phosphorus levels,232
17,FSC-A on Natural Killer,580
17,Apolipoprotein A1 levels,455441
17,Brain morphology (min-P),58809
17,Age when periods started (menarche),14047
17,Progressive supranuclear palsy [controlling for rs8070723],391
17,Serum levels of protein DLK1,6403
17,"Blood pressure medication | medication for cholesterol, blood pressure or diabetes",38742
17,"Blood protein levels [HBZ, 6919_3_3]",12863
17,"Blood protein levels [RLBP1, 12936_38_3]",12863
17,Blood protein levels [C-C motif chemokine 16],1127
17,Gut microbiota abundance (genus Erysipelatoclostridium id.11381),93
17,Osteoarthrosis,51037
17,Internal derangement of knee,33767
17,Lung function in never smokers (low FEV1 vs high FEV1),1105397
17,"Blood protein levels [LCMT1, 4237_70_3]",6403
17,Osteoarthritis (with total hip replacement),599
17,"Blood protein levels [CDCP1, 8589_13_3]",12863
17,Serum levels of protein BACH1,6403
17,Body mass index (joint analysis main effects and physical activity interaction),6164
17,Primary biliary cirrhosis,1518276
17,Medication use (thyroid preparations),31710
17,"Blood protein levels [RAB14, 14283_12_3]",12863
17,"Blood protein levels [GALNT2, 5764_4_3]",12863
17,Serum levels of protein MTPAP,6403
17,Serum levels of protein ARF6,6460
17,Protein quantitative trait loci (liver) [GPI],244
17,Colonoscopy-negative controls vs population controls,87
17,Thyroid stimulating hormone levels,145
17,"Eye color [EA, discovery]",5205
17,Metabolite levels [Unknown],2969
17,"Blood protein levels [KRTDAP, 5739_75_3]",12863
17,"Blood protein levels [PCDHB14, 10715_5_3]",12863
17,Serum levels of protein PDE2A,6403
17,"Blood protein levels [ZPBP, 8635_283_3]",6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [348 ms],4753
17,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant II (Nose), Segment 47]",78
17,Subjective well-being (MTAG),662
17,Asthma [Children],39462
17,Serum levels of protein MAPK12,6403
17,"Blood protein levels [NAB1, 13933_276_3]",12863
17,"Blood protein levels [PDIA4, 7146_16_3]",6403
17,Serum levels of protein PIK3R1,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [452 ms],22
17,Serum levels of protein TNFRSF1A,6403
17,"Blood protein levels [ECE1, 3611_70_4]",12863
17,"Blood protein levels [WFDC3, 6384_19_3]",12863
17,"Blood protein levels [HINT2, 5612_16_3]",12863
17,"Blood protein levels [NEURL4, 13468_5_3]",12863
17,Serum levels of protein GCSH,6403
17,Blood protein levels [Semaphorin-3A],3809
17,Electrocardiogram morphology (amplitude at temporal datapoints) [202 ms],125
17,Fed-up feelings,16099
17,Serum levels of protein SORCS2,6403
17,"Blood protein levels [CNGA2, 12872_35_3]",12863
17,"Blood protein levels [ESD, 4984_83_1]",12863
17,"Blood protein levels [IBSP, 14023_84_3]",12863
17,"Blood protein levels [LY6G6C, 6256_9_3]",12863
17,"Blood protein levels [PUF60, 10575_31_3]",12863
17,Peripheral artery disease,17588
17,"Other chronic ischemic heart disease, unspecified",1700
17,Leisure sedentary behaviour (computer use),6143
17,Optic cup area [EA],51989
17,Serum levels of protein TXNIP,6403
17,Serum levels of protein PKN1,6403
17,Verbal-numerical reasoning,16213
17,Urinary potassium excretion [EA],8866
17,Serum levels of protein CDK8;CCNC,6424
17,Angina | vascular/heart problems diagnosed by doctor,3108
17,Red vs. brown/black hair color,5196
17,Electrocardiogram morphology (amplitude at temporal datapoints) [160 ms],125
17,Inflammatory bowel disease,135542
17,Hematocrit,11019488
17,Thalamus volume,1463167
17,"Blood protein levels [ACBD7, 13563_259_3]",12863
17,Serum levels of protein HPGD,6403
17,"Blood protein levels [WDR1, 10723_41_3]",12863
17,Serum levels of protein P4HB,14139
17,"Blood protein levels [DKKL1, 3644_5_4]",12863
17,"Blood protein levels [EMILIN3, 9991_112_3]",12863
17,Serum levels of protein RPSA,6403
17,P-cresol sulfate levels,903
17,Serum levels of protein JAM2,6403
17,Mean corpuscular hemoglobin,2983384
17,Serum levels of protein AURKB,6424
17,"Blood protein levels [SLC3A1, 9000_177_3]",12863
17,Asthma [conditional],11089
17,"Blood protein levels [CCL8, 2785_15_2]",1300
17,Electrocardiogram morphology (amplitude at temporal datapoints) [16 ms],5396
17,Electrocardiogram morphology (amplitude at temporal datapoints) [136 ms],125
17,Hematological or dermatological disease,49
17,Autism spectrum disorder or schizophrenia,31706
17,Serum levels of protein DEF6,6403
17,"Blood protein levels [ZNRF3, 13428_52_3]",12863
17,Galanin peptide levels,10069
17,Esophageal squamous cell carcinoma,1034
17,Red blood cell count,17144480
17,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test) [EA],19042
17,Serum levels of protein PFN2,6403
17,"Blood protein levels [OLA1, 12659_13_3]",12863
17,"Blood protein levels [TCP11, 8334_65_3]",12863
17,"Number of operations, self-reported",163
17,Electrocardiogram morphology (amplitude at temporal datapoints) [62 ms],125
17,Serum levels of protein TMEM132B,6403
17,"Blood protein levels [DNAJB9, 11214_40_3]",12863
17,Arm fat mass (left),103202
17,Serum levels of protein QSOX2,6403
17,Medication use (antiglaucoma preparations and miotics),400
17,Pancreatic cancer,153
17,Phosphatidylcholine-O_44:5_[M+H]1+/Phosphatidylcholine-P_44:4_[M+H]1+ levels,18380
17,Amount of alcohol drunk on a typical drinking day,1342519
17,"Blood protein levels [TWSG1, 9234_8_3]",12863
17,"Blood protein levels [TXNIP, 11682_7_3]",12863
17,Trunk predicted mass,157362
17,Serum levels of protein UBE3A,6403
17,Tumor necrosis factor ligand superfamily member 12 levels,12368
17,Serum levels of protein CTXN3,6403
17,Generalized epilepsy,263
17,Serum levels of protein EIF1AD,6403
17,Betahistine | treatment/medication code,867
17,Male puberty timing (early vs. average onset facial hair),428
17,Protein quantitative trait loci (liver) [PRDX3],57
17,Erectile dysfunction,482
17,Interleukin-1 receptor-like 1 measurement,88
17,Maximum habitual alcohol consumption [EA],1381603
17,Serum levels of protein GSTA1,6403
17,"Blood protein levels [CD99L2, 10539_30_3]",12863
17,"Blood protein levels [FST, 4132_27_2]",12863
17,Serum levels of protein SLC26A11,6403
17,Serum levels of protein CLC,6403
17,"Blood protein levels [EA, Scavenger receptor class F member 1]",3187
17,"Asthma | non-cancer illness code, self-reported",50891
17,Serum levels of protein GRP,6403
17,"Blood protein levels [DDR1, 14704_10_3]",6460
17,Serum levels of protein CCL4L1,5829
17,Electrocardiogram morphology (amplitude at temporal datapoints) [164 ms],149
17,Gonarthrosis,296
17,Protein quantitative trait loci (liver) [CIITA],9
17,Height,4653629
17,Serum levels of protein SPATA20,15710
17,Serum levels of protein MAGEA3,6403
17,Serum levels of protein CDH11,6403
17,"Blood protein levels [EHD4, 11421_10_3]",12863
17,Platelet crit,235089
17,Serum levels of protein ZP4,6403
17,Blood metabolite levels [X-14304--leucylalanine],2969
17,Benign neoplasms,85
17,Age of smoking initiation (MTAG),92428
17,"Blood protein levels [ATP1B2, 7218_87_3]",18977
17,Serum levels of protein CCL15,1715
17,Serum levels of protein HMGB3,6460
17,"Blood protein levels [CLCA2, 8950_4_3]",12863
17,"Blood protein levels [MINOS1, 7956_11_3]",12863
17,"""Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified""",905
17,Immunological or systemic disorder,227
17,Medication use (antithrombotic agents),2794475
17,Hypertrophic cardiomyopathy (sarcomere negative),1136753
17,C-reactive protein,121381
17,Serum levels of protein CTRL,6403
17,LDL cholesterol levels in current drinkers,33513
17,Musician's dystonia,3136
17,"Rectal or colon adenoma/polyps | non-cancer illness code, self-reported",2268
17,Estimated glomerular filtration rate [EA],5166
17,Phosphatidate(40:5)_[M+OAc]1-/Phosphatidylglycerol(39:5)_[M-H]1- levels,636
17,"Blood protein levels [SCARF1, 5129_12_3]",6133
17,Electrocardiogram morphology (amplitude at temporal datapoints) [358 ms],4753
17,Obesity [Overweight],1119
17,CD127 on granulocyte,392
17,Other benign neoplasms of skin (controls excluding all cancers),85
17,Hypothyroidism and >3 levothyroxin purchases,8
17,Remission after SSRI treatment in MDD or neuroticism,884984
17,Brain region volumes [right lingual],1191698
17,"Blood protein levels [ASIP, 5676_54_3]",12863
17,Spherical power (right),12235
17,Serum levels of protein CLEC4G,6403
17,"Blood protein levels [RAB35, 13514_121_3]",12863
17,Serum levels of protein CD300A,4494
17,Ischemic stroke,5792
17,Electrocardiogram morphology (amplitude at temporal datapoints) [56 ms],125
17,Interleukin-27 levels,8689
17,"Blood protein levels [RNF13, 8087_250_3]",12863
17,"Blood protein levels [ZFYVE27, 13432_9_3]",12863
17,Serum levels of protein ADH5,6403
17,Cancer within the respiratory system,29
17,Protein quantitative trait loci (liver) [DPP7],15
17,Oily fish consumption,10639
17,Testosterone levels [men],43347
17,Coronary artery bypass grafting,24653
17,Serum levels of protein PVRIG,6403
17,"Blood protein levels [FOLR3, 5624_66_3]",12863
17,"Blood protein levels [ZPLD1, 5590_11_3]",6403
17,Dermatologic disease,49
17,Electrocardiogram morphology (amplitude at temporal datapoints) [172 ms],125
17,Electrocardiogram morphology (amplitude at temporal datapoints) [212 ms],125
17,CD8+ and CD8dim T cell %leukocyte,316
17,Granulocyte percentage of myeloid white cells,181800
17,Emphysema or chronic bronchitis,38087
17,"Blood protein levels [C5orf46, 9100_32_3]",12863
17,"Blood protein levels [ENAH, 9757_29_3]",12863
17,"Blood protein levels [GEM, 12817_1_3]",12863
17,"Blood protein levels [IFNA2, 3497_13_2]",12863
17,Facial morphology (segment 38),436
17,"Blood protein levels [NPFF, 5617_41_3]",12863
17,3mm strong meridian (left),60895
17,"Blood protein levels [AURKB, 3346_72_2]",12863
17,Osteoarthritis of the hip or knee (with total joint replacement),285
17,Glycated hemoglobin levels,273147
17,Neuroticism,10168662
17,Childhood asthma with severe exacerbations,106477
17,Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis),866473
17,Serum levels of protein RCN2,6403
17,Serum levels of protein KIR2DL2,6403
17,"Blood protein levels [SRL, 10940_25_3]",12863
17,Serum levels of protein TEX29,12806
17,Serum levels of protein NUCB1,6403
17,"Blood protein levels [SEPT10, 12690_33_3]",12863
17,Serum levels of protein PCDHB14,6403
17,White matter hyperintensity burden,69318
17,"Number of decayed, missing and filled tooth surfaces or use of dentures",64127
17,Bipolar I disorder,24796
17,White blood cell count [Japanese],16625
17,LDL cholesterol levels in current drinkers [EA],33430
17,Serum levels of protein CCM2,6460
17,Serum levels of protein UFC1,2516
17,Serum levels of protein MASP1,6403
17,Smoking initiation (ever regular vs never regular) [Conditioned on chr17:7803118],6740
17,Nasal polyps,1264
17,"Glaucoma | non-cancer illness code, self-reported",257
17,Serum levels of protein HNRNPH1,6403
17,"Blood protein levels [FBXL4, 9951_36_3]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [40 ms],5073
17,High blood pressure | illnesses of mother,25565
17,"""Alzheimer’s disease, wide definition (more control exclusions)""",7877
17,Serum levels of protein ST6GALNAC1,6403
17,General factor of neuroticism,2157086
17,Serum levels of protein JAKMIP3,6403
17,Height [Conditioned on rs227724],1183
17,"Blood protein levels [CDC42BPB, 3629_60_4]",12863
17,Inflammatory bowel disease [EA],55947
17,"Blood protein levels [MMP13, 4925_54_2]",12863
17,"Blood protein levels [TMEM87B, 13485_20_3]",12863
17,"Heel quantitative ultrasound index (qui), direct entry",120000
17,Protein quantitative trait loci (liver) [CAPN2],595
17,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,48
17,Age-related hearing impairment (MTAG),431
17,Red cell distribution width,6051126
17,Osteoarthritis of the hip or knee,23353
17,"Blood protein levels [COTL1, 4905_63_1]",12863
17,"Blood protein levels [KIR2DL2, 7773_20_3]",12863
17,Serum levels of protein CKAP2,6403
17,Serum levels of protein C7,6403
17,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [EA],125
17,Feeling fed-up,1380126
17,Atopic dermatitis,14352
17,Serum levels of protein PRLR,6403
17,Serum levels of protein PDK1,6403
17,"Blood protein levels [TEX29, 13500_9_3]",12863
17,Itch intensity from mosquito bite,4757
17,IgG glycosylation [IGP31],13065
17,Serum levels of protein ZNRF3,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-100 ms],2659
17,Hip shape (DXA scan) [hip shape mode 5],73
17,Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in non-secretors,56
17,Worry,1411005
17,Serum levels of protein TMCC3,6403
17,Serum levels of protein GALNT11,6424
17,"Blood protein levels [ADRM1, 9057_19_3]",12863
17,Brain region volumes [right pallidum],1467866
17,Corneal resistance factor (right),16510
17,Electrocardiogram morphology (amplitude at temporal datapoints) [96 ms],125
17,"""Psoriatic arthropathies, ICD10""",16
17,Ulcerative colitis [EA],47930
17,High cholesterol,74520
17,Serum levels of protein DYNLL2,1172
17,Serum levels of protein NSF,6403
17,Serum levels of protein PCYOX1L,6403
17,"Blood protein levels [HSPA6, 13672_3_3]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [196 ms],125
17,Protein quantitative trait loci (liver) [TPM3],29
17,Cannabis use,10535
17,Hypertrophic cardiomyopathy (MTAG),131980
17,Hypertrophic cardiomyopathy,1307085
17,Psoriasis or type 2 diabetes (trans-disease meta-analysis),5959
17,Serum levels of protein CSF2RA,6403
17,Acceptance of an invitation to participate in a mental health questionnaire,829
17,"Blood protein levels [DYNLL2, 11493_169_3]",1203
17,Serum levels of protein NPTX1,2627
17,Smoking initiation,5443
17,Serum levels of protein MXRA7,4421
17,Adult asthma,34477
17,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),50561
17,Multisite chronic pain,23977
17,"Blood protein levels [NRXN3, 7093_20_3]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [86 ms],125
17,"""Diabetes, varying definitions""",39
17,Eczema or dermatitis,49
17,Sleep duration (long sleep),1343302
17,Interleukin-1-receptor antagonist levels,22891
17,Serum levels of protein FAM3B,6403
17,Cardiorespiratory fitness (vo2 max),1128870
17,"Blood protein levels [MARCO, 9003_99_3]",12863
17,Corneal hysteresis (right),12618
17,Serum levels of protein PMEL,6403
17,Testicular germ cell tumor,152080
17,Estimated glomerular filtration rate in non-diabetics,58860
17,Venous thromboembolism,24509
17,"Blood protein levels [MAN2B2, 9251_28_3]",12863
17,Mean platelet (thrombocyte) volume,362730
17,Mucosal proctocolitis,37874
17,Fatty acid(20:1)_[M-H]1- levels,20531
17,Electrocardiogram morphology (amplitude at temporal datapoints) [312 ms],5913
17,Serum levels of protein VRK1,6517
17,Tonsillectomy,3876
17,Fibrinogen levels,44812
17,Handedness (non-right-handed vs right-handed),42604
17,Serum levels of protein AIFM1,6403
17,"Blood protein levels [MDM2, 13228_75_3]",12863
17,Coronary artery disease or ischemic stroke,6797
17,Serum levels of protein KLK14,6403
17,"Blood protein levels [CLEC2D, 7054_87_3]",12863
17,"Blood protein levels [ENTPD6, 8932_1_3]",12863
17,"Blood protein levels [SELL, 4831_4_2]",12863
17,Phosphatidylcholine_40:7_[M+OAc]1-/Phosphatidylserine_44:6_[M-H]1- levels,3768
17,Hypercholesterolemia,2941
17,Chronic lymphocytic leukemia or multiple sclerosis,8117
17,Dilated cardiomyopathy (MTAG),1107
17,Other and unspecified anaemias,71
17,Serum levels of protein ITSN1,6403
17,"Blood protein levels [MFN1, 11364_18_3]",12863
17,"Blood protein levels [mtb12, 15007_48_3]",6403
17,"Blood protein levels [YBX2, 6372_7_3]",12863
17,Anti-herpes simplex virus 2 IgG seropositivity,899
17,"Blood protein levels [APOH, 8288_27_3]",466
17,Monocyte percentage of white cells,571468
17,Serum levels of protein ZNF10,6403
17,Serum levels of protein NXPH3,6403
17,"Aspirin | medication for pain relief, constipation, heartburn",5682
17,Myopia (pathological),609
17,Treponemataceae abundance in stool,585
17,Protein levels in obesity [HCC-4],1158
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-86 ms],52
17,Coronary artery disease or large artery stroke,6674
17,Cortical surface area (MOSTest),1531617
17,"Blood protein levels [FCRL2, 8085_10_3]",12863
17,"Blood protein levels [HCAR2, 13495_48_3]",12863
17,Albumin-globulin ratio [conditional on round 2],13186
17,"Blood protein levels [ARHGEF2, 12848_9_3]",12863
17,Glaucoma,3618
17,OTU97_82 (Bacteroides) prevalence,30
17,Sensitivity to environmental stress and adversity,1342858
17,Cycle | types of transport used (excluding work),14839
17,"Blood protein levels [SPRN, 13447_42_3]",12863
17,"Blood protein levels [THSD1, 5621_64_3]",12863
17,Serum levels of protein CD74,6403
17,Renal function-related traits (eGRFcrea),82
17,Diastolic blood pressure x alcohol consumption interaction (2df test) [EA],794
17,"Blood protein levels [VSIG2, 8018_43_3]",466
17,Snoring [adjusted for BMI],93970
17,DNA methylation-estimated granulocyte proportions,43392
17,Gamma glutamyl transpeptidase,114202
17,"Blood protein levels [CDH15, 11215_6_3]",12863
17,"Blood protein levels [MADCAM1, 11258_41_3]",12863
17,"Heel quantitative ultrasound index (qui), direct entry (left)",23889
17,Serum levels of protein RIC3,6403
17,Colorectal cancer or advanced adenoma,947
17,Benign prostatic hyperplasia and lower urinary tract symptoms,290
17,Hormone measurements [Free thyroxine (FT4],887
17,CD4-CD8- T cell %leukocyte,691
17,Creatinine levels,437451
17,Serum levels of protein CNP,39425
17,Serum levels of protein ANP32B,6460
17,"Blood protein levels [CCL5, 5480_49_3]",10049
17,Diprosalic ointment | treatment/medication code,2208
17,"Blood protein levels [CDC34, 12532_28_3]",6403
17,Household income (MTAG),1487073
17,"Blood protein levels [SMIM10, 9379_248_3]",12863
17,"Blood protein levels [STX1B, 6966_144_3]",6403
17,Serum levels of protein CCL3L3,7770
17,Never | smoking status,11129
17,"Blood protein levels [KDR, 3651_50_5]",12863
17,Serum levels of protein PYY,2302
17,Had menopause,74971
17,Serum levels of protein THSD1,6403
17,Urate levels [women],433
17,Neutrophil count [EA],33250
17,"Blood protein levels [ARSB, 3172_28_2]",12863
17,"Blood protein levels [HS3ST5, 10731_10_3]",12863
17,"Blood protein levels [PIK3R1, 8863_3_3]",12863
17,Serum metabolite concentrations in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:3],995
17,Serum levels of protein VEGFA,1080
17,Hip index,106492
17,Medication use (beta blocking agents),16266
17,Serum levels of protein IL1B,6403
17,"Blood protein levels [PSMD9, 13931_22_3]",12863
17,"Blood protein levels [SIGLEC12, 8352_26_3]",12863
17,"Blood protein levels [ACAP2, 12343_14_3]",6403
17,"Blood protein levels [ITGB2, 12750_9_3]",12863
17,Essential hypertension (time to event),1764
17,"Blood protein levels [NDC80, 12730_3_3]",12863
17,Viral capsid antigen IgG seropositivity,10
17,Creatine kinase levels,33818
17,"Blood protein levels [C1QL1, 6404_20_3]",7401
17,Sex hormone-binding globulin levels [Women],13885
17,DNA methylation PhenoAge acceleration,9989
17,Electrocardiogram morphology (amplitude at temporal datapoints) [288 ms],1182
17,Serum levels of protein MPZL2,6403
17,Insomnia symptoms (never/rarely vs. sometimes/usually),2146
17,Natural Killer T Absolute Count,1324
17,Chronic obstructive pulmonary disease,2939462
17,PR interval,186680
17,Serum levels of protein C5orf63,6403
17,Serum levels of protein SERPINA12,6403
17,"Blood protein levels [C1QTNF1, 6304_8_3]",12863
17,Type 2 diabetes without complications,15078
17,"Blood protein levels [ARPC3, 13573_5_3]",12863
17,Polycystic ovary syndrome,627
17,Waist circumference adjusted for BMI in non-smokers,160
17,Erysipelatoclostridiaceae abundance in stool,64
17,Protein quantitative trait loci (liver) [MAT2A],26
17,Refractive error,1575255
17,Liver enzyme levels (alanine transaminase),199527
17,"Blood protein levels [LRP1, 8601_167_3]",12863
17,"Blood protein levels [SYTL4, 11563_51_3]",12863
17,3mm weak meridian (right),63161
17,Sex hormone-binding globulin levels [Men],16122
17,Psoriasis [fixed],8731
17,Serum levels of protein FZD10,6424
17,Serum levels of protein LMAN2,6403
17,Serum levels of protein PCDHB4,6403
17,Serum levels of protein ST14,6403
17,Complement C1r subcomponent-like protein measurement,50
17,Serum levels of protein CABP7,6403
17,Cholesterol levels,3559
17,Waist-to-hip ratio adjusted for body mass index,946
17,Waist-to-hip ratio adjusted for BMI (recessive genetic model),3686
17,Blood metabolite levels [X-14205--alpha-glutamyltyrosine],2969
17,Liver enzyme levels (gamma-glutamyl transferase),49374
17,Ischemic heart diseases,4221
17,Heel broadband ultrasound attenuation (left),22982
17,Electrocardiogram morphology (amplitude at temporal datapoints) [106 ms],125
17,QRS complex (12-leadsum) [EA],44579
17,Cognitive performance,973361
17,Neutrophil count [Japanese],33250
17,Mental health study participation (completed survey),829
17,Protein quantitative trait loci (liver) [SOD2],137
17,High myopia,5196
17,Waist circumference adjusted for BMI in active individuals,270
17,Electrocardiogram morphology (amplitude at temporal datapoints) [206 ms],125
17,Lobe attachment (rater-scored or self-reported),23
17,White blood cell types [neutrophil count],34334
17,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],50561
17,Thyroid problem (not cancer),16621
17,Serum levels of protein APBB3,12806
17,Serum levels of protein C1QTNF1,6403
17,Serum levels of protein EDDM3A,6403
17,"Blood protein levels [RNF149, 9773_15_3]",12863
17,N-acetylglucosamine/n-acetylgalactosamine levels,995
17,Open-angle glaucoma,223
17,Psychiatric diseases,12
17,Coffee consumption (cups per day),45987
17,Fibrinogen [EA],1667
17,Fat-free mass [female],18140
17,Serum levels of protein C1QBP,6403
17,"Blood protein levels [LIF, 7790_21_3]",12863
17,"Blood protein levels [PNPLA2, 9802_27_3]",12863
17,"""Type 2 diabetes, strict (exclude DM1)""",11632
17,Ulcerative colitis,202898
17,Serum levels of protein GCK,6403
17,Serum levels of protein IFNA7,6403
17,"Blood protein levels [MT1F, 10416_79_3]",12863
17,Serum levels of protein CYB5D2,6457
17,"Blood protein levels [SEL1L2, 9082_25_3]",6403
17,"Blood protein levels [GCSH, 10956_82_3]",12863
17,Serum levels of protein USP21,6403
17,Vertical cup-disc ratio (multi-trait analysis),2789
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-106 ms],198
17,Allergy,40653
17,Cataracts (operation),5672
17,Paracetamol | treatment/medication code,1417979
17,Serum levels of protein CLEC2D,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-20 ms],1232
17,Hemoglobin concentration,4952284
17,Liver enzyme levels (alkaline phosphatase),993174
17,Serum levels of protein RNF41,6403
17,Serum levels of protein CREBBP,6403
17,Serum levels of protein PDIA4,6403
17,"Blood protein levels [FLNA, 11124_9_3]",12863
17,"Blood protein levels [GP1BA, 4990_87_1]",10759
17,Simvador 10mg tablet | treatment/medication code,4891
17,"Presence of antiphospholipid antibodies [Anti-β2GPI IgG, 99th percentile]",1320
17,Serum levels of protein TRADD,6403
17,Protein quantitative trait loci (liver) [AFMID],360
17,Electrocardiogram morphology (amplitude at temporal datapoints) [150 ms],125
17,Nose size,51
17,Getting up in morning,1480107
17,T/B cell,9726
17,"Blood protein levels [BLVRA, 11382_5_3]",6403
17,"None of the above | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",65084
17,Spherical equivalent (joint analysis main effects and education interaction),481
17,Serum levels of protein JARID2,6403
17,Urinary metabolite levels in chronic kidney disease [X - 24455],402
17,Diastolic blood pressure x smoking status (current vs non-current) interaction (1df test) [African],130
17,Glycine levels,51189
17,Diastolic blood pressure x smoking status (ever vs never) interaction (2df test) [EA],15396
17,Serum levels of protein BRICD5,6403
17,Serum levels of protein FKBP2,6403
17,Non-albumin protein levels [NAP],5133
17,Cerebrospinal fluid progranulin levels,1546
17,Other  prurigo,48
17,Epithelial ovarian cancer,1080121
17,Daytime nap,2612985
17,Central corneal thickness,8977
17,"Blood protein levels [DEF6, 14090_23_3]",12863
17,"Blood protein levels [HHLA2, 14132_21_3]",12863
17,"Blood protein levels [RASA1, 5481_16_3]",12863
17,Serum levels of protein SEC11C,6403
17,Multiple myeloma,3432
17,Protein quantitative trait loci (liver) [COQ9],332
17,Serum levels of protein PKD2,6403
17,"Blood protein levels [LPO, 4801_13_3]",1217
17,"""Atopic  dermatitis, strict definition""",730
17,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),160
17,Mean corpuscular volume,4429753
17,Stool frequency,1076162
17,Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis),754634
17,Serum levels of protein SEL1L2,6416
17,"Blood protein levels [NQO2, 9754_33_3]",12863
17,"Blood protein levels [NRAS, 10531_18_3]",12863
17,"Blood protein levels [ZNF10, 11567_23_3]",12863
17,Autoimmune diseases,13869
17,Vitiligo,9914
17,Naratriptan | treatment/medication code,2683
17,1-methylnicotinamide levels,3735
17,Freckles,1252
17,Benign neoplasm of colon,85
17,Iron status biomarkers (ferritin levels),55116
17,Serum levels of protein TCEA2,6403
17,Serum levels of protein UTS2,6424
17,Serum levels of protein EMILIN3,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-28 ms],42959
17,Ankle spacing width (right),50205
17,Systolic blood pressure x alcohol consumption interaction (2df test) [EA],696
17,Blood protein levels [C-C motif chemokine 7],1282
17,Thyrotoxic hypokalemic periodic paralysis in Graves disease,2454
17,Glomerular filtration rate in non diabetics (creatinine),14431
17,Serum levels of protein PTPRR,780
17,Blood protein levels [Calcium/calmodulin-dependent protein kinase type 1D],3809
17,Waist-to-hip ratio adjusted for body mass index [women],726
17,Benign neoplasm: Colon (controls excluding all cancers),85
17,Unilateral cleft lip and palate,24
17,Ovarian cancer [All invasive],29271
17,Language functional connectivity,38564
17,Serum metabolite levels [Threonylphenylalanine],184
17,"Bronchitis | non-cancer illness code, self-reported",35879
17,Serum levels of protein WFIKKN2,10202
17,"Oesophageal disorder | non-cancer illness code, self-reported",2454
17,Serum levels of protein IBSP,6403
17,Facial morphology (segment 51),9161
17,"Blood protein levels [NDNF, 6604_59_3]",12863
17,"Blood protein levels [NHLRC3, 9087_8_3]",12863
17,"Blood protein levels [ADGRF1, 11243_90_3]",12863
17,"Blood protein levels [KIAA1024, 9075_121_3]",12863
17,Serum levels of protein IL13RA1,6403
17,Urinary metabolite levels in chronic kidney disease [nonenedioate (C9:1-DC],3072
17,Electrocardiogram morphology (amplitude at temporal datapoints) [170 ms],125
17,Electrocardiogram morphology (amplitude at temporal datapoints) [54 ms],125
17,Asthma (moderate or severe),37973
17,Phosphatidylcholine_40:6_[M+OAc]1-/Phosphatidylserine_44:5_[M-H]1- levels,3406
17,"Blood protein levels [FAM171A2, 13479_8_3]",12863
17,"Intra-ocular pressure, goldmann-correlated (right)",23013
17,"Blood protein levels [RAB18, 12945_33_3]",12863
17,"Blood protein levels [TYRO3, 13668_44_3]",6403
17,Natural Killer Absolute Count,1044
17,"Blood protein levels [SNRPF, 5494_52_3]",12863
17,Non-oily fish intake,1485
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-56 ms],53
17,Electrocardiogram morphology (amplitude at temporal datapoints) [214 ms],125
17,Number of sexual partners,1442943
17,Varicose veins,19241
17,Arm fat percentage (left),221858
17,Serum levels of protein CHIT1,6403
17,Serum levels of protein STX3,6403
17,Serum levels of protein DDX23,6403
17,"Blood protein levels [ENPP7, 4435_66_2]",679
17,Colon polyp,333
17,Glaucoma | eye problems/disorders,257
17,White matter microstructure (fractional anisotropy) [Fornix (cres) / Stria terminalis],1067123
17,Serum levels of protein SFRP2,6403
17,"Blood protein levels [ADCYAP1, 4593_11_1]",12863
17,Hip circumference,209214
17,"Blood protein levels [GCK, 12960_9_3]",12863
17,Serum levels of protein RAB26,3799
17,Electrocardiogram morphology (amplitude at temporal datapoints) [94 ms],125
17,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],207
17,Interstitial lung disease,2559755
17,Total bilirubin levels,180927
17,Serum levels of protein GPR68,6403
17,Serum levels of protein PRSS27,6403
17,"Blood protein levels [MVK, 11391_69_3]",12863
17,Proheparin-binding EGF-like growth factor levels,11463
17,Serum levels of protein C1orf185,6403
17,Endometrial cancer,36546
17,Oxalate (ethanedioate) levels,19210
17,Serum levels of protein ROCK2,6403
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-14 ms],1107
17,"Blood protein levels [Ccl22, 7664_173_3]",6460
17,"Blood protein levels [NDUFB4, 10677_9_3]",12863
17,"Hypothyroidism/myxoedema | non-cancer illness code, self-reported",5973
17,Rotator cuff tears,16403
17,Serum levels of protein PPP3R1,6403
17,"Blood protein levels [EPHA5, 14089_41_3]",12863
17,Angiotensin-converting enzyme activity,2428
17,QRS duration [European],770
17,Cortical surface area [Cuneus],676
17,Pain in limb,19
17,Lung function (FVC),6732223
17,Mean corpuscular haemoglobin concentration,29039
17,Serum levels of protein APOL1,6403
17,Other malignant neoplasms of skin (=non-melanoma skin cancer),85
17,Other psoriatic arthropathies,16
17,Electrocardiogram morphology (amplitude at temporal datapoints) [114 ms],125
17,Electrocardiogram morphology (amplitude at temporal datapoints) [488 ms],22
17,Joint mobility (Beighton score),1436707
17,Coffee consumption,37945
17,Menopause (age at onset) [japanese],72727
17,"Blood protein levels [DUSP4, 10035_6_3]",12863
17,"Blood protein levels [KLHL13, 12463_7_3]",12863
17,Serum levels of protein FBXL4,6403
17,Asthma (only as main-diagnosis) (more control exclusions),8919
17,Amyotrophic lateral sclerosis,478
17,Congenital malformations of the circulatory system,2346
17,Medication use (agents acting on the renin-angiotensin system),54557
17,"Blood protein levels [C5orf63, 13378_80_3]",12863
17,Haematocrit percentage,1403933
17,"""Type 2 diabetes, definitions combined, including avohilmo""",11632
17,Serum levels of protein CAMP,3784
17,"Blood protein levels [APMAP, 10605_22_3]",12863
17,Ascending aorta distensibility,5073
17,"""Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)""",28
17,Protein quantitative trait loci [Ft3],9
17,White matter hyperintensity volume x hypertension interaction (2df),25415
17,Waist circumference,129414
17,"Blood protein levels [DMKN, 5963_9_3]",12863
17,"For short-sightedness, i.e. only or mainly for distance viewing such as driving, cinema etc (called 'myopia') | reason for glasses/contact lenses",6492
17,Serum levels of protein MAN1B1,6403
17,COVID-19 (critical illness vs population),1541
17,Nontoxic multinodular goitre,152
17,"Peripheral nerve disorder | non-cancer illness code, self-reported",534
17,Ankylosing spondylitis [EA],62806
17,"Blood protein levels [JAK2, 4998_50_2]",12863
17,Vitamin D levels,2835
17,"Blood protein levels [CADM3, 3630_27_4]",12863
17,Electrocardiogram morphology (amplitude at temporal datapoints) [-98 ms],2513
17,Nucleated red blood cell percentage,52
17,Diverticulosis and diverticulitis,18878
17,Intracranial volume,1437029
17,Headache,1385103
17,Serum levels of protein GDF9,6403
17,Serum levels of protein TNNT2,6403
17,"Blood protein levels [AIP, 3839_60_2]",12863
17,High light scatter reticulocyte percentage,1472933
17,"Cerebrospinal fluid biomarker levels [WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2]",5912
17,"Blood protein levels [MAZ, 13436_54_3]",12863
17,Femur bone mineral density x serum urate levels interaction [male],995
17,Electrocardiogram morphology (amplitude at temporal datapoints) [116 ms],125
17,Electrocardiogram morphology (amplitude at temporal datapoints) [188 ms],125
17,Psoriasis,40561
17,"Blood protein levels [ABL2, 5261_13_3]",12863
17,Resistin levels,29759
17,Serum levels of protein ADRM1,6403
17,"Blood protein levels [COX7A1, 8390_25_3]",12863
17,"Blood protein levels [MCEE, 9388_18_3]",12863
17,"Blood protein levels [SPSB1, 13942_140_3]",12863
17,"Heel bone mineral density (bmd) t-score, automated (left)",22746
17,Blood metabolite ratios [aspartylphenylalanine/X-14450--phenylalanylleucine],2897
17,Bone mineral density (hip) and hip bone size,2919
17,White | bread type,1041
17,"Diastolic blood pressure x alcohol consumption interaction (2df test) [AA, EA]",98
17,Protein quantitative trait loci (liver) [EHHADH],80
17,White blood cell count [WBC],22891
17,"Blood protein levels [CD63, 9190_7_3]",12863
17,"Blood protein levels [STAU2, 12970_35_3]",12863
17,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) [women],223
17,Electrocardiogram morphology (amplitude at temporal datapoints) [310 ms],1182
17,Smoking initiation (ever regular vs never regular) [Conditioned on chr17:50193197],145
17,Brain morphology (MOSTest),1421276
17,Hemoglobin,1796737
17,"Blood protein levels [APBB3, 12784_10_3]",12863
17,"Blood protein levels [WFIKKN2, 13408_23_3]",5053
17,Cortical surface area [Rostral Anterior Cingulate],14703
17,Electrocardiogram morphology (amplitude at temporal datapoints) [20 ms],5396
17,Neutrophil percentage of granulocytes,146360
17,Osteoarthritis (hip),1432452
17,Hay fever and/or eczema,46679
17,Alanine aminotransferase levels,360009
17,Cystatin C levels,369795
17,Cortical thickness,1486988
17,"Blood protein levels [C2orf66, 5677_15_3]",12863
17,Hyperlipidemia,2966
17,Type 2 diabetes [Japanese],5188
17,"Blood protein levels [ANGPTL7, 6371_50_3]",6403
17,Serum levels of protein FAM213A,6460
17,Circulating myeloperoxidase levels (plasma),15504
17,"""Coxarthrosis,""",1525
17,Cerebrospinal fluid biomarker levels [C-C motif chemokine 15],1524
17,Presence of antiphospholipid antibodies [Anti-β2GPI IgG],466
17,White matter microstructure (fractional anisotropy) [Cingulate gyrus],759
17,"Blood protein levels [SLC35G2, 13501_10_3]",12863
17,Serum levels of protein TNNI3,6403
17,"Blood protein levels [ST6GALNAC1, 7867_154_3]",12863
17,Serum levels of protein FOLR3,6403
17,Serum levels of protein NDC80,6403
17,Serum levels of protein CCL3,1367
17,Ultradistal forearm bone mineral density,522
17,Finngen Rheumatological endpoints,296
17,Electrocardiogram morphology (amplitude at temporal datapoints) [148 ms],149
17,Dyslipidemia,36
17,Schizophrenia,1738561
17,Moyamoya disease,5521
17,Lifetime smoking index,40195
17,Serum levels of protein MOB1A,6403
17,"Blood protein levels [GSTM3, 9748_31_3]",12863
17,"Heel bone mineral density (bmd) t-score, automated (right)",15792
17,IgA nephropathy,14630
17,Kapake tablet | treatment/medication code,1509
17,Protein quantitative trait loci (liver) [ALDH6A1],318
17,General risk tolerance (MTAG),135251
17,Appendicular lean mass,830239
17,Eosinophill count,1643535
17,"Blood protein levels [ANGPTL4, 3796_79_2]",12863
17,Brain region volumes [left pallidum],4876
17,"Blood protein levels [ATP13A1, 13659_36_3]",12863
17,"Blood protein levels [TYMSOS, 8263_64_3]",12863
17,Serum levels of protein ADCYAP1,12806
17,"Blood protein levels [MAP2K3, 6151_18_3]",12863
17,Protein levels in obesity [WFKN2],3986
17,"Blood protein levels [SLITRK1, 3643_90_2]",6403
17,Pre-treatment viral load in HIV-1 infection,870
17,Age completed full time education,1450
17,Serum levels of protein LGALS3BP,183
17,Intracranial aneurysm,33836
17,Number of vehicles in household,35087
17,Mouth ulcers | mouth/teeth dental problems,25703
17,"Blood protein levels [KLRC3, 11571_75_3]",12863
17,"Blood protein levels [TRABD, 11262_39_3]",12863
17,IgG levels,1360
17,Electrocardiogram morphology (amplitude at temporal datapoints) [70 ms],125
17,Serum levels of protein DCUN1D5,6403
17,Serum levels of protein NUP210,6403
17,Other specified congenital malformation syndromes affecting multiple systems,42
17,Serum levels of protein SLC14A2,6403
17,Pattern 2 | hair/balding pattern,23399
17,Glaucoma suspect,257
17,Problematic alcohol use (MTAG),85831
17,Birth weight of first child,26797
17,Serum levels of protein ZPBP2,6403
17,Serum levels of protein DLL3,10049
17,"Blood protein levels [VSTM5, 8271_24_3]",12863
17,"Blood protein levels [WNT3A, 13236_25_3]",12863
17,Sodium levels,1441
17,Sleep duration (short sleep),280
17,Serum levels of protein CD47,6403
17,"Blood protein levels [NUCB1, 10451_11_3]",12863
17,"Blood protein levels [PGM1, 9173_21_3]",12863
17,"Blood protein levels [ITSN1, 14070_56_3]",12863
17,Serum levels of protein DLG3,6403
17,Corneal structure,393
17,Metabolite levels (small molecules and protein measures) [Citrate],291
17,Cataracts [male],54
18,Cognitive ability,18336
18,"Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA, men]",1117
18,"2,3-dihydroxy-2-methylbutyrate levels",1474
18,Cardicor 1.25mg tablet | treatment/medication code,67
18,White | bread type,696
18,Vitamin b1 preparation | treatment/medication code,237
18,Type 2 diabetes without complications,81
18,Electrocardiogram morphology (amplitude at temporal datapoints) [140 ms],74
18,Age at first birth,510
18,Electrocardiogram morphology (amplitude at temporal datapoints) [250 ms],16
18,Electrocardiogram morphology (amplitude at temporal datapoints) [132 ms],74
18,Sudden cardiac arrest [Recessive],243
18,Body fat percentage [men],785
18,"""Type 2 diabetes, definitions combined, including avohilmo""",778
18,Granulocyte %leukocyte,314
18,Asthma,60312
18,Hemoglobin concentration,21524
18,Platelet crit,13931
18,Waist circumference adjusted for BMI in non-smokers [women],1117
18,Body fat distribution (trunk fat ratio) [females],1638
18,3mm strong meridian (right),226
18,Problematic alcohol use (MTAG),116
18,Folding of antihelix,114
18,Subcortical volume (min-P),800
18,Type 2 diabetes [EA],897
18,Serum metabolite levels [M_HDL_PL],228
18,Supraventricular ectopy [African],116
18,Neutrophill percentage,330
18,Phosphatidylinositol_38:5_[M-H]1- levels,7
18,Combined resilience (covariance of educational attainment with residual cognitive resilience),1522
18,Phosphatidylcholine_40:8_[M+OAc]1-/Phosphatidylserine_44:7_[M-H]1- levels,7
18,Electrocardiogram morphology (amplitude at temporal datapoints) [152 ms],74
18,Icd10: c80 malignant neoplasm without specification of site | underlying (primary) cause of death,177
18,Lacunar stroke,5
18,Cognitive performance,970
18,Schizophrenia (MTAG),2401
18,Colpermin 0.2ml m/r gel e/c capsule | treatment/medication code,40
18,Body mass index and bone mineral density (pleiotropy),863
18,Facial morphology (segment 46),161
18,1-(1-enyl-palmitoyl)-2-arachidonoyl-gpc (p-16:0/20:4) levels,45
18,Protein quantitative trait loci (liver) [AKR1C3],29
18,Ear morphology,114
18,Body mass index and type 2 diabetes (pairwise),32
18,Body mass index (bmi),32251
18,Acceptance of an invitation to participate in a mental health questionnaire,218
18,Remission after SSRI treatment in MDD or neuroticism,262
18,Postprocedural disorders of nervous system,140
18,Electrocardiogram morphology (amplitude at temporal datapoints) [248 ms],16
18,Platelet distribution width,34395
18,Potassium in urine,109
18,Electrocardiogram morphology (amplitude at temporal datapoints) [254 ms],16
18,Electrocardiogram morphology (amplitude at temporal datapoints) [200 ms],16
18,Wrist | fractured bone site(s),1379
18,Rheumatoid arthritis (ACPA-negative),20
18,Worrier / anxious feelings,1389
18,Colorectal cancer,1234
18,Age first had sexual intercourse,816
18,Protein quantitative trait loci (liver) [SDHB],360
18,Body mass index (SNP x SNP interaction),1066
18,Protein quantitative trait loci (liver) [S100A6],484
18,Estimated glomerular filtration rate in non-diabetics,169
18,Childhood onset type 2 diabetes,288
18,Educational attainment (years of education) [conditional-joint],31385
18,Depressed affect,1379
18,Serum metabolite levels [valylleucine],11918
18,Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis),2684
18,Electrocardiogram morphology (amplitude at temporal datapoints) [182 ms],74
18,UBA7748 sp900314535 abundance in stool,6
18,Chronic obstructive pulmonary disease,794
18,Cortical surface area,16432
18,"Blood protein levels [HDHD2, 13472_35_3]",9365
18,Body mass index in physically inactive individuals [women],689
18,Electrocardiogram morphology (amplitude at temporal datapoints) [246 ms],16
18,"Allergic disease (asthma, hay fever and/or eczema) (age of onset)",11816
18,Medication use (calcium channel blockers),166
18,Colorectal cancer x BMI interaction (2df) [women],72
18,Metabolic syndrome,7706
18,"Disorders of muscle, ligament, and fascia",217
18,Disorders of lipoid metabolism,164
18,Educational attainment (college completion),208
18,Rate of cognitive decline in Alzheimer's disease [GEE model],2
18,Protein quantitative trait loci (liver) [CSRP1],53
18,Childhood body fatness,786
18,Age at menopause,444
18,Phosphatidylinositol_38:4_[M+H]1+ levels,7
18,Opioid sensitivity [AA],3308
18,Electrocardiogram morphology (amplitude at temporal datapoints) [-34 ms],1255
18,BMI in non-smokers [men],586
18,Predicted visceral adipose tissue,9226
18,Spherical power (left),4535
18,TNF-related apoptosis-inducing ligand levels,302
18,Waist-hip ratio [EA],699
18,Leg predicted mass (right),16083
18,Benign prostatic hyperplasia and lower urinary tract symptoms,486
18,"Waist circumference adjusted for BMI in active individuals [EA,women]",1117
18,Phosphatidylinositol_38:4_[M-H]1- levels,7
18,Year ended full time education,1239
18,Protein quantitative trait loci (liver) [CAPNS1],53
18,Time spent using computer,40
18,Ability to confide in someone,63
18,Electrocardiogram morphology (amplitude at temporal datapoints) [176 ms],16
18,Heel broadband ultrasound attenuation (right),1453
18,"Asthma | non-cancer illness code, self-reported",40
18,Beef intake,135
18,Electrocardiogram morphology (amplitude at temporal datapoints) [172 ms],114
18,Protein quantitative trait loci (liver) [LDHB],356
18,Protein quantitative trait loci (liver) [SERPINA3],18
18,Tense / 'highly strung',875
18,Complement C2 measurement,3603
18,Diabetes or endocrine disease,3812
18,Medication use (drugs used in diabetes),2389
18,Pattern 4 | hair/balding pattern,2425
18,Lifetime smoking index,1585
18,Walking pace,6978
18,Vitamin D levels,5056
18,"Heel bone mineral density (bmd) t-score, automated (left)",1414
18,Electrocardiogram morphology (amplitude at temporal datapoints) [-20 ms],163
18,FEV1,11022
18,"Blood protein levels [CNDP1, 7870_8_3]",221
18,Hand grip strength,6929
18,Urate levels [women],358
18,Educational attainment,197
18,Lung function (FEV1),1497
18,"""Diabetes, varying definitions""",859
18,Frailty index,55
18,Electrocardiogram morphology (amplitude at temporal datapoints) [224 ms],16
18,Adult body size,14477
18,Cheese intake,10846
18,Serum metabolite levels [arabonate/xylonate],7699
18,Low hand grip strength (60 years and older) (EWGSOP),1967
18,Colon adenocarcinoma,72
18,Endometriosis of ovary,4
18,Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis),2675
18,"Adenosine 3',5'-cyclic monophosphate (camp) levels",698
18,3-methylhistidine levels,171
18,Obesity [Obesity class I],696
18,Electrocardiogram morphology (amplitude at temporal datapoints) [-116 ms],453
18,Nervous feelings,638
18,Tuberculosis [binary model],242
18,Lipid metabolism phenotypes [XL-HDL-TG],48
18,Nap during day,4264
18,Cigarettes smoked per day (MTAG),347
18,Waist-hip ratio,90850
18,Glycated hemoglobin levels,5277
18,Low density lipoprotein cholesterol levels,7586
18,Spherical equivalent or myopia (age of diagnosis),299
18,Snoring,15
18,Cognitive aspects of educational attainment,1531
18,"Malabsorption/coeliac disease | non-cancer illness code, self-reported",1831
18,Asthma onset (childhood vs adult),158
18,Obesity [Obesity class II],863
18,"Smoking initiation (ever regular vs never regular) [Conditioned on chr18:50863861, chr18:49967811]",102
18,Hypertrophic cardiomyopathy (MTAG),9165
18,General factor of neuroticism,510
18,Ebbinghaus illusion (overestimation),107
18,HDL cholesterol levels [EA],220
18,Alcohol consumption (drinks per week) (MTAG),283
18,Waist-to-hip ratio adjusted for BMI,54865
18,Autoimmune thyroid disease,2396
18,"Waist circumference adjusted for body mass index [EA, women]",1117
18,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) [Modelling analysis]",36
18,Salt added to food,473
18,Total cholesterol levels [Trans-ethnic initial],220
18,Colon cancer,144
18,Leg fat mass (left),16693
18,Coenzyme Q10 levels,168
18,acne vulgaris,9177
18,Verbal-numerical reasoning,419
18,Menarche (age at onset) [japanese],1853
18,Brain morphology (MOSTest),7405
18,Brain morphology (min-P),1864
18,Frequency of depressed mood in last 2 weeks,799
18,Fasciitis,217
18,Atrial fibrillation,149
18,Waist circumference adjusted for body mass index [men],1117
18,Intelligence,974
18,White blood cell count (basophil),718
18,High cholesterol,45
18,Left ventricular internal dimension in diastole,193
18,Total cholesterol levels [BMI unadjusted],34
18,Electrocardiogram morphology (amplitude at temporal datapoints) [202 ms],16
18,Protein quantitative trait loci (liver) [NME8],4
18,N-acetylglucosamine/n-acetylgalactosamine levels,517
18,Cortical thickness,5188
18,T cell lymphocyte profile difference,151
18,Corneal resistance factor (left),273
18,Urinary sodium excretion [EA],109
18,Depressive symptoms x dependent stressful life events interaction (2df test),538
18,Electrocardiogram morphology (amplitude at temporal datapoints) [-18 ms],9256
18,Serum immune biomarker levels [YKL-40],2
18,Triglycerides,22001
18,"Waist circumference adjusted for body mass index [EA, men]",2234
18,Glomerular filtration rate in non diabetics (creatinine),231
18,Fracture of hand or wrist,567
18,Spherical equivalent (joint analysis main effects and education interaction),94
18,Dried fruit intake,10724
18,"Subcortical brain region volumes [Putamen, EA]",697
18,Waist-hip index,4503
18,Usual walking pace,5543
18,Accelerometer-based physical activity measurement (average acceleration),692
18,Body fat distribution (leg fat ratio),521
18,Oily fish intake,254
18,Phosphatidylcholine_38:7_[M+OAc]1-/Phosphatidylserine_42:6_[M-H]1- levels,37
18,Electrocardiogram morphology (amplitude at temporal datapoints) [136 ms],74
18,Esophageal squamous cell cancer (length of survival),13937
18,Waist circumference adjusted for BMI (adjusted for smoking behaviour) [men],1117
18,Urea levels,722
18,Age at first sexual intercourse,6387
18,Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis),1762
18,Electrocardiogram morphology (amplitude at temporal datapoints) [82 ms],58
18,Electrocardiogram morphology (amplitude at temporal datapoints) [-4 ms],54
18,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [women],1117
18,Diastolic blood pressure [Japanese],3809
18,"Systolic blood pressure, automated reading",755
18,"""Pain (limb, back, neck, head abdominally)""",199
18,Hypothyroidism or myxedema,3350
18,Protein quantitative trait loci (liver) [ENOSF1],15981
18,QRS duration,3658
18,Bipolar disorder,1586
18,Hip circumference adjusted for BMI,5502
18,Past tobacco smoking,56
18,3mm asymmetry angle (right),156
18,Electrocardiogram morphology (amplitude at temporal datapoints) [262 ms],16
18,Smoking cessation (MTAG),908
18,Morning vs. evening chronotype,123
18,Basophill percentage,16
18,Hair color,2230
18,"Pulse rate, automated reading",4945
18,Spherical equivalent,5257
18,Metabolic biomarkers (multivariate analysis),1875
18,Urinary potassium excretion [EA],109
18,Electrocardiogram morphology (amplitude at temporal datapoints) [-12 ms],9093
18,Trunk fat percentage,13111
18,Body mass index in physically active individuals [women],684
18,Serum metabolite levels [leucylalanine],11792
18,Keratitis,20
18,HDL cholesterol levels in current drinkers [Asian],228
18,Refractive error,5666
18,Worry too long after an embarrassing experience,2792
18,Sodium cromoglicate | treatment/medication code,346
18,Depression medications,629
18,Medication use (drugs affecting bone structure and mineralization),1368
18,Reticulocyte fraction of red cells,10178
18,Lymphocyte-to-monocyte ratio,311
18,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),1117
18,Brain region volumes [left putamen],694
18,Peak expiratory flow,1362
18,Medication use (diuretics),126
18,Mean platelet volume,70806
18,Eosinophill percentage,31010
18,None of the above | vascular/heart problems diagnosed by doctor,1870
18,"Seen doctor (gp) for nerves, anxiety, tension or depression",754
18,Low testosterone levels,298
18,MAP/microtubule affinity-regulating kinase 3 measurement,134
18,General risk tolerance (MTAG),7762
18,Risk-taking tendency (4-domain principal component model),809
18,Body mass index and triglycerides (pairwise),32
18,Neuroticism,16079
18,Opioid dependence [African],4180
18,Longevity (100 years and older) [EA],587
18,Feeling guilty,241
18,Colorectal cancer [East Asian],104
18,Serum albumin levels [EA],124
18,White matter microstructure (fractional anisotropy) [Sagittal stratum],21
18,Language functional connectivity,23
18,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)",31094
18,Mean spheric corpuscular volume,42571
18,Phosphatidylcholine_32:2_[M+H]1+/Phosphatidylethanolamine_35:2_[M+H]1+/Phosphatidate_37:3_[M+NH4]1+ levels,2428
18,Dermatologic disease,1334
18,Coffee consumption,782
18,Dorsalgia,718
18,Heel bone mineral density (bmd) (right),1414
18,Midgestational cytokine/chemokine levels (fetal genetic effect) [sIL2R-alpha],132
18,CD25++ CD8+ T cell Absolute Count,4
18,Major depressive disorder (MTAG),2725
18,Crohn's disease,4091
18,Body mass index [men],555
18,Electrocardiogram morphology (amplitude at temporal datapoints) [164 ms],114
18,Upper eyelid sagging severity [recessive],15
18,Hip circumference [EA],7898
18,Externalizing behaviour (multivariate analysis),10018
18,Immature reticulocyte fraction,7798
18,Amias 2mg tablet | treatment/medication code,165
18,Blood glucose levels,454
18,Influenza and pneumonia,85
18,Electrocardiogram morphology (amplitude at temporal datapoints) [-14 ms],9093
18,Brain region volumes [left entorhinal],178
18,"Trans fatty acid levels [Trans/trans-18:2, EA]",6
18,QRS duration [EA],9116
18,Conductive and sensorineural hearing loss,135
18,Cardiomyopathy,44
18,Neutrophill count,17191
18,Type 1 diabetes with ophthalmic complications,1168
18,Coffee consumption (cups per day),863
18,Electrocardiogram morphology (amplitude at temporal datapoints) [208 ms],16
18,Biological sex,10637
18,Esophageal cancer (squamous cell),1033
18,Spine bone size,595
18,"Cholelithiasis/gall stones | non-cancer illness code, self-reported",5
18,Whole body fat mass,15752
18,Corneal hysteresis (right),461
18,Hypertension,5004
18,Myasthenia gravis,328
18,Transplanted organ and tissue status,20
18,Protein quantitative trait loci (liver) [ALDH5A1],59
18,Electrocardiogram morphology (amplitude at temporal datapoints) [168 ms],114
18,Methylmalonate (mma) levels,228
18,Mean corpuscular hemoglobin,204945
18,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [men],1117
18,Electrocardiogram morphology (amplitude at temporal datapoints) [-40 ms],1186
18,Body size at age 10,9150
18,"Peritonitis | non-cancer illness code, self-reported",219
18,Electrocardiogram morphology (amplitude at temporal datapoints) [-36 ms],1255
18,Hematological or dermatological disease,1170
18,"Malignant neoplasm of rectum, rectosigmoid junction, and anus",72
18,Body fat distribution (arm fat ratio) [males],696
18,Normal facial asymmetry (angle of surface orientation score) [≥14 yr],527
18,Lymphocyte count,3
18,Total testosterone levels,49503
18,Body mass index (age <50),699
18,Fat-free mass [male],1813
18,Schizophrenia [EA],285
18,Length of time at current address,238
18,Piroxicam | treatment/medication code,97
18,"""Artrosis, including avohilmo""",34
18,"""Other diabetes, wide definition""",772
18,Smoking initiation,323
18,Total bilirubin levels,590
18,"Hypothyroidism/myxoedema | non-cancer illness code, self-reported",1800
18,Circulating plasma alpha-Klotho levels,1102
18,Hypothyroidism nos,615
18,Duration of moderate activity,163
18,Mitochondrial DNA copy number,481
18,Bread intake,201
18,Age completed full time education,1680
18,Other nonmalignant breast conditions,809
18,"Asthma | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",40
18,Electrocardiogram morphology (amplitude at temporal datapoints) [134 ms],74
18,Urinary albumin-to-creatinine ratio,40
18,LDL cholesterol,995
18,High blood pressure | vascular/heart problems diagnosed by doctor,1785
18,Age started wearing glasses or contact lenses,502
18,Ascorbate (vitamin c) levels,61
18,Leg fat mass (right),15220
18,Mean corpuscular volume,233400
18,Eczema,13565
18,Balding type 1,1786
18,"Heel quantitative ultrasound index (qui), direct entry (right)",1414
18,Metabolite levels (lipoprotein measures) [HDL diameter],228
18,"Lipid metabolism phenotypes [HDL.large, whole]",228
18,Electrocardiogram morphology (amplitude at temporal datapoints) [234 ms],16
18,Electrocardiogram morphology (amplitude at temporal datapoints) [142 ms],74
18,Macular thickness,2413
18,Sodium in urine,109
18,Average total household income before tax,417
18,Wheeze or whistling in the chest in last year,721
18,Gut microbiota relative abundance (bacterial taxa) [Clostridium_xylanovorans],2726
18,Metformin | treatment/medication code,196
18,"Hip circumference [EA, men]",755
18,Angina pectoris,41
18,Protein quantitative trait loci (liver) [ACLY],28
18,"Body mass index in physically active individuals [EA,women]",684
18,Electrocardiogram morphology (amplitude at temporal datapoints) [216 ms],16
18,Electrocardiogram morphology (amplitude at temporal datapoints) [122 ms],74
18,Neuropsychiatric disorders,1910
18,Fruit consumption,1604
18,"""Endocrine, nutritional and metabolic diseases""",7
18,Phosphatidylcholine_40:10_[M+OAc]1- levels,7
18,Heel bone mineral density T score,10601
18,Trunk fat mass,11984
18,"""Rheumatism, unspecified""",3
18,Multiple sclerosis,2823
18,Lymphocyte counts,35781
18,Aspartate aminotransferase levels,67724
18,Serum levels of protein CHST9,1010
18,BMI in smokers [men],586
18,Phosphatidylinositol_36:2_[M-H]1- levels,27
18,Eosinophill count,22243
18,Trunk predicted mass,35398
18,Fluid intelligence score,1792
18,Birth weight,242
18,"Waist-to-hip ratio adjusted for body mass index [EA, women]",32
18,A body shape index,2673
18,C-reactive protein levels [BMI-adjusted],682
18,White matter microstructure (mode of anisotropy) [Superior corona radiata],269
18,Electrocardiogram morphology (amplitude at temporal datapoints) [88 ms],58
18,Basophil percentage of white cells,1002
18,Lumbar spine bone mineral density,24
18,Drive faster than motorway speed limit,86
18,3mm strong meridian (left),401
18,Chronic kidney disease,183
18,Optic disc size,100
18,Total amyloid (SNP x SNP interaction),413
18,4-chlorobenzoic acid levels,138
18,Conjunctivitis,29
18,Myopia (age of diagnosis),474
18,Femur bone mineral density x serum urate levels interaction,88
18,HDL cholesterol levels x long total sleep time interaction (2df test),7
18,Highest math class taken,7285
18,Leukocyte telomere length,6369
18,Suffering from nerves,757
18,Worry too long after embarrassment,2595
18,Palmar fascial fibromatosis [Dupuytren],280
18,Pruritus and related conditions,229
18,Glomerular filtration rate,433
18,Asthma (more control exclusions),46
18,Body mass index [age 1-17],696
18,Breast cancer [conditional],60
18,Sum eosinophil basophil counts,7077
18,BMI (adjusted for smoking behaviour) [women],586
18,Testosterone levels,4709
18,Glomerular filtration rate (creatinine),886
18,Atopic dermatitis,393
18,"""Complications following infusion, transfusion and therapeutic injection""",31
18,Neuritic plaques (SNP x SNP interaction),58
18,Putamen volume,1307
18,Poisoning by narcotics and psychodysleptics [hallucinogens],298
18,Processed meat intake,376
18,Brain region volumes [right cerebellum white matter],88
18,Insomnia symptoms (never/rarely vs. sometimes/usually),209
18,Monocyte percentage of white cells,13598
18,Use of sun/uv protection,316
18,"Intra-ocular pressure, goldmann-correlated (left)",20
18,Protein quantitative trait loci (liver) [TGM2],304
18,Electrocardiogram morphology (amplitude at temporal datapoints) [116 ms],74
18,First line medication for Crohns disease,25
18,Resting heart rate,800
18,Schizophrenia [East Asian],17
18,"Allergic disease (asthma, hay fever or eczema)",7611
18,"Heel quantitative ultrasound index (qui), direct entry (left)",1414
18,Body mass index (joint analysis main effects and physical activity interaction),690
18,Ankle spacing width,12941
18,Mood instability,1267
18,Time spent doing light physical activity,4
18,Arm fat percentage (left),14287
18,"Ground coffee (include espresso, filter etc) | coffee type",8958
18,College or university degree | qualifications,5682
18,Heel bone mineral density (bmd),4377
18,Electrocardiogram morphology (amplitude at temporal datapoints) [218 ms],16
18,C-reactive protein levels,20488
18,Something else not mentioned | behavioural and miscellaneous addictions,1075
18,Impedance of arm (right),2016
18,Renal function-related traits (BUN),394
18,Metabolite levels [Cer d16:1/18:0],166
18,Serum bilirubin levels in metabolic syndrome,60
18,High light scatter reticulocyte count,38122
18,Bioavailable testosterone levels,23336
18,Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis),2786
18,Rheumatoid arthritis,5580
18,Adolescent idiopathic scoliosis,4554
18,Gamma glutamyl transferase levels,6922
18,High density lipoprotein cholesterol levels [conditional on round 3],256
18,Electrocardiogram morphology (amplitude at temporal datapoints) [108 ms],58
18,Motion sickness,195
18,Chronic back pain,666
18,3-hydroxypropylmercapturic acid levels in smokers [Japanese],106
18,Cerebrospinal fluid immune biomarker levels [MCP-1],55
18,Chin dimples,1320
18,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA],1117
18,"Body mass index (adult) [AA,Women]",639
18,Electrocardiogram morphology (amplitude at temporal datapoints) [194 ms],74
18,Alanine aminotransferase levels,18635
18,1-palmitoyl-2-arachidonoyl-gpc (16:0/20:4n6) levels,831
18,HDL cholesterol x physical activity interaction (2df test),228
18,"Loneliness, isolation",114
18,Subjective well-being (MTAG),1705
18,Frequency of unenthusiasm / disinterest in last 2 weeks,696
18,"""Atopic  dermatitis, strict definition""",124
18,Electrocardiogram morphology (amplitude at temporal datapoints) [256 ms],16
18,Obese vs. thin,643
18,"Blood protein levels [B4GALT6, 10832_24_3]",1172
18,Waist circumference and related phenotypes [waist circumference],945
18,Vascular endothelial growth factor levels,406
18,Electrocardiogram morphology (amplitude at temporal datapoints) [148 ms],74
18,Serum levels of protein CSNK2A1;CSNK2B,5223
18,Depressive symptoms x dependent stressful life events interaction (1df test),538
18,"""Articial joint operation, menisceal resection""",18
18,White blood cell count,141183
18,Age-related hearing impairment (MTAG),1081
18,Subjective well-being,556
18,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction) [women],1117
18,Erythrocyte cadmium concentration in never smokers,90
18,Electrocardiogram morphology (amplitude at temporal datapoints) [98 ms],58
18,Hypopharyngeal or laryngeal cancer,13
18,Body mass index,152777
18,Insomnia symptoms (never/rarely vs. usually),209
18,Corneal hysteresis (left),273
18,Guilty feelings,233
18,Acute appendicitis,511
18,Serum levels of protein HDHD2,9539
18,Insulin-like growth factor 1 levels,9568
18,High-sensitivity cardiac troponin T levels,2024
18,Late-onset myasthenia gravis,158
18,Hemoglobin A1c levels,10468
18,Sum basophil neutrophil counts,12773
18,Childhood obesity [EA],81
18,Colorectal cancer (controls excluding all cancers),76
18,Waist circumference adjusted for body mass index,10992
18,Other intervertebral disc disorders,753
18,Immune response to smallpox vaccine (IL-6) [AA],3137
18,6mm weak meridian (left),230
18,Basal metabolic rate variance,863
18,"Hip circumference [EA,women]",7624
18,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)",1239
18,Celiac disease or Rheumatoid arthritis,798
18,Conscientiousness,5407
18,Waist circumference adjusted for BMI in non-smokers,1117
18,Dupuytren's disease,75
18,Regular attendance at a religious group,175
18,3mm weak meridian (right),230
18,"""Benign neoplasm of colon, rectum, anus and anal canal (controls excluding all cancers)""",76
18,Cognitive ability (MTAG),19052
18,Cancer,191
18,Immature fraction of reticulocytes,18827
18,Alzheimer's disease or HDL levels (pleiotropy),223
18,"Waist circumference adjusted for BMI in active individuals [EA, men]",1117
18,Electrocardiogram morphology (amplitude at temporal datapoints) [104 ms],58
18,Electrocardiogram morphology (amplitude at temporal datapoints) [252 ms],16
18,Electrocardiogram morphology (amplitude at temporal datapoints) [240 ms],16
18,Creatinine levels,25934
18,Electrocardiogram morphology (amplitude at temporal datapoints) [-16 ms],9093
18,Waist circumference adjusted for BMI in active individuals [men],1117
18,Smoking initiation (ever regular vs never regular) (MTAG),16131
18,Major depressive disorder,2217
18,Body mass index (joint analysis main effects and physical activity interaction) [EA],689
18,Chronic obstructive pulmonary disease in non-current smokers,1017
18,Job involves heavy manual or physical work,46
18,"Insulin | medication for cholesterol, blood pressure or diabetes",285
18,"Varicose veins | non-cancer illness code, self-reported",1010
18,Tildiem 60mg m/r tablet | treatment/medication code,61
18,"""Erosion of teeth, including avohilmo""",12
18,Waist circumference adjusted for body mass index [women],1117
18,Neuroticism score,2250
18,Left ventricular internal dimension in systole,193
18,Malignant neoplasm of rectum (controls excluding all cancers),76
18,Monocyte count,53411
18,Serum phosphate levels,3903
18,"Blood protein levels [CHST9, 11646_4_3]",551
18,Medication use (HMG CoA reductase inhibitors),193
18,Corneal hysteresis,20
18,Hypothyroidism,7011
18,Body fat distribution (arm fat ratio) [females],696
18,Bullous keratopathy,20
18,Protein quantitative trait loci (liver) [TKT],29
18,Depressive symptoms (MTAG),2736
18,Parental longevity (both parents in top 10%),51
18,3-hydroxypropylmercapturic acid levels in smokers [AA],43
18,Cancer (pleiotropy),72
18,Number of sexual partners,1461
18,Neuroticism conditioned on self-rated math ability (multi-trait conditioning and joint analysis),1435
18,Physical activity (overall physical activity time),689
18,Diastolic blood pressure,36423
18,Corneal resistance factor (right),462
18,Testicular germ cell tumor,19
18,Drug-induced liver injury (statins),71
18,Lifetime number of sexual partners,221
18,Childhood body mass index,2130
18,Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis),1321
18,Pulse wave arterial stiffness index,75
18,Chronic obstructive pulmonary disease x current smoker interaction (main effect),1017
18,High density lipoprotein cholesterol levels,2812
18,"Body mass index (joint analysis main effects and physical activity interaction) [EA, men]",555
18,Facial morphology (segment 11),406
18,Handedness [Handedness],12
18,Red cell distribution width,111713
18,Height [AA],12746
18,Overall health rating,1730
18,Sensorineural hearing loss,135
18,Sleeplessness / insomnia,255
18,Intelligence (MTAG),26411
18,Direct bilirubin levels,11019
18,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),754
18,Rheumatoid arthritis [East Asian],3821
18,Serum metabolite levels [7-methylguanine],4254
18,1-stearoyl-2-arachidonoyl-gpc (18:0/20:4) levels,1031
18,Platelet-to-lymphocyte ratio,134
18,Motor neuron disease (with DMD),3
18,Social science traits (pleiotropy) (HIPO component 1),3010
18,Inflammatory skin disease [Psoriasis],11802
18,Ankle spacing width (left),1823
18,Obesity,3039
18,Autoimmune traits,2766
18,Autism spectrum disorder (MTAG),672
18,High-sensitivity cardiac troponin I concentration,269
18,Lymphocyte %leukocyte,314
18,None of the above | eye problems/disorders,63
18,Regular attendance at a pub or social club,786
18,Arthritis (juvenile idiopathic),548
18,Adverse response to drug [Macrolides [J01FA]],264
18,"Low forceps, not breech | delivery methods",363
18,"Seen a psychiatrist for nerves, anxiety, tension or depression",490
18,Thyroid hormone levels [FT4-Females],19
18,Schizophrenia,10138
18,Peak expiratory flow (pef),1342
18,Meprin A subunit beta levels,500
18,Chronic obstructive pulmonary disease x current smoker interaction (2df),1017
18,Benign neoplasm of colon,76
18,"Bone mineral density (paediatric, skull)",31
18,Hypertension [East Asian],3058
18,Waist circumference adjusted for BMI in active individuals [women],1117
18,Electrocardiogram morphology (amplitude at temporal datapoints) [138 ms],56
18,Heel bone mineral density,34563
18,Fractures,2758
18,Estradiol levels,4204
18,Number of days/week of moderate physical activity 10+ minutes,72
18,Feeling lonely,114
18,Arm fat mass (right),12727
18,Myocardial infarction,284
18,Dothiepin | treatment/medication code,54
18,Ever smoked,38
18,Body mass index (joint analysis main effects and physical activity interaction) [women],689
18,Contracture of palmar fascia [dupuytren's disease],217
18,Urinary albumin excretion,109
18,Obesity [Overweight],863
18,"Diastolic blood pressure, automated reading",1023
18,General cognitive ability,970
18,Something else | substance of prescription or over-the-counter medication addiction,275
18,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),220
18,Sleep duration,503
18,Electrocardiogram morphology (amplitude at temporal datapoints) [2 ms],54
18,Heart rate response to exercise,215
18,Rectal cancer,72
18,Serum levels of protein KLK1,6
18,Colorectal cancer [EA],51
18,"Forced vital capacity (fvc), best measure",7006
18,Leg predicted mass (left),16965
18,DHEAS levels,67
18,Electrocardiogram morphology (amplitude at temporal datapoints) [198 ms],16
18,Hand grip strength (left),7272
18,"""Hypothyroidism, strict autoimmune""",1630
18,Response to bleomycin (chromatid breaks),102
18,"""Diabetes, insuline treatment (Kela reimbursement) (more control exclusions)""",699
18,Waist circumference adjusted for BMI in non-smokers [men],1117
18,Systolic blood pressure,45193
18,Mean corpuscular haemoglobin,15967
18,High light scatter reticulocyte percentage of red cells,13467
18,Estimated glomerular filtration rate in diabetes,169
18,Protein quantitative trait loci (liver) [LBP],337
18,BMI in non-smokers [women],586
18,Menarche (age at onset),16107
18,Waist circumference [EA],614
18,Other osteochondrodysplasias,175
18,Electrocardiogram morphology (amplitude at temporal datapoints) [100 ms],58
18,Impedance of whole body,5864
18,Risk taking,278
18,Pancreatic cancer,1078
18,"None of the above | medication for cholesterol, blood pressure or diabetes",509
18,Fasting insulin,32
18,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],220
18,Body mass index [women],689
18,Diabetes,32
18,"Blood protein levels [TNFRSF11A, 8256_57_3]",183
18,Morning/evening person (chronotype),3253
18,Ulcerative colitis [EA],317
18,Nasopharyngeal carcinoma (SNP x SNP interaction),1448
18,HDL cholesterol levels [Trans-ethnic initial],870
18,Loneliness (MTAG),238
18,Sclerosing cholangitis and ulcerative colitis (combined) [PSC],63
18,Mosaic loss of chromosome Y (Y chromosome dosage),386
18,Electrocardiogram morphology (amplitude at temporal datapoints) [102 ms],58
18,Serum uric acid levels,2065
18,Vertex-wise cortical thickness,4176
18,Hot drink temperature,2456
18,Protein quantitative trait loci (liver) [YWHAZ],53
18,Electrocardiogram morphology (amplitude at temporal datapoints) [260 ms],16
18,Pulmonary arterial hypertension (without BMPR2 mutations),54
18,Corneal degeneration,20
18,Protein quantitative trait loci (liver) [AKR1C2],29
18,Basophil count,30889
18,Vertex-wise sulcal depth,11643
18,Retinol levels,858
18,Aspartate aminotransferase to alanine aminotransferase ratio,1039
18,Type 2 diabetes [conditional],118
18,Tumor necrosis factor receptor superfamily member 11A levels,2315
18,Poultry consumption,4550
18,Insomnia [Female],383
18,"Blonde | hair colour (natural, before greying)",1320
18,Nonatopic asthma and/or BMI,92
18,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event) [Cox proportional hazards regression model],162
18,Protein quantitative trait loci (liver) [UGDH],29
18,Low-grade serous and serous borderline ovarian cancer,8065
18,"""Obesity, other/unspecified""",780
18,Piriton 4mg tablet | treatment/medication code,179
18,Urinary albumin-to-creatinine ratio [EA],109
18,Electrocardiogram morphology (amplitude at temporal datapoints) [118 ms],74
18,Hernia of abodminal wall,170
18,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) [subset analysis]",2869
18,Obesity and other hyperalimentation,784
18,Malignant neoplasm of other and ill-defined sites within the digestive organs and peritoneum,72
18,A levels/as levels or equivalent | qualifications,676
18,BMI in smokers,586
18,Electrocardiogram morphology (amplitude at temporal datapoints) [-32 ms],69
18,Heel bone mineral density (bmd) (left),1414
18,Thyroid autoantibody positivity (anti-thyroglobulin (TgAb) and/or anti-thyroid peroxidase  (TPOAb) levels),1793
18,Pre-treatment viral load in HIV-1 infection,143
18,Electrocardiogram morphology (amplitude at temporal datapoints) [174 ms],74
18,"""Disorders of sclera, cornea, iris and ciliary body""",20
18,Electrocardiogram morphology (amplitude at temporal datapoints) [190 ms],74
18,Obesity (early onset extreme),1613
18,Fed-up feelings,1017
18,"Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA, women]",1117
18,Leg lean mass (fat adjusted),863
18,Electrocardiogram morphology (amplitude at temporal datapoints) [94 ms],58
18,Distance between home and job workplace,23
18,Appendicular lean mass,125763
18,Serum levels of protein B4GALT6,1172
18,"Heel bone mineral density (bmd) t-score, automated (right)",1414
18,Electrocardiogram morphology (amplitude at temporal datapoints) [-114 ms],453
18,Electrocardiogram morphology (amplitude at temporal datapoints) [154 ms],16
18,Magnesium  | vitamin and/or mineral supplement use,803
18,"""Asthma, including avohilmo""",46
18,Reticulocyte percentage,18
18,Phosphatidylcholine_38:9_[M+OAc]1-/Phosphatidylserine_42:8_[M-H]1- levels,7
18,Invasive breast cancer [mixed effect],5512
18,Clinical laboratory measurements [erythrocyte distribution width],6678
18,Body mass index [Japanese],1183
18,Comparative height size at age 10,4686
18,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Asian],228
18,Protein quantitative trait loci (liver) [ABCB6],36
18,Metabolite levels [phenylalanine],12
18,Protein quantitative trait loci (liver) [PGD],29
18,"Heel broadband ultrasound attenuation, direct entry",3777
18,Time spend outdoors in summer,76
18,Systemic lupus erythematosus,2172
18,Blood urea nitrogen levels,1947
18,Haematocrit percentage,2106
18,Trunk lean mass,362
18,P-selectin glycoprotein ligand 1 levels,9
18,Phospholipid levels (plasma) [proportions],2428
18,Body mass index in physically active individuals,690
18,Electrocardiogram morphology (amplitude at temporal datapoints) [264 ms],16
18,Sex hormone-binding globulin levels,29518
18,Impedance of arm (left),10420
18,PR interval,5678
18,Fat body mass,843
18,Systolic blood pressure [Japanese],3809
18,Plateletcrit,21337
18,"Hypertension | non-cancer illness code, self-reported",1647
18,Rheumatoid arthritis (ACPA-positive),98
18,Mental health study participation (completed survey),218
18,Waist-to-hip ratio adjusted for body mass index [women],32
18,Oral lichen ruber planus,4
18,Whole body fat-free mass,17946
18,Irritable mood,1209
18,Getting up in morning,253
18,Leg fat mass and leg lean mass (pleiotropy),863
18,Gut microbiota (bacterial taxa) [Erysipelotrichales order],394
18,"Lipid metabolism phenotypes [HDL-C.by.NMR, fasting]",228
18,Mean arterial pressure [Japanese],4006
18,Impedance of leg (right),4938
18,Soya | milk type used,4621
18,Brugada syndrome,1186
18,Biological sex (age adjusted),156
18,Electrocardiogram morphology (amplitude at temporal datapoints) [162 ms],114
18,Hypertrophic cardiomyopathy (sarcomere negative),5671
18,Protein quantitative trait loci (liver) [GSN],356
18,Clusterin-like protein 1 levels,1654
18,Mental health study participation (provided email address),4197
18,Miserableness,1234
18,"""Type 2 diabetes, strict (exclude DM1)""",775
18,Phosphatidylinositol_36:2_[M+H]1+ levels,68
18,Electrocardiogram morphology (amplitude at temporal datapoints) [144 ms],16
18,Daytime nap,8333
18,Fat-free mass,1910
18,Cardiovascular disease,5493
18,Monocyte percentage,931
18,Multisite chronic pain,1444
18,Resistant hypertension,42
18,Primary sclerosing cholangitis,3936
18,Feeling nervous,125
18,Electrocardiogram morphology (amplitude at temporal datapoints) [206 ms],16
18,Plasma free amino acid levels [Ala],5
18,Total bone mineral density x gut microbiota (﻿genus Dialister) interaction,8
18,"None of the above | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",16193
18,Protein quantitative trait loci (liver) [NPC2],3
18,Electrocardiogram morphology (amplitude at temporal datapoints) [178 ms],16
18,Intracranial aneurysm,2879
18,Place of birth in uk - east co-ordinate,264
18,Macrovascular complications in type 2 diabetes,871
18,Mean arterial pressure [East Asian],3491
18,Bipolar disorder or major depressive disorder,1672
18,Electrocardiogram morphology (amplitude at temporal datapoints) [96 ms],58
18,Benign neoplasm: Colon,76
18,Spherical power (right),314
18,Electrocardiogram morphology (amplitude at temporal datapoints) [130 ms],74
18,Protein quantitative trait loci (liver) [A2M],6
18,"""Atopic dermatitis, strict definition with reimbursement""",79
18,Reaction time,12953
18,Electrocardiogram morphology (amplitude at temporal datapoints) [232 ms],16
18,Parkinson's disease or first degree relation to individual with Parkinson's disease,2919
18,Body fat percentage or heart failure (MTAG),7764
18,Insomnia,3816
18,Body mass index in asthmatics [adult],2871
18,Atopic asthma,40
18,Atrial fibrillation/atrial flutter,43
18,Self-reported math ability,6505
18,Protein quantitative trait loci (liver) [COPS5],855
18,Autism spectrum disorder or schizophrenia,66
18,Electrocardiogram morphology (amplitude at temporal datapoints) [228 ms],16
18,Phosphatidylinositol_34:2_[M-H]1- levels,7
18,"None of the above | medication for pain relief, constipation, heartburn",209
18,Subjective wellbeing conditioned on average household income before tax (multi-trait conditioning and joint analysis),2873
18,Depression,7919
18,Obesity [adults],696
18,Worry/vulnerability (special factor of neuroticism),109
18,Leisure sedentary behaviour (television watching),5151
18,"Forced expiratory volume in 1-second (fev1), best measure",2226
18,Body mass index variance,863
18,Alcohol usually taken with meals,213
18,Ribulonate/xylulonate levels,2204
18,White matter microstructure (fractional anisotropy) [Fornix (cres) / Stria terminalis],21
18,Tuberculosis,113
18,Sumatriptan | treatment/medication code,841
18,"""Type 1 diabetes, wide definition, subgroup 1""",1135
18,"Body mass index [EA, women]",689
18,Waist circumference variance,863
18,Gallstone disease,350
18,Electrocardiogram morphology (amplitude at temporal datapoints) [-30 ms],69
18,Nicotine withdrawal symptom count,4
18,Serum albumin levels,6207
18,Bitter alcoholic beverage consumption,4550
18,Sensitivity to environmental stress and adversity,354
18,"""Carcinoma in situ of cervix uteri, endocervix""",11
18,Ocular pain,285
18,Ease of getting up in the morning,100
18,Electrocardiogram morphology (amplitude at temporal datapoints) [184 ms],74
18,Smoking initiation (ever regular vs never regular) [Conditioned on chr18:49967811],602
18,Participation in an health questionnaire (not invited vs invited),371
18,ADHD vs obsessive compulsive disorder (ordinary least squares (OLS)),9
18,Electrocardiogram morphology (amplitude at temporal datapoints) [128 ms],16
18,Myopic maculopathy,413
18,Electrocardiogram morphology (amplitude at temporal datapoints) [212 ms],16
18,"Neurological, eye or psychiatric disease",1506
18,Protein quantitative trait loci (liver) [FHL1],53
18,Phosphatidylinositol_36:4_[M-H]1- levels,7
18,Myeloid white cell count,8528
18,Medication use (agents acting on the renin-angiotensin system),1267
18,"Financial difficulties | illness, injury, bereavement, stress in last 2 years",128
18,Hypertrophic cardiomyopathy,17501
18,Low hand grip strength (60 years and older) (FNIH),4209
18,Corneal dystrophy,967
18,HDL cholesterol levels [BMI unadjusted],34
18,Cortical thickness (min-P),1064
18,Physical activity,689
18,"Inguinal hernia | non-cancer illness code, self-reported",49
18,Diffuse plaques (SNP x SNP interaction),213
18,Fatty acid desaturase activity (serum) [D6D],5
18,Tanning,6
18,Hand grip strength (right),21905
18,Schizophrenia vs ADHD (ordinary least squares (OLS)),415
18,Height,222738
18,Duration to first press of snap-button in each round,5001
18,Caffeine consumption from coffee or tea,399
18,Electrocardiogram morphology (amplitude at temporal datapoints) [188 ms],74
18,Age asthma diagnosed,158
18,"Age hay fever, rhinitis or eczema diagnosed",208
18,Basophil percentage of granulocytes,16
18,Leg lean mass,863
18,Corneal endothelial cell shape (percentage of hexagonally shaped cells),20
18,C-reactive protein levels or HDL-cholesterol levels (pleiotropy),999
18,Senokot 7.5mg tablet | treatment/medication code,2593
18,Lymphocyte percentage,4479
18,Phosphatidylcholine_34:4_[M+H]1+/Phosphatidylethanolamine_37:4_[M+H]1+/Phosphatidate_39:5_[M+NH4]1+ levels,2811
18,Total PHF-tau (SNP x SNP interaction),18663
18,Mean arterial pressure,13321
18,Standing height,37124
18,Urinary albumin-to-creatinine ratio in diabetes,50
18,Phosphatidylcholine_40:9_[M+OAc]1-/Phosphatidylserine_44:8_[M-H]1- levels,7
18,Brain region volumes [right putamen],861
18,Body mass index (joint analysis main effects and smoking interaction) [women],586
18,Broad depression or schizophrenia,116
18,Diseases of hard tissues of teeth,248
18,X-23587 levels,75
18,Body mass index [EA],689
18,Body mass index (joint analysis main effects and physical activity interaction) [men],555
18,Subacute thyroiditis,384
18,Serum metabolite levels (CMS) [M_HDL_PL],228
18,Electrocardiogram morphology (amplitude at temporal datapoints) [186 ms],74
18,Educational attainment (MTAG) [MTAG],66420
18,Neutrophil percentage of white cells,10725
18,Electrocardiogram morphology (amplitude at temporal datapoints) [214 ms],16
18,Electrocardiogram morphology (amplitude at temporal datapoints) [192 ms],74
18,Body mass index x sex x age interaction (4df test),699
18,Albumin-globulin ratio,1204
18,Pattern 1 | hair/balding pattern,2234
18,Obesity [children],696
18,Vitiligo,88
18,Sum neutrophil eosinophil counts,14560
18,Electrocardiogram morphology (amplitude at temporal datapoints) [112 ms],16
18,Never/rarely use spread | spread type,548
18,Urinary potassium excretion,109
18,Hyoscine butylbromide | treatment/medication code,27
18,HDL cholesterol,14407
18,Fractured/broken bones in last 5 years,1427
18,"Overweight, obesity and other hyperalimentation",863
18,Direct low density lipoprotein cholesterol levels,386
18,Atrial fibrillation [EA],43
18,Able to confide,114
18,A disintegrin and metalloproteinase with thrombospondin motifs 13 levels,77
18,"Other (e.g. cornflakes, frosties) | cereal type",5370
18,Total protein levels x insomnia interaction,254
18,Ever thought that life not worth living,706
18,1-stearoyl-2-oleoyl-gpc (18:0/18:1) levels,570
18,Leg fat percentage (left),29808
18,"Body mass index [EA, men]",555
18,Arm predicted mass (right),12409
18,Smoking status,6917
18,Subcortical volume (MOSTest),7155
18,Worry,1449
18,Panic disorder,26
18,Serum levels of protein DSG2,1339
18,Serpin B8 levels,413
18,Electrocardiogram morphology (amplitude at temporal datapoints) [114 ms],74
18,Electrocardiogram morphology (amplitude at temporal datapoints) [258 ms],16
18,Caffeine consumption from coffee,782
18,"""Benign neoplasm of colon, rectum, anus and anal canal""",76
18,Food allergy,40
18,17-hydroxyprogesterone (17-OHP) levels,12
18,Neutrophil count,104996
18,Average weekly red wine intake,4550
18,Smoking behaviour (cigarettes smoked per day),346
18,BMI in non-smokers,586
18,Alistipes abundance in stool,9
18,Arm fat percentage (right),13147
18,High light scatter reticulocyte percentage,8285
18,HDL cholesterol levels x short total sleep time interaction (2df test),16
18,Apolipoprotein A1 levels,23249
18,Household income,408
18,Alcohol consumption,472
18,Electrocardiogram morphology (amplitude at temporal datapoints) [90 ms],74
18,Electrocardiogram morphology (amplitude at temporal datapoints) [124 ms],74
18,"Lipid metabolism phenotypes [HDL.large, fasting]",228
18,Restless legs syndrome,104
18,Maxalt 5mg tablet | treatment/medication code,530
18,Lamb consumption,67
18,Hip circumference adjusted for BMI [EA],2156
18,Arm fat-free mass (right),12706
18,Paget's disease,683
18,Type 1 diabetes,20606
18,"High cholesterol | non-cancer illness code, self-reported",576
18,Follicular lymphoma,311
18,Electrocardiogram morphology (amplitude at temporal datapoints) [84 ms],58
18,"Other professional qualifications eg: nursing, teaching | qualifications",1
18,Ulcerative colitis,2103
18,Experiencing mood swings,1757
18,Sleep (1/2-day periodicity),1212
18,Ventricular ectopy or supraventricular ectopy (pleiotropy) [African],123
18,Gut microbiota (bacterial taxa) [Erysipelotrichaceae family],394
18,Breast cancer,9167
18,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),204
18,"Hip circumference adjusted for BMI [EA, women]",2156
18,Noncognitive aspects of educational attainment,2824
18,Heel broadband ultrasound attenuation (left),1414
18,Male puberty timing (age at voice breaking MTAG),164
18,Body mass index in physically active individuals [EA],684
18,Electrocardiogram morphology (amplitude at temporal datapoints) [170 ms],114
18,Prostate cancer,9855
18,Wholemeal or wholegrain | bread type,4197
18,3-hydroxy-1-methylpropylmercapturic acid levels in smokers [AA],43
18,Fresh fruit intake,3632
18,Loneliness,370
18,Feeling miserable,798
18,Electrocardiogram morphology (amplitude at temporal datapoints) [220 ms],16
18,Smoking status (ever vs never smokers),8348
18,Clinical laboratory measurements [mean corpuscular hemoglobin],6678
18,"""Excessive, freguent and irrelgular menstruation""",2
18,Red blood cell count,106733
18,Colorectal cancer or advanced adenoma,72
18,Protein quantitative trait loci (liver) [ACAD11],260
18,Femoral neck bone mineral density and trunk fat mass adjusted by trunk lean mass,35
18,Frequency of needing morning drink of alcohol after heavy drinking session in last year,76
18,"Age-related diseases, mortality and associated endophenotypes",14
18,None of the above | qualifications,1739
18,Normal facial asymmetry (angle of surface orientation score),527
18,Glucuronate levels,591
18,Adverse response to drug [Glucocorticoids [H02AB]],264
18,Forced expiratory volume in 1-second (fev1),6516
18,Body mass index (adult),639
18,Bone mineral density (spine),31
18,Asthma (childhood onset),26695
18,Psoriasis,12386
18,Serum levels of protein LCT,374
18,Electrocardiogram morphology (amplitude at temporal datapoints) [222 ms],16
18,Hypertriglyceridemia,894
18,BMI (adjusted for smoking behaviour),790
18,Alzheimer's disease/dementia | illnesses of adopted father,210
18,Dilzem sr 60mg long acting m/r capsule | treatment/medication code,126
18,Dentures,215
18,Electrocardiogram morphology (amplitude at temporal datapoints) [106 ms],58
18,Obesity (extreme),759
18,Degenerative disease of the spinal cord,580
18,Hypercholesterolemia,164
18,Mitochondrial DNA levels,2055
18,Body mass index (age>50),699
18,Mood swings,1472
18,Body fat distribution (arm fat ratio),696
18,Frequency of tiredness / lethargy in last 2 weeks,1210
18,Serum levels of protein SMURF1,179
18,Electrocardiogram morphology (amplitude at temporal datapoints) [210 ms],16
18,Morningness,8501
18,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],754
18,Diabetes mellitus,859
18,Macular pucker,33
18,Electrocardiogram morphology (amplitude at temporal datapoints) [244 ms],16
18,Domperidone | treatment/medication code,328
18,Age cataract diagnosed,60
18,Protein quantitative trait loci (liver) [LPP],53
18,"Heel bone mineral density (bmd) t-score, automated",3758
18,Mean corpuscular haemoglobin concentration,9579
18,Central corneal thickness,78
18,Malignant neoplasm of rectum,76
18,Waist circumference,15529
18,Alzheimer's disease (late onset),904
18,TRAIL levels,1704
18,Blood metabolite levels [X-03094],228
18,Place of birth in uk - north co-ordinate,579
18,Excessive hairiness,225
18,Hemoglobin,19360
18,Body fat percentage,18626
18,Electrocardiogram morphology (amplitude at temporal datapoints) [-28 ms],363
18,Sleep duration (short sleep),262
18,C-reactive protein,2434
18,UBA1446 sp002329245 abundance in stool,4
18,Protein quantitative trait loci (liver) [PRTN3],3
18,Eosinophil percentage of white cells,53947
18,Yes | hearing difficulty/problems,1006
18,Hallux valgus (acquired),62
18,X-12007 levels,1880
18,Renal transplant outcome [Five-year creatinine],345
18,"""Cholelithiasis, broad definition with cholecystitis""",350
18,Colon polyp,51
18,Medication use (thyroid preparations),3593
18,HDL cholesterol levels in current drinkers,769
18,X-13728 levels,295
18,Leisure/social activities: Sports club or gym,206
18,Eubacterium R sp000431535 abundance in stool,6
18,Waist circumference adjusted for body mass index [EA],2234
18,Adventurousness,482
18,Lean body mass,759
18,Indapamide | treatment/medication code,651
18,Anal and rectal polyp,72
18,Other paralytic syndromes,66
18,Colorectal polyp and colorectal cancer (MTAG) [Colorectal polyp],72
18,Anthropometric traits (multi-trait analysis),6771
18,Impedance of leg (left),8674
18,Type 1 diabetes with other specified/multiple/unspecified complications,1477
18,C-reactive protein levels or triglyceride levels (pleiotropy),696
18,Protein quantitative trait loci (liver) [DCN],15
18,Sociability score,12
18,Granulocyte count,14527
18,Irritability,416
18,Protein quantitative trait loci (liver) [TXNRD1],29
18,Cognitive performance (MTAG) [MTAG],22983
18,Highest math class taken (MTAG) [MTAG],15389
18,Spondylopathies,722
18,Waist circumference adjusted for BMI (adjusted for smoking behaviour) [women],1117
18,Other nutritional deficiencies,696
18,Moyamoya disease,864
18,Neuroticism (MTAG),1116
18,Body mass index in physically inactive individuals [EA],685
18,Spinal stenosis,819
18,Fractional excretion of metabolites in chronic kidney disease [Lysine],3
18,Arm fat mass (left),12747
18,White matter microstructure (radial diusivities) [Fornix (cres) / Stria terminalis],21
18,Pulse pressure,29204
18,Cholelithiasis,751
18,Poisoning by drugs primarily affecting the autonomic nervous system,453
18,Midgestational circulating levels of PBDEs (fetal genetic effect) [BDE-100],355
18,Metabolite levels [HexCer d18:1/16:0],3
18,Never | alcohol drinker status,15
18,Basophill count,16
18,Type 2 diabetes,28925
18,Sitting height ratio [EA],264
18,Electrocardiogram morphology (amplitude at temporal datapoints) [166 ms],114
18,Electrocardiogram morphology (amplitude at temporal datapoints) [238 ms],16
18,Bladder cancer,4621
18,Serum sclerostin levels,1069
18,Corneal opacity and other disorders of cornea,388
18,Autoimmune traits (pleiotropy),798
18,Cystatin C levels,8285
18,Body fat distribution (leg fat ratio) [females],1813
18,Neurofibrillary tangles (SNP x SNP interaction),5160
18,Mean platelet (thrombocyte) volume,9409
18,"Body mass index in physically active individuals [EA, men]",684
18,PR interval in Tripanosoma cruzi seropositivity,517
18,1-stearoyl-2-linoleoyl-gpc (18:0/18:2) levels,658
18,Nonatopic asthma and/or waist-to-hip ratio adjusted for BMI,44
18,Age when periods started (menarche),3075
18,Pancreas volume,599
18,Lung function (FEV1/FVC),24124
18,Self-reported math ability (MTAG) [MTAG],7320
18,Parkinson's disease,294
18,Lobe attachment (rater-scored or self-reported),755
18,HDL cholesterol levels in current drinkers [EA],228
18,Total body bone mineral density,12
18,Male-pattern baldness,12443
18,Serum 25-Hydroxyvitamin D levels,34351
18,Neurociticism,2287
18,Anxiety,751
18,"Lymphoedema | non-cancer illness code, self-reported",509
18,HDL cholesterol levels [Asian],220
18,Femoral neck bone mineral density,1134
18,Diastolic blood pressure [East Asian],3326
18,Hematological and biochemical traits [BUN],196
18,Electrocardiogram morphology (amplitude at temporal datapoints) [146 ms],56
18,"Intra-ocular pressure, goldmann-correlated (right)",20
18,Body fat distribution (trunk fat ratio),1638
18,"""Hypothyroidism,  other/unspecified""",1621
18,Chronic lymphocytic leukemia,3243
18,Electrocardiogram morphology (amplitude at temporal datapoints) [196 ms],16
18,"Blood pressure (smoking interaction) [SBP,Pack-years]",4
18,Mean time to correctly identify matches,6664
18,"Lipid metabolism phenotypes [HDL-C.by.NMR, whole]",228
18,Body mass index in physically active individuals [men],690
18,Estimated glomerular filtration rate [EA],499
18,Age-related disease endophenotypes,14
18,Spherical equivalent [EA],95
18,Waist circumference adjusted for BMI in active individuals [EA],1117
18,"Forced expiratory volume in 1-second (fev1), predicted",5710
18,Hip circumference,22530
18,Age-related hearing impairment (SNP x SNP interaction),2064
18,Electrocardiogram morphology (amplitude at temporal datapoints) [-26 ms],363
18,"Heel quantitative ultrasound index (qui), direct entry",3758
18,Haemoglobin concentration,9128
18,Fat-free mass [female],1813
18,Help-seeking from a GP,354
18,Coffee intake,782
18,Serum total protein level,7449
18,Corneal resistance factor,40
18,High-sensitivity cardiac troponin I concentration (MTAG),1022
18,Protein quantitative trait loci (liver) [LRRC59],144
18,Protein quantitative trait loci (liver) [CAPN2],124
18,Esophageal or stomach cancer,1700
18,Ankle spacing width (right),2836
18,Osteoporosis,1387
18,Gut microbiota (functional units) [PWY-5862_superpathway_of_demethylmenaquinol-9_biosynthesis],350
18,Electrocardiogram morphology (amplitude at temporal datapoints) [236 ms],16
18,Metabolite levels [BUN],394
18,Electrocardiogram morphology (amplitude at temporal datapoints) [120 ms],74
18,Electrocardiogram morphology (amplitude at temporal datapoints) [-38 ms],1255
18,Primary biliary cholangitis,3828
18,Forced vital capacity (fvc),7867
18,Pulse pressure [EA],240
18,Temazepam | treatment/medication code,84
18,Protein quantitative trait loci (liver) [ORM2],6
18,Cholelithiasis or gall stones,2
18,Phosphatidylcholine_36:7_[M+OAc]1-/Phosphatidylserine_40:6_[M-H]1- levels,7
18,"Body mass index (joint analysis main effects and physical activity interaction) [EA, women]",689
18,"Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)",1163
18,Colon adenocarcinoma (controls excluding all cancers),76
18,"Blood protein levels [DSG2, 9484_75_3]",1339
18,"Waist circumference adjusted for body mass index [EA,women]",1117
18,Lymphocyte percentage of white cells,8080
18,Creatinine (enzymatic) in urine,2514
18,Headache | pain type(s) experienced in last month,1528
18,Lung function (FVC),39347
18,Hemoglobin levels,15912
18,Urate levels,4953
18,Vitamin e product | treatment/medication code,8
18,Age of smoking initiation (MTAG),1821
18,Body mass index (adult) [AA],639
18,Hip index,93
18,Arabonate/xylonate levels,7879
18,CD39 on monocyte,136
18,Feeling worry,1405
18,Myopia,193
18,DNA methylation PhenoAge acceleration,131
18,"Number of decayed, missing and filled tooth surfaces or use of dentures",215
18,"Hayfever, allergic rhinitis or eczema | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",6217
18,Liver enzyme levels (alkaline phosphatase),3117
18,Statin medication,288
18,Protein quantitative trait loci (liver) [RPS18],304
18,Cutaneous mastocytosis (childhood),48
18,Eosinophil percentage of granulocytes,7970
18,Red blood cell (erythrocyte) count,19867
18,Imdur 60mg durule | treatment/medication code,752
18,Leg fat percentage (right),38585
18,Liver enzyme levels (gamma-glutamyl transferase),2153
18,Serum creatinine levels,8271
18,"Blood protein levels [COLEC12, 5457_5_2]",205
18,Self-rated health,127
18,Progesterone levels [women],172
18,Electrocardiogram morphology (amplitude at temporal datapoints) [110 ms],74
18,Intraocular pressure,355
18,Hip bone size,18
18,Never | smoking status,2131
18,Leg fat-free mass (right),15423
18,"""Other dorsopathies, not elsewhere classified""",746
18,Crohn's disease [EA],1329
18,Sensitivity / hurt feelings,187
18,Coronary artery disease,3951
18,Fuchs's corneal dystrophy,172
18,"HDL cholesterol levels [Asian initial, BMI unadjusted]",159
18,"Waist-hip ratio [EA, women]",699
18,"Lipid metabolism phenotypes [APOA1.assay, whole]",228
18,Home location - east co-ordinate (rounded),7
18,Whole body water mass,18940
18,Trunk fat-free mass,35631
18,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],769
18,Serum levels of protein CNDP1,534
18,Household income (MTAG),8808
18,HDL cholesterol levels,19584
18,Alcohol intake frequency.,12493
18,Mean reticulocyte volume,92322
18,Serum alkaline phosphatase levels,16802
18,Zinc  | vitamin and/or mineral supplement use,1084
18,Body mass index (joint analysis main effects and smoking interaction),586
18,Autoimmune diseases,112
18,Inverse distance to the nearest major road,2
18,Sitting height,18481
18,Basal metabolic rate,17691
18,Protein quantitative trait loci (liver) [DPYSL2],213
18,Cardiac troponin-I levels,269
18,Pulse rate,17
18,Electrocardiogram morphology (amplitude at temporal datapoints) [160 ms],114
18,Electrocardiogram morphology (amplitude at temporal datapoints) [242 ms],16
18,Electrocardiogram morphology (amplitude at temporal datapoints) [230 ms],16
18,Educational attainment (years of education),52113
18,Life satisfaction,5272
18,Chronotype,16387
18,Calcium levels,4702
18,Mammographic density (dense area),387
18,Other disorders of cornea,20
18,Feeling fed-up,622
18,Age-related hearing impairment [recessive],1198
18,Gut microbiota (bacterial taxa) [Erysipelotrichia class],394
18,Feeling hurt,2253
18,Insomnia [Male],46
18,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction) [men],1117
18,Isoleucine levels,7
18,"Lipid metabolism phenotypes [HDL-C.assay, whole]",228
18,Hip circumference variance,863
18,Serum levels of protein TNFRSF11A,194
18,Electrocardiogram morphology (amplitude at temporal datapoints) [158 ms],74
18,Anthropometric traits [height],6771
18,3mm weak meridian (left),226
18,Smoking initiation (ever regular vs never regular),2552
18,"Lipid metabolism phenotypes [HDL-C.assay, fasting]",228
18,Chlamydia trachomatis momp D antibody levels,120
18,Nonalcoholic fatty liver disease (imputed),43
18,Weight,58164
18,Non-albumin protein levels,5214
18,Electrocardiogram morphology (amplitude at temporal datapoints) [150 ms],74
18,Abnormal findings in nipple discharge synovial fluid wound secretions,9
18,Protein quantitative trait loci (liver) [CCDC58],1
18,Automobile speeding propensity,523
18,Electrocardiographic traits (multivariate),76
18,Metabolite levels [CE 16:0],1539
18,Intrinsic epigenetic age acceleration,100
18,Total cholesterol levels [EA],228
18,Granulocyte percentage of myeloid white cells,61
18,Alcohol consumption (drinks per week),5946
18,Suffer from 'nerves',704
18,Hay fever and/or eczema,14753
18,Total cholesterol levels,2744
18,Age at first live birth,105
18,Electrocardiogram morphology (amplitude at temporal datapoints) [156 ms],74
18,Age-related diseases and mortality,14
18,Systemising,6
18,"Cholesterol, total",807
18,BMI (adjusted for smoking behaviour) [men],586
18,Electrocardiogram morphology (amplitude at temporal datapoints) [204 ms],16
18,Leg fat-free mass (left),13144
18,Headache,254
18,Benign neoplasm: Colon (controls excluding all cancers),76
18,Asthma (age of onset),198
18,Electrocardiogram morphology (amplitude at temporal datapoints) [180 ms],74
18,"Lipid metabolism phenotypes [APOA1.assay, fasting]",228
18,Mean corpuscular hemoglobin concentration,48583
18,Depressive symptoms,9468
18,Pulmonary embolism with or without deep venous thrombosis,192
18,Mood disorders,691
18,LDL cholesterol levels,228
18,Calculus of kidney and ureter,2069
18,"Total cholesterol levels [Asian initial, BMI unadjusted]",159
18,Cardiovascular diseases,2
18,Hematocrit,30724
18,"Gut microbiota (bacterial taxa, rank normal transformation method) [G_Akkermansia_RNT]",88
18,Bilirubin levels,10370
18,Thyroid problem (not cancer),1950
18,Vertex-wise cortical surface area,14637
18,Positive affect,6356
18,Diglycerol levels,452
18,Inflammatory bowel disease,4637
18,Anxiety/tension (special factor of neuroticism),699
18,"""Type 2 diabetes, definitions combined""",778
18,Benign neoplasms (controls excluding all cancers),939
18,Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded),486
18,6mm strong meridian (left),624
18,Antipsychotic drug-induced weight gain,244
18,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),99
18,Time to complete round,429
18,Protein quantitative trait loci (liver) [FDXR],143
18,"""Carcinoma in situ of cervix uteri, endocervix (controls excluding all cancers)""",11
18,"Blood protein levels [EA, Beta-Ala-His dipeptidase]",122
18,Arm predicted mass (left),12966
18,6mm strong meridian (right),974
18,Protein quantitative trait loci (liver) [AKR1B10],157
18,Home location at assessment - north co-ordinate (rounded),12236
18,Dilated cardiomyopathy (MTAG),10064
18,Inflammatory bowel disease [EA],1862
18,Body mass index and fasting insulin (pairwise),32
18,Phospholipid levels in medium HDL,228
18,Total body bone mineral density [European],12
18,Phosphatidylcholine_38:8_[M+OAc]1-/Phosphatidylserine_42:7_[M-H]1- levels,28
18,Morning person,6509
18,Type 2 diabetes or prostate cancer (pleiotropy),1103
18,Protein quantitative trait loci (liver) [GPX2],29
18,Number of treatments/medications taken,301
18,QT interval (sulfonylurea treatment interaction) [EA],14
18,Estimated glomerular filtration rate,4974
18,Femur bone mineral density x serum urate levels interaction [female],24
18,Venous thromboembolism (SNP x SNP interaction),1898
18,Body mass index (age interaction),696
18,Hyperlipidemia,164
18,Protein quantitative trait loci (liver) [SERPINF1],88
18,Phosphatidylinositol_38:4_[M+NH4]1+ levels,42
18,Red blood cell (erythrocyte) distribution width,16240
18,Fish- and plant-related diet,254
18,Oxalate (ethanedioate) levels,2360
18,Systolic blood pressure [East Asian],5624
18,Rheumatoid arthritis [EA],1115
18,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction),1117
18,Asparaginase hypersensitivity in acute lymphoblastic leukemia,65
18,Electrocardiogram morphology (amplitude at temporal datapoints) [226 ms],16
18,"Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)",11816
18,Body mass index in physically inactive individuals,693
18,Reticulocyte count,34144
18,Neutrophil percentage of granulocytes,8870
18,"Waist circumference [EA, women]",614
18,Body fat percentage or coronary artery disease (MTAG),525
18,Waist circumference adjusted for BMI in active individuals,1117
18,Chronic obstructive pulmonary disease or resting heart rate (pleiotropy),260
18,Theta EEG coherence [interhemispheric posterior low theta coherence at P3-O1-P4-02],3
18,Triglyceride levels,16539
18,Cognitive traits (MTAG),556
18,Attention deficit hyperactivity disorder (MTAG),824
18,Brain region volumes [right insula],148
18,"Blood protein levels [CNDP1, 5456_59_2]",221
18,Flatulence,19
18,Osteoarthritis,5345
18,"Waist circumference [EA, men]",607
18,Tartronate (hydroxymalonate) levels,438
18,"Sphingomyelin (d18:1/22:1, d18:2/22:0, d16:1/24:1) levels",33
18,Platelet count,153315
18,Sex hormone-binding globulin levels adjusted for BMI,35698
18,Number of days/week walked 10+ minutes,302
18,CD33+ HLA DR+ CD14dim Absolute Count,16
18,Electrocardiogram morphology (amplitude at temporal datapoints) [126 ms],74
18,Urinary metabolite levels in chronic kidney disease [ribonate],7627
18,Serum urea levels,2584
18,Response to adalimumab in hidradenitis suppurativa (abscess and inflammatory nodule count increase),331
18,Eosinophil counts,174980
18,Celiac disease,2348
18,Body mass index (joint analysis main effects and smoking interaction) [men],586
18,Lung function (FVC) [EA],381
18,QRS duration [European],76
18,Hip bone mineral density and total body fat mass (bivariate analysis),35
18,Comparative body size at age 10,3613
18,Coronary artery disease [additive model],778
18,Diabetes diagnosed by doctor,838
18,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),769
18,Stable angina pectoris,41
18,Liver enzyme levels (alanine transaminase),12153
18,Walking for pleasure (not as a means of transport) | types of physical activity in last 4 weeks,338
18,Gastroesophageal reflux disease,2063
18,Dorsopathies,735
18,Attention deficit hyperactivity disorder (inattention symptoms),538
18,Divergent concomitant strabismus,27
18,Corneal curvature,1103
18,Obstructed labour due to maternal pelvic abnormality,210
18,Electrocardiogram morphology (amplitude at temporal datapoints) [86 ms],58
18,White blood cell (leukocyte) count,10227
18,Well-being spectrum (multivariate analysis),8464
18,Gamma glutamyl transpeptidase,2163
18,Femur bone mineral density x serum urate levels interaction [male],951
18,Mean sphered cell volume,38632
18,Arm fat-free mass (left),12819
18,High-sensitivity cardiac troponin T levels (MTAG),1022
18,Colorectal or endometrial cancer [opposite direction],202
18,Electrocardiogram morphology (amplitude at temporal datapoints) [-10 ms],9093
18,Waist circumference adjusted for BMI (adjusted for smoking behaviour),1117
18,Type 2 diabetes with other specified/multiple/unspecified complications,1145
18,Free thyroxine concentration,20
18,DNA methylation variation (age effect),1602
18,Abdominal aortic aneurysm,996
18,Total body bone mineral density (age 45-60),176
18,Hereditary corneal dystrophies,20
19,Serum uric acid levels,19051
19,Dialysis,295
19,"Urinary metabolites (H-NMR features) [1.7325, Lysine]",1310
19,Triacylglycerol_54:4_[M+NH4]1+ levels,863
19,Nevus count or cutaneous melanoma,286
19,"Blood protein levels [LILRA4, 8299_66_3]",123
19,Amyotrophic lateral sclerosis (sporadic),81
19,Reticulocyte count,625370
19,Serum alkaline phosphatase levels,241305
19,Triglyceride levels,227690
19,Triglyceride levels in medium VLDL [conditioned on 885 SNPs],3246
19,Serum levels of protein ARHGAP45,3872
19,Lipid metabolism phenotypes [M-LDL-C/M-LDL-PL],2844
19,Procollagen galactosyltransferase 1 measurement,1697
19,Fed-up feelings,2647
19,Asthma (only as main-diagnosis) (more control exclusions),64
19,Triacylglycerol_56:4_[M+NH4]1+ levels,622
19,Human milk oligosaccharide concentration (lacto-N-fucopentaose II) in secretors,29
19,Serum levels of protein TMCC3,1172
19,"Blood protein levels [C3, 5803_24_3]",1698
19,Hip minimal joint space width,8152
19,Phosphatidylglycerol-O_38:0_[M-H]1- levels,2218
19,Serum metabolite levels [LDL_C],3455
19,Carotid intima media thickness (mean-maximum),698
19,"Waist circumference [EA, men]",822
19,Mitochondrial heteroplasmy measurement,11469
19,Bring up phlegm/sputum/mucus on most days,10779
19,Serum metabolite levels [IDL_P],3455
19,"Blood protein levels [KLK13, 3200_49_2]",1365
19,Serum metabolite levels (CMS) [S_LDL_CE],3455
19,Coronary artery disease or ischemic stroke,3790
19,Nasopharyngeal carcinoma (SNP x SNP interaction),256
19,White matter microstructure (radial diusivities) [Fornix (column and body],387
19,Osteoarthritis (hip),271
19,Pulmonary heart disease,4251
19,"Cholesterol, total",147141
19,Smoking initiation (ever regular vs never regular) (MTAG),35533
19,Estimated glomerular filtration rate [EA],12278
19,"Midgestational circulating levels of organochlorine pesticides [p,p'-DDE]",2807
19,Serum metabolite levels (CMS) [Serum_C],3455
19,Alzheimer's disease or fasting insulin levels (pleiotropy),511
19,Body fat percentage and LDL-C (pairwise),972
19,Serum levels of protein QPCTL,1404
19,Serum levels of protein CKAP2,2196
19,Trunk predicted mass,150153
19,Platelet crit,136413
19,Educational attainment (MTAG) [MTAG],41364
19,Phosphatidylcholine-O_38:1_[M+H]1+/Phosphatidylcholine-P_38:0_[M+H]1+/Phosphatidylethanolamine-P_41:0_[M+H]1+ levels,611
19,Pure hypercholesterolaemia,3542
19,Cortical amyloid beta load [uncorrected for APOE4 status],1498
19,Serum levels of protein LILRB1,6654
19,Body mass index (joint analysis main effects and smoking interaction),3002
19,High-sensitivity C-reactive protein levels in HIV infection,531
19,Menopause (age at onset),51342
19,C-reactive protein,23840
19,"Blood protein levels [SIGLEC12, 10037_98_3]",5610
19,"Diabetes | non-cancer illness code, self-reported",16997
19,Serum metabolite levels [1-oleoyl-GPI (18:1)*],2201
19,Gonarthrosis [arthrosis of knee](FG),20244
19,Pulse pressure [Japanese],1194
19,Creatine kinase levels in off-statin users,431
19,HDL cholesterol levels [EA],2422
19,"Cerebral palsy | non-cancer illness code, self-reported",2918
19,"""Psoriatic arthropathies, ICD10""",2321
19,Smoking status (current vs mixed),595
19,CD20 on CD24+ CD27+ B cell,28136
19,Urinary metabolite ratios in chronic kidney disease [Lysine/Glutamine],1245
19,Polychlorinated biphenyl levels [PCB138],2095
19,Blood protein levels [Myeloid cell surface antigen CD33],515
19,Serum metabolite levels [XS_VLDL_P],2844
19,Bipolar disorder or major depressive disorder,85
19,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [men],383
19,Other congenital malformations of the digestive system,45
19,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)",23835
19,Serum levels of protein TGFB1,7717
19,LDL cholesterol to HDL cholesterol ratio,1300
19,Invasive epithelial ovarian cancer,4965
19,Protein quantitative trait loci [Siglec-3],713
19,Childhood allergy (age < 16),985
19,Cortical surface area [Superior parietal],195
19,Waist circumference adjusted for body mass index,100246
19,LDL cholesterol levels [BMI unadjusted],3946
19,Opioid overdose severity score,867
19,Serum levels of protein EID3,1456
19,Phosphatidylethanolamine-O_38:4_[M-H]1-/Phosphatidylethanolamine-P_38:3_[M-H]1- levels,659
19,Eosinophill count,116616
19,Metabolic syndrome,3588
19,DHEAS levels [women],4923
19,White matter microstructure (radial diusivities) [Posterior limb of internal capsule],6997
19,Longevity (90 years and older),693
19,Hip circumference adjusted for BMI,160819
19,Lymphocyte count,11938
19,"Blood protein levels [EA, Intercellular adhesion molecule 1]",1809
19,HDL Cholesterol - Triglycerides (HDLC-TG),693
19,Serum levels of protein MAPKAPK5,6930
19,Nephrotic syndrome,295
19,Inflammatory bowel disease (early onset),666
19,Bitter beverage consumption,533
19,"""Hypothyroidism,  other/unspecified""",2055
19,Iron status biomarkers (iron levels),1351
19,"""Benign neoplasm: Skin of eyelid, including canthus (controls excluding all cancers)""",31
19,Protein quantitative trait loci (liver) [RAC2],61
19,Protein quantitative trait loci (liver) [HPD],36
19,Neutrophil percentage of white cells,116039
19,Body fat distribution (trunk fat ratio) [females],108
19,Medication use (agents acting on the renin-angiotensin system),33963
19,Cerebrospinal fluid AB1-42 levels,14152
19,Longevity (age >99th survival percentile),4694
19,Phosphatidylethanolamine-ether levels [PEO(16:1;0-20:4;0],1362
19,Malignant neoplasm of liver and intrahepatic bile ducts (controls excluding all cancers),5210
19,"Blood protein levels [VPS29, 14318_1_3]",698
19,CD33dim HLA DR- Absolute Count,713
19,"Blood protein levels [ICAM5, 5124_62_3]",381
19,Protein quantitative trait loci (liver) [PSAP],12
19,Platelet aggregation [collagen 1],7893
19,Serum levels of protein PIP,10719
19,Had menopause,11323
19,Blood glucose levels,1276
19,Serum levels of protein USP21,6930
19,Heart rate response to recovery post exercise (20 sec),4208
19,Brain imaging [grey matter density of the right hippocampus],1498
19,Amyotrophic lateral sclerosis [Meta],601
19,Hard cardiovascular diseases,3542
19,"N-glycan levels [DG12, women]",53
19,LDL cholesterol levels in current drinkers,16520
19,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [AA],2595
19,Serum levels of protein RPN1,514
19,Electrocardiogram morphology (amplitude at temporal datapoints) [88 ms],129
19,Serum levels of protein LGALS4,12428
19,"Blood protein levels [EA, Killer cell immunoglobulin-like receptor 2DL4]",69
19,Total cholesterol levels [AA],9178
19,Phosphatidylcholine-O_35:1_[M+H]1+/Phosphatidylcholine-P_35:0_[M+H]1+/Phosphatidylethanolamine-O_38:1_[M+H]1+ levels,2757
19,Serum levels of protein RPS6KB1,317
19,Phosphatidylinositol_36:2_[M-H]1- levels,3478
19,Lipid traits [LDL-C],1761
19,Response to hepatitis C treatment,6444
19,"Age-related diseases, mortality and associated endophenotypes",9978
19,Cholesteryl ester_18:1_[M+NH4]1+ levels,622
19,"Urinary metabolites (H-NMR features) [1.9025, Lysine]",1310
19,Alzheimer's disease or HDL levels (pleiotropy),2469
19,Ganglion cell inner plexiform layer (GCIPL) thickness,5484
19,LDL cholesterol levels [EA],7061
19,Aspirin | treatment/medication code,3575
19,CD11c on granulocyte,815
19,"Blood protein levels [HSD17B14, 13972_4_3]",505
19,Arm fat mass (left),33268
19,Longevity (age >90th survival percentile),4435
19,Phospholipid levels in medium VLDL [conditioned on 885 SNPs],3246
19,Coronary artery bypass grafting,3542
19,Body fat percentage and HDL-C (pairwise),1808
19,Serum levels of protein SENP7,317
19,Dehydroepiandrosterone sulphate levels,8567
19,Femur bone mineral density x serum urate levels interaction,4457
19,Other type of spread/margarine | spread type,2669
19,Sphingolipid levels [Sphingomyeline C24:0],667
19,Serum levels of protein MSR1,61
19,"Blood protein levels [ARL2, 12587_65_3]",2391
19,"Hypertension | non-cancer illness code, self-reported",28838
19,Creatine kinase levels in statin users,855
19,"""Gonarthrosis, primary, with knee surgery""",5553
19,"Blood protein levels [APOE, 2418_55_9]",698
19,E-selectin levels,105
19,Protein quantitative trait loci (liver) [GALK1],7
19,Crohn's disease [EA],28840
19,Pulmonary embolism with or without deep venous thrombosis,4333
19,Complement factor B measurement,1770
19,Blood protein levels [MIA],4107
19,Other disorders of ear,2209
19,Any dementia,1498
19,LDL cholesterol,201022
19,Lymphocyte-to-monocyte ratio,33798
19,Other degenerative diseases of the nervous system,2996
19,Blood metabolite levels [dehydroisoandrosterone sulfate (DHEA-S],4923
19,Undefined dementia,1498
19,Serum metabolite levels [Remnant_C],2844
19,Hypolasia of dental enamel,295
19,Walking pace,42982
19,Eosinophill percentage,105050
19,DVT of lower extremities and pulmonary embolism,6975
19,"Blood protein levels [VIMP, 11286_78_3]",698
19,Serum levels of protein SPINT2,58
19,CD19 on CD20- CD38- B cell,7270
19,HDL cholesterol levels x short total sleep time interaction (2df test),4652
19,Cerebrospinal fluid biomarker levels [Low affinity immunoglobulin epsilon Fc receptor],624
19,Parental longevity (mother's attained age),1498
19,Triacylglycerol_58:7_[M+NH4]1+ levels,944
19,High blood pressure | illnesses of mother,2071
19,Sphingolipid levels [levels],2129
19,"""Type 2 diabetes, definitions combined, including avohilmo""",2396
19,Caspase 8 levels,743
19,Psychosis and Alzheimer's disease,1187
19,Serum immune biomarker levels [YKL-40],3530
19,Diabetes | illnesses of father,8874
19,"Blood protein levels [EA, Platelet glycoprotein VI]",9786
19,"Blood protein levels [FUT5, 4549_78_2]",409
19,Facial pigmentation measurement (polar light),202
19,Sphingomyelin_32:2_[M+H]1+ levels,3259
19,Heart rate response to recovery post exercise (30 sec),448
19,Tea consumption,21750
19,Percent mammographic density,10962
19,None of the above | qualifications,889
19,Gut microbiota abundance (genus Tyzzerella3 id.11335),1605
19,Type 2 diabetes without complications,1780
19,"Blood protein levels [EA, Myeloid cell surface antigen CD33]",1864
19,Abscess of Bartholin gland,86
19,Spherical equivalent or myopia (age of diagnosis),29520
19,Serum levels of protein SIGLEC6,9154
19,3mm asymmetry index (right),3554
19,Parental longevity (mother's age at death or mother's attained age),1498
19,Diverticulosis and diverticulitis,3082
19,Serum metabolite levels [1-linolenoyl-GPC (18:3)*],10386
19,Spontaneous adipocyte lipolysis,3555
19,Percent liver fat,15495
19,Triacylglyceride levels [Total_TAG],976
19,Alzheimer's disease (onset at age over 80),2196
19,"Other (e.g. cornflakes, frosties) | cereal type",1633
19,Diacylglycerol_38:6_[M+H-H2O]1+ levels,893
19,Phosphatidylinositol_38:4_[M+H]1+ levels,386
19,Brain region volumes [cerebellar vermal lobules I V],93
19,Nonatopic asthma,64
19,Serum levels of protein PFDN5,10043
19,Alzheimer's disease,30996
19,Blood metabolite ratios [arachidonate (20:4n6)/1-arachidonoylglycerophosphoinositol],1443
19,Whole body fat mass,31671
19,Serum metabolite levels [S_HDL_CE],611
19,Sphingomyelin_42:3_[M+H]1+ levels,693
19,Serum metabolite levels (CMS) [LDL_TG],2844
19,Facial pigmentation measurement (UV light),202
19,Serum levels of protein KIN,698
19,Protein levels in obesity [TECK],255
19,Oily fish intake,22109
19,Phosphatidylethanolamine-O_38:5_[M+H]1+/Phosphatidylethanolamine-P_38:4_[M+H]1+ levels,1498
19,N-glycan levels [DG7],106
19,Soluble ICAM-1,10804
19,Heel bone mineral density,267201
19,Age at first sexual intercourse,17474
19,Trunk fat mass,31277
19,Cingulate cortical amyloid beta load,3077
19,Cholesteryl ester_16:0_[M+NH4]1+ levels,622
19,Serum levels of protein PSD,1498
19,CD33- HLA DR+ Absolute Count,976
19,Abnormal serum enzyme levels,270
19,Gut microbiota (bacterial taxa) [Lentisphaerae],74
19,Basophil percentage of white cells,104896
19,Serum levels of protein PNLIPRP2,10719
19,Mean corpuscular haemoglobin concentration,27179
19,"""Cholelithiasis, broad definition with cholecystitis""",5180
19,Human milk oligosaccharide concentration (lacto-N-tetrose),4989
19,"""Disorder of lipoprotein metabolism, unspecified""",698
19,"""Other chronic obstructive pulmonary disease , including avohilmo""",30
19,Warfarin maintenance dose,9559
19,Essential hypertension,31915
19,Medication use (drugs used in diabetes),49245
19,Triacylglycerol_53:5_[M+NH4]1+ levels,8532
19,Chronic sinusitis,11425
19,Alzheimer's disease/dementia | illnesses of father,1498
19,"None of the above | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",10706
19,Pro-interleukin-16 levels,931
19,Neurological disorders,1498
19,Waist-hip ratio and coronary artery disease (pairwise),387
19,Pork consumption,16330
19,Schizophrenia vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),23201
19,Lipoprotein-associated phospholipase A2 activity and mass [activity],1304
19,Ideal cardiovascular health (clinical),611
19,"Blood protein levels [EA, Human Chorionic Gonadotropin]",1198
19,HDL cholesterol [AA],441
19,Serum levels of protein KLK13,3197
19,Lung function (FEV1/FVC),100191
19,Mean reticulocyte volume,292720
19,Stable angina pectoris,39193
19,Colorectal cancer [East Asian],10952
19,Protein quantitative trait loci (liver) [CTSS],975
19,Serum levels of protein B4GALT1,2022
19,Coronary revascularization (ANGIO or CABG),3542
19,Blood protein levels [Kunitz-type protease inhibitor 2],4749
19,Serum levels of protein PLAUR,576
19,"Blood protein levels [FAM159B, 10635_33_3]",698
19,Serum metabolite levels (CMS) [M_LDL_P],3455
19,"Blood protein levels [QPCTL, 8866_53_3]",1656
19,"Blood protein levels [EA, C-C motif chemokine 25]",1036
19,"Blood protein levels [PGLYRP1, 3329_14_2]",998
19,Myocardial fractal dimension (slice 6),166
19,"Heart rate variability traits (SDNN) [Hispanic, EA]",1973
19,Serum levels of protein IFIT2,893
19,LDL cholesterol levels [Asian],2595
19,LDL cholesterol levels in current drinkers [Hispanic],2595
19,Deposits [accretions] on teeth,295
19,"Cholesterol lowering medication | medication for cholesterol, blood pressure or diabetes",28075
19,Medication use (calcium channel blockers),2389
19,Other diseases of hard tissues of teeth,341
19,Appendicular lean mass,807470
19,Late-onset Alzheimer's disease,15434
19,Tea intake,23373
19,"Heel quantitative ultrasound index (qui), direct entry",30382
19,Diabetes,15332
19,Serum metabolite levels [1-stearoyl-2-linoleoyl-GPI (18:0/18:2],4088
19,Parental longevity (father's attained age),6001
19,Nexium 20mg tablet | treatment/medication code,1989
19,Electrocardiogram morphology (amplitude at temporal datapoints) [12 ms],2496
19,Family history of other specific disorders,41
19,Relative sugar intake,11682
19,Chronic obstructive pulmonary disease,9901
19,Eczema,4540
19,Electrocardiogram morphology (amplitude at temporal datapoints) [60 ms],129
19,"""Asthma, including avohilmo""",64
19,"Blood protein levels [IL27RA, 5132_71_3]",45
19,Sitting height,258326
19,Joint disorder,9386
19,Smoking initiation (ever regular vs never regular),3147
19,Electrocardiogram morphology (amplitude at temporal datapoints) [62 ms],129
19,Serum levels of protein VIMP,698
19,Triglyceride levels x long total sleep time interaction (2df test),6298
19,Sum neutrophil eosinophil counts,14039
19,"Allergic disease (asthma, hay fever or eczema)",192
19,Galectin-3 levels,17095
19,Heart rate variability traits (pvRSA/HF),3870
19,Urinary metabolite levels in chronic kidney disease [11-ketoetiocholanolone sulfate],4923
19,Serum levels of protein GGT2,982
19,Serum levels of protein PACSIN1,373
19,Lymphocyte counts,663655
19,epithelial cell adhesion molecule levels,16435
19,Growth differentiation factor-15 levels,32248
19,Acceptance of an invitation to wear a physical activity monitor,5355
19,hemolysis of donated blood (oxidative),4846
19,1-palmitoyl-2-docosahexaenoyl-gpc (16:0/22:6) levels,8220
19,Phosphatidylcholine-O(39:1)_[M+H]1+/Phosphatidylethanolamine-P(39:0)_[M+H]1+ levels,699
19,Serum metabolite levels [S_LDL_C],3455
19,Protein quantitative trait loci (liver) [TTN],756
19,Sphingomyelin(38:1)_[M+H]1+ levels,645
19,"""Conjunctivitis (acute, non atopic)""",52
19,Retinal vascular fractal density,7279
19,Liver enzyme levels (alkaline phosphatase),40214
19,Alzheimer's disease (age of onset),2191
19,Free cholesterol levels in medium VLDL [conditioned on 885 SNPs],3246
19,"Hiatus hernia | non-cancer illness code, self-reported",113
19,Arm fat mass (right),36316
19,Rabeprazole sodium | treatment/medication code,12399
19,Serum metabolite levels (CMS) [XS_VLDL_L],492
19,Disorders of lipid metabolism [Disorders of lipid metabolism],2844
19,Diacylglycerol_36:3_[M+H-H2O]1+ levels,944
19,Comparative body size at age 10,62781
19,Mean spheric corpuscular volume,233827
19,Leg fat percentage (right),34964
19,Ezetrol 10mg tablet | treatment/medication code,1498
19,Total cholesterol levels [BMI unadjusted],4057
19,Optic disc size,508
19,Serum levels of protein CEP57,698
19,Serum metabolite levels (CMS) [L_VLDL_C],8877
19,Chronic lower respiratory diseases,4068
19,Other nutritional deficiencies,1231
19,Undefined dementia (more control exclusions),1498
19,Carotid intima media thickness [cIMT],611
19,Leucine-rich alpha-2-glycoprotein 1 levels in type 2 diabetes,82
19,Able to pay rent/mortgage as an adult,1
19,Hepatitis C (spontaneous viral clearance),5883
19,Household income,1120
19,Rheumatoid arthritis (ACPA-positive),797
19,Loose teeth | mouth/teeth dental problems,692
19,Mental and behavioural disorders due to psychoctive substance use,143
19,Parental longevity (both parents in top 10%),1498
19,Morningness,20398
19,Serum levels of protein ACP5,4725
19,"Angina | non-cancer illness code, self-reported",3575
19,"""Atopic dermatitis, strict definition with reimbursement""",5375
19,"Parental longevity (combined parental attained age, Martingale residuals)",1498
19,malignant neoplasm of male genital organs,3352
19,Serum levels of protein OSCAR,1200
19,Basophil count,312207
19,"Blood protein levels [PSG3, 6444_15_3]",35120
19,Systemic sclerosis,7160
19,malignant neoplasm of male genital organs (controls excluding all cancers),3352
19,Phosphatidylinositol_38:4_[M-H]1- levels,386
19,Serum C-reactive protein concentration,1498
19,Obsessive-compulsive symptoms,297
19,Systolic blood pressure [EA],10
19,Serum metabolite levels [gamma-CEHC],4657
19,"Serum metabolite levels [androstenediol (3alpha, 17alpha) monosulfate (2]",5432
19,Serum levels of protein LILRA3,254
19,Serum levels of protein RALA,1498
19,Serum levels of protein MSN,1498
19,Lactate dehydrogenase levels in off-statin users,431
19,"Blood protein levels [PRSS57, 8351_17_3]",1210
19,N-formylanthranilic acid levels,360
19,BMI (adjusted for smoking behaviour),3824
19,"Blood protein levels [LILRB2, 5633_65_3]",3639
19,Periodontitis,953
19,Sphingomyelin_42:1_[M+H]1+ levels,858
19,LDL cholesterol [EA],614
19,CD45 on CD33- HLA DR+,713
19,Cereal intake,11682
19,General risk tolerance (MTAG),4533
19,Heme oxygenase 1 measurement,698
19,Vitamin B12 deficiency anaemia,2272
19,CD33 on CD33+ HLA DR+ CD14dim,767
19,Vitamin D levels,51538
19,Angina pectoris,19496
19,Fish- and plant-related diet [female],15914
19,Age at first birth,1316
19,"""Type 2 diabetes, wide definition""",1498
19,Serum levels of protein CD33,567
19,COVID-19 (RELEASE 4),421
19,Red blood cell count,936266
19,Phosphatidylcholine_36:7_[M+OAc]1-/Phosphatidylserine_40:6_[M-H]1- levels,3478
19,"Blood protein levels [SIGLEC14, 8248_222_3]",5610
19,Arm predicted mass (left),79313
19,Red blood cell (erythrocyte) count,151115
19,Cerebrospinal fluid t-tau levels in mild cognitive impairment,1498
19,Serum levels of protein LILRB2,6585
19,Body fat percentage and triglycerides (pairwise),1808
19,Altered mental status,1498
19,"Blood protein levels [GNAI3, 12650_43_3]",698
19,Alanine transaminase levels,1005
19,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),3902
19,Asthma,42751
19,"""Molar incisor hypoplasia, with caries""",295
19,"Blood protein levels [EA, Apolipoprotein E (isoform E2]",834
19,TNF-related apoptosis-inducing ligand levels,175
19,Processed meat intake,10184
19,Medium VLDL particle concentration [conditioned on 885 SNPs],3246
19,"Heel quantitative ultrasound index (qui), direct entry (left)",17403
19,Phospholipid levels in very small VLDL,1641
19,Triacylglycerol_52:3_[M+NH4]1+ levels,893
19,Pulmonary emphysema [Hispanic],996
19,Serum platinum levels after completion of cisplatin chemotherapy,307
19,Protein quantitative trait loci (liver) [ITIH4],274
19,Pulse rate,13740
19,Serum metabolite levels (CMS) [M_HDL_P],1816
19,DHEAS levels,4923
19,Offspring birth weight,5414
19,Tumor necrosis factor ligand superfamily member 14 levels,986
19,Contracture of palmar fascia [dupuytren's disease],690
19,Low density lipoprotein cholesterol levels [EA],27464
19,Cortical thickness,78361
19,Total cholesterol levels [Hispanic],3456
19,Anthropometric traits [height],108
19,Triacylglycerol_56:6_[M+NH4]1+ levels,9154
19,Regional enteritis,2437
19,"N-glycan levels [GP14, men]",53
19,Piriton 4mg tablet | treatment/medication code,3926
19,Serum metabolite levels (CMS) [PUFA],693
19,Electrocardiogram morphology (amplitude at temporal datapoints) [70 ms],129
19,Cholesteryl ester_18:2_[M+NH4]1+ levels,622
19,"LDL cholesterol levels [Asian initial, BMI unadjusted]",1832
19,Serum levels of protein LDHB,431
19,"""Alzheimer disease, including avohilmo""",1498
19,Sphingomyelin_40:2_[M+OAc]1- levels,611
19,Maternal history of Alzheimer's disease,6938
19,Insomnia symptoms (never/rarely vs. usually),74905
19,Phosphatidylinositol_36:2_[M+H]1+ levels,3478
19,Serum levels of protein IGFLR1,29614
19,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),3901
19,1-stearoyl-2-linoleoyl-gpc (18:0/18:2) levels,18685
19,"Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA, men]",383
19,Phosphatidylinositol_38:4_[M+NH4]1+ levels,386
19,Lung adenocarcinoma,533
19,Soluble urokinase plasminogen activator receptor levels,368
19,Macular telangiectasia type 2,334
19,Asthma (only as main-diagnosis),64
19,Breast cancer,234599
19,Simvastatin | treatment/medication code,28207
19,3mm weak meridian (left),2883
19,Lamb consumption,1498
19,Protein quantitative trait loci [sICAM-1],3326
19,Hip circumference variance,873
19,Pre-treatment viral load in HIV-1 infection,489
19,Alverine | treatment/medication code,1148
19,Electrocardiogram morphology (amplitude at temporal datapoints) [72 ms],129
19,Diacylglycerol_36:1_[M+H-H2O]1+ levels,798
19,SIR2-like protein 2 levels,755
19,Cortical surface area (min-P),253
19,Age-related disease endophenotypes,9467
19,Heel bone mineral density (bmd) (left),17592
19,Thrombosis,6975
19,Psoriatic and enteropathic arthropathies,2321
19,Smoking behavior [CPD],2489
19,Neuropathologic traits (pleiotropy) [EA],1498
19,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant II (Nose), Segment 47]",286
19,Processed meat consumption,11089
19,Relative carbohydrate intake,10184
19,Platelet aggregation [collagen 4],7893
19,Sphingomyelin_39:1_[M+OAc]1- levels,659
19,Serum levels of protein MAN1C1,2029
19,LDL cholesterol levels in current drinkers [EA],16520
19,Whole body fat-free mass,125673
19,Heart failure and coronary heart disease,2844
19,Atorvastatin | treatment/medication code,17629
19,Protein quantitative trait loci (liver) [SH3BGRL3],267
19,Resting heart rate,3450
19,Nasal polyps,2670
19,"N-glycan levels [DG9, men]",53
19,Myocardial infarction,90497
19,Myeloperoxidase levels,1106
19,Waist circumference variance,873
19,Cognitive performance,16830
19,CD33 on CD33+ HLA DR+,2232
19,Serum levels of protein EMC4,470
19,Psoriatic arthropathies,2321
19,Sphingomyelin_41:0_[M+H]1+ levels,611
19,Urinary metabolite ratios in chronic kidney disease [Lysine/Threonine],1310
19,Lifetime smoking index,837
19,Lipitor 10mg tablet | treatment/medication code,2196
19,Parental longevity (combined parental age at death),1498
19,Diabetes mellitus,14041
19,Waist-to-hip ratio adjusted for body mass index,5942
19,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),3754
19,Exfoliation syndrome,750
19,Leg fat-free mass (right),103948
19,Metabolite levels [Glycerolphosphocholine],3911
19,Phosphatidylglycerol-O_42:0_[M-H]1- levels,3184
19,Serum levels of protein C3,1997
19,Finngen Rheumatological endpoints,972
19,Serum levels of protein PMEPA1,190
19,Sodium in urine,12053
19,Midgestational circulating levels of PBDEs [BDE-99],2807
19,Cardiac arrhytmias,188
19,6mm strong meridian angle (right),1177
19,Cerebrospinal fluid biomarker levels [Sialic acid-binding Ig-like lectin 7],71
19,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],15612
19,Serum metabolite levels [L_LDL_FC],3455
19,Phosphatidylethanolamine-O_40:6_[M-H]1-/Phosphatidylethanolamine-P_40:5_[M-H]1- levels,659
19,Diacylglycerol_36:2_[M+H-H2O]1+ levels,1056
19,Metabolic syndrome [TG],1187
19,Blood protein levels [Kallikrein-11],85
19,Membranous nephropathy,4139
19,Ascorbate (vitamin c) levels,2754
19,Chronic hepatitis C infection,10065
19,Unspecified dementia,1498
19,Brain region volumes [left superior parietal],650
19,Stem cell growth factor beta levels,2006
19,Body fat percentage [European],775
19,Serum levels of protein SUMF1,698
19,Serum metabolite levels (CMS) [SM],611
19,"Blood protein levels [MDH1, 3853_56_1]",431
19,Hand grip strength,10813
19,Dietary macronutrient intake [Protein],10184
19,Cerebrospinal fluid t-tau:AB1-42 ratio,5382
19,Cardiovascular risk factors [LDL-cholesterol],698
19,Hydroxycholesterol_[M+H-2H2O]1+ levels,622
19,Phospholipid levels (plasma) [proportions],1797
19,Serum levels of protein PGLYRP1,880
19,Menarche (age at onset),54902
19,Serum metabolite levels [L_LDL_PL],3455
19,Protein levels in obesity [sICAM-5],381
19,Hyperplasia of prostate,271
19,Facial morphology (segment 5),547
19,Serum levels of protein GAL3ST2,846
19,Angiostatin measurement,431
19,Multiple sclerosis,57295
19,Behcet's disease,10843
19,Meat-related diet,40952
19,Fresh fruit intake,6354
19,Pancreatic beta-cell glucose sensitivity,873
19,Blood protein levels [Galactoside 3(4)-L-fucosyltransferase],350
19,Phosphatidylinositol(40:5)_[M-H]1- levels,716
19,Age when periods started (menarche),24930
19,"Blood protein levels [CRYZL1, 9207_60_3]",698
19,Hematuria (moderate to severe),893
19,Protein quantitative trait loci (liver) [HBG1],756
19,Atopic asthma,97
19,Hypertension,138188
19,Takayasu arteritis,3861
19,Lipid traits (pleiotropy) (HIPO component 1),4782
19,Hypothyroidism nos,2513
19,Protein S100-A12 levels,807
19,Cirrhosis (multi-trait analysis),2030
19,Alzheimer's disease/dementia | illnesses of siblings,1498
19,Serum levels of protein LRP1B,698
19,Platelet count,1200619
19,Vertex-wise cortical surface area,65809
19,Arm fat-free mass (right),112724
19,Serum levels of protein IFI16,698
19,Serum metabolite levels (CMS) [IDL_C],3455
19,Home location - north co-ordinate (rounded),357
19,Ovarian cyst,2645
19,Urinary metabolite ratios in chronic kidney disease [Lysine/Phenylalanine],1245
19,Body mass index variance,873
19,Other peripheral vertigo,74
19,Primary sclerosing cholangitis,8090
19,Postprandial triglyceride levels,9208
19,Serum levels of protein ADGRE2,138
19,Insomnia,6640
19,Schizophrenia vs bipolar disorder (ordinary least squares (OLS)),5894
19,Neurogenic locus notch homolog protein 3 levels,1814
19,Number of treatments/medications taken,1367
19,"Psoriasis | non-cancer illness code, self-reported",747
19,Cholelithiasis and cholecystitis,20020
19,Depression,85
19,3mm weak meridian (right),2979
19,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) [men],3902
19,Waist circumference adjusted for BMI (adjusted for smoking behaviour),4394
19,Lactate dehydrogenase levels,1169
19,Respiratory or ear-nose-throat disease,1429
19,Response to statins (LDL cholesterol change) [baseline LDL-C],698
19,Chronic kidney disease [eGFRcrea],1245
19,Serum levels of protein PGLYRP2,668
19,Serum levels of protein LHB,10387
19,Blood protein levels [Intercellular adhesion molecule 1],2916
19,Low density lipoprotein cholesterol levels [East Asian],5962
19,Metabolite levels [SM d18:1/20:0],1554
19,Cognitive decline (age-related),257
19,Cognitive traits (MTAG),693
19,Osteoarthritis (with total hip replacement),271
19,3-hydroxypropylmercapturic acid levels in smokers [Japanese],550
19,Systolic blood pressure,238026
19,Nonsyndromic cleft palate,30142
19,Red blood cell (erythrocyte) distribution width,151890
19,Ceramide_42:1_[M-H]1- levels,8532
19,Serum levels of protein GDI2,431
19,Serum metabolite levels (CMS) [S_LDL_FC],3455
19,"Blood protein levels [BIRC2, 10046_55_3]",698
19,Place of birth in uk - north co-ordinate,4211
19,Serum metabolite levels [1-palmitoyl-2-oleoyl-GPI (16:0/18:1)*],1625
19,"""Abnormal findings on examination of blood, without diagnosis""",270
19,Blood urea nitrogen levels,26847
19,Serum levels of protein IRF6,1868
19,"Hayfever, allergic rhinitis or eczema | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",6541
19,Logical memory (immediate recall),1498
19,Serum metabolite levels (CMS) [XS_VLDL_C],3455
19,Cerebral amyloid deposition positivity (PET imaging),1498
19,Renal failure,591
19,"Blood protein levels [PGLYRP2, 5601_2_3]",290
19,Other intervertebral disc disorders,172
19,Psoriasis vulgaris,2692
19,Serum levels of protein GOLM1,10880
19,Reading or mathematical ability [reading],6007
19,"Blood protein levels [C3, 2683_1_2]",1698
19,Drive faster than motorway speed limit,326
19,Serum metabolite levels [L_LDL_CE],3455
19,Pattern 4 | hair/balding pattern,26878
19,Serum prostate-specific antigen levels,635
19,Body mass index (joint analysis main effects and smoking interaction) [women],2695
19,Phosphatidylinositol_34:1_[M-H]1- levels,386
19,Waist-to-hip ratio adjusted for BMI (additive genetic model),85971
19,Hyperlipidemia,34387
19,"Blood protein levels [PSG4, 5649_83_3]",24080
19,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA],424
19,Blood metabolite levels [X-11440],4923
19,"Blood protein levels [EA, Apolipoprotein E]",1373
19,Hepatitis C (spontaneous viral clearance) [male],1461
19,Osteoclast-associated immunoglobulin-like receptor levels,2338
19,"Blood protein levels [APBB2, 12753_6_3]",698
19,Phosphatidylethanolamine-O_36:5_[M+H]1+/Phosphatidylethanolamine-P_36:4_[M+H]1+ levels,2417
19,N-glycan levels [DG12],106
19,Monocyte count,878469
19,Folate pathway vitamin levels [Plasma Vitamin B12],10880
19,Viral and other specified intestinal infections,10841
19,Atopic dermatitis,4815
19,Serum metabolite levels (CMS) [Remnant_C],3401
19,KELA_REIMBURSEMENT_202,447
19,Serum levels of protein C1orf56,893
19,Venous thromboembolism,46763
19,Waist-to-hip ratio adjusted for BMI,165350
19,Standing height,397228
19,White matter microstructure (axial diusivities) [Fornix (column and body],2020
19,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],4093
19,Goiter,460
19,"Blood protein levels [CD200R1L, 8980_19_3]",698
19,Alzheimer's disease biomarkers [tau],1197
19,IgA nephropathy,1031
19,Leg fat mass (right),28853
19,Matrix metalloproteinase-10 levels,10719
19,Serum levels of protein SULT2A1,4923
19,"Blood protein levels [DEFB119, 13455_10_3]",1928
19,Early age-related macular degeneration,334
19,Serum levels of protein CTSL,514
19,Type 1 diabetes,68785
19,Serum metabolite levels (CMS) [M_LDL_CE],3455
19,PR interval,6541
19,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [homoarginine, lysine, X-24736]",1245
19,Current tobacco smoking,533
19,Coronary artery disease [recessive model],670
19,Post-bronchodilator lung function in asthma (FVC),165
19,White blood cell count (monocyte),7804
19,LDL cholesterol levels x short total sleep time interaction (2df test),17547
19,"Cholesterol lowering medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",20059
19,Sphingomyelin_42:2_[M+H]1+ levels,693
19,"Blood protein levels [S100A13, 7223_60_3]",2391
19,Photic sneeze reflex,139
19,Phosphatidate(44:6)_[M+OAc]1-/Phosphatidylglycerol(43:6)_[M-H]1- levels,891
19,LDL cholesterol levels in HIV infection [EA],677
19,Fibrinogen levels,9387
19,LDL cholesterol levels [Trans-ethnic initial],8468
19,Alzheimer's disease or family history of Alzheimer's disease,31863
19,Gallbladder disease,18238
19,Breast cancer | illnesses of mother,9631
19,Macular thickness,9650
19,White matter hyperintensities,1218
19,Ankle spacing width (right),6390
19,"""Hypothyroidism, strict autoimmune, 3 medication purchases required""",1978
19,Human milk oligosaccharide concentration (sialyl-lacto-N-tetraose b),4989
19,Sphingolipid levels [SM 18:1Mol%],1462
19,Allergic rhinitis,165
19,Breakfast cereal skipping frequency,1597
19,Testosterone levels,68532
19,Impedance of leg (left),124870
19,High light scatter reticulocyte percentage,40196
19,"""Type 1 diabetes, strict definition, subgroup 1""",10843
19,"Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)",7421
19,Cortical surface area (MOSTest),253
19,Phosphatidylinositol(36:2)_[M-H]1- levels,289
19,Urinary albumin-to-creatinine ratio in diabetes,616
19,Blood protein levels [APOB],698
19,Benign prostatic hyperplasia and lower urinary tract symptoms,1
19,Serum levels of protein PRTN3,8546
19,Dyslipidemia,13874
19,"Blood protein levels [PSME1, 5918_5_3]",698
19,"Icd10: c18.9 colon, unspecified | underlying (primary) cause of death",1209
19,Body mass index [EA],3631
19,Aspartate aminotransferase levels,157049
19,Whole body water mass,111400
19,Serum levels of protein MAPK8,698
19,Serum levels of protein PRSS57,2173
19,Serum metabolite levels [L_LDL_L],3455
19,Major coronary heart disease event excluding revascularizations,3542
19,Total cholesterol levels [conditional on round 3],3440
19,Low-density lipoprotein receptor levels,1135
19,Small VLDL particle concentration [conditioned on 885 SNPs],3246
19,Hematological or dermatological disease,2321
19,Protein quantitative trait loci [Siglec-6],2068
19,Alzheimer's disease (late onset),37016
19,Triacylglycerol_52:4_[M+NH4]1+ levels,941
19,"""Female infertility, cervigal, vaginal, other or unspecified origin""",102
19,Diastolic blood pressure [EA],1120
19,Alzheimer's disease/dementia | illnesses of mother,2429
19,Phosphatidylglycerol-O_40:0_[M-H]1- levels,1796
19,Smoking cessation,1066
19,Neuritic plaques or cerebral amyloid angiopathy (pleiotropy),1498
19,Total protein levels x insomnia interaction,258
19,Strenuous sports or other exercises,15894
19,Oily fish consumption,16330
19,Glycated hemoglobin levels,9781
19,Plasma p-tau181 levels,1498
19,Triacylglyceride levels [TAG(52:5;0],976
19,Palmar fascial fibromatosis [Dupuytren],515
19,Asthma/COPD (KELA code 203),164
19,Cholesterol ester levels in medium VLDL,5128
19,Neurological blood protein biomarker levels [LAIR 2],750
19,Urinary metabolite levels in chronic kidney disease [lysine],11339
19,Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test),433
19,CD33+ HLA DR+ Absolute Count,713
19,Serum levels of protein TNFRSF14,299
19,"Blood protein levels [FUT3, 4548_4_2]",194
19,Human milk oligosaccharide concentration (difucosyllacto-N-tetrose),29
19,Adiponectin levels,4133
19,Liver enzyme levels (alanine transaminase),42968
19,Ischemic stroke,11955
19,Tumor necrosis factor receptor superfamily member 5 levels,2166
19,Obesity,873
19,Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis),2213
19,"Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)",1745
19,"HDL cholesterol levels [Asian initial, BMI unadjusted]",2324
19,White matter microstructure (mean diusivities) [Fornix (column and body],2020
19,Autism spectrum disorder or schizophrenia,98
19,Phosphatidylethanolamine-O_36:5_[M-H]1-/Phosphatidylethanolamine-P_36:4_[M-H]1- levels,1362
19,Glaucoma (multi-trait analysis),2818
19,Cholesteryl ester_22:6_[M+NH4]1+ levels,611
19,Prostate-specific antigen levels (conditioned on lead SNPs) [conditional on Round 1 SNPs],123
19,Triglyceride levels in very large HDL,9652
19,Doctor's advice | why reduced smoking,42
19,"""Myocardial infarction, strict""",5206
19,Neurofibrillary tangles (SNP x SNP interaction),18055
19,Calcium levels,90912
19,Metabolite levels [ALB],3933
19,Phosphatidylethanolamine-O_38:6_[M+H]1+/Phosphatidylethanolamine-P_38:5_[M+H]1+ levels,1788
19,Diabetic nephropathy (more control exclusions),295
19,Cholesterol efflux capacity (BHK stimulated assay),622
19,"Blood protein levels [APOB, 2797_56_2]",698
19,COVID-19 (hospitalized vs population) RELEASE 5,1490
19,N-glycan levels [DG9],106
19,Delirium due to conditions classified elsewhere,1498
19,Serum metabolite levels (CMS) [S_LDL_PL],611
19,Carpal tunnel syndrome,196
19,Serum levels of protein YWHAQ,893
19,"Blood protein levels [DKK2, 6546_41_3]",737
19,Blood metabolite levels [1-arachidonoylglycerophosphoinositol],1500
19,Serum levels of protein IL27RA,81
19,Granulocyte count,14877
19,Nonalcoholic fatty liver disease (imputed),27521
19,Serum metabolite levels (CMS) [IDL_P],3455
19,"Disorders of muscle, ligament, and fascia",690
19,Alzheimer's disease in hypertension-negative individuals,1498
19,Youthful appearance (self-reported),9158
19,Serum metabolite levels (CMS) [XS_VLDL_FC],4553
19,Feeling fed-up,2017
19,Metabolite levels [NG monomethyl arginine],1310
19,CD20 on memory B cell,28136
19,CD20 on switched memory B cell,28136
19,Trunk fat-free mass,159808
19,Cognitive aspects of educational attainment,13405
19,4-chlorobenzoic acid levels,2541
19,X-12101 levels,9854
19,Sphingomyelin(34:0)_[M+H]1+ levels,699
19,"""Type 2 diabetes, definitions combined""",2676
19,Electrocardiogram morphology (amplitude at temporal datapoints) [80 ms],129
19,Ovarian cancer [Serious invasive],8325
19,Waist-hip ratio and triglycerides (pairwise),972
19,Prostate-specific antigen levels (conditioned on lead SNPs) [conditional on Round 6 SNPs],2008
19,Heart rate response to recovery post exercise (10 sec),4016
19,Serum levels of protein TNFSF14,174
19,"Blonde | hair colour (natural, before greying)",26895
19,Osteoarthritis; localized,271
19,Serum levels of protein KLK7,1368
19,Cerebral amyloid angiopathy in APOEe4 carrier Alzheimer’s disease,1498
19,Lobar intracerebral hemorrhage,846
19,Serum levels of protein ECH1,291
19,"Systolic blood pressure [EA, initial]",353
19,CD33 on CD66b++ myeloid cell,1107
19,Fibrosis-4 index in high alcohol intake,1225
19,"Verbal declarative memory [PAR-dr, EA]",1301
19,Alzheimer disease and age of onset [between families],693
19,Triacylglycerol_58:10_[M+NH4]1+ levels,858
19,"Blood protein levels [KLK11, 7775_15_3]",146
19,Bipolar disorder (MTAG),86185
19,Body size at age 10,37086
19,Dietary macronutrient intake [Fat],25955
19,Total cholesterol levels [EA],23930
19,Total testosterone levels,111430
19,Serum metabolite levels (CMS) [S_LDL_P],3455
19,Alzheimer's disease (onset between ages 58 and 79),1498
19,Age first had sexual intercourse,569
19,Tumor necrosis factor ligand superfamily member 10 levels,478
19,Interleukin-1-receptor antagonist levels,1141
19,"Blood protein levels [EA, Sialic acid-binding Ig-like lectin 6]",136
19,Carotid intima media thickness [Age-sex-adjusted],4160
19,Esophageal disorder,3198
19,Intrahepatic Cholestasis of Pregnancy (ICP)  (more control exclusions),7294
19,Coxarthrosis [arthrosis of hip](FG),1878
19,Autoimmune diseases,447
19,Low density lipoprotein cholesterol levels,318759
19,Systolic blood pressure [East Asian],1252
19,Blood metabolite levels [myo-inositol],19389
19,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction) [men],3902
19,Cholesteryl ester_18:0_[M+NH4]1+ levels,622
19,Electrocardiogram morphology (amplitude at temporal datapoints) [132 ms],129
19,Gut microbiota (bacterial taxa) [Victivallis_vadensis],74
19,Protein quantitative trait loci (liver) [VAPB],52
19,"Blood protein levels [EA, Melanoma-derived growth regulatory protein]",21492
19,Body mass index (bmi),122318
19,Blood metabolite levels [glutaroyl carnitine],2215
19,Cerebrospinal AB1-42 levels in mild cognitive impairment,1498
19,CD33 on CD14+ monocyte,767
19,Amino-terminal enhancer of split measurement,120
19,Care involving dialysis,295
19,Systolic blood pressure (cigarette smoking interaction),198
19,Serum alkaline phosphatase levels [conditional on round 4],9189
19,Urea levels,2525
19,"Blood protein levels [SIGLEC7, 2742_68_2]",1860
19,"Blood protein levels [KLK13, 11152_46_3]",1365
19,Bioavailable testosterone levels,45555
19,White matter microstructure (axial diusivities) [Posterior limb of internal capsule],26283
19,"Blood protein levels [IGFLR1, 7244_16_3]",22407
19,Hypertensive diseases (excluding secondary),2532
19,Protein quantitative trait loci [SIG14],3495
19,Lewy body disease [Case/control],1498
19,Cerebral amyloid angiopathy [EA],1498
19,"""Hypertension, essential""",2273
19,Serum metabolite levels (CMS) [ApoB],3217
19,Protein levels in obesity [kallikrein 12],150
19,Homocysteine levels,10184
19,Iron status biomarkers (ferritin levels),24309
19,Pain [onset time of analgesia],25287
19,Antineutrophil cytoplasmic antibody-associated vasculitis,1917
19,Seropositive rheumatoid arthritis,447
19,Anti-polyomavirus 2 IgG seropositivity,3317
19,Hodgkin's lymphoma,517
19,"Blood protein levels [CGA CGB, 4914_10_1]",10387
19,Phosphatidylcholine-O_37:1_[M+H]1+/Phosphatidylcholine-P_37:0_[M+H]1+/Phosphatidylethanolamine-O_40:1_[M+H]1+ levels,1188
19,Disorders of lipoid metabolism,33394
19,C-reactive protein levels,244344
19,Serum levels of protein TCN1,10719
19,"Blood protein levels [CGA LHB, 2953_31_2]",10387
19,Mumps,10719
19,Triglyceride levels in large VLDL [conditioned on 885 SNPs],3246
19,Peak expiratory flow (pef),108
19,Mastocytosis,10352
19,Serum levels of protein NPTX2,893
19,Serum metabolite levels (CMS) [L_LDL_TG],2844
19,Urinary metabolite levels in chronic kidney disease [Lysine],1245
19,P wave terminal force,1480
19,Matrix metalloproteinase-7 levels,443
19,CD33 on Monocytic Myeloid-Derived Suppressor Cells,767
19,Eosinophil percentage of granulocytes,25222
19,Serum levels of protein UBA2,6930
19,Complement component C8 measurement,551
19,Gingvival huperplasia,322
19,Asthma (adult onset),128
19,Electrocardiogram morphology (amplitude at temporal datapoints) [82 ms],129
19,Autoimmune traits,2909
19,Vertex-wise sulcal depth,102148
19,Serum levels of protein CRP,1498
19,Phosphatidylinositol_34:2_[M-H]1- levels,3478
19,Serum albumin levels [EA],3420
19,Protein quantitative trait loci (liver) [GCDH],7166
19,"Systolic blood pressure, automated reading",23606
19,Sphingomyelin_36:2_[M+H]1+ levels,2330
19,Arm fat percentage (left),28475
19,Cigarettes smoked per day (MTAG),3784
19,"Lipid metabolism phenotypes [APOB.assay, whole]",3355
19,"""Rheumatoid arthritis , including avohilmo""",447
19,"Blood protein levels [TMCC3, 8922_4_3]",698
19,"Blood protein levels [HLA-DRB3, 6962_5_3]",698
19,Alcohol consumption (drinks per week),42703
19,Total body bone mineral density (MTAG),15945
19,Electrocardiogram morphology (amplitude at temporal datapoints) [102 ms],2747
19,Polychlorinated biphenyl levels [PCB99],2095
19,"Glaucoma [AA, prevalent]",350
19,"""Type 1 diabetes, strict definition""",10719
19,Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms,698
19,"Urinary metabolites (H-NMR features) [3.0325, Lysine]",1310
19,Time to answer,142
19,Bilirubin levels,31312
19,Phosphatidylcholine_38:7_[M+OAc]1-/Phosphatidylserine_42:6_[M-H]1- levels,3478
19,Diffuse plaques [EA],1498
19,Creatine kinase M-type:Creatine kinase B-type heterodimer measurement,540
19,Serum metabolite levels (CMS) [L_LDL_P],3455
19,Average weekly beer plus cider intake,721
19,"Blood protein levels [KLK11, 2831_29_1]",146
19,Protein quantitative trait loci (liver) [ACTN4],2647
19,Thyroid hormone levels [TSH],429
19,Verbal-numerical reasoning,2207
19,Serum metabolite levels (CMS) [S_LDL_L],3455
19,Serum metabolite levels [1-linoleoyl-GPI (18:2)*],1625
19,Age at loss of ambulation in Duchenne muscular dystrophy,1766
19,Serum levels of protein AKT2,1172
19,CD20 on IgD- CD38- B cell,28136
19,Reticulocyte percentage,57673
19,diarrhoeal disease at age 1 with doctor diagnosis,8781
19,Eosinophilic esophagitis,3177
19,Protein quantitative trait loci (liver) [AASS],11
19,Drug-induced adrenocortical insufficiency,30
19,Vitamin levels [Vitamin E alpha tocopherol],8532
19,Pattern 1 | hair/balding pattern,36470
19,Adult onset asthma and/or waist-to-hip ratio adjusted for BMI,5752
19,Triglyceride levels in current drinkers [EA],4579
19,Yes | hearing difficulty/problems,2814
19,Phosphatidylcholine_36:6_[M+OAc]1-/Phosphatidylserine_40:5_[M-H]1- levels,386
19,"Medication use (adrenergics, inhalants)",440
19,Serum levels of protein TBCA,888
19,Neurological diseases,1498
19,Adventurousness,4139
19,Cutaneous malignant melanoma,266
19,Thyrotoxicosis with toxic multinodular goitre,549
19,Cerebrospinal AB1-42 levels in normal cognition,1498
19,"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment",2911
19,"Waist-to-hip ratio adjusted for body mass index [EA, women]",41
19,"Forced vital capacity (fvc), best measure",82208
19,Second line medication for Crohns disease,447
19,Narcolepsy,5791
19,Opioid overdose severity score [AA],867
19,"Autism, asperger's or autistic spectrum disorder | mental health problems ever diagnosed by a professional",217
19,Impedance of leg (right),140266
19,Type 2 diabetes [conditional],1769
19,Urolithiasis,4388
19,Male puberty timing (age at voice breaking MTAG),10197
19,"Blood protein levels [ICAM5, 8245_27_3]",381
19,Itch intensity from mosquito bite adjusted by bite size,4064
19,Serum levels of protein KLK8,817
19,GIP levels in response to oral glucose tolerance test (fasting),873
19,Medication use (antithrombotic agents),45245
19,Impedance of whole body,181834
19,Urinary metabolite levels in chronic kidney disease [Octanoylcarnitine],8352
19,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Hispanic],2595
19,Granulocytic Myeloid-Derived Suppressor Cells Absolute Count,713
19,Place of birth in uk - east co-ordinate,328
19,Gut microbiota (bacterial taxa) [Victivallis],74
19,Malignant neoplasm of liver and intrahepatic bile ducts,5210
19,"Blood protein levels [OSCAR, 8702_42_3]",1138
19,Serum metabolite levels (CMS) [M_LDL_FC],3455
19,Number of incorrect matches in round,489
19,Heart rate response to recovery post exercise (40 sec),808
19,CD33 on CD33dim HLA DR-,2761
19,Urate levels [men],1883
19,Average total household income before tax,721
19,Phosphatidylcholine_40:8_[M+OAc]1-/Phosphatidylserine_44:7_[M-H]1- levels,386
19,Asthma or allergic disease (pleiotropy),64
19,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),14318
19,Alzheimer's disease [females],1498
19,Free cholesterol levels in IDL,2746
19,Serum levels of protein CSF3,6930
19,Femur bone mineral density x serum urate levels interaction [male],2881
19,"Atopic dermatitis [EA, fixed effects]",1382
19,"""Organic, including symptomatic, mental disorders""",1498
19,Urokinase-type plasminogen activator levels,920
19,Asthma (more control exclusions),64
19,Alzheimer's disease biomarkers [ptau],1197
19,"Aging traits (healthspan, parental lifespan or longevity) (multivariate analysis)",4342
19,"Diastolic blood pressure, automated reading",9955
19,"Lipid metabolism phenotypes [LDL-C.assay, whole]",3355
19,Post bronchodilator FEV1,253
19,Urinary albumin-to-creatinine ratio [EA],1916
19,Prostate-specific antigen levels (conditioned on lead SNPs) [conditional on Round 4 SNPs],359
19,Triacylglycerol_46:4_[M+NH4]1+ levels,738
19,Serum metabolite levels [XS_VLDL_PL],3336
19,Butter/spreadable butter | spread type,2331
19,Triacylglycerol_45:4_[M+NH4]1+ levels,659
19,"Heel quantitative ultrasound index (qui), direct entry (right)",19349
19,HDL cholesterol levels in current drinkers,2416
19,Acenocoumarol maintenance dosage,3911
19,Metabolite levels [SM d16:1/20:0],734
19,Asthma (mode),437
19,Pulse wave arterial stiffness index,938
19,Brain morphology (MOSTest),85741
19,Serum levels of protein FAM177A1,10719
19,Arm predicted mass (right),93289
19,hemolysis of donated blood (osmotic),688
19,LDL cholesterol levels in HIV infection [African American],677
19,Electrocardiogram morphology (amplitude at temporal datapoints) [90 ms],3508
19,Diabetes | illnesses of mother,1498
19,"Blood pressure medication | medication for cholesterol, blood pressure or diabetes",2607
19,Retinal vascular caliber [Retinal venular caliber],16330
19,Apolipoprotein B levels,115199
19,Psoriasis,30469
19,Age at menopause,31175
19,Rosuvastatin | treatment/medication code,4064
19,None of the above (group 1) | illnesses of father,3849
19,Protein quantitative trait loci (liver) [SERPINF1],274
19,Squamous cell lung carcinoma,533
19,"Blood protein levels [EA, EGF-like module-containing mucin-like hormone receptor-like 2]",396
19,Vertical cup-disc ratio (adjusted for vertical disc diameter),23
19,Other arthrosis,11344
19,Sleep duration,11711
19,Interleukin-27 levels,29307
19,Total cholesterol levels [Trans-ethnic initial],8468
19,Body fat distribution (leg fat ratio) [females],108
19,Serum levels of protein ADAM11,893
19,Sphingomyelin_34:1_[M+H]1+ levels,741
19,"""Dependence on enabling machines and devices, not elsewhere classified""",295
19,Electrocardiogram morphology (amplitude at temporal datapoints) [108 ms],129
19,Bronchodilator response in asthma (inhaled corticosteroid treatment interaction),31169
19,Pork intake,1633
19,Serum levels of protein FGF19,21438
19,Blood metabolite levels [X-12456],4767
19,Mean arterial pressure [East Asian],5020
19,"Heart attack/myocardial infarction | non-cancer illness code, self-reported",894
19,Urinary metabolite ratios in chronic kidney disease [Lysine/Asparagine],1245
19,Serum total protein level,170599
19,Serum metabolite levels (CMS) [DHA],8403
19,Lysine levels,2325
19,"None of the above | medication for cholesterol, blood pressure or diabetes",12805
19,Blood metabolite levels [X-13429],4923
19,Apolipoprotein Levels [APOB],611
19,Left atrial minimum volume,528
19,Lewy body disease [Ordinal II],1498
19,Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease),1002
19,Coronary angiopasty,698
19,Childhood ear infection,21686
19,Sphingomyelin_40:1_[M+OAc]1- levels,3184
19,Protein quantitative trait loci [Kallikrein 11],937
19,Protein quantitative trait loci (liver) [IGHG1],2542
19,Serum metabolite levels [X-11244],4923
19,"Blood protein levels [MAPK8, 3825_18_2]",698
19,"Blood protein levels [FCER2, 3291_30_2]",651
19,Serum 25-Hydroxyvitamin D levels,255977
19,Serum metabolite levels (CMS) [FAw6],693
19,Leg fat-free mass (left),91768
19,"Fracture nose | non-cancer illness code, self-reported",4298
19,Coffee intake,533
19,"Blood protein levels [IFI16, 12893_159_3]",698
19,Serum metabolite levels (CMS) [S_VLDL_CE],2844
19,Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease,875
19,Neurofibrillary tangles [Ordinal II],1055
19,Diastolic blood pressure (cigarette smoking interaction),198
19,Nicotine dependence,116
19,Vitamin B12 levels,21935
19,Total cholesterol levels,262525
19,Polymeric immunoglobulin receptor levels,15278
19,"Forced expiratory volume in 1-second (fev1), predicted",94339
19,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],2595
19,Alzheimer’s disease (Early onset),1498
19,Chronic diseases of tonsils and adenoids,2678
19,Chin dimples,239
19,Vascular dementia,4494
19,Serum metabolite levels [arabinose],3873
19,Sphingomyelin levels [SM(36:1;2],1462
19,Serum levels of protein CLEC11A,4390
19,Spleen volume,740
19,Never | smoking status,214
19,Liver volume,15219
19,Mean corpuscular haemoglobin,80797
19,Alzheimer’s disease (undefined) (more control exclusions),1498
19,"Blood protein levels [EBI3, 10851_77_3]",12779
19,Blood metabolite ratios [X-11820/cholesterol],611
19,Hypothyroidism or myxedema,19024
19,Arthrosis,10954
19,Posterior thalamic nuclei volume,3638
19,"Serum metabolite levels [androstenediol (3beta,17beta) disulfate (1]",4676
19,Advanced age-related macular degeneration [EA],2514
19,Sphingomyelin_38:2_[M+OAc]1- levels,2491
19,Plasma amyloid beta peptide concentrations (ABx-42),1498
19,Alcohol consumption,15771
19,"Serum metabolite levels [sphingomyelin (d18:1/20:1, d18:2/20:0)*]",1530
19,"""Atopic  dermatitis, strict definition""",1107
19,Matrix metalloproteinase-3 levels,358
19,Serum levels of protein C5orf38,2196
19,Osteoarthrosis,271
19,Breast Cancer in BRCA1 mutation carriers,14957
19,Serum metabolite ratios in chronic kidney disease [Hydroxysphingomyelin with acyl residue sum C22:2/Sphingomyelin with acyl residue sum C18:1],869
19,Pain and other conditions associated with female genital organs and menstrual cycle,94
19,Schizophrenia,192744
19,"Blood protein levels [PSG5, 9314_9_3]",18904
19,"""Diabetes, varying definitions""",6969
19,Metabolite levels [SM d18:2/18:0],734
19,Barrett's esophagus  or Esophageal adenocarcinoma [male],1146
19,Serum levels of protein KLK14,922
19,Hip circumference [EA],3569
19,Gut microbiota (bacterial taxa) [Bacilli class],683
19,Other/unspecified seropositiverheumatoid arthritis,447
19,Dry age-related macular degeneration (includes geographic atrophy),299
19,Participation in an health questionnaire (not invited vs invited),3595
19,Visceral adipose tissue volume,6267
19,Serum levels of protein CCL15,21852
19,Serum levels of protein FAM3B,10719
19,Nonalcoholic fatty liver disease,72103
19,DNA methylation PhenoAge acceleration,6091
19,Age-related macular degeneration,2329
19,Other diseases of upper respiratory tract,2501
19,"Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio)",533
19,Neuropathic pain in head and neck cancer,9020
19,Intelligence,19406
19,Triglycerides x physical activity interaction (2df test),7610
19,Phospholipid levels in large VLDL [conditioned on 885 SNPs],3246
19,Relative fat intake,15914
19,CD33+ HLA DR+ CD14- Absolute Count,713
19,Creatine kinase levels,3920
19,"Other chronic ischemic heart disease, unspecified",3542
19,Verbal declarative memory [ALL-dr],489
19,"Blood protein levels [UBA2, 12500_88_3]",698
19,COVID-19 (RELEASE 5),421
19,"Serum metabolite levels [glycosyl ceramide (d18:1/20:0, d16:1/22:0)*]",1227
19,Free cholesterol levels,111
19,Serum metabolite levels (CMS) [L_LDL_L],3455
19,Impedance of arm (left),98888
19,Arm fat-free mass (left),123431
19,Serum metabolite levels [glutarylcarnitine (C5-DC],1125
19,"Black | hair colour (natural, before greying)",14837
19,Inflammatory skin disease [Opposed],15682
19,Sphingomyelin_38:1_[M+OAc]1- levels,4369
19,Urinary metabolite levels in chronic kidney disease [X - 11440],3702
19,Urinary metabolite levels in chronic kidney disease [5-hydroxylysine],1245
19,Cardiovascular diseases (excluding rheumatic etc),1974
19,Adult onset asthma or type 2 diabetes,1498
19,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),18218
19,Smoking cessation (MTAG),533
19,Alzheimer’s disease and/or vascular dementia (clinical subgroup VaD+),1498
19,Mental health study participation (completed survey),9540
19,Insulin-related traits (multivariate analysis),1961
19,6mm weak meridian (right),2979
19,"Thyroid goitre | non-cancer illness code, self-reported",1514
19,Gut microbiota (bacterial taxa) [Victivallales],74
19,Other and/or unspecified nontoxic goitre,365
19,Alzheimer's disease [AA],465
19,Impedance of arm (right),98500
19,Phosphatidylcholine-O_36:1_[M+H]1+/Phosphatidylcholine-P_36:0_[M+H]1+/Phosphatidylethanolamine-O_39:1_[M+H]1+ levels,759
19,Serum levels of protein SIGLEC14,1885
19,Breakfast skipping,1597
19,Parkinson's disease progression (composite),1498
19,Obesity-related traits [Total energy expenditure adj for weight ],901
19,Serum metabolite levels [SM],611
19,Cataracts,900
19,Serum levels of protein LILRA4,123
19,Usual walking pace,9052
19,Urinary metabolite ratios in chronic kidney disease [Lysine/Serine],1310
19,"Waist-to-hip ratio adjusted for BMI in non-smokers [AA, men]",3902
19,"""Atherosclerosis, excluding cerebral, coronary and PAD""",2844
19,Phosphatidylinositol(36:4)_[M-H]1- levels,498
19,Alzheimer's disease (APOE e4 interaction),485
19,"Blood protein levels [TBCA, 12501_10_3]",2391
19,Verbal declarative memory [PAR-dr],1301
19,"Urinary metabolites (H-NMR features) [5.2125, Fucose]",16330
19,Serum total protein level [conditional on round 3],3723
19,Tumor necrosis factor receptor superfamily member 10C levels,11407
19,C-reactive protein levels or triglyceride levels (pleiotropy),11237
19,Mean arterial pressure x alcohol consumption interaction (2df test) [EA],324
19,Gut microbiota abundance (genus Ruminococcus torques group id.14377),9907
19,Electrocardiogram morphology (amplitude at temporal datapoints) [112 ms],129
19,Mitochondrial DNA levels,15890
19,Schizophrenia (MTAG),45966
19,Dietary macronutrient intake [Protein - model 2],10184
19,Multivitamin with calcium  | vitamin and/or mineral supplement use,9368
19,Levothyroxine sodium | treatment/medication code,4299
19,Succiniclasticum abundance in stool,422
19,Colorectal cancer,64488
19,"DDT metabolite (p,p'-DDE levels)",7731
19,"Blood protein levels [EA, Leukocyte immunoglobulin-like receptor subfamily B member 1]",4399
19,Obesity [Obesity class I],873
19,Waist circumference [EA],4489
19,Serum levels of protein SNRPF,1688
19,SSC-A on CD14+ monocyte,7604
19,Ankle spacing width,49004
19,Age-related hearing impairment (MTAG),2709
19,Protein quantitative trait loci (liver) [ACSS3],1996
19,Vitiligo,8266
19,Low density lipoprotein cholesterol levels [AA],3656
19,"Blood protein levels [C3, 4480_59_2]",356
19,Carotid intima media thickness,698
19,"N-glycan levels [DG9, women]",53
19,Mean platelet (thrombocyte) volume,156280
19,Serum metabolite levels [M_LDL_L],3455
19,Brain amyloid deposition (PET imaging),812
19,Ventolin 100micrograms inhaler | treatment/medication code,64
19,Brain morphology (min-P),24696
19,Protein quantitative trait loci (liver) [SULT2A1],8552
19,Protein quantitative trait loci (liver) [PRDX2],756
19,Cerebral amyloid angiopathy in Alzheimer’s disease,846
19,Degeneration of macula and posterior pole,299
19,N-glycan levels [GP14],53
19,Reticulocyte fraction of red cells,315400
19,"Blood protein levels [PRTN3, 3514_49_2]",2356
19,Kawasaki disease [EA],4855
19,Elevated serum prostate-specific antigen levels in healthy men,3451
19,Very long-chain saturated fatty acid levels (fatty acid 24:0),1742
19,Serum levels of protein GDF15,1177
19,Microalbumin in urine,59
19,Height,1251558
19,Triacylglycerol_52:6_[M+NH4]1+ levels,8532
19,Vitamin E levels,3911
19,Serum levels of protein RAB14,893
19,Cognitive function,118
19,Bone properties (heel) [BUA],10657
19,Retinal venular tortuosity,11357
19,Number of cigarettes previously smoked daily,1644
19,Waist-to-hip ratio adjusted for BMI in active individuals [EA],379
19,"Hip circumference adjusted for BMI [EA,men]",6080
19,Neuritic plaques or neurofibrillary tangles (pleiotropy),1498
19,beta-nerve growth factor levels,141
19,Total PHF-tau (SNP x SNP interaction),37831
19,Antihypertensive medication - note that there are other indications,2190
19,Peripheral artery disease,8116
19,Wet age-related macular degeneration,1797
19,Sphingomyelin_40:3_[M+H]1+ levels,693
19,Waist-to-hip ratio adjusted for BMI in active individuals,538
19,Diacylglycerol_36:5_[M+H-H2O]1+ levels,622
19,SSC-A on Natural Killer T,266
19,Gamma glutamyl transferase levels,212770
19,Age at first live birth,12536
19,Nasal polyp,750
19,Serum metabolite ratios in chronic kidney disease [Sphingomyelin with acyl residue sum C16:1/Sphingomyelin with acyl residue sum C18:1],912
19,"Blood protein levels [EA, CD209 antigen]",1760
19,Household income (MTAG),765
19,Prostate cancer,51750
19,Leg fat mass (left),28622
19,Serum metabolite levels [FreeC],3455
19,Response to fenofibrate (LDL cholesterol levels) [European],5951
19,"Blood protein levels [CUZD1, 7943_16_3]",698
19,HDL cholesterol levels [BMI unadjusted],1300
19,Serum levels of protein MIA,4890
19,Kawasaki disease,5636
19,Hip index,3293
19,Heart attack | vascular/heart problems diagnosed by doctor,1666
19,"Blood protein levels [EA, Small nuclear ribonucleoprotein F]",834
19,Body mass index and triglycerides (pairwise),972
19,Serum levels of protein PSG4,11858
19,Phosphatidylinositol(38:4)_[M-H]1- levels,3132
19,Sphingomyelin_36:1_[M+H]1+ levels,2330
19,Serum levels of protein EGFLAM,431
19,Worry,748
19,Neutrophill count,70362
19,Fat-free mass,21054
19,"Blood protein levels [KLK7, 3378_49_2]",630
19,Fortified wine intake,121
19,Fish- and plant-related diet,18404
19,Intrahepatic Cholestasis of Pregnancy (ICP),7269
19,Prostate-specific antigen levels,10607
19,Hypertensive diseases,2237
19,Bladder cancer,2866
19,"Total cholesterol levels [Asian initial, BMI unadjusted]",2356
19,Serum metabolite levels (CMS) [TotCho],611
19,Itch intensity from mosquito bite,2168
19,Cognitive impairment test score,3010
19,CD33 on Granulocytic Myeloid-Derived Suppressor Cells,586
19,"""Benign neoplasm: Skin of eyelid, including canthus""",31
19,"Waist circumference [EA, women]",972
19,Serum levels of protein CD209,2122
19,Current | smoking status,533
19,Gut microbiota (bacterial taxa) [Lentisphaeria],74
19,Total cholesterol levels in LDL,11247
19,Relative protein intake,10184
19,Serum metabolite levels [IDL_FC],3455
19,"Blood protein levels [APOE, 5312_49_3]",698
19,Mother still alive,1498
19,Peripheral vascular disease,1198
19,"""Congenital malformations of gallbladder, bile ducts and liver""",241
19,Diabetes or endocrine disease,19142
19,White blood cell (leukocyte) count,50493
19,Response to statins (LDL cholesterol percent change),698
19,Central cerebrospinal fluid amyloid beta 42 to 40 ratio (abnormal vs normal),1498
19,Neurological blood protein biomarker levels [Siglec-9],1460
19,Parental longevity (father's age at death),1498
19,"""Alzheimer’s disease, wide definition (more control exclusions)""",1498
19,Age high blood pressure diagnosed,118
19,Alzheimer’s disease (clinical subgroup AD++),1498
19,Acceptance of an invitation to participate in a mental health questionnaire,10390
19,"Blood protein levels [Il16, 7672_7_3]",698
19,"Blood pressure medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",3383
19,White blood cell count (basophil),40967
19,Serum levels of protein PSG9,4410
19,Vertical cup-disc ratio (multi-trait analysis),365
19,Phosphatidylethanolamine_25:0_[M-H]1- levels,3911
19,Highest math class taken (MTAG) [MTAG],39193
19,Systemic lupus erythematosus,85164
19,Serum levels of protein PCYOX1,8774
19,Neutrophil-to-lymphocyte ratio,20627
19,Cerebrospinal fluid biomarker levels [Kunitz-type protease inhibitor 2],2424
19,Diacylglycerol_38:5_[M+H-H2O]1+ levels,9428
19,Kallikrein-10 levels,11119
19,Verbal memory performance (immediate recall change),1187
19,Cancer (pleiotropy) [subset analysis],4965
19,Alzheimer disease,1498
19,Immature Myeloid-Derived Suppressor Cells Absolute Count,976
19,Subcortical volume (MOSTest),60312
19,Other chronic nonalcoholic liver disease,8506
19,"""Primary gonarthrosis, bilateral""",6234
19,Immature Myeloid-Derived Suppressor Cells %CD33dim HLA DR- CD66b-,976
19,Body mass index (joint analysis main effects and physical activity interaction) [EA],3631
19,Basophil percentage of granulocytes,9315
19,Male-pattern baldness,92729
19,Thrombomodulin levels,1283
19,Mucinous ovarian carcinoma [Invasive Only],1816
19,Urinary metabolite levels in chronic kidney disease [X - 24359],3915
19,Diastolic blood pressure [Japanese],947
19,Insomnia symptoms (never/rarely vs. sometimes/usually),74905
19,Conjunctival UV autofluorescence (CUVAF),1196
19,Estimated glomerular filtration rate,214990
19,"Blood protein levels [GP6, 3194_36_2]",8428
19,Serum metabolite levels [M_LDL_P],3455
19,Diacylglycerol_38:4_[M+H-H2O]1+ levels,3478
19,Presence of cardiac and vascular implants and grafts,2844
19,Sphingomyelin_40:3_[M+OAc]1- levels,693
19,Ever addicted to a behaviour or miscellanous,1549
19,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),14993
19,Childhood asthma with severe exacerbations,11161
19,Serum levels of protein PSG3,16339
19,Ankylosing spondylitis [EA],8708
19,Blood metabolite ratios [DSGEGDFXAEGGGVR/ADpSGEGDFXAEGGGVR],10962
19,Serum levels of protein TPSB2;TPSAB1,118
19,Blood protein levels [Sialic acid-binding Ig-like lectin 14],2805
19,Chronic liver disease and cirrhosis,9125
19,Eosinophil percentage of white cells,190916
19,Forced expiratory volume in 1-second (fev1),58909
19,Physical activity (Total log acceleration),2911
19,Insomnia [Female],4175
19,Medication use (diuretics),3569
19,GIP levels in response to oral glucose tolerance test (120 minutes),873
19,Family history of Alzheimer's disease,11723
19,Diffuse plaques (SNP x SNP interaction),9376
19,Waist-to-hip ratio adjusted for body mass index [EA],5828
19,Electrocardiogram morphology (amplitude at temporal datapoints) [130 ms],129
19,Serum levels of protein MDH1,431
19,"Blood protein levels [LILRB5, 7015_8_3]",431
19,C-reactive protein levels or LDL-cholesterol levels (pleiotropy),22017
19,Ankylosing spondylitis,8708
19,Problematic alcohol use (MTAG),15682
19,Peptic ulcer disease,10843
19,"Blood protein levels [RPN1, 6458_6_3]",5610
19,Alzheimer’s disease (clinical subgroup AD+),1498
19,Weight change compared with 1 year ago,1633
19,Ebbinghaus illusion (underestimation),125
19,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],14318
19,Sex hormone-binding globulin levels adjusted for BMI,328598
19,Creatinine levels,147915
19,Serum metabolite levels [1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4)*],8022
19,Soluble levels of adhesion molecules [ICAM],3326
19,Ready meals | type of meals eaten,340
19,Prostate-specific antigen levels (conditioned on lead SNPs) [conditional on Round 3 SNPs],282
19,Otitis media (chronic) [Finnish],958
19,Height [EA],6195
19,Serum metabolite levels [Serum_C],3455
19,Logical memory (delayed recall),1498
19,Type 2 diabetes and end-stage kidney disease,409
19,"Blood protein levels [KLK8, 2834_54_1]",817
19,Serum metabolite levels [linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2]*],270
19,Waist circumference adjusted for BMI in active individuals,538
19,Snoring,346
19,Crohn's disease,58534
19,High light scatter reticulocyte count,646996
19,Folate pathway vitamin levels [vitamin B12],10880
19,Growth/differentiation factor 15 measurement,3141
19,Knee pain | pain type(s) experienced in last month,10490
19,X-23739 levels,1898
19,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),2631
19,Cortical volume [Superior parietal],154
19,Medication use (glucocorticoids),128
19,CAG-177 sp002438685 abundance in stool,36
19,Dementia with Lewy bodies,5370
19,"Blood protein levels [SULT2A1, 9829_91_3]",4923
19,Triacylglycerol_54:6_[M+NH4]1+ levels,863
19,Neuroblastoma (pediatric),768
19,"Blood protein levels [SUMF1, 6941_11_3]",698
19,Total body bone mineral density (age 45-60),62
19,Body mass index,390066
19,Leg fat percentage (left),34469
19,"Urinary metabolite levels in chronic kidney disease [androstenediol (3beta,17beta]",3702
19,Serum metabolite levels [L_LDL_TG],2844
19,Serum metabolite levels [linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1]*],5122
19,Psoriasis or type 2 diabetes (trans-disease meta-analysis),447
19,Serum metabolite levels [M_LDL_PL],3455
19,Carotid intima media thickness (mean),698
19,Gamma-glutamyl hydrolase measurement,499
19,Schizophrenia [EA],21917
19,Serum levels of protein PSG5,13048
19,Sum basophil neutrophil counts,13225
19,Serum metabolite levels (CMS) [L_LDL_C],3455
19,Osteoarthritis of the hand,1752
19,"Blood protein levels [CD5, 5596_75_3]",3320
19,"Blood protein levels [KLK10, 6227_1_3]",2134
19,High light scatter reticulocyte percentage of red cells,284741
19,Non-oily fish intake,14966
19,Prostate cancer | illnesses of father,3082
19,Intraocular pressure,1729
19,Plasma ANGPTL8 levels,1219
19,"Blood protein levels [CD33, 3166_92_1]",586
19,Serum levels of protein LPO,11032
19,Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis),2213
19,Abdominal aortic aneurysm,7186
19,Predicted suicide risk,2881
19,Longevity,4173
19,Serum levels of protein OLFM2,3129
19,Essential hypertension (time to event),5894
19,Ratio of apolipoprotein A1 to apolipoprotein B,1498
19,"Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)",1175
19,Sensorineural hearing loss,3398
19,Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis),2213
19,"Triglyceride levels [Asian initial, BMI unadjusted]",1187
19,"Blood protein levels [CLEC11A, 2966_65_2]",378
19,Total triglycerides levels,16028
19,HDL cholesterol levels [Trans-ethnic initial],8130
19,"Blood protein levels [GDF15, 4374_45_2]",396
19,Sphingomyelin levels [SM(38:1;2],869
19,CD33 on basophil,827
19,Mitochondrial DNA copy number,22634
19,Medication use (HMG CoA reductase inhibitors),48830
19,Resistin levels,3588
19,Serum levels of protein CD5,1460
19,"Waist-to-hip ratio adjusted for body mass index [EA, men]",383
19,Growth differentiation factor-15 levels (conditioned on rs888663),2422
19,Protein quantitative trait loci (liver) [GPNMB],10
19,Type 2 diabetes (adjusted for BMI),22916
19,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),15612
19,Heel broadband ultrasound attenuation (left),13431
19,Body mass index (joint analysis main effects and physical activity interaction),3631
19,Hypertension [East Asian],3916
19,Phosphatidylinositol_40:6_[M-H]1- levels,3478
19,Gallbladder polyp,164
19,Intracranial aneurysm,25
19,Neutrophil percentage of granulocytes,35255
19,Gastroesophageal reflux disease,9712
19,Keratinocyte cancer (MTAG),3230
19,CD20 on unswitched memory B cell,28136
19,SSC-A on monocyte,7604
19,Fat-free mass [male],18307
19,Body mass index [Japanese],1475
19,Serum metabolite levels [S_LDL_PL],611
19,Adult body size,65716
19,Serum metabolite levels [DHA],8403
19,Father still alive,1498
19,vWF levels [EA],375
19,Urinary metabolite ratios in chronic kidney disease [Lysine/Tyrosine],1245
19,"""Ischaemic heart disease, wide definition""",3542
19,Polycystic ovary syndrome,1069
19,HDL cholesterol,58245
19,Waist-hip index,27723
19,Neuroticism score,1506
19,Pancreas fat,3442
19,Autoimmune traits (pleiotropy),447
19,Stem cell factor levels,241
19,Serum metabolite ratios in chronic kidney disease [Sphingomyelin with acyl residue sum C18:0/Sphingomyelin with acyl residue sum C24:0],912
19,"Insulin | medication for cholesterol, blood pressure or diabetes",1032
19,Nicotine metabolite ratio in current smokers,17794
19,Mean arterial pressure,29160
19,Alzheimer’s disease (Atypical or mixed) (more control exclusions),1498
19,Glomerular filtration rate (creatinine),9722
19,Overall health rating,4286
19,LDL cholesterol [AA],678
19,"Blood protein levels [LILRA6, 7059_14_3]",431
19,Serum levels of protein TXNRD1,431
19,Bone properties (heel) [VOS],9920
19,Abdominal subcutaneous adipose tissue volume,7528
19,Papulosquamous disorders,6294
19,Serum metabolite levels (CMS) [FreeC],3504
19,Parental longevity (mother's age at death),1498
19,Non-oily fish consumption,15682
19,Gonarthrosis,20244
19,Two-hour glucose,873
19,Osteoarthritis of the hip or knee,24
19,Telomere length,18240
19,Chlamydia trachomatis momp D antibody levels,22808
19,Blood metabolite levels [homocitrulline],1310
19,Alzheimer disease (more control exclusions),1498
19,"""Gout, unspecified""",170
19,"Blood protein levels [LHB, 8376_25_4]",10387
19,Number of sexual partners,7048
19,"Blood protein levels [LILRB2, 5091_28_3]",2359
19,Cerebrospinal fluid biomarker levels [Interleukin-27 receptor subunit alpha],81
19,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],15453
19,Cerebrospinal AB1-42 levels in Alzheimer's disease dementia,1498
19,HDL cholesterol levels [BMI adjusted],2622
19,Sphingolipid levels [proportions],4410
19,Dementia,1498
19,Magnesium  | vitamin and/or mineral supplement use,1897
19,Serum levels of protein KMT2C,698
19,Immature reticulocyte fraction,70531
19,COVID-19 (very severe respiratory confirmed vs population) RELEASE 5,5806
19,Obesity-related traits [Height change ],1060
19,Serum type 1 collagen metabolite levels,2040
19,Soluble E-selectin levels (adjusted for ABO rs2519093 genotypes),468
19,"Blood protein levels [REXO2, 13590_1_3]",431
19,Diverticulosis,3082
19,Serum metabolite levels (CMS) [L_LDL_PL],3455
19,C-reactive protein levels [AA],678
19,Epithelial ovarian cancer,15248
19,Mouth ulcers | mouth/teeth dental problems,5307
19,Neuritic plaque [Ordinal],1055
19,Longest period spent worried or anxious,59
19,Protein levels in obesity [Proteinase-3],238
19,Blood protein levels [Low affinity immunoglobulin epsilon Fc receptor],300
19,Protein quantitative trait loci (liver) [KRT8],331
19,Serum albumin levels,94763
19,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [alpha-CEHC glucuronide, alpha-CEHC glycine, alpha-CEHC sulfate, alpha-CEHC taurine, X-13689, X-24359]",3911
19,"Type 2 diabetes | non-cancer illness code, self-reported",883
19,Serum levels of protein HSD17B14,6109
19,Urokinase plasminogen activator surface receptor levels,14627
19,Cholesterol_[M+H-H2O]1+ levels,622
19,Serum levels of protein KLRC3,698
19,Triglyceride levels in IDL,366
19,Sphingomyelin_42:3_[M+OAc]1- levels,693
19,Serum metabolite levels [S_VLDL_CE],2844
19,Serum levels of protein APOE,3172
19,Serum levels of protein REXO2,431
19,Plasminogen measurement,431
19,High-grade serous ovarian cancer,4965
19,Total glycated albumin levels [EA],24862
19,Hand grip strength (right),36160
19,Lumbar spine bone mineral density,17865
19,Total bilirubin levels,30387
19,Early-onset Parkinson's disease,2042
19,Serum metabolite levels [pregnen-diol disulfate C21H34O8S2*],4676
19,"Blood protein levels [SIGLEC14, 5125_6_3]",3006
19,Statin medication,3297
19,Prostate cancer aggressiveness,270
19,"""Gout, strict definition""",170
19,Anthropometric traits (multi-trait analysis),108
19,"N-glycan levels [FUC-A, women]",53
19,Plateletcrit,261867
19,Human milk oligosaccharide concentration (2'-fucosyllactose),9127
19,Smoking initiation (ever regular vs never regular) [Conditioned on chr19:18460956],14975
19,Bisoprolol fumarate+hydrochlorothiazide 10mg/6.25mg tablet | treatment/medication code,5898
19,Hypertrichosis,16481
19,"""Articial joint operation, menisceal resection""",6459
19,Alzheimer’s disease (undefined),1498
19,Fasciitis,690
19,Serum levels of protein FCER2,1147
19,Leprosy,244
19,Snoring [adjusted for BMI],173
19,Eosinophil counts,970507
19,Age at menopause (last menstrual period),19094
19,Nicotine metabolite ratio in current smokers [conditioned on rs56113850],1706
19,Serum metabolite levels [L_LDL_P],3455
19,Neurofibrillary tangles,2996
19,Angina,5665
19,Low hand grip strength (60 years and older) (EWGSOP),296
19,Dimensional psychopathology (Cognitive),7721
19,Calcium | mineral and other dietary supplements,8241
19,Nonatopic asthma and/or waist-to-hip ratio adjusted for BMI,9060
19,Sphingomyelin_36:1_[M+OAc]1- levels,1523
19,Protein quantitative trait loci (liver) [DPP7],525
19,Alzheimer’s disease (Atypical or mixed),1498
19,Protein quantitative trait loci [ILT-2],13166
19,Urinary metabolite levels in chronic kidney disease [X - 21470],3702
19,Tartrate-resistant acid phosphatase type 5 levels,3074
19,"Aspirin | medication for pain relief, constipation, heartburn",3575
19,"Age hay fever, rhinitis or eczema diagnosed",566
19,Paternal history of Alzheimer's disease,2894
19,Dyspnoea,422
19,Nonspecific findings on examination of blood,420
19,Carotid intima media thickness (maximum),698
19,"Verbal declarative memory [ALL-dr, EA]",489
19,"Blood protein levels [LDHB, 3890_8_2]",431
19,"Urinary metabolites (H-NMR features) [5.2825, Fucose]",16330
19,Lipid traits [LDL],2157
19,Fasting insulin,1886
19,Tissue factor levels,10719
19,Serum levels of protein YWHAE,1498
19,Blood protein levels [CRP],693
19,Verbal memory performance (residualized delayed recall level),1197
19,Lung cancer,1097
19,Neuroticism conditioned on self-rated math ability (multi-trait conditioning and joint analysis),2213
19,Serum urate levels in chronic kidney disease,655
19,Body fat percentage,54397
19,Serum metabolite levels [lactosyl-N-palmitoyl-sphingosine (d18:1/16:0],3864
19,Secondary malignant neoplasm,1338
19,Neurological blood protein biomarker levels [PVR],1897
19,Number of days/week of moderate physical activity 10+ minutes,1674
19,Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis),73
19,Myeloblastin levels,562
19,Glomerular diseases,295
19,Distance between home and job workplace,313
19,Protein quantitative trait loci (liver) [GPX4],59
19,Hematuria,1786
19,Pubertal anthropometrics [Single Height-males],11161
19,Direct low density lipoprotein cholesterol levels,77759
19,Neurofibrillary tangles [EA],1498
19,None of the above (group 1) | illnesses of mother,1197
19,Sphingomyelin_36:0_[M+H]1+ levels,2566
19,Rheumatoid arthritis [EA],648
19,Triglyceride levels x short total sleep time interaction (2df test),10993
19,Delta-5 desaturase activity response to n3-polyunsaturated fat supplement,1313
19,Light-intensity physical activity duration,2911
19,Serum metabolite levels (CMS) [XS_VLDL_P],2844
19,HDL cholesterol levels x long total sleep time interaction (2df test),5254
19,Serum levels of protein ATF6B,9202
19,Parental lifespan [EA],1336
19,Cerebral amyloid deposition (PET imaging),2996
19,Triacylglycerol_56:5_[M+NH4]1+ levels,863
19,Body mass index and HDL-C (pairwise),972
19,Phosphatidylinositol_36:4_[M-H]1- levels,386
19,Triglycerides,168122
19,Cathepsin D levels,18086
19,Mammographic density (dense area),10719
19,Cardiovascular disease risk factors [CRP],1120
19,Gut microbiota (bacterial taxa) [Victivallaceae],74
19,Angina | vascular/heart problems diagnosed by doctor,3575
19,Serum levels of protein APBB2,698
19,C-reactive protein levels or HDL-cholesterol levels (pleiotropy),693
19,Waist-hip ratio and HDL-C (pairwise),972
19,Coronary artery disease,221647
19,D-dimer levels in HIV infection [AA],17937
19,Metabolite levels (lipoprotein measures) [Total cholesterol in medium VLDL],7614
19,"""Type1 diabetes, definitions combined""",10719
19,Urinary potassium to creatinine ratio,873
19,Serum levels of protein TOM1L1,846
19,Heart rate response to recovery post exercise (50 sec),808
19,Prostate cancer [European],149
19,Depressive symptoms,641
19,Diacylglycerol_33:3_[M+H-H2O]1+ levels,10962
19,"Blood protein levels [TMEM190, 10442_1_3]",2115
19,Diabetes diagnosed by doctor,6828
19,Tumor biomarkers [CA19-9],3542
19,"""Hyperlipidaemia, other/unspecified""",3358
19,Response to statins (LDL cholesterol change),1527
19,"Blood protein levels [APOE, 2937_10_2]",698
19,Coronary atherosclerosis,16344
19,Hepatocellular carcinoma,2752
19,Low testosterone levels,1507
19,"Blood protein levels [C5orf38, 6378_2_3]",698
19,CD33 on Immature Myeloid-Derived Suppressor Cells,827
19,Dementia in Alzheimer disease,1498
19,Glioma,9812
19,Alcohol use disorder (total score),10719
19,"Blood protein levels [EA, Intercellular adhesion molecule 5]",1908
19,Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded),1
19,Serum carcinoembryonic antigen levels,15250
19,Serum levels of protein BTNL8,10880
19,Alzheimer's disease [model 1],1238
19,Apolipoprotein A1 levels,107298
19,Hypercholesterolemia,32475
19,Heel bone mineral density (bmd) (right),19537
19,DNA methylation GrimAge acceleration,890
19,"Blood protein levels [SIGLEC6, 2741_22_2]",4672
19,"Light brown | hair colour (natural, before greying)",466
19,Urinary metabolite levels in chronic kidney disease [X - 24736],1245
19,Sphingomyelin_40:1_[M+H]1+ levels,738
19,Triglyceride levels in very small VLDL,430
19,Hemoglobin,151567
19,Age-related macular degeneration (whether dry or wet),1797
19,Electrocardiogram morphology (amplitude at temporal datapoints) [64 ms],129
19,Sphingomyelin_41:2_[M+H]1+ levels,932
19,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),218
19,Lung function (FEV1/FVC) [EA],87
19,Serum levels of protein FUT3,11663
19,Rheumatoid arthritis,1701
19,"Blood protein levels [EA, Kallikrein-7]",265
19,Protein quantitative trait loci (liver) [ORM1],762
19,Bronchitis,56
19,High density lipoprotein cholesterol levels,25037
19,"Yes, because of other reasons | major dietary changes in the last 5 years",1498
19,Blood protein levels [Melanoma-derived growth regulatory protein],5186
19,Kallikrein-6 levels,1642
19,Heart failure and antihypertensive medication,286
19,"Blood protein levels [LRP1B, 7640_29_3]",698
19,Lipoprotein-associated phospholipase A2 activity and mass [Activity concentrations],3537
19,Complement C3 and C4 levels [Serum level of C3],2085
19,Serum 25-Hydroxyvitamin D level variance,7057
19,Hippocampal volume,1498
19,"Blood protein levels [KLRC3, 11571_75_3]",698
19,Serum cancer antigen 125 levels,114
19,Transplanted organ and tissue status,295
19,Urinary sodium excretion [EA],11054
19,Protein quantitative trait loci [sICAM-5],3411
19,Fibroblastic disorders,515
19,Molar incisor hypoplasia,295
19,Smoking intensity (cotinine levels/cigarettes per day),533
19,Pediatric autoimmune diseases,10880
19,Cognitive decline (age-related) [EA],2299
19,Citramalate levels,9141
19,"Blood protein levels [CD209, 3029_52_2]",1100
19,General cognitive ability,4550
19,Cerebrospinal fluid biomarker levels [Myeloid cell surface antigen CD33],383
19,Urinary albumin-to-creatinine ratio,25175
19,White matter microstructure (fractional anisotropy) [Anterior corona radiata],13073
19,Smoking behaviour (cigarettes smoked per day),12432
19,Body mass index (SNP x SNP interaction),6371
19,BK polyomavirus VP1 antibody levels,21622
19,Blood protein levels [Leukocyte immunoglobulin-like receptor subfamily B member 1],11506
19,Alzheimer's disease [males],1498
19,Red blood cell traits (multivariate analysis),4487
19,"""Type 2 diabetes, strict (exclude DM1)""",2676
19,Sulphasalazine | treatment/medication code,2392
19,Triglycerides [EA],43922
19,Neuritic plaque [EA],1498
19,Serum metabolite levels [1-stearoyl-2-arachidonoyl-GPI (18:0/20:4],2691
19,Dementia and core Alzheimer's disease neuropathologic changes [Primary],1055
19,Sphingomyelin_40:0_[M+H]1+ levels,858
19,Barrett's esophagus,6167
19,Phosphatidylcholine_34:0_[M+H]1+/Phosphatidylethanolamine_37:0_[M+H]1+/Phosphatidate_39:1_[M+NH4]1+ levels,1111
19,"Serum metabolite levels [sphingomyelin (d18:1/19:0, d19:1/18:0)*]",39
19,"""Endocrine, nutritional and metabolic diseases""",698
19,Water intake,1633
19,Pre-treatment viral load in hepatitis C virus genotype 3,2632
19,Serum levels of protein CA11,3419
19,"Blood protein levels [EA, Granulocyte colony-stimulating factor]",5353
19,Phosphatidate(40:5)_[M+OAc]1-/Phosphatidylglycerol(39:5)_[M-H]1- levels,498
19,Cigarettes smoked per day (past),934
19,Polyarthropathies,617
19,Arm | fractured bone site(s),192
19,"Blood protein levels [TP53I11, 13022_20_3]",698
19,Leukocyte telomere length,34729
19,Urinary metabolite levels in chronic kidney disease [pregnenediol disulfate (C21H34O8S2],4767
19,Malignant neoplasm of prostate,3352
19,Bitter non-alcoholic beverage consumption,533
19,"Allergy, hypersensitivity or anaphylaxis",64
19,Fructosamine levels,41512
19,Hippocampal atrophy rate,1880
19,"Serum metabolite levels [sphingomyelin (d18:1/18:1, d18:2/18:0]",1435
19,Serum metabolite ratios in chronic kidney disease [Sphingomyelin with acyl residue sum C16:0/Sphingomyelin with acyl residue sum C18:0],869
19,C-reactive protein levels [BMI-adjusted],1498
19,Feeling worry,535
19,Cerebral amyloid angiopathy,1055
19,Diacylglycerol_38:3_[M+H-H2O]1+ levels,386
19,Myocardial fractal dimension (slice 4),129
19,Very small VLDL particle concentration,190
19,Human milk oligosaccharide concentration (difucosyllacto-N-tetrose) in secretors,29
19,"Blood protein levels [PRTN3, 13720_95_3]",11516
19,Serum metabolite levels (CMS) [L_LDL_FC],3455
19,Barrett's esophagus  or Esophageal adenocarcinoma,1146
19,Smoking behaviour (cigarette pack-years),533
19,Serum cancer antigen 19.9 levels,11998
19,Serum levels of protein FUT5,1751
19,Serum levels of protein PLA2G7,1498
19,Body fat percentage [male],3902
19,Medication use (beta blocking agents),5322
19,Serum levels of protein PSME1,2196
19,Smoking status,214
19,Cholesteryl ester_18:3_[M+NH4]1+ levels,622
19,White blood cell count (lymphocyte),3078
19,Vascular dementia (multiple infarctations),1498
19,Serum metabolite levels [homocitrulline],2462
19,Cotinine glucuronidation,7401
19,Platelet aggregation [collagen],7214
19,"Smoking behaviour (cigarettes smoked per day) [Conditioned on chr19:41338847, chr19:41371480, chr19:41353107]",509
19,CD20 on IgD+ CD38+ B cell,1023
19,Duodenal ulcer,10903
19,CD33+ HLA DR+ CD14dim Absolute Count,713
19,Other mental disorders due to brain damage and dysfunction and to physical disease,1498
19,FEV1,23104
19,Urinary albumin excretion,2839
19,Body fat percentage and coronary artery disease (pairwise),972
19,Phosphatidylethanolamine-O_34:3_[M-H]1-/Phosphatidylethanolamine-P_34:2_[M-H]1- levels,1362
19,Free cholesterol levels in very large HDL,190
19,Serum levels of protein ARL2,190
19,Serum levels of protein LILRA6,5150
19,Metformin | treatment/medication code,7661
19,Total cholesterol levels [East Asian],2302
19,"Blood protein levels [MIA, 2687_2_1]",4107
19,Alzheimer's disease [Japanese],1976
19,Femur bone mineral density x serum urate levels interaction [female],1195
19,Diseases of liver,196
19,Thyroid problem (not cancer),27499
19,"Blood protein levels [CD177, 13116_25_3]",25584
19,"""Diabetes, insuline treatment (Kela reimbursement) (more control exclusions)""",6969
19,BMI (adjusted for smoking behaviour) [women],2695
19,Alanine transaminase levels in high alcohol intake,8774
19,Serum levels of protein GSTM1,893
19,Myocardial fractal dimension (slice 5),129
19,Serum metabolite levels (CMS) [S_HDL_CE],611
19,Serum levels of protein HDAC8,893
19,LDL cholesterol levels,87488
19,"Blood protein levels [CTF1, 13732_79_3]",698
19,Lewy body disease [Ordinal I],1498
19,"Liver, biliary or pancreas problem",3731
19,Urinary metabolite levels in chronic kidney disease [alpha-CEHC sulfate],3911
19,Protein quantitative trait loci (liver) [MYO1B],1656
19,Mean diameter of LDL particles,1709
19,"Blood protein levels [APOE, 2938_55_2]",698
19,Cortical surface area [Inferior Parietal],248
19,"N-glycan levels [FUC-A, men]",53
19,White blood cell count,685940
19,Direct bilirubin levels,25625
19,Triacylglyceride levels [TAG(54:6;0],976
19,Lactadherin measurement,896
19,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),492
19,Triglyceride levels [Hispanic/Latino],49
19,Haemoglobin concentration,59760
19,Potassium in urine,22512
19,Triglyceride levels [EA],9335
19,Serum levels of protein CRLF1,3092
19,Serum levels of protein HBQ1,893
19,Multiple myeloma,736
19,Protein quantitative trait loci (liver) [KRT18],331
19,"Blood protein levels [TXNRD1, 13967_14_3]",431
19,Serum levels of protein KIT,118
19,Hypothyroidism,13881
19,Percentage of invited food questionnaires completed,6932
19,Cerebrospinal T-tau levels,1197
19,Type 2 diabetes with other specified/multiple/unspecified complications,7163
19,Amyloid status (abnormal vs normal),1498
19,Myopia (pathological),816
19,Intelligence (MTAG),4263
19,Serum levels of protein BIRC2,1498
19,Colorectal cancer or advanced adenoma,14015
19,High cholesterol,33368
19,Number of self-reported non-cancer illnesses,3639
19,Tonsillectomy,2486
19,Cardiovascular disease risk factors [LDL],3964
19,Protein quantitative trait loci (liver) [RPA3],194
19,College or university degree | qualifications,23405
19,Heel broadband ultrasound attenuation (right),14864
19,Cerebral microbleeds,1122
19,"Lipid metabolism phenotypes [LDL-C.assay, fasting]",3355
19,"Serum metabolite levels [androstenediol (3alpha, 17alpha) monosulfate (3]",4676
19,Blood protein levels [Kallikrein-12],1140
19,Cholesteryl ester_20:3_[M+NH4]1+ levels,659
19,Body mass index x sex x age interaction (4df test),693
19,Insulin-like growth factor 1 levels,164311
19,Hip circumference,51586
19,Mortality,1383
19,Cholecystitis,7664
19,Phosphatidylinositol levels [PI(18:0;0-20:4;0],1500
19,Serum metabolite levels [M_LDL_C],3455
19,"""Other diabetes, wide definition""",6969
19,Serum levels of protein HLA-DRB3,1192
19,Interleukin-18 levels,741
19,Lipoprotein phospholipase A2 activity in cardiovascular disease,875
19,"""Hypothyroidism, strict autoimmune""",1641
19,Diastolic blood pressure,176739
19,Blond vs. brown/black hair color,26582
19,Liver fat content (MRI proton density fat fraction measure),10030
19,Cystatin C levels,141689
19,"High cholesterol | non-cancer illness code, self-reported",28792
19,Psychiatric diseases,1498
19,Other abnormal blood chemistry,419
19,Cognitive impairment,1055
19,Basal cell carcinoma,7914
19,Blood metabolite levels [ADpSGEGDFXAEGGGVR],10719
19,Phosphatidylcholine_34:1_[M+H]1+/Phosphatidylethanolamine_37:1_[M+H]1+/Phosphatidate_39:2_[M+NH4]1+ levels,1111
19,"Blood protein levels [AZU1, 2751_16_2]",814
19,Electrocardiogram morphology (amplitude at temporal datapoints) [56 ms],152
19,Gut microbiota relative abundance (bacterial taxa) [Blautia_coccoides],150
19,Home location at assessment - north co-ordinate (rounded),248
19,C-X-C motif chemokine 16 levels,4107
19,Sex hormone-binding globulin levels,513296
19,Chronic lymphocytic leukemia,13835
19,Serum creatinine levels,38230
19,3mm strong meridian (left),3112
19,Metabolite levels [SM d18:2/20:0],734
19,CD33+ HLA DR+ CD14- %CD33+ HLA DR+,586
19,Primary biliary cirrhosis,2321
19,Body mass index and coronary artery disease (pairwise),972
19,Cholesterol efflux capacity (cAMP stimulated assay),611
19,Sphingomyelin_34:1_[M+OAc]1- levels,611
19,Vulvovaginal ulceration/inflammation in other diseases,107
19,Type 2 diabetes,204084
19,Interstitial lung disease,421
19,"""Coxarthrosis,""",1762
19,Stroke,3630
19,Bipolar disorder vs anorexia nervosa (ordinary least squares (OLS)),29404
19,Serum metabolite levels [lactosyl-N-nervonoyl-sphingosine (d18:1/24:1)*],3864
19,Very long-chain saturated fatty acid levels (fatty acid 20:0),1742
19,Triglyceride levels x smoking (current vs non smokers) interaction (1df test) [African],17
19,Hemoglobin concentration,267933
19,Haematocrit percentage,44086
19,Blood protein levels [Leukocyte immunoglobulin-like receptor subfamily B member 2],1831
19,Erythritol levels,599
19,Serum metabolite levels [IDL_L],3455
19,Serum metabolite levels (CMS) [S_VLDL_C],2844
19,Elevated serum carcinoembryonic antigen levels,379
19,Urinary sodium excretion,1701
19,Cortical surface area [Middle Temporal],248
19,Liver fibrosis and steatohepatitis severity (MRI cT1 measure),8532
19,Brain region volumes [X3rd ventricle],12239
19,Childhood steroid-sensitive nephrotic syndrome,598
19,Sphingomyelin_38:1_[M+H]1+ levels,1965
19,Apolipoprotein Levels [APOE],611
19,Protein quantitative trait loci [Fucosyltransferase 3],409
19,Age-related nuclear cataracts,1436
19,Vertex-wise cortical thickness,40801
19,"Red blood cell traits [EA, MCH]",9077
19,Phosphatidylcholine_38:9_[M+OAc]1-/Phosphatidylserine_42:8_[M-H]1- levels,386
19,Low density lipoprotein cholesterol levels [Hispanic],3412
19,Electrocardiogram morphology (amplitude at temporal datapoints) [230 ms],2747
19,Lipid levels in hepatitis C treatment,1589
19,Heart rate response to recovery post exercise,3870
19,Donors of organs and tissues,70
19,Cotinine levels in current smokers,362
19,"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)",22983
19,CD20 on IgD- CD38dim B cell,28136
19,Medication use (salicylic acid and derivatives),47095
19,Hyperemesis gravidarum,438
19,Metabolic traits [SM-11 + 2 other traits],10962
19,No | major dietary changes in the last 5 years,2897
19,Serum levels of protein REG1A,11520
19,Body fat distribution (arm fat ratio) [males],1365
19,Lisinopril | treatment/medication code,118
19,Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event),256
19,Cirrhosis (alcohol related),32814
19,Dermatologic disease,3592
19,Heart rate variability traits (RMSSD),3492
19,Glomerulonephritis,295
19,"Blood protein levels [LILRA5, 7787_25_3]",1928
19,Serum metabolite levels (CMS) [M_HDL_PL],1197
19,Blood protein levels [CDH1],10719
19,High blood pressure | vascular/heart problems diagnosed by doctor,11625
19,Sphingomyelin_38:2_[M+H]1+ levels,1637
19,Coronary heart disease,3790
19,Prostate-specific antigen levels (conditioned on lead SNPs) [conditional on Round5 SNPs],2349
19,Serum levels of protein AIMP1,8618
19,Monocytic Myeloid-Derived Suppressor Cells Absolute Count,586
19,Malignant neoplasm of prostate (controls excluding all cancers),3352
19,"Blood protein levels [EA, Sialic acid-binding Ig-like lectin 14]",4611
19,Neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy),1498
19,Gastric ulcer,325
19,Serum levels of protein FAM159B,1083
19,Diabetic retinopathy (more control exclusions),344
19,Granulocyte percentage of myeloid white cells,47165
19,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),22983
19,Benign neoplasms (controls excluding all cancers),3025
19,Serum levels of protein LILRA5,4224
19,Human milk oligosaccharide concentration (lacto-N-fucopentaose I),4706
19,3mm strong meridian (right),1886
19,Waist-hip ratio and LDL-C (pairwise),972
19,Automobile speeding propensity,297
19,Fasting triglyceride levels,9667
19,"""Artrosis, including avohilmo""",10954
19,Serum uric acid levels [EA],2121
19,Human milk oligosaccharide concentration (difucosyllactose),4834
19,Serum metabolite levels [L_LDL_C],3455
19,Low density lipoprotein cholesterol levels (on statin treatment),698
19,Positive affect,641
19,Ease of skin tanning,300
19,Meat-related diet [female],17180
19,"Heel bone mineral density (bmd) t-score, automated (right)",19349
19,Blood metabolite levels [X-12850],4767
19,Cardiac problem,3575
19,DNA methylation variation (age effect),1609
19,"Blood protein levels [PLAUR, 2652_15_1]",576
19,Cholelithiasis or gall stones,18905
19,Ever used hormone-replacement therapy (hrt),9516
19,Ceramide_41:1_[M-H]1- levels,8697
19,Chronic obstructive pulmonary disease or coronary artery disease (pleiotropy),5822
19,Cholelithiasis with other cholecystitis,15945
19,Previous | smoking status,995
19,Alzheimer’s disease (Late onset) (more control exclusions),1498
19,HDL cholesterol levels in current drinkers [EA],1831
19,"""Dislocation, sprain and strain of joints and ligaments at wrist and hand level""",358
19,Serum levels of protein GKN2,10719
19,Serum metabolite levels (CMS) [EstC],3455
19,Pancreas volume,1935
19,Triacylglycerol_58:9_[M+NH4]1+ levels,860
19,First line medication for Crohns disease,1663
19,Urate levels [women],300
19,Self-reported math ability,53067
19,Urinary metabolite ratios in chronic kidney disease [Lysine/Alanine],1245
19,"Cholelithiasis/gall stones | non-cancer illness code, self-reported",17012
19,Serum levels of protein CFL1,6930
19,Electrocardiogram morphology (amplitude at temporal datapoints) [86 ms],129
19,Ulcerative colitis,13829
19,Cerebrospinal fluid p-Tau181p:AB1-42 ratio,4197
19,Phosphatidylinositol levels [PI(18:0;0-20:3;0],1500
19,Neuritic plaque [Case/control],1055
19,Serum metabolite levels (CMS) [IDL_CE],3455
19,Serum metabolite levels [1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (P-16:0/18:2)*],3748
19,"Blood protein levels [KMT2C, 11402_17_3]",698
19,Takayasu arteritis [Turkish],1825
19,Alzheimer’s disease (clinical subgroup AD+++),1498
19,Human milk oligosaccharide concentration (lacto-N-fucopentaose I) in secretors,29
19,Serum levels of protein PSD2,7120
19,Smoking initiation,214
19,Serum levels of protein PDCD5,10043
19,Serum total cholesterol levels,3542
19,"Blood protein levels [ACP5, 3232_28_2]",1861
19,Obesity and other hyperalimentation,2436
19,Protein quantitative trait loci [Siglec-9],1460
19,Gut microbiota relative abundance (bacterial taxa) [Pelotomaculum],18
19,HDL cholesterol levels,110154
19,"Benign neuroma | non-cancer illness code, self-reported",5985
19,Metabolic disorders,3542
19,Serum metabolite levels [M_LDL_FC],3455
19,Disorders of tooth development and eruption,295
19,Alzheimer's disease in hypertension,1498
19,Ovarian cancer-related tumor marker CA 125 levels,432
19,Low myopia vs hyperopia,76
19,Cathepsin L1 levels,10813
19,Primary biliary cholangitis,14904
19,Electrocardiogram morphology (amplitude at temporal datapoints) [78 ms],2876
19,melanoma-derived growth regulatory protein levels,8214
19,"Blood protein levels [UMOD, 9451_20_3]",3320
19,Cholesteryl ester_14:0_[M+NH4]1+ levels,611
19,Triacylglycerol_47:4_[M+NH4]1+ levels,611
19,Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS)),1252
19,Protein quantitative trait loci (liver) [LRRC59],2657
19,Serum metabolite levels [1-stearoyl-2-oleoyl-GPI (18:0/18:1)*],4316
19,"Smoking cessation [Conditioned on chr19:41342842, chr19:41371480, chr19:41353107]",509
19,COVID-19 (critical illness vs population),3610
19,Phosphatidylinositol levels [PI(18:0;0-18:2;0],1500
19,Serum levels of protein CUZD1,1591
19,Number of days/week walked 10+ minutes,3268
19,Metabolite levels [Hex2Cer d18:1/24:1],4373
19,Gut microbiota abundance (genus Candidatus Soleaferrea id.11350),1480
19,Serum levels of protein DEFB119,2683
19,"Blood protein levels [CKAP2, 5345_51_3]",698
19,Blood protein levels [TNFRSF10C],175
19,Serous invasive ovarian cancer,4965
19,Adolescent idiopathic scoliosis,53557
19,Gamma glutamyl transpeptidase,26064
19,Caffeine consumption from coffee or tea,1508
19,6mm strong meridian (left),4304
19,Disorders of the thyroid gland,1361
19,Opioid exposure,874
19,Triacylglycerol_48:4_[M+NH4]1+ levels,977
19,Femur total bone mineral density x gut microbiota (﻿genus Lactococcus) interaction,10
19,None of the above | vascular/heart problems diagnosed by doctor,97295
19,Gallstone disease,17343
19,"Blood protein levels [HBQ1, 7965_25_3]",698
19,Ezetimibe | treatment/medication code,4750
19,Number of cigarettes currently smoked daily (current cigarette smokers),624
19,COVID-19 (hospitalized vs population),868
19,Falling risk,727
19,Glycine levels,6667
19,"Blood protein levels [LILRB1, 5090_49_2]",13166
19,Myopia (age of diagnosis),6306
19,Heart disease | illnesses of father,4590
19,LDL cholesterol [Hispanic],595
19,Alcohol consumption x experiences in childhood (felt loved by family member) interaction,268
19,Medication use (thyroid preparations),24137
19,Cortical surface area,80974
19,Urinary metabolite levels in chronic kidney disease [gamma-CEHC glucuronide],3915
19,Basophill percentage,42432
19,"Blood protein levels [EA, Sialic acid-binding Ig-like lectin 9]",1956
19,Any dementia (more control exclusions),1498
19,Triacylglycerol_58:8_[M+NH4]1+ levels,863
19,Home location - east co-ordinate (rounded),181
19,"Tonsiltis | non-cancer illness code, self-reported",2053
19,Serum metabolite levels (CMS) [M_LDL_L],3455
19,"Blood protein levels [KIN, 14643_27_3]",698
19,Sialic acid-binding Ig-like lectin 7 levels,420
19,Blood protein levels [C3],299
19,Minerals - magnesium | treatment/medication code,32
19,"Red blood cell traits [EA, MCV]",9183
19,Protein levels in obesity [MIA],4107
19,Neuroticism,5281
19,Spherical power (left),2053
19,Cortical thickness (MOSTest),248
19,High blood pressure | illnesses of siblings,118
19,White matter microstructure (mode of anisotropy) [Posterior limb of internal capsule],18305
19,"Asthma | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",10987
19,"Blood protein levels [LGALS4, 2982_82_2]",12496
19,Cerebrospinal fluid p-tau levels,1498
19,"Ganglion and cyst of synovium, tendon, and bursa",1353
19,Triacylglycerol_54:5_[M+NH4]1+ levels,863
19,Autoimmune thyroid disease,9401
19,Alzheimer disease and age of onset [within families],693
19,Disease progression in age-related macular degeneration,299
19,Spherical equivalent,43260
19,Serum metabolite levels [M_LDL_CE],3455
19,Colon cancer,1938
19,Serum metabolite levels [IDL_PL],3455
19,Hip circumference adjusted for BMI [EA],6678
19,Job involves mainly walking or standing,3817
19,Time to complete round,1988
19,Arthropathy nos,110
19,Phospholipase D3 measurement,9849
19,Hepatic cancer,4260
19,3-hydroxypropylmercapturic acid levels in smokers [Native Hawaiian],3477
19,Serum metabolite levels (CMS) [M_LDL_C],3455
19,Fosamax 5mg tablet | treatment/medication code,1819
19,Diacylglycerol_34:2_[M+H-H2O]1+ levels,944
19,Heel bone mineral density T score,91007
19,Monocyte percentage,60342
19,Moderate to vigorous physical activity levels,1498
19,Dupuytren's disease,1030
19,PCA3 expression level,2185
19,Phosphatidylinositol(34:1)_[M-H]1- levels,716
19,Age completed full time education,23919
19,"""Gonarthrosis,primary""",7431
19,High-density lipoprotein 3 cholesterol levels,349
19,Non-albumin protein levels,12520
19,Waist circumference adjusted for body mass index [EA],6005
19,CD20 on IgD- CD24- B cell,28136
19,"""Diabetes, insuline treatment (Kela reimbursement)""",6969
19,Nervous feelings,1302
19,Information processing speed (symbol digit substitution),1498
19,Type 2 diabetes with ophthalmic complications,893
19,Wheeze or whistling in the chest in last year,64
19,Cardiovascular disease,65317
19,"Number of decayed, missing and filled tooth surfaces or use of dentures",18248
19,Alcohol-related hepatocellular carcinoma,8532
19,Morning/evening person (chronotype),10842
19,Salt added to food,3618
19,Serum metabolite levels [cholesterol],10892
19,"Blood protein levels [VAV1, 5275_28_2]",5158
19,High density lipoprotein cholesterol levels [EA],4243
19,T cell lymphocyte profile difference,613
19,Plasma amyloid beta peptide concentration (ABx-40/ABx-42 ratio),1498
19,Urinary metabolite ratios in chronic kidney disease [Lysine/Glycine],1245
19,Cortical surface area [Superior Parietal],1563
19,CD33 on CD33dim HLA DR+ CD11b+,767
19,"N-glycan levels [DG7, women]",53
19,"Blood metabolite levels [5alpha-androstan-3beta,17beta-diol disulfate]",4767
19,"Blood protein levels [PDCD5, 12517_52_3]",10043
19,Serum metabolite levels [octadecanedioate],4657
19,Sphingomyelin_39:1_[M+H]1+ levels,659
19,Sphingomyelin_36:2_[M+OAc]1- levels,912
19,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [AA],2714
19,Varicose veins,15600
19,Lipoprotein (a) levels,29557
19,"Heel broadband ultrasound attenuation, direct entry",23539
19,Hair color,13922
19,Hematological and biochemical traits [TP],3933
19,Inflammatory skin disease [Psoriasis],4566
19,Protein quantitative trait loci (liver) [CLYBL],1370
19,Phosphatidylinositol(35:2)_[M-H]1- levels,498
19,Idiopathic pulmonary fibrosis,884
19,Sphingomyelin levels [SM(38:2;2],1462
19,Cerebrospinal fluid biomarker levels [Resistin],134
19,Leisure sedentary behaviour (television watching),28388
19,"Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) [AA, men]",3902
19,Arthropathic psoriasis,2321
19,diarrhoeal disease at age 1,8200
19,"""Symptoms and signs involving cognition, perception, emotional state and behaviour""",1498
19,"""Dementia, including avohilmo""",1498
19,Lectin-like oxidized LDL receptor 1 levels,265
19,"Blood protein levels [TNFRSF14, 11545_9_3]",356
19,HDL cholesterol x physical activity interaction (2df test),8377
19,Alcohol consumption (drinks per week) (MTAG),49905
19,Serum levels of protein SECTM1,10719
19,Serum metabolite levels [EstC],3455
19,Codeine | treatment/medication code,3656
19,Smoking status (ever vs never smokers),214
19,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) [subset analysis]",15389
19,Balding type 1,38455
19,Alzheimer’s disease (Early onset) (more control exclusions),1498
19,Serum metabolite levels [1-palmitoyl-2-linoleoyl-GPI (16:0/18:2],1625
19,Ankle spacing width (left),629
19,CCL25 levels,12480
19,Body mass index in physically active individuals,3824
19,"Response to hepatitis C treatment [combined, EA]",1704
19,Severity of nausea and vomiting of pregnancy,438
19,Body mass index in physically active individuals [EA],936
19,Serum levels of protein NEFL,1083
19,Electrocardiogram morphology (amplitude at temporal datapoints) [128 ms],129
19,Serum levels of protein CLK2,1282
19,Mucinous ovarian carcinoma,3632
19,Body mass index (age>50),693
19,Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis),73
19,Frequency of needing morning drink of alcohol after heavy drinking session in last year,120
19,Hemoglobin A1c levels,75728
19,Unstable angina pectoris,7453
19,Phosphatidylinositol_36:2_[M+NH4]1+ levels,3478
19,Serum levels of protein APOB,2196
19,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Asian],2714
19,Serum levels of protein FAM3D,10719
19,Neurofibrillary tangles [Ordinal I],1055
19,Non-melanoma skin cancer,1393
19,CD45 on Immature Myeloid-Derived Suppressor Cells,1689
19,UBA2658 sp002841545 abundance in stool,1751
19,Lipid metabolism phenotypes [L-LDL-FC],698
19,Cholelithiasis,36140
19,Left atrial active emptying fraction,6725
19,Hippocampal volume [uncorrected for APOE4 status],1498
19,"Blood protein levels [KLK14, 8620_56_3]",737
19,"""Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523""",196
19,Lamb/mutton intake,11682
19,Highest math class taken,6131
19,"Presence of antiphospholipid antibodies [Anti-β2GPI domain 1 IgG, 99th percentile]",4764
19,Systemic lupus erythematosus [EA],2245
19,Facial ageing,1647
19,Serum metabolite levels (CMS) [IDL_PL],3455
19,Left–right brain asymmetry,119
19,Platelet distribution width,395272
19,Sphingolipid levels [Sphingomyeline C18:1],1396
19,Trunk fat percentage,42485
19,"Blood protein levels [LILRA5, 8766_29_3]",1928
19,Serum levels of protein BAG4,3915
19,Serum metabolite levels [S_LDL_CE],3455
19,Alanine aminotransferase levels,140209
19,CD20 on IgD- CD27- B cell,28136
19,Serum levels of protein CCL25,14686
19,Serum metabolite levels (CMS) [XS_VLDL_PL],3336
19,Phosphatidylcholine_34:3_[M+H]1+/Phosphatidylethanolamine_37:3_[M+H]1+/Phosphatidate_39:4_[M+NH4]1+ levels,1120
19,Plasma plasminogen levels,6192
19,Waist circumference,47314
19,Neuritic plaque,2996
19,Serum metabolite levels (CMS) [LDL_C],3455
19,Vascular dementia (undefined),1498
19,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),447
19,Mean corpuscular hemoglobin concentration,406269
19,Blood protein levels [Sialic acid-binding Ig-like lectin 6],9166
19,"Pulse rate, automated reading",48481
19,Serum levels of protein TP53I11,1172
19,"Blood protein levels [KLK8, 13708_56_3]",817
19,"N-glycan levels [GP14, women]",53
19,Arm fat percentage (right),47144
19,Central cerebrospinal fluid amyloid beta 42 levels,1498
19,Serum metabolite levels (CMS) [IDL_L],3455
19,A levels/as levels or equivalent | qualifications,1180
19,"""Gout, FINNGEN""",170
19,Mean corpuscular hemoglobin,603584
19,"Blood protein levels [PFDN5, 4271_75_2]",10043
19,Biological sex,2054
19,Sphingomyelin_37:1_[M+H]1+ levels,1523
19,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction),383
19,Other coagulation defects,30
19,Inflammatory bowel disease [EA],28810
19,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],18218
19,Diverticular disease,6164
19,Cancer (pleiotropy),3352
19,Sphingolipid levels [Sphingomyeline C18:0],1396
19,Alzheimer's disease (late onset) [Japanese],219
19,Phosphatidylethanolamine-O_40:6_[M+H]1+/Phosphatidylethanolamine-P_40:5_[M+H]1+ levels,843
19,Serum levels of protein ICAM5,762
19,"Blood protein levels [ECH1, 12662_82_3]",187
19,Sleeplessness / insomnia,74905
19,Cerebrospinal fluid biomarker levels [Sialic acid-binding Ig-like lectin 9],2283
19,6mm strong meridian (right),3598
19,Hyperlipidemia (time to event),1314
19,"""Seropositive rheumatoid arthritis, wide""",447
19,Serum levels of protein C6orf58,10719
19,"Blood metabolite levels [4-androsten-3beta,17beta-diol disulfate 1]",4923
19,Sphingomyelin_42:2_[M+OAc]1- levels,611
19,Local histogram emphysema pattern [Moderate Centrilobular],325
19,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)",254
19,"Asthma | non-cancer illness code, self-reported",6105
19,Peak expiratory flow,13341
19,Ischemic heart disease,4739
19,Metabolite levels (lipoprotein measures) [Free cholesterol in large LDL],3542
19,Serum metabolite levels [IDL_C],3455
19,Serum levels of protein S100A13,190
19,Serum metabolite levels (CMS) [ApoB_ApoA1],3217
19,Other symptoms and signs involving cognitive functions and awareness,1498
19,Urinary albumin excretion (no hypertensive medication),1023
19,Protein quantitative trait loci (liver) [ACLY],31
19,Vesicare 5mg tablet | treatment/medication code,6050
19,Trans-4-hydroxyproline levels,6480
19,Alzheimer's disease progression score [uncorrected for APOE4 status and baseline cortical amyloid],1498
19,Diclofenac sodium+misoprostol | treatment/medication code,2660
19,CD24 on CD24+ CD27+ B cell,723
19,Codeine or tramadol medication,1055
19,Serum urea levels,42670
19,Serum metabolite levels [IDL_CE],3455
19,Protein quantitative trait loci [SPINT2],10187
19,Diaphragmatic hernia,6414
19,Phospholipid levels in small VLDL [conditioned on 885 SNPs],3246
19,STROKE,2842
19,Age-related hearing impairment [additive],2673
19,Skin pigmentation (conditioned on rs1426654 and rs35397),236
19,Soluble E-selectin levels,468
19,Major anomalies of jaw size,43
19,Femoral neck bone mineral density,9512
19,Serum metabolite levels [S_LDL_P],3455
19,Cerebrospinal fluid p-tau levels in mild cognitive impairment,1498
19,Age-related macular degeneration (choroidal neovascularisation),299
19,Atrial fibrillation and flutter,836
19,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction),538
19,Serum levels of protein TREML1,378
19,Weight,148188
19,Serum levels of protein LCT,10719
19,Sphingomyelin_34:2_[M+OAc]1- levels,3163
19,Diverticular disease of intestine,3547
19,Body fat distribution (arm fat ratio) [females],1473
19,No | hearing difficulty/problems,2814
19,Basophil %CD33dim HLA DR- CD66b-,713
19,Glucuronate levels,11539
19,Serum metabolite levels [ADpSGEGDFXAEGGGVR*],10717
19,Osteoarthritis (hip) [additive],271
19,Serum levels of protein CRYZL1,1591
19,Excessive attrition of teeth,322
19,IgG N-glycosylation phenotypes (multivariate analysis),313
19,Osteoarthritis,43739
19,Serum levels of protein B3GNT2,26303
19,Celecoxib | treatment/medication code,6101
19,Body fat distribution (leg fat ratio),12683
19,Asthma (childhood onset),13849
19,Triacylglycerol_54:7_[M+NH4]1+ levels,962
19,Serum levels of protein CTF1,2196
19,Spherical power (right),1440
19,Serum metabolite levels (CMS) [S_LDL_C],3455
19,Any mental disorder,1498
19,Age-related hearing impairment (low/mid frequency),3338
19,Coffee consumption,3718
19,6mm weak meridian (left),2912
19,Free cholesterol levels in large LDL,849
19,vWF levels,375
19,Glomerular filtration rate in non diabetics (creatinine),12149
19,LDL cholesterol x physical activity interaction (2df test),13952
19,Alcohol intake frequency.,16415
19,Age started hormone-replacement therapy (hrt),9731
19,"Lipid metabolism phenotypes [APOB.assay, fasting]",2844
19,Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined),5800
19,Sphingomyelin_35:1_[M+OAc]1- levels,912
19,Interstitial lung disease endpoints,447
19,Skin cancer,1260
19,Hyperopia,85
19,Bipolar disorder,109271
19,Pulse pressure,150317
19,Basal metabolic rate,86193
19,Chronic kidney disease,295
19,Obesity [Obesity class II],873
19,Basophil Absolute Count,713
19,Serum levels of protein CD200R1L,698
19,Male sexual orientation,71
19,Leg predicted mass (right),103753
19,Cerebrospinal fluid t-tau levels,4508
19,Blood metabolite levels [androsterone sulfate],2931
19,Longevity (85 years and older),693
19,Pregabalin | treatment/medication code,3574
19,Birth weight of first child,2971
19,Lipid or lipoprotein levels [LDL cholesterol],698
19,Serum levels of protein DKK2,737
19,Electrocardiogram morphology (amplitude at temporal datapoints) [110 ms],129
19,Gout,170
19,Triglycerides [Hispanic],10684
19,Breast cancer (estrogen-receptor negative),32893
19,Comparative height size at age 10,201273
19,Serum metabolite ratios in chronic kidney disease [Sphingomyelin with acyl residue sum C16:1/Sphingomyelin with acyl residue sum C18:0],912
19,Metabolite levels,3455
19,Metabolite levels [LDL],2674
19,"Blood protein levels [AKT2, 14685_17_3]",698
19,Parkinson's disease or first degree relation to individual with Parkinson's disease,1565
19,Diabetic nephropathy,295
19,Birth weight,67146
19,"Blood protein levels [ICAM1, 4342_10_3]",3411
19,Platelet aggregation [collagen 3],7893
19,P-cresol sulfate levels,4177
19,Serum levels of protein NDE1,1498
19,Serum metabolite levels [LA],693
19,Duration of walks,41
19,Haemorrhoidal disease,23982
19,Alzheimer's disease biomarkers [Cortical Ab],4225
19,Adhesion G protein-coupled receptor E2 levels,707
19,Phosphatidylcholine_40:9_[M+OAc]1-/Phosphatidylserine_44:8_[M-H]1- levels,386
19,Serum metabolite levels (CMS) [IDL_FC],3455
19,Major coronary heart disease event,3542
19,Ebbinghaus illusion (overestimation),19457
19,Serum levels of protein BPIFA2,10719
19,"Blood protein levels [SPINT2, 2843_13_2]",10224
19,Educational attainment (years of education) [conditional-joint],10142
19,Platelet aggregation [collagen 2],7893
19,Number of days/week of vigorous physical activity 10+ minutes,1633
19,PEG-asparaginase hypersensitivity without enzyme activity in childhood acute lymphoblastic leukaemia,309
19,Other and unspecified coagulation defects,30
19,Electrocardiogram morphology (amplitude at temporal datapoints) [68 ms],129
19,Dentures,16283
19,Forced vital capacity (fvc),75332
19,"Blood protein levels [GGT2, 6334_9_3]",698
19,N-acetylglucosamine/n-acetylgalactosamine levels,9461
19,Vascular dementia (subcortical),1498
19,CD33 on CD33+ HLA DR+ CD14-,2232
19,Phosphatidylinositol(40:6)_[M-H]1- levels,716
19,Serum metabolite levels (CMS) [LA],693
19,Addison's disease,139
19,"Urinary metabolites (H-NMR features) [1.2575, Fucose]",11042
19,Lymphocyte percentage,88871
19,Myeloid white cell count,12333
19,Iron status biomarkers (transferrin saturation),1351
19,Basophill count,5420
19,Non-small cell lung cancer,944
19,Cerebrospinal fluid biomarker levels [Sialic acid-binding Ig-like lectin 14],837
19,Waist-to-hip ratio adjusted for body mass index [men],383
19,Nontoxic multinodular goitre,365
19,Mean corpuscular volume,992680
19,Iron status biomarkers (total iron binding capacity),9269
19,Uterine fibroids,15339
19,Kidney stones,667
19,Creatinine (enzymatic) in urine,1666
19,Ideal cardiovascular health (clinical and behavioural),698
19,Aerodigestive squamous cell cancer (pleiotropy),533
19,Chronic obstructive pulmonary disease x current smoker interaction (2df),783
19,Smoking initiation (ever regular vs never regular) [Conditioned on chr19:4474725],752
19,Nonsyndromic cleft lip with or without cleft palate [EA],173
19,"Facial morphology (factor 11, projection of the nose)",88
19,Triglyceride levels [Trans-ethnic initial],8544
19,Monocyte percentage of white cells,167250
19,Menarche and menopause (age at onset) [age at natural menopause],10529
19,Skin pigmentation,585
19,Cerebrospinal fluid biomarker levels [Apolipoprotein E (isoform E2],1300
19,Insulin levels in response to oral glucose tolerance test (30 minutes),873
19,Electrocardiogram morphology (amplitude at temporal datapoints) [100 ms],129
19,"N-glycan levels [DG7, men]",53
19,"Blood protein levels [PCDHGA1, 6457_50_3]",35120
19,Coronary artery disease or large artery stroke,3790
19,Depressive symptom (anhedonia) (binary trait),1047
19,Matrix metalloproteinase-12 levels,431
19,Serum metabolite levels (CMS) [VLDL_C],492
19,"Blood protein levels [B3GNT2, 7980_72_3]",12918
19,P wave terminal force [EA],1480
19,Itch intensity from mosquito bite adjusted by bite size [women],1107
19,Cholesteryl ester_17:1_[M+NH4]1+ levels,858
19,Serum levels of protein ITGB6,317
19,Dietary macronutrient intake [Carbohydrate],10184
19,CD20 on IgD+ CD38- B cell,28136
19,Phosphatidylinositol(38:6)_[M-H]1- levels,4455
19,Triacylglycerol_56:8_[M+NH4]1+ levels,863
19,Peripheral atherosclerosis,2945
19,LDL cholesterol levels x long total sleep time interaction (2df test),12446
19,Systemic lupus erythematosus or rheumatoid arthritis [same effect],2292
19,General episode | hospital episode type,420
19,Immunological or systemic disorder,64
19,Serum levels of protein ELANE,377
19,Cortical surface area [Banks of the Superior Temporal Sulcus],248
19,Schizophrenia vs ADHD (ordinary least squares (OLS)),11098
19,Platelet-to-lymphocyte ratio,22401
19,Dried fruit intake,1556
19,Forns index in high alcohol intake,3874
19,Refractive error,70993
19,Heart rate variability traits (SDNN),3789
19,Sphingomyelin(42:0)_[M+OAc]1- levels,794
19,kallikrein-11 levels,400
19,Urinary potassium excretion [EA],801
19,Pediatric asthma,64
19,Predicted visceral adipose tissue,17662
19,Urate levels,109923
19,Dickkopf-related protein 1 levels,8506
19,"Blood protein levels [TGFB1, 14108_15_3]",12918
19,Self-reported math ability (MTAG) [MTAG],69804
19,Bipolar disorder vs major depressive disorder (ordinary least squares (OLS)),27377
19,Serum metabolite levels [S_LDL_FC],3455
19,Parental lifespan,4342
19,Triacylglycerol_46:5_[M+NH4]1+ levels,723
19,IDL particle concentration,704
19,Severe depression | illnesses of siblings,1
19,Lymphocyte percentage of white cells,148953
19,Estimated glomerular filtration rate in non-diabetics,15896
19,Heart rate increase in response to exercise,418
19,C-reactive protein levels or total cholesterol levels (pleiotropy),5687
19,Inflammatory bowel disease,21376
19,Delirium dementia and amnestic and other cognitive disorders,1498
19,Total cholesterol levels in medium VLDL [conditioned on 885 SNPs],3246
19,Body fat distribution (arm fat ratio),1365
19,Urinary metabolite ratios in chronic kidney disease [Lysine/Tryptophan],1245
19,Serum metabolite levels [X-11440],4923
19,Depressed affect,2017
19,"Blood protein levels [TNFSF14, 5355_69_3]",174
19,Serum levels of protein GP6,13734
19,Hand grip strength (left),92609
19,"Blood protein levels [B3GNT8, 9297_12_3]",39575
19,Obesity due to excess calories,873
19,"Blood protein levels [OLFM2, 8295_16_3]",1027
19,Dementias,1498
19,Hay fever and/or eczema,64
19,Foreign body in respiratory tract,27
19,Dentures | mouth/teeth dental problems,16944
19,"Heel bone mineral density (bmd) t-score, automated",30382
19,Neutrophill percentage,64865
19,Cooked vegetable consumption,15682
19,"None of the above | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",1386
19,Liver enzyme levels (gamma-glutamyl transferase),46922
19,Aspartate aminotransferase to alanine aminotransferase ratio,25492
19,Serum metabolite levels [S_LDL_L],3455
19,"""Disorders of gallbladder, biliary tract and pancreas""",5180
19,Pulse pressure [East Asian],3213
19,Serum metabolite levels (CMS) [M_LDL_PL],3455
19,Phosphatidylinositol(32:1)_[M-H]1- levels,6161
19,Serum metabolite levels (CMS) [L_LDL_CE],3455
19,Phosphatidylcholine-O_38:2_[M+H]1+/Phosphatidylcholine-P_38:1_[M+H]1+ levels,723
19,Mean platelet volume,579841
19,Ease of getting up in the morning,23999
19,Triglyceride levels in small VLDL [conditioned on 885 SNPs],3246
19,Waist-hip ratio,155652
19,"Urinary metabolites (H-NMR features) [5.2275, Fucose]",16330
19,"Forced expiratory volume in 1-second (fev1), best measure",53339
19,Post bronchodilator FEV1/FVC ratio,325
19,Protein quantitative trait loci (liver) [RAB14],90
19,Benign neoplasms,3025
19,SARS-CoV-2 infection,17540
19,Serum metabolite levels (CMS) [XS_VLDL_CE],3455
19,Serum levels of protein UMOD,1460
19,Cystatin-B levels,504
19,Excessive vomiting in pregnancy,315
19,Hemoglobin levels,170520
19,Heel bone mineral density (bmd),30082
19,Triglycerides [AA],218
19,Body fat distribution (trunk fat ratio),12683
19,Triglyceride levels in current drinkers,4579
19,Mastocytosis (KIT D816V positive),51
19,Caffeine consumption from coffee,533
19,Phosphatidylinositol(34:2)_[M-H]1- levels,412
19,Neutrophil count,714338
19,Blood metabolite ratios [ADSGEGDFXAEGGGVR/ADpSGEGDFXAEGGGVR],10719
19,Waist-hip ratio [EA],2332
19,Fruit consumption,16737
19,"""Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8""",7269
19,LDL cholesterol levels in current drinkers [Asian],2595
19,Alzheimer’s disease (Late onset),1498
19,Age started wearing glasses or contact lenses,135
19,Carotid intima media thickness (mean) [men],698
19,Ceramide_42:1_[M+H]1+ levels,8532
19,"Blood metabolite ratios [X-11440/4-androsten-3beta,17beta-diol disulfate 2]",4767
19,"""Delirium, not induced by alcohol and other psychoactive substances""",1498
19,Past tobacco smoking,214
19,Respiratory diseases,7365
19,"Blood protein levels [LILRA3, 6391_52_3]",1928
19,Chronotype,28234
19,Diacylglycerol_36:4_[M+H-H2O]1+ levels,944
19,Serum levels of protein DEAF1,6930
19,Very large VLDL particle concentration [conditioned on 885 SNPs],3246
19,Central cerebrospinal fluid amyloid beta 42 to 40 ratio,1498
19,"Blood protein levels [CCL25, 2705_5_2]",400
19,Serine protease 27 levels,11580
19,Leg predicted mass (left),91662
19,Cognitive decline,1813
19,Amyotrophic lateral sclerosis,3005
19,Estradiol levels,9879
19,Phosphatidylcholine-O_37:2_[M+H]1+/Phosphatidylcholine-P_37:1_[M+H]1+/Phosphatidylethanolamine-O_40:2_[M+H]1+ levels,723
19,"Serum metabolite levels [sphingomyelin (d18:1/20:0, d16:1/22:0)*]",1530
19,Cholesterol efflux capacity (ABCA-1 dependent assay),611
19,Phenylalanine levels,12714
19,Getting up in morning,21417
19,Type 2 diabetes [EA],7316
19,Cognitive ability (MTAG),765
19,Systolic blood pressure x alcohol consumption interaction (2df test) [EA],324
19,Alcohol use disorder (consumption score),11243
19,Ulcerative colitis [EA],5713
19,Atrial fibrillation and flutter with reimbursement,953
19,Metabolic biomarkers (multivariate analysis),7404
19,Blood protein levels [Sialic acid-binding Ig-like lectin 9],3633
19,Body mass index and LDL-C (pairwise),972
19,Idiopathic gout,170
19,CD20 on IgD+ CD24+ B cell,28136
19,Serum phosphate levels,59749
19,A body shape index,9488
19,N-glycan levels [FUC-A],106
19,"Cholesterol, total [Hispanic]",759
19,Triacylglycerol_56:7_[M+NH4]1+ levels,863
19,"Blood protein levels [NCR1, 8360_169_3]",633
19,Red cell distribution width,1382010
19,Cognitive performance (MTAG) [MTAG],27173
19,Migraine and/or pulse pressure,6094
19,Urinary metabolites [Lysine/valine ratio],1310
19,"Allergic disease (asthma, hay fever and/or eczema) (age of onset)",1175
19,BMI in non-smokers,2695
19,"Blood protein levels [CTSL, 9275_2_3]",5610
19,Parental longevity (father's age at death or father's attained age),4041
19,Sphingomyelin_40:2_[M+H]1+ levels,723
19,Age-related macular degeneration (geographic atrophy),299
19,Educational attainment (years of education),72258
19,Mouth ulcers,4450
19,Allergic rhinitis [Latino],7794
19,"""Asthma, hospital admissions , main diagnosis only""",64
19,"Blood protein levels [SIGLEC9, 3007_7_2]",3320
19,Memory loss,1498
19,Serum metabolite ratios in chronic kidney disease [Hydroxysphingomyelin with acyl residue sum C22:1/Sphingomyelin with acyl residue sum C18:0],869
19,Tumor biomarkers [CEA],379
19,Glucose levels,2936
19,Vitamin D insufficiency,7611
19,"Blood protein levels [CRLF1, 14747_9_3]",3092
19,Cerebrospinal P-tau181p levels,1197
19,"""Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium""",80
19,Serum levels of protein KLK11,146
19,LDL cholesterol levels [Hispanic],2595
19,"Blood protein levels [CEP57, 11276_1_3]",698
19,Total triglycerides levels [conditioned on 885 SNPs],3246
19,Serum levels of protein POLR1C,1282
19,Ischemic heart diseases,3542
19,Lung cancer in ever smokers,533
19,Spatial processing,755
19,Hepatitis C (spontaneous viral clearance) [female],1172
19,Diastolic blood pressure x alcohol consumption interaction (2df test) [EA],324
19,Immature fraction of reticulocytes,315878
19,Serum metabolite levels [gamma-CEHC glucuronide*],4657
19,Testicular germ cell tumor,19864
19,"Hypothyroidism/myxoedema | non-cancer illness code, self-reported",5580
19,Strontium product | treatment/medication code,8810
19,Toxoplasma gondii sag1 antibody levels,493
19,Protein quantitative trait loci (liver) [ABAT],11
19,Bipolar I disorder,67248
19,Blood protein levels in cardiovascular risk,47237
19,Migraine,7923
19,Serum levels of protein LILRB5,1275
19,CD33 on CD33dim HLA DR+ CD11b-,767
19,Noncognitive aspects of educational attainment,837
19,"Red | hair colour (natural, before greying)",156
19,Hematocrit,432585
19,Problematic alcohol use,10719
19,White blood cell count [Lymphocytes],4027
19,Phosphatidylinositol(34:0)_[M-H]1- levels,498
19,Serum levels of protein AZU1,567
19,Optic cup area,195
19,"Heel bone mineral density (bmd) t-score, automated (left)",17403
19,Fructosamine levels [EA],24862
19,Electrocardiogram morphology (amplitude at temporal datapoints) [84 ms],1516
19,Left-handedness,119
19,Bipolar disorder vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),29404
19,White matter microstructure (fractional anisotropy) [Posterior limb of internal capsule],12929
19,Serum lipase activity,10962
19,Executive function (trail making test B),1498
19,C-reactive protein measurement,1498
19,Blood protein levels [Intercellular adhesion molecule 5],2916
19,Lung function (FVC),132365
19,Aspartate aminotransferase platelet ratio index in high alcohol intake,9425
19,Human milk oligosaccharide concentration (fucodisialyllacto-N-hexaose),4834
19,Disorders of lipoprotein metabolism and other lipidaemias,3738
19,Dementia and core Alzheimer's disease neuropathologic changes [Complete],1055
19,Lipid traits [TC],1068
19,Metabolite levels [Hex2Cer d18:1/16:0],4373
19,Complement C3 levels,1412
19,Reaction time,6904
19,"""Endomtriosis ASRM stages 3,4""",1243
19,Mean sphered cell volume,306870
19,JC polyomavirus VP1 antibody levels,7197
19,Longevity (100 years and older) [EA],1498
19,Sum eosinophil basophil counts,70071
19,Conductive and sensorineural hearing loss,3445
19,Serum levels of protein PCDHGA1,14665
19,Vertigo,8968
19,Phosphatidylethanolamine-O_34:2_[M-H]1-/Phosphatidylethanolamine-P_34:1_[M-H]1- levels,3350
19,Heart rate response to exercise,434
19,Subcortical volume (min-P),26441
19,Externalizing behaviour (multivariate analysis),18771
19,Urinary metabolite levels in chronic kidney disease [alpha-CEHC glucuronide],3915
19,Aspartate transaminase levels in high alcohol intake,8774
19,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],3901
19,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Hispanic],2714
19,Serum levels of protein ARFGAP1,893
19,Serum levels of protein IGLL1,582
19,Posterior cortical atrophy and Alzheimer's disease,1120
19,Parkinson's disease progression (cognitive),1498
19,Serum levels of protein KLK10,1853
19,Blood protein levels [Interleukin-12 receptor subunit beta-1],3249
19,Fractional excretion of metabolites in chronic kidney disease [Lysine],1245
19,Serum levels of protein CFD,95
19,Other peripheral nerve disorders,108
19,Human milk oligosaccharide concentration (lacto-N-fucopentaose II),4863
19,Bendroflumethiazide | treatment/medication code,1856
19,Amyloid pathology,1498
19,Very long-chain saturated fatty acid levels (fatty acid 22:0),1742
19,Myocardial infarction (early onset),3790
19,C-reactive protein [AA women],781
19,"""Alzheimer’s disease, wide definition""",1498
19,Serum levels of protein CPE,1498
19,Serum levels of protein CNDP1,1980
20,Neuroticism,31992
20,Suffer from 'nerves',10325
20,Leg fat-free mass (right),152754
20,Malignant neoplasm of prostate (controls excluding all cancers),5847
20,Fibrinogen levels,60
20,Acceptance of an invitation to participate in a mental health questionnaire,185
20,Joint mobility (Beighton score),24071
20,Neurofibrillary tangles (SNP x SNP interaction),30607
20,Basophill percentage,5324
20,"Presence of antiphospholipid antibodies [Anti-β2GPI Domain 1 IgG, 99th percentile]",504
20,"Systolic blood pressure x alcohol consumption interaction (2df test) [AA, EA]",8
20,Hallux valgus (acquired),24360
20,Mean arterial pressure x alcohol consumption interaction (2df test) [EA],2982
20,Ceramide levels [CER(40:2;2],217
20,Femur bone mineral density x serum urate levels interaction [female],328
20,"""Mental and behavioural disorders due to alcohol, excluding acute intoxication""",12
20,Bioavailable testosterone levels,63671
20,Direct bilirubin levels,35937
20,Arm fat percentage (left),135761
20,Red blood cell (erythrocyte) distribution width,17969
20,Cerebrovascular diseases (FINNGEN),3772
20,Brain region volumes [left inferior parietal],1044
20,Hypothyroidism and >3 levothyroxin purchases,321
20,Body fat distribution (leg fat ratio) [males],24071
20,Mean reticulocyte volume,309387
20,Arm fat percentage (right),135271
20,Serum metabolite levels [guanidinoacetate],1332
20,Sphingomyelin(38:0)_[M+H]1+ levels,212
20,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C40:2/Phosphatidylcholine with acyl-alkyl residue sum C42:2],217
20,C-reactive protein levels [BMI-adjusted],20
20,Feeling nervous,11836
20,Tea intake,1121
20,"Allergic disease (asthma, hay fever and/or eczema) (age of onset)",258
20,Neutrophil count,242820
20,Resting heart rate,1891
20,Migraine and/or pulse pressure,839
20,Leiomyoma of uterus (controls excluding all cancers),386
20,Ceramide_41:1_[M-H]1- levels,217
20,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) [EA],107
20,"Heel quantitative ultrasound index (qui), direct entry (right)",25346
20,White blood cell (leukocyte) count,24870
20,Fluoxetine | treatment/medication code,49
20,Childhood body fatness,81
20,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],24
20,Protein quantitative trait loci (liver) [SERPINA3],1
20,Breast cancer,12661
20,Malignant neoplasm of respiratory system and intrathoracic organs,362
20,Mammographic density (dense area),818
20,"Age hay fever, rhinitis or eczema diagnosed",144
20,Central serous retinopathy [Japanese],440
20,Intrahepatic Cholestasis of Pregnancy (ICP)  (more control exclusions),20
20,Daytime nap,14156
20,Cardiovascular diseases (excluding rheumatic etc),3772
20,HDL cholesterol levels x thiazide or thiazide-like diuretics use interaction,36
20,Metabolite levels [SM d16:1/18:0],212
20,Cystatin D levels,220
20,Other diseases of jaws,22
20,Platelet-to-lymphocyte ratio,6156
20,Leg fat percentage (right),162954
20,Response to hepatitis C treatment [Decrease of PLT],2042
20,Pattern 1 | hair/balding pattern,46438
20,Electrocardiogram morphology (amplitude at temporal datapoints) [224 ms],19115
20,Major depressive disorder (MTAG),1440
20,Helping behaviour (self reported),219
20,"Kidney stone, ureter stone or bladder stone",23
20,Recurring oral aphthae,69
20,Sphingomyelin(37:1)_[M+H]1+ levels,192
20,Use of sun/uv protection,76472
20,Medication use (antithrombotic agents),1808
20,"Blood protein levels [CPNE1, 5346_24_3]",100118
20,Trunk predicted mass,113962
20,"Smoking cessation [Conditioned on chr20:62018289, chr20:61984317]",1048
20,Malignant neoplasm of skin,2955
20,Serum metabolite ratios in chronic kidney disease [Hydroxysphingomyelin with acyl residue sum C24:1/Sphingomyelin with acyl residue sum C24:0],217
20,Dermatologic disease,20728
20,Systemic lupus erythematosus,5668
20,UBA1375 sp002305795 abundance in stool,11
20,Electrocardiogram morphology (amplitude at temporal datapoints) [178 ms],19815
20,Facial morphology (segment 23),1524
20,Carbimazole | treatment/medication code,1418
20,Body fat distribution (arm fat ratio),814
20,Systolic blood pressure [East Asian],445
20,Triacylglycerol_46:5_[M+NH4]1+ levels,217
20,Vertex-wise cortical surface area,41043
20,Frequency of friend/family visits,19938
20,Electrocardiogram morphology (amplitude at temporal datapoints) [222 ms],19115
20,Factor VII activity,34981
20,Feeling tense,1885
20,Mean platelet (thrombocyte) volume,170684
20,Carbomers | treatment/medication code,83
20,Capecitabine-induced hand-foot syndrome in breast or colorectal cancer,18
20,Leg fat-free mass (left),142802
20,Ceramide levels [Total_CER],217
20,"Waist-to-hip ratio adjusted for body mass index [EA, women]",157
20,Diastolic blood pressure,230780
20,Cortical thickness (MOSTest),24269
20,Leukocyte telomere length [East Asian],19880
20,"Disorders of muscle, ligament, and fascia",458
20,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant II (Nose), Segment 43]",203
20,"Retinal problem | non-cancer illness code, self-reported",160
20,Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis),340
20,Arm fat mass (right),130097
20,"Bowel / intestinal obstruction | non-cancer illness code, self-reported",685
20,"""Thyrotoxicosis, other and/or unspecified""",1341
20,Medication use (calcium channel blockers),24005
20,Heel broadband ultrasound attenuation (right),5267
20,Heel broadband ultrasound attenuation (left),1348
20,Autoimmune diseases,1407
20,Antibody status in Tripanosoma cruzi seropositivity,42
20,P-cresol sulfate levels,241
20,Mean spheric corpuscular volume,94538
20,Colon cancer,653
20,Surgery on leg arteries (other than for varicose veins),132
20,"""Ulcerative colitis (strict definition, require KELA)""",34
20,Gut microbiota relative abundance (bacterial taxa) [Alistipes_shahii],470
20,Thyroid peroxidase antibody levels,1983
20,Protein quantitative trait loci (liver) [HINT1],9
20,Tonsillectomy,29448
20,"""Benign neoplasm of colon, rectum, anus and anal canal (controls excluding all cancers)""",11566
20,Glioblastoma (age-stratified) [Above median age-at-diagnosis],20049
20,Electrocardiogram morphology (amplitude at temporal datapoints) [140 ms],4984
20,Allergic rhinitis,673
20,DVT of lower extremities and pulmonary embolism,38411
20,Brain region volumes [left putamen],19889
20,IgM levels,760
20,Electrocardiogram morphology (amplitude at temporal datapoints) [240 ms],19115
20,Diabetes,8473
20,Serum levels of protein WFDC5,2795
20,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant II (Nose), Segment 45]",203
20,Nap during day,3307
20,Neuropsychiatric disorders,1440
20,Respiratory diseases,18698
20,"Eczema/dermatitis | non-cancer illness code, self-reported",16191
20,Major depressive disorder (stressful life events interaction),38
20,Protein quantitative trait loci (liver) [TAGLN2],134
20,Mouth ulcers | mouth/teeth dental problems,87
20,Liver enzyme levels (alanine transaminase),179532
20,Bitter non-alcoholic beverage consumption,1390
20,Intraocular pressure,6953
20,Sphingomyelin_37:1_[M+H]1+ levels,217
20,Sphingomyelin_43_2_[M+OAc]1- levels,294
20,Serum levels of protein CST1,2588
20,Had menopause,773
20,Low density lipoprotein cholesterol levels [EA],4735
20,Eye movement in schizophrenia (horizontal position gain),267
20,Electrocardiogram morphology (amplitude at temporal datapoints) [230 ms],19115
20,Diastolic blood pressure x educational attainment (some college) interaction (2df),331
20,Electrocardiogram morphology (amplitude at temporal datapoints) [206 ms],19815
20,Restless legs syndrome,1716
20,Stool frequency,5325
20,Circulating myeloperoxidase levels (serum),29
20,Cigarettes smoked per day (MTAG),15961
20,Ceramide levels [N24S16],217
20,Lung function (FEV1),20743
20,Sitting height,274133
20,Glaucoma (primary open-angle),882
20,Chloride levels,675
20,Hemoglobin concentration,159281
20,Vertical cup-disc ratio (adjusted for vertical disc diameter),1605
20,Protein quantitative trait loci (liver) [SFPQ],126
20,Electrocardiogram morphology (amplitude at temporal datapoints) [152 ms],700
20,Cortical surface area,52479
20,CAG-345 sp000433315 abundance in stool,646
20,Predicted visceral adipose tissue,9779
20,malignant neoplasm of male genital organs (controls excluding all cancers),5847
20,Gut microbiota relative abundance (bacterial taxa) [Clostridium_cellulolyticum],411
20,Facial morphology (segment 54),78
20,"Blood protein levels [ENO2, 11083_23_3]",99
20,Pattern 4 | hair/balding pattern,17542
20,C-X-C motif chemokine 16 levels,876
20,Serum levels of protein MLN,121
20,Systolic blood pressure x smoking status (current vs non-current) interaction (2df test) [African],47
20,Ischemic heart diseases,26173
20,Anal and rectal conditions,8779
20,Hair morphology traits [Hair loss pattern at 40 (binary],1362
20,Urinary calculus,136
20,Ceramide(40:1)_[M-H]1- levels,205
20,Gut microbiota (bacterial taxa) [Bacilli class],181
20,Trunk fat percentage,101651
20,Cataracts,8789
20,Alcohol intake frequency.,887
20,"Mean arterial pressure x alcohol consumption interaction (2df test) [AA, EA]",2923
20,Electrocardiogram morphology (amplitude at temporal datapoints) [-6 ms],6617
20,Serum levels of protein RRM1,5115
20,Waist-hip ratio [EA],1104
20,Facial morphology (segment 31),333
20,Bitter beverage consumption,1390
20,Protein quantitative trait loci (liver) [ABAT],17
20,Benign neoplasm of colon,15367
20,Blond vs. brown/black hair color,1711
20,Schizophrenia vs bipolar disorder (ordinary least squares (OLS)),17787
20,"Diastolic blood pressure [EA, initial]",3921
20,Chronic hepatitis C infection,5956
20,"Blood protein levels [COX8A, 10497_242_3]",99
20,Hyperthyroidism,2063
20,Diseases of the respiratory system,3075
20,Systolic blood pressure [EA],26
20,Self-reported math ability,13788
20,OTU99_137 (Ruminococcus) prevalence,3991
20,Arm fat-free mass (left),105827
20,Serum metabolite levels (CMS) [HDL_D],3039
20,Sphingomyelin(41:2)_[M+H]1+ levels,194
20,"Cholelithiasis/gall stones | non-cancer illness code, self-reported",20
20,Migraine,1927
20,Electrocardiogram morphology (amplitude at temporal datapoints) [184 ms],24799
20,Electrocardiogram morphology (amplitude at temporal datapoints) [226 ms],19115
20,Triglyceride levels [Asian],2648
20,"""Other chronic obstructive pulmonary disease , including avohilmo""",152
20,Electrocardiogram morphology (amplitude at temporal datapoints) [-180 ms],100
20,Obesity [Obesity class I],718
20,Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis),266
20,Cholecystitis,20
20,Vitiligo,5351
20,Facial morphology (segment 21),232
20,Age at first live birth,631
20,Cholelithiasis,306
20,Electrocardiogram morphology (amplitude at temporal datapoints) [368 ms],1123
20,Estimated glomerular filtration rate,287722
20,Apolipoprotein B levels,216553
20,"Heel bone mineral density (bmd) t-score, automated",54958
20,"Waist circumference [EA, women]",1104
20,facial morphology traits (multivariate analysis),396
20,HDL cholesterol levels [BMI unadjusted],2671
20,Type 2 diabetes with other specified/multiple/unspecified complications,102
20,Smoking initiation (ever regular vs never regular) [Conditioned on chr20:61984317],8492
20,"Ecg, heart rate",1123
20,Vertical cup-disc ratio,819
20,"Diastolic blood pressure, automated reading",13771
20,Serum levels of protein BPIFB1,3999
20,CD27 on CD24+ CD27+ B cell,1341
20,Protein quantitative trait loci (liver) [SBDS],15
20,Externalizing behaviour (multivariate analysis),3512
20,Trans-4-hydroxyproline levels,1676
20,Response to hepatitis C treatment [Change in Hb],1021
20,Food allergy [excluding GERA cohort],18
20,Mean diameter of HDL particles,3039
20,Meat-related diet,1236
20,"Blood protein levels [SIRPB1, 6247_9_3]",2188
20,Parkinson's disease or first degree relation to individual with Parkinson's disease,5235
20,Distal/Left-sided colorectal cancer,544
20,Benign neoplasms (controls excluding all cancers),1926
20,"HDL cholesterol levels [Asian initial, BMI unadjusted]",2446
20,Ceramide levels [CER(42:2;2],217
20,malignant neoplasm of male genital organs,5847
20,"""Hypertension, essential""",3952
20,Urate levels [East Asian],1899
20,One or more previous psychiatric episodes with another health care provider | history of psychiatric care on admission,942
20,Central serous retinopathy,440
20,Metabolite levels [Cer d16:1/23:0],212
20,"Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",8
20,Fat-free mass,34818
20,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),3235
20,Evening primrose oil product | treatment/medication code,148
20,Nonsyndromic cleft lip,174
20,Length of mobile phone use,19783
20,"""Asthma, unspecified (mode)""",38905
20,Gut microbiota (functional units) [GO:0008484|MF|04|sulfuric ester hydrolase activity],842
20,Ceramide_42:2_[M+H]1+ levels,237
20,"Relative wall thickness x antihypertensive treatment interaction [dCCB versus ACE, AA]",69
20,"""Disorders of gallbladder, biliary tract and pancreas""",237
20,Electrocardiogram morphology (amplitude at temporal datapoints) [208 ms],19815
20,Migraine and/or systolic blood pressure,398
20,Parenchymal hematoma in thrombolytic-treated acute ischaemic stroke,6887
20,White blood cell count (basophil),17707
20,Pork consumption,51651
20,"Blood protein levels [ASIP, 5676_54_3]",10643
20,"Diastolic blood pressure x alcohol consumption interaction (2df test) [AA, EA]",2923
20,"""Diabetes, insuline treatment (Kela reimbursement)""",1581
20,Sphingomyelin_39:1_[M+OAc]1- levels,217
20,Serum levels of protein MMP9,308
20,"Blood protein levels [EMILIN3, 8773_172_3]",15
20,Sphingomyelin_39:1_[M+H]1+ levels,217
20,Cognitive performance (MTAG) [MTAG],156030
20,Fruit consumption,2459
20,Adventurousness,2238
20,"""Burn and corrosion of shoulder and upper limb, except wrist and hand""",403
20,Optic neuritis,8
20,Worry,10772
20,Colon polyp,11539
20,Blood protein levels [Vitamin K-dependent protein C],34640
20,"Serum metabolite levels [ceramide (d18:2/24:1, d18:1/24:2)*]",204
20,Sphingomyelin(37:1)_[M-CH3]1- levels,192
20,Protein quantitative trait loci (liver) [VAPA],126
20,Serum levels of protein PRRG4,460
20,Colorectal cancer [East Asian],2032
20,Morning/evening person (chronotype),93
20,Hypercholesterolemia,3726
20,"Light brown | hair colour (natural, before greying)",2033
20,"Hip circumference [EA, men]",24071
20,Other malignant neoplasms of skin (=non-melanoma skin cancer),2955
20,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),8216
20,Obesity and other hyperalimentation,117
20,"Blood protein levels [MUL1, 9315_16_3]",600
20,Protein quantitative trait loci (liver) [ACAD11],21
20,Urinary metabolite levels in chronic kidney disease [Serotonin],52
20,Smoking status (ever vs never smokers),43973
20,Electrocardiogram morphology (amplitude at temporal datapoints) [194 ms],19815
20,HDL cholesterol levels x short total sleep time interaction (2df test),2648
20,Creutzfeldt-Jakob disease,442
20,Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis),340
20,C-reactive protein levels,220850
20,Circulating fibroblast growth factor 23 levels [EA],48
20,Infant length,42683
20,Autism spectrum disorder (MTAG),13247
20,C-reactive protein (red blood cell fatty acid level interaction) [OA],1090
20,Protein levels in obesity [CYTT],1611
20,Subjective well-being (MTAG),18719
20,Syndecan-4 levels,3194
20,"Cataract | non-cancer illness code, self-reported",189
20,Hallux valgus (bunion),24269
20,Ascending aorta minimum area,9296
20,High light scatter reticulocyte percentage,6956
20,Intracranial aneurysm,512
20,"Metabolite levels (lipoprotein measures) [Total lipids in small HDL, conditioned]",1288
20,High light scatter reticulocyte count,383994
20,C-reactive protein levels or total cholesterol levels (pleiotropy),20
20,Small HDL particle concentration,3039
20,LDL cholesterol levels x long total sleep time interaction (2df test),3779
20,Electrocardiogram morphology (amplitude at temporal datapoints) [136 ms],700
20,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],228
20,Sphingolipid levels [levels],217
20,Body mass index [Japanese],9394
20,Smoking status (heavy vs never),1931
20,Nontoxic multinodular goiter,447
20,Skin colour saturation,534
20,Other cataract,232
20,Basophil count,94605
20,Electrocardiogram morphology (amplitude at temporal datapoints) [192 ms],24799
20,Ceramide levels (C22:0),217
20,Triglycerides [EA],3039
20,Disorders related to length of gestation and fetal growth,10
20,High density lipoprotein cholesterol levels,138757
20,Cutaneous melanoma or hair colour,1266
20,Urea levels,1063
20,Ceramide_42:1_[M+H]1+ levels,237
20,Orofacial clefts [Asian],3
20,Protein quantitative trait loci (liver) [EIF2B1],18
20,Educational attainment (years of education),42430
20,Naratriptan | treatment/medication code,141
20,Neutrophil percentage of white cells,45199
20,Driving (hours per day),1393
20,"""Diseases of arteries, arterioles and capillaries""",53
20,Non-glioblastoma glioma,20049
20,"""Diabetes, insuline treatment (Kela reimbursement) (more control exclusions)""",1581
20,Electrocardiogram morphology (amplitude at temporal datapoints) [76 ms],4984
20,Obesity-related traits [Sedentary&light activity ],266
20,Serum 25-Hydroxyvitamin D level variance,56
20,Sphingomyelin_40:2_[M+H]1+ levels,217
20,Basophil percentage of granulocytes,5238
20,Myocardial infarction,7384
20,Blood urea nitrogen levels,5608
20,HDL cholesterol levels x long total sleep time interaction (2df test),3039
20,Serum metabolite levels [XL_HDL_PL],3039
20,Chronic obstructive pulmonary disease,1006
20,CD27 on memory B cell,1341
20,Monocyte percentage of white cells,95602
20,"Blood protein levels [TNFRSF6B, 5070_76_3]",16656
20,Metabolite levels [HexCer d16:1/22:0],217
20,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)",12958
20,"Heel quantitative ultrasound index (qui), direct entry (left)",25441
20,Subjective wellbeing conditioned on cognitive performance (multi-trait conditioning and joint analysis),19900
20,Hair shape,4126
20,Longest period of unenthusiasm / disinterest,27
20,Protein C levels [AA],34583
20,Senile cataract,464
20,Thrombomodulin levels,4637
20,Varicose veins,2293
20,Serum levels of protein CCDC126,3039
20,Metabolite levels [Cer d16:1/16:0],217
20,Nicotine dependence,9964
20,Red blood cell (erythrocyte) count,47269
20,Hyperplasia of prostate,822
20,"Blood protein levels [KIF3A, 13961_18_3]",99
20,Protein quantitative trait loci (liver) [SERPINA1],27
20,"""Benign neoplasm of colon, rectum, anus and anal canal""",12803
20,Smoking cessation,1088
20,CD27 on switched memory B cell,1341
20,"Blood protein levels [BPIFB1, 11246_3_3]",793
20,Depressive symptoms (MTAG),25171
20,Peak expiratory flow,65959
20,3mm weak meridian (right),46223
20,Heart rate,1123
20,Migraine and/or diastolic blood pressure,398
20,Electrocardiogram morphology (amplitude at temporal datapoints) [118 ms],4984
20,Protein quantitative trait loci (liver) [AZGP1],5
20,A body shape index,27472
20,Diabetes diagnosed by doctor,6592
20,Nose morphology [Nasal width],835
20,"""UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)""",34
20,Freckles,20045
20,Psychological distress,9952
20,"""Hypertension complicating pregnancy, childbirth, and the puerperium""",1839
20,Coffee intake,1390
20,Refractive error,101056
20,PR interval,8345
20,Actinic keratosis,2031
20,Leukocyte telomere length,16089
20,Levocetirizine | treatment/medication code,533
20,Caffeine consumption from tea,1088
20,Serum metabolite ratios in chronic kidney disease [Sphingomyelin with acyl residue sum C24:1/Sphingomyelin with acyl residue sum C26:1],217
20,Glycine levels,41
20,Protein quantitative trait loci (liver) [GALE],9
20,Hypertension (SNP x SNP interaction),13
20,Retinal nerve fibre layer (RNFL) thickness,1
20,Trochanter size,24071
20,Protein quantitative trait loci (liver) [FHL1],532
20,Autism spectrum disorder or schizophrenia,4785
20,Blood protein levels [TM],236
20,Spleen volume,101
20,Ceramide_42:1_[M-H]1- levels,217
20,Skin changes due to chronic exposure to nonionizing radiation,647
20,Sunburns,15958
20,Electrocardiogram morphology (amplitude at temporal datapoints) [198 ms],19815
20,Serum levels of protein CPXM1,4193
20,Macular thickness,2035
20,Osteoarthritis,24269
20,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant III (Mandible), Segment 26]",649
20,"Lipid metabolism phenotypes [HDL.large, whole]",3039
20,Eczema or dermatitis,18509
20,"High cholesterol | non-cancer illness code, self-reported",5800
20,"Hypertension | non-cancer illness code, self-reported",11297
20,C-reactive protein levels or LDL-cholesterol levels (pleiotropy),20
20,Chronic obstructive pulmonary disease or high blood pressure (pleiotropy),3768
20,QT dynamics during exercise,1052
20,"Heel quantitative ultrasound index (qui), direct entry",54958
20,Brain region volumes [right pallidum],19889
20,Triacylglycerol_49:5_[M+NH4]1+ levels,217
20,Vitamin K-dependent protein C measurement,57795
20,Serum levels of protein PI3,18849
20,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),1202
20,Phosphatidylcholine-O_30:1_[M+H]1+/Phosphatidylcholine-P_30:0_[M+H]1+/Phosphatidylethanolamine-O_33:1_[M+H]1+ levels,217
20,Low tan response,1872
20,CAG-485 sp002362485 abundance in stool,39
20,"Blood protein levels [CTSZ, 4971_1_1]",25
20,Inflammatory bowel disease [EA],14358
20,Brainstem volume,5211
20,Serum metabolite levels (CMS) [XL_HDL_CE],3039
20,Birth weight (MTAG),1927
20,Ceramide levels [N24DS19],217
20,"Hearing loss, difficulty in hearing",16
20,CD27 on unswitched memory B cell,1341
20,Other malignant neoplasms of skin (=non-melanoma skin cancer) (controls excluding all cancers),6145
20,"Allergy, hypersensitivity or anaphylaxis",301
20,Atrial fibrillation [EA],121
20,Metabolic disorders,7
20,Serum uric acid levels,39224
20,Plays computer games,346
20,LDL cholesterol x physical activity interaction (2df test),4407
20,Protein quantitative trait loci [CYTD],901
20,"""Articial joint operation, menisceal resection""",14244
20,Cortical surface area [Superior Parietal],1341
20,Diseases of the eye and adnexa,232
20,Atrial fibrillation and flutter,1216
20,Protein quantitative trait loci (liver) [S100A9],38
20,Brown vs. black hair color,2180
20,Medication use (HMG CoA reductase inhibitors),16394
20,"""Atopic dermatitis, strict definition with reimbursement""",25833
20,"Orofacial clefts [Meta-All, NSCL/P]",113
20,Lymphocyte counts,521484
20,Usual walking pace,21576
20,Heme oxygenase 1 measurement,25307
20,Suicide attempts [model 2],330
20,Pulse rate,1857
20,Monobrow,2749
20,Tobacco use disorder,699
20,Sphingomyelin_39:2_[M+H]1+ levels,217
20,Sotalol | treatment/medication code,339
20,Ossification of the posterior longitudinal ligament of the spine,600
20,Glioblastoma (age-stratified) [Below median age-at-diagnosis],20049
20,TPE interval (resting) [women],5293
20,Body size at age 10,2221
20,Serum levels of protein PSAPL1,3039
20,Glucose levels,10165
20,Tea consumption,673
20,Place of birth in uk - north co-ordinate,459
20,Worrier / anxious feelings,10221
20,Electrocardiogram morphology (amplitude at temporal datapoints) [236 ms],19115
20,Experiencing mood swings,1766
20,Brain region volumes [right ventral DC],603
20,Leiomyoma of uterus,377
20,"Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event) [Co-Dominant, Mixture cure model]",43
20,Loneliness (MTAG),19589
20,Blood protein levels [Cystatin-F],8571
20,Electrocardiogram morphology (amplitude at temporal datapoints) [164 ms],24799
20,Metabolite levels [Cer d18:1/23:0],217
20,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),1341
20,Ceramide levels [CER(40:1;2],217
20,Liver enzyme levels (alkaline phosphatase),137841
20,Balding type 1,18472
20,Protein quantitative trait loci [CPNE1],100263
20,Insomnia [Female],1990
20,Hip circumference,74834
20,"Forced expiratory volume in 1-second (fev1), predicted",49871
20,CD27 on IgD- CD38- B cell,1341
20,Stem cell factor levels,10170
20,"Sphingomyelin (d18:1/22:1, d18:2/22:0, d16:1/24:1) levels",537
20,Ceramide levels [N22S19],217
20,COPD (mode),362
20,Breakfast skipping,384
20,Gastroesophageal reflux disease,97
20,Disorders of lipoprotein metabolism and other lipidaemias,7
20,Abnormal involuntary movements,5
20,HDL cholesterol x physical activity interaction (2df test),2545
20,Psoriasis or type 2 diabetes (trans-disease meta-analysis)(opposite effect),6293
20,TestASV_38 (Ruminococcus) prevalence,3991
20,Hair morphology traits [Hair loss pattern at 40 (categorical],1362
20,Menarche (age at onset),55825
20,Mean corpuscular volume,370267
20,Brain region volumes [left caudate],19889
20,Irritable mood,13271
20,Presence of other functional implants,295
20,Type 2 diabetes [Greater Middle Eastern],129
20,Autoimmune traits,107
20,Ceramide(40:2)_[M-H]1- levels,212
20,Age of smoking initiation (MTAG),30601
20,Sphingomyelin(38:1)_[M+CH3]1- levels,1224
20,Electrocardiogram morphology (amplitude at temporal datapoints) [158 ms],24099
20,Mean corpuscular hemoglobin concentration,17191
20,Electrocardiogram morphology (amplitude at temporal datapoints) [160 ms],6107
20,Lung function (FVC) [EA],191
20,Metabolite levels [HexCer d16:1/16:0],212
20,Cholelithiasis or gall stones,20
20,Protein C levels [EA],53760
20,Bipolar disorder or major depressive disorder,1156
20,Metabolic syndrome,5001
20,Fasting blood glucose (BMI interaction),387
20,IFN-related cytopenia [IFN-related thrombocytopenia at wk 4],33319
20,Intelligence (MTAG),31397
20,Other joint disorders,11250
20,Electrocardiogram morphology (amplitude at temporal datapoints) [128 ms],4984
20,DNA methylation variation (age effect),1768
20,Neonatal white matter microstructure,452
20,Average monthly fortified wine intake,18
20,Coagulation factor VII measurement,37786
20,Cystatin C levels,20746
20,High blood pressure | illnesses of mother,3819
20,"""Atopic  dermatitis, strict definition""",22280
20,Reticulocyte percentage,4704
20,Skin cancer,17893
20,Heel bone mineral density (bmd) (right),25346
20,Facial morphology (segment 1),11582
20,Facial ageing,5878
20,Urate levels,189793
20,Spherical power (right),43456
20,6mm weak meridian (left),43977
20,Benign neoplasm of adrenal gland,2769
20,Trunk fat mass adjusted for trunk lean mass,454
20,Colorectal cancer [EA],10359
20,Major depressive disorder,18109
20,3mm strong meridian (left),98582
20,Colorectal polyp and colorectal cancer (MTAG) [Colorectal polyp],752
20,Serum metabolite levels [myristoyl dihydrosphingomyelin (d18:0/14:0)*],197
20,Ceramide_40:1_[M-H]1- levels,217
20,Serum levels of protein AKT2,99
20,Cardioembolic stroke (CCS and TOAST classification),95048
20,Insulin-like growth factor 1 levels,44851
20,Verbal-numerical reasoning,18327
20,Glycated hemoglobin levels,2780
20,"Icd10: c71.9 brain, unspecified | underlying (primary) cause of death",240
20,Cataracts (operation),250
20,Mean corpuscular hemoglobin,319953
20,Ease of skin tanning,55773
20,"Heel bone mineral density (bmd) t-score, automated (left)",6551
20,Calculus of kidney and ureter,23
20,Serum levels of protein POFUT1,137
20,Rheumatoid arthritis,25426
20,Age at menopause,30250
20,Electrocardiogram morphology (amplitude at temporal datapoints) [182 ms],24799
20,Never | smoking status,14843
20,Liver enzyme levels (gamma-glutamyl transferase),8079
20,Gut microbiota relative abundance (bacterial taxa) [Lactivibrio],540
20,Number of self-reported cancers,635
20,Bilirubin levels,58876
20,"Blood protein levels [TMED10, 6506_54_3]",8063
20,Adult diffuse glioma (IDH wildtype),18646
20,Triglycerides x physical activity interaction (2df test),196
20,Ceramide(40:0)_[M-H]1- levels,205
20,Creatinine levels,152142
20,Serum metabolite levels [XL_HDL_P],3039
20,Heel bone mineral density (bmd),54934
20,Depressed affect,1539
20,Educational attainment (years of education) [conditional-joint],4433
20,Ceramide levels [N24S20],217
20,Hyperuricemia,229
20,Insomnia,9709
20,Smoking initiation (ever regular vs never regular) [Conditioned on chr20:31175258],649
20,Autoimmune thyroid disease,235
20,Neurociticism,13742
20,"""Hypothyroidism, strict autoimmune, 3 medication purchases required""",1175
20,Atrial fibrillation,630
20,Hyperlipidemia,4349
20,Age when periods started (menarche),5258
20,Frequency of needing morning drink of alcohol after heavy drinking session in last year,95
20,Ulcerative colitis [EA],20421
20,Congenital left-sided heart lesions,19919
20,Brain morphology (MOSTest),175977
20,Forced expiratory volume in 1-second (fev1),90008
20,Type 2 diabetes without complications,102
20,"""Type 2 diabetes, wide definition""",159
20,Angina,18161
20,6mm strong meridian (left),46675
20,Bipolar I disorder,10200
20,Serum metabolite levels [XL_HDL_C],3039
20,CD40 on CD14+ CD16+ monocyte,881
20,Inflammatory bowel disease,71299
20,Gonarthrosis,11748
20,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],3076
20,"Rectal or colon adenoma/polyps | non-cancer illness code, self-reported",579
20,Malaise and fatigue,134
20,Inguinal hernia,96
20,Serum levels of protein YWHAB,7711
20,Femur bone mineral density x serum urate levels interaction,9375
20,Dermatitis and eczema,25399
20,Bipolar disorder vs major depressive disorder (ordinary least squares (OLS)),7078
20,Metabolite levels [SM d16:1/24:0],212
20,Electrocardiogram morphology (amplitude at temporal datapoints) [156 ms],24099
20,Electrocardiogram morphology (amplitude at temporal datapoints) [190 ms],24799
20,Fasting blood glucose,1301
20,Mitochondrial DNA levels,6079
20,Metabolite levels [SM d16:1/24:1],212
20,Depressive symptoms,53455
20,Pulse pressure,44194
20,Arthropathy nos,24071
20,"""Type 2 diabetes, definitions combined, including avohilmo""",102
20,Cholelithiasis and cholecystitis,20
20,Colorectal cancer,117949
20,Skin colour,54500
20,IgD- CD27- B cell %lymphocyte,1341
20,Tanning,10004
20,Serum levels of protein IL15,99
20,Electrocardiogram morphology (amplitude at temporal datapoints) [238 ms],19115
20,Contracture of palmar fascia [dupuytren's disease],746
20,Mitochondrial heteroplasmy measurement,19
20,Hernia,11
20,Serum levels of protein PROC,75224
20,Facial pigmentation,534
20,Serum levels of protein TP53,99
20,Sex hormone-binding globulin levels adjusted for BMI,241318
20,Plasma cystastin c levels in acute coronary syndrome,7153
20,Serum levels of protein TNF,99
20,Myeloid white cell count,193
20,Place of birth in uk - east co-ordinate,4
20,Serum levels of protein SPINT3,47761
20,Chronic kidney disease [eGFRcys],8115
20,LDL cholesterol levels in current drinkers,251
20,Electrocardiogram morphology (amplitude at temporal datapoints) [234 ms],19115
20,Diastolic blood pressure [East Asian],399
20,Cognitive aspects of educational attainment,30147
20,Unstable angina (intermediate coronary syndrome),525
20,No | ever had refractive laser eye surgery,235
20,"Allergic disease (asthma, hay fever or eczema)",58925
20,Marginal zone lymphoma or multiple sclerosis,2579
20,Blood protein levels [CD40],1341
20,Waist-to-hip ratio adjusted for BMI,147158
20,"Blood protein levels [DPYSL2, 13567_1_3]",99
20,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),3076
20,Serum levels of protein ANKRD46,99
20,Gallbladder disease,20
20,Highest math class taken (MTAG) [MTAG],127907
20,Estimated glomerular filtration rate [EA],11692
20,Lercanidipine | treatment/medication code,875
20,Water intake,51882
20,Ankle spacing width,120366
20,Thyrotoxicosis with diffuse goitre,1341
20,Serum metabolite levels [HDL_D],3039
20,Serum metabolite levels (CMS) [XL_HDL_C],3039
20,Moyamoya disease,7
20,"""Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8""",20
20,Body fat distribution (trunk fat ratio),24186
20,"Hepatitis a | non-cancer illness code, self-reported",26
20,Pulse wave arterial stiffness index,193
20,Membrane-bound aminopeptidase P levels,20
20,Whole body water mass,95105
20,Colorectal cancer (oestrogen-progestogen hormone therapy interaction) [Empirical Bayes],1004
20,"""Cholelithiasis, broad definition with cholecystitis""",237
20,Ceramide(41:1)_[M-H]1- levels,212
20,Serum levels of protein MB,99
20,Hypertension,27988
20,High blood pressure | illnesses of siblings,5344
20,"Red blood cell traits [EA, MCV]",69
20,Triglyceride levels x long total sleep time interaction (2df test),501
20,Weight,591909
20,Waist circumference,237884
20,Infant head circumference (MTAG),16981
20,Job involves mainly walking or standing,1475
20,"Blood protein levels [CST1, 5459_33_3]",1435
20,Ribavirin-induced anemia,1021
20,Serum levels of protein CBLN4,418
20,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Hispanic],37
20,Sphingolipid levels [Hydroxysphingomyeline C24:1],217
20,Serum metabolite levels (CMS) [L_HDL_CE],3039
20,"Forced vital capacity (fvc), best measure",134581
20,Preeclampsia (maternal genotype effect),4006
20,Triglyceride levels x short total sleep time interaction (2df test),3719
20,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],3039
20,Electrocardiogram morphology (amplitude at temporal datapoints) [-94 ms],289
20,Diastolic blood pressure (cigarette smoking interaction),3404
20,Oily fish consumption,51651
20,Overall health rating,1732
20,Estradiol levels,130
20,"Systolic blood pressure x alcohol consumption interaction (2df test) [Asian, EA]",1069
20,Bowel cancer | illnesses of father,12803
20,Metabolite levels [Cer d18:2/24:0],217
20,Kidney stones,110
20,Granulocyte percentage of myeloid white cells,19150
20,Lymphocyte percentage,144878
20,Serum metabolite levels (CMS) [S_HDL_FC],3039
20,First line medication for Crohns disease,13710
20,Electrocardiogram morphology (amplitude at temporal datapoints) [360 ms],1123
20,Type 2 diabetes or prostate cancer (pleiotropy),19170
20,Neuroblastoma (pediatric),2234
20,"Migraine | non-cancer illness code, self-reported",387
20,Aortic root size,370
20,Pulse pressure [East Asian],523
20,Cataract,266
20,Ebbinghaus illusion (overestimation),415
20,"Serum metabolite levels [sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2)*]",204
20,Sphingomyelin_38:1_[M+OAc]1- levels,217
20,Standing height,293665
20,Headache | pain type(s) experienced in last month,16844
20,Fish- and plant-related diet,2042
20,Ceramide levels [N23S20],217
20,Number of treatments/medications taken,22112
20,Hip circumference adjusted for BMI [EA],133513
20,"Blood protein levels [EA, Cystatin-C]",7457
20,Facial morphology (nostril size),396
20,Bipolar disorder (MTAG),1518
20,Protein quantitative trait loci (liver) [ACSM2A],1
20,Red blood cell count,430959
20,IgD- CD27- B cell %B cell,1341
20,"Blonde | hair colour (natural, before greying)",45556
20,Caudate nucleus volume,18689
20,Neutrophill count,18910
20,Type 2 diabetes [conditional],2860
20,Fasting plasma glucose,984
20,Rheumatic valve diseases,21
20,Myopia (age of diagnosis),15
20,Diaphragmatic hernia,24269
20,Benign neoplasm: Colon (controls excluding all cancers),11566
20,Serum levels of protein COLEC12,972
20,Pancreatic cancer,141
20,Cardiorespiratory fitness (vo2 max),1123
20,Electrocardiogram morphology (amplitude at temporal datapoints) [-96 ms],289
20,Menarche and menopause (age at onset) [age at natural menopause],18
20,Erosive tooth wear (severe vs non-severe) [male],162
20,Pallidum volume,19889
20,HDL cholesterol levels,180324
20,Fat-free mass [male],31742
20,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),3235
20,Waist-to-hip ratio adjusted for body mass index [women],157
20,Sum neutrophil eosinophil counts,20
20,Protein quantitative trait loci (liver) [ORM1],1
20,Alzheimer's disease or family history of Alzheimer's disease,2907
20,Electrocardiogram morphology (amplitude at temporal datapoints) [202 ms],24799
20,Haemorrhoidal disease,1428
20,Diffuse plaques (SNP x SNP interaction),3180
20,"""Hypothyroidism, strict autoimmune""",1175
20,Glaucoma (multi-trait analysis),1682
20,Facial morphology (segment 11),1145
20,"Blood protein levels [LBP, 3074_6_2]",99
20,"Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",844
20,Electrocardiogram morphology (amplitude at temporal datapoints) [142 ms],4984
20,Chin dimples,1680
20,Testicular germ cell tumor,22
20,Brain region volumes [right putamen],19889
20,Menopause (age at onset) [japanese],1645
20,Cardiovascular diseases,3772
20,Serum metabolite levels (CMS) [L_HDL_PL],3039
20,Longest period of depression,32
20,Gamma glutamyl transferase levels,67130
20,"Forced expiratory volume in 1-second (fev1), best measure",88780
20,Electrocardiogram morphology (amplitude at temporal datapoints) [286 ms],1123
20,Serum levels of protein BPI,3449
20,Eosinophill percentage,2498
20,Galectin-3-binding protein measurement,639
20,Nontoxic nodular goiter,1175
20,Schizophrenia or delusion (more control exclusions),4
20,Household income,1936
20,Heel bone mineral density T score,62340
20,Adult diffuse glioma (TERT mutation only),18646
20,"Blood pressure medication | medication for cholesterol, blood pressure or diabetes",10998
20,Pattern 2 | hair/balding pattern,1432
20,Other heart diseases,3789
20,"None of the above | medication for cholesterol, blood pressure or diabetes",5957
20,Red cell distribution width,254078
20,Haemoglobin concentration,25519
20,Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event) [Cox proportional hazards regression model],7
20,Serum metabolite ratios in chronic kidney disease [Hydroxysphingomyelin with acyl residue sum C16:1/Sphingomyelin with acyl residue sum C16:1],217
20,Waist-hip ratio,116172
20,Trunk fat mass,198084
20,Electrocardiogram morphology (amplitude at temporal datapoints) [314 ms],1123
20,circulating leptin levels adjusted for BMI,1731
20,Current tobacco smoking,465
20,Diseases of male genital organs,12
20,Femoral neck size,23344
20,Sleep apnoea,1022
20,Mean corpuscular haemoglobin concentration,1138
20,Serum levels of protein KIF3A,99
20,Hedonic well-being,20149
20,Polycystic ovary syndrome,14115
20,FEV1,81620
20,Low hand grip strength (60 years and older) (EWGSOP),14497
20,Electrocardiogram morphology (amplitude at temporal datapoints) [154 ms],19115
20,Impedance of arm (right),27997
20,Serum levels of protein NR3C2,1084
20,Relative age of first facial hair,2045
20,"Blood protein levels [YWHAB, 14156_33_3]",7059
20,Gamma-glutamylleucine levels,3452
20,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Asian],3039
20,Getting up in morning,89
20,Cough on most days,142
20,LDL cholesterol,131064
20,Eosinophil percentage of granulocytes,1007
20,Blood metabolite levels [X-08402],217
20,Nose morphology [Subnasal width],481
20,Phosphatidylglycerol-O_40:0_[M-H]1- levels,217
20,Cognitive ability (MTAG),24399
20,Trunk fat-free mass,115063
20,"Forced expiratory volume in 1-second (fev1), predicted percentage",17023
20,Triacylglycerol_49:4_[M+NH4]1+ levels,217
20,Ease of getting up in the morning,12492
20,Gastric cancer,13025
20,Breakfast cereal skipping frequency,384
20,Eosinophil counts,71930
20,Kawasaki disease,11910
20,CD27 on IgD- CD38dim B cell,1341
20,Ceramide levels [S20Sum],217
20,Chronic kidney disease,163
20,Serum metabolite levels [N1-methyladenosine],1296
20,Methylmalonate (mma) levels,1474
20,Serum levels of protein EIF5A2,99
20,Lymphocyte percentage of white cells,190968
20,Meniscus derangement,12449
20,Spherical equivalent or myopia (age of diagnosis),10021
20,Cardiovascular disease,13966
20,"Blood protein levels [EA, Copine-1]",6631
20,"Blood protein levels [CPXM1, 6255_74_3]",1084
20,Tuberculosis,85
20,Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test),44951
20,Serum metabolite levels (CMS) [S_HDL_L],3039
20,Atopic asthma,117
20,Alcohol consumption (drinks per week) (MTAG),11398
20,Blood glucose levels,19453
20,Phosphatidylcholine-O(36:1)_[M+H]1+/Phosphatidylethanolamine-O(39:1)_[M+H]1+/Phosphatidylcholine-P(36:0)_[M+H]1+ levels,192
20,Household income (MTAG),2134
20,Electrocardiogram morphology (amplitude at temporal datapoints) [352 ms],1123
20,Ceramide(41:0)_[M-H]1- levels,212
20,Lymphocyte-to-monocyte ratio,24573
20,Deep venous thrombosis,37724
20,"Blood protein levels [WFDC5, 6969_14_3]",2795
20,Squamous cell carcinoma,743
20,"Blood protein levels [LYPD3, 9307_3_3]",99
20,C-reactive protein levels or triglyceride levels (pleiotropy),3039
20,Leg fat mass (right),126065
20,"Pulse rate, automated reading",10535
20,Fasting blood glucose adjusted for BMI [Pomak],564
20,Leg fat mass (left),124317
20,Protein quantitative trait loci (liver) [TPM4],532
20,Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy) [Hispanic],132
20,Schizophrenia,54521
20,Cerebrospinal fluid biomarker levels [Bactericidal permeability-increasing protein],589
20,Gut microbiota (beta diversity),2860
20,"Blood protein levels [EA, Cystatin-SN]",1395
20,Orofacial clefts,70
20,Autism [Str],135
20,Protein quantitative trait loci (liver) [ISOC2],31
20,Knee pain | pain type(s) experienced in last month,24071
20,Bone mineral density [lumbar spine],243
20,Dyslipidemia,303
20,Ankle spacing width (right),36117
20,Age-related disease endophenotypes,5174
20,Coronary revascularization (ANGIO or CABG),126
20,Metabolite levels [SM d16:1/20:0],212
20,Alzheimer's disease (cognitive decline),190
20,Vertex-wise cortical thickness,212478
20,Mitochondrial DNA copy number,4869
20,"Blood protein levels [EA, Cystatin-F]",999
20,"Blood protein levels [MMP9, 2579_17_5]",308
20,Hematocrit,223522
20,Haematocrit percentage,35766
20,Cortical surface area [Inferior Parietal],1427
20,"Blood protein levels [CST2, 4324_33_2]",1435
20,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),3076
20,Serum levels of protein SIRPB1,2865
20,Serum levels of protein SLPI,1515
20,Fasting glucose adjusted for BMI,453
20,Knee pain,30553
20,Walking pace,27457
20,Fasciitis,504
20,"Kidney stone/ureter stone/bladder stone | non-cancer illness code, self-reported",23
20,Hypertensive diseases,5078
20,Metabolite levels [Cer d16:1/24:0],217
20,Pre-treatment viral load in HIV-1 infection,186
20,Serum parathyroid hormone levels,79
20,Body fat distribution (trunk fat ratio) [females],24885
20,Serum metabolite levels (CMS) [XL_HDL_FC],3039
20,Electrocardiogram morphology (amplitude at temporal datapoints) [298 ms],1123
20,Subcortical volume (MOSTest),161526
20,Alanine aminotransferase levels,191840
20,Monocyte percentage,24302
20,Simvastatin | treatment/medication code,5637
20,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),253
20,Glioma (high-grade),40636
20,Anthropometric traits [height],24071
20,Lung function (FVC) and waist to hip ratio adjusted for BMI [East Asian],24157
20,"Malignant melanoma | cancer code, self-reported",312
20,"Blood protein levels [EIF5A2, 11355_10_3]",99
20,Gut microbiota (bacterial taxa) [Clostridium_amygdalinum],335
20,Self-reported math ability (MTAG) [MTAG],26009
20,Estimated glomerular filtration rate in non-diabetics,16514
20,Neutrophil-to-lymphocyte ratio,1799
20,Electrocardiogram morphology (amplitude at temporal datapoints) [228 ms],19115
20,Glioblastoma [females],20049
20,Electrocardiogram morphology (amplitude at temporal datapoints) [110 ms],4984
20,Facial morphology (brow ridge protrusion 3),523
20,Urolithiasis,766
20,CD20 on IgD- CD27- B cell,1341
20,Distance between home and job workplace,145
20,"""Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified""",183
20,Sphingomyelin_32:1_[M+OAc]1- levels,217
20,Metabolite levels [Cer d16:1/20:0],212
20,Other arthropathies,24071
20,"Deep venous thrombosis (dvt) | non-cancer illness code, self-reported",33755
20,Electrocardiogram morphology (amplitude at temporal datapoints) [322 ms],1123
20,Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis),340
20,Total body bone mineral density,362
20,Body fat mass,124
20,Blood cell traits (multivariate analysis),24
20,Inverse distance to the nearest major road,7
20,LDL cholesterol levels x short total sleep time interaction (2df test),3909
20,Hand grip strength,864
20,Keratoconus,2120
20,Chlamydia trachomatis momp D antibody levels,448
20,Triacylglycerol_45:4_[M+NH4]1+ levels,217
20,Coronary angiopasty,126
20,Schizophrenia vs ADHD (ordinary least squares (OLS)),12484
20,Feeling fed-up,7768
20,Vitamin D insufficiency,365
20,Malignant neoplasm,1885
20,"Blood protein levels [CST7, 3302_58_1]",705
20,HDL cholesterol levels [EA],3076
20,Optic cup area,1342
20,Unswitched memory B cell %lymphocyte,1341
20,Glutamine levels,648
20,Photic sneeze reflex,1123
20,Granulocyte count,17372
20,Arm predicted mass (left),114397
20,"Lipid metabolism phenotypes [HDL.mean.size, fasting]",3039
20,Serum levels of protein SIRPG,442
20,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [AA],3039
20,Left–right brain asymmetry,47
20,CD40 levels,1341
20,"Blood protein levels [CST4, 14076_74_3]",3094
20,Aspartate aminotransferase to alanine aminotransferase ratio,1718
20,Sum basophil neutrophil counts,16368
20,"Ulcerative colitis | non-cancer illness code, self-reported",3494
20,Sphingomyelin_32:1_[M+H]1+ levels,217
20,"Blood pressure medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",11612
20,"Number of decayed, missing and filled tooth surfaces or use of dentures",141
20,Urinary calcium excretion,55
20,Diseases of the musculoskeletal system and connective tissue,10
20,Male puberty timing (age at voice breaking MTAG),9049
20,"Systolic blood pressure, automated reading",6425
20,Oil of peppermint | treatment/medication code,134
20,Lung function (low FEV1 vs high FEV1),118
20,Serum levels of protein FLRT3,111
20,"Waist circumference adjusted for body mass index [EA, men]",111
20,Factor VII activity [EA],36906
20,Leg predicted mass (left),105150
20,Average total household income before tax,9568
20,Protein quantitative trait loci (liver) [FBLN1],532
20,Age first had sexual intercourse,6595
20,Proinsulin levels,509
20,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction),111
20,Metabolite levels [Cer d18:1/22:0],217
20,Metabolite levels [HexCer d16:1/24:0],217
20,Red vs. non-red hair color,20045
20,Cerebrospinal fluid biomarker levels [Cystatin-SN],2017
20,Electrocardiogram morphology (amplitude at temporal datapoints) [200 ms],24799
20,C-reactive protein levels or HDL-cholesterol levels (pleiotropy),3059
20,Serum metabolite levels (CMS) [S_HDL_P],3039
20,"Basal cell carcinoma | cancer code, self-reported",2083
20,Gestational [pregnancy-induced] hypertension,17
20,Bipolar disorder,21445
20,Ceramide_42:1_[M+H-H2O]1+ levels,217
20,"Blood protein levels [IL15, 10795_32_3]",99
20,Protein quantitative trait loci (liver) [ASMTL],13
20,Worry too long after embarrassment,5407
20,Comparative body size at age 10,2854
20,Amyotrophic lateral sclerosis,2718
20,Metabolite levels (lipoprotein measures) [Phospholipids in very small VLDL],7
20,Fat-free mass [female],24071
20,Hay fever and/or eczema,18623
20,Protein quantitative trait loci (liver) [COL18A1],5732
20,Brain imaging measurements (variance) [mean cortical thickness variance],474
20,Thyroid problem (not cancer),285
20,Self-reported allergy,213
20,Cleft lip with or without cleft palate,70
20,Glioblastoma (age-stratified) [Median age-at-diagnosis],20049
20,Body fat distribution (arm fat ratio) [males],814
20,Blood protein levels [Cystatin-SA],1530
20,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C40:2/Phosphatidylcholine with acyl-alkyl residue sum C42:3],217
20,Cataracts [female],284
20,Protein quantitative trait loci (liver) [SERPINF1],27
20,Hand grip strength (right),44733
20,Neutrophill percentage,38324
20,Mean arterial pressure,15024
20,"Hypothyroidism/myxoedema | non-cancer illness code, self-reported",325
20,Sphingolipid levels [Cer24:0],217
20,TPE interval (resting),95549
20,White | bread type,4656
20,Serum metabolite levels (CMS) [S_HDL_PL],3039
20,Appendicular lean mass,964054
20,Invasive breast cancer [mixed effect],459
20,Serum levels of protein RSPO4,353
20,Phlebitis and thrombophlebitis,12098
20,Electrocardiogram morphology (amplitude at temporal datapoints) [166 ms],24799
20,Electrocardiogram morphology (amplitude at temporal datapoints) [218 ms],19815
20,Cheese intake,1512
20,Sphingomyelin(32:1)_[M+H]1+ levels,212
20,Cigarettes smoked per day (current),105
20,Facial morphology (segment 36),30
20,Waist-to-hip ratio adjusted for BMI in active individuals [EA],48422
20,Nonalcoholic fatty liver disease (imputed),209
20,Problematic alcohol use (MTAG),8142
20,Iron status biomarkers (total iron binding capacity),2499
20,Metabolite levels [Cer d18:1/25:0],217
20,Serum levels of protein LYPD3,99
20,Cortical surface area (MOSTest),12936
20,Wheeze or whistling in the chest in last year,20547
20,Serum total protein level,31173
20,Serum levels of protein EMILIN3,837
20,Cardiorespiratory fitness slope,643
20,Life satisfaction,597
20,B cell lymphocyte profile difference,7
20,Cranial base width,400
20,Smoking cessation (MTAG),21948
20,LDL cholesterol levels,216112
20,Phlebitis and thrombophlebitis of lower extremities,11939
20,Ulcerative colitis,10441
20,Ever worried more than most people would in similar situation,3023
20,Doctor diagnosed hayfever or allergic rhinitis,292
20,"Blood protein levels [WISP2, 6392_7_3]",1709
20,Total testosterone levels,32490
20,Serum albumin levels,53346
20,Red vs. brown/black hair color,534
20,Fibroblast growth factor 23 levels,669
20,Electrocardiogram morphology (amplitude at temporal datapoints) [88 ms],4984
20,Heel bone mineral density (bmd) (left),7826
20,Impedance of leg (right),89195
20,Pulmonary heart disease,1740
20,Male-pattern baldness [males],1362
20,"Waist circumference adjusted for body mass index [EA,women]",111
20,Whole body fat-free mass,96955
20,Number of vehicles in household,19938
20,Protein levels in obesity [LBP],42
20,General episode | hospital episode type,11
20,Cleft lip with or without cleft palate [Asian],3
20,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) [subset analysis]",24902
20,Total cholesterol levels,122202
20,Educational attainment (MTAG) [MTAG],54609
20,Electrocardiogram morphology (amplitude at temporal datapoints) [174 ms],24799
20,Birth weight,59201
20,Subcortical volume (min-P),20029
20,Medication use (agents acting on the renin-angiotensin system),24444
20,Factor VII levels,37612
20,Electrocardiogram morphology (amplitude at temporal datapoints) [204 ms],24799
20,Peak expiratory flow (pef),55007
20,LDL cholesterol levels [Trans-ethnic initial],5571
20,Smoking initiation,4797
20,Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in non-secretors,109
20,Electrocardiogram morphology (amplitude at temporal datapoints) [34 ms],249
20,Electrocardiogram morphology (amplitude at temporal datapoints) [36 ms],249
20,Cataract | eye problems/disorders,232
20,Pure hypercholesterolaemia,7
20,Osteoarthritis (self-reported),24385
20,Tyrosine-protein phosphatase non-receptor type substrate 1 levels,23595
20,"Blood protein levels [CLPSL1, 9526_3_3]",699
20,Gut microbiota (functional units) [GO:0071805|BP|04|potassium ion transmembrane transport],462
20,Age started hormone-replacement therapy (hrt),18
20,Femur total bone mineral density x gut microbiota (﻿genus Lactococcus) interaction,11
20,Time from waking to first cigarette,200
20,Duration of light diy,39
20,Adult body size,18532
20,Phosphatidylcholine_36:7_[M+OAc]1-/Phosphatidylserine_40:6_[M-H]1- levels,116238
20,"""Other diabetes, wide definition""",1581
20,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C40:2/Phosphatidylcholine with acyl-alkyl residue sum C40:5],217
20,Lung function (FVC) in asthma,23
20,Statin medication,2734
20,Systolic blood pressure,107130
20,N-acetylglutamate levels,1802
20,Subjective wellbeing conditioned on self-rated math ability (multi-trait conditioning and joint analysis),19811
20,LDL cholesterol levels in current drinkers [EA],184
20,Rheumatoid arthritis (ACPA-positive),4023
20,Serum metabolite ratios in chronic kidney disease [Phosphatidylcholine with acyl-alkyl residue sum C36:0/Phosphatidylcholine with acyl-alkyl residue sum C40:2],217
20,Glomerular filtration rate (creatinine),29200
20,Whole body fat mass,145474
20,DVT of lower extremities,37947
20,Type 2 diabetes (adjusted for BMI),1710
20,Crohn's disease [EA],6561
20,Blood pressure [Mean Arterial Pressure],3950
20,Impedance of whole body,140380
20,Celiac disease,2650
20,Oxalate (ethanedioate) levels,3602
20,Malignant neoplasm of respiratory system and intrathoracic organs (controls excluding all cancers),362
20,Volumetric brain MRI [ATCBV],106
20,DNA methylation (variation) [NESPAS-ICR],193
20,Non-obstructive azoospermia,104
20,HDL cholesterol levels in current drinkers [Hispanic],37
20,Plateletcrit,145478
20,Disorders of lipoid metabolism,4439
20,Electrocardiogram morphology (amplitude at temporal datapoints) [350 ms],1123
20,Total body bone mineral density [European],275
20,Serum levels of protein LGALS3BP,299
20,White matter microstructure (axial diusivities) [Fornix (column and body],97
20,High blood pressure | illnesses of father,45
20,Malnutrition,27
20,Total bilirubin levels,10752
20,"Heel broadband ultrasound attenuation, direct entry",53053
20,Sphingomyelin_40:3_[M+OAc]1- levels,217
20,Sphingomyelin(32:1)_[M-CH3]1- levels,212
20,"Polycystic kidney | non-cancer illness code, self-reported",637
20,"Aging traits (healthspan, parental lifespan or longevity) (multivariate analysis)",4153
20,Brain region volumes [left pallidum],140508
20,Impedance of leg (left),95201
20,Sphingomyelin(39:1)_[M+H]1+ levels,212
20,Triglyceride levels in current drinkers [EA],3039
20,Creutzfeldt-Jakob disease (sporadic),810
20,Brain connectivity [Efficiency - R-paracentral],5
20,Headache,15176
20,Glycerophospholipid levels [Phosphatidylcholine acyl-alkyl C40:2],217
20,Sphingomyelin(43:2)_[M-CH3]1- levels,205
20,Metabolite levels (lipoprotein measures) [Concentration of small HDL particles],3039
20,Lung function (FEV1/FVC),171497
20,GDP-fucose protein O-fucosyltransferase 1 measurement,2222
20,Immature reticulocyte fraction,59539
20,"Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)",258
20,Serum creatinine levels,30652
20,General risk tolerance (MTAG),6435
20,Smoking behaviour (cigarette pack-years),900
20,Serum phosphate levels,20906
20,A levels/as levels or equivalent | qualifications,82
20,White matter microstructure (mode of anisotropy) [Cingulate gyrus],146
20,Basophill count,4106
20,Rosuvastatin | treatment/medication code,306
20,White matter microstructure (axial diusivities) [Cingulate gyrus],97
20,Ceramide_42:2_[M+H-H2O]1+ levels,237
20,Electrocardiogram morphology (amplitude at temporal datapoints) [-4 ms],6617
20,Ceramide levels [N26S19],217
20,"For short-sightedness, i.e. only or mainly for distance viewing such as driving, cinema etc (called 'myopia') | reason for glasses/contact lenses",78
20,Putamen volume,38603
20,C-reactive protein,115051
20,"Black | hair colour (natural, before greying)",87341
20,HDL cholesterol levels in current drinkers [EA],3076
20,Subjective wellbeing conditioned on average household income before tax (multi-trait conditioning and joint analysis),19940
20,Cortical volume [Inferior parietal],108
20,Lipid traits [LDL],244
20,Monoclonal gammopathy of undetermined significance,8578
20,Eye color (hue),12702
20,Electrocardiogram morphology (amplitude at temporal datapoints) [138 ms],4984
20,Antihypertensive medication - note that there are other indications,40240
20,None of the above | vascular/heart problems diagnosed by doctor,12072
20,Skin sensitivity to sun,20045
20,Glioma [females],20049
20,"Lipid metabolism phenotypes [HDL.mean.size, whole]",3039
20,Cortical thickness,178215
20,Other non-epithelial cancer of skin,3585
20,Serum levels of protein APMAP,5839
20,Electrocardiogram morphology (amplitude at temporal datapoints) [120 ms],4984
20,Systolic blood pressure x alcohol consumption interaction (2df test) [EA],2803
20,Holdemania abundance in stool,9
20,Basal cell carcinoma,108122
20,Schizophrenia [EA],7222
20,Electrocardiogram morphology (amplitude at temporal datapoints) [358 ms],1123
20,Corneal hysteresis (right),2019
20,Serum levels of protein HNRNPC,99
20,Chronotype,18149
20,"Systolic blood pressure [EA, initial]",3921
20,Blood protein levels [Cystatin-D],930
20,Electrocardiogram morphology (amplitude at temporal datapoints) [284 ms],1123
20,Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster)(time to event) [EA],55
20,Monocyte count,311559
20,"Heel bone mineral density (bmd) t-score, automated (right)",25346
20,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],3039
20,Urate levels [women],1794
20,CD40 on CD14- CD16+ monocyte,881
20,Subjective wellbeing conditioned on highest math class (multi-trait conditioning and joint analysis),19811
20,Meat-related diet [female],2544
20,Sphingomyelin_33:1_[M+H]1+ levels,217
20,Height [AA],24225
20,Body fat percentage,305079
20,Arm predicted mass (right),125759
20,Serum levels of protein DPYSL2,99
20,Arm fat mass (left),123892
20,Serum metabolite levels (CMS) [XL_HDL_PL],3039
20,Benign prostatic hyperplasia and lower urinary tract symptoms,97
20,"Hayfever, allergic rhinitis or eczema | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",19974
20,"Cholesterol lowering medication | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",6396
20,Heart transplant/surgery,871
20,Internal derangement of knee,24198
20,Electrocardiogram morphology (amplitude at temporal datapoints) [186 ms],24799
20,Chronic hepatitis B infection,4511
20,Parkinson's disease,2250
20,Urinary sodium excretion [EA],282
20,Uterine fibroids,282
20,Sphingolipid levels [Hydroxysphingomyeline C16:1],217
20,Mean corpuscular hemoglobin [Asian],47
20,Extremely high intelligence,19500
20,Apolipoprotein A1 levels,270259
20,Serum levels of protein CST4,3079
20,Serum metabolite levels [S_HDL_P],3039
20,"Hip circumference adjusted for BMI [EA, women]",24071
20,Hair color,18659
20,Brain region volumes [left entorhinal],24071
20,Myeloperoxidase levels,1228
20,Prothrombin time,52485
20,Age started wearing glasses or contact lenses,80353
20,Taking other prescription medications,5281
20,Brain region volumes [right inferior parietal],1927
20,Testosterone levels,7194
20,Ceramide levels [N24DS20],217
20,Anti-Mullerian hormone levels in pre-menopausal women of late reproductive age,18
20,Protein quantitative trait loci (liver) [CSTA],12
20,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)",28231
20,Immature fraction of reticulocytes,200844
20,Advanced age-related macular degeneration [EA],756
20,Spherical equivalent,20273
20,"Facial morphology traits (59 NSCL/P endophenotypic segments) [Quadrant III (Mandible), Segment 13]",649
20,Protein C levels,57749
20,Low hand grip strength (60 years and older) (FNIH),11978
20,Electrocardiogram morphology (amplitude at temporal datapoints) [4 ms],6617
20,Highest math class taken,5262
20,Late-onset Alzheimer's disease,1005
20,Noncognitive aspects of educational attainment,778
20,CD40 on monocytes,881
20,Femoral neck bone mineral density,1161
20,Serum levels of protein MATN4,3727
20,Body fat percentage and triglycerides (pairwise),196
20,Megamonas abundance in stool,31
20,"Waist-to-hip ratio adjusted for BMI in active individuals [EA, men]",48276
20,"Blood protein levels [EA, Elafin]",17536
20,Hypothyroidism (congenital or acquired),321
20,Metopic nonsyndromic craniosynostosis,1604
20,Ceramide levels [N24S19],217
20,Mouth ulcers,171
20,Epstein-Barr virus copy number in lymphoblastoid cell lines [AA and Sub-Saharan African],26
20,Male-pattern baldness,59238
20,QRS duration,40641
20,Internar derangement of knee,11732
20,Protein quantitative trait loci (liver) [PON1],5
20,General cognitive ability,147658
20,Calcium levels,39599
20,Leisure sedentary behaviour (television watching),18179
20,Serum levels of protein GRID2,723
20,Number of cigarettes previously smoked daily,37
20,Childhood sunburn occasions,62315
20,"Blood protein levels [SPINT3, 7926_13_3]",47761
20,Pancreas fat,1527
20,Waist-to-hip ratio adjusted for BMI (additive genetic model),139132
20,Lipid metabolism phenotypes [L-HDL-L/M-HDL-L],3039
20,"Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA, men]",48276
20,Hand grip strength (left),40169
20,Protein quantitative trait loci (liver) [CSRP1],532
20,Creutzfeldt-Jakob disease (variant),399
20,Psoriasis or type 2 diabetes (trans-disease meta-analysis),6293
20,Adenosine Deaminase levels,1121
20,Cerebrospinal fluid biomarker levels [Cystatin-SA],1503
20,"2,3-dihydroxy-2-methylbutyrate levels",734
20,Ceramide levels [S19Sum],217
20,Platelet count,1053671
20,Total cholesterol levels [EA],21974
20,Alcohol consumption (drinks per week),12996
20,Spherical power (left),32324
20,Diabetes mellitus,10075
20,Lifetime smoking index,3525
20,Diastolic blood pressure x alcohol consumption interaction (2df test) [EA],1604
20,Electrocardiogram morphology (amplitude at temporal datapoints) [-26 ms],85
20,Serum levels of protein OXT,379
20,Gamma glutamyl transpeptidase,40211
20,Glioblastoma,40240
20,Motion sickness,149
20,Inflammatory skin disease [Psoriasis],2189
20,Metabolite levels,3039
20,Facial morphology [left alare-right alare distance],309
20,Idiopathic osteonecrosis of the femoral head,6
20,Heel bone mineral density,336909
20,"None of the above | medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",4133
20,Serum levels of protein WISP2,2560
20,Interleukin-6 receptor subunit beta measurement,725
20,Colorectal cancer or advanced adenoma,35248
20,Subjective wellbeing conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis),19940
20,"""Ischaemic heart disease, wide definition""",25606
20,"Blood protein levels [RSPO4, 8464_31_3]",239
20,Burning and freckling,20045
20,Serum metabolite levels [XL_HDL_FC],3039
20,Cortical surface area [Pericalcarine],837
20,Protein quantitative trait loci (liver) [PRELP],532
20,Protein quantitative trait loci (liver) [LRG1],14
20,Relative age voice broke,1163
20,Amlodipine | treatment/medication code,60
20,Medication use (drugs used in diabetes),94
20,"Dark brown | hair colour (natural, before greying)",55572
20,Malignant neoplasm of bronchus and lung (controls excluding all cancers),362
20,Serum levels of protein CST5,148
20,Phosphatidylcholine-O_35:1_[M+H]1+/Phosphatidylcholine-P_35:0_[M+H]1+/Phosphatidylethanolamine-O_38:1_[M+H]1+ levels,217
20,Vertex-wise sulcal depth,81169
20,Car/motor vehicle | types of transport used (excluding work),20056
20,Corneal resistance factor (right),2019
20,Lobe attachment (rater-scored or self-reported),27
20,Paracetamol + codeine | treatment/medication code,245
20,Reticulocyte fraction of red cells,129897
20,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),8291
20,Systolic blood pressure (cigarette smoking interaction),3404
20,None of the above | eye problems/disorders,57
20,Disorders of lens,232
20,Bumetanide | treatment/medication code,2159
20,Radiation-related disorders of the skin and subcutaneous tissue,1444
20,Smoking initiation (ever regular vs never regular) (MTAG),59691
20,"""Hypothyroidism, levothyroxin purchases""",321
20,Aspartate aminotransferase levels,169411
20,Electrocardiogram morphology (amplitude at temporal datapoints) [196 ms],19815
20,Arm fat-free mass (right),117616
20,Urinary albumin-to-creatinine ratio,35176
20,Non-melanoma skin cancer,18978
20,"Blood protein levels [CST5, 3803_10_2]",8977
20,Keratinocyte cancer (MTAG),3665
20,Malignant neoplasm of skin (controls excluding all cancers),6224
20,Protein quantitative trait loci (liver) [HNRNPH3],472
20,"Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) [AA, EA]",361
20,Nonsyndromic cleft lip with or without cleft palate,174
20,Cholelithiasis with other cholecystitis,20
20,Comparative height size at age 10,123244
20,Electrocardiogram morphology (amplitude at temporal datapoints) [170 ms],24099
20,Occipital cortical area (total cortical area interaction),4447
20,Serum levels of protein CSF2RB,1126
20,Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis),961
20,Psoriasis,33254
20,Electrocardiogram morphology (amplitude at temporal datapoints) [210 ms],19815
20,OTU97_117 (Ruminococcus) prevalence,3991
20,Thyrotoxicosis,1341
20,Home location at assessment - north co-ordinate (rounded),31
20,"Liver, biliary or pancreas problem",20
20,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,4
20,3mm weak meridian (left),49650
20,Cortical surface area (min-P),2464
20,Electrocardiogram morphology (amplitude at temporal datapoints) [-22 ms],85
20,Thyroid stimulating hormone levels,192
20,Triglycerides,76328
20,Age at first birth,8236
20,Eosinophil percentage of white cells,11580
20,Serum urea levels,7559
20,Eczema,45415
20,Glomerular filtration rate (cystatin C),9189
20,"Blood protein levels [CST3, 2609_59_2]",8063
20,N-acetylglucosamine/n-acetylgalactosamine levels,2262
20,"Blood protein levels [BPI, 4126_22_1]",600
20,Electrocardiogram morphology (amplitude at temporal datapoints) [162 ms],24799
20,Fasting glucose,10801
20,Serum uric acid levels [Japanese],2342
20,Sum eosinophil basophil counts,222
20,Mean platelet volume,883396
20,Loneliness,39270
20,Cognitive performance,32148
20,Body fat distribution (leg fat ratio),24071
20,Serum alkaline phosphatase levels,485705
20,Ankle spacing width (left),17102
20,Glioma [males],20049
20,Urinary albumin-to-creatinine ratio [EA],3729
20,Age cataract diagnosed,776
20,Combivent inhaler | treatment/medication code,1879
20,Birth length (MTAG),1410
20,Mean arterial pressure [East Asian],1149
20,Very long-chain saturated fatty acid levels (fatty acid 20:0),217
20,"Subcortical brain region volumes [Putamen, EA]",18854
20,Benign neoplasms,228
20,Protein quantitative trait loci (liver) [LPP],532
20,Ceramide_42:2_[M-H]1- levels,217
20,Asthma or allergic disease (pleiotropy),20838
20,Flat foot [pes planus] (acquired),11586
20,Femur bone mineral density x serum urate levels interaction [male],8549
20,Phosphatidylcholine-O_36:1_[M+H]1+/Phosphatidylcholine-P_36:0_[M+H]1+/Phosphatidylethanolamine-O_39:1_[M+H]1+ levels,217
20,"Cholesterol, total",123797
20,"Blood protein levels [POFUT1, 5634_39_3]",1710
20,Brain region volumes [left ventral DC],580
20,"""Type 2 diabetes, strict (exclude DM1)""",102
20,Glioblastoma [males],20049
20,Electrocardiogram morphology (amplitude at temporal datapoints) [172 ms],24099
20,"Blood protein levels [CST7, 14038_130_3]",3303
20,Serum metabolite levels [adenosine],1038
20,Electrocardiogram morphology (amplitude at temporal datapoints) [326 ms],1123
20,KANNO antigen negativity,160
20,Electrocardiogram morphology (amplitude at temporal datapoints) [296 ms],1123
20,"Waist circumference adjusted for body mass index [EA, women]",111
20,Ever used hormone-replacement therapy (hrt),18
20,"Atopic dermatitis [EA, fixed effects]",33239
20,Body fat distribution (leg fat ratio) [females],24186
20,"Blood protein levels [SIRPA, 5430_66_3]",6295
20,Elusimicrobiota abundance in stool,277
20,Osteoarthritis of the hip or knee,24360
20,Blood protein levels [Copine-1],108827
20,"Financial difficulties | illness, injury, bereavement, stress in last 2 years",19305
20,"Blood protein levels [PI3, 4982_54_1]",18849
20,Serum levels of protein TMED10,8090
20,Serum metabolite levels [glutarate (pentanedioate],652
20,TNF-related activation-induced cytokine levels,7
20,Electrocardiogram morphology (amplitude at temporal datapoints) [0 ms],6617
20,Response to hepatitis C treatment [Change of Hb],1021
20,"""Type 2 diabetes, definitions combined""",102
20,Asparaginase hypersensitivity in acute lymphoblastic leukemia,438
20,Hip circumference adjusted for BMI,136897
20,Lung function (FEV1) and waist to hip ratio adjusted for BMI [East Asian],35270
20,Smoking status,2947
20,Ceramide levels (C24:0),217
20,"Blood protein levels [NR3C2, 12931_16_3]",1084
20,Optic disc size,2014
20,Coffee consumption,2765
20,Bipolar disorder or type 2 diabetes,329
20,Protein quantitative trait loci (liver) [GC],46
20,"Alcohol use disorder (consumption score) [AA, women]",85
20,Intrahepatic Cholestasis of Pregnancy (ICP),20
20,Autism spectrum disorder,6956
20,Rheumatoid arthritis [EA],2572
20,Hemoglobin,80124
20,Glaucoma,349
20,Facial morphology (segment 2),675
20,Renal function-related traits (BUN),2334
20,Eicosanoid(C20H30O3)_[M-H]1- levels,2
20,Atopic dermatitis,151512
20,Medication use (antiglaucoma preparations and miotics),326
20,Thrombosis,1740
20,Chronic airway obstruction,762
20,"Intra-ocular pressure, goldmann-correlated (left)",19
20,Lung function (FVC),682717
20,Brain morphology (min-P),21370
20,Electrocardiogram morphology (amplitude at temporal datapoints) [214 ms],19115
20,Metabolite levels [Cer d18:2/23:0],217
20,Protein quantitative trait loci (liver) [NARS],126
20,Glomerular filtration rate,2497
20,Maximum heart rate during fitness test,1123
20,Knee osteoarthritis,96780
20,Optic disc area,2096
20,HDL cholesterol levels in current drinkers [AA],3039
20,"Blood protein levels [SIRPG, 9241_40_3]",442
20,CD40 on CD14+ CD16- monocyte,881
20,Glomerular filtration rate in non diabetics (creatinine),46026
20,Electrocardiogram morphology (amplitude at temporal datapoints) [180 ms],19815
20,Parental longevity (father's attained age),3793
20,"Vasculitis | non-cancer illness code, self-reported",333
20,Malignant neoplasm of bronchus and lung,362
20,Coronary atherosclerosis,126
20,Alteromonadaceae abundance in stool,43
20,Metabolic biomarkers (multivariate analysis),125209
20,Electrocardiogram morphology (amplitude at temporal datapoints) [188 ms],24799
20,Aphakia and other disorders of lens,232
20,Serum levels of protein PCDHA4,723
20,High blood pressure | vascular/heart problems diagnosed by doctor,11908
20,Age at first sexual intercourse,18254
20,Methylsuccinoylcarnitine levels,5337
20,Protein quantitative trait loci (liver) [C4B],5372
20,Serum oxytocin levels,436
20,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [AA],3039
20,"Melanomas of skin, dx or hx",635
20,Brain connectivity [Strength - R paracentral],5
20,Unspecified diffuse connective tissue disease,24269
20,Depression,6545
20,Cutaneous malignant melanoma,1500
20,Non-albumin protein levels,252
20,Intertrochanteric region size,24071
20,Waist-to-hip ratio adjusted for body mass index [men],24384
20,Electrocardiogram morphology (amplitude at temporal datapoints) [362 ms],1123
20,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],3039
20,Freckling,580
20,Protein quantitative trait loci (liver) [PSMD14],310
20,Prostate cancer,137919
20,Benign neoplasm: Colon,12803
20,Caffeine consumption from coffee or tea,1390
20,"Blood protein levels [EA, Cystatin-SA]",1305
20,Coronary artery aneurysm in Kawasaki disease,245
20,Venous thromboembolism (SNP x SNP interaction),177
20,Sphingomyelin_40:3_[M+H]1+ levels,217
20,"Red | hair colour (natural, before greying)",59613
20,Irritability,12308
20,"None of the above | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",19944
20,1-palmitoyl-2-arachidonoyl-gpc (16:0/20:4n6) levels,1799
20,Serum levels of protein PRDM1,99
20,Age completed full time education,17698
20,"Blood clot in the leg (dvt) | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",33755
20,Cutaneous squamous cell carcinoma,1068
20,Lawsonibacter sp000492175 abundance in stool,47
20,Offspring birth weight,20126
20,Platelet distribution width,396374
20,College or university degree | qualifications,17002
20,"Long-standing illness, disability or infirmity",1721
20,Blood protein levels [Cystatin-SN],1530
20,Sphingomyelin_43_2_[M+H]1+ levels,217
20,Sagittal craniosynostosis,135
20,Morning person,1989
20,Reticulocyte count,256848
20,Depressive symptoms x herpes simplex 1 infection interaction [additive],51
20,Protein quantitative trait loci (liver) [CPT2],4
20,Sex hormone-binding globulin levels,397066
20,Triglyceride levels in current drinkers [Asian],3039
20,Triglyceride levels [BMI adjusted],2671
20,Metabolite levels [Cer d18:2/22:0],217
20,"""Alcohol use disorder, ICD-based""",12
20,Triglyceride levels in current drinkers,3039
20,Body mass index,202748
20,Brain region volumes [Brain stem],24269
20,Hemoglobin levels,34637
20,Leg fat percentage (left),201897
20,Age high blood pressure diagnosed,3865
20,HDL cholesterol levels in current drinkers,3076
20,Hypothyroidism or myxedema,285
20,Spine bone size,24071
20,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA],24285
20,"Blood protein levels [MATN4, 7083_74_3]",3767
20,Hodgkin's lymphoma,1609
20,CD25 on IgD- CD27- B cell,1341
20,Isobutyrylcarnitine (c4) levels,346
20,"Blood protein levels [HNRNPC, 11429_80_3]",99
20,Total cholesterol levels in LDL,29
20,Postoperative survival time in hepatocellular carcinoma,20
20,Positive affect,20186
20,Total cholesterol levels [Trans-ethnic initial],78243
20,Electrocardiogram morphology (amplitude at temporal datapoints) [134 ms],4984
20,Lifetime number of sexual partners,182
20,RR interval (heart rate),1123
20,N-acetylleucine levels,661
20,Electrocardiogram morphology (amplitude at temporal datapoints) [150 ms],4984
20,"""Benign neoplasm: Colon, unspecified""",10105
20,Electrocardiogram morphology (amplitude at temporal datapoints) [176 ms],25922
20,Lipopolysaccharide-binding protein measurement,1253
20,Snoring,1060
20,Osteoarthritis (hip),305
20,Crohn's disease,29030
20,Hematological or dermatological disease,18619
20,Nonsyndromic cleft lip with cleft palate,43
20,Vertical cup-disc ratio (multi-trait analysis),2777
20,Mean sphered cell volume,33273
20,"None of the above | medication for pain relief, constipation, heartburn",8885
20,Pregnancy hypertension,1839
20,Ceramide(42:0)_[M-H]1- levels,212
20,Serum levels of protein ENO2,99
20,Kallikrein-6 levels,151
20,Developmental dysplasia of the hip,24071
20,Basophil percentage of white cells,34069
20,Arthropathies,11246
20,Metabolite levels [Cer d18:1/24:0],217
20,Cancer diagnosed by doctor,1700
20,Ceramide_42:1_[M+OAc]1- levels,217
20,6mm weak meridian (right),50074
20,Electrocardiogram morphology (amplitude at temporal datapoints) [220 ms],19115
20,Abdominal aortic aneurysm,8689
20,Eosinophill count,5649
20,Type 1 diabetes,4249
20,Varicose veins of lower extremity,421
20,Subjective well-being,20121
20,Body mass index (bmi),48332
20,White blood cell count,303469
20,Nevus count or cutaneous melanoma,2838
20,Total amyloid (SNP x SNP interaction),548
20,Triglyceride levels,104851
20,Basal metabolic rate,125413
20,Menopause (age at onset),10237
20,"Lipid metabolism phenotypes [HDL.large, fasting]",3039
20,Electrocardiogram morphology (amplitude at temporal datapoints) [316 ms],1123
20,Sitting height ratio [EA],416
20,Serum levels of protein CPNE1,100027
20,Forced vital capacity (fvc),74289
20,Oily fish intake,557
20,"Other chronic ischemic heart disease, unspecified",3635
20,Neuritic plaques (SNP x SNP interaction),1217
20,Caffeine consumption from coffee,1146
20,"""Diabetes, varying definitions""",1638
20,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],357
20,Sphingomyelin(39:1)_[M-CH3]1- levels,212
20,Nose size,1485
20,Central corneal thickness,825
20,Atenolol | treatment/medication code,56
20,Multiple sclerosis,7792
20,Tense / 'highly strung',5973
20,Respiratory mometasone | treatment/medication code,748
20,"Blood protein levels [FLRT3, 13123_3_3]",296
20,Haptoglobin measurement,738
20,IgD- CD27- B cell Absolute Count,1341
20,White matter integrity (fractional anisotropy),580
20,Inflammatory bowel disease and other gastroenteritis and colitis,34
20,Phosphatidylcholine-O_37:2_[M+H]1+/Phosphatidylcholine-P_37:1_[M+H]1+/Phosphatidylethanolamine-O_40:2_[M+H]1+ levels,217
20,Diastolic blood pressure [Japanese],8
20,Lumbar spine bone mineral density,9878
20,Venous thromboembolism,68148
20,Psoriasis vulgaris,6347
20,Graves' disease,10308
20,Electrocardiogram morphology (amplitude at temporal datapoints) [168 ms],24799
20,Mental composite score,187
20,Corneal curvature,1018
20,Maternal smoking around birth,303
20,Sphingomyelin_38:1_[M+H]1+ levels,217
20,Heavy menstrual bleeding,18
20,Well-being spectrum (multivariate analysis),24472
20,"Blood protein levels [OXT, 8356_88_3]",184
20,Lymphocyte count,1764
20,CD27 on IgD+ CD24+ B cell,1341
20,Waist circumference adjusted for body mass index [East Asian],1899
20,Optic cup area [EA],387
20,Cancer,33111
20,Insomnia [Male],2033
20,"Serum metabolite levels [sphingomyelin (d18:1/25:0, d19:0/24:1, d20:1/23:0, d19:1/24:0)*]",204
20,"Serum metabolite levels [sphingomyelin (d18:0/20:0, d16:0/22:0)*]",204
20,Mood instability,226
20,"Blood protein levels [APMAP, 10605_22_3]",192
20,"""Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)""",241
20,Serum metabolite levels [XL_HDL_L],3039
20,Electrocardiogram morphology (amplitude at temporal datapoints) [74 ms],4984
20,Medication use (diuretics),11014
20,Facial morphology (segment 60),669
20,Cataracts [male],334
20,Butyrate (4:0) levels,143
20,Body fat distribution (arm fat ratio) [females],115
20,Medication use (beta blocking agents),6452
20,"Serum metabolite levels [sphingomyelin (d18:1/21:0, d17:1/22:0, d16:1/23:0)*]",204
20,IBD patients in KELA-register,34
20,Electrocardiogram morphology (amplitude at temporal datapoints) [310 ms],1123
20,Multisite chronic pain,478
20,"Serum metabolite levels [sphingomyelin (d18:1/19:0, d19:1/18:0)*]",204
20,Systolic blood pressure x smoking status (current vs non-current) interaction (1df test) [African],75
20,Antibody level in response to infection [C. pneumoniae],168
20,Waist circumference adjusted for body mass index,191207
20,Essential hypertension,14839
20,Pattern 3 | hair/balding pattern,6123
20,High density lipoprotein cholesterol levels [EA],3059
20,Leg predicted mass (right),149305
20,Hemoglobin A1c levels,8370
20,Vitamin D levels,880
20,"Hip circumference adjusted for BMI [EA,men]",24071
20,1-stearoyl-2-arachidonoyl-gpc (18:0/20:4) levels,1142
20,Electrocardiogram morphology (amplitude at temporal datapoints) [-178 ms],100
20,Intralaminar thalamic nuclei volume,603
20,Ewing sarcoma,2234
20,Protein quantitative trait loci (liver) [HSPE1],65
20,Cognitive ability,19940
20,Lipid traits (pleiotropy) (HIPO component 1),46388
20,Number of self-reported non-cancer illnesses,18735
20,Serum 25-Hydroxyvitamin D levels,28114
20,Subjective wellbeing conditioned on educational attainment (multi-trait conditioning and joint analysis),19811
20,Gonarthrosis [arthrosis of knee](FG),12442
20,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),357
20,Atrovent 20micrograms inhaler | treatment/medication code,119
20,Obesity,117
20,Anxiety [EA],1180
20,Age at menopause (last menstrual period),5516
20,Electrocardiogram morphology (amplitude at temporal datapoints) [2 ms],6617
20,Interleukin-27 levels,19468
20,Ceramide(41:2)_[M-H]1- levels,192
20,Iron status biomarkers (ferritin levels),27
20,"Waist-to-hip ratio adjusted for body mass index [EA, men]",48467
20,High light scatter reticulocyte percentage of red cells,116520
20,Impedance of arm (left),34321
20,CX3CR1 on CD14- CD16+ monocyte,280
20,Sphingomyelin(38:1)_[M+H]1+ levels,212
20,Smoking behaviour (age at first cigarette),262
20,Protein quantitative trait loci (liver) [PABPC1],126
20,Glioma,120578
20,Phosphatidylinositol_34:2_[M-H]1- levels,116238
20,Triglyceride levels x loop diuretics use interaction [African],172
20,Home location - north co-ordinate (rounded),14
20,Low density lipoprotein cholesterol levels,412495
20,HDL cholesterol,120465
20,"Cholesterol lowering medication | medication for cholesterol, blood pressure or diabetes",5100
20,Electrocardiogram morphology (amplitude at temporal datapoints) [112 ms],4984
20,Hypothyroidism,1827
20,Serum levels of protein CST2,2584
20,Serum levels of protein LBP,99
20,Unspecified monoarthritis,24198
20,Dimethylglycine levels,1430
20,Nervous feelings,1850
20,Sphingomyelin_35:1_[M+H]1+ levels,217
20,Gallstone disease,20
20,Factor VII activity or levels,36181
20,Hip circumference [EA],30613
20,Serum metabolite levels (CMS) [L_HDL_P],3039
20,Serum levels of protein CAST,723
20,Melanomas of skin,635
20,Smoking behaviour (cigarettes smoked per day),16505
20,Hip bone size,24071
20,Percentage of invited food questionnaires completed,25533
20,Electrocardiogram morphology (amplitude at temporal datapoints) [232 ms],19115
20,High cholesterol,7971
20,HDL cholesterol levels [Trans-ethnic initial],2843
20,CD27 on IgD- CD38+ B cell,1341
20,Osteoporosis,13
20,Arthrosis,12296
20,"Hayfever/allergic rhinitis | non-cancer illness code, self-reported",292
20,Protein levels in obesity [CYTN],1611
20,Height,1150210
20,Diffuse large B-cell lymphoma or multiple sclerosis,1440
20,Hypertensive diseases (excluding secondary),8245
20,Serum levels of protein ASIP,209
20,Nontoxic multinodular goitre,1164
20,Citramalate levels,189
20,Melanoma,7977
20,6mm strong meridian (right),52979
20,Serum metabolite levels (CMS) [XL_HDL_P],3039
20,"""Hypothyroidism,  other/unspecified""",1175
20,Diacylglycerol_42:7_[M+H-H2O]1+ levels,217
20,Waist-to-hip ratio adjusted for body mass index,24541
20,3mm strong meridian (right),69304
20,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],3076
20,Hair color [red hair],822
20,"Blood protein levels [AKT2, 5360_9_2]",99
20,Schizophrenia (MTAG),30646
20,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [AA],3039
20,Platelet crit,59174
20,LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),228
20,Electrocardiogram morphology (amplitude at temporal datapoints) [-24 ms],85
20,Waist-hip index,33970
20,Biological sex,16868
20,Malignant neoplasm of prostate,5847
20,Methionine sulfoxide levels,1558
20,Serum levels of protein MUL1,3171
20,Multiple myeloma,6108
20,Gut bacterial pathway abundance (PWY.7234..inosine.5..phosphate.biosynthesis.III),238
20,Goiter,11
20,Total PHF-tau (SNP x SNP interaction),28917
20,Mean corpuscular haemoglobin,17336
20,Waist circumference adjusted for BMI (adjusted for smoking behaviour),1202
20,Current | smoking status,6253
20,Electrocardiogram morphology (amplitude at temporal datapoints) [328 ms],1123
20,Sleep duration,1605
20,Diabetes or endocrine disease,235
20,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Hispanic],37
20,Vitamin D levels (dietary vitamin D intake interaction),55
20,Height [EA],20
20,Adolescent idiopathic scoliosis,25639
20,Anticoagulant levels [PC],37612
20,Waist-to-hip ratio adjusted for body mass index [EA],48868
20,Major depressive disorder vs autism spectrum disorder (ordinary least squares (OLS)),6956
20,Snoring [adjusted for BMI],2094
20,Waist circumference [EA],1104
20,Metabolite levels [Cer d16:1/24:1],217
20,Electrocardiogram morphology (amplitude at temporal datapoints) [-2 ms],6617
20,Serum levels of protein CST7,15068
20,"Blood protein levels [EA, Cystatin-D]",920
20,"""Gonarthrosis,primary""",12787
20,Daytime sleepiness,138
20,Other noninfective gastroenteritis and colitis,1245
20,Asthma,106027
20,Protein quantitative trait loci (liver) [PARP1],126
20,Tumor necrosis factor receptor superfamily member 5 levels,4425
20,Serum metabolite levels (CMS) [XL_HDL_L],3039
20,Smoking initiation (ever regular vs never regular),6043
20,Bendroflumethiazide | treatment/medication code,5130
20,Metabolite levels [Cer d16:1/18:0],212
20,Waist circumference adjusted for body mass index [EA],218
20,Time spent using computer,171
20,Coronary artery disease,200548
20,Dupuytren's disease,279
20,Cerebrospinal fluid sTREM-2 levels,137
20,Intelligence,186064
20,Serum levels of protein CST3,7269
20,Youthful appearance (self-reported),5129
20,Medication use (thyroid preparations),2230
20,Blood protein levels in cardiovascular risk,4616
20,Qrs duration,298
20,Urinary bladder cancer,84
20,"Nose morphology (partial least square model) [Uyghur, female]",2
20,QRS complex (Cornell) [EA],19268
20,Type 2 diabetes,120019
20,Anthropometric traits (multi-trait analysis),24071
20,Morningness,17150
20,Hip index,5709
20,Serum levels of protein LAMA1;LAMB1;LAMC1,2517
20,"Blood protein levels [CSF2RB, 11137_43_3]",1084
20,Fasting insulin,92
20,Anal and rectal polyp,11674
20,Metabolite levels [S1P d16:1],212
20,Blood metabolite ratios [X-10510/palmitoyl sphingomyelin],217
21,Celiac disease or Rheumatoid arthritis,1395
21,Electrocardiogram morphology (amplitude at temporal datapoints) [72 ms],1197
21,Percentage of invited food questionnaires completed,904
21,Alcohol consumption (drinks per week) (MTAG),297
21,Electrocardiogram morphology (amplitude at temporal datapoints) [202 ms],174
21,Chronic kidney disease,13
21,Electrocardiogram morphology (amplitude at temporal datapoints) [52 ms],1197
21,Pattern 2 | hair/balding pattern,239
21,Granulocyte count,4508
21,Job involves heavy manual or physical work,93
21,"N,n,n-trimethyl-alanylproline betaine (tmap) levels",22278
21,Smoking initiation,1142
21,Total body bone mineral density,645
21,Fibrinogen levels,2361
21,Neutrophil percentage of white cells,2253
21,Vertex-wise cortical surface area,2309
21,Ganglion cell inner plexiform layer (GCIPL) thickness,7304
21,Serum urea levels,2276
21,Oxalate (ethanedioate) levels,4846
21,Electrocardiogram morphology (amplitude at temporal datapoints) [76 ms],1197
21,Worry/vulnerability (special factor of neuroticism),180
21,3mm cylindrical power angle (left),4
21,"Ulcerative colitis | non-cancer illness code, self-reported",787
21,Comparative height size at age 10,2078
21,Protein quantitative trait loci (liver) [ALDH5A1],4
21,Haemoglobin concentration,9785
21,"Rheumatoid arthritis | non-cancer illness code, self-reported",343
21,Pulse wave arterial stiffness index,194
21,Impedance of leg (left),4912
21,Arm fat percentage (right),8947
21,Joint damage progression in ACPA-negative rheumatoid arthritis,43
21,Electrocardiogram morphology (amplitude at temporal datapoints) [228 ms],174
21,Bitter alcoholic beverage consumption,402
21,Adrenocortical insufficiency,142
21,Thyroid problem (not cancer),399
21,Diabetes | illnesses of adopted father,2
21,Electrocardiogram morphology (amplitude at temporal datapoints) [224 ms],174
21,Myocardial infarction,4021
21,"Angina | non-cancer illness code, self-reported",629
21,Heart disease | illnesses of father,629
21,Cardiorespiratory fitness (800m run time),289
21,Abdominal aortic aneurysm,84
21,Serum albumin levels,80384
21,Sitting height,11675
21,Protein quantitative trait loci (liver) [ANXA2],869
21,Lymphocyte counts,162422
21,COVID-19 (very severe respiratory confirmed vs population) RELEASE 5,15238
21,Pediatric autoimmune diseases,787
21,Electrocardiogram morphology (amplitude at temporal datapoints) [236 ms],174
21,Myopia,3526
21,Medication use (agents acting on the renin-angiotensin system),694
21,Electrocardiographic traits (multivariate),76
21,TPE interval (response to exercise) [men],131
21,Heel bone mineral density,192921
21,CD11b on basophil,1101
21,Smoking initiation (ever regular vs never regular) (MTAG),67157
21,Height,126838
21,Impedance of arm (right),11432
21,Waist-to-hip ratio adjusted for BMI,27326
21,Basophil count,21687
21,Cognitive performance (MTAG) [MTAG],733
21,"Other chronic ischemic heart disease, unspecified",629
21,Waist-hip ratio,21175
21,interferon-related traits [IFNAR2_of_CD56dimCD16p],2621
21,Chronic obstructive pulmonary disease,634
21,Inflammatory bowel disease and other gastroenteritis and colitis,787
21,Electrocardiogram morphology (amplitude at temporal datapoints) [88 ms],1197
21,Dovonex 50micrograms/g cream | treatment/medication code,464
21,Low myopia vs hyperopia,4722
21,Coronary artery bypass grafting,565
21,Hip circumference adjusted for BMI,4943
21,Protein quantitative trait loci (liver) [FERMT2],45
21,LDL cholesterol,114426
21,Red blood cell count,99525
21,Melanoma,1593
21,Electrocardiogram morphology (amplitude at temporal datapoints) [330 ms],174
21,Electrocardiogram morphology (amplitude at temporal datapoints) [234 ms],174
21,"""Malignant neoplasm of breast, HER-positive""",134
21,Waist circumference adjusted for body mass index,5870
21,Fractures,910
21,Neutrophil percentage of granulocytes,496
21,Testicular germ cell tumor,97036
21,Motor neuron disease (with DMD),301
21,Blood protein levels [CSTB],5837
21,Keratinocyte cancer (MTAG),225
21,Weight,11066
21,Diverticulosis and diverticulitis,1971
21,Late-onset Alzheimer's disease,1754
21,Electrocardiogram morphology (amplitude at temporal datapoints) [208 ms],174
21,Autoimmune traits (pleiotropy),246
21,Diffuse plaques (SNP x SNP interaction),175
21,Leg predicted mass (right),1689
21,Monocyte count,20757
21,Standing height,39568
21,3mm weak meridian (right),4460
21,DNA methylation variation (age effect),477
21,6mm weak meridian (right),4460
21,Body mass index [Japanese],228
21,Electrocardiogram morphology (amplitude at temporal datapoints) [40 ms],36
21,HDL cholesterol,10639
21,"Blood protein levels [CBR3, 14091_42_3]",4921
21,Takayasu arteritis,1989
21,Glomerular filtration rate,941
21,Eosinophill percentage,5005
21,Protein quantitative trait loci (liver) [HBG1],11
21,Takayasu arteritis [Turkish],787
21,Mean corpuscular hemoglobin concentration,8525
21,Nasopharyngeal carcinoma (SNP x SNP interaction),2162
21,Smoking status (ever vs never smokers),1260
21,"Forced expiratory volume in 1-second (fev1), best measure",433
21,Electrocardiogram morphology (amplitude at temporal datapoints) [216 ms],174
21,Electrocardiogram morphology (amplitude at temporal datapoints) [218 ms],174
21,Serum levels of protein FAM3B,2100
21,Highest math class taken (MTAG) [MTAG],3297
21,Body fat percentage,16601
21,Waist circumference,206
21,Pancreatic cancer,2324
21,Generalized epilepsy,2374
21,Plavix 75mg tablet | treatment/medication code,178
21,S100 calcium-binding protein levels,1597
21,Psoriasis [EA],22
21,Osteoporosis,492
21,Smoking behaviour (cigarettes smoked per day),63010
21,Ischemic heart disease,629
21,High light scatter reticulocyte count,57683
21,Serum levels of protein ICOSLG,101
21,3mm weak meridian (left),4500
21,Alzheimer's disease,1061
21,Motor neuron disease,306
21,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)",426
21,Non-melanoma skin cancer,225
21,"Allergic disease (asthma, hay fever or eczema)",186
21,Systolic blood pressure,52449
21,Mean corpuscular haemoglobin,11736
21,Total protein levels x insomnia interaction,19
21,Age when periods started (menarche),19652
21,Serum uric acid levels,1254
21,Osteoarthritis of the hip or knee (with total joint replacement),56756
21,Hypothyroidism or myxedema,447
21,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],1352
21,Calculus of kidney and ureter,480
21,LDL cholesterol levels,63747
21,Red blood cell (erythrocyte) distribution width,5659
21,Electrocardiogram morphology (amplitude at temporal datapoints) [68 ms],1197
21,Pyridoxine preparation | treatment/medication code,6687
21,Electrocardiogram morphology (amplitude at temporal datapoints) [58 ms],1197
21,Monocyte percentage of white cells,97860
21,Trunk predicted mass,1379
21,Electrocardiogram morphology (amplitude at temporal datapoints) [54 ms],1197
21,Fluid intelligence score,559
21,Cardiovascular disease,27970
21,Serum alkaline phosphatase levels,21949
21,Age-related nuclear cataracts [Random effect],271
21,Psoriasis,9026
21,Gut microbiota (bacterial taxa) [k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Oscillospiraceae|g__Oscillibacter],3471
21,3mm strong meridian (left),4532
21,Skin colour,1031
21,Other anemias,2
21,Finngen Rheumatological endpoints,59
21,Protein quantitative trait loci (liver) [FMO5],1
21,Leg total mass,42
21,Leisure sedentary behaviour (television watching),32479
21,Chronic obstructive pulmonary disease or high blood pressure (pleiotropy),13946
21,Lung function (FVC),5647
21,Corneal hysteresis (left),3361
21,Glutathione peroxidase in non-alcoholic fatty liver disease x mastiha supplementation interaction,6759
21,Corneal resistance factor (right),4198
21,Problems related to negative life events in childhood,202
21,Whole body fat-free mass,2054
21,interferon-related traits [IFNAR2_of_CD8p_T],925
21,DNA methylation PhenoAge acceleration,919
21,Apolipoprotein B levels,130922
21,Platelet count,209325
21,Total PHF-tau (SNP x SNP interaction),11159
21,Platelet-to-lymphocyte ratio,593
21,Early onset COPD,7
21,Red blood cell traits [PCV],840
21,"Blood protein levels [EA, A disintegrin and metalloproteinase with thrombospondin motifs 5]",63
21,Immature reticulocyte fraction,13338
21,"Blonde | hair colour (natural, before greying)",4588
21,Ischemic heart diseases,629
21,"Heel quantitative ultrasound index (qui), direct entry (left)",607
21,Estimated glomerular filtration rate in diabetes,427
21,Other disorders of adrenal gland,218
21,Type 1 diabetes without complications,85
21,Blood protein levels [A disintegrin and metalloproteinase with thrombospondin motifs 5],154
21,Electrocardiogram morphology (amplitude at temporal datapoints) [82 ms],1197
21,Electrocardiogram morphology (amplitude at temporal datapoints) [240 ms],174
21,Basal cell carcinoma,437
21,Basophill percentage,3771
21,Leg fat percentage (right),14718
21,Autoimmune diseases,999
21,Electrocardiogram morphology (amplitude at temporal datapoints) [220 ms],174
21,Cystatin-B levels,18659
21,Waist-hip index,8728
21,Urinary calculus,131
21,Neutrophill percentage,814
21,Femur bone mineral density x serum urate levels interaction,194
21,Immature fraction of reticulocytes,26691
21,Electroencephalographic traits in alcoholism,1499
21,Myeloid white cell count,4069
21,Pattern 1 | hair/balding pattern,2472
21,Sum basophil neutrophil counts,808
21,COVID-19 (RELEASE 5),7412
21,Red cell distribution width,59063
21,Spherical equivalent,6706
21,Urinary electrolytes (magnesium/calcium ratio),85
21,Nonatopic asthma,208
21,Brain-derived neurotrophic factor levels,145
21,Bilirubin levels,10189
21,Sum neutrophil eosinophil counts,4508
21,Heart failure and coronary heart disease,834
21,"Blood protein levels [COL6A1, 11150_3_3]",5126
21,Coronary artery disease,8847
21,"Hypothyroidism/myxoedema | non-cancer illness code, self-reported",298
21,"""Artrosis, including avohilmo""",59
21,Interleukin-10 receptor B levels,1677
21,Parkinson's disease,3476
21,Protein quantitative trait loci (liver) [FDXR],1507
21,Asthma,3245
21,Electrocardiogram morphology (amplitude at temporal datapoints) [238 ms],174
21,Red blood cell (erythrocyte) count,6936
21,6mm strong meridian (left),4460
21,Bioavailable testosterone levels,24225
21,Levothyroxine sodium | treatment/medication code,621
21,Basal metabolic rate,2731
21,Doctor diagnosed sarcoidosis,216
21,Schizophrenia,76
21,Electrocardiogram morphology (amplitude at temporal datapoints) [212 ms],174
21,Electrocardiogram morphology (amplitude at temporal datapoints) [226 ms],174
21,Ventricular rate,37
21,Electrocardiogram morphology (amplitude at temporal datapoints) [56 ms],1197
21,Pre-treatment viral load in HIV-1 infection,6841
21,Tumor biomarkers [CEA],697
21,White blood cell types [basophil count],170
21,Identify largest number | fi2 ,397
21,Fasting plasma glucose,55
21,Tea intake,59
21,GI-bleeding,4
21,Caffeine consumption from tea,59
21,Rheumatoid arthritis,6711
21,Body size at age 10,807
21,"Hypertension | non-cancer illness code, self-reported",13751
21,Vertex-wise cortical thickness,3648
21,Protein quantitative trait loci (liver) [WARS],21
21,Major depressive disorder,5732
21,Mastocytosis,238
21,Primary sclerosing cholangitis,1820
21,Arm predicted mass (left),2046
21,Fresh fruit intake,68
21,Lymphocyte percentage,888
21,Calculus of kidney,284
21,Age started wearing glasses or contact lenses,46861
21,Predicted visceral adipose tissue,105
21,Neurofibrillary tangles (SNP x SNP interaction),22755
21,Gamma glutamyl transpeptidase,14284
21,Age-related nuclear cataracts,542
21,Heel bone mineral density (bmd),888
21,Electrocardiogram morphology (amplitude at temporal datapoints) [214 ms],174
21,Electrocardiogram morphology (amplitude at temporal datapoints) [338 ms],174
21,Corneal hysteresis (right),4305
21,Impedance of whole body,2421
21,Arm fat percentage (left),9059
21,Leg fat mass (right),1859
21,Refractive error,17637
21,Heel broadband ultrasound attenuation (left),226
21,Adult body size,28532
21,Blood urea nitrogen levels,5091
21,COVID-19 (critical illness vs population),14251
21,Electrocardiogram morphology (amplitude at temporal datapoints) [352 ms],174
21,Alanine aminotransferase levels,134384
21,Urea levels,108
21,Gut microbiota (beta diversity),348
21,Methylmalonate (mma) levels,1475
21,Type 1 diabetes with ophthalmic complications,37
21,Metabolic biomarkers (multivariate analysis),5732
21,Gut microbiota (bacterial taxa) [k__Bacteria|p__Firmicutes|c__Clostridia|o__Clostridiales|f__Oscillospiraceae],3471
21,Urolithiasis,947
21,Rheumatoid arthritis [EA],2905
21,"Asthma | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",193
21,Relative age of first facial hair,19743
21,"None of the above | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",65006
21,Age at first sexual intercourse,325
21,Balding type 1,1681
21,Monocyte percentage,1019
21,Central corneal thickness,3392
21,Heel broadband ultrasound attenuation (right),455
21,Low hand grip strength (60 years and older) (EWGSOP),4
21,Blood protein levels [Cystatin B],8335
21,"Heel bone mineral density (bmd) t-score, automated",4905
21,Cortical surface area,2102
21,Protein quantitative trait loci (liver) [TKT],18
21,Myeloproliferative neoplasms,80
21,Myopia (age of diagnosis),6947
21,Crohn's disease,10563
21,"Other joint disorder | non-cancer illness code, self-reported",32
21,Elevated serum carcinoembryonic antigen levels,697
21,Vitiligo,2433
21,Electrocardiogram morphology (amplitude at temporal datapoints) [244 ms],174
21,Myocardial infarction (early onset),711
21,Sum eosinophil basophil counts,6491
21,Serum levels of protein NCAM2,501
21,Protein quantitative trait loci (liver) [ACOT13],2826
21,Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis),1610
21,Corneal resistance factor (left),709
21,Moderate to vigorous physical activity levels,161
21,"""Malignant neoplasm of breast, HER2-negative""",134
21,Direct bilirubin levels,63946
21,Electrocardiogram morphology (amplitude at temporal datapoints) [184 ms],1197
21,Mean platelet volume,76263
21,Peak expiratory flow,3506
21,Other malignant neoplasms of skin (=non-melanoma skin cancer),123
21,Esophageal cancer,221
21,Cognitive performance,46397
21,B-cell acute lymphoblastic leukaemia (high-hyperdiploidy),185
21,Metabolite levels [TAG 54:5],107
21,Breast cancer,15306
21,Peritonsillar abscess,1083
21,Ankle spacing width (right),135
21,"""Disorders of thyroid, IBD co-morbidities""",60
21,3mm weak meridian angle (left),4
21,HDL cholesterol x physical activity interaction (2df test),1308
21,Glycated hemoglobin levels,3848
21,Mean corpuscular volume,160774
21,Fasciitis,5
21,Trunk fat mass,14650
21,Lipoprotein (a) levels,15222
21,Adolescent idiopathic scoliosis,3877
21,Heel bone mineral density (bmd) (right),1023
21,Vertex-wise sulcal depth,4262
21,White blood cell count (basophil),253
21,Obesity [waist],135
21,Time spent using computer,594
21,"""Type 1 diabetes, strict definition, subgroup 1""",696
21,Hypothyroidism,399
21,Migraine and/or diastolic blood pressure,629
21,Ebbinghaus illusion (overestimation),56
21,Eosinophill count,5856
21,Prostate cancer,1660
21,Menarche (age at onset),42331
21,Total testosterone levels,26021
21,Macular thickness,4702
21,Rheumatoid arthritis (ACPA-positive),3957
21,Electrocardiogram morphology (amplitude at temporal datapoints) [206 ms],174
21,Plasma homocysteine levels (post-methionine load test),163
21,Retinal nerve fibre layer thickness or ganglion cell inner plexiform layer thickness (MTAG),7187
21,Spontaneous coronary artery dissection,669
21,Cerebral glucose metabolic decline (right temporal gyrus),248
21,Electrocardiogram morphology (amplitude at temporal datapoints) [156 ms],1197
21,Pulse pressure,48049
21,Estimated glomerular filtration rate in non-diabetics,10
21,Haematocrit percentage,8886
21,Ankylosing spondylitis,4693
21,Haemorrhoidal disease,7758
21,"Blood protein levels [TFF1, 9185_15_3]",83
21,Neuroblastoma (11q deletion),90
21,Phosphatidylcholine_40:5_[M+H]1+ levels,79
21,Educational attainment (MTAG) [MTAG],21232
21,Basophil percentage of white cells,13531
21,Daytime nap,15931
21,A body shape index,5316
21,Peak expiratory flow (pef),404
21,"""Type 1 diabetes, wide definition""",262
21,Feeling nervous,108
21,Eye color traits [CHS1],60933
21,Migraine and/or pulse pressure,711
21,"Dark brown | hair colour (natural, before greying)",3863
21,Hypoparathyroidism,142
21,Autoimmune thyroid disease,295
21,IgD- CD38- B cell Absolute Count,27
21,6mm weak meridian (left),4460
21,"Kidney stone, ureter stone or bladder stone",197
21,Spherical power (right),6865
21,Impedance of leg (right),4142
21,Medication use (thyroid preparations),729
21,Apolipoprotein A1 levels,37527
21,"Intra-ocular pressure, goldmann-correlated (left)",467
21,Left–right brain asymmetry,283
21,Response to lithium treatment in bipolar disorder (continuous phenotype),18
21,Whole body water mass,1769
21,Interleukin-2 receptor subunit beta measurement,382
21,Mean sphered cell volume,18112
21,Serum levels of protein COL6A1,5126
21,Creatine kinase levels,2145
21,Arm fat-free mass (right),1473
21,Citramalate levels,25
21,Low density lipoprotein cholesterol levels,113359
21,Anorectal malformation,10696
21,Serum levels of protein IL10RB,335
21,Leg predicted mass (left),2287
21,Serum levels of protein TFF1,83
21,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],717
21,IBD patients in KELA-register,894
21,Celiac disease,492
21,Male-pattern baldness,3272
21,Major coronary heart disease event,629
21,Electrocardiogram morphology (amplitude at temporal datapoints) [344 ms],174
21,Basophil percentage of granulocytes,2
21,Insomnia,5680
21,Intracranial aneurysm,96
21,Cortical thickness,4582
21,Obesity-related traits [Sleep RQ],58
21,Arm predicted mass (right),829
21,Diverticular disease,1917
21,"Blood protein levels [NCAM2, 6507_16_3]",17
21,Smoking status,1260
21,Pattern 3 | hair/balding pattern,94
21,High light scatter reticulocyte percentage,15429
21,Celiac disease and Rheumatoid arthritis,267
21,Gastroesophageal reflux disease,3366
21,Eczema,617
21,Crohn's disease [EA],3942
21,Mean platelet (thrombocyte) volume,16308
21,Electrocardiogram morphology (amplitude at temporal datapoints) [230 ms],174
21,Narcolepsy,3205
21,White blood cell count,231048
21,None of the above | vascular/heart problems diagnosed by doctor,13714
21,Torticollis,390
21,QT interval [Hispanic/Latino],153
21,Homocysteine levels,1262
21,Electrocardiogram morphology (amplitude at temporal datapoints) [50 ms],1197
21,C-reactive protein levels [BMI-adjusted],787
21,COVID-19 (hospitalized vs population) RELEASE 5,15238
21,Electrocardiogram morphology (amplitude at temporal datapoints) [70 ms],1197
21,Age-related hearing impairment (SNP x SNP interaction),538
21,Electrocardiogram morphology (amplitude at temporal datapoints) [92 ms],1197
21,Platelet distribution width,88691
21,Eosinophil counts,82706
21,Hemoglobin concentration,43288
21,Sex hormone-binding globulin levels,123284
21,Place of birth in uk - north co-ordinate,2758
21,Neuritic plaque [Case/control],157
21,Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS)),758
21,Diabetic retinopathy,37
21,Intelligence,46397
21,Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis),1610
21,Cigarettes smoked per day (MTAG),68742
21,Multiple sclerosis,3475
21,Malignant neoplasm of skin,123
21,Coronary angiopasty,565
21,Intrinsic epigenetic age acceleration,3739
21,Pulmonary function [FEV1/FVC],633
21,FEV1,3504
21,Electrocardiogram morphology (amplitude at temporal datapoints) [114 ms],7640
21,"Blood protein levels [FAM3B, 9177_6_3]",412
21,Pattern 4 | hair/balding pattern,444
21,Plateletcrit,28570
21,Autoimmune traits,343
21,Addison's disease,1584
21,Birth weight,588
21,Total cholesterol levels,149388
21,Electrocardiogram morphology (amplitude at temporal datapoints) [42 ms],36
21,"""Type 1 diabetes, wide definition, subgroup 1""",37
21,"Diastolic blood pressure [EA, initial]",637
21,Coronary heart disease,711
21,Electrocardiogram morphology (amplitude at temporal datapoints) [48 ms],1197
21,Electrocardiogram morphology (amplitude at temporal datapoints) [232 ms],174
21,Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in non-secretors,45
21,"Heel quantitative ultrasound index (qui), direct entry",4905
21,Femur bone mineral density x serum urate levels interaction [male],480
21,Intraocular pressure,3525
21,"Blood protein levels [IL10RB, 2631_50_2]",335
21,Arm fat mass (left),181
21,Serum metabolite levels [betaine],60
21,C-reactive protein,10131
21,Inflammatory bowel disease [EA],3884
21,HDL cholesterol levels in current drinkers,778
21,Protein quantitative trait loci (liver) [ATOX1],11
21,Appendicular lean mass,170600
21,Protein quantitative trait loci (liver) [MACROD1],11
21,Hematocrit,62867
21,Lymphocyte percentage of white cells,1258
21,Medication use (diuretics),39
21,"Disorders of muscle, ligament, and fascia",11
21,HDL cholesterol levels,36460
21,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) [subset analysis]",5569
21,Leg lean mass,42
21,Red vs. brown/black hair color,585
21,Ulcerative colitis [EA],1556
21,Serum levels of protein COL18A1,8127
21,6-oxopiperidine-2-carboxylate levels,619
21,"Forced vital capacity (fvc), best measure",16149
21,Skin cancer,478
21,Amyotrophic lateral sclerosis (sporadic),248
21,Serum levels of protein CBR1,1462
21,Body mass index [Male],2530
21,Other malignant neoplasms of skin (=non-melanoma skin cancer) (controls excluding all cancers),123
21,No | breathing problems during period of job,1341
21,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],717
21,SAPHO syndrome,857
21,Secondary parkinsonism (more control exclusions),4
21,Asthma (adult onset),600
21,Osteoarthritis (with total hip replacement),366
21,IgG N-glycosylation phenotypes (multivariate analysis),74
21,Educational attainment (years of education) [conditional-joint],10691
21,QT interval,8903
21,Nevus count or cutaneous melanoma,1062
21,Forced expiratory volume in 1-second (fev1),222
21,Distance between home and job workplace,18
21,Hypertensive diseases,1098
21,Cardiac problem,629
21,"Black | hair colour (natural, before greying)",585
21,Body mass index,102632
21,Serum creatinine levels,4511
21,"Blood protein levels [IFNAR1, 9183_7_3]",901
21,Electrocardiogram morphology (amplitude at temporal datapoints) [38 ms],36
21,Alzheimer's disease or family history of Alzheimer's disease,593
21,Esotropia,8199
21,Hair color,4229
21,Malignant neoplasm of other and unspecified parts of biliary tract (controls excluding all cancers),56
21,Reticulocyte count,94941
21,Major coronary heart disease event excluding revascularizations,629
21,B-cell acute lymphoblastic leukaemia,185
21,Contracture of palmar fascia [dupuytren's disease],5
21,Brain morphology (MOSTest),100
21,Electrocardiogram morphology (amplitude at temporal datapoints) [332 ms],174
21,Cerebrospinal fluid t-tau:AB1-42 ratio,1147
21,"""Myocardial infarction, strict""",629
21,Electrocardiogram morphology (amplitude at temporal datapoints) [210 ms],174
21,N-acetylglucosamine/n-acetylgalactosamine levels,2061
21,Mean reticulocyte volume,53124
21,Heel bone mineral density (bmd) (left),2936
21,Cerebrospinal fluid neurofilament light levels,101
21,Age of smoking initiation (MTAG),63070
21,Osteoarthritis of the hip or knee,371
21,Electrocardiogram morphology (amplitude at temporal datapoints) [200 ms],174
21,Glycemic traits (pregnancy) [FCP],64
21,C-reactive protein levels,27525
21,Stroke,404
21,Geographic atrophy lesion growth rate in age-related macular degeneration,387
21,Serum levels of protein IFNAR1,901
21,Insomnia [Female],635
21,Serum phosphate levels,480
21,Urate levels,6007
21,Smoking initiation (ever regular vs never regular),63070
21,Mean spheric corpuscular volume,32681
21,Mitral valve prolapse,8968
21,Hypertension,15592
21,"Blood protein levels [ADAMTS5, 3168_8_2]",237
21,Age-related diseases and mortality,271
21,Eosinophil percentage of granulocytes,1939
21,Smoking x traumatic event in childhood (sexually molested) interaction,166
21,Granulocyte percentage of myeloid white cells,868
21,Protein quantitative trait loci (liver) [LRG1],8
21,QT dynamics during recovery from exercise,174
21,Arm fat mass (right),181
21,Eye color [discovery],1137
21,Atopic asthma,183
21,Intelligence (MTAG),559
21,"Bladder cancer | cancer code, self-reported",1321
21,Diastolic blood pressure,43861
21,Mean arterial pressure,4576
21,Coronary atherosclerosis,1258
21,Mean corpuscular hemoglobin,175512
21,Type 1 diabetes,22419
21,Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis),1610
21,Electrocardiogram morphology (amplitude at temporal datapoints) [242 ms],174
21,5-methylthioadenosine (mta) levels,175
21,Triglycerides,1376
21,Hip index,2255
21,Antihypertensive medication - note that there are other indications,42
21,"Pleurisy | non-cancer illness code, self-reported",608
21,Electrocardiogram morphology (amplitude at temporal datapoints) [204 ms],174
21,Gtn - glyceryl trinitrate | treatment/medication code,480
21,"Blood protein levels [PDXK, 11098_1_3]",105
21,Triglyceride levels,81690
21,Type 2 diabetes,24916
21,"Bone mineral density [hip, female]",98
21,Non-accommodative esotropia,8199
21,Hand grip strength (right),512
21,Fibrinogen [EA],787
21,White blood cell (leukocyte) count,39829
21,Feeling hurt,627
21,Liver enzyme levels (alanine transaminase),21194
21,Diverticulosis,1971
21,Ankle injury,93
21,COVID-19 (hospitalized vs population),7234
21,Age at first birth,13190
21,Serum levels of protein EVA1C,1144
21,Electrocardiogram morphology (amplitude at temporal datapoints) [336 ms],174
21,Body mass index (bmi),36191
21,Malignant neoplasm of skin (controls excluding all cancers),123
21,COVID-19 (RELEASE 4),7416
21,Hemoglobin A1c levels,10018
21,Angina,629
21,"Systolic blood pressure [EA, initial]",637
21,Total amyloid (SNP x SNP interaction),197
21,Frozen shoulder,5
21,Cognitive aspects of educational attainment,46397
21,"Blood protein levels [EVA1C, 8877_22_3]",1908
21,Noncognitive aspects of educational attainment,68
21,Estimated glomerular filtration rate,7648
21,Hip circumference,1017
21,"Blood protein levels [CBR1, 12381_26_3]",1462
21,Leg fat-free mass (right),1689
21,"Diastolic blood pressure, automated reading",226
21,Spherical equivalent or myopia (age of diagnosis),5483
21,Percentage gas trapping [All],75
21,Lung function (FEV1/FVC),60491
21,"Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)",629
21,Serum total protein level,38
21,Waist circumference adjusted for body mass index [EA],469
21,"Asthma | non-cancer illness code, self-reported",193
21,Essential hypertension,52
21,High density lipoprotein cholesterol levels,1468
21,Liver enzyme levels (alkaline phosphatase),299
21,Hepatocellular carcinoma,158
21,Stable angina pectoris,125
21,Femur bone mineral density x serum urate levels interaction [female],3
21,Reticulocyte fraction of red cells,55670
21,Hemoglobin,23499
21,Calculus of ureter,155
21,Protein quantitative trait loci (liver) [HBD],11
21,Ulcerative colitis,11747
21,"Heel quantitative ultrasound index (qui), direct entry (right)",983
21,Serum immune biomarker levels [YKL-40],123
21,Trunk fat-free mass,1379
21,Angina | vascular/heart problems diagnosed by doctor,629
21,Trospium | treatment/medication code,146
21,Graves' disease,1824
21,"Medication use (adrenergics, inhalants)",322
21,Malignant neoplasm of other and unspecified parts of biliary tract,56
21,Blond vs. brown/black hair color,3863
21,Spherical power (left),6794
21,Acute gastritis,3
21,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),717
21,Estimated glomerular filtration rate [EA],6
21,Heel bone mineral density T score,63546
21,"""Malignant neoplasm of breast, HER2-negative (controls excluding all cancers)""",134
21,Electrocardiogram morphology (amplitude at temporal datapoints) [116 ms],7640
21,Serum parathyroid hormone levels,480
21,Electrocardiogram morphology (amplitude at temporal datapoints) [80 ms],1197
21,"Pulse rate, automated reading",486
21,Malignant neoplasm of breast (controls excluding all cancers),134
21,Cutaneous malignant melanoma,531
21,Angina pectoris,1383
21,Leg fat-free mass (left),2304
21,"""Hepatic failure, not elsewhere classified""",135
21,Cortical surface area [Lateral Orbitofrontal],165
21,Cystatin C levels,6736
21,Blood and toenail selenium levels,60
21,Breast cancer [conditional],9
21,College or university degree | qualifications,1731
21,Gut microbiota (bacterial taxa) [Actinobacteria class],1682
21,Osteoarthritis (hip),195
21,Lifetime smoking index,15614
21,Protein quantitative trait loci (liver) [ACTN4],329
21,Gamma glutamyl transferase levels,69678
21,Electrocardiogram morphology (amplitude at temporal datapoints) [94 ms],1197
21,Blood protein levels in cardiovascular risk,8335
21,High light scatter reticulocyte percentage of red cells,29247
21,Alzheimer's disease (late onset),66
21,Coronary revascularization (ANGIO or CABG),565
21,Creatinine levels,9994
21,Electrocardiogram morphology (amplitude at temporal datapoints) [90 ms],1197
21,Comparative body size at age 10,705
21,N1-methyladenosine levels,5355
21,Self-reported math ability,821
21,Total body bone mineral density [European],729
21,"Forced expiratory volume in 1-second (fev1), predicted",3499
21,Aspartate aminotransferase levels,6653
21,6mm strong meridian (right),4460
21,Forced vital capacity (fvc),909
21,Nervous feelings,98
21,Ankylosing spondylitis [EA],787
21,QRS complex (12-leadsum) [EA],9837
21,Aspartate aminotransferase to alanine aminotransferase ratio,19772
21,Atrial fibrillation,38
21,Corneal curvature,1207
21,P-selectin glycoprotein ligand 1 levels,471
21,interferon-related traits [IFNAR2_of_CD56brightCD16n],1297
21,Neutrophil count,129555
21,Respiratory or ear-nose-throat disease,217
21,Simvador 10mg tablet | treatment/medication code,3171
21,Inflammatory bowel disease,19133
21,"Heel bone mineral density (bmd) t-score, automated (left)",2980
21,Direct low density lipoprotein cholesterol levels,63747
21,Electrocardiogram morphology (amplitude at temporal datapoints) [60 ms],1197
21,ADAMTS13 levels,219
21,Venous thromboembolism (SNP x SNP interaction),9457
21,Amyotrophic lateral sclerosis,299
21,Educational attainment (years of education),10267
21,High blood pressure | vascular/heart problems diagnosed by doctor,14018
21,Other non-epithelial cancer of skin,191
21,Hemoglobin levels,19015
21,Neutrophill count,5095
21,"Heel broadband ultrasound attenuation, direct entry",616
21,Malignant neoplasm of breast,134
21,3mm strong meridian (right),4460
21,Electrocardiographic traits [QT interval],257
21,Adiponectin levels,4389
21,Early-onset Parkinson's disease,1654
21,"Blood protein levels [ICOSLG, 9303_9_3]",901
21,Arm fat-free mass (left),2221
21,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),1352
21,Ginseng product | treatment/medication code,250
21,Externalizing behaviour (multivariate analysis),69388
21,Self-reported math ability (MTAG) [MTAG],821
21,Venous thromboembolism,239
21,Electrocardiogram morphology (amplitude at temporal datapoints) [84 ms],8837
21,Liver enzyme levels (gamma-glutamyl transferase),45782
21,P-cresol sulfate levels,1996
21,Hip shape (DXA scan) [hip shape mode 1],19
21,Alanine transaminase levels,4207
21,Serum levels of protein CBR3,8017
21,Leg fat percentage (left),8529
21,Parkinson's disease or first degree relation to individual with Parkinson's disease,2212
21,Eosinophil percentage of white cells,28482
21,Medication use (drugs affecting bone structure and mineralization),17
21,"""Malignant neoplasm of breast, HER-positive (controls excluding all cancers)""",134
21,"Eye color [EA, discovery]",1006
21,Platelet crit,5114
21,Blood metabolite levels [betaine],1024
21,Whole body fat mass,1980
21,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),130
21,Problematic alcohol use (MTAG),261
21,Respiratory diseases,207
21,"""Ischaemic heart disease, wide definition""",629
21,Calcium levels,3223
21,Pediatric asthma,159
21,Leg fat mass (left),2232
21,"Heel bone mineral density (bmd) t-score, automated (right)",983
21,Electrocardiogram morphology (amplitude at temporal datapoints) [222 ms],174
21,Tea consumption,59
21,Glucuronate levels,490
21,Serum 25-Hydroxyvitamin D levels,186
21,Protein quantitative trait loci (liver) [SDHB],20
21,Birth weight (MTAG),31
21,Trunk fat percentage,8775
21,Ease of skin tanning,877
21,Atrial fibrillation [EA],19
21,Symptoms and signs involving the digestive system and abdomen,7749
21,"Kidney stone/ureter stone/bladder stone | non-cancer illness code, self-reported",316
21,Homocysteine levels [WGHS],60
21,"Blood protein levels [COL18A1, 2201_17_6]",9038
21,Sex hormone-binding globulin levels adjusted for BMI,1739
21,Gut microbiota (bacterial taxa) [Actinobacteria phylum],1682
21,Esophageal squamous cell carcinoma,183
21,Joint mobility (Beighton score),1932
21,Serum levels of protein FTCD,542
21,General cognitive ability,47402
21,Insulin-like growth factor 1 levels,166670
21,Complement factor H measurement,1714
21,Kidney stones,1283
21,Number of sexual partners,254
21,Diabetes or endocrine disease,295
21,Vitamin D levels,62
21,CD11b on CD33dim HLA DR-,543
22,Smoking initiation (ever regular vs never regular),30012
22,Body fat percentage [male],22449
22,Chronic obstructive pulmonary disease x current smoker interaction (2df),5054
22,Gallbladder disease,832
22,vWF levels [EA],8929
22,Iron status biomarkers (ferritin levels),2250
22,Gut microbiota relative abundance (bacterial taxa) [Negativicutes],391
22,Creatine kinase levels,10301
22,Medication use (thyroid preparations),241391
22,Impedance of leg (right),39694
22,Ebbinghaus illusion (overestimation),2527
22,Protein quantitative trait loci (liver) [MPC1],136
22,Electrocardiogram morphology (amplitude at temporal datapoints) [458 ms],79
22,Blood protein levels [Gamma Glutamyltransferase],3441
22,Lymphoid leukaemia (controls excluding all cancers),148
22,Hemoglobin levels [Hispanic/Latino],750
22,Time spend outdoors in summer,90544
22,Worrier / anxious feelings,23926
22,Meat-related diet,151250
22,Basophil percentage of white cells,38639
22,College or university degree | qualifications,45453
22,Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL),2108
22,Polycythaemia vera,208
22,Rheumatoid arthritis [EA],6521
22,"Urinary 1,3-butadiene metabolite levels in smokers [MHBMA, AA]",3511
22,"""Malignant neoplasm of breast, HER2-negative (controls excluding all cancers)""",734
22,Impedance of leg (left),40696
22,"""Type 1 diabetes, wide definition""",24559
22,Particulate matter air pollution (pm2.5) absorbance; 2010,348
22,Immature reticulocyte fraction,35413
22,Eye color (saturation),2386
22,Plasma free amino acid levels (adjusted for one other PFAA) [Pro (adjusted for Ser],465
22,Malignant neoplasm of prostate (controls excluding all cancers),544
22,"Blood protein levels [IL17RA, 2992_59_2]",322
22,Metabolite levels [Proline],465
22,Triglyceride levels,332605
22,Corynebacterium abundance in stool,561
22,Red blood cell traits [MCH],750
22,Myopia (age of diagnosis),261
22,Daytime nap,2303
22,"""Ulcerative colitis (strict definition, require KELA)""",3221
22,Intraocular pressure and central corneal thickness (multi-trait analysis) [EA],1890
22,Protein quantitative trait loci (liver) [BPHL],13
22,Electrocardiogram morphology (amplitude at temporal datapoints) [448 ms],79
22,IgG glycosylation patterns [IgG2 FBn/Fn total],1460
22,Serum levels of protein TCN2,8425
22,Malignant neoplasm of breast (controls excluding all cancers),734
22,Impulsivity (motor),38
22,Sensorineural hearing loss,2878
22,White matter microstructure (mean diusivities) [Splenium of corpus callosum],155
22,Nasopharyngeal carcinoma (SNP x SNP interaction),183
22,"Blood protein levels [TYMP, 11361_73_3]",3499
22,Diseases of liver,2139
22,Kidney stones,6991
22,"Blood protein levels [CECR1, 6077_63_3]",26
22,PR interval,294715
22,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)",67360
22,Serum levels of protein TYMP,4136
22,"""Cluster headache, strict""",9
22,Waist-hip ratio,72161
22,Electrocardiogram morphology (amplitude at temporal datapoints) [0 ms],19704
22,Standing height,135637
22,"Clotting disorder/excessive bleeding | non-cancer illness code, self-reported",14617
22,Acne (severe),1316
22,Sum neutrophil eosinophil counts,5025
22,BAFF-R on IgD- CD38dim B cell,11783
22,"""Type 2 diabetes, definitions combined, including avohilmo""",2451
22,Frequency of tiredness / lethargy in last 2 weeks,75
22,Tonsillectomy,35118
22,Celiac disease,23686
22,Blood metabolite levels [X-11423--O-sulfo-L-tyrosine],679
22,Urinary metabolite levels in chronic kidney disease [X - 21785],1103
22,"Blood protein levels [TIMP3, 2480_58_3]",472
22,Myringotomy,361
22,C-reactive protein levels or triglyceride levels (pleiotropy),21567
22,Educational attainment (years of education),39418
22,"""Type 2 diabetes, strict (exclude DM1)""",8053
22,IgG glycosylation [IGP40],9916
22,Other anemias,750
22,Brain morphology (MOSTest),33599
22,Hip circumference,117187
22,"Forced expiratory volume in 1-second (fev1), predicted percentage",14416
22,LDL cholesterol levels [Trans-ethnic initial],8023
22,malignant neoplasm of male genital organs (controls excluding all cancers),544
22,Serum levels of protein TIMP3,565
22,Electrocardiogram morphology (amplitude at temporal datapoints) [442 ms],79
22,Creutzfeldt-Jakob disease (sporadic),155
22,"None of the above | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",150628
22,"Forced expiratory volume in 1-second (fev1), best measure",16546
22,Protein quantitative trait loci (liver) [CTSB],1
22,Mean corpuscular hemoglobin,636178
22,Cutaneous melanoma or hair colour,2464
22,Electrocardiogram morphology (amplitude at temporal datapoints) [426 ms],79
22,Uterine fibroids,28654
22,Platelet crit,255548
22,"""Hypothyroidism, drug reimbursement""",1425
22,Serum metabolite levels [X-11593],1308
22,Epigenetic age acceleration in alcohol use disorder,106
22,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [women],452
22,Multiple myeloma (hyperdiploidy) [HD vs. controls],6737
22,Electrocardiogram morphology (amplitude at temporal datapoints) [-20 ms],79
22,Mean reticulocyte volume,305797
22,Modified Stumvoll Insulin Sensitivity Index (BMI interaction),260
22,"Blood protein levels [NPTXR, 8997_4_3]",1782
22,Triglycerides,119190
22,BAFF-R on switched memory B cell,11783
22,Neuroticism score,57675
22,Ejection fraction,4984
22,vWF levels,8942
22,Positive affect,26277
22,Intracranial aneurysm,18185
22,"Pulse rate, automated reading",86921
22,Hemoglobin levels [Asian],750
22,Urinary metabolite levels in chronic kidney disease [gamma-glutamylphenylalanine],3024
22,IgG glycosylation patterns [IgG1 BG2n total/G2n],8345
22,Spherical power (right),954
22,White matter microstructure (radial diusivities) [Retrolenticular part of internal capsule],1195
22,"Gynecologic disease (multivariate analysis) [uterine fibroid, endometriosis]",2339
22,Oxalate (ethanedioate) levels,6966
22,"Hip circumference adjusted for BMI [EA, women]",7902
22,Benign neoplasm: Colon,173
22,White matter microstructure (mean diusivities) [Superior corona radiata],155
22,Mean corpuscular hemoglobin [EA],133
22,Highest math class taken (MTAG) [MTAG],299281
22,Hemoglobin,193083
22,IgG glycosylation patterns [IgG2_G0FNn],1470
22,Itch intensity from mosquito bite adjusted by bite size,2791
22,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),21044
22,Hip index,93172
22,IgG glycosylation [IGP5],8456
22,Interleukin-17 receptor A measurement,2267
22,Diseases of the ear and mastoid process,615
22,Serum albumin levels,80698
22,IgG glycosylation patterns [IgG1_G0FN/IgG1_G0F],10784
22,Protein quantitative trait loci (liver) [MPST],2021
22,Lesion of lateral popliteal nerve,6
22,Primary biliary cholangitis,21347
22,Hemoglobin concentration,241048
22,IgG glycosylation patterns [IgG1 FBG1n/G1n],10784
22,Celiac disease or Rheumatoid arthritis,9839
22,Educational attainment (MTAG) [MTAG],154436
22,Ease of skin tanning,26273
22,No | major dietary changes in the last 5 years,15205
22,Primary_lymphoid and hematopoietic malignant neoplasms,124
22,Nephropathy,2413
22,HDL cholesterol levels in current drinkers,9638
22,Brain region volumes [left lateral ventricle],34082
22,Femur bone mineral density x serum urate levels interaction [female],1294
22,"Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)",2615
22,Apolipoprotein A1 levels,293068
22,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [Asian],9638
22,Heme oxygenase 1 measurement,1809
22,Other diseases of liver,2139
22,Alanine aminotransferase levels in excessive alcohol consumption,2139
22,Fasciitis,1461
22,Bitter non-alcoholic beverage consumption,150017
22,Hypertrophic cardiomyopathy (sarcomere negative),1185
22,Electrocardiogram morphology (amplitude at temporal datapoints) [-28 ms],79
22,Hematological and biochemical traits [ALT],5073
22,Triacylglycerol_58:7_[M+NH4]1+ levels,2139
22,Interleukin-2 receptor subunit beta measurement,1036
22,Total amyloid (SNP x SNP interaction),6035
22,Liver fibrosis and steatohepatitis severity (MRI cT1 measure),3159
22,Eosinophil percentage of white cells,392449
22,Serum levels of protein ARFIP2,2139
22,Iron status biomarkers (transferrin levels),750
22,S-phenylmercapturic acid levels in smokers,4041
22,Sitting height,146646
22,Leg fat mass (left),16746
22,Neutrophil percentage of granulocytes,181372
22,C-reactive protein,65285
22,Nontoxic multinodular goitre,128
22,"Asthma | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",147932
22,Malignant neoplasm of meninges (controls excluding all cancers),10765
22,Eczema or dermatitis,2989
22,Left–right brain asymmetry,559
22,Vertical cup-disc ratio (multi-trait analysis),43322
22,Fibroblastic disorders,400
22,Carcinoma in situ of breast,106
22,Hepatitis B,10135
22,White matter microstructure (fractional anisotropy) [Anterior corona radiata],12690
22,Eosinophill percentage,205039
22,IgG glycosylation patterns [IgG2_G1FN(10)/(IgG1_G1FN(10) + IgG2_G1FN(10) +IgG4_G1FN(10],9055
22,Albumin-globulin ratio,2073
22,White matter microstructure (mean diusivities) [Retrolenticular part of internal capsule],155
22,Total body bone mineral density,10
22,Refractive error,33923
22,Skin colour,35022
22,Aspartate aminotransferase to alanine aminotransferase ratio,13239
22,Myeloproliferative diseases (CML excluded),175
22,Alanine aminotransferase levels [Asian],2139
22,Sleep duration,67699
22,None of the above | qualifications,3621
22,Mean corpuscular haemoglobin concentration,2847
22,Alcohol-associated liver disease in non drinkers,2157
22,"Blood pressure (smoking interaction) [SBP,CPD]",97
22,Spiriva 18micrograms inhalation capsule | treatment/medication code,6
22,Macrophage Migration Inhibitory Factor levels,31351
22,IgG glycosylation patterns [IgG1 Bisecting_GlcNAc],10784
22,Fed-up feelings,742
22,IgG glycosylation patterns [IgG1 FBG0n/G0n],10784
22,Serum metabolite levels [proline],1004
22,Liver enzyme levels (gamma-glutamyl transferase),142289
22,Crohn's disease [EA],25090
22,Ankle spacing width (right),41502
22,Chronic lymphocytic leukemia or multiple sclerosis,5250
22,Malignant neoplasm of liver and intrahepatic bile ducts (controls excluding all cancers),2139
22,Serum levels of protein PLXNB2,4199
22,Trospium | treatment/medication code,1648
22,Ankle spacing width (left),63943
22,Chronic obstructive pulmonary disease x current smoker interaction (main effect),5054
22,Gamma glutamyl transpeptidase,85318
22,Heel bone mineral density (bmd),90995
22,Blood metabolite ratios [valine/proline],759
22,Electrocardiogram morphology (amplitude at temporal datapoints) [428 ms],79
22,IgG glycosylation [IGP10],1460
22,C-reactive protein levels [BMI-adjusted],69553
22,IgG glycosylation patterns [IgG4_G1FN/IgG4_G1F],9055
22,Aspartate aminotransferase levels,85456
22,DNA methylation Hannum age acceleration,3575
22,Systolic blood pressure [East Asian],5828
22,Blood metabolite levels [cysteine-glutathione disulfide],2760
22,Urolithiasis,3077
22,Autism spectrum disorder or schizophrenia,64920
22,Fasting glucose,9333
22,BAFF-R on IgD- CD38+ B cell,11783
22,Serum uric acid levels,10585
22,Plasma free amino acid levels [Pro],219
22,Sleep (1/2-day periodicity),1477
22,"HDL cholesterol levels [Asian initial, BMI unadjusted]",9521
22,Male puberty timing (late vs. average onset facial hair),23309
22,3mm weak meridian (left),1004
22,"Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA, women]",452
22,Neutrophil percentage of white cells,445967
22,IgG digalactosylation phenotypes (multivariate analysis),9916
22,Alcohol use disorder (consumption score),22923
22,Hand grip strength (right),48891
22,IgG monogalactosylation phenotypes (multivariate analysis),1460
22,Depressive symptoms,78921
22,Arm fat-free mass (right),19677
22,Hepcidin levels [Iron],750
22,Malignant neoplasm of bladder,538
22,Electrocardiogram morphology (amplitude at temporal datapoints) [470 ms],79
22,Pattern 4 | hair/balding pattern,19650
22,Polycystic ovarian syndrome,127
22,Plasma free amino acid levels (adjusted for one other PFAA) [Leu (adjusted for Pro],465
22,Malignant immunoproliferative diseases,56
22,White matter microstructure (mean diusivities) [Cingulate gyrus],2419
22,Gamma glutamyl transferase levels,156246
22,Lung function (FEV1) [adults],190
22,Metabolic traits [proline + 5 other traits],758
22,Plasma free amino acid levels (adjusted for one other PFAA) [Pro (adjusted for Gly],465
22,Adolescent idiopathic scoliosis,21346
22,Nevus count or cutaneous melanoma,65065
22,Place of birth in uk - east co-ordinate,892
22,BAFF-R on transitional B cell,11783
22,Urinary metabolite levels in chronic kidney disease [gamma-glutamylglycine],3024
22,Basophil percentage of granulocytes,2164
22,Nervous feelings,57089
22,"Blood protein levels [EA, Metalloproteinase inhibitor 3]",1065
22,Cortical thickness,80681
22,IgG glycosylation patterns [IgG1 FBG2n/G2n],9055
22,Mitral valve prolapse,65
22,Asthma,907819
22,Bitter beverage consumption,86833
22,Body fat percentage and triglycerides (pairwise),20990
22,Hematocrit,373378
22,Gallstone disease,57883
22,Morningness,33515
22,Blood glucose levels,9609
22,Triglyceride levels in current drinkers,21044
22,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [Asian],9638
22,Serum metabolite levels [5-methyluridine (ribothymidine],13508
22,Heel bone mineral density (bmd) (right),109809
22,Mean platelet (thrombocyte) volume,145059
22,Electrocardiogram morphology (amplitude at temporal datapoints) [440 ms],79
22,Glioblastoma,7750
22,Triglyceride levels [Trans-ethnic initial],20827
22,BAFF-R on B cell,11783
22,Liver enzyme levels (alkaline phosphatase),45137
22,Hepatic cancer,7293
22,Electrocardiogram morphology (amplitude at temporal datapoints) [8 ms],19704
22,Malignant neoplasm of meninges,10316
22,White blood cell count,547480
22,White matter microstructure (radial diusivities) [Anterior corona radiata],28189
22,Serum metabolite levels [cysteineglutathionedisulfide],3446
22,Malignant neoplasm of endocrine gland,82
22,"Blood protein levels [SCUBE1, 8989_40_3]",396
22,Soft tissue disorders,129
22,General cognitive ability,52801
22,IgA levels,14073
22,Coffee consumption,32776
22,Bipolar disorder,28845
22,IgG glycosylation patterns [IgG1_G1FN/IgG1_G1F],10784
22,IgG glycosylation [IGP70],9916
22,Oesophageal varices,2139
22,Reticulocyte count,163409
22,BAFF-R on CD24+ CD27+ B cell,11783
22,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction),427
22,IgG glycosylation [IGP63],10402
22,Protein quantitative trait loci (liver) [ETFDH],136
22,Femur bone mineral density x serum urate levels interaction,240
22,IgG glycosylation patterns [IgG2_G2FN(10)/IgG4_G2FN],9055
22,Antihypertensive medication - note that there are other indications,6072
22,Bone mineral density (hip) and hip bone size,826
22,Malignant immunoproliferative diseases (controls excluding all cancers),56
22,Depression,105000
22,Fibrosis and chirrhosis of liver,2139
22,Cholelithiasis and cholecystitis,60245
22,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],30682
22,IgG glycosylation patterns [IgG4_G0FN],8345
22,Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO),111
22,Fat-free mass,15818
22,HDL cholesterol levels,261799
22,Metabolite levels (small molecules and protein measures) [Citrate],6129
22,Leiomyoma of uterus,999
22,Waist-hip index,61391
22,"Heel bone mineral density (bmd) t-score, automated (right)",109858
22,Current | smoking status,169635
22,Blond vs. brown/black hair color,6146
22,IgG fucosylation phenotypes (multivariate analysis),9916
22,Hepcidin/ferritin ratio,750
22,Protein quantitative trait loci (liver) [AKR1B10],4
22,"Hayfever, allergic rhinitis or eczema | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",7945
22,Blood protein levels [Interleukin-17 receptor A],570
22,Coronary artery disease,15197
22,IgG glycosylation patterns [IgG1 FBn/Fn],10784
22,IgG glycosylation [IGP50],1460
22,Voltarol 25mg e/c tablet | treatment/medication code,1390
22,White matter microstructure (fractional anisotropy) [Posterior thalamic radiation],683
22,LDL cholesterol levels,23662
22,Hypertrophy of breast,5988
22,Urate levels [women],2519
22,Serum levels of protein LGALS2,5747
22,Dupuytren's disease,1698
22,TPE interval (resting),792
22,Malignant neoplasm of endocrine gland (controls excluding all cancers),82
22,Whole body water mass,24187
22,Streptococcus infection,655
22,STROKE,321
22,Type 1 diabetes without complications,25289
22,Esophageal cancer (squamous cell),6322
22,Height,437861
22,"Blood protein levels [MIF, 8221_19_3]",32191
22,Direct bilirubin levels,4460
22,Chronic hepatitis C infection,3159
22,Diacylglycerol_38:6_[M+H-H2O]1+ levels,909
22,White matter hyperintensity volume (adjusted for hypertension),86
22,Percent mammographic density,2133
22,BAFF-R on CD20- B cell,11783
22,Serum metabolite levels [2'-deoxyuridine],2768
22,Frozen shoulder,951
22,"""Ischaemic Stroke, excluding all haemorrhages""",321
22,White matter microstructure (fractional anisotropy) [Uncinate fasciculus],57947
22,"Forced vital capacity (fvc), best measure",12209
22,Interleukin-17 receptor A levels,4320
22,Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis),2589
22,Metabolite levels,5375
22,Rheumatoid arthritis,59876
22,Pulse pressure,98509
22,Adventurousness,32386
22,Youthful appearance (self-reported),37781
22,Hernia,4087
22,"Waist-to-hip ratio adjusted for body mass index [EA, women]",904
22,Childhood sunburn occasions,997
22,Lung function (FEV1/FVC) [EA],1180
22,Automobile speeding propensity,892
22,Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction) [EA],427
22,"Blood protein levels [MMRN2, 9723_105_3]",472
22,Inflammatory bowel disease,57802
22,Cirrhosis (alcohol related),4600
22,CTACK levels,3213
22,Major depressive disorder (MTAG),493
22,Gastroesophageal reflux disease,30
22,BAFF-R on IgD+ CD24+ B cell,11783
22,Serum levels of protein TIMP4,472
22,Experiencing mood swings,26532
22,Calcium levels,148445
22,Cirrhosis,15145
22,Blood metabolite levels [X-11593--O-methylascorbate],1103
22,"Light brown | hair colour (natural, before greying)",1103
22,Total body bone mineral density (MTAG),7435
22,IgG glycosylation [IGP64],9916
22,Body mass index (bmi),18626
22,Parental longevity (mother's age at death),14
22,Hair color,11908
22,Dentures | mouth/teeth dental problems,21545
22,Year ended full time education,717
22,Chest pain felt outside physical activity,659
22,Glutarylcarnitine (c5-dc) levels,1372
22,Extremely high intelligence,384
22,Mean corpuscular volume [Asian],750
22,Home location - east co-ordinate (rounded),5
22,Total cholesterol levels,146875
22,Autoimmune traits (pleiotropy),9786
22,BAFF-R on memory B cell,11783
22,Haematocrit percentage,99633
22,Type 1 diabetes with other specified/multiple/unspecified complications,14893
22,IgG glycosylation patterns [IgG2 BG0n total/G0n],10735
22,Hashimoto thyroiditis,2582
22,Nevus count [Han & Eskin random effects],22164
22,Osteoarthritis (with total hip replacement),41134
22,Lung cancer,11324
22,Hand grip strength (left),4682
22,IgG glycosylation [IGP45],8456
22,White blood cell (leukocyte) count,48844
22,IgG glycosylation patterns [IgG2 BG2n total/G2n],1688
22,Pulse pressure [East Asian],1812
22,"Intra-ocular pressure, corneal-compensated (right)",869
22,Time to complete round,224
22,Gut microbiota (functional units) [GO:0008283|BP|02|cell proliferation],50
22,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)",78429
22,Spherical equivalent,40318
22,Age at first birth,26390
22,Stool frequency,57883
22,Urinary metabolite levels in chronic kidney disease [O-sulfo-L-tyrosine],679
22,Time spent using computer,1355
22,Protein quantitative trait loci (liver) [ARSA],563
22,Smoking cessation (MTAG),154126
22,"""Ulcerative colitis (strict definition, require KELA, min 2 HDR)""",3221
22,"Waist circumference adjusted for body mass index [EA,women]",427
22,Lateral ventricular volume in normal aging,26445
22,Brain region volumes [right ventral DC],1715
22,Hepcidin/ferritin ratio [Subset],750
22,3mm weak meridian (right),489
22,Serum levels of protein NPTXR,1782
22,Serum levels of protein FBLN1,2608
22,Liver abscess and sequelae of chronic liver disease,2139
22,Mosquito bite size,2849
22,Time from waking to first cigarette,566
22,Plasma free amino acid levels (adjusted for twenty other PFAAs) [Ala],465
22,Mathematical ability in children with dyslexia,79
22,Serum levels of protein CCL27,3345
22,Glycated haemoglobin HbA1c levels adjusted for BMI,2153
22,"""Discitis, unspecified""",675
22,Reticulon-4 receptor levels,464
22,Cutaneous malignant melanoma,23439
22,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) [EA],21044
22,Arm predicted mass (left),22115
22,Number of incorrect matches in round,783
22,Sunburns,997
22,Protein quantitative trait loci (liver) [ATP5F1D],136
22,Female genital prolapse,22587
22,BAFF-R on IgD- CD38- B cell,11783
22,Percent liver fat,4313
22,Carcinoma in situ of breast (controls excluding all cancers),98
22,Ezetrol 10mg tablet | treatment/medication code,140
22,Monocyte count,362969
22,Estimated glomerular filtration rate [EA],20443
22,Restless legs syndrome in migraine without aura,1
22,Lamb/mutton intake,57132
22,Language functional connectivity,1518
22,IgG glycosylation patterns [IgG4_G1FNn],8942
22,Conductive and sensorineural hearing loss,2878
22,White matter microstructure (mean diusivities) [Hippocampus ],197
22,Heel bone mineral density,652737
22,"Blood pressure (smoking interaction) [SBP,Pack-years]",97
22,Prostate cancer,41857
22,Urinary metabolite levels in chronic kidney disease [glycerophosphoserine],4236
22,Allopurinol | treatment/medication code,250
22,Lymphocyte counts,1240716
22,IgG glycosylation patterns [IgG4_G2FN],9055
22,3mm strong meridian (left),911
22,Diseases of middle ear and mastoid,779
22,Essential (haemorrhagic) thrombocythaemia,212
22,Sex hormone-binding globulin levels adjusted for BMI,424178
22,Waist-to-hip ratio adjusted for BMI in active individuals,427
22,"Renal failure requiring dialysis | non-cancer illness code, self-reported",9562
22,Iron status biomarkers [sTfR],750
22,Intelligence (MTAG),48960
22,Immature fraction of reticulocytes,80364
22,Other benign neoplasms of skin (controls excluding all cancers),82
22,"Gout | non-cancer illness code, self-reported",2139
22,"Blood protein levels [IGLL1, 6485_59_3]",144
22,5-acetylamino-6-amino-3-methyluracil levels,52
22,Male puberty timing (early vs. average onset facial hair),14088
22,Heel broadband ultrasound attenuation (right),13935
22,Levothyroxine sodium | treatment/medication code,12286
22,Advanced age-related macular degeneration [EA],1081
22,Serum levels of protein IGLL1,25
22,Triglycerides [EA],21201
22,Ankle spacing width,77425
22,IgG glycosylation patterns [IgG1 Bn total],10784
22,Esophageal varix,2461
22,Electrocardiogram morphology (amplitude at temporal datapoints) [450 ms],79
22,Medication use (calcium channel blockers),4975
22,Pork consumption,48077
22,Plasma free amino acid levels (adjusted for one other PFAA) [Pro (adjusted for Gln],465
22,IgG glycosylation [IGP74],1460
22,Electrocardiogram morphology (amplitude at temporal datapoints) [438 ms],79
22,Vertical cup-disc ratio,52061
22,Mean corpuscular volume,874970
22,malignant neoplasm of male genital organs,729
22,Diastolic blood pressure [East Asian],3442
22,End-stage kidney disease,289
22,LDL cholesterol,17842
22,High density lipoprotein cholesterol levels [EA],31005
22,Cortical surface area,169145
22,Arm fat mass (left),51015
22,1-stearoyl-2-linoleoyl-gpc (18:0/18:2) levels,3304
22,Hematological and biochemical traits [AST],5073
22,Neutrophill percentage,195619
22,Electrocardiogram morphology (amplitude at temporal datapoints) [420 ms],79
22,Multiple myeloma,14052
22,Facial morphology (segment 30),14667
22,Hay fever and/or eczema,2759
22,Vertex-wise sulcal depth,149044
22,Eosinophill count,199555
22,Waist-to-hip ratio adjusted for body mass index [EA],879
22,Coronary artery disease [additive model],2601
22,Serum levels of protein A4GALT,938
22,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [X-12708, X-21785]",1103
22,Risk-taking tendency (4-domain principal component model),2046
22,HDL cholesterol levels in current drinkers [Asian],9638
22,Total testosterone levels,162601
22,Chronic diseases of tonsils and adenoids,14343
22,Triacylglycerol_56:5_[M+NH4]1+ levels,2139
22,Haemorrhoidal disease,3581
22,Speech-reception-threshold (srt) estimate (left),1339
22,Electrocardiogram morphology (amplitude at temporal datapoints) [466 ms],79
22,Respiratory diseases,154126
22,Dermatitis and eczema,2962
22,Catechol O-methyltransferase levels,1103
22,Gut microbiota (beta diversity),363
22,Prostate cancer [European],171
22,Irritability,42832
22,Educational attainment (years of education) [conditional-joint],11673
22,"""Hypothyroidism, strict autoimmune, 3 medication purchases required""",11647
22,Hepcidin levels [Tf Sat],750
22,"""Hypothyroidism,  other/unspecified""",12325
22,Lung function (low FEV1 vs high FEV1),5103
22,Corneal curvature,260
22,BAFF-R on naive-mature B cell,11783
22,Cataracts,10287
22,Heel bone mineral density (bmd) (left),71995
22,DNA methylation variation (age effect),4003
22,Serum levels of protein RTN4R,1570
22,Disorders of lens,446
22,Serum levels of protein PTHLH,26
22,Pancreatic cancer,11361
22,Urinary metabolite levels in chronic kidney disease [gamma-glutamylhistidine],3024
22,Serum metabolite levels [3-ureidopropionate],530
22,Urinary metabolite levels in chronic kidney disease [X - 12708],1103
22,White matter microstructure (fractional anisotropy) [Posterior corona radiata ],197
22,Urate levels [East Asian],2916
22,Menarche (age at onset),17140
22,Age-related hearing impairment [additive],2932
22,Red blood cell (erythrocyte) count,44946
22,Autoimmune diseases,13328
22,IgG glycosylation patterns [IgG2 FBn/Fn],1460
22,Hand grip strength,58035
22,Protein quantitative trait loci (liver) [GSTT1],107044
22,hemolysis of donated blood (oxidative),5027
22,High-grade serous ovarian cancer,14305
22,Neutrophil count,292499
22,Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis),27246
22,IgG glycosylation [IGP71],9916
22,IgG glycosylation patterns [IgG4_G1FN],8942
22,Waist circumference adjusted for body mass index,108905
22,Vertex-wise cortical thickness,96000
22,"Blood protein levels [TCN2, 5584_21_3]",6959
22,Reticulocyte percentage,4882
22,"""Benign neoplasm: Rectum, anus and anal canal""",148
22,Waist-hip ratio [EA],452
22,Solifenacin | treatment/medication code,1231
22,Plantar fascial fibromatosis,450
22,Type 2 diabetes or prostate cancer (pleiotropy),2152
22,Malignant neoplasm,75
22,Iron status biomarkers [iron],1020
22,Bilirubin levels,39630
22,Atopic dermatitis,3476
22,Malignant neoplasm of breast,734
22,Fish- and plant-related diet [female],32389
22,Noncognitive aspects of educational attainment,47144
22,"""Diseases of pulp and periapical tissues, including avohilmo""",6536
22,IgG glycosylation patterns [IgG2_G1FN],1680
22,Benign neoplasm of ovary (controls excluding all cancers),90
22,Type 1 diabetes,179468
22,Dilated cardiomyopathy,19874
22,White matter microstructure (fractional anisotropy) [Sagittal stratum],32915
22,Benign neoplasm of meninges (controls excluding all cancers),14472
22,Liver enzyme levels [ALT],2916
22,Length of mobile phone use,3068
22,"""Atopic dermatitis, strict definition with reimbursement""",615
22,IgG glycosylation patterns [IgG2 Fn/Bn total],1460
22,Benign neoplasms (controls excluding all cancers),75
22,Protein quantitative trait loci (liver) [CYP2D6],16762
22,Protein quantitative trait loci (liver) [ATP5F1A],136
22,Mitochondrial DNA copy number,2423
22,IgG glycosylation patterns [IgG4 Bisecting_GlcNAc],9055
22,"1,5-anhydroglucitol levels [EA]",17117
22,Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis),26091
22,White matter microstructure (radial diusivities) [Posterior limb of internal capsule],155
22,Systemic lupus erythematosus,76649
22,IgG glycosylation [IgG1G1N],8456
22,General risk tolerance (MTAG),23867
22,IgG glycosylation [IGP22],8456
22,Malignant neoplasm of prostate,808
22,Fractional shortening,4984
22,IgG glycosylation patterns [IgG2_G0FN(10)/(IgG1_G0FN(10) + IgG2_G0FN(10) +IgG4_G0FN(10],8345
22,Nonsuppurative otitis media,721
22,Glaucoma (primary open-angle),139933
22,Pulse rate,58206
22,Neutrophill count,48596
22,Triacylglycerol_58:9_[M+NH4]1+ levels,909
22,Plasma free amino acid levels (adjusted for one other PFAA) [Val (adjusted for Pro],465
22,Hip circumference adjusted for BMI [EA],7902
22,Immune reponse to smallpox (secreted IL-1beta) [AA],4
22,Male-pattern baldness,22216
22,Lifetime smoking index,159807
22,Schizophrenia (MTAG),278392
22,Body fat percentage and HDL-C (pairwise),20990
22,Protein quantitative trait loci (liver) [DDT],28604
22,Serum metabolite levels [lactosyl-N-behenoyl-sphingosine (d18:1/22:0)*],4683
22,Malignant neoplasm of liver and intrahepatic bile ducts,2139
22,Serum levels of protein SCUBE1,422
22,Electrocardiogram morphology (amplitude at temporal datapoints) [-26 ms],79
22,Smoking initiation (ever regular vs never regular) (MTAG),45962
22,IgG glycosylation patterns [IgG4_G0Fn],9055
22,Subcortical volume (min-P),4175
22,Biological sex,291
22,N-acetylglucosamine/n-acetylgalactosamine levels,46
22,Left ventricle wall thickness,19777
22,Celiac disease and Rheumatoid arthritis,9839
22,"""Thyrotoxicosis, other and/or unspecified""",1118
22,Fatty acid(16:0)-OH_[M-H]1- levels,14
22,"Blood protein levels [PLXNB2, 10855_55_3]",12572
22,Impedance of whole body,163767
22,"""Benign neoplasm of colon, rectum, anus and anal canal""",82
22,Alzheimer's disease or HDL levels (pleiotropy),9839
22,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),20634
22,Forced vital capacity (fvc),9290
22,"""Chirrosis of liver, NAS""",2139
22,Platelet distribution width,623413
22,Diastolic blood pressure,39175
22,Melanoma,65435
22,Serum parathyroid hormone levels,5469
22,Externalizing behaviour (multivariate analysis),5401
22,IBD patients in KELA-register,3287
22,Rheumatoid arthritis (ACPA-positive),13040
22,IgG glycosylation patterns [IgG1_G1FNn],9055
22,Electrocardiogram morphology (amplitude at temporal datapoints) [436 ms],79
22,Birth weight (MTAG),1480
22,Urate levels,105240
22,Caffeine consumption from coffee,5734
22,IgG glycosylation patterns [IgG1_G1FN(10)/IgG4_G1FN],8996
22,Protein quantitative trait loci (liver) [MIF],28604
22,Plasma free amino acid levels (adjusted for one other PFAA) [Orn (adjusted for Pro],465
22,Non-alcoholic fatty liver disease activity score in non-alcoholic fatty liver disease,2224
22,Morning vs. evening chronotype,2996
22,Serum levels of protein FOXJ2,2001
22,Sphingomyelin(37:1)_[M+H]1+ levels,642
22,Schizophrenia,326439
22,Benign neoplasms,75
22,Health precaution | reason for reducing amount of alcohol drunk,477
22,Eosinophil percentage of granulocytes,185128
22,Bladder cancer,1558
22,Electrocardiogram morphology (amplitude at temporal datapoints) [434 ms],79
22,Protein quantitative trait loci (liver) [CSTA],17
22,Resting heart rate,55653
22,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),30272
22,CD45 on B cell,9055
22,Statin medication,2315
22,Insulin-related traits (multivariate analysis),524
22,Cognitive performance (MTAG) [MTAG],116234
22,BAFF-R on IgD- CD24- B cell,11783
22,Benign neoplasm: Cerebral meninges (controls excluding all cancers),10875
22,Alanine aminotransferase levels,168333
22,"Blood protein levels [APOL1, 11510_51_3]",489
22,"""Hypothyroidism, strict autoimmune""",11077
22,"Inguinal hernia | non-cancer illness code, self-reported",281
22,Waist-to-hip ratio adjusted for body mass index [women],904
22,Ever smoked,1353
22,Systemic lupus erythematosus or rheumatoid arthritis [same effect],9786
22,Disorders of the thyroid gland,11077
22,Contracture of palmar fascia [dupuytren's disease],1521
22,Blood protein levels [Metalloproteinase inhibitor 3],871
22,Special screening examination for neoplasms,91
22,Neuroticism (MTAG),26438
22,Waist-to-hip ratio adjusted for BMI,172455
22,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),13502
22,White matter microstructure (mean diusivities) [Superior longitudinal fasciculus],20225
22,Temperament (bipolar disorder) [Hyperthymic],544
22,Red blood cell (erythrocyte) distribution width,32675
22,Matrix metalloproteinase-3 levels,22449
22,HDL cholesterol levels [Asian],9638
22,Forced expiratory volume in 1-second (fev1),21632
22,Heel broadband ultrasound attenuation (left),15328
22,"Triglyceride levels x smoking (ever vs never smokers) interaction (2df test) [African, trans-ethnic]",28
22,"Number of decayed, missing and filled tooth surfaces or use of dentures",20606
22,Protein quantitative trait loci (liver) [ACSM2A],1424
22,Plasma free amino acid levels (adjusted for one other PFAA) [Pro (adjusted for Asn],465
22,Electrocardiogram morphology (amplitude at temporal datapoints) [-30 ms],79
22,Benign neoplasm: Colon (controls excluding all cancers),82
22,Electrocardiogram morphology (amplitude at temporal datapoints) [-16 ms],79
22,Major depressive disorder,53761
22,Feeling tense,56342
22,Hemoglobin levels,158464
22,"Intra-ocular pressure, goldmann-correlated (right)",903
22,Liver enzyme levels (alanine transaminase),69554
22,Creatinine (enzymatic) in urine,16053
22,Serum uric acid levels [Japanese],6057
22,Plasma free amino acid levels (adjusted for twenty other PFAAs) [Pro],465
22,Platelet-to-lymphocyte ratio,245346
22,Aspartate aminotransferase platelet ratio index in high alcohol intake,2139
22,Serum metabolite concentrations in chronic kidney disease [Proline],166
22,Fish- and plant-related diet,43495
22,"Blood protein levels [SHANK3, 13242_134_3]",1353
22,Atopic asthma,157235
22,Serum metabolite levels (CMS) [Cit],5375
22,White matter microstructure (fractional anisotropy) [Superior longitudinal fasciculus],197
22,Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),9827
22,BAFF-R on IgD+ CD38- B cell,11783
22,Cognitive aspects of educational attainment,86671
22,Guilty feelings,3899
22,Ever used hormone-replacement therapy (hrt),58203
22,Gout,4278
22,Myocardial infarction,2770
22,Age started wearing glasses or contact lenses,2063
22,Cheese intake,2384
22,Non-albumin protein levels,43047
22,Problematic alcohol use (MTAG),165656
22,IgG glycosylation [IGP49],9916
22,C-reactive protein levels [HIS],2870
22,Bin127 abundance in stool,874
22,Hypertrophic cardiomyopathy (MTAG),19704
22,Nonalcoholic fatty liver disease (imputed),12349
22,IgG glycosylation patterns [IgG2_G2FN/IgG2_G2F],1688
22,Hypothyroidism and >3 levothyroxin purchases,1743
22,Central corneal thickness,5642
22,Hematocrit [Hispanic/Latino],750
22,"""Benign neoplasm: Rectum, anus and anal canal (controls excluding all cancers)""",75
22,Chronic obstructive pulmonary disease x ever smoker interaction (2df),5054
22,High light scatter reticulocyte percentage of red cells,67040
22,Granulocyte count,4272
22,"Fracture nose | non-cancer illness code, self-reported",4151
22,Protein quantitative trait loci [TIMP-3],870
22,IgG glycosylation [IGP76],1460
22,Atrial fibrillation and flutter,1129
22,IgG sialylation phenotypes (multivariate analysis),8456
22,IgG glycosylation patterns [IgG1 BG0n total/G0n],10784
22,Type 2 diabetes [conditional],18323
22,Diacylglycerol_38:3_[M+H-H2O]1+ levels,2916
22,Arm fat percentage (right),180255
22,Trunk fat mass,80773
22,Mammographic density (dense area),4791
22,Cerebrospinal fluid sTREM-2 levels,1
22,Body fat percentage,384951
22,Birth weight,29423
22,Left ventricular internal dimension in systole,4984
22,Total protein levels x insomnia interaction,583
22,Platelet count,839672
22,Severity of nausea and vomiting of pregnancy,6401
22,Well-being spectrum (multivariate analysis),26450
22,IgG glycosylation patterns [IgG2 FBG2n/G2n],1680
22,Protein quantitative trait loci (liver) [EPHX1],41
22,Optic disc size,12997
22,"""Type 1 diabetes, wide definition, subgroup 1""",24648
22,Keratoconus,201
22,Appendicular lean mass,533874
22,IgG glycosylation patterns [IgG1 FBn/Fn total],10784
22,IgG glycosylation patterns [IgG1 FBn],10784
22,Eosinophil counts,1306856
22,Age-related hearing impairment (MTAG),5909
22,Protein quantitative trait loci (liver) [ATP5PO],136
22,KELA_REIMBURSEMENT_202,7766
22,IgG glycosylation patterns [IgG2 BG1n total/G1n],1460
22,Gut microbiota relative abundance (bacterial taxa) [Selenomonadales],391
22,FEV1,30063
22,Age-related hearing impairment (SNP x SNP interaction),2754
22,Oily fish consumption,48077
22,Neuronal pentraxin receptor levels,23561
22,"""Type 2 diabetes, definitions combined""",8856
22,Liver enzyme levels [GGT],2393
22,"Blood protein levels [TIMP4, 6462_12_3]",472
22,Glomerulosclerosis [AA],2049
22,Granulocyte percentage of myeloid white cells,8282
22,"Red blood cell traits [EA, MCH]",7341
22,Beef intake,48169
22,Mean spheric corpuscular volume,187068
22,Pattern 1 | hair/balding pattern,21001
22,BAFF-R on IgD+ CD24- B cell,11783
22,Iron status biomarkers (iron levels),2577
22,Electrocardiogram morphology (amplitude at temporal datapoints) [464 ms],79
22,Monocyte percentage of white cells,198722
22,Neutrophil-to-lymphocyte ratio,178572
22,Leg fat-free mass (right),25711
22,Leg predicted mass (right),25729
22,Mean sphered cell volume,88853
22,"Blood protein levels [LGALS2, 3033_57_1]",5747
22,Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals,643
22,White matter microstructure (radial diusivities) [Posterior thalamic radiation],155
22,Lymphocyte percentage,195603
22,IgG glycosylation patterns [IgG1_G0FN],8345
22,Protein quantitative trait loci (liver) [ATP5MG],136
22,Knee osteoarthritis,61
22,Electrocardiogram morphology (amplitude at temporal datapoints) [6 ms],19704
22,Impedance of arm (right),244374
22,Yes | hearing difficulty/problems,5351
22,Varicose veins,22935
22,Salt added to food,114
22,IgG glycosylation [IGP39],13652
22,"""Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523""",2139
22,General factor of neuroticism,90570
22,Type 2 diabetes and end-stage kidney disease,644
22,BAFF-R on unswitched memory B cell,11783
22,Forns index in high alcohol intake,6094
22,White matter microstructure (radial diusivities) [Splenium of corpus callosum],8119
22,Lung function (FEV1),6104
22,Testicular germ cell tumor,861
22,White matter microstructure (radial diusivities) [Uncinate fasciculus],197
22,Primary_lymphoid and hematopoietic malignant neoplasms (controls excluding all cancers),124
22,"Hepatitis | non-cancer illness code, self-reported",150
22,Body size at age 10,7300
22,Mean corpuscular haemoglobin,45680
22,IgG glycosylation [IGP68],9916
22,IgG glycosylation patterns [IgG2_G0FN/IgG2_G0F],10735
22,White matter microstructure (radial diusivities) [Superior corona radiata],197
22,Plasma free proline levels,465
22,Triacylglycerol(56:5)_[M+NH4]1+ levels,2916
22,Autoimmune traits,11264
22,Oily fish intake,32914
22,Urinary metabolite levels in chronic kidney disease [alpha-hydroxymetoprolol],40974
22,Glucose levels,1000
22,Mycobacteriaceae abundance in stool,561
22,Nonalcoholic steatohepatitis,2139
22,Glaucoma (multi-trait analysis),36595
22,Other disorders of ear,2878
22,Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test),452
22,Facial ageing,25601
22,Hematological and biochemical traits [Hb],3481
22,Allergy relief antihistamine 4mg tablet | treatment/medication code,820
22,High density lipoprotein cholesterol levels,80617
22,Vertex-wise cortical surface area,158528
22,Itch intensity from mosquito bite,2849
22,IgG glycosylation patterns [IgG1_G2FN/IgG1_G2F],8345
22,Alcohol-associated liver disease in light drinkers,2157
22,Graves' disease,5349
22,White matter microstructure (radial diusivities) [Genu of corpus callosum],7964
22,Leg fat-free mass (left),28721
22,Protein quantitative trait loci (liver) [ATP5F1B],136
22,Systemic atrophies primarly affecting the central nervous system,88
22,Smoking cessation,218511
22,C-reactive protein levels,214113
22,Type 2 diabetes with other specified/multiple/unspecified complications,1925
22,Childhood ear infection,722
22,"Heel bone mineral density (bmd) t-score, automated",94388
22,Trunk predicted mass,88447
22,Brain morphology (min-P),197
22,Gamma-glutamylglutamine levels,1725
22,Waist-to-hip ratio adjusted for body mass index,879
22,Serum total protein level,87310
22,Asthma x air pollution interaction (2df),279
22,Optic cup area,43250
22,Morning person,9314
22,IgG N-glycosylation phenotypes (multivariate analysis),20592
22,Fresh fruit intake,47752
22,Basophil count,263617
22,6mm strong meridian (right),27566
22,Apolipoprotein B levels,48309
22,Thyroid problem (not cancer),170915
22,Balding type 1,21001
22,IgA nephropathy [East Asian],6586
22,Diffuse large B-cell lymphoma or multiple sclerosis,5250
22,Thyrotoxicosis,1118
22,"Dark brown | hair colour (natural, before greying)",2531
22,Thyrotoxicosis with diffuse goitre,1263
22,Ocular sarcoidosis,2
22,IgG glycosylation patterns [IgG4_G0FN/IgG4_G0F],9055
22,Number of self-reported non-cancer illnesses,3724
22,Benign neoplasm of ovary,145
22,"Disorders of muscle, ligament, and fascia",553
22,Red blood cell count,444972
22,Diabetes or endocrine disease,2437
22,Executive function (trail making test B),22543
22,Spherical power (left),1437
22,Plasma free amino acid levels (adjusted for one other PFAA) [Ile (adjusted for Pro],465
22,Dentures,21561
22,Sum basophil neutrophil counts,25189
22,Tea consumption,13603
22,BAFF-R on CD20- CD38- B cell,11783
22,Glycated hemoglobin levels,38297
22,"Hypothyroidism/myxoedema | non-cancer illness code, self-reported",12286
22,Primary biliary cirrhosis,15622
22,Ascending aorta maximum area,840
22,Diabetes,1520
22,Waist circumference adjusted for body mass index [EA],427
22,Arm fat mass (right),37084
22,Fibrinogen levels,4059
22,Alanine transaminase levels in high alcohol intake,2262
22,Protein quantitative trait loci (liver) [MPC2],136
22,Body mass index,79491
22,Total bilirubin levels,25407
22,Been involved in combat or exposed to war-zone,5873
22,Left atrial total emptying fraction,79
22,"Heel quantitative ultrasound index (qui), direct entry (left)",72116
22,Trunk fat percentage,180229
22,Fibrosis-4 index in high alcohol intake,2564
22,Sarcoidosis,538
22,Sum eosinophil basophil counts,183880
22,Fibrinogen [EA],1319
22,Bipolar disorder or major depressive disorder,32198
22,Serous invasive ovarian cancer,14305
22,Tongue abnormality,83
22,Processed meat intake,138047
22,Type 2 diabetes (adjusted for BMI),24364
22,Systemic lupus erythematosus [EA],7143
22,Serum phosphate levels,22638
22,Plasma free amino acid levels (adjusted for one other PFAA) [Tyr (adjusted for Pro],465
22,IgG glycosylation patterns [IgG1_G0FNn],8345
22,"Heel quantitative ultrasound index (qui), direct entry",94388
22,Whole body fat mass,85400
22,White matter microstructure (radial diusivities) [Sagittal stratum],197
22,Smoking status,28572
22,Alcohol consumption (drinks per week),467523
22,Lymphocyte-to-monocyte ratio,176195
22,IgG glycosylation [IGP67],10402
22,Osteoprotegerin levels,2916
22,Brain region volumes [left ventral DC],1154
22,Urinary metabolite levels in chronic kidney disease [X - 12707],1103
22,Low density lipoprotein cholesterol levels,126360
22,Age at menopause (last menstrual period),58037
22,Serum levels of protein APOL1,715
22,Comamonas abundance in stool,18
22,Ovarian cyst,127
22,Smoking status (ever vs never smokers),26587
22,Urinary metabolite levels in chronic kidney disease [gamma-glutamyl-epsilon-lysine],3024
22,Body mass index [Japanese],2982
22,Neuritic plaques (SNP x SNP interaction),271
22,"Number of operations, self-reported",17026
22,White matter microstructure (fractional anisotropy) [Splenium of corpus callosum],8910
22,Faecalicatena sp002161355 abundance in stool,413
22,"Dupuytren's contracture | non-cancer illness code, self-reported",426
22,HDL cholesterol levels [Trans-ethnic initial],9642
22,Type 1 diabetes with ophthalmic complications,24836
22,Age-related macular degeneration,3544
22,Electrocardiogram morphology (amplitude at temporal datapoints) [-4 ms],19704
22,IgG glycosylation patterns [IgG2_G2FN(10)/(IgG1_G2FN(10) + IgG2_G2FN(10) +IgG4_G2FN(10],9055
22,Arm fat-free mass (left),39812
22,Nonalcoholic fatty liver disease [GOLD],2139
22,Comparative height size at age 10,37342
22,Total PHF-tau (SNP x SNP interaction),12661
22,Serum levels of protein PRRG1,1544
22,Lymphocyte percentage of white cells,379322
22,"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) [subset analysis]",40983
22,Serum alkaline phosphatase levels,109849
22,Serum interleukin-6 concentration in active individuals,8650
22,Protein quantitative trait loci [IL-17 sR],493
22,"Diastolic blood pressure, automated reading",190
22,"""Universal eryhrodermia, KELA reimbursement""",80
22,Systolic blood pressure x alcohol consumption interaction (2df test) [AA],113
22,Cutaneous nevi,22601
22,Metabolic biomarkers (multivariate analysis),180563
22,Sleep duration (short sleep),9055
22,Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis),29027
22,Tea intake,72583
22,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),427
22,Hematology traits [HGB],133
22,Optic cup area [EA],1519
22,"""Other noninflammatory disorders of uterus, except cervix""",6
22,Left-handedness,7771
22,Alcohol-associated liver disease in heavy drinkers,2619
22,Brain region volumes [left fusiform],1154
22,IgG glycosylation [IgG1G0N],8456
22,Adult body size,16839
22,"Blood protein levels [RTN4R, 5105_2_3]",217
22,"Allergic disease (asthma, hay fever or eczema)",314647
22,Spherical equivalent or myopia (age of diagnosis),11434
22,Birth length (MTAG),1480
22,Self-reported math ability (MTAG) [MTAG],176481
22,Chronotype,57296
22,Estimated glomerular filtration rate in non-diabetics,22554
22,Sex hormone-binding globulin levels,554748
22,Blood metabolite levels [X-01911],1103
22,"""Malignant neoplasm of breast, HER-positive""",75
22,Varicose veins of other sites,19
22,Ulcerative colitis,36323
22,White matter microstructure (fractional anisotropy) [Genu of corpus callosum],7964
22,3mm strong meridian (right),1392
22,No | hearing difficulty/problems,5351
22,Leg fat mass (right),25149
22,Triacylglycerol_56:6_[M+NH4]1+ levels,2139
22,Liver iron content,750
22,Atrial fibrillation/atrial flutter,42
22,Cirrhosis (multi-trait analysis),2174
22,"""Malignant neoplasm of breast, HER-positive (controls excluding all cancers)""",75
22,"Black | hair colour (natural, before greying)",21
22,Moyamoya disease,1158
22,IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis),9916
22,Macular thickness,28312
22,Caffeine consumption from coffee or tea,79207
22,IgG glycosylation [IGP69],1460
22,Gamma glutamyl transferase levels in low alcohol consumption,3530
22,Other and unspecified spinal muscular atrophies,95
22,Protein quantitative trait loci (liver) [GSTT2B],34990
22,Protein quantitative trait loci (liver) [MYO1B],12
22,Cognitive ability (MTAG),3791
22,Plasma free amino acid levels (adjusted for one other PFAA) [Ala (adjusted for Pro],465
22,Mean arterial pressure [East Asian],3361
22,End-stage renal disease (non-diabetic),440
22,IgG glycosylation patterns [IgG1 BG1n total/G1n],10784
22,Direct low density lipoprotein cholesterol levels,23810
22,Aspartate aminotransferase levels [Asian],2139
22,Aspartate transaminase levels in high alcohol intake,2139
22,Electrocardiogram morphology (amplitude at temporal datapoints) [418 ms],79
22,HDL cholesterol,105514
22,Intraocular pressure,182526
22,Estimated glomerular filtration rate,189882
22,Hypothyroidism or myxedema,171229
22,Basophill percentage,5395
22,Smoking initiation,2988
22,Hepcidin/transferrin saturation ratio [Subset],750
22,IgG glycosylation patterns [IgG1_G1FN],10735
22,Left | usual side of head for mobile phone use,125410
22,BAFF-R on IgD- CD27- B cell,11783
22,"""Malignant neoplasm of breast, HER2-negative""",734
22,Urate levels [men],2519
22,Vitamin b1 preparation | treatment/medication code,1017
22,Serum levels of protein RRM1,9081
22,Dilated cardiomyopathy (MTAG),19704
22,Alcoholic liver disease,4278
22,IgG glycosylation [IGP75],1460
22,Episodic memory (pairs-matching),747
22,Public transport | types of transport used (excluding work),570
22,Medication use (drugs used in diabetes),1938
22,Serum metabolite levels [X-01911],1103
22,Electrocardiogram morphology (amplitude at temporal datapoints) [432 ms],79
22,IgG glycosylation patterns [IgG1 Fn/Bn total],10784
22,Total cholesterol levels [EA],2139
22,Morning/evening person (chronotype),3223
22,Chronic liver disease and cirrhosis,2139
22,Mean corpuscular volume [EA],133
22,Venous thromboembolism (SNP x SNP interaction),30
22,GIP levels in response to oral glucose tolerance test (120 minutes),17291
22,IgG glycosylation patterns [IgG4_G2FN/IgG4_G2F],9055
22,"Blood protein levels [APOBEC3G, 13930_3_3]",4128
22,Atrial fibrillation,161
22,Hip circumference adjusted for BMI,69537
22,White matter microstructure (mode of anisotropy) [Superior corona radiata],22695
22,Uterine fibroids (MTAG),6086
22,White matter microstructure (fractional anisotropy) [Body of corpus callosum],20440
22,Total triglycerides levels,5036
22,IgG glycosylation patterns [IgG2 Bn total],1460
22,"Blood protein levels [TPST2, 8024_64_3]",162
22,Left ventricular global radial strain,19704
22,Gynecologic disease,4678
22,Relative age of first facial hair,14453
22,Femur bone mineral density x serum urate levels interaction [male],1837
22,Vitamin D levels,385
22,Cancer (pleiotropy),311
22,"Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event) [Recessive, Mixture cure model]",22
22,Pediatric non-alcoholic fatty liver disease activity score,5073
22,Ulcerative colitis [EA],20119
22,Arm predicted mass (right),34545
22,Nasal polyps,415
22,Electrocardiogram morphology (amplitude at temporal datapoints) [-22 ms],79
22,Primary sclerosing cholangitis,232
22,Cystatin C levels,64832
22,Hypertension,9750
22,Sodium in urine,7465
22,"""Benign neoplasm of colon, rectum, anus and anal canal (controls excluding all cancers)""",75
22,Hypothyroidism nos,12286
22,Amino acid levels [Proline],98
22,Total cholesterol levels [Trans-ethnic initial],7841
22,Glomerular filtration rate,9039
22,Mean corpuscular hemoglobin concentration [Asian],750
22,Intelligence,53633
22,Plateletcrit,176431
22,Cognitive ability,44031
22,Male puberty timing (early vs. average onset voice breaking),14088
22,"""Carcinoma in situ of breast, intraductal (controls excluding all cancers)""",106
22,Ovarian dysfunction,127
22,Red cell distribution width,414810
22,Neuropsychiatric disorders,493
22,Binge eating behaviour in bipolar disorder,1447
22,Serum creatinine levels,68851
22,Duration to first press of snap-button in each round,106
22,Spleen volume,6554
22,"Forced expiratory volume in 1-second (fev1), predicted",21915
22,Leg predicted mass (left),28758
22,Monocyte percentage,7020
22,Serotransferrin measurement,1020
22,Benign neoplasm of meninges,10914
22,Coffee consumption (cups per day),2348
22,Cardiometabolic and hematological traits [PLT],425
22,"""Hypothyroidism, levothyroxin purchases""",1743
22,Phosphatidylglycerol(32:1)_[M+OAc]1- levels,66
22,Bitter alcoholic beverage consumption,155914
22,Hemoglobin A1c levels,139122
22,Malignant neoplasm of thyroid gland,82
22,Caffeine consumption from tea,158585
22,Urinary metabolite levels in chronic kidney disease [gamma-glutamylleucine],3024
22,Arm fat percentage (left),86193
22,Blood urea nitrogen levels,4501
22,Serum levels of protein MMRN2,870
22,DNA methylation-estimated plasminogen activator inhibitor-1 levels,7974
22,High density lipoprotein cholesterol levels [conditional],2192
22,Vitiligo,317578
22,Current tobacco smoking,167119
22,IgG glycosylation patterns [IgG2_G1FN(10)/IgG4_G1FN],8996
22,IgA nephropathy,21748
22,Metabolite levels [Citrate],6101
22,Liver fat content (MRI proton density fat fraction measure),2139
22,Lamb consumption,53714
22,Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels) [S-DDCT concentration],69783
22,Respiratory or ear-nose-throat disease,55775
22,Hematological parameters [MCV],6347
22,Myocardial infarction [additive model],5907
22,"""Cholelithiasis, broad definition with cholecystitis""",1003
22,Interleukin-10 levels [AA],847
22,Verbal-numerical reasoning,84783
22,Asthma (childhood onset),157402
22,Diacylglycerol_38:5_[M+H-H2O]1+ levels,3048
22,Nonsyndromic cleft lip with cleft palate,4055
22,Protein quantitative trait loci (liver) [ATP5PB],136
22,Schizophrenia vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),40053
22,Certain disorders involving the immune mechanism,269
22,Systolic blood pressure,145028
22,Mood instability,22128
22,Colon cancer,14667
22,Mean arterial pressure,44677
22,Cardiovascular disease,3266
22,Haemoglobin concentration,88211
22,Hematological parameters [MCH],2906
22,Sleep duration (> 10 hours),344
22,Leiomyoma of uterus (controls excluding all cancers),726
22,Body fat percentage [men],14712
22,Low testosterone levels,2139
22,White matter microstructure (mean diusivities) [Posterior thalamic radiation],155
22,"Blood protein levels [EA, Interleukin-17 receptor A]",501
22,"Blood protein levels [CSF2RB, 10512_13_3]",293
22,Electrocardiogram morphology (amplitude at temporal datapoints) [-6 ms],19704
22,Hypothyroidism (congenital or acquired),1630
22,Handedness (left-handed vs. right-handed),72
22,Self-reported math ability,92694
22,6mm weak meridian (right),27278
22,Urinary calculus,3606
22,Townsend deprivation index at recruitment,1470
22,Waist-to-hip ratio adjusted for BMI in active individuals [EA],427
22,Metabolite levels [Hex2Cer d18:1/24:0],6968
22,Brugada syndrome,79
22,Estradiol levels,57
22,Creatinine levels,22262
22,Leg fat percentage (right),31912
22,Hematological and biochemical traits [GGT],34
22,Urinary albumin-to-creatinine ratio,22599
22,Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],20634
22,Serum urea levels,6535
22,BAFF-R on IgD+ CD38dim B cell,11783
22,White matter hyperintensity volume,86
22,4-chlorobenzoic acid levels,1253
22,Serum levels of protein CSF2RB,293
22,Bipolar disorder (MTAG),79840
22,Mood swings,26194
22,Serum levels of protein SCP2D1,3094
22,Metabolite levels [ALT],5037
22,N-glycan levels [plasma glycan peak 63],1370
22,Hereditary monor and sensory neuropathy,15
22,IgG glycosylation [IGP34],8456
22,Triacylglycerol(56:6)_[M+NH4]1+ levels,2916
22,Catechol O-methyltransferase measurement,1103
22,HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) [EA],30272
22,IgG glycosylation [IGP72],9916
22,Age when periods started (menarche),10182
22,Iron status biomarkers (total iron binding capacity),750
22,Medication use (antihypertensives),2716
22,IgG glycosylation patterns [IgG2 Bisecting_GlcNAc],1460
22,Depressive symptoms (MTAG),93765
22,Vertical cup-disc ratio (adjusted for vertical disc diameter),14881
22,6mm weak meridian (left),27443
22,Fat-free mass [female],8942
22,"Waist-hip ratio [EA, women]",452
22,Feeling nervous,17410
22,IgG glycosylation [IGP14],1460
22,Wilms tumor,1703
22,Myeloproliferative diseases,203
22,Cholelithiasis,62733
22,Butter/spreadable butter | spread type,90170
22,White matter microstructure (mean diusivities) [Sagittal stratum],155
22,High light scatter reticulocyte count,136766
22,IgG glycosylation patterns [IgG4_G0FNn],8345
22,Chronic lymphocytic leukemia,5250
22,X-21286 levels,776
22,Crohn's disease,61527
22,Asthma (time to event),157812
22,Tense / 'highly strung',58029
22,Whole body fat-free mass,26830
22,Peak expiratory flow (pef),12583
22,Household income (MTAG),5231
22,"""Inflammatory bowel disease, strict (require KELA)""",3221
22,Serum levels of protein TPST2,430
22,Electrocardiogram morphology (amplitude at temporal datapoints) [446 ms],79
22,Electrocardiogram morphology (amplitude at temporal datapoints) [-18 ms],79
22,Peak expiratory flow,61411
22,"Blood protein levels [PLXNB2, 9216_100_3]",12572
22,Schizophrenia [EA],36022
22,Hematological and biochemical traits [Hemoglobin],3481
22,Neurological blood protein biomarker levels [SCARF2],1303
22,Neuroticism,245705
22,Amyotrophic lateral sclerosis,6980
22,"""Atopic  dermatitis, strict definition""",615
22,Pancreas volume,318
22,Psoriasis,9786
22,Breast size,5916
22,NADPH--cytochrome P450 reductase measurement,2482
22,Adhesive capsulitis of shoulder,99
22,Factor VIII levels,2390
22,Constipation,620
22,Anthropometric traits (multi-trait analysis),322
22,Distance between home and job workplace,536
22,Pre-treatment viral load in HIV-1 infection,32
22,Chlamydia trachomatis momp D antibody levels,18989
22,Other chronic nonalcoholic liver disease,2139
22,Electrocardiogram morphology (amplitude at temporal datapoints) [468 ms],79
22,Irritable mood,42802
22,Hypertrophic cardiomyopathy,19704
22,Testosterone levels,19186
22,Glaucoma (primary open-angle) [European],7584
22,White matter microstructure (mean diusivities) [Posterior corona radiata ],20225
22,Senokot 7.5mg tablet | treatment/medication code,2347
22,Iron status biomarkers [MCV],750
22,Intrinsic epigenetic age acceleration,462
22,Cognitive performance,87017
22,Neurociticism,56044
22,Protein quantitative trait loci (liver) [COMT],750
22,Chronic obstructive pulmonary disease in non-current smokers,5054
22,Chronic obstructive pulmonary disease,554
22,Follicular cysts of skin and subcutaneous tissue,37
22,Processed meat consumption,17887
22,BAFF-R on IgD+ B cell,11783
22,Triacylglycerol_56:7_[M+NH4]1+ levels,909
22,CD19 on IgD- CD38dim B cell,168
22,Electrocardiogram morphology (amplitude at temporal datapoints) [-14 ms],79
22,Inflammatory bowel disease (early onset),10861
22,Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels) [S-DDCT/S-DCT ratio],40134
22,Iron  | vitamin and/or mineral supplement use,594
22,Feeling worry,13008
22,Average total household income before tax,22477
22,Esophageal cancer and gastric cancer [ESCC],1321
22,Protein quantitative trait loci (liver) [AKR7A3],108
22,IgG glycosylation patterns [IgG2 FBG0n/G0n],10735
22,High light scatter reticulocyte percentage,30869
22,Protein quantitative trait loci (liver) [CPT2],3209
22,Iron levels,1020
22,Age at menopause,63477
22,Mean corpuscular hemoglobin concentration,145187
22,White matter microstructure (radial diusivities) [Superior longitudinal fasciculus],20225
22,Urinary metabolite levels in chronic kidney disease [X - 22162],17956
22,TPE interval (resting) [women],792
22,Plasma free amino acid levels (adjusted for one other PFAA) [Pro (adjusted for Phe],465
22,Lymphocyte count,22357
22,Inflammatory bowel disease [EA],17450
22,Portal hypertension,2139
22,vWF and FVIII levels,1319
22,"Blood protein levels [PTHLH, 2962_50_2]",26
22,Alcohol consumption (drinks per week) (MTAG),326739
22,IgG glycosylation [IGP62],9916
22,IgG glycosylation patterns [IgG4_G2FNn],9055
22,Interstitial lung disease endpoints,7365
22,Hip bone size,1626
22,CD20 on IgD+ CD38dim B cell,9045
22,Diabetic ketoacidosis,12683
22,Bone mineral content [right arm],543
22,Multiple sclerosis,18592
22,Serum 25-Hydroxyvitamin D levels,150182
22,Coffee intake,6313
22,Neurofibrillary tangles (SNP x SNP interaction),8564
22,Malignant neoplasm of thyroid gland (controls excluding all cancers),82
22,Insomnia,26532
22,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),30682
22,Serum levels of protein MIF,32191
22,Benign neoplasm: Rectum (controls excluding all cancers),292
22,Electrocardiogram morphology (amplitude at temporal datapoints) [-2 ms],19704
22,Serum metabolite levels [cysteine-glutathione disulfide],3662
22,Hot drink temperature,784
22,Sensitivity to environmental stress and adversity,53504
22,Subcortical volume (MOSTest),24526
22,"Heel bone mineral density (bmd) t-score, automated (left)",71894
22,Iron status biomarkers (transferrin saturation),2250
22,IgG glycosylation patterns [IgG2 FBn],1460
22,Electrocardiogram morphology (amplitude at temporal datapoints) [-24 ms],79
22,"Blonde | hair colour (natural, before greying)",11780
22,"Heel broadband ultrasound attenuation, direct entry",20521
22,Triacylglycerol 56:6 levels,2916
22,Low tan response,997
22,Red blood cell traits [MCV],750
22,Worry,56324
22,Cortical thickness [Postcentral],1518
22,IgG glycosylation [IGP66],9916
22,White matter microstructure (fractional anisotropy) [Posterior limb of internal capsule],2977
22,Hypothyroidism,189870
22,Left ventricular global circumferential strain,19704
22,Anxiety,26438
22,IgG galactosylation phenotypes (multivariate analysis),9916
22,Glaucoma,7691
22,Medication use (HMG CoA reductase inhibitors),31589
22,Plasma free amino acid levels (adjusted for one other PFAA) [Thr (adjusted for Pro],465
22,GLP-1 levels in response to oral glucose tolerance test (120 minutes),17291
22,"Red blood cell traits [EA, MCV]",14692
22,X-22162 levels,28389
22,IgG disialylation phenotypes (multivariate analysis),8456
22,Serum levels of protein IL17RA,1985
22,HDL cholesterol x physical activity interaction (2df test),9804
22,BAFF-R on IgD+ CD38+ B cell,11783
22,Pediatric asthma,154032
22,Weight,106841
22,Serum levels of protein SHANK3,1319
22,Diffuse plaques (SNP x SNP interaction),883
22,White matter microstructure (fractional anisotropy) [Retrolenticular part of internal capsule],197
22,Trunk fat-free mass,84824
22,"""Malignant neoplasm of breast, HER-negative (controls excluding all cancers)""",98
22,Genitourinary diseases,115
22,"""Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO) , including avohilmo""",74
22,White blood cell count (monocyte),404
22,Handedness (Left-handed vs. non-left-handed),72
22,Optic disc area,16264
22,Lung function (FEV1/FVC),169264
22,Impedance of arm (left),196940
22,TPE interval (resting) [men],792
22,Optic disc area [Asian],6748
22,Breast cancer (estrogen-receptor negative),5937
22,Bioavailable testosterone levels,34216
22,Basal metabolic rate,24629
22,Age completed full time education,105
22,Mean platelet volume,529998
22,Lung function (FVC),77276
22,Leisure sedentary behaviour (television watching),45702
22,Reticulocyte fraction of red cells,70956
22,Myeloid white cell count,5827
22,"Icd10: c43.9 malignant melanoma of skin, unspecified | underlying (primary) cause of death",343
22,Urinary sodium excretion [EA],12478
22,A body shape index,84974
22,Electrocardiogram morphology (amplitude at temporal datapoints) [2 ms],19704
22,Nonalcoholic steatohepatitis-derived hepatocellular carcinoma,5073
22,Electrocardiogram morphology (amplitude at temporal datapoints) [444 ms],79
22,"Cholesterol, total",33378
22,IgG glycosylation [IGP9],9916
22,Red blood cell traits [MCHC],1020
22,Left ventricular mass to end-diastolic volume ratio,19777
22,Mitochondrial DNA levels,4420
22,IgG glycosylation patterns [IgG2_G1FN/IgG2_G1F],1460
22,Invasive breast cancer [mixed effect],428
22,"""Carcinoma in situ of breast, intraductal""",322
22,Neoclarityn 5mg tablet | treatment/medication code,165
22,acne vulgaris,50176
22,IgG glycosylation patterns [IgG1 FG0n/G0n],17511
22,"Heel quantitative ultrasound index (qui), direct entry (right)",109858
22,Heel bone mineral density x serum urate levels interaction [female],377
22,Regular attendance at a pub or social club,228
22,Eczema,166297
22,Leg fat percentage (left),14628
22,"Asthma | non-cancer illness code, self-reported",148094
22,Blood metabolite levels [uridine],3499
22,"Urinary metabolite modules (eigenmetabolites) in chronic kidney disease [gamma-glutamyl-epsilon-lysine, gamma-glutamylglycine, gamma-glutamylhistidine, gamma-glutamylleucine, gamma-glutamylphenylalanine, gamma-glutamylthreonine, tryptamine, tyramine, X-23593]",3024
22,Pulse wave arterial stiffness index,118
22,Polymyalgia rheumatica,60
22,Breast cancer,119274
22,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),1901
22,Palmar fascial fibromatosis [Dupuytren],400
22,Type 2 diabetes,228791
22,Serum linoleic acid concentration in metabolic syndrome,478
22,Comparative body size at age 10,4893
22,6mm strong meridian (left),27314
22,IgG glycosylation patterns [IgG2 FBG1n/G1n],1460
22,"2,3-dihydroxy-2-methylbutyrate levels",2685
22,Clinical laboratory measurements [hemoglobin concentration],750
22,Myocardial fractal dimension (slice 6),1945
22,Male puberty timing (age at voice breaking MTAG),14088
22,Nonalcoholic fatty liver disease,41001
22,Protein quantitative trait loci (liver) [FERMT2],71
22,Menopause (age at onset),58093
22,Highest math class taken,159341
22,"Medication use (adrenergics, inhalants)",10068
22,Insulin-like growth factor 1 levels,697928
22,Electrocardiogram morphology (amplitude at temporal datapoints) [4 ms],19704
22,Triglyceride levels x short total sleep time interaction (2df test),2537
22,Alcoholic liver damage,2139
22,Alanine transaminase levels,5036
22,IgG glycosylation patterns [IgG4_G1FN(10)/(IgG1_G1FN(10) + IgG2_G1FN(10) +IgG4_G1FN(10],8996
22,Ascending aorta minimum area,840
22,Autoimmune thyroid disease,1425
22,Blood metabolite levels [X-12749],679